DOI_cited	article_citing
10.1104/pp.011019	"<html><body><article article-type=""research-article"" xml:lang=""en"" xmlns:mml=""http://www.w3.org/1998/Math/MathML"" xmlns:xlink=""http://www.w3.org/1999/xlink""><?properties open_access?><front><journal-meta><journal-id journal-id-type=""nlm-ta"">BMC Complement Altern Med</journal-id><journal-id journal-id-type=""iso-abbrev"">BMC Complement Altern Med</journal-id><journal-title-group><journal-title>BMC Complementary and Alternative Medicine</journal-title></journal-title-group><issn pub-type=""epub"">1472-6882</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type=""pmid"">23819459</article-id><article-id pub-id-type=""pmc"">3718714</article-id><article-id pub-id-type=""publisher-id"">1472-6882-13-155</article-id><article-id pub-id-type=""doi"">10.1186/1472-6882-13-155</article-id><article-categories><subj-group subj-group-type=""heading""><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Antioxidant and anti-dermatophytic properties leaf and stem bark of<italic>Xylosma longifolium</italic>clos</article-title></title-group><contrib-group><contrib contrib-type=""author"" id=""A1""><name><surname>Devi</surname><given-names>Wangkheirakpam Radhapiyari</given-names></name><xref ref-type=""aff"" rid=""I1"">1</xref><email>radhawang@gmail.com</email></contrib><contrib contrib-type=""author"" id=""A2""><name><surname>Singh</surname><given-names>S Brojendro</given-names></name><xref ref-type=""aff"" rid=""I1"">1</xref><email>brojensagolsem@gmail.com</email></contrib><contrib contrib-type=""author"" corresp=""yes"" id=""A3""><name><surname>Singh</surname><given-names>Chingakham B</given-names></name><xref ref-type=""aff"" rid=""I1"">1</xref><email>kishore.ibsd@nic.in</email></contrib></contrib-group><aff id=""I1""><label>1</label>Medicinal and Horticultural Plant Resources Division, Institute of Bioresources and Sustainable Development, Imphal 795001, Manipur, India</aff><pub-date pub-type=""collection""><year>2013</year></pub-date><pub-date pub-type=""epub""><day>2</day><month>7</month><year>2013</year></pub-date><volume>13</volume><fpage>155</fpage><lpage>155</lpage><history><date date-type=""received""><day>17</day><month>8</month><year>2012</year></date><date date-type=""accepted""><day>2</day><month>5</month><year>2013</year></date></history><permissions><copyright-statement>Copyright © 2013 Devi et al.; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2013</copyright-year><copyright-holder>Devi et al.; licensee BioMed Central Ltd.</copyright-holder><license license-type=""open-access"" xlink:href=""http://creativecommons.org/licenses/by/2.0""><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type=""uri"" xlink:href=""http://creativecommons.org/licenses/by/2.0"">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href=""http://www.biomedcentral.com/1472-6882/13/155""></self-uri><abstract><sec><title>Background</title><p>The present study was carried out to assess the phytochemical and anti-dermatophytic effect of the leaf and bark extracts of<italic>Xylosma longifolium</italic>Clos. The leaf and stem bark are used by the indigenous people of Manipur, India for treatment of skin diseases.</p></sec><sec><title>Methods</title><p>The leaves and stem barks of<italic>Xylosma longifolium</italic>were extracted using petroleum ether, chloroform and methanol respectively. The different extracts of each plant parts were tested for antioxidant activity using DPPH assay. The phenolic content was assayed using Folin-Ciocalteu colorimetric method. Each extracts was further analysed by RP-HPLC to quantify some individual flavonoid components. The anti-dermatophytic activity was evaluated both by agar diffusion method and micro wells dilution method against the<italic>Microsporum boullardii</italic>MTCC 6059,<italic>M. canis</italic>(MTCC 2820 and MTCC 32700),<italic>M. gypseum</italic>MTCC 2819,<italic>Trichophyton ajelloi</italic>MTCC 4878,<italic>T. rubrum</italic>(MTCC 296 and MTCC 3272).</p></sec><sec><title>Results</title><p>The free radical scavenging activity values were ranged from 0.7 to 1.41 mg/ml and 0.6 to 1.23 mg/ml, respectively for leaf and stem bark extracts. The amount of total phenolic contents of the extracts occurred in both leaf and bark in the range of 12 to 56.6 mg GAE/100 g and 16 to 58 mg GAE/100 g respectively. RP-HPLC analysis for flavonoids revealed the presence of two major flavonoid compounds, rutin and catechin. Kaempferol was in trace or absent. Methanol leaf extract showed significant low inhibitory effect against tested fungus<italic>Trichophyton ajelloi</italic>MTCC 4878 (0.140625 mg/ml) as the most sensitive. These finding suggest that the methanol leaf extract tested contain compounds with antimicrobial properties.</p></sec><sec><title>Conclusion</title><p>The results of our study may partially justify the folkloric uses on the plant studied and further provide an evidence that the leaf extract of<italic>Xylosma longifolium</italic>might be indeed a potential sources of antimicrobial agents.</p></sec></abstract><kwd-group><kwd><italic>Xylosma Longifolium</italic></kwd><kwd>Phenolic</kwd><kwd>Flavonoid</kwd><kwd>Antioxidant</kwd><kwd>RP-HPLC</kwd><kwd>Anti-Dermatophytic</kwd></kwd-group></article-meta></front><sec><title>Background</title><p>Medicinal plants are known to be sourced of diverse nutrients and non-nutrient molecules. Many of the medicinal plants display antioxidant and antimicrobial properties which can protect the human body against both cellular oxidation reactions and pathogens. Antioxidants are vital substances which possess the ability to protect the body from damage caused by free radical induced oxidative stress [<xref ref-type=""bibr"" rid=""B1"">1</xref>]. There is an increasing interest in natural antioxidants, e.g., polyphenols, present in medicinal and dietary plants, which might help to prevent oxidative damage [<xref ref-type=""bibr"" rid=""B2"">2</xref>]. The presence of phenolic compounds (phenolic acids, polyphenols and flavonoids) in plants, herbs and spices, is gaining increasing attention because of their various functions, such as antioxidant activity and health benefits [<xref ref-type=""bibr"" rid=""B3"">3</xref>]. Thus, it is important to characterize different types of medicinal plants for their antioxidant and antimicrobial potentiality [<xref ref-type=""bibr"" rid=""B4"">4</xref>-<xref ref-type=""bibr"" rid=""B6"">6</xref>]. Medicinal plants are known to produce certain bioactive molecules which are responsible for their antimicrobial properties [<xref ref-type=""bibr"" rid=""B7"">7</xref>-<xref ref-type=""bibr"" rid=""B10"">10</xref>]. The substances that can inhibit pathogens and have little toxicity to host cells are considered as candidates for developing new antimicrobial drugs.</p><p>The incidence of dermatophytic infections has increased considerably during the past several decades [<xref ref-type=""bibr"" rid=""B11"">11</xref>]. Dermatophytes are responsible for serious human pathogenic disorders in various parts of the world. Although control measures are available, they have limited effectiveness. Conventional antifungal agents such as chlorohexidine and imidazole derivatives have limited uses. Due to their common side effects such as hepatotoxicity, nausea, diarrhoea and impotency [<xref ref-type=""bibr"" rid=""B12"">12</xref>], the use is restricted in pregnant and the young people.</p><p>In order to identify and develop the novel antimicrobial agent, a number of essential oils and extracts have been investigated extensively to achieve higher levels of human safety standards [<xref ref-type=""bibr"" rid=""B13"">13</xref>,<xref ref-type=""bibr"" rid=""B14"">14</xref>]. The screening of such natural products may offer potential resources since their use is widespread.</p><p><italic>Xylosma longifolium</italic>Clos. (Flacourtiaceae) is a medium sized tree, distributed in subtropical Himalaya, North-East India and East to West China. In India,<italic>X. longifolium</italic>is grown for its edible fruits [<xref ref-type=""bibr"" rid=""B15"">15</xref>], used in Assam, for intoxication, and also exhibits antispasmodic, dysentery, restlessness and insomnia [<xref ref-type=""bibr"" rid=""B15"">15</xref>,<xref ref-type=""bibr"" rid=""B16"">16</xref>] and also in Manipur, the fresh leaf and stem bark extracts is also used for curing ringworm, scabies and acne in folk medicine [<xref ref-type=""bibr"" rid=""B17"">17</xref>].</p><p>Medicinal substances from plant species of genus<italic>Xylosma</italic>exhibit antispasmodic, narcotic, and sedative [<xref ref-type=""bibr"" rid=""B18"">18</xref>] and against spider bites [<xref ref-type=""bibr"" rid=""B19"">19</xref>]. Methanol leaf, stem and root of<italic>X. terrae-reginae</italic>show antioxidant activity (IC<sub>50</sub>) from 10, 9.7 and 10.5 μg/ml respectively [<xref ref-type=""bibr"" rid=""B20"">20</xref>]. The root extract of<italic>X. terrae-reginae</italic>, the fractions of the leaves and barks of the roots of<italic>X. ciliatifolium</italic>and methanol leaf extract<italic>X. congestum</italic>result antibacterial activity [<xref ref-type=""bibr"" rid=""B20"">20</xref>-<xref ref-type=""bibr"" rid=""B23"">23</xref>]. Two new glucosides, 3-methoxy-4-hydroxyphenylpropane-7, 8-(6′-benzoyl-2′, 1′-O-β-glucopyranosyl)-7, 8, 9-trio, and 2-hydroxyphenyl-4-caffeoyl-β-d-glucoside, together with seven known compounds are isolated from the stem bark of<italic>X. longifolia</italic>and 8-hydroxy-6-methoxy-pentylisocoumarin exhibits against<italic>Mycobacterium tuberculosis</italic>[<xref ref-type=""bibr"" rid=""B24"">24</xref>]. The methanolic extract of the leaves of<italic>X. longifolium</italic>isolate β-sitosterol, β-amyrin, friedelin, olean-12-en-3α-ol-28-oic acid 3α-D-glucopyranoside [<xref ref-type=""bibr"" rid=""B25"">25</xref>], flavonoid kaempferol-3-β-xylopyranoside-4’-α-rhamnoside [<xref ref-type=""bibr"" rid=""B26"">26</xref>]. The aqueous and alcoholic leaf extracts of<italic>X.longifolium</italic>was investigated against bacterial and fungal strains [<xref ref-type=""bibr"" rid=""B26"">26</xref>].</p><p>There is no information available regarding the utilization of<italic>X. longifolium</italic>as a source of anti-dermatophytes. Therefore, the present objectives of this study are to evaluate its leaf and barks extracts for anti-dermatophytic properties which is used in folk medicine in Manipur, India as well as to find its chemical profiles such as total phenol, antioxidants and its flavonoids using three organic solvents with different polarity (petroleum ether, chloroform and methanol) for extraction.</p></sec><sec sec-type=""methods""><title>Methods</title><sec><title>Plant materials</title><p>The stem barks and leaves<italic>X. longifolium</italic>were collected from Imphal, Manipur, India. The plant material was identified by Botanical Survey of India, Kolkata and the herbarium voucher sample (WR234) was deposited in the Departmental Herbarium.</p></sec><sec><title>Plant extract</title><p>500 g of shade-dried pulverized plant materials were subjected to extraction in a Soxhlet apparatus successively with petroleum ether, chloroform and methanol, the volume of each solvent was 6 times the volume of plant extract. For each solvent, extraction was conducted until no more coloured matter was extracted. Solvent from each extracted mixture was evaporated to dryness using a rotary evaporator under reduce pressure at 40°C. All dried extracts were then kept in tightly fitting stopper bottles and stored in −4°C.</p></sec><sec><title>Determination of total phenolic contents</title><p>The total phenolic content (TPC) in the extracts was determined by the Folin-Ciocalteu colorimetric method given by Singleton &amp; Rossi [<xref ref-type=""bibr"" rid=""B27"">27</xref>]. Different concentrations of extracts were mixed with 1.0 ml of 10 fold diluted Folin-Ciocalteu reagent and 1 ml of saturated sodium carbonate solution. After allowing it to stand for 30 min at 30°C, the absorbance was measured at 725 nm with a UV-Visible spectrophotometer (Multiskan Spectrum, Thermo Scientific). Standard curve of gallic acid solution (10, 20, 40, 60, 80 and 100 ppm) was prepared using the similar procedure. Total phenolic was calculated using a standard gallic acid curve and results were expressed as mg gallic acid equivalent (GAE)/100 g of extract.</p></sec><sec><title>DPPH radical scavenging assay</title><p>The scavenging activity of extracts on DPPH was determined using the method described by [<xref ref-type=""bibr"" rid=""B28"">28</xref>]. This method depends on the reduction of purple DPPH to a yellow coloured diphenyl picrylhydrazine. The determination of the disappearance of free radicals was done using UV-visible spectrometer (Multiskan Spectrum, Thermo Scientific). The remaining DPPH which showed maximum absorption at 517 nm was measured. Each plant extract sample’s stock solution (1.0 mg/ml) was diluted to final concentrations of (0.6 .0.5, 0.4, 0.3, 0.2, 0.1, 0.05 and 0.01) mg/ml, in ethanol. One ml of a 0.3 mM DPPH ethanol solution was added to 2.5 ml of sample solution of different concentrations. These are test solutions. One ml of ethanol was added to 2.5 ml of sample solution of different concentration. These are blank solutions. One ml DPPH solution plus 2.5 ml of ethanol was used as a negative control. The blank for this solution is ethanol. As DPPH is sensitive to light, it is exposed to the minimum possible light. These solutions were allowed to react at room temperature for 30 minutes. The absorbance values were measured and converted into the percentage antioxidant activity using the following equation:</p><p><disp-formula><mml:math id=""M1"" name=""1472-6882-13-155-i1"" overflow=""scroll""><mml:mrow><mml:mi mathvariant=""normal"">Scavenging</mml:mi><mml:mspace width=""0.25em""></mml:mspace><mml:mi mathvariant=""normal"">capacity</mml:mi><mml:mfenced close="")"" open=""(""><mml:mi>%</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mn>100</mml:mn><mml:mo>–</mml:mo><mml:mfenced close=""]"" open=""[""><mml:mtable columnalign=""left""><mml:mtr><mml:mtd><mml:mfenced close="")"" open=""(""><mml:mrow><mml:mtext mathvariant=""normal"">absorbance of sample–absorbance of blank</mml:mtext></mml:mrow></mml:mfenced></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mo>×</mml:mo><mml:mn>100</mml:mn><mml:mo stretchy=""true"">/</mml:mo><mml:mtext mathvariant=""normal"">absorbance of control</mml:mtext></mml:mtd></mml:mtr></mml:mtable></mml:mfenced></mml:mrow></mml:math></disp-formula></p><p>The tests were done in triplicate. The SCa50 values were calculated by linear regression of plots, where the abscissa represents the concentration of the tested plant extracts and the ordinate the average percent of scavenging capacity. The concentration of sample required to scavenge 50% of DPPH (SCa50) were determined.</p></sec><sec><title>High performance liquid chromatography (HPLC) analysis</title><p>The flavonoid compounds present in the polar solvents can be separated by using Reverse Phase HPLC equipped with a photo-diode array detector (RP-HPLC-PDA). This establishes the light absorbance spectrum from visible and UV wavelengths of each detected compound, and show intense absorption in the UV region of the spectrum. Identification of the flavonoid compounds (Rutin, Catechin, Kaempferol) present in the extracts of leaves and barks of<italic>X. longifolium</italic>was performed on a Waters HPLC system equipped with reversed phase X-bridge™ C18 (4.6 mm × 250 mm i.d. 5 μm) column (Waters). The column temperature was set at 26°C [<xref ref-type=""bibr"" rid=""B29"">29</xref>]. Using a binary pump (Waters, Model No. 1525) on a binary solvent system consisting of (A) acetonitrile and (B) water in the ratio of (80:20 v/v) as mobile phase in isocratic mode with a constant flow rate of 1 ml/min. this was monitored at an absorbance of 259, 280 and 360 nm each of Rutin [<xref ref-type=""bibr"" rid=""B30"">30</xref>,<xref ref-type=""bibr"" rid=""B31"">31</xref>], Catechin [<xref ref-type=""bibr"" rid=""B30"">30</xref>,<xref ref-type=""bibr"" rid=""B32"">32</xref>] and Kaempferol [<xref ref-type=""bibr"" rid=""B33"">33</xref>] respectively, using a UV-detector (Photo-Diode Array, Waters Model No. 2996). The sample injection volume was 20 μl. The compounds were identified by comparing with standards of each identified compound using the retention time, the absorbance spectrum profile and also by running the samples after the addition of pure standards. The concentration of an individual flavonoid compounds (Rutin, Catechin, Kaempferol) in the plant extract was calculated based on peak height measurement and then finally converted to mg flavonoid/100 g DW.</p></sec><sec><title>Preparation of standard solutions</title><p>The standard solutions were prepared by dissolving each of the standards (namely Rutin, Catechin, Kaempferol) separately in methanol (HPLC grade) using serial dilutions. 10ppm was chosen as the optimum concentration which was within the detection range.</p></sec><sec><title>Microorganisms</title><p>The human skin infectious fungal pathogens used in the study (<italic>Microsporum boullardii</italic>6059,<italic>M. canis</italic>(2820 and 3270),<italic>M. gypseum</italic>2819,<italic>Trichophyton ajelloi</italic>4878,<italic>T. rubrum</italic>(296 and 3272) were collected from Microbial Tissue Collection Culture (MTCC), Chandigarh, India. All the strains are maintained on sabouraud dextrose agar (SDA, Hi-Media) at 4°C.</p></sec><sec><title>Preparation of the spore suspension and test sample</title><p>The fungi were grown on SDA plates at 32±2°C for 7–9 days, after which the spores were harvested from sporulation colonies and suspended in sterile normal saline water (0.9%). The turbidity of the resulting suspension was compared to 0.5 McFarland turbidity standards. The level of turbidity was equivalent to approximately 1.0×10<sup>8</sup>spores/ml [<xref ref-type=""bibr"" rid=""B34"">34</xref>,<xref ref-type=""bibr"" rid=""B35"">35</xref>].</p></sec><sec><title>In vitro anti-dermatophytic susceptibility assay</title><sec><title>Disc diffusion assay</title><p>The<italic>in vitro</italic>anti-dermatophytic activity of the extracts was assessed by agar well diffusion method using SDA in 10 cm petri dishes [<xref ref-type=""bibr"" rid=""B36"">36</xref>]. Six wells were pierced using sterile 6mm diameter cork borer in the agar, equidistant, and away from the border. Different concentrations of the extracts (9, 4.5, 2.25, 1.125 mg/ml) were prepared by two-fold dilution method. The graded concentrations of the extracts (20 μl) were deposited into the wells using micropipettes and left for 10 min at room temperature for diffusion. Negative and positive control was prepared using DMSO (final concentration of the DMSO in the highest concentration of plant extract tested did not exceed 0.4% (v/v) and did not affect the cell proliferation) and Amphotericin-B (16 μg/ml), respectively. The plates were inoculated at 32±2°C for 7–9 days. The experiment was repeated thrice and the average results were recorded in radial (mm).</p></sec><sec><title>Determination of minimum inhibitory concentration</title><p>Minimum inhibitory concentrations were determined using the micro wells dilution method [<xref ref-type=""bibr"" rid=""B37"">37</xref>]. The minimum inhibitory concentrations (MICs) of the crude extracts were determined by two fold serial dilution against the pathogens. Six microliter samples of tested extracts were dissolved in the DMSO (99.5%) employed to isolate and extract the crude extracts. These solutions were serially diluted with the DMSO and were added to sabouraud dextrose broth (SDB) at final concentrations of 0.0703125, 0.140625, 0.28125, 0.5625, 1.125, 2.25, 4.5, 9 mg/ml. A 10 μl spore’s suspension (1.0×10<sup>8</sup>spores/ml) of each test pathogens was inoculated in the test tubes in SDB medium and incubated at 32±2°C for 2–7 days. The control tubes containing SDB medium were inoculated only with fungal spore suspension. The minimum concentrations at which no visible growth were observed was defined as the MICs, which were expressed in mg/ml.</p></sec></sec><sec><title>Statistical analysis</title><p>Sampling proceeds on three independent replications (n=3) for each analytical parameters. Results presented in tables were reported as means ± standard deviation (SD). Data were subjected to one-way analysis of variance ANOVA, and the significant difference between means was determined by Duncan’s multiple range test. Differences at<italic>P</italic>&lt; 0.05 were considered statistically significant. Coefficients of determination (<italic>r</italic><sup><italic>2</italic></sup>) were calculated using Microsoft Excel 2010.</p></sec></sec><sec sec-type=""results""><title>Results</title><sec><title>TPC and DPPH scavenging activity</title><p>The total phenolic contents of the extracts from both leaf and bark (petroleum ether, chloroform and methanol) of<italic>X. longifolium</italic>were tested, and occurred in the range of 12±1.27 to 56.6±4.84 mg GAE/100 g and 16± 1.2 to 58±2.25 mg GAE/100g respectively (Table<xref ref-type=""table"" rid=""T1"">1</xref>). The total phenolic content of various leaf and bark extracts of petroleum ether, chloroform and methanol were noted to be 12±1.27, 34.6±2.04 and 56.6±4.84 mg GAE/100g and 16±1.2, 37.6±2.1 and 58±2.25 mg GAE/100 g of dry extract, respectively.</p><table-wrap id=""T1"" position=""float""><label>Table 1</label><caption><p><bold>The total phenolic, its flavonoid and SCa<sub>50</sub>of</bold><bold><italic>Xylosma longifolium</italic></bold><bold>extracts</bold></p></caption><table border=""1"" frame=""hsides"" rules=""groups""><colgroup><col align=""left""/><col align=""left""/><col align=""center""/><col align=""center""/><col align=""center""/><col align=""center""/><col align=""center""/></colgroup><thead valign=""top""><tr><th align=""left"" colspan=""2"" rowspan=""2"" valign=""top""><bold>Type of extract</bold></th><th align=""center"" rowspan=""2"" valign=""top""><bold>Total phenolic content (mg/100 g)</bold></th><th align=""center"" rowspan=""2"" valign=""top""><bold>SCa</bold><sub><bold>50</bold></sub><bold>(mg/ml)</bold></th><th align=""center"" colspan=""3"" valign=""bottom""><bold>Individual flavonoids (%)</bold><hr/></th></tr><tr><th align=""center""><bold>Rutin</bold></th><th align=""center""><bold>Catechin</bold></th><th align=""center""><bold>Kaempferol</bold></th></tr></thead><tbody valign=""top""><tr><td align=""left"" rowspan=""3"" valign=""bottom"">Leaf<hr/></td><td align=""left"" valign=""bottom"">PE<hr/></td><td align=""center"" valign=""bottom"">12±1.27<sup>b</sup><hr/></td><td align=""center"" valign=""bottom"">0.7±0.2<sup>a</sup><hr/></td><td align=""center"" valign=""bottom"">0.67<hr/></td><td align=""center"" valign=""bottom"">4.29<hr/></td><td align=""center"" valign=""bottom"">0<hr/></td></tr><tr><td align=""left"" valign=""bottom"">CH<hr/></td><td align=""center"" valign=""bottom"">34.6±2.4<sup>d</sup><hr/></td><td align=""center"" valign=""bottom"">1.3±0.12<sup>a</sup><hr/></td><td align=""center"" valign=""bottom"">0.65<hr/></td><td align=""center"" valign=""bottom"">1.73<hr/></td><td align=""center"" valign=""bottom"">0.03<hr/></td></tr><tr><td align=""left"" valign=""bottom"">ME<hr/></td><td align=""center"" valign=""bottom"">56.6±4.84<sup>h</sup><hr/></td><td align=""center"" valign=""bottom"">1.4±0.04<sup>a</sup><hr/></td><td align=""center"" valign=""bottom"">0.56<hr/></td><td align=""center"" valign=""bottom"">1.24<hr/></td><td align=""center"" valign=""bottom"">0.08<hr/></td></tr><tr><td align=""left"" rowspan=""3"" valign=""top"">Bark</td><td align=""left"" valign=""bottom"">PE<hr/></td><td align=""center"" valign=""bottom"">16±1.2<sup>b</sup><hr/></td><td align=""center"" valign=""bottom"">0.6±0.17<sup>a</sup><hr/></td><td align=""center"" valign=""bottom"">0.51<hr/></td><td align=""center"" valign=""bottom"">1.88<hr/></td><td align=""center"" valign=""bottom"">0<hr/></td></tr><tr><td align=""left"" valign=""bottom"">CH<hr/></td><td align=""center"" valign=""bottom"">37.6±1.94<sup>c</sup><hr/></td><td align=""center"" valign=""bottom"">1.0±0.35<sup>a</sup><hr/></td><td align=""center"" valign=""bottom"">0.22<hr/></td><td align=""center"" valign=""bottom"">1.56<hr/></td><td align=""center"" valign=""bottom"">0.021<hr/></td></tr><tr><td align=""left"">ME</td><td align=""center"">58±2.25<sup>d</sup></td><td align=""center"">1.23±0.56<sup>b</sup></td><td align=""center"">0.12</td><td align=""center"">1.72</td><td align=""center"">0.07</td></tr></tbody></table><table-wrap-foot><p>PE – petroleum ether, CH - chloroform, ME – methanol.</p><p>Means ± SD of triplicates. For each column, values followed by one or more of the same letters were not significant different at<italic>P</italic>&lt; 0.05.</p></table-wrap-foot></table-wrap><p>The DPPH free radical scavenging activity of the both leaf and bark extracts (petroleum ether, chloroform and methanol) of<italic>X. longifolium</italic>was studied (Table<xref ref-type=""table"" rid=""T1"">1</xref>). The SCa<sub>50</sub>values of both leaf and bark extracts were recorded in the range of 0.7±0.2 to 1.4±0.04 mg/ml and 0.6±0.17 to 1.23±0.56 mg/ml, respectively.</p></sec><sec><title>Flavonoid compounds analysis</title><p>The solvent extracts were analysed by HPLC to quantify the selected parts of the plant. The established HPLC-UV method was successfully applied for the determination of the three major flavonoid compounds (Rutin, Catechin, Kaempferol) present in different parts of the plant,<italic>X. longifolium</italic>. The contents of these compounds distributed in different parts of the plant, bark and leaf were shown in Table<xref ref-type=""table"" rid=""T1"">1</xref>. It can be seen that these compounds showed significant variations between the plants parts tested. The content of Rutin in leaf extract was found to be higher in petroleum ether (0.51%) than in chloroform (0.22%) and methanol extracts (0.12%) whereas in bark extract was resulted to be higher in petroleum ether (0.67%) than in chloroform (0.65%) and methanol extracts (0.56%) (Table<xref ref-type=""table"" rid=""T1"">1</xref>). The content of Catechin in leaf extract was found to be higher in petroleum ether extract (1.88%) than in methanol (1.72%) and chloroform (1.56%) whereas in bark extract was studied to be higher in petroleum ether extract (4.29%) than in chloroform (1.73%) and methanol extract (1.24%) (Table<xref ref-type=""table"" rid=""T1"">1</xref>). However, the contents of Rutin and Catechin presence found to be more in bark extracts than the leaf extracts. From the Kaempferol content studies it was in trace or absent.</p></sec><sec><title>Relation among DPPH scavenging activity, total Phenolic, and its flavonoid compounds</title><p>According to the results of the current study correlation between the content of either total phenolic or individual flavonoids and DPPH scavenging activity was calculated. There were a positive linear relationship between total phenolic content and DPPH scavenging activity of both leaf and bark extracts (<italic>r</italic><sup>2</sup>= 0.86 and<italic>r</italic><sup>2</sup>= 0.98 respectively). A highly significant correlation was found in bark extracts between total phenolic content and DPPH scavenging activity. The correlation with catechin and rutin in leaf and bark extracts were<italic>r</italic><sup>2</sup>= 0.99 and<italic>r</italic><sup>2</sup>= 0.54;<italic>r</italic><sup>2</sup>= 0.39 and<italic>r</italic><sup>2</sup>= 0.98 respectively. Thus rutin in leaf and catechin in bark extracts were found to be decreased.</p></sec><sec><title>Anti-dermatophytic activity and MIC of extracts</title><p>The extracts exhibited a moderate anti-dermatophytic activity against the tested fungal pathogens. As shown in Table<xref ref-type=""table"" rid=""T2"">2</xref>, different solvent extracts from leaf (9 mg/well) showed potent inhibitory effect on the growth of<italic>M. canis</italic>3270 and<italic>M. gypseum</italic>2819 (13 mm in radial) by petroleum ether;<italic>M. canis</italic>3270 (14 mm in radial) by chloroform and<italic>T. ajelloi</italic>4878 (19 mm in radial) by methanol. Again, different solvent extracts from bark exhibited the efficacy on the inhibition by petroleum ether of<italic>M. canis</italic>3270 (15 mm in radial), by chloroform of<italic>M. gypseum</italic>2819 (14 mm in radial) and by methanol of<italic>T. ajelloi</italic>4878 (15 mm in radial) against all the fungal pathogens tested (Table<xref ref-type=""table"" rid=""T2"">2</xref>). Thus comparative evaluation of the extracts showed variation in the levels of activity against the tested fungal strains (Table<xref ref-type=""table"" rid=""T2"">2</xref>). This variation of susceptibility from one species to another is evident from their zones of inhibition. In general,<italic>M. canis</italic>3270 and<italic>T. ajelloi</italic>4878 were found to be the most susceptible organisms to both methanol extracts of leaf and bark and requires chemical characterization for its bioactive principle. The diluted concentration of each extracts (4.5, 2.25, 1.125 mg/ml) did not show anti-dermatophytic activity.</p><table-wrap id=""T2"" position=""float""><label>Table 2</label><caption><p><bold>Anti-dermatophytic activity (zone of inhibition and MIC) of</bold><bold><italic>Xylosma longifolium</italic></bold><bold>extracts compared with commercial antibiotic 16 μg/ml Amphotericin-B</bold></p></caption><table border=""1"" frame=""hsides"" rules=""groups""><colgroup><col align=""center""/><col align=""center""/><col align=""center""/><col align=""center""/><col align=""center""/><col align=""center""/><col align=""center""/><col align=""center""/><col align=""center""/><col align=""center""/></colgroup><thead valign=""top""><tr><th align=""center""><bold>Part of plant</bold></th><th align=""center""><bold>Extracts</bold></th><th align=""center""><bold>Anti-dermatophytic activity</bold></th><th align=""center""><bold>MB</bold></th><th align=""center""><bold>MC-1</bold></th><th align=""center""><bold>MC-2</bold></th><th align=""center""><bold>MG</bold></th><th align=""center""><bold>TA</bold></th><th align=""center""><bold>TR-1</bold></th><th align=""center""><bold>TR-2</bold></th></tr></thead><tbody valign=""top""><tr><td align=""center"" rowspan=""6"" valign=""top"">Leaf<hr/></td><td align=""center"" rowspan=""2"" valign=""top"">PE<hr/></td><td align=""center"" valign=""bottom"">A<hr/></td><td align=""center"" valign=""bottom"">-<hr/></td><td align=""center"" valign=""bottom"">10±1.3<sup>c</sup><hr/></td><td align=""center"" valign=""bottom"">13±1.4<sup>c</sup><hr/></td><td align=""center"" valign=""bottom"">13±1.6<sup>d</sup><hr/></td><td align=""center"" valign=""bottom"">10±1.4<sup>c</sup><hr/></td><td align=""center"" valign=""bottom"">-<hr/></td><td align=""center"" valign=""bottom"">-<hr/></td></tr><tr><td align=""center"" valign=""bottom"">B<hr/></td><td align=""center"" valign=""bottom"">&gt;9<hr/></td><td align=""center"" valign=""bottom"">2.25<hr/></td><td align=""center"" valign=""bottom"">1.125<hr/></td><td align=""center"" valign=""bottom"">1.125<hr/></td><td align=""center"" valign=""bottom"">2.25<hr/></td><td align=""center"" valign=""bottom"">&gt;9<hr/></td><td align=""center"" valign=""bottom"">&gt;9<hr/></td></tr><tr><td align=""center"" rowspan=""2"" valign=""top"">CH<hr/></td><td align=""center"" valign=""bottom"">A<hr/></td><td align=""center"" valign=""bottom"">10±1.6<sup>d</sup><hr/></td><td align=""center"" valign=""bottom"">10±1.3<sup>c</sup><hr/></td><td align=""center"" valign=""bottom"">14±1.6<sup>d</sup><hr/></td><td align=""center"" valign=""bottom"">-<hr/></td><td align=""center"" valign=""bottom"">11±1.2<sup>c</sup><hr/></td><td align=""center"" valign=""bottom"">-<hr/></td><td align=""center"" valign=""bottom"">-<hr/></td></tr><tr><td align=""center"" valign=""bottom"">B<hr/></td><td align=""center"" valign=""bottom"">2.25<hr/></td><td align=""center"" valign=""bottom"">2.25<hr/></td><td align=""center"" valign=""bottom"">0.562<hr/></td><td align=""center"" valign=""bottom"">&gt;9<hr/></td><td align=""center"" valign=""bottom"">2.25<hr/></td><td align=""center"" valign=""bottom"">&gt;9<hr/></td><td align=""center"" valign=""bottom"">&gt;9<hr/></td></tr><tr><td align=""center"" rowspan=""2"" valign=""top"">ME<hr/></td><td align=""center"" valign=""bottom"">A<hr/></td><td align=""center"" valign=""bottom"">10±1.2<sup>c</sup><hr/></td><td align=""center"" valign=""bottom"">13±1.3<sup>c</sup><hr/></td><td align=""center"" valign=""bottom"">14±1.3<sup>c</sup><hr/></td><td align=""center"" valign=""bottom"">-<hr/></td><td align=""center"" valign=""bottom"">19±1.5<sup>c</sup><hr/></td><td align=""center"" valign=""bottom"">-<hr/></td><td align=""center"" valign=""bottom"">10±1.1<sup>c</sup><hr/></td></tr><tr><td align=""center"" valign=""bottom"">B<hr/></td><td align=""center"" valign=""bottom"">2.25<hr/></td><td align=""center"" valign=""bottom"">1.125<hr/></td><td align=""center"" valign=""bottom"">2.25<hr/></td><td align=""center"" valign=""bottom"">&gt;9<hr/></td><td align=""center"" valign=""bottom"">0.140625<hr/></td><td align=""center"" valign=""bottom"">&gt;9<hr/></td><td align=""center"" valign=""bottom"">2.25<hr/></td></tr><tr><td align=""center"" rowspan=""6"" valign=""top"">Bark<hr/></td><td align=""center"" rowspan=""2"" valign=""top"">PE<hr/></td><td align=""center"" valign=""bottom"">A<hr/></td><td align=""center"" valign=""bottom"">-<hr/></td><td align=""center"" valign=""bottom"">-<hr/></td><td align=""center"" valign=""bottom"">15±1.2<sup>c</sup><hr/></td><td align=""center"" valign=""bottom"">10±1.4<sup>c</sup><hr/></td><td align=""center"" valign=""bottom"">12±1.2<sup>c</sup><hr/></td><td align=""center"" valign=""bottom"">10±1.4<sup>c</sup><hr/></td><td align=""center"" valign=""bottom"">10±1.4<sup>c</sup><hr/></td></tr><tr><td align=""center"" valign=""bottom"">B<hr/></td><td align=""center"" valign=""bottom"">&gt;9<hr/></td><td align=""center"" valign=""bottom"">&gt;9<hr/></td><td align=""center"" valign=""bottom"">0.5625<hr/></td><td align=""center"" valign=""bottom"">2.25<hr/></td><td align=""center"" valign=""bottom"">2.25<hr/></td><td align=""center"" valign=""bottom"">2.25<hr/></td><td align=""center"" valign=""bottom"">2.25<hr/></td></tr><tr><td align=""center"" rowspan=""2"" valign=""top"">CH<hr/></td><td align=""center"" valign=""bottom"">A<hr/></td><td align=""center"" valign=""bottom"">-<hr/></td><td align=""center"" valign=""bottom"">-<hr/></td><td align=""center"" valign=""bottom"">10±1.3<sup>c</sup><hr/></td><td align=""center"" valign=""bottom"">14±1.4<sup>c</sup><hr/></td><td align=""center"" valign=""bottom"">12±1.5<sup>c</sup><hr/></td><td align=""center"" valign=""bottom"">11±1.3<sup>c</sup><hr/></td><td align=""center"" valign=""bottom"">12±1.4<sup>c</sup><hr/></td></tr><tr><td align=""center"" valign=""bottom"">B<hr/></td><td align=""center"" valign=""bottom"">&gt;9<hr/></td><td align=""center"" valign=""bottom"">&gt;9<hr/></td><td align=""center"" valign=""bottom"">2.25<hr/></td><td align=""center"" valign=""bottom"">0.5625<hr/></td><td align=""center"" valign=""bottom"">2.25<hr/></td><td align=""center"" valign=""bottom"">2.25<hr/></td><td align=""center"" valign=""bottom"">1.125<hr/></td></tr><tr><td align=""center"" rowspan=""2"" valign=""top"">ME<hr/></td><td align=""center"" valign=""bottom"">A<hr/></td><td align=""center"" valign=""bottom"">-<hr/></td><td align=""center"" valign=""bottom"">-<hr/></td><td align=""center"" valign=""bottom"">13±1.2<sup>c</sup><hr/></td><td align=""center"" valign=""bottom"">13±1.2<sup>c</sup><hr/></td><td align=""center"" valign=""bottom"">15±1.4<sup>c</sup><hr/></td><td align=""center"" valign=""bottom"">12±1.2<sup>c</sup><hr/></td><td align=""center"" valign=""bottom"">14±1.3<sup>c</sup><hr/></td></tr><tr><td align=""center"" valign=""bottom"">B<hr/></td><td align=""center"" valign=""bottom"">&gt;9<hr/></td><td align=""center"" valign=""bottom"">&gt;9<hr/></td><td align=""center"" valign=""bottom"">2.25<hr/></td><td align=""center"" valign=""bottom"">2.25<hr/></td><td align=""center"" valign=""bottom"">0.28125<hr/></td><td align=""center"" valign=""bottom"">2.25<hr/></td><td align=""center"" valign=""bottom"">1.125<hr/></td></tr><tr><td align=""center"" colspan=""2"" rowspan=""2"" valign=""top"">Amphotericin-B<hr/></td><td align=""center"" valign=""bottom"">A<hr/></td><td align=""center"" valign=""bottom"">16±0.9<sup>b</sup><hr/></td><td align=""center"" valign=""bottom"">17±1.0<sup>b</sup><hr/></td><td align=""center"" valign=""bottom"">19±1.0<sup>b</sup><hr/></td><td align=""center"" valign=""bottom"">19±0.8<sup>b</sup><hr/></td><td align=""center"" valign=""bottom"">20±1.1<sup>c</sup><hr/></td><td align=""center"" valign=""bottom"">16±0.9<sup>b</sup><hr/></td><td align=""center"" valign=""bottom"">18±1.1<sup>c</sup><hr/></td></tr><tr><td align=""center"" valign=""bottom"">B<hr/></td><td align=""center"" valign=""bottom"">1<hr/></td><td align=""center"" valign=""bottom"">0.125<hr/></td><td align=""center"" valign=""bottom"">0.06<hr/></td><td align=""center"" valign=""bottom"">0.25<hr/></td><td align=""center"" valign=""bottom"">&lt;0.06<hr/></td><td align=""center"" valign=""bottom"">0.25<hr/></td><td align=""center"" valign=""bottom"">0.125<hr/></td></tr><tr><td align=""center"" colspan=""2"">DMSO</td><td align=""center"">-</td><td align=""center"">-</td><td align=""center"">-</td><td align=""center"">-</td><td align=""center"">-</td><td align=""center"">-</td><td align=""center"">-</td><td align=""center""></td></tr></tbody></table><table-wrap-foot><p>A –The values (average of triplicate) are radial of zone of inhibition at 9 mg/ml; B – MIC (mg/ml) mean value n = 3, P &lt; 0.05.</p><p>PE – Petroleum ether; CH – Chloroform; ME - Methanol.</p><p><italic>Microsporum boullardii</italic>MTCC 6059 - MB;<italic>M. canis</italic>MTCC 2820 - MC-1;<italic>M. canis</italic>MTCC 3270 - MC-2;<italic>M. gypseum</italic>MTCC 2819 - MG;<italic>Trichophyton ajelloi</italic>MTCC 4878 -TA;<italic>T. rubrum</italic>MTCC 296 - TR-1;<italic>T. rubrum</italic>MTCC 3272 - TR-2; – no activity.</p><p>Means ± SD of triplicates. For each column, values followed by one or more of the same letters were not significant different at<italic>P</italic>&lt; 0.05.</p></table-wrap-foot></table-wrap><p>According to the results (Table<xref ref-type=""table"" rid=""T2"">2</xref>), the MICs of different leaf extracts on<italic>M. boullardii</italic>6059,<italic>M. canis</italic>2820,<italic>M. canis</italic>3270,<italic>M. gypseum</italic>2819,<italic>T. ajelloi</italic>4878,<italic>T. rubrum</italic>296,<italic>T. rubrum</italic>3272 were found to be 2.25, 2.25, 0.5625, 1.125, 0.140625, &gt;9, &gt;9 mg/ml, respectively.<italic>M. canis</italic>3270 and<italic>T. ajelloi</italic>4878 were found to be the most susceptible fungal pathogens to the chloroform and methanol leaf extracts of<italic>X. longifolium</italic>, respectively. Also the different dark extracts displayed potential effect of anti-dermatophytic activity as minimum inhibitory concentrations against the tested fungal pathogens, with their respective MIC values of<italic>M. boullardii</italic>6059,<italic>M. canis</italic>2820,<italic>M. canis</italic>3270,<italic>M. gypseum</italic>2819,<italic>T. ajelloi</italic>4878,<italic>T. rubrum</italic>296,<italic>T. rubrum</italic>3272 were found to be &gt;9, &gt;9, 0.5625, 2.25, 0.28125, 2.25, 2.25 mg/ml, respectively. As control, the DMSO did not affect the growth of the sample strains at the concentration used in this study. However, low to moderate anti-dermatophytic effect (9–0.140625 mg/ml) of bark extracts was observed against the tested fungal pathogens as a minimum inhibitory concentration. Highest sensitivity was shown by the entire test microbial towards leaf methanol extract against fungus<italic>T. ajelloi</italic>MTCC 4878 (MIC= 0.140625 mg/ml). The values of the plant extracts were compared with that of the reference antifungal drug Amphotericin-B (Table<xref ref-type=""table"" rid=""T2"">2</xref>).</p></sec></sec><sec><title>Discussions</title><p>In this study, the extraction of both leaf and bark was performed using three solvents of increasing polarity. Different solvent systems have been used for extractions from plant material [<xref ref-type=""bibr"" rid=""B38"">38</xref>] because the extraction yield is dependent on the polarity and the nature of solvents [<xref ref-type=""bibr"" rid=""B39"">39</xref>]. Trabelsi<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B40"">40</xref>] showed that the methanol is the best solvent to extract total phenolics. The ANOVA for all parameters assessed a significant influence on phenolic contents, antioxidant and antimicrobial activities of plant extracts. ANOVA is just a material used to look for significant differences.</p><p>The antioxidant activity of the extracts was determined using a DPPH scavenging assay. The DPPH assay is often used to evaluate the ability of antioxidants to scavenge free radicals which are known to be a major factor in biological damages caused by oxidative stress. This assay is known to give reliable information concerning the antioxidant ability of the tested compounds [<xref ref-type=""bibr"" rid=""B41"">41</xref>]. The principle of the assay is based on the colour change of the DPPH solution from purple to yellow as the radical is quenched by the antioxidant [<xref ref-type=""bibr"" rid=""B42"">42</xref>].</p><p>These results were consistent with the findings of many research groups who reported such correlation between total phenolic content and SCa<sub>50</sub>antioxidant activity [<xref ref-type=""bibr"" rid=""B43"">43</xref>-<xref ref-type=""bibr"" rid=""B46"">46</xref>]. The Folin–Ciocalteu assay used herein provides a crude estimation of the total phenolic compounds present in the extracts. Since it is not specific to polyphenols any interfering compounds may react with the reagent and thus leads to noticeable elevated phenolic concentrations [<xref ref-type=""bibr"" rid=""B47"">47</xref>]. In addition, phenolic compounds respond differently in this assay when the number of phenolic groups varies [<xref ref-type=""bibr"" rid=""B27"">27</xref>]. Several studies showed good correlation between total phenols and antioxidant activity [<xref ref-type=""bibr"" rid=""B42"">42</xref>,<xref ref-type=""bibr"" rid=""B48"">48</xref>-<xref ref-type=""bibr"" rid=""B50"">50</xref>].</p><p>Correlation between the content of either total phenol or individual flavonoids and antioxidant capacity data indicate that the antioxidant activity was obtained directly from phenolics, and also particularly catechin and rutin, and assures other experiments that mentioned the same vital role of catechin and rutin in lipid peroxidation inhibition [<xref ref-type=""bibr"" rid=""B51"">51</xref>,<xref ref-type=""bibr"" rid=""B52"">52</xref>].</p><p>In the present study, methanol leaf and bark extracts showed high antioxidant activities as compared to the other crude extracts. This is due to bioactive compounds such as polyphenols including tannins, flavonoid existed in high polar extracts [<xref ref-type=""bibr"" rid=""B53"">53</xref>]. Polyphenols are one of the major plant compounds with antioxidant activity. The antioxidant activity of phenolic compounds is reported to be mainly due to their redox properties [<xref ref-type=""bibr"" rid=""B54"">54</xref>], which can play an important role in adsorbing and neutralizing free radicals, quenching singlet and triplet oxygen, or decomposing peroxides. Organic extracts may be more beneficial than isolated constituents, because other compounds present in the extracts can change the chemical or biological properties of bioactive individual component [<xref ref-type=""bibr"" rid=""B55"">55</xref>].</p><p>Phenolic was also found to be one of the most constituents in both methanol leaf and bark extracts of<italic>X. longifolium</italic>. These may be due to the presence of high bioactive compounds as compared to other organic extracts. The key role of phenolic compounds to scavenge free radicals has been emphasized in several reports [<xref ref-type=""bibr"" rid=""B56"">56</xref>-<xref ref-type=""bibr"" rid=""B62"">62</xref>]. The phenolic compounds may contribute directly to the antioxidant action [<xref ref-type=""bibr"" rid=""B63"">63</xref>]. Total phenol content in the leaf and bark are comparable but varies with the extracting solvent, methanol been the best extracting solvent, follow by chloroform and petroleum ether.</p><p>RP-HPLC analysis is the most widely used method for the identification of plant flavonoid compounds. Because of the diversity and complexity of natural flavonoid in medicinal plants, it is difficult to characterize every compound and elucidate its structure. In<italic>X. longifolium</italic>leaf and bark extracts of petroleum ether result the presence of high flavonoids than other extracts. Flavonoid compounds can be defined as a large series of chemical constituents possessing at least one aromatic ring, bearing hydroxyl and other sub-constituents [<xref ref-type=""bibr"" rid=""B64"">64</xref>]. Increasingly, flavonoids are becoming the subject of medical research. They have been reported to possess many useful properties, including anti-inflammatory activity, oestrogenic activity, enzyme inhibition, antimicrobial activity, anti-allergic activity, antioxidant activity, vascular activity and cytotoxic anti-tumour activity [<xref ref-type=""bibr"" rid=""B26"">26</xref>,<xref ref-type=""bibr"" rid=""B65"">65</xref>-<xref ref-type=""bibr"" rid=""B71"">71</xref>]. For centuries, preparations that contain flavonoids as the principal physiologically active constituents, have been used by physicians and lay healers, in attempts to treat human diseases [<xref ref-type=""bibr"" rid=""B65"">65</xref>]. Owing to the widespread ability of flavonoids to inhibit spore germination of plant pathogens, they have been proposed for use against fungal pathogens in man [<xref ref-type=""bibr"" rid=""B66"">66</xref>].</p><p>Natural products may constitute an appropriate source of anti-infective agents. For example, flavonoids showed antimicrobial activity [<xref ref-type=""bibr"" rid=""B69"">69</xref>]. In fact, rutin displayed various biological activities that are beneficial to human health [<xref ref-type=""bibr"" rid=""B72"">72</xref>]. Studies showed that rutin give high positive correlation with DPPH in bark extracts. This is in agreement with previous study [<xref ref-type=""bibr"" rid=""B73"">73</xref>] which reported that the antimicrobial spectrums of the catechins. Catechin is the most represented individual flavonoid in all extracts and is best extracted by petroleum ether. The higher concentration is found in leaf.</p><p>There is a constant striving to develop safe and new natural antifungal agent to cure the fungal disorders of the increasing social and health implications, where the dermatophytes estimated lifetime risk of acquiring infection. Methods for less deleterious side effects of treatments include use of natural antifungal agents from essential oils and extracts than synthetic drugs [<xref ref-type=""bibr"" rid=""B74"">74</xref>].</p><p>In general, extracts derived from plants are considered as non-phytotoxic compounds and potentially effective against several microorganisms including many fungal and bacterial pathogens [<xref ref-type=""bibr"" rid=""B75"">75</xref>,<xref ref-type=""bibr"" rid=""B76"">76</xref>]. Since ancient times, interest have been given on the development of safer antifungal agents to control severe fungal diseases by the extracts and essential oils [<xref ref-type=""bibr"" rid=""B76"">76</xref>-<xref ref-type=""bibr"" rid=""B78"">78</xref>]. The results of the antifungal screening showed that the methanol leaf extract of<italic>X. longifolium</italic>have potential anti-dermatophytic activity against some of the skin fungal pathogens. This might be due to the presence of several bioactive compounds in extract of<italic>X. longifolium</italic>as evident by the finding of others [<xref ref-type=""bibr"" rid=""B20"">20</xref>-<xref ref-type=""bibr"" rid=""B26"">26</xref>,<xref ref-type=""bibr"" rid=""B74"">74</xref>-<xref ref-type=""bibr"" rid=""B79"">79</xref>]. Globally, the anti-dermatophytic activities of all the extracts are very low and seem not to be directly link to their total phenol and individual flavonoids contents. Besides, millions of people throughout the world are affected by superficial fungal infections, which are the most common skin diseases. These infections, which occur in both healthy and immune persons, are caused mainly by dermatophytes. In this study, it was observed that both leaves and barks methanol extracts of<italic>X. longifolium</italic>have great potential to inhibit the<italic>T. ajelloi</italic>4878, causing superficial fungal infections of the skin known as tinea infections.</p><p>Antimicrobial activities observed in this study might be due to the presence of flavonoid compounds or various other bioactive compounds. Extracts from various medicinal plants containing phenolic and flavonoids compounds have been previously reported to possess antimicrobial activity [<xref ref-type=""bibr"" rid=""B80"">80</xref>,<xref ref-type=""bibr"" rid=""B81"">81</xref>]. The properties of gallic, caffeic acids, vanillic acid, rutin, and quercetin of different wine were investigated against pathogenic microorganisms [<xref ref-type=""bibr"" rid=""B82"">82</xref>]. The presence of these compounds might contribute to antimicrobial activity [<xref ref-type=""bibr"" rid=""B20"">20</xref>,<xref ref-type=""bibr"" rid=""B22"">22</xref>-<xref ref-type=""bibr"" rid=""B26"">26</xref>,<xref ref-type=""bibr"" rid=""B77"">77</xref>]. The flavonoid compounds have antimicrobial activity against human pathogenic microorganisms with some mechanisms of action such as inhibition of nucleic acid synthesis, cytoplasmic membrane function and energy metabolisms. The antimicrobial activity of the extracts of<italic>X. longifolium</italic>might be due to one of such mechanisms of action mentioned above.</p><p>The results of this study suggested that<italic>X. longifolium</italic>extracts can be used against many tinea infections such as<italic>Epidermophyton</italic>sp.,<italic>Microsporum</italic>sp. and<italic>Trichophyton</italic>sp. where the pathogens have developed resistance against the specific fungicides [<xref ref-type=""bibr"" rid=""B24"">24</xref>,<xref ref-type=""bibr"" rid=""B26"">26</xref>,<xref ref-type=""bibr"" rid=""B83"">83</xref>,<xref ref-type=""bibr"" rid=""B84"">84</xref>]. The development of natural antifungal agents would also help to decrease the negative impact of synthetic agents such as residues, resistance and environmental pollution.</p></sec><sec sec-type=""conclusions""><title>Conclusions</title><p>The results of our study may partially justify the folkloric uses of this plant in traditional medicine and further provide an evidence that the leaf extract of<italic>Xylosma longifolium</italic>might be indeed a potential sources of antimicrobial agents as well as natural antioxidants. Further studies are required to isolate and characterize the bioactive molecules present in organic extracts of<italic>X. longifolium</italic>to evaluate proper action mechanism of the observed activities.</p></sec><sec><title>Abbreviations</title><p>DMSO: Dimethyl sulfoxide; DPPH: 1,1-Diphenyl-2-Picrylhydrazyl; DW: Distilled water.</p></sec><sec><title>Competing interests</title><p>The author(s) declare that they have no competing interests.</p></sec><sec><title>Authors’ contributions</title><p>RDW carried out the major portion of the work while BSS contribute in the HPLC part. BSC supervised the overall work. All authors the proofread and approved the final manuscript.</p></sec><sec><title>Pre-publication history</title><p>The pre-publication history for this paper can be accessed here:</p><p><ext-link ext-link-type=""uri"" xlink:href=""http://www.biomedcentral.com/1472-6882/13/155/prepub"">http://www.biomedcentral.com/1472-6882/13/155/prepub</ext-link></p></sec><back><sec><title>Acknowledgement</title><p>The authors are thankful to the Department of Biotechnology, Govt. of India, New Delhi for DBT-RA fellowship to W.R. Devi and also thank to Dr. Gusheinzed Waikhom, Dr. S. Sanjabihari, Mangi, Babuchandra, Bidya and Tonsing for their valuable suggestions and Lab. supports.</p></sec><ref-list><ref id=""B1""><mixed-citation publication-type=""journal""><name><surname>Ozsoy</surname><given-names>N</given-names></name><name><surname>Can</surname><given-names>A</given-names></name><name><surname>Yanardag</surname><given-names>R</given-names></name><name><surname>Akev</surname><given-names>N</given-names></name><article-title>Antioxidant activity of<italic>Smilax excelsa</italic>leaf extracts</article-title><source>Food Chem</source><year>2008</year><volume>110</volume><fpage>571</fpage><lpage>583</lpage><pub-id pub-id-type=""doi"">10.1016/j.foodchem.2008.02.037</pub-id></mixed-citation></ref><ref id=""B2""><mixed-citation publication-type=""journal""><name><surname>Silva</surname><given-names>BA</given-names></name><name><surname>Ferreres</surname><given-names>F</given-names></name><name><surname>Malva</surname><given-names>JO</given-names></name><name><surname>Dias</surname><given-names>ACP</given-names></name><article-title>Phytochemical and antioxidant characterization of<italic>Hypercium perforatum</italic>alcoholic extracts</article-title><source>Food Chem</source><year>2005</year><volume>90</volume><fpage>157</fpage><lpage>167</lpage><pub-id pub-id-type=""doi"">10.1016/j.foodchem.2004.03.049</pub-id></mixed-citation></ref><ref id=""B3""><mixed-citation publication-type=""journal""><name><surname>Sacchetti</surname><given-names>G</given-names></name><name><surname>Maietti</surname><given-names>S</given-names></name><name><surname>Muzzoli</surname><given-names>M</given-names></name><name><surname>Scaglianti</surname><given-names>M</given-names></name><name><surname>Manfredini</surname><given-names>S</given-names></name><name><surname>Radice</surname><given-names>M</given-names></name><article-title>Comparative evaluation of 11 essential oils of different origin as functional antioxidants, antiradicals and antimicrobials in foods</article-title><source>Food Chem</source><year>2005</year><volume>91</volume><fpage>621</fpage><lpage>632</lpage><pub-id pub-id-type=""doi"">10.1016/j.foodchem.2004.06.031</pub-id></mixed-citation></ref><ref id=""B4""><mixed-citation publication-type=""journal""><name><surname>Mothana</surname><given-names>RAA</given-names></name><name><surname>Lindequist</surname><given-names>U</given-names></name><article-title>Antimicrobial activity of some medicinal plants of the Island Sogotra</article-title><source>J Ethnopharmacol</source><year>2005</year><volume>96</volume><fpage>177</fpage><lpage>181</lpage><pub-id pub-id-type=""doi"">10.1016/j.jep.2004.09.006</pub-id><pub-id pub-id-type=""pmid"">15588668</pub-id></mixed-citation></ref><ref id=""B5""><mixed-citation publication-type=""journal""><name><surname>Bajpai</surname><given-names>M</given-names></name><name><surname>Pande</surname><given-names>A</given-names></name><name><surname>Tewari</surname><given-names>SK</given-names></name><name><surname>Prakash</surname><given-names>D</given-names></name><article-title>Phenolic content and antioxidant activity of some food and medicinal plants</article-title><source>Int J Food Sc Nut</source><year>2005</year><volume>56</volume><issue>4</issue><fpage>287</fpage><lpage>291</lpage><pub-id pub-id-type=""doi"">10.1080/09637480500146606</pub-id></mixed-citation></ref><ref id=""B6""><mixed-citation publication-type=""journal""><name><surname>Wojdylo</surname><given-names>A</given-names></name><name><surname>Oszmianski</surname><given-names>J</given-names></name><name><surname>Czemerys</surname><given-names>R</given-names></name><article-title>Antioxidant activity and phenolic compounds in 32 selected herbs</article-title><source>Food Chem</source><year>2007</year><volume>105</volume><fpage>940</fpage><lpage>949</lpage><pub-id pub-id-type=""doi"">10.1016/j.foodchem.2007.04.038</pub-id></mixed-citation></ref><ref id=""B7""><mixed-citation publication-type=""journal""><name><surname>Rios</surname><given-names>JL</given-names></name><name><surname>Recio</surname><given-names>MC</given-names></name><article-title>Medicinal plants and antimicrobial activity</article-title><source>J Ethnopharmacol</source><year>2005</year><volume>100</volume><fpage>80</fpage><lpage>84</lpage><pub-id pub-id-type=""doi"">10.1016/j.jep.2005.04.025</pub-id><pub-id pub-id-type=""pmid"">15964727</pub-id></mixed-citation></ref><ref id=""B8""><mixed-citation publication-type=""journal""><name><surname>Kuete</surname><given-names>V</given-names></name><name><surname>Wansi</surname><given-names>JD</given-names></name><name><surname>Mbaveng</surname><given-names>AT</given-names></name><name><surname>Kana</surname><given-names>SMM</given-names></name><name><surname>Tadjon</surname><given-names>AT</given-names></name><name><surname>Beng</surname><given-names>VP</given-names></name><name><surname>Etoa</surname><given-names>FX</given-names></name><name><surname>Wandji</surname><given-names>J</given-names></name><name><surname>Meyer</surname><given-names>JJM</given-names></name><name><surname>Lall</surname><given-names>N</given-names></name><article-title>Antimicrobial activity of the methanolic extract and compounds from<italic>Teclea afzelii</italic>(Rutaceae)</article-title><source>South Afric J Bot</source><year>2008</year><volume>74</volume><fpage>572</fpage><lpage>576</lpage><pub-id pub-id-type=""doi"">10.1016/j.sajb.2008.02.004</pub-id></mixed-citation></ref><ref id=""B9""><mixed-citation publication-type=""journal""><name><surname>Sonibare</surname><given-names>MA</given-names></name><name><surname>Soladoye</surname><given-names>MO</given-names></name><name><surname>Esan</surname><given-names>OO</given-names></name><name><surname>Sonibare</surname><given-names>OO</given-names></name><article-title>Phytochemical and antimicrobial studies of four species of Cola Schott &amp; Endl. (Sterculiaceae)</article-title><source>Afri J Trad Complem Alter Med</source><year>2009</year><volume>6</volume><issue>4</issue><fpage>518</fpage><lpage>52</lpage></mixed-citation></ref><ref id=""B10""><mixed-citation publication-type=""journal""><name><surname>Kuete</surname><given-names>V</given-names></name><article-title>Potential of Cameroonian plants and derived-products against microbial infections: A review</article-title><source>Planta Med</source><year>2010</year><volume>76</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type=""doi"">10.1055/s-0029-1240671</pub-id></mixed-citation></ref><ref id=""B11""><mixed-citation publication-type=""journal""><name><surname>Jessup</surname><given-names>CJ</given-names></name><name><surname>Warner</surname><given-names>J</given-names></name><name><surname>Isham</surname><given-names>N</given-names></name><name><surname>Hasan</surname><given-names>I</given-names></name><name><surname>Ghannoum</surname><given-names>MA</given-names></name><article-title>Antifungal susceptibility testing of dermatophytes: establishing a medium for inducing conidial growth and evaluation of susceptibility of clinical isolates</article-title><source>J Clin Microbiol</source><year>2000</year><volume>38</volume><issue>1</issue><fpage>341</fpage><lpage>344</lpage><pub-id pub-id-type=""pmid"">10618112</pub-id></mixed-citation></ref><ref id=""B12""><mixed-citation publication-type=""journal""><name><surname>Curtis</surname><given-names>C</given-names></name><article-title>Use and abuse of topical dermatological therapy in dogs and cats. Part 1. Shampoo</article-title><source>Ther Pract</source><year>1998</year><volume>20</volume><fpage>244</fpage><lpage>251</lpage></mixed-citation></ref><ref id=""B13""><mixed-citation publication-type=""journal""><name><surname>Baker</surname><given-names>JH</given-names></name><name><surname>Goodpasture</surname><given-names>HC</given-names></name><name><surname>Kuhns</surname><given-names>HR</given-names></name><name><surname>Rinaldi</surname><given-names>MC</given-names></name><article-title>Fungemia caused by an Amphotericin B-resistant isolate of<italic>Sporothrix schenckii</italic></article-title><source>Arch Pathol Lab Med</source><year>1989</year><volume>113</volume><fpage>1279</fpage><lpage>1281</lpage><pub-id pub-id-type=""pmid"">2554844</pub-id></mixed-citation></ref><ref id=""B14""><mixed-citation publication-type=""journal""><name><surname>Willocks</surname><given-names>L</given-names></name><name><surname>Leen</surname><given-names>CLS</given-names></name><name><surname>Brettle</surname><given-names>RP</given-names></name><name><surname>Urquart</surname><given-names>D</given-names></name><name><surname>Russel</surname><given-names>TB</given-names></name><name><surname>Milne</surname><given-names>JR</given-names></name><article-title><bold>Fluconazole resistance in AIDS patient</bold>s</article-title><source>J Antimicrob Chemother</source><year>1991</year><volume>28</volume><fpage>937</fpage><lpage>939</lpage><pub-id pub-id-type=""doi"">10.1093/jac/28.6.937</pub-id><pub-id pub-id-type=""pmid"">1816193</pub-id></mixed-citation></ref><ref id=""B15""><mixed-citation publication-type=""journal""><name><surname>Khare</surname><given-names>CP</given-names></name><article-title>Indian medicinal plants: an illustrated dictionary</article-title><source>Springer-Verlag</source><year>2007</year><volume>Berlin Heidelberg, New York</volume><fpage>725</fpage></mixed-citation></ref><ref id=""B16""><mixed-citation publication-type=""book""><name><surname>Chadha</surname><given-names>HR</given-names></name><source>The wealth of India raw materials, Publication and Information Directorate</source><year>2003</year><publisher-name>New Delhi: CSIR</publisher-name><comment><bold>XI</bold>:11</comment></mixed-citation></ref><ref id=""B17""><mixed-citation publication-type=""book""><name><surname>Sinha</surname><given-names>SC</given-names></name><source>Medicinal plants of Manipur, (Manipur Association for Science &amp; Society (MASS), Manipur Cultural Integration Conference (MCIC) Publishers, Palace Compound, Imphal)</source><year>1996</year><publisher-name>Calcutta: Manasi Printers</publisher-name></mixed-citation></ref><ref id=""B18""><mixed-citation publication-type=""book""><name><surname>Peter</surname><given-names>H</given-names></name><article-title>Institute of genetics and crop plant research</article-title><source>Mansfeld's Encyclopedia of Agricultural and Horticultural Crops (Except Ornamentals</source><year>2001</year><publisher-name>Berlin Heidelberg, New York: Springer-Verlin</publisher-name><fpage>1374</fpage></mixed-citation></ref><ref id=""B19""><mixed-citation publication-type=""journal""><name><surname>Catherina</surname><given-names>CG</given-names></name><name><surname>Mahabir</surname><given-names>PG</given-names></name><article-title>A quarter century of pharmacognostic research on panamanian flora: a review</article-title><source>Planta Med</source><year>2011</year><volume>77</volume><fpage>1189</fpage><lpage>1202</lpage><pub-id pub-id-type=""doi"">10.1055/s-0030-1271187</pub-id><pub-id pub-id-type=""pmid"">21674433</pub-id></mixed-citation></ref><ref id=""B20""><mixed-citation publication-type=""journal""><name><surname>Mosaddik</surname><given-names>MA</given-names></name><name><surname>Banbury</surname><given-names>L</given-names></name><name><surname>Forster</surname><given-names>P</given-names></name><name><surname>Booth</surname><given-names>R</given-names></name><name><surname>Markham</surname><given-names>J</given-names></name><name><surname>Leach</surname><given-names>D</given-names></name><name><surname>Waterman</surname><given-names>PG</given-names></name><article-title>Screening of some Australian flacourtiaceae species for in vitro antioxidant, cytotoxic and antimicrobial activity</article-title><source>Phytomedicine</source><year>2004</year><volume>11</volume><issue>5</issue><fpage>461</fpage><lpage>466</lpage><pub-id pub-id-type=""doi"">10.1016/j.phymed.2003.12.001</pub-id><pub-id pub-id-type=""pmid"">15330503</pub-id></mixed-citation></ref><ref id=""B21""><mixed-citation publication-type=""book""><name><surname>Andressa</surname><given-names>FP</given-names></name><source>Caracterização fitoquímica e atividades biológicas De Xylosma ciliatifolium (Clos) eichler, flacourtiaceae (salicaceae Sensu Lato)</source><year>2010</year><publisher-name>Dissertation: Universidade Federal Do Paraná Curitiba</publisher-name></mixed-citation></ref><ref id=""B22""><mixed-citation publication-type=""journal""><name><surname>Castro</surname><given-names>SBR</given-names></name><name><surname>Leal</surname><given-names>CAG</given-names></name><name><surname>Freire</surname><given-names>FR</given-names></name><name><surname>Carvalho</surname><given-names>DA</given-names></name><name><surname>Oliveira</surname><given-names>DF</given-names></name><name><surname>Figueiredo</surname><given-names>HCP</given-names></name><article-title>Antibacterial activity of plant extracts from brazil against fish pathogenic bacteria</article-title><source>Braz J Microbiol</source><year>2008</year><volume>39</volume><fpage>756</fpage><lpage>760</lpage><pub-id pub-id-type=""doi"">10.1590/S1517-83822008000400030</pub-id><pub-id pub-id-type=""pmid"">24031303</pub-id></mixed-citation></ref><ref id=""B23""><mixed-citation publication-type=""journal""><name><surname>Hyun-Kyung</surname><given-names>L</given-names></name><name><surname>Haeng-Byoung</surname><given-names>L</given-names></name><name><surname>Cheol-Soo</surname><given-names>K</given-names></name><name><surname>Young-Joon</surname><given-names>A</given-names></name><article-title>Anti-<italic>Helicobacter pylori</italic>activity of methanol extracts from Korean native plant species in Jeju Island</article-title><source>Agric Chem Biotechnol</source><year>2004</year><volume>47</volume><issue>2</issue><fpage>91</fpage><lpage>96</lpage></mixed-citation></ref><ref id=""B24""><mixed-citation publication-type=""journal""><name><surname>Bich</surname><given-names>NT</given-names></name><name><surname>Van</surname><given-names>CP</given-names></name><name><surname>Huong</surname><given-names>DTM</given-names></name><name><surname>Van</surname><given-names>HN</given-names></name><name><surname>Manh</surname><given-names>CN</given-names></name><name><surname>Tien</surname><given-names>HN</given-names></name><name><surname>Hong-jie</surname><given-names>Z</given-names></name><name><surname>Harry</surname><given-names>HSF</given-names></name><name><surname>Scott</surname><given-names>GF</given-names></name><name><surname>Djaja</surname><given-names>DS</given-names></name><name><surname>Van</surname><given-names>MC</given-names></name><article-title>Chemical constituents from<italic>Xylosma longifolia</italic>and their anti-tubercular activity</article-title><source>Phytochem Lett</source><year>2011</year><volume>4</volume><issue>3</issue><fpage>250</fpage><lpage>253</lpage><pub-id pub-id-type=""doi"">10.1016/j.phytol.2011.04.008</pub-id></mixed-citation></ref><ref id=""B25""><mixed-citation publication-type=""journal""><name><surname>Parveen</surname><given-names>M</given-names></name><name><surname>Ghalib</surname><given-names>RM</given-names></name><name><surname>Rehman</surname><given-names>R</given-names></name><name><surname>Ali</surname><given-names>M</given-names></name><article-title>ChemicalConstituents from the leaves of<italic>Xylosma longifolium</italic></article-title><source>Hamdard Medicus</source><year>2009</year><volume>3</volume><fpage>47</fpage></mixed-citation></ref><ref id=""B26""><mixed-citation publication-type=""journal""><name><surname>Parveen</surname><given-names>M</given-names></name><name><surname>Ghalib</surname><given-names>RM</given-names></name><article-title>Flavonoids and antimicrobial activity of leaves of<italic>Xylosma longifolium</italic></article-title><source>J Chil Chem Soc</source><year>2012</year><volume>57</volume><issue>N:1</issue><fpage>989</fpage><lpage>991</lpage></mixed-citation></ref><ref id=""B27""><mixed-citation publication-type=""journal""><name><surname>Singleton</surname><given-names>VL</given-names></name><name><surname>Rossi</surname><given-names>JA</given-names></name><article-title>Colorimetry of total phenolics with phosphomolybdic-phosptungslic acid reagents</article-title><source>Am J Enol Viticult</source><year>1965</year><volume>16</volume><fpage>144</fpage><lpage>158</lpage></mixed-citation></ref><ref id=""B28""><mixed-citation publication-type=""journal""><name><surname>Okada</surname><given-names>Y</given-names></name><name><surname>Okada</surname><given-names>M</given-names></name><article-title>Scavenging effect of soluble proteins in broad beans on free radicals and active oxygen species</article-title><source>J Agric Food Chem</source><year>1998</year><volume>46</volume><fpage>401</fpage><lpage>406</lpage><pub-id pub-id-type=""doi"">10.1021/jf970470l</pub-id><pub-id pub-id-type=""pmid"">10554253</pub-id></mixed-citation></ref><ref id=""B29""><mixed-citation publication-type=""journal""><name><surname>Chapuis-Lardy</surname><given-names>L</given-names></name><name><surname>Contour-Ansel</surname><given-names>D</given-names></name><name><surname>Bernhard-Reversat</surname><given-names>F</given-names></name><article-title>High-performance liquid chromatography of water-soluble phenolics in leaf litter of three<italic>Eucalyptus</italic>hybrids (Congo)</article-title><source>Plant Sci</source><year>2002</year><volume>163</volume><fpage>217</fpage><lpage>222</lpage><pub-id pub-id-type=""doi"">10.1016/S0168-9452(02)00099-7</pub-id></mixed-citation></ref><ref id=""B30""><mixed-citation publication-type=""journal""><name><surname>Yuangang</surname><given-names>Z</given-names></name><name><surname>Chunying</surname><given-names>L</given-names></name><name><surname>Yujie</surname><given-names>F</given-names></name><name><surname>Chunjian</surname><given-names>Z</given-names></name><article-title>Simultaneous determination of catechin, rutin, quercetin, kaempferol and isorhamnetin in the extract of sea buckthorn (<italic>Hippophae rhamnoides</italic>L.) leaves by RP-HPLC with DAD</article-title><source>J Pharm Biomed Anal</source><year>2006</year><volume>41</volume><fpage>714</fpage><lpage>719</lpage><pub-id pub-id-type=""doi"">10.1016/j.jpba.2005.04.052</pub-id><pub-id pub-id-type=""pmid"">16520013</pub-id></mixed-citation></ref><ref id=""B31""><mixed-citation publication-type=""journal""><name><surname>Kumar</surname><given-names>BSA</given-names></name><name><surname>Lakshman</surname><given-names>K</given-names></name><name><surname>Jayaveera</surname><given-names>KN</given-names></name><name><surname>Krishna</surname><given-names>NV</given-names></name><name><surname>Manjunat</surname><given-names>M</given-names></name><name><surname>Suresh</surname><given-names>MV</given-names></name><article-title>Estimation of rutin and quercetin in<italic>Amaranthus viridis</italic>Linn. by HPLC</article-title><source>Asian J Exp Sci</source><year>2009</year><volume>23</volume><issue>1</issue><fpage>51</fpage><lpage>54</lpage></mixed-citation></ref><ref id=""B32""><mixed-citation publication-type=""journal""><name><surname>Huafu</surname><given-names>W</given-names></name><name><surname>Gordon</surname><given-names>JP</given-names></name><name><surname>Keith</surname><given-names>H</given-names></name><article-title>HPLC determination of catechins in tea leaves and tea extracts using relative response factors</article-title><source>Food Chem</source><year>2003</year><volume>81</volume><issue>2</issue><fpage>307</fpage><lpage>312</lpage><pub-id pub-id-type=""doi"">10.1016/S0308-8146(02)00510-1</pub-id></mixed-citation></ref><ref id=""B33""><mixed-citation publication-type=""journal""><name><surname>Yi</surname><given-names>W</given-names></name><name><surname>Jiang</surname><given-names>C</given-names></name><name><surname>Jiang-Hua</surname><given-names>W</given-names></name><name><surname>Su</surname><given-names>Z</given-names></name><article-title>Simultaneous determination of quercetin, kaempferol and iso-rhamnetin accumulated human breast cancer cells, by high performance liquid chromatography</article-title><source>J Pharm Biomed Anal</source><year>2005</year><volume>39</volume><fpage>328</fpage><lpage>333</lpage><pub-id pub-id-type=""doi"">10.1016/j.jpba.2005.03.016</pub-id><pub-id pub-id-type=""pmid"">15905060</pub-id></mixed-citation></ref><ref id=""B34""><mixed-citation publication-type=""book""><collab>NCCLS (National Committee for Clinical Laboratory Standards)</collab><source>Specialty Collection: Susceptibility Testing. SC21-L. M7-A4</source><year>1997</year><publisher-name>Wayne, PA: NCCLS</publisher-name></mixed-citation></ref><ref id=""B35""><mixed-citation publication-type=""journal""><name><surname>Jennifer</surname><given-names>MA</given-names></name><article-title>Determination of MICs</article-title><source>J Antimicrobial Chemotherapy</source><year>2001</year><volume>48</volume><issue>S1</issue><fpage>5</fpage><lpage>16</lpage></mixed-citation></ref><ref id=""B36""><mixed-citation publication-type=""book""><name><surname>Reeves</surname><given-names>DS</given-names></name><name><surname>Phillips</surname><given-names>I</given-names></name><name><surname>Williams</surname><given-names>JD</given-names></name><source>Laboratory methods in antimicrobial Chemotherapy</source><year>1979</year><publisher-name>Edinburgh: Longman Group Ltd</publisher-name><fpage>20</fpage></mixed-citation></ref><ref id=""B37""><mixed-citation publication-type=""journal""><name><surname>Murray</surname><given-names>PR</given-names></name><name><surname>Baron</surname><given-names>EJ</given-names></name><name><surname>Pfaller</surname><given-names>MA</given-names></name><name><surname>Tenover</surname><given-names>FC</given-names></name><name><surname>Yolke</surname><given-names>RH</given-names></name><article-title>Manual of clinical microbiology</article-title><source>Sixth ed. ASM Washington</source><year>1995</year><volume>9</volume><issue>S1</issue><fpage>S42</fpage><lpage>S46</lpage></mixed-citation></ref><ref id=""B38""><mixed-citation publication-type=""book""><name><surname>Karmanoli</surname><given-names>K</given-names></name><person-group person-group-type=""editor"">Reigosa M, Pedrol N</person-group><article-title>Secondary metabolites as allelochemicals in plant defence against microorganisms of the phyllosphere</article-title><source>Allelopathy from molecules to ecosystem</source><year>2002</year><publisher-name>NH, USA: Science publishers Inc.</publisher-name><fpage>277</fpage><lpage>288</lpage></mixed-citation></ref><ref id=""B39""><mixed-citation publication-type=""journal""><name><surname>Pinelo</surname><given-names>M</given-names></name><name><surname>Rubilar</surname><given-names>M</given-names></name><name><surname>Sineiro</surname><given-names>J</given-names></name><name><surname>Nunez</surname><given-names>MJ</given-names></name><article-title>Extraction of antioxidant phenolics from almond hulls (<italic>Prunus amygdalus</italic>) and pine sawdust (<italic>Pinus pinaster</italic>)</article-title><source>Food Chem</source><year>2004</year><volume>85</volume><fpage>267</fpage><lpage>273</lpage><pub-id pub-id-type=""doi"">10.1016/j.foodchem.2003.06.020</pub-id></mixed-citation></ref><ref id=""B40""><mixed-citation publication-type=""journal""><name><surname>Goli</surname><given-names>A</given-names></name><name><surname>Barzegar</surname><given-names>M</given-names></name><name><surname>Sahari</surname><given-names>MA</given-names></name><article-title>Antioxidant activity and total phenolic compounds of pistachio (<italic>Pistachia vera</italic>) hull extracts</article-title><source>Food Chem</source><year>2004</year><volume>92</volume><fpage>521</fpage><lpage>525</lpage></mixed-citation></ref><ref id=""B41""><mixed-citation publication-type=""journal""><name><surname>Trabelsi</surname><given-names>N</given-names></name><name><surname>Megdiche</surname><given-names>W</given-names></name><name><surname>Ksouri</surname><given-names>R</given-names></name><name><surname>Falleh</surname><given-names>H</given-names></name><name><surname>Oueslati</surname><given-names>S</given-names></name><name><surname>Soumaya</surname><given-names>B</given-names></name><name><surname>Hajilaoui</surname><given-names>H</given-names></name><name><surname>Abdelly</surname><given-names>C</given-names></name><article-title>Solvent effects on phenolic contents and biological activities of the halophytes<italic>Limoniastrum monopetalum</italic>leaves</article-title><source>LWT – Food Sci Tech</source><year>2010</year><volume>43</volume><fpage>632</fpage><lpage>639</lpage><pub-id pub-id-type=""doi"">10.1016/j.lwt.2009.11.003</pub-id><pub-id pub-id-type=""pmid"">23787058</pub-id></mixed-citation></ref><ref id=""B42""><mixed-citation publication-type=""journal""><name><surname>Huang</surname><given-names>D</given-names></name><name><surname>Ou</surname><given-names>B</given-names></name><name><surname>Prior</surname><given-names>RL</given-names></name><article-title>The chemistry behind antioxidant capacity assays</article-title><source>J Agric Food Chem</source><year>2005</year><volume>53</volume><fpage>1841</fpage><lpage>856</lpage><pub-id pub-id-type=""doi"">10.1021/jf030723c</pub-id><pub-id pub-id-type=""pmid"">15769103</pub-id></mixed-citation></ref><ref id=""B43""><mixed-citation publication-type=""journal""><name><surname>Karagozler</surname><given-names>AA</given-names></name><name><surname>Erdag</surname><given-names>B</given-names></name><name><surname>Emek</surname><given-names>YC</given-names></name><name><surname>Uygun</surname><given-names>DA</given-names></name><article-title>Antioxidant activity and proline content of leaf extracts from<italic>Dorystoechas hastate</italic></article-title><source>Food Chem</source><year>2008</year><volume>111</volume><fpage>400</fpage><lpage>407</lpage><pub-id pub-id-type=""doi"">10.1016/j.foodchem.2008.03.089</pub-id></mixed-citation></ref><ref id=""B44""><mixed-citation publication-type=""journal""><name><surname>González</surname><given-names>EM</given-names></name><name><surname>de Ancos</surname><given-names>B</given-names></name><name><surname>Cano</surname><given-names>MP</given-names></name><article-title>Relation between bioactive compounds and free radical-scavenging capacity in berry fruits during frozen storage</article-title><source>J Sci Food Agric</source><year>2003</year><volume>83</volume><fpage>722</fpage><lpage>726</lpage><pub-id pub-id-type=""doi"">10.1002/jsfa.1359</pub-id></mixed-citation></ref><ref id=""B45""><mixed-citation publication-type=""journal""><name><surname>Llobera</surname><given-names>A</given-names></name><name><surname>Cañellas</surname><given-names>J</given-names></name><article-title>Dietary fibre content and antioxidant activity of Manto Negro red grape (<italic>Vitis vinifera</italic>): Pomace and stem</article-title><source>Food Chem</source><year>2007</year><volume>101</volume><fpage>659</fpage><lpage>666</lpage><pub-id pub-id-type=""doi"">10.1016/j.foodchem.2006.02.025</pub-id></mixed-citation></ref><ref id=""B46""><mixed-citation publication-type=""journal""><name><surname>Makris</surname><given-names>DP</given-names></name><name><surname>Boskou</surname><given-names>G</given-names></name><name><surname>Andrikopoulos</surname><given-names>NK</given-names></name><article-title>Polyphenolic content and<italic>in vitro</italic>antioxidant characteristics of wine industry and other agri-food solid waste extracts</article-title><source>J Food Comp Anal</source><year>2007</year><volume>20</volume><fpage>125</fpage><lpage>132</lpage><pub-id pub-id-type=""doi"">10.1016/j.jfca.2006.04.010</pub-id></mixed-citation></ref><ref id=""B47""><mixed-citation publication-type=""journal""><name><surname>Lecumberri</surname><given-names>E</given-names></name><name><surname>Mateos</surname><given-names>R</given-names></name><name><surname>Izquierdo-Pulido</surname><given-names>M</given-names></name><name><surname>Rupérez</surname><given-names>P</given-names></name><name><surname>Goya</surname><given-names>L</given-names></name><name><surname>Bravo</surname><given-names>L</given-names></name><article-title>Dietary fibre composition, antioxidant capacity and physico-chemical properties of a fibrerich product from cocoa (<italic>Theobroma cacao</italic>L.)</article-title><source>Food Chem</source><year>2007</year><volume>104</volume><fpage>948</fpage><lpage>954</lpage><pub-id pub-id-type=""doi"">10.1016/j.foodchem.2006.12.054</pub-id></mixed-citation></ref><ref id=""B48""><mixed-citation publication-type=""journal""><name><surname>Prior</surname><given-names>RL</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Schaich</surname><given-names>K</given-names></name><article-title>Standardized methods for the determination of antioxidant capacity and phenolics in foods and dietary supplements</article-title><source>J Agric Food Chem</source><year>2005</year><volume>53</volume><fpage>4290</fpage><lpage>4302</lpage><pub-id pub-id-type=""doi"">10.1021/jf0502698</pub-id><pub-id pub-id-type=""pmid"">15884874</pub-id></mixed-citation></ref><ref id=""B49""><mixed-citation publication-type=""journal""><name><surname>Bourgou</surname><given-names>S</given-names></name><name><surname>Ksouri</surname><given-names>R</given-names></name><name><surname>Bellila</surname><given-names>A</given-names></name><name><surname>Skandrani</surname><given-names>I</given-names></name><name><surname>Falleh</surname><given-names>H</given-names></name><name><surname>Marzouk</surname><given-names>B</given-names></name><article-title>Phenolic composition and biological properties and potential apllications in food-a review</article-title><source>Int J Food Microbiol</source><year>2008</year><volume>94</volume><fpage>223</fpage><lpage>253</lpage></mixed-citation></ref><ref id=""B50""><mixed-citation publication-type=""journal""><name><surname>Falleh</surname><given-names>H</given-names></name><name><surname>Ksouri</surname><given-names>R</given-names></name><name><surname>Chaieb</surname><given-names>K</given-names></name><name><surname>Karray-Bouraoui</surname><given-names>N</given-names></name><name><surname>Trabelsi</surname><given-names>N</given-names></name><name><surname>Boulaaba</surname><given-names>M</given-names></name><name><surname>Abdelly</surname><given-names>C</given-names></name><article-title>Phenolic composition of<italic>Cynara cardunculus</italic>L. organs, and their biological activities</article-title><source>C R Biol</source><year>2008</year><volume>331</volume><fpage>372</fpage><lpage>379</lpage><pub-id pub-id-type=""doi"">10.1016/j.crvi.2008.02.008</pub-id><pub-id pub-id-type=""pmid"">18472083</pub-id></mixed-citation></ref><ref id=""B51""><mixed-citation publication-type=""journal""><name><surname>Verstraeten</surname><given-names>SV</given-names></name><name><surname>Keen</surname><given-names>CL</given-names></name><name><surname>Schmitz</surname><given-names>HH</given-names></name><name><surname>Fraga</surname><given-names>CEG</given-names></name><name><surname>Oteiza</surname><given-names>PI</given-names></name><article-title>Flavan-3-Ols and procyanidins protect liposomes against lipid oxidation and disruption of the bilayer structure</article-title><source>Free Radic Biol Med</source><year>2003</year><volume>34</volume><issue>1</issue><fpage>84</fpage><lpage>92</lpage><pub-id pub-id-type=""doi"">10.1016/S0891-5849(02)01185-1</pub-id><pub-id pub-id-type=""pmid"">12498983</pub-id></mixed-citation></ref><ref id=""B52""><mixed-citation publication-type=""journal""><name><surname>Lotito</surname><given-names>SB</given-names></name><name><surname>Fre</surname><given-names>B</given-names></name><article-title>Relevance of apple polyphenols as antioxidants in human plasma: contrasting<italic>in vitro</italic>and<italic>in vivo</italic>effects</article-title><source>Free Radic Biol Med</source><year>2004</year><volume>36</volume><issue>2</issue><fpage>201</fpage><lpage>211</lpage><pub-id pub-id-type=""pmid"">14744632</pub-id></mixed-citation></ref><ref id=""B53""><mixed-citation publication-type=""other""><name><surname>Al-Obid</surname><given-names>MR</given-names></name><article-title>Date skin as a source of antioxidant activity and free radical scavenging</article-title><source>First International Meeting of Date Palm Phoenix dactylifera L., Qas- sim</source><year>2003</year><fpage>643</fpage><lpage>658</lpage></mixed-citation></ref><ref id=""B54""><mixed-citation publication-type=""journal""><name><surname>Galato</surname><given-names>D</given-names></name><name><surname>Ckless</surname><given-names>K</given-names></name><name><surname>Susin</surname><given-names>MF</given-names></name><name><surname>Giacomelli</surname><given-names>C</given-names></name><name><surname>Riberio Do Valle</surname><given-names>RM</given-names></name><name><surname>Spineeli</surname><given-names>A</given-names></name><article-title>Antioxidant capacity of phenolic and related compounds: correlation among electrochemical, visible spectroscopy methods and structure – antioxidant activity</article-title><source>Redox Rep</source><year>2001</year><volume>6</volume><fpage>250</fpage></mixed-citation></ref><ref id=""B55""><mixed-citation publication-type=""journal""><name><surname>Borchers</surname><given-names>AT</given-names></name><name><surname>Keen</surname><given-names>CI</given-names></name><name><surname>Gerstiwin</surname><given-names>ME</given-names></name><article-title>Mushrooms, tumors and immunity: an update</article-title><source>Exp Biol Med</source><year>2004</year><volume>229</volume><fpage>393</fpage><lpage>406</lpage></mixed-citation></ref><ref id=""B56""><mixed-citation publication-type=""journal""><name><surname>Rauha</surname><given-names>JP</given-names></name><name><surname>Remes</surname><given-names>S</given-names></name><name><surname>Heinonen</surname><given-names>M</given-names></name><name><surname>Hopia</surname><given-names>A</given-names></name><name><surname>Kahkonen</surname><given-names>M</given-names></name><name><surname>Kujala</surname><given-names>T</given-names></name><name><surname>Pihlaja</surname><given-names>K</given-names></name><name><surname>Vuorela</surname><given-names>H</given-names></name><name><surname>Vuorela</surname><given-names>P</given-names></name><article-title>Antimicrobial effects of Finnish plant extracts containing flavonoids and other phenolic compounds</article-title><source>In J Food Microbiol</source><year>2000</year><volume>56</volume><fpage>3</fpage><lpage>12</lpage><pub-id pub-id-type=""doi"">10.1016/S0168-1605(00)00218-X</pub-id></mixed-citation></ref><ref id=""B57""><mixed-citation publication-type=""journal""><name><surname>Archana</surname><given-names>B</given-names></name><name><surname>Dasgupta</surname><given-names>N</given-names></name><name><surname>De</surname><given-names>B</given-names></name><article-title><italic>In vitro</italic>study of antioxidant activity of<italic>Syzgium cumini</italic>fruit</article-title><source>Food Chem</source><year>2005</year><volume>90</volume><fpage>727</fpage><lpage>733</lpage><pub-id pub-id-type=""doi"">10.1016/j.foodchem.2004.04.033</pub-id></mixed-citation></ref><ref id=""B58""><mixed-citation publication-type=""journal""><name><surname>Hatano</surname><given-names>T</given-names></name><name><surname>Edamatsu</surname><given-names>R</given-names></name><name><surname>Mori</surname><given-names>A</given-names></name><name><surname>Fujita</surname><given-names>Y</given-names></name><name><surname>Yasuhara</surname><given-names>E</given-names></name><article-title>Effect of interaction of tannins with co-existing substances. VI. Effects of tannins and related polyphenols on superoxide anion radical and on DPPH radical</article-title><source>Chem Pharm Bul</source><year>1989</year><volume>37</volume><fpage>2016</fpage><lpage>2021</lpage><pub-id pub-id-type=""doi"">10.1248/cpb.37.2016</pub-id></mixed-citation></ref><ref id=""B59""><mixed-citation publication-type=""journal""><name><surname>Velioglu</surname><given-names>YS</given-names></name><name><surname>Mazza</surname><given-names>G</given-names></name><name><surname>Gao</surname><given-names>L</given-names></name><name><surname>Oomah</surname><given-names>BD</given-names></name><article-title>Antioxidant activity and total phenolics in selected fruits, vegetables and grain products</article-title><source>J Agric Food Chem</source><year>1998</year><volume>46</volume><fpage>4113</fpage><lpage>4117</lpage><pub-id pub-id-type=""doi"">10.1021/jf9801973</pub-id></mixed-citation></ref><ref id=""B60""><mixed-citation publication-type=""journal""><name><surname>Vinson</surname><given-names>JA</given-names></name><name><surname>Young</surname><given-names>H</given-names></name><name><surname>Xuchui</surname><given-names>S</given-names></name><name><surname>Zubik</surname><given-names>L</given-names></name><article-title>Phenol antioxidant quantity and quality in foods: vegetables</article-title><source>J Agric Food Chem</source><year>1998</year><volume>46</volume><fpage>3630</fpage><lpage>3634</lpage><pub-id pub-id-type=""doi"">10.1021/jf980295o</pub-id></mixed-citation></ref><ref id=""B61""><mixed-citation publication-type=""journal""><name><surname>Gülçin</surname><given-names>I</given-names></name><name><surname>Oktay</surname><given-names>M</given-names></name><name><surname>Küfrevioğlu</surname><given-names>Ӧİ</given-names></name><name><surname>Aslan</surname><given-names>A</given-names></name><article-title>Determination of antioxidant activity of lichen<italic>Cetraria islandica</italic>(L.) Ach</article-title><source>J Ethnopharmacol</source><year>2002</year><volume>79</volume><fpage>325</fpage><lpage>329</lpage><pub-id pub-id-type=""doi"">10.1016/S0378-8741(01)00396-8</pub-id><pub-id pub-id-type=""pmid"">11849836</pub-id></mixed-citation></ref><ref id=""B62""><mixed-citation publication-type=""journal""><name><surname>Oktay</surname><given-names>M</given-names></name><name><surname>Gülçin</surname><given-names>I</given-names></name><name><surname>Küfrevioğlu</surname><given-names>Ӧİ</given-names></name><article-title>Determination of in vitro antioxidant activity of fennel (<italic>Foeniculum vulgare</italic>) seed extracts</article-title><source>Lebensmittel-Wissenchaft und Technologie</source><year>2003</year><volume>36</volume><fpage>263</fpage><lpage>271</lpage></mixed-citation></ref><ref id=""B63""><mixed-citation publication-type=""journal""><name><surname>Duh</surname><given-names>PD</given-names></name><name><surname>Tu</surname><given-names>YY</given-names></name><name><surname>Yen</surname><given-names>GC</given-names></name><article-title>Antioxidant activity of water extract of Harug Jyur (<italic>Chrysanthemum morifolium</italic>Ramat)</article-title><source>Lebensmittel-Wissenchaft und Technologie</source><year>1999</year><volume>32</volume><fpage>269</fpage><lpage>277</lpage></mixed-citation></ref><ref id=""B64""><mixed-citation publication-type=""book""><name><surname>Ribereau-Gayon</surname><given-names>P</given-names></name><person-group person-group-type=""editor"">Dunod</person-group><article-title>Notions generales sur les composes phenoliques, methodes generales d’etudes des composes phenoliques</article-title><source>Les Composés Phenoliques des Vegetaux</source><year>1968</year><publisher-name>Paris</publisher-name></mixed-citation></ref><ref id=""B65""><mixed-citation publication-type=""journal""><name><surname>Havsteen</surname><given-names>B</given-names></name><article-title>Flavonoids, a class of natural products of high pharmacological potency</article-title><source>Biochem Pharmacol</source><year>1983</year><volume>32</volume><fpage>1141</fpage><lpage>8</lpage><pub-id pub-id-type=""doi"">10.1016/0006-2952(83)90262-9</pub-id><pub-id pub-id-type=""pmid"">6342623</pub-id></mixed-citation></ref><ref id=""B66""><mixed-citation publication-type=""journal""><name><surname>Harborne</surname><given-names>JB</given-names></name><name><surname>Williams</surname><given-names>CA</given-names></name><article-title>Advances in flavonoid research since 1992</article-title><source>Phytochem</source><year>2000</year><volume>55</volume><fpage>481</fpage><lpage>504</lpage><pub-id pub-id-type=""doi"">10.1016/S0031-9422(00)00235-1</pub-id></mixed-citation></ref><ref id=""B67""><mixed-citation publication-type=""book""><name><surname>Harborne</surname><given-names>JB</given-names></name><name><surname>Baxter</surname><given-names>H</given-names></name><source>The handbook of natural flavonoids. Vols 1 and 2</source><year>1999</year><publisher-name>Chichester, UK: John Wiley and Sons</publisher-name></mixed-citation></ref><ref id=""B68""><mixed-citation publication-type=""book""><name><surname>JrE</surname><given-names>M</given-names></name><name><surname>Chithan</surname><given-names>K</given-names></name><person-group person-group-type=""editor"">Harborne JB</person-group><article-title>The impact of plant flavonoids on mammalian biology: implications for immunity, inflammation and cancer</article-title><source>The flavonoids: advances in research since 1986</source><year>1993</year><publisher-name>London, UK: Chapman and Hall</publisher-name></mixed-citation></ref><ref id=""B69""><mixed-citation publication-type=""journal""><name><surname>Baise</surname><given-names>HP</given-names></name><name><surname>Walker</surname><given-names>TS</given-names></name><name><surname>Stermitz</surname><given-names>FR</given-names></name><name><surname>Hufbauer</surname><given-names>RS</given-names></name><name><surname>Vivanco</surname><given-names>JM</given-names></name><article-title>Enantiometric dependent phytotoxic and antimicrobial activity of (±)–catechin; a rhizosecreted racemic mixture from<italic>Centaurea maculosa</italic>(spotted knapweed)</article-title><source>Plant Physiol</source><year>2002</year><volume>128</volume><fpage>1173</fpage><lpage>1177</lpage><pub-id pub-id-type=""doi"">10.1104/pp.011019</pub-id><pub-id pub-id-type=""pmid"">11950966</pub-id></mixed-citation></ref><ref id=""B70""><mixed-citation publication-type=""journal""><name><surname>Cushnie</surname><given-names>T</given-names></name><name><surname>Lamb</surname><given-names>A</given-names></name><article-title>Antimicrobial activity of flavonoids</article-title><source>Int J Antimicrob Agents</source><year>2005</year><volume>26</volume><issue>5</issue><fpage>343</fpage><lpage>356</lpage><pub-id pub-id-type=""doi"">10.1016/j.ijantimicag.2005.09.002</pub-id><pub-id pub-id-type=""pmid"">16323269</pub-id></mixed-citation></ref><ref id=""B71""><mixed-citation publication-type=""journal""><name><surname>Shimamura</surname><given-names>T</given-names></name><name><surname>Zhao</surname><given-names>WH</given-names></name><name><surname>Hu</surname><given-names>ZQ</given-names></name><article-title>Mechanism of action and potential for use of tea catechin in an anti-infective agent</article-title><source>Anti-infective Agents in Medic Chem</source><year>2007</year><volume>6</volume><fpage>57</fpage><lpage>62</lpage><pub-id pub-id-type=""doi"">10.2174/187152107779314124</pub-id></mixed-citation></ref><ref id=""B72""><mixed-citation publication-type=""journal""><name><surname>Tavares</surname><given-names>AC</given-names></name><name><surname>Goncalves</surname><given-names>MJ</given-names></name><name><surname>Cavaleira</surname><given-names>C</given-names></name><name><surname>Cruz</surname><given-names>MT</given-names></name><name><surname>Lopes</surname><given-names>MC</given-names></name><name><surname>Canhoto</surname><given-names>J</given-names></name><name><surname>Salgueiro</surname><given-names>LR</given-names></name><article-title>Essential oil of<italic>Daucus carota</italic>subsp.<italic>halophilus</italic>: composition, antifungal activity and cytotoxicity</article-title><source>J Ethnopharmacol</source><year>2008</year><volume>119</volume><fpage>129</fpage><lpage>134</lpage><pub-id pub-id-type=""doi"">10.1016/j.jep.2008.06.012</pub-id><pub-id pub-id-type=""pmid"">18606215</pub-id></mixed-citation></ref><ref id=""B73""><mixed-citation publication-type=""journal""><name><surname>Koda</surname><given-names>T</given-names></name><name><surname>Kuroda</surname><given-names>Y</given-names></name><name><surname>Imai</surname><given-names>H</given-names></name><article-title>Protective effect of rutin against spatial memory impairment induced by trimethyltin in rats</article-title><source>Nutr Res</source><year>2008</year><volume>28</volume><fpage>629</fpage><lpage>634</lpage><pub-id pub-id-type=""doi"">10.1016/j.nutres.2008.06.004</pub-id><pub-id pub-id-type=""pmid"">19083469</pub-id></mixed-citation></ref><ref id=""B74""><mixed-citation publication-type=""journal""><name><surname>Kabuki</surname><given-names>T</given-names></name><name><surname>Nakajima</surname><given-names>H</given-names></name><name><surname>Arai</surname><given-names>M</given-names></name><name><surname>Ueda</surname><given-names>S</given-names></name><name><surname>Kuwabara</surname><given-names>Y</given-names></name><name><surname>Dosaka</surname><given-names>S</given-names></name><article-title>Characterization of novel antimicrobial compounds from mango (<italic>Mangifera indica</italic>L.) kernel seeds</article-title><source>Food Chem</source><year>2000</year><volume>50</volume><fpage>565</fpage><lpage>570</lpage></mixed-citation></ref><ref id=""B75""><mixed-citation publication-type=""journal""><name><surname>Perry</surname><given-names>NB</given-names></name><name><surname>Foster</surname><given-names>LM</given-names></name><article-title>Antiviral and antifungal flavonoids, plus triterpene from Hebe cuppressoides</article-title><source>Plants Med</source><year>1994</year><volume>60</volume><fpage>491</fpage><lpage>492</lpage><pub-id pub-id-type=""doi"">10.1055/s-2006-959549</pub-id></mixed-citation></ref><ref id=""B76""><mixed-citation publication-type=""journal""><name><surname>Pandey</surname><given-names>DK</given-names></name><name><surname>Tripathi</surname><given-names>NN</given-names></name><name><surname>Tripathi</surname><given-names>RD</given-names></name><name><surname>Dixit</surname><given-names>SN</given-names></name><article-title>Fungitoxic and phytotoxic properties of the essential oil<italic>Caesulia axillaris</italic>Roxb</article-title><source>Angewa Bot</source><year>1982</year><volume>56</volume><fpage>259</fpage><lpage>267</lpage></mixed-citation></ref><ref id=""B77""><mixed-citation publication-type=""journal""><name><surname>Chung</surname><given-names>PH</given-names></name><name><surname>Lee</surname><given-names>CW</given-names></name><name><surname>Chou</surname><given-names>JY</given-names></name><name><surname>Murugan</surname><given-names>M</given-names></name><name><surname>Shieh</surname><given-names>BJ</given-names></name><name><surname>Chen</surname><given-names>HM</given-names></name><article-title>Antifungal activity of crude extracts and essential oil of<italic>Moringa olifera</italic>Lam</article-title><source>Bioresour Technol</source><year>2007</year><volume>98</volume><fpage>232</fpage><lpage>236</lpage><pub-id pub-id-type=""doi"">10.1016/j.biortech.2005.11.003</pub-id><pub-id pub-id-type=""pmid"">16406607</pub-id></mixed-citation></ref><ref id=""B78""><mixed-citation publication-type=""journal""><name><surname>Prasad</surname><given-names>NR</given-names></name><name><surname>Anandi</surname><given-names>C</given-names></name><name><surname>Balasubramania</surname><given-names>S</given-names></name><name><surname>Pugalendi</surname><given-names>KV</given-names></name><article-title>Antidermatophytic activity of extracts from<italic>Psoralea corylifolia</italic>(Fabaceae) correlate with the presence of a flavonoid compound</article-title><source>J Ethnopharmacol</source><year>2004</year><volume>91</volume><fpage>21</fpage><lpage>34</lpage><pub-id pub-id-type=""doi"">10.1016/j.jep.2003.11.010</pub-id><pub-id pub-id-type=""pmid"">15036462</pub-id></mixed-citation></ref><ref id=""B79""><mixed-citation publication-type=""journal""><name><surname>Vivek</surname><given-names>KB</given-names></name><name><surname>Jung</surname><given-names>IY</given-names></name><name><surname>Sun</surname><given-names>CK</given-names></name><article-title>Antioxidant and antidermatophytic activities of essential oil and extracts of<italic>Magnolia liliflora</italic>Desr</article-title><source>Food Chem Toxicol</source><year>2009</year><volume>47</volume><fpage>260</fpage><lpage>2612</lpage><pub-id pub-id-type=""doi"">10.1016/j.fct.2008.11.015</pub-id><pub-id pub-id-type=""pmid"">19049815</pub-id></mixed-citation></ref><ref id=""B80""><mixed-citation publication-type=""journal""><name><surname>Urzua</surname><given-names>A</given-names></name><name><surname>Torre</surname><given-names>R</given-names></name><name><surname>Bueno</surname><given-names>C</given-names></name><name><surname>Mendoza</surname><given-names>L</given-names></name><article-title>Flavonoids and diterpenoids in the trichome resinous exudate from<italic>Psudeognaphalium cheivanthifolium.</italic>P. heterotrichium and P. vira vira</article-title><source>Biochem Syst Ecol</source><year>1995</year><volume>23</volume><fpage>459</fpage><pub-id pub-id-type=""doi"">10.1016/0305-1978(95)00025-P</pub-id></mixed-citation></ref><ref id=""B81""><mixed-citation publication-type=""journal""><name><surname>Ayaz</surname><given-names>F</given-names></name><name><surname>HayIrlIoglu-Ayaz</surname><given-names>S</given-names></name><name><surname>Alpay-Karaoglu</surname><given-names>S</given-names></name><name><surname>Gruz</surname><given-names>J</given-names></name><name><surname>Valentová</surname><given-names>K</given-names></name><name><surname>Ulrichová</surname><given-names>J</given-names></name><name><surname>Starnad</surname><given-names>M</given-names></name><article-title>Phenolic acid contents of kale (<italic>Brassica oleraceae</italic>L. var.<italic>acephala</italic>DC.) extracts and their antioxidant and antibacterial activities</article-title><source>Food Chem</source><year>2008</year><volume>107</volume><fpage>19</fpage><lpage>25</lpage><pub-id pub-id-type=""doi"">10.1016/j.foodchem.2007.07.003</pub-id></mixed-citation></ref><ref id=""B82""><mixed-citation publication-type=""journal""><name><surname>Rahman</surname><given-names>M</given-names></name><name><surname>Moon</surname><given-names>S</given-names></name><article-title>Antimicrobial phenolic derivatives from<italic>Dendranthema zawadskii</italic>var.<italic>latilobum kitamura</italic>(Asteraceae)</article-title><source>Arch Pharm Res</source><year>2007</year><volume>30</volume><fpage>1374</fpage><lpage>1379</lpage><pub-id pub-id-type=""doi"">10.1007/BF02977359</pub-id><pub-id pub-id-type=""pmid"">18087803</pub-id></mixed-citation></ref><ref id=""B83""><mixed-citation publication-type=""journal""><name><surname>Vaquero</surname><given-names>MJR</given-names></name><name><surname>Alberto</surname><given-names>MR</given-names></name><name><surname>de Nadra</surname><given-names>MCM</given-names></name><article-title>Antibacterial effect of phenolic compounds from different wines</article-title><source>Food Control</source><year>2007</year><volume>18</volume><fpage>93</fpage><lpage>101</lpage><pub-id pub-id-type=""doi"">10.1016/j.foodcont.2005.08.010</pub-id></mixed-citation></ref><ref id=""B84""><mixed-citation publication-type=""journal""><name><surname>Ghannoum</surname><given-names>MA</given-names></name><name><surname>Rice</surname><given-names>LB</given-names></name><article-title>Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance</article-title><source>Clin Microbial Rev</source><year>1999</year><volume>12</volume><issue>4</issue><fpage>501</fpage><lpage>517</lpage></mixed-citation></ref></ref-list>"
10.1104/pp.011019	"<html><body><p>BMC_Complement_Altern_Med/PMC3733846.nxml                                                           0000664 0011011 0007774 00000317441 13031245651 016673  0                                                                                                    ustar   pmc                             pmcdev<!DOCTYPE article PUBLIC ""-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN"" ""JATS-archivearticle1.dtd""><dc:date>2007</dc:date><dcterms:bibliographiccitation>BMC Plant Biology 7(1): 25-. (2007)</dcterms:bibliographiccitation><dc:identifier type=""sici"">1471-2229(2007)7:1&lt;25&gt;</dc:identifier><dcterms:ispartof>urn:ISSN:1471-2229</dcterms:ispartof><license rdf:about=""http://creativecommons.org/licenses/by/2.0""><permits rdf:resource=""http://web.resource.org/cc/Reproduction"" xmlns=""""></permits><permits rdf:resource=""http://web.resource.org/cc/Distribution"" xmlns=""""></permits><requires rdf:resource=""http://web.resource.org/cc/Notice"" xmlns=""""></requires><requires rdf:resource=""http://web.resource.org/cc/Attribution"" xmlns=""""></requires><permits rdf:resource=""http://web.resource.org/cc/DerivativeWorks"" xmlns=""""></permits></license>--&gt;<abstract><sec><title>Background</title><p>The economic and biological implications of plant invasion are overwhelming; however, the processes by which plants become successful invaders are not well understood. Limited genetic resources are available for most invasive and weedy species, making it difficult to study molecular and genetic aspects that may be associated with invasion.</p></sec><sec><title>Results</title><p>As an initial step towards understanding the molecular mechanisms by which plants become invasive, we have generated a normalized Expressed Sequence Tag (EST) library comprising seven invasive populations of<italic>Centaurea maculosa</italic>, an invasive aster in North America. Seventy-seven percent of the 4423 unique transcripts showed significant similarity to existing proteins in the NCBI database and could be grouped based on gene ontology assignments.</p></sec><sec><title>Conclusion</title><p>The<italic>C. maculosa</italic>EST library represents an initial step towards looking at gene-specific expression in this species, and will pave the way for creation of other resources such as microarray chips that can help provide a view of global gene expression in invasive<italic>C. maculosa</italic>and its native counterparts. To our knowledge, this is the first published set of ESTs derived from an invasive weed that will be targeted to study invasive behavior. Understanding the genetic basis of evolution for increased invasiveness in exotic plants is critical to understanding the mechanisms through which exotic invasions occur.</p></sec></abstract><sec><title>Background</title><p>Invasive weeds are regarded as major threats to biodiversity because they can spread through communities, displacing or even eradicating native species. Over 25,000 invasive plant species have been documented in the United States, invading nearly 700,000 hectares per year, with a cost exceeding 34.5 billion dollars per year [<xref ref-type=""bibr"" rid=""B1"">1</xref>]. Multiple non-exclusive ecological hypotheses exist to explain plant invasion in new habitats [<xref ref-type=""bibr"" rid=""B2"">2</xref>]. The niche hypothesis suggests invaders are able to take advantage of unutilized resources in new environments [<xref ref-type=""bibr"" rid=""B3"">3</xref>]. The natural enemy release hypothesis suggests invaders escape their natural enemies when moving to new environments, allowing them to obtain high population densities [<xref ref-type=""bibr"" rid=""B4"">4</xref>]. The novel weapons hypothesis suggests that invaders come equipped with an arsenal of chemical weapons that are detrimental to the resident community of the invaded habitat [<xref ref-type=""bibr"" rid=""B5"">5</xref>]. The plant community in the invader's native habitat has had time to co-evolve defenses against these chemical weapons, whereas the invaded community has not, allowing invaders to obtain a competitive advantage in their new environment [<xref ref-type=""bibr"" rid=""B5"">5</xref>]. The evolution of increased competitive ability (EICA) hypothesis expands on the idea of natural enemy release, suggesting that invaders have rapidly evolved in their new environment to direct more resources to competitive ability over defense [<xref ref-type=""bibr"" rid=""B6"">6</xref>]. Similarly, the allelopathic advantages against resident species (AARS) hypothesis expands on the idea of novel weapons, suggesting that novel weapons which increase plant competitive ability are selected for in the invasive range [<xref ref-type=""bibr"" rid=""B7"">7</xref>]. All these hypotheses are supported at least in part by data from field experiments which are often coupled with physiological and biochemical studies; however, it remains unclear why some plants become problematic invaders and others do not. One aspect that is rarely investigated in relation to invasive weeds and their native counterparts is the potential for modified gene regulation in the introduced range. As limited genetic resources are available for most invaders and other weedy species [<xref ref-type=""bibr"" rid=""B8"">8</xref>], defense and growth response genes cannot be effectively monitored at the molecular level to test hypotheses of plant invasion.</p><p><italic>Centaurea maculosa</italic>Lam. (spotted knapweed) is a Eurasian native that has become a particularly problematic invasive weed in the northwestern United States, infesting over 4.5 million acres in Montana alone [<xref ref-type=""bibr"" rid=""B9"">9</xref>]. Spotted knapweed often colonizes disturbed areas in North America, but also invades rangelands, pastures and prairies, where it displaces native species and establishes dense monocultures. Diploid and tetraploid forms of the weed exist in the native range, but only tetraploid plants have been identified in North America [<xref ref-type=""bibr"" rid=""B10"">10</xref>]. The diploid form contains 18 chromosomes [<xref ref-type=""bibr"" rid=""B11"">11</xref>], with a DNA content (2C) near 3.6 picograms based on measures from closely related species of the same chromosome number [<xref ref-type=""bibr"" rid=""B12"">12</xref>]. This translates to an estimated genome size of approximately 1,800 Mbp. Molecular markers and karyotyping have been used to identify the two forms, as it is impossible to distinguish between them based on morphological characters [<xref ref-type=""bibr"" rid=""B10"">10</xref>]. Both forms are short-lived outcrossing perennials of the aster family; however, the diploid is monocarpic while the tetraploid is polycarpic. Also, the tetraploid can tolerate dense vegetation and thus may be a better competitor than the diploid. This is presumed to be the main reason why only the tetraploid form is invasive in North America, while it is not considered invasive or even predominant in its native Eurasian habitat [<xref ref-type=""bibr"" rid=""B10"">10</xref>]. Ecological and greenhouse investigations suggest that invasive<italic>C. maculosa</italic>is a strong competitor against North American natives, even in the presence of biocontrol agents that have been introduced to limit the spread of the weed [<xref ref-type=""bibr"" rid=""B13"">13</xref>-<xref ref-type=""bibr"" rid=""B17"">17</xref>]. Also, common garden studies suggest that North American<italic>C. maculosa</italic>seeds germinate more readily than their Eurasian counterparts and the resulting individuals are larger, more robust, and better able to fend off and compensate for herbivore attack, under both greenhouse and field conditions [Ridenour<italic>et al</italic>. submitted]. These studies give partial support to the EICA hypotheses. There is also evidence that<italic>Centaurea</italic>species (<italic>C. maculosa</italic>and<italic>C. diffusa</italic>) produce allelopathic compounds that inhibit growth and germination of North American plant species more severely than their native congneners, lending support to the novel weapons hypothesis [<xref ref-type=""bibr"" rid=""B5"">5</xref>,<xref ref-type=""bibr"" rid=""B7"">7</xref>,<xref ref-type=""bibr"" rid=""B15"">15</xref>,<xref ref-type=""bibr"" rid=""B16"">16</xref>], although the production of allelochemicals seems to be variable [<xref ref-type=""bibr"" rid=""B18"">18</xref>]. It is not clear what combination of effects cause<italic>C. maculosa</italic>to become invasive in North America.</p><p>As an initial step towards understanding the molecular mechanisms by which plants become invasive, we have generated a normalized Expressed Sequence Tag (EST) library representing seven invasive populations of<italic>C. maculosa</italic>. Here we describe candidate genes that could be utilized in future experiments to correlate plant gene expression and ecological hypotheses proposed for invasive success. To the best of our knowledge, this is the first published set of ESTs derived from an invasive weed that will be targeted to study invasive behavior.</p></sec><sec><title>Results and discussion</title><sec><title>Library creation and sequence annotation</title><p>Seeds from seven invasive populations of<italic>Centaurea maculosa</italic>Lam were grown for one to two months, at which time two to three entire plants per population were harvested. Tissue was frozen in liquid nitrogen and shipped to Agencourt biosciences for normalized cDNA library construction. Single pass directional sequencing was performed on 4969 randomly selected clones from the<italic>C. maculosa</italic>normalized cDNA library (GenBank accessions<ext-link ext-link-type=""gen"" xlink:href=""EL930664"">EL930664</ext-link>-<ext-link ext-link-type=""gen"" xlink:href=""EL935630"">EL935630</ext-link>). These sequences were assembled into 4423 unique contigs (contiguous consensus sequences) or ""unigenes"" using Noble Foundation's in-house pipeline based on TIGR Assembler [<xref ref-type=""bibr"" rid=""B19"">19</xref>].</p><p>The library consisted of 894 contig-forming ESTs which created 348 unigenes and 4075 singlet ESTs, each representing a unique sequence. Of the 348 unigene contigs, the majority contained only two EST sequences [see Additional File<xref ref-type=""supplementary-material"" rid=""S1"">1</xref>]. The largest unigene contig, which had high similarity to a chlorophyll a-b binding protein, contained 17 ESTs. Interestingly, the second largest unigene contig, a compilation of ten sequences, had extremely low similarity to known sequences and was not able to be annotated. Other large unigene contigs were annotated as polyphenol (catechol) oxidase, chloroplast ATP synthase, photosystem I subunits II and XI, polygalacturonase (a pectinase), and the small subunit of RUBISCO. Normalization should remove most redundant transcripts and enrich for low abundant regulatory genes in the library. However, it is interesting that one of the most abundant transcripts found, polyphenol oxidase, is a potential defense-related protein [<xref ref-type=""bibr"" rid=""B20"">20</xref>]. Overall redundancy of the library was 18% (number of clustered ESTs/total ESTs) which suggests that the normalization process was effective, and that continued sequencing of the library has the potential to uncover many more unique transcripts. Sequence quality was high; over 80% of the unigenes were between 800–1100 bp in length [see Additional File<xref ref-type=""supplementary-material"" rid=""S2"">2</xref>], with an average size of 784 bp.</p><p>To annotate the<italic>C. maculosa</italic>ESTs, the 4423 unigenes were translated in all frames and searched for similarity against the NCBI non-redundant protein database using BLASTX (E-value of 10<sup>-4</sup>or less). Of the entire unigene set, 77% (3392) had significant similarity to genes in the NCBI database, while the remaining 1031 sequences had low similarity and were not able to be annotated. In the group of annotated sequences, 35% (1177 unigenes) had top BLAST hits to transcripts from<italic>Arabidopsis thaliana</italic>, whereas only 10% (338 unigenes) had top hits to<italic>Orzya</italic>cultivars. Taxonomically, 64% (2182) of the annotated unigene top hits grouped into the rosids clade (which includes the families Brassicacea and Fabaceae), 20.6% grouped into the asterids clade (which includes the families Asteraceae and Solanacea), and 11.8% grouped into the commelinids clade (which includes members of the Poaceae family and other monocots) [see Additional File<xref ref-type=""supplementary-material"" rid=""S3"">3</xref>]. Thirty four unigenes had top hits to non-plant sequences. Most of these non-plant sequences were annotated as hypothetical or unknown proteins.</p></sec><sec><title>Functional categorization of Centaurea unigenes</title><p>Gene ontology (GO) assignment programs were used to functionally categorize unigenes in the library. Unigene GO terms were counted and grouped in a hierarchical fashion into the major GO functional categories of Cellular Component, Biological Process and Molecular Function. The GO categories of cellular component and biological process contained over 3000<italic>Centaurea</italic>unigene annotations, whereas the molecular function category contained only 2162 annotations. Each category contained approximately 16% unigenes that were annotated as ""unknown,"" but this number does not account for the unigenes that were unable to be annotated in GO format (Figure<xref ref-type=""fig"" rid=""F1"">1</xref>).</p><p>Approximately 38% of the unigene annotations were grouped into the 'physiological process' category of the Biological Process GO (Figure<xref ref-type=""fig"" rid=""F1"">1</xref>), which includes subcategories such as metabolism, transport, photosynthesis, apoptosis, and homeostasis. The next largest category of unigene annotations (~34%), 'cellular process,' has some overlap of subcategories with physiological processes (i.e., metabolism, transport), but includes unique subcategories such as cell communication, recognition, and differentiation. Five percent of unigene annotations fell in the 'stimulus response' category which includes subcategories that relate to plant response to abiotic and biotic stresses, such as pathogen attack. Thirty unigenes were subcategorized as responding to hormone stimulus, and most of these fell into the ethylene and jasmonic acid signaling pathways. Ethylene- and jasmonic acid-mediated pathways have been implicated in the defense of plants against pathogens and insects [<xref ref-type=""bibr"" rid=""B21"">21</xref>,<xref ref-type=""bibr"" rid=""B22"">22</xref>], and these transcripts may be up-regulated in<italic>C. maculosa</italic>under biotic stress conditions. Only a small percentage of unigene annotations fell into the reproduction category of biological processes (0.3%), but this is not entirely surprising, as reproductive structures such as flowers were not used in the starting material for the library.</p><p>Over 38% (829) of the unigene annotations fell into the 'catalytic activity' category of the molecular function GO (Figure<xref ref-type=""fig"" rid=""F1"">1</xref>). Specific catalytic activities associated with these unigenes covered a range of GOs, with the largest amount of unigenes falling into the transferase and hydrolase categories (282 and 266 unigenes, respectively). These types of enzymes are involved in many intracellular processes including primary and secondary metabolism, signal transduction, and post translational modification of proteins. The next largest category under molecular function was 'binding' (~27%, 580 unigenes) with the majority of unigenes being associated with nucleotide/nucleic acid binding (134 and 230 unigenes, respectively).</p><p>Transporters accounted for nearly 8% of all unigene annotations, the majority being ion transporters and transporters with carrier activity (54 and 48 unigenes). Eighteen unigenes fell into the 'ATP-ase coupled transporter' category, which includes transporters of xenobiotics, steroids, sugars, peptides and other small molecules. However, most unigenes could not be subcategorized with a specific transport role. Uptake and translocation of nutrients in plants differ, and regulated expression of specific transporters may allow increased competitive ability in different situations (e.g., increased expression of metal transporters may be beneficial in metal-limiting environments) [<xref ref-type=""bibr"" rid=""B23"">23</xref>-<xref ref-type=""bibr"" rid=""B25"">25</xref>]. Depending on the specific transporter, these genes could be interesting targets for understanding root exudation or other release strategies for<italic>Centaurea</italic>secondary metabolites and uptake of nutrients, and may aid in understanding the role of transport in competitive ability of<italic>Centaurea</italic>.</p><p>One hundred twenty-seven unigene annotations were designated as transcriptional regulators, with the majority (118) being subcategorized as having 'transcription factor activity.' Transcription factors are responsible for modulating cellular responses to biotic and abiotic stimuli [<xref ref-type=""bibr"" rid=""B26"">26</xref>], and they may play important roles in plant invasion by up- or down-regulating the expression of genes involved in defense and growth responses. Transcription factors identified in the<italic>Centaurea</italic>library made up ~6% of the GO annotations for molecular function, whereas ~4% of the<italic>Arabidopsis</italic>genome sequences are annotated as transcription factors (The<italic>Arabidopsis</italic>Information Resource, TAIR).</p><p>Over two-thirds of the unigenes were localized by cellular component to either cell or organelle, as shown in Figure<xref ref-type=""fig"" rid=""F1"">1</xref>. Of these, 164 unigenes were assigned to the nucleus, 357 to the mitochondrion, 52 to the chloroplast, and 37 to the cytosol. Thirty-five unigenes were assigned to the cell wall category and 290 unigenes were assigned to the membrane category, although only 27 could be further categorized to the plasma membrane. These membrane proteins may be interesting targets to investigate transport and/or signal transduction.</p><p>A wide variety of functional categories were represented in the<italic>Centaurea</italic>library. Many of these unigenes could be used as candidates for production of a microarray to visualize changes in global gene expression, or to look at more specific changes in regulation related to plant defense or stress.</p></sec><sec><title>Unigene candidates for testing ecological hypotheses</title><sec><title>Evolution and plasticity</title><p>The EICA hypothesis suggests that when plants are introduced into a new range, they escape their enemies and rapidly evolve to put more resources into growth/reproduction and less into defense [<xref ref-type=""bibr"" rid=""B5"">5</xref>]. Evolution through random mutation, movement of transposable elements, and genetic recombination may facilitate changes in plant genes or gene expression which give them a competitive and evolutionary advantage [<xref ref-type=""bibr"" rid=""B27"">27</xref>]. In addition, novel environments can reveal genetic variants in a population that possess advantageous phenotypes due to adaptive or developmental plasticity [<xref ref-type=""bibr"" rid=""B28"">28</xref>]. Candidate unigenes from the<italic>Centaurea</italic>cDNA library potentially involved in genome evolution and plasticity are described below.</p><sec><title>Mobile elements</title><p>Mobile, or transposable elements (transposons) have the ability to modify DNA sequences by 'jumping' in and out of places in the genome, and certain mobile elements carry gene fragments that, when transposed, lead to repetition or creation of new genetic material [<xref ref-type=""bibr"" rid=""B29"">29</xref>]. Mobile elements can modify genome size, gene regulation, and gene function, all of which contribute to genome evolution [<xref ref-type=""bibr"" rid=""B29"">29</xref>,<xref ref-type=""bibr"" rid=""B30"">30</xref>]. In the invasive<italic>Centaurea</italic>cDNA library, six transposable element-related unigenes were identified [see Additional File<xref ref-type=""supplementary-material"" rid=""S4"">4</xref>]. Normally transposable elements are found in non-coding regions of their host genomes and are considered 'silent;' however, expressed transposable elements, such as those found in the<italic>Centaurea</italic>cDNA library, have been detected in plants at specific growth stages and under biotic stress conditions such as pathogen attack and wounding [<xref ref-type=""bibr"" rid=""B32"">32</xref>,<xref ref-type=""bibr"" rid=""B33"">33</xref>]. Evidence from such experiments support Barbara McClintock's idea that transposable elements may play a role in genome evolution through organismal adaptation to stress [<xref ref-type=""bibr"" rid=""B34"">34</xref>], and it would be interesting to test this idea in relation to plant invasion.</p></sec><sec><title>Heat-shock proteins</title><p>Heat shock protein 90 (Hsp90), a stress-induced protein, has been shown to buffer genetic variation in morphogenic pathways in the fruit fly<italic>Drosophila melanogaster</italic>and the cruciferous plant<italic>Arabiodpsis</italic>[<xref ref-type=""bibr"" rid=""B28"">28</xref>]. As a chaperone of proteins that regulate growth and development, Hsp90 may allow for the storage and release of genetic variation, as well as allowing phenotypic plasticity in an organism's response to their environment [<xref ref-type=""bibr"" rid=""B28"">28</xref>,<xref ref-type=""bibr"" rid=""B35"">35</xref>]. Eight heat shock-related unigenes were identified in the<italic>Centaruea</italic>cDNA library [see Additional File<xref ref-type=""supplementary-material"" rid=""S4"">4</xref>]. One unigene is closely related to Hsp90, one to Hsp60, one to Hsp70, and the others are annotated as 'putative heat-shock proteins' or 'heat shock factors.' Only two of these unigenes have top BLAST hits to sequences from<italic>A. thaliana</italic>, suggesting there may be a wide diversity of Hsp90 related sequences in<italic>Centaurea</italic>. Understanding the mechanism of these proteins in relation to plant genotype, environment and defense response throughout the native and invasive range of<italic>C. maculosa</italic>may give some clues to the plasticity of the species.</p></sec></sec><sec><title>Secondary metabolism</title><p>As explained above the AARS hypothesis proposes that novel weapons, often in the form of secondary metabolites, are selected for in invasive plants in the introduced ranges. Members of the aster family are capable of synthesis of a broad spectrum of secondary metabolites that may aid in basal and induced defense response, as well as in competition against other plants [<xref ref-type=""bibr"" rid=""B16"">16</xref>,<xref ref-type=""bibr"" rid=""B36"">36</xref>]. Included in the list of secondary metabolites synthesized by<italic>Centaurea spp</italic>. are polyacetylenes and related thiophenes, flavonoids (flavones and flavonols and their derivatives in particular) and their glycosides, phenolics and lignans, coumarins, anthocyanins, cyanogenic glycosides (prunasin), mono-, sesqui-, di- and tri-terpenoids (with sesquiterpene lactones particularly diverse), and steroidal compounds [<xref ref-type=""bibr"" rid=""B36"">36</xref>]. Described below are several<italic>Centaurea</italic>unigenes which share sequence similarity with characterized genes involved in plant secondary metabolite biosynthesis. Further study of these candidate genes may aid in understanding the relative influence of AARS in<italic>Centaurea</italic>invasion.</p><sec><title>Sesquiterpene lactones</title><p><italic>C. maculosa</italic>is known to accumulate the sesquiterpene lactone, cnicin, at concentrations approaching 2% of dry weight on the leaves of the inflorescence stem [<xref ref-type=""bibr"" rid=""B37"">37</xref>]. This compound is thought to act as a protectant against herbivory of generalist herbivores and acts as an oviposition stimulant for specialist herbivores [<xref ref-type=""bibr"" rid=""B38"">38</xref>] including<italic>Agapeta zoegana</italic>, a biological control agent introduced for the control of<italic>C. maculosa</italic>in the North America. Additionally, cnicin is phytotoxic to several plant species [<xref ref-type=""bibr"" rid=""B39"">39</xref>], appears to inhibit the rumen microbial activity of sheep (thereby reducing digestibility of<italic>C. maculosa</italic>[<xref ref-type=""bibr"" rid=""B40"">40</xref>]), possesses broad spectrum anti-fungal activity [<xref ref-type=""bibr"" rid=""B41"">41</xref>], and is being examined as a potential pesticide for control of formosan termite [<xref ref-type=""bibr"" rid=""B42"">42</xref>]. Sesquiterpenes are synthesized through cyclization of farnesyl pyrophosphate (FPP) followed by further modification steps including oxidation, reduction, and glycosylation reactions. The genes responsible for the committed step that catalyzes the conversion of FPP to sesquiterpene hydrocarbons are well-characterized, including sesquiterpene synthases from aster family members such as<italic>Artemisia annua</italic>,<italic>Solidago canadensis</italic>,<italic>Helianthus annuus</italic>,<italic>Ixeris dentata</italic>,<italic>Chicorium intybus</italic>, and<italic>Lactuca sativa</italic>. In the<italic>Centaurea</italic>cDNA library, no unigenes were annotated as a sesquiterpene synthase. However, several unigenes revealed high sequence simlarity to genes involved in the synthesis of the iosprenoid pyrophosphates, metabolic precursors to the terpenoids. BLAST similarity searches revealed two unigenes which closely matched the<italic>Antirrhinum majus</italic>geranyl diphosphate synthase, which catalyzes the condensation of two isopenyl pyrophosphate units to form a ten-carbon precursor (geranyl pyrophosphate – GPP) of monoterpenoids. GPP can then be extended further to FPP, geranylgeranyl pyrophosphate (GGPP), and ultimately to dolichol phosphate, a polyprenoid involved in the formation of glycoproteins via the endomembrane system. Two unigenes were annotated as dehydrodolichol phosphate synthases by GO annotation.</p><p>Following formation of the ring structure, sesquiterpene skeletons can be modified through oxidation, reduction, and glycosylation reactions to form an enormous diversity of secondary products including cnicin, a sesquiterpene lactone found in<italic>C. maculosa</italic>. Sesquiterpene lactones commonly occur in the Asteraceae, but the biosynthetic routes for individual metabolites are relatively poorly characterized. One of the most well-characterized of the biosynthetic pathways leading to sesquiterpene lactones is that for artemisinin, a compound of value as an anti-malarial drug [<xref ref-type=""bibr"" rid=""B43"">43</xref>] isolated from the aster<italic>Artemisia annua</italic>. Recently the oxidation steps which generate artemisinic acid, a precursor of artemisinin, were characterized and the entire pathway to artemisinic acid reconstructed in yeast [<xref ref-type=""bibr"" rid=""B44"">44</xref>]. The reaction proceeds from FPP to the sesquiterpene, amorphadiene (catalyzed by amorphadiene synthase), and then to artemisinic acid, a reaction catalyzed by a single p450 enzyme which performs a three-step oxidation reaction to form a carboxylic acid. A unigene from the<italic>Centaurea</italic>library (CENT_UG_03500) demonstrates 93% amino acid sequence identity to this three-step oxidase and a nearly identical gene from the related<italic>A. obtusifolia</italic>[see Additional File<xref ref-type=""supplementary-material"" rid=""S5"">5</xref>], highly suggestive of a role in the biosynthesis of the cnicin or other sesquiterpene lactones of<italic>C. maculosa</italic>.</p></sec><sec><title>Acetylenes</title><p>The polyacetylelenes are secondary metabolites derived from fatty acids, and are characteristic of many aster genera. Acetylenes contain highly reduced carbon-carbon triple bonds. The biosynthetic route has been only recently characterized for a small group of acetylenes [<xref ref-type=""bibr"" rid=""B45"">45</xref>]. Alignment of established acetylenases, Δ<sup>12</sup>oleic acid desaturates, and<italic>C. maculosa</italic>unigenes annotated as desaturases reveals three<italic>C. maculosa</italic>ESTs which cluster closely to<italic>H. annuus</italic>acetylenase, but are distinct from<italic>H. annuus</italic>Δ<sup>12</sup>oleic acid desaturates (Figure<xref ref-type=""fig"" rid=""F2"">2</xref>), suggesting that these genes may be involved in acetylene production in<italic>C. maculosa</italic>.</p></sec><sec><title>Flavonoids</title><p>The basic flavonoid pathway is the best-characterized metabolic pathway of plant secondary metabolism [<xref ref-type=""bibr"" rid=""B46"">46</xref>]. More than 800 flavonoid structures have been characterized from the Asteraceae, in the Cardueae tribe, which contains<italic>Centaurea spp</italic>., that are particularly rich in hydroxy-methylated flavonols and flavones [<xref ref-type=""bibr"" rid=""B47"">47</xref>]. The early steps of the pathway involve the generation of phenylpropanoid monomers which are condensed with three malonyl CoA units to form the chalcones, followed by isomerization, hydroxylation, methylation, glycosylation, and polymerizations steps [<xref ref-type=""bibr"" rid=""B46"">46</xref>]. Many steps of the general flavonoid pathway are represented in the<italic>Centaurea</italic>cDNA library, with clones present that show similarity to most characterized enzymatic functions [see Additional File<xref ref-type=""supplementary-material"" rid=""S6"">6</xref>]. However, no unigenes showed significant sequence similarity to flavonol synthase (FLS), the gene responsible for generation of the flavonols, or flavone synthase (FS), the gene product of which converts flavanones to flavones. Each of these genes are oxoglutarate-dependent dioxygenases, and several unigenes suggest this function, as revealed by GO annotation. Further, only two FS clones from Asteraceae members (<italic>Gerbera hydrida</italic>and<italic>Callistephus chinensis</italic>) are reported in GenBank, and only one Asteraceae sequence is annotated as an FLS gene (from<italic>G. hybrida</italic>), suggesting that one or more of the unannotated 2-oxoglutarate-dependent dioxygenases may be FLS or FS genes.</p><p>As<italic>C. maculosa</italic>has been reported to exude catechin, a phytotoxic secondary metabolite, from its root [<xref ref-type=""bibr"" rid=""B15"">15</xref>,<xref ref-type=""bibr"" rid=""B16"">16</xref>], the study of genes involved in secondary metabolism in<italic>C. maculosa</italic>may help reveal how this compound and other potential 'novel weapons' are synthesized. The AARS hypothesis suggests that plants may evolve to produce more of the effective 'weapon' compounds when in the invaded environment [<xref ref-type=""bibr"" rid=""B7"">7</xref>], so it would also be interesting to test the activity of some of these proteins in native and invasive populations.</p></sec></sec><sec><title>Defense-response genes</title><p>One of the main predictions of EICA is that plants in their new environment rapidly evolve to put more resources into growth/reproduction and less into defense, as they have escaped their co-evolved pathogens and predators [<xref ref-type=""bibr"" rid=""B5"">5</xref>]. Thus, native plants should show higher levels of basal defense compounds and should out-perform invasives when both are exposed to pathogens from the native environment. The<italic>Centaurea</italic>cDNA library contains a variety of unigenes annotated as defense response genes [see Additional File<xref ref-type=""supplementary-material"" rid=""S7"">7</xref>], as well as components of signaling pathways that may be involved in defense mechanisms. These include<italic>Centaurea</italic>sequences similar to three lipoxygenase (LOX) proteins, two phenylalanine ammonia lyase (PAL) proteins, and three calmodulin binding proteins. Also identified was a<italic>Centaurea</italic>sequence similar to the<italic>Arabidopsis</italic>activated disease resistance-like (ADR1-like) gene, which contains nucleotide binding site – leucine rich repeat (NBS-LRR) motifs characteristic of defense-response proteins [<xref ref-type=""bibr"" rid=""B48"">48</xref>]. Four<italic>Centaurea</italic>unigenes show high similarity to another LRR containing<italic>Arabidopsis</italic>transcript (At3g20820) that is suspected to be involved in the defense response signal transduction pathway. The<italic>Centaurea</italic>library contains seven other unigenes, not annotated as ""defense related,"" that contain LRR motifs or leucine zippers [see Additional File<xref ref-type=""supplementary-material"" rid=""S7"">7</xref>]. One<italic>Centaurea</italic>unigene shows similarity to the R gene-mediated disease resistance gene (EDS1) from<italic>Arabidopsis</italic>, which is required for SA accumulation and production of pathogenesis related (PR) proteins [<xref ref-type=""bibr"" rid=""B49"">49</xref>]. Two unigenes show similarity to a PR-1 type protein from<italic>Sambucus nigra</italic>, similar to<italic>Arabidopsis</italic>PR-1-related transcript At4g33720. In addition, twelve of the unigenes annotated as having 'transcription factor activity' in the GO molecular function categorization are similar to WRKY transcription factors [see Additional File<xref ref-type=""supplementary-material"" rid=""S7"">7</xref>] which may be involved in initial steps of the defense-response signaling pathway [<xref ref-type=""bibr"" rid=""B50"">50</xref>]. With this<italic>C. maculosa</italic>sequence information it will be possible to test levels of basal defense responses at the level of gene expression in populations of native and invasive plants. Genes involved only in induced defense response may be under represented in the library, as the plants that were used in library creation did not undergo interspecific competition, pathogen stress, or herbivory and were not grown under field conditions. However, many of the unigenes identified have been implicated in induced defenses in other systems (PR-1 and EDS-like unigenes), and these may be good candidates for studying induced as well as basal defense response. Future experiments can be coupled with more traditional tests of morphology and biochemistry in order to supplement data concerning hypotheses of plant invasion.</p></sec></sec></sec><sec><title>Conclusion</title><p>This is the first report of a cDNA library from an invasive weed. The<italic>Centaurea</italic>cDNA library, consisting of 4423 unique transcripts (unigenes), represents an initial step towards looking at gene-specific expression in this species, and will pave the way for creation of other resources such as microarray chips that can help provide a view of global gene expression in invasive<italic>C. maculosa</italic>and its native counterparts. These technologies can likely be extrapolated to look at other invasive knapweeds (<italic>C. diffusa, C. solstitialis, C. virgata</italic>and<italic>Acroptilon repens</italic>) also problematic in North America. By comparing native and invasive<italic>C. maculosa</italic>plants under different stresses, including herbivory and pathogen infection, it will be possible to test hypotheses such as EICA using molecular resources coupled with classical (physiological/ecological) techniques.</p><p>This technology will also be useful to help understand differences in gene expression between diploid and tetraploid<italic>C. maculosa</italic>populations, and give insight into the effects of chromosome doubling and polyploidization events in the plant world. Additionally, by looking at secondary metabolite accumulation and the genes responsible for their production in<italic>C. maculosa</italic>, it may be possible to knock out those genes, create mutants defective in the production of allelochemicals, and to finally determine unequivocally whether allelopathy (novel weapons) is involved in the invasive success of some weeds.</p><p>Understanding the genetic basis of evolution for increased invasiveness in exotic plants is critical to understanding the mechanisms through which exotic invasions occur. The<italic>Centaurea</italic>cDNA library provides a unique resource that will be valuable to geneticists, molecular biologists, and ecologists alike.</p></sec><sec sec-type=""methods""><title>Methods</title><sec><title>Plant material</title><p>Seeds from seven invasive populations of<italic>Centaurea maculosa</italic>Lam were obtained from Ray Callaway (University of Montana, Missoula). Five populations originated from Montana, one from Washington, and one from Virginia. Six seeds from each of the seven populations were sterilized by heating at 50°C for ten minutes in distilled water. Seeds were cooled to ambient temperature, rinsed with sterile water and placed in Petri dishes containing moist germination paper. Plates were wrapped in parafilm and placed in a growth chamber with a photoperiod of 20 hours light/six hours dark at a constant temperature of 25°C. Upon the emergence of cotyledons, seedlings were planted in 2.5 cm pots in a mix of 70% sand, 10% perlite, and 20% autoclaved potting soil and transported to the greenhouse. Pots were placed in a flat and covered with plastic wrap for approximately one week until seedlings became established. Plants were given sufficient water and fertilized once per week with a dilute solution of Miracle Gro (Maryville, OH). After approximately two months, two to three plants per population were removed from pots and their roots were washed to remove soil particles. All plants were in the form of small rosettes, lacking stem and floral tissue. Entire plants, including roots, were wrapped in foil, frozen in liquid nitrogen, and stored at -80°C until processing.</p></sec><sec><title>Creation of normalized cDNA library</title><p>Plant tissue was shipped in dry ice to Agencourt Bioscience Corporation (Beverly MA). Total RNA was extracted and optimized first strand cDNA synthesis was performed using a primer adapted with a rare enzyme cut site. cDNA fragments were size-selected by agarose gel electrophoresis, and directionally cloned into a pAGEN-1 vector. A positive control containing the Tet<sup>R</sup>gene was used during construction of the primary library to ensure library quality. Single-stranded DNA was made from a portion of the primary library by phagemid production, and reactions were treated with DNase I to ensure the removal of double-stranded DNA. A second portion of the primary library was linearized and transcribed into anti-sense RNA with biotinylated dNTPs. Oligo dT and primer extension were used to pre-block the poly-A region prior to hybridization. The anti-sense RNA and single-stranded circular DNA were hybridized, and abundant clones were removed using streptavidin. To reduce the amount of empty vectors, a Not1 oligo and<italic>Taq</italic>polymerase were used to synthesize double stranded DNA from the single stranded normalized library prior to final transfection.</p><p>The normalized library was plated and 4969 clones were randomly selected for sequencing. Automated plasmid purification was achieved using the SPRI (SprintPrep™) technique, which harvests plasmid DNA directly from lysed bacterial cultures, trapping both plasmid and genomic DNA to functionalized bead particles and selectively eluting only the plasmid (Beckman Biomek FX robots and CCS Packard DNATraks).</p></sec><sec><title>Sequencing reactions</title><p>DNA templates were sequenced in 384-well format using BigDye<sup>®</sup>Version 3.1 reactions on ABI3730 instruments at Agencourt Biosciences. Thermal cycling was performed using 384-well Thermal cyclers (ABI, MJ Research). Sequencing Reactions were purified using Agencourt's CleanSeq<sup>®</sup>dye-terminator removal kit. All reads are processed using Phred base calling software and constantly monitored against quality metrics using the Phred Q20. The quality scores for each run were monitored through the Oracle 9i driven Laboratory Information Management System (LIMS).<italic>C. maculosa</italic>ESTs were trimmed of vector sequence and the data was transferred to a secure site for download.</p></sec><sec><title>Sequence analysis</title><p>To determine the number of unique transcripts in the library, an in-house pipeline program was used to cluster and assemble the trimmed EST sequences. The pipeline essentially utilizes TIGR Assembler with its default parameters (overlap of at least 40 bp with 94% identity). The PLAN web system (Personal BLAST Navigator, Noble foundation) was used to do a BLASTX search against the non-redundant protein (NR) database for functional annotation, and gene ontology (GO) sequence database for functional categorization [<xref ref-type=""bibr"" rid=""B19"">19</xref>]. The BLASTX search considered translation of the assembled consensus (unigenes) in multiple reading frames. The top NR hit for each unigene sequence (E-value 10<sup>-4</sup>or less) and top hits from GO assignment were deposited in PLAN and can be searched by keyword or unigene accession number (PLAN Project 30060, CENT_UG_00001-CENT_UG_04423). GO annotation was used to categorize unigenes into functional categories by molecular function, cellular component and biological process. A customized in-house program was used to count the number of unigenes being grouped under different GO term categories in a hierarchical fashion [<xref ref-type=""bibr"" rid=""B19"">19</xref>]. The vector trimmed EST sequences have also been deposited in GenBank (accession numbers<ext-link ext-link-type=""gen"" xlink:href=""EL930664"">EL930664</ext-link>-<ext-link ext-link-type=""gen"" xlink:href=""EL935630"">EL935630</ext-link>).</p></sec></sec><sec><title>Authors' contributions</title><p>AKB: designed and performed research, analyzed data, wrote manuscript</p><p>CDB: analyzed data, wrote manuscript</p><p>JH, XD, PXZ: provided new analytical techniques (PLAN database)</p><p>JMV: designed research, edited and approved manuscript</p></sec><sec><title>Data deposition</title><p>GenBank Accession numbers:</p><p><ext-link ext-link-type=""gen"" xlink:href=""EL930664"">EL930664</ext-link>-<ext-link ext-link-type=""gen"" xlink:href=""EL935630"">EL935630</ext-link></p><p>Database EST ID (NCBI) numbers:</p><p>45411770-45416736</p><p>PLAN database accession numbers for Centaurea EST sequences:</p><p>(public projects section, project 30060)</p><p>CENT_UG_00001 through CENT_UG_04423</p></sec><sec sec-type=""supplementary-material""><title>Supplementary Material</title><supplementary-material content-type=""local-data"" id=""S1""><caption><title>Additional file 1</title><p><bold>Distribution of assembled<italic>Centaurea</italic>ESTs by cluster size</bold>. The data represent clustering of<italic>Centaurea</italic>ESTs into unique sequence clusters (unigenes) and show distribution by cluster size. The 4969<italic>Centaurea</italic>ESTs were assembled into 4423 unique contigs or 'unigenes' using the PLAN database (Noble foundation). In total, 4075 singlet ESTs were unique (not pictured on graph); 348 could be assembled into clusters containing one or more<italic>Centaurea</italic>unigene, and were plotted relative to their abundance in the EST library.</p></caption><media mime-subtype=""msword"" mimetype=""application"" xlink:href=""1471-2229-7-25-S1.doc""><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type=""local-data"" id=""S2""><caption><title>Additional file 2</title><p><bold>Title: Distribution of<italic>Centaurea</italic>unigenes by sequence length</bold>. The data represent distribution of<italic>Centaurea</italic>unigenes by sequence length. The 4423<italic>Centaurea</italic>unigenes were plotted by their relative abundance based on sequence length in base pairs.</p></caption><media mime-subtype=""msword"" mimetype=""application"" xlink:href=""1471-2229-7-25-S2.doc""><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type=""local-data"" id=""S3""><caption><title>Additional file 3</title><p><bold>Taxonomic clades associated with<italic>Centaurea</italic>unigene top BLAST hits</bold>. The data represent taxonomic clades associated with the top similarities of known sequences to<italic>Centaurea</italic>unigenes.<italic>Centaurea</italic>unigenes were used to query BLASTX nr database, and the top hit for each unigene was deposited in the PLAN database (3392 unigenes had significant top BLAST hits, others were unable to be annotated). These top hits were assembled by taxonomic group. Approximately 35% of the unigenes had top hits to<italic>Arabidopsis</italic>, which is part of the Rosid clade.</p></caption><media mime-subtype=""msword"" mimetype=""application"" xlink:href=""1471-2229-7-25-S3.doc""><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type=""local-data"" id=""S4""><caption><title>Additional file 4</title><p><bold>Evolution/Plasticity-related sequences in<italic>Centaurea</italic>cDNA library</bold>. The table lists sequences identified in the<italic>Centaurea</italic>cDNA library that may be related to evolution and plasticity, based on similarity to known sequences. Evolution-plasticity related sequences from the<italic>Centaurea</italic>cDNA library are represented by<italic>Centaurea</italic>unigene identification number (from the PLAN database). Accession number, organism, functional description, and E value of the top BLAST hit for each unigene is listed.</p></caption><media mime-subtype=""msword"" mimetype=""application"" xlink:href=""1471-2229-7-25-S4.doc""><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type=""local-data"" id=""S5""><caption><title>Additional file 5</title><p><bold>Alignment of<italic>Centaurea</italic>unigene (CENT_UG_03500) and related sequences</bold>. The data represent predicted amino acid sequence alignment of<italic>Centaurea</italic>unigene 03500 with related sequences involved in sesquiterpene lactone synthesis. Sesquiterpene lactone synthesis proteins from<italic>Artemisia obtusifolia</italic>and<italic>A. annua</italic>were aligned with<italic>Centaurea</italic>unigene 03500 using (Clustal W). Stars<bold>(*)</bold>indicate complete sequence conservation;<bold>(:)</bold>represents amino acids of a similar nature.</p></caption><media mime-subtype=""msword"" mimetype=""application"" xlink:href=""1471-2229-7-25-S5.doc""><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type=""local-data"" id=""S6""><caption><title>Additional file 6</title><p><bold>Flavanoid Pathway- related sequences in<italic>Centaurea</italic>cDNA library</bold>. The table lists sequences identified in the<italic>Centaurea</italic>cDNA library that may be involved in the flavanoid pathway, based on similarity to known sequences. Proposed function (Func) of flavanoid pathway related sequences in the<italic>Centaurea</italic>cDNA library; PAL (phenylalanine ammonia lyase), C4H(cinnamate 4-hydroxylase), C4L (4-coumaryl-CoA ligase), CHS (chalcone synthase), CHI (chalcone isomerase), F3'H (flavanoid 3'-hydroxylase), GT (glycosyl transferase), OMT (O-methyltransferase). The number of unigenes and their identification numbers (PLAN database) are listed for each functional group.</p></caption><media mime-subtype=""msword"" mimetype=""application"" xlink:href=""1471-2229-7-25-S6.doc""><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type=""local-data"" id=""S7""><caption><title>Additional file 7</title><p><bold>Defense-response-related sequences in<italic>Centuarea</italic>cDNA library</bold>. The table lists sequences identified in the<italic>Centaurea</italic>cDNA library that may be involved in defense response, based on similarity to known sequences. Defense-response-related sequences from the<italic>Centaurea</italic>cDNA library are represented by<italic>Centaurea</italic>unigene identification number (PLAN database). Accession number, organism, functional description, and E value of the top BLAST hit for each unigene is listed.</p></caption><media mime-subtype=""msword"" mimetype=""application"" xlink:href=""1471-2229-7-25-S7.doc""><caption><p>Click here for file</p></caption></media></supplementary-material></sec><back><ack><sec><title>Acknowledgements</title><p>The studies described here were partially funded by the National Science Foundation (grant IBN 0335203 to J.M.V.), US Department of Defense-SERDP (grant CS1388 to J.M.V) and by funds provided by Colorado State University.</p></sec></ack><ref-list><ref id=""B1""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Pimentel</surname><given-names>D</given-names></name><name><surname>Lach</surname><given-names>L</given-names></name><name><surname>Zuniga</surname><given-names>R</given-names></name><name><surname>Morrison</surname><given-names>D</given-names></name></person-group><article-title>Environmental and economic costs associated with non-indigenous species in the United States</article-title><source>BioSci</source><year>2000</year><volume>50</volume><fpage>53</fpage><lpage>65</lpage><pub-id pub-id-type=""doi"">10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2</pub-id></citation></ref><ref id=""B2""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Hierro</surname><given-names>J</given-names></name><name><surname>Maron</surname><given-names>J</given-names></name><name><surname>Callaway</surname><given-names>RM</given-names></name></person-group><article-title>A biogeographical approach to plant invasions: the importance of studying exotics in their introduced<italic>and</italic>native range</article-title><source>J Eco</source><year>2005</year><volume>93</volume><fpage>5</fpage><lpage>15</lpage></citation></ref><ref id=""B3""><citation citation-type=""book""><person-group person-group-type=""author""><name><surname>Elton</surname><given-names>C</given-names></name></person-group><source>The Ecology of Invasions by Animals and Plants</source><year>1958</year><publisher-name>Metheun, London</publisher-name></citation></ref><ref id=""B4""><citation citation-type=""book""><person-group person-group-type=""author""><name><surname>Darwin</surname><given-names>C</given-names></name></person-group><source>On the Origin of Species by Means of Natural Selection, or the Preservation of Favoured Races in the Struggle for Life</source><year>1859</year><publisher-name>John Murray, London</publisher-name></citation></ref><ref id=""B5""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Callaway</surname><given-names>RM</given-names></name><name><surname>Aschehoug</surname><given-names>E</given-names></name></person-group><article-title>Invasive plants versus their new and old neighbors: a mechanism for exotic invasion</article-title><source>Science</source><year>2000</year><volume>290</volume><fpage>521</fpage><lpage>523</lpage><pub-id pub-id-type=""pmid"">11039934</pub-id><pub-id pub-id-type=""doi"">10.1126/science.290.5491.521</pub-id></citation></ref><ref id=""B6""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Blossey</surname><given-names>B</given-names></name><name><surname>Notzold</surname><given-names>R</given-names></name></person-group><article-title>Evolution of increased competitive ability in invasive nonindigenous plants–a hypothesis</article-title><source>J Eco</source><year>1995</year><volume>83</volume><fpage>887</fpage><lpage>889</lpage></citation></ref><ref id=""B7""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Callaway</surname><given-names>RM</given-names></name><name><surname>Ridenour</surname><given-names>WM</given-names></name></person-group><article-title>Novel weapons: invasive success and the evolution of increased competitive ability</article-title><source>Front Eco Env</source><year>2004</year><volume>2</volume><fpage>436</fpage><lpage>443</lpage></citation></ref><ref id=""B8""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Basu</surname><given-names>C</given-names></name><name><surname>Halfhill</surname><given-names>MD</given-names></name><name><surname>Mueller</surname><given-names>TC</given-names></name><name><surname>Stewart</surname><given-names>CN</given-names><suffix>Jr</suffix></name></person-group><article-title>Weed genomics: new tools to understand weed biology</article-title><source>TIPS</source><year>2004</year><volume>9</volume><fpage>391</fpage><lpage>398</lpage></citation></ref><ref id=""B9""><citation citation-type=""book""><person-group person-group-type=""author""><name><surname>Mauer</surname><given-names>T</given-names></name><name><surname>Russo</surname><given-names>MJ</given-names></name><name><surname>Evans</surname><given-names>M</given-names></name></person-group><source>Element Stewardship Abstract for Centaurea maculosa</source><year>2001</year><publisher-name>Arlington, Virginia: The Nature Conservancy</publisher-name></citation></ref><ref id=""B10""><citation citation-type=""other""><person-group person-group-type=""author""><name><surname>Oschmann</surname><given-names>J</given-names></name></person-group><article-title>On the taxonomy of spotted knapweed (<italic>Centaurea stoebe</italic>L.)</article-title><source>Proceedings from The First International Knapweed Symposium of the Twenty First Century</source><year>2001</year><fpage>33</fpage><lpage>41</lpage></citation></ref><ref id=""B11""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Powell</surname><given-names>AM</given-names></name><name><surname>Kyhos</surname><given-names>DW</given-names></name><name><surname>Raven</surname><given-names>PH</given-names></name></person-group><article-title>Chromosome numbers in compositae. X</article-title><source>Am J Botany</source><year>1974</year><volume>61</volume><fpage>909</fpage><lpage>913</lpage><pub-id pub-id-type=""doi"">10.2307/2441628</pub-id></citation></ref><ref id=""B12""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Grime</surname><given-names>JP</given-names></name><name><surname>Shacklock</surname><given-names>JML</given-names></name><name><surname>Band</surname><given-names>SR</given-names></name></person-group><article-title>Nuclear DNA contents, shoot phenology and species co-existence in a limestone grassland community</article-title><source>New Phyt</source><year>1985</year><volume>100</volume><fpage>435</fpage><lpage>445</lpage><pub-id pub-id-type=""doi"">10.1111/j.1469-8137.1985.tb02792.x</pub-id></citation></ref><ref id=""B13""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Weir</surname><given-names>TL</given-names></name><name><surname>Bais</surname><given-names>HP</given-names></name><name><surname>Vivanco</surname><given-names>JM</given-names></name></person-group><article-title>Intraspecfic and interspecific interactions mediated by a phytotoxin, (-)-catechin, secreted by the roots of<italic>Centaurea maculosa</italic>(spotted knapweed)</article-title><source>J Chem Eco</source><year>2003</year><volume>29</volume><fpage>2397</fpage><lpage>2412</lpage><pub-id pub-id-type=""doi"">10.1023/A:1026313031091</pub-id></citation></ref><ref id=""B14""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Perry</surname><given-names>LG</given-names></name><name><surname>Johnson</surname><given-names>C</given-names></name><name><surname>Alford</surname><given-names>ER</given-names></name><name><surname>Vivanco</surname><given-names>JM</given-names></name><name><surname>Paschke</surname><given-names>MW</given-names></name></person-group><article-title>Screening of grassland plants for restoration after spotted knapweed invasion</article-title><source>Rest Eco</source><year>2005</year><volume>13</volume><fpage>725</fpage><lpage>735</lpage><pub-id pub-id-type=""doi"">10.1111/j.1526-100X.2005.00092.x</pub-id></citation></ref><ref id=""B15""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Bais</surname><given-names>HP</given-names></name><name><surname>Walker</surname><given-names>TS</given-names></name><name><surname>Stermitz</surname><given-names>FR</given-names></name><name><surname>Hufbauer</surname><given-names>RA</given-names></name><name><surname>Vivanco</surname><given-names>JM</given-names></name></person-group><article-title>Enantiomeric-dependant phytotoxic and antimicrobial activity of (±)-catechin. A rhizosecreted racemic mixture from spotted knapweed</article-title><source>Plant Phys</source><year>2002</year><volume>128</volume><fpage>1173</fpage><lpage>1179</lpage><pub-id pub-id-type=""doi"">10.1104/pp.011019</pub-id></citation></ref><ref id=""B16""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Bais</surname><given-names>HP</given-names></name><name><surname>Vepachedu</surname><given-names>R</given-names></name><name><surname>Gilroy</surname><given-names>S</given-names></name><name><surname>Callaway</surname><given-names>RM</given-names></name><name><surname>Vivanco</surname><given-names>JM</given-names></name></person-group><article-title>Allelopathy and exotic plant invasion: From molecules and genes to species interactions</article-title><source>Science</source><year>2003</year><volume>301</volume><fpage>1377</fpage><lpage>1380</lpage><pub-id pub-id-type=""pmid"">12958360</pub-id><pub-id pub-id-type=""doi"">10.1126/science.1083245</pub-id></citation></ref><ref id=""B17""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Callaway</surname><given-names>RM</given-names></name><name><surname>DeLuca</surname><given-names>TH</given-names></name><name><surname>Belliveau</surname><given-names>WM</given-names></name></person-group><article-title>Biological-control herbivores may increase competitive ability of the noxious weed<italic>Centaurea maculosa</italic></article-title><source>Eco</source><year>1999</year><volume>80</volume><fpage>1196</fpage><lpage>1201</lpage><pub-id pub-id-type=""doi"">10.2307/177067</pub-id></citation></ref><ref id=""B18""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Blair</surname><given-names>A</given-names></name><name><surname>Hanson</surname><given-names>B</given-names></name><name><surname>Brunk</surname><given-names>G</given-names></name><name><surname>Marrs</surname><given-names>R</given-names></name><name><surname>Westra</surname><given-names>P</given-names></name><name><surname>Nissen</surname><given-names>S</given-names></name><name><surname>Hufbauer</surname><given-names>RA</given-names></name></person-group><article-title>New techniques and findings in the study of a candidate allelochemical implicated in invasion success</article-title><source>Eco Letters</source><year>2005</year><volume>8</volume><fpage>1039</fpage><lpage>1047</lpage><pub-id pub-id-type=""doi"">10.1111/j.1461-0248.2005.00805.x</pub-id></citation></ref><ref id=""B19""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>He</surname><given-names>J</given-names></name><name><surname>Dai</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>PX</given-names></name></person-group><article-title>PLAN: A Web Platform for Automating High-Throughput BLAST Searches and for Managing and Mining Results</article-title><source>BMC Bioinformatics</source><year>2007</year><volume>8</volume><fpage>53</fpage><pub-id pub-id-type=""pmid"">17291345</pub-id><pub-id pub-id-type=""doi"">10.1186/1471-2105-8-53</pub-id></citation></ref><ref id=""B20""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Shi</surname><given-names>C</given-names></name><name><surname>Dai</surname><given-names>Y</given-names></name><name><surname>Xia</surname><given-names>B</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Xie</surname><given-names>Y</given-names></name><name><surname>Qingliang</surname><given-names>L</given-names></name></person-group><article-title>The purification and spectral properties of polyphenol oxidase I from<italic>Nicotiana tabacum</italic></article-title><source>Plant Mol Bio Reporter</source><year>2001</year><volume>19</volume><fpage>381a</fpage><lpage>h</lpage></citation></ref><ref id=""B21""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Ecker</surname><given-names>JR</given-names></name><name><surname>Davis</surname><given-names>RW</given-names></name></person-group><article-title>Plant defense genes are regulated by ethylene</article-title><source>Proc Natl Acad Sci USA</source><year>1987</year><volume>84</volume><fpage>5202</fpage><lpage>5206</lpage><pub-id pub-id-type=""pmid"">16593860</pub-id><pub-id pub-id-type=""doi"">10.1073/pnas.84.15.5202</pub-id></citation></ref><ref id=""B22""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Kunkel</surname><given-names>BN</given-names></name><name><surname>Brooks</surname><given-names>DM</given-names></name></person-group><article-title>Cross talk between signaling pathways in pathogen defense</article-title><source>Curr Opin Plant Biol</source><year>2002</year><volume>5</volume><fpage>325</fpage><lpage>331</lpage><pub-id pub-id-type=""pmid"">12179966</pub-id><pub-id pub-id-type=""doi"">10.1016/S1369-5266(02)00275-3</pub-id></citation></ref><ref id=""B23""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Bereczky</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Schubert</surname><given-names>V</given-names></name><name><surname>Ganal</surname><given-names>M</given-names></name><name><surname>Bauer</surname><given-names>P</given-names></name></person-group><article-title>Differential regulation of nramp and irt metal transporter genes in wild type and iron uptake mutants of tomato</article-title><source>J Bio Chem</source><year>2003</year><volume>278</volume><fpage>24679</fpage><lpage>24704</lpage></citation></ref><ref id=""B24""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Meerts</surname><given-names>P</given-names></name><name><surname>Duchene</surname><given-names>P</given-names></name><name><surname>Gruber</surname><given-names>W</given-names></name><name><surname>Lefebvre</surname><given-names>C</given-names></name></person-group><article-title>Metal accumulation and competitive ability in metallicolous and non-metallicolous<italic>Thlaspi caerulescens</italic>fed with different Zn salts</article-title><source>Plant &amp; Soil</source><year>2003</year><volume>249</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type=""doi"">10.1023/A:1022510130148</pub-id></citation></ref><ref id=""B25""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Lasat</surname><given-names>MM</given-names></name><name><surname>Pence</surname><given-names>NS</given-names></name><name><surname>Garvin</surname><given-names>DF</given-names></name><name><surname>Ebbs</surname><given-names>SD</given-names></name><name><surname>Kochian</surname><given-names>LV</given-names></name></person-group><article-title>Molecular physiology of zinc transport in the Zn hyperaccumulator<italic>Thlaspi caerulescens</italic></article-title><source>J Exp Botany</source><year>2000</year><volume>51</volume><fpage>71</fpage><lpage>79</lpage><pub-id pub-id-type=""pmid"">10938797</pub-id><pub-id pub-id-type=""doi"">10.1093/jexbot/51.342.71</pub-id></citation></ref><ref id=""B26""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Singh</surname><given-names>KB</given-names></name><name><surname>Foley</surname><given-names>RC</given-names></name><name><surname>Onate-Sanchez</surname><given-names>L</given-names></name></person-group><article-title>Transcription factors in plant defense and stress response</article-title><source>Curr Opinion Plant Bio</source><year>2002</year><volume>5</volume><fpage>430</fpage><lpage>436</lpage><pub-id pub-id-type=""doi"">10.1016/S1369-5266(02)00289-3</pub-id></citation></ref><ref id=""B27""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Mooney</surname><given-names>HA</given-names></name><name><surname>Cleland</surname><given-names>EE</given-names></name></person-group><article-title>The evolutionary impact of invasive species</article-title><source>Proc Nat Acad Sci USA</source><year>2001</year><volume>98</volume><fpage>5446</fpage><lpage>5451</lpage><pub-id pub-id-type=""pmid"">11344292</pub-id><pub-id pub-id-type=""doi"">10.1073/pnas.091093398</pub-id></citation></ref><ref id=""B28""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Queitsch</surname><given-names>C</given-names></name><name><surname>Sangster</surname><given-names>TA</given-names></name><name><surname>Lindquist</surname><given-names>S</given-names></name></person-group><article-title>Hsp90 as a capacitor of phenotypic variation</article-title><source>Nature</source><year>2002</year><volume>417</volume><fpage>618</fpage><lpage>624</lpage><pub-id pub-id-type=""pmid"">12050657</pub-id><pub-id pub-id-type=""doi"">10.1038/nature749</pub-id></citation></ref><ref id=""B29""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Kazazian</surname><given-names>HH</given-names></name></person-group><article-title>Mobile elements: drivers of genome evolution</article-title><source>Science</source><year>2004</year><volume>303</volume><fpage>1626</fpage><lpage>1633</lpage><pub-id pub-id-type=""pmid"">15016989</pub-id><pub-id pub-id-type=""doi"">10.1126/science.1089670</pub-id></citation></ref><ref id=""B30""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Morgante</surname><given-names>M</given-names></name></person-group><article-title>Plant genome organization and diversity: the year of the junk!</article-title><source>Curr Opinion in Biotech</source><year>2006</year><volume>17</volume><fpage>168</fpage><lpage>173</lpage></citation></ref><ref id=""B31""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Kwon</surname><given-names>S</given-names></name><name><surname>Park</surname><given-names>K</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>N</given-names></name></person-group><article-title>Rim 2/Hipa CACTA transposon display; A new genetic marker technique in Oryza species</article-title><source>BMC Genetics</source><year>2005</year><volume>6</volume><fpage>15</fpage><lpage>28</lpage><pub-id pub-id-type=""pmid"">15766385</pub-id><pub-id pub-id-type=""doi"">10.1186/1471-2156-6-15</pub-id></citation></ref><ref id=""B32""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Kimura</surname><given-names>Y</given-names></name><name><surname>Shimada</surname><given-names>S</given-names></name><name><surname>Sogo</surname><given-names>R</given-names></name><name><surname>Kusaba</surname><given-names>M</given-names></name><name><surname>Sunaga</surname><given-names>T</given-names></name><name><surname>Betsuyaku</surname><given-names>S</given-names></name><name><surname>Eto</surname><given-names>Y</given-names></name><name><surname>Nakayashiki</surname><given-names>H</given-names></name><name><surname>Mayama</surname><given-names>S</given-names></name></person-group><article-title>OARE-1, a Ty1-copia retrotransposon in oat activated by abiotic and biotic stresses</article-title><source>Plant Cell Phys</source><year>2001</year><volume>42</volume><fpage>1345</fpage><lpage>1354</lpage><pub-id pub-id-type=""doi"">10.1093/pcp/pce171</pub-id></citation></ref><ref id=""B33""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Takeda</surname><given-names>S</given-names></name><name><surname>Sugimoto</surname><given-names>K</given-names></name><name><surname>Otsuki</surname><given-names>H</given-names></name><name><surname>Hirochika</surname><given-names>H</given-names></name></person-group><article-title>Transcriptional activation of the tobacco retrotransposon Tto1 by wounding and methyl jasmonate</article-title><source>Plant Mol Bio</source><year>1998</year><volume>36</volume><fpage>365</fpage><lpage>376</lpage><pub-id pub-id-type=""pmid"">9484477</pub-id><pub-id pub-id-type=""doi"">10.1023/A:1005911413528</pub-id></citation></ref><ref id=""B34""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Mc Clintock</surname><given-names>B</given-names></name></person-group><article-title>The significance of response of the genome to challenge</article-title><source>Science</source><year>1984</year><volume>226</volume><fpage>792</fpage><lpage>801</lpage><pub-id pub-id-type=""pmid"">15739260</pub-id><pub-id pub-id-type=""doi"">10.1126/science.15739260</pub-id></citation></ref><ref id=""B35""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Burch-Smith</surname><given-names>T</given-names></name><name><surname>Schiff</surname><given-names>M</given-names></name><name><surname>Feng</surname><given-names>S</given-names></name><name><surname>Dines</surname><given-names>SP</given-names></name></person-group><article-title>Molecular chaperone Hsp90 associates with resistance protein N and its signaling proteins SGT1 and Rar1 to modulate an innate immune response in plants</article-title><source>J Bio Chem</source><year>2004</year><volume>279</volume><fpage>2101</fpage><lpage>2108</lpage><pub-id pub-id-type=""pmid"">14583611</pub-id><pub-id pub-id-type=""doi"">10.1074/jbc.M310029200</pub-id></citation></ref><ref id=""B36""><citation citation-type=""book""><person-group person-group-type=""author""><name><surname>Benderson</surname><given-names>W</given-names></name></person-group><source>Natural substances in the compositae:<italic>The Bohlmann Files at the BGBM</italic>(Freie Universitat Berlin, Botanischer Garten und Botanisches Museum)</source><year>2003</year><publisher-name>Berlin-Dahem</publisher-name><ext-link ext-link-type=""uri"" xlink:href=""http://bohlmann.bgbm.org/bohlmann/""></ext-link></citation></ref><ref id=""B37""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Locken</surname><given-names>LJ</given-names></name><name><surname>Kelsey</surname><given-names>RG</given-names></name></person-group><article-title>Cnicin concentrations in<italic>Centaurea maculosa</italic>, spotted knapweed</article-title><source>Biochem Syst Eco</source><year>1987</year><volume>15</volume><fpage>313</fpage><lpage>320</lpage><pub-id pub-id-type=""doi"">10.1016/0305-1978(87)90005-6</pub-id></citation></ref><ref id=""B38""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Landau</surname><given-names>I</given-names></name><name><surname>Muller-Scharer</surname><given-names>H</given-names></name><name><surname>Ward</surname><given-names>PI</given-names></name></person-group><article-title>Influence of cnicin, a sesquiterpene lactone of<italic>Centaurea maculosa</italic>(Asteraceae), on specialist and generalist insect herbivores</article-title><source>J Chem Eco</source><year>1994</year><volume>20</volume><fpage>929</fpage><lpage>942</lpage><pub-id pub-id-type=""doi"">10.1007/BF02059588</pub-id></citation></ref><ref id=""B39""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Kelsey</surname><given-names>RG</given-names></name><name><surname>Locken</surname><given-names>LJ</given-names></name></person-group><article-title>Phytotoxic properties of cnicin, a sesquiterpene lactone from<italic>Centaurea maculosa</italic>(spotted knapweed)</article-title><source>J Chem Eco</source><year>1987</year><volume>13</volume><fpage>19</fpage><lpage>33</lpage><pub-id pub-id-type=""doi"">10.1007/BF01020348</pub-id></citation></ref><ref id=""B40""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Olson</surname><given-names>BE</given-names></name><name><surname>Kelsey</surname><given-names>RG</given-names></name></person-group><article-title>Effect of<italic>Centaurea maculosa</italic>on sheep rumen microbial activity and mass<italic>in vitro</italic></article-title><source>J Chem Eco</source><year>1997</year><volume>23</volume><fpage>1131</fpage><lpage>1144</lpage><pub-id pub-id-type=""doi"">10.1023/B:JOEC.0000006391.88098.12</pub-id></citation></ref><ref id=""B41""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Panagouleas</surname><given-names>C</given-names></name><name><surname>Skaltsa</surname><given-names>H</given-names></name><name><surname>Lazari</surname><given-names>D</given-names></name><name><surname>Skaltsounis</surname><given-names>AL</given-names></name><name><surname>Sokovic</surname><given-names>M</given-names></name></person-group><article-title>Antifungal activity of secondary metabolites of<italic>Centaurea raphanina</italic>ssp mixta, growing wild in Greece</article-title><source>Pharm Bio</source><year>2003</year><volume>41</volume><fpage>266</fpage><lpage>270</lpage></citation></ref><ref id=""B42""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Meepagala</surname><given-names>KM</given-names></name><name><surname>Osbrink</surname><given-names>W</given-names></name><name><surname>Sturtz</surname><given-names>G</given-names></name><name><surname>Lax</surname><given-names>A</given-names></name></person-group><article-title>Plant-derived natural products exhibiting activity against Formosan subterranean termites (<italic>Coptotermes formosanus</italic>)</article-title><source>Pest Mangmnt Sci</source><year>2006</year><volume>62</volume><fpage>565</fpage><lpage>570</lpage><pub-id pub-id-type=""doi"">10.1002/ps.1214</pub-id></citation></ref><ref id=""B43""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Towie</surname><given-names>N</given-names></name></person-group><article-title>Malaria breakthrough raises spectre of drug resistance</article-title><source>Nature</source><year>2006</year><volume>440</volume><fpage>852</fpage><pub-id pub-id-type=""pmid"">16612346</pub-id><pub-id pub-id-type=""doi"">10.1038/440852b</pub-id></citation></ref><ref id=""B44""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Ro</surname><given-names>DK</given-names></name><name><surname>Paradise</surname><given-names>EM</given-names></name><name><surname>Ouellet</surname><given-names>M</given-names></name><name><surname>Fisher</surname><given-names>K</given-names></name><name><surname>Newman</surname><given-names>KL</given-names></name><etal></etal></person-group><article-title>Production of the antimalarial drug precursor artemisinic acid in engineered yeast</article-title><source>Nature</source><year>2006</year><volume>440</volume><fpage>940</fpage><lpage>943</lpage><pub-id pub-id-type=""pmid"">16612385</pub-id><pub-id pub-id-type=""doi"">10.1038/nature04640</pub-id></citation></ref><ref id=""B45""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Cahoon</surname><given-names>EB</given-names></name><name><surname>Schnurr</surname><given-names>JA</given-names></name><name><surname>Huffman</surname><given-names>EA</given-names></name><name><surname>Minto</surname><given-names>RE</given-names></name></person-group><article-title>Fungal responsive fatty acid acetylenases occur widely in evolutionarily distant plant families</article-title><source>Plant J</source><year>2003</year><volume>34</volume><fpage>671</fpage><lpage>683</lpage><pub-id pub-id-type=""pmid"">12787248</pub-id><pub-id pub-id-type=""doi"">10.1046/j.1365-313X.2003.01757.x</pub-id></citation></ref><ref id=""B46""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Winkel-Shirley</surname><given-names>B</given-names></name></person-group><article-title>Flavonoid Biosynthesis. A Colorful Model for Genetics, Biochemistry, Cell Biology, and Biotechnology</article-title><source>Plant Phys</source><year>2001</year><volume>126</volume><fpage>485</fpage><lpage>493</lpage><pub-id pub-id-type=""doi"">10.1104/pp.126.2.485</pub-id></citation></ref><ref id=""B47""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Emerenciano</surname><given-names>VP</given-names></name><name><surname>Militao</surname><given-names>JSLT</given-names></name><name><surname>Campos</surname><given-names>CC</given-names></name><name><surname>Romoff</surname><given-names>P</given-names></name><name><surname>Kaplan</surname><given-names>MAC</given-names></name><name><surname>Zambon</surname><given-names>M</given-names></name><name><surname>Brant</surname><given-names>AJ</given-names></name></person-group><article-title>Flavonoids as chemotaxonomic markers for Asteraceae</article-title><source>Biochem Syst Eco</source><year>2001</year><volume>29</volume><fpage>947</fpage><lpage>957</lpage><pub-id pub-id-type=""doi"">10.1016/S0305-1978(01)00033-3</pub-id></citation></ref><ref id=""B48""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Chini</surname><given-names>A</given-names></name><name><surname>Loake</surname><given-names>GJ</given-names></name></person-group><article-title>Motifs specific for the ADR1 NBS-LRR protein family are conserved among NBS-LRR sequences from both dicotyledonous and monocotyledonous plants</article-title><source>Planta</source><year>2005</year><volume>221</volume><fpage>597</fpage><lpage>601</lpage><pub-id pub-id-type=""pmid"">15889273</pub-id><pub-id pub-id-type=""doi"">10.1007/s00425-005-1499-3</pub-id></citation></ref><ref id=""B49""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Ochsenbein</surname><given-names>C</given-names></name><name><surname>Przbyla</surname><given-names>D</given-names></name><name><surname>Danon</surname><given-names>A</given-names></name><name><surname>Landgraf</surname><given-names>F</given-names></name><name><surname>Gobel</surname><given-names>C</given-names></name><name><surname>Imboden</surname><given-names>A</given-names></name><name><surname>Feussner</surname><given-names>I</given-names></name><name><surname>Apel</surname><given-names>K</given-names></name></person-group><article-title>The role of EDS1 (enhanced disease susceptibility) during singlet oxygen-mediated stress response of<italic>Arabidopsis</italic></article-title><source>Plant J</source><year>2006</year><volume>47</volume><fpage>445</fpage><lpage>456</lpage><pub-id pub-id-type=""pmid"">16790029</pub-id><pub-id pub-id-type=""doi"">10.1111/j.1365-313X.2006.02793.x</pub-id></citation></ref><ref id=""B50""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Dong</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Zhixiang</surname><given-names>C</given-names></name></person-group><article-title>Expression profiles of<italic>Arabidopsis</italic>WRKY gene superfamily during plant defense response</article-title><source>Plant Mol Bio</source><year>2003</year><volume>51</volume><fpage>21</fpage><lpage>37</lpage><pub-id pub-id-type=""pmid"">12602888</pub-id><pub-id pub-id-type=""doi"">10.1023/A:1020780022549</pub-id></citation></ref></ref-list><sec sec-type=""display-objects""><title>Figures and Tables</title><fig id=""F1"" position=""float""><label>Figure 1</label><caption><p><bold>Gene Ontology annotation of<italic>Centaurea</italic>Unigenes</bold>. A normalized cDNA library was created from whole plants representing seven invasive populations of<italic>Centaurea maculosa</italic>. Five thousand ESTs were sequenced from the 5' end (Agencourt biosciences), and assembled into 4,423 contigs, or '<italic>Centaurea</italic>unigenes.' Unigenes were translated in all frames and the resulting amino acid sequences were used as BLAST queries. Top BLAST hits provided annotation and functional categorization (gene ontology assignment) for each<italic>Centaurea</italic>unigene. Not all unigenes were able to be annotated by GO programs. Computational analysis was done using the PLAN database (Noble Foundation).</p></caption><graphic xlink:href=""1471-2229-7-25-1""></graphic></fig><fig id=""F2"" position=""float""><label>Figure 2</label><caption><p><bold>Phylogenetic analysis of acetylenease-related sequences from<italic>Centaurea</italic>cDNA library</bold>.<italic>C. maculosa</italic>EST sequences with similarity to fatty acid desaturase genes were clustered with previously characterized genes from<italic>Helianthus annuus</italic>(Hean),<italic>Petroselinum crispum</italic>(Pecr) fungal elicited desaturases (ELI), and with sterol desaturasase from<italic>Arabidopsis thalania</italic>as an outgroup. CENT_UG_00643, CENT_UG_00475, and CENT_UG_00098 cluster with the characterized acetylenase from<italic>H. annuus</italic>, distinct from the remaining Δ12 desaturases (Del12), suggesting potential for acetylenase activity.</p></caption><graphic xlink:href=""1471-2229-7-25-2""></graphic></fig></sec>"
10.1073/pnas.0501997102	"<html><body><article-title>S1P3 receptor-induced reorganization of epithelial tight junctions compromises lung barrier integrity and is potentiated by TNF</article-title>.<source>Proc Natl Acad Sci U S A</source>(<year>2005</year>)<volume>102</volume>(<issue>26</issue>):<fpage>9270</fpage>–<lpage>5</lpage>.<pub-id pub-id-type=""doi"">10.1073/pnas.0501997102</pub-id><pub-id pub-id-type=""pmid"">15968000</pub-id><ref id=""B56""><label>56</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Bachofen</surname><given-names>M</given-names></name><name><surname>Weibel</surname><given-names>ER</given-names></name></person-group><article article-type=""research-article"" xmlns:mml=""http://www.w3.org/1998/Math/MathML"" xmlns:xlink=""http://www.w3.org/1999/xlink""><?properties open_access?><front><journal-meta><journal-id journal-id-type=""nlm-ta"">Int J Mol Sci</journal-id><journal-id journal-id-type=""iso-abbrev"">Int J Mol Sci</journal-id><journal-id journal-id-type=""publisher-id"">ijms</journal-id><journal-title-group><journal-title>International Journal of Molecular Sciences</journal-title></journal-title-group><issn pub-type=""epub"">1422-0067</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type=""pmid"">29211013</article-id><article-id pub-id-type=""pmc"">5751239</article-id><article-id pub-id-type=""doi"">10.3390/ijms18122636</article-id><article-id pub-id-type=""publisher-id"">ijms-18-02636</article-id><article-categories><subj-group subj-group-type=""heading""><subject>Article</subject></subj-group></article-categories><title-group><article-title>Pharmacokinetics, Pharmacodynamics, Tolerability, and Food Effect of Cenerimod, a Selective S1P<sub>1</sub>Receptor Modulator in Healthy Subjects</article-title></title-group><contrib-group><contrib contrib-type=""author""><name><surname>Juif</surname><given-names>Pierre-Eric</given-names></name><xref ref-type=""aff"" rid=""af1-ijms-18-02636"">1</xref><xref ref-type=""corresp"" rid=""c1-ijms-18-02636"">*</xref></contrib><contrib contrib-type=""author""><name><surname>Baldoni</surname><given-names>Daniela</given-names></name><xref ref-type=""aff"" rid=""af1-ijms-18-02636"">1</xref></contrib><contrib contrib-type=""author""><name><surname>Reyes</surname><given-names>Maribel</given-names></name><xref ref-type=""aff"" rid=""af1-ijms-18-02636"">1</xref></contrib><contrib contrib-type=""author""><name><surname>Wilbraham</surname><given-names>Darren</given-names></name><xref ref-type=""aff"" rid=""af2-ijms-18-02636"">2</xref></contrib><contrib contrib-type=""author""><name><surname>Febbraro</surname><given-names>Salvatore</given-names></name><xref ref-type=""aff"" rid=""af3-ijms-18-02636"">3</xref></contrib><contrib contrib-type=""author""><name><surname>Vaclavkova</surname><given-names>Andrea</given-names></name><xref ref-type=""aff"" rid=""af4-ijms-18-02636"">4</xref></contrib><contrib contrib-type=""author""><name><surname>Hoch</surname><given-names>Matthias</given-names></name><xref ref-type=""aff"" rid=""af1-ijms-18-02636"">1</xref></contrib><contrib contrib-type=""author""><name><surname>Dingemanse</surname><given-names>Jasper</given-names></name><xref ref-type=""aff"" rid=""af1-ijms-18-02636"">1</xref></contrib></contrib-group><aff id=""af1-ijms-18-02636""><label>1</label>Department of Clinical Pharmacology, Idorsia Pharmaceuticals Ltd., Allschwil 4123, Switzerland;<email>daniela.baldoni@idorsia.com</email>(D.B.);<email>maribel.reyes.centeno@gmail.com</email>(M.R.);<email>Matthias.Hoch@astrazeneca.com</email>(M.H.);<email>jasper.dingemanse@idorsia.com</email>(J.D.)</aff><aff id=""af2-ijms-18-02636""><label>2</label>Quintiles Drug Research Unit, London SE1 1YR, UK;<email>wilbraham_darren@lilly.com</email></aff><aff id=""af3-ijms-18-02636""><label>3</label>Simbec Research Ltd., Merthyr Tydfil CF48 4DR, UK;<email>febbras@doctors.org.uk</email></aff><aff id=""af4-ijms-18-02636""><label>4</label>Department of Global Drug Safety, Actelion Pharmaceuticals Ltd., Allschwil 4123, Switzerland;<email>andrea.vaclavkova@actelion.com</email></aff><author-notes><corresp id=""c1-ijms-18-02636""><label>*</label>Correspondence:<email>pierre-eric.juif@idorsia.com</email>; Tel.: +41-58-844-0622; Fax: +41-61-565-6200</corresp></author-notes><pub-date pub-type=""epub""><day>06</day><month>12</month><year>2017</year></pub-date><pub-date pub-type=""collection""><month>12</month><year>2017</year></pub-date><volume>18</volume><issue>12</issue><elocation-id>2636</elocation-id><history><date date-type=""received""><day>31</day><month>10</month><year>2017</year></date><date date-type=""accepted""><day>01</day><month>12</month><year>2017</year></date></history><permissions><copyright-statement>© 2017 by the authors.</copyright-statement><copyright-year>2017</copyright-year><license license-type=""open-access""><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type=""uri"" xlink:href=""http://creativecommons.org/licenses/by/4.0/"">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>The pharmacokinetics, pharmacodynamics, tolerability, and food effect of cenerimod, a potent sphingosine-1-phosphate subtype 1 receptor modulator, were investigated in three sub-studies. Two double-blind, placebo-controlled, randomised studies in healthy male subjects were performed. Cenerimod was administered either as single dose (1, 3, 10 or 25 mg; Study 1) or once daily for 35 days (0.5, 1, 2 or 4 mg; Study 2). A two-period cross-over, open-label study was performed to assess the food effect (1 mg, Study 3). The pharmacokinetic profile of cenerimod was characterised by a<italic>t</italic><sub>max</sub>of 5.0–6.2 h. Terminal half-life after single and multiple doses ranged from 170 to 199 h and 283 to 539 h, respectively. Food had no relevant effect on the pharmacokinetics of cenerimod. A dose-dependent decrease in lymphocyte count was observed after initiation of cenerimod and reached a plateau (maximum change from baseline: −64%) after 20–23 days of treatment. Lymphocyte counts returned to baseline values at end-of-study examination. One serious adverse event of circulatory collapse (25 mg dose group, maximum tolerated dose: 10 mg) and adverse events of mild-to-moderate intensity were reported. Treatment initiation was associated with transient decreases in heart rate and blood pressure at doses &gt;1 and ≥10 mg, respectively.</p></abstract><kwd-group><kwd>pharmacokinetics</kwd><kwd>pharmacodynamics</kwd><kwd>S1P<sub>1</sub>receptor modulator</kwd><kwd>lymphocyte</kwd><kwd>tolerability</kwd><kwd>food effect</kwd></kwd-group></article-meta></front><sec id=""sec1-ijms-18-02636""><title>1. Introduction</title><p>Sphingosine-1-phosphate (S1P) is synthesised and secreted by many cell types. This phospholipid is a ligand of and binds to G-protein-coupled receptors (S1P<sub>1</sub>–S1P<sub>5</sub>) to modulate a wide range of physiological systems [<xref ref-type=""bibr"" rid=""B1-ijms-18-02636"">1</xref>,<xref ref-type=""bibr"" rid=""B2-ijms-18-02636"">2</xref>,<xref ref-type=""bibr"" rid=""B3-ijms-18-02636"">3</xref>]. Repeated administration of S1P<sub>1</sub>receptor (S1P<sub>1</sub>R) modulators triggers a sustained internalisation of this receptor and induces a long-lasting inhibition of the egress of lymphocytes from lymphoid organs [<xref ref-type=""bibr"" rid=""B4-ijms-18-02636"">4</xref>]. This reduction in lymphocyte count in peripheral blood is considered a therapeutic approach to treat autoimmune diseases. In this respect, the non-selective S1P receptor modulator fingolimod (Gilenya<sup>®</sup>) is used to treat patients with relapsing multiple sclerosis [<xref ref-type=""bibr"" rid=""B5-ijms-18-02636"">5</xref>] and selective S1P<sub>1</sub>R modulators have achieved proof-of-concept in multiple sclerosis [<xref ref-type=""bibr"" rid=""B6-ijms-18-02636"">6</xref>] and psoriasis [<xref ref-type=""bibr"" rid=""B7-ijms-18-02636"">7</xref>]. Whereas cardiodynamic (heart rate [HR] reduction, delay in atrio ventricular (AV) conduction) and pulmonary effects had initially been related to S1P<sub>3</sub>agonism [<xref ref-type=""bibr"" rid=""B8-ijms-18-02636"">8</xref>,<xref ref-type=""bibr"" rid=""B9-ijms-18-02636"">9</xref>,<xref ref-type=""bibr"" rid=""B10-ijms-18-02636"">10</xref>], these effects were also observed with selective modulation of S1P<sub>1</sub>R [<xref ref-type=""bibr"" rid=""B11-ijms-18-02636"">11</xref>,<xref ref-type=""bibr"" rid=""B12-ijms-18-02636"">12</xref>,<xref ref-type=""bibr"" rid=""B13-ijms-18-02636"">13</xref>,<xref ref-type=""bibr"" rid=""B14-ijms-18-02636"">14</xref>,<xref ref-type=""bibr"" rid=""B15-ijms-18-02636"">15</xref>].</p><p>Cenerimod (ACT-334441) is a potent S1P<sub>1</sub>R modulator. In vitro and in vivo preclinical studies revealed that cenerimod is highly selective for the human S1P<sub>1</sub>R. Indeed, compared to S1P, cenerimod is 16-fold more potent on the S1P<sub>1</sub>R (EC<sub>50</sub>: 1 vs. 16 nM for cenerimod vs. S1P) and 2000-fold less active on the S1P<sub>3</sub>receptor (EC<sub>50</sub>: 228 vs. 0.1 nM for cenerimod vs. S1P) [<xref ref-type=""bibr"" rid=""B16-ijms-18-02636"">16</xref>]. In animal species and man, the binding of cenerimod to plasma proteins is &gt;99.9%. In rats and dogs, single- and multiple-dose administration of cenerimod at doses &gt;0.3 mg/kg induced a dose-dependent and reversible reduction of lymphocyte count. In a mouse model of multiple sclerosis (experimental autoimmune encephalomyelitis), preventive and therapeutic treatment with cenerimod (6 mg/kg/day) led to clinical and histological efficacy. In rats, a decrease in HR was observed at doses ≥0.3 mg/kg, this reduction was similar at doses of 1 and 3 mg/kg. The pharmacokinetic (PK) profile of cenerimod (0.1 mg/kg) revealed a rapid absorption and a terminal half-life (<italic>t</italic><sub>1/2</sub>) of 12 and 7.5 h in male rats and dogs, respectively. Multiple-dose administration led to a greater than dose-proportional exposure in both rats and dogs between 3 and 10 mg/kg.</p><p>The aim of the studies reported here was to assess for the first time in humans the PK, pharmacodynamics (PD), food effect (only after single dose), safety, and tolerability of cenerimod as a single oral dose or once daily (o.d.) multiple oral doses for 35 days.</p></sec><sec id=""sec2-ijms-18-02636""><title>2. Results</title><sec id=""sec2dot1-ijms-18-02636""><title>2.1. Pharmacokinetics</title><p>As described in<xref ref-type=""table"" rid=""ijms-18-02636-t001"">Table 1</xref>and depicted in<xref ref-type=""fig"" rid=""ijms-18-02636-f001"">Figure 1</xref>A, after single-dose administration, cenerimod was slowly absorbed with a median time to reach maximum concentration (<italic>t</italic><sub>max</sub>) between 5.0 and 6.2 h (range: 4.0–8.0 h). Cenerimod was eliminated from plasma with a geometric mean<italic>t</italic><sub>1/2</sub>(95% confidence interval (CI)) that varied from 170 (134–213) to 199 (188–211) h. Exposure to cenerimod was slightly more than dose proportional as estimated from the power model. The linear regression slope (95% CI) was 1.07 (1.00–1.13), 1.05 (0.99–1.11), and 1.07 (1.01–1.13) for maximum plasma concentration (<italic>C</italic><sub>max</sub>), area under the plasma drug concentration-time curve (AUC) from 0 to 24 h (AUC<sub>0–24</sub>), and AUC from 0 to infinity (AUC<sub>0–∞</sub>), respectively.</p><p>In Study 2, similar<italic>t</italic><sub>max</sub>values were observed on Day 1 (5.0 to 6.0 h) and Day 35 (4.3 to 6.0 h). Cenerimod was eliminated from plasma with a geometric mean terminal<italic>t</italic><sub>1/2</sub>(95% CI) of 283 (210–381), 436 (359–529), 415 (358–481), and 539 (492–591) h following 0.5, 1, 2 and 4 mg doses, respectively. Cenerimod was shown to accumulate substantially over the 35 days of administration (<xref ref-type=""fig"" rid=""ijms-18-02636-f001"">Figure 1</xref>C), as reflected by higher<italic>C</italic><sub>max</sub>and AUC<sub>0–24</sub>values on Day 35 than on Day 1 (<xref ref-type=""table"" rid=""ijms-18-02636-t001"">Table 1</xref>). The accumulation ratio (geometric mean Day 35/Day 1 ratio) was 5–7 for<italic>C</italic><sub>max</sub>and 7–9 for AUC<sub>0–24</sub>across the cenerimod dose groups (<xref ref-type=""table"" rid=""ijms-18-02636-t001"">Table 1</xref>). Plasma concentration-time profiles of cenerimod over the 35-day dosing period revealed a gradual increase in trough concentrations and steady-state conditions at lower doses were reached after 20 to 32 days of treatment (<xref ref-type=""fig"" rid=""ijms-18-02636-f001"">Figure 1</xref>C). On Day 1 and Day 35, exposure to cenerimod was shown to be dose-proportional across all dose groups. The linear regression slope (95% CI) was 0.96 (0.84–1.07) and 0.93 (0.83–1.03) on Day 1 for<italic>C</italic><sub>max</sub>and AUC<sub>0–24</sub>, respectively, and 0.91 (0.75–1.08), 0.93 (0.75–1.10), and 1.00 (0.78–1.22) on Day 35 for<italic>C</italic><sub>max</sub>, AUC<sub>0–24</sub>, and AUC<sub>0–∞</sub>, respectively.</p><p>Volume of distribution at steady-state (Vss/F) increased with dose. The geometric mean (95% CI) Vss/F was 758 (525–1095), 874 (592–1290), 1294 (1157–1446), and 1483 (947–2324) L at doses of 0.5, 1, 2 and 4 mg, respectively. Geometric mean (95% CI) clearance (CL/F) was comparable across dose groups, between 1.39 (1.08–1.79) and 2.16 (1.79–2.61) L/h.</p><p>The concentration-time profiles of cenerimod under fed or fasted conditions are depicted in<xref ref-type=""fig"" rid=""ijms-18-02636-f001"">Figure 1</xref>B. A slightly slower rate of absorption reflected by a higher median<italic>t</italic><sub>max</sub>(7.0 (min–max: 6.0–12.0) h) and a lower<italic>C</italic><sub>max</sub>(4.35 (3.5–5.4) ng/mL) was observed following cenerimod administration in fed condition compared to fasted condition (<italic>t</italic><sub>max</sub>: 6.0 (6.0–8.0) h;<italic>C</italic><sub>max</sub>: 4.73 (4.1–5.5) ng/mL).<xref ref-type=""table"" rid=""ijms-18-02636-t001"">Table 1</xref>reveals a similar exposure to cenerimod following fed and fasted administration. The geometric least squares (LS) mean ratio (90% CI) (fed (reference) vs. fasted, in %) was 92.0% (84.97–99.54), 90.2% (84.52–96.31), and 97.1% (87.55–107.69) for<italic>C</italic><sub>max</sub>, AUC<sub>0–24</sub>, and AUC<sub>0–∞</sub>, respectively. The 90% CIs of the geometric LS mean ratios were all within the limits of 80–125%.</p></sec><sec id=""sec2dot2-ijms-18-02636""><title>2.2. Pharmacodynamics</title><p>In Study 1, a dose-dependent decrease in lymphocyte count was observed following single-dose administration of cenerimod at doses ≥3 mg (<xref ref-type=""fig"" rid=""ijms-18-02636-f002"">Figure 2</xref>A). At doses ≥3 mg, a significant decrease in lymphocyte count was observed (<italic>p</italic>&lt; 0.05 baseline vs. nadir in the 3, 10 and 25 mg dose groups) and the maximal mean percentage change from baseline (± standard deviation (SD)) was significantly more pronounced compared to placebo: −34.5 ± 13.8% (8 h post-dose,<italic>p</italic>= 0.01), −60.7 ± 11.4% (8 h post-dose,<italic>p</italic>&lt; 0.0001), and −76.1 ± 10.4% (16 h post-dose,<italic>p</italic>&lt; 0.0001) in the 3, 10 and 25 mg dose groups, respectively. This effect was also reflected by the maximum effect (<italic>E</italic><sub>max)</sub>and area under the effect curve (AUEC) values (<xref ref-type=""table"" rid=""ijms-18-02636-t002"">Table 2</xref>).</p><p>In Study 2, when administered o.d. for 35 days, cenerimod led to a gradual, dose-dependent reduction in lymphocyte count that reached a plateau 20 to 23 days after first dose (<xref ref-type=""fig"" rid=""ijms-18-02636-f002"">Figure 2</xref>C,<xref ref-type=""table"" rid=""ijms-18-02636-t002"">Table 2</xref>). The maximum (%) change from baseline (mean ± SD) was −33.6 ± 15.0% (Day 36,<italic>p</italic>= 0.0002 vs. baseline), −50.1 ± 4.4% (Day 35,<italic>p</italic>= 0.0009 vs. baseline), −64.1 ± 8.7% (Day 23,<italic>p</italic>&lt; 0.0001 vs. baseline), and −56.3 ± 7.0% (Day 36,<italic>p</italic>&lt; 0.0001 vs. baseline) following doses of 0.5, 1, 2 and 4 mg, respectively. The nadir lymphocyte count was observed in the 4 mg group (0.60 ± 0.09 × 10<sup>9</sup>cells/L). In the placebo group, the largest decrease was −13.8 ± 12.9% (<italic>p</italic>= 0.22) and lymphocyte count was ≥1.0 × 10<sup>9</sup>cells/L during the entire study.</p><p>In Study 3, a similar maximal mean decrease in lymphocyte count was observed in fed (−20.5 ± 14.6%, 6 h post-dose;<italic>p</italic>= 0.049 vs. baseline) and fasted (−20.6 ± 12.1%, 1.5 h post-dose;<italic>p</italic>= 0.08 vs. baseline) conditions (<xref ref-type=""fig"" rid=""ijms-18-02636-f002"">Figure 2</xref>B). Food had no effect on the time to nadir,<italic>E</italic><sub>max</sub>, and AUEC (<xref ref-type=""table"" rid=""ijms-18-02636-t002"">Table 2</xref>).</p><p>Lymphocyte count in each subject returned to at least the lower limit of the normal range (i.e., 80% of baseline) at end-of-study.</p></sec><sec id=""sec2dot3-ijms-18-02636""><title>2.3. Pharmacokinetics/Pharmacodynamics</title><p>The PK/PD relationship has been investigated and is depicted in<xref ref-type=""fig"" rid=""ijms-18-02636-f003"">Figure 3</xref>. Based on Study 2 data, concentration and decrease in lymphocyte count vs. time follow similar profiles.</p></sec><sec id=""sec2dot4-ijms-18-02636""><title>2.4. Safety and Tolerability</title><p>Apart from a severe and serious adverse event of circulatory collapse reported in Study 1 (6 h after administration of 25 mg cenerimod, lowest supine blood pressure (BP): 39/23 mmHg, pulse rate: 60 bpm, resolved without sequelae within 24 h following administration of atropine and ephedrine), all adverse events (AEs) were of mild-to-moderate intensity and resolved without sequelae. Most of the observed AEs were considered unrelated to study drug. The serious adverse event defined the maximum tolerated single dose of 10 mg. Pooling of the 3 studies revealed a similar number of subjects experiencing at least one AE following cenerimod (36 subjects, 64%) or placebo (11 subjects, 69%).</p><p>The most frequently reported AEs were headache, dizziness, chest pain (this combined chest pain, chest discomfort, musculoskeletal chest pain, and non-cardiac chest pain), and nasopharyngitis (<xref ref-type=""table"" rid=""ijms-18-02636-t003"">Table 3</xref>). There were no apparent drug-related effects on body temperature, clinical chemistry variables, coagulation variables, or physical examination.</p><p>As expected, based on many other S1P<sub>1</sub>R modulators in development [<xref ref-type=""bibr"" rid=""B15-ijms-18-02636"">15</xref>], a transient decrease in HR was observed following start of cenerimod administration. As shown in<xref ref-type=""fig"" rid=""ijms-18-02636-f004"">Figure 4</xref>A, this decrease was dose-dependent in Study 1. The maximum decrease from baseline (mean ± SD) was −8 ± 9 (<italic>p</italic>= 0.055 vs. baseline), −10 ± 5 (<italic>p</italic>= 0.03 vs. baseline), −17 ± 7 (<italic>p</italic>&lt; 0.001 vs. baseline), and −21 ± 11 (<italic>p</italic>= 0.007 vs. baseline) bpm 4 h after cenerimod administration at doses of 1, 3, 10 and 25 mg, respectively. Placebo administration led to a slight decrease in HR (maximum change from baseline (mean ± SD): −4 ± 9;<italic>p</italic>= 0.43 vs. baseline). When compared to placebo, a significant decrease in HR was observed after single doses of 10 and 25 mg (<italic>p</italic>= 0.007). A dose–response relationship was not observed in Study 2 and the maximum mean ± SD change from baseline was −10 ± 4 (<italic>p</italic>= 0.0001 vs. baseline), −9 ± 6 (<italic>p</italic>= 0.004 vs. baseline), −9 ± 5 (<italic>p</italic>= 0.002 vs. baseline), and −12 ± 5 (<italic>p</italic>&lt; 0.001 vs. baseline) bpm 2.5 h after the first administration of cenerimod at doses of 0.5, 1, 2 and 4 mg, respectively (<xref ref-type=""fig"" rid=""ijms-18-02636-f004"">Figure 4</xref>C). This effect was observed following the first dose and the second administration of cenerimod (Day 2) led to a less pronounced decrease in HR, which returned to baseline values within 7 to 14 days. Maximum change from baseline (mean ± SD) in the placebo group was −11 ± 8 bpm (<italic>p</italic>= 0.006 vs. baseline). In Study 3, no significant difference was observed between the change from baseline (mean ± SD) in fasted (−11 ± 10 bpm;<italic>p</italic>= 0.04 vs. baseline) and fed (−7 ± 5 bpm;<italic>p</italic>= 0.276 vs. baseline) conditions (<italic>p</italic>= 0.297 fed vs. fasted;<xref ref-type=""fig"" rid=""ijms-18-02636-f004"">Figure 4</xref>B).</p></sec></sec><sec id=""sec3-ijms-18-02636""><title>3. Discussion</title><p>This study provides the first PK, PD, safety, and tolerability data for cenerimod, a selective oral S1P<sub>1</sub>R modulator, in healthy male subjects. Single and multiple o.d. oral doses of up to 10 and 4 mg (up to 35 days), respectively, were well tolerated. The nature and severity of AEs reported in the present studies were similar to those observed following administration of other representatives of this drug class, e.g., ponesimod [<xref ref-type=""bibr"" rid=""B7-ijms-18-02636"">7</xref>,<xref ref-type=""bibr"" rid=""B11-ijms-18-02636"">11</xref>,<xref ref-type=""bibr"" rid=""B12-ijms-18-02636"">12</xref>], fingolimod [<xref ref-type=""bibr"" rid=""B17-ijms-18-02636"">17</xref>,<xref ref-type=""bibr"" rid=""B18-ijms-18-02636"">18</xref>], or siponimod [<xref ref-type=""bibr"" rid=""B19-ijms-18-02636"">19</xref>]. Furthermore, decreases in BP were triggered following single high doses of cenerimod as previously observed with ponesimod [<xref ref-type=""bibr"" rid=""B11-ijms-18-02636"">11</xref>].</p><p>Pharmacokinetic evaluation revealed that exposure to cenerimod was slightly more than dose-proportional for single doses and dose-proportional across the entire dose range for multiple doses. The intersubject variability was low to moderate for<italic>C</italic><sub>max</sub>(9.1–27.3%), AUC<sub>0–24</sub>(11.0–27.6%), and<italic>t</italic><sub>1/2</sub>(5.3–28.6%). Multiple-dose PK of cenerimod are characterised by steady-state concentrations reached 20–32 days following o.d. administration and exposure is approximately 5- to 9-fold greater than after the initial dose. Compared to single-dose, multiple-dose PK revealed similar<italic>t</italic><sub>max</sub>(4–6 h), but longer, dose-dependent<italic>t</italic><sub>1/2</sub>(283–539 h), and higher intersubject variability (≤45.0%). These PK properties of cenerimod resemble those of fingolimod [<xref ref-type=""bibr"" rid=""B20-ijms-18-02636"">20</xref>] or amiselimod [<xref ref-type=""bibr"" rid=""B21-ijms-18-02636"">21</xref>] more than of ponesimod [<xref ref-type=""bibr"" rid=""B11-ijms-18-02636"">11</xref>,<xref ref-type=""bibr"" rid=""B12-ijms-18-02636"">12</xref>] or siponimod [<xref ref-type=""bibr"" rid=""B19-ijms-18-02636"">19</xref>]. Based on the present data and its lipophilic properties, it is plausible that cenerimod accumulates in several tissues.</p><p>As expected, based on its pharmacological mode of action, cenerimod decreased the lymphocyte count in peripheral blood. Following single-dose administration, this reduction was different from placebo at doses ≥3 mg and was dose-dependent. Single- and multiple-dose administration of 25 and 2 mg led to a maximal decrease of circulating lymphocytes of 76% and 64%, respectively. This is in good agreement with previous data obtained from fingolimod and ponesimod administered at supra-therapeutic doses [<xref ref-type=""bibr"" rid=""B11-ijms-18-02636"">11</xref>,<xref ref-type=""bibr"" rid=""B12-ijms-18-02636"">12</xref>,<xref ref-type=""bibr"" rid=""B13-ijms-18-02636"">13</xref>,<xref ref-type=""bibr"" rid=""B17-ijms-18-02636"">17</xref>,<xref ref-type=""bibr"" rid=""B18-ijms-18-02636"">18</xref>]. The effect was sustained and reversible within 7 and 40 days after single- and multiple-dose administration of cenerimod. In line with multiple-dose administration of ponesimod or fingolimod, lymphocyte counts decreased and reached a plateau [<xref ref-type=""bibr"" rid=""B12-ijms-18-02636"">12</xref>,<xref ref-type=""bibr"" rid=""B13-ijms-18-02636"">13</xref>,<xref ref-type=""bibr"" rid=""B17-ijms-18-02636"">17</xref>]. Interestingly, the percent change from baseline and AUEC were slightly higher in the 2 mg compared to the 4 mg dose group. This may be explained by a lower mean baseline of lymphocyte count in the 4 mg group compared to the 2 mg group since the same threshold was reached (~0.6 × 10<sup>9</sup>cells/L) as shown in<xref ref-type=""table"" rid=""ijms-18-02636-t002"">Table 2</xref>. Experience with other selective S1P<sub>1</sub>R modulators such as siponimod and ponesimod has shown that a lymphocyte count reduction of 60–70% from baseline is associated with a plateau of efficacy for treatment of multiple sclerosis, while a 20–30% reduction in lymphocyte count is associated with minimal efficacy [<xref ref-type=""bibr"" rid=""B6-ijms-18-02636"">6</xref>,<xref ref-type=""bibr"" rid=""B19-ijms-18-02636"">19</xref>].</p><p>The overall pattern of reported AEs is similar to the one observed with the non-selective S1P receptor modulator fingolimod or the selective S1P<sub>1</sub>R modulators ceralifimod, ozanimod and ponesimod [<xref ref-type=""bibr"" rid=""B11-ijms-18-02636"">11</xref>,<xref ref-type=""bibr"" rid=""B12-ijms-18-02636"">12</xref>,<xref ref-type=""bibr"" rid=""B17-ijms-18-02636"">17</xref>,<xref ref-type=""bibr"" rid=""B18-ijms-18-02636"">18</xref>,<xref ref-type=""bibr"" rid=""B22-ijms-18-02636"">22</xref>,<xref ref-type=""bibr"" rid=""B23-ijms-18-02636"">23</xref>]. Nevertheless, incidence of AEs such as bradycardia and dyspnoea was lower with cenerimod compared to fingolimod [<xref ref-type=""bibr"" rid=""B17-ijms-18-02636"">17</xref>,<xref ref-type=""bibr"" rid=""B18-ijms-18-02636"">18</xref>] or ponesimod [<xref ref-type=""bibr"" rid=""B11-ijms-18-02636"">11</xref>,<xref ref-type=""bibr"" rid=""B12-ijms-18-02636"">12</xref>]. Following single doses of 10 and 25 mg and multiple doses of 1 mg, a slight decrease in FEV<sub>1</sub>was observed. This effect might be related to agonism of S1P<sub>1</sub>R although mainly S1P<sub>3</sub>receptors have been shown to mediate S1P effects on the lung [<xref ref-type=""bibr"" rid=""B24-ijms-18-02636"">24</xref>].</p><p>Although the role of S1P<sub>3</sub>receptors in S1P-induced HR effect has been described [<xref ref-type=""bibr"" rid=""B8-ijms-18-02636"">8</xref>,<xref ref-type=""bibr"" rid=""B10-ijms-18-02636"">10</xref>], another signalling might be involved based on the HR effect of highly selective S1P<sub>1</sub>R modulators [<xref ref-type=""bibr"" rid=""B11-ijms-18-02636"">11</xref>,<xref ref-type=""bibr"" rid=""B12-ijms-18-02636"">12</xref>,<xref ref-type=""bibr"" rid=""B19-ijms-18-02636"">19</xref>]. Previous studies have revealed that both S1P<sub>1</sub>and S1P<sub>3</sub>agonism prior to receptor internalisation [<xref ref-type=""bibr"" rid=""B8-ijms-18-02636"">8</xref>,<xref ref-type=""bibr"" rid=""B10-ijms-18-02636"">10</xref>,<xref ref-type=""bibr"" rid=""B25-ijms-18-02636"">25</xref>] lead to a reduction in HR via stimulation of the inward rectifier potassium current (I<sub>K.ACh</sub>) [<xref ref-type=""bibr"" rid=""B26-ijms-18-02636"">26</xref>]. Internalisation of S1P<sub>1</sub>R and their desensitisation explain that treatment initiation triggers a transient decrease in HR [<xref ref-type=""bibr"" rid=""B27-ijms-18-02636"">27</xref>].</p><p>Cenerimod displays advantages over fingolimod and ponesimod in terms of selectivity on the S1P<sub>1</sub>R. In addition, the long<italic>t</italic><sub>1/2</sub>of cenerimod, compared to ponesimod, will allow a built-in natural uptitration and a longer duration for drug holiday [<xref ref-type=""bibr"" rid=""B15-ijms-18-02636"">15</xref>].</p><p>Single doses of cenerimod up to 10 mg were well tolerated and the tolerability profile of cenerimod is similar to that of ponesimod. In conclusion, the present promising results warrant further development of cenerimod in patients suffering from autoimmune disorders, e.g., systemic lupus erythematosus (NCT02472795).</p></sec><sec id=""sec4-ijms-18-02636""><title>4. Materials and Methods</title><sec id=""sec4dot1-ijms-18-02636""><title>4.1. Subjects</title><p>In these three sub-studies, healthy male subjects aged between 18 and 47 years were included. The health of the subjects was assessed at the screening visit, which included recording of the medical history, medications taken during the 3 months preceding the screening visit, a physical examination, measurement of body weight and height, clinical laboratory tests, recording of vital signs, and standard electrocardiogram (ECG). At screening, subjects had to have PR interval &lt;200 ms, HR 55–90 bpm, systolic and diastolic blood pressure (BP) 100–150 and 50–90 mm Hg, respectively, (FEV<sub>1</sub>) and (FVC) &gt;80% of the predicted value, and a normal total lymphocyte count (&gt;10<sup>9</sup>lymphocytes/L). Written informed consent was obtained from each individual participating in the study prior to any study procedure and after adequate explanation of the aims, methods, objectives and potential hazards of the studies. The single-ascending dose study (Study 1) was performed prior to and in a different centre than the multiple-ascending dose (Study 2) and the food effect study (Study 3). All protocols were approved by the Reading and Plymouth Independent Ethics Committees (UK) (date of approval of initial protocol from Institutional Review Board (IRB), 10 November 2010 for SAD, 20 April 2012 for MAD and food effect). These studies were performed according to good clinical practice and in accordance with the principles of the Declaration of Helsinki.</p></sec><sec id=""sec4dot2-ijms-18-02636""><title>4.2. Study Design</title><p>This work was performed in two centres located in the UK. Study 1 and Study 2 were single-centre, randomised, double-blind, placebo-controlled, parallel-group single- and multiple-ascending oral dose studies, respectively. Study 3 was a two-way cross-over, open-label, food effect study. A total of 72 male subjects (32, 32 and 8 subjects in Study 1, Study 2 and Study 3, respectively) were enrolled, 8 subjects were assigned per dose group (ratio 3:1 for active:placebo in Study 1 and Study 2). Female subjects were excluded based on the potential teratogenic risk of cenerimod. Cenerimod (capsule formulation) was administered at a single dose of 1, 3, 10 or 25 mg in Study 1 and o.d. for 35 days at doses of 0.5, 1, 2 and 4 mg in Study 2. In Study 3, a single dose of 1 mg cenerimod was administered either in fed (i.e., a high-fat and high-calorie (as described in the Food and Drug Administration (FDA) guidance [<xref ref-type=""bibr"" rid=""B28-ijms-18-02636"">28</xref>], breakfast 30 min before cenerimod administration) or in fasted conditions, with a washout period of at least 45 days between the study drug administrations. All treatments were administered in the morning (fasted condition in Study 1 and Study 2) with approximately 240 mL of water. Based on the ratio of the lowest-observed-adverse-effect-levels in the 4-week rat and dog toxicology studies and human equivalent doses at the planned starting dose of 1 mg, the safety margins were 33.8 and 116.8, respectively. PK and PD profiles after multiple oral o.d. doses were predicted from data obtained during Study 1 and supported the selection of doses in Study 2.</p><p>Subjects were admitted to the clinical centre on Day −1 and remained in the clinic until Day 7 (Study 1 and Study 3) or Day 41 (Study 2) when they were discharged if this was allowed on the basis of their medical condition (HR ≥45 bpm or ≥70% of baseline, no clinically relevant treatment-emergent ECG abnormalities, FEV<sub>1</sub>and FVC ≥80% of baseline, and absolute lymphocyte count ≥10<sup>9</sup>lymphocytes/L). Subjects returned to the clinic for weekly outpatient visits (until Day 21 in Study 3, and in the 10 and 25 mg dose groups in Study 1, Day 56 for the 0.5 mg dose group in Study 2, and Day 84 in the 1, 2 and 4 mg dose groups in Study 2). An end-of-study visit comprising the same examinations as at the screening visit was conducted at least 28 days after the last administration of cenerimod.</p></sec><sec id=""sec4dot3-ijms-18-02636""><title>4.3. Pharmacokinetic Assessments</title><p>In Study 1 and Study 3, blood samples of about 3 mL were collected in ethylene di-amine tetra acetic acid (EDTA) tubes pre-dose and at 0.5, 1, 1.5, 2.5, 4, 6, 8, 12, 16, 24, 36, 48, 72, 96, 120 and 144 h after study drug administration. In addition, blood PK samplings were performed on Day 14, Day 21 and Day 28 in Study 3, and in the 10 and 25 mg dose group in Study 1. In Study 2, blood sampling was performed pre-dose and 1, 2.5, 4, 6, 8, 12, 16 h on Day 1 and Day 35 for a full PK profile after the first and the last dose. Samples were collected pre-dose from Day 2 to Day 34 and also at each outpatient visit until the end-of-study examination. After centrifugation, plasma was transferred into a polypropylene tube and stored at −21 °C (±5 °C) pending analysis. Plasma concentrations of cenerimod were determined using a validated liquid chromatography coupled to tandem mass spectrometry assay with a lower limit of quantification of 0.1 ng/mL and using a pentadeuterated form of cenerimod as internal standard. The method was linear in the concentration range 0.1–100 ng/mL. Analysis of quality-control samples of all runs showed that inter-batch coefficients of variation (precision) were &lt;8.8%, whereas the average intra-batch accuracy was in the range 96.0–102.7%. Noncompartmental PK analyses were performed using Professional WinNonlin 6.1 software (Pharsight Corp., Mountain View, CA, USA). The variables<italic>C</italic><sub>max</sub>and<italic>t</italic><sub>max</sub>were directly obtained from the plasma concentration-time profiles, AUC<sub>0–t</sub>was calculated using the trapezoidal method [<xref ref-type=""bibr"" rid=""B29-ijms-18-02636"">29</xref>], and<italic>t</italic><sub>1/2</sub>was calculated as ln 2/λz, where λz is the terminal elimination rate constant estimated by log-linear regression analysis.</p></sec><sec id=""sec4dot4-ijms-18-02636""><title>4.4. Pharmacodynamic Assessments</title><p>Analysis of the lymphocyte count in peripheral blood was performed at the same time points as PK samples in Study 1 and Study 3. In Study 2, lymphocyte count was assessed on Day 1, every 3 days from Day 2 to Day 35, and at each outpatient visit. Assessment of lymphocyte count was part of the clinical haematology evaluation. To assess lymphocyte count, blood samples of 2.7 mL were collected into a K<sub>3</sub>-EDTA polypropylene tube and analysis was performed using a cell counter. The measured individual whole blood lymphocyte counts were used to establish the effect-time curve, lymphocyte nadir (<italic>E</italic><sub>max</sub>), and time to nadir (<italic>t</italic><sub>max</sub>). The area under the effect-curve (AUEC) was calculated according to the linear trapezoidal rule using the measured lymphocyte count (effect)-time values.</p></sec><sec id=""sec4dot5-ijms-18-02636""><title>4.5. Safety and Tolerability Assessments</title><p>Safety and tolerability were evaluated by monitoring AEs, vital signs measurements (supine BP), 12-lead ECG recordings, pulmonary function tests (PFTs), clinical laboratory, physical, and neurological examinations. ECG variables and BP were recorded pre-dose and 0.5, 1, 1.5, 2.5, 4, 6, 8, 12, 16, 24, 36, 48, 72, 96, 120 and 144 h after study drug administration in Study 1. For the single-dose groups of 10 and 25 mg in Study 1 and for Study 3, study day 14, 21 and 28 time points were added. In Study 2, recordings of BP and 12-lead ECG were performed pre-dose and 1, 2.5, 4, 6, 8, 12, 16 h post-dose on Day 1 and pre-dose and 4, 6, 8, 12 h post-dose from Day 2 to Day 35. Additional recordings were done at each outpatient visit.</p></sec><sec id=""sec4dot6-ijms-18-02636""><title>4.6. Statistical Analysis</title><p>Pharmacokinetic variables were analysed descriptively providing the geometric mean and 95% CIs for<italic>C</italic><sub>max</sub>, AUC<sub>0–24</sub>, AUC<sub>0–∞</sub>, and<italic>t</italic><sub>1/2</sub>, and the median with the range for<italic>t</italic><sub>max</sub>. Dose proportionality of log transformed<italic>C</italic><sub>max</sub>, AUC<sub>0–24</sub>, and AUC<sub>0–∞</sub>values was explored by the power model [<xref ref-type=""bibr"" rid=""B30-ijms-18-02636"">30</xref>]. Pharmacodynamic and cardiodynamic data are expressed as mean ± SD. The Student’s<italic>t</italic>-test was used to analyse the effects of cenerimod on the lymphocyte count and HR. Comparisons of baseline versus nadir (i.e., lowest value measured) and placebo vs. treatment were performed. Safety and tolerability data were analysed descriptively by treatment group and data from placebo subjects were pooled. Differences were considered to be statistically significant at<italic>p</italic>&lt; 0.05.</p><p>SAS<sup>®</sup>software, version 9.2 (SAS Institute, Cary, NC, USA) was used for the statistical analysis and descriptive statistics of clinical and PK data.</p></sec></sec><back><ack><title>Acknowledgments</title><p>The authors wish to express their thanks to Mark Enzler and Christoph Siethoff at Swiss BioQuant AG, Switzerland for the bio-analytical assay and the project managers Sandrine Gioria and Isabelle Naëije. This study was sponsored by Actelion Pharmaceuticals Ltd.</p></ack><notes><title>Author Contributions</title><p>Jasper Dingemanse conceived and designed the experiments; Darren Wilbraham and Salvatore Febbraro performed the experiments; Daniela Baldoni, Maribel Reyes, Andrea Vaclavkova, Matthias Hoch and Pierre-Eric Juif analyzed the data; Jasper Dingemanse and Pierre-Eric Juif wrote the paper.</p></notes><notes notes-type=""COI-statement""><title>Conflicts of Interest</title><p>All authors have completed the Unified Competing Interest form at<uri xlink:href=""http://www.icmje.org/coi_disclosure.pdf"">http://www.icmje.org/coi_disclosure.pdf</uri>(available on request from the corresponding author). Actelion Pharmaceuticals Ltd., the predecessor of Idorsia Pharmaceuticals Ltd., provided funding for these clinical trials. At the time of the study conduct or reporting, Pierre-Eric Juif, Daniela Baldoni, Maribel Reyes, Andrea Vaclavkova, Matthias Hoch and Jasper Dingemanse were full-time employees of Actelion Pharmaceuticals Ltd. Darren Wilbraham and Salvatore Febbraro were employees of Quintiles and Simbec, respectively. There are no other relationships or activities that could appear to have influenced the submitted work. Quintiles Drug Research Unit at Guy’s Hospital (Study 1) and Simbec Research Ltd. (Study 2 and Study 3) received financial compensation for the clinical conduct.</p></notes><glossary><title>Abbreviations</title><array orientation=""portrait""><tbody><tr><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">AE</td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">adverse event</td></tr><tr><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">AUC<sub>0–24</sub></td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">area under the plasma drug concentration-time curve from 0 to 24 h</td></tr><tr><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">AUC<sub>0–∞</sub></td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">area under the plasma drug concentration-time curve from 0 to infinity</td></tr><tr><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">AUC</td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">area under the plasma drug concentration-time curve</td></tr><tr><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">AUEC</td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">area under the effect-time curve</td></tr><tr><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">CI</td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">confidence interval</td></tr><tr><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">CL/F</td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">apparent oral clearance</td></tr><tr><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top""><italic>C</italic><sub>max</sub></td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">maximum plasma concentration</td></tr><tr><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top""><italic>E</italic><sub>max</sub></td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">maximum effect</td></tr><tr><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">ECG</td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">electrocardiogram</td></tr><tr><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">EDTA</td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">ethylene di-amine tetra acetic acid</td></tr><tr><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">FEV<sub>1</sub></td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">forced expiratory volume in 1 s</td></tr><tr><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">FVC</td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">forced vital capacity</td></tr><tr><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">HR</td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">heart rate</td></tr><tr><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">LS</td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">least squares</td></tr><tr><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">o.d.</td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">once daily</td></tr><tr><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">PD</td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">pharmacodynamics</td></tr><tr><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">PK</td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">pharmacokinetics</td></tr><tr><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">S1P</td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">sphingosine-1-phosphate</td></tr><tr><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">S1P<sub>1</sub>R</td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">S1P<sub>1</sub>receptor</td></tr><tr><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">SD</td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">standard deviation</td></tr><tr><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top""><italic>t</italic><sub>1/2</sub></td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">terminal half-life</td></tr><tr><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top""><italic>t</italic><sub>max</sub></td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">time to reach maximum concentration</td></tr><tr><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">Vss/F</td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">apparent volume of distribution at steady-state</td></tr></tbody></array></glossary><ref-list><title>References</title><ref id=""B1-ijms-18-02636""><label>1.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Rivera</surname><given-names>J.</given-names></name><name><surname>Proia</surname><given-names>R.L.</given-names></name><name><surname>Olivera</surname><given-names>A.</given-names></name></person-group><article-title>The alliance of sphingosine-1-phosphate and its receptors in immunity</article-title><source>Nat. Rev. Immunol.</source><year>2008</year><volume>8</volume><fpage>753</fpage><lpage>763</lpage><pub-id pub-id-type=""doi"">10.1038/nri2400</pub-id><pub-id pub-id-type=""pmid"">18787560</pub-id></element-citation></ref><ref id=""B2-ijms-18-02636""><label>2.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Spiegel</surname><given-names>S.</given-names></name><name><surname>Milstien</surname><given-names>S.</given-names></name></person-group><article-title>Sphingosine-1-phosphate: An enigmatic signalling lipid</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2003</year><volume>4</volume><fpage>397</fpage><lpage>407</lpage><pub-id pub-id-type=""doi"">10.1038/nrm1103</pub-id><pub-id pub-id-type=""pmid"">12728273</pub-id></element-citation></ref><ref id=""B3-ijms-18-02636""><label>3.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Takuwa</surname><given-names>Y.</given-names></name><name><surname>Okamoto</surname><given-names>Y.</given-names></name><name><surname>Yoshioka</surname><given-names>K.</given-names></name><name><surname>Takuwa</surname><given-names>N.</given-names></name></person-group><article-title>Sphingosine-1-phosphate signaling and biological activities in the cardiovascular system</article-title><source>Biochim. Biophys. Acta</source><year>2008</year><volume>1781</volume><fpage>483</fpage><lpage>488</lpage><pub-id pub-id-type=""doi"">10.1016/j.bbalip.2008.04.003</pub-id><pub-id pub-id-type=""pmid"">18472021</pub-id></element-citation></ref><ref id=""B4-ijms-18-02636""><label>4.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Thangada</surname><given-names>S.</given-names></name><name><surname>Khanna</surname><given-names>K.M.</given-names></name><name><surname>Blaho</surname><given-names>V.A.</given-names></name><name><surname>Oo</surname><given-names>M.L.</given-names></name><name><surname>Im</surname><given-names>D.S.</given-names></name><name><surname>Guo</surname><given-names>C.</given-names></name><name><surname>Lefrancois</surname><given-names>L.</given-names></name><name><surname>Hla</surname><given-names>T.</given-names></name></person-group><article-title>Cell-surface residence of sphingosine 1-phosphate receptor 1 on lymphocytes determines lymphocyte egress kinetics</article-title><source>J. Exp. Med.</source><year>2010</year><volume>207</volume><fpage>1475</fpage><lpage>1483</lpage><pub-id pub-id-type=""doi"">10.1084/jem.20091343</pub-id><pub-id pub-id-type=""pmid"">20584883</pub-id></element-citation></ref><ref id=""B5-ijms-18-02636""><label>5.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Kappos</surname><given-names>L.</given-names></name><name><surname>Antel</surname><given-names>J.</given-names></name><name><surname>Comi</surname><given-names>G.</given-names></name><name><surname>Montalban</surname><given-names>X.</given-names></name><name><surname>O’Connor</surname><given-names>P.</given-names></name><name><surname>Polman</surname><given-names>C.H.</given-names></name><name><surname>Haas</surname><given-names>T.</given-names></name><name><surname>Korn</surname><given-names>A.A.</given-names></name><name><surname>Karlsson</surname><given-names>G.</given-names></name><name><surname>Radue</surname><given-names>E.W.</given-names></name><etal></etal></person-group><article-title>Oral fingolimod (FTY720) for relapsing multiple sclerosis</article-title><source>NEJM</source><year>2006</year><volume>355</volume><fpage>1124</fpage><lpage>1140</lpage><pub-id pub-id-type=""doi"">10.1056/NEJMoa052643</pub-id><pub-id pub-id-type=""pmid"">16971719</pub-id></element-citation></ref><ref id=""B6-ijms-18-02636""><label>6.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Olsson</surname><given-names>T.</given-names></name><name><surname>Boster</surname><given-names>A.</given-names></name><name><surname>Fernandez</surname><given-names>O.</given-names></name><name><surname>Freedman</surname><given-names>M.S.</given-names></name><name><surname>Pozzilli</surname><given-names>C.</given-names></name><name><surname>Bach</surname><given-names>D.</given-names></name><name><surname>Berkani</surname><given-names>O.</given-names></name><name><surname>Mueller</surname><given-names>M.S.</given-names></name><name><surname>Sidorenko</surname><given-names>T.</given-names></name><name><surname>Radue</surname><given-names>E.W.</given-names></name><etal></etal></person-group><article-title>Oral ponesimod in relapsing-remitting multiple sclerosis: A randomised phase II trial</article-title><source>J. Neurol. Neurosurg. Psychiatry</source><year>2014</year><volume>85</volume><fpage>1198</fpage><lpage>1208</lpage><pub-id pub-id-type=""doi"">10.1136/jnnp-2013-307282</pub-id><pub-id pub-id-type=""pmid"">24659797</pub-id></element-citation></ref><ref id=""B7-ijms-18-02636""><label>7.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Vaclavkova</surname><given-names>A.</given-names></name><name><surname>Chimenti</surname><given-names>S.</given-names></name><name><surname>Arenberger</surname><given-names>P.</given-names></name><name><surname>Hollo</surname><given-names>P.</given-names></name><name><surname>Sator</surname><given-names>P.G.</given-names></name><name><surname>Burcklen</surname><given-names>M.</given-names></name><name><surname>Stefani</surname><given-names>M.</given-names></name><name><surname>D’Ambrosio</surname><given-names>D.</given-names></name></person-group><article-title>Oral ponesimod in patients with chronic plaque psoriasis: A randomised, double-blind, placebo-controlled phase 2 trial</article-title><source>Lancet</source><year>2014</year><volume>384</volume><fpage>2036</fpage><lpage>2045</lpage><pub-id pub-id-type=""doi"">10.1016/S0140-6736(14)60803-5</pub-id><pub-id pub-id-type=""pmid"">25127208</pub-id></element-citation></ref><ref id=""B8-ijms-18-02636""><label>8.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Forrest</surname><given-names>M.</given-names></name><name><surname>Sun</surname><given-names>S.Y.</given-names></name><name><surname>Hajdu</surname><given-names>R.</given-names></name><name><surname>Bergstrom</surname><given-names>J.</given-names></name><name><surname>Card</surname><given-names>D.</given-names></name><name><surname>Doherty</surname><given-names>G.</given-names></name><name><surname>Hale</surname><given-names>J.</given-names></name><name><surname>Keohane</surname><given-names>C.</given-names></name><name><surname>Meyers</surname><given-names>C.</given-names></name><name><surname>Milligan</surname><given-names>J.</given-names></name><etal></etal></person-group><article-title>Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes</article-title><source>J. Pharmacol. Exp. Ther.</source><year>2004</year><volume>309</volume><fpage>758</fpage><lpage>768</lpage><pub-id pub-id-type=""doi"">10.1124/jpet.103.062828</pub-id><pub-id pub-id-type=""pmid"">14747617</pub-id></element-citation></ref><ref id=""B9-ijms-18-02636""><label>9.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Gon</surname><given-names>Y.</given-names></name><name><surname>Wood</surname><given-names>M.R.</given-names></name><name><surname>Kiosses</surname><given-names>W.B.</given-names></name><name><surname>Jo</surname><given-names>E.</given-names></name><name><surname>Sanna</surname><given-names>M.G.</given-names></name><name><surname>Chun</surname><given-names>J.</given-names></name><name><surname>Rosen</surname><given-names>H.</given-names></name></person-group><article-title>S1P<sub>3</sub>receptor-induced reorganization of epithelial tight junctions compromises lung barrier integrity and is potentiated by TNF</article-title><source>PNAS</source><year>2005</year><volume>102</volume><fpage>9270</fpage><lpage>9275</lpage><pub-id pub-id-type=""doi"">10.1073/pnas.0501997102</pub-id><pub-id pub-id-type=""pmid"">15968000</pub-id></element-citation></ref><ref id=""B10-ijms-18-02636""><label>10.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Sanna</surname><given-names>M.G.</given-names></name><name><surname>Liao</surname><given-names>J.</given-names></name><name><surname>Jo</surname><given-names>E.</given-names></name><name><surname>Alfonso</surname><given-names>C.</given-names></name><name><surname>Ahn</surname><given-names>M.Y.</given-names></name><name><surname>Peterson</surname><given-names>M.S.</given-names></name><name><surname>Webb</surname><given-names>B.</given-names></name><name><surname>Lefebvre</surname><given-names>S.</given-names></name><name><surname>Chun</surname><given-names>J.</given-names></name><name><surname>Gray</surname><given-names>N.</given-names></name><etal></etal></person-group><article-title>Sphingosine 1-phosphate (S1P) receptor subtypes S1P<sub>1</sub>and S1P<sub>3</sub>, respectively, regulate lymphocyte recirculation and heart rate</article-title><source>J. Biol. Chem.</source><year>2004</year><volume>279</volume><fpage>13839</fpage><lpage>13848</lpage><pub-id pub-id-type=""doi"">10.1074/jbc.M311743200</pub-id><pub-id pub-id-type=""pmid"">14732717</pub-id></element-citation></ref><ref id=""B11-ijms-18-02636""><label>11.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Brossard</surname><given-names>P.</given-names></name><name><surname>Derendorf</surname><given-names>H.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Maatouk</surname><given-names>H.</given-names></name><name><surname>Halabi</surname><given-names>A.</given-names></name><name><surname>Dingemanse</surname><given-names>J.</given-names></name></person-group><article-title>Pharmacokinetics and pharmacodynamics of ponesimod, a selective S1P<sub>1</sub>receptor modulator, in the first-in-human study</article-title><source>Br. J. Clin. Pharmacol.</source><year>2013</year><volume>76</volume><fpage>888</fpage><lpage>896</lpage><pub-id pub-id-type=""doi"">10.1111/bcp.12129</pub-id><pub-id pub-id-type=""pmid"">23594176</pub-id></element-citation></ref><ref id=""B12-ijms-18-02636""><label>12.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Brossard</surname><given-names>P.</given-names></name><name><surname>Scherz</surname><given-names>M.</given-names></name><name><surname>Halabi</surname><given-names>A.</given-names></name><name><surname>Maatouk</surname><given-names>H.</given-names></name><name><surname>Krause</surname><given-names>A.</given-names></name><name><surname>Dingemanse</surname><given-names>J.</given-names></name></person-group><article-title>Multiple-dose tolerability, pharmacokinetics, and pharmacodynamics of ponesimod, an S1P<sub>1</sub>receptor modulator: Favorable impact of dose up-titration</article-title><source>J. Clin. Pharmacol.</source><year>2014</year><volume>54</volume><fpage>179</fpage><lpage>188</lpage><pub-id pub-id-type=""doi"">10.1002/jcph.244</pub-id><pub-id pub-id-type=""pmid"">24408162</pub-id></element-citation></ref><ref id=""B13-ijms-18-02636""><label>13.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Hoch</surname><given-names>M.</given-names></name><name><surname>D’Ambrosio</surname><given-names>D.</given-names></name><name><surname>Wilbraham</surname><given-names>D.</given-names></name><name><surname>Brossard</surname><given-names>P.</given-names></name><name><surname>Dingemanse</surname><given-names>J.</given-names></name></person-group><article-title>Clinical pharmacology of ponesimod, a selective S1P<sub>1</sub>receptor modulator, after uptitration to supratherapeutic doses in healthy subjects</article-title><source>Eur. J. Pharm. Sci.</source><year>2014</year><volume>63C</volume><fpage>147</fpage><lpage>153</lpage><pub-id pub-id-type=""doi"">10.1016/j.ejps.2014.07.005</pub-id><pub-id pub-id-type=""pmid"">25046167</pub-id></element-citation></ref><ref id=""B14-ijms-18-02636""><label>14.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Reyes</surname><given-names>M.</given-names></name><name><surname>Brossard</surname><given-names>P.</given-names></name><name><surname>Chassard</surname><given-names>D.</given-names></name><name><surname>Hoch</surname><given-names>M.</given-names></name><name><surname>Dingemanse</surname><given-names>J.</given-names></name></person-group><article-title>Effects of ponesimod, a selective S1P<sub>1</sub>receptor modulator, on the pharmacokinetics of a hormonal combination contraceptive</article-title><source>Eur. J. Clin. Pharmacol.</source><year>2014</year><volume>70</volume><fpage>287</fpage><lpage>293</lpage><pub-id pub-id-type=""doi"">10.1007/s00228-013-1625-2</pub-id><pub-id pub-id-type=""pmid"">24362488</pub-id></element-citation></ref><ref id=""B15-ijms-18-02636""><label>15.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Juif</surname><given-names>P.E.</given-names></name><name><surname>Kraehenbuehl</surname><given-names>S.</given-names></name><name><surname>Dingemanse</surname><given-names>J.</given-names></name></person-group><article-title>Clinical pharmacology, efficacy, and safety aspects of sphingosine-1-phosphate receptor modulators</article-title><source>Expert Opin. Drug Metab. Toxicol.</source><year>2016</year><volume>12</volume><fpage>879</fpage><lpage>895</lpage><pub-id pub-id-type=""doi"">10.1080/17425255.2016.1196188</pub-id><pub-id pub-id-type=""pmid"">27249325</pub-id></element-citation></ref><ref id=""B16-ijms-18-02636""><label>16.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Piali</surname><given-names>L.</given-names></name><name><surname>Birker-Robaczewska</surname><given-names>M.</given-names></name><name><surname>Lescop</surname><given-names>C.</given-names></name><name><surname>Froidevaux</surname><given-names>S.</given-names></name><name><surname>Schmitz</surname><given-names>N.</given-names></name><name><surname>Morrison</surname><given-names>K.</given-names></name><name><surname>Kohl</surname><given-names>C.</given-names></name><name><surname>Rey</surname><given-names>M.</given-names></name><name><surname>Studer</surname><given-names>R.</given-names></name><name><surname>Vezzali</surname><given-names>E.</given-names></name><etal></etal></person-group><article-title>Cenerimod, a novel selective S1P<sub>1</sub>receptor modulator with unique signaling properties</article-title><source>Pharmacol. Res. Perspect.</source><year>2017</year><comment>accepted</comment><pub-id pub-id-type=""doi"">10.1002/prp2.370</pub-id></element-citation></ref><ref id=""B17-ijms-18-02636""><label>17.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Kovarik</surname><given-names>J.M.</given-names></name><name><surname>Schmouder</surname><given-names>R.</given-names></name><name><surname>Barilla</surname><given-names>D.</given-names></name><name><surname>Riviere</surname><given-names>G.J.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Hunt</surname><given-names>T.</given-names></name></person-group><article-title>Multiple-dose FTY720: Tolerability, pharmacokinetics, and lymphocyte responses in healthy subjects</article-title><source>J. Clin. Pharmacol.</source><year>2004</year><volume>44</volume><fpage>532</fpage><lpage>537</lpage><pub-id pub-id-type=""doi"">10.1177/0091270004264165</pub-id><pub-id pub-id-type=""pmid"">15102874</pub-id></element-citation></ref><ref id=""B18-ijms-18-02636""><label>18.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Kovarik</surname><given-names>J.M.</given-names></name><name><surname>Schmouder</surname><given-names>R.</given-names></name><name><surname>Barilla</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Kraus</surname><given-names>G.</given-names></name></person-group><article-title>Single-dose FTY720 pharmacokinetics, food effect, and pharmacological responses in healthy subjects</article-title><source>Br. J. Clin. Pharmacol.</source><year>2004</year><volume>57</volume><fpage>586</fpage><lpage>591</lpage><pub-id pub-id-type=""doi"">10.1111/j.1365-2125.2003.02065.x</pub-id><pub-id pub-id-type=""pmid"">15089811</pub-id></element-citation></ref><ref id=""B19-ijms-18-02636""><label>19.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Selmaj</surname><given-names>K.</given-names></name><name><surname>Li</surname><given-names>D.K.</given-names></name><name><surname>Hartung</surname><given-names>H.P.</given-names></name><name><surname>Hemmer</surname><given-names>B.</given-names></name><name><surname>Kappos</surname><given-names>L.</given-names></name><name><surname>Freedman</surname><given-names>M.S.</given-names></name><name><surname>Stuve</surname><given-names>O.</given-names></name><name><surname>Rieckmann</surname><given-names>P.</given-names></name><name><surname>Montalban</surname><given-names>X.</given-names></name><name><surname>Ziemssen</surname><given-names>T.</given-names></name><etal></etal></person-group><article-title>Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): An adaptive, dose-ranging, randomised, phase 2 study</article-title><source>Lancet Neurol.</source><year>2013</year><volume>12</volume><fpage>756</fpage><lpage>767</lpage><pub-id pub-id-type=""doi"">10.1016/S1474-4422(13)70102-9</pub-id><pub-id pub-id-type=""pmid"">23764350</pub-id></element-citation></ref><ref id=""B20-ijms-18-02636""><label>20.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>David</surname><given-names>O.J.</given-names></name><name><surname>Kovarik</surname><given-names>J.M.</given-names></name><name><surname>Schmouder</surname><given-names>R.L.</given-names></name></person-group><article-title>Clinical pharmacokinetics of fingolimod</article-title><source>Clin. Pharmacokinet.</source><year>2012</year><volume>51</volume><fpage>15</fpage><lpage>28</lpage><pub-id pub-id-type=""doi"">10.2165/11596550-000000000-00000</pub-id><pub-id pub-id-type=""pmid"">22149256</pub-id></element-citation></ref><ref id=""B21-ijms-18-02636""><label>21.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Sugahara</surname><given-names>K.</given-names></name><name><surname>Maeda</surname><given-names>Y.</given-names></name><name><surname>Shimano</surname><given-names>K.</given-names></name><name><surname>Mogami</surname><given-names>A.</given-names></name><name><surname>Kataoka</surname><given-names>H.</given-names></name><name><surname>Ogawa</surname><given-names>K.</given-names></name><name><surname>Hikida</surname><given-names>K.</given-names></name><name><surname>Kumagai</surname><given-names>H.</given-names></name><name><surname>Asayama</surname><given-names>M.</given-names></name><name><surname>Yamamoto</surname><given-names>T.</given-names></name><etal></etal></person-group><article-title>Amiselimod, a novel sphingosine 1-phosphate receptor-1 modulator, has potent therapeutic efficacy for autoimmune diseases, with low bradycardia risk</article-title><source>Br. J. Clin. Pharmacol.</source><year>2017</year><volume>174</volume><fpage>15</fpage><lpage>27</lpage><pub-id pub-id-type=""doi"">10.1111/bph.13641</pub-id><pub-id pub-id-type=""pmid"">27714763</pub-id></element-citation></ref><ref id=""B22-ijms-18-02636""><label>22.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Krosser</surname><given-names>S.</given-names></name><name><surname>Wolna</surname><given-names>P.</given-names></name><name><surname>Fischer</surname><given-names>T.Z.</given-names></name><name><surname>Boschert</surname><given-names>U.</given-names></name><name><surname>Stoltz</surname><given-names>R.</given-names></name><name><surname>Zhou</surname><given-names>M.</given-names></name><name><surname>Darpo</surname><given-names>B.</given-names></name></person-group><article-title>Effect of ceralifimod (ONO-4641) on lymphocytes and cardiac function: Randomized, double-blind, placebo-controlled trial with an open-label fingolimod arm</article-title><source>J. Clin. Pharmacol.</source><year>2015</year><volume>55</volume><fpage>1051</fpage><lpage>1060</lpage><pub-id pub-id-type=""doi"">10.1002/jcph.513</pub-id><pub-id pub-id-type=""pmid"">25855155</pub-id></element-citation></ref><ref id=""B23-ijms-18-02636""><label>23.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Olson</surname><given-names>A.</given-names></name><name><surname>Hartung</surname><given-names>J.</given-names></name><name><surname>Timony</surname><given-names>G.</given-names></name><name><surname>Peach</surname><given-names>R.</given-names></name><name><surname>Boehm</surname><given-names>M.</given-names></name><name><surname>Rosen</surname><given-names>H.</given-names></name><name><surname>Smith</surname><given-names>H.</given-names></name><name><surname>Pan</surname><given-names>C.</given-names></name><name><surname>Brooks</surname><given-names>J.</given-names></name><name><surname>Gujrathi</surname><given-names>S.</given-names></name></person-group><article-title>Safety and tolerability of orally administered RPC1063, a novel S1P<sub>1</sub>receptor modulator, in healthy adult volunteers, results of a phase 1 study</article-title><source>Neurology</source><year>2013</year><volume>80</volume><fpage>P01.178</fpage></element-citation></ref><ref id=""B24-ijms-18-02636""><label>24.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Marsolais</surname><given-names>D.</given-names></name><name><surname>Rosen</surname><given-names>H.</given-names></name></person-group><article-title>Chemical modulators of sphingosine-1-phosphate receptors as barrier-oriented therapeutic molecules</article-title><source>Nat. Rev. Drug Discov.</source><year>2009</year><volume>8</volume><fpage>297</fpage><lpage>307</lpage><pub-id pub-id-type=""doi"">10.1038/nrd2356</pub-id><pub-id pub-id-type=""pmid"">19300460</pub-id></element-citation></ref><ref id=""B25-ijms-18-02636""><label>25.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Koyrakh</surname><given-names>L.</given-names></name><name><surname>Roman</surname><given-names>M.I.</given-names></name><name><surname>Brinkmann</surname><given-names>V.</given-names></name><name><surname>Wickman</surname><given-names>K.</given-names></name></person-group><article-title>The heart rate decrease caused by acute FTY720 administration is mediated by the G protein-gated potassium channel I</article-title><source>Am. J. Transplant.</source><year>2005</year><volume>5</volume><fpage>529</fpage><lpage>536</lpage><pub-id pub-id-type=""doi"">10.1111/j.1600-6143.2005.00754.x</pub-id><pub-id pub-id-type=""pmid"">15707407</pub-id></element-citation></ref><ref id=""B26-ijms-18-02636""><label>26.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Guo</surname><given-names>J.</given-names></name><name><surname>MacDonell</surname><given-names>K.L.</given-names></name><name><surname>Giles</surname><given-names>W.R.</given-names></name></person-group><article-title>Effects of sphingosine 1-phosphate on pacemaker activity in rabbit sino-atrial node cells</article-title><source>Pflugers Arch.</source><year>1999</year><volume>438</volume><fpage>642</fpage><lpage>648</lpage><pub-id pub-id-type=""doi"">10.1007/s004249900067</pub-id><pub-id pub-id-type=""pmid"">10555561</pub-id></element-citation></ref><ref id=""B27-ijms-18-02636""><label>27.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Bigaud</surname><given-names>M.</given-names></name><name><surname>Guerini</surname><given-names>D.</given-names></name><name><surname>Billich</surname><given-names>A.</given-names></name><name><surname>Bassilana</surname><given-names>F.</given-names></name><name><surname>Brinkmann</surname><given-names>V.</given-names></name></person-group><article-title>Second generation S1P pathway modulators: Research strategies and clinical developments</article-title><source>Biochim. Biophys. Acta</source><year>2014</year><volume>1841</volume><fpage>745</fpage><lpage>758</lpage><pub-id pub-id-type=""doi"">10.1016/j.bbalip.2013.11.001</pub-id><pub-id pub-id-type=""pmid"">24239768</pub-id></element-citation></ref><ref id=""B28-ijms-18-02636""><label>28.</label><element-citation publication-type=""book""><source>Guidance for Industry Food-Effect Bioavailability and Fed Bioequivalence Studies</source><publisher-name>US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER)</publisher-name><publisher-loc>Washington, DC, USA</publisher-loc><year>2002</year></element-citation></ref><ref id=""B29-ijms-18-02636""><label>29.</label><element-citation publication-type=""book""><person-group person-group-type=""author""><name><surname>Gibaldi</surname><given-names>M.</given-names></name><name><surname>Perrier</surname><given-names>D.</given-names></name></person-group><source>Pharmacokinetics</source><publisher-name>Marcel Dekker</publisher-name><publisher-loc>New York, NY, USA</publisher-loc><year>1982</year></element-citation></ref><ref id=""B30-ijms-18-02636""><label>30.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Gough</surname><given-names>K.</given-names></name><name><surname>Hutchison</surname><given-names>M.</given-names></name><name><surname>Keene</surname><given-names>O.</given-names></name><name><surname>Byrom</surname><given-names>B.</given-names></name><name><surname>Ellis</surname><given-names>S.</given-names></name><name><surname>Lacey</surname><given-names>L.</given-names></name><name><surname>McKellar</surname><given-names>J.</given-names></name></person-group><article-title>Assessment of dose proportionality: Report from the statisticians in the pharmaceutical industry/pharmacokinetics UK joint working group</article-title><source>Drug Inf. J.</source><year>1995</year><volume>29</volume><fpage>1039</fpage><lpage>1048</lpage><pub-id pub-id-type=""doi"">10.1177/009286159502900324</pub-id></element-citation></ref></ref-list>"
10.1073/pnas.0501997102	"<floats-group><fig id=""ijms-18-02636-f001"" orientation=""portrait"" position=""float""><label>Figure 1</label><caption><p>Arithmetic mean (with standard deviation) plasma concentration-time profiles of cenerimod following single or multiple o.d. oral doses in healthy subjects. Panels (<bold>A</bold>,<bold>B</bold>) represent the concentration of cenerimod after single ascending doses (<italic>N</italic>= 6 per dose group) and single-dose administration in fasted versus fed conditions (1 mg,<italic>N</italic>= 8), respectively; Panel (<bold>C</bold>) depicts the concentration of cenerimod until the end-of-study (EOS) (<italic>N</italic>= 6 per dose group, the black bar represents the treatment duration of 35 days) on linear scale (semi-logarithmic scale shown as inset).</p></caption><graphic xlink:href=""ijms-18-02636-g001""></graphic></fig><fig id=""ijms-18-02636-f002"" orientation=""portrait"" position=""float""><label>Figure 2</label><caption><p>Arithmetic mean (with standard deviation) lymphocyte count in peripheral blood versus time profiles from 0 h to EOS after single-dose administration of cenerimod (Panel (<bold>A</bold>),<italic>N</italic>= 6 per dose group,<italic>N</italic>= 8 for placebo group); single-dose administration in fed or fasted conditions (Panel (<bold>B</bold>),<italic>N</italic>= 8); and after multiple o.d. oral doses for 35 days (Panel (<bold>C</bold>),<italic>N</italic>= 6 per dose group,<italic>N</italic>= 8 for placebo group). The black bar represents the treatment duration. The horizontal dotted lines represent the baseline values. EOS: end-of-study.</p></caption><graphic xlink:href=""ijms-18-02636-g002""></graphic></fig><fig id=""ijms-18-02636-f003"" orientation=""portrait"" position=""float""><label>Figure 3</label><caption><p>Arithmetic mean total lymphocyte count (Panel (<bold>A</bold>)) and cenerimod concentration (Panel (<bold>B</bold>)) versus time profiles from 0 h to EOS after multiple-dose o.d. oral doses of cenerimod (Study 2) for 35 days (<italic>N</italic>= 6 per dose group,<italic>N</italic>= 8 for placebo group). The black bar represents the treatment duration. EOS: end-of-study.</p></caption><graphic xlink:href=""ijms-18-02636-g003""></graphic></fig><fig id=""ijms-18-02636-f004"" orientation=""portrait"" position=""float""><label>Figure 4</label><caption><p>Arithmetic mean (with standard deviation) heart rate versus time profiles from 0 h to EOS after single-dose administration of cenerimod (Panel (<bold>A</bold>),<italic>N</italic>= 6 per dose group,<italic>N</italic>= 8 for placebo group), single-dose administration in fed or fasted conditions (Panel (<bold>B</bold>),<italic>N</italic>= 8), and after multiple o.d. oral doses for 35 days (Panel (<bold>C</bold>),<italic>N</italic>= 6 per dose group,<italic>N</italic>= 8 for placebo group). The black bar represents the treatment duration, left part effect over 24 h and right part over 36 days until EOS. The horizontal dotted lines represent the baseline values. EOS: end-of-study.</p></caption><graphic xlink:href=""ijms-18-02636-g004""></graphic></fig><table-wrap id=""ijms-18-02636-t001"" orientation=""portrait"" position=""float""><object-id pub-id-type=""pii"">ijms-18-02636-t001_Table 1</object-id><label>Table 1</label><caption><p>Pharmacokinetic parameters of cenerimod estimated following single-dose (Study 1), o.d. for 35 days (Study 2), and single-dose administration in fed or fasted conditions (Study 3).</p></caption><table frame=""hsides"" rules=""groups""><thead><tr><th align=""center"" colspan=""1"" rowspan=""3"" style=""border-top:solid thin;border-bottom:solid thin"" valign=""middle""><article article-type=""research-article"" xml:lang=""en"" xmlns:mml=""http://www.w3.org/1998/Math/MathML"" xmlns:xlink=""http://www.w3.org/1999/xlink""><?properties open_access?><front><journal-meta><journal-id journal-id-type=""nlm-ta"">Respir Res</journal-id><journal-id journal-id-type=""iso-abbrev"">Respir. Res</journal-id><journal-title-group><journal-title>Respiratory Research</journal-title></journal-title-group><issn pub-type=""ppub"">1465-9921</issn><issn pub-type=""epub"">1465-993X</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type=""pmid"">22559818</article-id><article-id pub-id-type=""pmc"">3424121</article-id><article-id pub-id-type=""publisher-id"">1465-9921-13-36</article-id><article-id pub-id-type=""doi"">10.1186/1465-9921-13-36</article-id><article-categories><subj-group subj-group-type=""heading""><subject>Research</subject></subj-group></article-categories><title-group><article-title>Hyperoxia disrupts pulmonary epithelial barrier in newborn rats via the deterioration of occludin and ZO-1</article-title></title-group><contrib-group><contrib contrib-type=""author"" id=""A1""><name><surname>You</surname><given-names>Kai</given-names></name><xref ref-type=""aff"" rid=""I1"">1</xref><email>xuxw@sj-hospital.org</email></contrib><contrib contrib-type=""author"" id=""A2""><name><surname>Xu</surname><given-names>Xuewen</given-names></name><xref ref-type=""aff"" rid=""I2"">2</xref><email>xxw6698@sina.com</email></contrib><contrib contrib-type=""author"" id=""A3""><name><surname>Fu</surname><given-names>Jianhua</given-names></name><xref ref-type=""aff"" rid=""I1"">1</xref><email>fujh@sj-hospital.org</email></contrib><contrib contrib-type=""author"" id=""A4""><name><surname>Xu</surname><given-names>Shuyan</given-names></name><xref ref-type=""aff"" rid=""I1"">1</xref><email>1258357838@qq.com</email></contrib><contrib contrib-type=""author"" id=""A5""><name><surname>Yue</surname><given-names>Xiaohong</given-names></name><xref ref-type=""aff"" rid=""I3"">3</xref><email>46363502@qq.com</email></contrib><contrib contrib-type=""author"" id=""A6""><name><surname>Yu</surname><given-names>Zhiling</given-names></name><xref ref-type=""aff"" rid=""I1"">1</xref><email>yuzl@sj-hospital.org</email></contrib><contrib contrib-type=""author"" corresp=""yes"" id=""A7""><name><surname>Xue</surname><given-names>Xindong</given-names></name><xref ref-type=""aff"" rid=""I1"">1</xref><email>xuexd@sj-hospital.org</email></contrib></contrib-group><aff id=""I1""><label>1</label>Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, 110004, China</aff><aff id=""I2""><label>2</label>Department of Urology, Shengjing Hospital of China Medical University, Shenyang, 110004, China</aff><aff id=""I3""><label>3</label>Department of Pediatrics, Fengtian Hospital Affiliated to Shenyang Medical College, Shenyang, 110024, China</aff><pub-date pub-type=""ppub""><year>2012</year></pub-date><pub-date pub-type=""epub""><day>4</day><month>5</month><year>2012</year></pub-date><volume>13</volume><issue>1</issue><fpage>36</fpage><lpage>36</lpage><history><date date-type=""received""><day>3</day><month>2</month><year>2012</year></date><date date-type=""accepted""><day>4</day><month>5</month><year>2012</year></date></history><permissions><copyright-statement>Copyright ©2012 You et al.; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2012</copyright-year><copyright-holder>You et al.; licensee BioMed Central Ltd.</copyright-holder><license license-type=""open-access"" xlink:href=""http://creativecommons.org/licenses/by/2.0""><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type=""uri"" xlink:href=""http://creativecommons.org/licenses/by/2.0"">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href=""http://www.respiratory-research.com/content/13/1/36""></self-uri><abstract><sec><title>Background</title><p>Prolonged exposure to hyperoxia in neonates can cause hyperoxic acute lung injury (HALI), which is characterized by increased pulmonary permeability and diffuse infiltration of various inflammatory cells. Disruption of the epithelial barrier may lead to altered pulmonary permeability and maintenance of barrier properties requires intact epithelial tight junctions (TJs). However, in neonatal animals, relatively little is known about how the TJ proteins are expressed in the pulmonary epithelium, including whether expression of TJ proteins is regulated in response to hyperoxia exposure. This study determines whether changes in tight junctions play an important role in disruption of the pulmonary epithelial barrier during hyperoxic acute lung injury.</p></sec><sec><title>Methods</title><p>Newborn rats, randomly divided into two groups, were exposed to hyperoxia (95% oxygen) or normoxia for 1–7 days, and the severity of lung injury was assessed; location and expression of key tight junction protein occludin and ZO-1 were examined by immunofluorescence staining and immunobloting; messenger RNA in lung tissue was studied by RT-PCR; transmission electron microscopy study was performed for the detection of tight junction morphology.</p></sec><sec><title>Results</title><p>We found that different durations of hyperoxia exposure caused different degrees of lung injury in newborn rats. Treatment with hyperoxia for prolonged duration contributed to more serious lung injury, which was characterized by increased wet-to-dry ratio, extravascular lung water content, and bronchoalveolar lavage fluid (BALF):serum FD4 ratio. Transmission electron microscopy study demonstrated that hyperoxia destroyed the structure of tight junctions and prolonged hyperoxia exposure, enhancing the structure destruction. The results were compatible with pathohistologic findings. We found that hyperoxia markedly disrupted the membrane localization and downregulated the cytoplasm expression of the key tight junction proteins occludin and ZO-1 in the alveolar epithelium by immunofluorescence. The changes of messenger RNA and protein expression of occludin and ZO-1 in lung tissue detected by RT-PCR and immunoblotting were consistent with the degree of lung injury.</p></sec><sec><title>Conclusions</title><p>These data suggest that the disruption of the pulmonary epithelial barrier induced by hyperoxia is, at least in part, due to massive deterioration in the expression and localization of key TJ proteins.</p></sec></abstract><kwd-group><kwd>Acute lung injury</kwd><kwd>Hyperoxia</kwd><kwd>Newborn</kwd><kwd>Permeability</kwd><kwd>Tight Junction</kwd></kwd-group></article-meta></front><sec><title>Background</title><p>Therapy with a high concentration of oxygen (hyperoxia) is often necessary to treat neonates with respiratory failure in neonatal intensive care units. However, one of the main complications is hyperoxia-induced lung injury, which may later result in serious sequela, such as bronchopulmonary dysplasia (BPD) [<xref ref-type=""bibr"" rid=""B1"">1</xref>,<xref ref-type=""bibr"" rid=""B2"">2</xref>]. The neonates with BPD continue to show decreased lung capacity at school age and even as young adolescents [<xref ref-type=""bibr"" rid=""B3"">3</xref>-<xref ref-type=""bibr"" rid=""B5"">5</xref>]. BPD has a negative impact not only on short-term and long-term pulmonary function but also on overall growth and neurodevelopment of these infants [<xref ref-type=""bibr"" rid=""B6"">6</xref>,<xref ref-type=""bibr"" rid=""B7"">7</xref>]. However, the mechanism of hyperoxia-induced lung injury is still not completely understood and currently there are no evidence-based effective strategies to prevent or treat this disease. Thus, there is an urgent need to understand how hyperoxia exposure initially influences pulmonary structure and function and how this lastingly disrupts lung development.</p><p>It is well known that the major pathologic finding associated with hyperoxia exposure at the early stage is hyperoxia-induced acute lung injury, which is frequently accompanied by an inflammatory response within lungs [<xref ref-type=""bibr"" rid=""B8"">8</xref>,<xref ref-type=""bibr"" rid=""B9"">9</xref>]. This response is characterized by increased pulmonary permeability and diffuse infiltration of various inflammatory cells [<xref ref-type=""bibr"" rid=""B10"">10</xref>-<xref ref-type=""bibr"" rid=""B12"">12</xref>]. Disruption of the epithelial barrier may lead to altered pulmonary permeability and airways fluid accumulation [<xref ref-type=""bibr"" rid=""B13"">13</xref>,<xref ref-type=""bibr"" rid=""B14"">14</xref>]. However, little attention has been done on the molecular mechanisms involved in disruption of the pulmonary epithelial barrier in neonatal hyperoxic lung injury.</p><p>The permeability barrier in terminal airspaces of the lung is due in large part to tight junctions between alveolar epithelial cells, which are continuous, circumferential, belt-like structures and regulate the flow of molecules between apical and basolateral compartments [<xref ref-type=""bibr"" rid=""B15"">15</xref>,<xref ref-type=""bibr"" rid=""B16"">16</xref>]. Tight junction is a primary barrier that regulates the diffusion of solutes through the paracellular pathway. Occludin and zonula occludens 1 (ZO-1) are two well characterized proteins in tight junctions. Occludin is a transmembrane protein which provides most of the barrier function of the tight junction [<xref ref-type=""bibr"" rid=""B17"">17</xref>,<xref ref-type=""bibr"" rid=""B18"">18</xref>]. Zonula occludens 1 is an intracellular protein, located between occludin and cytoskeletal proteins and thought to affect paracellular permeability [<xref ref-type=""bibr"" rid=""B19"">19</xref>]. Occludin and ZO-1 proteins form the intact intercellular barrier at tight junctions, and differences in the expression of these key TJ proteins account for differences in barrier function and paracellular permeability among epithelia [<xref ref-type=""bibr"" rid=""B20"">20</xref>-<xref ref-type=""bibr"" rid=""B23"">23</xref>]. For example, previous studies in intestinal epithelia have shown that serious impairment of intestinal barrier function is associated with an increased permeability and morphological changes through downregulation and localization shift of occluding [<xref ref-type=""bibr"" rid=""B24"">24</xref>,<xref ref-type=""bibr"" rid=""B25"">25</xref>]. Others have reported that changes in occludin and ZO-1 expression in response to environmental stimuli may account for changes in barrier properties in the pulmonary epithelia [<xref ref-type=""bibr"" rid=""B24"">24</xref>,<xref ref-type=""bibr"" rid=""B26"">26</xref>-<xref ref-type=""bibr"" rid=""B28"">28</xref>].</p><p>However, our current understanding of the structural components and regulation of tight junctions in the alveolar epithelium is insufficient, and previous studies were mainly performed in adult animals or cells and have scarcely been examined in the neonatal period. The primary objective of this study was to determine whether there were changes in alveolar barrier structure and function in newborn rats exposed to hyperoxia and whether tight junction proteins were differentially expressed in the lung during experimental acute lung injury induced by hyperoxia and whether these changes account for impairment in alveolar barrier properties and are relevant to pulmonary edema formation.</p></sec><sec sec-type=""methods""><title>Methods</title><sec><title>Animals and hyperoxia exposure protocol</title><p>Time-dated, pregnant Wistar rats (200–220 g) were purchased from the Center for Experimental Animals of China Medical University. All animal procedures were reviewed and approved by the Laboratory Animal Ethics Committee of China Medical University. Pups were delivered naturally at term gestation (22 days). The full-term newborn rats from twelve litters were randomly marked and assigned to two groups and were exposed to hyperoxia (95% oxygen; experimental group) or normoxia (21%; control group) beginning on the day of birth. The inhaled oxygen concentration was measured and recorded continuously with an analyzer equipped with a strip-chart recorder (model 572; Servomex, Norwood, MA). Humidity was routinely 60%–70%. Nursing rat dams were switched every 24 hours between the hyperoxic and normoxic chambers, to avoid oxygen toxicity and provide equal nutrition to each litter. Chambers were open for 10 min per day for weighing and cage cleaning. Pups were sacrificed and lungs were harvested at the end of 1, 3, 5 and 7 days of exposure.</p></sec><sec><title>Lung histology</title><p>The lungs of a random sample from each group were inflated by intratracheal instillation of 4% formaldehyde solution at a hydrostatic pressure of 18 cmH<sub>2</sub>O. The lungs were then fixed in 4% paraformaldehyde for 24 h. Lung tissue was dehydrated with graded alcohol, placed in xylene for 1 h and then embedded in paraffin at 60°C. Sections of lung (5 μm) were stained with hematoxylin and eosin. Lung sections from all lungs were examined for any histological changes. From each section, 20 random areas were examined at × 400 magnification. Within each field, lung injury was scored according to a new histologic acute lung injury (ALI) scoring system [<xref ref-type=""bibr"" rid=""B29"">29</xref>]. Histopathological evaluation was performed by an independent pathologist who was blinded to the experimental group.</p></sec><sec><title>Wet/dry lung weight ratio and excess lung water measurement</title><p>The right upper lung lobes from random samples of two groups were excised at the end of the experiment and were weighed to determine the wet lung weight. After that, the tissues were placed in an oven and maintained at a temperature of 80°C for 48 hours before being weighed again to give final dry weight. The presence of pulmonary edema was examined by calculating the pulmonary wet/dry ratio (W/D).</p><p>To determine the extravascular water in the lung, a blood sample was obtained from cardiac puncture to measure the hemoglobin concentration. After the determination of lung wet weight, the tissue was homogenized and dried. Measurements of the hemoglobin concentration in the lung homogenate also allowed for the calculation of excess lung water according to the standard methods used as previously described [<xref ref-type=""bibr"" rid=""B30"">30</xref>,<xref ref-type=""bibr"" rid=""B31"">31</xref>].</p></sec><sec><title>Measurement of bronchoalveolar epithelial permeability</title><p>Pups were injected via the saphenous vein with fluorescein isothiocyanate-conjugated dextran 4000 (FD4) solution in PBS (25 mg/ml; 10 mg/kg) after the anesthesia. Fifteen minutes later, the trachea was exposed, and the lungs were lavaged three times with 1 ml of sterile saline per wash. The aliquots of bronchoalveolar lavage fluid (BALF) were collected. Blood was obtained by cardiac puncture, and the serum was collected by centrifugation at 3,000 rpm for 5 min. The concentrations of FD4 in the BALF and serum (20 fold diluted by PBS) were determined with a spectrofluorometer (F-4500; Hitachi, Tokyo, Japan) using an excitation filter of 492 nm and an emission wavelength of 515 nm. The BALF:serum fluorescence ratio was calculated and used as a measure of pulmonary epithelial permeability.</p></sec><sec><title>Transmission electron microscopy study</title><p>After dissection of lung, the specimens were fixed in 2.5% glutaraldehyde overnight at 4°C. The tissues were washed in phosphate buffer (pH 7.4), postfixed in 1% osmium tetroxide in phosphate buffer (pH 7.4), dehydrated in graded ethanol solutions, treated in propylene oxide and embedded in epoxy-resin embedding media. 60-nm thin transverse random sections were collected on single copper slot grids coated with parlodion, stained with uranyl acetate and lead citrate, and observed with a JEM-1200EX transmission electron microscope (Hitachi Electronic Company, Japan). Images were documented by using Kodak SO163 EM film.</p></sec><sec><title>Immunofluorescence staining</title><p>Lungs of right middle lobe were inflated with 4% paraformaldehyde, soaked in 3% paraformaldehyde for 3 h at 4°C, cryoprotected in 30% sucrose for 12 h at 4°C and frozen at 80°C. Frozen sections (10 μm) were air dried and then washed three times with PBS. The sections were incubated with 0.5% Triton X-100 for 5 min at room temperature and then washed three times with PBS. The sections were then blocked with 10% goat serum for 30 min at 37°C and incubated with primary antibodies as follows: 1:200 diluted occludin (mouse monoclone antibody; Zymed Laboratories, South San Francisco, Calif) and 1:80 diluted ZO-1 (rabbit polyclone antibody; Zymed Laboratories, South San Francisco, Calif) together overnight at 4°C. As negative controls, some sections were incubated in the absence of the primary antibodies. Tissue sections were washed four times with PBS-Triton. The second antibody against mouse was conjugated with Alexa fluor-488 (green fluorescence) and the anti-rabbit antibody with Alexa fluor-594 (red fluorescence) for 60 min at 37°C. Sections were washed three times with PBS, and the nuclei were stained with DAPI (1:2000; Sigma Chemical) for 2 min. After sufficient washes, images were captured by confocal laser scanning microscopy (MTC-600, BIO-RAD, USA).</p></sec><sec><title>Immunoblotting</title><p>Briefly, equal amounts of protein extract were mixed in 1 × Laemmli buffer and boiled for 3 min. The proteins were electrophoresed on 7.5% precast SDS-polyacrylamide gels (80 V for 120 min). Then the proteins were transferred electrophoretically onto polyvinylidene difluoride (PVDF) membranes (40 V for 180 min). The membranes were incubated for 1 h in 1:10 normal donkey serum to block nonspecific binding. The PVDF membranes were then incubated overnight at 4°C with primary antibodies occludin (1:500), ZO-1 (1:250), and β-actin (1:4,000) diluted in PBS-0.02% Tween 20. Some samples were incubated in the solution without primary antibodies to be negative controls. After washing three times in PBS, the membranes were incubated at room temperature for 90 min with horseradish peroxidase-conjugated secondary antibody. The membrane was then washesd in PBS and impregnated with the enhanced chemiluminescence substrate (ECL kit; Santa Cruz Biotechnology) and was used to expose the radiograhic film. All the bands were scanned with ChemiImager 5500 V2.03 software, and IDVs were calculated by computerized image analysis system (Fluor Chen 2.0) and normalized to that of β-actin.</p></sec><sec><title>RT-PCR</title><p>Differential expression of occludin and ZO-1 was validated by a separate comparison of new subjects using RT-PCR. These studies compared spontaneously pups in normoxia group with pups exposured to hyperoxia. Briefly, lung tissue was dissected and homogenized. RNA was extracted (Invitrogen, Camarillo, Calif, USA) following the manufacturer's instructions. cDNA was generated from 1 μg total of each sample (SuperScript III; Invitrogen). The sequences of following primers were designed by Primer Premier 5.0 software (Premier Biosoft International, Palo Alto, Calif) and are shown in Table<xref ref-type=""table"" rid=""T1"">1</xref>. The amplification reaction was carried out in 30 cycles at 95°C for 45 s, 55°C for 45 s, and 75°C for 1 min in a thermal cycler. PCR products were electrophoresed on 2.5% agarose gels. Gels were photographed by a ChemiImager 5500 gel image analysis instrument (Alpha Innotech, USA). The integrated density values (IDVs) of PCR product bands were calculated by computerized image analysis system (Fluor Chen 2.0) and expressed relative to that of β-actin.</p><table-wrap id=""T1"" position=""float""><label>Table 1</label><caption><p>List of primers used for measuring gene expression by RT-PCR</p></caption><table border=""1"" frame=""hsides"" rules=""groups""><colgroup><col align=""center""/><col align=""center""/><col align=""center""/></colgroup><thead valign=""top""><tr><th align=""left""><bold>Gene name</bold></th><th align=""center""><bold>Forward Primer</bold></th><th align=""center""><bold>Reverse Primer</bold></th></tr></thead><tbody valign=""top""><tr><td align=""left"" valign=""bottom"">Occludin<hr/></td><td align=""center"" valign=""bottom"">TTGGGAGCCTTGACATCTTGTTC<hr/></td><td align=""center"" valign=""bottom"">GCCATACATGTCATTGCTTGGTG<hr/></td></tr><tr><td align=""left"" valign=""bottom"">ZO-1<hr/></td><td align=""center"" valign=""bottom"">CCATCTTTGGACCGATTGCTG<hr/></td><td align=""center"" valign=""bottom"">TAATGCCCGAGCTCCGATG<hr/></td></tr><tr><td align=""left"">β-actin</td><td align=""center"">GGAGATTACTGCCCTGGCTCCTA</td><td align=""center"">GACTCATCGTACTCCTGCTTGCTG</td></tr></tbody></table></table-wrap></sec><sec><title>Statistical analysis</title><p>SPSS 18.0 software was used for this statistical analysis. Data were summarized as mean ± SD. Student<italic>t</italic>-test was used to determine the significant difference between two groups. One-way analysis of variance (ANOVA) and post hoc comparisons (Bonferroni test) were used to determine the significant difference among multiple groups. A P value of less than 0.05 was considered to be statistically significant.</p></sec></sec><sec sec-type=""results""><title>Results</title><sec><title>Lung histology shows levels of lung injury after different days of hyperoxia exposure</title><p>Formalin-fixed paraffin-embedded lung tissues from newborn rats after different days of hyperoxia or normoxia exposure were treated with hematoxylin-eosin (HE) staining. On the first day, the alveolar-like structures in full-term newborn rat lungs exposed to normoxia were irregular, and a small number of septa could be seen (Figure<xref ref-type=""fig"" rid=""F1"">1</xref>A). There was no obvious difference in pulmonary morphology in newborn rats exposed to hyperoxia compared with that of the normoxia group on day 1 (Figure<xref ref-type=""fig"" rid=""F1"">1</xref>B). The septa became thinner and the numbers increased in the normoxia group on the third day (Figure<xref ref-type=""fig"" rid=""F1"">1</xref>C). The septa were thickened and vascular congestion was also observed. There was neutrophil infiltration in the interstitial space in the hyperoxia group on day 3 (Figure<xref ref-type=""fig"" rid=""F1"">1</xref>D). On the fifth day, the alveoli grew in number, and the septa continued to be thinner in the normoxia group (Figure<xref ref-type=""fig"" rid=""F1"">1</xref>E). After 5 days of hyperoxia, histological evaluation of lung tissue in newborn rats revealed increased neutrophil infiltration in the interstitium. There was more severe interstitial edema and a few inflammatory cells infiltrating the alveolar space (Figure<xref ref-type=""fig"" rid=""F1"">1</xref>F). The alveoli were regular and uniformly distributed in newborn rats exposed to normoxia on the seventh day (Figure<xref ref-type=""fig"" rid=""F1"">1</xref>G). In the hyperoxia group, there was increased loss of pulmonary epithelial architecture, more inflammatory cells and red blood cell infiltration in the alveolar space with proteinaceous debris filling the airspaces on day 7 (Figure<xref ref-type=""fig"" rid=""F1"">1</xref>H). After 7 days of hyperoxia, the lung injury appeared more severe than that observed on day 3 or day 5. Treatment with hyperoxia for 3 days resulted in a less severe injury to lung tissue compared with that observed on day 5. The observation demonstrated that more severe lung injury happened in newborn rats with longer hyperoxia exposure. Lung injury scores, shown in Figure<xref ref-type=""fig"" rid=""F1"">1</xref>I, supported the observation that the lung injury level of newborn rats treated with hyperoxia was time-dependent.</p><fig id=""F1"" position=""float""><label>Figure 1</label><caption><p><bold>Lung histology shows levels of lung injury after different days of hyperoxia exposure (original magnification × 400).</bold>The alveolar-like structures in full-term newborn rat lungs exposed to normoxia were irregular, and there were a small number of septa on the first day (<bold>A</bold>). There was no obvious difference in pulmonary morphology in newborn rats exposed to hyperoxia compared with that of the normoxia group on day 1 (<bold>B</bold>). The septa became thinner and the numbers increased in normoxia group on the third day (<bold>C</bold>). The septa were thickened and there was neutrophils infiltration in the interstitial space in hyperoxia group on day 3 (<bold>D</bold>). On the fifth day, the alveoli grew in number, and the septa continued to be thinner in normoxia group (<bold>E</bold>). In the hyperoxia group, there was more severe interstitial edema and a few inflammatory cells infiltration in the alveolar space on day 5 (<bold>F</bold>). The alveoli were regular and uniformly distributed in newborn rats exposed to normoxia on the seventh day (<bold>G</bold>). In the hyperoxia group, there was more inflammatory cells and red blood cell infiltration in the alveolar space with proteinaceous debris filling the airspaces on day 7 (<bold>H</bold>). Lung injury scores following exposure of newborn rats to normoxia for 1d or hyperoxia for 1d, 3d, 5d and 7d. 20 random high-power fields (400 × total magnification) were independently scored in a blinded fashion for each condition (<bold>I</bold>). Data are the mean ± SEM (n = 6 in each group); **<italic>P</italic>&lt; 0.01 versus normoxia group;<bold>&amp;&amp;</bold><italic>P</italic>&lt; 0.01 versus 1 day of hyperoxia exposure group;<bold>##</bold><italic>P</italic>&lt; 0.01 versus 3 days of hyperoxia exposure group;<bold>$$</bold><italic>P</italic>&lt; 0.01 versus 5 days of hyperoxia exposure group.</p></caption><graphic xlink:href=""1465-9921-13-36-1""></graphic></fig></sec><sec><title>Effect of hyperoxia exposure on pulmonary edema</title><p>Pulmonary edema formation, indicative of injury to the pulmonary epithelial barrier, often happens with an increase in the total water W/D ratio. Our study revealed there was no difference in W/D ratio between the normoxia group and the hyperoxia group on the first day (<italic>P</italic>&gt; 0.05). On the third day, W/D ratio in the hyperoxia groups was significantly higher than that of the normoxia group (<italic>P</italic>&lt; 0.05). After 5 days of hyperoxia exposure, W/D ratio was much higher than that of the normoxia group (<italic>P</italic>&lt; 0.01). There was significant increase in W/D ratio in newborn rats with 7 days of hyperoxia exposure compared with that in corresponding normoxia group (<italic>P</italic>&lt; 0.01) (Figure<xref ref-type=""fig"" rid=""F2"">2</xref>A).</p><fig id=""F2"" position=""float""><label>Figure 2</label><caption><p><bold>Effect of hyperoxia exposure on pulmonary edema after different days of hyperoxia exposure.</bold>Effects of hyperoxia exposure on pulmonary edema were determined by the wet-to-dry (W/D) ratio of lung weight (<bold>A</bold>) and extravascular lung water content (<bold>B</bold>) following exposure of newborn rats to normoxia or hyperoxia for 1, 3, 5 and 7 days. Hyperoxia significantly increased the W/D ratio of lung weight and extravascular lung water content compared with normoxia on 5 and 7 days. Data are the mean ± SEM (n = 6 in each group); *<italic>P</italic>&lt; 0.05, **<italic>P</italic>&lt; 0.01 versus normoxia group;<bold>##</bold><italic>P</italic>&lt; 0.01 versus 3 days of hyperoxia exposure group;<bold>$$</bold><italic>P</italic>&lt; 0.01 versus 5 days of hyperoxia exposure group.</p></caption><graphic xlink:href=""1465-9921-13-36-2""></graphic></fig><p>The measurement of extravascular lung water content is also valuable in studies of mechanisms of increased permeability pulmonary edema. The extravascular lung water content in newborn rats with hyperoxia exposure was higher than that with normoxia exposure and the results were almost the same with the lung W/D ratio (Figure<xref ref-type=""fig"" rid=""F2"">2</xref>B).</p></sec><sec><title>Hyperoxia exposure decreases pulmonary epithelial barrier function</title><p>Generally, pulmonary epithelial barrier function decreases with an increase of bronchoalveolar epithelial permeability. We monitored the changes in pulmonary epithelial barrier function by examining the effect of hyperoxia exposure on bronchoalveolar epithelial permeability. Bronchoalveolar epithelial permeability was determined by measuring the leakage of FD4 from serum into BALF in rats (Figure<xref ref-type=""fig"" rid=""F3"">3</xref>). On the first day, there was no obvious difference in the BALF:serum fluorescence ratios between the hyperoxia and normoxia groups (<italic>P</italic>&gt; 0.05). After 3 days of hyperoxia exposure, the ratios of BALF:serum fluorescence in newborn rats were significantly higher than those in normoxia group (<italic>P</italic>&lt; 0.05). The BALF:serum fluorescence ratios in hyperoxia group were approximately 2-fold higher than those in the control group on day 5 (<italic>P</italic>&lt; 0.01). On the seventh days, the BALF:serum FD4 ratios in hyperoxia group further increased and were more than 3-fold higher than those in the normoxia group (<italic>P</italic>&lt; 0.01). Prolonged treatment with hyperoxia exposure significantly increased the bronchoalveolar epithelial permeability.</p><fig id=""F3"" position=""float""><label>Figure 3</label><caption><p><bold>The permeability of pulmonary epithelia after different days of hyperoxia exposure.</bold>Newborn rats received an intravenous injection of FD4. Fifteen minutes later, bronchoalveolar lavage fluid (BALF) and serum were collected, and the BALF:serum FD4 ratio was determined. Data are the mean ± SEM (n = 6 in each group); *<italic>P</italic>&lt; 0.05, **<italic>P</italic>&lt; 0.01 versus normoxia group;<bold>##</bold><italic>P</italic>&lt; 0.01 versus 3 days of hyperoxia exposure group;<bold>$$</bold><italic>P</italic>&lt; 0.01 versus 5 days of hyperoxia exposure group.</p></caption><graphic xlink:href=""1465-9921-13-36-3""></graphic></fig></sec><sec><title>Morphological alterations of tight junction in alveolar epithelia during hyperoxia exposure</title><p>Since hyperoxia exposure increased the bronchoalveolar epithelial permeability in newborn rats, it might alter the morphology of tight junction in the alveolar epithelium. The integrity of pulmonary epithelium and morphological alterations of tight junction were studied by transmission electron microscopy in newborn rats with normoxia and hyperoxia exposure. Random sampling of left lung from newborn rats exposed to normoxia showed obvious and frequent junctions between all epithelial cells which were extremely tight (Figure<xref ref-type=""fig"" rid=""F4"">4</xref>A). The tight junctions were ultrastructurally normal (Figure<xref ref-type=""fig"" rid=""F4"">4</xref>B). In contrast, after treatment with hyperoxia for 7 days, random sampling of left lungs from newborn rats showed loss of tight junctions between alveolar epithelial cells (Figure<xref ref-type=""fig"" rid=""F4"">4</xref>C). The tight junctions were irregularly widened (Figure<xref ref-type=""fig"" rid=""F4"">4</xref>D). Epithelial cells appeared retracted from each other with clear paracellular gaps. After 5 days of hyperoxia exposure, the tight junctions were also widened but to a much less extent (Figure<xref ref-type=""fig"" rid=""F4"">4</xref>E, F). Morphology of tight junction showed no observable changes in newborn rats exposed to hyperoxia for 1 day or 3 day (Figure<xref ref-type=""fig"" rid=""F4"">4</xref>G, H).</p><fig id=""F4"" position=""float""><label>Figure 4</label><caption><p><bold>Hyperoxia exposure disrupts alveolar epithelial tight junctions.</bold>The integrity of pulmonary epithelium and morphological alterations of tight junction were studied by transmission electron microscopy in both normoxia and hyperoxia groups. Tight junctions between pulmonary epithelial cells were extremely tight in the lungs from normoxia-treated newborn rats (<bold>A</bold>and<bold>B</bold>). After treatment with hyperoxia for 7 days, tight junctions were irregularly widened (<bold>C</bold>and<bold>D</bold>). Tight junctions were open between epithelial cells in newborn rats with hyperoxia for 5 days, and paracellular gaps were visible between alveolar epithelial cells (<bold>E</bold>and<bold>F</bold>). Intact tight junctions remained between alveolar epithelial cells in newborn rats exposed to hyperoxia for 1 and 3 days (<bold>G</bold>and<bold>H</bold>).</p></caption><graphic xlink:href=""1465-9921-13-36-4""></graphic></fig></sec><sec><title>Effects of hyperoxia exposure on the localization and expression of ZO-1 and occludin in alveolar epithelia</title><p>The morphology of tight junctions in the alveolar epithelium altered when exposed to hyperoxia. Then the localization and expression of tight junction proteins in the alveolar epithelium might change. ZO-1 and occludin, which are two of the best-characterized tight junction proteins, were examined by immunofluorescence staining from frozen sections of the right middle lobe. ZO-1 was localized in lung tissue from rats with normoxia exposure as a continuous line along the boundaries between neighboring bronchial and alveolar epithelial cells (Figure<xref ref-type=""fig"" rid=""F5"">5</xref>A). Within one day of hyperoxia exposure, ZO-1 distribution in tight junctions was not obviously diminished. After 3 and 5 days, hyperoxia exposure induced partial breakdown of membrane staining and decreased cytoplasm staining of ZO-1 in the alveolar epithelium (Figure<xref ref-type=""fig"" rid=""F5"">5</xref>B). Treatment with hyperoxia for 7 days induced a fragmented staining pattern on the membrane (Figure<xref ref-type=""fig"" rid=""F5"">5</xref>C). The features of occludin immunostaining were similar to that of ZO-1. A consecutive line along the membrane and diffuse in the cytoplasm staining of occludin was shown in the alveolar epithelium of control rats (Figure<xref ref-type=""fig"" rid=""F5"">5</xref>D). The intensity of this staining was dramatically reduced in lung tissues from rats which were exposed to hyperoxia for 7 days (Figure<xref ref-type=""fig"" rid=""F5"">5</xref>E).</p><fig id=""F5"" position=""float""><label>Figure 5</label><caption><p><bold>Hyperoxia exposure alters location and expression of ZO-1 and occludin in alveolar epithelial.</bold>Immunostaining and western blot analysis were performed to identify alteration in location and expression of ZO-1 and occludin in alveolar epithelial. A continuous line along the membrane and diffuse in the cytoplasm staining of ZO-1 and occludin was shown in the alveolar epithelium of control rats (A, D). After 3 and 5 days, hyperoxia exposure induced partial breakdown of membrane staining and decreased cytoplasm staining of ZO-1 in the alveolar epithelium (B). The staining intensity of ZO-1 and occludin was dramatically reduced in lung tissues from rats which were exposed to hyperoxia for 7 days (C, E). Bars represent 50 μm. After 7 days of hyperoxia exposure, the expression of ZO-1 and occludin dramatically declined and was virtually undetectable examined by Western blotting. β-actin immunoreactive bands were used to demonstrate equal loading (F, H). Densitometric quantification of ZO-1 and occludin protein levels was expressed as fold increase compared with normoxia for 1 day group (set as 1) (G, I). Values are presented as means ± SD; *<italic>P</italic>&lt; 0.05, **<italic>P</italic>&lt; 0.01 versus normoxia group. The results shown are representative of experiments that were repeated 4 times.</p></caption><graphic xlink:href=""1465-9921-13-36-5""></graphic></fig><p>Furthermore, we detected the protein expression of ZO-1 and occludin from lung tissue by immunoblotting. Hyperoxia exposure can induce different levels of tight junction proteins expression in neonatal rat lung tissue after 1–7 days of duration. The protein expression levels of ZO-1 increased slightly after one day of hyperoxia exposure and clear ZO-1 bands were apparent in both experimental and control group on day 1. However, the decrease of ZO-1 expression was statistically significant after 3 days of hyperoxia exposure (<italic>P</italic>&lt; 0.01). Further decreased expression of these proteins was observed in newborn rats with prolonged hyperoxia exposure (Figure<xref ref-type=""fig"" rid=""F5"">5</xref>F, G). The decrease of occludin expression was statistically significant on day 5 (<italic>P</italic>&lt; 0.05). After 7 days of hyperoxia exposure, the expression dramatically declined and was virtually undetectable by Western blotting (Figure<xref ref-type=""fig"" rid=""F5"">5</xref>H, I).</p></sec><sec><title>Hyperoxia exposure decreases the mRNA expression of ZO-1 and occludin in the lung of newborn rats</title><p>The messenger RNA expressions of ZO-1 and occludin were further examined in lung tissue by RT-PCR. The results showed that 1 day of hyperoxia exposure significantly depressed the messenger RNA levels of ZO-1 (<italic>P</italic>&lt; 0.01). The messenger RNA levels were markedly downregulated in newborn rats with prolonged hyperoxia exposure (<italic>P</italic>&lt; 0.01) (Figure<xref ref-type=""fig"" rid=""F6"">6</xref>A, B). The decrease of occludin mRNA level was statistically significant after 3 or 5 days of hyperoxia exposure (<italic>P</italic>&lt; 0.05). Treatment with hyperoxia for 7 days had the greatest depressive effect on these messenger RNA levels (<italic>P</italic>&lt; 0.01) (Figure<xref ref-type=""fig"" rid=""F6"">6</xref>C, D). The results were consistent with the changes of these protein expressions in lung tissue.</p><fig id=""F6"" position=""float""><label>Figure 6</label><caption><p><bold>mRNA expression levels of ZO-1 and occludin in lung tissue.</bold>RNA was extracted from the lung tissue in both normoxia and hyperoxia groups, converted to cDNA and quantification of ZO-1 and occludin mRNA expression was determined using RT-PCR. β-actin was used as an internal control (<bold>A</bold>,<bold>C</bold>). Semiquantitative analysis of ZO-1 and occludin after different days of hyperoxia exposure (<bold>B</bold>,<bold>D</bold>). Values are presented as means ± SD; *<italic>P</italic>&lt; 0.05, **<italic>P</italic>&lt; 0.01 versus normoxia group. All experiments were performed independently 4 times.</p></caption><graphic xlink:href=""1465-9921-13-36-6""></graphic></fig></sec></sec><sec><title>Disscussion</title><p>Although hyperoxia exposure is the most common cause of lung injury for neonates requiring respiratory support, the molecular and cellular mechanisms underlying this phenomenon remain elusive. Non-cardiogenic pulmonary edema and diffuse infiltration of inflammatory cells have been confirmed as the major pathologic findings in hyperoxia-induced acute lung injury [<xref ref-type=""bibr"" rid=""B9"">9</xref>,<xref ref-type=""bibr"" rid=""B10"">10</xref>]. Previous studies on mechanisms related to these pathologic changes are mostly focused on abnormal secretion of cytokines, and imbalance between oxidation and antioxidation [<xref ref-type=""bibr"" rid=""B2"">2</xref>,<xref ref-type=""bibr"" rid=""B8"">8</xref>,<xref ref-type=""bibr"" rid=""B32"">32</xref>,<xref ref-type=""bibr"" rid=""B33"">33</xref>]. However, treatment against those factors is insufficient [<xref ref-type=""bibr"" rid=""B34"">34</xref>-<xref ref-type=""bibr"" rid=""B36"">36</xref>]. Furthermore, the molecular mechanisms involved in disruption of the pulmonary epithelial barrier itself are seldom investigated in neonatal hyperoxic lung injury and no such research is concerned with how tight junctions change during the disease. Thus, our study was undertaken to explore possible mechanisms of impairment of pulmonary epithelial integrity and find what role tight junctions play in newborn animals with hyperoxia exposure.</p><p>Our study, for the first time, demonstrated alterations in the structure and function of tight junctions in hyperoxia-induced lung injury in newborn animals. We observed that hyperoxia exposure impaired pulmonary epithelial tight junctions with increased pulmonary epithelial permeability in an in vivo model. Also, we found that the expression of occludin and ZO-1 decreased during hyperoxia exposure and the alterations were consistent with changes in the barrier function of the bronchoalveolar epithelium, suggesting these key tight junction proteins might play important roles in the disruption of epithelial integrity in hyperoxic lung injury in newborn rats.</p><p>This study provided new evidence that hyperoxia exposure led to inflammation and pulmonary edema. According to the histologic findings, we confirmed that proteinaceous fluid and neutrophil infiltration in lung tissue markedly increased after hyperoxia exposure. Pulmonary neutrophil sequestration and transmigration are demonstrated as typical manifestations of acute lung injury [<xref ref-type=""bibr"" rid=""B37"">37</xref>,<xref ref-type=""bibr"" rid=""B38"">38</xref>]. In this study, the results of lung W/D ratio and extravascular lung water content reached a common consensus that, there was obvious pulmonary edema in newborn rats with prolonged hyperoxia exposure, which were comparable with the severity of changes in pathology. These results are in accordance with previous studies which show polymorphonuclear cell infiltration and edema formation in hyperoxia-induced ALI [<xref ref-type=""bibr"" rid=""B39"">39</xref>,<xref ref-type=""bibr"" rid=""B40"">40</xref>].</p><p>We also showed that hyperoxia exposure in newborn rats significantly increased bronchoalveolar epithelial permeability (about 2–4 fold). The magnitude of the functional alteration in pulmonary epithelial barrier peaked after 7 days of hyperoxia exposure while the BALF:serum FD4 ratio was almost unchanged on day 1. The data demonstrated treatment with hyperoxia for prolonged duration contributed to more serious lung injury. Our findings are consitent with other studies which show hyperoxia increases pulmonary permeability [<xref ref-type=""bibr"" rid=""B41"">41</xref>,<xref ref-type=""bibr"" rid=""B42"">42</xref>]. It has been determined that severe lung injury and inflammatory reaction was induced by 95% O2 for 3 and 7 days with protein leak across the alveolar epithelium increasing in rat pups [<xref ref-type=""bibr"" rid=""B43"">43</xref>]. BALF albumin levels and neutrophil count are significantly increased in adult rats with hyperoxia exposure, suggesting the alteration in alveolar epithelial barrier function [<xref ref-type=""bibr"" rid=""B44"">44</xref>].</p><p>Since maintenance of normal pulmonary barrier function depends on intact epithelial tight junctions [<xref ref-type=""bibr"" rid=""B24"">24</xref>,<xref ref-type=""bibr"" rid=""B26"">26</xref>], transmission electron microscopy was used in this study to examine their morphological alterations. We observed that treatment with hyperoxia in newborn rats destroyed the structure of tight junctions. Using immunofluorescence, we showed that hyperoxia exposure markedly disrupted the membrane localization and downregulated the cytoplasm expression of the key tight junction proteins occludin and ZO-1 in the alveolar epithelium and the results were confirmed by immunoblotting and RT-PCR. Functional opening of tight junction barrier and down-regulation of occludin and ZO-1 protein expression have been also found in acute lung injury in adult animals [<xref ref-type=""bibr"" rid=""B27"">27</xref>,<xref ref-type=""bibr"" rid=""B28"">28</xref>]. Previous studies in intestinal epithelia have shown that morphology of tight junctions change through downregulation and localization shift of occluding [<xref ref-type=""bibr"" rid=""B24"">24</xref>,<xref ref-type=""bibr"" rid=""B25"">25</xref>].</p><p>Furthermore, our study showed that prolonged hyperoxia exposure enhanced the structure destruction of epithelial tight junctions while decreasing in occludin and ZO-1 expression was more obvious. This temporal pattern of changes in the expression of key tight junction proteins was paralleled by changes in the barrier function of the bronchoalveolar epithelium, which suggested decreased synthesis of occludin and ZO-1 at a transcriptional level may be a mechanism for the rapid disruption of epithelial integrity in newborn animals with hyperoxia-induced lung injury. However, abnormal structure of the tight junction was not found in groups with 1 or 3 days of hyperoxia exposure. Also, pathohistologic findings showed there was no inflammation and protein leakage until the third day of hyperoxia exposure. This phenomenon suggests that mild-to-moderate deterioration of these proteins may not be enough to change the morphology of tight junctions and cause severe lung edema.</p><p>A preliminary study has given some clue that oxidative stress induces tyrosine phosphorylation and dissociates the occludin-ZO-1 complexes from the cytoskeleton by a tyrosine kinase-dependent mechanism [<xref ref-type=""bibr"" rid=""B45"">45</xref>]. Whether hyperoxia disrupts alveolar epithelial barrier function by means of tyrosine phosphorylation and dissociation of occludin-ZO-1 complexes needs further study.</p></sec><sec sec-type=""conclusions""><title>Conclusion</title><p>Taken together, this study demonstrates that hyperoxia exposure in newborn rats impairs the structure and function of alveolar epithelial tight junctions and the changes are enhanced with prolonged hyperoxia exposure. Our data demonstrate occludin and ZO-1 expressions decrease during hyperoxia-induced acute lung injury in neonatal animals and the alterations are consistent with the severity of lung injury. Therefore, we propose that the disruption of the pulmonary epithelial barrier induced by hyperoxia is, at least in part, due to massive deterioration in the expression and localization of key TJ proteins. How deterioration of these proteins impairs the function of pulmonary epithelial barrier needs further study.</p></sec><sec><title>Abbreviations</title><p>BALF: Bronchoalveolar lavage fluid; BPD: Bronchopulmonary dysplasia; FD4: Fluorescein isothiocyanate-conjugated dextran 4000; HALI: Hyperoxic acute lung injury; TJ: Tight junction; ZO-1: Zonula occludens 1.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors’ contributions</title><p>KY performed all the experiments, analyzed the data, and wrote the manuscript. JF and XXue participated in the design of the experiments and manuscript revision. XXu and SX participated in the animal studies and coordinated the immunostaining studies. ZY and XY helped to perform the statistical analysis. All authors read and approved the final manuscript.</p></sec><back><sec><title>Acknowledgements</title><p>This work was supported by grant from the Natural Science Foundation of China (No: 30872781).</p></sec><ref-list><ref id=""B1""><mixed-citation publication-type=""journal""><name><surname>Jobe</surname><given-names>AH</given-names></name><name><surname>Bancalari</surname><given-names>E</given-names></name><article-title>Bronchopulmonary dysplasia</article-title><source>Am J Respir Crit Care Med</source><year>2001</year><volume>163</volume><fpage>1723</fpage><lpage>1729</lpage><pub-id pub-id-type=""pmid"">11401896</pub-id></mixed-citation></ref><ref id=""B2""><mixed-citation publication-type=""journal""><name><surname>Bancalari</surname><given-names>E</given-names></name><name><surname>Claure</surname><given-names>N</given-names></name><name><surname>Sosenko</surname><given-names>IR</given-names></name><article-title>Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition</article-title><source>Semin Neonatol</source><year>2003</year><volume>8</volume><fpage>63</fpage><lpage>71</lpage><pub-id pub-id-type=""doi"">10.1016/S1084-2756(02)00192-6</pub-id><pub-id pub-id-type=""pmid"">12667831</pub-id></mixed-citation></ref><ref id=""B3""><mixed-citation publication-type=""journal""><name><surname>Smith</surname><given-names>VC</given-names></name><name><surname>Zupancic</surname><given-names>JA</given-names></name><name><surname>McCormick</surname><given-names>MC</given-names></name><name><surname>Croen</surname><given-names>LA</given-names></name><name><surname>Greene</surname><given-names>J</given-names></name><name><surname>Escobar</surname><given-names>GJ</given-names></name><name><surname>Richardson</surname><given-names>DK</given-names></name><article-title>Rehospitalization in the first year of life among infants with bronchopulmonary dysplasia</article-title><source>J Pediatr</source><year>2004</year><volume>144</volume><fpage>799</fpage><lpage>803</lpage><pub-id pub-id-type=""pmid"">15192629</pub-id></mixed-citation></ref><ref id=""B4""><mixed-citation publication-type=""journal""><name><surname>Doyle</surname><given-names>LW</given-names></name><article-title>Respiratory function at age 8–9 years in extremely low birthweight/very preterm children born in Victoria in 1991–1992</article-title><source>Pediatr Pulmonol</source><year>2006</year><volume>41</volume><fpage>570</fpage><lpage>576</lpage><pub-id pub-id-type=""doi"">10.1002/ppul.20412</pub-id><pub-id pub-id-type=""pmid"">16617453</pub-id></mixed-citation></ref><ref id=""B5""><mixed-citation publication-type=""journal""><name><surname>Doyle</surname><given-names>LW</given-names></name><name><surname>Faber</surname><given-names>B</given-names></name><name><surname>Callanan</surname><given-names>C</given-names></name><name><surname>Freezer</surname><given-names>N</given-names></name><name><surname>Ford</surname><given-names>GW</given-names></name><name><surname>Davis</surname><given-names>NM</given-names></name><article-title>Bronchopulmonary dysplasia in very low birth weight subjects and lung function in late adolescence</article-title><source>Pediatrics</source><year>2006</year><volume>118</volume><fpage>108</fpage><lpage>113</lpage><pub-id pub-id-type=""doi"">10.1542/peds.2005-2522</pub-id><pub-id pub-id-type=""pmid"">16818555</pub-id></mixed-citation></ref><ref id=""B6""><mixed-citation publication-type=""journal""><name><surname>Short</surname><given-names>EJ</given-names></name><name><surname>Klein</surname><given-names>NK</given-names></name><name><surname>Lewis</surname><given-names>BA</given-names></name><name><surname>Fulton</surname><given-names>S</given-names></name><name><surname>Eisengart</surname><given-names>S</given-names></name><name><surname>Kercsmar</surname><given-names>C</given-names></name><name><surname>Baley</surname><given-names>J</given-names></name><name><surname>Singer</surname><given-names>LT</given-names></name><article-title>Cognitive and academic consequences of bronchopulmonary dysplasia and very low birth weight: 8-year-old outcomes</article-title><source>Pediatrics</source><year>2003</year><volume>112</volume><fpage>e359</fpage><pub-id pub-id-type=""doi"">10.1542/peds.112.5.e359</pub-id><pub-id pub-id-type=""pmid"">14595077</pub-id></mixed-citation></ref><ref id=""B7""><mixed-citation publication-type=""journal""><name><surname>Anderson</surname><given-names>PJ</given-names></name><name><surname>Doyle</surname><given-names>LW</given-names></name><article-title>Neurodevelopmental outcome of bronchopulmonary dysplasia</article-title><source>Semin Perinatol</source><year>2006</year><volume>30</volume><fpage>227</fpage><lpage>232</lpage><pub-id pub-id-type=""doi"">10.1053/j.semperi.2006.05.010</pub-id><pub-id pub-id-type=""pmid"">16860163</pub-id></mixed-citation></ref><ref id=""B8""><mixed-citation publication-type=""journal""><name><surname>Kotecha</surname><given-names>S</given-names></name><name><surname>Chan</surname><given-names>B</given-names></name><name><surname>Azam</surname><given-names>N</given-names></name><name><surname>Silverman</surname><given-names>M</given-names></name><name><surname>Shaw</surname><given-names>RJ</given-names></name><article-title>Increase in interleukin-8 and soluble intercellular adhesion molecule-1 in bronchoalveolar lavage fluid from premature infants who develop chronic lung disease</article-title><source>Arch Dis Child Fetal Neonatal Ed</source><year>1995</year><volume>72</volume><fpage>F90</fpage><lpage>F96</lpage><pub-id pub-id-type=""doi"">10.1136/fn.72.2.F90</pub-id><pub-id pub-id-type=""pmid"">7712280</pub-id></mixed-citation></ref><ref id=""B9""><mixed-citation publication-type=""journal""><name><surname>Coalson</surname><given-names>JJ</given-names></name><article-title>Pathology of new bronchopulmonary dysplasia</article-title><source>Semin Neonatol</source><year>2003</year><volume>8</volume><fpage>73</fpage><lpage>81</lpage><pub-id pub-id-type=""doi"">10.1016/S1084-2756(02)00193-8</pub-id><pub-id pub-id-type=""pmid"">12667832</pub-id></mixed-citation></ref><ref id=""B10""><mixed-citation publication-type=""journal""><name><surname>Warner</surname><given-names>BB</given-names></name><name><surname>Stuart</surname><given-names>LA</given-names></name><name><surname>Papes</surname><given-names>RA</given-names></name><name><surname>Wispe</surname><given-names>JR</given-names></name><article-title>Functional and pathological effects of prolonged hyperoxia in neonatal mice</article-title><source>Am J Physiol</source><year>1998</year><volume>275</volume><fpage>L110</fpage><lpage>L117</lpage><pub-id pub-id-type=""pmid"">9688942</pub-id></mixed-citation></ref><ref id=""B11""><mixed-citation publication-type=""journal""><name><surname>Corne</surname><given-names>J</given-names></name><name><surname>Chupp</surname><given-names>G</given-names></name><name><surname>Lee</surname><given-names>CG</given-names></name><name><surname>Homer</surname><given-names>RJ</given-names></name><name><surname>Zhu</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Ma</surname><given-names>B</given-names></name><name><surname>Du</surname><given-names>Y</given-names></name><name><surname>Roux</surname><given-names>F</given-names></name><name><surname>McArdle</surname><given-names>J</given-names></name><etal></etal><article-title>IL-13 stimulates vascular endothelial cell growth factor and protects against hyperoxic acute lung injury</article-title><source>J Clin Invest</source><year>2000</year><volume>106</volume><fpage>783</fpage><lpage>791</lpage><pub-id pub-id-type=""doi"">10.1172/JCI9674</pub-id><pub-id pub-id-type=""pmid"">10995789</pub-id></mixed-citation></ref><ref id=""B12""><mixed-citation publication-type=""journal""><name><surname>Altemeier</surname><given-names>WA</given-names></name><name><surname>Sinclair</surname><given-names>SE</given-names></name><article-title>Hyperoxia in the intensive care unit: why more is not always better</article-title><source>Curr Opin Crit Care</source><year>2007</year><volume>13</volume><fpage>73</fpage><lpage>78</lpage><pub-id pub-id-type=""doi"">10.1097/MCC.0b013e32801162cb</pub-id><pub-id pub-id-type=""pmid"">17198052</pub-id></mixed-citation></ref><ref id=""B13""><mixed-citation publication-type=""journal""><name><surname>Crandall</surname><given-names>ED</given-names></name><name><surname>Matthay</surname><given-names>MA</given-names></name><article-title>Alveolar epithelial transport. Basic science to clinical medicine</article-title><source>Am J Respir Crit Care Med</source><year>2001</year><volume>163</volume><fpage>1021</fpage><lpage>1029</lpage><pub-id pub-id-type=""pmid"">11282783</pub-id></mixed-citation></ref><ref id=""B14""><mixed-citation publication-type=""journal""><name><surname>Ware</surname><given-names>LB</given-names></name><name><surname>Matthay</surname><given-names>MA</given-names></name><article-title>Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome</article-title><source>Am J Respir Crit Care Med</source><year>2001</year><volume>163</volume><fpage>1376</fpage><lpage>1383</lpage><pub-id pub-id-type=""pmid"">11371404</pub-id></mixed-citation></ref><ref id=""B15""><mixed-citation publication-type=""journal""><name><surname>Schneeberger</surname><given-names>EE</given-names></name><name><surname>Lynch</surname><given-names>RD</given-names></name><article-title>Structure, function, and regulation of cellular tight junctions</article-title><source>Am J Physiol</source><year>1992</year><volume>262</volume><fpage>L647</fpage><lpage>L661</lpage><pub-id pub-id-type=""pmid"">1616050</pub-id></mixed-citation></ref><ref id=""B16""><mixed-citation publication-type=""journal""><name><surname>Gonzalez-Mariscal</surname><given-names>L</given-names></name><name><surname>Betanzos</surname><given-names>A</given-names></name><name><surname>Nava</surname><given-names>P</given-names></name><name><surname>Jaramillo</surname><given-names>BE</given-names></name><article-title>Tight junction proteins</article-title><source>Prog Biophys Mol Biol</source><year>2003</year><volume>81</volume><fpage>1</fpage><lpage>44</lpage><pub-id pub-id-type=""doi"">10.1016/S0079-6107(02)00037-8</pub-id><pub-id pub-id-type=""pmid"">12475568</pub-id></mixed-citation></ref><ref id=""B17""><mixed-citation publication-type=""journal""><name><surname>McCarthy</surname><given-names>KM</given-names></name><name><surname>Skare</surname><given-names>IB</given-names></name><name><surname>Stankewich</surname><given-names>MC</given-names></name><name><surname>Furuse</surname><given-names>M</given-names></name><name><surname>Tsukita</surname><given-names>S</given-names></name><name><surname>Rogers</surname><given-names>RA</given-names></name><name><surname>Lynch</surname><given-names>RD</given-names></name><name><surname>Schneeberger</surname><given-names>EE</given-names></name><article-title>Occludin is a functional component of the tight junction</article-title><source>J Cell Sci</source><year>1996</year><volume>109</volume><issue>Pt 9</issue><fpage>2287</fpage><lpage>2298</lpage><pub-id pub-id-type=""pmid"">8886979</pub-id></mixed-citation></ref><ref id=""B18""><mixed-citation publication-type=""journal""><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Merzdorf</surname><given-names>C</given-names></name><name><surname>Paul</surname><given-names>DL</given-names></name><name><surname>Goodenough</surname><given-names>DA</given-names></name><article-title>COOH terminus of occludin is required for tight junction barrier function in early Xenopus embryos</article-title><source>J Cell Biol</source><year>1997</year><volume>138</volume><fpage>891</fpage><lpage>899</lpage><pub-id pub-id-type=""doi"">10.1083/jcb.138.4.891</pub-id><pub-id pub-id-type=""pmid"">9265654</pub-id></mixed-citation></ref><ref id=""B19""><mixed-citation publication-type=""journal""><name><surname>Denker</surname><given-names>BM</given-names></name><name><surname>Nigam</surname><given-names>SK</given-names></name><article-title>Molecular structure and assembly of the tight junction</article-title><source>Am J Physiol</source><year>1998</year><volume>274</volume><fpage>F1</fpage><lpage>F9</lpage><pub-id pub-id-type=""pmid"">9458817</pub-id></mixed-citation></ref><ref id=""B20""><mixed-citation publication-type=""journal""><name><surname>Ohtake</surname><given-names>K</given-names></name><name><surname>Maeno</surname><given-names>T</given-names></name><name><surname>Ueda</surname><given-names>H</given-names></name><name><surname>Ogihara</surname><given-names>M</given-names></name><name><surname>Natsume</surname><given-names>H</given-names></name><name><surname>Morimoto</surname><given-names>Y</given-names></name><article-title>Poly-L-arginine enhances paracellular permeability via serine/threonine phosphorylation of ZO-1 and tyrosine dephosphorylation of occludin in rabbit nasal epithelium</article-title><source>Pharm Res</source><year>2003</year><volume>20</volume><fpage>1838</fpage><lpage>1845</lpage><pub-id pub-id-type=""pmid"">14661930</pub-id></mixed-citation></ref><ref id=""B21""><mixed-citation publication-type=""journal""><name><surname>Ye</surname><given-names>L</given-names></name><name><surname>Martin</surname><given-names>TA</given-names></name><name><surname>Parr</surname><given-names>C</given-names></name><name><surname>Harrison</surname><given-names>GM</given-names></name><name><surname>Mansel</surname><given-names>RE</given-names></name><name><surname>Jiang</surname><given-names>WG</given-names></name><article-title>Biphasic effects of 17-beta-estradiol on expression of occludin and transendothelial resistance and paracellular permeability in human vascular endothelial cells</article-title><source>J Cell Physiol</source><year>2003</year><volume>196</volume><fpage>362</fpage><lpage>369</lpage><pub-id pub-id-type=""doi"">10.1002/jcp.10315</pub-id><pub-id pub-id-type=""pmid"">12811830</pub-id></mixed-citation></ref><ref id=""B22""><mixed-citation publication-type=""journal""><name><surname>Chasiotis</surname><given-names>H</given-names></name><name><surname>Wood</surname><given-names>CM</given-names></name><name><surname>Kelly</surname><given-names>SP</given-names></name><article-title>Cortisol reduces paracellular permeability and increases occludin abundance in cultured trout gill epithelia</article-title><source>Mol Cell Endocrinol</source><year>2010</year><volume>323</volume><fpage>232</fpage><lpage>238</lpage><pub-id pub-id-type=""doi"">10.1016/j.mce.2010.02.030</pub-id><pub-id pub-id-type=""pmid"">20193737</pub-id></mixed-citation></ref><ref id=""B23""><mixed-citation publication-type=""journal""><name><surname>Raleigh</surname><given-names>DR</given-names></name><name><surname>Boe</surname><given-names>DM</given-names></name><name><surname>Yu</surname><given-names>D</given-names></name><name><surname>Weber</surname><given-names>CR</given-names></name><name><surname>Marchiando</surname><given-names>AM</given-names></name><name><surname>Bradford</surname><given-names>EM</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>Schneeberger</surname><given-names>EE</given-names></name><name><surname>Shen</surname><given-names>L</given-names></name><name><surname>Turner</surname><given-names>JR</given-names></name><article-title>Occludin S408 phosphorylation regulates tight junction protein interactions and barrier function</article-title><source>J Cell Biol</source><year>2011</year><volume>193</volume><fpage>565</fpage><lpage>582</lpage><pub-id pub-id-type=""doi"">10.1083/jcb.201010065</pub-id><pub-id pub-id-type=""pmid"">21536752</pub-id></mixed-citation></ref><ref id=""B24""><mixed-citation publication-type=""journal""><name><surname>Han</surname><given-names>X</given-names></name><name><surname>Fink</surname><given-names>MP</given-names></name><name><surname>Yang</surname><given-names>R</given-names></name><name><surname>Delude</surname><given-names>RL</given-names></name><article-title>Increased iNOS activity is essential for intestinal epithelial tight junction dysfunction in endotoxemic mice</article-title><source>Shock</source><year>2004</year><volume>21</volume><fpage>261</fpage><lpage>270</lpage><pub-id pub-id-type=""doi"">10.1097/01.shk.0000112346.38599.10</pub-id><pub-id pub-id-type=""pmid"">14770040</pub-id></mixed-citation></ref><ref id=""B25""><mixed-citation publication-type=""journal""><name><surname>Noth</surname><given-names>R</given-names></name><name><surname>Lange-Grumfeld</surname><given-names>J</given-names></name><name><surname>Stuber</surname><given-names>E</given-names></name><name><surname>Kruse</surname><given-names>ML</given-names></name><name><surname>Ellrichmann</surname><given-names>M</given-names></name><name><surname>Hasler</surname><given-names>R</given-names></name><name><surname>Hampe</surname><given-names>J</given-names></name><name><surname>Bewig</surname><given-names>B</given-names></name><name><surname>Rosenstiel</surname><given-names>P</given-names></name><name><surname>Schreiber</surname><given-names>S</given-names></name><name><surname>Arlt</surname><given-names>A</given-names></name><article-title>Increased intestinal permeability and tight junction disruption by altered expression and localization of occludin in a murine graft versus host disease model</article-title><source>BMC Gastroenterol</source><year>2011</year><volume>11</volume><fpage>109</fpage><pub-id pub-id-type=""doi"">10.1186/1471-230X-11-109</pub-id><pub-id pub-id-type=""pmid"">21977944</pub-id></mixed-citation></ref><ref id=""B26""><mixed-citation publication-type=""journal""><name><surname>Gon</surname><given-names>Y</given-names></name><name><surname>Wood</surname><given-names>MR</given-names></name><name><surname>Kiosses</surname><given-names>WB</given-names></name><name><surname>Jo</surname><given-names>E</given-names></name><name><surname>Sanna</surname><given-names>MG</given-names></name><name><surname>Chun</surname><given-names>J</given-names></name><name><surname>Rosen</surname><given-names>H</given-names></name><article-title>S1P3 receptor-induced reorganization of epithelial tight junctions compromises lung barrier integrity and is potentiated by TNF</article-title><source>Proc Natl Acad Sci U S A</source><year>2005</year><volume>102</volume><fpage>9270</fpage><lpage>9275</lpage><pub-id pub-id-type=""doi"">10.1073/pnas.0501997102</pub-id><pub-id pub-id-type=""pmid"">15968000</pub-id></mixed-citation></ref><ref id=""B27""><mixed-citation publication-type=""journal""><name><surname>Mazzon</surname><given-names>E</given-names></name><name><surname>Cuzzocrea</surname><given-names>S</given-names></name><article-title>Role of TNF-alpha in lung tight junction alteration in mouse model of acute lung inflammation</article-title><source>Respir Res</source><year>2007</year><volume>8</volume><fpage>75</fpage><pub-id pub-id-type=""doi"">10.1186/1465-9921-8-75</pub-id><pub-id pub-id-type=""pmid"">17971210</pub-id></mixed-citation></ref><ref id=""B28""><mixed-citation publication-type=""journal""><name><surname>Zhang</surname><given-names>YL</given-names></name><name><surname>Li</surname><given-names>QQ</given-names></name><name><surname>Guo</surname><given-names>W</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><article-title>Effects of chronic ethanol ingestion on tight junction proteins and barrier function of alveolar epithelium in the rat</article-title><source>Shock</source><year>2007</year><volume>28</volume><fpage>245</fpage><lpage>252</lpage><pub-id pub-id-type=""doi"">10.1097/SHK.0b013e31803404a9</pub-id><pub-id pub-id-type=""pmid"">17515855</pub-id></mixed-citation></ref><ref id=""B29""><mixed-citation publication-type=""journal""><name><surname>Matute-Bello</surname><given-names>G</given-names></name><name><surname>Downey</surname><given-names>G</given-names></name><name><surname>Moore</surname><given-names>BB</given-names></name><name><surname>Groshong</surname><given-names>SD</given-names></name><name><surname>Matthay</surname><given-names>MA</given-names></name><name><surname>Slutsky</surname><given-names>AS</given-names></name><name><surname>Kuebler</surname><given-names>WM</given-names></name><article-title>An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals</article-title><source>Am J Respir Cell Mol Biol</source><year>2011</year><volume>44</volume><fpage>725</fpage><lpage>738</lpage><pub-id pub-id-type=""doi"">10.1165/rcmb.2009-0210ST</pub-id><pub-id pub-id-type=""pmid"">21531958</pub-id></mixed-citation></ref><ref id=""B30""><mixed-citation publication-type=""journal""><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Koshy</surname><given-names>S</given-names></name><name><surname>Folkesson</surname><given-names>HG</given-names></name><article-title>Involvement of {alpha}ENaC and Nedd4-2 in the conversion from lung fluid secretion to fluid absorption at birth in the rat as assayed by RNA interference analysis</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><year>2007</year><volume>293</volume><fpage>L1069</fpage><lpage>L1078</lpage><pub-id pub-id-type=""doi"">10.1152/ajplung.00151.2007</pub-id><pub-id pub-id-type=""pmid"">17693485</pub-id></mixed-citation></ref><ref id=""B31""><mixed-citation publication-type=""journal""><name><surname>Song</surname><given-names>Y</given-names></name><name><surname>Fukuda</surname><given-names>N</given-names></name><name><surname>Bai</surname><given-names>C</given-names></name><name><surname>Ma</surname><given-names>T</given-names></name><name><surname>Matthay</surname><given-names>MA</given-names></name><name><surname>Verkman</surname><given-names>AS</given-names></name><article-title>Role of aquaporins in alveolar fluid clearance in neonatal and adult lung, and in oedema formation following acute lung injury: studies in transgenic aquaporin null mice</article-title><source>J Physiol</source><year>2000</year><volume>525</volume><issue>Pt 3</issue><fpage>771</fpage><lpage>779</lpage><pub-id pub-id-type=""pmid"">10856128</pub-id></mixed-citation></ref><ref id=""B32""><mixed-citation publication-type=""journal""><name><surname>Ben-Ari</surname><given-names>J</given-names></name><name><surname>Makhoul</surname><given-names>IR</given-names></name><name><surname>Dorio</surname><given-names>RJ</given-names></name><name><surname>Buckley</surname><given-names>S</given-names></name><name><surname>Warburton</surname><given-names>D</given-names></name><name><surname>Walker</surname><given-names>SM</given-names></name><article-title>Cytokine response during hyperoxia: sequential production of pulmonary tumor necrosis factor and interleukin-6 in neonatal rats</article-title><source>Isr Med Assoc J</source><year>2000</year><volume>2</volume><fpage>365</fpage><lpage>369</lpage><pub-id pub-id-type=""pmid"">10892391</pub-id></mixed-citation></ref><ref id=""B33""><mixed-citation publication-type=""journal""><name><surname>Auten</surname><given-names>RL</given-names></name><name><surname>Davis</surname><given-names>JM</given-names></name><article-title>Oxygen toxicity and reactive oxygen species: the devil is in the details</article-title><source>Pediatr Res</source><year>2009</year><volume>66</volume><fpage>121</fpage><lpage>127</lpage><pub-id pub-id-type=""doi"">10.1203/PDR.0b013e3181a9eafb</pub-id><pub-id pub-id-type=""pmid"">19390491</pub-id></mixed-citation></ref><ref id=""B34""><mixed-citation publication-type=""journal""><name><surname>Doyle</surname><given-names>LW</given-names></name><name><surname>Ehrenkranz</surname><given-names>RA</given-names></name><name><surname>Halliday</surname><given-names>HL</given-names></name><article-title>Dexamethasone treatment in the first week of life for preventing bronchopulmonary dysplasia in preterm infants: a systematic review</article-title><source>Neonatology</source><year>2010</year><volume>98</volume><fpage>217</fpage><lpage>224</lpage><pub-id pub-id-type=""doi"">10.1159/000286210</pub-id><pub-id pub-id-type=""pmid"">20389126</pub-id></mixed-citation></ref><ref id=""B35""><mixed-citation publication-type=""journal""><name><surname>Dani</surname><given-names>C</given-names></name><name><surname>Cecchi</surname><given-names>A</given-names></name><name><surname>Bertini</surname><given-names>G</given-names></name><article-title>Role of oxidative stress as physiopathologic factor in the preterm infant</article-title><source>Minerva Pediatr</source><year>2004</year><volume>56</volume><fpage>381</fpage><lpage>394</lpage><pub-id pub-id-type=""pmid"">15457136</pub-id></mixed-citation></ref><ref id=""B36""><mixed-citation publication-type=""journal""><name><surname>Comhair</surname><given-names>SA</given-names></name><name><surname>Erzurum</surname><given-names>SC</given-names></name><article-title>Antioxidant responses to oxidant-mediated lung diseases</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><year>2002</year><volume>283</volume><fpage>L246</fpage><lpage>L255</lpage><pub-id pub-id-type=""pmid"">12114185</pub-id></mixed-citation></ref><ref id=""B37""><mixed-citation publication-type=""journal""><name><surname>Deng</surname><given-names>H</given-names></name><name><surname>Mason</surname><given-names>SN</given-names></name><name><surname>Auten</surname><given-names>RL</given-names></name><article-title>Lung inflammation in hyperoxia can be prevented by antichemokine treatment in newborn rats</article-title><source>Am J Respir Crit Care Med</source><year>2000</year><volume>162</volume><fpage>2316</fpage><lpage>2323</lpage><pub-id pub-id-type=""pmid"">11112157</pub-id></mixed-citation></ref><ref id=""B38""><mixed-citation publication-type=""journal""><name><surname>Reutershan</surname><given-names>J</given-names></name><name><surname>Basit</surname><given-names>A</given-names></name><name><surname>Galkina</surname><given-names>EV</given-names></name><name><surname>Ley</surname><given-names>K</given-names></name><article-title>Sequential recruitment of neutrophils into lung and bronchoalveolar lavage fluid in LPS-induced acute lung injury</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><year>2005</year><volume>289</volume><fpage>L807</fpage><lpage>L815</lpage><pub-id pub-id-type=""doi"">10.1152/ajplung.00477.2004</pub-id><pub-id pub-id-type=""pmid"">15951336</pub-id></mixed-citation></ref><ref id=""B39""><mixed-citation publication-type=""journal""><name><surname>Jankov</surname><given-names>RP</given-names></name><name><surname>Johnstone</surname><given-names>L</given-names></name><name><surname>Luo</surname><given-names>X</given-names></name><name><surname>Robinson</surname><given-names>BH</given-names></name><name><surname>Tanswell</surname><given-names>AK</given-names></name><article-title>Macrophages as a major source of oxygen radicals in the hyperoxic newborn rat lung</article-title><source>Free Radic Biol Med</source><year>2003</year><volume>35</volume><fpage>200</fpage><lpage>209</lpage><pub-id pub-id-type=""doi"">10.1016/S0891-5849(03)00305-8</pub-id><pub-id pub-id-type=""pmid"">12853076</pub-id></mixed-citation></ref><ref id=""B40""><mixed-citation publication-type=""journal""><name><surname>Yi</surname><given-names>M</given-names></name><name><surname>Jankov</surname><given-names>RP</given-names></name><name><surname>Belcastro</surname><given-names>R</given-names></name><name><surname>Humes</surname><given-names>D</given-names></name><name><surname>Copland</surname><given-names>I</given-names></name><name><surname>Shek</surname><given-names>S</given-names></name><name><surname>Sweezey</surname><given-names>NB</given-names></name><name><surname>Post</surname><given-names>M</given-names></name><name><surname>Albertine</surname><given-names>KH</given-names></name><name><surname>Auten</surname><given-names>RL</given-names></name><name><surname>Tanswell</surname><given-names>AK</given-names></name><article-title>Opposing effects of 60% oxygen and neutrophil influx on alveologenesis in the neonatal rat</article-title><source>Am J Respir Crit Care Med</source><year>2004</year><volume>170</volume><fpage>1188</fpage><lpage>1196</lpage><pub-id pub-id-type=""doi"">10.1164/rccm.200402-215OC</pub-id><pub-id pub-id-type=""pmid"">15347560</pub-id></mixed-citation></ref><ref id=""B41""><mixed-citation publication-type=""journal""><name><surname>Ahamed</surname><given-names>K</given-names></name><name><surname>Epaud</surname><given-names>R</given-names></name><name><surname>Holzenberger</surname><given-names>M</given-names></name><name><surname>Bonora</surname><given-names>M</given-names></name><name><surname>Flejou</surname><given-names>JF</given-names></name><name><surname>Puard</surname><given-names>J</given-names></name><name><surname>Clement</surname><given-names>A</given-names></name><name><surname>Henrion-Caude</surname><given-names>A</given-names></name><article-title>Deficiency in type 1 insulin-like growth factor receptor in mice protects against oxygen-induced lung injury</article-title><source>Respir Res</source><year>2005</year><volume>6</volume><fpage>31</fpage><pub-id pub-id-type=""doi"">10.1186/1465-9921-6-31</pub-id><pub-id pub-id-type=""pmid"">15819984</pub-id></mixed-citation></ref><ref id=""B42""><mixed-citation publication-type=""journal""><name><surname>Lozon</surname><given-names>TI</given-names></name><name><surname>Eastman</surname><given-names>AJ</given-names></name><name><surname>Matute-Bello</surname><given-names>G</given-names></name><name><surname>Chen</surname><given-names>P</given-names></name><name><surname>Hallstrand</surname><given-names>TS</given-names></name><name><surname>Altemeier</surname><given-names>WA</given-names></name><article-title>PKR-dependent CHOP induction limits hyperoxia-induced lung injury</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><year>2011</year><volume>300</volume><fpage>L422</fpage><lpage>L429</lpage><pub-id pub-id-type=""doi"">10.1152/ajplung.00166.2010</pub-id><pub-id pub-id-type=""pmid"">21186267</pub-id></mixed-citation></ref><ref id=""B43""><mixed-citation publication-type=""journal""><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Luo</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Deng</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>F</given-names></name><name><surname>Shang</surname><given-names>L</given-names></name><name><surname>Jian</surname><given-names>C</given-names></name><name><surname>Yue</surname><given-names>S</given-names></name><article-title>Glutamate mediates hyperoxia-induced newborn rat lung injury through N-methyl-D-aspartate receptors</article-title><source>Am J Respir Cell Mol Biol</source><year>2009</year><volume>40</volume><fpage>260</fpage><lpage>267</lpage><pub-id pub-id-type=""pmid"">18757305</pub-id></mixed-citation></ref><ref id=""B44""><mixed-citation publication-type=""journal""><name><surname>Aggarwal</surname><given-names>NR</given-names></name><name><surname>D'Alessio</surname><given-names>FR</given-names></name><name><surname>Tsushima</surname><given-names>K</given-names></name><name><surname>Files</surname><given-names>DC</given-names></name><name><surname>Damarla</surname><given-names>M</given-names></name><name><surname>Sidhaye</surname><given-names>VK</given-names></name><name><surname>Fraig</surname><given-names>MM</given-names></name><name><surname>Polotsky</surname><given-names>VY</given-names></name><name><surname>King</surname><given-names>LS</given-names></name><article-title>Moderate oxygen augments lipopolysaccharide-induced lung injury in mice</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><year>2010</year><volume>298</volume><fpage>L371</fpage><lpage>L381</lpage><pub-id pub-id-type=""doi"">10.1152/ajplung.00308.2009</pub-id><pub-id pub-id-type=""pmid"">20034961</pub-id></mixed-citation></ref><ref id=""B45""><mixed-citation publication-type=""journal""><name><surname>Rao</surname><given-names>RK</given-names></name><name><surname>Basuroy</surname><given-names>S</given-names></name><name><surname>Rao</surname><given-names>VU</given-names></name><name><surname>Karnaky</surname><given-names>KJ</given-names></name><name><surname>Gupta</surname><given-names>A</given-names></name><article-title>Tyrosine phosphorylation and dissociation of occludin-ZO-1 and E-cadherin-beta-catenin complexes from the cytoskeleton by oxidative stress</article-title><source>Biochem J</source><year>2002</year><volume>368</volume><fpage>471</fpage><lpage>481</lpage><pub-id pub-id-type=""doi"">10.1042/BJ20011804</pub-id><pub-id pub-id-type=""pmid"">12169098</pub-id></mixed-citation></ref></ref-list>"
10.1038/77997	"<html><body><article article-type=""research-article"" xml:lang=""en"" xmlns:mml=""http://www.w3.org/1998/Math/MathML"" xmlns:xlink=""http://www.w3.org/1999/xlink""><?properties open_access?><front><journal-meta><journal-id journal-id-type=""nlm-ta"">BMC Evol Biol</journal-id><journal-id journal-id-type=""iso-abbrev"">BMC Evol. Biol</journal-id><journal-title-group><journal-title>BMC Evolutionary Biology</journal-title></journal-title-group><issn pub-type=""epub"">1471-2148</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type=""pmid"">19014598</article-id><article-id pub-id-type=""pmc"">2605760</article-id><article-id pub-id-type=""publisher-id"">1471-2148-8-316</article-id><article-id pub-id-type=""doi"">10.1186/1471-2148-8-316</article-id><article-categories><subj-group subj-group-type=""heading""><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Insights into the evolutionary origins of clostridial neurotoxins from analysis of the<italic>Clostridium botulinum</italic>strain A neurotoxin gene cluster</article-title></title-group><contrib-group><contrib contrib-type=""author"" id=""A1""><name><surname>Doxey</surname><given-names>Andrew C</given-names></name><xref ref-type=""aff"" rid=""I1"">1</xref><email>acdoxey@uwaterloo.ca</email></contrib><contrib contrib-type=""author"" id=""A2""><name><surname>Lynch</surname><given-names>Michael DJ</given-names></name><xref ref-type=""aff"" rid=""I1"">1</xref><email>mdjlynch@sciborg.uwaterloo.ca</email></contrib><contrib contrib-type=""author"" id=""A3""><name><surname>Müller</surname><given-names>Kirsten M</given-names></name><xref ref-type=""aff"" rid=""I1"">1</xref><email>kmmuller@sciborg.uwaterloo.ca</email></contrib><contrib contrib-type=""author"" id=""A4""><name><surname>Meiering</surname><given-names>Elizabeth M</given-names></name><xref ref-type=""aff"" rid=""I2"">2</xref><email>meiering@uwaterloo.ca</email></contrib><contrib contrib-type=""author"" corresp=""yes"" id=""A5""><name><surname>McConkey</surname><given-names>Brendan J</given-names></name><xref ref-type=""aff"" rid=""I1"">1</xref><email>mcconkey@uwaterloo.ca</email></contrib></contrib-group><aff id=""I1""><label>1</label>Department of Biology, University of Waterloo, 200 University Avenue West, Waterloo, Ontario, N2L 3G1, Canada</aff><aff id=""I2""><label>2</label>Guelph-Waterloo Centre for Graduate Studies in Chemistry and Biochemistry, University of Waterloo, 200 University Avenue West, Waterloo, Ontario, N2L 3G1, Canada</aff><pub-date pub-type=""collection""><year>2008</year></pub-date><pub-date pub-type=""epub""><day>14</day><month>11</month><year>2008</year></pub-date><volume>8</volume><fpage>316</fpage><lpage>316</lpage><history><date date-type=""received""><day>21</day><month>4</month><year>2008</year></date><date date-type=""accepted""><day>14</day><month>11</month><year>2008</year></date></history><permissions><copyright-statement>Copyright ©2008 Doxey et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2008</copyright-year><copyright-holder>Doxey et al; licensee BioMed Central Ltd.</copyright-holder><license license-type=""open-access"" xlink:href=""http://creativecommons.org/licenses/by/2.0""><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type=""uri"" xlink:href=""http://creativecommons.org/licenses/by/2.0"">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href=""http://www.biomedcentral.com/1471-2148/8/316""></self-uri><abstract><sec><title>Background</title><p>Clostridial neurotoxins (CNTs) are the most deadly toxins known and causal agents of botulism and tetanus neuroparalytic diseases. Despite considerable progress in understanding CNT structure and function, the evolutionary origins of CNTs remain a mystery as they are unique to<italic>Clostridium</italic>and possess a sequence and structural architecture distinct from other protein families. Uncovering the origins of CNTs would be a significant contribution to our understanding of how pathogens evolve and generate novel toxin families.</p></sec><sec><title>Results</title><p>The<italic>C. botulinum</italic>strain A genome was examined for potential homologues of CNTs. A key link was identified between the neurotoxin and the flagellin gene (CBO0798) located immediately upstream of the BoNT/A neurotoxin gene cluster. This flagellin sequence displayed the strongest sequence similarity to the neurotoxin and NTNH homologue out of all proteins encoded within<italic>C. botulinum</italic>strain A. The CBO0798 gene contains a unique hypervariable region, which in closely related flagellins encodes a collagenase-like domain. Remarkably, these collagenase-containing flagellins were found to possess the characteristic HEXXH zinc-protease motif responsible for the neurotoxin's endopeptidase activity. Additional links to collagenase-related sequences and functions were detected by further analysis of CNTs and surrounding genes, including sequence similarities to collagen-adhesion domains and collagenases. Furthermore, the neurotoxin's HCRn domain was found to exhibit both structural and sequence similarity to eukaryotic collagen jelly-roll domains.</p></sec><sec><title>Conclusion</title><p>Multiple lines of evidence suggest that the neurotoxin and adjacent genes evolved from an ancestral collagenase-like gene cluster, linking CNTs to another major family of clostridial proteolytic toxins. Duplication, reshuffling and assembly of neighboring genes within the BoNT/A neurotoxin gene cluster may have lead to the neurotoxin's unique architecture. This work provides new insights into the evolution of<italic>C. botulinum</italic>neurotoxins and the evolutionary mechanisms underlying the origins of virulent genes.</p></sec></abstract></article-meta></front><sec><title>Background</title><p>Clostridial neurotoxins (CNTs) are the most poisonous biological toxins known and molecular agents of botulism and tetanus neuroparalytic diseases [<xref ref-type=""bibr"" rid=""B1"">1</xref>]. Due to their extreme toxicity and potential threat as bioterrorism agents, they are listed as Category A agents by the Centers for Disease Control and Prevention along with other deadly agents such as anthrax. Elucidating the mechanisms by which CNTs evolved is therefore of significant importance to our understanding of pathogen evolution and emerging diseases.</p><p>While considerable progress has been made in understanding CNT structure and function [<xref ref-type=""bibr"" rid=""B2"">2</xref>-<xref ref-type=""bibr"" rid=""B9"">9</xref>], like many toxins and virulence factors, the evolutionary origins of CNTs are unclear. CNTs are produced by four phylogenetically distinct groups (I-IV) of<italic>C. botulinum</italic>, and also by strains of<italic>C. tetani</italic>,<italic>C. baratii</italic>, and<italic>C. butyricum</italic>[<xref ref-type=""bibr"" rid=""B10"">10</xref>]. As demonstrated by the scattered phyletic distribution of neurotoxin-producing clostridia [<xref ref-type=""bibr"" rid=""B10"">10</xref>] and the patterns of sequence similarity between different neurotoxin gene clusters [<xref ref-type=""bibr"" rid=""B11"">11</xref>], CNT genes appear to have undergone significant lateral transfer between different species of<italic>Clostridium</italic>. The occurrence of lateral transfer is also supported by the discovery of plasmid-encoded neurotoxin genes in numerous<italic>C. botulinum</italic>strains [<xref ref-type=""bibr"" rid=""B12"">12</xref>], as well as the existence of putative insertion sequences flanking the neurotoxin gene cluster [<xref ref-type=""bibr"" rid=""B13"">13</xref>].</p><p>While CNTs have undergone frequent lateral transfer between species of<italic>Clostridium</italic>, no CNT homologues have been identified outside of the<italic>Clostridium</italic>genus. CNTs form an isolated protein family according to SCOP [<xref ref-type=""bibr"" rid=""B14"">14</xref>] and PFAM [<xref ref-type=""bibr"" rid=""B15"">15</xref>] and have a unique structural architecture that complicates the identification of related proteins and potential ancestors. While CNT domains have little detectable sequence similarity to proteins outside of the CNT family, there are however some structural and functional similarities to other domain families. The beta-trefoil, a three-fold symmetrical structure that forms the C-terminal receptor binding domain (HCRc) and associated hemagglutinin components, is common to interleukins, ricin-like lectins, and fibroblast growth factors [<xref ref-type=""bibr"" rid=""B16"">16</xref>]. The adjacent HCRn domain, also involved in receptor binding, forms a jelly-roll like structure similar to laminin globular G domains [<xref ref-type=""bibr"" rid=""B4"">4</xref>]. The central translocase adopts a long alpha-helical structure containing alpha-helical bundles that resemble those found in translocase-like domains of other toxins [<xref ref-type=""bibr"" rid=""B17"">17</xref>]. Lastly, the N-terminal catalytic domain has been grouped under the zincin-like group of metalloproteases by SCOP and under the Peptidase MA clan by the MEROPS database [<xref ref-type=""bibr"" rid=""B18"">18</xref>]. It contains a HEXXH zinc-binding motif found in other zinc endopeptidases, but has only weak structural similarity to other members of the Peptidase MA clan [<xref ref-type=""bibr"" rid=""B5"">5</xref>].</p><p>Diversity of domain and fold composition and extreme sequence divergence are common features of bacterial toxins [<xref ref-type=""bibr"" rid=""B19"">19</xref>]. Rapid sequence evolution in toxin genes is largely a consequence of the evolutionary 'arms race' between pathogen and host [<xref ref-type=""bibr"" rid=""B19"">19</xref>]. Therefore, it is important to consider that evolutionarily related toxins may only share weak sequence similarity and may have undergone considerable structural rearrangements. Here, we present evidence supporting the hypothesis that CNTs were formed within an ancestral<italic>Clostridium</italic>species by duplications and rearrangements of neighboring genes within the neurotoxin gene cluster, and identify the likely evolutionary precursors of CNTs and surrounding genes. Multiple links to collagenase-related sequences and functions are detected through an analysis of the nearby flagellin and hemagglutinin genes (strain A) in addition to the CNT domains. The detected links provide novel insights into the evolutionary origins and ancestral function of the neurotoxin gene cluster.</p></sec><sec><title>Results and Discussion</title><sec><title>Ancient gene duplications within the BoNT/A neurotoxin gene cluster</title><p>A comprehensive analysis of pairwise sequence similarities was performed for all proteins encoded within the<italic>C. botulinum</italic>(strain Hall A, ATCC 3502) genome [<xref ref-type=""bibr"" rid=""B20"">20</xref>], in an attempt to identify distant homologues of CNTs and possible sequence remnants of the evolutionary process by which CNTs originated. This initial analysis was limited to a single genome for a more sensitive detection of pairwise homologies using a restricted database, however subsequent searches were also performed using all available clostridial genomes. For the 3615 proteins encoded within<italic>C. botulinum</italic>(strain Hall A, ATCC 3502) [<xref ref-type=""bibr"" rid=""B20"">20</xref>], a 'heat map' of pairwise sequence similarity was constructed (see Methods) (Figure<xref ref-type=""fig"" rid=""F1"">1</xref>). For each pairwise alignment, the<italic>E</italic>-value and percentile rank relative to all other pairwise alignments was calculated using SSEARCH [<xref ref-type=""bibr"" rid=""B21"">21</xref>]. When compared by percentile rank, the neurotoxin gene cluster stood out as a ""hot spot"" of local pairwise sequence similarities. The neurotoxin gene cluster can be seen as a distinct cluster of high-scoring pairs in the centre of the heat map region in Figure<xref ref-type=""fig"" rid=""F1"">1A</xref>. Based on both the percentile ranks and<italic>E</italic>-values for the pairwise alignments corresponding to these genes (Figure<xref ref-type=""fig"" rid=""F1"">1B</xref>), there are clear sequence similarities between multiple sequences within this region, including BoNT/A, non-toxic non-hemagglutinin (NTNH), the adjacent hemagglutinin (HA) components and the adjacent CBO0798 gene encoding a flagellin protein (NCBI accession YP_001253335). BoNT/A and NTNH produced the top-scoring alignments with each other out of 3615 proteins in<italic>C. botulinum</italic>strain A (<italic>E</italic>= 1e-22, 9e-24), an expected result given previously identified sequence similarities between BoNTs and NTNH [<xref ref-type=""bibr"" rid=""B22"">22</xref>] as well as their virtually identical domain architecture as identified by the NCBI's conserved domain database annotation (e.g., for NCBI IDs ABP48106 and BAA90660). Surprisingly, the next highest match in both cases corresponds to the CBO0798 flagellin gene located immediately upstream of the neurotoxin gene cluster (Figure<xref ref-type=""fig"" rid=""F2"">2A</xref>). The associated<italic>E</italic>-values were 0.041 and 0.42 for BoNT/A and NTNH, respectively (Figure<xref ref-type=""fig"" rid=""F1"">1B</xref>). CBO0798 aligned with NTNH and BONT/A in two different CNT regions (I and II) (Figure<xref ref-type=""fig"" rid=""F2"">2B</xref>, Additional Files<xref ref-type=""supplementary-material"" rid=""S1"">1</xref>,<xref ref-type=""supplementary-material"" rid=""S2"">2</xref>). Additional searches using the sequences of CNTs from other strains also identified CBO0798 as the most consistent top ranked hit out of all<italic>C. botulinum</italic>strain A proteins with sequence identities between CNTs and CBO0798 ranging from 20–24%, and the strongest alignments involving region II of CNTs (Additional File<xref ref-type=""supplementary-material"" rid=""S1"">1</xref>).</p><fig id=""F1"" position=""float""><label>Figure 1</label><caption><p><bold>Protein sequence similarity heat map surrounding the BoNT/A neurotoxin gene cluster</bold>. Sequence similarity scores,<italic>E</italic>-values and percentile ranks were calculated for all pairwise combinations of putative proteins encoded in the<italic>C. botulinum</italic>strain A genome. A) A heat map of the percentile ranks for pairwise alignments involving 100 genes surrounding the neurotoxin gene cluster (described in Methods). B) Similarity ranks and<italic>E</italic>-values (in brackets) for pairwise protein sequence alignments in the neurotoxin gene cluster, corresponding to BoNT/A, NTNH, CBO0798, associated hemagglutinin components and other neighboring genes.<italic>E</italic>-values &lt; 1 are in boldface.</p></caption><graphic xlink:href=""1471-2148-8-316-1""></graphic></fig><fig id=""F2"" position=""float""><label>Figure 2</label><caption><p><bold>Genomic location of flagellin CBO0798 and regions of sequence similarity with CNTs</bold>. A) Genomic context of the neurotoxin gene cluster for<italic>C. botulinum</italic>A. str. Hall. B) Domain structure of CNTs and regions of detected similarity with NTNH (region I) and BoNT/A (region 2) according to SSEARCH. A consensus CNT secondary structure based on a multiple sequence alignment is indicated below the schematic, with black lines representing alpha helices and grey lines representing beta sheets. C) The structure of BoNT/A (PDB ID<ext-link ext-link-type=""pdb"" xlink:href=""3BTA"">3BTA</ext-link>) with region II highlighted in red. D) A Smith-Waterman alignment of region II from<italic>C. butyricum</italic>BoNT/E and CBO0798.</p></caption><graphic xlink:href=""1471-2148-8-316-2""></graphic></fig><p>In addition to the detected similarities between CBO0798-BoNT/A and NTNH-BoNT/A, sequence similarities were also detected between the beta-trefoil hemagglutinin components (HA33 and HA17). HA33 and HA17 were identified as reciprocal top ranked matches (<italic>E</italic>= 0.041, 0.2), and a weak similarity was detected between HA33 and the C-terminal (beta-trefoil) regions of NTNH (ranked 10th,<italic>E</italic>= 2.4). Sequence similarity was also found between the hemagglutinin components HA70 and residues 39–474 of NTNH (ranked #2 out of all pairwise alignments with HA70 as the query,<italic>E</italic>= 0.72). Though the<italic>E</italic>-values calculated above are not all statistically significant, the high-ranking scores relative to the 3615<italic>C. botulinum</italic>proteins suggest that multiple genes within the BoNT/A neurotoxin gene cluster are likely distant homologues that have undergone extensive sequence divergence.</p></sec><sec><title>Sequence similarity to the upstream flagellin gene</title><p>To identify other clostridial sequences homologous to CBO0798, a PSI-BLAST [<xref ref-type=""bibr"" rid=""B23"">23</xref>] search was conducted starting with the CBO0798 sequence (default parameters, results restricted to<italic>Clostridia</italic>). All homologues identified in the first iteration were members of the flagellin family. The second iteration identified additional flagellins, followed by the type E botulinum toxin (BoNT/E) from<italic>C. butyricum</italic>with an<italic>E</italic>-value of 0.05 [23% sequence identity over residues 88–406 of flagellin and 727–1045 (region II) of BoNT/E, see Additional File<xref ref-type=""supplementary-material"" rid=""S2"">2</xref>for the alignment]. To check for the influence of composition on the alignment, two permutation reshuffling tests were performed, which calculate the probability that random sequences of the same composition could result in similar alignment scores. The permutation reshuffling tests detected significant sequence similarity between the two proteins with (p = 0.0024) and without (p = 0.011) statistically overrepresented amino acids included (see Methods).</p><p>According to the sequence alignments produced by PSI-BLAST and SSEARCH, the region of CNTs with the strongest detected similarity to CBO0798 (region II) includes most of the translocase domain as well as the HCRn domain (Figure<xref ref-type=""fig"" rid=""F2"">2B–D</xref>). Region I was also detected by SSEARCH (Additional File<xref ref-type=""supplementary-material"" rid=""S1"">1</xref>), spanning the peptidase and 'belt' region, though without definitive statistical significance (<italic>E</italic>= 0.41). The translocase, an extended alpha-helical domain, has a general structural similarity to the central helical regions of known flagellin structures (see PDB IDs<ext-link ext-link-type=""pdb"" xlink:href=""1io1"">1io1</ext-link>,<ext-link ext-link-type=""pdb"" xlink:href=""2zbi"">2zbi</ext-link>,<ext-link ext-link-type=""pdb"" xlink:href=""2d4x"">2d4x</ext-link>). The beta-rich domains of flagellin are highly variable however, and it is this variable region of flagellin that shares similarity with the HCRn domain of CNTs. As a structure is not available for the variable region of CBO0798, 3D-PSSM [<xref ref-type=""bibr"" rid=""B24"">24</xref>] was used to predict the fold of CBO0798's central region. The structure for the CNT's HCRn jelly-roll domain was the top ranked structural match for this region (<italic>E</italic>= 0.34), additionally supporting homology between the two proteins.</p><p>CBO0798 is annotated in the NCBI database as a member of the flagellar hook associated protein 3 (FlgL) family. This flagellin gene has been mentioned in previous CNT studies due to its close proximity to the neurotoxin gene cluster [<xref ref-type=""bibr"" rid=""B13"">13</xref>] and its existence in numerous<italic>C. botulinum</italic>type A strains and associated plasmids [<xref ref-type=""bibr"" rid=""B25"">25</xref>]. Flagellins are also known to have key roles in the virulence of bacterial pathogens [<xref ref-type=""bibr"" rid=""B26"">26</xref>], have been shown by mass spectrometry studies to interact with CNT components [<xref ref-type=""bibr"" rid=""B27"">27</xref>], and possess previously unreported common structural features with CNTs (i.e., both contain a central region composed of extended alpha-helices followed by beta-rich domains [<xref ref-type=""bibr"" rid=""B4"">4</xref>,<xref ref-type=""bibr"" rid=""B28"">28</xref>]). These additional functional and structural links further support a potential evolutionary relationship between CBO0798 and CNTs.</p></sec><sec><title>Collagenase-like domains in the flagellin hypervariable region</title><p>Comparative sequence analysis of CBO0798 was performed by aligning CBO0798 to other flagellins from<italic>Clostridium</italic>species (Additional File<xref ref-type=""supplementary-material"" rid=""S3"">3</xref>). According to the alignment, CBO0798 has a highly divergent central region containing a unique insert (residues ~135–360), and this insert region comprises a large portion of CBO0798's alignments with CNTs. The existence of a unique central region within CBO0798 is not surprising, since flagellins are known to contain conserved regions at the N- and C-terminus but have a hypervariable central region that is structurally exposed on the flagellar surface [<xref ref-type=""bibr"" rid=""B26"">26</xref>]. As the structurally exposed region of the flagellar filament, the hypervariable region can interact with the host cell and is thus critical to flagellin-mediated virulence [<xref ref-type=""bibr"" rid=""B26"">26</xref>]. Interestingly, it is the variable region of CBO0798 that is central to the CBO0798-CNT alignments and that was predicted by 3D-PSSM to possess a jelly-roll fold similar to HCRn.</p><p>To characterize the origins of the insert, we examined similarly located inserts identified within the hypervariable region of a small number of additional flagellins from<italic>Clostridium</italic>species (Additional File<xref ref-type=""supplementary-material"" rid=""S3"">3</xref>). While the sequences within the hypervariable region are highly divergent from one another as expected, one insert in particular [the insert of FliA(H) from<italic>C. haemolyticum</italic>] was identified to be both the largest insert and the only insert region with detected homology to other proteins using PSI-BLAST. FliA(H) is a relatively close homolog of CBO0798, as FliA(H) was the only flagellin detected using CBO0798's C-terminal region (residues 114–452) as a BLAST query sequence (<italic>E</italic>= 0.076). A PSI-BLAST search revealed that the hypervariable region of FliA(H) possesses significant similarity to microbial collagenases (<italic>E</italic>= 8e-04, iteration 2) and to the hypervariable regions of several flagellins from non-clostridial species (Figure<xref ref-type=""fig"" rid=""F3"">3</xref>). Remarkably, both the detected microbial collagenases and collagenase-like regions within the identified flagellins contain a HEXXH motif, the critical catalytic residues responsible for the CNT's zinc-endopeptidase activity. The alignment of CBO0798 with collagenase-containing flagellins and alignment of the HEXXH-containing segments from these flagellins, BoNT/B, and a representative microbial collagenase are shown in Figure<xref ref-type=""fig"" rid=""F3"">3</xref>.</p><fig id=""F3"" position=""float""><label>Figure 3</label><caption><p><bold>Collagenase-like sequences within the flagellin hypervariable region</bold>. A) A multiple alignment of CBO0798 and collagenase-containing flagellins identified by PSI-BLAST. Vertical black bars in the alignment correspond to the collagenase-containing region identified by a PSI-BLAST search using<italic>C. haemolyticum</italic>FliA(H) as the query. B) A schematic of a representative collagenase-containing flagellin based on the FliA(H) sequence. An alignment of similar HEXXH-containing segments from BoNT/B, a microbial collagenase, and the collagenase-containing flagellins are shown below the schematic. Accession numbers are provided in the Methods.</p></caption><graphic xlink:href=""1471-2148-8-316-3""></graphic></fig><p>The identified link to collagenase sequences by analysis of the flagellin hypervariable region is a striking result given the strong similarities between collagenases and the CNT's Peptidase M27 domain. Both collagenases (Peptidase M9s) and Peptidase M27's are zinc-endopeptidases and are grouped under the same peptidase family (thermolysin-like Peptidase MA clan) by the MEROPS database [<xref ref-type=""bibr"" rid=""B18"">18</xref>]. As exotoxins, collagenases play a major role in clostridial toxicity by degrading collagenous host tissues [<xref ref-type=""bibr"" rid=""B29"">29</xref>,<xref ref-type=""bibr"" rid=""B30"">30</xref>]. For instance,<italic>C. perfringens</italic>, a species responsible for clostridial myonecrosis (gas gangrene), produces a tissue-degrading collagenase known as kappa-toxin [<xref ref-type=""bibr"" rid=""B30"">30</xref>]. Collagenases are therefore an excellent candidate evolutionary precursor of CNTs as both collagenases and CNTs function as clostridial toxins, and both share the same fundamental proteolytic mechanism.</p><p>As the hypervariable region encodes the outer exposed portion of the flagellin filament, it would be ideally situated to interact with (and potentially degrade) host cell wall components such as collagen. The identified sequences may therefore encode a novel family of virulent flagellins with collagenase activity. Future experimental verification of this predicted activity would be valuable, and could potentially lead to new avenues of research concerning the virulent functions of bacterial flagellins.</p></sec><sec><title>Additional evidence of collagenase-related functions within the neurotoxin gene cluster</title><p>Several additional links to collagenases and collagen-related domains were detected for other sequences present within the BoNT/A neurotoxin gene cluster. All sequenced<italic>Clostridium</italic>genomes were screened for potential homologues of each of the BoNT/A neurotoxin gene cluster components. In a dataset of over 55000 sequences, a search of BoNT/A detected flagellin as the third top ranked hit outside of the CNT family (<italic>E</italic>= 0.23). While HA33 expectedly displayed similarities with other ricin-like components (e.g., a ricin-domain from a<italic>C. acetobutylicum</italic>cellulase, NP_347343,<italic>E</italic>= 0.019), HA70 displayed the strongest similarity to<italic>C. perfringens</italic>enterotoxin (YP_697710,<italic>E</italic>= 0.0042) followed by<italic>C. tetani</italic>collagenase (NP_783761,<italic>E</italic>= 0.22). A HEXXH binding motif was also identified within this collagenase sequence. A PSI-BLAST search of flagellin CBO0798 restricted to the<italic>Clostridium</italic>genus also detected collagen-adhesion proteins with alignments spanning the hypervariable region after three iterations (<italic>E</italic>= 0.017, ZP_02635881). This result is consistent with the analysis linking CBO0798 with flagellins containing collagenase-like hypervariable regions.</p><p>Another key result was obtained when examining sequence and structural similarities between the HCRn domain and the full NCBI nr database, including eukaryotic sequences. After two iterations starting with BoNT/A's HCRn domain, PSI-BLAST detected a region of chicken type XII collagen (AAA48635,<italic>E</italic>= 0.03). The detected sequence similarity occurred with collagen's thrombospondin N-terminal like domains. Recently, the structure of this family of domains has been determined for the NC4 domain of collagen IX [<xref ref-type=""bibr"" rid=""B31"">31</xref>]. The fold of NC4 (PDB ID<ext-link ext-link-type=""pdb"" xlink:href=""2UUR"">2UUR</ext-link>) is remarkably similar to that of HCRn (Figure<xref ref-type=""fig"" rid=""F4"">4</xref>). To determine the extent of structural similarity between these two domains, we analyzed structural neighbours of the NC4 domain using the VAST structural alignment algorithm [<xref ref-type=""bibr"" rid=""B32"">32</xref>]. Sorted by VAST<italic>E</italic>-value, the two most structurally similar domains to PDB ID<ext-link ext-link-type=""pdb"" xlink:href=""2UUR"">2UUR</ext-link>were its identified fold family (PDB IDs<ext-link ext-link-type=""pdb"" xlink:href=""2ES3"">2ES3</ext-link>and<ext-link ext-link-type=""pdb"" xlink:href=""2OUJ"">2OUJ</ext-link>), the thrombospondin N-terminal domain), followed by the HCRn domain (PDB ID<ext-link ext-link-type=""pdb"" xlink:href=""1DLL"">1DLL</ext-link>) of the tetanus neurotoxin (<italic>E</italic>= 10e-9.9). Ranked by sequence similarity based on structural alignments, the tetanus HCRn domain (PDB ID<ext-link ext-link-type=""pdb"" xlink:href=""1YYN"">1YYN</ext-link>) ranked first out of all known structures in the Protein Data Bank (%ID = 17.7).</p><fig id=""F4"" position=""float""><label>Figure 4</label><caption><p><bold>Structural similarity between HCRn and the NC4 domain of collagen IX</bold>. A structural superposition of the human collagen IX NC4 domain (<ext-link ext-link-type=""pdb"" xlink:href=""2UUR"">2UUR</ext-link>) and the TeNT HCRn domain (<ext-link ext-link-type=""pdb"" xlink:href=""1YYN"">1YYN</ext-link>) was performed using the VAST alignment algorithm<ext-link ext-link-type=""uri"" xlink:href=""http://www.ncbi.nlm.nih.gov/Structure/VAST/vastsearch.html"">http://www.ncbi.nlm.nih.gov/Structure/VAST/vastsearch.html</ext-link>. In the structural alignment<ext-link ext-link-type=""pdb"" xlink:href=""2UUR"">2UUR</ext-link>and<ext-link ext-link-type=""pdb"" xlink:href=""1YYN"">1YYN</ext-link>are colored pink and blue respectively.</p></caption><graphic xlink:href=""1471-2148-8-316-4""></graphic></fig><p>As the detected similarities between the HCRn domain and the collagen NC4 domain occur across kingdoms, this may represent an instance of structural mimicry rather than a direct evolutionary relationship. Given the multiple identified links to collagenases, and that structural mimicry of collagen has been proposed as a mechanism for other collagenase enzymes [<xref ref-type=""bibr"" rid=""B33"">33</xref>], the link between HCRn and the collagen NC4 domain may be indicative of a similar mechanism. A role in collagen-binding is entirely possible for CNTs as previous studies have shown that expression of TeNT enhances adhesion of epithelial cells to collagen, laminin, and fibronectin [<xref ref-type=""bibr"" rid=""B34"">34</xref>]. While the observed similarities support the hypothesis of convergent evolution and structural mimicry, the possibility that HCRn was transferred to<italic>Clostridium</italic>from a eukaryotic source cannot be completely ruled out. This scenario has been demonstrated recently for the<italic>Clostridium</italic>glyceraldehyde-3-phosphate dehydrogenase gene [<xref ref-type=""bibr"" rid=""B35"">35</xref>].</p></sec></sec><sec sec-type=""conclusions""><title>Conclusion</title><p>A comprehensive search was conducted for potential distant homologues of CNTs, starting with a genomic analysis of<italic>C. botulinum</italic>strain A, followed by a more general search involving additional clostridial and eukaryotic species. Multiple independent links to collagenase-related sequences were identified, including the detected similarities involving the upstream flagellin gene (CBO0798) in the BoNT/A neurotoxin gene cluster, distant BLAST hits to collagenase-related domains, and detected structural similarities to the collagen NC4 domain. As microbial collagenases are phyletically widespread compared to CNTs, they represent a protein family likely to be ancestral to CNTs. Given this and the multiple detected links to collagenase-related sequences, it is proposed that the ancestral function of the neurotoxin gene cluster may have been related to collagen binding and degradation, a hypothesis that places CNT sequence, structure, and function within the broader context of other clostridial toxins and the evolution of clostridial pathogenesis.</p><p>The CBO0798 flagellin gene appears to be a divergent member of a unique class of flagellins containing a collagenase-like hypervariable domain, an ideal arrangement for the development of novel virulent functions and co-evolution with host cell walls. It is possible that repeats and rearrangements of a gene ancestral to CBO0798 may have been involved in the origin of the ancestral CNT gene. To date, the CBO0798 flagellin sequence has only been identified in a number of group I strains (see [<xref ref-type=""bibr"" rid=""B25"">25</xref>]), and identification and analysis of additional CBO0798 homologues in other strains could provide a broader context to the evolutionary relationship between flagellins, collagenases, and CNTs.</p></sec><sec sec-type=""methods""><title>Methods</title><sec><title>Sequence dataset and database searches</title><p>Botulinum neurotoxins A-G (P10845, ABM73983, BAA08418, AAB24244, CAA43999, 1904210A, CAA52275), and NTNH/A (YP_001253341) sequences were retrieved from NCBI. The flagellin and collagenase sequences used in the alignment of the HEXXH-containing segment (Figure<xref ref-type=""fig"" rid=""F3"">3</xref>) were<italic>Clostridium haemolyticum</italic>flagellin [FliA(H)], BAB87738;<italic>Pseudoalteromonas tunicata</italic>flagellin, ZP_01132756;<italic>Azoarcus</italic>BH72 flagellin, YP_934037;<italic>Desulfuromonas acetoxidans</italic>flagellin, ZP_01312630; and<italic>Burkholderia pseudomallei</italic>collagenase, ZP_01765667. The following default parameters were used in all PSI-BLAST [<xref ref-type=""bibr"" rid=""B23"">23</xref>] searches unless specified otherwise: Blosum62 matrix, Gap existence: 11, Gap Extension: 1,<italic>E</italic>-value cutoff = 0.005, with conditional compositional matrix score adjustment. The SSEARCH [<xref ref-type=""bibr"" rid=""B21"">21</xref>] program from the FASTA package (version 3.515) was used to search the<italic>C. botulinum</italic>protein database, and was obtained via the SANGER website<ext-link ext-link-type=""ftp"" xlink:href=""ftp://ftp.sanger.ac.uk/pub/pathogens/cb/"">ftp://ftp.sanger.ac.uk/pub/pathogens/cb/</ext-link>. SSEARCH was run with default parameters, except for the -z 11 flag, which computes the regression by reshuffling the target sequence library (removing the influence of homologous sequences present within the genome). For searching additional<italic>Clostridium</italic>species, the following protein sequence databases were retrieved from the NCBI FTP server:<italic>C. acetobutylicum</italic>ATCC 824,<italic>C. beijerinckii</italic>NCIMB 8052,<italic>C. botulinum</italic>A ATCC 3502,<italic>C. botulinum</italic>A ATCC 19397,<italic>C. botulinum</italic>A Hall,<italic>C. botulinum</italic>A3 Loch Maree,<italic>C. botulinum</italic>B1 Okra,<italic>C. botulinum</italic>F Langeland,<italic>C. difficile</italic>630,<italic>C. kluyveri</italic>DSM 555,<italic>C. noyvi</italic>NT,<italic>C. perfringens</italic>13,<italic>C. perfringens</italic>ATCC 131245,<italic>C. perfringens</italic>SM101,<italic>C. phytofermentans</italic>ISDg,<italic>C. tetani</italic>E88,<italic>C. thermocellum</italic>ATCC 27405.</p></sec><sec><title>Construction of sequence similarity heat map</title><p>A perl program was written to generate a 2D sequence similarity matrix based on all-against-all Smith-Waterman alignment scores using 3615 sequences from the<italic>C. botulinum</italic>protein database. Proteins were ranked by<italic>E</italic>-values computed by the SSEARCH program with default parameters. The matrix consists of query sequences on the Y-axis, target database proteins on the X-axis, and data values correspond to percentile ranks. This approach was used to detect distant pairwise similarities within gene clusters that may reflect ancient gene duplication blocks. The matrix was visualized using Treeview version 1.1.1<ext-link ext-link-type=""uri"" xlink:href=""http://rana.lbl.gov/EisenSoftware.htm"">http://rana.lbl.gov/EisenSoftware.htm</ext-link>.</p></sec><sec><title>Permutation testing</title><p>The PRSS component of the FASTA package [<xref ref-type=""bibr"" rid=""B21"">21</xref>] was used for sequence reshuffling and the permutation test. The permutation reshuffling test calculates the optimal Smith-Waterman alignments of the first query sequence with N reshuffled versions of the second query sequence. The alignment score of the unshuffled sequences is compared to the distribution of scores obtained using the reshuffled query sequence, which is fit to an extreme value distribution. From this distribution, the probability that the observed alignment score could have resulted from a random sequence of the same composition is estimated. Default parameters were used and 1000 reshuffled sequences were used to generate the random distribution of alignment scores.</p><p>To detect potential compositional bias, the composition of CNTs and CBO0798 was analyzed relative to all protein sequences in<italic>C. botulinum</italic>strain A as a reference. One amino acid type, asparagine, was found to be significantly elevated in both CBO0798 and CNT sequences (Z &gt; 2 standard deviations). To verify that PSI-BLAST hits from CBO0798 to CNTs sequences were not due to composition, all asparagine residues were removed from CBO0798 and the top-scoring alignment detected via PSI-BLAST (<italic>C. butyricum</italic>BoNT/E), and permutation reshuffling tests were repeated using the altered sequences.</p></sec></sec><sec><title>Authors' contributions</title><p>A.C.D. designed and performed the analysis and wrote the paper. B.J.M. designed the analysis and co-wrote the paper. E.M.M., M.D.J.L. and K.M.M. assisted with analysis and preparation of the manuscript.</p></sec><sec sec-type=""supplementary-material""><title>Supplementary Material</title><supplementary-material content-type=""local-data"" id=""S1""><caption><title>Additional file 1</title><p><bold>Detected sequence similarities between CBO0798 (flagellin) and CNT sequences.</bold>SSEARCH was used to screen the<italic>C. botulinum</italic>A protein database (3615 sequences) plus the target CNTs using default parameters.<italic>E</italic>-values were calculated within SSEARCH using randomly reshuffled copies of the library sequences, as described in Methods. CBO0798's rank relative to all 3615<italic>C. botulinum</italic>proteins, associated E-value, and the alignment regions are reported for nine search cases (BoNT/A-G, TeNT, and NTNHA). The flagellin aligned to two separate regions in the CNTs, suggesting an ancestral duplication.</p></caption><media mime-subtype=""pdf"" mimetype=""application"" xlink:href=""1471-2148-8-316-S1.pdf""><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type=""local-data"" id=""S2""><caption><title>Additional file 2</title><p><bold>Key alignments between CBO0798 and CNTs produced by SSEARCH and PSI-BLAST.</bold>Smith-Waterman alignments between BoNT/A-CBO0798 and NTNH-CBO0798 were performed using SSEARCH (default parameters used with -z 11 flag). The listed<italic>E</italic>-values are based on a single pairwise alignment of both sequences rather than a database search. The alignment between CBO0798 and BoNT/E from<italic>C. butyricum</italic>is the result of a PSI-BLAST search of CBO0798 (restricted to<italic>Clostridia</italic>) using default parameters with composition-based statistics.</p></caption><media mime-subtype=""pdf"" mimetype=""application"" xlink:href=""1471-2148-8-316-S2.pdf""><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type=""local-data"" id=""S3""><caption><title>Additional file 3</title><p><bold>Multiple alignment of clostridial flagellins.</bold>The N- and C-terminal domains are indicated, and the intermediate section represents the flagellin hypervariable region. The collagenase-like insert identified within the hypervariable region of FliA(H) is boxed in red. CBO0798 is underlined in black. Additional clostridial flagellins containing large hypervariable region inserts are grouped with CBO0798 and FliA(H) at the beginning of the alignment.</p></caption><media mime-subtype=""pdf"" mimetype=""application"" xlink:href=""1471-2148-8-316-S3.pdf""><caption><p>Click here for file</p></caption></media></supplementary-material></sec><back><sec><title>Acknowledgements</title><p>This work was supported by grants from the National Science and Engineering Research Council (NSERC) to B.J.M., K.M.M., and E.M.M., and Ontario Early Researcher Awards (ERA) to B.J.M. and K.M.M. A.C.D. is a recipient of an NSERC Canada Graduate Scholarship and M.D.J.L. is a recipient of an Ontario Graduate Scholarship (OGS).</p></sec><ref-list><ref id=""B1""><mixed-citation publication-type=""journal""><name><surname>Montecucco</surname><given-names>C</given-names></name><name><surname>Molgo</surname><given-names>J</given-names></name><article-title>Botulinal neurotoxins: revival of an old killer</article-title><source>Curr Opin Pharmacol</source><year>2005</year><volume>5</volume><fpage>274</fpage><lpage>279</lpage><pub-id pub-id-type=""doi"">10.1016/j.coph.2004.12.006</pub-id><pub-id pub-id-type=""pmid"">15907915</pub-id></mixed-citation></ref><ref id=""B2""><mixed-citation publication-type=""journal""><name><surname>Simpson</surname><given-names>LL</given-names></name><article-title>Kinetic studies on the interaction between botulinum toxin type A and the cholinergic neuromuscular junction</article-title><source>J Pharmacol Exp Ther</source><year>1980</year><volume>212</volume><fpage>16</fpage><lpage>21</lpage><pub-id pub-id-type=""pmid"">6243359</pub-id></mixed-citation></ref><ref id=""B3""><mixed-citation publication-type=""journal""><name><surname>Blasi</surname><given-names>J</given-names></name><name><surname>Chapman</surname><given-names>ER</given-names></name><name><surname>Link</surname><given-names>E</given-names></name><name><surname>Binz</surname><given-names>T</given-names></name><name><surname>Yamasaki</surname><given-names>S</given-names></name><name><surname>De Camilli</surname><given-names>P</given-names></name><name><surname>Südhof</surname><given-names>TC</given-names></name><name><surname>Niemann</surname><given-names>H</given-names></name><name><surname>Jahn</surname><given-names>R</given-names></name><article-title>Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25</article-title><source>Nature</source><year>1993</year><volume>365</volume><fpage>160</fpage><lpage>163</lpage><pub-id pub-id-type=""doi"">10.1038/365160a0</pub-id><pub-id pub-id-type=""pmid"">8103915</pub-id></mixed-citation></ref><ref id=""B4""><mixed-citation publication-type=""journal""><name><surname>Lacy</surname><given-names>DB</given-names></name><name><surname>Tepp</surname><given-names>W</given-names></name><name><surname>Cohen</surname><given-names>AC</given-names></name><name><surname>DasGupta</surname><given-names>BR</given-names></name><name><surname>Stevens</surname><given-names>RC</given-names></name><article-title>Crystal structure of botulinum neurotoxin type A and implications for toxicity</article-title><source>Nat Struct Biol</source><year>1998</year><volume>5</volume><fpage>898</fpage><lpage>902</lpage><pub-id pub-id-type=""doi"">10.1038/2338</pub-id><pub-id pub-id-type=""pmid"">9783750</pub-id></mixed-citation></ref><ref id=""B5""><mixed-citation publication-type=""journal""><name><surname>Hanson</surname><given-names>MA</given-names></name><name><surname>Stevens</surname><given-names>RC</given-names></name><article-title>Cocrystal structure of synaptobrevin-II bound to botulinum neurotoxin type B at 2.0 A resolution</article-title><source>Nat Struct Biol</source><year>2000</year><volume>7</volume><fpage>687</fpage><lpage>692</lpage><pub-id pub-id-type=""doi"">10.1038/77997</pub-id><pub-id pub-id-type=""pmid"">10932255</pub-id></mixed-citation></ref><ref id=""B6""><mixed-citation publication-type=""journal""><name><surname>Swaminathan</surname><given-names>S</given-names></name><name><surname>Eswaramoorthy</surname><given-names>S</given-names></name><article-title>Structural analysis of the catalytic and binding sites of<italic>Clostridium botulinum</italic>neurotoxin B</article-title><source>Nat Struct Biol</source><year>2000</year><volume>7</volume><fpage>693</fpage><lpage>699</lpage><pub-id pub-id-type=""doi"">10.1038/78005</pub-id><pub-id pub-id-type=""pmid"">10932256</pub-id></mixed-citation></ref><ref id=""B7""><mixed-citation publication-type=""journal""><name><surname>Dong</surname><given-names>M</given-names></name><name><surname>Yeh</surname><given-names>F</given-names></name><name><surname>Tepp</surname><given-names>WH</given-names></name><name><surname>Dean</surname><given-names>C</given-names></name><name><surname>Johnson</surname><given-names>EA</given-names></name><name><surname>Janz</surname><given-names>R</given-names></name><name><surname>Chapman</surname><given-names>ER</given-names></name><article-title>SV2 Is the Protein Receptor For Botulinum Neurotoxin A</article-title><source>Science</source><year>2006</year><volume>312</volume><fpage>592</fpage><lpage>596</lpage><pub-id pub-id-type=""doi"">10.1126/science.1123654</pub-id><pub-id pub-id-type=""pmid"">16543415</pub-id></mixed-citation></ref><ref id=""B8""><mixed-citation publication-type=""journal""><name><surname>Jin</surname><given-names>R</given-names></name><name><surname>Rummel</surname><given-names>A</given-names></name><name><surname>Binz</surname><given-names>T</given-names></name><name><surname>Brunger</surname><given-names>AT</given-names></name><article-title>Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity</article-title><source>Nature</source><year>2006</year><volume>444</volume><fpage>1092</fpage><lpage>1095</lpage><pub-id pub-id-type=""doi"">10.1038/nature05387</pub-id><pub-id pub-id-type=""pmid"">17167421</pub-id></mixed-citation></ref><ref id=""B9""><mixed-citation publication-type=""journal""><name><surname>Chai</surname><given-names>Q</given-names></name><name><surname>Arndt</surname><given-names>JW</given-names></name><name><surname>Dong</surname><given-names>M</given-names></name><name><surname>Tepp</surname><given-names>WH</given-names></name><name><surname>Johnson</surname><given-names>EA</given-names></name><name><surname>Chapman</surname><given-names>ER</given-names></name><name><surname>Stevens</surname><given-names>RC</given-names></name><article-title>Structural basis of cell surface receptor recognition by botulinum neurotoxin B</article-title><source>Nature</source><year>2006</year><volume>444</volume><fpage>1096</fpage><lpage>1100</lpage><pub-id pub-id-type=""doi"">10.1038/nature05411</pub-id><pub-id pub-id-type=""pmid"">17167418</pub-id></mixed-citation></ref><ref id=""B10""><mixed-citation publication-type=""journal""><name><surname>Collins</surname><given-names>MD</given-names></name><name><surname>East</surname><given-names>AK</given-names></name><article-title>Phylogeny and taxonomy of the food-borne pathogen<italic>Clostridium botulinum</italic>and its neurotoxins</article-title><source>J Appl Microbiol</source><year>1998</year><volume>84</volume><fpage>5</fpage><lpage>17</lpage><pub-id pub-id-type=""doi"">10.1046/j.1365-2672.1997.00313.x</pub-id><pub-id pub-id-type=""pmid"">15244052</pub-id></mixed-citation></ref><ref id=""B11""><mixed-citation publication-type=""journal""><name><surname>Jacobson</surname><given-names>MJ</given-names></name><name><surname>Lin</surname><given-names>G</given-names></name><name><surname>Raphael</surname><given-names>B</given-names></name><name><surname>Andreadis</surname><given-names>J</given-names></name><name><surname>Johnson</surname><given-names>EA</given-names></name><article-title>Analysis of neurotoxin cluster genes in<italic>Clostridium botulinum</italic>strains producing botulinum neurotoxin serotype A subtypes</article-title><source>Appl Environ Microbiol</source><year>2008</year><volume>74</volume><fpage>2778</fpage><lpage>2786</lpage><pub-id pub-id-type=""doi"">10.1128/AEM.02828-07</pub-id><pub-id pub-id-type=""pmid"">18326685</pub-id></mixed-citation></ref><ref id=""B12""><mixed-citation publication-type=""journal""><name><surname>Marshall</surname><given-names>KM</given-names></name><name><surname>Bradshaw</surname><given-names>M</given-names></name><name><surname>Pellett</surname><given-names>S</given-names></name><name><surname>Johnson</surname><given-names>EA</given-names></name><article-title>Plasmid encoded neurotoxin genes in<italic>Clostridium botulinum</italic>serotype A subtypes</article-title><source>Biochem Biophys Res Commun</source><year>2007</year><volume>361</volume><fpage>49</fpage><lpage>54</lpage><pub-id pub-id-type=""doi"">10.1016/j.bbrc.2007.06.166</pub-id><pub-id pub-id-type=""pmid"">17658467</pub-id></mixed-citation></ref><ref id=""B13""><mixed-citation publication-type=""journal""><name><surname>Dineen</surname><given-names>SS</given-names></name><name><surname>Bradshaw</surname><given-names>M</given-names></name><name><surname>Johnson</surname><given-names>EA</given-names></name><article-title>Neurotoxin gene clusters in<italic>Clostridium botulinum</italic>type A strains: sequence comparison and evolutionary implications</article-title><source>Curr Microbiol</source><year>2003</year><volume>46</volume><fpage>345</fpage><lpage>352</lpage><pub-id pub-id-type=""doi"">10.1007/s00284-002-3851-1</pub-id><pub-id pub-id-type=""pmid"">12732962</pub-id></mixed-citation></ref><ref id=""B14""><mixed-citation publication-type=""journal""><name><surname>Murzin</surname><given-names>AG</given-names></name><name><surname>Brenner</surname><given-names>SE</given-names></name><name><surname>Hubbard</surname><given-names>T</given-names></name><name><surname>Chothia</surname><given-names>C</given-names></name><article-title>SCOP: a structural classification of proteins database for the investigation of sequences and structures</article-title><source>J Mol Biol</source><year>1995</year><volume>247</volume><fpage>536</fpage><lpage>540</lpage><pub-id pub-id-type=""pmid"">7723011</pub-id></mixed-citation></ref><ref id=""B15""><mixed-citation publication-type=""journal""><name><surname>Finn</surname><given-names>RD</given-names></name><name><surname>Mistry</surname><given-names>J</given-names></name><name><surname>Schuster-Böckler</surname><given-names>B</given-names></name><name><surname>Griffiths-Jones</surname><given-names>S</given-names></name><name><surname>Hollich</surname><given-names>V</given-names></name><name><surname>Lassmann</surname><given-names>T</given-names></name><name><surname>Moxon</surname><given-names>S</given-names></name><name><surname>Marshall</surname><given-names>M</given-names></name><name><surname>Khanna</surname><given-names>A</given-names></name><name><surname>Durbin</surname><given-names>R</given-names></name><name><surname>Eddy</surname><given-names>SR</given-names></name><name><surname>Sonnhammer</surname><given-names>EL</given-names></name><name><surname>Bateman</surname><given-names>A</given-names></name><article-title>Pfam: clans, web tools and services</article-title><source>Nucleic Acids Res</source><year>2006</year><volume>34</volume><fpage>D247</fpage><lpage>D251</lpage><pub-id pub-id-type=""doi"">10.1093/nar/gkj149</pub-id><pub-id pub-id-type=""pmid"">16381856</pub-id></mixed-citation></ref><ref id=""B16""><mixed-citation publication-type=""journal""><name><surname>Murzin</surname><given-names>AG</given-names></name><name><surname>Lesk</surname><given-names>AM</given-names></name><name><surname>Chothia</surname><given-names>C</given-names></name><article-title>beta-Trefoil fold. Patterns of structure and sequence in the Kunitz inhibitors interleukins-1 beta and 1 alpha and fibroblast growth factors</article-title><source>J Mol Biol</source><year>1992</year><volume>223</volume><fpage>531</fpage><lpage>543</lpage><pub-id pub-id-type=""doi"">10.1016/0022-2836(92)90668-A</pub-id><pub-id pub-id-type=""pmid"">1738162</pub-id></mixed-citation></ref><ref id=""B17""><mixed-citation publication-type=""journal""><name><surname>Wiener</surname><given-names>M</given-names></name><name><surname>Freymann</surname><given-names>D</given-names></name><name><surname>Ghosh</surname><given-names>P</given-names></name><name><surname>Stroud</surname><given-names>RM</given-names></name><article-title>Crystal structure of colicin Ia</article-title><source>Nature</source><year>1997</year><volume>385</volume><fpage>461</fpage><lpage>464</lpage><pub-id pub-id-type=""doi"">10.1038/385461a0</pub-id><pub-id pub-id-type=""pmid"">9009197</pub-id></mixed-citation></ref><ref id=""B18""><mixed-citation publication-type=""journal""><name><surname>Rawlings</surname><given-names>ND</given-names></name><name><surname>Morton</surname><given-names>FR</given-names></name><name><surname>Barrett</surname><given-names>AJ</given-names></name><article-title>MEROPS: the peptidase database</article-title><source>Nucleic Acids Res</source><year>2006</year><volume>34</volume><fpage>D270</fpage><lpage>D272</lpage><pub-id pub-id-type=""doi"">10.1093/nar/gkj089</pub-id><pub-id pub-id-type=""pmid"">16381862</pub-id></mixed-citation></ref><ref id=""B19""><mixed-citation publication-type=""journal""><name><surname>de Maagd</surname><given-names>RA</given-names></name><name><surname>Bravo</surname><given-names>A</given-names></name><name><surname>Berry</surname><given-names>C</given-names></name><name><surname>Crickmore</surname><given-names>N</given-names></name><name><surname>Schnepf</surname><given-names>HE</given-names></name><article-title>Structure, diversity, and evolution of protein toxins from spore-forming entomopathogenic bacteria</article-title><source>Annu Rev Genet</source><year>2003</year><volume>37</volume><fpage>409</fpage><lpage>433</lpage><pub-id pub-id-type=""doi"">10.1146/annurev.genet.37.110801.143042</pub-id><pub-id pub-id-type=""pmid"">14616068</pub-id></mixed-citation></ref><ref id=""B20""><mixed-citation publication-type=""journal""><name><surname>Sebaihia</surname><given-names>M</given-names></name><name><surname>Peck</surname><given-names>MW</given-names></name><name><surname>Minton</surname><given-names>NP</given-names></name><name><surname>Thomson</surname><given-names>NR</given-names></name><name><surname>Holden</surname><given-names>MT</given-names></name><name><surname>Mitchell</surname><given-names>WJ</given-names></name><name><surname>Carter</surname><given-names>AT</given-names></name><name><surname>Bentley</surname><given-names>SD</given-names></name><name><surname>Mason</surname><given-names>DR</given-names></name><name><surname>Crossman</surname><given-names>L</given-names></name><name><surname>Paul</surname><given-names>CJ</given-names></name><name><surname>Ivens</surname><given-names>A</given-names></name><name><surname>Wells-Bennik</surname><given-names>MH</given-names></name><name><surname>Davis</surname><given-names>IJ</given-names></name><name><surname>Cerdeño-Tárraga</surname><given-names>AM</given-names></name><name><surname>Churcher</surname><given-names>C</given-names></name><name><surname>Quail</surname><given-names>MA</given-names></name><name><surname>Chillingworth</surname><given-names>T</given-names></name><name><surname>Feltwell</surname><given-names>T</given-names></name><name><surname>Fraser</surname><given-names>A</given-names></name><name><surname>Goodhead</surname><given-names>I</given-names></name><name><surname>Hance</surname><given-names>Z</given-names></name><name><surname>Jagels</surname><given-names>K</given-names></name><name><surname>Larke</surname><given-names>N</given-names></name><name><surname>Maddison</surname><given-names>M</given-names></name><name><surname>Moule</surname><given-names>S</given-names></name><name><surname>Mungall</surname><given-names>K</given-names></name><name><surname>Norbertczak</surname><given-names>H</given-names></name><name><surname>Rabbinowitsch</surname><given-names>E</given-names></name><name><surname>Sanders</surname><given-names>M</given-names></name><name><surname>Simmonds</surname><given-names>M</given-names></name><name><surname>White</surname><given-names>B</given-names></name><name><surname>Whithead</surname><given-names>S</given-names></name><name><surname>Parkhill</surname><given-names>J</given-names></name><article-title>Genome sequence of a proteolytic (Group I)<italic>Clostridium botulinum</italic>strain Hall A and comparative analysis of the clostridial genomes</article-title><source>Genome Res</source><year>2001</year><volume>17</volume><fpage>1082</fpage><lpage>1092</lpage><pub-id pub-id-type=""doi"">10.1101/gr.6282807</pub-id><pub-id pub-id-type=""pmid"">17519437</pub-id></mixed-citation></ref><ref id=""B21""><mixed-citation publication-type=""journal""><name><surname>Pearson</surname><given-names>WR</given-names></name><name><surname>Lipman</surname><given-names>DJ</given-names></name><article-title>Improved tools for biological sequence comparison</article-title><source>Proc Natl Acad Sci USA</source><year>1988</year><volume>85</volume><fpage>2444</fpage><lpage>2448</lpage><pub-id pub-id-type=""doi"">10.1073/pnas.85.8.2444</pub-id><pub-id pub-id-type=""pmid"">3162770</pub-id></mixed-citation></ref><ref id=""B22""><mixed-citation publication-type=""journal""><name><surname>Arndt</surname><given-names>JW</given-names></name><name><surname>Gu</surname><given-names>J</given-names></name><name><surname>Jaroszewski</surname><given-names>L</given-names></name><name><surname>Schwarzenbacher</surname><given-names>R</given-names></name><name><surname>Hanson</surname><given-names>MA</given-names></name><name><surname>Lebeda</surname><given-names>FJ</given-names></name><name><surname>Stevens</surname><given-names>RC</given-names></name><article-title>The structure of the neurotoxin-associated protein HA33/A from<italic>Clostridium botulinum</italic>suggests a reoccurring beta-trefoil fold in the progenitor toxin complex</article-title><source>J Mol Biol</source><year>2005</year><volume>346</volume><fpage>1083</fpage><lpage>1093</lpage><pub-id pub-id-type=""doi"">10.1016/j.jmb.2004.12.039</pub-id><pub-id pub-id-type=""pmid"">15701519</pub-id></mixed-citation></ref><ref id=""B23""><mixed-citation publication-type=""journal""><name><surname>Altschul</surname><given-names>SF</given-names></name><name><surname>Madden</surname><given-names>TL</given-names></name><name><surname>Schäffer</surname><given-names>AA</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Miller</surname><given-names>W</given-names></name><name><surname>Lipman</surname><given-names>DJ</given-names></name><article-title>Gapped BLAST and PSI-BLAST: a new generation of protein database search programs</article-title><source>Nucleic Acids Res</source><year>1997</year><volume>25</volume><fpage>3389</fpage><lpage>3402</lpage><pub-id pub-id-type=""doi"">10.1093/nar/25.17.3389</pub-id><pub-id pub-id-type=""pmid"">9254694</pub-id></mixed-citation></ref><ref id=""B24""><mixed-citation publication-type=""journal""><name><surname>Fischer</surname><given-names>D</given-names></name><name><surname>Barret</surname><given-names>C</given-names></name><name><surname>Bryson</surname><given-names>K</given-names></name><name><surname>Elofsson</surname><given-names>A</given-names></name><name><surname>Godzik</surname><given-names>A</given-names></name><name><surname>Jones</surname><given-names>D</given-names></name><name><surname>Karplus</surname><given-names>KJ</given-names></name><name><surname>Kelley</surname><given-names>LA</given-names></name><name><surname>MacCallum</surname><given-names>RM</given-names></name><name><surname>Pawowski</surname><given-names>K</given-names></name><name><surname>Rost</surname><given-names>B</given-names></name><name><surname>Rychlewski</surname><given-names>L</given-names></name><name><surname>Sternberg</surname><given-names>M</given-names></name><article-title>CAFASP-1: critical assessment of fully automated structure prediction methods</article-title><source>Proteins</source><year>1999</year><volume>3</volume><fpage>209</fpage><lpage>217</lpage><pub-id pub-id-type=""doi"">10.1002/(SICI)1097-0134(1999)37:3+&lt;209::AID-PROT27&gt;3.0.CO;2-Y</pub-id><pub-id pub-id-type=""pmid"">10526371</pub-id></mixed-citation></ref><ref id=""B25""><mixed-citation publication-type=""journal""><name><surname>Smith</surname><given-names>TJ</given-names></name><name><surname>Hill</surname><given-names>KK</given-names></name><name><surname>Foley</surname><given-names>BT</given-names></name><name><surname>Detter</surname><given-names>JC</given-names></name><name><surname>Munk</surname><given-names>AC</given-names></name><name><surname>Bruce</surname><given-names>DC</given-names></name><name><surname>Doggett</surname><given-names>NA</given-names></name><name><surname>Smith</surname><given-names>LA</given-names></name><name><surname>Marks</surname><given-names>JD</given-names></name><name><surname>Xie</surname><given-names>G</given-names></name><name><surname>Brettin</surname><given-names>TS</given-names></name><article-title>Analysis of the Neurotoxin Complex Genes in<italic>Clostridium botulinum</italic>A1–A4 and B1 Strains: BoNT/A3, /Ba4 and /B1 Clusters Are Located within Plasmids</article-title><source>PLoS ONE</source><year>2007</year><volume>2</volume><fpage>e1271</fpage><pub-id pub-id-type=""doi"">10.1371/journal.pone.0001271</pub-id><pub-id pub-id-type=""pmid"">18060065</pub-id></mixed-citation></ref><ref id=""B26""><mixed-citation publication-type=""journal""><name><surname>Ramos</surname><given-names>HC</given-names></name><name><surname>Rumbo</surname><given-names>M</given-names></name><name><surname>Sirard</surname><given-names>JC</given-names></name><article-title>Bacterial flagellins: mediators of pathogenicity and host immune responses in mucosa</article-title><source>Trends Microbiol</source><year>2004</year><volume>12</volume><fpage>509</fpage><lpage>517</lpage><pub-id pub-id-type=""doi"">10.1016/j.tim.2004.09.002</pub-id><pub-id pub-id-type=""pmid"">15488392</pub-id></mixed-citation></ref><ref id=""B27""><mixed-citation publication-type=""journal""><name><surname>Hines</surname><given-names>HB</given-names></name><name><surname>Lebeda</surname><given-names>F</given-names></name><name><surname>Hale</surname><given-names>M</given-names></name><name><surname>Brueggemann</surname><given-names>EE</given-names></name><article-title>Characterization of botulinum progenitor toxins by mass spectrometry</article-title><source>Appl Environ Microbiol</source><year>2005</year><volume>71</volume><fpage>4478</fpage><lpage>4486</lpage><pub-id pub-id-type=""doi"">10.1128/AEM.71.8.4478-4486.2005</pub-id><pub-id pub-id-type=""pmid"">16085839</pub-id></mixed-citation></ref><ref id=""B28""><mixed-citation publication-type=""journal""><name><surname>Samatey</surname><given-names>FA</given-names></name><name><surname>Imada</surname><given-names>K</given-names></name><name><surname>Nagashima</surname><given-names>S</given-names></name><name><surname>Vonderviszt</surname><given-names>F</given-names></name><name><surname>Kumasaka</surname><given-names>T</given-names></name><name><surname>Yamamoto</surname><given-names>M</given-names></name><name><surname>Namba</surname><given-names>K</given-names></name><article-title>Structure of the bacterial flagellar protofilament and implications for a switch for supercoiling</article-title><source>Nature</source><year>2001</year><volume>410</volume><fpage>331</fpage><lpage>337</lpage><pub-id pub-id-type=""doi"">10.1038/35066504</pub-id><pub-id pub-id-type=""pmid"">11268201</pub-id></mixed-citation></ref><ref id=""B29""><mixed-citation publication-type=""journal""><name><surname>Hatheway</surname><given-names>CL</given-names></name><article-title>Toxigenic Clostridia</article-title><source>Clin Microbiol Rev</source><year>1990</year><volume>3</volume><fpage>66</fpage><lpage>98</lpage><pub-id pub-id-type=""pmid"">2404569</pub-id></mixed-citation></ref><ref id=""B30""><mixed-citation publication-type=""journal""><name><surname>Harrington</surname><given-names>DJ</given-names></name><article-title>Bacterial collagenases and collagen-degrading enzymes and their potential role in human disease</article-title><source>Infect Immun</source><year>1996</year><volume>64</volume><fpage>1885</fpage><lpage>9</lpage><pub-id pub-id-type=""pmid"">8675283</pub-id></mixed-citation></ref><ref id=""B31""><mixed-citation publication-type=""journal""><name><surname>Leppänen</surname><given-names>VM</given-names></name><name><surname>Tossavainen</surname><given-names>H</given-names></name><name><surname>Permi</surname><given-names>P</given-names></name><name><surname>Lehtiö</surname><given-names>L</given-names></name><name><surname>Rönnholm</surname><given-names>G</given-names></name><name><surname>Goldman</surname><given-names>A</given-names></name><name><surname>Kilpelaïnen</surname><given-names>I</given-names></name><name><surname>Pihlajamaa</surname><given-names>T</given-names></name><article-title>Crystal structure of the N-terminal NC4 domain of collagen IX, a zinc binding member of the laminin-neurexin-sex hormone binding globulin (LNS) domain family</article-title><source>J Biol Chem</source><year>2007</year><volume>282</volume><fpage>23219</fpage><lpage>23230</lpage><pub-id pub-id-type=""doi"">10.1074/jbc.M702514200</pub-id><pub-id pub-id-type=""pmid"">17553797</pub-id></mixed-citation></ref><ref id=""B32""><mixed-citation publication-type=""journal""><name><surname>Gibrat</surname><given-names>JF</given-names></name><name><surname>Madej</surname><given-names>T</given-names></name><name><surname>Bryant</surname><given-names>SH</given-names></name><article-title>Surprising similarities in structure comparison</article-title><source>Curr Opin Struct Biol</source><year>1996</year><volume>6</volume><fpage>377</fpage><lpage>385</lpage><pub-id pub-id-type=""doi"">10.1016/S0959-440X(96)80058-3</pub-id><pub-id pub-id-type=""pmid"">8804824</pub-id></mixed-citation></ref><ref id=""B33""><mixed-citation publication-type=""journal""><name><surname>De Souza</surname><given-names>SJ</given-names></name><name><surname>Pereira</surname><given-names>HM</given-names></name><name><surname>Jacchieri</surname><given-names>S</given-names></name><name><surname>Brentani</surname><given-names>RR</given-names></name><article-title>Collagen/collagenase interaction: does the enzyme mimic the conformation of its own substrate?</article-title><source>FASEB J</source><year>1996</year><volume>10</volume><fpage>927</fpage><lpage>930</lpage><pub-id pub-id-type=""pmid"">8666171</pub-id></mixed-citation></ref><ref id=""B34""><mixed-citation publication-type=""journal""><name><surname>Proux-Gillardeaux</surname><given-names>V</given-names></name><name><surname>Gavard</surname><given-names>J</given-names></name><name><surname>Irinopoulou</surname><given-names>T</given-names></name><name><surname>Mège</surname><given-names>RM</given-names></name><name><surname>Galli</surname><given-names>T</given-names></name><article-title>Tetanus neurotoxin-mediated cleavage of cellubrevin impairs epithelial cell migration and integrin-dependent cell adhesion</article-title><source>Proc Natl Acad Sci USA</source><year>2005</year><volume>102</volume><fpage>6362</fpage><lpage>7</lpage><pub-id pub-id-type=""doi"">10.1073/pnas.0409613102</pub-id><pub-id pub-id-type=""pmid"">15851685</pub-id></mixed-citation></ref><ref id=""B35""><mixed-citation publication-type=""other""><name><surname>Takishita</surname><given-names>K</given-names></name><name><surname>Inagaki</surname><given-names>Y</given-names></name><article-title>Eukaryotic origin of glyceraldehyde-3-phosphate dehydrogenase genes in<italic>Clostridium thermocellum</italic>and<italic>Clostridium cellulolyticum</italic>genomes and putative fates of the exogenous gene in the subsequent genome evolution</article-title><source>Gene</source><comment>in press [<italic>2008, Mar 10, doi:10.1016/j.gene.2008.03.001</italic>]</comment></mixed-citation></ref></ref-list>"
10.1213/01.ane.0000221167.58135.3d	"<html><body><p>(PDF 92 KB)</p></body><back><glossary><title>Abbreviations</title><def-list><def-list><def-item><term>RBC</term><def><p>Red blood cell</p></def></def-item><def-item><term>OPCAB</term><def><p>Off-pump coronary artery bypass</p></def></def-item><def-item><term>MACCE</term><def><p>Major adverse cardiovascular and cerebral event</p></def></def-item><def-item><term>ICU</term><def><p>Intensive care unit</p></def></def-item><def-item><term>CABG</term><def><p>Coronary artery bypass grafting.</p></def></def-item></def-list></def-list></glossary><fn-group><fn><p><bold>Competing interests</bold></p><p>The authors declare that they have no competing interests.</p></fn><fn><p><bold>Authors’ contributions</bold></p><p>YJ, JJM, KSH, DMH designed and coordinated the study. YJ, JJM, JYB, HYH, KBK, KSH collected patient data. YJ, DMH, JJM, JYB, TKK analyzed the data. JJM, JYB, TKK prepared manuscript and submitted article. YJ, HYH, KBK, DMH, KSH contributed to data interpretation and revision of the manuscript. YJ was the principal investigator and the cardiothoracic anesthesiologist. All authors have seen and approved the final version of the manuscript.</p></fn></fn-group><ack><title>Acknowledgements</title><p>The authors thank to the Medical Research Collaborating Center (MRCC) of Seoul National University Hospital for the statistical assistance and supervision.</p></ack><ref-list id=""Bib1""><title>References</title><ref id=""CR1""><label>1.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Kim-Shapiro</surname><given-names>DB</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Gladwin</surname><given-names>MT</given-names></name></person-group><article-title>Storage lesion: role of red blood cell breakdown</article-title><source>Transfusion</source><year>2011</year><volume>51</volume><issue>4</issue><fpage>844</fpage><lpage>851</lpage><pub-id pub-id-type=""doi"">10.1111/j.1537-2995.2011.03100.x</pub-id><pub-id pub-id-type=""pmid"">21496045</pub-id></element-citation></ref><ref id=""CR2""><label>2.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Doctor</surname><given-names>A</given-names></name><name><surname>Spinella</surname><given-names>P</given-names></name></person-group><article-title>Effect of processing and storage on red blood cell function in vivo</article-title><source>Semin Perinatol</source><year>2012</year><volume>36</volume><issue>4</issue><fpage>248</fpage><lpage>259</lpage><pub-id pub-id-type=""doi"">10.1053/j.semperi.2012.04.005</pub-id><pub-id pub-id-type=""pmid"">22818545</pub-id></element-citation></ref><ref id=""CR3""><label>3.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Roback</surname><given-names>JD</given-names></name></person-group><article-title>Vascular effects of the red blood cell storage lesion</article-title><source>Hematology Am Soc Hematol Educ Program</source><year>2011</year><volume>2011</volume><fpage>475</fpage><lpage>479</lpage><pub-id pub-id-type=""doi"">10.1182/asheducation-2011.1.475</pub-id><pub-id pub-id-type=""pmid"">22160077</pub-id></element-citation></ref><ref id=""CR4""><label>4.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Van de Watering</surname><given-names>L</given-names></name></person-group><article-title>Red cell storage and prognosis</article-title><source>Vox Sang</source><year>2011</year><volume>100</volume><issue>1</issue><fpage>36</fpage><lpage>45</lpage><pub-id pub-id-type=""doi"">10.1111/j.1423-0410.2010.01441.x</pub-id><pub-id pub-id-type=""pmid"">21175654</pub-id></element-citation></ref><ref id=""CR5""><label>5.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Van de Watering</surname><given-names>L</given-names></name><name><surname>Lorinser</surname><given-names>J</given-names></name><name><surname>Versteegh</surname><given-names>M</given-names></name><name><surname>Westendord</surname><given-names>R</given-names></name><name><surname>Brand</surname><given-names>A</given-names></name></person-group><article-title>Effects of storage time of red blood cell transfusions on the prognosis of coronary artery bypass graft patients</article-title><source>Transfusion</source><year>2006</year><volume>46</volume><issue>10</issue><fpage>1712</fpage><lpage>1718</lpage><pub-id pub-id-type=""doi"">10.1111/j.1537-2995.2006.00958.x</pub-id><pub-id pub-id-type=""pmid"">17002627</pub-id></element-citation></ref><ref id=""CR6""><label>6.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>McKenny</surname><given-names>M</given-names></name><name><surname>Ryan</surname><given-names>T</given-names></name><name><surname>Tate</surname><given-names>H</given-names></name><name><surname>Graham</surname><given-names>B</given-names></name><name><surname>Young</surname><given-names>VK</given-names></name><name><surname>Dowd</surname><given-names>N</given-names></name></person-group><article-title>Age of transfused blood is not associated with increased postoperative adverse outcome after cardiac surgery</article-title><source>Br J Anaesth</source><year>2011</year><volume>106</volume><issue>5</issue><fpage>643</fpage><lpage>649</lpage><pub-id pub-id-type=""doi"">10.1093/bja/aer029</pub-id><pub-id pub-id-type=""pmid"">21414977</pub-id></element-citation></ref><ref id=""CR7""><label>7.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Van Straten</surname><given-names>AH</given-names></name><name><surname>Soliman Hamad</surname><given-names>MA</given-names></name><name><surname>Van Zundert</surname><given-names>AA</given-names></name><name><surname>Martens</surname><given-names>EJ</given-names></name><name><surname>Ter Woorst</surname><given-names>JF</given-names></name><name><surname>de Wolf</surname><given-names>AM</given-names></name><name><surname>Scharnhorst</surname><given-names>V</given-names></name></person-group><article-title>Effect of duration of red blood cell storage on early and late mortality after coronary artery bypass grafting</article-title><source>J Thorac Cardiovasc Surg</source><year>2011</year><volume>141</volume><issue>1</issue><fpage>231</fpage><lpage>237</lpage><pub-id pub-id-type=""doi"">10.1016/j.jtcvs.2010.02.059</pub-id><pub-id pub-id-type=""pmid"">20621313</pub-id></element-citation></ref><ref id=""CR8""><label>8.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Yap</surname><given-names>CH</given-names></name><name><surname>Lau</surname><given-names>L</given-names></name><name><surname>Krishnaswamy</surname><given-names>M</given-names></name><name><surname>Gaskell</surname><given-names>M</given-names></name><name><surname>Yii</surname><given-names>M</given-names></name></person-group><article-title>Age of transfused red cells and early outcomes after cardiac surgery</article-title><source>Ann Thorac Surg</source><year>2008</year><volume>86</volume><issue>2</issue><fpage>554</fpage><lpage>559</lpage><pub-id pub-id-type=""doi"">10.1016/j.athoracsur.2008.04.040</pub-id><pub-id pub-id-type=""pmid"">18640333</pub-id></element-citation></ref><ref id=""CR9""><label>9.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Koch</surname><given-names>CG</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Sessler</surname><given-names>DI</given-names></name><name><surname>Figueroa</surname><given-names>P</given-names></name><name><surname>Hoeltge</surname><given-names>GA</given-names></name><name><surname>Mihaljevic</surname><given-names>T</given-names></name><name><surname>Blackstone</surname><given-names>EH</given-names></name></person-group><article-title>Duration of red-cell storage and complications after cardiac surgery</article-title><source>N Engl J Med</source><year>2008</year><volume>358</volume><issue>12</issue><fpage>1229</fpage><lpage>1239</lpage><pub-id pub-id-type=""doi"">10.1056/NEJMoa070403</pub-id><pub-id pub-id-type=""pmid"">18354101</pub-id></element-citation></ref><ref id=""CR10""><label>10.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Esper</surname><given-names>SA</given-names></name><name><surname>Subramaniam</surname><given-names>K</given-names></name><name><surname>Tanaka</surname><given-names>KA</given-names></name></person-group><article-title>Pathophysiology of cardiopulmonary bypass: current strategies for the prevention and treatment of anemia, coagulopathy, and organ dysfunction</article-title><source>Semin Cardiothorac Vasc Anesth</source><year>2014</year><volume>18</volume><issue>2</issue><fpage>161</fpage><lpage>176</lpage><pub-id pub-id-type=""doi"">10.1177/1089253214532375</pub-id><pub-id pub-id-type=""pmid"">24876231</pub-id></element-citation></ref><ref id=""CR11""><label>11.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Sweeney</surname><given-names>J</given-names></name><name><surname>Kouttab</surname><given-names>N</given-names></name><name><surname>Kurtis</surname><given-names>J</given-names></name></person-group><article-title>Stored red blood cell supernatant facilitates thrombin generation</article-title><source>Transfusion</source><year>2009</year><volume>49</volume><issue>8</issue><fpage>1569</fpage><lpage>1579</lpage><pub-id pub-id-type=""doi"">10.1111/j.1537-2995.2009.02196.x</pub-id><pub-id pub-id-type=""pmid"">19413726</pub-id></element-citation></ref><ref id=""CR12""><label>12.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Lamy</surname><given-names>A</given-names></name><name><surname>Devereaux</surname><given-names>PJ</given-names></name><name><surname>Prabhakaran</surname><given-names>D</given-names></name><name><surname>Taggart</surname><given-names>DP</given-names></name><name><surname>Hu</surname><given-names>S</given-names></name><name><surname>Paolasso</surname><given-names>E</given-names></name><name><surname>Straka</surname><given-names>Z</given-names></name><name><surname>Piegas</surname><given-names>LS</given-names></name><name><surname>Akar</surname><given-names>AR</given-names></name><name><surname>Jain</surname><given-names>AR</given-names></name><name><surname>Noiseux</surname><given-names>N</given-names></name><name><surname>Padmanabhan</surname><given-names>C</given-names></name><name><surname>Bahamondes</surname><given-names>JC</given-names></name><name><surname>Novick</surname><given-names>RJ</given-names></name><name><surname>Vaijyanath</surname><given-names>P</given-names></name><name><surname>Reddy</surname><given-names>S</given-names></name><name><surname>Tao</surname><given-names>L</given-names></name><name><surname>Olavegogeascoechea</surname><given-names>PA</given-names></name><name><surname>Airan</surname><given-names>B</given-names></name><name><surname>Sulling</surname><given-names>TA</given-names></name><name><surname>Whitlock</surname><given-names>RP</given-names></name><name><surname>Ou</surname><given-names>Y</given-names></name><name><surname>Ng</surname><given-names>J</given-names></name><name><surname>Chrolavicius</surname><given-names>S</given-names></name><name><surname>Yusuf</surname><given-names>S</given-names></name></person-group><article-title>Off-pump or on-pump coronary-artery bypass grafting at 30 days</article-title><source>N Engl J Med</source><year>2012</year><volume>366</volume><issue>16</issue><fpage>1489</fpage><lpage>1497</lpage><pub-id pub-id-type=""doi"">10.1056/NEJMoa1200388</pub-id><pub-id pub-id-type=""pmid"">22449296</pub-id></element-citation></ref><ref id=""CR13""><label>13.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Vincent</surname><given-names>JL</given-names></name><name><surname>Moreno</surname><given-names>R</given-names></name><name><surname>Takala</surname><given-names>J</given-names></name><name><surname>Willatts</surname><given-names>S</given-names></name><name><surname>De Mendonca</surname><given-names>A</given-names></name><name><surname>Bruining</surname><given-names>H</given-names></name><name><surname>Reinhart</surname><given-names>CK</given-names></name><name><surname>Suter</surname><given-names>PM</given-names></name><name><surname>Thijs</surname><given-names>LG</given-names></name></person-group><article-title>The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure: on behalf of the working group on sepsis-related problems of the European Society of Intensive Care Medicine</article-title><source>Intensive Care Med</source><year>1996</year><volume>22</volume><issue>7</issue><fpage>707</fpage><lpage>710</lpage><pub-id pub-id-type=""doi"">10.1007/BF01709751</pub-id><pub-id pub-id-type=""pmid"">8844239</pub-id></element-citation></ref><ref id=""CR14""><label>14.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Vamvakas</surname><given-names>EC</given-names></name><name><surname>Carven</surname><given-names>JH</given-names></name></person-group><article-title>Length of storage of transfused red cells and postoperative morbidity in patients undergoing coronary artery bypass graft surgery</article-title><source>Transfusion</source><year>2000</year><volume>40</volume><issue>1</issue><fpage>101</fpage><lpage>109</lpage><pub-id pub-id-type=""doi"">10.1046/j.1537-2995.2000.40010101.x</pub-id><pub-id pub-id-type=""pmid"">10644819</pub-id></element-citation></ref><ref id=""CR15""><label>15.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Voorhuis</surname><given-names>FT</given-names></name><name><surname>Dieleman</surname><given-names>JM</given-names></name><name><surname>de Vooght</surname><given-names>KM</given-names></name><name><surname>van Dijk</surname><given-names>D</given-names></name><name><surname>van Herwerden</surname><given-names>LA</given-names></name><name><surname>Peelen</surname><given-names>LM</given-names></name><name><surname>van Klei</surname><given-names>WA</given-names></name></person-group><article-title>Storage time of red blood cell concentrates and adverse outcomes after cardiac surgery: a cohort study</article-title><source>Ann Hematol</source><year>2013</year><volume>92</volume><issue>12</issue><fpage>1701</fpage><lpage>1706</lpage><pub-id pub-id-type=""doi"">10.1007/s00277-013-1832-z</pub-id><pub-id pub-id-type=""pmid"">23832235</pub-id></element-citation></ref><ref id=""CR16""><label>16.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Basran</surname><given-names>S</given-names></name><name><surname>Frumento</surname><given-names>RJ</given-names></name><name><surname>Cohen</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Du</surname><given-names>Y</given-names></name><name><surname>Nishanian</surname><given-names>E</given-names></name><name><surname>Kaplan</surname><given-names>HS</given-names></name><name><surname>Stafford-Smith</surname><given-names>M</given-names></name><name><surname>Bennett-Guerrero</surname><given-names>E</given-names></name></person-group><article-title>The association between duration of storage of transfused red blood cells and morbidity and mortality after reoperative cardiac surgery</article-title><source>Anesth Analg</source><year>2006</year><volume>103</volume><issue>1</issue><fpage>15</fpage><lpage>20</lpage><pub-id pub-id-type=""doi"">10.1213/01.ane.0000221167.58135.3d</pub-id><pub-id pub-id-type=""pmid"">16790618</pub-id></element-citation></ref><ref id=""CR17""><label>17.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Weinberg</surname><given-names>JA</given-names></name><name><surname>McGwin</surname><given-names>G</given-names><suffix>Jr</suffix></name><name><surname>Griffin</surname><given-names>RL</given-names></name><name><surname>Huynh</surname><given-names>VQ</given-names></name><name><surname>Cherry</surname><given-names>SA</given-names><suffix>III</suffix></name><name><surname>Marques</surname><given-names>MB</given-names></name><name><surname>Reiff</surname><given-names>DA</given-names></name><name><surname>Kerby</surname><given-names>JD</given-names></name><name><surname>Rue</surname><given-names>LW</given-names><suffix>III</suffix></name></person-group><article-title>Age of transfused blood: an independent predictor of mortality despite universal leukoreduction</article-title><source>J Trauma</source><year>2008</year><volume>65</volume><issue>2</issue><fpage>279</fpage><lpage>282</lpage><pub-id pub-id-type=""doi"">10.1097/TA.0b013e31817c9687</pub-id><pub-id pub-id-type=""pmid"">18695462</pub-id></element-citation></ref><ref id=""CR18""><label>18.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Almac</surname><given-names>E</given-names></name><name><surname>Ince</surname><given-names>C</given-names></name></person-group><article-title>The impact of storage on red cell function in blood transfusion</article-title><source>Best Pract Res Clin Anaesthesiol</source><year>2007</year><volume>21</volume><issue>2</issue><fpage>195</fpage><lpage>208</lpage><pub-id pub-id-type=""doi"">10.1016/j.bpa.2007.01.004</pub-id><pub-id pub-id-type=""pmid"">17650772</pub-id></element-citation></ref><ref id=""CR19""><label>19.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Steiner</surname><given-names>ME</given-names></name><name><surname>Stowell</surname><given-names>C</given-names></name></person-group><article-title>Does red blood cell storage affect clinical outcome? When in doubt, do the experiment</article-title><source>Transfusion</source><year>2009</year><volume>49</volume><issue>7</issue><fpage>1286</fpage><lpage>1290</lpage><pub-id pub-id-type=""doi"">10.1111/j.1537-2995.2009.02265.x</pub-id><pub-id pub-id-type=""pmid"">19602209</pub-id></element-citation></ref><ref id=""CR20""><label>20.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Kor</surname><given-names>DJ</given-names></name><name><surname>Van Buskirk</surname><given-names>CM</given-names></name><name><surname>Gajic</surname><given-names>O</given-names></name></person-group><article-title>Red blood cell storage lesion</article-title><source>Bosn J Basic Med Sci</source><year>2009</year><volume>9 Suppl 1</volume><fpage>21</fpage><lpage>27</lpage><pub-id pub-id-type=""pmid"">19912115</pub-id></element-citation></ref><ref id=""CR21""><label>21.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Koch</surname><given-names>CG</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Duncan</surname><given-names>AI</given-names></name><name><surname>Mihaljevic</surname><given-names>T</given-names></name><name><surname>Loop</surname><given-names>FD</given-names></name><name><surname>Starr</surname><given-names>NJ</given-names></name><name><surname>Blackstone</surname><given-names>EH</given-names></name></person-group><article-title>Transfusion in coronary artery bypass grafting is associated with reduced long-term survival</article-title><source>Ann Thorac Surg</source><year>2006</year><volume>81</volume><issue>5</issue><fpage>1650</fpage><lpage>1657</lpage><pub-id pub-id-type=""doi"">10.1016/j.athoracsur.2005.12.037</pub-id><pub-id pub-id-type=""pmid"">16631651</pub-id></element-citation></ref><ref id=""CR22""><label>22.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Koch</surname><given-names>CG</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Van Wagoner</surname><given-names>DR</given-names></name><name><surname>Duncan</surname><given-names>AI</given-names></name><name><surname>Gillinov</surname><given-names>AM</given-names></name><name><surname>Blackstone</surname><given-names>EH</given-names></name></person-group><article-title>Red cell transfusion is associated with an increased risk for postoperative atrial fibrillation</article-title><source>Ann Thorac Surg</source><year>2006</year><volume>82</volume><issue>5</issue><fpage>1747</fpage><lpage>1756</lpage><pub-id pub-id-type=""doi"">10.1016/j.athoracsur.2006.05.045</pub-id><pub-id pub-id-type=""pmid"">17062241</pub-id></element-citation></ref><ref id=""CR23""><label>23.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Koch</surname><given-names>CG</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Duncan</surname><given-names>AI</given-names></name><name><surname>Mihaljevic</surname><given-names>T</given-names></name><name><surname>Cosgrove</surname><given-names>DM</given-names></name><name><surname>Loop</surname><given-names>FD</given-names></name><name><surname>Starr</surname><given-names>NJ</given-names></name><name><surname>Blackstone</surname><given-names>EH</given-names></name></person-group><article-title>Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting</article-title><source>Crit Care Med</source><year>2006</year><volume>34</volume><issue>6</issue><fpage>1608</fpage><lpage>1616</lpage><pub-id pub-id-type=""doi"">10.1097/01.CCM.0000217920.48559.D8</pub-id><pub-id pub-id-type=""pmid"">16607235</pub-id></element-citation></ref><ref id=""CR24""><label>24.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Sowemimo-Coker</surname><given-names>SO</given-names></name></person-group><article-title>Red blood cell hemolysis during processing</article-title><source>Transfus Med Rev</source><year>2002</year><volume>16</volume><issue>1</issue><fpage>46</fpage><lpage>60</lpage><pub-id pub-id-type=""doi"">10.1053/tmrv.2002.29404</pub-id><pub-id pub-id-type=""pmid"">11788929</pub-id></element-citation></ref><ref id=""CR25""><label>25.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Vymazal</surname><given-names>T</given-names></name><name><surname>Horacek</surname><given-names>M</given-names></name><name><surname>Durpekt</surname><given-names>R</given-names></name><name><surname>Hladikova</surname><given-names>M</given-names></name><name><surname>Cvachovec</surname><given-names>K</given-names></name></person-group><article-title>Is allogeneic blood transfusion a risk factor for sternal dehiscence following cardiac surgery? A prospective observational study</article-title><source>Int Heart J</source><year>2009</year><volume>50</volume><issue>5</issue><fpage>601</fpage><lpage>607</lpage><pub-id pub-id-type=""doi"">10.1536/ihj.50.601</pub-id><pub-id pub-id-type=""pmid"">19809209</pub-id></element-citation></ref><ref id=""CR26""><label>26.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Banbury</surname><given-names>MK</given-names></name><name><surname>Brizzio</surname><given-names>ME</given-names></name><name><surname>Rajeswaran</surname><given-names>J</given-names></name><name><surname>Lytle</surname><given-names>BW</given-names></name><name><surname>Blackstone</surname><given-names>EH</given-names></name></person-group><article-title>Transfusion increases the risk of postoperative infection after cardiovascular surgery</article-title><source>J Am Coll Surg</source><year>2006</year><volume>202</volume><issue>1</issue><fpage>131</fpage><lpage>138</lpage><pub-id pub-id-type=""doi"">10.1016/j.jamcollsurg.2005.08.028</pub-id><pub-id pub-id-type=""pmid"">16377506</pub-id></element-citation></ref><ref id=""CR27""><label>27.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Friedman</surname><given-names>ND</given-names></name><name><surname>Bull</surname><given-names>AL</given-names></name><name><surname>Russo</surname><given-names>PL</given-names></name><name><surname>Leder</surname><given-names>K</given-names></name><name><surname>Reid</surname><given-names>C</given-names></name><name><surname>Billah</surname><given-names>B</given-names></name><name><surname>Marasco</surname><given-names>S</given-names></name><name><surname>McBryde</surname><given-names>E</given-names></name><name><surname>Richards</surname><given-names>MJ</given-names></name></person-group><article-title>An alternative scoring system to predict risk for surgical site infection complicating coronary artery bypass graft surgery</article-title><source>Infect Control Hosp Epidemiol</source><year>2007</year><volume>28</volume><issue>10</issue><fpage>1162</fpage><lpage>1168</lpage><pub-id pub-id-type=""doi"">10.1086/519534</pub-id><pub-id pub-id-type=""pmid"">17828693</pub-id></element-citation></ref><ref id=""CR28""><label>28.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Andreasen</surname><given-names>JJ</given-names></name><name><surname>Dethlefsen</surname><given-names>C</given-names></name><name><surname>Modrau</surname><given-names>IS</given-names></name><name><surname>Baech</surname><given-names>J</given-names></name><name><surname>Schonheyder</surname><given-names>HC</given-names></name><name><surname>Moeller</surname><given-names>JK</given-names></name><name><surname>Johnsen</surname><given-names>SP</given-names></name></person-group><article-title>Storage time of allogeneic red blood cells is associated with risk of severe postoperative infection after coronary artery bypass grafting</article-title><source>Eur J Cardiothorac Surg</source><year>2011</year><volume>39</volume><issue>3</issue><fpage>329</fpage><lpage>334</lpage><pub-id pub-id-type=""doi"">10.1016/j.ejcts.2010.06.019</pub-id><pub-id pub-id-type=""pmid"">20702101</pub-id></element-citation></ref><ref id=""CR29""><label>29.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Allen</surname><given-names>M</given-names></name></person-group><article-title>Lactate and acid base as a hemodynamic monitor and markers of cellular perfusion</article-title><source>Pediatr Crit Care Med</source><year>2011</year><volume>12</volume><issue>4 Suppl</issue><fpage>S43</fpage><lpage>S49</lpage><pub-id pub-id-type=""doi"">10.1097/PCC.0b013e3182211aed</pub-id><pub-id pub-id-type=""pmid"">22129549</pub-id></element-citation></ref><ref id=""CR30""><label>30.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Witte</surname><given-names>MB</given-names></name><name><surname>Barbul</surname><given-names>A</given-names></name></person-group><article-title>Role of nitric oxide in wound repair</article-title><source>Am J Surg</source><year>2002</year><volume>183</volume><issue>4</issue><fpage>406</fpage><lpage>412</lpage><pub-id pub-id-type=""doi"">10.1016/S0002-9610(02)00815-2</pub-id><pub-id pub-id-type=""pmid"">11975928</pub-id></element-citation></ref><ref id=""CR31""><label>31.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Schwentker</surname><given-names>A</given-names></name><name><surname>Vodovotz</surname><given-names>Y</given-names></name><name><surname>Weller</surname><given-names>R</given-names></name><name><surname>Billiar</surname><given-names>TR</given-names></name></person-group><article-title>Nitric oxide and wound repair: role of cytokines?</article-title><source>Nitric Oxide</source><year>2002</year><volume>7</volume><issue>1</issue><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type=""doi"">10.1016/S1089-8603(02)00002-2</pub-id><pub-id pub-id-type=""pmid"">12175813</pub-id></element-citation></ref><ref id=""CR32""><label>32.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Luo</surname><given-names>JD</given-names></name><name><surname>Chen</surname><given-names>AF</given-names></name></person-group><article-title>Nitric oxide: a newly discovered function on wound healing</article-title><source>Acta Pharmacol Sin</source><year>2005</year><volume>26</volume><issue>3</issue><fpage>259</fpage><lpage>264</lpage><pub-id pub-id-type=""doi"">10.1111/j.1745-7254.2005.00058.x</pub-id><pub-id pub-id-type=""pmid"">15715920</pub-id></element-citation></ref><ref id=""CR33""><label>33.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Han</surname><given-names>G</given-names></name><name><surname>Nguyen</surname><given-names>LN</given-names></name><name><surname>Macherla</surname><given-names>C</given-names></name><name><surname>Chi</surname><given-names>Y</given-names></name><name><surname>Friedman</surname><given-names>JM</given-names></name><name><surname>Nosanchuk</surname><given-names>JD</given-names></name><name><surname>Martinez</surname><given-names>LR</given-names></name></person-group><article-title>Nitric oxide-releasing nanoparticles accelerate wound healing by promoting fibroblast migration and collagen deposition</article-title><source>Am J Pathol</source><year>2012</year><volume>180</volume><issue>4</issue><fpage>1465</fpage><lpage>1473</lpage><pub-id pub-id-type=""doi"">10.1016/j.ajpath.2011.12.013</pub-id><pub-id pub-id-type=""pmid"">22306734</pub-id></element-citation></ref><ref id=""CR34""><label>34.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Vamvakas</surname><given-names>EC</given-names></name><name><surname>Blajchman</surname><given-names>MA</given-names></name></person-group><article-title>Transfusion-related immunomodulation (TRIM): an update</article-title><source>Blood Rev</source><year>2007</year><volume>21</volume><issue>6</issue><fpage>327</fpage><lpage>348</lpage><pub-id pub-id-type=""doi"">10.1016/j.blre.2007.07.003</pub-id><pub-id pub-id-type=""pmid"">17804128</pub-id></element-citation></ref><ref id=""CR35""><label>35.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Phelan</surname><given-names>HA</given-names></name><name><surname>Eastman</surname><given-names>AL</given-names></name><name><surname>Aldy</surname><given-names>K</given-names></name><name><surname>Carroll</surname><given-names>EA</given-names></name><name><surname>Nakonezny</surname><given-names>PA</given-names></name><name><surname>Jan</surname><given-names>T</given-names></name><name><surname>Howard</surname><given-names>JL</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Friese</surname><given-names>RS</given-names></name><name><surname>Minei</surname><given-names>JP</given-names></name></person-group><article-title>Prestorage leukoreduction abrogates the detrimental effect of aging on packed red cells transfused after trauma: a prospective cohort study</article-title><source>Am J Surg</source><year>2012</year><volume>203</volume><issue>2</issue><fpage>198</fpage><lpage>204</lpage><pub-id pub-id-type=""doi"">10.1016/j.amjsurg.2011.05.012</pub-id><pub-id pub-id-type=""pmid"">21924400</pub-id></element-citation></ref><ref id=""CR36""><label>36.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Steiner</surname><given-names>ME</given-names></name><name><surname>Assmann</surname><given-names>SF</given-names></name><name><surname>Levy</surname><given-names>JH</given-names></name><name><surname>Marshall</surname><given-names>J</given-names></name><name><surname>Pulkrabek</surname><given-names>S</given-names></name><name><surname>Sloan</surname><given-names>SR</given-names></name><name><surname>Triulzi</surname><given-names>D</given-names></name><name><surname>Stowell</surname><given-names>CP</given-names></name></person-group><article-title>Addressing the question of the effect of RBC storage on clinical outcomes: the Red Cell Storage Duration Study (RECESS) (Section 7)</article-title><source>Transfus Apher Sci</source><year>2010</year><volume>43</volume><issue>1</issue><fpage>107</fpage><lpage>116</lpage><pub-id pub-id-type=""doi"">10.1016/j.transci.2010.05.014</pub-id><pub-id pub-id-type=""pmid"">20655807</pub-id></element-citation></ref><ref-list id=""BSec1""><title>Pre-publication history</title><ref id=""CR37""><mixed-citation publication-type=""other"">The pre-publication history for this paper can be accessed here:<ext-link ext-link-type=""uri"" xlink:href=""http://www.biomedcentral.com/1471-2253/14/95/prepub"">http://www.biomedcentral.com/1471-2253/14/95/prepub</ext-link></mixed-citation></ref></ref-list></ref-list>"
10.1213/01.ane.0000221167.58135.3d	"<p>BMC_Anesthesiol/PMC4240803.nxml                                                                     0000664 0011011 0007774 00000245353 13031245222 014733  0                                                                                                    ustar   pmc                             pmcdev<!DOCTYPE article PUBLIC ""-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN"" ""JATS-archivearticle1.dtd""><aff id=""I1""><sup>1</sup>Department of Anaesthesiology and Perioperative Medicine, University of Louisville, Louisville, KY, USA</aff><aff id=""I2""><sup>2</sup>Blood Bank University Hospital, Institute of Pathology, University of Louisville, Louisville, KY, USA</aff><aff id=""I3""><sup>3</sup>Trauma Institute, Department of Surgery, University of Louisville, Louisville, KY, USA</aff><aff id=""I4""><sup>4</sup>Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA</aff><aff id=""I5""><sup>5</sup>Department of Outcomes Research, Anaesthesiology Institute, Cleveland Clinic, Cleveland, OH, USA</aff><author-notes><corresp id=""cor1"">*Detlef Obal:<email>d.obal@louisville.edu</email></corresp><fn fn-type=""other""><p>Academic Editor: Nikolaos K. Kanakaris</p></fn></author-notes><pub-date pub-type=""ppub""><year>2017</year></pub-date><pub-date pub-type=""epub""><day>14</day><month>5</month><year>2017</year></pub-date><volume>2017</volume><elocation-id>3718615</elocation-id><history><date date-type=""received""><day>26</day><month>10</month><year>2016</year></date><date date-type=""rev-recd""><day>23</day><month>3</month><year>2017</year></date><date date-type=""accepted""><day>5</day><month>4</month><year>2017</year></date></history><permissions><copyright-statement>Copyright © 2017 Alexander Bautista et al.</copyright-statement><copyright-year>2017</copyright-year><license xlink:href=""https://creativecommons.org/licenses/by/4.0/""><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Background</title><p>Prolonged storage of packed red blood cells (PRBCs) may increase morbidity and mortality, and patients having massive transfusion might be especially susceptible. We therefore tested the hypothesis that prolonged storage increases mortality in patients receiving massive transfusion after trauma or nontrauma surgery. Secondarily, we considered the extent to which storage effects differ for trauma and nontrauma surgery.</p></sec><sec><title>Methods</title><p>We considered surgical patients given more than 10 units of PRBC within 24 hours and evaluated the relationship between mean PRBC storage duration and in-hospital mortality using multivariable logistic regression. Potential nonlinearities in the relationship were assessed via restricted cubic splines. The secondary hypothesis was evaluated by considering whether there was an interaction between the type of surgery (trauma versus nontrauma) and the effect of storage duration on outcomes.</p></sec><sec><title>Results</title><p>305 patients were given a total of 8,046 units of PRBCs, with duration ranging from 8 to 36 days (mean ± SD: 22 ± 6 days). The odds ratio [95% confidence interval (CI)] for in-hospital mortality corresponding to a one-day in mean PRBC storage duration was 0.99 (0.95, 1.03,<italic>P</italic>= 0.77). The relationship did not differ for trauma and nontrauma patients (<italic>P</italic>= 0.75). Results were similar after adjusting for multiple potential confounders.</p></sec><sec><title>Conclusions</title><p>Mortality after massive blood transfusion was no worse in patients transfused with PRBC stored for long periods. Trauma and nontrauma patients did not differ in their susceptibility to prolonged PRBC storage.</p></sec></abstract><funding-group><award-group><funding-source>National Center for Advancing Translational Sciences</funding-source><award-id>KL2TR000440</award-id></award-group></funding-group></p><body><sec id=""sec1""><title>1. Background</title><p>Over 14 million units of blood products are transfused in the United States (U.S.) annually [<xref ref-type=""bibr"" rid=""B1"">1</xref>]. Massive blood transfusions are given to 3–5% [<xref ref-type=""bibr"" rid=""B2"">2</xref>] of the civilian and 8–10% [<xref ref-type=""bibr"" rid=""B3"">3</xref>] of the military trauma patient population. Patients requiring massive blood transfusion are at high risk for adverse clinical outcomes largely because of their serious trauma, but also as a direct consequence of receiving numerous blood products. Transfusions of blood products are associated with several complications and current evidence suggests that transfusions independently increase the risk of morbidity and death in critically ill patients [<xref ref-type=""bibr"" rid=""B4"">4</xref>–<xref ref-type=""bibr"" rid=""B8"">8</xref>], with mortality increasing linearly as a function of the amount of blood transfused. For example, a recent trauma registry analysis found that major blood loss constitutes an important prognostic factor for the survival [<xref ref-type=""bibr"" rid=""B9"">9</xref>] and the authors of the PROMMTT trial [<xref ref-type=""bibr"" rid=""B10"">10</xref>] demonstrated an adjusted odd ratio of 6-hour mortality for patients receiving ≥4 units within 30 minutes of 2.1 (95% confidence interval: 1.2–3.5). Overall, adverse consequences of transfusions add about $17 billion to United States healthcare costs which exceeds the costs of blood acquisition and transfusion combined [<xref ref-type=""bibr"" rid=""B11"">11</xref>].</p><p>Koch and colleagues identified a strong association between storage of red cells more than 14 days and major complications and mortality after coronary artery bypass graft (CABG) surgery [<xref ref-type=""bibr"" rid=""B1"">1</xref>]. The United States Food and Drug Administration allows storage of PRBCs for up to 42 days; however, it is well established that stored red cells undergo substantial biochemical and morphological changes during this period. Important dysfunction includes reduced oxygen delivery resulting from progressive decrease in 2,3-diphosphoglycerate (2,3-DPG) concentrations [<xref ref-type=""bibr"" rid=""B12"">12</xref>], reduced PRBC-dependent vasodilation [<xref ref-type=""bibr"" rid=""B13"">13</xref>] (for review see [<xref ref-type=""bibr"" rid=""B14"">14</xref>,<xref ref-type=""bibr"" rid=""B15"">15</xref>]), decreased cell membrane deformability [<xref ref-type=""bibr"" rid=""B16"">16</xref>,<xref ref-type=""bibr"" rid=""B17"">17</xref>] which potentially obstructs capillary flow, consumption of clotting factors, and activation of intravascular coagulation through PRBC derived microvesicles [<xref ref-type=""bibr"" rid=""B18"">18</xref>]. Prolonged PRBC storage is also thought to increase the risk of severe infection after CABG surgery [<xref ref-type=""bibr"" rid=""B19"">19</xref>].</p><p>Other studies, though, do not identify harm from transfusion of older blood. For example, Edgren and colleagues [<xref ref-type=""bibr"" rid=""B20"">20</xref>] analysed the Scandinavian Donations and Transfusions (SCANDAT) database and found that the initial trend towards a seven-day risk of death reduction diminishes within the 2-year follow-up and that transfusion of older blood is likely to contribute to less than 5% to excess mortality. Saager and colleagues similarly reported no relationship between prolonged median storage duration and mortality in a retrospective analysis of data from noncardiac surgery patients [<xref ref-type=""bibr"" rid=""B21"">21</xref>]. More importantly, two large randomized trials, RECESS and ABLE, concluded that PRBC storage duration did not affect the outcome after CABG surgery [<xref ref-type=""bibr"" rid=""B22"">22</xref>] or in critically ill patients [<xref ref-type=""bibr"" rid=""B23"">23</xref>].</p><p>Routine surgical patients, if given blood, usually receive just one or two units. Trauma patients differ in often experiencing major blood loss and consequently requiring large amounts of blood products. Trauma patients, along with nontrauma patients, who are given large amounts of blood (i.e., ≥10 units) may thus be especially susceptible to injury from blood that has been long stored.</p><p>Consistent with this theory, Zallen and colleagues performed a small prospective database analysis in trauma patients and concluded that multiorgan failure was more likely when patients were transfused with blood stored for 30 days than when stored for 24 days [<xref ref-type=""bibr"" rid=""B24"">24</xref>]. Two similar small studies suggest that prolonged blood storage duration is associated with an increased need [<xref ref-type=""bibr"" rid=""B25"">25</xref>] and increased duration of critical care [<xref ref-type=""bibr"" rid=""B26"">26</xref>]. Furthermore Weinberg and colleagues [<xref ref-type=""bibr"" rid=""B27"">27</xref>] included 176 trauma patients who were given at least one unit of blood within 24 hours after hospital arrival. Those given six units or more of PRBC, with at least three units stored for more than 14 days, had an odds ratio of dying of 7.8 (95% CI 2.3–26.3), twice the odds ratio of patients who received blood stored for less than 14 days. Previous published reports focused mainly on the impact of different storage durations in relative small numbers of transfused PRBCs (i.e., 5–10 units) on clinical outcome [<xref ref-type=""bibr"" rid=""B24"">24</xref>,<xref ref-type=""bibr"" rid=""B26"">26</xref>,<xref ref-type=""bibr"" rid=""B28"">28</xref>,<xref ref-type=""bibr"" rid=""B29"">29</xref>].</p><p>We therefore tested the hypothesis that mean storage duration of transfused PRBC is associated with in-hospital mortality in patients given more than 10 units of PRBC within 24 hours. We also compared the relationship between storage duration and mortality in trauma and nontrauma patients who required massive blood transfusion for elective surgery. Specifically, we tested the secondary hypothesis that the relationship between blood storage duration and mortality is similar in trauma and nontrauma patients given massive amounts of blood.</p></sec><sec id=""sec2""><title>2. Patients and Methods</title><p>The University of Louisville Hospital is a level-one trauma centre with about 3,000 trauma admissions/year. After the approval by the institutional review board at the University of Louisville, we performed this retrospective observational cohort study. Our analysis was restricted to patients who were given more than 10 units of PRBCs within a 24-hour surgical intervention according to the Hospital Blood Bank database. We include neither patients who died within six hours after starting massive blood transfusion and suffered from irreversible lethal injuries (i.e., gunshot to the head, open brain injuries) nor patients with more than 20% incomplete data or inadequate documentation within the medical records into our analysis. In addition to eligibility criteria for the study, we excluded patients for whom storage duration information was unavailable for &gt;10% of their transfused PRBC units.</p><p>We accessed the University Hospital Information Management system to retrieve baseline demographic, perioperative, and outcome variables as listed in<xref ref-type=""table"" rid=""tab1"">Table 1</xref>. Trauma scores and injury schemes were retrieved from the hospital's trauma database and reviewed by an attending trauma surgeon (J.S.).</p><p>Patients' medical records were reviewed from the time they arrived in the Emergency Department (ED, trauma patients) or the start of massive blood transfusion (nontrauma patients) until the time of discharge. We considered Emergency Department, Surgical and Anaesthesia, Laboratory, and Blood Bank records. Only initial surgical procedures were considered.</p><p>Information regarding storage duration of blood components, ABO blood type, and the time at which each product was released by the University of Louisville Hospital Blood Bank was collected from the same database. All PRBCs were leukoreduced by the blood supplier (usually the American Red Cross) and stored in AS-1 solution.</p><p>Preprocedure biochemistry and blood gas data were retrieved from either ED records or, if not available, from the initial intraoperative blood collection. Postprocedure biochemistry and haematological values were obtained from the final intraoperative or initial postanesthesia care unit blood samples.</p><sec id=""sec2.1""><title>2.1. Statistical Methods</title><p>Data analysis followed a stepwise approach: first, baseline potential confounding variables were assessed for balance using standard univariable numerical summaries across quartiles of observed mean PRBC storage duration.</p><p>To evaluate the principal hypothesis of the study, namely, that mean PRBC storage duration is associated with in-hospital mortality, we conducted both a univariable analysis and a (primary) multivariable analysis. Within our logistic regression models, patient mean PRBC storage duration was analysed as a continuous variable. Potential nonlinearities in the relationship between patient mean PRBC storage duration and mortality were assessed using a Chi-squared goodness of fit test, which compared a model that incorporated restricted cubic splines to a model that assumed a linear effect. The secondary hypotheses regarding the existence of differential relationships for trauma and nontrauma patients were evaluated by adding an interaction term between patient mean PRBC storage duration and an indicator for trauma to these models.</p><p>To construct the multivariable model, we used backward stepwise variable selection, starting with a “full” model that included the variables listed in<xref ref-type=""table"" rid=""tab1"">Table 1</xref>(excluding the indicator variables describing the type of trauma that occurred in lieu of the fact that we analysed trauma as a binary variable that was linearly dependent on these indicator variables) provided the variables were not &gt;10% missing. Variable selection was implemented in a penalized fashion, based on Akaike's Information Criterion (AIC) [<xref ref-type=""bibr"" rid=""B30"">30</xref>]. By introducing a penalty proportional to each additional parameter in the model, the AIC encourages parsimonious models.</p><p>The potential confounding variables we considered were year of admission, age, female sex, patient blood type, along with a history of heart disease, pulmonary disease, renal disease, hypertension, diabetes mellitus, carcinoma, liver disease, tobacco use, alcohol use, or illicit drug use. We also considered preprocedural hemoglobins, heart rate, systolic blood pressure, blood pH, platelet count, international normalized ratio, prothrombin time, activated partial thromboplastin time, and number of transfused PRBC units. And finally, we also included duration of surgery. The multivariable models included only patients with complete information on these covariates.</p><p>R statistical software version 3.2.0 (The R Foundation for Statistical Computing, Vienna, Austria) for 64-bit Microsoft Windows operating system was used to perform all analyses. We used a Type I error rate of 5% for the evaluation of all hypotheses.</p></sec></sec><sec id=""sec3""><title>3. Results</title><p>We identified 496 consecutive trauma and nontrauma patients who were given more than 10 units of PRBCs within 24 hours of surgery over a six-year period. 191 were excluded, mostly because patients died within six hours or because of missing data or failure to meet inclusion criteria. A detailed enrolment scheme is attached as<xref ref-type=""fig"" rid=""fig1"">Figure 1</xref>and a summary of baseline characteristics for the four quartile groups of patient mean PRBC storage duration defined among the remaining 305 patients is given in<xref ref-type=""table"" rid=""tab1"">Table 1</xref>. Baseline characteristics by type of surgery (trauma versus nontrauma) are presented in<xref ref-type=""table"" rid=""tab2"">Table 2</xref>. With patients staying an average of 21 days (minimum: 1 day, maximum: 138 days) in the hospital, the overall in-hospital mortality was 101/305 (33.1%), including 23/90 (25.6%) of nontrauma patients and 76/213 (35.7%) of trauma patients.</p><p>Overall, patient mean PRBC storage duration ranged from 8 to 37 days, with a mean ± standard deviation storage duration of 22 ± 6 days.<xref ref-type=""fig"" rid=""fig2"">Figure 2(a)</xref>displays a histogram, as well as the estimated (nonlinear) relationship with in-hospital mortality, based on the univariable logistic regression model. The restricted cubic spline term which characterized the nonlinear relationship did not significantly improve the model fit (<italic>P</italic>= 0.78, Chi-squared goodness of fit test), suggesting that a linear approximation sufficed. Based on this simpler model, the odds ratio (95% confidence interval) for in-hospital mortality corresponding to a one-day increase in patient mean PRBC storage duration was estimated at 0.99 (0.95, 1.03,<italic>P</italic>= 0.77, Chi-squared test for model coefficients). No significant evidence of differential relationships between trauma and nontrauma patients was found (<italic>P</italic>= 0.87 for the interaction between trauma and patient mean PRBC storage duration; see<xref ref-type=""fig"" rid=""fig2"">Figure 2(b)</xref>).</p><p>Data from 259 patients were included in our multivariable modelling. The stepwise variable selection procedure identified age, renal disease, alcohol use, preprocedure blood pH, activated partial thromboplastin time, and number of units transfused as covariates for the final multivariable model. However, results were similar to those obtained from the univariable modelling. The adjusted odds ratio (95% CI) for patient mean PRBC storage duration was 0.98 (0.93, 1.04).</p><p>Secondary outcomes are summarized in Tables<xref ref-type=""table"" rid=""tab3"">3</xref>and<xref ref-type=""table"" rid=""tab4"">4</xref>. There was no significant relationship between mean storage duration and in-hospital mortality. Patients who were given blood of the first and third quartile had a slightly (nonsignificantly) longer hospitalization, ICU stay, and mechanical ventilation than patients given blood from the second or fourth storage duration quartile.</p><p>About 22% of all patients suffered from disseminated intravascular coagulation, independent of blood storage duration, and the incidence of myocardial infarction appeared to increase with storage duration. A third of all patients suffered from infections (i.e., surgical site infection or pneumonia), while almost 40% of all patients developed acute respiratory distress syndrome with no particular prevalence towards a particular mean storage duration.</p></sec><sec id=""sec4""><title>4. Discussion</title><p>We included patients given massive transfusion, defined by transfusion of 10 or more units of PRBCs within 24 hours. Only about 5% of the estimated annual 50 million trauma cases in the U.S. require this much blood, but they account for 10 to 15% of all transfused blood products [<xref ref-type=""bibr"" rid=""B2"">2</xref>] and accrue more than 4 billion dollars of health care cost [<xref ref-type=""bibr"" rid=""B31"">31</xref>]. Blood transfusion is a strong independent predictor of mortality in trauma and nontrauma patients [<xref ref-type=""bibr"" rid=""B32"">32</xref>], especially in massively transfused patients [<xref ref-type=""bibr"" rid=""B33"">33</xref>]. Our results are consistent in that mortality was high in our massively transfused patients, many of whom did not even live six hours. Among those who lived and thus qualified for our analysis, a third died during their initial hospitalization.</p><p>Two recent meta-analyses evaluated the relationship between PRBC storage duration and long-term mortality, multiple organ failure, in-hospital infections, duration of mechanical ventilation, and respiratory failure requiring ventilator support [<xref ref-type=""bibr"" rid=""B34"">34</xref>,<xref ref-type=""bibr"" rid=""B35"">35</xref>]. The analysis suggested that storage duration did not affect outcome, but the authors noted considerable heterogeneity concerning patient populations, diversity of interventions, and measurement of clinical outcome. In contrast, Wang and colleagues analysed 21 studies including a total of 409,966 patients concluding that older blood is associated with increased mortality [<xref ref-type=""bibr"" rid=""B36"">36</xref>].</p><p>Patients having cardiovascular/CABG surgery are well studied, but both prospective and retrospective data conflict regarding the potential harm of prolonged stored blood products [<xref ref-type=""bibr"" rid=""B1"">1</xref>,<xref ref-type=""bibr"" rid=""B37"">37</xref>–<xref ref-type=""bibr"" rid=""B40"">40</xref>]. The most recent large prospective trials in cardiac surgery patients [<xref ref-type=""bibr"" rid=""B22"">22</xref>] and critically ill patients [<xref ref-type=""bibr"" rid=""B23"">23</xref>] demonstrate no difference in outcomes including the incidence of multiorgan dysfunction syndrome or mortality [<xref ref-type=""bibr"" rid=""B22"">22</xref>], the incidence of major illnesses, duration of hemodynamic instability, renal or ventilator support, length of stay in the hospital, or transfusion reactions [<xref ref-type=""bibr"" rid=""B23"">23</xref>]. However, patients in both studies were typically given just one or two units of red cells.</p><p>Trauma patients are likely to experience multiorgan failure [<xref ref-type=""bibr"" rid=""B24"">24</xref>,<xref ref-type=""bibr"" rid=""B41"">41</xref>], infection [<xref ref-type=""bibr"" rid=""B28"">28</xref>], kidney failure [<xref ref-type=""bibr"" rid=""B27"">27</xref>], pneumonia [<xref ref-type=""bibr"" rid=""B42"">42</xref>,<xref ref-type=""bibr"" rid=""B43"">43</xref>], deep vein thrombosis [<xref ref-type=""bibr"" rid=""B41"">41</xref>], and death [<xref ref-type=""bibr"" rid=""B27"">27</xref>,<xref ref-type=""bibr"" rid=""B41"">41</xref>,<xref ref-type=""bibr"" rid=""B43"">43</xref>,<xref ref-type=""bibr"" rid=""B44"">44</xref>]. Risk is presumably largely related to tissue injury, but the need for large amounts of blood products contributes [<xref ref-type=""bibr"" rid=""B33"">33</xref>].</p><p>Massively transfused patients have been underrepresented in previous studies. For example, only 13% of patients in Edgren's database [<xref ref-type=""bibr"" rid=""B20"">20</xref>] received more than five units of PRBCs, the RECESS trial [<xref ref-type=""bibr"" rid=""B22"">22</xref>] included only 145 patients who received more than eight units, and only 156 trauma patients in the ABLE trial were given more than four units of blood [<xref ref-type=""bibr"" rid=""B23"">23</xref>]. Even in the recently published INFORM trial [<xref ref-type=""bibr"" rid=""B45"">45</xref>] including 30,000 patients randomized to transfusion of short-term or long-term stored PRBCs, the number of trauma patients and massive transfused patients was negligible similar to other studies including even fewer massively transfused patients [<xref ref-type=""bibr"" rid=""B24"">24</xref>,<xref ref-type=""bibr"" rid=""B28"">28</xref>,<xref ref-type=""bibr"" rid=""B42"">42</xref>,<xref ref-type=""bibr"" rid=""B43"">43</xref>]. Our analysis is the first focusing exclusively on patients who received a minimum of at least ten units of PRBCs within 24 hours, representing transfusion of 8,046 units in just 305 patients. Nonetheless, there was no association between mean storage duration of PRBCs and in-hospital mortality. Nor was there a differential effect amongst trauma and nontrauma patients.</p><p>Stored PRBCs undergo progressive structural and conformational changes associated with proposed subsequent worsening of quality, function, and viability of PRBC after transfusion [<xref ref-type=""bibr"" rid=""B17"">17</xref>,<xref ref-type=""bibr"" rid=""B46"">46</xref>,<xref ref-type=""bibr"" rid=""B47"">47</xref>]. Assessing effects of blood product age in our patient population receiving at least 10 units of PRBCs is challenging as the majority of patients do not receive exclusively old nor young blood products, but a mixture of both.</p><p>Unfortunately, no clear cut-off time has been defined after which changes during storage become clinically important with the result that various investigators have used arbitrary storage thresholds (i.e., 14 days [<xref ref-type=""bibr"" rid=""B27"">27</xref>], 21 days [<xref ref-type=""bibr"" rid=""B22"">22</xref>], or 28 days [<xref ref-type=""bibr"" rid=""B41"">41</xref>] of storage time) or based their analyses on the oldest unit [<xref ref-type=""bibr"" rid=""B41"">41</xref>]. As most blood banks in the U.S. and worldwide follow the inventory principle “first-in-first-out” to avoid outdating of stored blood products [<xref ref-type=""bibr"" rid=""B23"">23</xref>,<xref ref-type=""bibr"" rid=""B48"">48</xref>], massively transfused patients typically receive PRBCs with a considerable range of storage durations because a single patient may use a considerable fraction of the matching units for an entire hospital, even in a major trauma centre like the University of Louisville Hospital. We therefore used mean storage time as a continuous variable, with a consequence that the difference between the first and fourth quartile of PRBC storage duration was only six days. However, histograms displaying the distribution of PRBC storage duration considering median, minimum, and maximum storage duration revealed a similar difference between patients receiving short or prolonged stored products (<xref ref-type=""fig"" rid=""fig3"">Figure 3</xref>). With the relative broad distribution of storage times of PRBCs/patient, it is not possible to determine whether a specific storage threshold exists (i.e., 35 days [<xref ref-type=""bibr"" rid=""B49"">49</xref>]) beyond which age will effect outcome in this particular patient population. While this relatively small range limits our ability to assess the specific effects of blood age on mortality, our conclusion that storage duration and mortality are unassociated probably applies broadly.</p><p>Mortality within 6 hours after hospital admission increased is doubled in patients who receive 4 or more units of resuscitation fluid [<xref ref-type=""bibr"" rid=""B50"">50</xref>]. We excluded 36 patients who died within the first 6 hours after starting massive transfusion as most experienced such severe trauma (i.e., penetrating trauma to major vessels and organs with 50% of the patient during initial surgery) that the storage lesion of transfused red cells is unlikely to have caused their demise. In fact, some investigators postulate that some detrimental effects of prolonged red cell storage become evident more than two weeks after transfusion [<xref ref-type=""bibr"" rid=""B1"">1</xref>]. Our average observation time was 21 days (minimum: 1 day, maximum: 138 days) and therefore remains possible that we missed longer-term transfusion-related outcomes.</p><p>As in all observational studies—particularly, those involving emergency surgeries in trauma patients—missing data are a major concern. We reviewed the records of 498 patients who had massive blood transfusions. Despite all efforts, we were unable to retrieve complete data for many patients, a problem that has been noted in previous studies [<xref ref-type=""bibr"" rid=""B51"">51</xref>]. We therefore only included patients in whom more than 80% of all study-related data were available. A limitation of our analysis is that we cannot determine the effect of missing data in the patients we included, much less the effect of excluding patients who had much missing data.</p><p>In summary, our data suggest that the median storage time of PRBCs transfused is not associated with in-hospital mortality amongst patients given at least 10 units of PRBC within 24 hours.</p></sec></body><back><ack><title>Acknowledgments</title><p>Dr. Dalton's effort was supported by the Clinical and Translational Science Collaborative of Cleveland from the National Center for Advancing Translational Sciences (NCATS) component of the National Institutes of Health and NIH roadmap for Medical Research (KL2TR000440).</p></ack><sec><title>Disclosure</title><p>The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.</p></sec><sec><title>Conflicts of Interest</title><p>The authors declare that they have no conflicts of interest.</p></sec><sec><title>Authors' Contributions</title><p>Daniel I. Sessler and Detlef Obal were responsible for study design and concept; Alexander Bautista, Theodore B. Wright, Janice Meany, Sunitha K. Kandadai, Benjamin Brown, Kareim Khalafalla, and Saeed Hashem were responsible for data collection; Jason W. Smith was responsible for assigning trauma scores and evaluation of trauma severity; Tayyeb M. Ayyoubi and Janice Meany were responsible for reviewing Blood Bank data; Jarrod E. Dalton and Detlef Obal were responsible for statistical analysis; Tayyeb M. Ayyoubi, Jarrod E. Dalton, Anupama Wadhwa, and Detlef Obal were responsible for data analysis; Alexander Bautista, Theodore B. Wright, Anupama Wadhwa, Daniel I. Sessler, and Detlef Obal were responsible for writing manuscript. Alexander Bautista and Theodore B. Wright contributed equally to this work.</p></sec><ref-list><ref id=""B1""><label>1</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Koch</surname><given-names>C. G.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Sessler</surname><given-names>D. I.</given-names></name><etal></etal></person-group><article-title>Duration of red-cell storage and complications after cardiac surgery</article-title><source><italic>New England Journal of Medicine</italic></source><year>2008</year><volume>358</volume><issue>12</issue><fpage>1229</fpage><lpage>1239</lpage><pub-id pub-id-type=""other"">2-s2.0-40949102607</pub-id><pub-id pub-id-type=""doi"">10.1056/NEJMoa070403</pub-id><pub-id pub-id-type=""pmid"">18354101</pub-id></element-citation></ref><ref id=""B2""><label>2</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Como</surname><given-names>J. J.</given-names></name><name><surname>Dutton</surname><given-names>R. P.</given-names></name><name><surname>Scalea</surname><given-names>T. M.</given-names></name><name><surname>Edelman</surname><given-names>B. B.</given-names></name><name><surname>Hess</surname><given-names>J. R.</given-names></name></person-group><article-title>Blood transfusion rates in the care of acute trauma</article-title><source><italic>Transfusion</italic></source><year>2004</year><volume>44</volume><issue>6</issue><fpage>809</fpage><lpage>813</lpage><pub-id pub-id-type=""other"">2-s2.0-2942622291</pub-id><pub-id pub-id-type=""doi"">10.1111/j.1537-2995.2004.03409.x</pub-id><pub-id pub-id-type=""pmid"">15157244</pub-id></element-citation></ref><ref id=""B3""><label>3</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Holcomb</surname><given-names>J. B.</given-names></name><name><surname>Jenkins</surname><given-names>D.</given-names></name><name><surname>Rhee</surname><given-names>P.</given-names></name><etal></etal></person-group><article-title>Damage control resuscitation: directly addressing the early coagulopathy of trauma</article-title><source><italic>The Journal of trauma</italic></source><year>2007</year><volume>62</volume><issue>2</issue><fpage>307</fpage><lpage>310</lpage><pub-id pub-id-type=""pmid"">17297317</pub-id></element-citation></ref><ref id=""B4""><label>4</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Cherkas</surname><given-names>D.</given-names></name></person-group><article-title>Traumatic hemorrhagic shock: advances in fluid management</article-title><source><italic>Emergency medicine practice</italic></source><year>2011</year><volume>13</volume><issue>11</issue><fpage>1</fpage><lpage>20</lpage></element-citation></ref><ref id=""B5""><label>5</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Robinson III</surname><given-names>W. P.</given-names></name><name><surname>Ahn</surname><given-names>J.</given-names></name><name><surname>Stiffler</surname><given-names>A.</given-names></name><etal></etal></person-group><article-title>Blood transfusion is an independent predictor of increased mortality in nonoperatively managed blunt hepatic and splenic injuries</article-title><source><italic>The Journal of trauma</italic></source><year>2005</year><volume>58</volume><issue>3</issue><fpage>437</fpage><lpage>445</lpage><pub-id pub-id-type=""pmid"">15761334</pub-id></element-citation></ref><ref id=""B6""><label>6</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Malone</surname><given-names>D. L.</given-names></name><name><surname>Dunne</surname><given-names>J.</given-names></name><name><surname>Tracy</surname><given-names>J. K.</given-names></name><name><surname>Putnam</surname><given-names>A. T.</given-names></name><name><surname>Scalea</surname><given-names>T. M.</given-names></name><name><surname>Napolitano</surname><given-names>L. M.</given-names></name></person-group><article-title>Blood transfusion, independent of shock severity, is associated with worse outcome in trauma</article-title><source><italic>The Journal of Trauma</italic></source><year>2003</year><volume>54</volume><issue>5</issue><fpage>898</fpage><lpage>907</lpage><pub-id pub-id-type=""doi"">10.1097/01.TA.0000060261.10597.5C</pub-id><pub-id pub-id-type=""other"">2-s2.0-0037868079</pub-id><pub-id pub-id-type=""pmid"">12777902</pub-id></element-citation></ref><ref id=""B7""><label>7</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Taylor</surname><given-names>R. W.</given-names></name><name><surname>Manganaro</surname><given-names>L.</given-names></name><name><surname>O'Brien</surname><given-names>J.</given-names></name><name><surname>Trottier</surname><given-names>S. J.</given-names></name><name><surname>Parkar</surname><given-names>N.</given-names></name><name><surname>Veremakis</surname><given-names>C.</given-names></name></person-group><article-title>Impact of allogenic packed red blood cell transfusion on nosocomial infection rates in the critically ill patient</article-title><source><italic>Critical Care Medicine</italic></source><year>2002</year><volume>30</volume><issue>10</issue><fpage>2249</fpage><lpage>2254</lpage><pub-id pub-id-type=""other"">2-s2.0-0036796878</pub-id><pub-id pub-id-type=""doi"">10.1097/00003246-200210000-00012</pub-id><pub-id pub-id-type=""pmid"">12394952</pub-id></element-citation></ref><ref id=""B8""><label>8</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Koch</surname><given-names>C. G.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Duncan</surname><given-names>A. I.</given-names></name><etal></etal></person-group><article-title>Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting</article-title><source><italic>Critical Care Medicine</italic></source><year>2006</year><volume>34</volume><issue>6</issue><fpage>1608</fpage><lpage>1616</lpage><pub-id pub-id-type=""other"">2-s2.0-33744509867</pub-id><pub-id pub-id-type=""doi"">10.1097/01.CCM.0000217920.48559.D8</pub-id><pub-id pub-id-type=""pmid"">16607235</pub-id></element-citation></ref><ref id=""B9""><label>9</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Huber-Wagner</surname><given-names>S.</given-names></name><name><surname>Qvick</surname><given-names>M.</given-names></name><name><surname>Mussack</surname><given-names>T.</given-names></name><etal></etal></person-group><article-title>Massive blood transfusion and outcome in 1062 polytrauma patients: a prospective study based on the Trauma Registry of the German Trauma Society</article-title><source><italic>Vox Sanguinis</italic></source><year>2007</year><volume>92</volume><issue>1</issue><fpage>69</fpage><lpage>78</lpage><pub-id pub-id-type=""doi"">10.1111/j.1423-0410.2006.00858.x</pub-id><pub-id pub-id-type=""other"">2-s2.0-33845681164</pub-id><pub-id pub-id-type=""pmid"">17181593</pub-id></element-citation></ref><ref id=""B10""><label>10</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Holcomb</surname><given-names>J. B.</given-names></name><name><surname>Fox</surname><given-names>E. E.</given-names></name><name><surname>Wade</surname><given-names>C. E.</given-names></name></person-group><article-title>The PRospective observational multicenter major trauma transfusion (PROMMTT) study</article-title><source><italic>Journal of Trauma and Acute Care Surgery</italic></source><year>2013</year><volume>75</volume><issue>1 , supplement 1</issue><fpage>S1</fpage><lpage>S2</lpage><pub-id pub-id-type=""doi"">10.1097/TA.0b013e3182983876</pub-id><pub-id pub-id-type=""other"">2-s2.0-84880399264</pub-id><pub-id pub-id-type=""pmid"">23778505</pub-id></element-citation></ref><ref id=""B11""><label>11</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Shander</surname><given-names>A.</given-names></name><name><surname>Hofmann</surname><given-names>A.</given-names></name><name><surname>Gombotz</surname><given-names>H.</given-names></name><name><surname>Theusinger</surname><given-names>O. M.</given-names></name><name><surname>Spahn</surname><given-names>D. R.</given-names></name></person-group><article-title>Estimating the cost of blood: past, present, and future directions</article-title><source><italic>Best Practice and Research: Clinical Anaesthesiology</italic></source><year>2007</year><volume>21</volume><issue>2</issue><fpage>271</fpage><lpage>289</lpage><pub-id pub-id-type=""other"">2-s2.0-34250160149</pub-id><pub-id pub-id-type=""doi"">10.1016/j.bpa.2007.01.002</pub-id><pub-id pub-id-type=""pmid"">17650777</pub-id></element-citation></ref><ref id=""B12""><label>12</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Hamasaki</surname><given-names>N.</given-names></name><name><surname>Yamamoto</surname><given-names>M.</given-names></name></person-group><article-title>Red blood cell function and blood storage</article-title><source><italic>Vox Sanguinis</italic></source><year>2000</year><volume>79</volume><issue>4</issue><fpage>191</fpage><lpage>197</lpage><pub-id pub-id-type=""other"">2-s2.0-0034512705</pub-id><pub-id pub-id-type=""doi"">10.1159/000056729</pub-id><pub-id pub-id-type=""pmid"">11155068</pub-id></element-citation></ref><ref id=""B13""><label>13</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Bennett-Guerrero</surname><given-names>E.</given-names></name><name><surname>Veldman</surname><given-names>T. H.</given-names></name><name><surname>Doctor</surname><given-names>A.</given-names></name><etal></etal></person-group><article-title>Evolution of adverse changes in stored RBCs</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>2007</year><volume>104</volume><issue>43</issue><fpage>17063</fpage><lpage>17068</lpage><pub-id pub-id-type=""doi"">10.1073/pnas.0708160104</pub-id><pub-id pub-id-type=""other"">2-s2.0-36749038312</pub-id><pub-id pub-id-type=""pmid"">17940021</pub-id></element-citation></ref><ref id=""B14""><label>14</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Cohen</surname><given-names>B.</given-names></name><name><surname>Matot</surname><given-names>I.</given-names></name><name><surname>Hemmings</surname><given-names>H. C.</given-names></name></person-group><article-title>Aged erythrocytes: a fine wine or sour grapes?</article-title><source><italic>British Journal of Anaesthesia</italic></source><year>2013</year><volume>111, supplement 1</volume><fpage>i62</fpage><lpage>i70</lpage><pub-id pub-id-type=""doi"">10.1093/bja/aet405</pub-id><pub-id pub-id-type=""other"">2-s2.0-84890721765</pub-id><pub-id pub-id-type=""pmid"">24335400</pub-id></element-citation></ref><ref id=""B15""><label>15</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Zimring</surname><given-names>J. C.</given-names></name></person-group><article-title>Fresh versus old blood: are there differences and do they matter?</article-title><source><italic>American Society of Hematology</italic></source><year>2013</year><volume>2013</volume><fpage>651</fpage><lpage>655</lpage><pub-id pub-id-type=""doi"">10.1182/asheducation-2013.1.651</pub-id></element-citation></ref><ref id=""B16""><label>16</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Frank</surname><given-names>S. M.</given-names></name><name><surname>Abazyan</surname><given-names>B.</given-names></name><name><surname>Ono</surname><given-names>M.</given-names></name><etal></etal></person-group><article-title>Decreased erythrocyte deformability after transfusion and the effects of erythrocyte storage duration</article-title><source><italic>Anesthesia &amp; Analgesia</italic></source><year>2013</year><volume>116</volume><issue>5</issue><fpage>975</fpage><lpage>981</lpage><pub-id pub-id-type=""doi"">10.1213/ANE.0b013e31828843e6</pub-id><pub-id pub-id-type=""other"">2-s2.0-84876770704</pub-id><pub-id pub-id-type=""pmid"">23449853</pub-id></element-citation></ref><ref id=""B17""><label>17</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Berezina</surname><given-names>T. L.</given-names></name><name><surname>Zaets</surname><given-names>S. B.</given-names></name><name><surname>Morgan</surname><given-names>C.</given-names></name><etal></etal></person-group><article-title>Influence of storage on red blood cell rheological properties</article-title><source><italic>Journal of Surgical Research</italic></source><year>2002</year><volume>102</volume><issue>1</issue><fpage>6</fpage><lpage>12</lpage><pub-id pub-id-type=""other"">2-s2.0-0036352736</pub-id><pub-id pub-id-type=""doi"">10.1006/jsre.2001.6306</pub-id><pub-id pub-id-type=""pmid"">11792145</pub-id></element-citation></ref><ref id=""B18""><label>18</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Zecher</surname><given-names>D.</given-names></name><name><surname>Cumpelik</surname><given-names>A.</given-names></name><name><surname>Schifferli</surname><given-names>J. A.</given-names></name></person-group><article-title>Erythrocyte-derived microvesicles amplify systemic inflammation by thrombin-dependent activation of complement</article-title><source><italic>Arteriosclerosis, Thrombosis, and Vascular Biology</italic></source><year>2014</year><volume>34</volume><issue>2</issue><fpage>313</fpage><lpage>320</lpage><pub-id pub-id-type=""other"">2-s2.0-84894994184</pub-id><pub-id pub-id-type=""doi"">10.1161/ATVBAHA.113.302378</pub-id></element-citation></ref><ref id=""B19""><label>19</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Andreasen</surname><given-names>J. J.</given-names></name><name><surname>Dethlefsen</surname><given-names>C.</given-names></name><name><surname>Modrau</surname><given-names>I. S.</given-names></name><etal></etal></person-group><article-title>Storage time of allogeneic red blood cells is associated with risk of severe postoperative infection after coronary artery bypass grafting</article-title><source><italic>European Journal of Cardio-Thoracic Surgery</italic></source><year>2011</year><volume>39</volume><issue>3</issue><fpage>329</fpage><lpage>334</lpage><pub-id pub-id-type=""doi"">10.1016/j.ejcts.2010.06.019</pub-id><pub-id pub-id-type=""pmid"">20702101</pub-id></element-citation></ref><ref id=""B20""><label>20</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Edgren</surname><given-names>G.</given-names></name><name><surname>Kamper-Jørgensen</surname><given-names>M.</given-names></name><name><surname>Eloranta</surname><given-names>S.</given-names></name><etal></etal></person-group><article-title>Duration of red blood cell storage and survival of transfused patients</article-title><source><italic>Transfusion</italic></source><year>2010</year><volume>50</volume><issue>6</issue><fpage>1185</fpage><lpage>1195</lpage><pub-id pub-id-type=""other"">2-s2.0-77953098749</pub-id><pub-id pub-id-type=""doi"">10.1111/j.1537-2995.2010.02583.x</pub-id><pub-id pub-id-type=""pmid"">20158690</pub-id></element-citation></ref><ref id=""B21""><label>21</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Saager</surname><given-names>L.</given-names></name><name><surname>Turan</surname><given-names>A.</given-names></name><name><surname>Dalton</surname><given-names>J. E.</given-names></name><name><surname>Figueroa</surname><given-names>P. I.</given-names></name><name><surname>Sessler</surname><given-names>D. I.</given-names></name><name><surname>Kurz</surname><given-names>A.</given-names></name></person-group><article-title>Erythrocyte storage duration is not associated with increased mortality in noncardiac surgical patients: a retrospective analysis of 6,994 patients</article-title><source><italic>Anesthesiology</italic></source><year>2013</year><volume>118</volume><issue>1</issue><fpage>51</fpage><lpage>58</lpage><pub-id pub-id-type=""doi"">10.1097/ALN.0b013e3182746ba4</pub-id><pub-id pub-id-type=""other"">2-s2.0-84871611759</pub-id><pub-id pub-id-type=""pmid"">23154297</pub-id></element-citation></ref><ref id=""B22""><label>22</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Steiner</surname><given-names>M. E.</given-names></name><name><surname>Ness</surname><given-names>P. M.</given-names></name><name><surname>Assmann</surname><given-names>S. F.</given-names></name><etal></etal></person-group><article-title>Effects of red-cell storage duration on patients undergoing cardiac surgery</article-title><source><italic>The New England Journal of Medicine</italic></source><year>2015</year><volume>372</volume><issue>15</issue><fpage>1419</fpage><lpage>1429</lpage><pub-id pub-id-type=""doi"">10.1056/NEJMoa1414219</pub-id><pub-id pub-id-type=""pmid"">25853746</pub-id></element-citation></ref><ref id=""B23""><label>23</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Lacroix</surname><given-names>J.</given-names></name><name><surname>Hébert</surname><given-names>P. C.</given-names></name><name><surname>Fergusson</surname><given-names>D. A.</given-names></name><etal></etal></person-group><article-title>Age of transfused blood in critically ill adults</article-title><source><italic>The New England Journal of Medicine</italic></source><year>2015</year><volume>372</volume><issue>15</issue><fpage>1410</fpage><lpage>1418</lpage><pub-id pub-id-type=""doi"">10.1056/nejmoa1500704</pub-id><pub-id pub-id-type=""other"">2-s2.0-84927168718</pub-id><pub-id pub-id-type=""pmid"">25853745</pub-id></element-citation></ref><ref id=""B24""><label>24</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Zallen</surname><given-names>G.</given-names></name><name><surname>Offner</surname><given-names>P. J.</given-names></name><name><surname>Moore</surname><given-names>E. E.</given-names></name><etal></etal></person-group><article-title>Age of transfused blood is an independent risk factor for postinjury multiple organ failure</article-title><source><italic>The American Journal of Surgery</italic></source><year>1999</year><volume>178</volume><issue>6</issue><fpage>570</fpage><lpage>572</lpage><pub-id pub-id-type=""pmid"">10670874</pub-id></element-citation></ref><ref id=""B25""><label>25</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Murrell</surname><given-names>Z.</given-names></name><name><surname>Haukoos</surname><given-names>J. S.</given-names></name><name><surname>Putnam</surname><given-names>B.</given-names></name><name><surname>Klein</surname><given-names>S. R.</given-names></name></person-group><article-title>The effect of older blood on mortality, need for ICU care, and the length of ICU stay after major trauma</article-title><source><italic>American Surgeon</italic></source><year>2005</year><volume>71</volume><issue>9</issue><fpage>781</fpage><lpage>785</lpage><pub-id pub-id-type=""other"">2-s2.0-33644966172</pub-id><pub-id pub-id-type=""pmid"">16468518</pub-id></element-citation></ref><ref id=""B26""><label>26</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Keller</surname><given-names>M. E.</given-names></name><name><surname>Jean</surname><given-names>R.</given-names></name><name><surname>LaMorte</surname><given-names>W. W.</given-names></name><name><surname>Millham</surname><given-names>F.</given-names></name><name><surname>Hirsch</surname><given-names>E.</given-names></name></person-group><article-title>Effects of age of transfused blood on length of stay in trauma patients: a preliminary report</article-title><source><italic>Journal of Trauma</italic></source><year>2002</year><volume>53</volume><issue>5</issue><fpage>1023</fpage><lpage>1025</lpage><pub-id pub-id-type=""doi"">10.1097/00005373-200211000-00037</pub-id><pub-id pub-id-type=""other"">2-s2.0-0036850296</pub-id><pub-id pub-id-type=""pmid"">12435963</pub-id></element-citation></ref><ref id=""B27""><label>27</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Weinberg</surname><given-names>J. A.</given-names></name><name><surname>McGwin</surname><given-names>G.</given-names><suffix>Jr.</suffix></name><name><surname>Griffin</surname><given-names>R. L.</given-names></name><etal></etal></person-group><article-title>Age of transfused blood: an independent predictor of mortality despite universal leukoreduction</article-title><source><italic>The Journal of Trauma</italic></source><year>2008</year><volume>65</volume><issue>2</issue><fpage>279</fpage><lpage>284</lpage><pub-id pub-id-type=""doi"">10.1097/TA.0b013e31817c9687</pub-id><pub-id pub-id-type=""other"">2-s2.0-51649129137</pub-id><pub-id pub-id-type=""pmid"">18695462</pub-id></element-citation></ref><ref id=""B28""><label>28</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Offner</surname><given-names>P. J.</given-names></name><name><surname>Moore</surname><given-names>E. E.</given-names></name><name><surname>Biffl</surname><given-names>W. L.</given-names></name><name><surname>Johnson</surname><given-names>J. L.</given-names></name><name><surname>Silliman</surname><given-names>C. C.</given-names></name></person-group><article-title>Increased rate of infection associated with transfusion of old blood after severe injury</article-title><source><italic>Archives of Surgery</italic></source><year>2002</year><volume>137</volume><issue>6</issue><fpage>711</fpage><lpage>717</lpage><pub-id pub-id-type=""doi"">10.1001/archsurg.137.6.711</pub-id><pub-id pub-id-type=""other"">2-s2.0-0036274340</pub-id><pub-id pub-id-type=""pmid"">12049543</pub-id></element-citation></ref><ref id=""B29""><label>29</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Kiraly</surname><given-names>L. N.</given-names></name><name><surname>Underwood</surname><given-names>S.</given-names></name><name><surname>Differding</surname><given-names>J. A.</given-names></name><name><surname>Schreiber</surname><given-names>M. A.</given-names></name></person-group><article-title>Transfusion of aged packed red blood cells results in decreased tissue oxygenation in critically injured trauma patients</article-title><source><italic>Journal of Trauma—Injury, Infection and Critical Care</italic></source><year>2009</year><volume>67</volume><issue>1</issue><fpage>29</fpage><lpage>32</lpage><pub-id pub-id-type=""doi"">10.1097/TA.0b013e3181af6a8c</pub-id><pub-id pub-id-type=""other"">2-s2.0-70350436086</pub-id></element-citation></ref><ref id=""B30""><label>30</label><element-citation publication-type=""book""><person-group person-group-type=""author""><name><surname>Akaike</surname><given-names>H.</given-names></name></person-group><source><italic>Akaike’s Information Criterion</italic></source><year>2011</year><publisher-loc>Berlin, Germany</publisher-loc><publisher-name>Springer</publisher-name></element-citation></ref><ref id=""B31""><label>31</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Corso</surname><given-names>P.</given-names></name><name><surname>Finkelstein</surname><given-names>E.</given-names></name><name><surname>Miller</surname><given-names>T.</given-names></name><name><surname>Fiebelkorn</surname><given-names>I.</given-names></name><name><surname>Zaloshnja</surname><given-names>E.</given-names></name></person-group><article-title>Incidence and lifetime costs of injuries in the United States</article-title><source><italic>Injury Prevention</italic></source><year>2006</year><volume>12</volume><issue>4</issue><fpage>212</fpage><lpage>218</lpage><pub-id pub-id-type=""other"">2-s2.0-33747623062</pub-id><pub-id pub-id-type=""doi"">10.1136/ip.2005.010983</pub-id><pub-id pub-id-type=""pmid"">16887941</pub-id></element-citation></ref><ref id=""B32""><label>32</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Turan</surname><given-names>A.</given-names></name><name><surname>Yang</surname><given-names>D.</given-names></name><name><surname>Bonilla</surname><given-names>A.</given-names></name><etal></etal></person-group><article-title>Morbidity and mortality after massive transfusion in patients undergoing non-cardiac surgery</article-title><source><italic>Canadian Journal of Anesthesia</italic></source><year>2013</year><volume>60</volume><issue>8</issue><fpage>761</fpage><lpage>770</lpage><pub-id pub-id-type=""other"">2-s2.0-84880811212</pub-id><pub-id pub-id-type=""doi"">10.1007/s12630-013-9937-3</pub-id><pub-id pub-id-type=""pmid"">23609882</pub-id></element-citation></ref><ref id=""B33""><label>33</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Johnson</surname><given-names>D. J.</given-names></name><name><surname>Scott</surname><given-names>A. V.</given-names></name><name><surname>Barodka</surname><given-names>V. M.</given-names></name><etal></etal></person-group><article-title>Morbidity and mortality after high-dose transfusion</article-title><source><italic>Anesthesiology</italic></source><year>2016</year><volume>124</volume><issue>2</issue><fpage>387</fpage><lpage>395</lpage><pub-id pub-id-type=""doi"">10.1097/ALN.0000000000000945</pub-id><pub-id pub-id-type=""other"">2-s2.0-84955755882</pub-id><pub-id pub-id-type=""pmid"">26569167</pub-id></element-citation></ref><ref id=""B34""><label>34</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Brunskill</surname><given-names>S. J.</given-names></name><name><surname>Wilkinson</surname><given-names>K. L.</given-names></name><name><surname>Doree</surname><given-names>C.</given-names></name><name><surname>Trivella</surname><given-names>M.</given-names></name><name><surname>Stanworth</surname><given-names>S.</given-names></name></person-group><article-title>Transfusion of fresher versus older red blood cells for all conditions</article-title><source><italic>Cochrane Database of Systematic Reviews</italic></source><year>2015</year><volume>5</volume><issue>5</issue><pub-id pub-id-type=""publisher-id"">CD010801</pub-id><pub-id pub-id-type=""doi"">10.1002/14651858.cd010801.pub2</pub-id><pub-id pub-id-type=""other"">2-s2.0-84945389828</pub-id></element-citation></ref><ref id=""B35""><label>35</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Ng</surname><given-names>M. S. Y.</given-names></name><name><surname>Ng</surname><given-names>A. S. Y.</given-names></name><name><surname>Chan</surname><given-names>J.</given-names></name><name><surname>Tung</surname><given-names>J.-P.</given-names></name><name><surname>Fraser</surname><given-names>J. F.</given-names></name></person-group><article-title>Effects of packed red blood cell storage duration on post-transfusion clinical outcomes: a meta-analysis and systematic review</article-title><source><italic>Intensive Care Medicine</italic></source><year>2015</year><volume>41</volume><issue>12</issue><fpage>2087</fpage><lpage>2097</lpage><pub-id pub-id-type=""other"">2-s2.0-84946486214</pub-id><pub-id pub-id-type=""doi"">10.1007/s00134-015-4078-5</pub-id><pub-id pub-id-type=""pmid"">26438223</pub-id></element-citation></ref><ref id=""B36""><label>36</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Sun</surname><given-names>J.</given-names></name><name><surname>Solomon</surname><given-names>S. B.</given-names></name><name><surname>Klein</surname><given-names>H. G.</given-names></name><name><surname>Natanson</surname><given-names>C.</given-names></name></person-group><article-title>Transfusion of older stored blood and risk of death: a meta-analysis</article-title><source><italic>Transfusion</italic></source><year>2012</year><volume>52</volume><issue>6</issue><fpage>1184</fpage><lpage>1195</lpage><pub-id pub-id-type=""doi"">10.1111/j.1537-2995.2011.03466.x</pub-id><pub-id pub-id-type=""other"">2-s2.0-84861782317</pub-id><pub-id pub-id-type=""pmid"">22188419</pub-id></element-citation></ref><ref id=""B37""><label>37</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Vamvakas</surname><given-names>E. C.</given-names></name><name><surname>Carven</surname><given-names>J. H.</given-names></name></person-group><article-title>Transfusion and postoperative pneumonia in coronary artery bypass graft surgery: effect of the length of storage of transfused red cells</article-title><source><italic>Transfusion</italic></source><year>1999</year><volume>39</volume><issue>7</issue><fpage>701</fpage><lpage>710</lpage><pub-id pub-id-type=""doi"">10.1046/j.1537-2995.1999.39070701.x</pub-id><pub-id pub-id-type=""other"">2-s2.0-0032776024</pub-id><pub-id pub-id-type=""pmid"">10413277</pub-id></element-citation></ref><ref id=""B38""><label>38</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Basran</surname><given-names>S.</given-names></name><name><surname>Frumento</surname><given-names>R. J.</given-names></name><name><surname>Cohen</surname><given-names>A.</given-names></name><etal></etal></person-group><article-title>The association between duration of storage of transfused red blood cells and morbidity and mortality after reoperative cardiac surgery</article-title><source><italic>Anesthesia and Analgesia</italic></source><year>2006</year><volume>103</volume><issue>1</issue><fpage>15</fpage><lpage>20</lpage><pub-id pub-id-type=""other"">2-s2.0-33745855540</pub-id><pub-id pub-id-type=""doi"">10.1213/01.ane.0000221167.58135.3d</pub-id><pub-id pub-id-type=""pmid"">16790618</pub-id></element-citation></ref><ref id=""B39""><label>39</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Wasser</surname><given-names>M. N. J. M.</given-names></name><name><surname>Houbiers</surname><given-names>J. G. A.</given-names></name><name><surname>D'Amaro</surname><given-names>J.</given-names></name><etal></etal></person-group><article-title>The effect of fresh versus stored blood on post-operative bleeding after coronary bypass surgery: a prospective randomized study</article-title><source><italic>British Journal of Haematology</italic></source><year>1989</year><volume>72</volume><issue>1</issue><fpage>81</fpage><lpage>84</lpage><pub-id pub-id-type=""doi"">10.1111/j.1365-2141.1989.tb07656.x</pub-id><pub-id pub-id-type=""other"">2-s2.0-0024563319</pub-id><pub-id pub-id-type=""pmid"">2786735</pub-id></element-citation></ref><ref id=""B40""><label>40</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Yap</surname><given-names>C.-H.</given-names></name><name><surname>Lau</surname><given-names>L.</given-names></name><name><surname>Krishnaswamy</surname><given-names>M.</given-names></name><name><surname>Gaskell</surname><given-names>M.</given-names></name><name><surname>Yii</surname><given-names>M.</given-names></name></person-group><article-title>Age of transfused red cells and early outcomes after cardiac surgery</article-title><source><italic>Annals of Thoracic Surgery</italic></source><year>2008</year><volume>86</volume><issue>2</issue><fpage>554</fpage><lpage>559</lpage><pub-id pub-id-type=""doi"">10.1016/j.athoracsur.2008.04.040</pub-id><pub-id pub-id-type=""other"">2-s2.0-47149104543</pub-id><pub-id pub-id-type=""pmid"">18640333</pub-id></element-citation></ref><ref id=""B41""><label>41</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Spinella</surname><given-names>P. C.</given-names></name><name><surname>Carroll</surname><given-names>C. L.</given-names></name><name><surname>Staff</surname><given-names>I.</given-names></name><etal></etal></person-group><article-title>Duration of red blood cell storage is associated with increased incidence of deep vein thrombosis and in hospital mortality in patients with traumatic injuries</article-title><source><italic>Critical Care</italic></source><year>2009</year><volume>13</volume><issue>5, article R151</issue><pub-id pub-id-type=""doi"">10.1186/cc8050</pub-id><pub-id pub-id-type=""other"">2-s2.0-77949901861</pub-id></element-citation></ref><ref id=""B42""><label>42</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Vandromme</surname><given-names>M. J.</given-names></name><name><surname>McGwin</surname><given-names>G.</given-names></name><name><surname>Weinberg</surname><given-names>J. A.</given-names></name></person-group><article-title>Blood transfusion in the critically ill: does storage age matter?</article-title><source><italic>Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine</italic></source><year>2009</year><volume>17, article 35</volume><pub-id pub-id-type=""doi"">10.1186/1757-7241-17-35</pub-id><pub-id pub-id-type=""other"">2-s2.0-77249176482</pub-id></element-citation></ref><ref id=""B43""><label>43</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Weinberg</surname><given-names>J. A.</given-names></name><name><surname>McGwin</surname><given-names>G.</given-names></name><name><surname>Marques</surname><given-names>M. B.</given-names></name><etal></etal></person-group><article-title>Transfusions in the less severely injured: does age of transfused blood affect outcomes?</article-title><source><italic>The Journal of Trauma: Injury, Infection, and Critical Care</italic></source><year>2008</year><volume>65</volume><issue>4</issue><fpage>794</fpage><lpage>798</lpage><pub-id pub-id-type=""doi"">10.1097/TA.0b013e318184aa11</pub-id></element-citation></ref><ref id=""B44""><label>44</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Purdy</surname><given-names>F. R.</given-names></name><name><surname>Tweeddale</surname><given-names>M. G.</given-names></name><name><surname>Merrick</surname><given-names>P. M.</given-names></name></person-group><article-title>Association of mortality with age of blood transfused in septic ICU patients</article-title><source><italic>Canadian Journal of Anaesthesia</italic></source><year>1997</year><volume>44</volume><issue>12</issue><fpage>1256</fpage><lpage>1261</lpage><pub-id pub-id-type=""other"">2-s2.0-0031426967</pub-id><pub-id pub-id-type=""doi"">10.1007/BF03012772</pub-id><pub-id pub-id-type=""pmid"">9429042</pub-id></element-citation></ref><ref id=""B45""><label>45</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Heddle</surname><given-names>N. M.</given-names></name><name><surname>Cook</surname><given-names>R. J.</given-names></name><name><surname>Arnold</surname><given-names>D. M.</given-names></name><etal></etal></person-group><article-title>Effect of short-term vs. long-term blood storage on mortality after transfusion</article-title><source><italic>The New England Journal of Medicine</italic></source><year>2016</year><volume>375</volume><issue>20</issue><fpage>1937</fpage><lpage>1945</lpage><pub-id pub-id-type=""doi"">10.1056/NEJMoa1609014</pub-id><pub-id pub-id-type=""pmid"">27775503</pub-id></element-citation></ref><ref id=""B46""><label>46</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>D'almeida</surname><given-names>M. S.</given-names></name><name><surname>Jagger</surname><given-names>J.</given-names></name><name><surname>Duggan</surname><given-names>M.</given-names></name><name><surname>White</surname><given-names>M.</given-names></name><name><surname>Ellis</surname><given-names>C.</given-names></name><name><surname>Chin-Yee</surname><given-names>I. H.</given-names></name></person-group><article-title>A comparison of biochemical and functional alterations of rat and human erythrocytes stored in CPDA-1 for 29 days: implications for animal models of transfusion</article-title><source><italic>Transfusion Medicine</italic></source><year>2000</year><volume>10</volume><issue>4</issue><fpage>291</fpage><lpage>303</lpage><pub-id pub-id-type=""doi"">10.1046/j.1365-3148.2000.00267.x</pub-id><pub-id pub-id-type=""other"">2-s2.0-0034531327</pub-id><pub-id pub-id-type=""pmid"">11123813</pub-id></element-citation></ref><ref id=""B47""><label>47</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Grimshaw</surname><given-names>K.</given-names></name><name><surname>Sahler</surname><given-names>J.</given-names></name><name><surname>Spinelli</surname><given-names>S. L.</given-names></name><name><surname>Phipps</surname><given-names>R. P.</given-names></name><name><surname>Blumberg</surname><given-names>N.</given-names></name></person-group><article-title>New frontiers in transfusion biology: identification and significance of mediators of morbidity and mortality in stored red blood cells</article-title><source><italic>Transfusion</italic></source><year>2011</year><volume>51</volume><issue>4</issue><fpage>874</fpage><lpage>880</lpage><pub-id pub-id-type=""doi"">10.1111/j.1537-2995.2011.03095.x</pub-id><pub-id pub-id-type=""other"">2-s2.0-79954606146</pub-id><pub-id pub-id-type=""pmid"">21496049</pub-id></element-citation></ref><ref id=""B48""><label>48</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>McDaniel</surname><given-names>L. M.</given-names></name><name><surname>Triulzi</surname><given-names>D. J.</given-names></name><name><surname>Cramer</surname><given-names>J.</given-names></name><etal></etal></person-group><article-title>Massive transfusion protocol activation does not result in preferential use of older red blood cells</article-title><source><italic>Journal of Blood Transfusion</italic></source><year>2014</year><volume>2014</volume><fpage>5</fpage><pub-id pub-id-type=""publisher-id"">328967</pub-id><pub-id pub-id-type=""doi"">10.1155/2014/328967</pub-id></element-citation></ref><ref id=""B49""><label>49</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Goel</surname><given-names>R.</given-names></name><name><surname>Johnson</surname><given-names>D. J.</given-names></name><name><surname>Scott</surname><given-names>A. V.</given-names></name><etal></etal></person-group><article-title>Red blood cells stored 35 days or more are associated with adverse outcomes in high-risk patients</article-title><source><italic>Transfusion</italic></source><year>2016</year><volume>56</volume><issue>7</issue><fpage>1690</fpage><lpage>1698</lpage><pub-id pub-id-type=""other"">2-s2.0-84977660707</pub-id><pub-id pub-id-type=""doi"">10.1111/trf.13559</pub-id><pub-id pub-id-type=""pmid"">27062463</pub-id></element-citation></ref><ref id=""B50""><label>50</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Rahbar</surname><given-names>E.</given-names></name><name><surname>Fox</surname><given-names>E. E.</given-names></name><name><surname>Del Junco</surname><given-names>D. J.</given-names></name><etal></etal></person-group><article-title>Early resuscitation intensity as a surrogate for bleeding severity and early mortality in the PROMMTT study</article-title><source><italic>Journal of Trauma and Acute Care Surgery</italic></source><year>2013</year><volume>75</volume><issue>1, supplement 1</issue><fpage>S16</fpage><lpage>S23</lpage><pub-id pub-id-type=""doi"">10.1097/TA.0b013e31828fa535</pub-id><pub-id pub-id-type=""other"">2-s2.0-84880402299</pub-id><pub-id pub-id-type=""pmid"">23778506</pub-id></element-citation></ref><ref id=""B51""><label>51</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Trickey</surname><given-names>A. W.</given-names></name><name><surname>Fox</surname><given-names>E. E.</given-names></name><name><surname>Del Junco</surname><given-names>D. J.</given-names></name><etal></etal></person-group><article-title>The impact of missing trauma data on predicting massive transfusion</article-title><source><italic>Journal of Trauma and Acute Care Surgery</italic></source><year>2013</year><volume>75</volume><issue>1, supplement 1</issue><fpage>S68</fpage><lpage>S74</lpage><pub-id pub-id-type=""doi"">10.1097/TA.0b013e3182914530</pub-id><pub-id pub-id-type=""other"">2-s2.0-84880416692</pub-id><pub-id pub-id-type=""pmid"">23778514</pub-id></element-citation></ref></ref-list>"
10.1213/01.ane.0000221167.58135.3d	"<floats-group><fig id=""fig1"" orientation=""portrait"" position=""float""><label>Figure 1</label><caption><p>Enrolment scheme.</p></caption><graphic xlink:href=""BMRI2017-3718615.001""></graphic></fig><fig id=""fig2"" orientation=""portrait"" position=""float""><label>Figure 2</label><caption><p>(a) Univariable relationship between patient mean red blood cell (RBC) storage duration and in-hospital mortality. Results presented as estimate and pointwise 95% confidence interval. A histogram of the observed values of patient mean RBC storage duration underlies the plot. The<italic>P</italic>value represents a Chi-squared test of association for a univariable logistic regression model which incorporated restricted cubic splines to allow for nonlinearities. (b) Univariable relationship between patient mean red blood cell (RBC) storage duration and in-hospital mortality, separately for trauma (dashed lines) and nontrauma (continuous line/shaded region) patients. Results presented as group-specific estimates and pointwise 95% confidence intervals. Histograms of the observed values of patient mean RBC storage duration underlie the plot. The lack of significance indicated by the<italic>P</italic>value in the figure indicates that our data did not support the hypothesis that the nature of the relationship differed among the groups (i.e., test for the interaction between group and patient mean RBC storage duration).</p></caption><graphic xlink:href=""BMRI2017-3718615.002""></graphic></fig><fig id=""fig3"" orientation=""portrait"" position=""float""><label>Figure 3</label><caption><p>Histograms of the observed values of patient RBC storage duration assembled taking (a) mean, (b) median, (c) minimum, and (d) maximum storage duration as dependent variable. The histogram indicates lack of discrimination between short and prolonged stored blood products.</p></caption><graphic xlink:href=""BMRI2017-3718615.003""></graphic></fig><table-wrap content-type=""sidewaystable"" id=""tab1"" orientation=""portrait"" position=""float""><label>Table 1</label><caption><p>Summary of baseline patient characteristics by quartiles of patient-specific mean storage duration of transfused red blood cells. Statistics reported as a percentage, mean ± standard deviation, or median [first quartile, third quartile]. Medians and quartiles are reported when the sample skewness coefficient is &gt;0.9 in absolute value.</p></caption><table frame=""hsides"" rules=""groups""><thead><tr><th align=""left"" colspan=""1"" rowspan=""1"">Factor</th><th align=""center"" colspan=""1"" rowspan=""1"">Level</th><th align=""center"" colspan=""1"" rowspan=""1"">First quartile<break></break>(8.0–17.7 days)</th><th align=""center"" colspan=""1"" rowspan=""1"">Second quartile<break></break>(17.7–21.6 days)</th><th align=""center"" colspan=""1"" rowspan=""1"">Third quartile<break></break>(21.6–26.6 days)</th><th align=""center"" colspan=""1"" rowspan=""1"">Fourth quartile<break></break>(26.6–36.6 days)</th><th align=""center"" colspan=""1"" rowspan=""1"">Percent missing</th></tr></thead><tbody><tr><td align=""left"" colspan=""1"" rowspan=""1""></td><td align=""center"" colspan=""1"" rowspan=""1""></td><td align=""center"" colspan=""1"" rowspan=""1"">(<italic>N</italic>= 77)</td><td align=""center"" colspan=""1"" rowspan=""1"">(<italic>N</italic>= 76)</td><td align=""center"" colspan=""1"" rowspan=""1"">(<italic>N</italic>= 76)</td><td align=""center"" colspan=""1"" rowspan=""1"">(<italic>N</italic>= 76)</td><td align=""center"" colspan=""1"" rowspan=""1""></td></tr><tr><td colspan=""7"" rowspan=""1""><article article-type=""research-article"" xml:lang=""en"" xmlns:mml=""http://www.w3.org/1998/Math/MathML"" xmlns:xlink=""http://www.w3.org/1999/xlink""><?properties open_access?><front><journal-meta><journal-id journal-id-type=""nlm-ta"">Crit Care</journal-id><journal-id journal-id-type=""iso-abbrev"">Crit Care</journal-id><journal-title-group><journal-title>Critical Care</journal-title></journal-title-group><issn pub-type=""ppub"">1364-8535</issn><issn pub-type=""epub"">1466-609X</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type=""pmid"">23566599</article-id><article-id pub-id-type=""pmc"">3672637</article-id><article-id pub-id-type=""publisher-id"">cc12600</article-id><article-id pub-id-type=""doi"">10.1186/cc12600</article-id><article-categories><subj-group subj-group-type=""heading""><subject>Research</subject></subj-group></article-categories><title-group><article-title>Relationship between red cell storage duration and outcomes in adults receiving red cell transfusions: a systematic review</article-title></title-group><contrib-group><contrib contrib-type=""author"" id=""A1""><name><surname>Lelubre</surname><given-names>Christophe</given-names></name><xref ref-type=""aff"" rid=""I1"">1</xref><email>Christophe.Lelubre@ulb.ac.be</email></contrib><contrib contrib-type=""author"" corresp=""yes"" id=""A2""><name><surname>Vincent</surname><given-names>Jean-Louis</given-names></name><xref ref-type=""aff"" rid=""I1"">1</xref><email>jlvincen@ulb.ac.be</email></contrib></contrib-group><aff id=""I1""><label>1</label>Department of Intensive Care, Erasme Hospital, Université Libre de Bruxelles, Route de Lennik 808, 1070 Brussels, Belgium</aff><pub-date pub-type=""ppub""><year>2013</year></pub-date><pub-date pub-type=""epub""><day>8</day><month>4</month><year>2013</year></pub-date><volume>17</volume><issue>2</issue><fpage>R66</fpage><lpage>R66</lpage><history><date date-type=""received""><day>22</day><month>1</month><year>2013</year></date><date date-type=""rev-recd""><day>26</day><month>3</month><year>2013</year></date><date date-type=""accepted""><day>5</day><month>4</month><year>2013</year></date></history><permissions><copyright-statement>Copyright © 2013 Lelubre et al.; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2013</copyright-year><copyright-holder>Lelubre et al.; licensee BioMed Central Ltd.</copyright-holder><license license-type=""open-access"" xlink:href=""http://creativecommons.org/licenses/by/2.0""><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type=""uri"" xlink:href=""http://creativecommons.org/licenses/by/2.0"">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href=""http://ccforum.com/content/17/2/R66""></self-uri><abstract><sec><title>Introduction</title><p>The duration of red blood cell (RBC) storage before transfusion may alter RBC function and supernatant and, therefore, influence the incidence of complications or even mortality.</p></sec><sec><title>Methods</title><p>A MEDLINE search from 1983 to December 2012 was performed to identify studies reporting age of transfused RBCs and mortality or morbidity in adult patients.</p></sec><sec><title>Results</title><p>Fifty-five studies were identified; most were single-center (93%) and retrospective (64%), with only a few, small randomized studies (eight studies, 14.5%). The numbers of subjects included ranged from eight to 364,037. Morbidity outcomes included hospital and intensive care unit (ICU) length of stay (LOS), infections, multiple organ failure, microcirculatory alterations, cancer recurrence, thrombosis, bleeding, vasospasm after subarachnoid hemorrhage, and cognitive dysfunction. Overall, half of the studies showed no deleterious effects of aged compared to fresh blood on any endpoint. Eleven of twenty-two (50%) studies reported no increased mortality, three of nine (33%) showed no increased LOS with older RBCs and eight of twelve (66%) studies showed no increased risks of organ failure. Ten of eighteen (55%) studies showed increased infections with transfusion of older RBCs. The considerable heterogeneity among studies and numerous methodological flaws precluded a formal meta-analysis.</p></sec><sec><title>Conclusions</title><p>In this systematic review, we could find no definitive argument to support the superiority of fresh over older RBCs for transfusion.</p></sec></abstract></article-meta></front><body><sec sec-type=""intro""><title>Introduction</title><p>Red blood cell (RBC) transfusions are one of the most common medical interventions [<xref ref-type=""bibr"" rid=""B1"">1</xref>]. Although they can be lifesaving, RBC transfusions have come under intense scrutiny over the last few decades [<xref ref-type=""bibr"" rid=""B2"">2</xref>]. In a recent review of 45 observational studies that had reported the impact of transfusion on outcomes in different patient groups (trauma; general, cardiac, orthopedic and neurosurgical; acute coronary syndrome; intensive care (ICU) patients), RBC transfusion was an independent predictor of death, infectious complications and acute respiratory distress syndrome (ARDS) [<xref ref-type=""bibr"" rid=""B3"">3</xref>].</p><p>The 'storage lesion' refers to the multiple complex biochemical and biomechanical alterations that occur during<italic>ex vivo</italic>storage, modifying RBC properties and the supernatant [<xref ref-type=""bibr"" rid=""B4"">4</xref>] (Table<xref ref-type=""table"" rid=""T1"">1</xref>). A progressive decrease in 2,3-diphosphoglycerate (DPG) levels may impair oxygen delivery [<xref ref-type=""bibr"" rid=""B5"">5</xref>], and a decreased adenosine triphosphate (ATP) pool reduces Na<sup>+</sup>-K<sup>+</sup>-ATPase activity and, possibly, ATP-mediated hypoxic vasodilation. Decreased antioxidant capacities of the erythrocyte may alter reduction of methemoglobin [<xref ref-type=""bibr"" rid=""B6"">6</xref>], generating reactive oxygen species (ROS) through the Fenton reaction. Complex, irreversible membrane changes (including alterations in protein band 3 [<xref ref-type=""bibr"" rid=""B7"">7</xref>] and release of procoagulant [<xref ref-type=""bibr"" rid=""B8"">8</xref>] vesicles) lead to poorly deformable sphero-echinocytes with increased adherence to the endothelium [<xref ref-type=""bibr"" rid=""B9"">9</xref>] and increased susceptibility to phagocytosis [<xref ref-type=""bibr"" rid=""B10"">10</xref>]. Changes also occur in the supernatant, with a progressive decrease in pH, increased potassium concentration, and release of proinflammatory molecules, complement or biologically active lipids (platelet-activating factor). Release of hemoglobin (free or contained in microparticles) may scavenge nitric oxide (NO) in the transfusion recipient and lead to vasoconstriction [<xref ref-type=""bibr"" rid=""B11"">11</xref>] and iron and heme may generate redox injuries, cytotoxicity and inflammation [<xref ref-type=""bibr"" rid=""B12"">12</xref>,<xref ref-type=""bibr"" rid=""B13"">13</xref>]. RBCs prone to increased oxidative injury undergo protein and lipid peroxidation with release of lysophospholipids, which may cause transfusion-associated acute lung injury (ALI) [<xref ref-type=""bibr"" rid=""B14"">14</xref>]. However, animal models describing altered blood flow following transfusion of old RBCs [<xref ref-type=""bibr"" rid=""B15"">15</xref>,<xref ref-type=""bibr"" rid=""B16"">16</xref>] may be of limited relevance to humans [<xref ref-type=""bibr"" rid=""B17"">17</xref>]. Some alterations described<italic>ex vivo</italic>, such as the decreases in 2,3-DPG or ATP levels, may be at least partly reversible after transfusion [<xref ref-type=""bibr"" rid=""B17"">17</xref>]. Therefore, the impact of storage lesions observed<italic>in vitro</italic>may not be relevant clinically [<xref ref-type=""bibr"" rid=""B18"">18</xref>,<xref ref-type=""bibr"" rid=""B19"">19</xref>]. Some recent meta-analyses [<xref ref-type=""bibr"" rid=""B20"">20</xref>-<xref ref-type=""bibr"" rid=""B22"">22</xref>] have been attempted, but the heterogeneity and methodological limitations of the studies included prevented definitive conclusions. The duration of RBC storage varies among units. Large observational studies have reported a mean duration of RBC storage of between 16 and 21 days [<xref ref-type=""bibr"" rid=""B23"">23</xref>], with a maximum storage duration before transfusion being generally limited to 42 days (with standard preservative solutions). However, the regulatory requirements for this limit are based only on the percentage RBC survival 24 h after transfusion (which has to be ≥ 75%), not on oxygen delivery capacities or clinical endpoints [<xref ref-type=""bibr"" rid=""B24"">24</xref>].</p><table-wrap id=""T1"" position=""float""><label>Table 1</label><caption><p>Main components of the storage lesion.</p></caption><table frame=""hsides"" rules=""groups""><thead><tr><th align=""center"">Changes occurring to the RBC</th><th align=""center"">Changes occurring in the supernatant</th></tr></thead><tbody><tr><td align=""center""><italic>Metabolic changes</italic></td><td></td></tr><tr><td><hr/></td><td></td></tr><tr><td align=""center"">• Decreased 2-3 DPG, possibly with impaired oxygen delivery [<xref ref-type=""bibr"" rid=""B5"">5</xref>]<break></break>• Decreased phosphate and adenine pool (AMP, ADP, ATP) [<xref ref-type=""bibr"" rid=""B24"">24</xref>]<break></break>• Decreased glutathione levels [<xref ref-type=""bibr"" rid=""B6"">6</xref>]<break></break>• Decreased S-nitroso hemoglobin [<xref ref-type=""bibr"" rid=""B110"">110</xref>]<break></break>• Increased lactate levels</td><td align=""center"">• Decreased pH<break></break>• Increased potassium concentrations (decreased Na-K-ATPase activity) with increased risks of hyperkalemia<break></break>• Release of various molecules:<break></break>○ Proinflammatory cytokines (IL-1beta, IL-6, IL-8, TNF-alpha) and complement<break></break>○ Biologically active lipids such as platelet-activating factor (PAF) [<xref ref-type=""bibr"" rid=""B14"">14</xref>]<break></break>○ Free hemoglobin prone to scavenge nitric oxide (NO) of the recipient (together with Hb-containing microparticles) [<xref ref-type=""bibr"" rid=""B109"">109</xref>]<break></break>○ Heme and iron [<xref ref-type=""bibr"" rid=""B12"">12</xref>] with potential redox injuries, cytotoxicity and inflammation</td></tr><tr><td><hr/></td><td></td></tr><tr><td align=""center""><italic>Oxidative stress</italic></td><td></td></tr><tr><td><hr/></td><td></td></tr><tr><td align=""center"">• Protein oxidation including cytoskeleton [<xref ref-type=""bibr"" rid=""B111"">111</xref>]<break></break>• Lipid peroxidation, generation of lysophospholipids prone to cause cases of TRALI, generation of prostaglandins and isoprostanes [<xref ref-type=""bibr"" rid=""B112"">112</xref>]</td><td></td></tr><tr><td><hr/></td><td></td></tr><tr><td align=""center""><italic>Shape and membrane changes</italic></td><td></td></tr><tr><td><hr/></td><td></td></tr><tr><td align=""center"">• Shift from early reversible echinocytes to irreversible sphero-echinocytes<break></break>• Generation of microvesicles with procoagulant properties<break></break>• Increased RBC rigidity and adherence to vascular endothelium<sup>2</sup><break></break>• Decreased CD47 expression, increased phosphatidylserine exposure</td><td></td></tr></tbody></table><table-wrap-foot><p>ADP, adenosine diphosphate; AMP, adenosine monophosphate; ATP, adenosine triphosphate; DPG, diphosphoglycerate; Hb, hemoglobin; IL, interleukin; RBC, red blood cell; TNF-alpha, tumor necrosis factor alpha; TRALI, transfusion-related acute lung injury.</p></table-wrap-foot></table-wrap><p>The aim of this article was to review the clinical evidence related to the potential impact of RBC storage on outcomes in adult patients.</p></sec><sec sec-type=""materials|methods""><title>Materials and methods</title><p>A MEDLINE search (accessed through Pubmed and Ovid) of the literature was performed to identify studies in adult patients that linked the duration of storage of transfused RBCs with physiologic variables (oxygen consumption, alterations of microcirculation), morbidity and mortality. Morbidity outcomes included infection; postoperative bleeding; thrombosis, including myocardial infarction; duration of mechanical ventilation; multiple organ dysfunction including acute renal failure; ICU and hospital lengths of stay (LOS); and other less common endpoints, such as cancer recurrence, vasospasm after subarachnoid hemorrhage (SAH) or cognitive dysfunction. Medical Subject Headings (MeSH) terms ('Erythrocytes', 'Blood Transfusion', 'Mortality', 'Infection', 'Pneumonia', 'Acute Kidney Injury', 'Length of Stay', 'Multiple Organ Failure', 'Respiration, Artificial', 'Venous Thrombosis', 'Neoplasms', 'Microcirculation', 'Oxygen Consumption', 'Vasospasm, Intracranial') and non-MeSH terms ('Age', 'Storage', 'Duration') were used for the search process. All studies on adult patients (more than 19 years old) published from 1983 to December 2012 (last access, December 15, 2012) and written in any language were selected for individual screening. The Cochrane Library was searched using the same search strategy. Bibliographic references of relevant studies were also checked manually to complete the search process. Review articles, editorials, meta-analyses, abstracts of scientific meetings or studies that were subsequently retracted were not included. The flow diagram related to the search process is shown in Figure<xref ref-type=""fig"" rid=""F1"">1</xref>according to the PRISMA statement [<xref ref-type=""bibr"" rid=""B25"">25</xref>]. Once selected, additional data regarding potential confounders (for example, data on leukoreduction status) were collected, and studies were grouped according to their primary outcome measure for qualitative synthesis. Given their particular importance in causal inference, randomized controlled trials (RCTs) were also considered separately.</p><fig id=""F1"" position=""float""><label>Figure 1</label><caption><p><bold>Flow diagram of study selection</bold>.</p></caption><graphic xlink:href=""cc12600-1""></graphic></fig><p>Mean values are given +/- standard deviation (SD) and median values are given with interquartile ranges (IQR). All relative risks (RR), odds ratios (OR) or hazard ratios (HR) are provided with 95% confidence intervals (CI).</p></sec><sec sec-type=""results""><title>Results</title><p>The search process retrieved 4,053 (3,902 after duplicate removal) studies, of which 2,183 were excluded, leaving 1,719 studies that were assessed for eligibility (Figure<xref ref-type=""fig"" rid=""F1"">1</xref>). Of these, 1,664 were excluded for various reasons (reviews and editorials, meta-analyses, subsequent retraction of one study on cardiac surgery patients [<xref ref-type=""bibr"" rid=""B26"">26</xref>,<xref ref-type=""bibr"" rid=""B27"">27</xref>], and studies not reporting RBC storage variables or no clinical endpoint as defined earlier). Accordingly, the analysis included 55 studies (Table<xref ref-type=""table"" rid=""T2"">2</xref>), with a total of 407,185 patients. Most studies were retrospective (<italic>n</italic>= 35, 64%) and single-center (<italic>n</italic>= 51, 93%). The number of transfused subjects ranged from eight to 364,037 (median: 268 patients, IQR: 61 to 757). Only a small proportion of the studies were randomized trials (<italic>n</italic>= 8, 14.5%); the eight randomized studies had fewer included patients (median = 21 patients, IQR: 10.5 to 83.75) and, in the majority, physiological variables were reported as the primary outcome measure (<italic>n</italic>= 6 studies) (Table<xref ref-type=""table"" rid=""T3"">3</xref>).</p><table-wrap id=""T2"" position=""float""><label>Table 2</label><caption><p>Overview of the studies reporting the age of transfused red blood cells (RBCs) and patient outcomes.</p></caption><table frame=""hsides"" rules=""groups""><thead><tr><th align=""center"">First author</th><th align=""center"">Year</th><th align=""center"">Year(s) of enrollment</th><th align=""center"">Design</th><th align=""center"">Country/continent</th><th align=""center"">Leuko-reduction</th><th align=""center"">Setting</th><th align=""center"">Number of patients transfused</th><th align=""center"">Summary of main results</th></tr></thead><tbody><tr><td align=""left"" colspan=""9""><bold>Studies addressing mortality</bold></td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Purdy<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B42"">42</xref>]</td><td align=""center"">1997</td><td align=""center"">1992</td><td align=""center"">Retrospective single-center</td><td align=""center"">Canada</td><td align=""center"">NR</td><td align=""center"">ICU septic</td><td align=""center"">31</td><td align=""center"">Non-survivors received a greater proportion of older RBCs</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Mynster<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B53"">53</xref>]</td><td align=""center"">2001</td><td align=""center"">1991-1993</td><td align=""center"">Retrospective multicenter</td><td align=""center"">Europe</td><td align=""center"">No</td><td align=""center"">Cancer</td><td align=""center"">740</td><td align=""center"">Mortality not different between patients transfused with RBCs aged more or less than 21 days</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Murrell<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B48"">48</xref>]</td><td align=""center"">2005</td><td align=""center"">2001-2003</td><td align=""center"">Retrospective single-center</td><td align=""center"">USA</td><td align=""center"">Mix (95% LR)</td><td align=""center"">Trauma</td><td align=""center"">275</td><td align=""center"">No correlation between 'dose of aged blood' and hospital mortality</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">van de Watering<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B38"">38</xref>]</td><td align=""center"">2006</td><td align=""center"">1993-1999</td><td align=""center"">Retrospective single-center</td><td align=""center"">Europe</td><td align=""center"">No</td><td align=""center"">Cardiac surgery</td><td align=""center"">2,732</td><td align=""center"">No correlation between storage time variables and 30-day mortality</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Koch<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B32"">32</xref>]</td><td align=""center"">2008</td><td align=""center"">1998-2006</td><td align=""center"">Retrospective single-center</td><td align=""center"">USA</td><td align=""center"">Mix</td><td align=""center"">Cardiac surgery</td><td align=""center"">6,002</td><td align=""center"">Higher hospital and one-year mortality rate in older blood group</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Yap<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B41"">41</xref>]</td><td align=""center"">2008</td><td align=""center"">2001-2007</td><td align=""center"">Retrospective single-center</td><td align=""center"">Australia</td><td align=""center"">Mix (3.8% LR)</td><td align=""center"">Cardiac surgery</td><td align=""center"">670</td><td align=""center"">No association between storage duration and mortality</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Dessertaine<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B43"">43</xref>]</td><td align=""center"">2008</td><td align=""center"">2005-2006</td><td align=""center"">Retrospective single-center</td><td align=""center"">Europe</td><td align=""center"">Yes</td><td align=""center"">ICU</td><td align=""center"">534</td><td align=""center"">No association between the age of transfused red cells and mortality</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Weinberg<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B44"">44</xref>]</td><td align=""center"">2008</td><td align=""center"">2000-2007</td><td align=""center"">Retrospective single-center</td><td align=""center"">USA</td><td align=""center"">Yes</td><td align=""center"">Trauma</td><td align=""center"">1,813</td><td align=""center"">Transfusion of large (but not small) volumes of older blood associated with an increased risk of death</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Weinberg<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B46"">46</xref>]</td><td align=""center"">2008</td><td align=""center"">2000-2007</td><td align=""center"">Retrospective single-center</td><td align=""center"">USA</td><td align=""center"">Yes</td><td align=""center"">Trauma</td><td align=""center"">430</td><td align=""center"">Slightly increased mortality with transfusion of older blood (&gt; 14 days old)</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Spinella<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B47"">47</xref>]</td><td align=""center"">2009</td><td align=""center"">2004-2007</td><td align=""center"">Retrospective single-center</td><td align=""center"">USA</td><td align=""center"">Mix</td><td align=""center"">Trauma</td><td align=""center"">202</td><td align=""center"">Hospital mortality higher for patients transfused with older RBCs; increased storage time independently associated with mortality</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Edgren<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B30"">30</xref>]</td><td align=""center"">2010</td><td align=""center"">1995-2002</td><td align=""center"">Retrospective multicenter</td><td align=""center"">Europe</td><td align=""center"">Mix</td><td align=""center"">Mix</td><td align=""center"">364,037</td><td align=""center"">5% increased mortality after two years of follow-up</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Weinberg<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B45"">45</xref>]</td><td align=""center"">2010</td><td align=""center"">2000-2009</td><td align=""center"">Retrospective single-center</td><td align=""center"">USA</td><td align=""center"">Yes</td><td align=""center"">Trauma</td><td align=""center"">1,647</td><td align=""center"">Trend toward higher mortality rate with older blood when transfused more than three RBC units</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Eikelboom<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B50"">50</xref>]</td><td align=""center"">2010</td><td align=""center"">2002-2006</td><td align=""center"">Retrospective single-center</td><td align=""center"">Canada</td><td align=""center"">Yes</td><td align=""center"">Cardiovascular disease</td><td align=""center"">4,933</td><td align=""center"">Greater risk of hospital mortality in the highest age quartile of RBCs</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Robinson<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B51"">51</xref>]</td><td align=""center"">2010</td><td align=""center"">1999-2005</td><td align=""center"">Retrospective single-center</td><td align=""center"">Canada</td><td align=""center"">NR</td><td align=""center"">PCI</td><td align=""center"">909</td><td align=""center"">Storage duration associated with 30-day mortality</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">van Straten<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B40"">40</xref>]</td><td align=""center"">2011</td><td align=""center"">1998-2007</td><td align=""center"">Retrospective single-center</td><td align=""center"">Europe</td><td align=""center"">Yes</td><td align=""center"">Cardiac surgery</td><td align=""center"">3,597</td><td align=""center"">No effect of RBC storage duration on early or late postoperative mortality</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">McKenny<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B39"">39</xref>]</td><td align=""center"">2011</td><td align=""center"">2002-2007</td><td align=""center"">Retrospective single-center</td><td align=""center"">Europe</td><td align=""center"">Yes</td><td align=""center"">Cardiac surgery</td><td align=""center"">1,153</td><td align=""center"">No association between RBC storage duration and postoperative mortality</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Kekre<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B54"">54</xref>]</td><td align=""center"">2011</td><td align=""center"">2002-2007</td><td align=""center"">Retrospective single-center</td><td align=""center"">Canada</td><td align=""center"">Yes</td><td align=""center"">HSCT</td><td align=""center"">555</td><td align=""center"">Non-relapse 100-day mortality reduced in the subgroup of patients receiving exclusively old blood (&gt; 14 days old)</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Pettila<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B29"">29</xref>]</td><td align=""center"">2011</td><td align=""center"">2008</td><td align=""center"">Prospective, multicenter</td><td align=""center"">Australia - New Zealand</td><td align=""center"">Mix</td><td align=""center"">ICU</td><td align=""center"">757</td><td align=""center"">Exposure to the highest age quartile of RBCs associated with a higher hospital mortality rate compared to lowest quartile</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Hassan<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B49"">49</xref>]</td><td align=""center"">2011</td><td align=""center"">2003-2005</td><td align=""center"">Retrospective single-center</td><td align=""center"">USA</td><td align=""center"">NR</td><td align=""center"">Trauma</td><td align=""center"">820</td><td align=""center"">Number of older units not associated with increased mortality</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Saager<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B31"">31</xref>]</td><td align=""center"">2012</td><td align=""center"">2005-2009</td><td align=""center"">Retrospective single-center</td><td align=""center"">USA</td><td align=""center"">Yes</td><td align=""center"">Non-cardiac surgery</td><td align=""center"">6,994</td><td align=""center"">No relationship between median RBC storage duration and postoperative mortality (up to two years)</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Dunn<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B52"">52</xref>]</td><td align=""center"">2012</td><td align=""center"">2000-2010</td><td align=""center"">Retrospective single-center</td><td align=""center"">USA</td><td align=""center"">NR</td><td align=""center"">Liver transplant</td><td align=""center"">509</td><td align=""center"">Transfusion of older blood not associated with increased two-year mortality</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Kor<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B28"">28</xref>]</td><td align=""center"">2012</td><td align=""center"">2008-2010</td><td align=""center"">Randomized single-center study</td><td align=""center"">USA</td><td align=""center"">Yes</td><td align=""center"">ICU</td><td align=""center"">100</td><td align=""center"">Similar mortality between fresh and standard issue RBCs but not powered for this outcome</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""left"" colspan=""9""><bold>Studies addressing ICU or hospital length of stay</bold></td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Vamvakas<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B56"">56</xref>]</td><td align=""center"">2000</td><td align=""center"">1995</td><td align=""center"">Retrospective single-center</td><td align=""center"">USA</td><td align=""center"">Mix (mostly not)</td><td align=""center"">Cardiac surgery</td><td align=""center"">268</td><td align=""center"">No association between RBC storage duration and postoperative ICU and hospital LOS</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Keller<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B58"">58</xref>]</td><td align=""center"">2002</td><td align=""center"">1998-1999</td><td align=""center"">Retrospective single-center</td><td align=""center"">USA</td><td align=""center"">No</td><td align=""center"">Trauma</td><td align=""center"">86</td><td align=""center"">Number of units of blood older than 14 days associated with an increased hospital LOS</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Leal-Noval<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B55"">55</xref>]</td><td align=""center"">2003</td><td align=""center"">1998-2000</td><td align=""center"">Prospective single-center</td><td align=""center"">Europe</td><td align=""center"">No</td><td align=""center"">Cardiac surgery</td><td align=""center"">585</td><td align=""center"">No association between mean duration of RBC storage and ICU LOS</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Murrell<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B48"">48</xref>]</td><td align=""center"">2005</td><td align=""center"">2001-2003</td><td align=""center"">Retrospective single-center</td><td align=""center"">USA</td><td align=""center"">Mix (95% LR)</td><td align=""center"">Trauma</td><td align=""center"">275</td><td align=""center"">Association between 'dose of aged blood' and ICU LOS</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">van de Watering<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B38"">38</xref>]</td><td align=""center"">2006</td><td align=""center"">1993-1999</td><td align=""center"">Retrospective single-center</td><td align=""center"">Europe</td><td align=""center"">No</td><td align=""center"">Cardiac surgery</td><td align=""center"">2,732</td><td align=""center"">No correlation between storage time variables and ICU LOS</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Yap<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B41"">41</xref>]</td><td align=""center"">2008</td><td align=""center"">2001-2007</td><td align=""center"">Retrospective single-center</td><td align=""center"">Australia</td><td align=""center"">Mix (3.8% LR)</td><td align=""center"">Cardiac surgery</td><td align=""center"">670</td><td align=""center"">No association between length of storage and ICU LOS</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">McKenny<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B39"">39</xref>]</td><td align=""center"">2011</td><td align=""center"">2002-2007</td><td align=""center"">Retrospective single-center</td><td align=""center"">Europe</td><td align=""center"">Yes</td><td align=""center"">Cardiac surgery</td><td align=""center"">1,153</td><td align=""center"">No association between length of storage and ICU LOS</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Sanders<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B57"">57</xref>]</td><td align=""center"">2011</td><td align=""center"">2005-2007</td><td align=""center"">Retrospective single-center</td><td align=""center"">Europe</td><td align=""center"">Yes</td><td align=""center"">Cardiac surgery</td><td align=""center"">444</td><td align=""center"">Age of blood was a significant but modest predictor of postoperative LOS</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Kekre<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B54"">54</xref>]</td><td align=""center"">2011</td><td align=""center"">2002-2007</td><td align=""center"">Retrospective single-center</td><td align=""center"">Canada</td><td align=""center"">Yes</td><td align=""center"">HSCT</td><td align=""center"">555</td><td align=""center"">No correlation between age of transfused RBCs and hospital LOS</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""left"" colspan=""9""><bold>Studies addressing age of transfused RBCs and occurrence of infections</bold></td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Edna<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B61"">61</xref>]</td><td align=""center"">1998</td><td align=""center"">1980-1992</td><td align=""center"">Retrospective single-center</td><td align=""center"">Europe</td><td align=""center"">No</td><td align=""center"">Cancer</td><td align=""center"">240</td><td align=""center"">Age of RBCs not different in subjects developing postoperative infections and those who did not</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Vamvakas<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B59"">59</xref>]</td><td align=""center"">1999</td><td align=""center"">1995</td><td align=""center"">Retrospective single-center</td><td align=""center"">USA</td><td align=""center"">Mix</td><td align=""center"">Cardiac surgery</td><td align=""center"">256</td><td align=""center"">Independent relationship between the age of transfused RBCs and the incidence of postoperative pneumonia or wound infection</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Mynster<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B53"">53</xref>]</td><td align=""center"">2001</td><td align=""center"">1991-1993</td><td align=""center"">Retrospective multicenter</td><td align=""center"">Europe</td><td align=""center"">No</td><td align=""center"">Cancer</td><td align=""center"">740</td><td align=""center"">Increased risks of postoperative infections with transfusions of RBCs aged 20 days or more</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Offner<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B64"">64</xref>]</td><td align=""center"">2002</td><td align=""center"">1992-</td><td align=""center"">Retrospective single-center</td><td align=""center"">USA</td><td align=""center"">No</td><td align=""center"">Trauma</td><td align=""center"">61</td><td align=""center"">Number of units older than 14 and 21 days as an independent risk factor for major infections</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Leal-Noval<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B55"">55</xref>]</td><td align=""center"">2003</td><td align=""center"">1998-2000</td><td align=""center"">Prospective single-center</td><td align=""center"">Europe</td><td align=""center"">No</td><td align=""center"">Cardiac surgery</td><td align=""center"">585</td><td align=""center"">Independent relation between the oldest RBC unit and postoperative pneumonia</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Taylor<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B66"">66</xref>]</td><td align=""center"">2006</td><td align=""center"">2001-2003</td><td align=""center"">Prospective</td><td align=""center"">USA</td><td align=""center"">Mix</td><td align=""center"">ICU</td><td align=""center"">449</td><td align=""center"">Maximum age of transfused RBCs not associated with increased risks of nosocomial infections</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Koch<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B32"">32</xref>]</td><td align=""center"">2008</td><td align=""center"">1998-2006</td><td align=""center"">Retrospective single-center</td><td align=""center"">USA</td><td align=""center"">Mix</td><td align=""center"">Cardiac surgery</td><td align=""center"">6,002</td><td align=""center"">Higher rates of postoperative sepsis or septicemia (but not pneumonia or wound infections) with older RBCs</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Weinberg<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B46"">46</xref>]</td><td align=""center"">2008</td><td align=""center"">2000-2007</td><td align=""center"">Retrospective single-center</td><td align=""center"">USA</td><td align=""center"">Yes</td><td align=""center"">Trauma</td><td align=""center"">430</td><td align=""center"">Occurrence of pneumonia related to the volume of old blood (&gt; 14 days old) transfused</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Yap<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B41"">41</xref>]</td><td align=""center"">2008</td><td align=""center"">2001-2007</td><td align=""center"">Retrospective single-center</td><td align=""center"">Australia</td><td align=""center"">Mix (3.8% LR)</td><td align=""center"">Cardiac surgery</td><td align=""center"">670</td><td align=""center"">No association between storage of RBCs and postoperative pneumonia</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Dessertaine<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B43"">43</xref>]</td><td align=""center"">2008</td><td align=""center"">2005-2006</td><td align=""center"">Retrospective single-center</td><td align=""center"">Europe</td><td align=""center"">Yes</td><td align=""center"">ICU</td><td align=""center"">534</td><td align=""center"">No independent association between the age of RBCs and nosocomial infections</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Vandromme<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B63"">63</xref>]</td><td align=""center"">2009</td><td align=""center"">2004-2007</td><td align=""center"">Retrospective single-center</td><td align=""center"">USA</td><td align=""center"">Yes</td><td align=""center"">Trauma</td><td align=""center"">1,183</td><td align=""center"">Increased risks of pneumonia after transfusion of exclusively old RBCs (&gt; 14 days)</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Basora<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B113"">113</xref>]</td><td align=""center"">2010</td><td align=""center"">2004-2005</td><td align=""center"">Retrospective single-center</td><td align=""center"">Europe</td><td align=""center"">Yes</td><td align=""center"">Knee arthroplasty</td><td align=""center"">335</td><td align=""center"">No independent association between age of transfused RBCs and postoperative wound infection</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">McKenny<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B39"">39</xref>]</td><td align=""center"">2011</td><td align=""center"">2002-2007</td><td align=""center"">Retrospective single-center</td><td align=""center"">Europe</td><td align=""center"">Yes</td><td align=""center"">Cardiac surgery</td><td align=""center"">1,153</td><td align=""center"">No association between storage of RBCs and postoperative pneumonia</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Andreasen<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B60"">60</xref>]</td><td align=""center"">2011</td><td align=""center"">2003-2008</td><td align=""center"">Retrospective multicenter</td><td align=""center"">Europe</td><td align=""center"">No</td><td align=""center"">Cardiac surgery</td><td align=""center"">1,748</td><td align=""center"">Greater risk of postoperative wound infections and septicemia with RBCs older than 14 days</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Hassan<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B49"">49</xref>]</td><td align=""center"">2011</td><td align=""center"">2003-2005</td><td align=""center"">Retrospective single-center</td><td align=""center"">USA</td><td align=""center"">NR</td><td align=""center"">Trauma</td><td align=""center"">820</td><td align=""center"">Number of units older than 14 days as a significant risk factor for severe sepsis or septic shock</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Juffermans<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B67"">67</xref>]</td><td align=""center"">2011</td><td align=""center"">2004-2007</td><td align=""center"">Retrospective single-center</td><td align=""center"">Europe</td><td align=""center"">Yes</td><td align=""center"">ICU septic</td><td align=""center"">67</td><td align=""center"">Storage time as a confounder for the association of RBCs with infection</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Juffermans<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B65"">65</xref>]</td><td align=""center"">2012</td><td align=""center"">2004-2007</td><td align=""center"">Retrospective single-center</td><td align=""center"">Europe</td><td align=""center"">Yes</td><td align=""center"">Trauma/TBI</td><td align=""center"">196</td><td align=""center"">Modest association between transfusion of RBCs older than 14 days and occurrence of new infections</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Dunn<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B52"">52</xref>]</td><td align=""center"">2012</td><td align=""center"">2000-2010</td><td align=""center"">Retrospective single-center</td><td align=""center"">USA</td><td align=""center"">NR</td><td align=""center"">Liver transplant</td><td align=""center"">509</td><td align=""center"">No independent association between the age of RBCs and postoperative infections</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""left"" colspan=""9""><bold>Studies addressing organ failure</bold></td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Zallen<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B68"">68</xref>]</td><td align=""center"">1999</td><td align=""center"">NR</td><td align=""center"">Retrospective single-center</td><td align=""center"">USA</td><td align=""center"">NR</td><td align=""center"">Trauma</td><td align=""center"">63</td><td align=""center"">Mean age of blood (or number of units older than 14 or 21 days) as independent risk factors for MOF</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Vamvakas<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B56"">56</xref>]</td><td align=""center"">2000</td><td align=""center"">1995</td><td align=""center"">Retrospective single-center</td><td align=""center"">USA</td><td align=""center"">Mix (mostly not)</td><td align=""center"">Cardiac surgery</td><td align=""center"">268</td><td align=""center"">Length of RBC storage not associated with prolonged endotracheal intubation</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Keller<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B58"">58</xref>]</td><td align=""center"">2002</td><td align=""center"">1998-1999</td><td align=""center"">Retrospective single-center</td><td align=""center"">USA</td><td align=""center"">No</td><td align=""center"">Trauma</td><td align=""center"">86</td><td align=""center"">Duration of MV not associated with RBC storage duration</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Leal-Noval<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B55"">55</xref>]</td><td align=""center"">2003</td><td align=""center"">1998-2000</td><td align=""center"">Prospective single-center</td><td align=""center"">Europe</td><td align=""center"">No</td><td align=""center"">Cardiac surgery</td><td align=""center"">585</td><td align=""center"">No relationship between RBC storage duration and prolonged MV</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Gajic<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B70"">70</xref>]</td><td align=""center"">2004</td><td align=""center"">2001</td><td align=""center"">Retrospective single-center</td><td align=""center"">USA</td><td align=""center"">Mix</td><td align=""center"">ICU</td><td align=""center"">181</td><td align=""center"">No association between mean age or age of the oldest unit transfused and occurrence of ALI</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Yap<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B41"">41</xref>]</td><td align=""center"">2008</td><td align=""center"">2001-2007</td><td align=""center"">Retrospective single-center</td><td align=""center"">Australia</td><td align=""center"">Mix (3.8% LR)</td><td align=""center"">Cardiac surgery</td><td align=""center"">670</td><td align=""center"">No association between storage duration and occurrence of postoperative renal failure or prolonged MV</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Koch<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B32"">32</xref>]</td><td align=""center"">2008</td><td align=""center"">1998-2006</td><td align=""center"">Retrospective single-center</td><td align=""center"">USA</td><td align=""center"">Mix</td><td align=""center"">Cardiac surgery</td><td align=""center"">6,002</td><td align=""center"">Increased risk of a composite outcome (including MOF and renal failure) with transfusion of older blood; higher rates of MV &gt; 72 hours when patients transfused only old RBC</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Weinberg<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B46"">46</xref>]</td><td align=""center"">2008</td><td align=""center"">2000-2007</td><td align=""center"">Retrospective single-center</td><td align=""center"">USA</td><td align=""center"">Yes</td><td align=""center"">Trauma</td><td align=""center"">430</td><td align=""center"">Old blood (&gt; 14 days) associated with acute renal dysfunction after adjustment</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">McKenny<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B39"">39</xref>]</td><td align=""center"">2011</td><td align=""center"">2002-2007</td><td align=""center"">Retrospective single-center</td><td align=""center"">Europe</td><td align=""center"">Yes</td><td align=""center"">Cardiac surgery</td><td align=""center"">1,153</td><td align=""center"">No association between storage duration and occurrence of postoperative renal failure or prolonged MV</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Sanders<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B57"">57</xref>]</td><td align=""center"">2011</td><td align=""center"">2005-2007</td><td align=""center"">Retrospective single-center</td><td align=""center"">Europe</td><td align=""center"">Yes</td><td align=""center"">Cardiac surgery</td><td align=""center"">444</td><td align=""center"">Higher rates of renal failure among patients transfused with old blood</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Kor<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B28"">28</xref>]</td><td align=""center"">2012</td><td align=""center"">2008-2010</td><td align=""center"">Randomized single-center study</td><td align=""center"">USA</td><td align=""center"">Yes</td><td align=""center"">ICU</td><td align=""center"">100</td><td align=""center"">Similar measures of pulmonary function after transfusion of either fresh or standard issue RBCs</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Weiskopf<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B69"">69</xref>]</td><td align=""center"">2012</td><td align=""center"">NR</td><td align=""center"">Randomized single-center study</td><td align=""center"">USA</td><td align=""center"">Mix</td><td align=""center"">Volunteers</td><td align=""center"">35</td><td align=""center"">Equivalent mild decrements in pulmonary gas exchange variables after transfusion of either fresh (1.7 hour) or older (&gt; 21 days) RBCs</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""left"" colspan=""9""><bold>Studies addressing tissue oxygenation and microcirculation</bold></td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Marik<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B71"">71</xref>]</td><td align=""center"">1993</td><td align=""center"">NR</td><td align=""center"">Prospective single-center study</td><td align=""center"">USA</td><td align=""center"">NR</td><td align=""center"">ICU</td><td align=""center"">23</td><td align=""center"">Inverse correlation between the age of transfused RBCs and the maximal change in gastric mucosal pH (pHi)</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Fernandes<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B72"">72</xref>]</td><td align=""center"">2001</td><td align=""center"">1996</td><td align=""center"">Randomized single-center study</td><td align=""center"">South America</td><td align=""center"">NR</td><td align=""center"">ICU septic</td><td align=""center"">15</td><td align=""center"">No correlation between the age of transfused RBCs and the pHi</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Walsh<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B73"">73</xref>]</td><td align=""center"">2004</td><td align=""center"">1999-2000</td><td align=""center"">Randomized single-center study</td><td align=""center"">Europe</td><td align=""center"">Yes</td><td align=""center"">ICU</td><td align=""center"">22</td><td align=""center"">No difference in pHi or gastric to arterial PCO<sub>2</sub>gap with transfusions of fresh or older RBCs</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Sakr<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B75"">75</xref>]</td><td align=""center"">2007</td><td align=""center"">NR</td><td align=""center"">Prospective single-center</td><td align=""center"">Europe</td><td align=""center"">Yes</td><td align=""center"">ICU</td><td align=""center"">35</td><td align=""center"">No correlation between the storage time and the changes in capillary perfusion</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Leal-Noval<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B77"">77</xref>]</td><td align=""center"">2008</td><td align=""center"">2004-2006</td><td align=""center"">Prospective single-center</td><td align=""center"">Europe</td><td align=""center"">Yes</td><td align=""center"">Severe TBI</td><td align=""center"">66</td><td align=""center"">Transfusion of RBCs aged more than 19 days failed to increase cerebral tissue oxygenation</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Kiraly<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B79"">79</xref>]</td><td align=""center"">2009</td><td align=""center"">NR</td><td align=""center"">Prospective single-center</td><td align=""center"">USA</td><td align=""center"">NR</td><td align=""center"">Trauma</td><td align=""center"">32</td><td align=""center"">Patients transfused with &gt; 21 days old RBCs had a significant decrease in the area under the curve of tissue saturation (StO<sub>2</sub>)</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Creteur<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B81"">81</xref>]</td><td align=""center"">2009</td><td align=""center"">NR</td><td align=""center"">Prospective single-center</td><td align=""center"">Europe</td><td align=""center"">Yes</td><td align=""center"">ICU</td><td align=""center"">44</td><td align=""center"">No association between RBC storage time and oxygenation variables (NIRS)</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Yuruk<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B76"">76</xref>]</td><td align=""center"">2012</td><td align=""center"">NR</td><td align=""center"">Randomized single-center study</td><td align=""center"">Europe</td><td align=""center"">Yes</td><td align=""center"">Hematology patients</td><td align=""center"">20</td><td align=""center"">Increase in perfused vessel density similar in both RBC age groups</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Berra<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B82"">82</xref>]</td><td align=""center"">2012</td><td align=""center"">2010</td><td align=""center"">Randomized single-center study</td><td align=""center"">USA</td><td align=""center"">Yes</td><td align=""center"">Healthy volunteers</td><td align=""center"">9</td><td align=""center"">Reactive hyperemia index unchanged after transfusion of 40-day stored blood compared with transfusion of three-day stored blood</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Roberson<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B83"">83</xref>]</td><td align=""center"">2012</td><td align=""center"">NR</td><td align=""center"">Prospective single-center</td><td align=""center"">USA</td><td align=""center"">Yes</td><td align=""center"">Healthy volunteers</td><td align=""center"">8</td><td align=""center"">No effect of storage duration on tissue oxygen saturation and sublingual microcirculatory flow index</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Kopterides<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B84"">84</xref>]</td><td align=""center"">2012</td><td align=""center"">2008-2011</td><td align=""center"">Prospective single-center</td><td align=""center"">Europe</td><td align=""center"">Mix</td><td align=""center"">ICU septic</td><td align=""center"">37</td><td align=""center"">No relationship between age of RBCs and change in lactate/pyruvate ratio (microdialysis)</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""left"" colspan=""9""><bold>Other outcomes</bold></td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Wasser<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B87"">87</xref>]</td><td align=""center"">1989</td><td align=""center"">NR</td><td align=""center"">Randomized single-center study</td><td align=""center"">Europe</td><td align=""center"">No</td><td align=""center"">Cardiac surgery</td><td align=""center"">237</td><td align=""center"">No differences in postoperative bleeding, coagulation tests, or transfusion requirements</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Mynster<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B53"">53</xref>]</td><td align=""center"">2001</td><td align=""center"">1991-1993</td><td align=""center"">Retrospective multicenter</td><td align=""center"">Europe</td><td align=""center"">No</td><td align=""center"">Cancer</td><td align=""center"">740</td><td align=""center"">Higher recurrence rate of cancer in patients who received a transfusion of RBCs stored &lt; 21 days</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Leal-Noval<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B55"">55</xref>]</td><td align=""center"">2003</td><td align=""center"">1998-2000</td><td align=""center"">Prospective single-center</td><td align=""center"">Europe</td><td align=""center"">No</td><td align=""center"">Cardiac surgery</td><td align=""center"">585</td><td align=""center"">No association between duration of storage of RBCs and postoperative myocardial infarction</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Weiskopf<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B88"">88</xref>]</td><td align=""center"">2006</td><td align=""center"">NR</td><td align=""center"">Randomized single-center study</td><td align=""center"">USA</td><td align=""center"">No</td><td align=""center"">Volunteers</td><td align=""center"">9</td><td align=""center"">Reversal of anemia-induced cognitive dysfunction similar after transfusion of fresh or stored RBCs</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Spinella<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B47"">47</xref>]</td><td align=""center"">2009</td><td align=""center"">2004-2007</td><td align=""center"">Retrospective single-center</td><td align=""center"">USA</td><td align=""center"">Mix</td><td align=""center"">Trauma</td><td align=""center"">202</td><td align=""center"">Association between maximum age of RBCs (&gt; 21 or 28 days) and deep vein thrombosis (DVT)</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Naidech<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B86"">86</xref>]</td><td align=""center"">2011</td><td align=""center"">NR</td><td align=""center"">Retrospective single-center</td><td align=""center"">USA</td><td align=""center"">NR</td><td align=""center"">SAH</td><td align=""center"">119</td><td align=""center"">No association between age of RBCs and vasospasm or cerebral infarction</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Katsios<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B85"">85</xref>]</td><td align=""center"">2011</td><td align=""center"">2001-2002</td><td align=""center"">Prospective single-center</td><td align=""center"">Canada</td><td align=""center"">No</td><td align=""center"">ICU</td><td align=""center"">261</td><td align=""center"">No association between the age of transfused RBCs and the occurrence of DVT</td></tr><tr><td colspan=""9""><hr/></td></tr><tr><td align=""center"">Cata<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B89"">89</xref>]</td><td align=""center"">2011</td><td align=""center"">1998-2007</td><td align=""center"">Retrospective single-center</td><td align=""center"">USA</td><td align=""center"">NR</td><td align=""center"">Prostate cancer</td><td align=""center"">316</td><td align=""center"">No association between the age of transfused RBCs and the five-year prostate cancer recurrence</td></tr></tbody></table><table-wrap-foot><p>DVT, deep vein thrombosis; HSCT, hematopoietic stem cell transplantation; ICU, intensive care unit; LOS, length of stay; LR, leukoreduced; MV, mechanical ventilation; NIRS, near-infrared spectroscopy; NR, not reported; PCI, percutaneous coronary intervention; SAH, subarachnoid hemorrhage: TBI, traumatic brain injury.</p></table-wrap-foot></table-wrap><table-wrap id=""T3"" position=""float""><label>Table 3</label><caption><p>Randomized controlled trials assessing the effects of red blood cell (RBC) storage duration on various outcomes (feasibility trials excluded).</p></caption><table frame=""hsides"" rules=""groups""><thead><tr><th align=""center"">First author</th><th align=""center"">Year published (recruitment period)</th><th align=""center"">Country/region</th><th align=""center"">Leuko-reduction</th><th align=""center"">Setting</th><th align=""center"">Number of patients</th><th align=""center"">Number of units transfused</th><th align=""center"">Age of RBCs in each group</th><th align=""center"">Outcome(s) reported</th><th align=""center"">Summary of results</th></tr></thead><tbody><tr><td align=""center"">Wasser<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B87"">87</xref>]</td><td align=""center"">1989 (NR)</td><td align=""center"">Europe</td><td align=""center"">No</td><td align=""center"">Cardiac surgery</td><td align=""center"">237 (118 in fresh group, 119 in old group)</td><td align=""center"">5.4 +/-1.9 (fresh group) and 6.0+/-2.4 (older group)</td><td align=""center"">&lt; 12 h (fresh group) vs. 2-5 days (older group)</td><td align=""center"">Postoperative bleeding</td><td align=""center"">No differences in postoperative bleeding, coagulation tests, or transfusion requirements</td></tr><tr><td colspan=""10""><hr/></td></tr><tr><td align=""center"">Fernandes<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B72"">72</xref>]</td><td align=""center"">2001 (1996)</td><td align=""center"">South America</td><td align=""center"">NR</td><td align=""center"">ICU septic patients</td><td align=""center"">15 (10 transfused, 5 receiving 5% albumin)</td><td align=""center"">1 unit</td><td align=""center"">12.8 ± 8.1 days in transfused group</td><td align=""center"">Oxygen delivery and consumption; changes in pHi (tonometry)</td><td align=""center"">No correlation between the age of transfused RBCs and the pHi</td></tr><tr><td colspan=""10""><hr/></td></tr><tr><td align=""center"">Walsh<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B73"">73</xref>]</td><td align=""center"">2004 (1999-2000)</td><td align=""center"">Europe</td><td align=""center"">Yes</td><td align=""center"">ICU patients with MV</td><td align=""center"">22 (10 in fresh group, 22 in old group)</td><td align=""center"">2 units</td><td align=""center"">2 days vs. 28 days (median durations)</td><td align=""center"">pHi or gastric to arterial PCO<sub>2</sub>gap</td><td align=""center"">No difference in pHi or gastric to arterial PCO<sub>2</sub>gap between fresh or older RBCs</td></tr><tr><td colspan=""10""><hr/></td></tr><tr><td align=""center"">Weiskopf<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B88"">88</xref>]</td><td align=""center"">2006 (NR)</td><td align=""center"">USA</td><td align=""center"">No</td><td align=""center"">Healthy volunteers</td><td align=""center"">9 (crossover design)</td><td align=""center"">2 autologous units</td><td align=""center"">3.4 hours vs. 23 days (median durations)</td><td align=""center"">Cognitive dysfunction</td><td align=""center"">Reversal of anemia-induced cognitive dysfunction similar after transfusion of fresh or stored RBCs</td></tr><tr><td colspan=""10""><hr/></td></tr><tr><td align=""center"">Berra<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B82"">82</xref>]</td><td align=""center"">2012 (2010)</td><td align=""center"">USA</td><td align=""center"">Yes</td><td align=""center"">Healthy volunteers</td><td align=""center"">9 (crossover design)</td><td align=""center"">1 autologous unit</td><td align=""center"">3 days vs. 40 days</td><td align=""center"">Reactive hyperhemia index</td><td align=""center"">Reactive hyperemia index unchanged after transfusion of 40-day stored blood compared with transfusion of three-day stored blood</td></tr><tr><td colspan=""10""><hr/></td></tr><tr><td align=""center"">Yuruk<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B76"">76</xref>]</td><td align=""center"">2012 (NR)</td><td align=""center"">Europe</td><td align=""center"">Yes</td><td align=""center"">Hematology patients</td><td align=""center"">20 (10 per arm)</td><td align=""center"">3 units</td><td align=""center"">7 days vs. 23 days (median durations)</td><td align=""center"">Sublingual microcirculation variables</td><td align=""center"">Increase in perfused vessel density similar in both RBC age groups</td></tr><tr><td colspan=""10""><hr/></td></tr><tr><td align=""center"">Weiskopf<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B69"">69</xref>]</td><td align=""center"">2012 (NR)</td><td align=""center"">USA</td><td align=""center"">Mix (57% LR)</td><td align=""center"">Healthy volunteers</td><td align=""center"">35 (crossover design)</td><td align=""center"">2 autologous units</td><td align=""center"">1.7 hours vs. 24.5 days</td><td align=""center"">Pulmonary function tests (A-aDO2, V<sub>D</sub>/V<sub>T</sub>))</td><td align=""center"">Equivalent mild decrements in pulmonary gas exchange variables after transfusion of either fresh or older RBCs</td></tr><tr><td colspan=""10""><hr/></td></tr><tr><td align=""center"">Kor<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B28"">28</xref>]</td><td align=""center"">2012 (2008-2010)</td><td align=""center"">USA</td><td align=""center"">Yes</td><td align=""center"">ICU patients with MV</td><td align=""center"">100 (50 per arm)</td><td align=""center"">1 unit in each group</td><td align=""center"">4 days vs. 26.5 days (median durations)</td><td align=""center"">Pulmonary function tests; mortality (not powered for this)</td><td align=""center"">Similar measures of pulmonary function (and mortality) after transfusion of either fresh or standard issue RBCs</td></tr></tbody></table><table-wrap-foot><p>ICU, intensive care unit; LR, leukoreduced; MV, mechanical ventilation; NR, not reported.</p></table-wrap-foot></table-wrap><sec><title>Effect on mortality</title><p>We identified 22 studies that reported mortality as an endpoint, 20 of which were retrospective. Six studies focused on trauma patients, five on cardiac surgery patients, four on ICU patients and seven on mixed or other populations (patients with colorectal cancer, patients with cardiovascular disease or undergoing percutaneous coronary intervention, patients receiving hematopoietic stem cell transplantation or undergoing liver transplantation). Among these 22 studies, only one was a randomized trial, but this single-center study was small and not primarily powered for mortality [<xref ref-type=""bibr"" rid=""B28"">28</xref>]. In this trial conducted on 100 mechanically ventilated ICU patients, patients randomized to exclusively receive fresh RBCs (<italic>n</italic>= 50, median RBC age: 4.0 days) had similar mortality rates (36% in the fresh group vs. 40% in the standard issue group,<italic>P</italic>= 0.41) than those receiving standard RBCs (<italic>n</italic>= 50, median RBC age: 26.5 days) [<xref ref-type=""bibr"" rid=""B28"">28</xref>]. We identified one prospective, observational study, an Australian multicenter study of 757 critically ill patients (including a mix of medical and surgical patients) in which exposure to the highest age quartile of RBCs (average age: 17.6 days) was associated with a significantly higher hospital mortality rate compared to lowest quartile (average age: 7.5 days) RBCs, even after correction for disease severity (APACHE III score) and the number of units transfused (OR: 2.01 (1.07 to 3.77),<italic>P</italic>= 0.03) [<xref ref-type=""bibr"" rid=""B29"">29</xref>].</p><p>The largest study to date exploring the association between age of transfused RBCs and mortality comes from the Swedish/Danish SCANDAT database exploring 404,959 transfusion episodes in more than 300,000 (mainly trauma and surgical) patients from 1995 to 2002: administration of RBCs aged 30 to 42 days was associated with a 5% increased mortality (HR: 1.05; 95% CI, 1.02 to 1.08) after two years of follow-up [<xref ref-type=""bibr"" rid=""B30"">30</xref>], but the authors acknowledged that this risk could have been overestimated in view of a greater baseline risk in recipients of older units. In another retrospective, registry-based analysis of 6,994 surgical patients with comorbidities (ASA score more than III in 80% of patients; cardiac surgery patients excluded) receiving a median of two leukoreduced RBC units, Saager<italic>et al</italic>. found no relationship between median RBC storage duration and postoperative mortality (up to two years) in a Cox regression model (adjusting for ABO group and number of units transfused) [<xref ref-type=""bibr"" rid=""B31"">31</xref>].</p><p>Some studies included more homogeneous patient populations. In cardiac surgery patients, the largest study was a single-center, retrospective study of 6,002 patients undergoing coronary artery bypass graft (CABG), valve surgery or both. Patients transfused with older blood (median: 20 days) had greater hospital mortality compared to those receiving fresher (median: 11 days) blood (2.8% vs. 1.7%,<italic>P</italic>= 0.004). Patients transfused with older blood also had a higher one-year mortality rate (11.0 vs. 7.4%,<italic>P</italic>&lt; 0.001) [<xref ref-type=""bibr"" rid=""B32"">32</xref>]. However, these results were much debated and challenged by other groups that were unable to find such an association [<xref ref-type=""bibr"" rid=""B33"">33</xref>-<xref ref-type=""bibr"" rid=""B37"">37</xref>]. In a single-center study of 2,732 patients undergoing CABG, van de Watering<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B38"">38</xref>] found no correlation between storage time variables and 30-day mortality in adjusted multivariate analyses. In this study, 30-day mortality was similar in patients receiving exclusively older (mean: 24.3 +/- 3.5 days) or younger RBCs (mean: 12.7 +/- 2.8 days). In a retrospective study of 1,153 cardiac surgery patients, McKenny<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B39"">39</xref>] found no association between RBC storage duration and postoperative mortality in a multivariate analysis. In another retrospective, single-center study of 3,597 patients with isolated CABG, van Straten<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B40"">40</xref>] found no effect of RBC storage duration on early or late postoperative mortality. In a single-center, retrospective cohort study of 670 patients undergoing CABG and/or valve surgery, Yap and coworkers also found no association between storage duration and mortality [<xref ref-type=""bibr"" rid=""B41"">41</xref>].</p><p>Two retrospective studies examined the association of RBC storage with mortality in critically ill patients. The first was a small cohort of 31 septic patients in which non-survivors received a greater proportion of older RBCs (&gt; 20 days old) compared to survivors, who received a greater proportion of younger RBCs (&lt; 10 days old) [<xref ref-type=""bibr"" rid=""B42"">42</xref>]. In another retrospective, single-center study of 534 general ICU patients, there was no association between the age of transfused red cells (median of maximum age of RBCs: 23 days) and mortality in multivariate analyses [<xref ref-type=""bibr"" rid=""B43"">43</xref>].</p><p>We found six studies with mortality as an outcome in trauma patients. In a retrospective cohort study of 1,813 severe trauma patients (mean Injury Severity Score (ISS) 26), transfusion of large (but not small) volumes of older blood (more than 14 days old) was associated with an increased risk of death compared to transfusion of the same volumes of younger blood (&lt; 14 days old), suggesting that the age of transfused RBCs could potentiate the already known association between volume of blood transfused and mortality, even though the authors used universal leukoreduction [<xref ref-type=""bibr"" rid=""B44"">44</xref>]. The same authors reported similar data in another retrospective study with a somewhat higher mortality rate with older blood when patients received more than three RBC units (20.1% in fresh blood vs. 27.0% in the old blood group,<italic>P</italic>= 0.08) [<xref ref-type=""bibr"" rid=""B45"">45</xref>]. In less severely injured trauma patients (mean ISS 14.4), transfusion of older blood (&gt; 14 days old) was also associated with increased mortality, although to a lesser extent (OR: 1.12, CI: 1.02 to 1.23) [<xref ref-type=""bibr"" rid=""B46"">46</xref>]. In a smaller retrospective analysis of 202 patients transfused with at least five units of RBCs, Spinella<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B47"">47</xref>] found that hospital mortality was higher for patients transfused with older RBCs (maximum RBC age: 28 or more days) than with younger RBCs (maximum RBC age less than 28 days) (26.7% vs. 13.9%,<italic>P</italic>= 0.02). In a multivariate analysis, increased storage time was independently associated with mortality (OR: 4.00; 95% CI: 1.31 to 11.61). Not all studies in trauma patients have reported deleterious effects of RBC storage on mortality. In a retrospective study of 271 trauma patients, Murrell<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B48"">48</xref>] found no correlation between the age of blood (expressed as the 'dose of aged blood') and hospital mortality (OR: 1.21, 95% CI: 0.87 to 1.69) after controlling for confounders. In another retrospective cohort of 820 transfused trauma patients, the total number of RBC units but not the number of older (&gt; 14 days old) units transfused was independently associated with increased mortality [<xref ref-type=""bibr"" rid=""B49"">49</xref>]. These studies were, however, smaller than the previous ones.</p><p>Two studies examined the outcomes of medical patients with cardiovascular disease. In a retrospective study of 4,933 patients, Eikelboom<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B50"">50</xref>] showed a greater risk of hospital mortality (relative risk 1.48, 95% CI: 1.07 to 2.05) in the highest age quartile of RBCs (31 to 42 days). In a retrospective cohort study of 909 transfused patients following percutaneous coronary intervention, RBC storage duration was associated with 30-day mortality (HR: 1.02 (1.01 to 1.04),<italic>P</italic>= 0.02). Patients receiving only RBCs aged &gt; 28 days had an even higher risk of mortality (HR: 2.49 (1.45 to 4.25),<italic>P</italic>= 0.001) [<xref ref-type=""bibr"" rid=""B51"">51</xref>]. In a retrospective analysis of 509 patients undergoing liver transplantation, transfusion of more than 10 units of RBCs was associated with increased two-year mortality, but the age of the transfused RBCs was not [<xref ref-type=""bibr"" rid=""B52"">52</xref>]. In a secondary analysis of a prospective multicenter study on patients with colorectal cancer [<xref ref-type=""bibr"" rid=""B53"">53</xref>], transfused patients had a shorter survival than the non-transfused patients (3.0 years vs. 4.6 years,<italic>P</italic>= 0.004) but mortality was not significantly different between patients transfused with RBCs aged more or less than 21 days. In a retrospective single-center study on 555 patients undergoing hematopoietic stem cell transplantation, non-relapse 100-day mortality was reduced in the subgroup of patients receiving exclusively old blood (&gt; 14 days old) compared to those receiving fresher (&lt; 14 days old) blood (6% vs. 0% at 100 days,<italic>P</italic>= 0.04) [<xref ref-type=""bibr"" rid=""B54"">54</xref>].</p></sec><sec><title>Influence on hospital or ICU length of stay</title><p>Nine studies evaluated the LOS as a surrogate marker of global morbidity associated with RBC transfusion. Six of the studies included cardiac surgery patients; when controlling for potential confounders, there was no relationship between age of transfused RBCs and postoperative LOS in five of the studies [<xref ref-type=""bibr"" rid=""B38"">38</xref>,<xref ref-type=""bibr"" rid=""B39"">39</xref>,<xref ref-type=""bibr"" rid=""B41"">41</xref>,<xref ref-type=""bibr"" rid=""B55"">55</xref>,<xref ref-type=""bibr"" rid=""B56"">56</xref>]. In the only prospective study, there was a significant association between ICU LOS and number of units transfused but not the mean duration of RBC storage [<xref ref-type=""bibr"" rid=""B55"">55</xref>]. Other retrospective studies yielded similar results. In the study of van De Watering<italic>et al</italic>. mentioned earlier [<xref ref-type=""bibr"" rid=""B38"">38</xref>], storage time had no independent effect on ICU LOS. In the studies by Yap<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B41"">41</xref>] and McKenny<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B39"">39</xref>], there was no association between length of storage and ICU LOS. In another retrospective study of 268 patients undergoing CABG, Vamvakas and Carven could not find any association between RBC storage duration and postoperative ICU and hospital LOS in a multivariate analyses also controlling for number of units received [<xref ref-type=""bibr"" rid=""B56"">56</xref>]. One retrospective study of 444 cardiac surgery patients by Sanders<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B57"">57</xref>] yielded different results, with the age of blood a significant but modest predictor of postoperative LOS (OR: 1.05, 95% CI: 1.01 to 1.09). However, this analysis was limited by a number of imbalances between groups.</p><p>Two studies evaluated LOS in trauma patients. In a small retrospective study of 86 transfused patients, the number of units of blood older than 14 days was strongly associated with an increased hospital LOS [<xref ref-type=""bibr"" rid=""B58"">58</xref>], each additional unit older than 14 days old being associated with an increased length of stay of two days. In the study by Murrell and coworkers mentioned earlier, the dose of aged blood was significantly associated with a longer ICU stay (RR 1.15, 95% CI: 1.11 to 1.20) after controlling for confounders [<xref ref-type=""bibr"" rid=""B48"">48</xref>].</p><p>In the study by Kekre and coworkers on patients undergoing hematopoietic stem cell transplantation [<xref ref-type=""bibr"" rid=""B54"">54</xref>], there was no correlation between age of transfused RBCs and hospital LOS.</p></sec><sec><title>Influence on infections</title><p>Eighteen studies reported on the possible influence of age of transfused RBCs on the risk of infection.</p><p>Studies performed in cardiac surgery patients generated conflicting results. In the prospective study of Leal-Noval and coworkers [<xref ref-type=""bibr"" rid=""B55"">55</xref>], there was an independent relation between the oldest RBC unit transfused (but not the mean duration of storage of all the transfused units) and the development of postoperative pneumonia (OR: 1.06, 95% CI: 1.01 to 1.11,<italic>P</italic>= 0.018), but not mediastinitis. In the retrospective study by Koch and coworkers [<xref ref-type=""bibr"" rid=""B32"">32</xref>], patients transfused with older RBCs (&gt; 14 days old) had significantly higher rates of postoperative sepsis or septicemia (4.0% vs. 2.8%,<italic>P</italic>= 0.01), whereas rates of pneumonia and wound infections were similar. Two other studies reported detrimental effects associated with storage time of non-leukoreduced RBCs. In a retrospective, single center study of 256 cardiac surgery patients, Vamvakas<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B59"">59</xref>] reported an independent relationship between the age of transfused RBCs and the incidence of postoperative pneumonia or wound infection after correcting for the number of units transfused. In this study, the risk of pneumonia increased by 1% per day of increase in the mean storage time of transfused red cells (<italic>P</italic>&lt; 0.05). In a multicenter retrospective Danish study on 1,748 patients transfused after CABG, storage time more than 14 days was associated with a greater risk of postoperative wound infections and septicemia (adjusted OR: 2.5, 95% CI: 1.2 to 4.2). The adjusted risk of severe infection increased by 23% for each unit transfused in patients receiving only old RBCs [<xref ref-type=""bibr"" rid=""B60"">60</xref>]. Other studies found no link between storage time of transfused RBCs and infections. In the smaller cohort of Yap and coworkers [<xref ref-type=""bibr"" rid=""B41"">41</xref>], no association was found between storage of RBCs and postoperative pneumonia in multivariate analyses. Similar findings were reported in the study by McKenny and coworkers [<xref ref-type=""bibr"" rid=""B39"">39</xref>].</p><p>Two studies were conducted in patients undergoing surgery for colorectal cancer. In a single-center, retrospective study performed between 1980 and 1992 on 290 patients undergoing colorectal resection for adenocarcinoma, age of transfused RBCs was not different in subjects developing postoperative infections and those who did not [<xref ref-type=""bibr"" rid=""B61"">61</xref>]. In a retrospective analysis of 225 patients undergoing colorectal cancer surgery, Mynster and Nielsen [<xref ref-type=""bibr"" rid=""B62"">62</xref>] found that a blood storage time exceeding 20 days was an independent risk factor for postoperative infection (wound or intra-abdominal infection, anastomotic leakage, pneumonia, septicemia; OR, 2.35; 95% CI, 1.27 to 4.37;<italic>P</italic>= 0.007).</p><p>Five studies were conducted in trauma patients, all suggesting deleterious consequences of storage duration on infectious complications. In the study by Weinberg and coworkers [<xref ref-type=""bibr"" rid=""B46"">46</xref>] evaluating 1,624 trauma patients, occurrence of pneumonia was directly related to the volume of old blood (&gt; 14 days old) transfused (OR 1.10, CI 1.04 to 1.17), but not young blood (&lt; 14 days old), after multiple adjustments. Also, in a retrospective cohort of 1,183 transfused trauma patients, receipt of exclusively old RBCs (&gt; 14 days) significantly increased the risk of pneumonia (adjusted RR for age, gender, ISS, mechanism of injury, ventilator days and RBC volume 1.42 (1.01 to 2.02)), whereas the transfusion of exclusively young RBCs (&lt; 14 days) or mixed RBCs did not [<xref ref-type=""bibr"" rid=""B63"">63</xref>]. In a smaller study of 61 massively transfused trauma patients, those who developed major infections had received more units of RBCs greater than 14 or 21 days old. The number of units older than 14 and 21 days was identified as an independent risk factor for major infections in a multivariate analysis [<xref ref-type=""bibr"" rid=""B64"">64</xref>]. In the previously described study by Hassan and coworkers [<xref ref-type=""bibr"" rid=""B49"">49</xref>], the number of older (&gt; 14 days old) units of RBCs transfused was a significant risk factor for severe sepsis or septic shock especially when more than seven units were transfused (OR 1.9, 95% CI: 1.1 to 3.4,<italic>P</italic>= 0.03). Recently, in a retrospective study of 196 transfused trauma patients receiving selective digestive tract decontamination, Juffermans<italic>et al</italic>. found a modest association between transfusion of RBCs older than 14 days and occurrence of new infections in multivariate analysis (OR 1.04, 95% CI 1.01 to 1.07) [<xref ref-type=""bibr"" rid=""B65"">65</xref>].</p><p>We identified three studies in septic and/or ICU patients. In a prospective study of 449 medical and surgical ICU patients, Taylor and colleagues [<xref ref-type=""bibr"" rid=""B66"">66</xref>] found that the number of units of transfused RBCs was associated with an increased risk of nosocomial infection in a multivariate regression analysis, but the maximum age of transfused RBCs was not. In a retrospective study of 134 patients with sepsis, Juffermans<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B67"">67</xref>] found a direct relation between the total number of transfused RBCs and the risk of developing secondary infections (OR 1.26, 95% CI 1.09 to 1.45) after controlling for immunosuppression. Storage time was identified as a confounder for the association of RBCs with infection. In another retrospective, single-center study of 534 general ICU patients, Dessertaine<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B43"">43</xref>] found no independent association between the age of transfused red cells (median of the maximum RBC ages: 23 days) and the development of nosocomial infection.</p><p>The risk of infection was also studied in other populations. In a retrospective analysis of 509 patients undergoing liver transplantation, Dunn<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B52"">52</xref>] reported no independent association between the age of transfused RBCs and the incidence of postoperative infections. In a secondary analysis of an RCT on patients undergoing knee arthroplasty, there was no independent association between postoperative wound infection and age of transfused RBCs [<xref ref-type=""bibr"" rid=""B68"">68</xref>].</p></sec><sec><title>Influence on organ failure (including acute kidney injury and respiratory failure)</title><p>We identified 12 studies that addressed the effects of transfused RBCs on multiple organ failure (MOF).</p><p>Four studies looked at postoperative acute renal failure in cardiac surgery patients. A retrospective study by Koch and coworkers [<xref ref-type=""bibr"" rid=""B32"">32</xref>] found an increased risk of MOF (unadjusted comparison 0.7% vs. 0.2%,<italic>P</italic>= 0.007) and renal insufficiency (unadjusted comparison 2.7% vs. 1.6%,<italic>P</italic>= 0.003) associated with transfusion of older blood (&gt; 14 days old). In a multivariate analysis, there was an increased risk of a composite outcome (including MOF and renal failure) associated with transfusion of older blood (adjusted OR: 1.16; 95% CI: 1.01 to 1.33,<italic>P</italic>= 0.03). A smaller study by Sanders and coworkers [<xref ref-type=""bibr"" rid=""B57"">57</xref>] also showed somewhat higher rates of renal failure among patients transfused with any old blood (12.5% vs. 3.1%,<italic>P</italic>= 0.054) (unadjusted risks) compared to other patients. In a multivariate analysis, every day increase in storage was associated with a 7% increase in risk of new renal complications. These results have been challenged by two other studies that found no association between storage duration and occurrence of postoperative renal failure [<xref ref-type=""bibr"" rid=""B39"">39</xref>,<xref ref-type=""bibr"" rid=""B41"">41</xref>].</p><p>Two studies included trauma patients. In a small study of 63 matched case-control trauma patients, Zallen and coworkers found that mean age of blood and number of units older than 14 or 21 days were independent risk factors for MOF in a limited multivariate analysis [<xref ref-type=""bibr"" rid=""B68"">68</xref>]. In a study by Weinberg<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B45"">45</xref>] the receipt of old blood (&gt; 14 days old) was associated with acute renal dysfunction (OR 1.18, CI 1.07 to 1.29) after adjustment for age, sex, ISS, thoracic injury and need for mechanical ventilation, whereas the receipt of young blood (&lt; 14 days old) was not.</p><p>Some studies focused on the development of respiratory failure, assessed by physiologic and immunologic variables, or the duration of mechanical ventilation (MV). In a randomized, crossover study of 35 healthy volunteers, Weiskopf and coworkers [<xref ref-type=""bibr"" rid=""B69"">69</xref>] found equivalent mild decrements in pulmonary gas exchange (alveolo-arterial oxygen gradient ((A-a)DO<sub>2</sub>), dead space to tidal volume ratio (V<sub>D</sub>/V<sub>T</sub>)) after isovolemic transfusion of either two units of fresh (1.7 hour) or older (&gt; 21 days) autologous RBCs. No differences between leukoreduced and non-leukoreduced units were noted. Also, in a single-center randomized clinical trial in mechanically ventilated ICU patients, patients randomized to receive exclusively fresh RBCs (<italic>n</italic>= 50 patients, median RBC age: 4.0 days) had similar measures of pulmonary function (changes in PaO<sub>2</sub>/FIO<sub>2</sub>ratio, changes in V<sub>D</sub>/V<sub>T</sub>, static compliance) when compared to those receiving standard issue RBCs (<italic>n</italic>= 50 patients, median RBC age: 26.5 days) [<xref ref-type=""bibr"" rid=""B28"">28</xref>]. Eight other observational studies analyzed the duration of MV or the occurrence of ALI. In the study by Koch and coworkers [<xref ref-type=""bibr"" rid=""B32"">32</xref>] in 6,002 cardiac surgery patients, patients receiving only old RBCs (14 days) had higher rates of MV &gt; 72 hours compared to those transfused with only younger (&lt; 14 days) blood (unadjusted risk 9.7% vs. 5.6%,<italic>P</italic>&lt; 0.001) but no adjusted risk for longer MV duration was calculated. These findings were not found in six other studies [<xref ref-type=""bibr"" rid=""B39"">39</xref>,<xref ref-type=""bibr"" rid=""B41"">41</xref>,<xref ref-type=""bibr"" rid=""B46"">46</xref>,<xref ref-type=""bibr"" rid=""B55"">55</xref>,<xref ref-type=""bibr"" rid=""B56"">56</xref>,<xref ref-type=""bibr"" rid=""B58"">58</xref>]. In a retrospective study on 181 mechanically ventilated ICU patients, Gajic and coworkers [<xref ref-type=""bibr"" rid=""B70"">70</xref>] found no association between storage variables (mean age or age of the oldest unit transfused) and occurrence of ALI.</p></sec><sec><title>Influence on tissue oxygenation and the microcirculation</title><p>Several studies using various devices addressed the question of whether aged RBCs could alter the microcirculation in humans. In a prospective, non-randomized study of 23 septic patients, Marik and Sibbald [<xref ref-type=""bibr"" rid=""B71"">71</xref>] reported an inverse correlation between the age of transfused RBCs (three units of stored RBCs of varying age) and the maximal change in gastric mucosal pH (pHi) during the subsequent hours (r = -0.71,<italic>P</italic>&lt; 0.001). In a multivariate analysis, age of transfused RBCs was the only predictor of the changes in pHi, suggesting that older, less deformable RBCs could promote mucosal ischemia. These data were, however, challenged by later studies. In particular, Fernandes and colleagues [<xref ref-type=""bibr"" rid=""B72"">72</xref>] compared 15 anemic septic patients randomly assigned to receive either one RBC unit (mean storage time: 12.8 ± 8.1 days) or 500 mL of a 5% albumin solution. There was no increase in oxygen delivery or consumption following RBC transfusion (but the baseline hemoglobin concentration was relatively high) and no correlation between the age of transfused RBCs and the pHi. Likewise, in a randomized, double-blinded study on 22 anemic ICU patients, Walsh and coworkers [<xref ref-type=""bibr"" rid=""B73"">73</xref>] reported no difference in pHi or gastric to arterial PCO<sub>2</sub>gap with transfusions of two units of leukoreduced RBCs stored for less than five days (median: 2 days) or more than 20 days (median: 28 days). Comparisons of this work with the previous study by Marik and Sibbald [<xref ref-type=""bibr"" rid=""B71"">71</xref>] is difficult because of differences in patient populations and the use or not of leukodepleted blood [<xref ref-type=""bibr"" rid=""B74"">74</xref>]. Sakr and coworkers [<xref ref-type=""bibr"" rid=""B75"">75</xref>] performed a prospective study evaluating transfusion-induced changes in the sublingual microcirculation of 35 septic patients (using an orthogonal polarization spectral imaging technique). Oxygen uptake and microcirculatory variables were globally unaltered after the administration of one or two units of leukoreduced RBCs (median age: 24 days; IQR: 12 to 28 days); considerable interindividual variability in sublingual capillary perfusion was noted among these patients and no correlation between the storage time and the changes in capillary perfusion was found [<xref ref-type=""bibr"" rid=""B75"">75</xref>].</p><p>In another small randomized trial on 20 hematology outpatients transfused with three units of either young (median: 7 days) or older blood (median: 23 days), viscosity and perfused vessel density in sublingual microcirculation (assessed with sidestream dark field imaging - SDF) increased after transfusion, but this increase was similar in both RBC age groups [<xref ref-type=""bibr"" rid=""B76"">76</xref>]. Interestingly, the aggregability index was also increased following RBC transfusion whereas the RBC deformability index was unchanged, with no differences between older and younger blood groups. Leal-Noval and coworkers [<xref ref-type=""bibr"" rid=""B77"">77</xref>] assessed the effects of transfusion of leukoreduced RBCs on cerebral tissue oxygenation (PtiO<sub>2</sub>) in patients with severe traumatic brain injury divided into four quartiles according to length of storage of transfused RBCs (&lt; 10 days,<italic>n</italic>= 18; 10 to 14 days,<italic>n</italic>= 15; 15 to 19 days,<italic>n</italic>= 17; &gt; 19 days,<italic>n</italic>= 16). Transfusion of RBCs stored for less than 19 days increased PtiO<sub>2</sub>for up to six hours, whereas transfusion of RBCs aged more than 19 days failed to do so. There was a trend toward an inverse relationship between storage time and the relative increment in PtiO<sub>2</sub>from the baseline value, but there were concerns about methodological limitations in this study [<xref ref-type=""bibr"" rid=""B78"">78</xref>]. Kiraly and coworkers [<xref ref-type=""bibr"" rid=""B79"">79</xref>] performed a prospective, non-randomized study in 32 hemodynamically stable, non-septic, ICU trauma patients requiring a transfusion. Patients transfused with 'old' red cells (&gt; 21 days old,<italic>n</italic>= 17 patients) had a significant decrease in the area under the curve (AUC) of tissue oxygen saturation (StO<sub>2</sub>) as measured by near-infrared spectroscopy (NIRS [<xref ref-type=""bibr"" rid=""B80"">80</xref>]), whereas patients receiving 'new' red cells (&lt; 21 days,<italic>n</italic>= 15 patients) and a control, non-transfused group had a stable StO<sub>2</sub>AUC. Moreover, a slightly negative correlation between the age of the oldest unit transfused and the changes in oxygenation was noted (r<sup>2</sup>= 0.25). In a prospective study on 44 hemodynamically stable ICU patients also monitored with NIRS, Creteur and coworkers [<xref ref-type=""bibr"" rid=""B81"">81</xref>] found no association between RBC storage time (median: 18 days; IQR: 11 to 27 days) and oxygenation variables (changes in the StO<sub>2</sub>upslope, changes in NIR oxygen consumption). Also, in a randomized crossover study in nine healthy volunteers, reactive hyperemia index (measured by peripheral arterial tonometry and reflecting NO bioavailability and endothelial function) was unchanged after transfusion of one unit of 40-day stored autologous blood compared with transfusion of three-day stored blood [<xref ref-type=""bibr"" rid=""B82"">82</xref>]. Another recent study on eight healthy volunteers receiving sequentially one unit of seven-day AS-3 stored and one unit of 42-day stored autologous blood found no effect of storage duration on oxygenation variables (tissue oxygen saturation - brain and thenar eminence, and sublingual microcirculatory flow index) [<xref ref-type=""bibr"" rid=""B83"">83</xref>]. Recently, Kopterides<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B84"">84</xref>] reported no relationship between age of transfused RBCs (median: 16 days) and post-transfusional change in lactate/pyruvate ratio (microdialysis assessment) in 37 ICU patients with sepsis.</p></sec><sec><title>Other outcomes</title><p>a) Thrombotic events</p><p>In a retrospective study of 202 trauma patients, Spinella and coworkers found an association between maximum age of transfused RBCs (&gt; 21 or 28 days) and the occurrence of deep vein thrombosis (DVT) but no multivariate analysis was performed to confirm this observation [<xref ref-type=""bibr"" rid=""B47"">47</xref>]. Moreover, these results were challenged by a prospective study of 261 medico-surgical ICU patients in which there was no association between the age of transfused RBCs and the occurrence of DVT [<xref ref-type=""bibr"" rid=""B85"">85</xref>]. Leal-Noval and coworkers found no association between duration of storage of transfused RBCs and postoperative myocardial infarction [<xref ref-type=""bibr"" rid=""B55"">55</xref>].</p><p>b) Vasospasm after subarachnoid hemorrhage</p><p>In a retrospective, single-center study of 119 patients transfused after SAH, Naidech and coworkers could not find any association between age of RBCs and poor outcomes (vasospasm, cerebral infarction, dependence or mortality at three months) [<xref ref-type=""bibr"" rid=""B86"">86</xref>].</p><p>c) Bleeding</p><p>One may hypothesize that stored blood (especially in the absence of leukoreduction) could increase bleeding through an altered viability of platelets and a decrease in coagulation factors, such as factor VIII. In patients undergoing CABG surgery, Wasser and coworkers [<xref ref-type=""bibr"" rid=""B87"">87</xref>] found no differences in postoperative bleeding, coagulation tests, or transfusion requirements between the study group (two units of fresh blood followed by stored RBCs (aged from two to five days) if required) and the control group (stored blood only), except for a subgroup of patients with thrombocytopenia.</p><p>d) Cognitive dysfunction</p><p>In a randomized crossover study on healthy volunteers submitted to acute normovolemic hemodilution (target hemoglobin 5 g/dl), Weiskopf<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B88"">88</xref>] found that reversal of anemia-induced cognitive dysfunction was similar after transfusion of two units of fresh (storage less than five hours) or stored (three weeks storage) RBCs.</p><p>e) Cancer recurrence</p><p>Immunomodulation associated with RBC transfusion may influence cancer recurrence after surgery. In a retrospective study of 740 patients with colorectal cancer, Mynster and coworkers [<xref ref-type=""bibr"" rid=""B53"">53</xref>] found a higher recurrence rate of cancer in patients who received a transfusion of RBCs stored &lt; 21 days (HR: 1.5; 95% CI: 1.04 to 2.18,<italic>P</italic>= 0.03 for colorectal cancer) than in patients who received blood stored ≥ 21 days. Another retrospective study of 316 patients undergoing surgery for prostate cancer found no association between the age of transfused allogeneic RBCs and the five-year cancer recurrence defined by prostate specific antigen levels [<xref ref-type=""bibr"" rid=""B89"">89</xref>].</p></sec></sec><sec sec-type=""discussion""><title>Discussion</title><p>It is interesting to note the quasi-exponential growth in the number of publications related to the impact of RBC storage since 1989, with 50% of the studies published during or after 2009. We identified 55 studies that reported an association between RBC storage and outcomes in adult patients. Of these, 26 studies (47%) suggested detrimental effects of RBC storage on any clinical endpoint, whereas the remainder (53%) did not.</p><p>Comparison among studies is difficult because of the high degree of heterogeneity. First, studies included different patient populations (cardiac surgery, trauma, sepsis, cancer patients) with different baseline risks. Interestingly, 91% of the studies on trauma patients showed a deleterious impact of older RBCs on any endpoint, whereas only 45% of studies in cardiac surgery patients and 36% of studies in ICU patients suggested such an association. It is intriguing to consider that trauma patients may be more sensitive to the age of transfused RBCs than other patients [<xref ref-type=""bibr"" rid=""B90"">90</xref>]. Second, studies also included different mortality and morbidity outcomes and the criteria for organ dysfunction varied. Third, the way in which the age of transfused RBCs was reported also varied (mean age of all RBCs transfused, maximum age of RBCs, mean of the two oldest units, proportion of RBCs older than a given number of days,...), each analysis having its own advantages and limitations. Studies that report the mean or median age of all units transfused assume that fresher units offset the deleterious effect of older blood but this may not be true. Dichotomization of RBC age below or above a given time based on more or less proven pathophysiological evidence may also be problematic [<xref ref-type=""bibr"" rid=""B18"">18</xref>,<xref ref-type=""bibr"" rid=""B91"">91</xref>]. Recently, in a simulation-based analysis of four RCTs (three currently ongoing) that used distinct categorization of RBC storage, the type of temporal pattern assumed for the RBC storage lesion (smooth or sharp sigmoid curve centered on 7, 21 or 35 days; linear relation) had a profound impact on the statistical power of the trials for various outcomes, such that it was below 80% in numerous cases [<xref ref-type=""bibr"" rid=""B91"">91</xref>]; in particular, none of the studies had sufficient power to detect harmful consequences of RBC storage lesions if they were assumed to occur during the last week of storage. One must take into account the fact that older units are more often transfused during massive transfusions, which are obviously associated with worse outcomes [<xref ref-type=""bibr"" rid=""B18"">18</xref>]. Fourth, the blood preparation, including leukoreduction and use of additive solutions, varied among the studies; these practices have evolved over time and place and may influence the results. We found only 17 studies (35% of all studies) that reported use of exclusively leukoreduced RBCs, 10 studies (20%) reporting use of exclusively non-leukoreduced units and 11 studies (22%) reported use of a mix of leukoreduced and non-leukoreduced RBCs.</p><p>Most of the studies were retrospective with associated limitations. Control for potential confounders is particularly important. Problems with bias (recently reviewed and listed in [<xref ref-type=""bibr"" rid=""B18"">18</xref>]) are well illustrated by the phenomenon of confounding by indication, occurring when the indication for a treatment causes the outcome studied [<xref ref-type=""bibr"" rid=""B92"">92</xref>]. The most notable example of this effect concerns sicker patients who have a poorer prognosis and are also prone to receive more blood transfusions, leading, if no correction is applied, to the spurious association between number of blood transfusions and poorer outcomes. Another, more subtle problem is that patients who need multiple transfusions are, in general, more likely to receive some older blood [<xref ref-type=""bibr"" rid=""B38"">38</xref>,<xref ref-type=""bibr"" rid=""B92"">92</xref>]. Transfusion thresholds, which have evolved over time and may vary between centers, may also play a role because they may modify the global exposure of a patient population to blood transfusions. Also, temporality of the association between transfusion and outcome is not always clear. Statistical methods, like multivariate analyses, are required to correct for some biases (for example, correction for the total number of units transfused, which is one of the most important biases in the transfusion literature). In some studies, there was poor control for the number of transfused RBCs or imbalances in ABO groups [<xref ref-type=""bibr"" rid=""B32"">32</xref>,<xref ref-type=""bibr"" rid=""B93"">93</xref>] and possibly other unknown biases. The small number of patients included in many studies may also be of concern: 'negativity' of small studies should not be interpreted as proof for absence of effect [<xref ref-type=""bibr"" rid=""B18"">18</xref>].</p><p>Unfortunately, performing a quantitative meta-analysis is complicated by the significant clinical heterogeneity between studies, even if tests for statistical heterogeneity are passed. Moreover, meta-analyses do not improve the quality of individual studies [<xref ref-type=""bibr"" rid=""B94"">94</xref>], a major concern in our systematic review, which identified numerous biased studies. For these reasons we chose not to perform a meta-analysis. Nevertheless, some have been attempted [<xref ref-type=""bibr"" rid=""B20"">20</xref>-<xref ref-type=""bibr"" rid=""B22"">22</xref>], resulting, not surprisingly, in conflicting results. The most recent meta-analysis by Wang and coworkers showed detrimental effects of RBC storage on mortality (pooled OR 1.16; 95% CI 1.07 to 1.24,<italic>P</italic>= 0.0001), pneumonia (pooled OR 1.17; 95% CI 1.08 to 1.27,<italic>P</italic>= 0.0001) and multiple organ dysfunction syndrome (pooled OR 2.26; 95% CI 1.56 to 3.25,<italic>P</italic>&lt; 0.0001); in this study, 97 patients (95% CI 63 to 199) was cited as the number to treat with exclusively fresh blood to save one life [<xref ref-type=""bibr"" rid=""B20"">20</xref>]. Another meta-analysis by Vamvakas that included only studies reporting adjusted results for mortality, found that the age of blood was not associated with a higher risk of mortality [<xref ref-type=""bibr"" rid=""B22"">22</xref>].</p><p>Transfusion policies in some centers recommend use of fresh RBCs for special populations, such as fetuses (intrauterine transfusions) or neonates, although the evidence for this approach is poor [<xref ref-type=""bibr"" rid=""B95"">95</xref>]. If one could choose, one would prefer fresher blood, although storage for a few days at 4°C may be beneficial to reduce the risk of some cell-associated viruses and other pathogens that cannot survive for long in these conditions [<xref ref-type=""bibr"" rid=""B95"">95</xref>]. Moreover, the delivery of fresher blood may be associated with major organizational problems although some recent pilot trials suggest the feasibility of such an approach [<xref ref-type=""bibr"" rid=""B96"">96</xref>,<xref ref-type=""bibr"" rid=""B97"">97</xref>]. Some would argue that the best way to resolve this problematic issue with adequate control for known and unknown biases may be achieved by large RCTs. It is intriguing to note that among eight randomized trials already published (without pilot trials) [<xref ref-type=""bibr"" rid=""B28"">28</xref>,<xref ref-type=""bibr"" rid=""B69"">69</xref>,<xref ref-type=""bibr"" rid=""B72"">72</xref>,<xref ref-type=""bibr"" rid=""B73"">73</xref>,<xref ref-type=""bibr"" rid=""B76"">76</xref>,<xref ref-type=""bibr"" rid=""B82"">82</xref>,<xref ref-type=""bibr"" rid=""B87"">87</xref>,<xref ref-type=""bibr"" rid=""B88"">88</xref>], none demonstrated detrimental effects of RBC storage duration on outcomes, although the studies were small and mostly reported physiological outcomes. Several large randomized studies are ongoing (notably ABLE [<xref ref-type=""bibr"" rid=""B98"">98</xref>] and RECESS [<xref ref-type=""bibr"" rid=""B99"">99</xref>]) and their investigators have had to face various obstacles. First, as the differences in clinically relevant outcomes (such as mortality) are (if present) expected to be low, large numbers of patients are required to detect these differences. Second, these trials must overcome logistic problems so that the blood banks can appropriately deliver exclusively young or older RBC units (compared to an<italic>a priori</italic>defined threshold), as illustrated in several studies [<xref ref-type=""bibr"" rid=""B96"">96</xref>,<xref ref-type=""bibr"" rid=""B100"">100</xref>-<xref ref-type=""bibr"" rid=""B102"">102</xref>]. Third, even if the duration of storage is still within acceptable limits, administration of exclusively older RBCs to patients may raise ethical concerns. Use of standard RBCs instead of exclusively old RBCs may overcome this issue (for example, in the ABLE study [<xref ref-type=""bibr"" rid=""B98"">98</xref>]).</p><p>Our study has several strengths and limitations. First, we considered clinically relevant outcomes, which we discussed separately and were the basis for the study classification. Studies reporting biological outcomes (hemolysis [<xref ref-type=""bibr"" rid=""B103"">103</xref>], survival of RBCs after transfusion [<xref ref-type=""bibr"" rid=""B104"">104</xref>], hematocrit response [<xref ref-type=""bibr"" rid=""B105"">105</xref>] or mitogenic activity of plasma after transfusion [<xref ref-type=""bibr"" rid=""B106"">106</xref>]), or evolution of clinical scores after RBC administration [<xref ref-type=""bibr"" rid=""B107"">107</xref>], were not considered. Pediatric studies were also not included, because newborns and children may represent a particular population with specific pathologies. Also, we did not consider feasibility studies (pilot trials before large RCTs) [<xref ref-type=""bibr"" rid=""B96"">96</xref>,<xref ref-type=""bibr"" rid=""B97"">97</xref>,<xref ref-type=""bibr"" rid=""B101"">101</xref>], which were not primarily powered to assess the clinical relevancy of RBC storage duration. Finally, we chose to refrain from performing a quantitative meta-analysis because of the high number of biased studies, which could have led to erroneous conclusions.</p><p>In conclusion, our systematic review indicates that the influence of RBC age on various outcomes is equivocal. The quality of the evidence is currently too poor to make recommendations to change current transfusion practice. Our observations are reassuring, because major differences would have serious consequences for the organization of blood banks [<xref ref-type=""bibr"" rid=""B108"">108</xref>].</p></sec><sec><title>Key messages</title><p>• The duration of red blood cell (RBC) storage before transfusion may alter RBC function and, hence, potentially influence the incidence of complications or even mortality, but this is controversial.</p><p>• Fifty-five studies were identified that had reported the effects of age of transfused RBCs on mortality or morbidity in adult patients, but the marked heterogeneity among studies prevented a formal meta-analysis.</p><p>• Half of the studies showed no deleterious effects of aged compared to fresh blood on any endpoint.</p><p>• This systematic review found no definitive argument to support the superiority of fresh over older RBCs for transfusion.</p></sec><sec><title>Abbreviations</title><p>A-aDO<sub>2</sub>: alveolo-arterial oxygen gradient; ALI: acute lung injury; ARDS: acute respiratory distress syndrome; AUC: area under the curve; CABG: coronary artery bypass grafting; CI: confidence interval; DVT: deep vein thrombosis; HR: hazard ratio; ICU: intensive care unit; IQR: interquartile range; LOS: length of stay; MOF: multiple organ failure; MV: mechanical ventilation; NIRS: near-infrared spectroscopy; OR: odds ratio; pHi: gastric mucosal pH; PtiO<sub>2</sub>: cerebral tissue oxygenation; RBC: red blood cell; RCT: randomized controlled trial; RR: relative risk; SAH: subarachnoid hemorrhage; SD: standard deviation; SDF: sidestream dark field; StO<sub>2</sub>: tissue oxygen saturation; V<sub>D</sub>: dead space; V<sub>T</sub>: tidal volume.</p></sec><sec><title>Competing interests</title><p>The authors have no competing interests to declare in relation to this article</p></sec><sec><title>Authors' contributions</title><p>CL and JLV designed the study. CL performed the literature search and drafted the manuscript. JLV critically revised the text. Both authors read and approved the final manuscript.</p></sec></body><back><ref-list><ref id=""B1""><mixed-citation publication-type=""journal""><name><surname>Hess</surname><given-names>JR</given-names></name><article-title>Red cell changes during storage</article-title><source>Transfus Apher Sci</source><year>2010</year><volume>43</volume><fpage>51</fpage><lpage>59</lpage><pub-id pub-id-type=""doi"">10.1016/j.transci.2010.05.009</pub-id><pub-id pub-id-type=""pmid"">20558107</pub-id></mixed-citation></ref><ref id=""B2""><mixed-citation publication-type=""journal""><name><surname>Klein</surname><given-names>HG</given-names></name><name><surname>Spahn</surname><given-names>DR</given-names></name><name><surname>Carson</surname><given-names>JL</given-names></name><article-title>Red blood cell transfusion in clinical practice</article-title><source>Lancet</source><year>2007</year><volume>370</volume><fpage>415</fpage><lpage>426</lpage><pub-id pub-id-type=""doi"">10.1016/S0140-6736(07)61197-0</pub-id><pub-id pub-id-type=""pmid"">17679019</pub-id></mixed-citation></ref><ref id=""B3""><mixed-citation publication-type=""journal""><name><surname>Marik</surname><given-names>PE</given-names></name><name><surname>Corwin</surname><given-names>HL</given-names></name><article-title>Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature</article-title><source>Crit Care Med</source><year>2008</year><volume>36</volume><fpage>2667</fpage><lpage>2674</lpage><pub-id pub-id-type=""doi"">10.1097/CCM.0b013e3181844677</pub-id><pub-id pub-id-type=""pmid"">18679112</pub-id></mixed-citation></ref><ref id=""B4""><mixed-citation publication-type=""journal""><name><surname>Chin-Yee</surname><given-names>I</given-names></name><name><surname>Arya</surname><given-names>N</given-names></name><name><surname>d'Almeida</surname><given-names>MS</given-names></name><article-title>The red cell storage lesion and its implication for transfusion</article-title><source>Transfus Sci</source><year>1997</year><volume>18</volume><fpage>447</fpage><lpage>458</lpage><pub-id pub-id-type=""doi"">10.1016/S0955-3886(97)00043-X</pub-id><pub-id pub-id-type=""pmid"">10175158</pub-id></mixed-citation></ref><ref id=""B5""><mixed-citation publication-type=""journal""><name><surname>Hamasaki</surname><given-names>N</given-names></name><name><surname>Yamamoto</surname><given-names>M</given-names></name><article-title>Red blood cell function and blood storage</article-title><source>Vox Sang</source><year>2000</year><volume>79</volume><fpage>191</fpage><lpage>197</lpage><pub-id pub-id-type=""doi"">10.1046/j.1423-0410.2000.7940191.x</pub-id><pub-id pub-id-type=""pmid"">11155068</pub-id></mixed-citation></ref><ref id=""B6""><mixed-citation publication-type=""journal""><name><surname>Korgun</surname><given-names>DK</given-names></name><name><surname>Bilmen</surname><given-names>S</given-names></name><name><surname>Yesilkaya</surname><given-names>A</given-names></name><article-title>Alterations in the erythrocyte antioxidant system of blood stored in blood bags</article-title><source>Res Commun Mol Pathol Pharmacol</source><year>2001</year><volume>109</volume><fpage>357</fpage><lpage>363</lpage><pub-id pub-id-type=""pmid"">12889518</pub-id></mixed-citation></ref><ref id=""B7""><mixed-citation publication-type=""journal""><name><surname>Bosman</surname><given-names>GJ</given-names></name><name><surname>Lasonder</surname><given-names>E</given-names></name><name><surname>Luten</surname><given-names>M</given-names></name><name><surname>Roerdinkholder-Stoelwinder</surname><given-names>B</given-names></name><name><surname>Novotny</surname><given-names>VM</given-names></name><name><surname>Bos</surname><given-names>H</given-names></name><name><surname>De Grip</surname><given-names>WJ</given-names></name><article-title>The proteome of red cell membranes and vesicles during storage in blood bank conditions</article-title><source>Transfusion</source><year>2008</year><volume>48</volume><fpage>827</fpage><lpage>835</lpage><pub-id pub-id-type=""pmid"">18346024</pub-id></mixed-citation></ref><ref id=""B8""><mixed-citation publication-type=""journal""><name><surname>Sweeney</surname><given-names>J</given-names></name><name><surname>Kouttab</surname><given-names>N</given-names></name><name><surname>Kurtis</surname><given-names>J</given-names></name><article-title>Stored red blood cell supernatant facilitates thrombin generation</article-title><source>Transfusion</source><year>2009</year><volume>49</volume><fpage>1569</fpage><lpage>1579</lpage><pub-id pub-id-type=""doi"">10.1111/j.1537-2995.2009.02196.x</pub-id><pub-id pub-id-type=""pmid"">19413726</pub-id></mixed-citation></ref><ref id=""B9""><mixed-citation publication-type=""journal""><name><surname>Chin-Yee</surname><given-names>IH</given-names></name><name><surname>Gray-Statchuk</surname><given-names>L</given-names></name><name><surname>Milkovich</surname><given-names>S</given-names></name><name><surname>Ellis</surname><given-names>CG</given-names></name><article-title>Transfusion of stored red blood cells adhere in the rat microvasculature</article-title><source>Transfusion</source><year>2009</year><volume>49</volume><fpage>2304</fpage><lpage>2310</lpage><pub-id pub-id-type=""doi"">10.1111/j.1537-2995.2009.02315.x</pub-id><pub-id pub-id-type=""pmid"">19624601</pub-id></mixed-citation></ref><ref id=""B10""><mixed-citation publication-type=""journal""><name><surname>Bosman</surname><given-names>GJ</given-names></name><name><surname>Lasonder</surname><given-names>E</given-names></name><name><surname>Groenen-Dopp</surname><given-names>YA</given-names></name><name><surname>Willekens</surname><given-names>FL</given-names></name><name><surname>Werre</surname><given-names>JM</given-names></name><name><surname>Novotny</surname><given-names>VM</given-names></name><article-title>Comparative proteomics of erythrocyte aging in vivo and in vitro</article-title><source>J Proteomics</source><year>2010</year><volume>73</volume><fpage>396</fpage><lpage>402</lpage><pub-id pub-id-type=""doi"">10.1016/j.jprot.2009.07.010</pub-id><pub-id pub-id-type=""pmid"">19660581</pub-id></mixed-citation></ref><ref id=""B11""><mixed-citation publication-type=""journal""><name><surname>Donadee</surname><given-names>C</given-names></name><name><surname>Raat</surname><given-names>NJ</given-names></name><name><surname>Kanias</surname><given-names>T</given-names></name><name><surname>Tejero</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>JS</given-names></name><name><surname>Kelley</surname><given-names>EE</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Reynolds</surname><given-names>H</given-names></name><name><surname>Azarov</surname><given-names>I</given-names></name><name><surname>Frizzell</surname><given-names>S</given-names></name><name><surname>Meyer</surname><given-names>EM</given-names></name><name><surname>Donnenberg</surname><given-names>AD</given-names></name><name><surname>Qu</surname><given-names>L</given-names></name><name><surname>Triulzi</surname><given-names>D</given-names></name><name><surname>Kim-Shapiro</surname><given-names>DB</given-names></name><name><surname>Gladwin</surname><given-names>MT</given-names></name><article-title>Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion</article-title><source>Circulation</source><year>2011</year><volume>124</volume><fpage>465</fpage><lpage>476</lpage><pub-id pub-id-type=""doi"">10.1161/CIRCULATIONAHA.110.008698</pub-id><pub-id pub-id-type=""pmid"">21747051</pub-id></mixed-citation></ref><ref id=""B12""><mixed-citation publication-type=""journal""><name><surname>Hod</surname><given-names>EA</given-names></name><name><surname>Spitalnik</surname><given-names>SL</given-names></name><article-title>Harmful effects of transfusion of older stored red blood cells: iron and inflammation</article-title><source>Transfusion</source><year>2011</year><volume>51</volume><fpage>881</fpage><lpage>885</lpage><pub-id pub-id-type=""doi"">10.1111/j.1537-2995.2011.03096.x</pub-id><pub-id pub-id-type=""pmid"">21496050</pub-id></mixed-citation></ref><ref id=""B13""><mixed-citation publication-type=""journal""><name><surname>Hod</surname><given-names>EA</given-names></name><name><surname>Brittenham</surname><given-names>GM</given-names></name><name><surname>Billote</surname><given-names>GB</given-names></name><name><surname>Francis</surname><given-names>RO</given-names></name><name><surname>Ginzburg</surname><given-names>YZ</given-names></name><name><surname>Hendrickson</surname><given-names>JE</given-names></name><name><surname>Jhang</surname><given-names>J</given-names></name><name><surname>Schwartz</surname><given-names>J</given-names></name><name><surname>Sharma</surname><given-names>S</given-names></name><name><surname>Sheth</surname><given-names>S</given-names></name><name><surname>Sireci</surname><given-names>AN</given-names></name><name><surname>Stephens</surname><given-names>HL</given-names></name><name><surname>Stotler</surname><given-names>BA</given-names></name><name><surname>Wojczyk</surname><given-names>BS</given-names></name><name><surname>Zimring</surname><given-names>JC</given-names></name><name><surname>Spitalnik</surname><given-names>SL</given-names></name><article-title>Transfusion of human volunteers with older, stored red blood cells produces extravascular hemolysis and circulating non-transferrin-bound iron</article-title><source>Blood</source><year>2011</year><volume>118</volume><fpage>6675</fpage><lpage>6682</lpage><pub-id pub-id-type=""doi"">10.1182/blood-2011-08-371849</pub-id><pub-id pub-id-type=""pmid"">22021369</pub-id></mixed-citation></ref><ref id=""B14""><mixed-citation publication-type=""journal""><name><surname>Silliman</surname><given-names>CC</given-names></name><name><surname>Voelkel</surname><given-names>NF</given-names></name><name><surname>Allard</surname><given-names>JD</given-names></name><name><surname>Elzi</surname><given-names>DJ</given-names></name><name><surname>Tuder</surname><given-names>RM</given-names></name><name><surname>Johnson</surname><given-names>JL</given-names></name><name><surname>Ambruso</surname><given-names>DR</given-names></name><article-title>Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model</article-title><source>J Clin Invest</source><year>1998</year><volume>101</volume><fpage>1458</fpage><lpage>1467</lpage><pub-id pub-id-type=""doi"">10.1172/JCI1841</pub-id><pub-id pub-id-type=""pmid"">9525989</pub-id></mixed-citation></ref><ref id=""B15""><mixed-citation publication-type=""journal""><name><surname>Raat</surname><given-names>NJ</given-names></name><name><surname>Verhoeven</surname><given-names>AJ</given-names></name><name><surname>Mik</surname><given-names>EG</given-names></name><name><surname>Gouwerok</surname><given-names>CW</given-names></name><name><surname>Verhaar</surname><given-names>R</given-names></name><name><surname>Goedhart</surname><given-names>PT</given-names></name><name><surname>de Korte</surname><given-names>D</given-names></name><name><surname>Ince</surname><given-names>C</given-names></name><article-title>The effect of storage time of human red cells on intestinal microcirculatory oxygenation in a rat isovolemic exchange model</article-title><source>Crit Care Med</source><year>2005</year><volume>33</volume><fpage>39</fpage><lpage>45</lpage><pub-id pub-id-type=""doi"">10.1097/01.CCM.0000150655.75519.02</pub-id><pub-id pub-id-type=""pmid"">15644646</pub-id></mixed-citation></ref><ref id=""B16""><mixed-citation publication-type=""journal""><name><surname>van Bommel</surname><given-names>J</given-names></name><name><surname>de Korte</surname><given-names>D</given-names></name><name><surname>Lind</surname><given-names>A</given-names></name><name><surname>Siegemund</surname><given-names>M</given-names></name><name><surname>Trouwborst</surname><given-names>A</given-names></name><name><surname>Verhoeven</surname><given-names>AJ</given-names></name><name><surname>Ince</surname><given-names>C</given-names></name><name><surname>Henny</surname><given-names>CP</given-names></name><article-title>The effect of the transfusion of stored RBCs on intestinal microvascular oxygenation in the rat</article-title><source>Transfusion</source><year>2001</year><volume>41</volume><fpage>1515</fpage><lpage>1523</lpage><pub-id pub-id-type=""doi"">10.1046/j.1537-2995.2001.41121515.x</pub-id><pub-id pub-id-type=""pmid"">11778066</pub-id></mixed-citation></ref><ref id=""B17""><mixed-citation publication-type=""journal""><name><surname>d'Almeida</surname><given-names>MS</given-names></name><name><surname>Jagger</surname><given-names>J</given-names></name><name><surname>Duggan</surname><given-names>M</given-names></name><name><surname>White</surname><given-names>M</given-names></name><name><surname>Ellis</surname><given-names>C</given-names></name><name><surname>Chin-Yee</surname><given-names>IH</given-names></name><article-title>A comparison of biochemical and functional alterations of rat and human erythrocytes stored in CPDA-1 for 29 days: implications for animal models of transfusion</article-title><source>Transfus Med</source><year>2000</year><volume>10</volume><fpage>291</fpage><lpage>303</lpage><pub-id pub-id-type=""doi"">10.1046/j.1365-3148.2000.00267.x</pub-id><pub-id pub-id-type=""pmid"">11123813</pub-id></mixed-citation></ref><ref id=""B18""><mixed-citation publication-type=""journal""><name><surname>van de Watering</surname><given-names>L</given-names></name><article-title>Pitfalls in the current published observational literature on the effects of red blood cell storage</article-title><source>Transfusion</source><year>2011</year><volume>51</volume><fpage>1847</fpage><lpage>1854</lpage><pub-id pub-id-type=""doi"">10.1111/j.1537-2995.2010.03015.x</pub-id><pub-id pub-id-type=""pmid"">21831185</pub-id></mixed-citation></ref><ref id=""B19""><mixed-citation publication-type=""journal""><name><surname>Spinella</surname><given-names>PC</given-names></name><name><surname>Sparrow</surname><given-names>RL</given-names></name><name><surname>Hess</surname><given-names>JR</given-names></name><name><surname>Norris</surname><given-names>PJ</given-names></name><article-title>Properties of stored red blood cells: understanding immune and vascular reactivity</article-title><source>Transfusion</source><year>2011</year><volume>51</volume><fpage>894</fpage><lpage>900</lpage><pub-id pub-id-type=""doi"">10.1111/j.1537-2995.2011.03103.x</pub-id><pub-id pub-id-type=""pmid"">21496052</pub-id></mixed-citation></ref><ref id=""B20""><mixed-citation publication-type=""journal""><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Solomon</surname><given-names>SB</given-names></name><name><surname>Klein</surname><given-names>HG</given-names></name><name><surname>Natanson</surname><given-names>C</given-names></name><article-title>Transfusion of older stored blood and risk of death: a meta-analysis</article-title><source>Transfusion</source><year>2012</year><volume>52</volume><fpage>1184</fpage><lpage>1195</lpage><pub-id pub-id-type=""doi"">10.1111/j.1537-2995.2011.03466.x</pub-id><pub-id pub-id-type=""pmid"">22188419</pub-id></mixed-citation></ref><ref id=""B21""><mixed-citation publication-type=""journal""><name><surname>Vamvakas</surname><given-names>EC</given-names></name><article-title>Meta-analysis of clinical studies of the purported deleterious effects of ""old"" (versus ""fresh"") red blood cells: are we at equipoise?</article-title><source>Transfusion</source><year>2010</year><volume>50</volume><fpage>600</fpage><lpage>610</lpage><pub-id pub-id-type=""pmid"">20042031</pub-id></mixed-citation></ref><ref id=""B22""><mixed-citation publication-type=""journal""><name><surname>Vamvakas</surname><given-names>EC</given-names></name><article-title>Purported deleterious effects of ""old"" versus ""fresh"" red blood cells: an updated meta-analysis</article-title><source>Transfusion</source><year>2011</year><volume>51</volume><fpage>1122</fpage><lpage>1123</lpage><pub-id pub-id-type=""doi"">10.1111/j.1537-2995.2010.03017.x</pub-id><pub-id pub-id-type=""pmid"">21545596</pub-id></mixed-citation></ref><ref id=""B23""><mixed-citation publication-type=""journal""><name><surname>Lelubre</surname><given-names>C</given-names></name><name><surname>Vincent</surname><given-names>JL</given-names></name><article-title>Red blood cell transfusion in the critically ill patient</article-title><source>Ann Intensive Care</source><year>2011</year><volume>1</volume><fpage>43</fpage><pub-id pub-id-type=""doi"">10.1186/2110-5820-1-43</pub-id><pub-id pub-id-type=""pmid"">21970512</pub-id></mixed-citation></ref><ref id=""B24""><mixed-citation publication-type=""journal""><name><surname>Hess</surname><given-names>JR</given-names></name><article-title>An update on solutions for red cell storage</article-title><source>Vox Sang</source><year>2006</year><volume>91</volume><fpage>13</fpage><lpage>19</lpage><pub-id pub-id-type=""doi"">10.1111/j.1423-0410.2006.00778.x</pub-id><pub-id pub-id-type=""pmid"">16756596</pub-id></mixed-citation></ref><ref id=""B25""><mixed-citation publication-type=""journal""><name><surname>Moher</surname><given-names>D</given-names></name><name><surname>Liberati</surname><given-names>A</given-names></name><name><surname>Tetzlaff</surname><given-names>J</given-names></name><name><surname>Altman</surname><given-names>DG</given-names></name><article-title>Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement</article-title><source>PLoS Med</source><year>2009</year><volume>6</volume><fpage>e1000097</fpage><pub-id pub-id-type=""doi"">10.1371/journal.pmed.1000097</pub-id><pub-id pub-id-type=""pmid"">19621072</pub-id></mixed-citation></ref><ref id=""B26""><mixed-citation publication-type=""journal""><name><surname>Basran</surname><given-names>S</given-names></name><name><surname>Frumento</surname><given-names>RJ</given-names></name><name><surname>Cohen</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Du</surname><given-names>Y</given-names></name><name><surname>Nishanian</surname><given-names>E</given-names></name><name><surname>Kaplan</surname><given-names>HS</given-names></name><name><surname>Stafford-Smith</surname><given-names>M</given-names></name><name><surname>Bennett-Guerrero</surname><given-names>E</given-names></name><article-title>The association between duration of storage of transfused red blood cells and morbidity and mortality after reoperative cardiac surgery</article-title><source>Anesth Analg</source><year>2006</year><volume>103</volume><fpage>15</fpage><lpage>20</lpage><pub-id pub-id-type=""doi"">10.1213/01.ane.0000221167.58135.3d</pub-id><pub-id pub-id-type=""pmid"">16790618</pub-id></mixed-citation></ref><ref id=""B27""><mixed-citation publication-type=""journal""><name><surname>Basran</surname><given-names>S</given-names></name><name><surname>Frumento</surname><given-names>R</given-names></name><name><surname>Cohen</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Du</surname><given-names>Y</given-names></name><name><surname>Nishanian</surname><given-names>E</given-names></name><name><surname>Kaplan</surname><given-names>HS</given-names></name><name><surname>Stafford-Smith</surname><given-names>M</given-names></name><name><surname>Bennett-Guerrero</surname><given-names>E</given-names></name><article-title>Request for retraction</article-title><source>Anesth Analg</source><year>2009</year><volume>108</volume><fpage>1991</fpage><pub-id pub-id-type=""pmid"">19448240</pub-id></mixed-citation></ref><ref id=""B28""><mixed-citation publication-type=""journal""><name><surname>Kor</surname><given-names>DJ</given-names></name><name><surname>Kashyap</surname><given-names>R</given-names></name><name><surname>Weiskopf</surname><given-names>RB</given-names></name><name><surname>Wilson</surname><given-names>GA</given-names></name><name><surname>van Buskirk</surname><given-names>CM</given-names></name><name><surname>Winters</surname><given-names>JL</given-names></name><name><surname>Malinchoc</surname><given-names>M</given-names></name><name><surname>Hubmayr</surname><given-names>RD</given-names></name><name><surname>Gajic</surname><given-names>O</given-names></name><article-title>Fresh red blood cell transfusion and short-term pulmonary, immunologic, and coagulation status: a randomized clinical trial</article-title><source>Am J Respir Crit Care Med</source><year>2012</year><volume>185</volume><fpage>842</fpage><lpage>850</lpage><pub-id pub-id-type=""doi"">10.1164/rccm.201107-1332OC</pub-id><pub-id pub-id-type=""pmid"">22281833</pub-id></mixed-citation></ref><ref id=""B29""><mixed-citation publication-type=""journal""><name><surname>Pettila</surname><given-names>V</given-names></name><name><surname>Westbrook</surname><given-names>AJ</given-names></name><name><surname>Nichol</surname><given-names>AD</given-names></name><name><surname>Bailey</surname><given-names>MJ</given-names></name><name><surname>Wood</surname><given-names>EM</given-names></name><name><surname>Syres</surname><given-names>G</given-names></name><name><surname>Phillips</surname><given-names>LE</given-names></name><name><surname>Street</surname><given-names>A</given-names></name><name><surname>French</surname><given-names>C</given-names></name><name><surname>Murray</surname><given-names>L</given-names></name><name><surname>Orford</surname><given-names>N</given-names></name><name><surname>Santamaria</surname><given-names>JD</given-names></name><name><surname>Bellomo</surname><given-names>R</given-names></name><name><surname>Cooper</surname><given-names>DJ</given-names></name><article-title>Age of red blood cells and mortality in the critically ill</article-title><source>Crit Care</source><year>2011</year><volume>15</volume><fpage>R116</fpage><pub-id pub-id-type=""doi"">10.1186/cc10142</pub-id><pub-id pub-id-type=""pmid"">21496231</pub-id></mixed-citation></ref><ref id=""B30""><mixed-citation publication-type=""journal""><name><surname>Edgren</surname><given-names>G</given-names></name><name><surname>Kamper-Jorgensen</surname><given-names>M</given-names></name><name><surname>Eloranta</surname><given-names>S</given-names></name><name><surname>Rostgaard</surname><given-names>K</given-names></name><name><surname>Custer</surname><given-names>B</given-names></name><name><surname>Ullum</surname><given-names>H</given-names></name><name><surname>Murphy</surname><given-names>EL</given-names></name><name><surname>Busch</surname><given-names>MP</given-names></name><name><surname>Reilly</surname><given-names>M</given-names></name><name><surname>Melbye</surname><given-names>M</given-names></name><name><surname>Hjalgrim</surname><given-names>H</given-names></name><name><surname>Nyren</surname><given-names>O</given-names></name><article-title>Duration of red blood cell storage and survival of transfused patients</article-title><source>Transfusion</source><year>2010</year><volume>50</volume><fpage>1185</fpage><lpage>1195</lpage><pub-id pub-id-type=""doi"">10.1111/j.1537-2995.2010.02583.x</pub-id><pub-id pub-id-type=""pmid"">20158690</pub-id></mixed-citation></ref><ref id=""B31""><mixed-citation publication-type=""journal""><name><surname>Saager</surname><given-names>L</given-names></name><name><surname>Turan</surname><given-names>A</given-names></name><name><surname>Dalton</surname><given-names>JE</given-names></name><name><surname>Figueroa</surname><given-names>PI</given-names></name><name><surname>Sessler</surname><given-names>DI</given-names></name><name><surname>Kurz</surname><given-names>A</given-names></name><article-title>Erythrocyte storage duration is not associated with increased mortality in noncardiac surgical patients: a retrospective analysis of 6,994 patients</article-title><source>Anesthesiology</source><year>2013</year><volume>118</volume><fpage>51</fpage><lpage>58</lpage><pub-id pub-id-type=""doi"">10.1097/ALN.0b013e3182746ba4</pub-id><pub-id pub-id-type=""pmid"">23154297</pub-id></mixed-citation></ref><ref id=""B32""><mixed-citation publication-type=""journal""><name><surname>Koch</surname><given-names>CG</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Sessler</surname><given-names>DI</given-names></name><name><surname>Figueroa</surname><given-names>P</given-names></name><name><surname>Hoeltge</surname><given-names>GA</given-names></name><name><surname>Mihaljevic</surname><given-names>T</given-names></name><name><surname>Blackstone</surname><given-names>EH</given-names></name><article-title>Duration of red-cell storage and complications after cardiac surgery</article-title><source>N Engl J Med</source><year>2008</year><volume>358</volume><fpage>1229</fpage><lpage>1239</lpage><pub-id pub-id-type=""doi"">10.1056/NEJMoa070403</pub-id><pub-id pub-id-type=""pmid"">18354101</pub-id></mixed-citation></ref><ref id=""B33""><mixed-citation publication-type=""journal""><name><surname>Dzik</surname><given-names>W</given-names></name><article-title>Fresh blood for everyone? Balancing availability and quality of stored RBCs</article-title><source>Transfus Med</source><year>2008</year><volume>18</volume><fpage>260</fpage><lpage>265</lpage><pub-id pub-id-type=""doi"">10.1111/j.1365-3148.2008.00870.x</pub-id><pub-id pub-id-type=""pmid"">18783585</pub-id></mixed-citation></ref><ref id=""B34""><mixed-citation publication-type=""journal""><name><surname>Benjamin</surname><given-names>RJ</given-names></name><name><surname>Dodd</surname><given-names>RY</given-names></name><article-title>Red-cell storage and complications of cardiac surgery</article-title><source>N Engl J Med</source><year>2008</year><volume>358</volume><fpage>2840</fpage><lpage>2841</lpage><pub-id pub-id-type=""pmid"">18579822</pub-id></mixed-citation></ref><ref id=""B35""><mixed-citation publication-type=""journal""><name><surname>Frenzel</surname><given-names>T</given-names></name><name><surname>Sibrowski</surname><given-names>W</given-names></name><name><surname>Westphal</surname><given-names>M</given-names></name><article-title>Red-cell storage and complications of cardiac surgery</article-title><source>N Engl J Med</source><year>2008</year><volume>358</volume><fpage>2841</fpage><lpage>2842</lpage><pub-id pub-id-type=""pmid"">18584826</pub-id></mixed-citation></ref><ref id=""B36""><mixed-citation publication-type=""journal""><name><surname>Zimrin</surname><given-names>AB</given-names></name><name><surname>Hess</surname><given-names>JR</given-names></name><article-title>Current issues relating to the transfusion of stored red blood cells</article-title><source>Vox Sang</source><year>2009</year><volume>96</volume><fpage>93</fpage><lpage>103</lpage><pub-id pub-id-type=""doi"">10.1111/j.1423-0410.2008.01117.x</pub-id><pub-id pub-id-type=""pmid"">19152602</pub-id></mixed-citation></ref><ref id=""B37""><mixed-citation publication-type=""journal""><name><surname>Jy</surname><given-names>W</given-names></name><name><surname>Ricci</surname><given-names>M</given-names></name><name><surname>Shariatmadar</surname><given-names>S</given-names></name><name><surname>Gomez-Marin</surname><given-names>O</given-names></name><name><surname>Horstman</surname><given-names>LH</given-names></name><name><surname>Ahn</surname><given-names>YS</given-names></name><article-title>Microparticles in stored red blood cells as potential mediators of transfusion complications</article-title><source>Transfusion</source><year>2011</year><volume>51</volume><fpage>886</fpage><lpage>893</lpage><pub-id pub-id-type=""doi"">10.1111/j.1537-2995.2011.03099.x</pub-id><pub-id pub-id-type=""pmid"">21496051</pub-id></mixed-citation></ref><ref id=""B38""><mixed-citation publication-type=""journal""><name><surname>van de Watering</surname><given-names>L</given-names></name><name><surname>Lorinser</surname><given-names>J</given-names></name><name><surname>Versteegh</surname><given-names>M</given-names></name><name><surname>Westendord</surname><given-names>R</given-names></name><name><surname>Brand</surname><given-names>A</given-names></name><article-title>Effects of storage time of red blood cell transfusions on the prognosis of coronary artery bypass graft patients</article-title><source>Transfusion</source><year>2006</year><volume>46</volume><fpage>1712</fpage><lpage>1718</lpage><pub-id pub-id-type=""doi"">10.1111/j.1537-2995.2006.00958.x</pub-id><pub-id pub-id-type=""pmid"">17002627</pub-id></mixed-citation></ref><ref id=""B39""><mixed-citation publication-type=""journal""><name><surname>McKenny</surname><given-names>M</given-names></name><name><surname>Ryan</surname><given-names>T</given-names></name><name><surname>Tate</surname><given-names>H</given-names></name><name><surname>Graham</surname><given-names>B</given-names></name><name><surname>Young</surname><given-names>VK</given-names></name><name><surname>Dowd</surname><given-names>N</given-names></name><article-title>Age of transfused blood is not associated with increased postoperative adverse outcome after cardiac surgery</article-title><source>Br J Anaesth</source><year>2011</year><volume>106</volume><fpage>643</fpage><lpage>649</lpage><pub-id pub-id-type=""doi"">10.1093/bja/aer029</pub-id><pub-id pub-id-type=""pmid"">21414977</pub-id></mixed-citation></ref><ref id=""B40""><mixed-citation publication-type=""journal""><name><surname>van Straten</surname><given-names>AH</given-names></name><name><surname>Soliman Hamad</surname><given-names>MA</given-names></name><name><surname>van Zundert</surname><given-names>AA</given-names></name><name><surname>Martens</surname><given-names>EJ</given-names></name><name><surname>ter Woorst</surname><given-names>JF</given-names></name><name><surname>de Wolf</surname><given-names>AM</given-names></name><name><surname>Scharnhorst</surname><given-names>V</given-names></name><article-title>Effect of duration of red blood cell storage on early and late mortality after coronary artery bypass grafting</article-title><source>J Thorac Cardiovasc Surg</source><year>2011</year><volume>141</volume><fpage>231</fpage><lpage>237</lpage><pub-id pub-id-type=""doi"">10.1016/j.jtcvs.2010.02.059</pub-id><pub-id pub-id-type=""pmid"">20621313</pub-id></mixed-citation></ref><ref id=""B41""><mixed-citation publication-type=""journal""><name><surname>Yap</surname><given-names>CH</given-names></name><name><surname>Lau</surname><given-names>L</given-names></name><name><surname>Krishnaswamy</surname><given-names>M</given-names></name><name><surname>Gaskell</surname><given-names>M</given-names></name><name><surname>Yii</surname><given-names>M</given-names></name><article-title>Age of transfused red cells and early outcomes after cardiac surgery</article-title><source>Ann Thorac Surg</source><year>2008</year><volume>86</volume><fpage>554</fpage><lpage>559</lpage><pub-id pub-id-type=""doi"">10.1016/j.athoracsur.2008.04.040</pub-id><pub-id pub-id-type=""pmid"">18640333</pub-id></mixed-citation></ref><ref id=""B42""><mixed-citation publication-type=""journal""><name><surname>Purdy</surname><given-names>FR</given-names></name><name><surname>Tweeddale</surname><given-names>MG</given-names></name><name><surname>Merrick</surname><given-names>PM</given-names></name><article-title>Association of mortality with age of blood transfused in septic ICU patients</article-title><source>Can J Anaesth</source><year>1997</year><volume>44</volume><fpage>1256</fpage><lpage>1261</lpage><pub-id pub-id-type=""doi"">10.1007/BF03012772</pub-id><pub-id pub-id-type=""pmid"">9429042</pub-id></mixed-citation></ref><ref id=""B43""><mixed-citation publication-type=""journal""><name><surname>Dessertaine</surname><given-names>G</given-names></name><name><surname>Hammer</surname><given-names>L</given-names></name><name><surname>Chenais</surname><given-names>F</given-names></name><name><surname>Remy</surname><given-names>J</given-names></name><name><surname>Schwebel</surname><given-names>C</given-names></name><name><surname>Tabah</surname><given-names>A</given-names></name><name><surname>Ara-Somohano</surname><given-names>C</given-names></name><name><surname>Bonadona</surname><given-names>A</given-names></name><name><surname>Hamidfar-Roy</surname><given-names>R</given-names></name><name><surname>Barnoud</surname><given-names>D</given-names></name><name><surname>Timsit</surname><given-names>JF</given-names></name><article-title>[Does red blood cell storage time still influence ICU survival?]</article-title><source>Transfus Clin Biol</source><year>2008</year><volume>15</volume><fpage>154</fpage><lpage>159</lpage><pub-id pub-id-type=""doi"">10.1016/j.tracli.2008.06.001</pub-id><pub-id pub-id-type=""pmid"">18757224</pub-id></mixed-citation></ref><ref id=""B44""><mixed-citation publication-type=""journal""><name><surname>Weinberg</surname><given-names>JA</given-names></name><name><surname>McGwin</surname><given-names>G</given-names><suffix>Jr</suffix></name><name><surname>Griffin</surname><given-names>RL</given-names></name><name><surname>Huynh</surname><given-names>VQ</given-names></name><name><surname>Cherry</surname><given-names>SA</given-names></name><name><surname>Marques</surname><given-names>MB</given-names></name><name><surname>Reiff</surname><given-names>DA</given-names></name><name><surname>Kerby</surname><given-names>JD</given-names></name><name><surname>Rue</surname><given-names>LW</given-names></name><article-title>Age of transfused blood: an independent predictor of mortality despite universal leukoreduction</article-title><source>J Trauma</source><year>2008</year><volume>65</volume><fpage>279</fpage><lpage>282</lpage><pub-id pub-id-type=""doi"">10.1097/TA.0b013e31817c9687</pub-id><pub-id pub-id-type=""pmid"">18695462</pub-id></mixed-citation></ref><ref id=""B45""><mixed-citation publication-type=""journal""><name><surname>Weinberg</surname><given-names>JA</given-names></name><name><surname>McGwin</surname><given-names>G</given-names><suffix>Jr</suffix></name><name><surname>Vandromme</surname><given-names>MJ</given-names></name><name><surname>Marques</surname><given-names>MB</given-names></name><name><surname>Melton</surname><given-names>SM</given-names></name><name><surname>Reiff</surname><given-names>DA</given-names></name><name><surname>Kerby</surname><given-names>JD</given-names></name><name><surname>Rue</surname><given-names>LW</given-names></name><article-title>Duration of red cell storage influences mortality after trauma</article-title><source>J Trauma</source><year>2010</year><volume>69</volume><fpage>1427</fpage><lpage>1431</lpage><pub-id pub-id-type=""doi"">10.1097/TA.0b013e3181fa0019</pub-id><pub-id pub-id-type=""pmid"">21150522</pub-id></mixed-citation></ref><ref id=""B46""><mixed-citation publication-type=""journal""><name><surname>Weinberg</surname><given-names>JA</given-names></name><name><surname>McGwin</surname><given-names>G</given-names><suffix>Jr</suffix></name><name><surname>Marques</surname><given-names>MB</given-names></name><name><surname>Cherry</surname><given-names>SA</given-names></name><name><surname>Reiff</surname><given-names>DA</given-names></name><name><surname>Kerby</surname><given-names>JD</given-names></name><name><surname>Rue</surname><given-names>LW</given-names></name><article-title>Transfusions in the less severely injured: does age of transfused blood affect outcomes?</article-title><source>J Trauma</source><year>2008</year><volume>65</volume><fpage>794</fpage><lpage>798</lpage><pub-id pub-id-type=""doi"">10.1097/TA.0b013e318184aa11</pub-id><pub-id pub-id-type=""pmid"">18849793</pub-id></mixed-citation></ref><ref id=""B47""><mixed-citation publication-type=""journal""><name><surname>Spinella</surname><given-names>PC</given-names></name><name><surname>Carroll</surname><given-names>CL</given-names></name><name><surname>Staff</surname><given-names>I</given-names></name><name><surname>Gross</surname><given-names>R</given-names></name><name><surname>McQuay</surname><given-names>J</given-names></name><name><surname>Keibel</surname><given-names>L</given-names></name><name><surname>Wade</surname><given-names>CE</given-names></name><name><surname>Holcomb</surname><given-names>JB</given-names></name><article-title>Duration of red blood cell storage is associated with increased incidence of deep vein thrombosis and in hospital mortality in patients with traumatic injuries</article-title><source>Crit Care</source><year>2009</year><volume>13</volume><fpage>R151</fpage><pub-id pub-id-type=""doi"">10.1186/cc8050</pub-id><pub-id pub-id-type=""pmid"">19772604</pub-id></mixed-citation></ref><ref id=""B48""><mixed-citation publication-type=""journal""><name><surname>Murrell</surname><given-names>Z</given-names></name><name><surname>Haukoos</surname><given-names>JS</given-names></name><name><surname>Putnam</surname><given-names>B</given-names></name><name><surname>Klein</surname><given-names>SR</given-names></name><article-title>The effect of older blood on mortality, need for ICU care, and the length of ICU stay after major trauma</article-title><source>Am Surg</source><year>2005</year><volume>71</volume><fpage>781</fpage><lpage>785</lpage><pub-id pub-id-type=""pmid"">16468518</pub-id></mixed-citation></ref><ref id=""B49""><mixed-citation publication-type=""journal""><name><surname>Hassan</surname><given-names>M</given-names></name><name><surname>Pham</surname><given-names>TN</given-names></name><name><surname>Cuschieri</surname><given-names>J</given-names></name><name><surname>Warner</surname><given-names>KJ</given-names></name><name><surname>Nester</surname><given-names>T</given-names></name><name><surname>Maier</surname><given-names>RV</given-names></name><name><surname>Shalhub</surname><given-names>S</given-names></name><name><surname>O'Keefe</surname><given-names>GE</given-names></name><article-title>The association between the transfusion of older blood and outcomes after trauma</article-title><source>Shock</source><year>2011</year><volume>35</volume><fpage>3</fpage><lpage>8</lpage><pub-id pub-id-type=""doi"">10.1097/SHK.0b013e3181e76274</pub-id><pub-id pub-id-type=""pmid"">20823694</pub-id></mixed-citation></ref><ref id=""B50""><mixed-citation publication-type=""journal""><name><surname>Eikelboom</surname><given-names>JW</given-names></name><name><surname>Cook</surname><given-names>RJ</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Heddle</surname><given-names>NM</given-names></name><article-title>Duration of red cell storage before transfusion and in-hospital mortality</article-title><source>Am Heart J</source><year>2010</year><volume>159</volume><fpage>737</fpage><lpage>743</lpage><pub-id pub-id-type=""doi"">10.1016/j.ahj.2009.12.045</pub-id><pub-id pub-id-type=""pmid"">20435180</pub-id></mixed-citation></ref><ref id=""B51""><mixed-citation publication-type=""journal""><name><surname>Robinson</surname><given-names>SD</given-names></name><name><surname>Janssen</surname><given-names>C</given-names></name><name><surname>Fretz</surname><given-names>EB</given-names></name><name><surname>Berry</surname><given-names>B</given-names></name><name><surname>Chase</surname><given-names>AJ</given-names></name><name><surname>Siega</surname><given-names>AD</given-names></name><name><surname>Carere</surname><given-names>RG</given-names></name><name><surname>Fung</surname><given-names>A</given-names></name><name><surname>Simkus</surname><given-names>G</given-names></name><name><surname>Klinke</surname><given-names>WP</given-names></name><name><surname>Hilton</surname><given-names>JD</given-names></name><article-title>Red blood cell storage duration and mortality in patients undergoing percutaneous coronary intervention</article-title><source>Am Heart J</source><year>2010</year><volume>159</volume><fpage>876</fpage><lpage>881</lpage><pub-id pub-id-type=""doi"">10.1016/j.ahj.2010.02.018</pub-id><pub-id pub-id-type=""pmid"">20435199</pub-id></mixed-citation></ref><ref id=""B52""><mixed-citation publication-type=""journal""><name><surname>Dunn</surname><given-names>LK</given-names></name><name><surname>Thiele</surname><given-names>RH</given-names></name><name><surname>Ma</surname><given-names>JZ</given-names></name><name><surname>Sawyer</surname><given-names>RG</given-names></name><name><surname>Nemergut</surname><given-names>EC</given-names></name><article-title>Duration of red blood cell storage and outcomes following orthotopic liver transplantation</article-title><source>Liver Transpl</source><year>2012</year><volume>18</volume><fpage>475</fpage><lpage>481</lpage><pub-id pub-id-type=""doi"">10.1002/lt.23379</pub-id><pub-id pub-id-type=""pmid"">22238247</pub-id></mixed-citation></ref><ref id=""B53""><mixed-citation publication-type=""journal""><name><surname>Mynster</surname><given-names>T</given-names></name><name><surname>Nielsen</surname><given-names>HJ</given-names></name><article-title>Storage time of transfused blood and disease recurrence after colorectal cancer surgery</article-title><source>Dis Colon Rectum</source><year>2001</year><volume>44</volume><fpage>955</fpage><lpage>964</lpage><pub-id pub-id-type=""doi"">10.1007/BF02235483</pub-id><pub-id pub-id-type=""pmid"">11496075</pub-id></mixed-citation></ref><ref id=""B54""><mixed-citation publication-type=""journal""><name><surname>Kekre</surname><given-names>N</given-names></name><name><surname>Chou</surname><given-names>A</given-names></name><name><surname>Tokessey</surname><given-names>M</given-names></name><name><surname>Doucette</surname><given-names>S</given-names></name><name><surname>Tinmouth</surname><given-names>A</given-names></name><name><surname>Tay</surname><given-names>J</given-names></name><name><surname>Allan</surname><given-names>DS</given-names></name><article-title>Storage time of transfused red blood cells and impact on clinical outcomes in hematopoietic stem cell transplantation</article-title><source>Transfusion</source><year>2011</year><volume>51</volume><fpage>2488</fpage><lpage>2494</lpage><pub-id pub-id-type=""doi"">10.1111/j.1537-2995.2011.03166.x</pub-id><pub-id pub-id-type=""pmid"">21569047</pub-id></mixed-citation></ref><ref id=""B55""><mixed-citation publication-type=""journal""><name><surname>Leal-Noval</surname><given-names>SR</given-names></name><name><surname>Jara-Lopez</surname><given-names>I</given-names></name><name><surname>Garcia-Garmendia</surname><given-names>JL</given-names></name><name><surname>Marin-Niebla</surname><given-names>A</given-names></name><name><surname>Herruzo-Aviles</surname><given-names>A</given-names></name><name><surname>Camacho-Larana</surname><given-names>P</given-names></name><name><surname>Loscertales</surname><given-names>J</given-names></name><article-title>Influence of erythrocyte concentrate storage time on postsurgical morbidity in cardiac surgery patients</article-title><source>Anesthesiology</source><year>2003</year><volume>98</volume><fpage>815</fpage><lpage>822</lpage><pub-id pub-id-type=""doi"">10.1097/00000542-200304000-00005</pub-id><pub-id pub-id-type=""pmid"">12657840</pub-id></mixed-citation></ref><ref id=""B56""><mixed-citation publication-type=""journal""><name><surname>Vamvakas</surname><given-names>EC</given-names></name><name><surname>Carven</surname><given-names>JH</given-names></name><article-title>Length of storage of transfused red cells and postoperative morbidity in patients undergoing coronary artery bypass graft surgery</article-title><source>Transfusion</source><year>2000</year><volume>40</volume><fpage>101</fpage><lpage>109</lpage><pub-id pub-id-type=""doi"">10.1046/j.1537-2995.2000.40010101.x</pub-id><pub-id pub-id-type=""pmid"">10644819</pub-id></mixed-citation></ref><ref id=""B57""><mixed-citation publication-type=""journal""><name><surname>Sanders</surname><given-names>J</given-names></name><name><surname>Patel</surname><given-names>S</given-names></name><name><surname>Cooper</surname><given-names>J</given-names></name><name><surname>Berryman</surname><given-names>J</given-names></name><name><surname>Farrar</surname><given-names>D</given-names></name><name><surname>Mythen</surname><given-names>M</given-names></name><name><surname>Montgomery</surname><given-names>HE</given-names></name><article-title>Red blood cell storage is associated with length of stay and renal complications after cardiac surgery</article-title><source>Transfusion</source><year>2011</year><volume>51</volume><fpage>2286</fpage><lpage>2294</lpage><pub-id pub-id-type=""doi"">10.1111/j.1537-2995.2011.03170.x</pub-id><pub-id pub-id-type=""pmid"">21564106</pub-id></mixed-citation></ref><ref id=""B58""><mixed-citation publication-type=""journal""><name><surname>Keller</surname><given-names>ME</given-names></name><name><surname>Jean</surname><given-names>R</given-names></name><name><surname>LaMorte</surname><given-names>WW</given-names></name><name><surname>Millham</surname><given-names>F</given-names></name><name><surname>Hirsch</surname><given-names>E</given-names></name><article-title>Effects of age of transfused blood on length of stay in trauma patients: a preliminary report</article-title><source>J Trauma</source><year>2002</year><volume>53</volume><fpage>1023</fpage><lpage>1025</lpage><pub-id pub-id-type=""doi"">10.1097/00005373-200211000-00037</pub-id><pub-id pub-id-type=""pmid"">12435963</pub-id></mixed-citation></ref><ref id=""B59""><mixed-citation publication-type=""journal""><name><surname>Vamvakas</surname><given-names>EC</given-names></name><name><surname>Carven</surname><given-names>JH</given-names></name><article-title>Transfusion and postoperative pneumonia in coronary artery bypass graft surgery: effect of the length of storage of transfused red cells</article-title><source>Transfusion</source><year>1999</year><volume>39</volume><fpage>701</fpage><lpage>710</lpage><pub-id pub-id-type=""doi"">10.1046/j.1537-2995.1999.39070701.x</pub-id><pub-id pub-id-type=""pmid"">10413277</pub-id></mixed-citation></ref><ref id=""B60""><mixed-citation publication-type=""journal""><name><surname>Andreasen</surname><given-names>JJ</given-names></name><name><surname>Dethlefsen</surname><given-names>C</given-names></name><name><surname>Modrau</surname><given-names>IS</given-names></name><name><surname>Baech</surname><given-names>J</given-names></name><name><surname>Schonheyder</surname><given-names>HC</given-names></name><name><surname>Moeller</surname><given-names>JK</given-names></name><name><surname>Johnsen</surname><given-names>SP</given-names></name><article-title>Storage time of allogeneic red blood cells is associated with risk of severe postoperative infection after coronary artery bypass grafting</article-title><source>Eur J Cardiothorac Surg</source><year>2011</year><volume>39</volume><fpage>329</fpage><lpage>334</lpage><pub-id pub-id-type=""doi"">10.1016/j.ejcts.2010.06.019</pub-id><pub-id pub-id-type=""pmid"">20702101</pub-id></mixed-citation></ref><ref id=""B61""><mixed-citation publication-type=""journal""><name><surname>Edna</surname><given-names>TH</given-names></name><name><surname>Bjerkeset</surname><given-names>T</given-names></name><article-title>Association between transfusion of stored blood and infective bacterial complications after resection for colorectal cancer</article-title><source>Eur J Surg</source><year>1998</year><volume>164</volume><fpage>449</fpage><lpage>456</lpage><pub-id pub-id-type=""pmid"">9696446</pub-id></mixed-citation></ref><ref id=""B62""><mixed-citation publication-type=""journal""><name><surname>Mynster</surname><given-names>T</given-names></name><name><surname>Nielsen</surname><given-names>HJ</given-names></name><article-title>The impact of storage time of transfused blood on postoperative infectious complications in rectal cancer surgery. Danish RANX05 Colorectal Cancer Study Group</article-title><source>Scand J Gastroenterol</source><year>2000</year><volume>35</volume><fpage>212</fpage><lpage>217</lpage><pub-id pub-id-type=""doi"">10.1080/003655200750024416</pub-id><pub-id pub-id-type=""pmid"">10720122</pub-id></mixed-citation></ref><ref id=""B63""><mixed-citation publication-type=""journal""><name><surname>Vandromme</surname><given-names>MJ</given-names></name><name><surname>McGwin</surname><given-names>G</given-names><suffix>Jr</suffix></name><name><surname>Marques</surname><given-names>MB</given-names></name><name><surname>Kerby</surname><given-names>JD</given-names></name><name><surname>Rue</surname><given-names>LW</given-names></name><name><surname>Weinberg</surname><given-names>JA</given-names></name><article-title>Transfusion and pneumonia in the trauma intensive care unit: an examination of the temporal relationship</article-title><source>J Trauma</source><year>2009</year><volume>67</volume><fpage>97</fpage><lpage>101</lpage><pub-id pub-id-type=""doi"">10.1097/TA.0b013e3181a5a8f9</pub-id><pub-id pub-id-type=""pmid"">19590316</pub-id></mixed-citation></ref><ref id=""B64""><mixed-citation publication-type=""journal""><name><surname>Offner</surname><given-names>PJ</given-names></name><name><surname>Moore</surname><given-names>EE</given-names></name><name><surname>Biffl</surname><given-names>WL</given-names></name><name><surname>Johnson</surname><given-names>JL</given-names></name><name><surname>Silliman</surname><given-names>CC</given-names></name><article-title>Increased rate of infection associated with transfusion of old blood after severe injury</article-title><source>Arch Surg</source><year>2002</year><volume>137</volume><fpage>711</fpage><lpage>716</lpage><pub-id pub-id-type=""doi"">10.1001/archsurg.137.6.711</pub-id><pub-id pub-id-type=""pmid"">12049543</pub-id></mixed-citation></ref><ref id=""B65""><mixed-citation publication-type=""journal""><name><surname>Juffermans</surname><given-names>NP</given-names></name><name><surname>Vlaar</surname><given-names>AP</given-names></name><name><surname>Prins</surname><given-names>DJ</given-names></name><name><surname>Goslings</surname><given-names>JC</given-names></name><name><surname>Binnekade</surname><given-names>JM</given-names></name><article-title>The age of red blood cells is associated with bacterial infections in critically ill trauma patients</article-title><source>Blood Transfus</source><year>2012</year><volume>10</volume><fpage>290</fpage><lpage>295</lpage><pub-id pub-id-type=""pmid"">22395349</pub-id></mixed-citation></ref><ref id=""B66""><mixed-citation publication-type=""journal""><name><surname>Taylor</surname><given-names>RW</given-names></name><name><surname>O'Brien</surname><given-names>J</given-names></name><name><surname>Trottier</surname><given-names>SJ</given-names></name><name><surname>Manganaro</surname><given-names>L</given-names></name><name><surname>Cytron</surname><given-names>M</given-names></name><name><surname>Lesko</surname><given-names>MF</given-names></name><name><surname>Arnzen</surname><given-names>K</given-names></name><name><surname>Cappadoro</surname><given-names>C</given-names></name><name><surname>Fu</surname><given-names>M</given-names></name><name><surname>Plisco</surname><given-names>MS</given-names></name><name><surname>Sadaka</surname><given-names>FG</given-names></name><name><surname>Veremakis</surname><given-names>C</given-names></name><article-title>Red blood cell transfusions and nosocomial infections in critically ill patients</article-title><source>Crit Care Med</source><year>2006</year><volume>34</volume><fpage>2302</fpage><lpage>2308</lpage><pub-id pub-id-type=""doi"">10.1097/01.CCM.0000234034.51040.7F</pub-id><pub-id pub-id-type=""pmid"">16849995</pub-id></mixed-citation></ref><ref id=""B67""><mixed-citation publication-type=""journal""><name><surname>Juffermans</surname><given-names>NP</given-names></name><name><surname>Prins</surname><given-names>DJ</given-names></name><name><surname>Vlaar</surname><given-names>AP</given-names></name><name><surname>Nieuwland</surname><given-names>R</given-names></name><name><surname>Binnekade</surname><given-names>JM</given-names></name><article-title>Transfusion-related risk of secondary bacterial infections in sepsis patients: a retrospective cohort study</article-title><source>Shock</source><year>2011</year><volume>35</volume><fpage>355</fpage><lpage>359</lpage><pub-id pub-id-type=""doi"">10.1097/SHK.0b013e3182086094</pub-id><pub-id pub-id-type=""pmid"">21192282</pub-id></mixed-citation></ref><ref id=""B68""><mixed-citation publication-type=""journal""><name><surname>Zallen</surname><given-names>G</given-names></name><name><surname>Offner</surname><given-names>PJ</given-names></name><name><surname>Moore</surname><given-names>EE</given-names></name><name><surname>Blackwell</surname><given-names>J</given-names></name><name><surname>Ciesla</surname><given-names>DJ</given-names></name><name><surname>Gabriel</surname><given-names>J</given-names></name><name><surname>Denny</surname><given-names>C</given-names></name><name><surname>Silliman</surname><given-names>CC</given-names></name><article-title>Age of transfused blood is an independent risk factor for postinjury multiple organ failure</article-title><source>Am J Surg</source><year>1999</year><volume>178</volume><fpage>570</fpage><lpage>572</lpage><pub-id pub-id-type=""doi"">10.1016/S0002-9610(99)00239-1</pub-id><pub-id pub-id-type=""pmid"">10670874</pub-id></mixed-citation></ref><ref id=""B69""><mixed-citation publication-type=""journal""><name><surname>Weiskopf</surname><given-names>RB</given-names></name><name><surname>Feiner</surname><given-names>J</given-names></name><name><surname>Toy</surname><given-names>P</given-names></name><name><surname>Twiford</surname><given-names>J</given-names></name><name><surname>Shimabukuro</surname><given-names>D</given-names></name><name><surname>Lieberman</surname><given-names>J</given-names></name><name><surname>Looney</surname><given-names>MR</given-names></name><name><surname>Lowell</surname><given-names>CA</given-names></name><name><surname>Gropper</surname><given-names>MA</given-names></name><article-title>Fresh and stored red blood cell transfusion equivalently induce subclinical pulmonary gas exchange deficit in normal humans</article-title><source>Anesth Analg</source><year>2012</year><volume>114</volume><fpage>511</fpage><lpage>519</lpage><pub-id pub-id-type=""doi"">10.1213/ANE.0b013e318241fcd5</pub-id><pub-id pub-id-type=""pmid"">22262647</pub-id></mixed-citation></ref><ref id=""B70""><mixed-citation publication-type=""journal""><name><surname>Gajic</surname><given-names>O</given-names></name><name><surname>Rana</surname><given-names>R</given-names></name><name><surname>Mendez</surname><given-names>JL</given-names></name><name><surname>Rickman</surname><given-names>OB</given-names></name><name><surname>Lymp</surname><given-names>JF</given-names></name><name><surname>Hubmayr</surname><given-names>RD</given-names></name><name><surname>Moore</surname><given-names>SB</given-names></name><article-title>Acute lung injury after blood transfusion in mechanically ventilated patients</article-title><source>Transfusion</source><year>2004</year><volume>44</volume><fpage>1468</fpage><lpage>1474</lpage><pub-id pub-id-type=""doi"">10.1111/j.1537-2995.2004.04053.x</pub-id><pub-id pub-id-type=""pmid"">15383020</pub-id></mixed-citation></ref><ref id=""B71""><mixed-citation publication-type=""journal""><name><surname>Marik</surname><given-names>PE</given-names></name><name><surname>Sibbald</surname><given-names>WJ</given-names></name><article-title>Effect of stored-blood transfusion on oxygen delivery in patients with sepsis</article-title><source>JAMA</source><year>1993</year><volume>269</volume><fpage>3024</fpage><lpage>3029</lpage><pub-id pub-id-type=""doi"">10.1001/jama.1993.03500230106037</pub-id><pub-id pub-id-type=""pmid"">8501845</pub-id></mixed-citation></ref><ref id=""B72""><mixed-citation publication-type=""journal""><name><surname>Fernandes</surname><given-names>CJ</given-names><suffix>Jr</suffix></name><name><surname>Akamine</surname><given-names>N</given-names></name><name><surname>De Marco</surname><given-names>FV</given-names></name><name><surname>De Souza</surname><given-names>JA</given-names></name><name><surname>Lagudis</surname><given-names>S</given-names></name><name><surname>Knobel</surname><given-names>E</given-names></name><article-title>Red blood cell transfusion does not increase oxygen consumption in critically ill septic patients</article-title><source>Crit Care</source><year>2001</year><volume>5</volume><fpage>362</fpage><lpage>367</lpage><pub-id pub-id-type=""doi"">10.1186/cc1070</pub-id><pub-id pub-id-type=""pmid"">11737926</pub-id></mixed-citation></ref><ref id=""B73""><mixed-citation publication-type=""journal""><name><surname>Walsh</surname><given-names>TS</given-names></name><name><surname>McArdle</surname><given-names>F</given-names></name><name><surname>McLellan</surname><given-names>SA</given-names></name><name><surname>Maciver</surname><given-names>C</given-names></name><name><surname>Maginnis</surname><given-names>M</given-names></name><name><surname>Prescott</surname><given-names>RJ</given-names></name><name><surname>McClelland</surname><given-names>DB</given-names></name><article-title>Does the storage time of transfused red blood cells influence regional or global indexes of tissue oxygenation in anemic critically ill patients?</article-title><source>Crit Care Med</source><year>2004</year><volume>32</volume><fpage>364</fpage><lpage>371</lpage><pub-id pub-id-type=""doi"">10.1097/01.CCM.0000108878.23703.E0</pub-id><pub-id pub-id-type=""pmid"">14758149</pub-id></mixed-citation></ref><ref id=""B74""><mixed-citation publication-type=""journal""><name><surname>Marik</surname><given-names>P</given-names></name><article-title>Does the age of blood matter?</article-title><source>Crit Care Med</source><year>2004</year><volume>32</volume><fpage>1442</fpage><lpage>1443</lpage><pub-id pub-id-type=""pmid"">15187558</pub-id></mixed-citation></ref><ref id=""B75""><mixed-citation publication-type=""journal""><name><surname>Sakr</surname><given-names>Y</given-names></name><name><surname>Chierego</surname><given-names>M</given-names></name><name><surname>Piagnerelli</surname><given-names>M</given-names></name><name><surname>Verdant</surname><given-names>C</given-names></name><name><surname>Dubois</surname><given-names>MJ</given-names></name><name><surname>Koch</surname><given-names>M</given-names></name><name><surname>Creteur</surname><given-names>J</given-names></name><name><surname>Gullo</surname><given-names>A</given-names></name><name><surname>Vincent</surname><given-names>JL</given-names></name><name><surname>De Backer</surname><given-names>D</given-names></name><article-title>Microvascular response to red blood cell transfusion in patients with severe sepsis</article-title><source>Crit Care Med</source><year>2007</year><volume>35</volume><fpage>1639</fpage><lpage>1644</lpage><pub-id pub-id-type=""doi"">10.1097/01.CCM.0000269936.73788.32</pub-id><pub-id pub-id-type=""pmid"">17522571</pub-id></mixed-citation></ref><ref id=""B76""><mixed-citation publication-type=""other""><name><surname>Yuruk</surname><given-names>K</given-names></name><name><surname>Milstein</surname><given-names>DM</given-names></name><name><surname>Bezemer</surname><given-names>R</given-names></name><name><surname>Bartels</surname><given-names>SA</given-names></name><name><surname>Biemond</surname><given-names>BJ</given-names></name><name><surname>Ince</surname><given-names>C</given-names></name><article-title>Transfusion of banked red blood cells and the effects on hemorrheology and microvascular hemodynamics in anemic hematology outpatients</article-title><source>Transfusion</source><year>2012</year><comment>in press doi: 10.1111/j.1537-2995.2012.03905</comment></mixed-citation></ref><ref id=""B77""><mixed-citation publication-type=""journal""><name><surname>Leal-Noval</surname><given-names>SR</given-names></name><name><surname>Munoz-Gomez</surname><given-names>M</given-names></name><name><surname>Arellano-Orden</surname><given-names>V</given-names></name><name><surname>Marin-Caballos</surname><given-names>A</given-names></name><name><surname>maya-Villar</surname><given-names>R</given-names></name><name><surname>Marin</surname><given-names>A</given-names></name><name><surname>Puppo-Moreno</surname><given-names>A</given-names></name><name><surname>Ferrandiz-Millon</surname><given-names>C</given-names></name><name><surname>Flores-Cordero</surname><given-names>JM</given-names></name><name><surname>Murillo-Cabezas</surname><given-names>F</given-names></name><article-title>Impact of age of transfused blood on cerebral oxygenation in male patients with severe traumatic brain injury</article-title><source>Crit Care Med</source><year>2008</year><volume>36</volume><fpage>1290</fpage><lpage>1296</lpage><pub-id pub-id-type=""doi"">10.1097/CCM.0b013e3181692dfc</pub-id><pub-id pub-id-type=""pmid"">18379257</pub-id></mixed-citation></ref><ref id=""B78""><mixed-citation publication-type=""journal""><name><surname>Netzer</surname><given-names>G</given-names></name><name><surname>Dutton</surname><given-names>RP</given-names></name><name><surname>Hess</surname><given-names>JR</given-names></name><article-title>Right data, wrong conclusions</article-title><source>Crit Care Med</source><year>2008</year><volume>36</volume><fpage>1383</fpage><lpage>1384</lpage><pub-id pub-id-type=""doi"">10.1097/CCM.0b013e31816a10a3</pub-id><pub-id pub-id-type=""pmid"">18379283</pub-id></mixed-citation></ref><ref id=""B79""><mixed-citation publication-type=""journal""><name><surname>Kiraly</surname><given-names>LN</given-names></name><name><surname>Underwood</surname><given-names>S</given-names></name><name><surname>Differding</surname><given-names>JA</given-names></name><name><surname>Schreiber</surname><given-names>MA</given-names></name><article-title>Transfusion of aged packed red blood cells results in decreased tissue oxygenation in critically injured trauma patients</article-title><source>J Trauma</source><year>2009</year><volume>67</volume><fpage>29</fpage><lpage>32</lpage><pub-id pub-id-type=""doi"">10.1097/TA.0b013e3181af6a8c</pub-id><pub-id pub-id-type=""pmid"">19590304</pub-id></mixed-citation></ref><ref id=""B80""><mixed-citation publication-type=""other""><name><surname>Santora</surname><given-names>RJ</given-names></name><name><surname>Moore</surname><given-names>FA</given-names></name><article-title>Monitoring trauma and intensive care unit resuscitation with tissue hemoglobin oxygen saturation</article-title><source>Crit Care</source><year>2009</year><issue>Suppl 5</issue><fpage>S10</fpage><pub-id pub-id-type=""pmid"">19951382</pub-id></mixed-citation></ref><ref id=""B81""><mixed-citation publication-type=""other""><name><surname>Creteur</surname><given-names>J</given-names></name><name><surname>Neves</surname><given-names>AP</given-names></name><name><surname>Vincent</surname><given-names>JL</given-names></name><article-title>Near-infrared spectroscopy technique to evaluate the effects of red blood cell transfusion on tissue oxygenation</article-title><source>Crit Care</source><year>2009</year><issue>Suppl 5</issue><fpage>S11</fpage><pub-id pub-id-type=""pmid"">19951383</pub-id></mixed-citation></ref><ref id=""B82""><mixed-citation publication-type=""journal""><name><surname>Berra</surname><given-names>L</given-names></name><name><surname>Coppadoro</surname><given-names>A</given-names></name><name><surname>Yu</surname><given-names>B</given-names></name><name><surname>Lei</surname><given-names>C</given-names></name><name><surname>Spagnolli</surname><given-names>E</given-names></name><name><surname>Steinbicker</surname><given-names>AU</given-names></name><name><surname>Bloch</surname><given-names>KD</given-names></name><name><surname>Lin</surname><given-names>T</given-names></name><name><surname>Sammy</surname><given-names>FY</given-names></name><name><surname>Warren</surname><given-names>HS</given-names></name><name><surname>Fernandez</surname><given-names>BO</given-names></name><name><surname>Feelisch</surname><given-names>M</given-names></name><name><surname>Dzik</surname><given-names>WH</given-names></name><name><surname>Stowell</surname><given-names>CP</given-names></name><name><surname>Zapol</surname><given-names>WM</given-names></name><article-title>Transfusion of stored autologous blood does not alter reactive hyperemia index in healthy volunteers</article-title><source>Anesthesiology</source><year>2012</year><volume>117</volume><fpage>56</fpage><lpage>63</lpage><pub-id pub-id-type=""doi"">10.1097/ALN.0b013e31825575e6</pub-id><pub-id pub-id-type=""pmid"">22531338</pub-id></mixed-citation></ref><ref id=""B83""><mixed-citation publication-type=""journal""><name><surname>Roberson</surname><given-names>RS</given-names></name><name><surname>Lockhart</surname><given-names>E</given-names></name><name><surname>Shapiro</surname><given-names>NI</given-names></name><name><surname>Bandarenko</surname><given-names>N</given-names></name><name><surname>McMahon</surname><given-names>TJ</given-names></name><name><surname>Massey</surname><given-names>MJ</given-names></name><name><surname>White</surname><given-names>WD</given-names></name><name><surname>Bennett-Guerrero</surname><given-names>E</given-names></name><article-title>Impact of transfusion of autologous 7- versus 42-day-old AS-3 red blood cells on tissue oxygenation and the microcirculation in healthy volunteers</article-title><source>Transfusion</source><year>2012</year><volume>52</volume><fpage>2459</fpage><lpage>2464</lpage><pub-id pub-id-type=""doi"">10.1111/j.1537-2995.2012.03615.x</pub-id><pub-id pub-id-type=""pmid"">22452273</pub-id></mixed-citation></ref><ref id=""B84""><mixed-citation publication-type=""journal""><name><surname>Kopterides</surname><given-names>P</given-names></name><name><surname>Theodorakopoulou</surname><given-names>M</given-names></name><name><surname>Nikitas</surname><given-names>N</given-names></name><name><surname>Ilias</surname><given-names>I</given-names></name><name><surname>Vassiliadi</surname><given-names>DA</given-names></name><name><surname>Orfanos</surname><given-names>SE</given-names></name><name><surname>Tsangaris</surname><given-names>I</given-names></name><name><surname>Maniatis</surname><given-names>NA</given-names></name><name><surname>Tsantes</surname><given-names>AE</given-names></name><name><surname>Travlou</surname><given-names>A</given-names></name><name><surname>Dimitriadis</surname><given-names>G</given-names></name><name><surname>Armaganidis</surname><given-names>A</given-names></name><name><surname>Ungerstedt</surname><given-names>U</given-names></name><name><surname>Dimopoulou</surname><given-names>I</given-names></name><article-title>Red blood cell transfusion affects microdialysis-assessed interstitial lactate/pyruvate ratio in critically ill patients with late sepsis</article-title><source>Intensive Care Med</source><year>2012</year><volume>38</volume><fpage>1843</fpage><lpage>1850</lpage><pub-id pub-id-type=""doi"">10.1007/s00134-012-2635-8</pub-id><pub-id pub-id-type=""pmid"">22777518</pub-id></mixed-citation></ref><ref id=""B85""><mixed-citation publication-type=""journal""><name><surname>Katsios</surname><given-names>C</given-names></name><name><surname>Griffith</surname><given-names>L</given-names></name><name><surname>Spinella</surname><given-names>P</given-names></name><name><surname>Lacroix</surname><given-names>J</given-names></name><name><surname>Crowther</surname><given-names>M</given-names></name><name><surname>Hebert</surname><given-names>P</given-names></name><name><surname>Meade</surname><given-names>M</given-names></name><name><surname>Geerts</surname><given-names>W</given-names></name><name><surname>Rabbat</surname><given-names>C</given-names></name><name><surname>Cook</surname><given-names>D</given-names></name><article-title>Red blood cell transfusion and increased length of storage are not associated with deep vein thrombosis in medical and surgical critically ill patients: a prospective observational cohort study</article-title><source>Crit Care</source><year>2011</year><volume>15</volume><fpage>R263</fpage><pub-id pub-id-type=""doi"">10.1186/cc10526</pub-id><pub-id pub-id-type=""pmid"">22044745</pub-id></mixed-citation></ref><ref id=""B86""><mixed-citation publication-type=""journal""><name><surname>Naidech</surname><given-names>AM</given-names></name><name><surname>Liebling</surname><given-names>SM</given-names></name><name><surname>Duran</surname><given-names>IM</given-names></name><name><surname>Ault</surname><given-names>ML</given-names></name><article-title>Packed red blood cell age does not impact adverse events or outcomes after subarachnoid haemorrhage</article-title><source>Transfus Med</source><year>2011</year><volume>21</volume><fpage>130</fpage><lpage>133</lpage><pub-id pub-id-type=""doi"">10.1111/j.1365-3148.2010.01048.x</pub-id><pub-id pub-id-type=""pmid"">21062382</pub-id></mixed-citation></ref><ref id=""B87""><mixed-citation publication-type=""journal""><name><surname>Wasser</surname><given-names>MN</given-names></name><name><surname>Houbiers</surname><given-names>JG</given-names></name><name><surname>D'Amaro</surname><given-names>J</given-names></name><name><surname>Hermans</surname><given-names>J</given-names></name><name><surname>Huysmans</surname><given-names>HA</given-names></name><name><surname>van Konijnenburg</surname><given-names>GC</given-names></name><name><surname>Brand</surname><given-names>A</given-names></name><article-title>The effect of fresh versus stored blood on post-operative bleeding after coronary bypass surgery: a prospective randomized study</article-title><source>Br J Haematol</source><year>1989</year><volume>72</volume><fpage>81</fpage><lpage>84</lpage><pub-id pub-id-type=""doi"">10.1111/j.1365-2141.1989.tb07656.x</pub-id><pub-id pub-id-type=""pmid"">2786735</pub-id></mixed-citation></ref><ref id=""B88""><mixed-citation publication-type=""journal""><name><surname>Weiskopf</surname><given-names>RB</given-names></name><name><surname>Feiner</surname><given-names>J</given-names></name><name><surname>Hopf</surname><given-names>H</given-names></name><name><surname>Lieberman</surname><given-names>J</given-names></name><name><surname>Finlay</surname><given-names>HE</given-names></name><name><surname>Quah</surname><given-names>C</given-names></name><name><surname>Kramer</surname><given-names>JH</given-names></name><name><surname>Bostrom</surname><given-names>A</given-names></name><name><surname>Toy</surname><given-names>P</given-names></name><article-title>Fresh blood and aged stored blood are equally efficacious in immediately reversing anemia-induced brain oxygenation deficits in humans</article-title><source>Anesthesiology</source><year>2006</year><volume>104</volume><fpage>911</fpage><lpage>920</lpage><pub-id pub-id-type=""doi"">10.1097/00000542-200605000-00005</pub-id><pub-id pub-id-type=""pmid"">16645441</pub-id></mixed-citation></ref><ref id=""B89""><mixed-citation publication-type=""journal""><name><surname>Cata</surname><given-names>JP</given-names></name><name><surname>Klein</surname><given-names>EA</given-names></name><name><surname>Hoeltge</surname><given-names>GA</given-names></name><name><surname>Dalton</surname><given-names>JE</given-names></name><name><surname>Mascha</surname><given-names>E</given-names></name><name><surname>O'Hara</surname><given-names>J</given-names></name><name><surname>Russell</surname><given-names>A</given-names></name><name><surname>Kurz</surname><given-names>A</given-names></name><name><surname>Ben-Elihayhu</surname><given-names>S</given-names></name><name><surname>Sessler</surname><given-names>DI</given-names></name><article-title>Blood storage duration and biochemical recurrence of cancer after radical prostatectomy</article-title><source>Mayo Clin Proc</source><year>2011</year><volume>86</volume><fpage>120</fpage><lpage>127</lpage><pub-id pub-id-type=""doi"">10.4065/mcp.2010.0313</pub-id><pub-id pub-id-type=""pmid"">21282486</pub-id></mixed-citation></ref><ref id=""B90""><mixed-citation publication-type=""journal""><name><surname>Weinberg</surname><given-names>JA</given-names></name><name><surname>Barnum</surname><given-names>SR</given-names></name><name><surname>Patel</surname><given-names>RP</given-names></name><article-title>Red blood cell age and potentiation of transfusion-related pathology in trauma patients</article-title><source>Transfusion</source><year>2011</year><volume>51</volume><fpage>867</fpage><lpage>873</lpage><pub-id pub-id-type=""doi"">10.1111/j.1537-2995.2011.03098.x</pub-id><pub-id pub-id-type=""pmid"">21496048</pub-id></mixed-citation></ref><ref id=""B91""><mixed-citation publication-type=""journal""><name><surname>Pereira</surname><given-names>A</given-names></name><article-title>Will clinical studies elucidate the connection between the length of storage of transfused red blood cells and clinical outcomes? An analysis based on the simulation of randomized controlled trials</article-title><source>Transfusion</source><year>2013</year><volume>53</volume><fpage>34</fpage><lpage>40</lpage><pub-id pub-id-type=""doi"">10.1111/j.1537-2995.2012.03656.x</pub-id><pub-id pub-id-type=""pmid"">22519710</pub-id></mixed-citation></ref><ref id=""B92""><mixed-citation publication-type=""journal""><name><surname>Middelburg</surname><given-names>RA</given-names></name><name><surname>van de Watering</surname><given-names>LM</given-names></name><name><surname>van der Bom</surname><given-names>JG</given-names></name><article-title>Blood transfusions: good or bad? Confounding by indication, an underestimated problem in clinical transfusion research</article-title><source>Transfusion</source><year>2010</year><volume>50</volume><fpage>1181</fpage><lpage>1183</lpage><pub-id pub-id-type=""doi"">10.1111/j.1537-2995.2010.02675.x</pub-id><pub-id pub-id-type=""pmid"">20456689</pub-id></mixed-citation></ref><ref id=""B93""><mixed-citation publication-type=""journal""><name><surname>Jenkins</surname><given-names>PV</given-names></name><name><surname>O'Donnell</surname><given-names>JS</given-names></name><article-title>ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?</article-title><source>Transfusion</source><year>2006</year><volume>46</volume><fpage>1836</fpage><lpage>1844</lpage><pub-id pub-id-type=""doi"">10.1111/j.1537-2995.2006.00975.x</pub-id><pub-id pub-id-type=""pmid"">17002642</pub-id></mixed-citation></ref><ref id=""B94""><mixed-citation publication-type=""journal""><name><surname>Ioannidis</surname><given-names>JP</given-names></name><name><surname>Lau</surname><given-names>J</given-names></name><article-title>Pooling research results: benefits and limitations of meta-analysis</article-title><source>Jt Comm J Qual Improv</source><year>1999</year><volume>25</volume><fpage>462</fpage><lpage>469</lpage><pub-id pub-id-type=""pmid"">10481815</pub-id></mixed-citation></ref><ref id=""B95""><mixed-citation publication-type=""journal""><name><surname>Flegel</surname><given-names>WA</given-names></name><article-title>Fresh blood for transfusion: how old is too old for red blood cell units?</article-title><source>Blood Transfus</source><year>2012</year><volume>10</volume><fpage>247</fpage><lpage>251</lpage><pub-id pub-id-type=""pmid"">22889813</pub-id></mixed-citation></ref><ref id=""B96""><mixed-citation publication-type=""journal""><name><surname>Heddle</surname><given-names>NM</given-names></name><name><surname>Cook</surname><given-names>RJ</given-names></name><name><surname>Arnold</surname><given-names>DM</given-names></name><name><surname>Crowther</surname><given-names>MA</given-names></name><name><surname>Warkentin</surname><given-names>TE</given-names></name><name><surname>Webert</surname><given-names>KE</given-names></name><name><surname>Hirsh</surname><given-names>J</given-names></name><name><surname>Barty</surname><given-names>RL</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Lester</surname><given-names>C</given-names></name><name><surname>Eikelboom</surname><given-names>JW</given-names></name><article-title>The effect of blood storage duration on in-hospital mortality: a randomized controlled pilot feasibility trial</article-title><source>Transfusion</source><year>2012</year><volume>52</volume><fpage>1203</fpage><lpage>1212</lpage><pub-id pub-id-type=""doi"">10.1111/j.1537-2995.2011.03521.x</pub-id><pub-id pub-id-type=""pmid"">22257314</pub-id></mixed-citation></ref><ref id=""B97""><mixed-citation publication-type=""journal""><name><surname>Aubron</surname><given-names>C</given-names></name><name><surname>Syres</surname><given-names>G</given-names></name><name><surname>Nichol</surname><given-names>A</given-names></name><name><surname>Bailey</surname><given-names>M</given-names></name><name><surname>Board</surname><given-names>J</given-names></name><name><surname>Magrin</surname><given-names>G</given-names></name><name><surname>Murray</surname><given-names>L</given-names></name><name><surname>Presneill</surname><given-names>J</given-names></name><name><surname>Sutton</surname><given-names>J</given-names></name><name><surname>Vallance</surname><given-names>S</given-names></name><name><surname>Morrison</surname><given-names>S</given-names></name><name><surname>Bellomo</surname><given-names>R</given-names></name><name><surname>Cooper</surname><given-names>DJ</given-names></name><article-title>A pilot feasibility trial of allocation of freshest available red blood cells versus standard care in critically ill patients</article-title><source>Transfusion</source><year>2012</year><volume>52</volume><fpage>1196</fpage><lpage>1202</lpage><pub-id pub-id-type=""doi"">10.1111/j.1537-2995.2011.03437.x</pub-id><pub-id pub-id-type=""pmid"">22082281</pub-id></mixed-citation></ref><ref id=""B98""><mixed-citation publication-type=""journal""><name><surname>Lacroix</surname><given-names>J</given-names></name><name><surname>Hebert</surname><given-names>P</given-names></name><name><surname>Fergusson</surname><given-names>D</given-names></name><name><surname>Tinmouth</surname><given-names>A</given-names></name><name><surname>Blajchman</surname><given-names>MA</given-names></name><name><surname>Callum</surname><given-names>J</given-names></name><name><surname>Cook</surname><given-names>D</given-names></name><name><surname>Marshall</surname><given-names>JC</given-names></name><name><surname>McIntyre</surname><given-names>L</given-names></name><name><surname>Turgeon</surname><given-names>AF</given-names></name><article-title>The Age of Blood Evaluation (ABLE) randomized controlled trial: study design</article-title><source>Transfus Med Rev</source><year>2011</year><volume>25</volume><fpage>197</fpage><lpage>205</lpage><pub-id pub-id-type=""doi"">10.1016/j.tmrv.2011.03.001</pub-id><pub-id pub-id-type=""pmid"">21550205</pub-id></mixed-citation></ref><ref id=""B99""><mixed-citation publication-type=""journal""><name><surname>Steiner</surname><given-names>ME</given-names></name><name><surname>Assmann</surname><given-names>SF</given-names></name><name><surname>Levy</surname><given-names>JH</given-names></name><name><surname>Marshall</surname><given-names>J</given-names></name><name><surname>Pulkrabek</surname><given-names>S</given-names></name><name><surname>Sloan</surname><given-names>SR</given-names></name><name><surname>Triulzi</surname><given-names>D</given-names></name><name><surname>Stowell</surname><given-names>CP</given-names></name><article-title>Addressing the question of the effect of RBC storage on clinical outcomes: the Red Cell Storage Duration Study (RECESS) (Section 7)</article-title><source>Transfus Apher Sci</source><year>2010</year><volume>43</volume><fpage>107</fpage><lpage>116</lpage><pub-id pub-id-type=""doi"">10.1016/j.transci.2010.05.014</pub-id><pub-id pub-id-type=""pmid"">20655807</pub-id></mixed-citation></ref><ref id=""B100""><mixed-citation publication-type=""journal""><name><surname>Schulman</surname><given-names>CI</given-names></name><name><surname>Nathe</surname><given-names>K</given-names></name><name><surname>Brown</surname><given-names>M</given-names></name><name><surname>Cohn</surname><given-names>SM</given-names></name><article-title>Impact of age of transfused blood in the trauma patient</article-title><source>J Trauma</source><year>2002</year><volume>52</volume><fpage>1224</fpage><lpage>1225</lpage><pub-id pub-id-type=""doi"">10.1097/00005373-200206000-00036</pub-id><pub-id pub-id-type=""pmid"">12045660</pub-id></mixed-citation></ref><ref id=""B101""><mixed-citation publication-type=""journal""><name><surname>Hebert</surname><given-names>PC</given-names></name><name><surname>Chin-Yee</surname><given-names>I</given-names></name><name><surname>Fergusson</surname><given-names>D</given-names></name><name><surname>Blajchman</surname><given-names>M</given-names></name><name><surname>Martineau</surname><given-names>R</given-names></name><name><surname>Clinch</surname><given-names>J</given-names></name><name><surname>Olberg</surname><given-names>B</given-names></name><article-title>A pilot trial evaluating the clinical effects of prolonged storage of red cells</article-title><source>Anesth Analg</source><year>2005</year><volume>100</volume><fpage>1433</fpage><lpage>1438</lpage><pub-id pub-id-type=""doi"">10.1213/01.ANE.0000148690.48803.27</pub-id><pub-id pub-id-type=""pmid"">15845701</pub-id></mixed-citation></ref><ref id=""B102""><mixed-citation publication-type=""journal""><name><surname>Bennett-Guerrero</surname><given-names>E</given-names></name><name><surname>Stafford-Smith</surname><given-names>M</given-names></name><name><surname>Waweru</surname><given-names>PM</given-names></name><name><surname>Bredehoeft</surname><given-names>SJ</given-names></name><name><surname>Campbell</surname><given-names>ML</given-names></name><name><surname>Haley</surname><given-names>NR</given-names></name><name><surname>Phillips-Bute</surname><given-names>B</given-names></name><name><surname>Newman</surname><given-names>MF</given-names></name><name><surname>Bandarenko</surname><given-names>N</given-names></name><article-title>A prospective, double-blind, randomized clinical feasibility trial of controlling the storage age of red blood cells for transfusion in cardiac surgical patients</article-title><source>Transfusion</source><year>2009</year><volume>49</volume><fpage>1375</fpage><lpage>1383</lpage><pub-id pub-id-type=""doi"">10.1111/j.1537-2995.2009.02152.x</pub-id><pub-id pub-id-type=""pmid"">19389021</pub-id></mixed-citation></ref><ref id=""B103""><mixed-citation publication-type=""journal""><name><surname>Fogh-Andersen</surname><given-names>N</given-names></name><name><surname>Mogensen</surname><given-names>F</given-names></name><article-title>On the safety of using stored bank blood for chronic hemodialysis patients</article-title><source>Transfusion</source><year>1984</year><volume>24</volume><fpage>505</fpage><lpage>507</lpage><pub-id pub-id-type=""doi"">10.1046/j.1537-2995.1984.24685066811.x</pub-id><pub-id pub-id-type=""pmid"">6506183</pub-id></mixed-citation></ref><ref id=""B104""><mixed-citation publication-type=""journal""><name><surname>Luten</surname><given-names>M</given-names></name><name><surname>Roerdinkholder-Stoelwinder</surname><given-names>B</given-names></name><name><surname>Schaap</surname><given-names>NP</given-names></name><name><surname>De Grip</surname><given-names>WJ</given-names></name><name><surname>Bos</surname><given-names>HJ</given-names></name><name><surname>Bosman</surname><given-names>GJ</given-names></name><article-title>Survival of red blood cells after transfusion: a comparison between red cells concentrates of different storage periods</article-title><source>Transfusion</source><year>2008</year><volume>48</volume><fpage>1478</fpage><lpage>1485</lpage><pub-id pub-id-type=""doi"">10.1111/j.1537-2995.2008.01734.x</pub-id><pub-id pub-id-type=""pmid"">18482180</pub-id></mixed-citation></ref><ref id=""B105""><mixed-citation publication-type=""journal""><name><surname>Pieracci</surname><given-names>FM</given-names></name><name><surname>Moore</surname><given-names>EE</given-names></name><name><surname>Chin</surname><given-names>T</given-names></name><name><surname>Townsend</surname><given-names>N</given-names></name><name><surname>Gonzalez</surname><given-names>E</given-names></name><name><surname>Burlew</surname><given-names>CC</given-names></name><name><surname>Barnett</surname><given-names>CC</given-names><suffix>Jr</suffix></name><article-title>The age of transfused blood predicts hematocrit response among critically ill surgical patients</article-title><source>Am J Surg</source><year>2012</year><volume>204</volume><fpage>269</fpage><lpage>273</lpage><pub-id pub-id-type=""doi"">10.1016/j.amjsurg.2011.10.017</pub-id><pub-id pub-id-type=""pmid"">22465434</pub-id></mixed-citation></ref><ref id=""B106""><mixed-citation publication-type=""journal""><name><surname>Hoh</surname><given-names>H</given-names></name><name><surname>Umpleby</surname><given-names>H</given-names></name><name><surname>Cooper</surname><given-names>A</given-names></name><name><surname>Taylor</surname><given-names>I</given-names></name><article-title>Recurrence of colorectal cancer and perioperative blood transfusion. Is blood storage time important?</article-title><source>Dis Colon Rectum</source><year>1990</year><volume>33</volume><fpage>127</fpage><lpage>130</lpage><pub-id pub-id-type=""doi"">10.1007/BF02055541</pub-id><pub-id pub-id-type=""pmid"">2298098</pub-id></mixed-citation></ref><ref id=""B107""><mixed-citation publication-type=""journal""><name><surname>Lebiedz</surname><given-names>P</given-names></name><name><surname>Glasmeyer</surname><given-names>S</given-names></name><name><surname>Hilker</surname><given-names>E</given-names></name><name><surname>Yilmaz-Neuhaus</surname><given-names>A</given-names></name><name><surname>Karaboutas</surname><given-names>T</given-names></name><name><surname>Reinecke</surname><given-names>H</given-names></name><name><surname>Sibrowski</surname><given-names>W</given-names></name><name><surname>Nofer</surname><given-names>JR</given-names></name><article-title>Influence of red blood cell storage time on clinical course and cytokine profile in septic shock patients</article-title><source>Transfus Med Hemother</source><year>2012</year><volume>39</volume><fpage>271</fpage><lpage>276</lpage><pub-id pub-id-type=""doi"">10.1159/000339807</pub-id><pub-id pub-id-type=""pmid"">22969697</pub-id></mixed-citation></ref><ref id=""B108""><mixed-citation publication-type=""journal""><name><surname>Zubair</surname><given-names>AC</given-names></name><article-title>Clinical impact of blood storage lesions</article-title><source>Am J Hematol</source><year>2010</year><volume>85</volume><fpage>117</fpage><lpage>122</lpage><pub-id pub-id-type=""pmid"">20052749</pub-id></mixed-citation></ref><ref id=""B109""><mixed-citation publication-type=""journal""><name><surname>Roback</surname><given-names>JD</given-names></name><article-title>Vascular effects of the red blood cell storage lesion</article-title><source>Hematology Am Soc Hematol Educ Program</source><year>2011</year><volume>2011</volume><fpage>475</fpage><lpage>479</lpage><pub-id pub-id-type=""doi"">10.1182/asheducation-2011.1.475</pub-id><pub-id pub-id-type=""pmid"">22160077</pub-id></mixed-citation></ref><ref id=""B110""><mixed-citation publication-type=""journal""><name><surname>Reynolds</surname><given-names>JD</given-names></name><name><surname>Ahearn</surname><given-names>GS</given-names></name><name><surname>Angelo</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Cobb</surname><given-names>F</given-names></name><name><surname>Stamler</surname><given-names>JS</given-names></name><article-title>S-nitrosohemoglobin deficiency: a mechanism for loss of physiological activity in banked blood</article-title><source>Proc Natl Acad Sci USA</source><year>2007</year><volume>104</volume><fpage>17058</fpage><lpage>17062</lpage><pub-id pub-id-type=""doi"">10.1073/pnas.0707958104</pub-id><pub-id pub-id-type=""pmid"">17940022</pub-id></mixed-citation></ref><ref id=""B111""><mixed-citation publication-type=""journal""><name><surname>Kay</surname><given-names>MM</given-names></name><name><surname>Flowers</surname><given-names>N</given-names></name><name><surname>Goodman</surname><given-names>J</given-names></name><name><surname>Bosman</surname><given-names>G</given-names></name><article-title>Alteration in membrane protein band 3 associated with accelerated erythrocyte aging</article-title><source>Proc Natl Acad Sci USA</source><year>1989</year><volume>86</volume><fpage>5834</fpage><lpage>5838</lpage><pub-id pub-id-type=""doi"">10.1073/pnas.86.15.5834</pub-id><pub-id pub-id-type=""pmid"">2527366</pub-id></mixed-citation></ref><ref id=""B112""><mixed-citation publication-type=""journal""><name><surname>Grimshaw</surname><given-names>K</given-names></name><name><surname>Sahler</surname><given-names>J</given-names></name><name><surname>Spinelli</surname><given-names>SL</given-names></name><name><surname>Phipps</surname><given-names>RP</given-names></name><name><surname>Blumberg</surname><given-names>N</given-names></name><article-title>New frontiers in transfusion biology: identification and significance of mediators of morbidity and mortality in stored red blood cells</article-title><source>Transfusion</source><year>2011</year><volume>51</volume><fpage>874</fpage><lpage>880</lpage><pub-id pub-id-type=""doi"">10.1111/j.1537-2995.2011.03095.x</pub-id><pub-id pub-id-type=""pmid"">21496049</pub-id></mixed-citation></ref><ref id=""B113""><mixed-citation publication-type=""journal""><name><surname>Basora</surname><given-names>M</given-names></name><name><surname>Pereira</surname><given-names>A</given-names></name><name><surname>Soriano</surname><given-names>A</given-names></name><name><surname>Martinez-Pastor</surname><given-names>JC</given-names></name><name><surname>Sanchez-Etayo</surname><given-names>G</given-names></name><name><surname>Tio</surname><given-names>M</given-names></name><name><surname>Salazar</surname><given-names>F</given-names></name><article-title>Allogeneic blood transfusion does not increase the risk of wound infection in total knee arthroplasty</article-title><source>Vox Sang</source><year>2010</year><volume>98</volume><fpage>124</fpage><lpage>129</lpage><pub-id pub-id-type=""doi"">10.1111/j.1423-0410.2009.01242.x</pub-id><pub-id pub-id-type=""pmid"">19754522</pub-id></mixed-citation></ref></ref-list>"
10.1213/01.ane.0000221167.58135.3d	"<html><body><p>Crit_Care/PMC3672721.nxml                                                                           0000664 0011011 0007774 00000211232 13032724501 013626  0                                                                                                    ustar   pmc                             pmcdev<!DOCTYPE article PUBLIC ""-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN"" ""JATS-archivearticle1.dtd""></p><tbody><tr valign=""top""><td align=""center"">Age of patient</td><td align=""center"">18 [<xref ref-type=""bibr"" rid=""CR2"">2</xref>-<xref ref-type=""bibr"" rid=""CR4"">4</xref>,<xref ref-type=""bibr"" rid=""CR19"">19</xref>,<xref ref-type=""bibr"" rid=""CR21"">21</xref>,<xref ref-type=""bibr"" rid=""CR31"">31</xref>-<xref ref-type=""bibr"" rid=""CR43"">43</xref>]</td><td align=""center"">−0.0417 (−0.0680 to −0.0154)</td><td align=""center"">0.002</td></tr><tr valign=""top""><td align=""center"">Publication year</td><td align=""center"">18 [<xref ref-type=""bibr"" rid=""CR2"">2</xref>-<xref ref-type=""bibr"" rid=""CR4"">4</xref>,<xref ref-type=""bibr"" rid=""CR19"">19</xref>,<xref ref-type=""bibr"" rid=""CR21"">21</xref>,<xref ref-type=""bibr"" rid=""CR31"">31</xref>-<xref ref-type=""bibr"" rid=""CR43"">43</xref>]</td><td align=""center"">−0.1056 (−0.2103 to −0.0009)</td><td align=""center"">0.048</td></tr><tr valign=""top""><td align=""center"">Admission Hb</td><td align=""center"">9 [<xref ref-type=""bibr"" rid=""CR2"">2</xref>-<xref ref-type=""bibr"" rid=""CR4"">4</xref>,<xref ref-type=""bibr"" rid=""CR21"">21</xref>,<xref ref-type=""bibr"" rid=""CR38"">38</xref>-<xref ref-type=""bibr"" rid=""CR42"">42</xref>]</td><td align=""center"">−0.1848 (−0.4343 to 0.0648)</td><td align=""center"">0.147</td></tr><tr valign=""top""><td align=""center"">Units transfused</td><td align=""center"">12 [<xref ref-type=""bibr"" rid=""CR2"">2</xref>,<xref ref-type=""bibr"" rid=""CR3"">3</xref>,<xref ref-type=""bibr"" rid=""CR19"">19</xref>,<xref ref-type=""bibr"" rid=""CR21"">21</xref>,<xref ref-type=""bibr"" rid=""CR31"">31</xref>,<xref ref-type=""bibr"" rid=""CR32"">32</xref>,<xref ref-type=""bibr"" rid=""CR35"">35</xref>-<xref ref-type=""bibr"" rid=""CR37"">37</xref>,<xref ref-type=""bibr"" rid=""CR42"">42</xref>,<xref ref-type=""bibr"" rid=""CR43"">43</xref>]</td><td align=""center"">−0.1676 (−0.3856 to 0.0504)</td><td align=""center"">0.132</td></tr><tr valign=""top""><td align=""center"">Pretransfusion Hb</td><td align=""center"">7 [<xref ref-type=""bibr"" rid=""CR2"">2</xref>-<xref ref-type=""bibr"" rid=""CR4"">4</xref>,<xref ref-type=""bibr"" rid=""CR21"">21</xref>,<xref ref-type=""bibr"" rid=""CR34"">34</xref>,<xref ref-type=""bibr"" rid=""CR42"">42</xref>,<xref ref-type=""bibr"" rid=""CR43"">43</xref>]</td><td align=""center"">−0.2157 (−0.8588 to 0.4275)</td><td align=""center"">0.511</td></tr><tr valign=""top""><td align=""center"">APACHE II</td><td align=""center"">8 [<xref ref-type=""bibr"" rid=""CR2"">2</xref>-<xref ref-type=""bibr"" rid=""CR4"">4</xref>,<xref ref-type=""bibr"" rid=""CR21"">21</xref>,<xref ref-type=""bibr"" rid=""CR34"">34</xref>,<xref ref-type=""bibr"" rid=""CR38"">38</xref>,<xref ref-type=""bibr"" rid=""CR40"">40</xref>,<xref ref-type=""bibr"" rid=""CR42"">42</xref>]</td><td align=""center"">0.0202 (−0.0569 to 0.0973)</td><td align=""center"">0.607</td></tr></tbody><table-wrap-foot><p>APACHE II, acute physiology and chronic health evaluation II; CI, confidence interval; Hb, hemoglobulin.</p></table-wrap-foot><sec id=""Sec13""><title>Publication bias</title><p>There was significant heterogeneity (<italic>P</italic>= 0.007) across studies. Visual inspection of the funnel plot (Figure S6 in Additional file<xref ref-type=""media"" rid=""MOESM6"">6</xref>) indicated the presence of a moderate publication bias. Begg’s test suggests that significant publication bias was not likely (<italic>P</italic>= 0.570). Furthermore, when looked for missing studies using the trim-and-fill random effects model, no studies needed to be imputed.</p></sec><sec id=""Sec14"" sec-type=""discussion""><title>Discussion</title><p>Whether RBC transfusion is linked to higher or lower mortality in critically ill patients has been a matter of debate for more than a decade. Our review was aimed to determine whether allogeneic RBC transfusion is beneficial or harmful for ICU patients, and clarify the nature of discrepancies among previous observation studies. The main findings are as follows.<list list-type=""alpha-lower""><list-item><p>There is no consistent evidence linking RBC transfusion to in-hospital mortality in ICU patients</p><p>The initially overall pooled results suggested that allogeneic blood transfusion was associated with an 11% to 85% increased risk for in-hospital mortality. However, after excluding studies with unadjusted estimates only [<xref ref-type=""bibr"" rid=""CR19"">19</xref>,<xref ref-type=""bibr"" rid=""CR31"">31</xref>] or studies with median overall quality [<xref ref-type=""bibr"" rid=""CR31"">31</xref>,<xref ref-type=""bibr"" rid=""CR32"">32</xref>,<xref ref-type=""bibr"" rid=""CR42"">42</xref>], the association became null. Therefore, we could not draw a definitive conclusion. The results of sensitivity analyses suggested that such risk association may be attributable to studies without adjustment for confounders. In studies adjusted for confounders, studies that reached effect size by using the Cox regression model, and studies that implemented detailed information about leukodepleted blood measurement, we found that RBC transfusion did not increase risk of in-hospital death.</p></list-item><list-item><p>There is no evidence indicating that RBC transfusion is associated with increased mortality in patients admitted to ICU for sepsis and shock, trauma and surgical reasons.</p><p>Type of patients is an extremely important confounder for survival after RBC transfusion. Different types of patients have different responses to RBCs transfusion. For example, age of transfused RBCs could potentiate the risk association of volume of RBC transfused in trauma patients, but less so in other types of patients [<xref ref-type=""bibr"" rid=""CR44"">44</xref>,<xref ref-type=""bibr"" rid=""CR45"">45</xref>]. In our subgroup analysis, we separate enrolled studies into four groups according to patients’ population: all ICU admissions (seven studies), sepsis and shock (two studies), surgical (three studies), trauma (three studies), and others (three studies, one on patients with ALI or ARDS, one on patients with intracerebral hemorrhage, and one on patients with anemia and renal dysfunction). As presented in Table<xref ref-type=""table"" rid=""Tab3"">3</xref>, the results suggested that there was no association between RBC transfusion and mortality in sepsis and shock, surgical, trauma and ‘other’ patients. The pooled overall effect estimate of seven studies on all ICU admissions was significant (RR 1.513, 95%CI 1.123 to 2.039). However, in these seven studies, we noticed that one study did not adjust for any confounders, therefore had a high risk of bias [<xref ref-type=""bibr"" rid=""CR19"">19</xref>]. Actually, after excluding this study, we observed a 7% reduction but still significant pooled overall effect estimate (RR 1.406, 95% 1.016 to 1.945). In a large, multiple center study by Vincent et al., admission type of patients were elective surgery (41.4%), medical (32.6%), emergency surgery (16.6%), trauma (7.6%) and other (1.6%) [<xref ref-type=""bibr"" rid=""CR2"">2</xref>]. In our analysis, we were unable to identify medical ICU patients as an independent subgroup. Literature on the safety of RBC transfusion in medical ICU patients was poor. In the SOAP study, medical admission was found to be an independent predictor for risk of 30-day mortality in ICU patients (RR 1.47, 95% 1.24 to 1.74) [<xref ref-type=""bibr"" rid=""CR35"">35</xref>]. Further studies are needed to identify whether medical admissions are less tolerant of RBC transfusion than other patient populations.</p></list-item><list-item><p>There is a lack of evidence on whether leukodepleted RBC transfusion could reduce in-hospital mortality in ICU patients.</p><p>Immunomodulating effects of transfused RBCs have been suggested as potential cause of many adverse effects [<xref ref-type=""bibr"" rid=""CR46"">46</xref>]. Leukocytes from donated blood may play a key role in immune system suppression; however, the exact mechanism is unclear [<xref ref-type=""bibr"" rid=""CR47"">47</xref>]. Studies had reported a decrease in mortality rate among patients receiving prestorage leukoreduced blood compared to patients receiving nonfiltered blood [<xref ref-type=""bibr"" rid=""CR22"">22</xref>,<xref ref-type=""bibr"" rid=""CR23"">23</xref>]; however, a meta-analysis of 12 RCTs comparing leukodepleted and nonleukodepleted RBCs failed to identify an association between leukoreduction and mortality (OR 1.14, 95%CI, 0.89 to 1.45) [<xref ref-type=""bibr"" rid=""CR48"">48</xref>]. Of the eighteen studies included in our review, only seven of them had information on percentage of patients receiving nonfiltered blood. Filtered RBCs were routinely used in two studies, Sakr et al. [<xref ref-type=""bibr"" rid=""CR21"">21</xref>] suggested that RBC transfusion was independently associated with lower risk of mortality (RR 0.96, 95%CI, 0.95 to 0.98) while Engoren et al. [<xref ref-type=""bibr"" rid=""CR38"">38</xref>] found no association. In our subgroup analyses, studies were divided into four groups according to the usage of leukoreduction. In a subset of 11 studies that did not report information on leukoreduction, the pooled effect estimate suggested that RBC transfusion was associated with higher mortality (RR 1.851, 95%CI, 1.229 to 2.786); however, the pooled effect estimates of other subgroups were not significant, regardless of the degree of implementation of leukodepleted blood (Table<xref ref-type=""table"" rid=""Tab3"">3</xref>). Studies lacking information on leukoreduction had a higher risk of in-hospital mortality. Because of insufficient information, we cannot tell whether the use of leukodepleted blood could decrease mortality in transfused patients. Another possible explanation is that studies lacking leukoreduction information also had lower qualities, hence indicating high risk of bias. We recommend that further studies should take leukoreduction implementation into consideration.</p></list-item><list-item><p>Study and statistical analysis methods are of considerable importance in explaining the association between RBC transfusion and in-hospital mortality.</p><p>To model the association between RBC transfusion and in-hospital mortality, 10 of the 18 included studies used multivariable logistic regression, and reported OR as the outcome measurement. Pooled effect estimate of this subset of studies found that there is a risk association between RBC transfusion and mortality (RR 1.465, 95%CI, 1.049 to 2.045). In contrast, in five studies used Cox regression, there was no independent association between RBC transfusion and mortality (RR 0.901, 95%CI, 0.622 to 1.305). This may be because that selection of statistical model may have effect on the final result. As logistic regression did not take time-dependent variables into consideration, with increasing follow-up time, the logistic regression coefficients become less reliable [<xref ref-type=""bibr"" rid=""CR49"">49</xref>]. For the same transfusion data, treating transfusion and living status as a time-dependent variable or not may result in different conclusions. Our review suggests that the statistical analysis method may cause disagreement between previous studies.</p><p>Previous research revealed that older and more severely ill patients were more likely to have comorbidities after RBC transfusion [<xref ref-type=""bibr"" rid=""CR2"">2</xref>,<xref ref-type=""bibr"" rid=""CR4"">4</xref>]. The quality of a study relies on the completeness of data on possible confounders [<xref ref-type=""bibr"" rid=""CR34"">34</xref>]. Patients’ admission characteristics and disease severity are two major confounders that can have an impact on transfused patients’ risk of death. Multivariable confounder-adjustment analyses and propensity score analyses are implemented in most of the studies to control imbalances between transfused and nontransfused groups. Under propensity matched groups, patients were matched by their probability to receive a transfusion, thus statistically reducing confounding bias. Previous findings revealed that propensity score analysis could produce estimates that were more precise and robust than regular logistic regression while there were seven or fewer events per confounding variables, but might produce unstable estimates when events per confounder were more than eight [<xref ref-type=""bibr"" rid=""CR50"">50</xref>]. Most of our included studies reported multivariable confounder-adjusted estimates (Table<xref ref-type=""table"" rid=""Tab3"">3</xref>), and the mostly used confounders in adjustments were patient characteristics at admission including age, gender and admission symptom score; seven studies used propensity score analyses. Subgroup analyses of the seven propensity score matched studies and the other nine no propensity score matched confounder-adjusted studies all showed no association between RBC transfusion and death (RR 1.089, 95%CI, 0.767 to 1.546; RR 1.358, 95%CI, 0.965 to 1.910 respectively), while the other two studies with unadjusted effect estimates only showed an increased risk (RR 3.933, 95%CI 2.107 to 7.343). This suggests that studies that did not fully adjust for confounders may overestimate the negative effects of RBC transfusion. This finding supported the view of Ruttinger et al. [<xref ref-type=""bibr"" rid=""CR34"">34</xref>] that RBC transfusion may be only a surrogate marker for disease severity and is not causally related to mortality. Ruttinger’s study even suggested the pitfalls of propensity score and multivariate analyses; both cannot adjust for unobserved or unknown confounders, and not all factors that may influence transfusion practice had been collected. Ruttinger considered variables reflecting disease severity during ICU stay, and found that the number of RBC transfusion units was associated with increased mortality, and the association attenuated but persisted while only adjusted for admission variables. When controlling for variables of disease severity during ICU stay, this association vanished. Disease severity during ICU stay might be particularly important. We suggest that further research should take this into consideration. In our review, we performed meta-regression analyses to assess whether the mean number of units of blood transfused, mean admission Hb level and mean admission symptom score could explain disagreement between study results. Mean number of units of RBC transfused were reported in twelve studies, mean admission Hb level were reported in nine studies, mean APACHE II score were reported in eight studies, mean SOFA score were reported in four studies [<xref ref-type=""bibr"" rid=""CR2"">2</xref>-<xref ref-type=""bibr"" rid=""CR4"">4</xref>,<xref ref-type=""bibr"" rid=""CR42"">42</xref>], and mean SAPS II [<xref ref-type=""bibr"" rid=""CR35"">35</xref>] and mean APACHE III score [<xref ref-type=""bibr"" rid=""CR39"">39</xref>] were reported in only one study, respectively. Results of meta-regression failed to identify significant association across studies for mean number of units of RBC transfused (coefficient −0.1676, 95%CI, −0.3865 to 0.0504), mean admission Hb level (coefficient −0.1848, 95%CI, −0.4343 to 0.0648) and mean APACHE II score (coefficient 0.0202, 95%CI, −0.0569 to 0.0973). In other words, these variables could not explain the disagreement across studies.</p></list-item><list-item><p>Blood transfusion may decrease risk of mortality in older patients.</p><p>The slope estimate was significant −0.0417 (95%CI, −0.0680 to −0.0154) (Figure S8 in Additional file<xref ref-type=""media"" rid=""MOESM7"">7</xref>), suggesting that with older age, transfused patients had better chances of survival. This is interesting since age has long been known as a predictor for worse outcomes including mortality. We speculate that this may be due to the following reasons. (1) Older patients and younger patients have different etiology of anemia. Older patients are more likely to have nutritional deficiency, chronic diseases and unexplained anemia [<xref ref-type=""bibr"" rid=""CR51"">51</xref>]. Consequently, older patients and younger patients may differ in disease severity and clinical treatment. (2) Hb level may be a potential explanation. Using World Health Organization (WHO) definition of anemia (Hb level &lt;13 g/dL in men and &lt;12 g/dL in women), the corrected annual incidence of anemia increased with age [<xref ref-type=""bibr"" rid=""CR52"">52</xref>], and the study found that even a ‘higher’ Hb level was associated with risk of death in older people [<xref ref-type=""bibr"" rid=""CR53"">53</xref>]. Older patients may have different ‘optimal’ Hb concentrations, a ‘mildly low’ and ‘low-normal’ Hb level may be well tolerated in young patients, but not in older people [<xref ref-type=""bibr"" rid=""CR54"">54</xref>,<xref ref-type=""bibr"" rid=""CR55"">55</xref>].</p><p>Literature on patient’s age, survival and blood transfusion is controversial in defining anemia in older people. Although we identified a significant association between mean age of patient and survival, there was no strong evidence to support this view. Further research could explore whether blood transfusion is more effective in improving survival in older patients.</p></list-item><list-item><p>The debate on whether it is beneficial or harmful for RBC transfusion: articles tend to report lower risk effect estimates.</p><p>The number of reports concerning such issues has grown fast in recent years, as shown in Figure S7 in Additional file<xref ref-type=""media"" rid=""MOESM8"">8</xref>. The meta-regression analysis produced a significant effect for publication year. Recent studies are more likely to report relativity lower risk ratios, indicating that RBC transfusion might have gradually become safer [<xref ref-type=""bibr"" rid=""CR56"">56</xref>]. Safety concerns in RBC transfusion have emerged during the past two decades along with clinical practice changes [<xref ref-type=""bibr"" rid=""CR57"">57</xref>]. The most important change in clinical practice is the recognition that the decision to transfuse should not be driven by a single Hb threshold, but by the physiologic state of the individual patient, presence of comorbidity, cardiopulmonary physiologic parameters, and evidence of blood loss [<xref ref-type=""bibr"" rid=""CR56"">56</xref>,<xref ref-type=""bibr"" rid=""CR58"">58</xref>]. In our meta-analysis, seven studies from the years 2002 to 2012 had reported average pretransfused Hb levels, and the mean Hb levels ranged from 6.6 g/dL to 8.6 g/dL. Meta-regression for pretransfusion Hb level failed to identify the significance for risk of mortality (coefficient −0.216, 95%CI −0.859 to 0.428).</p></list-item></list></p><sec id=""Sec15""><title>Limitations</title><p>It should be noted that the present meta-analysis had several limitations. First, all studies included in the meta-analysis were observational studies. Limited by study design, a causal relationship could not be determined. A convincible causal relationship needs further research in large RCTs. Second, limited by our recognition of exact mechanisms of transfusion-related complications, the potential confounders for death were not fully adjusted and may not all be included in our meta-analysis, this may have led to potential risk of bias. Third, the number of studies in subgroup and meta-regression analyses was relativity small, and therefore produced unstable effect estimates. Fourth, our study only focused on mortality within one month, while patients with death after one month of hospitalization may have high risk of transfusion. Finally, publication bias may still exist from unpublished studies, and publications in sources out of our literature search criteria.</p></sec></sec><sec id=""Sec16"" sec-type=""conclusion""><title>Conclusions</title><p>Our systematic review and meta-analysis summarized published literature on the relation between RBC transfusion and in-hospital mortality of ICU patients. We conclude that there is a lack of evidence to support the claim that ICU patients who receive RBC transfusion have an increased risk of in-hospital mortality. In studies that have adjusted for confounders, RBC transfusion did not increase the risk of in-hospital mortality in ICU patients. The review also suggests possible reasons to explain the discrepancies between previous studies. Our finding points to the need to identify risk factors for mortality in patients admitted to the medical ICU to account for all possible confounders for mortality. RCTs are warranted to provide convincible evidence of casual association.</p></sec><sec id=""Sec17""><title>Key messages</title><p><list list-type=""bullet""><list-item><p>There was no consistent evidence to link RBC transfusion with mortality in ICU patients.</p></list-item><list-item><p>In studies that had adjusted for confounders, RBC transfusion was not associated with in-hospital mortality in ICU patients.</p></list-item><list-item><p>The discrepancies on risk of mortality and RBC transfusion between previous studies may be due to different types of patients, information on leukoreduction, study design and statistical methods, age of patients, and publication year.</p></list-item></list></p></sec><back><app-group><app id=""App1""><sec id=""Sec18""><title>Additional files</title><p><media id=""MOESM1"" position=""anchor"" xlink:href=""13054_2014_515_MOESM1_ESM.pdf""><label>Additional file 1: Figure S1.</label><caption><p>Risk of bias assessment.</p></caption></media><media id=""MOESM2"" position=""anchor"" xlink:href=""13054_2014_515_MOESM2_ESM.jpeg""><label>Additional file 2: Figure S2.</label><caption><p>Association between red blood cell transfusion and in-hospital mortality, grouped by type of patient.</p></caption></media><media id=""MOESM3"" position=""anchor"" xlink:href=""13054_2014_515_MOESM3_ESM.jpeg""><label>Additional file 3: Figure S3.</label><caption><p>Association between red blood cell transfusion and in-hospital mortality, grouped by outcome measurement.</p></caption></media><media id=""MOESM4"" position=""anchor"" xlink:href=""13054_2014_515_MOESM4_ESM.jpeg""><label>Additional file 4: Figure S4.</label><caption><p>Association between red blood cell transfusion and in-hospital mortality, grouped by adjustment for confounding.</p></caption></media><media id=""MOESM5"" position=""anchor"" xlink:href=""13054_2014_515_MOESM5_ESM.jpeg""><label>Additional file 5: Figure S5.</label><caption><p>Association between red blood cell transfusion and in-hospital mortality, grouped by leukoreduced usage.</p></caption></media><media id=""MOESM6"" position=""anchor"" xlink:href=""13054_2014_515_MOESM6_ESM.pdf""><label>Additional file 6: Figure S6.</label><caption><p>Funnel plot for assessing publication bias of studies.</p></caption></media><media id=""MOESM7"" position=""anchor"" xlink:href=""13054_2014_515_MOESM7_ESM.jpeg""><label>Additional file 7: Figure S8.</label><caption><p>Meta-regression for mortality associated with mean age of patient.</p></caption></media><media id=""MOESM8"" position=""anchor"" xlink:href=""13054_2014_515_MOESM8_ESM.jpeg""><label>Additional file 8: Figure S7.</label><caption><p>Meta-regression for mortality associated with published year of article.</p></caption></media></p></sec></app></app-group><glossary><title>Abbreviations</title><def-list><def-list><def-item><term>ALI</term><def><p>acute lung injury</p></def></def-item><def-item><term>APACHE</term><def><p>acute physiology and chronic health evaluation</p></def></def-item><def-item><term>ARDS</term><def><p>acute respiratory distress syndrome</p></def></def-item><def-item><term>CI</term><def><p>confidence interval</p></def></def-item><def-item><term>Hb</term><def><p>hemoglobin</p></def></def-item><def-item><term>HR</term><def><p>hazard ratio</p></def></def-item><def-item><term>ICU</term><def><p>intensive care unit</p></def></def-item><def-item><term>LOS</term><def><p>length of stay</p></def></def-item><def-item><term>OR</term><def><p>odds ratio</p></def></def-item><def-item><term>RBC</term><def><p>red blood cell</p></def></def-item><def-item><term>RCT</term><def><p>randomized controlled trial</p></def></def-item><def-item><term>RR</term><def><p>relative risk</p></def></def-item><def-item><term>SAPS II</term><def><p>simplified acute physiology score II</p></def></def-item><def-item><term>SOFA</term><def><p>sepsis-related organ failure assessment</p></def></def-item><def-item><term>TRALI</term><def><p>transfusion-related acute lung injury</p></def></def-item></def-list></def-list></glossary><fn-group><fn><p>Yi Zheng and Caihong Lu contributed equally to this work.</p></fn><fn><p><bold>Competing interests</bold></p><p>The authors declare that they have no competing interests.</p></fn><fn><p><bold>Authors’ contributions</bold></p><p>YZ, CL, SW and PY carried out the literature search and drafted the manuscript. YZ, CL, YL and LL participated in the design of the study and performed the statistical analysis. YL, LL and PY conceived the study, and participated in the study design and contributed to drafting the manuscript. All authors read and approved the final manuscript.</p></fn><fn><p><bold>Authors’ information</bold></p><p>Yi Zheng and Caihong Lu: the first two authors should be regarded as joint first authors.</p></fn></fn-group><ref-list id=""Bib1""><title>References</title><ref id=""CR1""><label>1.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>von Ahsen</surname><given-names>N</given-names></name><name><surname>Muller</surname><given-names>C</given-names></name><name><surname>Serke</surname><given-names>S</given-names></name><name><surname>Frei</surname><given-names>U</given-names></name><name><surname>Eckardt</surname><given-names>KU</given-names></name></person-group><article-title>Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients</article-title><source>Crit Care Med</source><year>1999</year><volume>27</volume><fpage>2630</fpage><lpage>2639</lpage><pub-id pub-id-type=""doi"">10.1097/00003246-199912000-00005</pub-id><pub-id pub-id-type=""pmid"">10628602</pub-id></element-citation></ref><ref id=""CR2""><label>2.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Vincent</surname><given-names>JL</given-names></name><name><surname>Baron</surname><given-names>JF</given-names></name><name><surname>Reinhart</surname><given-names>K</given-names></name><name><surname>Gattinoni</surname><given-names>L</given-names></name><name><surname>Thijs</surname><given-names>L</given-names></name><name><surname>Webb</surname><given-names>A</given-names></name><name><surname>Meier-Hellmann</surname><given-names>A</given-names></name><name><surname>Nollet</surname><given-names>G</given-names></name><name><surname>Peres-Bota</surname><given-names>D</given-names></name></person-group><article-title>Anemia and blood transfusion in critically ill patients</article-title><source>JAMA</source><year>2002</year><volume>288</volume><fpage>1499</fpage><lpage>1507</lpage><pub-id pub-id-type=""doi"">10.1001/jama.288.12.1499</pub-id><pub-id pub-id-type=""pmid"">12243637</pub-id></element-citation></ref><ref id=""CR3""><label>3.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Corwin</surname><given-names>HL</given-names></name><name><surname>Gettinger</surname><given-names>A</given-names></name><name><surname>Pearl</surname><given-names>RG</given-names></name><name><surname>Fink</surname><given-names>MP</given-names></name><name><surname>Levy</surname><given-names>MM</given-names></name><name><surname>Abraham</surname><given-names>E</given-names></name><name><surname>MacIntyre</surname><given-names>NR</given-names></name><name><surname>Shabot</surname><given-names>MM</given-names></name><name><surname>Duh</surname><given-names>MS</given-names></name><name><surname>Shapiro</surname><given-names>MJ</given-names></name></person-group><article-title>The CRIT study: anemia and blood transfusion in the critically ill–current clinical practice in the United States</article-title><source>Crit Care Med</source><year>2004</year><volume>32</volume><fpage>39</fpage><lpage>52</lpage><pub-id pub-id-type=""doi"">10.1097/01.CCM.0000104112.34142.79</pub-id><pub-id pub-id-type=""pmid"">14707558</pub-id></element-citation></ref><ref id=""CR4""><label>4.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Park</surname><given-names>DW</given-names></name><name><surname>Chun</surname><given-names>BC</given-names></name><name><surname>Kwon</surname><given-names>SS</given-names></name><name><surname>Yoon</surname><given-names>YK</given-names></name><name><surname>Choi</surname><given-names>WS</given-names></name><name><surname>Sohn</surname><given-names>JW</given-names></name><name><surname>Peck</surname><given-names>KR</given-names></name><name><surname>Kim</surname><given-names>YS</given-names></name><name><surname>Choi</surname><given-names>YH</given-names></name><name><surname>Choi</surname><given-names>JY</given-names></name><name><surname>Kim</surname><given-names>SI</given-names></name><name><surname>Eom</surname><given-names>JS</given-names></name><name><surname>Kim</surname><given-names>HY</given-names></name><name><surname>Cheong</surname><given-names>HJ</given-names></name><name><surname>Song</surname><given-names>YG</given-names></name><name><surname>Choi</surname><given-names>HJ</given-names></name><name><surname>Kim</surname><given-names>JM</given-names></name><name><surname>Kim</surname><given-names>MJ</given-names></name></person-group><article-title>Red blood cell transfusions are associated with lower mortality in patients with severe sepsis and septic shock: a propensity-matched analysis*</article-title><source>Crit Care Med</source><year>2012</year><volume>40</volume><fpage>3140</fpage><lpage>3145</lpage><pub-id pub-id-type=""doi"">10.1097/CCM.0b013e3182657b75</pub-id><pub-id pub-id-type=""pmid"">22975891</pub-id></element-citation></ref><ref id=""CR5""><label>5.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Walsh</surname><given-names>TS</given-names></name><name><surname>Lee</surname><given-names>RJ</given-names></name><name><surname>Maciver</surname><given-names>CR</given-names></name><name><surname>Garrioch</surname><given-names>M</given-names></name><name><surname>Mackirdy</surname><given-names>F</given-names></name><name><surname>Binning</surname><given-names>AR</given-names></name><name><surname>Cole</surname><given-names>S</given-names></name><name><surname>McClelland</surname><given-names>DB</given-names></name></person-group><article-title>Anemia during and at discharge from intensive care: the impact of restrictive blood transfusion practice</article-title><source>Intensive Care Med</source><year>2006</year><volume>32</volume><fpage>100</fpage><lpage>109</lpage><pub-id pub-id-type=""doi"">10.1007/s00134-005-2855-2</pub-id><pub-id pub-id-type=""pmid"">16328221</pub-id></element-citation></ref><ref id=""CR6""><label>6.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Hebert</surname><given-names>PC</given-names></name><name><surname>Wells</surname><given-names>G</given-names></name><name><surname>Tweeddale</surname><given-names>M</given-names></name><name><surname>Martin</surname><given-names>C</given-names></name><name><surname>Marshall</surname><given-names>J</given-names></name><name><surname>Pham</surname><given-names>B</given-names></name><name><surname>Blajchman</surname><given-names>M</given-names></name><name><surname>Schweitzer</surname><given-names>I</given-names></name><name><surname>Pagliarello</surname><given-names>G</given-names></name></person-group><article-title>Does transfusion practice affect mortality in critically ill patients? Transfusion Requirements in Critical Care (TRICC) Investigators and the Canadian Critical Care Trials Group</article-title><source>Am J Respir Crit Care Med</source><year>1997</year><volume>155</volume><fpage>1618</fpage><lpage>1623</lpage><pub-id pub-id-type=""doi"">10.1164/ajrccm.155.5.9154866</pub-id><pub-id pub-id-type=""pmid"">9154866</pub-id></element-citation></ref><ref id=""CR7""><label>7.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Go</surname><given-names>AS</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Ackerson</surname><given-names>LM</given-names></name><name><surname>Lepper</surname><given-names>K</given-names></name><name><surname>Robbins</surname><given-names>S</given-names></name><name><surname>Massie</surname><given-names>BM</given-names></name><name><surname>Shlipak</surname><given-names>MG</given-names></name></person-group><article-title>Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study</article-title><source>Circulation</source><year>2006</year><volume>113</volume><fpage>2713</fpage><lpage>2723</lpage><pub-id pub-id-type=""doi"">10.1161/CIRCULATIONAHA.105.577577</pub-id><pub-id pub-id-type=""pmid"">16754803</pub-id></element-citation></ref><ref id=""CR8""><label>8.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Salisbury</surname><given-names>AC</given-names></name><name><surname>Alexander</surname><given-names>KP</given-names></name><name><surname>Reid</surname><given-names>KJ</given-names></name><name><surname>Masoudi</surname><given-names>FA</given-names></name><name><surname>Rathore</surname><given-names>SS</given-names></name><name><surname>Wang</surname><given-names>TY</given-names></name><name><surname>Bach</surname><given-names>RG</given-names></name><name><surname>Marso</surname><given-names>SP</given-names></name><name><surname>Spertus</surname><given-names>JA</given-names></name><name><surname>Kosiborod</surname><given-names>M</given-names></name></person-group><article-title>Incidence, correlates, and outcomes of acute, hospital-acquired anemia in patients with acute myocardial infarction</article-title><source>Circ Cardiovasc Qual Outcomes</source><year>2010</year><volume>3</volume><fpage>337</fpage><lpage>346</lpage><pub-id pub-id-type=""doi"">10.1161/CIRCOUTCOMES.110.957050</pub-id><pub-id pub-id-type=""pmid"">20488919</pub-id></element-citation></ref><ref id=""CR9""><label>9.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Mehdi</surname><given-names>U</given-names></name><name><surname>Toto</surname><given-names>RD</given-names></name></person-group><article-title>Anemia, diabetes, and chronic kidney disease</article-title><source>Diabetes Care</source><year>2009</year><volume>32</volume><fpage>1320</fpage><lpage>1326</lpage><pub-id pub-id-type=""doi"">10.2337/dc08-0779</pub-id><pub-id pub-id-type=""pmid"">19564475</pub-id></element-citation></ref><ref id=""CR10""><label>10.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Carson</surname><given-names>JL</given-names></name><name><surname>Duff</surname><given-names>A</given-names></name><name><surname>Poses</surname><given-names>RM</given-names></name><name><surname>Berlin</surname><given-names>JA</given-names></name><name><surname>Spence</surname><given-names>RK</given-names></name><name><surname>Trout</surname><given-names>R</given-names></name><name><surname>Noveck</surname><given-names>H</given-names></name><name><surname>Strom</surname><given-names>BL</given-names></name></person-group><article-title>Effect of anaemia and cardiovascular disease on surgical mortality and morbidity</article-title><source>Lancet</source><year>1996</year><volume>348</volume><fpage>1055</fpage><lpage>1060</lpage><pub-id pub-id-type=""doi"">10.1016/S0140-6736(96)04330-9</pub-id><pub-id pub-id-type=""pmid"">8874456</pub-id></element-citation></ref><ref id=""CR11""><label>11.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Conrad</surname><given-names>SA</given-names></name><name><surname>Dietrich</surname><given-names>KA</given-names></name><name><surname>Hebert</surname><given-names>CA</given-names></name><name><surname>Romero</surname><given-names>MD</given-names></name></person-group><article-title>Effect of red cell transfusion on oxygen consumption following fluid resuscitation in septic shock</article-title><source>Circ Shock</source><year>1990</year><volume>31</volume><fpage>419</fpage><lpage>429</lpage><pub-id pub-id-type=""pmid"">2397567</pub-id></element-citation></ref><ref id=""CR12""><label>12.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Marik</surname><given-names>PE</given-names></name><name><surname>Sibbald</surname><given-names>WJ</given-names></name></person-group><article-title>Effect of stored-blood transfusion on oxygen delivery in patients with sepsis</article-title><source>JAMA</source><year>1993</year><volume>269</volume><fpage>3024</fpage><lpage>3029</lpage><pub-id pub-id-type=""doi"">10.1001/jama.1993.03500230106037</pub-id><pub-id pub-id-type=""pmid"">8501845</pub-id></element-citation></ref><ref id=""CR13""><label>13.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Mohsenifar</surname><given-names>Z</given-names></name><name><surname>Ross</surname><given-names>DJ</given-names></name></person-group><article-title>Oxygen consumption is independent of changes in oxygen delivery in severe adult respiratory distress syndrome</article-title><source>Am Rev Respir Dis</source><year>1992</year><volume>145</volume><fpage>978</fpage><lpage>979</lpage><pub-id pub-id-type=""doi"">10.1164/ajrccm/145.4_Pt_1.978</pub-id><pub-id pub-id-type=""pmid"">1554229</pub-id></element-citation></ref><ref id=""CR14""><label>14.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Apstein</surname><given-names>CS</given-names></name><name><surname>Dennis</surname><given-names>RC</given-names></name><name><surname>Briggs</surname><given-names>L</given-names></name><name><surname>Vogel</surname><given-names>WM</given-names></name><name><surname>Frazer</surname><given-names>J</given-names></name><name><surname>Valeri</surname><given-names>CR</given-names></name></person-group><article-title>Effect of erythrocyte storage and oxyhemoglobin affinity changes on cardiac function</article-title><source>Am J Physiol</source><year>1985</year><volume>248</volume><fpage>H508</fpage><lpage>H515</lpage><pub-id pub-id-type=""pmid"">3985174</pub-id></element-citation></ref><ref id=""CR15""><label>15.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Wolfe</surname><given-names>LC</given-names></name><name><surname>Byrne</surname><given-names>AM</given-names></name><name><surname>Lux</surname><given-names>SE</given-names></name></person-group><article-title>Molecular defect in the membrane skeleton of blood bank-stored red cells. Abnormal spectrin-protein 4.1-actin complex formation</article-title><source>J Clin Invest</source><year>1986</year><volume>78</volume><fpage>1681</fpage><lpage>1686</lpage><pub-id pub-id-type=""doi"">10.1172/JCI112762</pub-id><pub-id pub-id-type=""pmid"">3782475</pub-id></element-citation></ref><ref id=""CR16""><label>16.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Blumberg</surname><given-names>N</given-names></name><name><surname>Heal</surname><given-names>JM</given-names></name></person-group><article-title>Immunomodulation by blood transfusion: an evolving scientific and clinical challenge</article-title><source>Am J Med</source><year>1996</year><volume>101</volume><fpage>299</fpage><lpage>308</lpage><pub-id pub-id-type=""doi"">10.1016/S0002-9343(96)00124-6</pub-id><pub-id pub-id-type=""pmid"">8873492</pub-id></element-citation></ref><ref id=""CR17""><label>17.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Linda</surname><given-names>CS</given-names></name><name><surname>Dennis</surname><given-names>CD</given-names></name><name><surname>Ronald</surname><given-names>JF</given-names></name><name><surname>Gerson Greenburg</surname><given-names>A</given-names></name><name><surname>Chantal</surname><given-names>RH</given-names></name><name><surname>Dennis</surname><given-names>FL</given-names></name><name><surname>Russell</surname><given-names>KL</given-names></name><name><surname>Ellison</surname><given-names>CP</given-names></name><name><surname>Randall</surname><given-names>SP</given-names></name><name><surname>Andrew</surname><given-names>DR</given-names></name><name><surname>Richard</surname><given-names>BW</given-names></name><name><surname>Steven</surname><given-names>HW</given-names></name><name><surname>John</surname><given-names>FZ</given-names></name></person-group><article-title>Practice guidelines for blood component therapy: a report by the American Society of Anesthesiologists Task Force on Blood Component Therapy</article-title><source>Anesthesiology</source><year>1996</year><volume>84</volume><fpage>732</fpage><lpage>747</lpage><pub-id pub-id-type=""doi"">10.1097/00000542-199603000-00032</pub-id><pub-id pub-id-type=""pmid"">8659805</pub-id></element-citation></ref><ref id=""CR18""><label>18.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Cermakova</surname><given-names>Z</given-names></name><name><surname>Simetka</surname><given-names>O</given-names></name><name><surname>Koristka</surname><given-names>M</given-names></name></person-group><article-title>Transfusion-related acute lung injury (TRALI) - review</article-title><source>Ceska Gynekol</source><year>2013</year><volume>78</volume><fpage>211</fpage><lpage>215</lpage><pub-id pub-id-type=""pmid"">23710988</pub-id></element-citation></ref><ref id=""CR19""><label>19.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Taylor</surname><given-names>RW</given-names></name><name><surname>O’Brien</surname><given-names>J</given-names></name><name><surname>Trottier</surname><given-names>SJ</given-names></name><name><surname>Manganaro</surname><given-names>L</given-names></name><name><surname>Cytron</surname><given-names>M</given-names></name><name><surname>Lesko</surname><given-names>MF</given-names></name><name><surname>Arnzen</surname><given-names>K</given-names></name><name><surname>Cappadoro</surname><given-names>C</given-names></name><name><surname>Fu</surname><given-names>M</given-names></name><name><surname>Plisco</surname><given-names>MS</given-names></name><name><surname>Sadaka</surname><given-names>FG</given-names></name><name><surname>Veremakis</surname><given-names>C</given-names></name></person-group><article-title>Red blood cell transfusions and nosocomial infections in critically ill patients</article-title><source>Crit Care Med</source><year>2006</year><volume>34</volume><fpage>2302</fpage><lpage>2308</lpage><pub-id pub-id-type=""doi"">10.1097/01.CCM.0000234034.51040.7F</pub-id><pub-id pub-id-type=""pmid"">16849995</pub-id></element-citation></ref><ref id=""CR20""><label>20.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Marik</surname><given-names>PE</given-names></name><name><surname>Corwin</surname><given-names>HL</given-names></name></person-group><article-title>Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature</article-title><source>Crit Care Med</source><year>2008</year><volume>36</volume><fpage>2667</fpage><lpage>2674</lpage><pub-id pub-id-type=""doi"">10.1097/CCM.0b013e3181844677</pub-id><pub-id pub-id-type=""pmid"">18679112</pub-id></element-citation></ref><ref id=""CR21""><label>21.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Sakr</surname><given-names>Y</given-names></name><name><surname>Lobo</surname><given-names>S</given-names></name><name><surname>Knuepfer</surname><given-names>S</given-names></name><name><surname>Esser</surname><given-names>E</given-names></name><name><surname>Bauer</surname><given-names>M</given-names></name><name><surname>Settmacher</surname><given-names>U</given-names></name><name><surname>Barz</surname><given-names>D</given-names></name><name><surname>Reinhart</surname><given-names>K</given-names></name></person-group><article-title>Anemia and blood transfusion in a surgical intensive care unit</article-title><source>Crit Care</source><year>2010</year><volume>14</volume><fpage>R92</fpage><pub-id pub-id-type=""doi"">10.1186/cc9026</pub-id><pub-id pub-id-type=""pmid"">20497535</pub-id></element-citation></ref><ref id=""CR22""><label>22.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>van de Watering</surname><given-names>LM</given-names></name><name><surname>Hermans</surname><given-names>J</given-names></name><name><surname>Houbiers</surname><given-names>JG</given-names></name><name><surname>van den Broek</surname><given-names>PJ</given-names></name><name><surname>Bouter</surname><given-names>H</given-names></name><name><surname>Boer</surname><given-names>F</given-names></name><name><surname>Harvey</surname><given-names>MS</given-names></name><name><surname>Huysmans</surname><given-names>HA</given-names></name><name><surname>Brand</surname><given-names>A</given-names></name></person-group><article-title>Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial</article-title><source>Circulation</source><year>1998</year><volume>97</volume><fpage>562</fpage><lpage>568</lpage><pub-id pub-id-type=""doi"">10.1161/01.CIR.97.6.562</pub-id><pub-id pub-id-type=""pmid"">9494026</pub-id></element-citation></ref><ref id=""CR23""><label>23.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Hebert</surname><given-names>PC</given-names></name><name><surname>Wells</surname><given-names>G</given-names></name><name><surname>Marshall</surname><given-names>J</given-names></name><name><surname>Martin</surname><given-names>C</given-names></name><name><surname>Tweeddale</surname><given-names>M</given-names></name><name><surname>Pagliarello</surname><given-names>G</given-names></name><name><surname>Blajchman</surname><given-names>M</given-names></name></person-group><article-title>Transfusion requirements in critical care. A pilot study. Canadian Critical Care Trials Group</article-title><source>JAMA</source><year>1995</year><volume>273</volume><fpage>1439</fpage><lpage>1444</lpage><pub-id pub-id-type=""doi"">10.1001/jama.1995.03520420055038</pub-id><pub-id pub-id-type=""pmid"">7723158</pub-id></element-citation></ref><ref id=""CR24""><label>24.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Basran</surname><given-names>S</given-names></name><name><surname>Frumento</surname><given-names>RJ</given-names></name><name><surname>Cohen</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Du</surname><given-names>Y</given-names></name><name><surname>Nishanian</surname><given-names>E</given-names></name><name><surname>Kaplan</surname><given-names>HS</given-names></name><name><surname>Stafford-Smith</surname><given-names>M</given-names></name><name><surname>Bennett-Guerrero</surname><given-names>E</given-names></name></person-group><article-title>The association between duration of storage of transfused red blood cells and morbidity and mortality after reoperative cardiac surgery</article-title><source>Anesth Analg</source><year>2006</year><volume>103</volume><fpage>15</fpage><lpage>20</lpage><pub-id pub-id-type=""doi"">10.1213/01.ane.0000221167.58135.3d</pub-id><pub-id pub-id-type=""pmid"">16790618</pub-id></element-citation></ref><ref id=""CR25""><label>25.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Eikelboom</surname><given-names>JW</given-names></name><name><surname>Cook</surname><given-names>RJ</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Heddle</surname><given-names>NM</given-names></name></person-group><article-title>Duration of red cell storage before transfusion and in-hospital mortality</article-title><source>Am Heart J</source><year>2010</year><volume>159</volume><fpage>737</fpage><lpage>743</lpage><pub-id pub-id-type=""doi"">10.1016/j.ahj.2009.12.045</pub-id><pub-id pub-id-type=""pmid"">20435180</pub-id></element-citation></ref><ref id=""CR26""><label>26.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Hebert</surname><given-names>PC</given-names></name><name><surname>Wells</surname><given-names>G</given-names></name><name><surname>Blajchman</surname><given-names>MA</given-names></name><name><surname>Marshall</surname><given-names>J</given-names></name><name><surname>Martin</surname><given-names>C</given-names></name><name><surname>Pagliarello</surname><given-names>G</given-names></name><name><surname>Tweeddale</surname><given-names>M</given-names></name><name><surname>Schweitzer</surname><given-names>I</given-names></name><name><surname>Yetisir</surname><given-names>E</given-names></name><collab>Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group</collab></person-group><article-title>A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care</article-title><source>N Engl J Med</source><year>1999</year><volume>340</volume><fpage>409</fpage><lpage>417</lpage><pub-id pub-id-type=""doi"">10.1056/NEJM199902113400601</pub-id><pub-id pub-id-type=""pmid"">9971864</pub-id></element-citation></ref><ref id=""CR27""><label>27.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>von Elm</surname><given-names>E</given-names></name><name><surname>Altman</surname><given-names>DG</given-names></name><name><surname>Egger</surname><given-names>M</given-names></name><name><surname>Pocock</surname><given-names>SJ</given-names></name><name><surname>Gotzsche</surname><given-names>PC</given-names></name><name><surname>Vandenbroucke</surname><given-names>JP</given-names></name></person-group><article-title>The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies</article-title><source>J Clin Epidemiol</source><year>2008</year><volume>61</volume><fpage>344</fpage><lpage>349</lpage><pub-id pub-id-type=""doi"">10.1016/j.jclinepi.2007.11.008</pub-id><pub-id pub-id-type=""pmid"">18313558</pub-id></element-citation></ref><ref id=""CR28""><label>28.</label><element-citation publication-type=""book""><person-group person-group-type=""author""><name><surname>Borenstein</surname><given-names>M</given-names></name><name><surname>Hedges</surname><given-names>L</given-names></name><name><surname>Higgins</surname><given-names>J</given-names></name><name><surname>Rothstein</surname><given-names>H</given-names></name></person-group><source>Comprehensive Meta-Analysis Version 2</source><year>2005</year><publisher-loc>Biostat</publisher-loc><publisher-name>Englewood, NJ</publisher-name></element-citation></ref><ref id=""CR29""><label>29.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Yu</surname><given-names>KF</given-names></name></person-group><article-title>What’s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes</article-title><source>JAMA</source><year>1998</year><volume>280</volume><fpage>1690</fpage><lpage>1691</lpage><pub-id pub-id-type=""doi"">10.1001/jama.280.19.1690</pub-id><pub-id pub-id-type=""pmid"">9832001</pub-id></element-citation></ref><ref id=""CR30""><label>30.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>McNutt</surname><given-names>LA</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name><name><surname>Xue</surname><given-names>X</given-names></name><name><surname>Hafner</surname><given-names>JP</given-names></name></person-group><article-title>Estimating the relative risk in cohort studies and clinical trials of common outcomes</article-title><source>Am J Epidemiol</source><year>2003</year><volume>157</volume><fpage>940</fpage><lpage>943</lpage><pub-id pub-id-type=""doi"">10.1093/aje/kwg074</pub-id><pub-id pub-id-type=""pmid"">12746247</pub-id></element-citation></ref><ref id=""CR31""><label>31.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Croce</surname><given-names>MA</given-names></name><name><surname>Tolley</surname><given-names>EA</given-names></name><name><surname>Claridge</surname><given-names>JA</given-names></name><name><surname>Fabian</surname><given-names>TC</given-names></name></person-group><article-title>Transfusions result in pulmonary morbidity and death after a moderate degree of injury</article-title><source>J Trauma</source><year>2005</year><volume>59</volume><fpage>19</fpage><lpage>23</lpage><pub-id pub-id-type=""doi"">10.1097/01.TA.0000171459.21450.DC</pub-id><pub-id pub-id-type=""pmid"">16096534</pub-id></element-citation></ref><ref id=""CR32""><label>32.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Robinson</surname><given-names>WP</given-names><suffix>3rd</suffix></name><name><surname>Ahn</surname><given-names>J</given-names></name><name><surname>Stiffler</surname><given-names>A</given-names></name><name><surname>Rutherford</surname><given-names>EJ</given-names></name><name><surname>Hurd</surname><given-names>H</given-names></name><name><surname>Zarzaur</surname><given-names>BL</given-names></name><name><surname>Baker</surname><given-names>CC</given-names></name><name><surname>Meyer</surname><given-names>AA</given-names></name><name><surname>Rich</surname><given-names>PB</given-names></name></person-group><article-title>Blood transfusion is an independent predictor of increased mortality in nonoperatively managed blunt hepatic and splenic injuries</article-title><source>J Trauma</source><year>2005</year><volume>58</volume><fpage>437</fpage><lpage>444</lpage><pub-id pub-id-type=""doi"">10.1097/01.TA.0000153935.18997.14</pub-id><pub-id pub-id-type=""pmid"">15761334</pub-id></element-citation></ref><ref id=""CR33""><label>33.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Netzer</surname><given-names>G</given-names></name><name><surname>Shah</surname><given-names>CV</given-names></name><name><surname>Iwashyna</surname><given-names>TJ</given-names></name><name><surname>Lanken</surname><given-names>PN</given-names></name><name><surname>Finkel</surname><given-names>B</given-names></name><name><surname>Fuchs</surname><given-names>B</given-names></name><name><surname>Guo</surname><given-names>W</given-names></name><name><surname>Christie</surname><given-names>JD</given-names></name></person-group><article-title>Association of RBC transfusion with mortality in patients with acute lung injury</article-title><source>Chest</source><year>2007</year><volume>132</volume><fpage>1116</fpage><lpage>1123</lpage><pub-id pub-id-type=""doi"">10.1378/chest.07-0145</pub-id><pub-id pub-id-type=""pmid"">17505028</pub-id></element-citation></ref><ref id=""CR34""><label>34.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Ruttinger</surname><given-names>D</given-names></name><name><surname>Wolf</surname><given-names>H</given-names></name><name><surname>Kuchenhoff</surname><given-names>H</given-names></name><name><surname>Jauch</surname><given-names>KW</given-names></name><name><surname>Hartl</surname><given-names>WH</given-names></name></person-group><article-title>Red cell transfusion: an essential factor for patient prognosis in surgical critical illness?</article-title><source>Shock</source><year>2007</year><volume>28</volume><fpage>165</fpage><lpage>171</lpage><pub-id pub-id-type=""doi"">10.1097/shk.0b013e31803df84d</pub-id><pub-id pub-id-type=""pmid"">17529904</pub-id></element-citation></ref><ref id=""CR35""><label>35.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Vincent</surname><given-names>JL</given-names></name><name><surname>Sakr</surname><given-names>Y</given-names></name><name><surname>Sprung</surname><given-names>C</given-names></name><name><surname>Harboe</surname><given-names>S</given-names></name><name><surname>Damas</surname><given-names>P</given-names></name></person-group><article-title>Are blood transfusions associated with greater mortality rates? Results of the Sepsis Occurrence in Acutely Ill Patients study</article-title><source>Anesthesiology</source><year>2008</year><volume>108</volume><fpage>31</fpage><lpage>39</lpage><pub-id pub-id-type=""doi"">10.1097/01.anes.0000296070.75956.40</pub-id><pub-id pub-id-type=""pmid"">18156879</pub-id></element-citation></ref><ref id=""CR36""><label>36.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Bochicchio</surname><given-names>GV</given-names></name><name><surname>Napolitano</surname><given-names>L</given-names></name><name><surname>Joshi</surname><given-names>M</given-names></name><name><surname>Bochicchio</surname><given-names>K</given-names></name><name><surname>Meyer</surname><given-names>W</given-names></name><name><surname>Scalea</surname><given-names>TM</given-names></name></person-group><article-title>Outcome analysis of blood product transfusion in trauma patients: a prospective, risk-adjusted study</article-title><source>World J Surg</source><year>2008</year><volume>32</volume><fpage>2185</fpage><lpage>2189</lpage><pub-id pub-id-type=""doi"">10.1007/s00268-008-9655-0</pub-id><pub-id pub-id-type=""pmid"">18575931</pub-id></element-citation></ref><ref id=""CR37""><label>37.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Bursi</surname><given-names>F</given-names></name><name><surname>Barbieri</surname><given-names>A</given-names></name><name><surname>Politi</surname><given-names>L</given-names></name><name><surname>Di Girolamo</surname><given-names>A</given-names></name><name><surname>Malagoli</surname><given-names>A</given-names></name><name><surname>Grimaldi</surname><given-names>T</given-names></name><name><surname>Rumolo</surname><given-names>A</given-names></name><name><surname>Busani</surname><given-names>S</given-names></name><name><surname>Girardis</surname><given-names>M</given-names></name><name><surname>Jaffe</surname><given-names>AS</given-names></name><name><surname>Modena</surname><given-names>MG</given-names></name></person-group><article-title>Perioperative red blood cell transfusion and outcome in stable patients after elective major vascular surgery</article-title><source>Eur J Vasc Endovasc Surg</source><year>2009</year><volume>37</volume><fpage>311</fpage><lpage>318</lpage><pub-id pub-id-type=""doi"">10.1016/j.ejvs.2008.12.002</pub-id><pub-id pub-id-type=""pmid"">19111480</pub-id></element-citation></ref><ref id=""CR38""><label>38.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Engoren</surname><given-names>M</given-names></name><name><surname>Arslanian-Engoren</surname><given-names>C</given-names></name></person-group><article-title>Long-term survival in the intensive care unit after erythrocyte blood transfusion</article-title><source>Am J Crit Care</source><year>2009</year><volume>18</volume><fpage>124</fpage><lpage>131</lpage><pub-id pub-id-type=""doi"">10.4037/ajcc2009193</pub-id><pub-id pub-id-type=""pmid"">19255102</pub-id></element-citation></ref><ref id=""CR39""><label>39.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Parsons</surname><given-names>EC</given-names></name><name><surname>Hough</surname><given-names>CL</given-names></name><name><surname>Seymour</surname><given-names>CW</given-names></name><name><surname>Cooke</surname><given-names>CR</given-names></name><name><surname>Rubenfeld</surname><given-names>GD</given-names></name><name><surname>Watkins</surname><given-names>TR</given-names></name></person-group><article-title>Red blood cell transfusion and outcomes in patients with acute lung injury, sepsis and shock</article-title><source>Crit Care</source><year>2011</year><volume>15</volume><fpage>R221</fpage><pub-id pub-id-type=""doi"">10.1186/cc10458</pub-id><pub-id pub-id-type=""pmid"">21936902</pub-id></element-citation></ref><ref id=""CR40""><label>40.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Sheth</surname><given-names>KN</given-names></name><name><surname>Gilson</surname><given-names>AJ</given-names></name><name><surname>Chang</surname><given-names>Y</given-names></name><name><surname>Kumar</surname><given-names>MA</given-names></name><name><surname>Rahman</surname><given-names>RM</given-names></name><name><surname>Rost</surname><given-names>NS</given-names></name><name><surname>Schwab</surname><given-names>K</given-names></name><name><surname>Cortellini</surname><given-names>L</given-names></name><name><surname>Goldstein</surname><given-names>JN</given-names></name><name><surname>Smith</surname><given-names>EE</given-names></name><name><surname>Greenberg</surname><given-names>SM</given-names></name><name><surname>Rosand</surname><given-names>J</given-names></name></person-group><article-title>Packed red blood cell transfusion and decreased mortality in intracerebral hemorrhage</article-title><source>Neurosurgery</source><year>2011</year><volume>68</volume><fpage>1286</fpage><lpage>1292</lpage><pub-id pub-id-type=""pmid"">21307801</pub-id></element-citation></ref><ref id=""CR41""><label>41.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Brophy</surname><given-names>DF</given-names></name><name><surname>Harpe</surname><given-names>SE</given-names></name><name><surname>Carl</surname><given-names>DE</given-names></name><name><surname>Brophy</surname><given-names>GM</given-names></name></person-group><article-title>An epidemiological study of anemia and renal dysfunction in patients admitted to ICUs across the United States</article-title><source>Anemia</source><year>2012</year><volume>2012</volume><fpage>938140</fpage><pub-id pub-id-type=""doi"">10.1155/2012/938140</pub-id><pub-id pub-id-type=""pmid"">22924126</pub-id></element-citation></ref><ref id=""CR42""><label>42.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Silva Junior</surname><given-names>JM</given-names></name><name><surname>Rezende</surname><given-names>E</given-names></name><name><surname>Amendola</surname><given-names>CP</given-names></name><name><surname>Tomita</surname><given-names>R</given-names></name><name><surname>Torres</surname><given-names>D</given-names></name><name><surname>Ferrari</surname><given-names>MT</given-names></name><name><surname>Toledo</surname><given-names>DO</given-names></name><name><surname>Oliveira</surname><given-names>AM</given-names></name><name><surname>Marques</surname><given-names>JA</given-names></name></person-group><article-title>Red blood cell transfusions worsen the outcomes even in critically ill patients undergoing a restrictive transfusion strategy</article-title><source>Sao Paulo Med J</source><year>2012</year><volume>130</volume><fpage>77</fpage><lpage>83</lpage><pub-id pub-id-type=""doi"">10.1590/S1516-31802012000200002</pub-id><pub-id pub-id-type=""pmid"">22481752</pub-id></element-citation></ref><ref id=""CR43""><label>43.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Sekhon</surname><given-names>MS</given-names></name><name><surname>McLean</surname><given-names>N</given-names></name><name><surname>Henderson</surname><given-names>WR</given-names></name><name><surname>Chittock</surname><given-names>DR</given-names></name><name><surname>Griesdale</surname><given-names>DE</given-names></name></person-group><article-title>Association of hemoglobin concentration and mortality in critically ill patients with severe traumatic brain injury</article-title><source>Crit Care</source><year>2012</year><volume>16</volume><fpage>R128</fpage><pub-id pub-id-type=""doi"">10.1186/cc11431</pub-id><pub-id pub-id-type=""pmid"">22817913</pub-id></element-citation></ref><ref id=""CR44""><label>44.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Weinberg</surname><given-names>JA</given-names></name><name><surname>McGwin</surname><given-names>G</given-names><suffix>Jr</suffix></name><name><surname>Griffin</surname><given-names>RL</given-names></name><name><surname>Huynh</surname><given-names>VQ</given-names></name><name><surname>Cherry</surname><given-names>SA</given-names><suffix>3rd</suffix></name><name><surname>Marques</surname><given-names>MB</given-names></name><name><surname>Reiff</surname><given-names>DA</given-names></name><name><surname>Kerby</surname><given-names>JD</given-names></name><name><surname>Rue</surname><given-names>LW</given-names><suffix>3rd</suffix></name></person-group><article-title>Age of transfused blood: an independent predictor of mortality despite universal leukoreduction</article-title><source>J Trauma</source><year>2008</year><volume>65</volume><fpage>279</fpage><lpage>282</lpage><pub-id pub-id-type=""doi"">10.1097/TA.0b013e31817c9687</pub-id><pub-id pub-id-type=""pmid"">18695462</pub-id></element-citation></ref><ref id=""CR45""><label>45.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Lelubre</surname><given-names>C</given-names></name><name><surname>Vincent</surname><given-names>JL</given-names></name></person-group><article-title>Relationship between red cell storage duration and outcomes in adults receiving red cell transfusions: a systematic review</article-title><source>Crit Care</source><year>2013</year><volume>17</volume><fpage>R66</fpage><pub-id pub-id-type=""doi"">10.1186/cc12600</pub-id><pub-id pub-id-type=""pmid"">23566599</pub-id></element-citation></ref><ref id=""CR46""><label>46.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Vamvakas</surname><given-names>EC</given-names></name><name><surname>Blajchman</surname><given-names>MA</given-names></name></person-group><article-title>Transfusion-related immunomodulation (TRIM): an update</article-title><source>Blood Rev</source><year>2007</year><volume>21</volume><fpage>327</fpage><lpage>348</lpage><pub-id pub-id-type=""doi"">10.1016/j.blre.2007.07.003</pub-id><pub-id pub-id-type=""pmid"">17804128</pub-id></element-citation></ref><ref id=""CR47""><label>47.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Shander</surname><given-names>A</given-names></name></person-group><article-title>Anemia in the critically ill</article-title><source>Crit Care Clin</source><year>2004</year><volume>20</volume><fpage>159</fpage><lpage>178</lpage><pub-id pub-id-type=""doi"">10.1016/j.ccc.2004.01.002</pub-id><pub-id pub-id-type=""pmid"">15135458</pub-id></element-citation></ref><ref id=""CR48""><label>48.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Bilgin</surname><given-names>YM</given-names></name><name><surname>van de Watering</surname><given-names>LM</given-names></name><name><surname>Brand</surname><given-names>A</given-names></name></person-group><article-title>Clinical effects of leucoreduction of blood transfusions</article-title><source>Neth J Med</source><year>2011</year><volume>69</volume><fpage>441</fpage><lpage>450</lpage><pub-id pub-id-type=""pmid"">22058263</pub-id></element-citation></ref><ref id=""CR49""><label>49.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Green</surname><given-names>MS</given-names></name><name><surname>Symons</surname><given-names>MJ</given-names></name></person-group><article-title>A comparison of the logistic risk function and the proportional hazards model in prospective epidemiologic studies</article-title><source>J Chronic Dis</source><year>1983</year><volume>36</volume><fpage>715</fpage><lpage>723</lpage><pub-id pub-id-type=""doi"">10.1016/0021-9681(83)90165-0</pub-id><pub-id pub-id-type=""pmid"">6630407</pub-id></element-citation></ref><ref id=""CR50""><label>50.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Cepeda</surname><given-names>MS</given-names></name><name><surname>Boston</surname><given-names>R</given-names></name><name><surname>Farrar</surname><given-names>JT</given-names></name><name><surname>Strom</surname><given-names>BL</given-names></name></person-group><article-title>Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders</article-title><source>Am J Epidemiol</source><year>2003</year><volume>158</volume><fpage>280</fpage><lpage>287</lpage><pub-id pub-id-type=""doi"">10.1093/aje/kwg115</pub-id><pub-id pub-id-type=""pmid"">12882951</pub-id></element-citation></ref><ref id=""CR51""><label>51.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Bross</surname><given-names>MH</given-names></name><name><surname>Soch</surname><given-names>K</given-names></name><name><surname>Smith-Knuppel</surname><given-names>T</given-names></name></person-group><article-title>Anemia in older persons</article-title><source>Am Fam Physician</source><year>2010</year><volume>82</volume><fpage>480</fpage><lpage>487</lpage><pub-id pub-id-type=""pmid"">20822082</pub-id></element-citation></ref><ref id=""CR52""><label>52.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Ania</surname><given-names>BJ</given-names></name><name><surname>Suman</surname><given-names>VJ</given-names></name><name><surname>Fairbanks</surname><given-names>VF</given-names></name><name><surname>Rademacher</surname><given-names>DM</given-names></name><name><surname>Melton</surname><given-names>LJ</given-names><suffix>3rd</suffix></name></person-group><article-title>Incidence of anemia in older people: an epidemiologic study in a well defined population</article-title><source>J Am Geriatr Soc</source><year>1997</year><volume>45</volume><fpage>825</fpage><lpage>831</lpage><pub-id pub-id-type=""pmid"">9215333</pub-id></element-citation></ref><ref id=""CR53""><label>53.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Zakai</surname><given-names>NA</given-names></name><name><surname>Katz</surname><given-names>R</given-names></name><name><surname>Hirsch</surname><given-names>C</given-names></name><name><surname>Shlipak</surname><given-names>MG</given-names></name><name><surname>Chaves</surname><given-names>PH</given-names></name><name><surname>Newman</surname><given-names>AB</given-names></name><name><surname>Cushman</surname><given-names>M</given-names></name></person-group><article-title>A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: the Cardiovascular Health Study</article-title><source>Arch Intern Med</source><year>2005</year><volume>165</volume><fpage>2214</fpage><lpage>2220</lpage><pub-id pub-id-type=""doi"">10.1001/archinte.165.19.2214</pub-id><pub-id pub-id-type=""pmid"">16246985</pub-id></element-citation></ref><ref id=""CR54""><label>54.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Chaves</surname><given-names>PH</given-names></name><name><surname>Ashar</surname><given-names>B</given-names></name><name><surname>Guralnik</surname><given-names>JM</given-names></name><name><surname>Fried</surname><given-names>LP</given-names></name></person-group><article-title>Looking at the relationship between hemoglobin concentration and prevalent mobility difficulty in older women. Should the criteria currently used to define anemia in older people be reevaluated?</article-title><source>J Am Geriatr Soc</source><year>2002</year><volume>50</volume><fpage>1257</fpage><lpage>1264</lpage><pub-id pub-id-type=""doi"">10.1046/j.1532-5415.2002.50313.x</pub-id><pub-id pub-id-type=""pmid"">12133021</pub-id></element-citation></ref><ref id=""CR55""><label>55.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Milman</surname><given-names>N</given-names></name><name><surname>Pedersen</surname><given-names>AN</given-names></name><name><surname>Ovesen</surname><given-names>L</given-names></name><name><surname>Schroll</surname><given-names>M</given-names></name></person-group><article-title>Hemoglobin concentrations in 358 apparently healthy 80-year-old Danish men and women. Should the reference interval be adjusted for age?</article-title><source>Aging Clin Exp Res</source><year>2008</year><volume>20</volume><fpage>8</fpage><lpage>14</lpage><pub-id pub-id-type=""doi"">10.1007/BF03324741</pub-id><pub-id pub-id-type=""pmid"">18283222</pub-id></element-citation></ref><ref id=""CR56""><label>56.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Napolitano</surname><given-names>LM</given-names></name><name><surname>Kurek</surname><given-names>S</given-names></name><name><surname>Luchette</surname><given-names>FA</given-names></name><name><surname>Anderson</surname><given-names>GL</given-names></name><name><surname>Bard</surname><given-names>MR</given-names></name><name><surname>Bromberg</surname><given-names>W</given-names></name><name><surname>Chiu</surname><given-names>WC</given-names></name><name><surname>Cipolle</surname><given-names>MD</given-names></name><name><surname>Clancy</surname><given-names>KD</given-names></name><name><surname>Diebel</surname><given-names>L</given-names></name><name><surname>Hoff</surname><given-names>WS</given-names></name><name><surname>Hughes</surname><given-names>KM</given-names></name><name><surname>Munshi</surname><given-names>I</given-names></name><name><surname>Nayduch</surname><given-names>D</given-names></name><name><surname>Sandhu</surname><given-names>R</given-names></name><name><surname>Yelon</surname><given-names>JA</given-names></name><name><surname>Corwin</surname><given-names>HL</given-names></name><name><surname>Barie</surname><given-names>PS</given-names></name><name><surname>Tisherman</surname><given-names>SA</given-names></name><name><surname>Hebert</surname><given-names>PC</given-names></name></person-group><article-title>Clinical practice guideline: red blood cell transfusion in adult trauma and critical care</article-title><source>J Trauma</source><year>2009</year><volume>67</volume><fpage>1439</fpage><lpage>1442</lpage><pub-id pub-id-type=""doi"">10.1097/TA.0b013e3181ba7074</pub-id><pub-id pub-id-type=""pmid"">20009700</pub-id></element-citation></ref><ref id=""CR57""><label>57.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Lelubre</surname><given-names>C</given-names></name><name><surname>Vincent</surname><given-names>JL</given-names></name></person-group><article-title>Red blood cell transfusion in the critically ill patient</article-title><source>Ann Intensive Care</source><year>2011</year><volume>1</volume><fpage>43</fpage><pub-id pub-id-type=""doi"">10.1186/2110-5820-1-43</pub-id><pub-id pub-id-type=""pmid"">21970512</pub-id></element-citation></ref><ref id=""CR58""><label>58.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Hare</surname><given-names>GM</given-names></name><name><surname>Baker</surname><given-names>JE</given-names></name><name><surname>Mazer</surname><given-names>CD</given-names></name></person-group><article-title>Perioperative management of acute and chronic anemia: has the pendulum swung too far?</article-title><source>Can J Anaesth</source><year>2009</year><volume>56</volume><fpage>183</fpage><lpage>189</lpage><pub-id pub-id-type=""doi"">10.1007/s12630-009-9051-8</pub-id><pub-id pub-id-type=""pmid"">19247738</pub-id></element-citation></ref></ref-list>"
10.1213/01.ane.0000221167.58135.3d	"Crit_Care/PMC4256754.nxml                                                                           0000664 0011011 0007774 00000151673 13032773631 013657  0                                                                                                    ustar   pmc                             pmcdev<!DOCTYPE article PUBLIC ""-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN"" ""JATS-archivearticle1.dtd""><ext-link ext-link-type=""uri"" xlink:href=""http://dx.doi.org/10.1213/01.ane.0000221167.58135.3d"">doi:10.1213/01.ane.0000221167.58135.3d</ext-link><italic>OR</italic>odds ratio,<italic>CI</italic>confidence interval,<italic>COPD</italic>chronic obstructive pulmonary disease,<italic>PVD</italic>peripheral vascular disease,<italic>LVEF</italic>left ventricular ejection fraction<p>* used as a continuous variable</p><sec id=""Sec9"" sec-type=""discussion""><title>Discussion</title><p>This study demonstrated, in a selected group of patients, that it is safe to perform cardiac surgery without the immediate availability of RBCs in the operating room. This resulted in a considerable reduction in cross-matching and transportation with possible damage of non-used RBC. We used data from an earlier report of our group [<xref ref-type=""bibr"" rid=""CR4"">4</xref>] to identify patients with a relatively low risk for receiving perioperative RBC transfusions.</p><p>Transfusion of RBCs is not only associated with an increase in morbidity and mortality, but also with a longer ICU stay and total hospital stay [<xref ref-type=""bibr"" rid=""CR1"">1</xref>]. Moreover, the effect of duration of storage of RBC on morbidity has been addressed [<xref ref-type=""bibr"" rid=""CR5"">5</xref>–<xref ref-type=""bibr"" rid=""CR10"">10</xref>]. In an earlier retrospective analysis of 10,626 patients undergoing cardiac surgery in our institution [<xref ref-type=""bibr"" rid=""CR2"">2</xref>], we found a significant correlation between the number of RBC units received by the patients and the incidence of early mortality. McKenny et al. [<xref ref-type=""bibr"" rid=""CR9"">9</xref>] also found the number of transfused RBC units to be associated with adverse outcome and longer hospital stay after cardiac surgery. Koch et al. [<xref ref-type=""bibr"" rid=""CR11"">11</xref>] found significantly reduced survival among transfused patients compared with non-transfused patients. Both early (6 months) and late hazard phases (up to 10 years) showed that transfusion of red cells is associated with a decreased survival in isolated CABG patients. According to these authors, attention should be directed toward blood conservation methods and a more judicious use of the RBCs [<xref ref-type=""bibr"" rid=""CR11"">11</xref>].</p><p>One of the primary rationales of the NERC protocol is to help maintenance of adequate preservation of the RBCs. Non-used units of blood must be returned back to the blood bank for further use. However, the quality of these RBC units is likely to be adversely influenced by the improper reservation in the operation room as well as during transport [<xref ref-type=""bibr"" rid=""CR12"">12</xref>]. The value of transfusion of these RBC units is physiologically less effective and can even increase the incidence of postoperative complications [<xref ref-type=""bibr"" rid=""CR13"">13</xref>–<xref ref-type=""bibr"" rid=""CR15"">15</xref>].</p><p>The effect of storage time of RBCs on the outcome after cardiac surgery has gained an increasing interest in recent literature. In an earlier study, storage time of the RBCs was not found to be a significant predictor of early or late mortality after CABG in our centre [<xref ref-type=""bibr"" rid=""CR5"">5</xref>]. The endpoint of that study was all-cause mortality without analysing the effect of storage time of RBCs on morbidity.</p><p>On the other hand, Sanders et al. [<xref ref-type=""bibr"" rid=""CR10"">10</xref>] found that patients receiving older blood have an increased incidence of prolonged hospital stay and renal complications compared with those receiving new blood [<xref ref-type=""bibr"" rid=""CR10"">10</xref>]. Koch et al.[<xref ref-type=""bibr"" rid=""CR6"">6</xref>] also found a correlation between transfusion of old blood and mortality and both renal and pulmonary complications after cardiac surgery. The controversy between different reports might be explained by the various patient populations studied, differences in study design or analysis, or different methods of blood storage. [<xref ref-type=""bibr"" rid=""CR5"">5</xref>]</p><p>The criteria of selected patients who are candidates of this NERC protocol are of utmost importance. We applied these criteria after studying the risk factors of perioperative transfusion in our centre [<xref ref-type=""bibr"" rid=""CR4"">4</xref>]. These criteria can vary in different centres and according to the availability of RBC units. If the blood is not electively ordered, it must be possible to deliver it on time if urgently needed.</p><p>Several blood conservation strategies [<xref ref-type=""bibr"" rid=""CR16"">16</xref>–<xref ref-type=""bibr"" rid=""CR18"">18</xref>] have been proposed in order to improve outcome after cardiac surgery, reduce the need for donor blood and hence lower the overall costs of transfusion. A wide variation in clinical practice and the application of guidelines have been reported in as many as 1402 surveys in 1061 institutions in the United States and Canada [<xref ref-type=""bibr"" rid=""CR19"">19</xref>] Most of these studies examined liberal versus restrictive transfusion practices in cardiac surgery. However, there is no prospective randomised trial comparing the outcomes of a program that practises blood conservation versus the common practice of blood use in cardiac surgery [<xref ref-type=""bibr"" rid=""CR20"">20</xref>]. Our NERC protocol is prospectively designed and the data of patients are prospectively collected as well. Only 19 % of the patients needed blood transfusions during the whole hospital stay. In all these patients, the blood needed was immediately available on site in the hospital. In the present study, the incidence of postoperative complications is comparable with the general incidence of complications in our institution as demonstrated in previous studies of similar patients in our department [<xref ref-type=""bibr"" rid=""CR2"">2</xref>]. Univariate predictors of postoperative need for blood transfusion were found to be gender (female sex), LVEF &lt;35 %, logistic and additive EuroSCORE.</p><p>The use of cell saver for shed blood or residual blood is a routine in our daily cardiac surgical practice. Current evidence suggests that the use of a cell saver reduces exposure to allergenic blood products or red blood cell transfusion for patients undergoing cardiac surgery [<xref ref-type=""bibr"" rid=""CR21"">21</xref>].</p><sec id=""Sec10""><title>Limitations</title><p>The results of this observational single-centre study must be interpreted with caution. Our findings were the result of the local protocol agreed upon by a team of anaesthesiologists, ICU physicians, cardiac surgeons and the blood bank. Whether the same results can be applied to other institutions remains to be investigated. The lack of a control group is also a shortcoming. However, matching this group with another group that was operated earlier was not convenient.</p></sec></sec><sec id=""Sec11"" sec-type=""conclusion""><title>Conclusions</title><p>In a selected group of patients, it is safe to perform cardiac surgery without the immediate availability of RBCs in the operating room. Preoperative univariate predictors of the need for postoperative RBC transfusion were female gender, left ventricular function (LVEF) &lt;35 % and the EuroSCORE.</p></sec><back><ack><sec id=""d30e1016""><title>Conflict of interests</title><p>None declared</p></sec></ack><ref-list id=""Bib1""><title>References</title><ref id=""CR1""><label>1.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Murphy</surname><given-names>GJ</given-names></name><name><surname>Reeves</surname><given-names>BC</given-names></name><name><surname>Rogers</surname><given-names>CA</given-names></name><etal></etal></person-group><article-title>Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery</article-title><source>Circulation</source><year>2007</year><volume>116</volume><issue>22</issue><fpage>2544</fpage><lpage>52</lpage><pub-id pub-id-type=""doi"">10.1161/CIRCULATIONAHA.107.698977</pub-id><pub-id pub-id-type=""pmid"">17998460</pub-id></element-citation></ref><ref id=""CR2""><label>2.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>van Straten</surname><given-names>AH</given-names></name><name><surname>Bekker</surname><given-names>MW</given-names></name><name><surname>Soliman Hamad</surname><given-names>MA</given-names></name><etal></etal></person-group><article-title>Transfusion of red blood cells: the impact on short-term and long-term survival after coronary artery bypass grafting, a ten-year follow-up</article-title><source>Interact Cardiovasc Thorac Surg</source><year>2010</year><volume>10</volume><issue>1</issue><fpage>37</fpage><lpage>42</lpage><pub-id pub-id-type=""doi"">10.1510/icvts.2009.214551</pub-id><pub-id pub-id-type=""pmid"">19815567</pub-id></element-citation></ref><ref id=""CR3""><label>3.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Koch</surname><given-names>CG</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Duncan</surname><given-names>AI</given-names></name><etal></etal></person-group><article-title>Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting</article-title><source>Crit Care Med</source><year>2006</year><volume>34</volume><fpage>1608</fpage><lpage>16</lpage><pub-id pub-id-type=""doi"">10.1097/01.CCM.0000217920.48559.D8</pub-id><pub-id pub-id-type=""pmid"">16607235</pub-id></element-citation></ref><ref id=""CR4""><label>4.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>van Straten</surname><given-names>AH</given-names></name><name><surname>Kats</surname><given-names>S</given-names></name><name><surname>Bekker</surname><given-names>MW</given-names></name><etal></etal></person-group><article-title>Risk factors for red blood cell transfusion after coronary artery bypass graft surgery</article-title><source>J Cardiothorac Vasc Anesth</source><year>2010</year><volume>24</volume><fpage>413</fpage><lpage>7</lpage><pub-id pub-id-type=""doi"">10.1053/j.jvca.2010.01.001</pub-id><pub-id pub-id-type=""pmid"">20231104</pub-id></element-citation></ref><ref id=""CR5""><label>5.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>van Straten</surname><given-names>AH</given-names></name><name><surname>Soliman Hamad</surname><given-names>MA</given-names></name><name><surname>van Zundert</surname><given-names>AA</given-names></name></person-group><article-title>Martens EJ, ter Woorst JF, de Wolf AM Effect of duration of red blood cell storage on early and late mortality after coronary artery bypass grafting</article-title><source>J Thorac Cardiovasc Surg</source><year>2011</year><volume>141</volume><issue>1</issue><fpage>231</fpage><lpage>7</lpage><pub-id pub-id-type=""doi"">10.1016/j.jtcvs.2010.02.059</pub-id><pub-id pub-id-type=""pmid"">20621313</pub-id></element-citation></ref><ref id=""CR6""><label>6.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Koch</surname><given-names>CG</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Sessler</surname><given-names>DI</given-names></name><etal></etal></person-group><article-title>Duration of red-cell storage and complications after cardiac surgery</article-title><source>N Engl J Med</source><year>2008</year><volume>20</volume><issue>358</issue><fpage>1229</fpage><lpage>39</lpage><pub-id pub-id-type=""doi"">10.1056/NEJMoa070403</pub-id><pub-id pub-id-type=""pmid"">18354101</pub-id></element-citation></ref><ref id=""CR7""><label>7.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Basran</surname><given-names>S</given-names></name><name><surname>Frumento</surname><given-names>RJ</given-names></name><name><surname>Cohen</surname><given-names>A</given-names></name><etal></etal></person-group><article-title>The association between duration of storage of transfused red blood cells and morbidity and mortality after reoperative cardiac surgery</article-title><source>Anesth Analg</source><year>2006</year><volume>103</volume><fpage>15</fpage><lpage>20</lpage><pub-id pub-id-type=""doi"">10.1213/01.ane.0000221167.58135.3d</pub-id><pub-id pub-id-type=""pmid"">16790618</pub-id></element-citation></ref><ref id=""CR8""><label>8.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Van de Watering</surname><given-names>L</given-names></name><name><surname>Lorinser</surname><given-names>J</given-names></name><name><surname>Versteegh</surname><given-names>M</given-names></name><etal></etal></person-group><article-title>Effects of storage time of red blood cell transfusions on the prognosis of coronary artery bypass graft patients</article-title><source>Transfusion</source><year>2006</year><volume>46</volume><fpage>1712</fpage><lpage>8</lpage><pub-id pub-id-type=""doi"">10.1111/j.1537-2995.2006.00958.x</pub-id><pub-id pub-id-type=""pmid"">17002627</pub-id></element-citation></ref><ref id=""CR9""><label>9.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>McKenny</surname><given-names>M</given-names></name><name><surname>Ryan</surname><given-names>T</given-names></name><name><surname>Tate</surname><given-names>H</given-names></name><etal></etal></person-group><article-title>Age of transfused blood is not associated with increased postoperative adverse outcome after cardiac surgery</article-title><source>Br J Anaesth</source><year>2011</year><volume>106</volume><fpage>643</fpage><lpage>9</lpage><pub-id pub-id-type=""doi"">10.1093/bja/aer029</pub-id><pub-id pub-id-type=""pmid"">21414977</pub-id></element-citation></ref><ref id=""CR10""><label>10.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Sanders</surname><given-names>J</given-names></name><name><surname>Patel</surname><given-names>S</given-names></name><name><surname>Cooper</surname><given-names>J</given-names></name><etal></etal></person-group><article-title>Red blood cell storage is associated with length of stay and renal complications after cardiac surgery</article-title><source>Transfusion</source><year>2011</year><volume>51</volume><issue>11</issue><fpage>2286</fpage><lpage>94</lpage><pub-id pub-id-type=""doi"">10.1111/j.1537-2995.2011.03170.x</pub-id><pub-id pub-id-type=""pmid"">21564106</pub-id></element-citation></ref><ref id=""CR11""><label>11.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Koch</surname><given-names>CG</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Duncan</surname><given-names>AI</given-names></name><etal></etal></person-group><article-title>Transfusion in coronary artery bypass grafting is associated with reduced long-term survival</article-title><source>Ann Thorac Surg</source><year>2006</year><volume>81</volume><issue>5</issue><fpage>1650</fpage><lpage>7</lpage><pub-id pub-id-type=""doi"">10.1016/j.athoracsur.2005.12.037</pub-id><pub-id pub-id-type=""pmid"">16631651</pub-id></element-citation></ref><ref id=""CR12""><label>12.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Zimrin</surname><given-names>AB</given-names></name><name><surname>Hess</surname><given-names>JR</given-names></name></person-group><article-title>Current issues relating to the transfusion of stored red blood cells</article-title><source>Vox Sang</source><year>2009</year><volume>96</volume><issue>2</issue><fpage>93</fpage><lpage>103</lpage><pub-id pub-id-type=""doi"">10.1111/j.1423-0410.2008.01117.x</pub-id><pub-id pub-id-type=""pmid"">19152602</pub-id></element-citation></ref><ref id=""CR13""><label>13.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Dzik</surname><given-names>W</given-names></name></person-group><article-title>Fresh blood for everyone? Balancing availability and quality of stored RBCs</article-title><source>Transfus Med</source><year>2008</year><volume>18</volume><issue>4</issue><fpage>260</fpage><lpage>5</lpage><pub-id pub-id-type=""doi"">10.1111/j.1365-3148.2008.00870.x</pub-id><pub-id pub-id-type=""pmid"">18783585</pub-id></element-citation></ref><ref id=""CR14""><label>14.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Hod</surname><given-names>EA</given-names></name><name><surname>Brittenham</surname><given-names>GM</given-names></name><name><surname>Billote</surname><given-names>GB</given-names></name><etal></etal></person-group><article-title>Transfusion of human volunteers with older, stored red blood cells produces extravascular hemolysis and circulating non-transferrin-bound iron</article-title><source>Blood</source><year>2011</year><volume>118</volume><issue>25</issue><fpage>6675</fpage><lpage>82</lpage><pub-id pub-id-type=""doi"">10.1182/blood-2011-08-371849</pub-id><pub-id pub-id-type=""pmid"">22021369</pub-id></element-citation></ref><ref id=""CR15""><label>15.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Tinmouth</surname><given-names>A</given-names></name><name><surname>Fergusson</surname><given-names>D</given-names></name><name><surname>Yee</surname><given-names>IC</given-names></name><etal></etal></person-group><article-title>Clinical consequences of red cell storage in the critically ill</article-title><source>Transfusion</source><year>2006</year><volume>46</volume><issue>11</issue><fpage>2014</fpage><lpage>27</lpage><pub-id pub-id-type=""doi"">10.1111/j.1537-2995.2006.01026.x</pub-id><pub-id pub-id-type=""pmid"">17076859</pub-id></element-citation></ref><ref id=""CR16""><label>16.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Beckmann</surname><given-names>SR</given-names></name><name><surname>Carlile</surname><given-names>D</given-names></name><name><surname>Bissinger</surname><given-names>RC</given-names></name><etal></etal></person-group><article-title>Improved coagulation and blood conservation in the golden hours after cardiopulmonary bypass</article-title><source>J Extra Corp Technol</source><year>2007</year><volume>39</volume><fpage>103</fpage><lpage>8</lpage></element-citation></ref><ref id=""CR17""><label>17.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Takagi</surname><given-names>H</given-names></name><name><surname>Manabe</surname><given-names>H</given-names></name><name><surname>Kawai</surname><given-names>N</given-names></name><etal></etal></person-group><article-title>Aprotinin increases mortality as compared with tranexamic acid in cardiac surgery: a meta-analysis of randomized head-to-head trials</article-title><source>Interact Cardiovasc Thorac Surg</source><year>2009</year><volume>9</volume><fpage>98</fpage><lpage>101</lpage><pub-id pub-id-type=""doi"">10.1510/icvts.2008.198325</pub-id><pub-id pub-id-type=""pmid"">19380335</pub-id></element-citation></ref><ref id=""CR18""><label>18.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Raghunathan</surname><given-names>K</given-names></name><name><surname>Connelly</surname><given-names>NR</given-names></name><name><surname>Kanter</surname><given-names>GJ</given-names></name></person-group><article-title>ε-Aminocaproic acid and clinical value in cardiac anesthesia</article-title><source>J Cardiothorac Vasc Anesth</source><year>2011</year><volume>25</volume><fpage>16</fpage><lpage>9</lpage><pub-id pub-id-type=""doi"">10.1053/j.jvca.2010.07.024</pub-id><pub-id pub-id-type=""pmid"">20870423</pub-id></element-citation></ref><ref id=""CR19""><label>19.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Likosky</surname><given-names>DS</given-names></name><name><surname>FitzGerald</surname><given-names>DC</given-names></name><name><surname>Groom</surname><given-names>RC</given-names></name><etal></etal></person-group><article-title>The effect of the perioperative blood transfusion and blood conservation in cardiac surgery Clinical Practice Guidelines of the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists upon clinical practices</article-title><source>J Extra Corp Technol</source><year>2010</year><volume>42</volume><fpage>114</fpage><lpage>21</lpage></element-citation></ref><ref id=""CR20""><label>20.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Moskowitz</surname><given-names>DM</given-names></name><name><surname>McCullough</surname><given-names>JN</given-names></name><name><surname>Shander</surname><given-names>A</given-names></name><etal></etal></person-group><article-title>The impact of blood conservation on outcomes in cardiac surgery: is it safe and effective?</article-title><source>Ann Thorac Surg</source><year>2010</year><volume>90</volume><fpage>451</fpage><lpage>8</lpage><pub-id pub-id-type=""doi"">10.1016/j.athoracsur.2010.04.089</pub-id><pub-id pub-id-type=""pmid"">20667328</pub-id></element-citation></ref><ref id=""CR21""><label>21.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Bainbridge</surname><given-names>D</given-names></name><name><surname>Martin</surname><given-names>J</given-names></name><etal></etal></person-group><article-title>The efficacy of an intraoperative cell saver during cardiac surgery: a meta-analysis of randomized trials</article-title><source>Anesth Analg</source><year>2009</year><volume>109</volume><fpage>320</fpage><lpage>30</lpage><pub-id pub-id-type=""doi"">10.1213/ane.0b013e3181aa084c</pub-id><pub-id pub-id-type=""pmid"">19608798</pub-id></element-citation></ref></ref-list>"
10.1038/35044106	"<html><body><italic>In vivo</italic>gene therapy for diabetes mellitus<source><italic>Trends in Molecular Medicine</italic></source><year>2003</year><volume>9</volume><issue>10</issue><fpage>430</fpage><lpage>435</lpage><pub-id pub-id-type=""doi"">10.1016/j.molmed.2003.08.003</pub-id><pub-id pub-id-type=""other"">2-s2.0-0142246189</pub-id><pub-id pub-id-type=""pmid"">14557055</pub-id><ref id=""B58""><label>58</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Zalzman</surname><given-names>M.</given-names></name><name><surname>Gupta</surname><given-names>S.</given-names></name><name><surname>Giri</surname><given-names>R. K.</given-names></name><etal></etal></person-group><article-title>Reversal of hyperglycemia in mice by using human expandable insulin-producing cells differentiated from fetal liver progenitor cells</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>2003</year><volume>100</volume><issue>12</issue><fpage>7253</fpage><lpage>7258</lpage><pub-id pub-id-type=""doi"">10.1073/pnas.1136854100</pub-id><pub-id pub-id-type=""other"">2-s2.0-0038472015</pub-id><pub-id pub-id-type=""pmid"">12756298</pub-id></element-citation></ref><ref id=""B59""><label>59</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Jun</surname><given-names>H.-S.</given-names></name><name><surname>Yoon</surname><given-names>J.-W.</given-names></name></person-group><article-title>Approaches for the cure of type 1 diabetes by cellular and gene therapy</article-title><source><italic>Current Gene Therapy</italic></source><year>2005</year><volume>5</volume><issue>2</issue><fpage>249</fpage><lpage>262</lpage><pub-id pub-id-type=""doi"">10.2174/1566523053544209</pub-id><pub-id pub-id-type=""other"">2-s2.0-15944397246</pub-id><pub-id pub-id-type=""pmid"">15853732</pub-id></element-citation></ref><ref id=""B60""><label>60</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Morral</surname><given-names>N.</given-names></name></person-group><article-title>Novel targets and therapeutic strategies for type 2 diabetes</article-title><source><italic>Trends in Endocrinology and Metabolism</italic></source><year>2003</year><volume>14</volume><issue>4</issue><fpage>169</fpage><lpage>175</lpage><pub-id pub-id-type=""doi"">10.1016/s1043-2760(03)00031-6</pub-id><pub-id pub-id-type=""other"">2-s2.0-0038408484</pub-id><pub-id pub-id-type=""pmid"">12714277</pub-id></element-citation></ref><ref id=""B61""><label>61</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>O'Doherty</surname><given-names>R. M.</given-names></name><name><surname>Lehman</surname><given-names>D. L.</given-names></name><name><surname>Télémaque-Potts</surname><given-names>S.</given-names></name><name><surname>Newgard</surname><given-names>C. B.</given-names></name></person-group><article-title>Metabolic impact of glucokinase overexpression in liver: lowering of blood glucose in fed rats is accompanied by hyperlipidemia</article-title><source><italic>Diabetes</italic></source><year>1999</year><volume>48</volume><issue>10</issue><fpage>2022</fpage><lpage>2027</lpage><pub-id pub-id-type=""doi"">10.2337/diabetes.48.10.2022</pub-id><pub-id pub-id-type=""other"">2-s2.0-0032884829</pub-id><pub-id pub-id-type=""pmid"">10512368</pub-id></element-citation></ref><ref id=""B62""><label>62</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Morral</surname><given-names>N.</given-names></name><name><surname>McEvoy</surname><given-names>R.</given-names></name><name><surname>Dong</surname><given-names>H.</given-names></name><etal></etal></person-group><article-title>Adenovirus-mediated expression of glucokinase in the liver as an adjuvant treatment for type 1 diabetes</article-title><source><italic>Human Gene Therapy</italic></source><year>2002</year><volume>13</volume><issue>13</issue><fpage>1561</fpage><lpage>1570</lpage><pub-id pub-id-type=""doi"">10.1089/10430340260201653</pub-id><pub-id pub-id-type=""other"">2-s2.0-0036377928</pub-id><pub-id pub-id-type=""pmid"">12228011</pub-id></element-citation></ref><ref id=""B63""><label>63</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>O'Doherty</surname><given-names>R. M.</given-names></name><name><surname>Jensen</surname><given-names>P. B.</given-names></name><name><surname>Anderson</surname><given-names>P.</given-names></name><etal></etal></person-group><article-title>Activation of direct and indirect pathways of glycogen synthesis by hepatic overexpression of protein targeting to glycogen</article-title><source><italic>The Journal of Clinical Investigation</italic></source><year>2000</year><volume>105</volume><issue>4</issue><fpage>479</fpage><lpage>488</lpage><pub-id pub-id-type=""doi"">10.1172/jci8673</pub-id><pub-id pub-id-type=""other"">2-s2.0-0033995047</pub-id><pub-id pub-id-type=""pmid"">10683377</pub-id></element-citation></ref><ref id=""B64""><label>64</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Newgard</surname><given-names>C. B.</given-names></name><name><surname>Brady</surname><given-names>M. J.</given-names></name><name><surname>O'Doherty</surname><given-names>R. M.</given-names></name><name><surname>Saltiel</surname><given-names>A. R.</given-names></name></person-group><article-title>Organizing glucose disposal: emerging roles of the glycogen targeting subunits of protein phosphatase-1</article-title><source><italic>Diabetes</italic></source><year>2000</year><volume>49</volume><issue>12</issue><fpage>1967</fpage><lpage>1977</lpage><pub-id pub-id-type=""doi"">10.2337/diabetes.49.12.1967</pub-id><pub-id pub-id-type=""other"">2-s2.0-0033664155</pub-id><pub-id pub-id-type=""pmid"">11117996</pub-id></element-citation></ref><ref id=""B65""><label>65</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Dong</surname><given-names>H.</given-names></name><name><surname>Woo</surname><given-names>S. L. C.</given-names></name></person-group><article-title>Hepatic insulin production for type 1 diabetes</article-title><source><italic>Trends in Endocrinology and Metabolism</italic></source><year>2001</year><volume>12</volume><issue>10</issue><fpage>441</fpage><lpage>446</lpage><pub-id pub-id-type=""doi"">10.1016/s1043-2760(01)00491-x</pub-id><pub-id pub-id-type=""other"">2-s2.0-0035656779</pub-id><pub-id pub-id-type=""pmid"">11701342</pub-id></element-citation></ref><ref id=""B66""><label>66</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Yoon</surname><given-names>J. W.</given-names></name><name><surname>Jun</surname><given-names>H. S.</given-names></name></person-group><article-title>Recent advances in insulin gene therapy for type 1 diabetes</article-title><source><italic>Trends in Molecular Medicine</italic></source><year>2002</year><volume>8</volume><issue>2</issue><fpage>62</fpage><lpage>68</lpage><pub-id pub-id-type=""doi"">10.1016/s1471-4914(02)02279-7</pub-id><pub-id pub-id-type=""other"">2-s2.0-0036156567</pub-id><pub-id pub-id-type=""pmid"">11815271</pub-id></element-citation></ref><ref id=""B67""><label>67</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Short</surname><given-names>D. K.</given-names></name><name><surname>Okada</surname><given-names>S.</given-names></name><name><surname>Yamauchi</surname><given-names>K.</given-names></name><name><surname>Pessin</surname><given-names>J. E.</given-names></name></person-group><article-title>Adenovirus-mediated transfer of a modified human proinsulin gene reverses hyperglycemia in diabetic mice</article-title><source><italic>American Journal of Physiology—Endocrinology &amp; Metabolism</italic></source><year>1998</year><volume>275</volume><issue>5</issue><fpage>E748</fpage><lpage>E756</lpage><pub-id pub-id-type=""other"">2-s2.0-0031730473</pub-id></element-citation></ref><ref id=""B68""><label>68</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Muzzin</surname><given-names>P.</given-names></name><name><surname>Eisensmitht</surname><given-names>R. C.</given-names></name><name><surname>Copeland</surname><given-names>K. C.</given-names></name><name><surname>Woo</surname><given-names>S. L. C.</given-names></name></person-group><article-title>Hepatic insulin gene expression as treatment for type 1 diabetes mellitus in rats</article-title><source><italic>Molecular Endocrinology</italic></source><year>1997</year><volume>11</volume><issue>6</issue><fpage>833</fpage><lpage>837</lpage><pub-id pub-id-type=""doi"">10.1210/me.11.6.833</pub-id><pub-id pub-id-type=""other"">2-s2.0-0030946203</pub-id><pub-id pub-id-type=""pmid"">9171246</pub-id></element-citation></ref><ref id=""B69""><label>69</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Auricchio</surname><given-names>A.</given-names></name><name><surname>Gao</surname><given-names>G.-P.</given-names></name><name><surname>Yu</surname><given-names>Q. C.</given-names></name><etal></etal></person-group><article-title>Constitutive and regulated expression of processed insulin following<italic>in vivo</italic>hepatic gene transfer</article-title><source><italic>Gene Therapy</italic></source><year>2002</year><volume>9</volume><issue>14</issue><fpage>963</fpage><lpage>971</lpage><pub-id pub-id-type=""doi"">10.1038/sj.gt.3301746</pub-id><pub-id pub-id-type=""other"">2-s2.0-0036328505</pub-id><pub-id pub-id-type=""pmid"">12085245</pub-id></element-citation></ref><ref id=""B70""><label>70</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Hui</surname><given-names>H.</given-names></name><name><surname>Perfetti</surname><given-names>R.</given-names></name></person-group><article-title>Pancreas duodenum homeobox-1 regulates pancreas development during embryogenesis and islet cell function in adulthood</article-title><source><italic>European Journal of Endocrinology</italic></source><year>2002</year><volume>146</volume><issue>2</issue><fpage>129</fpage><lpage>141</lpage><pub-id pub-id-type=""doi"">10.1530/eje.0.1460129</pub-id><pub-id pub-id-type=""other"">2-s2.0-0036180326</pub-id><pub-id pub-id-type=""pmid"">11834421</pub-id></element-citation></ref><ref id=""B71""><label>71</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Lee</surname><given-names>H. C.</given-names></name><name><surname>Kim</surname><given-names>S.-J.</given-names></name><name><surname>Kim</surname><given-names>K.-S.</given-names></name><name><surname>Shin</surname><given-names>H.-C.</given-names></name><name><surname>Yoon</surname><given-names>J.-W.</given-names></name></person-group><article-title>Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue</article-title><source><italic>Nature</italic></source><year>2000</year><volume>408</volume><issue>6811</issue><fpage>483</fpage><lpage>488</lpage><pub-id pub-id-type=""doi"">10.1038/35044106</pub-id><pub-id pub-id-type=""other"">2-s2.0-0034707028</pub-id><pub-id pub-id-type=""pmid"">11100731</pub-id></element-citation></ref><ref id=""B72""><label>72</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Kojima</surname><given-names>H.</given-names></name><name><surname>Fujimiya</surname><given-names>M.</given-names></name><name><surname>Matsumura</surname><given-names>K.</given-names></name><etal></etal></person-group><article-title>NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice</article-title><source><italic>Nature Medicine</italic></source><year>2003</year><volume>9</volume><issue>5</issue><fpage>596</fpage><lpage>603</lpage><pub-id pub-id-type=""doi"">10.1038/nm867</pub-id><pub-id pub-id-type=""other"">2-s2.0-0038413922</pub-id></element-citation></ref><ref id=""B73""><label>73</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Ferber</surname><given-names>S.</given-names></name><name><surname>Halkin</surname><given-names>A.</given-names></name><name><surname>Cohen</surname><given-names>H.</given-names></name><etal></etal></person-group><article-title>Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia</article-title><source><italic>Nature Medicine</italic></source><year>2000</year><volume>6</volume><issue>5</issue><fpage>568</fpage><lpage>572</lpage><pub-id pub-id-type=""doi"">10.1038/75050</pub-id><pub-id pub-id-type=""other"">2-s2.0-0034068602</pub-id></element-citation></ref><ref id=""B74""><label>74</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Halban</surname><given-names>P. A.</given-names></name><name><surname>Kahn</surname><given-names>S. E.</given-names></name><name><surname>Lernmark</surname><given-names>Å.</given-names></name><name><surname>Rhodes</surname><given-names>C. J.</given-names></name></person-group><article-title>Gene and cell-replacement therapy in the treatment of type 1 diabetes. How high must the standards be set?</article-title><source><italic>Diabetes</italic></source><year>2001</year><volume>50</volume><issue>10</issue><fpage>2181</fpage><lpage>2191</lpage><pub-id pub-id-type=""doi"">10.2337/diabetes.50.10.2181</pub-id><pub-id pub-id-type=""other"">2-s2.0-0035491791</pub-id><pub-id pub-id-type=""pmid"">11574396</pub-id></element-citation></ref><ref id=""B75""><label>75</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Pastors</surname><given-names>J. G.</given-names></name><name><surname>Warshaw</surname><given-names>H.</given-names></name><name><surname>Daly</surname><given-names>A.</given-names></name><name><surname>Franz</surname><given-names>M.</given-names></name><name><surname>Kulkarni</surname><given-names>K.</given-names></name></person-group><article-title>The evidence for the effectiveness of medical nutrition therapy in diabetes management</article-title><source><italic>Diabetes Care</italic></source><year>2002</year><volume>25</volume><issue>3</issue><fpage>608</fpage><lpage>613</lpage><pub-id pub-id-type=""doi"">10.2337/diacare.25.3.608</pub-id><pub-id pub-id-type=""other"">2-s2.0-0036517849</pub-id><pub-id pub-id-type=""pmid"">11874956</pub-id></element-citation></ref><ref id=""B76""><label>76</label><element-citation publication-type=""journal""><collab>American Diabetes Association</collab><article-title>Diagnosis and classification of diabetes mellitus</article-title><source><italic>Diabetes Care</italic></source><year>2004</year><volume>1</volume><fpage>S5</fpage><lpage>S10</lpage></element-citation></ref><ref id=""B77""><label>77</label><element-citation publication-type=""other""><comment>American Diabetes Association, 2008</comment></element-citation></ref><ref id=""B78""><label>78</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Thatte</surname><given-names>U. M.</given-names></name><name><surname>Dahanukar</surname><given-names>S. A.</given-names></name></person-group><article-title>Immunotherapeutic modification of experimental infections by Indian medicinal plants</article-title><source><italic>Phytotherapy Research</italic></source><year>1989</year><volume>3</volume><issue>2</issue><fpage>43</fpage><lpage>49</lpage><pub-id pub-id-type=""doi"">10.1002/ptr.2650030202</pub-id><pub-id pub-id-type=""other"">2-s2.0-0024381224</pub-id></element-citation></ref><ref id=""B79""><label>79</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Prasad</surname><given-names>S. K.</given-names></name><name><surname>Kulshreshtha</surname><given-names>A.</given-names></name><name><surname>Qureshi</surname><given-names>T. N.</given-names></name></person-group><article-title>Antidiabetic activity of some herbal plants in streptozotocin induced diabetic albino rats</article-title><source><italic>Pakistan Journal of Nutrition</italic></source><year>2009</year><volume>8</volume><issue>5</issue><fpage>551</fpage><lpage>557</lpage><pub-id pub-id-type=""doi"">10.3923/pjn.2009.551.557</pub-id><pub-id pub-id-type=""other"">2-s2.0-60849101539</pub-id></element-citation></ref><ref id=""B80""><label>80</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Bnouham</surname><given-names>M.</given-names></name><name><surname>Ziyyat</surname><given-names>A.</given-names></name><name><surname>Mekhfi</surname><given-names>H.</given-names></name><name><surname>Tahri</surname><given-names>A.</given-names></name><name><surname>Legssyer</surname><given-names>A.</given-names></name></person-group><article-title>Medicinal plants with potential antidiabetic activity—a review of ten years of herbal medicine research (1990—2000)</article-title><source><italic>International Journal of Diabetes and Metabolism</italic></source><year>2006</year><volume>14</volume><issue>1</issue><fpage>1</fpage><lpage>25</lpage><pub-id pub-id-type=""other"">2-s2.0-34249071640</pub-id></element-citation></ref><ref id=""B81""><label>81</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Grover</surname><given-names>J. K.</given-names></name><name><surname>Yadav</surname><given-names>S.</given-names></name><name><surname>Vats</surname><given-names>V.</given-names></name></person-group><article-title>Medicinal plants of India with anti-diabetic potential</article-title><source><italic>Journal of Ethnopharmacology</italic></source><year>2002</year><volume>81</volume><issue>1</issue><fpage>81</fpage><lpage>100</lpage><pub-id pub-id-type=""doi"">10.1016/S0378-8741(02)00059-4</pub-id><pub-id pub-id-type=""other"">2-s2.0-0036000246</pub-id><pub-id pub-id-type=""pmid"">12020931</pub-id></element-citation></ref><ref id=""B82""><label>82</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Babu</surname><given-names>P. A.</given-names></name><name><surname>Suneetha</surname><given-names>G.</given-names></name><name><surname>Boddepalli</surname><given-names>R.</given-names></name><etal></etal></person-group><article-title>A database of 389 medicinal plants for diabetes</article-title><source><italic>Bioinformation</italic></source><year>2006</year><volume>1</volume><issue>4</issue><fpage>130</fpage><lpage>131</lpage><pub-id pub-id-type=""doi"">10.6026/97320630001130</pub-id><pub-id pub-id-type=""pmid"">17597872</pub-id></element-citation></ref><ref id=""B83""><label>83</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Jung</surname><given-names>M.</given-names></name><name><surname>Park</surname><given-names>M.</given-names></name><name><surname>Lee</surname><given-names>H. C.</given-names></name><name><surname>Kan</surname><given-names>Y.-H.</given-names></name><name><surname>Kang</surname><given-names>E. S.</given-names></name><name><surname>Kim</surname><given-names>S. K.</given-names></name></person-group><article-title>Antidiabetic agents from medicinal plants</article-title><source><italic>Current Medicinal Chemistry</italic></source><year>2006</year><volume>13</volume><issue>10</issue><fpage>1203</fpage><lpage>1218</lpage><pub-id pub-id-type=""doi"">10.2174/092986706776360860</pub-id><pub-id pub-id-type=""other"">2-s2.0-33645979959</pub-id><pub-id pub-id-type=""pmid"">16719780</pub-id></element-citation></ref><ref id=""B84""><label>84</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Tiwari</surname><given-names>P.</given-names></name><name><surname>Mishra</surname><given-names>B. N.</given-names></name><name><surname>Sangwan</surname><given-names>N. S.</given-names></name></person-group><article-title>Phytochemical and pharmacological properties of<italic>Gymnema sylvestre</italic>: an important medicinal plant</article-title><source><italic>BioMed Research International</italic></source><year>2014</year><volume>2014</volume><fpage>18</fpage><pub-id pub-id-type=""publisher-id"">830285</pub-id><pub-id pub-id-type=""doi"">10.1155/2014/830285</pub-id><pub-id pub-id-type=""other"">2-s2.0-84893428191</pub-id></element-citation></ref><ref id=""B95""><label>85</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Tiwari</surname><given-names>P.</given-names></name><name><surname>Sangwan</surname><given-names>R. S.</given-names></name><name><surname>Asha</surname></name><name><surname>Mishra</surname><given-names>B. N.</given-names></name><name><surname>Sabir</surname><given-names>F.</given-names></name><name><surname>Sangwan</surname><given-names>N. S.</given-names></name></person-group><article-title>Molecular cloning and biochemical characterization of a recombinant sterol 3-O-glucosyltransferase from<italic>Gymnema sylvestre</italic>R.Br. catalyzing biosynthesis of steryl glucosides</article-title><source><italic>BioMed Research International</italic></source><year>2014</year><volume>2014</volume><fpage>14</fpage><pub-id pub-id-type=""publisher-id"">934351</pub-id><pub-id pub-id-type=""doi"">10.1155/2014/934351</pub-id></element-citation></ref><ref id=""B85""><label>86</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Sakthivel</surname><given-names>K.</given-names></name><name><surname>Rajesh</surname><given-names>C.</given-names></name><name><surname>Senthamarai</surname><given-names>R.</given-names></name></person-group><article-title>Stem cell treatment for diabetes</article-title><source><italic>International Journal of Pharma and Bio Sciences</italic></source><year>2010</year><volume>1</volume><issue>4</issue><fpage>333</fpage><lpage>338</lpage><pub-id pub-id-type=""other"">2-s2.0-84455202714</pub-id></element-citation></ref><ref id=""B86""><label>87</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Campbell</surname><given-names>R. K.</given-names></name></person-group><article-title>Type 2 diabetes: where we are today: an overview of disease burden, current treatments, and treatment strategies</article-title><source><italic>Journal of the American Pharmaceutical Association</italic></source><year>2009</year><volume>49</volume><fpage>S3</fpage><lpage>S9</lpage><pub-id pub-id-type=""doi"">10.1331/japha.2009.09077</pub-id><pub-id pub-id-type=""other"">2-s2.0-70350517412</pub-id></element-citation></ref><ref id=""B87""><label>88</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Elmquist</surname><given-names>J. K.</given-names></name><name><surname>Elias</surname><given-names>C. F.</given-names></name><name><surname>Saper</surname><given-names>C. B.</given-names></name></person-group><article-title>From lesions to leptin: hypothalamic control of food intake and body weight</article-title><source><italic>Neuron</italic></source><year>1999</year><volume>22</volume><issue>2</issue><fpage>221</fpage><lpage>232</lpage><pub-id pub-id-type=""doi"">10.1016/s0896-6273(00)81084-3</pub-id><pub-id pub-id-type=""other"">2-s2.0-0033082380</pub-id><pub-id pub-id-type=""pmid"">10069329</pub-id></element-citation></ref><ref id=""B88""><label>89</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Coppari</surname><given-names>R.</given-names></name><name><surname>Ichinose</surname><given-names>M.</given-names></name><name><surname>Lee</surname><given-names>C. E.</given-names></name><etal></etal></person-group><article-title>The hypothalamic arcuate nucleus: a key site for mediating leptin's effects on glucose homeostasis and locomotor activity</article-title><source><italic>Cell Metabolism</italic></source><year>2005</year><volume>1</volume><issue>1</issue><fpage>63</fpage><lpage>72</lpage><pub-id pub-id-type=""doi"">10.1016/j.cmet.2004.12.004</pub-id><pub-id pub-id-type=""other"">2-s2.0-17844389670</pub-id><pub-id pub-id-type=""pmid"">16054045</pub-id></element-citation></ref><ref id=""B89""><label>90</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Huo</surname><given-names>L.</given-names></name><name><surname>Gamber</surname><given-names>K.</given-names></name><name><surname>Greeley</surname><given-names>S.</given-names></name><etal></etal></person-group><article-title>Leptin-dependent control of glucose balance and locomotor activity by POMC neurons</article-title><source><italic>Cell Metabolism</italic></source><year>2009</year><volume>9</volume><issue>6</issue><fpage>537</fpage><lpage>547</lpage><pub-id pub-id-type=""doi"">10.1016/j.cmet.2009.05.003</pub-id><pub-id pub-id-type=""other"">2-s2.0-66049133685</pub-id><pub-id pub-id-type=""pmid"">19490908</pub-id></element-citation></ref><ref id=""B90""><label>91</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Morton</surname><given-names>G. J.</given-names></name><name><surname>Gelling</surname><given-names>R. W.</given-names></name><name><surname>Niswender</surname><given-names>K. D.</given-names></name><name><surname>Morrison</surname><given-names>C. D.</given-names></name><name><surname>Rhodes</surname><given-names>C. J.</given-names></name><name><surname>Schwartz</surname><given-names>M. W.</given-names></name></person-group><article-title>Leptin regulates insulin sensitivity via phosphatidylinositol-3-OH kinase signaling in mediobasal hypothalamic neurons</article-title><source><italic>Cell Metabolism</italic></source><year>2005</year><volume>2</volume><issue>6</issue><fpage>411</fpage><lpage>420</lpage><pub-id pub-id-type=""doi"">10.1016/j.cmet.2005.10.009</pub-id><pub-id pub-id-type=""other"">2-s2.0-30044447631</pub-id><pub-id pub-id-type=""pmid"">16330326</pub-id></element-citation></ref><ref id=""B91""><label>92</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>German</surname><given-names>J.</given-names></name><name><surname>Kim</surname><given-names>F.</given-names></name><name><surname>Schwartz</surname><given-names>G. J.</given-names></name><etal></etal></person-group><article-title>Hypothalamic leptin signaling regulates hepatic insulin sensitivity via a neurocircuit involving the vagus nerve</article-title><source><italic>Endocrinology</italic></source><year>2009</year><volume>150</volume><issue>10</issue><fpage>4502</fpage><lpage>4511</lpage><pub-id pub-id-type=""doi"">10.1210/en.2009-0445</pub-id><pub-id pub-id-type=""other"">2-s2.0-70349337472</pub-id><pub-id pub-id-type=""pmid"">19574396</pub-id></element-citation></ref><ref id=""B92""><label>93</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Fujikawa</surname><given-names>T.</given-names></name><name><surname>Chuang</surname><given-names>J.-C.</given-names></name><name><surname>Sakata</surname><given-names>I.</given-names></name><name><surname>Ramadori</surname><given-names>G.</given-names></name><name><surname>Coppari</surname><given-names>R.</given-names></name></person-group><article-title>Leptin therapy improves insulin-deficient type 1 diabetes by CNS-dependent mechanisms in mice</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>2010</year><volume>107</volume><issue>40</issue><fpage>17391</fpage><lpage>17396</lpage><pub-id pub-id-type=""doi"">10.1073/pnas.1008025107</pub-id><pub-id pub-id-type=""other"">2-s2.0-78049271280</pub-id><pub-id pub-id-type=""pmid"">20855609</pub-id></element-citation></ref><ref id=""B93""><label>94</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Chowdary</surname><given-names>K. P. R.</given-names></name><name><surname>Rao</surname><given-names>Y. S.</given-names></name></person-group><article-title>Mucoadhesive microspheres for controlled drug delivery</article-title><source><italic>Biological and Pharmaceutical Bulletin</italic></source><year>2004</year><volume>27</volume><issue>11</issue><fpage>1717</fpage><lpage>1724</lpage><pub-id pub-id-type=""doi"">10.1248/bpb.27.1717</pub-id><pub-id pub-id-type=""other"">2-s2.0-22044457597</pub-id><pub-id pub-id-type=""pmid"">15516712</pub-id></element-citation></ref><ref id=""B94""><label>95</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Odegaard</surname><given-names>J. I.</given-names></name><name><surname>Ricardo-Gonzalez</surname><given-names>R. R.</given-names></name><name><surname>Goforth</surname><given-names>M. H.</given-names></name><etal></etal></person-group><article-title>Macrophage-specific PPAR<italic>γ</italic>controls alternative activation and improves insulin resistance</article-title><source><italic>Nature</italic></source><year>2007</year><volume>447</volume><issue>7148</issue><fpage>1116</fpage><lpage>1120</lpage><pub-id pub-id-type=""doi"">10.1038/nature05894</pub-id><pub-id pub-id-type=""other"">2-s2.0-34347354309</pub-id><pub-id pub-id-type=""pmid"">17515919</pub-id></element-citation></ref><floats-group><fig id=""fig1"" orientation=""portrait"" position=""float""><label>Figure 1</label><caption><p>A schematic representation of general occurrence and approaches in diabetes management.</p></caption><graphic xlink:href=""JDR2015-340838.001""></graphic></fig><table-wrap id=""tab1"" orientation=""portrait"" position=""float""><label>Table 1</label><caption><p>Representation of the multiple primary and secondary forms of diabetes, the defective metabolism, and the adverse effects on the body organs.</p></caption><table frame=""hsides"" rules=""groups""><thead><tr><th align=""left"" colspan=""1"" rowspan=""1"">Classification of diabetes</th><th align=""left"" colspan=""1"" rowspan=""1"">Effects on the body</th><th align=""left"" colspan=""1"" rowspan=""1"">Symptoms</th></tr></thead><tbody><tr><td align=""center"" colspan=""3"" rowspan=""1"">Primary diabetes</td></tr><tr><td align=""left"" colspan=""1"" rowspan=""1"">Insulin dependent diabetes mellitus</td><td align=""left"" colspan=""1"" rowspan=""1"">Destruction of<italic>β</italic>cells</td><td align=""left"" colspan=""1"" rowspan=""1"">Deficiency of insulin</td></tr><tr><td align=""left"" colspan=""1"" rowspan=""1"">Non insulin dependent diabetes mellitus</td><td align=""left"" colspan=""1"" rowspan=""1"">Insulin resistance</td><td align=""left"" colspan=""1"" rowspan=""1"">Loss of insulin secretion</td></tr><tr><td align=""center"" colspan=""3"" rowspan=""1""><pub-id pub-id-type=""doi"">10.1038/35044106</pub-id><pub-id pub-id-type=""doi"">10.1038/35044106</pub-id><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.<abstract id=""Abs1""><p>To explore the anti-tumor effect and immune mechanism mediated by a new recombinant adeno-associated virus (rAAV) encoding secondary lymphoid tissue chemokine (SLC) mature peptide gene. AAV Helper-Free system was used for rAAV-SLC package. The anti-tumor effect of SLC was detected by bearing tumor established from Hepal-6 cells both in C57BL/6J and nude mice. Flow cytometry analysis and IHC for Tumor-infiltrating T cells and CD11c+DCs were also investigated to explore the immunological mechanism. rAAV-SLC was successfully packaged in AAV293 cells and transfected Hepal-6 tumor cells at high efficiency. The anti-tumor effect was demonstrated by less tumor weight and longer survival outcome. Coincident with the anti-tumor response, local elaboration of SLC within the tumor bed elicited a heavy infiltration of CD4<sup>+</sup>, CD8<sup>+</sup>T cells and CD11c<sup>+</sup>dendritic cells into the tumor sites. More importantly, there was higher infiltration of Foxp3+ regulatory T cells (Tregs). Local elaboration of SLC mediated by rAAV-SLC has strong T cell mediated anti-tumor effect. The study also suggested that Tregs in the tumor microenvironment tampered the anti-tumor effect.</p></abstract><kwd-group xml:lang=""en""><title>Keywords</title><kwd>Recombinant adeno-associated virus</kwd><kwd>Secondary lymphoid tissue chemokine</kwd><kwd>Anti-tumor effect</kwd><kwd>Tregs</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>© Springer Science+Business Media Dordrecht 2013</meta-value></custom-meta></custom-meta-group><sec id=""Sec1"" sec-type=""intro""><title>Introduction</title><p>Chemokines are small diffusible or matrix-associated proteins that transmit chemotactic signals into cells through pertussis toxin-sensitive, G protein-coupled receptors. Among those chemokines, the chemokine secondary lymphoid tissue chemokine (SLC/CCL21) has been demonstrated to be unique one. It has been believed SLC and its receptor CCR7 play an important role in establishing the functional micro-environment in the secondary lymphoid tissues [<xref ref-type=""bibr"" rid=""CR1"">1</xref>–<xref ref-type=""bibr"" rid=""CR12"">12</xref>]. SLC is constitutively produced by high endothelial venules and by stromal cells within T cell zones of lymphoid organs. CCR7 is present on T cell subpopulations and is up-regulated by maturing dendritic cells and helps direct the immune effector cells to secondary lymphoid organs [<xref ref-type=""bibr"" rid=""CR6"">6</xref>,<xref ref-type=""bibr"" rid=""CR13"">13</xref>,<xref ref-type=""bibr"" rid=""CR14"">14</xref>]. A spontaneous mouse line lacking SLC/CCL21 [<xref ref-type=""bibr"" rid=""CR15"">15</xref>] and CCR7 knockout mice [<xref ref-type=""bibr"" rid=""CR16"">16</xref>] show impaired homing of T cells into lymph nodes and Peyer’s patches within the small intestine. In addition to CCR7, SLC also interacts with the CXCR3 receptor, through which block angiogenesis in vivo [<xref ref-type=""bibr"" rid=""CR17"">17</xref>]. Previous work demonstrated that the chemotactic activity of SLC for DCs and T cells could be harnessed to generate antitumor immune responses [<xref ref-type=""bibr"" rid=""CR18"">18</xref>–<xref ref-type=""bibr"" rid=""CR20"">20</xref>]. Intratumoral injection of SLC-gene-modified DCs resulted in more significant tumor growth inhibition [<xref ref-type=""bibr"" rid=""CR21"">21</xref>]. It can be estimated that stronger response will be induced by attracting much larger numbers of effector T cells and APCs to the site of tumor, if a more efficient expression system established to produce SLC in tumor bed. The efficiency of an expression vector is one of the key aspects for gene therapy. Recently, it has been extensively demonstrated that recombinant adeno-associated virus (rAAV) are emerging nonpathogenic vectors with potential for cancer gene therapy. rAAV can successfully infect and transduce a broad variety of cell and tissue types, such as brain, liver, muscle, etc. [<xref ref-type=""bibr"" rid=""CR22"">22</xref>–<xref ref-type=""bibr"" rid=""CR25"">25</xref>]. Over the last several years, some in vivo studies using AAV have shown efficacious results in the treatment of multiple diseases in animal models and in human clinical trials [<xref ref-type=""bibr"" rid=""CR26"">26</xref>,<xref ref-type=""bibr"" rid=""CR27"">27</xref>].</p><p>In this study, we evaluated the potential of rAAV as a vector for in vivo SLC gene modification of tumors and tested its antitumor properties.</p></sec><sec id=""Sec2"" sec-type=""materials|methods""><title>Materials and methods</title><sec id=""Sec3""><title>Animals</title><p>C57BL/6J (H-2<sup>b</sup>), BALB/c (H-2<sup>d</sup>) and female nude mice, all 6–8 weeks of age, were purchased from Chinese Academy of Sciences and housed at the Animal Maintenance Facility of the Fudan University Shanghai Medical College.</p></sec><sec id=""Sec4""><title>Medium and chemokine</title><p>Complete medium consisted of RPMI 1640 with 10 % heat-inactivated FCS, 0.1 mM nonessential amino acids, 1 μM sodium pyruvate, 2 mM fresh<sc>l</sc>-glutamine, 100 μg/ml streptomycin, 100 units/ml penicillin, 50 μg/ml gentamicin, 0.5 μg/ml fungizone. Serum-free Opti-MEM I medium (GIBCO-BRL, Gaithersburg, Md.) Recombinant murine SLC was obtained from BIODESIGN (Saco,ME); Rat-anti-mouse SLC antibody was purchased from eBioScience company.</p></sec><sec id=""Sec5""><title>Cell lines</title><p>A mouse hepatocellular carcinoma cell line, Hepal-6 tumor cells (ATCC, catalog No: CRL-1830) were purchased from Chinese Academy of Sciences. AAV293 cells were purchased from Stratagen System Company.</p></sec><sec id=""Sec6""><title>Production and purification of rAAV-SLC</title><p>AAV Helper-Free system (Stratagene System Company, USA) was used for rAAV package. To amplify the fragments containing full coding region, the following specific primers of murine chemokine SLC was used. 5′AGC GAA TTC TAC AGC TCT GGT CTC ATC CTC A 3′ (sense), cloned into EcoR | site; 5′GCG CTC GAG GTC TCT TTT CTA GCT CCC TCT TTG 3′ (antisense), cloned into Xho | site. Total cellular RNA was extracted from lymph nodes from C57BL/6 J mice. The above fragments were amplified by RT-PCR (QIAGEN, Germany). After confirming the entire nucleotide sequence of PCR products, the EcoRI-XhoI fragment was inserted into the multiple cloning sites (MCS) of the pAAV-IRES-hrGFP vector, which contains the CMV promoter and AAV2 inverted terminal repeats (ITRs). rAAV-SLC serotype 2 vectors were prepared by using the three-plasmid cotransfection system. In addition, hrGFP expression was used to ascertain the transduction efficiency of the respective target. AAV293 cells were harvested 72 h post-transfection and lysed by repeated freezing and thawing. DNase|treatment of viral preparations was performed to digest unencapsidated DNA, and Real-time Quantitative PCR (QIAGEN) analysis was used to determine the particle genome titer.</p></sec><sec id=""Sec7""><title>Cy3-labeled viral transduction</title><p>To investigate the infectious entry pathway of rAAV-SLC and assess AAV-mediated gene transfer, purified virus was labeled with the carbocyanine dye Cy3 (Amersham, NJ, USA). Hepal-6 cells were infected with 1 × 10<sup>11</sup>particles/ml of Cy3-conjugated rAAV (~10<sup>6</sup>particles/cell) in binding buffer (DMEM containing 2 mM glucose, 10 mM HEPES [pH 7.3], and 1 % bovine serum albumin) at 37 °C unless otherwise noted. Cells were washed 3 times with binding buffer prior to infection. Prior to fixation, the binding buffer was removed and the cells were washed 3 times again. Cells were then fixed with 4 % paraformaldehyde in PBS for 15 min at room temperature and washed 3 times with PBS. Where indicated, cells were either treated for 5 min at room temperature with 1-μg/ml DAPI (Inc., Eugene, OR) in PBS with 0.1 % Triton X-100 and washed 3 times with PBS or mounted in medium containing DAPI, which was used to indicate the position of the cell nucleus. Distribution of Cy3-AAV particles in Hepal-6 cells at different time points (Control, 60 min, 2 h, 12 h, 24 h, 72 h) post infection was analyzed by confocal microscopy.</p><p>Twenty-four hours before transfection, Hepal-6 cells were plated in growth medium without antibiotics and grew to be approximately 80 % confluent. The cells were washed once with serum free Opti-MEM I medium, and incubated with 100 MOI of rAAV for different time points (control, 60 min, 2 h, 12 h, 24 h, 72 h) at 37 °C with 7 % CO2 with gentle agitation every 15 min. After infection, cells were washed three times and then cultured in complete RPMI medium until further analyses.</p></sec><sec id=""Sec8""><title>Detection of SLC produced by Hepal-6 cells infected with rAAV-SLC</title><p>SLC expression of Hepal-6 cells post-transfection was confirmed by RT-PCR and specific ELISA. Supernatants were collected from Hepal-6 cells with either rAAV-GFP or rAAV-SLC 48 h post-infection and stored in −76 °C for further use. A chemotaxis assay was used to further determine the levels and the bioactivity of SLC produced in the supernatant of SLC-modified Hepal-6 cells. Supernatants from infected cells were added to the bottom chamber of 24-well plates with 6.5-mm diameter, 5 μm pore polycarbonate Transwell insets (Corning Coster, Cambridge, MA) in duplicate samples, as the source of chemo attractant in chemotaxis assays, with T cells (10<sup>7</sup>) being performed in the upper chamber as responder cells. At the same time, recombinant mouse SLC (100 ng/ml, BIODESIGN, ME) were added to the bottom chamber as positive control. T cells were purified from normal C57BL/6J mouse spleen using mouse T cell recovery column kit (Cedarlane, Ontario, Canada) according to the instructions of the manufacturer. For determining the number of cells, 10<sup>4</sup>polystyrene beads (15-μm diameter; Bangs Laboratories, Fishers, IN) were added to the lower chamber previously. Samples were stained with antibodies against CD3 (for T cells) and counted on a FACS caliber (Becton–Dickinson, San Jose, CA). The percentage of migration in each sample (% input) was determined from numbers of the starting cells and the migrated cells by the equation: [(No cells<sup>Sample</sup>/No cells<sup>Input</sup>) × 5] × 100.</p></sec><sec id=""Sec9""><title>Tumor establishment in C57BL/6J and nude mice</title><p>Hepal-6 cells (2 × 10<sup>6</sup>cells/200 μl), infected by rAAV-SLC or rAAV-GFP virus or noninfected as mock control were injected subcutaneously (s.c.) into the right flank of 6–8-week-old C57BL/6 J and nude mice. At the same time, intra-tumor (i.t.) injection of rAAV-SLC (5 μl, 0.6<bold>×</bold>10<sup>9</sup>viral particles) into established tumors was studied. As previously indicated, the AAV viral vectors were delivered to six sites, 0.5 mm apart, along the needle track as the needle was withdrawn with a volume of ~0.8 μl at each of the six sites over 10 min. The needle was left in the tissue for an additional 5 min and then was slowly withdrawn. Developing tumors were monitored every day for 45 days. Tumors were harnessed on the day of 20 and weighed.</p></sec><sec id=""Sec10""><title>Western blot analysis for SLC expression in the tumor sites</title><p>The harnessed tumor tissues were lysed with lysis buffer (RIPA) on ice. After centrifugation at 14,000 rpm at 4 °C for 30 min, supernatants were collected and total protein concentrations were determined by BCA assay (Pierce, Rockford, IL). Equal amounts of denatured proteins were loaded onto 10 % SDS-PAGE gel and transferred on PVDF membrane (Millipore, Bedford, MA). Membranes were blocked with 5 % nonfat milk in TBST (1× TBS containing 0.1 % Tween 20), then incubated with primary antibodies to SLC and β-actin (eBioScience, San Diego, CA) overnight, After three times washing with TBST, HRP-conjugated secondary antibodies (KPL, Gaithersburg, MD) were bound and performed with chemiluminescence using SuperSignal West Pico substrate (Pierce, Rockford, IL).</p></sec><sec id=""Sec11""><title>IHC and flow cytometry analysis of tumor-infiltrating T cells and CD11c+ DCs</title><p>For analysis of cells infiltration, some tumors were harvested, removed of extraneous tissues on the day 20. Half of each tumor sample was used for OCT embedding and Serial 5 μm-thick Cryostat sections were performed by incubation with mAbs (PharMingen, San Diego, CA, USA) recognizing CD11c+ dendritic cells, CD4+Tcells, CD8+T cells as well as Foxp3+Tregs. Isotype-matched antibodies were used as a control. The remaining half was digested for 2 h at room temperature in 1 mg/ml type IV collagenase (Sigma, USA) with constant stirring. Digested tumors were passed through a 70 μm nylon mesh, washed once with HBSS, and resuspended in PBS/3 % BSA to ~1 × 10<sup>6</sup>cells/ml. Polystyrene beads (15-μm diameter) were added to the samples to achieve a concentration of 5 × 10<sup>5</sup>beads/ml. Samples were stained for the presence of FITC-conjugated CD25, PE-conjugated antibodies CD4, CD8, CD11c and Foxp3. Samples were analyzed by flow cytometry analysis with counting of 50,000 lymphocyte-sized events (based on splenocyte controls). The number of infiltrating CD4+ or CD8+cells was determined by the following equation: (No of PE-events/No of bead events) × 5 × 510<sup>5</sup>× 5 cell sample column.</p></sec><sec id=""Sec12""><title>Statistical analysis</title><p>Statistical analyses were performed with software from SPSS 10.0 for Windows, Inc. (Chicago, IL). Results were evaluated by Student’s<italic>t</italic>tests. A<italic>P</italic>value  &lt; 0.05 was taken as the level of significance.</p></sec></sec><sec id=""Sec13"" sec-type=""results""><title>Results</title><sec id=""Sec14""><title>High transduction efficiency of liver cancer cells using rAAV-SLC</title><p>AAV Help-Free System was used for the package of rAAV-SLC. Firstly, the entire nucleotide sequence of SLC was cloned into the MCS of the pAAV-IRES-hrGFP vector. Positive clones was demonstrated by restriction digestion and PCR, as shown in Fig.<xref ref-type=""fig"" rid=""Fig1"">1</xref>a–c. As followed, a new rAAV 2 encoding SLC peptide (rAAV-SLC) was successfully packaged in AAV293 cells by three-plasmids co-transfection system, as shown in Fig.<xref ref-type=""fig"" rid=""Fig1"">1</xref>d, 72 h post-transfection, the virus particles was harvested. Virus titer was 1.25 × 10<sup>11</sup>analysed by Real-time PCR, which was used to infect Hepal-6 cells later, with GFP as a marker of gene expression. Hepal-6 cells are highly susceptible to rAAV-mediated transduction. 2 h post-transfection the viral particles were observed to shift toward the nucleus and begin to accumulate at the nuclear envelope (Fig.<xref ref-type=""fig"" rid=""Fig1"">1</xref>e). 72 h post-transfection, based on the expression the marker gene GFP, it was found that about 50 % Hepal-6 tumor cells were positive in showing the transduction efficiency (Fig.<xref ref-type=""fig"" rid=""Fig1"">1</xref>f). There was no difference in transduction efficiency between the rAAV-SLC and rAAV-GFP. The control groups of single rAAV transduction have black background. The expression of SLC and its bioactivities were demonstrated in intro by ELISA and chemotaxis assay (Data not shown).<fig id=""Fig1""><label>Fig. 1</label><caption><p>rAAV-SLC was constructed and infected Hepal-6 cells at high efficiency.<bold>a</bold>The entire nucleotide sequence of SLC was cloned into the MCS of the pAAV-IRES-hrGFP vector; Positive clones were demonstrated by restriction digestion (<bold>b</bold>) and by PCR (<bold>c</bold>); (<bold>d</bold>) rAAV-SLC was packaged in AAV293 cells by using the three-plasmid co-transfection system. GFP expression was served as a useful expression marker;<bold>e</bold>distribution of Cy3-rAAV-SLC particles (<italic>red</italic>) in Hepal-6 cells 2 h post-transduction were observed to shift toward the nucleus and begin to accumulate at the nuclear envelope, detected by laser scanning confocal microscope. The position of the cell nucleus was assessed by DAPI (<italic>blue</italic>) staining. A representative image is shown, consisting of a single plane of focus through the center of a cell;<bold>f</bold>72 h post-transduction, SLC expression in Hepal-6 cells were analyzed by fluorescence microscopy for GFP detection</p></caption><graphic id=""MO1"" xlink:href=""11033_2013_2663_Fig1_HTML""></graphic></fig></p></sec><sec id=""Sec15""><title>rAAV-SLC induced a potent anti-tumor effect</title><p>The local expression of SLC in tumor sites of tumor bearing mice models were analyzed by Western-blot assay, we found the local expression of SLC in the tumors established from Hepal-6 cell lines previously transfected by rAAV-SLC. There was lower level local expression of SLC in the group of intra-tumor (i.t.) injection of rAAV-SLC into established tumors, as shown in Fig.<xref ref-type=""fig"" rid=""Fig2"">2</xref>a, b. The effect of rAAV-induced local expression SLC to enhance antitumor immune responses was subsequently tested. To elucidate in detail the mechanism of rAAV-SLC anti-tumor effect, we also examined its effect in nude mice. SLC-producing tumors showed an obviously delayed progression when compared to rAAV-GFP tumors (<italic>p</italic>&lt; 0.01). rAAV-SLC had stronger anti-tumor effect compared with i.t.rAAV-SLC treated group (<italic>p</italic>&lt; 0.05) in C57BL/6J mice. No difference was observed between GFP-expressing and normal background tumors, as shown in Fig.<xref ref-type=""fig"" rid=""Fig2"">2</xref>c, d. In parallel to reduced growth, SLC local expression was also associated with significantly improved survival as shown in Fig.<xref ref-type=""fig"" rid=""Fig2"">2</xref>e, f. The development of tumors was faster in nude mice than in C57BL/6J mice, and showed poorer survival.<fig id=""Fig2""><label>Fig. 2</label><caption><p>rAAV induced potent antitumor effect in vivo.<bold>a</bold>In C57BL/6J mice and<bold>b</bold>nude mice, the local expression of SLC in tumor sites was analyzed by Western-blot assay;<bold>c</bold>,<bold>d</bold>SLC-producing tumors showed a delayed progression and restrained in tumor weight when compared to rAAV-GFP tumors. No difference was observed between GFP-expressing and mock background tumors;<bold>e</bold>,<bold>f</bold>SLC-production was also associated with significantly improved survival. There was a worse survival in nude mice models, compared with C57BL/6J mice models.<italic>Bars</italic>SD, **<italic>p</italic>&lt; 0.01 compared with rAAV-GFP group, *<italic>p</italic>&lt; 0.05 compared with rAAV-SLC group; i.t., intra-tumor injection</p></caption><graphic id=""MO2"" xlink:href=""11033_2013_2663_Fig2_HTML""></graphic></fig></p></sec><sec id=""Sec16""><title>Local expression of SLC promoted the recruitment of T cells and DCs to the tumors in vivo</title><p>Because SLC is chemotactic for T cells and DCs, we hypothesized that SLC expressed from tumor cells would elicit migration of these cells to the tumor site. To quantify the number of infiltrating CD4+ and CD8+T cell lymphocytes as well as CD11c+DCs were determined by flow cytometry and IHC analysis. These analysis illustrated that SLC-expression induced significantly higher numbers of CD4+, CD8+T cells and CD11c+DCs recruitment when compared to control (<italic>p</italic>&lt; 0.01, as shown in Fig.<xref ref-type=""fig"" rid=""Fig3"">3</xref>). A modest increase in infiltrated immune cells was also observed in rAAV-GFP pre-infected tumors.<fig id=""Fig3""><label>Fig. 3</label><caption><p>The observed antitumor effect of rAAV-SLC was immune-mediated.<bold>a</bold>The collected cells from tumor samples were stained FITC-CD11c, FITC-CD3 together with PE-CD4 or PE-CD8 for flow cytometric evaluation. Compared to control and rAAV-GFP, significantly higher numbers of CD11c+dendritic cells, CD4+T cells and CD8+T cells infiltration in SLC-treated mice were observed.<italic>Bars</italic>SD, *<italic>p</italic>&lt; 0.05, **<italic>p</italic>&lt; 0.01; i.t., intra-tumor injection;<bold>b</bold>serial 5 μm-thick Cryostat sections of tumor samples were performed by incubation with mAbs recognizing CD11c+dendritic cells, CD4+T cells and CD8+T cells. Positive cells were detected by DAB staining</p></caption><graphic id=""MO3"" xlink:href=""11033_2013_2663_Fig3_HTML""></graphic></fig></p></sec><sec id=""Sec17""><title>Local expression of SLC also promoted higher infiltration of CD25+Foxp3+regulatory T cells (Tregs) in the tumor sites</title><p>In order to further explore the mechanism of SLC mediated anti-tumor effect, infiltrated CD25+Foxp3+Tregs in the tumor sites were also tested by<underline>FACS</underline>(Fig.<xref ref-type=""fig"" rid=""Fig4"">4</xref>a) and IHC (Fig.<xref ref-type=""fig"" rid=""Fig4"">4</xref>b). There were more infiltrated Tregs in the groups of SLC local expression (<italic>p</italic>&lt; 0.01).<fig id=""Fig4""><label>Fig. 4</label><caption><p>More Foxp3+regulatory T cells (Tregs) in the tumor sites were detected by FACS and IHC.<bold>a</bold>The collected cells from tumor samples were stained with FITC-CD25, PE-Foxp3 for flow cytometric evaluation of Tregs. Compared to control and rAAV-GFP, significantly higher numbers of Treg cells infiltration in mice with rAAV-SLC treatment.<italic>Bars</italic>SD, *<italic>p</italic>&lt; 0.05, **<italic>p</italic>&lt; 0.01; i.t., intra-tumor injection.<bold>b</bold>For IHC analysis of regulatory T cells infiltration, tumors cryostat sections were performed by incubation with mAbs recognizing Foxp3. Positive cells were detected by DAB. More Foxp3 positive cells were found in the tumor sites of mice with rAAV-SLC treatment</p></caption><graphic id=""MO4"" xlink:href=""11033_2013_2663_Fig4_HTML""></graphic></fig></p></sec></sec><sec id=""Sec18"" sec-type=""discussion""><title>Discussion</title><p>In several studies, cytokine genes have been introduced into tumor cells in an attempt to provide a microenvironment that favors innate and acquired immune mechanisms to prevent or reverse tumor development [<xref ref-type=""bibr"" rid=""CR28"">28</xref>]. In particular, chemokine gene transfer offers the possibility to trigger the recruitment of initiators or effectors of the immune response within the tumor [<xref ref-type=""bibr"" rid=""CR29"">29</xref>,<xref ref-type=""bibr"" rid=""CR30"">30</xref>]. The chemokine m6Ckine/SLC has been proposed to play a role in favoring the interactions between dendritic cells and T cells in secondary lymphoid organs, through its interaction with the CCR7 receptor [<xref ref-type=""bibr"" rid=""CR9"">9</xref>,<xref ref-type=""bibr"" rid=""CR12"">12</xref>,<xref ref-type=""bibr"" rid=""CR16"">16</xref>,<xref ref-type=""bibr"" rid=""CR31"">31</xref>–<xref ref-type=""bibr"" rid=""CR33"">33</xref>]. Previous works demonstrated that SLC chemotactic activity for DCs and T cells could be harnessed to generate antitumor immune responses [<xref ref-type=""bibr"" rid=""CR20"">20</xref>,<xref ref-type=""bibr"" rid=""CR34"">34</xref>–<xref ref-type=""bibr"" rid=""CR38"">38</xref>]. Almost all of the past reports showed that antitumor effect of SLC was mediated by greatly enhancing the tumor infiltration of mature dendritic cells and CD8+T cells [<xref ref-type=""bibr"" rid=""CR39"">39</xref>–<xref ref-type=""bibr"" rid=""CR41"">41</xref>].</p><p>We reasoned that such an activity would be additionally improved by in situ activation of recruited DCs and T cells via local expression of SLC. In this study, we applied rAAV vector to<underline>deliver</underline>SLC directly into the tumor cells for its broad host range, excellent safety profile, and the ability to integrate into the host genome as well as long-term expression in infected hosts [<xref ref-type=""bibr"" rid=""CR42"">42</xref>,<xref ref-type=""bibr"" rid=""CR43"">43</xref>]. Different from other reports [<xref ref-type=""bibr"" rid=""CR21"">21</xref>,<xref ref-type=""bibr"" rid=""CR34"">34</xref>,<xref ref-type=""bibr"" rid=""CR38"">38</xref>,<xref ref-type=""bibr"" rid=""CR44"">44</xref>], we harnessed long-term local elaboration of SLC in the tumor bed mediated by rAAV vector to detect its antitumor effect. We have shown that rAAV-SLC was more effective in generating systemic antitumor responses and was accompanied by extensive CD4+, CD8+T cells, as well as CD11c+DCs infiltrating into the tumor sites. This is consistent with previous studies. On the other hand, the results also suggest that SLC local expression in tumor bed plays another role in anti-tumor effect on destroying the solid tumor barrier by infiltrating extensive lymphocytes. The ‘barrier’ formed around solid tumors by infiltrating host stroma hinders the presentation of tumor antigens in DLNs and, in the absence of a robust co-stimulatory environment, specific T cells can remain ignorant [<xref ref-type=""bibr"" rid=""CR45"">45</xref>,<xref ref-type=""bibr"" rid=""CR46"">46</xref>]. Additional obstacles for T cell homing and expansion inside tumors may also prevent tumor eradication [<xref ref-type=""bibr"" rid=""CR47"">47</xref>]. Murine models have shown that abundant, activated, tumor antigen–specific T cells fail to reject tumors even when they can reject skin grafts or less established tumors bearing the same antigen [<xref ref-type=""bibr"" rid=""CR48"">48</xref>]. Thus, the tumor barrier may be an important contributor to the failure of tumor rejection. It is possible that the active recruitment of naïve T cells into tumors, followed by their activation through robust co-stimulation and sufficient antigen load, may overcome these obstacles in antitumor immunity.</p><p>However, we also found there was higher infiltration of Foxp3+ regulatory T cells (Tregs) mediated by rAAV-SLC treatment. It has been thoroughly demonstrated that during the tumor development, tumor microenvironment (such as the secretion of TGF-β and IL-10) can educate T cells into regulatory T cells (Treg) or more and more T cells became ignorant. Tregs are identified as a small proportion of CD4+T cells that highly express CD25 (IL-2R α-chain) on their surface and specifically express Foxp3 [<xref ref-type=""bibr"" rid=""CR49"">49</xref>–<xref ref-type=""bibr"" rid=""CR53"">53</xref>]. These CD4+CD25+Foxp3+Tregs act in a regulatory way by suppressing the activation of other T cells and control the immune responses induced by DCs in vivo [<xref ref-type=""bibr"" rid=""CR54"">54</xref>,<xref ref-type=""bibr"" rid=""CR55"">55</xref>]. It has especially been shown Tregs prevent CD8+T cell maturation by inhibiting CD4+T cells in tumor sites [<xref ref-type=""bibr"" rid=""CR56"">56</xref>]. Therefore, the infiltration of CD4+CD25+Foxp3+Tregs is a major obstacle for developing effective antitumor treatments. So in this study, the observed higher infiltration of Tregs in tumor sites played an important role in the tampered anti-tumor effect of SLC treatment. Further study is followed.</p><p>In summary, our study indicates that mouse SLC gene transferred into liver cancer cell line by rAAV has strong T cell mediated anti-tumor effects. Our work also suggests a comprehensive immune therapy strategy applicable for solid tumors based on cooperative interaction of multiple effector cell types including Tregs. This strategy may overcome functional immune impairment observed in patients with advanced malignancy.</p></sec><back><ack><p>This work has been supported by National Science Foundation of China (No. 30871312) and The National Basic Research Program of China (973 program), Grant Number 2011CB910700.</p></ack><ref-list id=""Bib1""><title>References</title><ref id=""CR1""><label>1.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Nagira</surname><given-names>M</given-names></name><name><surname>Imai</surname><given-names>T</given-names></name><name><surname>Hieshima</surname><given-names>K</given-names></name><name><surname>Kusuda</surname><given-names>J</given-names></name><name><surname>Ridanpaa</surname><given-names>M</given-names></name><name><surname>Takagi</surname><given-names>S</given-names></name><name><surname>Nishimura</surname><given-names>M</given-names></name><name><surname>Kakizaki</surname><given-names>M</given-names></name><name><surname>Nomiyama</surname><given-names>H</given-names></name><name><surname>Yoshie</surname><given-names>O</given-names></name></person-group><article-title>Molecular cloning of a novel human CC chemokine secondary lymphoid-tissue chemokine that is a potent chemoattractant for lymphocytes and mapped to chromosome 9p13</article-title><source>J Biol Chem</source><year>1997</year><volume>272</volume><fpage>19518</fpage><lpage>19524</lpage><pub-id pub-id-type=""doi"">10.1074/jbc.272.31.19518</pub-id><pub-id pub-id-type=""pmid"">9235955</pub-id></element-citation></ref><ref id=""CR2""><label>2.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Hromas</surname><given-names>R</given-names></name><name><surname>Kim</surname><given-names>CH</given-names></name><name><surname>Klemsz</surname><given-names>M</given-names></name><name><surname>Krathwohl</surname><given-names>M</given-names></name><name><surname>Fife</surname><given-names>K</given-names></name><name><surname>Cooper</surname><given-names>S</given-names></name><name><surname>Schnizlein-Bick</surname><given-names>C</given-names></name><name><surname>Broxmeyer</surname><given-names>HE</given-names></name></person-group><article-title>Isolation and characterization of Exodus-2, a novel C–C chemokine with a unique 37-amino acid carboxyl-terminal extension</article-title><source>J Immunol</source><year>1997</year><volume>159</volume><fpage>2554</fpage><lpage>2558</lpage><pub-id pub-id-type=""pmid"">9300671</pub-id></element-citation></ref><ref id=""CR3""><label>3.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Gunn</surname><given-names>MD</given-names></name><name><surname>Tangemann</surname><given-names>K</given-names></name><name><surname>Tam</surname><given-names>C</given-names></name><name><surname>Cyster</surname><given-names>JG</given-names></name><name><surname>Rosen</surname><given-names>SD</given-names></name><name><surname>Williams</surname><given-names>LT</given-names></name></person-group><article-title>A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes</article-title><source>Proc Natl Acad Sci USA</source><year>1998</year><volume>95</volume><fpage>258</fpage><lpage>263</lpage><pub-id pub-id-type=""doi"">10.1073/pnas.95.1.258</pub-id><pub-id pub-id-type=""pmid"">9419363</pub-id></element-citation></ref><ref id=""CR4""><label>4.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Yoshida</surname><given-names>R</given-names></name><name><surname>Nagira</surname><given-names>M</given-names></name><name><surname>Kitaura</surname><given-names>M</given-names></name><name><surname>Imagawa</surname><given-names>N</given-names></name><name><surname>Imai</surname><given-names>T</given-names></name><name><surname>Yoshie</surname><given-names>O</given-names></name></person-group><article-title>Secondary lymphoid-tissue chemokine is a functional ligand for the CC chemokine receptor CCR7</article-title><source>J Biol Chem</source><year>1998</year><volume>273</volume><fpage>7118</fpage><lpage>7122</lpage><pub-id pub-id-type=""doi"">10.1074/jbc.273.12.7118</pub-id><pub-id pub-id-type=""pmid"">9507024</pub-id></element-citation></ref><ref id=""CR5""><label>5.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Nagira</surname><given-names>M</given-names></name><name><surname>Imai</surname><given-names>T</given-names></name><name><surname>Yoshida</surname><given-names>R</given-names></name><name><surname>Takagi</surname><given-names>S</given-names></name><name><surname>Iwasaki</surname><given-names>M</given-names></name><name><surname>Baba</surname><given-names>M</given-names></name><name><surname>Tabira</surname><given-names>Y</given-names></name><name><surname>Akagi</surname><given-names>J</given-names></name><name><surname>Nomiyama</surname><given-names>H</given-names></name><name><surname>Yoshie</surname><given-names>O</given-names></name></person-group><article-title>A lymphocyte-specific CC chemokine, secondary lymphoid tissue chemokine (SLC), is a highly efficient chemoattractant for B cells and activated T cells</article-title><source>Eur J Immunol</source><year>1998</year><volume>28</volume><fpage>1516</fpage><lpage>1523</lpage><pub-id pub-id-type=""doi"">10.1002/(SICI)1521-4141(199805)28:05&lt;1516::AID-IMMU1516&gt;3.0.CO;2-J</pub-id><pub-id pub-id-type=""pmid"">9603456</pub-id></element-citation></ref><ref id=""CR6""><label>6.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Campbell</surname><given-names>JJ</given-names></name><name><surname>Bowman</surname><given-names>EP</given-names></name><name><surname>Murphy</surname><given-names>K</given-names></name><name><surname>Youngman</surname><given-names>KR</given-names></name><name><surname>Siani</surname><given-names>MA</given-names></name><name><surname>Thompson</surname><given-names>DA</given-names></name><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>Zlotnik</surname><given-names>A</given-names></name><name><surname>Butcher</surname><given-names>EC</given-names></name></person-group><article-title>6-C-kine (SLC), a lymphocyte adhesion-triggering chemokine expressed by high endothelium, is an agonist for the MIP-3beta receptor CCR7</article-title><source>J Cell Biol</source><year>1998</year><volume>141</volume><fpage>1053</fpage><lpage>1059</lpage><pub-id pub-id-type=""doi"">10.1083/jcb.141.4.1053</pub-id><pub-id pub-id-type=""pmid"">9585422</pub-id></element-citation></ref><ref id=""CR7""><label>7.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Willimann</surname><given-names>K</given-names></name><name><surname>Legler</surname><given-names>DF</given-names></name><name><surname>Loetscher</surname><given-names>M</given-names></name><name><surname>Roos</surname><given-names>RS</given-names></name><name><surname>Delgado</surname><given-names>MB</given-names></name><name><surname>Clark-Lewis</surname><given-names>I</given-names></name><name><surname>Baggiolini</surname><given-names>M</given-names></name><name><surname>Moser</surname><given-names>B</given-names></name></person-group><article-title>The chemokine SLC is expressed in T cell areas of lymph nodes and mucosal lymphoid tissues and attracts activated T cells via CCR7</article-title><source>Eur J Immunol</source><year>1998</year><volume>28</volume><fpage>2025</fpage><lpage>2034</lpage><pub-id pub-id-type=""doi"">10.1002/(SICI)1521-4141(199806)28:06&lt;2025::AID-IMMU2025&gt;3.0.CO;2-C</pub-id><pub-id pub-id-type=""pmid"">9645384</pub-id></element-citation></ref><ref id=""CR8""><label>8.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Pachynski</surname><given-names>RK</given-names></name><name><surname>Wu</surname><given-names>SW</given-names></name><name><surname>Gunn</surname><given-names>MD</given-names></name><name><surname>Erle</surname><given-names>DJ</given-names></name></person-group><article-title>Secondary lymphoid-tissue chemokine (SLC) stimulates integrin alpha 4 beta 7-mediated adhesion of lymphocytes to mucosal addressin cell adhesion molecule-1 (MAdCAM-1) under flow</article-title><source>J Immunol</source><year>1998</year><volume>161</volume><fpage>952</fpage><lpage>956</lpage><pub-id pub-id-type=""pmid"">9670974</pub-id></element-citation></ref><ref id=""CR9""><label>9.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Gunn</surname><given-names>MD</given-names></name><name><surname>Kyuwa</surname><given-names>S</given-names></name><name><surname>Tam</surname><given-names>C</given-names></name><name><surname>Kakiuchi</surname><given-names>T</given-names></name><name><surname>Matsuzawa</surname><given-names>A</given-names></name><name><surname>Williams</surname><given-names>LT</given-names></name><name><surname>Nakano</surname><given-names>H</given-names></name></person-group><article-title>Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization</article-title><source>J Exp Med</source><year>1999</year><volume>189</volume><fpage>451</fpage><lpage>460</lpage><pub-id pub-id-type=""doi"">10.1084/jem.189.3.451</pub-id><pub-id pub-id-type=""pmid"">9927507</pub-id></element-citation></ref><ref id=""CR10""><label>10.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Kim</surname><given-names>CH</given-names></name><name><surname>Pelus</surname><given-names>LM</given-names></name><name><surname>Appelbaum</surname><given-names>E</given-names></name><name><surname>Johanson</surname><given-names>K</given-names></name><name><surname>Anzai</surname><given-names>N</given-names></name><name><surname>Broxmeyer</surname><given-names>HE</given-names></name></person-group><article-title>CCR7 ligands, SLC/6Ckine/Exodus2/TCA4 and CKbeta-11/MIP-3beta/ELC, are chemoattractants for CD56(+)CD16(−) NK cells and late stage lymphoid progenitors</article-title><source>Cell Immunol</source><year>1999</year><volume>193</volume><fpage>226</fpage><lpage>235</lpage><pub-id pub-id-type=""doi"">10.1006/cimm.1999.1483</pub-id><pub-id pub-id-type=""pmid"">10222066</pub-id></element-citation></ref><ref id=""CR11""><label>11.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Chan</surname><given-names>VW</given-names></name><name><surname>Kothakota</surname><given-names>S</given-names></name><name><surname>Rohan</surname><given-names>MC</given-names></name><name><surname>Panganiban-Lustan</surname><given-names>L</given-names></name><name><surname>Gardner</surname><given-names>JP</given-names></name><name><surname>Wachowicz</surname><given-names>MS</given-names></name><name><surname>Winter</surname><given-names>JA</given-names></name><name><surname>Williams</surname><given-names>LT</given-names></name></person-group><article-title>Secondary lymphoid-tissue chemokine (SLC) is chemotactic for mature dendritic cells</article-title><source>Blood</source><year>1999</year><volume>93</volume><fpage>3610</fpage><lpage>3616</lpage><pub-id pub-id-type=""pmid"">10339465</pub-id></element-citation></ref><ref id=""CR12""><label>12.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Stein</surname><given-names>JV</given-names></name><name><surname>Soriano</surname><given-names>SF</given-names></name><name><surname>M’Rini</surname><given-names>C</given-names></name><name><surname>Nombela-Arrieta</surname><given-names>C</given-names></name><name><surname>de Buitrago</surname><given-names>GG</given-names></name><name><surname>Rodriguez-Frade</surname><given-names>JM</given-names></name><name><surname>Mellado</surname><given-names>M</given-names></name><name><surname>Girard</surname><given-names>JP</given-names></name><name><surname>Martinez</surname><given-names>AC</given-names></name></person-group><article-title>CCR7-mediated physiological lymphocyte homing involves activation of a tyrosine kinase pathway</article-title><source>Blood</source><year>2003</year><volume>101</volume><fpage>38</fpage><lpage>44</lpage><pub-id pub-id-type=""doi"">10.1182/blood-2002-03-0841</pub-id><pub-id pub-id-type=""pmid"">12393730</pub-id></element-citation></ref><ref id=""CR13""><label>13.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Kellermann</surname><given-names>SA</given-names></name><name><surname>Hudak</surname><given-names>S</given-names></name><name><surname>Oldham</surname><given-names>ER</given-names></name><name><surname>Liu</surname><given-names>YJ</given-names></name><name><surname>McEvoy</surname><given-names>LM</given-names></name></person-group><article-title>The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3 beta are potent chemoattractants for in vitro- and in vivo-derived dendritic cells</article-title><source>J Immunol</source><year>1999</year><volume>162</volume><fpage>3859</fpage><lpage>3864</lpage><pub-id pub-id-type=""pmid"">10201903</pub-id></element-citation></ref><ref id=""CR14""><label>14.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Ueno</surname><given-names>T</given-names></name><name><surname>Hara</surname><given-names>K</given-names></name><name><surname>Willis</surname><given-names>MS</given-names></name><name><surname>Malin</surname><given-names>MA</given-names></name><name><surname>Hopken</surname><given-names>UE</given-names></name><name><surname>Gray</surname><given-names>DH</given-names></name><name><surname>Matsushima</surname><given-names>K</given-names></name><name><surname>Lipp</surname><given-names>M</given-names></name><name><surname>Springer</surname><given-names>TA</given-names></name><name><surname>Boyd</surname><given-names>RL</given-names></name><name><surname>Yoshie</surname><given-names>O</given-names></name><name><surname>Takahama</surname><given-names>Y</given-names></name></person-group><article-title>Role for CCR7 ligands in the emigration of newly generated T lymphocytes from the neonatal thymus</article-title><source>Immunity</source><year>2002</year><volume>16</volume><fpage>205</fpage><lpage>218</lpage><pub-id pub-id-type=""doi"">10.1016/S1074-7613(02)00267-4</pub-id><pub-id pub-id-type=""pmid"">11869682</pub-id></element-citation></ref><ref id=""CR15""><label>15.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Mori</surname><given-names>S</given-names></name><name><surname>Nakano</surname><given-names>H</given-names></name><name><surname>Aritomi</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>CR</given-names></name><name><surname>Gunn</surname><given-names>MD</given-names></name><name><surname>Kakiuchi</surname><given-names>T</given-names></name></person-group><article-title>Mice lacking expression of the chemokines CCL21-ser and CCL19 (plt mice) demonstrate delayed but enhanced T cell immune responses</article-title><source>J Exp Med</source><year>2001</year><volume>193</volume><fpage>207</fpage><lpage>218</lpage><pub-id pub-id-type=""doi"">10.1084/jem.193.2.207</pub-id><pub-id pub-id-type=""pmid"">11148224</pub-id></element-citation></ref><ref id=""CR16""><label>16.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Forster</surname><given-names>R</given-names></name><name><surname>Schubel</surname><given-names>A</given-names></name><name><surname>Breitfeld</surname><given-names>D</given-names></name><name><surname>Kremmer</surname><given-names>E</given-names></name><name><surname>Renner-Muller</surname><given-names>I</given-names></name><name><surname>Wolf</surname><given-names>E</given-names></name><name><surname>Lipp</surname><given-names>M</given-names></name></person-group><article-title>CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs</article-title><source>Cell</source><year>1999</year><volume>99</volume><fpage>23</fpage><lpage>33</lpage><pub-id pub-id-type=""doi"">10.1016/S0092-8674(00)80059-8</pub-id><pub-id pub-id-type=""pmid"">10520991</pub-id></element-citation></ref><ref id=""CR17""><label>17.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Soto</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Strieter</surname><given-names>RM</given-names></name><name><surname>Copeland</surname><given-names>NG</given-names></name><name><surname>Gilbert</surname><given-names>DJ</given-names></name><name><surname>Jenkins</surname><given-names>NA</given-names></name><name><surname>Hedrick</surname><given-names>J</given-names></name><name><surname>Zlotnik</surname><given-names>A</given-names></name></person-group><article-title>The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3</article-title><source>Proc Natl Acad Sci USA</source><year>1998</year><volume>95</volume><fpage>8205</fpage><lpage>8210</lpage><pub-id pub-id-type=""doi"">10.1073/pnas.95.14.8205</pub-id><pub-id pub-id-type=""pmid"">9653165</pub-id></element-citation></ref><ref id=""CR18""><label>18.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Warren</surname><given-names>P</given-names></name><name><surname>Song</surname><given-names>W</given-names></name><name><surname>Holle</surname><given-names>E</given-names></name><name><surname>Holmes</surname><given-names>L</given-names></name><name><surname>Wei</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Wagner</surname><given-names>T</given-names></name><name><surname>Yu</surname><given-names>X</given-names></name></person-group><article-title>Combined HSV-TK/GCV and secondary lymphoid tissue chemokine gene therapy inhibits tumor growth and elicits potent antitumor CTL response in tumor-bearing mice</article-title><source>Anticancer Res</source><year>2002</year><volume>22</volume><fpage>599</fpage><lpage>604</lpage><pub-id pub-id-type=""pmid"">12014627</pub-id></element-citation></ref><ref id=""CR19""><label>19.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Sharma</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>SC</given-names></name><name><surname>Hillinger</surname><given-names>S</given-names></name><name><surname>Zhu</surname><given-names>LX</given-names></name><name><surname>Huang</surname><given-names>M</given-names></name><name><surname>Batra</surname><given-names>RK</given-names></name><name><surname>Lin</surname><given-names>JF</given-names></name><name><surname>Burdick</surname><given-names>MD</given-names></name><name><surname>Strieter</surname><given-names>RM</given-names></name><name><surname>Dubinett</surname><given-names>SM</given-names></name></person-group><article-title>SLC/CCL21-mediated anti-tumor responses require IFNgamma, MIG/CXCL9 and IP-10/CXCL10</article-title><source>Mol Cancer</source><year>2003</year><volume>2</volume><fpage>22</fpage><pub-id pub-id-type=""doi"">10.1186/1476-4598-2-22</pub-id><pub-id pub-id-type=""pmid"">12740040</pub-id></element-citation></ref><ref id=""CR20""><label>20.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Tolba</surname><given-names>KA</given-names></name><name><surname>Bowers</surname><given-names>WJ</given-names></name><name><surname>Muller</surname><given-names>J</given-names></name><name><surname>Housekneckt</surname><given-names>V</given-names></name><name><surname>Giuliano</surname><given-names>RE</given-names></name><name><surname>Federoff</surname><given-names>HJ</given-names></name><name><surname>Rosenblatt</surname><given-names>JD</given-names></name></person-group><article-title>Herpes simplex virus (HSV) amplicon-mediated codelivery of secondary lymphoid tissue chemokine and CD40L results in augmented antitumor activity</article-title><source>Cancer Res</source><year>2002</year><volume>62</volume><fpage>6545</fpage><lpage>6551</lpage><pub-id pub-id-type=""pmid"">12438249</pub-id></element-citation></ref><ref id=""CR21""><label>21.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Yang</surname><given-names>SC</given-names></name><name><surname>Hillinger</surname><given-names>S</given-names></name><name><surname>Riedl</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Zhu</surname><given-names>L</given-names></name><name><surname>Huang</surname><given-names>M</given-names></name><name><surname>Atianzar</surname><given-names>K</given-names></name><name><surname>Kuo</surname><given-names>BY</given-names></name><name><surname>Gardner</surname><given-names>B</given-names></name><name><surname>Batra</surname><given-names>RK</given-names></name><name><surname>Strieter</surname><given-names>RM</given-names></name><name><surname>Dubinett</surname><given-names>SM</given-names></name><name><surname>Sharma</surname><given-names>S</given-names></name></person-group><article-title>Intratumoral administration of dendritic cells overexpressing CCL21 generates systemic antitumor responses and confers tumor immunity</article-title><source>Clin Cancer Res</source><year>2004</year><volume>10</volume><fpage>2891</fpage><lpage>2901</lpage><pub-id pub-id-type=""doi"">10.1158/1078-0432.CCR-03-0380</pub-id><pub-id pub-id-type=""pmid"">15102698</pub-id></element-citation></ref><ref id=""CR22""><label>22.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>During</surname><given-names>MJ</given-names></name><name><surname>Samulski</surname><given-names>RJ</given-names></name><name><surname>Elsworth</surname><given-names>JD</given-names></name><name><surname>Kaplitt</surname><given-names>MG</given-names></name><name><surname>Leone</surname><given-names>P</given-names></name><name><surname>Xiao</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Freese</surname><given-names>A</given-names></name><name><surname>Taylor</surname><given-names>JR</given-names></name><name><surname>Roth</surname><given-names>RH</given-names></name><name><surname>Sladek</surname><given-names>JR</given-names><suffix>Jr</suffix></name><name><surname>O’Malley</surname><given-names>KL</given-names></name><name><surname>Redmond</surname><given-names>DE</given-names><suffix>Jr</suffix></name></person-group><article-title>In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector</article-title><source>Gene Ther</source><year>1998</year><volume>5</volume><fpage>820</fpage><lpage>827</lpage><pub-id pub-id-type=""doi"">10.1038/sj.gt.3300650</pub-id><pub-id pub-id-type=""pmid"">9747462</pub-id></element-citation></ref><ref id=""CR23""><label>23.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Bjorklund</surname><given-names>A</given-names></name><name><surname>Kirik</surname><given-names>D</given-names></name><name><surname>Rosenblad</surname><given-names>C</given-names></name><name><surname>Georgievska</surname><given-names>B</given-names></name><name><surname>Lundberg</surname><given-names>C</given-names></name><name><surname>Mandel</surname><given-names>RJ</given-names></name></person-group><article-title>Towards a neuroprotective gene therapy for Parkinson’s disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model</article-title><source>Brain Res</source><year>2000</year><volume>886</volume><fpage>82</fpage><lpage>98</lpage><pub-id pub-id-type=""doi"">10.1016/S0006-8993(00)02915-2</pub-id><pub-id pub-id-type=""pmid"">11119690</pub-id></element-citation></ref><ref id=""CR24""><label>24.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Kessler</surname><given-names>PD</given-names></name><name><surname>Podsakoff</surname><given-names>GM</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>McQuiston</surname><given-names>SA</given-names></name><name><surname>Colosi</surname><given-names>PC</given-names></name><name><surname>Matelis</surname><given-names>LA</given-names></name><name><surname>Kurtzman</surname><given-names>GJ</given-names></name><name><surname>Byrne</surname><given-names>BJ</given-names></name></person-group><article-title>Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein</article-title><source>Proc Natl Acad Sci USA</source><year>1996</year><volume>93</volume><fpage>14082</fpage><lpage>14087</lpage><pub-id pub-id-type=""doi"">10.1073/pnas.93.24.14082</pub-id><pub-id pub-id-type=""pmid"">8943064</pub-id></element-citation></ref><ref id=""CR25""><label>25.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Xu</surname><given-names>R</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Tse</surname><given-names>LY</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Chan</surname><given-names>PC</given-names></name><name><surname>Xu</surname><given-names>S</given-names></name><name><surname>Xiao</surname><given-names>W</given-names></name><name><surname>Kung</surname><given-names>HF</given-names></name><name><surname>Krissansen</surname><given-names>GW</given-names></name><name><surname>Fan</surname><given-names>ST</given-names></name></person-group><article-title>Long-term expression of angiostatin suppresses metastatic liver cancer in mice</article-title><source>Hepatology</source><year>2003</year><volume>37</volume><fpage>1451</fpage><lpage>1460</lpage><pub-id pub-id-type=""doi"">10.1053/jhep.2003.50244</pub-id><pub-id pub-id-type=""pmid"">12774025</pub-id></element-citation></ref><ref id=""CR26""><label>26.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Lee</surname><given-names>HC</given-names></name><name><surname>Kim</surname><given-names>SJ</given-names></name><name><surname>Kim</surname><given-names>KS</given-names></name><name><surname>Shin</surname><given-names>HC</given-names></name><name><surname>Yoon</surname><given-names>JW</given-names></name></person-group><article-title>Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue</article-title><source>Nature</source><year>2000</year><volume>408</volume><fpage>483</fpage><lpage>488</lpage><pub-id pub-id-type=""doi"">10.1038/35044106</pub-id><pub-id pub-id-type=""pmid"">11100731</pub-id></element-citation></ref><ref id=""CR27""><label>27.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Su</surname><given-names>H</given-names></name><name><surname>Joho</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Barcena</surname><given-names>A</given-names></name><name><surname>Arakawa-Hoyt</surname><given-names>J</given-names></name><name><surname>Grossman</surname><given-names>W</given-names></name><name><surname>Kan</surname><given-names>YW</given-names></name></person-group><article-title>Adeno-associated viral vector delivers cardiac-specific and hypoxia-inducible VEGF expression in ischemic mouse hearts</article-title><source>Proc Natl Acad Sci USA</source><year>2004</year><volume>101</volume><fpage>16280</fpage><lpage>16285</lpage><pub-id pub-id-type=""doi"">10.1073/pnas.0407449101</pub-id><pub-id pub-id-type=""pmid"">15534198</pub-id></element-citation></ref><ref id=""CR28""><label>28.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Lollini</surname><given-names>PL</given-names></name><name><surname>Forni</surname><given-names>G</given-names></name></person-group><article-title>Specific and nonspecific immunity in the prevention of spontaneous tumours</article-title><source>Immunol Today</source><year>1999</year><volume>20</volume><fpage>347</fpage><lpage>350</lpage><pub-id pub-id-type=""doi"">10.1016/S0167-5699(99)01450-4</pub-id><pub-id pub-id-type=""pmid"">10431153</pub-id></element-citation></ref><ref id=""CR29""><label>29.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Mule</surname><given-names>JJ</given-names></name><name><surname>Custer</surname><given-names>M</given-names></name><name><surname>Averbook</surname><given-names>B</given-names></name><name><surname>Yang</surname><given-names>JC</given-names></name><name><surname>Weber</surname><given-names>JS</given-names></name><name><surname>Goeddel</surname><given-names>DV</given-names></name><name><surname>Rosenberg</surname><given-names>SA</given-names></name><name><surname>Schall</surname><given-names>TJ</given-names></name></person-group><article-title>RANTES secretion by gene-modified tumor cells results in loss of tumorigenicity in vivo: role of immune cell subpopulations</article-title><source>Hum Gene Ther</source><year>1996</year><volume>7</volume><fpage>1545</fpage><lpage>1553</lpage><pub-id pub-id-type=""doi"">10.1089/hum.1996.7.13-1545</pub-id><pub-id pub-id-type=""pmid"">8864755</pub-id></element-citation></ref><ref id=""CR30""><label>30.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Dilloo</surname><given-names>D</given-names></name><name><surname>Bacon</surname><given-names>K</given-names></name><name><surname>Holden</surname><given-names>W</given-names></name><name><surname>Zhong</surname><given-names>W</given-names></name><name><surname>Burdach</surname><given-names>S</given-names></name><name><surname>Zlotnik</surname><given-names>A</given-names></name><name><surname>Brenner</surname><given-names>M</given-names></name></person-group><article-title>Combined chemokine and cytokine gene transfer enhances antitumor immunity</article-title><source>Nat Med</source><year>1996</year><volume>2</volume><fpage>1090</fpage><lpage>1095</lpage><pub-id pub-id-type=""doi"">10.1038/nm1096-1090</pub-id><pub-id pub-id-type=""pmid"">8837606</pub-id></element-citation></ref><ref id=""CR31""><label>31.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Ploix</surname><given-names>C</given-names></name><name><surname>Lo</surname><given-names>D</given-names></name><name><surname>Carson</surname><given-names>MJ</given-names></name></person-group><article-title>A ligand for the chemokine receptor CCR7 can influence the homeostatic proliferation of CD4 T cells and progression of autoimmunity</article-title><source>J Immunol</source><year>2001</year><volume>167</volume><fpage>6724</fpage><lpage>6730</lpage><pub-id pub-id-type=""pmid"">11739486</pub-id></element-citation></ref><ref id=""CR32""><label>32.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Banas</surname><given-names>B</given-names></name><name><surname>Wornle</surname><given-names>M</given-names></name><name><surname>Berger</surname><given-names>T</given-names></name><name><surname>Nelson</surname><given-names>PJ</given-names></name><name><surname>Cohen</surname><given-names>CD</given-names></name><name><surname>Kretzler</surname><given-names>M</given-names></name><name><surname>Pfirstinger</surname><given-names>J</given-names></name><name><surname>Mack</surname><given-names>M</given-names></name><name><surname>Lipp</surname><given-names>M</given-names></name><name><surname>Grone</surname><given-names>HJ</given-names></name><name><surname>Schlondorff</surname><given-names>D</given-names></name></person-group><article-title>Roles of SLC/CCL21 and CCR7 in human kidney for mesangial proliferation, migration, apoptosis, and tissue homeostasis</article-title><source>J Immunol</source><year>2002</year><volume>168</volume><fpage>4301</fpage><lpage>4307</lpage><pub-id pub-id-type=""pmid"">11970971</pub-id></element-citation></ref><ref id=""CR33""><label>33.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Jang</surname><given-names>MH</given-names></name><name><surname>Sougawa</surname><given-names>N</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Hirata</surname><given-names>T</given-names></name><name><surname>Hiroi</surname><given-names>T</given-names></name><name><surname>Tohya</surname><given-names>K</given-names></name><name><surname>Guo</surname><given-names>Z</given-names></name><name><surname>Umemoto</surname><given-names>E</given-names></name><name><surname>Ebisuno</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>BG</given-names></name><name><surname>Seoh</surname><given-names>JY</given-names></name><name><surname>Lipp</surname><given-names>M</given-names></name><name><surname>Kiyono</surname><given-names>H</given-names></name><name><surname>Miyasaka</surname><given-names>M</given-names></name></person-group><article-title>CCR7 is critically important for migration of dendritic cells in intestinal lamina propria to mesenteric lymph nodes</article-title><source>J Immunol</source><year>2006</year><volume>176</volume><fpage>803</fpage><lpage>810</lpage><pub-id pub-id-type=""pmid"">16393963</pub-id></element-citation></ref><ref id=""CR34""><label>34.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Sharma</surname><given-names>S</given-names></name><name><surname>Stolina</surname><given-names>M</given-names></name><name><surname>Luo</surname><given-names>J</given-names></name><name><surname>Strieter</surname><given-names>RM</given-names></name><name><surname>Burdick</surname><given-names>M</given-names></name><name><surname>Zhu</surname><given-names>LX</given-names></name><name><surname>Batra</surname><given-names>RK</given-names></name><name><surname>Dubinett</surname><given-names>SM</given-names></name></person-group><article-title>Secondary lymphoid tissue chemokine mediates T cell-dependent antitumor responses in vivo</article-title><source>J Immunol</source><year>2000</year><volume>164</volume><fpage>4558</fpage><lpage>4563</lpage><pub-id pub-id-type=""pmid"">10779757</pub-id></element-citation></ref><ref id=""CR35""><label>35.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Vicari</surname><given-names>AP</given-names></name><name><surname>Ait-Yahia</surname><given-names>S</given-names></name><name><surname>Chemin</surname><given-names>K</given-names></name><name><surname>Mueller</surname><given-names>A</given-names></name><name><surname>Zlotnik</surname><given-names>A</given-names></name><name><surname>Caux</surname><given-names>C</given-names></name></person-group><article-title>Antitumor effects of the mouse chemokine 6Ckine/SLC through angiostatic and immunological mechanisms</article-title><source>J Immunol</source><year>2000</year><volume>165</volume><fpage>1992</fpage><lpage>2000</lpage><pub-id pub-id-type=""pmid"">10925282</pub-id></element-citation></ref><ref id=""CR36""><label>36.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Kirk</surname><given-names>CJ</given-names></name><name><surname>Hartigan-O’Connor</surname><given-names>D</given-names></name><name><surname>Nickoloff</surname><given-names>BJ</given-names></name><name><surname>Chamberlain</surname><given-names>JS</given-names></name><name><surname>Giedlin</surname><given-names>M</given-names></name><name><surname>Aukerman</surname><given-names>L</given-names></name><name><surname>Mule</surname><given-names>JJ</given-names></name></person-group><article-title>T cell-dependent antitumor immunity mediated by secondary lymphoid tissue chemokine: augmentation of dendritic cell-based immunotherapy</article-title><source>Cancer Res</source><year>2001</year><volume>61</volume><fpage>2062</fpage><lpage>2070</lpage><pub-id pub-id-type=""pmid"">11280767</pub-id></element-citation></ref><ref id=""CR37""><label>37.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Nomura</surname><given-names>T</given-names></name><name><surname>Hasegawa</surname><given-names>H</given-names></name><name><surname>Kohno</surname><given-names>M</given-names></name><name><surname>Sasaki</surname><given-names>M</given-names></name><name><surname>Fujita</surname><given-names>S</given-names></name></person-group><article-title>Enhancement of anti-tumor immunity by tumor cells transfected with the secondary lymphoid tissue chemokine EBI-1-ligand chemokine and stromal cell-derived factor-1alpha chemokine genes</article-title><source>Int J Cancer</source><year>2001</year><volume>91</volume><fpage>597</fpage><lpage>606</lpage><pub-id pub-id-type=""doi"">10.1002/1097-0215(200002)9999:9999&lt;::AID-IJC1107&gt;3.0.CO;2-J</pub-id><pub-id pub-id-type=""pmid"">11267967</pub-id></element-citation></ref><ref id=""CR38""><label>38.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Sharma</surname><given-names>S</given-names></name><name><surname>Stolina</surname><given-names>M</given-names></name><name><surname>Zhu</surname><given-names>L</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Batra</surname><given-names>R</given-names></name><name><surname>Huang</surname><given-names>M</given-names></name><name><surname>Strieter</surname><given-names>R</given-names></name><name><surname>Dubinett</surname><given-names>SM</given-names></name></person-group><article-title>Secondary lymphoid organ chemokine reduces pulmonary tumor burden in spontaneous murine bronchoalveolar cell carcinoma</article-title><source>Cancer Res</source><year>2001</year><volume>61</volume><fpage>6406</fpage><lpage>6412</lpage><pub-id pub-id-type=""pmid"">11522634</pub-id></element-citation></ref><ref id=""CR39""><label>39.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Flanagan</surname><given-names>K</given-names></name><name><surname>Moroziewicz</surname><given-names>D</given-names></name><name><surname>Kwak</surname><given-names>H</given-names></name><name><surname>Horig</surname><given-names>H</given-names></name><name><surname>Kaufman</surname><given-names>HL</given-names></name></person-group><article-title>The lymphoid chemokine CCL21 costimulates naive T cell expansion and Th1 polarization of non-regulatory CD4+T cells</article-title><source>Cell Immunol</source><year>2004</year><volume>231</volume><fpage>75</fpage><lpage>84</lpage><pub-id pub-id-type=""doi"">10.1016/j.cellimm.2004.12.006</pub-id><pub-id pub-id-type=""pmid"">15919372</pub-id></element-citation></ref><ref id=""CR40""><label>40.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Yamano</surname><given-names>T</given-names></name><name><surname>Kaneda</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>S</given-names></name><name><surname>Hiramatsu</surname><given-names>SH</given-names></name><name><surname>Hoon</surname><given-names>DS</given-names></name></person-group><article-title>Enhancement of immunity by a DNA melanoma vaccine against TRP2 with CCL21 as an adjuvant</article-title><source>Mol Ther</source><year>2006</year><volume>13</volume><fpage>194</fpage><lpage>202</lpage><pub-id pub-id-type=""doi"">10.1016/j.ymthe.2005.05.018</pub-id><pub-id pub-id-type=""pmid"">16112911</pub-id></element-citation></ref><ref id=""CR41""><label>41.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Hisada</surname><given-names>M</given-names></name><name><surname>Yoshimoto</surname><given-names>T</given-names></name><name><surname>Kamiya</surname><given-names>S</given-names></name><name><surname>Magami</surname><given-names>Y</given-names></name><name><surname>Miyaji</surname><given-names>H</given-names></name><name><surname>Yoneto</surname><given-names>T</given-names></name><name><surname>Tamada</surname><given-names>K</given-names></name><name><surname>Aoki</surname><given-names>T</given-names></name><name><surname>Koyanagi</surname><given-names>Y</given-names></name><name><surname>Mizuguchi</surname><given-names>J</given-names></name></person-group><article-title>Synergistic antitumor effect by coexpression of chemokine CCL21/SLC and costimulatory molecule LIGHT</article-title><source>Cancer Gene Ther</source><year>2004</year><volume>11</volume><fpage>280</fpage><lpage>288</lpage><pub-id pub-id-type=""doi"">10.1038/sj.cgt.7700676</pub-id><pub-id pub-id-type=""pmid"">15002032</pub-id></element-citation></ref><ref id=""CR42""><label>42.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Kaplitt</surname><given-names>MG</given-names></name><name><surname>Leone</surname><given-names>P</given-names></name><name><surname>Samulski</surname><given-names>RJ</given-names></name><name><surname>Xiao</surname><given-names>X</given-names></name><name><surname>Pfaff</surname><given-names>DW</given-names></name><name><surname>O’Malley</surname><given-names>KL</given-names></name><name><surname>During</surname><given-names>MJ</given-names></name></person-group><article-title>Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain</article-title><source>Nat Genet</source><year>1994</year><volume>8</volume><fpage>148</fpage><lpage>154</lpage><pub-id pub-id-type=""doi"">10.1038/ng1094-148</pub-id><pub-id pub-id-type=""pmid"">7842013</pub-id></element-citation></ref><ref id=""CR43""><label>43.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>CL</given-names></name><name><surname>Qian</surname><given-names>JQ</given-names></name><name><surname>Yan</surname><given-names>JT</given-names></name><name><surname>Cianflone</surname><given-names>K</given-names></name><name><surname>Xiao</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>DW</given-names></name></person-group><article-title>Long-term modifications of blood pressure in normotensive and spontaneously hypertensive rats by gene delivery of rAAV-mediated cytochrome P450 arachidonic acid hydroxylase</article-title><source>Cell Res</source><year>2005</year><volume>15</volume><fpage>717</fpage><lpage>724</lpage><pub-id pub-id-type=""doi"">10.1038/sj.cr.7290341</pub-id><pub-id pub-id-type=""pmid"">16212878</pub-id></element-citation></ref><ref id=""CR44""><label>44.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Yang</surname><given-names>SC</given-names></name><name><surname>Batra</surname><given-names>RK</given-names></name><name><surname>Hillinger</surname><given-names>S</given-names></name><name><surname>Reckamp</surname><given-names>KL</given-names></name><name><surname>Strieter</surname><given-names>RM</given-names></name><name><surname>Dubinett</surname><given-names>SM</given-names></name><name><surname>Sharma</surname><given-names>S</given-names></name></person-group><article-title>Intrapulmonary administration of CCL21 gene-modified dendritic cells reduces tumor burden in spontaneous murine bronchoalveolar cell carcinoma</article-title><source>Cancer Res</source><year>2006</year><volume>66</volume><fpage>3205</fpage><lpage>3213</lpage><pub-id pub-id-type=""doi"">10.1158/0008-5472.CAN-05-3619</pub-id><pub-id pub-id-type=""pmid"">16540672</pub-id></element-citation></ref><ref id=""CR45""><label>45.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Ochsenbein</surname><given-names>AF</given-names></name><name><surname>Klenerman</surname><given-names>P</given-names></name><name><surname>Karrer</surname><given-names>U</given-names></name><name><surname>Ludewig</surname><given-names>B</given-names></name><name><surname>Pericin</surname><given-names>M</given-names></name><name><surname>Hengartner</surname><given-names>H</given-names></name><name><surname>Zinkernagel</surname><given-names>RM</given-names></name></person-group><article-title>Immune surveillance against a solid tumor fails because of immunological ignorance</article-title><source>Proc Natl Acad Sci USA</source><year>1999</year><volume>96</volume><fpage>2233</fpage><lpage>2238</lpage><pub-id pub-id-type=""doi"">10.1073/pnas.96.5.2233</pub-id><pub-id pub-id-type=""pmid"">10051624</pub-id></element-citation></ref><ref id=""CR46""><label>46.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Ochsenbein</surname><given-names>AF</given-names></name><name><surname>Sierro</surname><given-names>S</given-names></name><name><surname>Odermatt</surname><given-names>B</given-names></name><name><surname>Pericin</surname><given-names>M</given-names></name><name><surname>Karrer</surname><given-names>U</given-names></name><name><surname>Hermans</surname><given-names>J</given-names></name><name><surname>Hemmi</surname><given-names>S</given-names></name><name><surname>Hengartner</surname><given-names>H</given-names></name><name><surname>Zinkernagel</surname><given-names>RM</given-names></name></person-group><article-title>Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction</article-title><source>Nature</source><year>2001</year><volume>411</volume><fpage>1058</fpage><lpage>1064</lpage><pub-id pub-id-type=""doi"">10.1038/35082583</pub-id><pub-id pub-id-type=""pmid"">11429607</pub-id></element-citation></ref><ref id=""CR47""><label>47.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Wick</surname><given-names>M</given-names></name><name><surname>Dubey</surname><given-names>P</given-names></name><name><surname>Koeppen</surname><given-names>H</given-names></name><name><surname>Siegel</surname><given-names>CT</given-names></name><name><surname>Fields</surname><given-names>PE</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Bluestone</surname><given-names>JA</given-names></name><name><surname>Schreiber</surname><given-names>H</given-names></name></person-group><article-title>Antigenic cancer cells grow progressively in immune hosts without evidence for T cell exhaustion or systemic anergy</article-title><source>J Exp Med</source><year>1997</year><volume>186</volume><fpage>229</fpage><lpage>238</lpage><pub-id pub-id-type=""doi"">10.1084/jem.186.2.229</pub-id><pub-id pub-id-type=""pmid"">9221752</pub-id></element-citation></ref><ref id=""CR48""><label>48.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Hanson</surname><given-names>HL</given-names></name><name><surname>Donermeyer</surname><given-names>DL</given-names></name><name><surname>Ikeda</surname><given-names>H</given-names></name><name><surname>White</surname><given-names>JM</given-names></name><name><surname>Shankaran</surname><given-names>V</given-names></name><name><surname>Old</surname><given-names>LJ</given-names></name><name><surname>Shiku</surname><given-names>H</given-names></name><name><surname>Schreiber</surname><given-names>RD</given-names></name><name><surname>Allen</surname><given-names>PM</given-names></name></person-group><article-title>Eradication of established tumors by CD8+T cell adoptive immunotherapy</article-title><source>Immunity</source><year>2000</year><volume>13</volume><fpage>265</fpage><lpage>276</lpage><pub-id pub-id-type=""doi"">10.1016/S1074-7613(00)00026-1</pub-id><pub-id pub-id-type=""pmid"">10981969</pub-id></element-citation></ref><ref id=""CR49""><label>49.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Sakaguchi</surname><given-names>S</given-names></name><name><surname>Sakaguchi</surname><given-names>N</given-names></name><name><surname>Asano</surname><given-names>M</given-names></name><name><surname>Itoh</surname><given-names>M</given-names></name><name><surname>Toda</surname><given-names>M</given-names></name></person-group><article-title>Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases</article-title><source>J Immunol</source><year>1995</year><volume>155</volume><fpage>1151</fpage><lpage>1164</lpage><pub-id pub-id-type=""pmid"">7636184</pub-id></element-citation></ref><ref id=""CR50""><label>50.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>O’Garra</surname><given-names>A</given-names></name><name><surname>Vieira</surname><given-names>P</given-names></name></person-group><article-title>Regulatory T cells and mechanisms of immune system control</article-title><source>Nat Med</source><year>2004</year><volume>10</volume><fpage>801</fpage><lpage>805</lpage><pub-id pub-id-type=""doi"">10.1038/nm0804-801</pub-id><pub-id pub-id-type=""pmid"">15286781</pub-id></element-citation></ref><ref id=""CR51""><label>51.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Piccirillo</surname><given-names>CA</given-names></name><name><surname>Thornton</surname><given-names>AM</given-names></name></person-group><article-title>Cornerstone of peripheral tolerance: naturally occurring CD4+CD25+regulatory T cells</article-title><source>Trends Immunol</source><year>2004</year><volume>25</volume><fpage>374</fpage><lpage>380</lpage><pub-id pub-id-type=""doi"">10.1016/j.it.2004.04.009</pub-id><pub-id pub-id-type=""pmid"">15207505</pub-id></element-citation></ref><ref id=""CR52""><label>52.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Hori</surname><given-names>S</given-names></name><name><surname>Nomura</surname><given-names>T</given-names></name><name><surname>Sakaguchi</surname><given-names>S</given-names></name></person-group><article-title>Control of regulatory T cell development by the transcription factor Foxp3</article-title><source>Science</source><year>2003</year><volume>299</volume><fpage>1057</fpage><lpage>1061</lpage><pub-id pub-id-type=""doi"">10.1126/science.1079490</pub-id><pub-id pub-id-type=""pmid"">12522256</pub-id></element-citation></ref><ref id=""CR53""><label>53.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Khattri</surname><given-names>R</given-names></name><name><surname>Cox</surname><given-names>T</given-names></name><name><surname>Yasayko</surname><given-names>SA</given-names></name><name><surname>Ramsdell</surname><given-names>F</given-names></name></person-group><article-title>An essential role for Scurfin in CD4+CD25+T regulatory cells</article-title><source>Nat Immunol</source><year>2003</year><volume>4</volume><fpage>337</fpage><lpage>342</lpage><pub-id pub-id-type=""doi"">10.1038/ni909</pub-id><pub-id pub-id-type=""pmid"">12612581</pub-id></element-citation></ref><ref id=""CR54""><label>54.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Shevach</surname><given-names>EM</given-names></name></person-group><article-title>Certified professionals: CD4(+)CD25(+) suppressor T cells</article-title><source>J Exp Med</source><year>2001</year><volume>193</volume><fpage>F41</fpage><lpage>F46</lpage><pub-id pub-id-type=""doi"">10.1084/jem.193.11.F41</pub-id><pub-id pub-id-type=""pmid"">11390442</pub-id></element-citation></ref><ref id=""CR55""><label>55.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Oldenhove</surname><given-names>G</given-names></name><name><surname>de Heusch</surname><given-names>M</given-names></name><name><surname>Urbain-Vansanten</surname><given-names>G</given-names></name><name><surname>Urbain</surname><given-names>J</given-names></name><name><surname>Maliszewski</surname><given-names>C</given-names></name><name><surname>Leo</surname><given-names>O</given-names></name><name><surname>Moser</surname><given-names>M</given-names></name></person-group><article-title>CD4+CD25+regulatory T cells control T helper cell type 1 responses to foreign antigens induced by mature dendritic cells in vivo</article-title><source>J Exp Med</source><year>2003</year><volume>198</volume><fpage>259</fpage><lpage>266</lpage><pub-id pub-id-type=""doi"">10.1084/jem.20030654</pub-id><pub-id pub-id-type=""pmid"">12874259</pub-id></element-citation></ref><ref id=""CR56""><label>56.</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Chaput</surname><given-names>N</given-names></name><name><surname>Darrasse-Jeze</surname><given-names>G</given-names></name><name><surname>Bergot</surname><given-names>AS</given-names></name><name><surname>Cordier</surname><given-names>C</given-names></name><name><surname>Ngo-Abdalla</surname><given-names>S</given-names></name><name><surname>Klatzmann</surname><given-names>D</given-names></name><name><surname>Azogui</surname><given-names>O</given-names></name></person-group><article-title>Regulatory T cells prevent CD8 T cell maturation by inhibiting CD4 Th cells at tumor sites</article-title><source>J Immunol</source><year>2007</year><volume>179</volume><fpage>4969</fpage><lpage>4978</lpage><pub-id pub-id-type=""pmid"">17911581</pub-id></element-citation></ref></ref-list>"
10.4049/jimmunol.170.1.64	"<html><body><article-title>Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells</article-title>.<source>Blood</source>(<year>2003</year>)<volume>102</volume>(<issue>13</issue>):<fpage>4448</fpage>–<lpage>55</lpage>.<pub-id pub-id-type=""doi"">10.1182/blood-2003-06-1801</pub-id><pub-id pub-id-type=""pmid"">12933572</pub-id><ref id=""B152""><label>152</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Van Kaer</surname><given-names>L</given-names></name><name><surname>Ashton-Rickardt</surname><given-names>PG</given-names></name><name><surname>Ploegh</surname><given-names>HL</given-names></name><name><surname>Tonegawa</surname><given-names>S</given-names></name></person-group>.<article-title>TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4-8+ T cells</article-title>.<source>Cell</source>(<year>1992</year>)<volume>71</volume>(<issue>7</issue>):<fpage>1205</fpage>–<lpage>14</lpage>.<pub-id pub-id-type=""doi"">10.1016/S0092-8674(05)80068-6</pub-id><pub-id pub-id-type=""pmid"">1473153</pub-id></mixed-citation></ref><ref id=""B153""><label>153</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Chefalo</surname><given-names>PJ</given-names></name><name><surname>Grandea</surname><given-names>AG</given-names><suffix>III</suffix></name><name><surname>Van Kaer</surname><given-names>L</given-names></name><name><surname>Harding</surname><given-names>CV</given-names></name></person-group>.<article-title>Tapasin-/- and TAP1-/- macrophages are deficient in vacuolar alternate class I MHC (MHC-I) processing due to decreased MHC-I stability at phagolysosomal pH</article-title>.<source>J Immunol</source>(<year>2003</year>)<volume>170</volume>(<issue>12</issue>):<fpage>5825</fpage>–<lpage>33</lpage>.<pub-id pub-id-type=""doi"">10.4049/jimmunol.170.1.643</pub-id><pub-id pub-id-type=""pmid"">12794107</pub-id></mixed-citation></ref><ref id=""B154""><label>154</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Merzougui</surname><given-names>N</given-names></name><name><surname>Kratzer</surname><given-names>R</given-names></name><name><surname>Saveanu</surname><given-names>L</given-names></name><name><surname>van Endert</surname><given-names>P</given-names></name></person-group>.<article-title>A proteasome-dependent, TAP-independent pathway for cross-presentation of phagocytosed antigen</article-title>.<source>EMBO Rep</source>(<year>2011</year>)<volume>12</volume>(<issue>12</issue>):<fpage>1257</fpage>–<lpage>64</lpage>.<pub-id pub-id-type=""doi"">10.1038/embor.2011.203</pub-id><pub-id pub-id-type=""pmid"">22037009</pub-id></mixed-citation></ref><ref id=""B155""><label>155</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Pfeifer</surname><given-names>JD</given-names></name><name><surname>Wick</surname><given-names>MJ</given-names></name><name><surname>Roberts</surname><given-names>RL</given-names></name><name><surname>Findlay</surname><given-names>K</given-names></name><name><surname>Normark</surname><given-names>SJ</given-names></name><name><surname>Harding</surname><given-names>CV</given-names></name></person-group>.<article-title>Phagocytic processing of bacterial antigens for class I MHC presentation to T cells</article-title>.<source>Nature</source>(<year>1993</year>)<volume>361</volume>(<issue>6410</issue>):<fpage>359</fpage>–<lpage>62</lpage>.<pub-id pub-id-type=""doi"">10.1038/361359a0</pub-id><pub-id pub-id-type=""pmid"">7678924</pub-id></mixed-citation></ref><ref id=""B156""><label>156</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Shen</surname><given-names>L</given-names></name><name><surname>Sigal</surname><given-names>LJ</given-names></name><name><surname>Boes</surname><given-names>M</given-names></name><name><surname>Rock</surname><given-names>KL</given-names></name></person-group>.<article-title>Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo</article-title>.<source>Immunity</source>(<year>2004</year>)<volume>21</volume>(<issue>2</issue>):<fpage>155</fpage>–<lpage>65</lpage>.<pub-id pub-id-type=""doi"">10.1016/j.immuni.2004.07.004</pub-id><pub-id pub-id-type=""pmid"">15308097</pub-id></mixed-citation></ref><ref id=""B157""><label>157</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Lennon-Dumenil</surname><given-names>AM</given-names></name><name><surname>Bakker</surname><given-names>AH</given-names></name><name><surname>Maehr</surname><given-names>R</given-names></name><name><surname>Fiebiger</surname><given-names>E</given-names></name><name><surname>Overkleeft</surname><given-names>HS</given-names></name><name><surname>Rosemblatt</surname><given-names>M</given-names></name><etal></etal></person-group></mixed-citation></ref></body></html>"
10.1055/s-2006-924577	"<html><body><article article-type=""research-article"" xmlns:mml=""http://www.w3.org/1998/Math/MathML"" xmlns:xlink=""http://www.w3.org/1999/xlink""><?properties open_access?><front><journal-meta><journal-id journal-id-type=""nlm-ta"">Int J Health Geogr</journal-id><journal-title-group><journal-title>International Journal of Health Geographics</journal-title></journal-title-group><issn pub-type=""epub"">1476-072X</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type=""pmid"">20152039</article-id><article-id pub-id-type=""pmc"">2834578</article-id><article-id pub-id-type=""publisher-id"">1476-072X-9-7</article-id><article-id pub-id-type=""doi"">10.1186/1476-072X-9-7</article-id><article-categories><subj-group subj-group-type=""heading""><subject>Research</subject></subj-group></article-categories><title-group><article-title>Spatial analysis of learning and developmental disorders in upper Cape Cod, Massachusetts using generalized additive models</article-title></title-group><contrib-group><contrib contrib-type=""author"" corresp=""yes"" id=""A1""><name><surname>Hoffman</surname><given-names>Kate</given-names></name><xref ref-type=""aff"" rid=""I1"">1</xref><email>hoffmank@bu.edu</email></contrib><contrib contrib-type=""author"" id=""A2""><name><surname>Webster</surname><given-names>Thomas F</given-names></name><xref ref-type=""aff"" rid=""I1"">1</xref><email>twebster@bu.edu</email></contrib><contrib contrib-type=""author"" id=""A3""><name><surname>Weinberg</surname><given-names>Janice M</given-names></name><xref ref-type=""aff"" rid=""I2"">2</xref><email>janicew@bu.edu</email></contrib><contrib contrib-type=""author"" id=""A4""><name><surname>Aschengrau</surname><given-names>Ann</given-names></name><xref ref-type=""aff"" rid=""I3"">3</xref><email>aaschen@bu.edu</email></contrib><contrib contrib-type=""author"" id=""A5""><name><surname>Janulewicz</surname><given-names>Patricia A</given-names></name><xref ref-type=""aff"" rid=""I3"">3</xref><email>paj@bu.edu</email></contrib><contrib contrib-type=""author"" id=""A6""><name><surname>White</surname><given-names>Roberta F</given-names></name><xref ref-type=""aff"" rid=""I1"">1</xref><email>rwhite@bu.edu</email></contrib><contrib contrib-type=""author"" id=""A7""><name><surname>Vieira</surname><given-names>Verónica M</given-names></name><xref ref-type=""aff"" rid=""I1"">1</xref><email>vmv@bu.edu</email></contrib></contrib-group><aff id=""I1""><label>1</label>Department of Environmental Health, Boston University School of Public Health, Boston, USA</aff><aff id=""I2""><label>2</label>Department of Biostatistics, Boston University School of Public Health, Boston, USA</aff><aff id=""I3""><label>3</label>Department of Epidemiology, Boston University School of Public Health, Boston, USA</aff><pub-date pub-type=""collection""><year>2010</year></pub-date><pub-date pub-type=""epub""><day>12</day><month>2</month><year>2010</year></pub-date><volume>9</volume><fpage>7</fpage><lpage>7</lpage><history><date date-type=""received""><day>2</day><month>11</month><year>2009</year></date><date date-type=""accepted""><day>12</day><month>2</month><year>2010</year></date></history><permissions><copyright-statement>Copyright ©2010 Hoffman et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2010</copyright-year><copyright-holder>Hoffman et al; licensee BioMed Central Ltd.</copyright-holder><license license-type=""open-access"" xlink:href=""http://creativecommons.org/licenses/by/2.0""><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type=""uri"" xlink:href=""http://creativecommons.org/licenses/by/2.0"">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href=""http://www.ij-healthgeographics.com/content/9/1/7""></self-uri><abstract><p>The spatial variability of three indicators of learning and developmental disability (LDD) was assessed for Cape Cod, Massachusetts. Maternal reports of receiving special education services, attention deficit hyperactivity disorder, and educational attainment were available for a birth cohort from 1969-1983. Using generalized additive models and residential history, maps of the odds of LDD were produced that also controlled for known risk factors. While results were not statistically significant, they suggest that children living in certain parts of Cape Cod were more likely to have a LDD. The spatial variation may be due to variation in the physical and social environment.</p></abstract></article-meta></front><sec><title>Background</title><p>The prevalence of learning and developmental disabilities (LDDs) has increased over the last four decades [<xref ref-type=""bibr"" rid=""B1"">1</xref>,<xref ref-type=""bibr"" rid=""B2"">2</xref>]. Current prevalence estimates suggest that 5 to 15% of children in the United States are afflicted with disorders of learning and development, including disorders of memory, reduced IQ, attention deficit hyperactivity disorder (ADHD), autism spectrum disorders, conduct disorders and developmental delays [<xref ref-type=""bibr"" rid=""B2"">2</xref>-<xref ref-type=""bibr"" rid=""B5"">5</xref>]. The increased prevalence of LDDs has largely been attributed to improved diagnosis; however, evidence also suggests that the underlying prevalence of dysfunction is increasing [<xref ref-type=""bibr"" rid=""B2"">2</xref>]. Although the specific mechanisms for learning and developmental disorders remain unclear, much research has been conducted to identify their risk factors. These studies have consistently found that males and children from economic or culturally disadvantaged backgrounds have greater risk of being diagnosed with an LDD [<xref ref-type=""bibr"" rid=""B1"">1</xref>,<xref ref-type=""bibr"" rid=""B6"">6</xref>]. Numerous pre-birth risk factors have also been identified including lack of prenatal care; increased maternal age; pre-term delivery; low birth weight and prenatal alcohol, tobacco, and drug use [<xref ref-type=""bibr"" rid=""B7"">7</xref>-<xref ref-type=""bibr"" rid=""B10"">10</xref>]. Additional research suggests that the development of learning and developmental disorders is affected by intrinsic causes such as genetic differences in brain structure or biochemical imbalances [<xref ref-type=""bibr"" rid=""B11"">11</xref>]. However, it has also been suggested that the increased prevalence is attributable, at least in part, to chronic exposures to environmental toxicants [<xref ref-type=""bibr"" rid=""B12"">12</xref>-<xref ref-type=""bibr"" rid=""B15"">15</xref>].</p><p>Brain development begins in utero and continues throughout adolescence. This lengthy developmental period, coupled with its extreme complexity, leaves the developing brain particularly susceptible to adverse effects of chemical exposures [<xref ref-type=""bibr"" rid=""B16"">16</xref>]. Subtle changes in either structure or function can lead to profound neurological consequences that can persist over a lifetime. Prenatal and early childhood exposures to a number of environmental toxicants such as lead, methylmercury and polychlorinated biphenyls (PCBs) have been associated with damage to children's developing brains and nervous systems, and have been linked to specific neurological deficits and disorders [<xref ref-type=""bibr"" rid=""B4"">4</xref>,<xref ref-type=""bibr"" rid=""B12"">12</xref>,<xref ref-type=""bibr"" rid=""B13"">13</xref>,<xref ref-type=""bibr"" rid=""B17"">17</xref>-<xref ref-type=""bibr"" rid=""B30"">30</xref>]. While the neurotoxicological effects of a select few chemicals are fairly well characterized, relatively little is known about the 80,000 chemicals registered for commercial use with the Environmental Protection Agency [<xref ref-type=""bibr"" rid=""B20"">20</xref>].</p><p>The evolution of geographical information systems (GIS) and statistical methods has increased the use of spatial analyses to investigate the association between geographically-based exposures such as environmental contaminants and the risk of LDD. A number of studies have used residential proximity to a contaminant source to define exposure and assess the risk of neurological impairment associated with potential neurotoxicants [<xref ref-type=""bibr"" rid=""B31"">31</xref>-<xref ref-type=""bibr"" rid=""B33"">33</xref>]. Using this method, Dahlgren and colleagues found evidence that exposures to wood processing waste chemicals increase the severity of neurological symptoms reported in children and adults and was associated with impaired performance on neuropsychological tests [<xref ref-type=""bibr"" rid=""B31"">31</xref>].</p><p>While cluster analysis does not prove causation, it can serve as a useful tool in generating hypotheses about potential exposures that warrant further investigation [<xref ref-type=""bibr"" rid=""B34"">34</xref>]. In Binghamton, New York, Margai and Henry utilized two cluster detection methods, the Morans I Statistic and the Spatial Scan Statistic, to identify a spatial cluster of learning disability cases associated with historically significant sources of lead (i.e. automobile-related facilities and industries that dealt with lead and other byproducts) [<xref ref-type=""bibr"" rid=""B35"">35</xref>]. Conclusions were limited, however, because analyses were based on census block group prevalence and the investigators were unable to adjust for individual-level confounders.</p><p>New methods of spatial epidemiology involving generalized additive models (GAMs) permit analysis of point-based data while adjusting for individual-level variables [<xref ref-type=""bibr"" rid=""B36"">36</xref>,<xref ref-type=""bibr"" rid=""B37"">37</xref>]. The current research assesses the spatial variability of learning and developmental disorders in a cohort residing in the upper Cape Cod region of Massachusetts. Two general indicators of cognitive and behavioral function are addressed: receiving special education services for academic or behavioral difficulties and educational attainment. ADHD, a specific neurodevelopmental disorder, is also a focus of this study. Residential history data is used to examine potential differences in susceptibility during the prenatal and early childhood periods.</p></sec><sec sec-type=""materials|methods""><title>Materials and methods</title><sec><title>Outcome Data</title><p>Data were collected as part of a large retrospective cohort study examining the association between exposure to tetrachloroethylene (PCE)-contaminated public drinking water and the risk of reproductive and developmental disorders in upper Cape Cod, MA [<xref ref-type=""bibr"" rid=""B38"">38</xref>]. Eligible families had at least one child born while they were living in the upper Cape Cod towns of Barnstable, Bourne, Falmouth, Mashpee, or Sandwich between 1969 and 1983 (Figure<xref ref-type=""fig"" rid=""F1"">1a</xref>). Birth certificates and questionnaires completed by mothers (or fathers, if mothers were unavailable) were used to gather information on outcome variables as well as potential confounders.</p><fig id=""F1"" position=""float""><label>Figure 1</label><caption><p><bold>Upper Cape Cod study area</bold>. (A) Cape Cod is located in Massachusetts in the northeastern United States. (B) Distribution of participants' residences by outcome status. Locations have been altered to preserve confidentiality.</p></caption><graphic xlink:href=""1476-072X-9-7-1""></graphic></fig><p>Children were excluded if they came from a multiple pregnancy; died before the age of 21 years; had a history of lead poisoning, fetal alcohol syndrome, mental retardation, cerebral palsy; or their mothers reported prenatal exposure to a known teratogen, daily or weekly marijuana use, or seven or more drinks of alcoholic beverages per week during the prenatal period. The final population was comprised of 1,574 subjects (Table<xref ref-type=""table"" rid=""T1"">1</xref>; Figure<xref ref-type=""fig"" rid=""F1"">1b</xref>). To avoid clustering within families, analyses included only the eldest enrolled child in each family.</p><table-wrap id=""T1"" position=""float""><label>Table 1</label><caption><p>Selected characteristics of case and non-case children.</p></caption><table frame=""hsides"" rules=""groups""><thead><tr><th align=""left"">Variable</th><th align=""center"" colspan=""2"">Special Education</th><th align=""center"" colspan=""2"">Educational Attainment</th><th align=""center"" colspan=""2"">ADHD</th></tr><tr><th></th><th align=""center"" colspan=""2""><bold>N = 1538</bold><sup><bold>a</bold></sup></th><th align=""center"" colspan=""2""><bold>N = 1542</bold><sup><bold>b</bold></sup></th><th align=""center"" colspan=""2""><bold>N = 1535</bold><sup><bold>c</bold></sup></th></tr><tr><th></th><th align=""center"">Cases</th><th align=""center"">Non-Cases</th><th align=""center"">Cases</th><th align=""center"">Non-Cases</th><th align=""center"">Cases</th><th align=""center"">Non-Cases</th></tr><tr><th></th><th align=""center"">N (%)</th><th align=""center"">N (%)</th><th align=""center"">N (%)</th><th align=""center"">N (%)</th><th align=""center"">N (%)</th><th align=""center"">N (%)</th></tr></thead><tbody><tr><td align=""left"">Male</td><td align=""center"">186 (66.9)</td><td align=""center"">592 (47.0)</td><td align=""center"">219 (66.8)</td><td align=""center"">562 (46.7)</td><td align=""center"">105 (74.5)</td><td align=""center"">673 (48.3)</td></tr><tr><td align=""left"">Female</td><td align=""center"">92 (33.1)</td><td align=""center"">668 (53.0)</td><td align=""center"">124 (36.2)</td><td align=""center"">637 (53.1)</td><td align=""center"">36 (25.5)</td><td align=""center"">721 (51.7)</td></tr><tr><td align=""left"">Birth Weight</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align=""left"">&lt;2500 g</td><td align=""center"">8 (2.9)</td><td align=""center"">32 (2.5)</td><td align=""center"">12 (3.5)</td><td align=""center"">29 (2.5)</td><td align=""center"">3 (2.1)</td><td align=""center"">38 (2.7)</td></tr><tr><td align=""left"">&gt;= 2500 g</td><td align=""center"">270 (97.1)</td><td align=""center"">1228 (97.5)</td><td align=""center"">331 (96.5)</td><td align=""center"">1170 (97.5)</td><td align=""center"">138 (97.9)</td><td align=""center"">1356 (97.3)</td></tr><tr><td align=""left"">Gestational Duration</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align=""left"">&lt;37 Weeks</td><td align=""center"">15 (5.4)</td><td align=""center"">50 (4.0)</td><td align=""center"">14 (4.1)</td><td align=""center"">51 (4.3)</td><td align=""center"">8 (5.7)</td><td align=""center"">57 (4.1)</td></tr><tr><td align=""left"">&gt;= 37 Weeks</td><td align=""center"">263 (94.6)</td><td align=""center"">1210 (96.0)</td><td align=""center"">329 (95.9)</td><td align=""center"">1148 (95.7)</td><td align=""center"">133 (94.3)</td><td align=""center"">1332 (95.9)</td></tr><tr><td align=""left"">Maternal Cigarette Smoking<break></break>During Pregnancy</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align=""left"">Yes</td><td align=""center"">81 (29.1)</td><td align=""center"">331 (26.3)</td><td align=""center"">116 (33.8)</td><td align=""center"">296 (24.7)</td><td align=""center"">41 (29.1)</td><td align=""center"">370 (26.6)</td></tr><tr><td align=""left"">No</td><td align=""center"">194 (69.8)</td><td align=""center"">910 (72.2)</td><td align=""center"">220 (64.1)</td><td align=""center"">887 (74.0)</td><td align=""center"">99 (70.2)</td><td align=""center"">1002 (71.9)</td></tr><tr><td align=""left"">Missing</td><td align=""center"">3 (1.1)</td><td align=""center"">19 (1.5)</td><td align=""center"">7 (2.1)</td><td align=""center"">16 (1.3)</td><td align=""center"">1 (0.7)</td><td align=""center"">22 (1.6)</td></tr><tr><td align=""left"">Maternal Alcoholic Beverage Consumption<break></break>During Pregnancy</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align=""left"">Yes</td><td align=""center"">99 (35.6)</td><td align=""center"">487 (38.7)</td><td align=""center"">111 (32.4)</td><td align=""center"">475 (39.6)</td><td align=""center"">55 (39.0)</td><td align=""center"">527 (37.8)</td></tr><tr><td align=""left"">No</td><td align=""center"">175 (62.9)</td><td align=""center"">750 (59.5)</td><td align=""center"">224 (65.3)</td><td align=""center"">703 (58.6)</td><td align=""center"">85 (60.2)</td><td align=""center"">839 (60.2)</td></tr><tr><td align=""left"">Missing</td><td align=""center"">4 (1.4)</td><td align=""center"">23 (1.8)</td><td align=""center"">8 (2.3)</td><td align=""center"">21 (1.8)</td><td align=""center"">1 (0.7)</td><td align=""center"">22 (1.6)</td></tr><tr><td align=""left"">Maternal Race</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align=""left"">White</td><td align=""center"">270 (97.1)</td><td align=""center"">1205 (95.6)</td><td align=""center"">327 (95.3)</td><td align=""center"">1152 (96.1)</td><td align=""center"">136 (96.5)</td><td align=""center"">1335 (95.8)</td></tr><tr><td align=""left"">Other</td><td align=""center"">8 (2.9)</td><td align=""center"">55 (4.4)</td><td align=""center"">16 (4.7)</td><td align=""center"">47 (3.9)</td><td align=""center"">5 (3.5)</td><td align=""center"">59 (4.2)</td></tr><tr><td align=""left"">Maternal Education</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align=""left"">&lt;High School</td><td align=""center"">13 (4.7)</td><td align=""center"">39 (3.1)</td><td align=""center"">31 (9.0)</td><td align=""center"">23 (1.9)</td><td align=""center"">4 (2.8)</td><td align=""center"">48 (3.4)</td></tr><tr><td align=""left"">High School</td><td align=""center"">115 (41.4)</td><td align=""center"">435 (34.5)</td><td align=""center"">183 (53.3)</td><td align=""center"">362 (30.2)</td><td align=""center"">44 (31.2)</td><td align=""center"">505 (36.2)</td></tr><tr><td align=""left"">Some College</td><td align=""center"">71 (25.5)</td><td align=""center"">404 (32.0)</td><td align=""center"">82 (24.0)</td><td align=""center"">396 (33.0)</td><td align=""center"">39 (27.7)</td><td align=""center"">434 (31.1)</td></tr><tr><td align=""left"">4 Year College Grad</td><td align=""center"">79 (28.4)</td><td align=""center"">382 (30.3)</td><td align=""center"">47 (13.7)</td><td align=""center"">418 (34.9)</td><td align=""center"">54 (38.3)</td><td align=""center"">407 (29.2)</td></tr><tr><td align=""left"">Paternal Occupation</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align=""left"">Blue Collar</td><td align=""center"">94 (33.8)</td><td align=""center"">376 (29.8)</td><td align=""center"">114 (33.2)</td><td align=""center"">329 (27.4)</td><td align=""center"">39 (27.7)</td><td align=""center"">426 (30.6)</td></tr><tr><td align=""left"">White Collar</td><td align=""center"">118 (42.4)</td><td align=""center"">643 (51.0)</td><td align=""center"">143 (41.7)</td><td align=""center"">651 (54.3)</td><td align=""center"">71 (50.3)</td><td align=""center"">690 (49.5)</td></tr><tr><td align=""left"">Other</td><td align=""center"">63 (22.7)</td><td align=""center"">221 (17.5)</td><td align=""center"">83 (24.2)</td><td align=""center"">199 (16.6)</td><td align=""center"">30 (21.3)</td><td align=""center"">256 (18.4)</td></tr><tr><td align=""left"">Missing</td><td align=""center"">3 (1.1)</td><td align=""center"">20 (1.6)</td><td align=""center"">3 (0.9)</td><td align=""center"">20 (1.7)</td><td align=""center"">1 (0.7)</td><td align=""center"">22 (1.6)</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Missing special education information N = 36.</p><p><sup>b</sup>Missing educational attainment information N = 32.</p><p><sup>c</sup>Missing ADHD information N = 39.</p></table-wrap-foot></table-wrap><p>Several measures of learning and developmental disabilities were collected by self-administered questionnaires, including maternal report of diagnoses of Attention Deficit Disorder (ADD) and Hyperactive Disorder (HD), difficulty sitting still or paying attention in school, difficulties or tutoring in reading and math, special education class placement for academic or developmental problems, repeating a grade, having an individualized education plan (IEP), receiving special education class placement, and educational attainment. Three binary outcome measures of learning and developmental disabilities, which were thought to be the least subject to misclassification of the outcome, are examined here.</p></sec><sec><title>Special Education Placement</title><p>The first objective measure was based on maternal report of children receiving special education services for academic or behavioral difficulties. Since 1975, special education has been mandated under the Individuals with Disabilities Education Act (IDEA), which requires provisions for specifically designed instruction for individuals with disabilities. Although a number of different conditions are included as disabilities under IDEA, in general, the delivery of special educations services is an indicator of learning and developmental disabilities [<xref ref-type=""bibr"" rid=""B39"">39</xref>].</p><p>All students receiving special education services, even those with mild disabilities, are required by law to have an individualized education plan (IEP) which outlines specific educational goals and special provisions to aid in their education. Special education placement was defined by either maternal report of special classroom placement for academic or developmental difficulties or assignment of an IEP. In most instances, both events were reported by mothers.</p></sec><sec><title>Maternal Report of ADHD</title><p>The second outcome measure combined maternal reporting of ADD and HD. Attention deficit hyperactivity disorder is the most common neurodevelopmental disorder of childhood, with an estimated prevalence between 7 and 16% of US children [<xref ref-type=""bibr"" rid=""B4"">4</xref>,<xref ref-type=""bibr"" rid=""B40"">40</xref>]. Children diagnosed with ADHD comprise a heterogeneous population sharing common symptoms, including inattention, impulsivity, and, in some cases, hyperactivity, or a combination of symptoms. As with other learning and developmental disorders, ADHD risk is influenced by biological, reproductive, environmental, and nutritional factors [<xref ref-type=""bibr"" rid=""B41"">41</xref>].</p><p>Until 1994, the Diagnostic Statistical Manual (DSM) listed ADD and HD as separate conditions [<xref ref-type=""bibr"" rid=""B42"">42</xref>]. Beginning with the DSM-IV, both outcomes were included as sub-types of the same condition, Attention Deficit Hyperactivity Disorder (ADHD) [<xref ref-type=""bibr"" rid=""B43"">43</xref>]. Research suggests that structural abnormalities in the frontal cortex and temporal lobe observed in both ADD and HD are similar [<xref ref-type=""bibr"" rid=""B44"">44</xref>]. For these reasons, reports from the questionnaire of ADD or HD were combined into a single outcome for the purposes of this study.</p></sec><sec><title>Educational Attainment</title><p>The third outcome measure was highest level of educational attainment. Educational attainment is influenced by a number of factors related to learning and developmental disability, including low academic achievement, behavior problems, absenteeism, grade retention, and low parental educational expectations [<xref ref-type=""bibr"" rid=""B45"">45</xref>,<xref ref-type=""bibr"" rid=""B46"">46</xref>]. Although educational attainment is not a direct measure of learning or developmental disorder, the two outcomes are highly correlated [<xref ref-type=""bibr"" rid=""B47"">47</xref>,<xref ref-type=""bibr"" rid=""B48"">48</xref>]. Educational attainment data were divided into two categories: (1) completing high school or less education and (2) education beyond high school.</p></sec><sec><title>Residential History Data</title><p>Mothers were asked to provide a residential history from before the birth of the child to age 18 years. All eligible addresses in the study area were geocoded using GIS and each residence was assigned corresponding latitude and longitude coordinates. The residential history was used to examine location at different developmental stages. To reflect exposures during the prenatal period, analyses were based on the residential location at birth. As early childhood chemical exposures are also thought to impact LDD risk, we conducted a second set of analyses including the residence from birth through age five years. Multiple residences for the same individual, however, may generate an artificial spatial cluster caused by a single case moving within a small area. To avoid potential bias due to the inclusion of multiple residences for the same individual, we used the address with the longest duration of residence from birth to age 5 years [<xref ref-type=""bibr"" rid=""B36"">36</xref>].</p></sec><sec><title>Statistical Analyses</title><p>The log odds of each indicator of learning and developmental disability were estimated using generalized additive models, an extension of linear models that can incorporate both nonparametric and parametric model components and can be used to analyze binary outcome data [<xref ref-type=""bibr"" rid=""B49"">49</xref>]. For non-parametric model components, GAMs replace the beta coefficients of an ordinary logistic regression with a smooth term. In these analyses, a bivariate smooth was applied to latitude and longitude coordinates representing geographic location. Covariates were modeled as parametric terms.</p><p>A locally weighted regression smoother (loess), which adapts to differences in population density across the study area was used. The circular region or neighborhood from which data are drawn to predict the smooth is based on the percentage of data points in the neighborhood (with weighting based on distance from the center) and is referred to as the span size. Choice of span size produces a trade off between bias and variability. A large span size results in a smoother surface with low variability, but increased bias. Conversely, choosing a small span size results in high variability and comparatively low bias. To determine the optimal amount of smoothing in each analysis, Akaike's Information Criterion (AIC) was minimized [<xref ref-type=""bibr"" rid=""B49"">49</xref>].</p><p>A rectangular grid covering the study area was generated using the minimum and maximum latitude and longitude coordinates of study participant residences (approximate grid cell size 0.1 km<sup>2</sup>). Using GIS, a map of the study area was used to clip out points where participants could not live, such as water bodies or conservation land. At each grid point within the study area, an odds ratio (OR) was calculated using the entire study area as the referent group; the odds at each point was divided by the odds from a reduced model which omitted the latitude and longitude smooth term. Odds ratios were mapped using a continuous color scale (dark blue to dark red). A constant scale range was used for all maps of a particular outcome.</p><p>For each outcome, the null hypothesis that learning and developmental disability risk does not depend on location (e.g. the map surface is a horizontal plane) was tested. Locations of individuals were permuted 999 times while preserving their outcome status and covariates. For each permutation, the GAM with the optimal span size from the original dataset was run and the deviance statistic computed. If this global statistic indicated that location was statistically significant at p-value &lt; 0.05, point-wise departures from the null hypothesis were evaluated using the distribution of the log odds at each point from the same set of permutations used to calculate the global statistic. Areas with significantly increased and decreased log odds were defined to include all observed points ranking in the upper and lower 2.5% of the point-wise distribution respectively.</p><p>A detailed discussion of the statistical methods of mapping population-based case control data using GAMs is provided by Webster and colleagues [<xref ref-type=""bibr"" rid=""B37"">37</xref>]. Statistical analyses were performed in S-Plus using the<italic>gam</italic>package and a local scoring algorithm GAM estimation procedure [<xref ref-type=""bibr"" rid=""B49"">49</xref>,<xref ref-type=""bibr"" rid=""B50"">50</xref>]. All maps were created using ArcGIS 9.2 [<xref ref-type=""bibr"" rid=""B51"">51</xref>].</p><p>Potential confounders were assessed based on the<italic>a priori</italic>expectation of their association with learning and developmental disorders. Drawing from existing research, sex, race, birth weight, gestational duration, year of birth, socioeconomic status (represented by mother's educational attainment and father's occupation), maternal alcohol or tobacco use during pregnancy, and PCE exposure were included as core confounders to include in all analyses. Spatial confounding was assessed by visually comparing maps with and without adjustment. The following variables did not change the appearance of the maps and were dropped from all presented models: mother's age, breastfeeding, maternal history of learning difficulties, occasional maternal marijuana use during pregnancy, pregnancy complications, prenatal exposure to solvents, and iron and multivitamin supplementation during pregnancy. Children with missing covariate data were excluded from the analyses (less than 2.1% for maternal smoking during pregnancy, 2.5% for maternal alcohol during pregnancy, and 1.7% for paternal occupation). Available characteristics of excluded children, including outcome prevalence, were very similar to children without missing data.</p></sec></sec><sec><title>Results</title><sec><title>Special Education Services</title><p>Of the 1,484 children with complete outcome and covariate data, 270 (18.2%) received special education services. In adjusted models, children receiving special education services were more likely to be male (OR = 2.24; 95% CI 1.71-2.96) and from lower SES families (highest maternal educational attainment compared to lowest OR = 0.79; 95% CI 0.54-1.15). For analyses using either the birth address or early childhood address the optimal span size was 0.95 (Table<xref ref-type=""table"" rid=""T2"">2</xref>). Maps produced from both sets of analyses were similar. We show results of the adjusted birth address analysis in Figure<xref ref-type=""fig"" rid=""F2"">2</xref>. Each map showed an area of increased risk of needing special education services in the northern area of the town of Bourne but the difference was not statistically significant (birth address p-value = 0.57; early childhood p-value = 0.38). Maps with and without adjustment were similar indicating that spatial confounding was not an issue (data not shown).</p><table-wrap id=""T2"" position=""float""><label>Table 2</label><caption><p>Summary of special education services models (270 Cases, 1214 Non-Cases).</p></caption><table frame=""hsides"" rules=""groups""><thead><tr><th align=""left"">Analysis</th><th align=""center""><bold>Span</bold><sup><bold>a</bold></sup></th><th align=""center""><bold>Deviance p-value</bold><sup><bold>b</bold></sup></th><th align=""center"">Figure Number</th></tr></thead><tbody><tr><td align=""left"">Adjusted<sup>c</sup><break></break>Birth Residence</td><td align=""center"">0.95</td><td align=""center"">0.57</td><td align=""center"">2</td></tr><tr><td colspan=""4""><hr/></td></tr><tr><td align=""left"">Crude<break></break>Birth Residence</td><td align=""center"">0.95</td><td align=""center"">0.30</td><td align=""center"">---</td></tr><tr><td colspan=""4""><hr/></td></tr><tr><td align=""left"">Adjusted<sup>c</sup><break></break>Early Childhood Residence</td><td align=""center"">0.95</td><td align=""center"">0.38</td><td align=""center"">---</td></tr><tr><td colspan=""4""><hr/></td></tr><tr><td align=""left"">Crude<break></break>Early Childhood Residence</td><td align=""center"">0.95</td><td align=""center"">0.22</td><td align=""center"">---</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Optimal span obtained by using the Akaike' Information Criterion (AIC).</p><p><sup>b</sup>Null hypothesis is that the map is flat.</p><p><sup>c</sup>Adjusted for sex, race, birth weight, gestational duration, year of birth, socioeconomic status, maternal alcohol or tobacco use during pregnancy, and PCE exposure.</p></table-wrap-foot></table-wrap><fig id=""F2"" position=""float""><label>Figure 2</label><caption><p><bold>Special education service results for birth address</bold>. Fully adjusted model. The optimal span is 0.95. The map was not significantly different from flat (p = 0.57).</p></caption><graphic xlink:href=""1476-072X-9-7-2""></graphic></fig></sec><sec><title>ADHD</title><p>The reported prevalence of ADHD in the study population was 9.4% (139 cases; 1340 non-cases; Table<xref ref-type=""table"" rid=""T3"">3</xref>), consistent with other United States population estimates during the same time period [<xref ref-type=""bibr"" rid=""B40"">40</xref>]. As maps of ADHD were similar using birth address and early childhood address, the former is shown (Figure<xref ref-type=""fig"" rid=""F3"">3</xref>). The risk of ADHD appears slightly elevated in the northern region of upper Cape Cod, but the difference was not statistically significant (optimal span size = 0.95; p-value = 0.33). Adjusting for potential spatial confounders made no appreciable difference in the map of ADHD risk, suggesting that spatial confounding was not an issue (data not shown).</p><fig id=""F3"" position=""float""><label>Figure 3</label><caption><p><bold>ADHD results for birth address</bold>. Fully adjusted model. The optimal span is 0.95. The map was not significantly different from flat (p = 0.33).</p></caption><graphic xlink:href=""1476-072X-9-7-3""></graphic></fig><table-wrap id=""T3"" position=""float""><label>Table 3</label><caption><p>Summary of ADHD models (139 Cases, 1340 Non-Cases).</p></caption><table frame=""hsides"" rules=""groups""><thead><tr><th align=""left"">Analysis</th><th align=""center""><bold>Span</bold><sup><bold>a</bold></sup></th><th align=""center""><bold>Deviance p-value</bold><sup><bold>b</bold></sup></th><th align=""center"">Figure Number</th></tr></thead><tbody><tr><td align=""left"">Adjusted<sup>c</sup><break></break>Birth Residence</td><td align=""center"">0.95</td><td align=""center"">0.33</td><td align=""center"">3</td></tr><tr><td colspan=""4""><hr/></td></tr><tr><td align=""left"">Crude<break></break>Birth Residence</td><td align=""center"">0.95</td><td align=""center"">0.17</td><td align=""center"">---</td></tr><tr><td colspan=""4""><hr/></td></tr><tr><td align=""left"">Adjusted<sup>c</sup><break></break>Early Childhood Residence</td><td align=""center"">0.95</td><td align=""center"">0.35</td><td align=""center"">---</td></tr><tr><td colspan=""4""><hr/></td></tr><tr><td align=""left"">Crude<break></break>Early Childhood Residence</td><td align=""center"">0.95</td><td align=""center"">0.32</td><td align=""center"">---</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Optimal span obtained by using the Akaike' Information Criterion (AIC).</p><p><sup>b</sup>Null hypothesis is that the map is flat.</p><p><sup>c</sup>Adjusted for sex, race, birth weight, gestational duration, year of birth, socioeconomic status, maternal alcohol or tobacco use during pregnancy, and PCE exposure.</p></table-wrap-foot></table-wrap></sec><sec><title>Educational Attainment</title><p>Mothers reported that 22.3% of their children did not receive education beyond high school (Table<xref ref-type=""table"" rid=""T4"">4</xref>). Boys were more likely to have low educational attainment (OR = 2.18; 95% CI 1.66-2.87) as were children from lower SES families (father employed in blue collar verse white collar occupations OR = 1.64; 95% CI 1.20-2.26). Using early childhood address, the adjusted analysis for the risk of low educational attainment appeared elevated in areas of Bourne and Mashpee (optimal span size = 0.60, p-value = 0.22; Table<xref ref-type=""table"" rid=""T4"">4</xref>; Figure<xref ref-type=""fig"" rid=""F4"">4</xref>). The pattern of the risk surface was very similar using the birth address when the same span size was used for both analyses (not shown). Changes in the span size between the crude and adjusted models (optimal span sizes of 0.15 and 0.60 respectively) were primarily due to confounding by SES variables (mother's educational attainment).</p><fig id=""F4"" position=""float""><label>Figure 4</label><caption><p><bold>Educational attainment results for early childhood addresses</bold>. Fully adjusted model, optimal 0.60 span. The map was not significantly different from flat (p = 0.22).</p></caption><graphic xlink:href=""1476-072X-9-7-4""></graphic></fig><table-wrap id=""T4"" position=""float""><label>Table 4</label><caption><p>Summary of educational attainment models (331 Cases, 1155 Non-Cases).</p></caption><table frame=""hsides"" rules=""groups""><thead><tr><th align=""left"">Analysis</th><th align=""center""><bold>Span</bold><sup><bold>a</bold></sup></th><th align=""center""><bold>Deviance p-value</bold><sup><bold>b</bold></sup></th><th align=""center"">Figure Number</th></tr></thead><tbody><tr><td align=""left"">Adjusted<sup>c</sup><break></break>Birth Residence</td><td align=""center"">0.95</td><td align=""center"">0.89</td><td align=""center"">---</td></tr><tr><td colspan=""4""><hr/></td></tr><tr><td align=""left"">Crude<break></break>Birth Residence</td><td align=""center"">0.20</td><td align=""center"">0.002</td><td align=""center"">---</td></tr><tr><td colspan=""4""><hr/></td></tr><tr><td align=""left"">Adjusted<sup>c</sup><break></break>Early Childhood Residence</td><td align=""center"">0.60</td><td align=""center"">0.22</td><td align=""center"">4</td></tr><tr><td colspan=""4""><hr/></td></tr><tr><td align=""left"">Crude<break></break>Early Childhood Residence</td><td align=""center"">0.15</td><td align=""center"">&lt;0.001</td><td align=""center"">---</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>Optimal span obtained by using the Akaike' Information Criterion (AIC).</p><p><sup>b</sup>Null hypothesis is that the map is flat.</p><p><sup>c</sup>Adjusted for sex, race, birth weight, gestational duration, year of birth, socioeconomic status, maternal alcohol or tobacco use during pregnancy, and PCE exposure.</p></table-wrap-foot></table-wrap></sec></sec><sec><title>Discussion</title><p>The risk of two indicators of learning and developmental disorders--special education placement and ADHD--was elevated in the Bourne and Falmouth areas of upper Cape Cod; however, the variability was not statistically significant (alpha = 0.05). The risk of low educational attainment was elevated in portions of Mashpee and Bourne, but not statistically significant. Spatial variability of the outcomes was evaluated using two periods of residence, reflecting prenatal residence and early childhood residences (before age 5 years). The similarity of the results--when evaluated using the same span size--was likely related to residential stability; less than one third of subjects moved during this period. Consequently, each analysis was based on many of the same addresses.</p><p>The spatial investigation approach used in this study has a number of strengths. Unlike previous spatial analyses of LDD, it was possible to use point-based data and avoid potential biases due to data aggregation within arbitrary political boundaries [<xref ref-type=""bibr"" rid=""B35"">35</xref>]. Additionally, it was possible to adjust for numerous covariates to assess potential spatial confounding. While it is often assumed that spatial confounding produces disease clusters, adjusting for covariates in these analyses made little difference in maps which we attribute to the relative homogeneity of the upper Cape Cod study population. Lastly, using residential history data enabled the examination of LDD risk during the prenatal and early childhood periods which are likely more relevant to the etiology of learning and development disorder risk than exposures associated with the address at diagnosis.</p><p>This investigation also has several limitations. Indicators of learning and developmental disability were obtained through maternal report. However, Faraone and colleagues found that maternal report of ADHD in particular was highly reliable (sensitivity and specificity, 95 and 97% respectively) [<xref ref-type=""bibr"" rid=""B52"">52</xref>]. In this cohort, 48 mothers (18% of cases) reported that their child was placed in special education but did not report that their child had an IEP. Because special education placement indicates more severe dysfunction, it is possible that mothers were more likely to remember special education class placement than the presence of an IEP. To reduce the misclassification of individuals with more severe dysfunction as non-cases by defining special education services by an IEP, all children whose mothers reported their child received any form of special education services were included as cases. Results were similar when we defined special education placement by the report of an IEP (data not shown).</p><p>We examined indicators of learning and developmental disability that were readily collected using a retrospective study design. However, these indicators are not sensitive enough to identify geographic areas where individuals experience more subtle dysfunction. ADHD, for example, is diagnosed using the number of symptoms and behaviors. A continuous outcome based on the number and severity of symptoms might have identified regions in upper Cape Cod where subclinical symptoms are elevated, even when a significant increase in ADHD diagnosis is not observed.</p><p>Residential history data allowed us to take into account location during different periods of development for individuals. Unfortunately, there were too few cases to perform more data-intensive space-time analyses as we have done previously with breast cancer in Cape Cod [<xref ref-type=""bibr"" rid=""B53"">53</xref>]. When possible, consideration of both location and time of exposure may generate hypotheses on short term environmental exposures.</p><p>The optimal tradeoff between bias and variance of the smooth (e.g. the optimal span size) was determined by minimizing the AIC. Selecting the optimal span for a given dataset, however, may obscure important map features at smaller scales. Examining different span sizes may reveal important features of the data. Similarly, p-values were used to evaluate global spatial variation as well as local areas of increased or decreased risk. Confidence intervals might be considered more informative, but the information is difficult to show graphically for surfaces. Permutation tests were conducted using the optimal span size of the observed data. Although the optimal span size was generally large for these data, permuted datasets may have had a larger optimal span size under the null hypothesis that the map is flat. The effect of using the optimal span of the observed data for permuted data could result in a p-value that is too small. This is a topic of future research.</p><p>Although results were not statistically significant, spatial variation was suggested in the study area. If real, there may be several possible explanations, including residual confounding at the individual level by unmeasured variables, as well as differences in the social and physical environment. Although the pattern of risk was similar for ADHD and special education placement, maps of the risk of low educational attainment displayed a different pattern. Educational attainment may be a less specific indicator of an LDD than the other outcomes considered, which were based on maternal report of an outcome that required evaluation by school or health care professionals. Differences in the pattern of risk between the outcomes may also be related to differences in educational resources or other school-related factors. There were no school-based data available to test this hypothesis. In upper Cape Cod, town boundaries approximate public school district boundaries. If variability was due solely to school district related factors we would not have expected odds estimates to vary within towns. There may be other group-level variables of importance. Statistical methods are needed for combined spatial and multilevel analyses; we are currently working on this problem. The suggestive spatial variation in LDDs could also be related to environmental exposure. In the northern part of the study area, several hazardous waste sites as well as a power plant were identified in previous health studies [<xref ref-type=""bibr"" rid=""B54"">54</xref>]. As data on environmental exposures from these or other sources in the area were not available, further assessment of exposure may be warranted.</p></sec><sec><title>Conclusions</title><p>These exploratory analyses produced maps of the risk of three indicators of LDD--special education placement, ADHD, and low educational attainment--in upper Cape Cod using GAMs and GIS. Results suggest that children living in certain parts of upper Cape Cod may have been more likely to have an LDD. The addresses used (birth addresses or childhood addresses) did not affect the spatial distribution of observed odds. Adjustment for known risk factors had little effect. Observed variation, although not statistically significant, may be due to local differences in the social or physical environment.</p></sec><sec><title>List of Abbreviations</title><p>(AIC): Akaike's Information Criterion; (ADD): attention deficit disorder; (ADHD): attention deficit hyperactivity disorder; (DSM): Diagnostic Statistical Manual; (GAMs): generalized additive models; (GIS): geographical information systems; (HD): hyperactive disorder; (IEP): individualized education plan; (LDD): learning and developmental disability; (loess): locally weighted regression smoother; (OR): odds ratio; (PCBs): polychlorinated biphenyls; (PCE): tetrachloroethylene.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>KH conducted spatial analyses and drafted the manuscript. TW collaborated on all analytic and editorial decisions. JW provided statistical support and consulted on analytic and editorial issues. AA provided the data and assisted in the epidemiologic analysis and editing. PJ and RW provided guidance relevant to the epidemiologic investigation of learning and development disabilities and edited the manuscript. VV collaborated on all analytic and editorial decisions and provided support for spatial analyses. All authors have read and approved the final manuscript.</p></sec><back><sec><title>Acknowledgements</title><p>This work was supported by the Boston University Center for Interdisciplinary Research in Environmental Exposures and Health and by grant P42ES007381 from the National Institute of Environmental Health (NIEHS), National Institutes of Health (NIH). The contents are solely the responsibility of the authors and do not necessarily represent the official views of NIEHS, NIH.</p></sec><ref-list><ref id=""B1""><mixed-citation publication-type=""journal""><name><surname>Lyon</surname><given-names>GR</given-names></name><article-title>Learning disabilities</article-title><source>Future Child</source><year>1996</year><volume>6</volume><fpage>54</fpage><lpage>76</lpage><pub-id pub-id-type=""doi"">10.2307/1602494</pub-id><pub-id pub-id-type=""pmid"">8689262</pub-id></mixed-citation></ref><ref id=""B2""><mixed-citation publication-type=""journal""><name><surname>Perrin</surname><given-names>JM</given-names></name><name><surname>Bloom</surname><given-names>SR</given-names></name><name><surname>Gortmaker</surname><given-names>SL</given-names></name><article-title>The increase of childhood chronic conditions in the United States</article-title><source>Jama</source><year>2007</year><volume>297</volume><fpage>2755</fpage><lpage>2759</lpage><pub-id pub-id-type=""doi"">10.1001/jama.297.24.2755</pub-id><pub-id pub-id-type=""pmid"">17595277</pub-id></mixed-citation></ref><ref id=""B3""><mixed-citation publication-type=""journal""><name><surname>Boyle</surname><given-names>CA</given-names></name><name><surname>Decoufle</surname><given-names>P</given-names></name><name><surname>Yeargin-Allsopp</surname><given-names>M</given-names></name><article-title>Prevalence and health impact of developmental disabilities in US children</article-title><source>Pediatrics</source><year>1994</year><volume>93</volume><fpage>399</fpage><lpage>403</lpage><pub-id pub-id-type=""pmid"">7509480</pub-id></mixed-citation></ref><ref id=""B4""><mixed-citation publication-type=""journal""><name><surname>Braun</surname><given-names>JM</given-names></name><name><surname>Kahn</surname><given-names>RS</given-names></name><name><surname>Froehlich</surname><given-names>T</given-names></name><name><surname>Auinger</surname><given-names>P</given-names></name><name><surname>Lanphear</surname><given-names>BP</given-names></name><article-title>Exposures to environmental toxicants and attention deficit hyperactivity disorder in U.S. children</article-title><source>Environ Health Perspect</source><year>2006</year><volume>114</volume><fpage>1904</fpage><lpage>1909</lpage><pub-id pub-id-type=""pmid"">17185283</pub-id></mixed-citation></ref><ref id=""B5""><mixed-citation publication-type=""journal""><name><surname>Landrigan</surname><given-names>PJ</given-names></name><name><surname>Schechter</surname><given-names>CB</given-names></name><name><surname>Lipton</surname><given-names>JM</given-names></name><name><surname>Fahs</surname><given-names>MC</given-names></name><name><surname>Schwartz</surname><given-names>J</given-names></name><article-title>Environmental pollutants and disease in American children: estimates of morbidity, mortality, and costs for lead poisoning, asthma, cancer, and developmental disabilities</article-title><source>Environ Health Perspect</source><year>2002</year><volume>110</volume><fpage>721</fpage><lpage>728</lpage><pub-id pub-id-type=""pmid"">12117650</pub-id></mixed-citation></ref><ref id=""B6""><mixed-citation publication-type=""journal""><name><surname>Duncan</surname><given-names>GJ</given-names></name><name><surname>Brooks-Gunn</surname><given-names>J</given-names></name><name><surname>Klebanov</surname><given-names>PK</given-names></name><article-title>Economic deprivation and early childhood development</article-title><source>Child Dev</source><year>1994</year><volume>65</volume><fpage>296</fpage><lpage>318</lpage><pub-id pub-id-type=""doi"">10.2307/1131385</pub-id><pub-id pub-id-type=""pmid"">7516849</pub-id></mixed-citation></ref><ref id=""B7""><mixed-citation publication-type=""journal""><name><surname>Biederman</surname><given-names>J</given-names></name><name><surname>Faraone</surname><given-names>SV</given-names></name><article-title>Attention-deficit hyperactivity disorder</article-title><source>Lancet</source><year>2005</year><volume>366</volume><fpage>237</fpage><lpage>248</lpage><pub-id pub-id-type=""doi"">10.1016/S0140-6736(05)66915-2</pub-id><pub-id pub-id-type=""pmid"">16023516</pub-id></mixed-citation></ref><ref id=""B8""><mixed-citation publication-type=""journal""><name><surname>Chapman</surname><given-names>DA</given-names></name><name><surname>Scott</surname><given-names>KG</given-names></name><name><surname>Mason</surname><given-names>CA</given-names></name><article-title>Early risk factors for mental retardation: role of maternal age and maternal education</article-title><source>Am J Ment Retard</source><year>2002</year><volume>107</volume><fpage>46</fpage><lpage>59</lpage><pub-id pub-id-type=""doi"">10.1352/0895-8017(2002)107&lt;0046:ERFFMR&gt;2.0.CO;2</pub-id><pub-id pub-id-type=""pmid"">11806749</pub-id></mixed-citation></ref><ref id=""B9""><mixed-citation publication-type=""journal""><name><surname>Cherkes-Julkowski</surname><given-names>M</given-names></name><article-title>Learning disability, attention-deficit disorder, and language impairment as outcomes of prematurity: a longitudinal descriptive study</article-title><source>J Learn Disabil</source><year>1998</year><volume>31</volume><fpage>294</fpage><lpage>306</lpage><pub-id pub-id-type=""doi"">10.1177/002221949803100309</pub-id><pub-id pub-id-type=""pmid"">9599962</pub-id></mixed-citation></ref><ref id=""B10""><mixed-citation publication-type=""journal""><name><surname>Resnick</surname><given-names>MB</given-names></name><name><surname>Gueorguieva</surname><given-names>RV</given-names></name><name><surname>Carter</surname><given-names>RL</given-names></name><name><surname>Ariet</surname><given-names>M</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Roth</surname><given-names>J</given-names></name><name><surname>Bucciarelli</surname><given-names>RL</given-names></name><name><surname>Curran</surname><given-names>JS</given-names></name><name><surname>Mahan</surname><given-names>CS</given-names></name><article-title>The impact of low birth weight, perinatal conditions, and sociodemographic factors on educational outcome in kindergarten</article-title><source>Pediatrics</source><year>1999</year><volume>104</volume><fpage>e74</fpage><pub-id pub-id-type=""doi"">10.1542/peds.104.6.e74</pub-id><pub-id pub-id-type=""pmid"">10586008</pub-id></mixed-citation></ref><ref id=""B11""><mixed-citation publication-type=""book""><name><surname>Swanson</surname><given-names>HL</given-names></name><name><surname>Harris</surname><given-names>KR</given-names></name><name><surname>Graham</surname><given-names>S</given-names></name><source>Handbook of learning disabilities</source><year>2003</year><publisher-name>New York: Guilford Press</publisher-name></mixed-citation></ref><ref id=""B12""><mixed-citation publication-type=""journal""><name><surname>Landrigan</surname><given-names>PJ</given-names></name><name><surname>Carlson</surname><given-names>JE</given-names></name><name><surname>Bearer</surname><given-names>CF</given-names></name><name><surname>Cranmer</surname><given-names>JS</given-names></name><name><surname>Bullard</surname><given-names>RD</given-names></name><name><surname>Etzel</surname><given-names>RA</given-names></name><name><surname>Groopman</surname><given-names>J</given-names></name><name><surname>McLachlan</surname><given-names>JA</given-names></name><name><surname>Perera</surname><given-names>FP</given-names></name><name><surname>Reigart</surname><given-names>JR</given-names></name><name><surname>Robison</surname><given-names>L</given-names></name><name><surname>Schell</surname><given-names>L</given-names></name><name><surname>Suk</surname><given-names>WA</given-names></name><article-title>Children's health and the environment: a new agenda for prevention research</article-title><source>Environ Health Perspect</source><year>1998</year><volume>106</volume><issue>Suppl 3</issue><fpage>787</fpage><lpage>794</lpage><pub-id pub-id-type=""doi"">10.2307/3434190</pub-id><pub-id pub-id-type=""pmid"">9646038</pub-id></mixed-citation></ref><ref id=""B13""><mixed-citation publication-type=""journal""><name><surname>Landrigan</surname><given-names>PJ</given-names></name><name><surname>Claudio</surname><given-names>L</given-names></name><name><surname>Markowitz</surname><given-names>SB</given-names></name><name><surname>Berkowitz</surname><given-names>GS</given-names></name><name><surname>Brenner</surname><given-names>BL</given-names></name><name><surname>Romero</surname><given-names>H</given-names></name><name><surname>Wetmur</surname><given-names>JG</given-names></name><name><surname>Matte</surname><given-names>TD</given-names></name><name><surname>Gore</surname><given-names>AC</given-names></name><name><surname>Godbold</surname><given-names>JH</given-names></name><name><surname>Wolff</surname><given-names>MS</given-names></name><article-title>Pesticides and inner-city children: exposures, risks, and prevention</article-title><source>Environ Health Perspect</source><year>1999</year><volume>107</volume><issue>Suppl 3</issue><fpage>431</fpage><lpage>437</lpage><pub-id pub-id-type=""pmid"">10346991</pub-id></mixed-citation></ref><ref id=""B14""><mixed-citation publication-type=""journal""><name><surname>Preston</surname><given-names>BL</given-names></name><name><surname>Warren</surname><given-names>RC</given-names></name><name><surname>Wooten</surname><given-names>SM</given-names></name><name><surname>Gragg</surname><given-names>RD</given-names></name><name><surname>Walker</surname><given-names>B</given-names></name><article-title>Environmental health and antisocial behavior: implications for public policy</article-title><source>J Environ Health</source><year>2001</year><volume>63</volume><fpage>9</fpage><lpage>19</lpage><pub-id pub-id-type=""pmid"">11383041</pub-id></mixed-citation></ref><ref id=""B15""><mixed-citation publication-type=""journal""><name><surname>Schneider</surname><given-names>D</given-names></name><name><surname>Freeman</surname><given-names>N</given-names></name><article-title>Children's environmental health risks: a state-of-the-art conference</article-title><source>Arch Environ Health</source><year>2001</year><volume>56</volume><fpage>103</fpage><lpage>110</lpage><pub-id pub-id-type=""doi"">10.1080/00039890109604060</pub-id><pub-id pub-id-type=""pmid"">11339672</pub-id></mixed-citation></ref><ref id=""B16""><mixed-citation publication-type=""journal""><name><surname>Rice</surname><given-names>D</given-names></name><name><surname>Barone</surname><given-names>S</given-names><suffix>Jr</suffix></name><article-title>Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models</article-title><source>Environ Health Perspect</source><year>2000</year><volume>108</volume><issue>Suppl 3</issue><fpage>511</fpage><lpage>533</lpage><pub-id pub-id-type=""doi"">10.2307/3454543</pub-id><pub-id pub-id-type=""pmid"">10852851</pub-id></mixed-citation></ref><ref id=""B17""><mixed-citation publication-type=""journal""><name><surname>Bellinger</surname><given-names>DC</given-names></name><article-title>Interpreting the literature on lead and child development: the neglected role of the ""experimental system""</article-title><source>Neurotoxicol Teratol</source><year>1995</year><volume>17</volume><fpage>201</fpage><lpage>212</lpage><pub-id pub-id-type=""doi"">10.1016/0892-0362(94)00081-N</pub-id><pub-id pub-id-type=""pmid"">7542726</pub-id></mixed-citation></ref><ref id=""B18""><mixed-citation publication-type=""journal""><name><surname>Cheuk</surname><given-names>DK</given-names></name><name><surname>Wong</surname><given-names>V</given-names></name><article-title>Attention-deficit hyperactivity disorder and blood mercury level: a case-control study in chinese children</article-title><source>Neuropediatrics</source><year>2006</year><volume>37</volume><fpage>234</fpage><lpage>240</lpage><pub-id pub-id-type=""doi"">10.1055/s-2006-924577</pub-id><pub-id pub-id-type=""pmid"">17177150</pub-id></mixed-citation></ref><ref id=""B19""><mixed-citation publication-type=""journal""><name><surname>Fergusson</surname><given-names>DM</given-names></name><name><surname>Fergusson</surname><given-names>JE</given-names></name><name><surname>Horwood</surname><given-names>LJ</given-names></name><name><surname>Kinzett</surname><given-names>NG</given-names></name><article-title>A longitudinal study of dentine lead levels, intelligence, school performance and behaviour. Part III. Dentine lead levels and attention/activity</article-title><source>J Child Psychol Psychiatry</source><year>1988</year><volume>29</volume><fpage>811</fpage><lpage>824</lpage><pub-id pub-id-type=""doi"">10.1111/j.1469-7610.1988.tb00755.x</pub-id><pub-id pub-id-type=""pmid"">3235491</pub-id></mixed-citation></ref><ref id=""B20""><mixed-citation publication-type=""journal""><name><surname>Grandjean</surname><given-names>P</given-names></name><name><surname>Landrigan</surname><given-names>PJ</given-names></name><article-title>Developmental neurotoxicity of industrial chemicals</article-title><source>Lancet</source><year>2006</year><volume>368</volume><fpage>2167</fpage><lpage>2178</lpage><pub-id pub-id-type=""doi"">10.1016/S0140-6736(06)69665-7</pub-id><pub-id pub-id-type=""pmid"">17174709</pub-id></mixed-citation></ref><ref id=""B21""><mixed-citation publication-type=""journal""><name><surname>Grandjean</surname><given-names>P</given-names></name><name><surname>White</surname><given-names>RF</given-names></name><name><surname>Nielsen</surname><given-names>A</given-names></name><name><surname>Cleary</surname><given-names>D</given-names></name><name><surname>de Oliveira Santos</surname><given-names>EC</given-names></name><article-title>Methylmercury neurotoxicity in Amazonian children downstream from gold mining</article-title><source>Environ Health Perspect</source><year>1999</year><volume>107</volume><fpage>587</fpage><lpage>591</lpage><pub-id pub-id-type=""doi"">10.2307/3434402</pub-id><pub-id pub-id-type=""pmid"">10379006</pub-id></mixed-citation></ref><ref id=""B22""><mixed-citation publication-type=""journal""><name><surname>Huisman</surname><given-names>M</given-names></name><name><surname>Koopman-Esseboom</surname><given-names>C</given-names></name><name><surname>Fidler</surname><given-names>V</given-names></name><name><surname>Hadders-Algra</surname><given-names>M</given-names></name><name><surname>Paauw</surname><given-names>CG van der</given-names></name><name><surname>Tuinstra</surname><given-names>LG</given-names></name><name><surname>Weisglas-Kuperus</surname><given-names>N</given-names></name><name><surname>Sauer</surname><given-names>PJ</given-names></name><name><surname>Touwen</surname><given-names>BC</given-names></name><name><surname>Boersma</surname><given-names>ER</given-names></name><article-title>Perinatal exposure to polychlorinated biphenyls and dioxins and its effect on neonatal neurological development</article-title><source>Early Hum Dev</source><year>1995</year><volume>41</volume><fpage>111</fpage><lpage>127</lpage><pub-id pub-id-type=""doi"">10.1016/0378-3782(94)01611-R</pub-id><pub-id pub-id-type=""pmid"">7601016</pub-id></mixed-citation></ref><ref id=""B23""><mixed-citation publication-type=""journal""><name><surname>Huisman</surname><given-names>M</given-names></name><name><surname>Koopman-Esseboom</surname><given-names>C</given-names></name><name><surname>Lanting</surname><given-names>CI</given-names></name><name><surname>Paauw</surname><given-names>CG van der</given-names></name><name><surname>Tuinstra</surname><given-names>LG</given-names></name><name><surname>Fidler</surname><given-names>V</given-names></name><name><surname>Weisglas-Kuperus</surname><given-names>N</given-names></name><name><surname>Sauer</surname><given-names>PJ</given-names></name><name><surname>Boersma</surname><given-names>ER</given-names></name><name><surname>Touwen</surname><given-names>BC</given-names></name><article-title>Neurological condition in 18-month-old children perinatally exposed to polychlorinated biphenyls and dioxins</article-title><source>Early Hum Dev</source><year>1995</year><volume>43</volume><fpage>165</fpage><lpage>176</lpage><pub-id pub-id-type=""doi"">10.1016/0378-3782(95)01674-0</pub-id><pub-id pub-id-type=""pmid"">8903761</pub-id></mixed-citation></ref><ref id=""B24""><mixed-citation publication-type=""journal""><name><surname>Jacobson</surname><given-names>JL</given-names></name><name><surname>Jacobson</surname><given-names>SW</given-names></name><article-title>Intellectual impairment in children exposed to polychlorinated biphenyls in utero</article-title><source>N Engl J Med</source><year>1996</year><volume>335</volume><fpage>783</fpage><lpage>789</lpage><pub-id pub-id-type=""doi"">10.1056/NEJM199609123351104</pub-id><pub-id pub-id-type=""pmid"">8703183</pub-id></mixed-citation></ref><ref id=""B25""><mixed-citation publication-type=""journal""><name><surname>Jacobson</surname><given-names>JL</given-names></name><name><surname>Jacobson</surname><given-names>SW</given-names></name><article-title>Teratogen update: polychlorinated biphenyls</article-title><source>Teratology</source><year>1997</year><volume>55</volume><fpage>338</fpage><lpage>347</lpage><pub-id pub-id-type=""doi"">10.1002/(SICI)1096-9926(199705)55:5&lt;338::AID-TERA6&gt;3.0.CO;2-V</pub-id><pub-id pub-id-type=""pmid"">9261928</pub-id></mixed-citation></ref><ref id=""B26""><mixed-citation publication-type=""journal""><name><surname>Lanphear</surname><given-names>BP</given-names></name><name><surname>Hornung</surname><given-names>R</given-names></name><name><surname>Khoury</surname><given-names>J</given-names></name><name><surname>Yolton</surname><given-names>K</given-names></name><name><surname>Baghurst</surname><given-names>P</given-names></name><name><surname>Bellinger</surname><given-names>DC</given-names></name><name><surname>Canfield</surname><given-names>RL</given-names></name><name><surname>Dietrich</surname><given-names>KN</given-names></name><name><surname>Bornschein</surname><given-names>R</given-names></name><name><surname>Greene</surname><given-names>T</given-names></name><name><surname>Rothenberg</surname><given-names>SJ</given-names></name><name><surname>Needleman</surname><given-names>HL</given-names></name><name><surname>Schnaas</surname><given-names>L</given-names></name><name><surname>Wasserman</surname><given-names>G</given-names></name><name><surname>Graziano</surname><given-names>J</given-names></name><name><surname>Roberts</surname><given-names>R</given-names></name><article-title>Low-level environmental lead exposure and children's intellectual function: an international pooled analysis</article-title><source>Environ Health Perspect</source><year>2005</year><volume>113</volume><fpage>894</fpage><lpage>899</lpage><pub-id pub-id-type=""pmid"">16002379</pub-id></mixed-citation></ref><ref id=""B27""><mixed-citation publication-type=""journal""><name><surname>Needleman</surname><given-names>HL</given-names></name><name><surname>Bellinger</surname><given-names>D</given-names></name><article-title>The health effects of low level exposure to lead</article-title><source>Annu Rev Public Health</source><year>1991</year><volume>12</volume><fpage>111</fpage><lpage>140</lpage><pub-id pub-id-type=""doi"">10.1146/annurev.pu.12.050191.000551</pub-id><pub-id pub-id-type=""pmid"">1828669</pub-id></mixed-citation></ref><ref id=""B28""><mixed-citation publication-type=""journal""><name><surname>Needleman</surname><given-names>HL</given-names></name><name><surname>Gunnoe</surname><given-names>C</given-names></name><name><surname>Leviton</surname><given-names>A</given-names></name><name><surname>Reed</surname><given-names>R</given-names></name><name><surname>Peresie</surname><given-names>H</given-names></name><name><surname>Maher</surname><given-names>C</given-names></name><name><surname>Barrett</surname><given-names>P</given-names></name><article-title>Deficits in psychologic and classroom performance of children with elevated dentine lead levels</article-title><source>N Engl J Med</source><year>1979</year><volume>300</volume><fpage>689</fpage><lpage>695</lpage><pub-id pub-id-type=""pmid"">763299</pub-id></mixed-citation></ref><ref id=""B29""><mixed-citation publication-type=""journal""><name><surname>Rice</surname><given-names>DC</given-names></name><article-title>Neurotoxicity of lead, methylmercury, and PCBs in relation to the Great Lakes</article-title><source>Environ Health Perspect</source><year>1995</year><volume>103</volume><issue>Suppl 9</issue><fpage>71</fpage><lpage>87</lpage><pub-id pub-id-type=""doi"">10.2307/3432725</pub-id><pub-id pub-id-type=""pmid"">8635443</pub-id></mixed-citation></ref><ref id=""B30""><mixed-citation publication-type=""journal""><name><surname>Rice</surname><given-names>DC</given-names></name><article-title>Behavioral effects of lead: commonalities between experimental and epidemiologic data</article-title><source>Environ Health Perspect</source><year>1996</year><volume>104</volume><issue>Suppl 2</issue><fpage>337</fpage><lpage>351</lpage><pub-id pub-id-type=""doi"">10.2307/3432654</pub-id><pub-id pub-id-type=""pmid"">9182041</pub-id></mixed-citation></ref><ref id=""B31""><mixed-citation publication-type=""journal""><name><surname>Dahlgren</surname><given-names>J</given-names></name><name><surname>Warshaw</surname><given-names>R</given-names></name><name><surname>Thornton</surname><given-names>J</given-names></name><name><surname>Anderson-Mahoney</surname><given-names>CP</given-names></name><name><surname>Takhar</surname><given-names>H</given-names></name><article-title>Health effects on nearby residents of a wood treatment plant</article-title><source>Environ Res</source><year>2003</year><volume>92</volume><fpage>92</fpage><lpage>98</lpage><pub-id pub-id-type=""doi"">10.1016/S0013-9351(02)00065-8</pub-id><pub-id pub-id-type=""pmid"">12854688</pub-id></mixed-citation></ref><ref id=""B32""><mixed-citation publication-type=""journal""><name><surname>Dayal</surname><given-names>H</given-names></name><name><surname>Gupta</surname><given-names>S</given-names></name><name><surname>Trieff</surname><given-names>N</given-names></name><name><surname>Maierson</surname><given-names>D</given-names></name><name><surname>Reich</surname><given-names>D</given-names></name><article-title>Symptom clusters in a community with chronic exposure to chemicals in two superfund sites</article-title><source>Arch Environ Health</source><year>1995</year><volume>50</volume><fpage>108</fpage><lpage>111</lpage><pub-id pub-id-type=""pmid"">7786046</pub-id></mixed-citation></ref><ref id=""B33""><mixed-citation publication-type=""journal""><name><surname>Kilburn</surname><given-names>KH</given-names></name><article-title>Neurotoxicity from airborne chemicals around a superfund site</article-title><source>Environ Res</source><year>1999</year><volume>81</volume><fpage>92</fpage><lpage>99</lpage><pub-id pub-id-type=""doi"">10.1006/enrs.1998.3971</pub-id><pub-id pub-id-type=""pmid"">10433840</pub-id></mixed-citation></ref><ref id=""B34""><mixed-citation publication-type=""journal""><name><surname>Wartenberg</surname><given-names>D</given-names></name><article-title>Investigating disease clusters: why, when and how?</article-title><source>J R Statist Soc A</source><year>2001</year><volume>164</volume><fpage>13</fpage><lpage>22</lpage><pub-id pub-id-type=""doi"">10.1111/1467-985X.00181</pub-id></mixed-citation></ref><ref id=""B35""><mixed-citation publication-type=""journal""><name><surname>Margai</surname><given-names>F</given-names></name><name><surname>Henry</surname><given-names>N</given-names></name><article-title>A community-based assessment of learning disabilities using environmental and contextual risk factors</article-title><source>Soc Sci Med</source><year>2003</year><volume>56</volume><fpage>1073</fpage><lpage>1085</lpage><pub-id pub-id-type=""doi"">10.1016/S0277-9536(02)00104-1</pub-id><pub-id pub-id-type=""pmid"">12593879</pub-id></mixed-citation></ref><ref id=""B36""><mixed-citation publication-type=""journal""><name><surname>Vieira</surname><given-names>V</given-names></name><name><surname>Webster</surname><given-names>T</given-names></name><name><surname>Weinberg</surname><given-names>J</given-names></name><name><surname>Aschengrau</surname><given-names>A</given-names></name><name><surname>Ozonoff</surname><given-names>D</given-names></name><article-title>Spatial analysis of lung, colorectal, and breast cancer on Cape Cod: an application of generalized additive models to case-control data</article-title><source>Environ Health</source><year>2005</year><volume>4</volume><fpage>11</fpage><pub-id pub-id-type=""doi"">10.1186/1476-069X-4-11</pub-id><pub-id pub-id-type=""pmid"">15955253</pub-id></mixed-citation></ref><ref id=""B37""><mixed-citation publication-type=""journal""><name><surname>Webster</surname><given-names>T</given-names></name><name><surname>Vieira</surname><given-names>V</given-names></name><name><surname>Weinberg</surname><given-names>J</given-names></name><name><surname>Aschengrau</surname><given-names>A</given-names></name><article-title>Method for mapping population-based case-control studies: an application using generalized additive models</article-title><source>Int J Health Geogr</source><year>2006</year><volume>5</volume><fpage>26</fpage><pub-id pub-id-type=""doi"">10.1186/1476-072X-5-26</pub-id><pub-id pub-id-type=""pmid"">16764727</pub-id></mixed-citation></ref><ref id=""B38""><mixed-citation publication-type=""journal""><name><surname>Janulewicz</surname><given-names>PA</given-names></name><name><surname>White</surname><given-names>RF</given-names></name><name><surname>Winter</surname><given-names>MR</given-names></name><name><surname>Weinberg</surname><given-names>JM</given-names></name><name><surname>Gallagher</surname><given-names>LE</given-names></name><name><surname>Vieira</surname><given-names>V</given-names></name><name><surname>Webster</surname><given-names>TF</given-names></name><name><surname>Aschengrau</surname><given-names>A</given-names></name><article-title>Risk of learning and behavioral disorders following prenatal and early postnatal exposure to tetrachloroethylene (PCE)-contaminated drinking water</article-title><source>Neurotoxicol Teratol</source><year>2008</year><volume>30</volume><fpage>175</fpage><lpage>185</lpage><pub-id pub-id-type=""doi"">10.1016/j.ntt.2008.01.007</pub-id><pub-id pub-id-type=""pmid"">18353612</pub-id></mixed-citation></ref><ref id=""B39""><mixed-citation publication-type=""journal""><name><surname>MacMillan</surname><given-names>DL</given-names></name><name><surname>Gresham</surname><given-names>FM</given-names></name><name><surname>Bocian</surname><given-names>KM</given-names></name><article-title>Discrepancy between definitions of learning disabilities and school practices: an empirical investigation</article-title><source>J Learn Disabil</source><year>1998</year><volume>31</volume><fpage>314</fpage><lpage>326</lpage><pub-id pub-id-type=""doi"">10.1177/002221949803100401</pub-id><pub-id pub-id-type=""pmid"">9666608</pub-id></mixed-citation></ref><ref id=""B40""><mixed-citation publication-type=""journal""><name><surname>Faraone</surname><given-names>SV</given-names></name><name><surname>Sergeant</surname><given-names>J</given-names></name><name><surname>Gillberg</surname><given-names>C</given-names></name><name><surname>Biederman</surname><given-names>J</given-names></name><article-title>The worldwide prevalence of ADHD: is it an American condition?</article-title><source>World Psychiatry</source><year>2003</year><volume>2</volume><fpage>104</fpage><lpage>113</lpage><pub-id pub-id-type=""pmid"">16946911</pub-id></mixed-citation></ref><ref id=""B41""><mixed-citation publication-type=""journal""><name><surname>Rowland</surname><given-names>AS</given-names></name><name><surname>Lesesne</surname><given-names>CA</given-names></name><name><surname>Abramowitz</surname><given-names>AJ</given-names></name><article-title>The epidemiology of attention-deficit/hyperactivity disorder (ADHD): a public health view</article-title><source>Ment Retard Dev Disabil Res Rev</source><year>2002</year><volume>8</volume><fpage>162</fpage><lpage>170</lpage><pub-id pub-id-type=""doi"">10.1002/mrdd.10036</pub-id><pub-id pub-id-type=""pmid"">12216060</pub-id></mixed-citation></ref><ref id=""B42""><mixed-citation publication-type=""book""><collab>American Psychiatric Association</collab><source>Diagnostic criteria from DSM-III-R</source><year>1987</year><publisher-name>Washington, DC: American Psychiatric Association</publisher-name></mixed-citation></ref><ref id=""B43""><mixed-citation publication-type=""book""><collab>American Psychiatric Association</collab><source>Diagnostic criteria from DSM-IV</source><year>1994</year><publisher-name>Washington, D.C.: American Psychiatric Association</publisher-name></mixed-citation></ref><ref id=""B44""><mixed-citation publication-type=""journal""><name><surname>Shaw</surname><given-names>P</given-names></name><name><surname>Eckstrand</surname><given-names>K</given-names></name><name><surname>Sharp</surname><given-names>W</given-names></name><name><surname>Blumenthal</surname><given-names>J</given-names></name><name><surname>Lerch</surname><given-names>JP</given-names></name><name><surname>Greenstein</surname><given-names>D</given-names></name><name><surname>Clasen</surname><given-names>L</given-names></name><name><surname>Evans</surname><given-names>A</given-names></name><name><surname>Giedd</surname><given-names>J</given-names></name><name><surname>Rapoport</surname><given-names>JL</given-names></name><article-title>Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation</article-title><source>Proc Natl Acad Sci USA</source><year>2007</year><volume>104</volume><fpage>19649</fpage><lpage>19654</lpage><pub-id pub-id-type=""doi"">10.1073/pnas.0707741104</pub-id><pub-id pub-id-type=""pmid"">18024590</pub-id></mixed-citation></ref><ref id=""B45""><mixed-citation publication-type=""journal""><name><surname>Cairns</surname><given-names>RB</given-names></name><name><surname>Cairns</surname><given-names>BD</given-names></name><name><surname>Neckerman</surname><given-names>HJ</given-names></name><article-title>Early school dropout: configurations and determinants</article-title><source>Child Dev</source><year>1989</year><volume>60</volume><fpage>1437</fpage><lpage>1452</lpage><pub-id pub-id-type=""doi"">10.2307/1130933</pub-id><pub-id pub-id-type=""pmid"">2612252</pub-id></mixed-citation></ref><ref id=""B46""><mixed-citation publication-type=""journal""><name><surname>Kortering</surname><given-names>L</given-names></name><name><surname>Haring</surname><given-names>N</given-names></name><name><surname>Klockars</surname><given-names>A</given-names></name><article-title>The identification of high-school dropouts identified as learning disabled: evaluating the utility of a discriminant analysis function</article-title><source>Except Child</source><year>1992</year><volume>58</volume><fpage>422</fpage><lpage>435</lpage><pub-id pub-id-type=""pmid"">1582436</pub-id></mixed-citation></ref><ref id=""B47""><mixed-citation publication-type=""journal""><name><surname>Kemp</surname><given-names>SE</given-names></name><article-title>Dropout policies and trends for students with and without disabilities</article-title><source>Adolescence</source><year>2006</year><volume>41</volume><fpage>235</fpage><lpage>250</lpage><pub-id pub-id-type=""pmid"">16981614</pub-id></mixed-citation></ref><ref id=""B48""><mixed-citation publication-type=""other""><collab>United States Department of Education</collab><article-title>A new era: revitalizing special education for children and their families</article-title><source>President's Commission on Excellence in Special Education. Washington, D.C</source><year>2002</year></mixed-citation></ref><ref id=""B49""><mixed-citation publication-type=""book""><name><surname>Hastie</surname><given-names>T</given-names></name><name><surname>Tibshirani</surname><given-names>R</given-names></name><source>Generalized additive models</source><year>1990</year><edition>1</edition><publisher-name>London; New York: Chapman and Hall</publisher-name></mixed-citation></ref><ref id=""B50""><mixed-citation publication-type=""other""><collab>Insightful</collab><article-title>S-Plus</article-title><ext-link ext-link-type=""uri"" xlink:href=""http://spotfire.tibco.com/Products/SPLUS-Client.aspx"">http://spotfire.tibco.com/Products/SPLUS-Client.aspx</ext-link></mixed-citation></ref><ref id=""B51""><mixed-citation publication-type=""other""><collab>ESRI</collab><article-title>ArcMap</article-title><ext-link ext-link-type=""uri"" xlink:href=""http://www.esri.com/software/arcgis/index.html"">http://www.esri.com/software/arcgis/index.html</ext-link></mixed-citation></ref><ref id=""B52""><mixed-citation publication-type=""journal""><name><surname>Faraone</surname><given-names>SV</given-names></name><name><surname>Biederman</surname><given-names>J</given-names></name><name><surname>Milberger</surname><given-names>S</given-names></name><article-title>How reliable are maternal reports of their children's psychopathology? One-year recall of psychiatric diagnoses of ADHD children</article-title><source>J Am Acad Child Adolesc Psychiatry</source><year>1995</year><volume>34</volume><fpage>1001</fpage><lpage>1008</lpage><pub-id pub-id-type=""doi"">10.1097/00004583-199508000-00009</pub-id><pub-id pub-id-type=""pmid"">7665438</pub-id></mixed-citation></ref><ref id=""B53""><mixed-citation publication-type=""journal""><name><surname>Vieira</surname><given-names>V</given-names></name><name><surname>Webster</surname><given-names>T</given-names></name><name><surname>Weinberg</surname><given-names>J</given-names></name><name><surname>Aschengrau</surname><given-names>A</given-names></name><article-title>Spatial-temporal analysis of breast cancer in upper Cape Cod, Massachusetts</article-title><source>Int J Health Geo</source><year>2008</year><volume>7</volume><fpage>46</fpage><pub-id pub-id-type=""doi"">10.1186/1476-072X-7-46</pub-id></mixed-citation></ref><ref id=""B54""><mixed-citation publication-type=""book""><name><surname>Aschengrau</surname><given-names>A</given-names></name><name><surname>Ozonoff</surname><given-names>D</given-names></name><source>Upper Cape Cancer Incidence Study. Final Report</source><year>1991</year><publisher-name>Boston: Massachusetts Department of Public Health</publisher-name></mixed-citation></ref></ref-list>"
10.1055/s-2006-924577	"<html><body><p>Int_J_Health_Geogr/PMC2836293.nxml                                                                  0000664 0011011 0007774 00000212765 13032452420 015425  0                                                                                                    ustar   pmc                             pmcdev<!DOCTYPE article PUBLIC ""-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN"" ""JATS-archivearticle1.dtd""><article article-type=""review-article"" xmlns:mml=""http://www.w3.org/1998/Math/MathML"" xmlns:xlink=""http://www.w3.org/1999/xlink""><?properties open_access?><front><journal-meta><journal-id journal-id-type=""nlm-ta"">J Occup Med Toxicol</journal-id><journal-title-group><journal-title>Journal of Occupational Medicine and Toxicology (London, England)</journal-title></journal-title-group><issn pub-type=""epub"">1745-6673</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type=""pmid"">21232090</article-id><article-id pub-id-type=""pmc"">3025977</article-id><article-id pub-id-type=""publisher-id"">1745-6673-6-2</article-id><article-id pub-id-type=""doi"">10.1186/1745-6673-6-2</article-id><article-categories><subj-group subj-group-type=""heading""><subject>Review</subject></subj-group></article-categories><title-group><article-title>Is dental amalgam safe for humans? The opinion of the scientific committee of the European Commission</article-title></title-group><contrib-group><contrib contrib-type=""author"" corresp=""yes"" id=""A1""><name><surname>Mutter</surname><given-names>Joachim</given-names></name><xref ref-type=""aff"" rid=""I1"">1</xref><email>jm@zahnklinik.de</email></contrib></contrib-group><aff id=""I1""><label>1</label>Department of Environmental and integrative medicine Lohnerhofstraße 2, 78467 Constance/Germany</aff><pub-date pub-type=""collection""><year>2011</year></pub-date><pub-date pub-type=""epub""><day>13</day><month>1</month><year>2011</year></pub-date><volume>6</volume><fpage>2</fpage><lpage>2</lpage><history><date date-type=""received""><day>23</day><month>3</month><year>2010</year></date><date date-type=""accepted""><day>13</day><month>1</month><year>2011</year></date></history><permissions><copyright-statement>Copyright ©2011 Mutter; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2011</copyright-year><copyright-holder>Mutter; licensee BioMed Central Ltd.</copyright-holder><license license-type=""open-access"" xlink:href=""http://creativecommons.org/licenses/by/2.0""><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type=""uri"" xlink:href=""http://creativecommons.org/licenses/by/2.0"">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href=""http://www.occup-med.com/content/6/1/2""></self-uri><abstract><p>It was claimed by the Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR)) in a report to the EU-Commission that ""....no risks of adverse systemic effects exist and the current use of dental amalgam does not pose a risk of systemic disease..."" [1, available from:<ext-link ext-link-type=""uri"" xlink:href=""http://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_016.pdf"">http://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_016.pdf</ext-link>].</p><p>SCENIHR disregarded the toxicology of mercury and did not include most important scientific studies in their review. But the real scientific data show that:</p><p>(a) Dental amalgam is by far the main source of human total mercury body burden. This is proven by autopsy studies which found 2-12 times more mercury in body tissues of individuals with dental amalgam. Autopsy studies are the most valuable and most important studies for examining the amalgam-caused mercury body burden.</p><p>(b) These autopsy studies have shown consistently that many individuals with amalgam have toxic levels of mercury in their brains or kidneys.</p><p>(c) There is no correlation between mercury levels in blood or urine, and the levels in body tissues or the severity of clinical symptoms. SCENIHR only relied on levels in urine or blood.</p><p>(d) The half-life of mercury in the brain can last from several years to decades, thus mercury accumulates over time of amalgam exposure in body tissues to toxic levels. However, SCENIHR state that the half-life of mercury in the body is only ""20-90 days"".</p><p>(e) Mercury vapor is about ten times more toxic than lead on human neurons and with synergistic toxicity to other metals.</p><p>(f) Most studies cited by SCENIHR which conclude that amalgam fillings are safe have severe methodical flaws.</p></abstract></article-meta></front><sec><title>Dental amalgam is the main source of mercury in human tissues</title><p>SCENIHR (Scientific Committee on Emerging and Newly Identified Health Risks) from the European Commission claim [<xref ref-type=""bibr"" rid=""B1"">1</xref>]: ""Exposure to mercury is difficult to measure. The indications for mercury exposure are therefore normally obtained by measuring mercury levels in urine and blood of individuals.""</p><p>SCENIHR did not cite any autopsy studies, which are the most reliable studies for assessing mercury levels in tissues.</p><p>An approx. 2-5-fold increase of mercury levels in blood and urine in living individuals with dental amalgam as well as a 2-12 fold increase in several body tissues was observed in deceased individuals with dental amalgam [<xref ref-type=""bibr"" rid=""B2"">2</xref>-<xref ref-type=""bibr"" rid=""B21"">21</xref>]. Additionally, studies with animals have confirmed the fact that dental amalgam leads to significantly increased levels in the tissues [<xref ref-type=""bibr"" rid=""B22"">22</xref>-<xref ref-type=""bibr"" rid=""B28"">28</xref>].</p><p>According to these studies, dental amalgam is responsible for at least 60-95% of mercury deposits in human tissues. This was not acknowledged by SCENIHR.</p></sec><sec><title>No organic mercury compounds through dental amalgam?</title><p>SCENIHR [<xref ref-type=""bibr"" rid=""B1"">1</xref>] state that ""there is no evidence that biotransformation of amalgam derived mercury takes place intra-orally in association with bacterial activity.""</p><p>In contrast to this claim studies have shown that mercury (Hg) from dental amalgam is transformed into organic mercury compounds by microorganisms in the human gastrointestinal tract [<xref ref-type=""bibr"" rid=""B29"">29</xref>-<xref ref-type=""bibr"" rid=""B31"">31</xref>]. Leistevuo et al. (2001) found a three-fold increase of methylmercury levels in saliva of individuals with dental amalgam compared to individuals without amalgam, although frequency and kind of fish consumption were identical in both groups. Mercury levels in saliva exceed mercury limits for sewage in 20% of individuals with amalgam [<xref ref-type=""bibr"" rid=""B30"">30</xref>]. The form of methylmercury derived from dental amalgam may be much more toxic (up to 20 times) than the form of methylmercury found in fish (see section ""toxicity of mercury"").</p></sec><sec><title>Toxic mercury levels in vitro and in vivo</title><p>Inorganic mercury levels of 0.02 ng Hg/g (2 μl of 0.1 μMolar Hg in 2 ml substrate) led to the total destruction of intracellular mircrotubuli and to the degeneration of axons [<xref ref-type=""bibr"" rid=""B32"">32</xref>]. In other experiments inorganic mercury levels of 36 ng Hg/g (0.18 μMol Hg) led to increased oxidative stress as a prerequisite for further cell damage [<xref ref-type=""bibr"" rid=""B33"">33</xref>,<xref ref-type=""bibr"" rid=""B34"">34</xref>].</p><p>Mercury vapor inhalation in doses which also occur in humans with many amalgam fillings and chewing led to pathological changes in the brains of animals after 14 days [<xref ref-type=""bibr"" rid=""B35"">35</xref>,<xref ref-type=""bibr"" rid=""B36"">36</xref>].</p></sec><sec><title>No toxic mercury levels in humans through dental amalgam?</title><p>In a recent autopsy study, it was found that individuals with more than 12 amalgam fillings have more than 10-times higher mercury levels in several tissues including the brain, compared to individuals with only 0-3 amalgam fillings [<xref ref-type=""bibr"" rid=""B11"">11</xref>].</p><p>The average mercury level in the brain of EU citizens with more than 12 amalgam fillings was 300 ng Hg/g brain tissue [<xref ref-type=""bibr"" rid=""B11"">11</xref>], which is well above mercury levels proven to be toxic in vitro on neurons (0.02 -36 ng Hg/g) (see above).</p><p>In another autopsy, individuals with more than 10 amalgams have 504 ng Hg/g in their kidney tissues (0-2 amalgams: 54 ng Hg/g) and 83.3 ng Hg/g in the liver (0-2 amalgams: 17.68 ng Hg/g) [<xref ref-type=""bibr"" rid=""B5"">5</xref>].</p><p>Mercury levels in thyroid- and pituitary glands were 55 ng Hg/g and 200 ng Hg/g respectively and again, these levels correlates significantly with numbers of amalgam fillings [<xref ref-type=""bibr"" rid=""B37"">37</xref>].</p><p>Because the levels found in these studies are only average levels, a significant portion of individuals with dental amalgam have more than twice (standard deviation) these toxic mercury levels in their body tissues. It is important to note that mercury levels found in subcellular fractions like microsomes, mitochondria and other cell compartments even exceed the average levels of the brain samples analysed in these studies [<xref ref-type=""bibr"" rid=""B38"">38</xref>].</p></sec><sec><title>Toxic mercury levels in Alzheimer's disease</title><p>The average mercury load in brain tissues of individuals with Alzheimer`s disease was 20 to 178 ng Hg/g; in some cases the load exceeded up to (236- 698 ng Hg/g). In 15% of the human brain samples the mercury load was above 100 ng Hg/g [<xref ref-type=""bibr"" rid=""B39"">39</xref>-<xref ref-type=""bibr"" rid=""B41"">41</xref>]. The average mercury load in the pituitary gland was 400 ng Hg/g [<xref ref-type=""bibr"" rid=""B42"">42</xref>]. These levels are again well far above established toxic levels (see above).</p></sec><sec><title>Pathological changes, caused by mercury, in most german human brains?</title><p>About 20% of individuals in the age group of 20 years, 50% of individuals in the age group of 50 years, and 90% of people in the age group of 85 years living in Germany show pathological changes in their brains that are typical for Alzheimer's disease [<xref ref-type=""bibr"" rid=""B43"">43</xref>] and mercury toxicity. This coverage of pathological brain changes caused by very low levels of mercury in experiments and not by low levels of other metals (like lead, iron, aluminum, copper, manganese, chromium, cadmium) [<xref ref-type=""bibr"" rid=""B32"">32</xref>,<xref ref-type=""bibr"" rid=""B36"">36</xref>] resembles the frequency of dental amalgam fillings implanted in humans: About 80-90% of people living in Germany have dental amalgam over decades. It must be noted that about 30-50% of german people above the age of 85 years have Alzheimer's disease (AD) and there are many hints that mercury plays the major pathogenetic role in AD [<xref ref-type=""bibr"" rid=""B44"">44</xref>].</p></sec><sec><title>Maternal amalgam as the main source of mercury in infant tissues</title><p>Maternal amalgam fillings lead to a significant increase of mercury levels in fetal and infant body tissues including the brain [<xref ref-type=""bibr"" rid=""B6"">6</xref>]. Furthermore, placental, fetal and infant mercury body burden correlates with the number of amalgam fillings of the mothers [<xref ref-type=""bibr"" rid=""B6"">6</xref>,<xref ref-type=""bibr"" rid=""B45"">45</xref>-<xref ref-type=""bibr"" rid=""B52"">52</xref>].</p><p>Mercury levels in amniotic fluid [<xref ref-type=""bibr"" rid=""B53"">53</xref>] and breast milk [<xref ref-type=""bibr"" rid=""B54"">54</xref>-<xref ref-type=""bibr"" rid=""B56"">56</xref>] also significantly correlate with the number of maternal amalgam fillings.</p></sec><sec><title>Mercury in infant tissues: Increased risk of neurodevelopmental disorders?</title><p>Drasch et al. found mercury levels of up to 20 ng Hg/g in German infant brain tissues which were mainly caused by dental amalgam fillings of their mothers [<xref ref-type=""bibr"" rid=""B6"">6</xref>]. As described above, mercury levels of 0,02 ng Hg/g led to degeneration of axons [<xref ref-type=""bibr"" rid=""B32"">32</xref>]. Furthermore, the mercury levels found in the brains of infants whose mothers were dental amalgam bearers are sufficient enough to inhibit the function of the important enzyme methionin synthetase [<xref ref-type=""bibr"" rid=""B57"">57</xref>,<xref ref-type=""bibr"" rid=""B58"">58</xref>]. Methionin synthetase is crucial for methylation, a central step for most important metabolic reactions the the body, including the development of the brain, the maturation of nerve cells and the production of neurotransmitters.</p><p>Maternal amalgam fillings also increase significantly mercury levels in cord blood [<xref ref-type=""bibr"" rid=""B59"">59</xref>,<xref ref-type=""bibr"" rid=""B60"">60</xref>]. The risk for delayed neurodevelopment of children was 3.58- times increased when mercury levels in cord blood were higher than 0.8 ng Hg/ml [<xref ref-type=""bibr"" rid=""B61"">61</xref>]. It is important to note that mercury levels of 0.2 - 5 ng Hg/ml cord blood are considered ""normal"" in Germany [<xref ref-type=""bibr"" rid=""B62"">62</xref>], thus leaving many infants with mercury levels that may cause neurodevelopmental deficits.</p></sec><sec><title>No correlation between mercury in urine or blood and in body tissues</title><p>The SCENIHR report is based on studies which have measured mercury levels in biomarkers such as urine for the assessment of clinical symptoms or mercury body burden. However, the WHO states (1991) that</p><p>""Mercury typifies a ""retention"" toxicity and much of the mercury taken into the body is absorbed by the solid tissues. The amount in urine represents mercury being excreted. However, the main question is how much is being retained in the different body tissues"".</p><p>It has been shown in experiments with animals and men that in spite of normal or low mercury levels in blood, hair and urine high mercury levels are found in critical tissues such as brain and kidney [<xref ref-type=""bibr"" rid=""B7"">7</xref>,<xref ref-type=""bibr"" rid=""B13"">13</xref>,<xref ref-type=""bibr"" rid=""B20"">20</xref>,<xref ref-type=""bibr"" rid=""B22"">22</xref>,<xref ref-type=""bibr"" rid=""B25"">25</xref>,<xref ref-type=""bibr"" rid=""B28"">28</xref>,<xref ref-type=""bibr"" rid=""B46"">46</xref>,<xref ref-type=""bibr"" rid=""B63"">63</xref>,<xref ref-type=""bibr"" rid=""B64"">64</xref>]. A recent study on deceased individuals confirm that there exists no correlation between inorganic mercury levels in urine or blood and mercury levels in brain tissues [<xref ref-type=""bibr"" rid=""B37"">37</xref>].</p><p>Drasch and coauthors have shown that 64% of individuals occupationally exposed to mercury vapor and having typical clinical signs of mercury intoxication had urine levels of mercury below 5 μg/l, which represent the No Observed Adverse Effect Level (NOAEL). The same results were found for mercury levels in blood and hair [<xref ref-type=""bibr"" rid=""B65"">65</xref>-<xref ref-type=""bibr"" rid=""B67"">67</xref>].</p></sec><sec><title>Paradoxical association between mercury levels in urine and clinical symptoms</title><p>There is even a paradoxical correlation between mercury levels in urine, blood or hair and clinical symptoms: Subjects with highest urine levels of mercury showed best recovery rates from neuropsychological complaints after removing their amalgam fillings [<xref ref-type=""bibr"" rid=""B68"">68</xref>]. Also children with highest mercury levels in hair showed better performance in developmental tests [<xref ref-type=""bibr"" rid=""B69"">69</xref>]. Another study indicates that in spite of a significantly higher exposure to mercury in their mothers` womb autistic children had up to 15-times lower mercury levels in their infant hair than healthy children [<xref ref-type=""bibr"" rid=""B46"">46</xref>]. Furthermore, the lower the mercury levels in infant hair, the higher was the severity of autism [<xref ref-type=""bibr"" rid=""B46"">46</xref>].</p><p>Despite higher mercury body burden, a ""amalgam hypersensitivity"" group showed slightly lower levels of mercury in their saliva, blood and urine [<xref ref-type=""bibr"" rid=""B70"">70</xref>]. Even after provocation with the mercury chelator DMPS, the ""amalgam hypersensitivity"" group excreted in mean only 7,77 μg Hg via urine in 24 h whereas healthy amalgam bearers excreted 12,69 μg Hg/24h [<xref ref-type=""bibr"" rid=""B70"">70</xref>].</p><p>Furthermore, studies confirm that the ratio of fecal to urine excretion is 12 to 1 [<xref ref-type=""bibr"" rid=""B13"">13</xref>]. This proves that the majority of excreted mercury leaves through the bilary transport system of the liver via the fecal route. Urine mercury therefore represents a minor excretory route of less than 8% of mercury being excreted. Also, urine mercury is a measure of mercury being excreted by the kidney---not a measure of total mercury body burden.</p></sec><sec><title>Safety levels for mercury?</title><p>In view of the data presented above, it is impossible to determine any safety levels below which adverse effects can be excluded [<xref ref-type=""bibr"" rid=""B71"">71</xref>]. SCENIHR used safety limits which were deduced from studies with workers occupationally exposed to mercury. However, these limits cannot be applied to individuals with amalgam fillings and must be critically evaluated:</p><p>a) Frequently, mercury exposure of workers in the chlorine-alkali industry is used for comparison although the simultaneous exposure to chlorine considerably diminishes the absorption of mercury into the body tissues of animals by 50-100% [<xref ref-type=""bibr"" rid=""B72"">72</xref>].</p><p>b) Workers exposed to mercury usually represent a group whose mercury-exposure starts only with adulthood (for about 8 hours a day, 5 days a week), while amalgam bearers can be exposed to mercury in the womb through maternal amalgam fillings during their childhood and until death at a rate of 24 hours per day, 7 days per week.</p><p>c) Workers are a selected healthy group, while pregnant women, infants, children and individuals with illnesses (such as multiple sclerosis, autoimmunity, cancer, psychiatric diseases) do not start working at all either due to industrial safety regulations or to early health problems during working.</p><p>d) Despite mercury exposure below ""safety limits"", significant adverse health effects were found in most studies in workers exposed occupationally to mercury, even several years after the exposure had ceased [<xref ref-type=""bibr"" rid=""B73"">73</xref>-<xref ref-type=""bibr"" rid=""B81"">81</xref>].</p></sec><sec><title>Body half-time period of mercury</title><p>SCENIHR state that the body half-time (of mercury) is ""20-90 days"".</p><p>Particularly in the brain, mercury has a significantly longer half-time of more than 17 years [<xref ref-type=""bibr"" rid=""B63"">63</xref>,<xref ref-type=""bibr"" rid=""B64"">64</xref>,<xref ref-type=""bibr"" rid=""B82"">82</xref>-<xref ref-type=""bibr"" rid=""B87"">87</xref>].</p></sec><sec><title>Toxicity of mercury</title><p>SCENIHR did not mention the specific toxicity of mercury vapor coming off dental amalgam fillings. This should be mentioned in a risk analysis:</p><p>Mercury has been shown to be 10 times more toxic than lead (Pb) in vitro [<xref ref-type=""bibr"" rid=""B88"">88</xref>-<xref ref-type=""bibr"" rid=""B90"">90</xref>]. Mercury is the most toxic non-radioactive element. Mercury vapor is one of the most toxic forms of mercury along with some of the organic mercury compounds. This extraordinary toxicity is also determined by the following properties:</p><p>a) Mercury is the only metal representing a volatile gas at room temperature, which is readily absorbed (80%) by the respiratory system.</p><p>b) Mercury vapor from amalgam penetrate into tissues with great ease, because of its monopolar atomic configuration.</p><p>c) Once inside the cells, mercury vapor is oxidized to Hg<sup>2+</sup>, the very toxic form of mercury which binds covalently to thiol groups of proteins inhibiting their biological activity.</p><p>d) Hg<sup>2+</sup>is more toxic than Pb<sup>2+</sup>, Cadmium (Cd<sup>2+</sup>) and other metals because it has a higher affinity due to ""covalent bond"" formation with thiol groups (cysteines in proteins) causing irreversible inhibition. Other metals form reversible bonds with proteins and are therefore less toxic.</p><p>e) Hg<sup>2+</sup>does not bind tightly enough to the carboxylate groups of natural organic acids (natural chelators like citrate) for its toxicity to be prevented.</p><p>f) Chelating agents, like EDTA, which normally inhibit the toxic effect of heavy metals like lead, have no inhibitory effect on the toxicity of mercury or may even increase it [<xref ref-type=""bibr"" rid=""B91"">91</xref>,<xref ref-type=""bibr"" rid=""B92"">92</xref>]. Other chelating agents (DMPS and DMSA) inhibit the toxic effect of Cd<sup>2+</sup>and Pb<sup>2+,</sup>but not of Hg<sup>2+</sup>[<xref ref-type=""bibr"" rid=""B93"">93</xref>]. DMPS, DMSA or natural chelators like vitamin C, glutathione or alpha-lipoic acid are not able to remove mercury from nervous tissues [<xref ref-type=""bibr"" rid=""B94"">94</xref>]. DMPS or DMSA may even increase the inhibitory activity of Hg<sup>2+</sup>and Cd<sup>2+</sup>on enzymes but not of Pb<sup>2+</sup>[<xref ref-type=""bibr"" rid=""B95"">95</xref>]. Furthermore, DMPS in animals led to an increase of mercury concentrations in the spinal cord [<xref ref-type=""bibr"" rid=""B96"">96</xref>].</p><p>The toxicity of methylmercury which is bound to cysteine in fish seems to be far lower (only approx. 1/20) than methylmercury compounds usually used in experiments [<xref ref-type=""bibr"" rid=""B97"">97</xref>].</p><p>Furthermore, marine fish represents a significant source of selenium and essential omega-3-fatty acids, which are known to protect effectively against mercury toxicity. Nevertheless, methylmercurychloride, which proved to be more toxic than methylmercury in fish, showed less neurotoxicity for the growing nervous system in vivo than did mercury vapor [<xref ref-type=""bibr"" rid=""B98"">98</xref>].</p><p>Investigations by Drasch et al. show similar correlations: The population of a goldmining area, which was exposed to mercury vapor, showed significantly more neurological symptoms of mercury intoxication than a control group which mainly was exposed to methylmercury from fish consumption, despite their mercury levels in hair and plasma being higher compared to the individuals exposed to mercury vapor [<xref ref-type=""bibr"" rid=""B65"">65</xref>,<xref ref-type=""bibr"" rid=""B66"">66</xref>]. Another study also points to smaller neurotoxicity of methymercury from fish compared to iatrogenic mercury sources (amalgam, thimerosal) [<xref ref-type=""bibr"" rid=""B46"">46</xref>]. Here, in contrast to the numbers of dental amalgam in the mothers, no correlation between maternal fish consumption during pregnancy and the risk of autism for their children was found.</p><p>In summary, mercury vapor coming off dental amalgam or methylmercury derived from amalgam in the gastrointestinal tract has not reacted with anything yet and has the full toxic potential. On the other hand, methylmercury in fish has already reacted with fish proteins and other protective molecules or atoms in fish tissues such as glutathione or selenium, which are enriched in fish. Furthermore, newest studies confirm that most individuals with dental amalgam fillings are exposed to toxic mercury levels [<xref ref-type=""bibr"" rid=""B99"">99</xref>,<xref ref-type=""bibr"" rid=""B100"">100</xref>].</p></sec><sec><title>Synergistic toxicity of mercury to lead (Pb)</title><p>Some scientists try to argue that results gained by animal or cell testing are overestimated and not comparable to the situation of the human body. However, in contrast to test animals in experiments, humans are exposed to many other toxins simultaneously, thus the effects add up or are even synergistic [<xref ref-type=""bibr"" rid=""B101"">101</xref>,<xref ref-type=""bibr"" rid=""B102"">102</xref>]. For example, it has been proven that the combination of the Lethal Dose 1% of mercury (LD1<sub>Hg</sub>) together with the LD1 of lead (Pb) results in the death of all animals, so the following toxicological equation can be assumed: LD1 (Hg) + LD1 (Pb) = LD 100 [<xref ref-type=""bibr"" rid=""B101"">101</xref>].</p><p>In this context, it must be considered that modern humans have more mercury and between 10-1,000-times more lead in their body tissues than ancient humans.</p><p>In other experiments, the addition of aluminumhydroxide (often in vaccines), antibiotics, thimerosal (sometimes in vaccines) and testosterone increased the toxicity of mercury [<xref ref-type=""bibr"" rid=""B108"">108</xref>,<xref ref-type=""bibr"" rid=""B109"">109</xref>]. The synergistic toxicity of testosterone explain the observation, that much more males than females suffers from autism or amyotrophic lateral sclerosis.</p></sec><sec><title>No adverse effects through dental amalgam?</title><p>SCENIHR states ""It is generally concluded that no increased risk on adverse systemic effects exists and we do not consider that the current use of dental amalgam poses a risk of systemic disease"" and ""....some local adverse effects are occasionally seen with dental amalgam fillings, but the incidence is low and normally readily managed""</p><p>SCENIHR has neglected numerous scientific studies which find significant adverse health effects from dental amalgam:</p></sec><sec><title>Cytotoxicity of amalgam in comparison to composites</title><p>SCENIHR compare the toxicity of amalgam with composites. However, in most experiments, even inorganic mercury, which is much less toxic than mercury vapor (because inorganic mercury is not able to penetrate easily into the cells), was proven to be much more toxic than any composite compound: Mercury was shown to be 100-800- fold more toxic than composite components for human cells [<xref ref-type=""bibr"" rid=""B110"">110</xref>-<xref ref-type=""bibr"" rid=""B114"">114</xref>].</p></sec><sec><title>Genotoxicity, oxidative stress, cancer</title><p>Dental amalgam fillings have been found to cause DNA damage in human blood cells. [<xref ref-type=""bibr"" rid=""B115"">115</xref>]. Even low levels of inorganic mercury lead to significant DNA damage in human tissue cells and lymphocytes [<xref ref-type=""bibr"" rid=""B116"">116</xref>]. This effect, which trigger cancer, has been found with mercury levels below those normally causing cytotoxicity and cell death. Furthermore, aberrations of chromosomes can be provoked by amalgam in cell cultures [<xref ref-type=""bibr"" rid=""B117"">117</xref>]. Amalgam bearers show significantly increased oxidative stress in saliva [<xref ref-type=""bibr"" rid=""B118"">118</xref>,<xref ref-type=""bibr"" rid=""B119"">119</xref>] and blood [<xref ref-type=""bibr"" rid=""B120"">120</xref>,<xref ref-type=""bibr"" rid=""B121"">121</xref>]. The increase of oxidative stress correlates with the numbers of amalgam fillings. Mercury levels normally seen in tissues of individuals with amalgam fillings lead to increased oxidative stress and reduction of glutathione levels, thus inducing cellular damage [<xref ref-type=""bibr"" rid=""B33"">33</xref>,<xref ref-type=""bibr"" rid=""B34"">34</xref>]. Significantly elevated mercury levels have also been observed in breast cancer tissues [<xref ref-type=""bibr"" rid=""B122"">122</xref>]. Mercury deposited in the tissue is mostly bound to selenium, which means that the this selenium is no longer available for the body. Therefore, amalgam may aggravate a latent deficiency of selenium, particularly in countries with suboptimal selenium supply (e.g. in Central Europe) [<xref ref-type=""bibr"" rid=""B123"">123</xref>,<xref ref-type=""bibr"" rid=""B124"">124</xref>].</p></sec><sec><title>Antibiotic resistance</title><p>It has been shown that mercury from dental amalgam can induce mercury resistant bacteria [<xref ref-type=""bibr"" rid=""B125"">125</xref>-<xref ref-type=""bibr"" rid=""B127"">127</xref>]. This leads to a general antibiotic resistance in oral bacteria and in other body sites [<xref ref-type=""bibr"" rid=""B127"">127</xref>], which is particularly true when the antibiotic resistance genes are contained within the same mobile element as the mercury resistance operon [<xref ref-type=""bibr"" rid=""B128"">128</xref>,<xref ref-type=""bibr"" rid=""B129"">129</xref>]. Mercury resistance is common in human oral bacteria [<xref ref-type=""bibr"" rid=""B130"">130</xref>,<xref ref-type=""bibr"" rid=""B131"">131</xref>]. Monkeys with dental amalgam also showed an increase in antibiotic resistant bacteria in their stools [<xref ref-type=""bibr"" rid=""B127"">127</xref>,<xref ref-type=""bibr"" rid=""B132"">132</xref>].</p></sec><sec><title>Penetration of amalgam in tooth bone and jaw</title><p>Experiments on monkeys and sheep have shown that mercury from amalgam penetrates easily into the dentin roots as well as into the jaw bone [<xref ref-type=""bibr"" rid=""B25"">25</xref>,<xref ref-type=""bibr"" rid=""B26"">26</xref>]. The fact that this was also shown for humans [<xref ref-type=""bibr"" rid=""B133"">133</xref>] confirms an alternative route of mercury exposure caused by amalgam.</p></sec><sec><title>Skin</title><p>There is a correlation between atopic eczema and IgE-levels and the body burden of mercury [<xref ref-type=""bibr"" rid=""B134"">134</xref>]. Amalgam fillings can induce lichenoid reactions [<xref ref-type=""bibr"" rid=""B135"">135</xref>-<xref ref-type=""bibr"" rid=""B139"">139</xref>]. In more than 90% of the cases, these lesions have been found to recover upon removal of amalgam, no matter whether an allergy patch test was positive or not. Granulomatosis improved likewise [<xref ref-type=""bibr"" rid=""B140"">140</xref>]. Also, other forms of dermatitis seem to be related to dental amalgams [<xref ref-type=""bibr"" rid=""B141"">141</xref>,<xref ref-type=""bibr"" rid=""B142"">142</xref>].</p></sec><sec><title>Autoimmune disorders and mercury hypersensitivity</title><p>Constant low-dose mercury exposure, as is common in amalgam bearers, has been considered a possible cause for certain autoimmune diseases, e.g. multiple sclerosis, rheumatoid arthritis or systemic lupus erythematosus (SLE) [<xref ref-type=""bibr"" rid=""B135"">135</xref>,<xref ref-type=""bibr"" rid=""B143"">143</xref>-<xref ref-type=""bibr"" rid=""B152"">152</xref>]. These effects occur with exposure below mercury safety limits [<xref ref-type=""bibr"" rid=""B153"">153</xref>]. Recent research has shown that mercury and ethylmercury have the ability to inhibit the first step (phagocytosis) in the innate and acquired immune response of humans at very low levels [<xref ref-type=""bibr"" rid=""B154"">154</xref>]. This shows that mercury exposures quite below the average exposure through amalgam exposure can cause disruption of the immune system at all ages.</p></sec><sec><title>Only ""rare cases of proven allergic reactions""?</title><p>SCENIHR only accept the ""proof"" of allergic reactions to amalgam, which is a positive cutaneous patch test. However, it has been shown that in more than 90% of the cases with mucosal reactions these lesions have been found to recover by removal of amalgam, no matter whether a cutaneous patch test was positive or not [<xref ref-type=""bibr"" rid=""B137"">137</xref>,<xref ref-type=""bibr"" rid=""B139"">139</xref>,<xref ref-type=""bibr"" rid=""B140"">140</xref>]. Therefore the relevance of the cutaneous patch test in detecting sensitivity or allergy to mercury implanted in the oral cavity without any epicutaneous contact has been severely questioned [<xref ref-type=""bibr"" rid=""B155"">155</xref>].</p><p>The results with another validated test system reveal that there are more than just ""rare cases"" with immunological complaints due to dental amalgam [<xref ref-type=""bibr"" rid=""B148"">148</xref>,<xref ref-type=""bibr"" rid=""B150"">150</xref>,<xref ref-type=""bibr"" rid=""B152"">152</xref>,<xref ref-type=""bibr"" rid=""B156"">156</xref>-<xref ref-type=""bibr"" rid=""B162"">162</xref>].</p><p>There may also be a correlation between atopic eczema, IgE-levels and the body burden of mercury, which is also not detected by means of cutaneous patch tests [<xref ref-type=""bibr"" rid=""B134"">134</xref>].</p><p>Because mercury from maternal dental amalgam is one of the main sources of mercury body burden in fetal and infant tissues, postnatal atopic eczema disappear after mercury detoxification of the infants [<xref ref-type=""bibr"" rid=""B163"">163</xref>].</p></sec><sec><title>Heart diseases</title><p>Mercury may cause hypertension and myocardial infarction [<xref ref-type=""bibr"" rid=""B164"">164</xref>].</p><p>Significant mercury accumulation (22,000 times higher than controls) has been found in heart tissues with a form of heart insufficiency [<xref ref-type=""bibr"" rid=""B165"">165</xref>].</p></sec><sec><title>Urinary system</title><p>SCENIHR cited only one review performed by a dentist and published in a dental trade journal [<xref ref-type=""bibr"" rid=""B166"">166</xref>] as well as 5-7 year studies on initially healthy children, also performed mainly by dentists, to back up their argument that ""there is no evidence that dental amalgam fillings affect kidney function in humans"". However, there are many other studies suggesting quite the opposite:</p><p>In animal experiments, an impairment of renal functions due to amalgam fillings has been observed [<xref ref-type=""bibr"" rid=""B23"">23</xref>,<xref ref-type=""bibr"" rid=""B146"">146</xref>,<xref ref-type=""bibr"" rid=""B167"">167</xref>]. Humans with amalgam fillings show more signs of tubular and glomerular damage when compared to individuals without dental amalgams [<xref ref-type=""bibr"" rid=""B15"">15</xref>]. The frequently mentioned children amalgam trial study found first signs of kidney damage (microalbuminuria) [<xref ref-type=""bibr"" rid=""B168"">168</xref>] even after only 5 years of amalgam exposure.</p></sec><sec><title>Alzheimer's disease (AD)</title><p>SCENIHR questioned that mercury may contribute to the development of AD. As a proof of this statement they cited only one study [<xref ref-type=""bibr"" rid=""B41"">41</xref>] published in the trade journal of the world-wide leading American Dental Association (ADA) [<xref ref-type=""bibr"" rid=""B102"">102</xref>]. In contrast, other studies have shown that mercury play a major pathogenetic role in AD [<xref ref-type=""bibr"" rid=""B108"">108</xref>,<xref ref-type=""bibr"" rid=""B109"">109</xref>,<xref ref-type=""bibr"" rid=""B169"">169</xref>,<xref ref-type=""bibr"" rid=""B170"">170</xref>]. A new systematic analysis of the literature regarding the role of mercury in AD found a significant association [<xref ref-type=""bibr"" rid=""B124"">124</xref>].</p></sec><sec><title>Parkinson's disease (PD)</title><p>Heavy metals have long been suspected to be a cause of PD, with several studies showing a relation, including epidemiological studies [<xref ref-type=""bibr"" rid=""B171"">171</xref>-<xref ref-type=""bibr"" rid=""B180"">180</xref>]. Elemental mercury has induced PD [<xref ref-type=""bibr"" rid=""B175"">175</xref>], and in a case report, the condition of PD substantially improved after treatment with a mercury chelator [<xref ref-type=""bibr"" rid=""B173"">173</xref>] and remained unchanged during a 5-year follow-up period [<xref ref-type=""bibr"" rid=""B173"">173</xref>]. In another study, significantly elevated blood mercury levels were found in 13 of 14 patients with PD compared to healthy controls [<xref ref-type=""bibr"" rid=""B172"">172</xref>]. This supports the conclusion of a previous study which found a correlation between blood mercury levels and PD [<xref ref-type=""bibr"" rid=""B176"">176</xref>]. Another study found significantly higher amalgam exposure in individuals with PD compared to healthy controls [<xref ref-type=""bibr"" rid=""B179"">179</xref>].</p></sec><sec><title>Adverse health effects in dental staff?</title><p>SCENIHR state that ""the incidence of reported adverse effects [in dental staff and dentists] is very low"".</p><p>A simple literature research reveals quite the opposite: Dentists working with amalgam have an increased mercury exposure [<xref ref-type=""bibr"" rid=""B17"">17</xref>,<xref ref-type=""bibr"" rid=""B181"">181</xref>,<xref ref-type=""bibr"" rid=""B182"">182</xref>]. In most studies available, mercury exposure in dental clinics resulted in significant adverse health effects in dental workers. In some studies, the clinical outcome was not correlated with mercury levels in urine or blood, and some authors falsely concluded that mercury was therefore not the cause of the adverse effects. However, this is not scientific since urine- or blood mercury levels did not correlate with tissue levels (see above). Lindbohm et al. (2007) found a two-fold increased risk for miscarriage through occupational exposure to mercury (OR 2,0; 95% CI 1,0- 4,1). The effect from mercury exposure was stronger than from exposure to acrylate compounds, disinfectants or organic solvents [<xref ref-type=""bibr"" rid=""B199"">199</xref>].</p><p>Even 30 years after cessation of mercury exposure, dental nurses showed significant adverse health effects [<xref ref-type=""bibr"" rid=""B200"">200</xref>]. In spite of the fact that 85% of the dentists and dental technicians tested showed mercury related toxicities in both behavior and physiological parameters, and 15% showed increased mercury induced neurological deficits with polymorphism of the CPOX4 gene [<xref ref-type=""bibr"" rid=""B186"">186</xref>,<xref ref-type=""bibr"" rid=""B188"">188</xref>,<xref ref-type=""bibr"" rid=""B201"">201</xref>], SCENIHR still maintain that amalgams do not cause any significant medical problems in dental workers, because urine and blood levels are below ""safety limits"".</p></sec><sec><title>Infertility</title><p>SCENIHR stated that ""There is no evidence of any association between amalgam restorations and either male or female fertility or obstetric parameters"". As a proof of this statement, SCENIHR cited just one study, which examines only semen parameters in men. However, other studies point to the opposite direction, especially when examining women:</p><p>Female dental assistants exposed to amalgam showed a higher rate of infertility [<xref ref-type=""bibr"" rid=""B198"">198</xref>]. Women with more amalgam fillings or increased mercury levels in urine (after mobilization with DMPS) had a higher incidence of infertility [<xref ref-type=""bibr"" rid=""B202"">202</xref>-<xref ref-type=""bibr"" rid=""B204"">204</xref>]. Heavy metal detoxification led to spontaneous pregnancies in a considerable part of the infertile patients [<xref ref-type=""bibr"" rid=""B203"">203</xref>]. Exposure to mercury also lead to decreased male fertility [<xref ref-type=""bibr"" rid=""B205"">205</xref>-<xref ref-type=""bibr"" rid=""B207"">207</xref>]. A Norwegian study which is often cited as a proof that mercury exposure in dental clinics does not cause infertility suffers from methodological flaws insofar as only women were included who had already given birth to at least one child. Women without children were excluded. Such a study certainly cannot answer the question if working with amalgam leads to infertility or not. Moreover, the exposure time to amalgam was not calculated and thus not included as a covariate into the study.</p></sec><sec><title>Multiple Sclerosis (MS)</title><p>A 7,5-fold increased level of mercury was found in the cerebrospinal fluid (CSF) of MS patients [<xref ref-type=""bibr"" rid=""B208"">208</xref>]. It would be difficult to speculate that the presence of this increase in the CSF would not at least exacerbate the problems associated with MS or any other neurological disease. The prevalence of MS has been shown to be correlated with the prevalence of caries [<xref ref-type=""bibr"" rid=""B209"">209</xref>,<xref ref-type=""bibr"" rid=""B210"">210</xref>] and the prevalence of amalgam [<xref ref-type=""bibr"" rid=""B211"">211</xref>,<xref ref-type=""bibr"" rid=""B212"">212</xref>]. Several MS epidemics occurred after acute exposure to mercury vapor or lead [<xref ref-type=""bibr"" rid=""B213"">213</xref>]. In animal models inorganic mercury caused a loss of Schwann cells which build the myelin sheaths and stabilize the axons of neurons [<xref ref-type=""bibr"" rid=""B214"">214</xref>]. Autoimmune pathogenesis, including antibodies against myelin basic protein (MBP), can be provoked by mercury and by other heavy metals [<xref ref-type=""bibr"" rid=""B148"">148</xref>].</p><p>MS patients who had their amalgam fillings removed showed fewer depressions, less aggression and less psychotic and compulsory behaviors when compared to a group of MS patients with amalgam fillings [<xref ref-type=""bibr"" rid=""B215"">215</xref>]. They also had significantly lower levels of mercury in blood [<xref ref-type=""bibr"" rid=""B216"">216</xref>]. After amalgam removal, pathological oligoclonal bands in the CSF disappeared in MS patients [<xref ref-type=""bibr"" rid=""B217"">217</xref>]. Removal of dental amalgam also led to a recovery in a significant proportion of MS patients [<xref ref-type=""bibr"" rid=""B147"">147</xref>]. A retrospective study on 20,000 military individuals revealed a significantly higher risk for MS in individuals with more amalgam fillings [<xref ref-type=""bibr"" rid=""B218"">218</xref>]. This risk was underestimated, because the study cohort which was selected by means of medical examination consisted exclusively of individuals with good health at the time of joining the military [<xref ref-type=""bibr"" rid=""B218"">218</xref>]. Another problem occurring in some studies is the absence of documentation of the dental status before or at the time of the onset of multiple sclerosis. In spite of these limitations [<xref ref-type=""bibr"" rid=""B219"">219</xref>] a reanalysis found a 3.9- fold increased risk for multiple sclerosis in individuals with amalgam compared to individuals with no amalgam. A recent systematic review also found an increased risk for MS caused by dental amalgam in spite of the fact that most studies did not use proper amalgam-free controls [<xref ref-type=""bibr"" rid=""B220"">220</xref>].</p></sec><sec><title>Amyotrophic Lateral Sclerosis (ALS)</title><p>SCENIHR state that ""there is no evidence for a relationship between Amyotrophic Lateral Sclerosis (ALS) and mercury""</p><p>In contrast to the statement of SCENIHR, there are many studies which suggest that mercury may play a pathogenetic role in ALS:</p><p>Mercury vapor is absorbed by motor neurons [<xref ref-type=""bibr"" rid=""B221"">221</xref>] where it leads to increased oxidative stress. In experiments, mercury vapor was found to promote motor neuron diseases such as ALS [<xref ref-type=""bibr"" rid=""B222"">222</xref>-<xref ref-type=""bibr"" rid=""B226"">226</xref>]. It was proofed that mercury enhances glutamate toxicity in neurons, which is one factor in ALS. Case reports show a correlation between accidental mercury exposure and ALS [<xref ref-type=""bibr"" rid=""B227"">227</xref>,<xref ref-type=""bibr"" rid=""B228"">228</xref>]. There is a reported case of a Swedish woman with more than 34 amalgam fillings who suffered from ALS. After removal of these fillings she recovered [<xref ref-type=""bibr"" rid=""B229"">229</xref>]. A retrospective study reported a statistically significant association between an increased number of amalgam fillings and the risk of motor neuron diseases [<xref ref-type=""bibr"" rid=""B218"">218</xref>].</p></sec><sec><title>""Amalgam disease"" and markers of sensitivity</title><p>Among the most frequently reported symptoms due to amalgam fillings are: Chronic fatigue, headache, migraine, increased susceptibility to infections, muscle pain, lack of concentration, digestion disorders, sleeping disorders, low memory capacity, joint pain, depression, heart sensations, vegetative disregulation, mood disorders and many more [<xref ref-type=""bibr"" rid=""B161"">161</xref>,<xref ref-type=""bibr"" rid=""B215"">215</xref>,<xref ref-type=""bibr"" rid=""B216"">216</xref>,<xref ref-type=""bibr"" rid=""B230"">230</xref>-<xref ref-type=""bibr"" rid=""B234"">234</xref>].</p><p>Until recently it was not possible to differentiate between „amalgam-sensitive"" and „amalgam-resistant"" persons by their mercury levels in blood or urine or an epicutaneous test (patch test) [<xref ref-type=""bibr"" rid=""B9"">9</xref>,<xref ref-type=""bibr"" rid=""B21"">21</xref>]. However, it could be shown that subjects could react to a mercury patch test with psychosomatic complaints, although there was no allergic reaction of the skin [<xref ref-type=""bibr"" rid=""B235"">235</xref>]. In addition, neutrophil granulocytes in amalgam-sensitive subjects react differently compared to those in amalgam-resistant subjects [<xref ref-type=""bibr"" rid=""B236"">236</xref>] and different activities of the superoxide dismutase could be found [<xref ref-type=""bibr"" rid=""B237"">237</xref>].</p></sec><sec><title>Increased susceptibility to mercury and amalgam</title><p>SCENIHR did not mentioned any susceptibility parameters which make a significant proportion of the population more susceptible to mercury from dental amalgam:</p><sec><title>a) Abnormal porphyrine profiles due to mercury exposure</title><p>It is known that mercury exposure leads to aberrant urine porphyrine profiles in dentists [<xref ref-type=""bibr"" rid=""B238"">238</xref>] and autistic children and that this aberrancy was reversed by treating these children with a mercury chelator [<xref ref-type=""bibr"" rid=""B239"">239</xref>-<xref ref-type=""bibr"" rid=""B241"">241</xref>].</p><p>A genetic polymorphism of coproporphyrinoxidase (CPOX4) [<xref ref-type=""bibr"" rid=""B188"">188</xref>,<xref ref-type=""bibr"" rid=""B201"">201</xref>] leads to increased susceptibility to mercury and thus to a higher risk for neurobehavioral complaints [<xref ref-type=""bibr"" rid=""B242"">242</xref>].</p><p>The critical question here is the effect of mercury vapor exposure on brain porphyrine profiles since an aberrancy in brain heme has been associated with the inability to remove beta-amyloid protein from brain cells, which in turn may lead to Alzheimer's disease [<xref ref-type=""bibr"" rid=""B243"">243</xref>].</p><p>It should be noted that porphyrins lead to heme, and heme is critical for several biochemical mechanisms: (i) heme is the oxygen carrying cofactor for haemoglobin, (ii) heme is a critical cofactor for the P450 class of enzymes that are responsible for detoxifying xenobiotics from the body, (iii) heme is a necessary cofactor for one of the complexes in the electron transport system of mitochondria and therefore ATP-synthesis.</p><p>Therefore, mercury inhibition of heme production could have a multitude of secondary effects causing human complaints and illnesses.</p><p>In spite of the fact that 85% of the dentists and dental technicians tested showed mercury related toxicities in both behavior and physiological parameters, and 15% showed an increase of mercury induced neurological deficits with polymorphism of the CPOX4 gene, organized dentistry and SCENIHR still maintain that amalgams do not cause any significant medical problems because the urine and blood levels are below safety limits.</p></sec><sec><title>b) Brain derived neurotrophic factor</title><p>Another genetic polymorphism of the brain derived neurotrophic factor (BNDF) increases also the susceptibility to very low level mercury exposure [<xref ref-type=""bibr"" rid=""B186"">186</xref>,<xref ref-type=""bibr"" rid=""B187"">187</xref>].</p></sec><sec><title>c) Apolipoprotein E diversity</title><p>It could be shown that amalgam sensitive persons are significantly more likely to be carriers of the apolipoprotein E4-allel (APO-E4) than symptom free controls and that they are less likely to carry the APO-E2 [<xref ref-type=""bibr"" rid=""B231"">231</xref>,<xref ref-type=""bibr"" rid=""B234"">234</xref>]. APO-E4 is known to be the major genetic risk factor for Alzheimer's disease, whereas APO-E2 decreases the risk. It has been postulated that this is due to the difference in capacity to remove heavy metals from the cerebrospinal fluid [<xref ref-type=""bibr"" rid=""B44"">44</xref>,<xref ref-type=""bibr"" rid=""B92"">92</xref>,<xref ref-type=""bibr"" rid=""B102"">102</xref>,<xref ref-type=""bibr"" rid=""B124"">124</xref>,<xref ref-type=""bibr"" rid=""B231"">231</xref>,<xref ref-type=""bibr"" rid=""B234"">234</xref>,<xref ref-type=""bibr"" rid=""B244"">244</xref>]. APO-E2 possesses two cysteines with metal binding sulfhydryl-groups whereas APO-E4 does not have any cysteine residues.</p></sec><sec><title>d) Glutathione metabolism</title><p>Reduced glutathione (GSH) is the main natural chelator for heavy metals in the body due to its sulfhydryl-containing cysteine. Only mercury, which is bound to glutathione (or selenium), is capable of leaving the body via urine or biliary excretion. Thus, a high level of glutathione is crucial for mercury metabolism. It has been described that polymorphisms in genes leading to impaired GSH production cause higher retention of inorganic and organic mercury in the body. Other factors which may increase susceptibility to low dose mercury exposure, e.g. low levels of selenium, abnormal reaction of neutrophil granulocytes, activity of super oxide dismutase, D4-receptor positive methionine synthetase and impaired methionine transulfuration- and methylation pathways (about 15% of the population), led to decreased mercury protecting agents, like S-adenyl-methionine, cysteine, GSH and metallothionine [<xref ref-type=""bibr"" rid=""B44"">44</xref>,<xref ref-type=""bibr"" rid=""B245"">245</xref>-<xref ref-type=""bibr"" rid=""B247"">247</xref>].</p></sec></sec><sec><title>Improvement after removal of amalgam</title><p>Significant improvement of health and above mentioned diseases (including Multiple Sclerosis and other autoimmune diseases) have been reported after amalgam removal (in most studies with elaborate protective measures to minimize mercury exposure) [<xref ref-type=""bibr"" rid=""B68"">68</xref>,<xref ref-type=""bibr"" rid=""B147"">147</xref>,<xref ref-type=""bibr"" rid=""B149"">149</xref>,<xref ref-type=""bibr"" rid=""B150"">150</xref>,<xref ref-type=""bibr"" rid=""B159"">159</xref>,<xref ref-type=""bibr"" rid=""B161"">161</xref>,<xref ref-type=""bibr"" rid=""B217"">217</xref>,<xref ref-type=""bibr"" rid=""B230"">230</xref>,<xref ref-type=""bibr"" rid=""B233"">233</xref>,<xref ref-type=""bibr"" rid=""B234"">234</xref>,<xref ref-type=""bibr"" rid=""B248"">248</xref>-<xref ref-type=""bibr"" rid=""B251"">251</xref>].</p></sec><sec><title>No neurodevelopmental disorders through mercury?</title><p>SCENIHR stated that ""There is no evidence of a causal relationship between dental amalgam and autism"" and ""... that no link has been yet established between vaccines, thimerosal and autism"".</p><p>Nonetheless other authors come to opposite conclusions:</p><p>""...mercury exposure altered cell number and cell division; these impacts have been postulated as modes of action for the observed adverse effects in neuronal development. The potential implications of such observations are evident when evaluated in context with research showing that altered cell proliferation and focal neuropathologic effects have been linked with specific neurobehavioral deficits (e.g., autism)."" [<xref ref-type=""bibr"" rid=""B252"">252</xref>]</p><p>Cheuk and Wong (2006) in patients diagnosed with attention-deficit hyperactivity disorder and Desoto and Hitlan (2007) in patients diagnosed with autistic disorders found significant elevations in blood mercury levels in comparison with controls [<xref ref-type=""bibr"" rid=""B253"">253</xref>,<xref ref-type=""bibr"" rid=""B254"">254</xref>]. Adams et al. (2007) observed significant increases in the mercury levels of baby teeth in infants with autistic disorders in comparison with controls [<xref ref-type=""bibr"" rid=""B255"">255</xref>]. Mercury in baby teeth mirrors mercury exposure in the womb.</p><p>Recent brain pathology studies have revealed elevations in mercury levels and mercury-associated oxidative stress markers in patients diagnosed with autistic disorders. The level of mercury in the urine of autistic children shows an increase of 3-5 times after appropriate treatment with the mercury chelator DMSA compared to healthy children [<xref ref-type=""bibr"" rid=""B259"">259</xref>]. Autistic children also excrete higher concentrations of coproporphyrine which is specific for mercury intoxication [<xref ref-type=""bibr"" rid=""B239"">239</xref>,<xref ref-type=""bibr"" rid=""B240"">240</xref>,<xref ref-type=""bibr"" rid=""B260"">260</xref>,<xref ref-type=""bibr"" rid=""B261"">261</xref>]. Detoxification of mercury with DMSA normalizes the abnormal coproporphyrin levels in autistic children [<xref ref-type=""bibr"" rid=""B239"">239</xref>,<xref ref-type=""bibr"" rid=""B240"">240</xref>] and led to improvement of symptoms [<xref ref-type=""bibr"" rid=""B262"">262</xref>]. Additionally, experimental as well as epidemiological studies indicate that mercury exposure is responsible for autism or a deterioration of the disease. Prenatal exposure to maternal amalgam [<xref ref-type=""bibr"" rid=""B46"">46</xref>,<xref ref-type=""bibr"" rid=""B263"">263</xref>], maternal thimerosal [<xref ref-type=""bibr"" rid=""B46"">46</xref>,<xref ref-type=""bibr"" rid=""B264"">264</xref>] and postnatal sources (mercury from vaccines for the child) together with a genetic sensitivity may trigger autism. In animal experiments vaccination with thimerosal led to symptoms similar to autism [<xref ref-type=""bibr"" rid=""B265"">265</xref>]. Epidemiological studies confirm a significant association between low-dose mercury exposure and neurodevelopmental disorders [<xref ref-type=""bibr"" rid=""B266"">266</xref>][<xref ref-type=""bibr"" rid=""B267"">267</xref>][<xref ref-type=""bibr"" rid=""B268"">268</xref>][<xref ref-type=""bibr"" rid=""B269"">269</xref>][<xref ref-type=""bibr"" rid=""B270"">270</xref>][<xref ref-type=""bibr"" rid=""B271"">271</xref>]. Autistic children show decreased levels of the natural mercury chelator glutathione [<xref ref-type=""bibr"" rid=""B272"">272</xref>]; it is known that mercury is capable of causing this phenomen [<xref ref-type=""bibr"" rid=""B273"">273</xref>]. In some preliminary therapy studies with chelation therapy led to improvement of symptoms [<xref ref-type=""bibr"" rid=""B263"">263</xref>]. The Autism Research Institute therefore lists chelation as the most effective therapeutic approach among 88 therapies including 53 medications [<xref ref-type=""bibr"" rid=""B274"">274</xref>].</p><p>Zahir et al. (2005) described that the access of mercury</p><p>""...to man through multiple pathways air, water, food, cosmetic products and even vaccines increase the exposure. Fetuses and infants are more susceptible to mercury toxicity. Mothers consuming diet containing mercury pass the toxicant to fetuses and to infants through breast milk. Decreased performance in the areas of motor function and memory has been reported among children exposed to presumably safe mercury levels [...] Mercury has been found to be a causative agent of various sorts of disorders, including neurological, nephrological, immunological, cardiac, motor, reproductive and even genetic. Recently heavy metal mediated toxicity has been linked to diseases like Alzheimer's, Parkinson's, Autism, Lupus, Amyotrophic lateral sclerosis, etc.""[<xref ref-type=""bibr"" rid=""B275"">275</xref>].</p><p>Some studies which found no associations between mercury exposure and autism have severe methodical flaws [<xref ref-type=""bibr"" rid=""B245"">245</xref>].</p></sec><sec><title>Severe methodical flaws in studies cited by SCENIHR as a proof of the safety of dental amalgam</title><p>In order to study toxic effects it is necessary to compare at least two samples: one that was exposed to the substance in question and one that was not. One of the main problems in most of the amalgam studies is that the vast majority did not incorporate a true control group that had never been exposed to dental amalgam. Even when comparing samples with and without dental fillings, the sample without dental fillings had been exposed to dental amalgam earlier in life. The studies cited frequently not only by SCENIHR as a proof of the putative harmlessness of amalgam do not use ""proper"" non-amalgam control groups. There is a prominent example to describe:</p><p>The Swedish twin study [<xref ref-type=""bibr"" rid=""B276"">276</xref>] actually only compared 57 twin-pairs in a co-twin analysis, and not 587 as mentioned by the authors and many governmental institutions. As the average age of the sample was 66 years, 25% had no teeth at the time of investigation, many had missing teeth and an unknown number had crowns using other dental materials. Root fillings with amalgam and amalgam fillings under crowns were not calculated. As an allegedly ""non-amalgam"" group, they were compared with individuals who still had teeth with amalgam fillings. The authors found that individuals with more amalgam fillings (which means also more own teeth) had a better health status. It is fair to assume that individuals with few or no teeth or teeth that have been restored with crowns or bridges had probably had dental amalgam previously. As mercury accumulates in body tissues, this ""amalgam free group"" might have a higher mercury body burden than the ""amalgam group"" with currently existing amalgam fillings.</p><p>SCENIHR also cited Zimmer et al. (2002) as a proof of the safety of amalgam. But this study compared two groups exposed to amalgam (all female, one group of patients who claimed to be suffering from symptoms they related to their amalgam fillings and the other group which did not report any association between complaints and their amalgam) in terms of mercury levels in body fluids and psychometric tests. The mean number of amalgam fillings was identical in both groups. They found equal mercury levels in both amalgam groups. Zimmer et al. (p. 210) conclude: ""Thus, mercury released from amalgam fillings was not a likely cause of complaints reported by the amalgam sensitive subjects"" [<xref ref-type=""bibr"" rid=""B21"">21</xref>]. It is not clear why these authors come to such a conclusion. Furthermore it is known from animal experiments and pharmacological studies that individuals given equal amounts of a toxin might react differently. An example for this is that not every smoker develops lung cancer, although smoking is now accepted as a main cause for cancer.</p></sec><sec><title>""Children amalgam trials""</title><p>SCENIHR based their statement about the safety of dental amalgam also on two children amalgam trials. These studies show severe methodical flaws:</p><p>In two randomised trials on children it was evaluated whether mercury containing dental amalgam had adverse neuropsychological or renal effects [<xref ref-type=""bibr"" rid=""B277"">277</xref>,<xref ref-type=""bibr"" rid=""B278"">278</xref>]. Healthy children were randomised to either amalgam or composite surface restoration. Two children in the amalgam group died (one possibly by committing suicide) and were excluded from the study.</p><p>Power calculation (binomial - adverse event versus no event) indicates that psychological illness, having prevalence of 6.7% in the composite-treated children, would have to have had a prevalence of at least 14.5% in the amalgam group to have an 80% chance of being proven statistically (observed was 9.0%). Similarly for neurological illness, observed prevalences in the composite group (0.4% composite, 1.5% amalgam) would have needed at least 4.5% prevalence in the amalgam group to be significant. From the authors it was concluded that ""there is no reason to discontinue use of mercury amalgam"" [<xref ref-type=""bibr"" rid=""B277"">277</xref>] and that ""dental amalgam [...] emits small amounts of mercury vapor"" [<xref ref-type=""bibr"" rid=""B278"">278</xref>].</p><p>The first conclusion is a classic error: Due to its lack of power, the study provides false reassurance that mercury is 'safe'. To effectively evaluate the effect sizes seen, the trial should have been much larger (1500-2500/group).</p><p>Urine porphyrin profiles and markers of oxidative stress, which are elevated in individuals with dental amalgam [<xref ref-type=""bibr"" rid=""B19"">19</xref>,<xref ref-type=""bibr"" rid=""B119"">119</xref>] were not measured. Also, genetic polymorphism, which increase the susceptibility to mercury, like BDNF-Polymorphism [<xref ref-type=""bibr"" rid=""B186"">186</xref>,<xref ref-type=""bibr"" rid=""B188"">188</xref>] and Glutathion-S-Transferase gene polymorphism [<xref ref-type=""bibr"" rid=""B279"">279</xref>] were not measured either. Furthermore, the real exposure level of mercury (mercury vapor emitted in the oral cavity) was not determined, which questions the ethics of such a study. Research has demonstrated that the emission of mercury vapor was much higher than what has been ""estimated"" by dentists. Chew et al. (1991) showed that 43.5 microgram/cm<sup>2</sup>/day mercury was released from a ""non-mercury releasing amalgam"" and this remained constant over the study period of 2 years [<xref ref-type=""bibr"" rid=""B280"">280</xref>].</p><p>Mean mercury urine levels were significantly higher in the amalgam groups [<xref ref-type=""bibr"" rid=""B277"">277</xref>,<xref ref-type=""bibr"" rid=""B278"">278</xref>], although in years 3 to 7 the levels of mercury in the urine of the amalgam bearers continuously dropped until they approached the levels of the amalgam free children [<xref ref-type=""bibr"" rid=""B278"">278</xref>]. But restorative treatment was used in years 6 and 7, which should have increased or at least maintained the urine mercury levels. This needed explaining. In the Chew study above [<xref ref-type=""bibr"" rid=""B280"">280</xref>], the amount of mercury released was steady for 2 years (the length of the study). It is known that amalgam do not stop releasing mercury vapor within 7 years. The question therefore is what the drop was caused by after year 2? Urine mercury levels are a measure of the amount of mercury being excreted via this route. Therefore, after two years of mercury exposure the route of kidney excretion of mercury appears to be becoming less effective. This is consistent with the well-known fact that increased mercury exposure inhibits its own excretion. It has been published and verified that over 90% of mercury excreted by humans leaves through the biliary transport system of the liver and is excreted in the feces, not in the urine [<xref ref-type=""bibr"" rid=""B13"">13</xref>]. The conclusion of Bellinger et al. [<xref ref-type=""bibr"" rid=""B277"">277</xref>] that ""there is no reason to discontinue use of mercury amalgam"" is amazing, because possible adverse effects may need more than five years of mercury exposure to develop. If mercury is involved in the pathogenesis of Alzheimer's disease, the disease may need up to 50 years to be diagnosed clinically [<xref ref-type=""bibr"" rid=""B44"">44</xref>].</p><p>One of the included criteria for the two studies was ""no interfering health conditions"" including neurodevelopmental disorders. The Centers for Disease Control and Prevention (CDC) in Atlanta (USA) reports that 1 in 6 American children have a neurodevelopmental disorder. However, above mentined papers conclude that amalgams should remain a viable clinical option in dental restorative treatment [<xref ref-type=""bibr"" rid=""B278"">278</xref>] and they did not exclude use on children with neurodevelopmental disorders - exactly the type of child, however, which they excluded from their studies. As mercury exposure during pregnancy may be the prime cause of neurodevelopmental disorders [<xref ref-type=""bibr"" rid=""B46"">46</xref>,<xref ref-type=""bibr"" rid=""B61"">61</xref>,<xref ref-type=""bibr"" rid=""B245"">245</xref>], this conclusion from the children amalgam is unsafe for the public.</p></sec><sec><title>Amalgam for mercury pollution</title><p>There has been an alarmingly increase of mercury in our environment [<xref ref-type=""bibr"" rid=""B281"">281</xref>] and human bodies [<xref ref-type=""bibr"" rid=""B282"">282</xref>] over the last decades. The UNEP reports on a 3-5 fold increase over the last 25 years [<xref ref-type=""bibr"" rid=""B281"">281</xref>].</p><p>In the European Union (EU) the usage of amalgam amounts to 120 tons yearly. Dentists are the 2<sup>nd</sup>largest user group in the EU [<xref ref-type=""bibr"" rid=""B283"">283</xref>,<xref ref-type=""bibr"" rid=""B284"">284</xref>].</p><p>Recent calculations done by Hylander [<xref ref-type=""bibr"" rid=""B284"">284</xref>,<xref ref-type=""bibr"" rid=""B285"">285</xref>] show that there are 40 tons of mercury in teeth with dental amalgam of Swedish people, which results to the excretion of 100 kg of mercury per year in wastewater. 1300 to 2200 tons of mercury in dental amalgam is present in the teeth of citizens in the EU (27 countries) [<xref ref-type=""bibr"" rid=""B284"">284</xref>], and for the USA the respective figures are about 1000 tons. In the US, dental amalgam is the 3rd most significant source of environmental mercury [<xref ref-type=""bibr"" rid=""B286"">286</xref>]. In contrast to the EU, removed amalgam is not separated from the wastewater of dental clinics in the US. But even in most EU-countries, where such separators are in use, parts of the dental amalgam leaks into the environment [<xref ref-type=""bibr"" rid=""B284"">284</xref>].</p><p>This mercury from dental amalgam (i.e. mercury emissions from dental clinics in wastewater, excreted mercury emissions from amalgam in living individuals, mercury emissions from elevated mercury deposits in tissues of deceased and cremated humans with dental amalgam) enter into the environment. When including environmental costs into the economic calculation (except costs from amalgam related diseases), amalgam is the most costly dental material as was shown by Hylander and Godsite [<xref ref-type=""bibr"" rid=""B283"">283</xref>].</p></sec><sec><title>The role of organized dentistry in SCENIHR and in defending amalgam</title><p>The SCENIHR amalgam expert group consisted of one engineer (chairman), four dentists, a toxicologist and two veterinarians. The chairman has tight contacts to the industry. No experts for medicine or environmental medicine were included. One must wonder why it were the dentists who represented the strongest party in SCENIHR.</p><p>Due to their education and clinical experience, dentist are not able to judge medical systemic adverse side effects caused by dental amalgam, like multiple sclerosis, autism, autoimmunity, Alzheimer's disease, psychiatric diseases etc. Usage of dental amalgam may increase worldwide (increasing caries epidemic in undeveloped countries which constitute the highest percentage of the world`s population ). Today, dental organisations are the only trade group of health professionals who endorse the use of a product that is primarily made of mercury. Every amalgam patent has been produced according to dental organisations specifications [<xref ref-type=""bibr"" rid=""B287"">287</xref>,<xref ref-type=""bibr"" rid=""B288"">288</xref>]. This may indeed be a critical point, because organized dentistry, which has always support the use of dental amalgam, are responsible for adverse side effects [<xref ref-type=""bibr"" rid=""B287"">287</xref>,<xref ref-type=""bibr"" rid=""B288"">288</xref>]. Therefore, the strategies of organized dentistry used to influence science and politics over the last decades [<xref ref-type=""bibr"" rid=""B287"">287</xref>-<xref ref-type=""bibr"" rid=""B290"">290</xref>] may be analogous to other well known topics with existing conflicts of interest, where effective measures have been applied to influence science and politics regarding dangerous products [<xref ref-type=""bibr"" rid=""B291"">291</xref>-<xref ref-type=""bibr"" rid=""B295"">295</xref>].</p></sec><sec><title>Competing interests</title><p>The author declare that he have no competing interests.</p></sec><back><ref-list><ref id=""B1""><mixed-citation publication-type=""other""><collab>Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR)</collab><article-title>The safety of dental amalgam and alternative dental restoration materials for patients and users</article-title><source>Europaen Commision</source><year>2008</year><fpage>1</fpage><lpage>74</lpage><ext-link ext-link-type=""uri"" xlink:href=""http://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_016.pdf"">http://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_016.pdf</ext-link></mixed-citation></ref><ref id=""B2""><mixed-citation publication-type=""journal""><name><surname>Barregard</surname><given-names>J</given-names></name><name><surname>Svalander</surname><given-names>C</given-names></name><name><surname>Schutz</surname><given-names>A</given-names></name><name><surname>Westberg</surname><given-names>G</given-names></name><name><surname>Sällsten</surname><given-names>G</given-names></name><name><surname>Blohmé</surname><given-names>I</given-names></name><name><surname>Mölne</surname><given-names>J</given-names></name><name><surname>Attman</surname><given-names>PO</given-names></name><name><surname>Haglind</surname><given-names>P</given-names></name><article-title>Cadmium, mercury, and lead in kidney cortex of the general Swedish population: a study of biopsies from living kidney donors</article-title><source>Environ Health Perspect</source><year>1999</year><volume>107</volume><fpage>867</fpage><lpage>871</lpage><pub-id pub-id-type=""pmid"">10544153</pub-id></mixed-citation></ref><ref id=""B3""><mixed-citation publication-type=""journal""><name><surname>Becker</surname><given-names>K</given-names></name><name><surname>Kaus</surname><given-names>S</given-names></name><name><surname>Krause</surname><given-names>C</given-names></name><name><surname>Lepom</surname><given-names>P</given-names></name><name><surname>Schulz</surname><given-names>C</given-names></name><name><surname>Seiwert</surname><given-names>M</given-names></name><name><surname>Seifert</surname><given-names>B</given-names></name><article-title>German Environmental Survey 1998 (GerES lll): environmental pollutants in blood of the German population</article-title><source>Int J Hyg Environ Health</source><year>2002</year><volume>205</volume><fpage>297</fpage><lpage>308</lpage><pub-id pub-id-type=""doi"">10.1078/1438-4639-00155</pub-id><pub-id pub-id-type=""pmid"">12068749</pub-id></mixed-citation></ref><ref id=""B4""><mixed-citation publication-type=""journal""><name><surname>Becker</surname><given-names>K</given-names></name><name><surname>Schulz</surname><given-names>C</given-names></name><name><surname>Kaus</surname><given-names>S</given-names></name><name><surname>Seiwert</surname><given-names>M</given-names></name><name><surname>Seifert</surname><given-names>B</given-names></name><article-title>German Environmental Survey 1998 (GerES III): Environmental pollutants in the urine of the German population</article-title><source>Int J Hyg Environ Health</source><year>2003</year><volume>206</volume><fpage>15</fpage><lpage>24</lpage><pub-id pub-id-type=""doi"">10.1078/1438-4639-00188</pub-id><pub-id pub-id-type=""pmid"">12621899</pub-id></mixed-citation></ref><ref id=""B5""><mixed-citation publication-type=""journal""><name><surname>Drasch</surname><given-names>G</given-names></name><name><surname>Schupp</surname><given-names>I</given-names></name><name><surname>Riedl</surname><given-names>G</given-names></name><name><surname>Günther</surname><given-names>G</given-names></name><article-title>Einfluß von Amalgamfüllungen auf die Quecksilberkonzentration in menschlichen Organen</article-title><source>Dtsch Zahnärztl Z</source><year>1992</year><volume>47</volume><fpage>490</fpage><lpage>496</lpage></mixed-citation></ref><ref id=""B6""><mixed-citation publication-type=""journal""><name><surname>Drasch</surname><given-names>G</given-names></name><name><surname>Schupp</surname><given-names>I</given-names></name><name><surname>Hofl</surname><given-names>H</given-names></name><name><surname>Reinke</surname><given-names>R</given-names></name><name><surname>Roider</surname><given-names>G</given-names></name><article-title>Mercury burden of human fetal and infant tissues</article-title><source>Eur J Ped</source><year>1994</year><volume>153</volume><fpage>607</fpage><lpage>610</lpage><pub-id pub-id-type=""doi"">10.1007/BF02190671</pub-id></mixed-citation></ref><ref id=""B7""><mixed-citation publication-type=""journal""><name><surname>Drasch</surname><given-names>G</given-names></name><name><surname>Wanghofer</surname><given-names>E</given-names></name><name><surname>Roider</surname><given-names>G</given-names></name><article-title>Are blood, urine, hair, and muscle valid bio-monitoring parameters for the internal burden of men with the heavy metals mercury, lead and cadmium?</article-title><source>Trace Elem Electrolyt</source><year>1997</year><volume>14</volume><fpage>116</fpage><lpage>123</lpage></mixed-citation></ref><ref id=""B8""><mixed-citation publication-type=""journal""><name><surname>Eggleston</surname><given-names>DW</given-names></name><name><surname>Nylander</surname><given-names>M</given-names></name><article-title>Correlation of dental amalgam with mercury in brain tissue</article-title><source>J Prosth Dent</source><year>1987</year><volume>58</volume><fpage>704</fpage><lpage>707</lpage><pub-id pub-id-type=""doi"">10.1016/0022-3913(87)90424-0</pub-id></mixed-citation></ref><ref id=""B9""><mixed-citation publication-type=""journal""><name><surname>Gottwald</surname><given-names>B</given-names></name><name><surname>Traencker</surname><given-names>I</given-names></name><name><surname>Kupfer</surname><given-names>J</given-names></name><name><surname>Ganss</surname><given-names>C</given-names></name><name><surname>Eis</surname><given-names>D</given-names></name><name><surname>Schill</surname><given-names>WB</given-names></name><name><surname>Gieler</surname><given-names>U</given-names></name><article-title>""Amalgam disease"" -- poisoning, allergy, or psychic disorder?</article-title><source>Int J Hyg Environ Health</source><year>2001</year><volume>204</volume><fpage>223</fpage><lpage>229</lpage><pub-id pub-id-type=""doi"">10.1078/1438-4639-00097</pub-id><pub-id pub-id-type=""pmid"">11833294</pub-id></mixed-citation></ref><ref id=""B10""><mixed-citation publication-type=""journal""><name><surname>Guzzi</surname><given-names>G</given-names></name><name><surname>Grandi</surname><given-names>M</given-names></name><name><surname>Cattaneo</surname><given-names>C</given-names></name><article-title>Should amalgam fillings be removed?</article-title><source>Lancet</source><year>2002</year><volume>360</volume><fpage>2081</fpage><pub-id pub-id-type=""doi"">10.1016/S0140-6736(02)11971-4</pub-id><pub-id pub-id-type=""pmid"">12504440</pub-id></mixed-citation></ref><ref id=""B11""><mixed-citation publication-type=""journal""><name><surname>Guzzi</surname><given-names>G</given-names></name><name><surname>Grandi</surname><given-names>M</given-names></name><name><surname>Cattaneo</surname><given-names>C</given-names></name><name><surname>Calza</surname><given-names>S</given-names></name><name><surname>Minoia</surname><given-names>C</given-names></name><name><surname>Ronchi</surname><given-names>A</given-names></name><name><surname>Gatti</surname><given-names>A</given-names></name><name><surname>Severi</surname><given-names>G</given-names></name><article-title>Dental amalgam and mercury levels in autopsy tissues: food for thought</article-title><source>Am J Forensic Med Pathol</source><year>2006</year><volume>27</volume><fpage>42</fpage><lpage>45</lpage><pub-id pub-id-type=""doi"">10.1097/01.paf.0000201177.62921.c8</pub-id><pub-id pub-id-type=""pmid"">16501347</pub-id></mixed-citation></ref><ref id=""B12""><mixed-citation publication-type=""journal""><name><surname>Levy</surname><given-names>M</given-names></name><name><surname>Schwartz</surname><given-names>S</given-names></name><name><surname>Dijak</surname><given-names>M</given-names></name><name><surname>Weber</surname><given-names>JP</given-names></name><name><surname>Tardif</surname><given-names>R</given-names></name><name><surname>Rouah</surname><given-names>F</given-names></name><article-title>Childhood urine mercury excretion: dental amalgam and fish consumption as exposure factors</article-title><source>Environ Res</source><year>2004</year><volume>94</volume><fpage>283</fpage><lpage>290</lpage><pub-id pub-id-type=""doi"">10.1016/j.envres.2003.07.004</pub-id><pub-id pub-id-type=""pmid"">15016596</pub-id></mixed-citation></ref><ref id=""B13""><mixed-citation publication-type=""journal""><name><surname>Lorscheider</surname><given-names>FL</given-names></name><name><surname>Vimy</surname><given-names>MJ</given-names></name><name><surname>Summers</surname><given-names>AO</given-names></name><article-title>Mercury exposure from ""silver"" tooth fillings: emerging evidence questions a traditional dental paradigm</article-title><source>FASEB Journal</source><year>1995</year><volume>9</volume><fpage>504</fpage><lpage>508</lpage><pub-id pub-id-type=""pmid"">7737458</pub-id></mixed-citation></ref><ref id=""B14""><mixed-citation publication-type=""journal""><name><surname>Kingman</surname><given-names>A</given-names></name><name><surname>Albertini</surname><given-names>T</given-names></name><name><surname>Brown</surname><given-names>LJ</given-names></name><article-title>Mercury concentrations in urine and whole blood associated with amalgam exposure in a US military population</article-title><source>J Dent Res</source><year>1998</year><volume>77</volume><fpage>461</fpage><lpage>471</lpage><pub-id pub-id-type=""doi"">10.1177/00220345980770030501</pub-id><pub-id pub-id-type=""pmid"">9496919</pub-id></mixed-citation></ref><ref id=""B15""><mixed-citation publication-type=""journal""><name><surname>Mortada</surname><given-names>WI</given-names></name><name><surname>Sobh</surname><given-names>MA</given-names></name><name><surname>El-Defrawy</surname><given-names>MM</given-names></name><name><surname>Farahat</surname><given-names>SE</given-names></name><article-title>Mercury in dental restoration: is there a risk of nephrotoxicity?</article-title><source>J Nephrol</source><year>2002</year><volume>15</volume><fpage>171</fpage><lpage>176</lpage><pub-id pub-id-type=""pmid"">12018634</pub-id></mixed-citation></ref><ref id=""B16""><mixed-citation publication-type=""journal""><name><surname>Nylander</surname><given-names>M</given-names></name><article-title>Mercury in pituitary glands of dentists</article-title><source>Lancet</source><year>1986</year><volume>22</volume><fpage>442</fpage><pub-id pub-id-type=""doi"">10.1016/S0140-6736(86)92395-0</pub-id></mixed-citation></ref><ref id=""B17""><mixed-citation publication-type=""journal""><name><surname>Nylander</surname><given-names>M</given-names></name><name><surname>Weiner</surname><given-names>J</given-names></name><article-title>Mercury and selenium concentrations and their interrelations in organs from dental staff and the general population</article-title><source>Br J Ind Med</source><year>1991</year><volume>48</volume><fpage>729</fpage><lpage>734</lpage><pub-id pub-id-type=""pmid"">1835404</pub-id></mixed-citation></ref><ref id=""B18""><mixed-citation publication-type=""journal""><name><surname>Nylander</surname><given-names>M</given-names></name><name><surname>Friberg</surname><given-names>L</given-names></name><name><surname>Lind</surname><given-names>B</given-names></name><article-title>Mercury concentrations in the human brain and kidneys in relation to exposure from dental amalgam fillings</article-title><source>Swed Dent J</source><year>1987</year><volume>11</volume><fpage>179</fpage><lpage>187</lpage><pub-id pub-id-type=""pmid"">3481133</pub-id></mixed-citation></ref><ref id=""B19""><mixed-citation publication-type=""journal""><name><surname>Pizzichini</surname><given-names>M</given-names></name><name><surname>Fonzi</surname><given-names>M</given-names></name><name><surname>Giannerini</surname><given-names>M</given-names></name><name><surname>Mencarelli</surname><given-names>M</given-names></name><name><surname>Gasparoni</surname><given-names>A</given-names></name><name><surname>Rocchi</surname><given-names>G</given-names></name><name><surname>Kaitsas</surname><given-names>V</given-names></name><name><surname>Fonzi</surname><given-names>L</given-names></name><article-title>Influence of amalgam fillings on Hg levels and total antioxidant activity in plasma of healthy donors</article-title><source>Sci Total Environ</source><year>2003</year><volume>301</volume><fpage>43</fpage><lpage>50</lpage><pub-id pub-id-type=""doi"">10.1016/S0048-9697(02)00291-7</pub-id><pub-id pub-id-type=""pmid"">12493183</pub-id></mixed-citation></ref><ref id=""B20""><mixed-citation publication-type=""journal""><name><surname>Weiner</surname><given-names>JA</given-names></name><name><surname>Nylander</surname><given-names>M</given-names></name><article-title>The relationship between mercury concentration in human organs and different predictor variables</article-title><source>Sci Tot Environ</source><year>1993</year><volume>138</volume><fpage>101</fpage><lpage>115</lpage><pub-id pub-id-type=""doi"">10.1016/0048-9697(93)90408-X</pub-id></mixed-citation></ref><ref id=""B21""><mixed-citation publication-type=""journal""><name><surname>Zimmer</surname><given-names>H</given-names></name><name><surname>Ludwig</surname><given-names>H</given-names></name><name><surname>Bader</surname><given-names>M</given-names></name><article-title>Determination of mercury in blood, urine and saliva for the biological monitoring of an exposure from amalgam fillings in a group with self-reported adverse health effects</article-title><source>Int J Hyg Environ Health</source><year>2002</year><volume>205</volume><fpage>205</fpage><lpage>211</lpage><pub-id pub-id-type=""doi"">10.1078/1438-4639-00146</pub-id><pub-id pub-id-type=""pmid"">12040918</pub-id></mixed-citation></ref><ref id=""B22""><mixed-citation publication-type=""journal""><name><surname>Danscher</surname><given-names>G</given-names></name><name><surname>Hørsted-Bindsley</surname><given-names>P</given-names></name><name><surname>Rungby</surname><given-names>J</given-names></name><article-title>Traces of mercury in organs from primates with amalgam fillings</article-title><source>Exp Mol Pathol</source><year>1990</year><volume>52</volume><fpage>291</fpage><lpage>299</lpage><pub-id pub-id-type=""doi"">10.1016/0014-4800(90)90070-T</pub-id><pub-id pub-id-type=""pmid"">2115006</pub-id></mixed-citation></ref><ref id=""B23""><mixed-citation publication-type=""journal""><name><surname>Galic</surname><given-names>N</given-names></name><name><surname>Prpic-Mehicic</surname><given-names>G</given-names></name><name><surname>Prester</surname><given-names>LJ</given-names></name><name><surname>Blanusa</surname><given-names>M</given-names></name><name><surname>Krnic</surname><given-names>Z</given-names></name><name><surname>Ferencic</surname><given-names>Z</given-names></name><article-title>Dental amalgam mercury exposure in rats</article-title><source>Biometals</source><year>1999</year><volume>12</volume><fpage>227</fpage><lpage>237</lpage><pub-id pub-id-type=""doi"">10.1023/A:1009267513632</pub-id><pub-id pub-id-type=""pmid"">10581685</pub-id></mixed-citation></ref><ref id=""B24""><mixed-citation publication-type=""journal""><name><surname>Galic</surname><given-names>N</given-names></name><name><surname>Prpic-Mehicic</surname><given-names>G</given-names></name><name><surname>Prester</surname><given-names>LB</given-names></name><name><surname>Krnic</surname><given-names>Z</given-names></name><name><surname>Blanusa</surname><given-names>M</given-names></name><name><surname>Erceg</surname><given-names>D</given-names></name><article-title>Elimination of mercury from amalgam in rats</article-title><source>J Trace Elem Med Biol</source><year>2001</year><volume>15</volume><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type=""doi"">10.1016/S0946-672X(01)80018-3</pub-id><pub-id pub-id-type=""pmid"">11603820</pub-id></mixed-citation></ref><ref id=""B25""><mixed-citation publication-type=""journal""><name><surname>Hahn</surname><given-names>LJ</given-names></name><name><surname>Kloiber</surname><given-names>R</given-names></name><name><surname>Vimy</surname><given-names>MJ</given-names></name><name><surname>Takahashi</surname><given-names>Y</given-names></name><name><surname>Lorscheider</surname><given-names>FL</given-names></name><article-title>Dental ""silver"" tooth fillings: a source of mercury exposure revealed by whole-body image scan and tissue analysis</article-title><source>FASEB Journal</source><year>1989</year><volume>3</volume><fpage>2641</fpage><lpage>2646</lpage><pub-id pub-id-type=""pmid"">2636872</pub-id></mixed-citation></ref><ref id=""B26""><mixed-citation publication-type=""journal""><name><surname>Hahn</surname><given-names>LJ</given-names></name><name><surname>Kloiber</surname><given-names>R</given-names></name><name><surname>Leininger</surname><given-names>RW</given-names></name><name><surname>Vimy</surname><given-names>M</given-names></name><name><surname>Lorscheider</surname><given-names>FL</given-names></name><article-title>Whole-body imaging of the distribution of mercury released from dental fillings into monkey tissues</article-title><source>FASEB Journal</source><year>1990</year><volume>4</volume><fpage>3256</fpage><lpage>3260</lpage><pub-id pub-id-type=""pmid"">2227216</pub-id></mixed-citation></ref><ref id=""B27""><mixed-citation publication-type=""journal""><name><surname>Lorscheider</surname><given-names>FL</given-names></name><name><surname>Vimy</surname><given-names>MJ</given-names></name><article-title>Mercury exposure from ""silver"" fillings</article-title><source>Lancet</source><year>1991</year><volume>337</volume><fpage>1103</fpage><pub-id pub-id-type=""doi"">10.1016/0140-6736(91)91757-L</pub-id><pub-id pub-id-type=""pmid"">1673530</pub-id></mixed-citation></ref><ref id=""B28""><mixed-citation publication-type=""journal""><name><surname>Vimy</surname><given-names>MJ</given-names></name><name><surname>Takahashi</surname><given-names>Y</given-names></name><name><surname>Lorscheider</surname><given-names>FL</given-names></name><article-title>Maternal-fetal distribution of mercury (203 Hg) released from dental amalgam fillings</article-title><source>Am J Physiol</source><year>1990</year><volume>258</volume><fpage>939</fpage><lpage>945</lpage></mixed-citation></ref><ref id=""B29""><mixed-citation publication-type=""journal""><name><surname>Heintze</surname><given-names>U</given-names></name><name><surname>Edwardsson</surname><given-names>S</given-names></name><name><surname>Derand</surname><given-names>T</given-names></name><name><surname>Birkhed</surname><given-names>D</given-names></name><article-title>Methylation of mercury from dental amalgam and mercuric chloride by oral streptococci in vitro</article-title><source>Scand J Dent Re</source><year>1983</year><volume>91</volume><fpage>150</fpage><lpage>152</lpage></mixed-citation></ref><ref id=""B30""><mixed-citation publication-type=""journal""><name><surname>Leistevuo</surname><given-names>J</given-names></name><name><surname>Leistevuo</surname><given-names>T</given-names></name><name><surname>Helenius</surname><given-names>H</given-names></name><name><surname>Pyy</surname><given-names>L</given-names></name><name><surname>Osterblad</surname><given-names>M</given-names></name><name><surname>Huovinen</surname><given-names>P</given-names></name><name><surname>Tenovuo</surname><given-names>J</given-names></name><article-title>Dental amalgam fillings and the amount of organic mercury in human saliva</article-title><source>Caries Res</source><year>2001</year><volume>35</volume><fpage>163</fpage><lpage>166</lpage><pub-id pub-id-type=""doi"">10.1159/000047450</pub-id><pub-id pub-id-type=""pmid"">11385194</pub-id></mixed-citation></ref><ref id=""B31""><mixed-citation publication-type=""journal""><name><surname>Yannai</surname><given-names>S</given-names></name><name><surname>Berdicevsky</surname><given-names>I</given-names></name><name><surname>Duek</surname><given-names>L</given-names></name><article-title>Transformations of inorganic mercury by Candida albicans and Saccharomyces cerevisiae</article-title><source>Appl Environ Microbiol</source><year>1991</year><volume>57</volume><fpage>245</fpage><lpage>247</lpage><pub-id pub-id-type=""pmid"">2036011</pub-id></mixed-citation></ref><ref id=""B32""><mixed-citation publication-type=""journal""><name><surname>Leong</surname><given-names>CCW</given-names></name><name><surname>Syed</surname><given-names>NI</given-names></name><name><surname>Lorscheider</surname><given-names>FL</given-names></name><article-title>Retrograde degeneration of neurite membrane structural integrity of nerve growth cones following in vitro exposure to mercury</article-title><source>Neuro Report</source><year>2001</year><volume>12</volume><fpage>733</fpage><lpage>737</lpage></mixed-citation></ref><ref id=""B33""><mixed-citation publication-type=""journal""><name><surname>Olivieri</surname><given-names>G</given-names></name><name><surname>Brack</surname><given-names>C</given-names></name><name><surname>Muller-Spahn</surname><given-names>F</given-names></name><name><surname>Stähelin</surname><given-names>HB</given-names></name><name><surname>Herrmann</surname><given-names>M</given-names></name><name><surname>Renard</surname><given-names>P</given-names></name><name><surname>Brockhaus</surname><given-names>M</given-names></name><name><surname>Hock</surname><given-names>C</given-names></name><article-title>Mercury induces cell cytotoxicity and oxidative stress and increases beta-amyloid secretion and tau phosphorylation in SHSY5Y neuroblastoma cells</article-title><source>J Neurochem</source><year>2000</year><volume>71</volume><fpage>231</fpage><lpage>236</lpage></mixed-citation></ref><ref id=""B34""><mixed-citation publication-type=""journal""><name><surname>Olivieri</surname><given-names>G</given-names></name><name><surname>Novakovic</surname><given-names>M</given-names></name><name><surname>Savaskan</surname><given-names>E</given-names></name><name><surname>Meier</surname><given-names>F</given-names></name><name><surname>Baysang</surname><given-names>G</given-names></name><name><surname>Brockhaus</surname><given-names>M</given-names></name><name><surname>Müller-Spahn</surname><given-names>F</given-names></name><article-title>The effects of ß-Estradiol on SHSY5Y neuroblastoma cells during heavy metal induced oxidative stress, neurotoxicity and ß-Amyloid secretion</article-title><source>Neuroscience</source><year>2002</year><volume>113</volume><fpage>849</fpage><lpage>855</lpage><pub-id pub-id-type=""doi"">10.1016/S0306-4522(02)00211-7</pub-id><pub-id pub-id-type=""pmid"">12182891</pub-id></mixed-citation></ref><ref id=""B35""><mixed-citation publication-type=""book""><name><surname>Pendergrass</surname><given-names>JC</given-names></name><name><surname>Haley</surname><given-names>BE</given-names></name><person-group person-group-type=""editor"">Friberg LT, Schrauzer GN</person-group><article-title>Mercury-EDTA Complex Specifically Blocks Brain-Tubulin-GTP Interactions: Similarity to Observations in Alzheimer's Disease</article-title><source>Status Quo and Perspective of Amalgam and Other Dental Materials. International Symposium Proceedings</source><year>1995</year><publisher-name>Stuttgart: Thieme Verlag</publisher-name><fpage>98</fpage><lpage>105</lpage></mixed-citation></ref><ref id=""B36""><mixed-citation publication-type=""book""><name><surname>Pendergrass</surname><given-names>JC</given-names></name><name><surname>Haley</surname><given-names>BE</given-names></name><person-group person-group-type=""editor"">Sigel A, Sigel H</person-group><article-title>Inhibition of brain tubulin-guanosine 5'-triphosphate interactions by mercury: similarity to observations in Alzheimer's diseased brain</article-title><source>MetalIons on Biological systems</source><year>1997</year><publisher-name>New York: Dekker</publisher-name><fpage>461</fpage><lpage>478</lpage></mixed-citation></ref><ref id=""B37""><mixed-citation publication-type=""journal""><name><surname>Björkman</surname><given-names>L</given-names></name><name><surname>Lundekvam</surname><given-names>BF</given-names></name><name><surname>Laegreid</surname><given-names>T</given-names></name><article-title>Mercury in human brain, blood, muscle and toenails in relation to exposure: an autopsy study</article-title><source>Environ Health</source><year>2007</year><volume>11</volume><fpage>6:30</fpage></mixed-citation></ref><ref id=""B38""><mixed-citation publication-type=""journal""><name><surname>Wenstrup</surname><given-names>D</given-names></name><name><surname>Ehmann</surname><given-names>WD</given-names></name><name><surname>Markesbery</surname><given-names>WR</given-names></name><article-title>Trace element imbalances in isolated subcellular fractions of Alzheimer's disease brains</article-title><source>Brain Research</source><year>1990</year><volume>533</volume><fpage>125</fpage><lpage>31</lpage><pub-id pub-id-type=""doi"">10.1016/0006-8993(90)91804-P</pub-id><pub-id pub-id-type=""pmid"">2085723</pub-id></mixed-citation></ref><ref id=""B39""><mixed-citation publication-type=""journal""><name><surname>Ehmann</surname><given-names>WD</given-names></name><name><surname>Markesbery</surname><given-names>WR</given-names></name><name><surname>Alauddin</surname><given-names>M</given-names></name><name><surname>Hossain</surname><given-names>TIM</given-names></name><name><surname>Brubakern</surname><given-names>EH</given-names></name><article-title>Brain trace elements in Alzheimer's disease</article-title><source>Neurotoxicology</source><year>1986</year><volume>7</volume><fpage>197</fpage><lpage>206</lpage><pub-id pub-id-type=""pmid"">3537853</pub-id></mixed-citation></ref><ref id=""B40""><mixed-citation publication-type=""journal""><name><surname>Thompson</surname><given-names>CM</given-names></name><name><surname>Markesbery</surname><given-names>WR</given-names></name><name><surname>Ehmann</surname><given-names>WD</given-names></name><name><surname>Mao</surname><given-names>YX</given-names></name><name><surname>Vance</surname><given-names>DE</given-names></name><article-title>Regional brain trace-element studies in Alzheimer's disease</article-title><source>Neurotoxicology</source><year>1988</year><volume>9</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type=""pmid"">3393299</pub-id></mixed-citation></ref><ref id=""B41""><mixed-citation publication-type=""journal""><name><surname>Saxe</surname><given-names>SR</given-names></name><name><surname>Wekstein</surname><given-names>MW</given-names></name><name><surname>Kryscio</surname><given-names>RJ</given-names></name><name><surname>Henry</surname><given-names>RG</given-names></name><name><surname>Cornett</surname><given-names>CR</given-names></name><name><surname>Snowdon</surname><given-names>DA</given-names></name><name><surname>Grant</surname><given-names>FT</given-names></name><name><surname>Schmitt</surname><given-names>FA</given-names></name><name><surname>Donegan</surname><given-names>SJ</given-names></name><name><surname>Wekstein</surname><given-names>DR</given-names></name><name><surname>Ehmann</surname><given-names>WD</given-names></name><name><surname>Markesbery</surname><given-names>WR</given-names></name><article-title>Alzheimer's disease, dental amalgam and mercury</article-title><source>J Am Dent Ass</source><year>1999</year><volume>130</volume><fpage>191</fpage><lpage>199</lpage><pub-id pub-id-type=""pmid"">10036842</pub-id></mixed-citation></ref><ref id=""B42""><mixed-citation publication-type=""journal""><name><surname>Cornett</surname><given-names>CR</given-names></name><name><surname>Ehmann</surname><given-names>WD</given-names></name><name><surname>Wekstein</surname><given-names>DR</given-names></name><name><surname>Markesbery</surname><given-names>WR</given-names></name><article-title>Trace elements in Alzheimer's disease pituitary glands</article-title><source>Biol Trace Element Res</source><year>1998</year><volume>62</volume><fpage>107</fpage><lpage>114</lpage><pub-id pub-id-type=""doi"">10.1007/BF02820026</pub-id></mixed-citation></ref><ref id=""B43""><mixed-citation publication-type=""journal""><name><surname>Braak</surname><given-names>H</given-names></name><article-title>Neuroanatomy of Alzheimer's disease</article-title><source>Alzheimer's Disease Review</source><year>1997</year><volume>3</volume><fpage>235</fpage><lpage>47</lpage></mixed-citation></ref><ref id=""B44""><mixed-citation publication-type=""journal""><name><surname>Mutter</surname><given-names>J</given-names></name><name><surname>Naumann</surname><given-names>J</given-names></name><name><surname>Sadaghiani</surname><given-names>C</given-names></name><name><surname>Schneider</surname><given-names>R</given-names></name><name><surname>Walach</surname><given-names>H</given-names></name><article-title>Alzheimer Disease: Mercury as a pathogenic factor and apolipoprotein E as a moderator</article-title><source>Neuro Endocrinol Lett</source><year>2004</year><volume>25</volume><fpage>275</fpage><lpage>283</lpage></mixed-citation></ref><ref id=""B45""><mixed-citation publication-type=""journal""><name><surname>Ask</surname><given-names>K</given-names></name><name><surname>Akesson</surname><given-names>A</given-names></name><name><surname>Berglund</surname><given-names>M</given-names></name><name><surname>Vahter</surname><given-names>M</given-names></name><article-title>Inorganic mercury and methylmercury in placentas of Swedish women</article-title><source>Environ Health Perspect</source><year>2002</year><volume>110</volume><fpage>523</fpage><lpage>526</lpage><pub-id pub-id-type=""doi"">10.1289/ehp.02110523</pub-id><pub-id pub-id-type=""pmid"">12003757</pub-id></mixed-citation></ref><ref id=""B46""><mixed-citation publication-type=""journal""><name><surname>Holmes</surname><given-names>AS</given-names></name><name><surname>Blaxill</surname><given-names>MF</given-names></name><name><surname>Haley</surname><given-names>BE</given-names></name><article-title>Reduced levels of mercury in first baby haircuts of autistic children</article-title><source>Int J Toxicol</source><year>2003</year><volume>22</volume><fpage>277</fpage><lpage>85</lpage><pub-id pub-id-type=""doi"">10.1080/10915810305120</pub-id><pub-id pub-id-type=""pmid"">12933322</pub-id></mixed-citation></ref><ref id=""B47""><mixed-citation publication-type=""journal""><name><surname>Morgan</surname><given-names>DL</given-names></name><name><surname>Chanda</surname><given-names>SM</given-names></name><name><surname>Price</surname><given-names>HC</given-names></name><name><surname>Fernando</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Brambila</surname><given-names>E</given-names></name><name><surname>O'Connor</surname><given-names>RW</given-names></name><name><surname>Beliles</surname><given-names>RP</given-names></name><name><surname>Barone</surname><given-names>S</given-names><suffix>Jr</suffix></name><article-title>Disposition of inhaled mercury vapor in pregnant rats: maternal toxicity and effects on developmental outcome</article-title><source>Toxicol Sci</source><year>2002</year><volume>66</volume><fpage>261</fpage><lpage>273</lpage><pub-id pub-id-type=""doi"">10.1093/toxsci/66.2.261</pub-id><pub-id pub-id-type=""pmid"">11896293</pub-id></mixed-citation></ref><ref id=""B48""><mixed-citation publication-type=""journal""><name><surname>Takahashi</surname><given-names>Y</given-names></name><name><surname>Tsuruta</surname><given-names>S</given-names></name><name><surname>Hasegawa</surname><given-names>J</given-names></name><name><surname>Kameyama</surname><given-names>Y</given-names></name><name><surname>Yoshida</surname><given-names>M</given-names></name><article-title>Release of mercury from dental amalgam fillings in pregnant rats and distribution of mercury in maternal and fetal tissues</article-title><source>Toxicology</source><year>2001</year><volume>163</volume><fpage>115</fpage><lpage>126</lpage><pub-id pub-id-type=""doi"">10.1016/S0300-483X(01)00390-0</pub-id><pub-id pub-id-type=""pmid"">11516521</pub-id></mixed-citation></ref><ref id=""B49""><mixed-citation publication-type=""journal""><name><surname>Takahashi</surname><given-names>Y</given-names></name><name><surname>Tsuruta</surname><given-names>S</given-names></name><name><surname>Arimoto</surname><given-names>M</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name><name><surname>Yoshida</surname><given-names>M</given-names></name><article-title>Placental transfer of mercury in pregnant rats which received dental amalgam restorations</article-title><source>Toxicology</source><year>2003</year><volume>185</volume><fpage>23</fpage><lpage>33</lpage><pub-id pub-id-type=""doi"">10.1016/S0300-483X(02)00588-7</pub-id><pub-id pub-id-type=""pmid"">12505442</pub-id></mixed-citation></ref><ref id=""B50""><mixed-citation publication-type=""journal""><name><surname>Vahter</surname><given-names>M</given-names></name><name><surname>Akesson</surname><given-names>A</given-names></name><name><surname>Lind</surname><given-names>B</given-names></name><name><surname>Bjors</surname><given-names>U</given-names></name><name><surname>Schutz</surname><given-names>A</given-names></name><name><surname>Berglund</surname><given-names>F</given-names></name><article-title>Longitudinal study of methylmercury and inorganic mercury in blood and urin of pregnant and lactating women, as well as in umbilical cord blood</article-title><source>Environ Res</source><year>2000</year><volume>84</volume><fpage>186</fpage><lpage>194</lpage><pub-id pub-id-type=""doi"">10.1006/enrs.2000.4098</pub-id><pub-id pub-id-type=""pmid"">11068932</pub-id></mixed-citation></ref><ref id=""B51""><mixed-citation publication-type=""journal""><name><surname>Yoshida</surname><given-names>M</given-names></name><name><surname>Satoh</surname><given-names>M</given-names></name><name><surname>Shimada</surname><given-names>A</given-names></name><name><surname>Yamamoto</surname><given-names>E</given-names></name><name><surname>Yasutake</surname><given-names>A</given-names></name><name><surname>Tohyama</surname><given-names>C</given-names></name><article-title>Maternal-to-fetus transfer of mercury in metallothionein-null pregnant mice after exposure to mercury vapor</article-title><source>Toxicology</source><year>2002</year><volume>175</volume><fpage>215</fpage><lpage>222</lpage><pub-id pub-id-type=""doi"">10.1016/S0300-483X(02)00084-7</pub-id><pub-id pub-id-type=""pmid"">12049849</pub-id></mixed-citation></ref><ref id=""B52""><mixed-citation publication-type=""journal""><name><surname>Yoshida</surname><given-names>M</given-names></name><name><surname>Watanabe</surname><given-names>C</given-names></name><name><surname>Satoh</surname><given-names>M</given-names></name><name><surname>Yasutake</surname><given-names>A</given-names></name><name><surname>Sawada</surname><given-names>M</given-names></name><name><surname>Ohtsuka</surname><given-names>Y</given-names></name><name><surname>Akama</surname><given-names>Y</given-names></name><name><surname>Tohyama</surname><given-names>C</given-names></name><article-title>Susceptibility of Metallothionein-Null Mice to the Behavioural Alterations Caused by Exposure to Mercury Vapour at Human-Relevant Concentration</article-title><source>Toxicol Sci</source><year>2004</year><volume>80</volume><fpage>69</fpage><lpage>73</lpage><pub-id pub-id-type=""doi"">10.1093/toxsci/kfh138</pub-id><pub-id pub-id-type=""pmid"">15071173</pub-id></mixed-citation></ref><ref id=""B53""><mixed-citation publication-type=""journal""><name><surname>Luglie</surname><given-names>PF</given-names></name><name><surname>Campus</surname><given-names>G</given-names></name><name><surname>Chessa</surname><given-names>G</given-names></name><name><surname>Spano</surname><given-names>G</given-names></name><name><surname>Capobianco</surname><given-names>G</given-names></name><name><surname>Fadda</surname><given-names>GM</given-names></name><name><surname>Dessole</surname><given-names>S</given-names></name><article-title>Effect of amalgam fillings on the mercury concentration in human amniotic fluid</article-title><source>Arch Gynecol Obstet</source><year>2005</year><volume>271</volume><fpage>138</fpage><lpage>142</lpage><pub-id pub-id-type=""doi"">10.1007/s00404-003-0578-6</pub-id><pub-id pub-id-type=""pmid"">14689312</pub-id></mixed-citation></ref><ref id=""B54""><mixed-citation publication-type=""journal""><name><surname>Drasch</surname><given-names>G</given-names></name><name><surname>Aigner</surname><given-names>S</given-names></name><name><surname>Roider</surname><given-names>G</given-names></name><name><surname>Staiger</surname><given-names>F</given-names></name><name><surname>Lipowskyn</surname><given-names>G</given-names></name><article-title>Mercury in human colostrum and early breast milk. Its dependence on dental amalgam and other factors</article-title><source>J Trace Elem Med Biol</source><year>1998</year><volume>12</volume><fpage>23</fpage><lpage>27</lpage><pub-id pub-id-type=""pmid"">9638609</pub-id></mixed-citation></ref><ref id=""B55""><mixed-citation publication-type=""journal""><name><surname>Oskarsson</surname><given-names>A</given-names></name><name><surname>Schultz</surname><given-names>A</given-names></name><name><surname>Skerfving</surname><given-names>S</given-names></name><name><surname>Hallen</surname><given-names>IP</given-names></name><name><surname>Ohlin</surname><given-names>B</given-names></name><name><surname>Lagerkvist</surname><given-names>BJ</given-names></name><article-title>Total and inorganic mercury in breast milk in relation to fish consumption and amalgam in lactating women</article-title><source>Arch Environ Health</source><year>1996</year><volume>51</volume><fpage>234</fpage><lpage>241</lpage><pub-id pub-id-type=""doi"">10.1080/00039896.1996.9936021</pub-id><pub-id pub-id-type=""pmid"">8687245</pub-id></mixed-citation></ref><ref id=""B56""><mixed-citation publication-type=""journal""><name><surname>Vimy</surname><given-names>MJ</given-names></name><name><surname>Hooper</surname><given-names>DE</given-names></name><name><surname>King</surname><given-names>WW</given-names></name><name><surname>Lorscheider</surname><given-names>FL</given-names></name><article-title>Mercury from maternal ""silver"" tooth fillings in sheep and human breast milk. A source of neonatal exposure</article-title><source>Biol Trace Element Res</source><year>1997</year><volume>56</volume><fpage>143</fpage><lpage>152</lpage><pub-id pub-id-type=""doi"">10.1007/BF02785388</pub-id></mixed-citation></ref><ref id=""B57""><mixed-citation publication-type=""journal""><name><surname>Waly</surname><given-names>M</given-names></name><name><surname>Olteanu</surname><given-names>H</given-names></name><name><surname>Banerjee</surname><given-names>R</given-names></name><name><surname>Choi</surname><given-names>SW</given-names></name><name><surname>Mason</surname><given-names>JB</given-names></name><name><surname>Parker</surname><given-names>BS</given-names></name><name><surname>Sukumar</surname><given-names>S</given-names></name><name><surname>Shim</surname><given-names>S</given-names></name><name><surname>Sharma</surname><given-names>A</given-names></name><name><surname>Benzecry</surname><given-names>JM</given-names></name><name><surname>Power-Charnitsky</surname><given-names>VA</given-names></name><name><surname>Deth</surname><given-names>RC</given-names></name><article-title>Activation of methionine synthase by insulin-like growth factor and dopamine: a target for neurodevelopmental toxins and thimerosal</article-title><source>Mol Psychiatry</source><year>2004</year><volume>9</volume><fpage>358</fpage><lpage>370</lpage><pub-id pub-id-type=""doi"">10.1038/sj.mp.4001476</pub-id><pub-id pub-id-type=""pmid"">14745455</pub-id></mixed-citation></ref><ref id=""B58""><mixed-citation publication-type=""other""><name><surname>Deth</surname><given-names>RC</given-names></name><article-title>Truth revealed: New scientific discoveries regarding mercury in medicine and autism</article-title><source>Congression Testimony before the US House of Representatives. Subcommittee in human rights and wellness</source><year>2004</year></mixed-citation></ref><ref id=""B59""><mixed-citation publication-type=""journal""><name><surname>Palkovicova</surname><given-names>L</given-names></name><name><surname>Ursinyova</surname><given-names>M</given-names></name><name><surname>Masanova</surname><given-names>V</given-names></name><name><surname>Yu</surname><given-names>Z</given-names></name><name><surname>Hertz-Picciotto</surname><given-names>I</given-names></name><article-title>Maternal amalgam dental fillings as the source of mercury exposure in developing fetus and newborn</article-title><source>J Expo Sci Environ Epidemiol</source><year>2008</year><volume>18</volume><issue>Suppl 3</issue><fpage>326</fpage><lpage>331</lpage><pub-id pub-id-type=""doi"">10.1038/sj.jes.7500606</pub-id><pub-id pub-id-type=""pmid"">17851449</pub-id></mixed-citation></ref><ref id=""B60""><mixed-citation publication-type=""journal""><name><surname>Unuvar</surname><given-names>E</given-names></name><name><surname>Ahmadov</surname><given-names>H</given-names></name><name><surname>Kiziler</surname><given-names>AR</given-names></name><article-title>Mercury levels in cord blood and meconium of healthy newborns and venous blood of their mothers: Clinical, prospective cohort study</article-title><source>Sci Total Environ</source><year>2007</year><volume>374</volume><issue>Suppl 1</issue><fpage>60</fpage><lpage>70</lpage><pub-id pub-id-type=""pmid"">17258795</pub-id></mixed-citation></ref><ref id=""B61""><mixed-citation publication-type=""journal""><name><surname>Jedrychowski</surname><given-names>W</given-names></name><name><surname>Jankowski</surname><given-names>J</given-names></name><name><surname>Flak</surname><given-names>E</given-names></name><name><surname>Skarupa</surname><given-names>A</given-names></name><name><surname>Mroz</surname><given-names>E</given-names></name><name><surname>Sochacka-Tatara</surname><given-names>E</given-names></name><name><surname>Lisowska-Miszczyk</surname><given-names>I</given-names></name><name><surname>Szpanowska-Wohn</surname><given-names>A</given-names></name><name><surname>Rauh</surname><given-names>V</given-names></name><name><surname>Skolicki</surname><given-names>Z</given-names></name><name><surname>Kaim</surname><given-names>I</given-names></name><name><surname>Perera</surname><given-names>F</given-names></name><article-title>Effects of prenatal exposure to mercury on cognitive and psychomotor function in one-year-old infants: epidemiologic cohort study in Poland</article-title><source>Ann Epidemiol</source><year>2006</year><volume>16</volume><fpage>439</fpage><lpage>447</lpage><pub-id pub-id-type=""doi"">10.1016/j.annepidem.2005.06.059</pub-id><pub-id pub-id-type=""pmid"">16275013</pub-id></mixed-citation></ref><ref id=""B62""><mixed-citation publication-type=""journal""><name><surname>Stoz</surname><given-names>F</given-names></name><name><surname>Aicham</surname><given-names>P</given-names></name><name><surname>Jovanovic</surname><given-names>S</given-names></name><name><surname>Steuer</surname><given-names>W</given-names></name><name><surname>Mayer</surname><given-names>R</given-names></name><article-title>Ist ein generelles Amalgam-Verbot gerechtfertigt? [Is a generalized amalgam banning appropriate?]</article-title><source>Z Geburtsh Neonat</source><year>1995</year><volume>199</volume><fpage>35</fpage><lpage>41</lpage></mixed-citation></ref><ref id=""B63""><mixed-citation publication-type=""journal""><name><surname>Hargreaves</surname><given-names>RJ</given-names></name><name><surname>Evans</surname><given-names>JG</given-names></name><name><surname>Janota</surname><given-names>I</given-names></name><name><surname>Magos</surname><given-names>L</given-names></name><name><surname>Cavanagh</surname><given-names>JB</given-names></name><article-title>Persistant mercury in nerve cells 16 years after metallic mercury poisoning</article-title><source>Neuropath Appl Neurobiol</source><year>1988</year><volume>14</volume><fpage>443</fpage><lpage>452</lpage><pub-id pub-id-type=""doi"">10.1111/j.1365-2990.1988.tb01336.x</pub-id></mixed-citation></ref><ref id=""B64""><mixed-citation publication-type=""journal""><name><surname>Opitz</surname><given-names>H</given-names></name><name><surname>Schweinsberg</surname><given-names>F</given-names></name><name><surname>Grossmann</surname><given-names>T</given-names></name><name><surname>Wendt-Gallitelli</surname><given-names>MF</given-names></name><name><surname>Meyermann</surname><given-names>R</given-names></name><article-title>Demonstration of mercury in the human brain and other organs 17 years after metallic mercury exposure</article-title><source>Clin Neuropath</source><year>1996</year><volume>15</volume><fpage>139</fpage><lpage>144</lpage></mixed-citation></ref><ref id=""B65""><mixed-citation publication-type=""journal""><name><surname>Drasch</surname><given-names>G</given-names></name><name><surname>Böse-O'Reilly</surname><given-names>S</given-names></name><name><surname>Beinhoff</surname><given-names>C</given-names></name><name><surname>Roider</surname><given-names>G</given-names></name><name><surname>Maydl</surname><given-names>S</given-names></name><article-title>The Mt. Diwata study on the Philippines 1999 - assessing mercury intoxication of the population by small scale gold mining</article-title><source>Sci Total Environ</source><year>2001</year><volume>267</volume><fpage>151</fpage><lpage>168</lpage><pub-id pub-id-type=""doi"">10.1016/S0048-9697(00)00806-8</pub-id><pub-id pub-id-type=""pmid"">11286210</pub-id></mixed-citation></ref><ref id=""B66""><mixed-citation publication-type=""journal""><name><surname>Drasch</surname><given-names>G</given-names></name><name><surname>Böse-O`Reilly</surname><given-names>S</given-names></name><name><surname>Maydl</surname><given-names>S</given-names></name><name><surname>Roider</surname><given-names>G</given-names></name><article-title>Scientific comment on the German human biological monitoring values (HBM values) for mercury</article-title><source>Int J Hyg Environ Health</source><year>2002</year><volume>205</volume><fpage>509</fpage><lpage>512</lpage><pub-id pub-id-type=""doi"">10.1078/1438-4639-00178</pub-id><pub-id pub-id-type=""pmid"">12455274</pub-id></mixed-citation></ref><ref id=""B67""><mixed-citation publication-type=""journal""><name><surname>Drasch</surname><given-names>G</given-names></name><name><surname>Böse-O'Reilly</surname><given-names>S</given-names></name><name><surname>Maydl</surname><given-names>S</given-names></name><name><surname>Roider</surname><given-names>G</given-names></name><article-title>Response to the letter of the Human Biomonitoring Commission</article-title><source>Int J Hyg Environ Health</source><year>2004</year><volume>207</volume><fpage>183</fpage><lpage>184</lpage><pub-id pub-id-type=""doi"">10.1078/1438-4639-00280</pub-id></mixed-citation></ref><ref id=""B68""><mixed-citation publication-type=""journal""><name><surname>Stenman</surname><given-names>S</given-names></name><name><surname>Grans</surname><given-names>L</given-names></name><article-title>Symptoms and differential diagnosis of patients fearing mercury toxicity from amalgam fillings</article-title><source>Scand J Work Environ Health</source><year>1997</year><volume>23</volume><fpage>59</fpage><lpage>63</lpage><pub-id pub-id-type=""pmid"">9456068</pub-id></mixed-citation></ref><ref id=""B69""><mixed-citation publication-type=""journal""><name><surname>Grandjean</surname><given-names>P</given-names></name><name><surname>Weihe</surname><given-names>P</given-names></name><name><surname>White</surname><given-names>R</given-names></name><article-title>Milestone development in infants exposed to methylmercury from human milk</article-title><source>Neurotoxicology</source><year>1995</year><volume>16</volume><fpage>27</fpage><lpage>33</lpage><pub-id pub-id-type=""pmid"">7603642</pub-id></mixed-citation></ref><ref id=""B70""><mixed-citation publication-type=""journal""><name><surname>Köhler</surname><given-names>W</given-names></name><name><surname>Linde</surname><given-names>K</given-names></name><name><surname>Halbach</surname><given-names>S</given-names></name><name><surname>Zilker</surname><given-names>T</given-names></name><name><surname>Kremers</surname><given-names>L</given-names></name><name><surname>Saller</surname><given-names>R</given-names></name><name><surname>Melchart</surname><given-names>D</given-names></name><article-title>Prognos in the diagnosos of amalgam hypersensitivity: a diagnostic case-control study</article-title><source>Forsch Komplement Med</source><year>2007</year><volume>14</volume><fpage>18</fpage><lpage>24</lpage></mixed-citation></ref><ref id=""B71""><mixed-citation publication-type=""other""><collab>WHO</collab><article-title>Mercury in Health Care</article-title><source>Policy Paper</source><year>2005</year><ext-link ext-link-type=""uri"" xlink:href=""http://www.who.int/water_sanitation_health/medicalwaste/mercurypolpaper.pdf"">http://www.who.int/water_sanitation_health/medicalwaste/mercurypolpaper.pdf</ext-link></mixed-citation></ref><ref id=""B72""><mixed-citation publication-type=""journal""><name><surname>Viola</surname><given-names>P</given-names></name><name><surname>Cassano</surname><given-names>GB</given-names></name><article-title>The effect of chlorine on mercury vapor intoxication. Autoradiographic study</article-title><source>Med Lavoro</source><year>1968</year><volume>59</volume><fpage>437</fpage><lpage>44</lpage><pub-id pub-id-type=""pmid"">5738990</pub-id></mixed-citation></ref><ref id=""B73""><mixed-citation publication-type=""journal""><name><surname>Kishi</surname><given-names>R</given-names></name><name><surname>Doi</surname><given-names>R</given-names></name><name><surname>Fukuchi</surname><given-names>Y</given-names></name><name><surname>Satoh</surname><given-names>H</given-names></name><name><surname>Satoh</surname><given-names>T</given-names></name><name><surname>Ono</surname><given-names>A</given-names></name><name><surname>Moriwaka</surname><given-names>F</given-names></name><name><surname>Tashiro</surname><given-names>K</given-names></name><name><surname>Takahata</surname><given-names>N</given-names></name><article-title>Subjective symptoms and neurobehavioral performances of ex-mercury miners at an average of 18 years after the cessation of chronic exposure to mercury vapor. Mercury Workers Study Group</article-title><source>Environl Res</source><year>1993</year><volume>62</volume><fpage>289</fpage><lpage>302</lpage><pub-id pub-id-type=""doi"">10.1006/enrs.1993.1114</pub-id></mixed-citation></ref><ref id=""B74""><mixed-citation publication-type=""journal""><name><surname>Mathiesen</surname><given-names>T</given-names></name><name><surname>Ellingsen</surname><given-names>DG</given-names></name><name><surname>Kjuus</surname><given-names>H</given-names></name><article-title>Neuropsychological effects associated with exposure to mercury vapor among former chloralkali workers</article-title><source>Scand J Work Environ Health</source><year>1999</year><volume>25</volume><fpage>342</fpage><lpage>350</lpage><pub-id pub-id-type=""pmid"">10505660</pub-id></mixed-citation></ref><ref id=""B75""><mixed-citation publication-type=""journal""><name><surname>Meyer-Baron</surname><given-names>M</given-names></name><name><surname>Schaeper</surname><given-names>M</given-names></name><name><surname>Seeber</surname><given-names>A</given-names></name><article-title>A meta-analysis for neurobehavioral results due to occupational mercury exposure</article-title><source>Arch Toxicol</source><year>2002</year><volume>76</volume><fpage>127</fpage><lpage>136</lpage><pub-id pub-id-type=""doi"">10.1007/s00204-002-0327-9</pub-id><pub-id pub-id-type=""pmid"">11967617</pub-id></mixed-citation></ref><ref id=""B76""><mixed-citation publication-type=""journal""><name><surname>Piikivi</surname><given-names>L</given-names></name><name><surname>Hanninen</surname><given-names>H</given-names></name><name><surname>Martelin</surname><given-names>T</given-names></name><name><surname>Mantere</surname><given-names>P</given-names></name><article-title>Psychological performance and long-term exposure to mercury vapors</article-title><source>Scand J Work Environ Health</source><year>1984</year><volume>10</volume><fpage>35</fpage><lpage>41</lpage><pub-id pub-id-type=""pmid"">6740275</pub-id></mixed-citation></ref><ref id=""B77""><mixed-citation publication-type=""journal""><name><surname>Roels</surname><given-names>H</given-names></name><name><surname>Gennart</surname><given-names>JP</given-names></name><name><surname>Lauwerys</surname><given-names>R</given-names></name><name><surname>Buchet</surname><given-names>JP</given-names></name><name><surname>Malchaire</surname><given-names>J</given-names></name><name><surname>Bernard</surname><given-names>A</given-names></name><article-title>Surveillance of workers exposed to mercury vapour: validation of a previously proposed biological threshold limit value for mercury concentration in urine</article-title><source>Am J Ind Med</source><year>1985</year><volume>7</volume><fpage>45</fpage><lpage>71</lpage><pub-id pub-id-type=""doi"">10.1002/ajim.4700070106</pub-id><pub-id pub-id-type=""pmid"">3871586</pub-id></mixed-citation></ref><ref id=""B78""><mixed-citation publication-type=""journal""><name><surname>Smith</surname><given-names>PJ</given-names></name><name><surname>Langolf</surname><given-names>GD</given-names></name><name><surname>Goldberg</surname><given-names>J</given-names></name><article-title>Effects of occupational exposure to elemental mercury on short term memory</article-title><source>Br J Ind Med</source><year>1983</year><volume>40</volume><fpage>413</fpage><lpage>419</lpage><pub-id pub-id-type=""pmid"">6626469</pub-id></mixed-citation></ref><ref id=""B79""><mixed-citation publication-type=""journal""><name><surname>Soleo</surname><given-names>L</given-names></name><name><surname>Urbano</surname><given-names>ML</given-names></name><name><surname>Petrera</surname><given-names>V</given-names></name><name><surname>Ambrosi</surname><given-names>L</given-names></name><article-title>Effects of low exposure to inorganic mercury on psychological performance</article-title><source>Brit J Ind Med</source><year>1990</year><volume>47</volume><fpage>105</fpage><lpage>109</lpage></mixed-citation></ref><ref id=""B80""><mixed-citation publication-type=""other""><name><surname>Williamson</surname><given-names>AM</given-names></name><name><surname>Teo</surname><given-names>RK</given-names></name><name><surname>Sanderson</surname><given-names>J</given-names></name><article-title>Occupational mercury exposure and its consequences for behaviour. Int Arch Occup Environ Health</article-title><year>1982</year><volume>50</volume><fpage>273</fpage><lpage>286</lpage><pub-id pub-id-type=""pmid"">7129652</pub-id></mixed-citation></ref><ref id=""B81""><mixed-citation publication-type=""journal""><name><surname>Zavariz</surname><given-names>C</given-names></name><name><surname>Glina</surname><given-names>DM</given-names></name><article-title>Clinico-neuro-psychological evaluation of workers exposed to metallic mercury in the electric lamp industry</article-title><source>Rev Saud Publica</source><year>1992</year><volume>26</volume><fpage>356</fpage><lpage>65</lpage><comment>(In Portugese with English abstract)</comment></mixed-citation></ref><ref id=""B82""><mixed-citation publication-type=""journal""><name><surname>He</surname><given-names>F</given-names></name><name><surname>Zhow</surname><given-names>X</given-names></name><name><surname>Lin</surname><given-names>B</given-names></name><name><surname>Xiung</surname><given-names>YP</given-names></name><name><surname>Chen</surname><given-names>SY</given-names></name><name><surname>Zhang</surname><given-names>SL</given-names></name><name><surname>Ru</surname><given-names>JY</given-names></name><name><surname>Deng</surname><given-names>MH</given-names></name><article-title>Prognosis of Mercury poisoning in mercury refinery workers</article-title><source>Ann Acad Med Singapore</source><year>1984</year><volume>13</volume><fpage>389</fpage><lpage>393</lpage><pub-id pub-id-type=""pmid"">6497343</pub-id></mixed-citation></ref><ref id=""B83""><mixed-citation publication-type=""journal""><name><surname>Kishi</surname><given-names>R</given-names></name><name><surname>Doi</surname><given-names>R</given-names></name><name><surname>Fukushi</surname><given-names>Y</given-names></name><name><surname>Satoh</surname><given-names>H</given-names></name><name><surname>Ono</surname><given-names>A</given-names></name><article-title>Residual neurobehavioural effects associated with chronic exposure to mercury vapour</article-title><source>Occup Environ Med</source><year>1994</year><volume>51</volume><fpage>35</fpage><lpage>41</lpage><pub-id pub-id-type=""doi"">10.1136/oem.51.1.35</pub-id><pub-id pub-id-type=""pmid"">8124461</pub-id></mixed-citation></ref><ref id=""B84""><mixed-citation publication-type=""journal""><name><surname>Kobal</surname><given-names>A</given-names></name><name><surname>Horvat</surname><given-names>M</given-names></name><name><surname>Prezelj</surname><given-names>M</given-names></name><name><surname>Briski</surname><given-names>AS</given-names></name><name><surname>Krsnik</surname><given-names>M</given-names></name><name><surname>Dizdarevic</surname><given-names>T</given-names></name><name><surname>Mazej</surname><given-names>D</given-names></name><name><surname>Falnoga</surname><given-names>I</given-names></name><name><surname>Stibilj</surname><given-names>V</given-names></name><name><surname>Arneric</surname><given-names>N</given-names></name><name><surname>Kobal</surname><given-names>D</given-names></name><name><surname>Osredkar</surname><given-names>J</given-names></name><article-title>The impact of long-term past exposure to elemental mercury on antioxidative capacity and lipid peroxidation in mercury miners</article-title><source>J Trace Elem Med Biol</source><year>2004</year><volume>17</volume><fpage>261</fpage><lpage>274</lpage><pub-id pub-id-type=""doi"">10.1016/S0946-672X(04)80028-2</pub-id><pub-id pub-id-type=""pmid"">15139389</pub-id></mixed-citation></ref><ref id=""B85""><mixed-citation publication-type=""journal""><name><surname>Letz</surname><given-names>R</given-names></name><name><surname>Gerr</surname><given-names>F</given-names></name><name><surname>Cragle</surname><given-names>D</given-names></name><name><surname>Green</surname><given-names>R</given-names></name><name><surname>Watkins</surname><given-names>J</given-names></name><name><surname>Fidler</surname><given-names>A</given-names></name><article-title>Residual neurologic deficits 30 years after occupational exposure to elemental mercury</article-title><source>Neurotoxicology</source><year>2000</year><volume>21</volume><fpage>459</fpage><lpage>474</lpage><pub-id pub-id-type=""pmid"">11022856</pub-id></mixed-citation></ref><ref id=""B86""><mixed-citation publication-type=""journal""><name><surname>Sugita</surname><given-names>M</given-names></name><article-title>The biological half-time of heavy metals. The existence of a third, `slowest' component</article-title><source>Int Arch Occup Environ Health</source><year>1978</year><volume>41</volume><fpage>25</fpage><lpage>40</lpage><pub-id pub-id-type=""doi"">10.1007/BF00377797</pub-id><pub-id pub-id-type=""pmid"">627414</pub-id></mixed-citation></ref><ref id=""B87""><mixed-citation publication-type=""journal""><name><surname>Takahata</surname><given-names>N</given-names></name><name><surname>Hayashi</surname><given-names>H</given-names></name><name><surname>Watanabe</surname><given-names>S</given-names></name><name><surname>Anso</surname><given-names>T</given-names></name><article-title>Accumulation of mercury in the brains of two autopsy cases with chronic inorganic mercury poisoning</article-title><source>Folia Psychiatr Neurol Jpn</source><year>1970</year><volume>24</volume><fpage>59</fpage><lpage>69</lpage><pub-id pub-id-type=""pmid"">5535917</pub-id></mixed-citation></ref><ref id=""B88""><mixed-citation publication-type=""journal""><name><surname>Stoiber</surname><given-names>T</given-names></name><name><surname>Bonacker</surname><given-names>D</given-names></name><name><surname>Bohm</surname><given-names>K</given-names></name><article-title>Disturbed microtubule function and induction of micronuclei by chelate complexes of mercury(II)</article-title><source>Mutat Res</source><year>2004</year><volume>563</volume><fpage>97</fpage><lpage>106</lpage><pub-id pub-id-type=""pmid"">15364276</pub-id></mixed-citation></ref><ref id=""B89""><mixed-citation publication-type=""journal""><name><surname>Stoiber</surname><given-names>T</given-names></name><name><surname>Degen</surname><given-names>GH</given-names></name><name><surname>Bolt</surname><given-names>HM</given-names></name><name><surname>Unger</surname><given-names>E</given-names></name><article-title>Interaction of mercury(II) with the microtubule cytoskeleton in IMR-32 neuroblastoma cells</article-title><source>Toxicol Lett</source><year>2004</year><volume>151</volume><issue>Suppl 1</issue><fpage>99</fpage><lpage>104</lpage><pub-id pub-id-type=""doi"">10.1016/j.toxlet.2003.11.017</pub-id><pub-id pub-id-type=""pmid"">15177645</pub-id></mixed-citation></ref><ref id=""B90""><mixed-citation publication-type=""journal""><name><surname>Thier</surname><given-names>R</given-names></name><name><surname>Bonacker</surname><given-names>D</given-names></name><name><surname>Stoiber</surname><given-names>T</given-names></name><article-title>Interaction of metal salts with cytoskeletal motor protein systems</article-title><source>Toxicol Lett</source><year>2003</year><volume>140</volume><fpage>75</fpage><lpage>81</lpage><pub-id pub-id-type=""doi"">10.1016/S0378-4274(02)00502-7</pub-id><pub-id pub-id-type=""pmid"">12676453</pub-id></mixed-citation></ref><ref id=""B91""><mixed-citation publication-type=""journal""><name><surname>Duhr</surname><given-names>EF</given-names></name><name><surname>Pendergrass</surname><given-names>JC</given-names></name><name><surname>Slevin</surname><given-names>JT</given-names></name><name><surname>Haley</surname><given-names>BE</given-names></name><article-title>HgEDTA complex inhibits GTP interactions with the E-site of brain beta-tubulin</article-title><source>Toxicol Appl Pharmacol</source><year>1993</year><volume>122</volume><fpage>273</fpage><lpage>280</lpage><pub-id pub-id-type=""doi"">10.1006/taap.1993.1196</pub-id><pub-id pub-id-type=""pmid"">8212009</pub-id></mixed-citation></ref><ref id=""B92""><mixed-citation publication-type=""journal""><name><surname>Pendergrass</surname><given-names>JC</given-names></name><name><surname>Haley</surname><given-names>BE</given-names></name><name><surname>Vimy</surname><given-names>MJ</given-names></name><name><surname>Winfield</surname><given-names>SA</given-names></name><name><surname>Lorscheider</surname><given-names>FL</given-names></name><article-title>Mercury vapor inhalation inhibits binding of GTP to tubulin in rat brain: similarity to a molecular lesion in Alzheimer diseased brain</article-title><source>Neurotoxicology</source><year>1996</year><volume>18</volume><fpage>315</fpage><lpage>324</lpage></mixed-citation></ref><ref id=""B93""><mixed-citation publication-type=""journal""><name><surname>Soares</surname><given-names>FA</given-names></name><name><surname>Farina</surname><given-names>M</given-names></name><name><surname>Santos</surname><given-names>FW</given-names></name><name><surname>Souza</surname><given-names>D</given-names></name><name><surname>Rocha</surname><given-names>JB</given-names></name><name><surname>Nogueira</surname><given-names>CW</given-names></name><article-title>Interaction between metals and chelating agents affects glutamate binding on brain synaptic membranes</article-title><source>Neurochem Res</source><year>2003</year><volume>28</volume><fpage>1859</fpage><lpage>1865</lpage><pub-id pub-id-type=""doi"">10.1023/A:1026175825871</pub-id><pub-id pub-id-type=""pmid"">14649728</pub-id></mixed-citation></ref><ref id=""B94""><mixed-citation publication-type=""journal""><name><surname>Aposhian</surname><given-names>HV</given-names></name><name><surname>Morgan</surname><given-names>DL</given-names></name><name><surname>Queen</surname><given-names>HL</given-names></name><name><surname>Maiorino</surname><given-names>RM</given-names></name><name><surname>Aposhian</surname><given-names>MM</given-names></name><article-title>Vitamin C, glutathione, or lipoic acid did not decrease brain or kidney mercury in rats exposed to mercury vapor</article-title><source>J Toxicol Clin Toxicol</source><year>2003</year><volume>41</volume><fpage>339</fpage><lpage>347</lpage><pub-id pub-id-type=""doi"">10.1081/CLT-120022000</pub-id><pub-id pub-id-type=""pmid"">12870874</pub-id></mixed-citation></ref><ref id=""B95""><mixed-citation publication-type=""journal""><name><surname>Nogueira</surname><given-names>CW</given-names></name><name><surname>Soares</surname><given-names>FA</given-names></name><name><surname>Nascimento</surname><given-names>PC</given-names></name><name><surname>Muller</surname><given-names>D</given-names></name><name><surname>Rocha</surname><given-names>JB</given-names></name><article-title>2,3-Dimercaptopropane-1-sulfonic acid and meso-2,3-dimercaptosuccinic acid increase mercury- and cadmium-induced inhibition of delta-aminolevulinate dehydratase</article-title><source>Toxicology</source><year>2003</year><volume>184</volume><fpage>85</fpage><lpage>95</lpage><pub-id pub-id-type=""doi"">10.1016/S0300-483X(02)00575-9</pub-id><pub-id pub-id-type=""pmid"">12499112</pub-id></mixed-citation></ref><ref id=""B96""><mixed-citation publication-type=""journal""><name><surname>Ewan</surname><given-names>KB</given-names></name><name><surname>Pamphlett</surname><given-names>R</given-names></name><article-title>Increased inorganic mercury in spinal motor neurons follwoing chelating agents</article-title><source>Neurotoxicology</source><year>1996</year><volume>17</volume><fpage>343</fpage><lpage>349</lpage><pub-id pub-id-type=""pmid"">8856730</pub-id></mixed-citation></ref><ref id=""B97""><mixed-citation publication-type=""journal""><name><surname>Harris</surname><given-names>HH</given-names></name><name><surname>Pickering</surname><given-names>IJ</given-names></name><name><surname>George</surname><given-names>GN</given-names></name><article-title>The chemical form of mercury in fish</article-title><source>Science</source><year>2003</year><volume>301</volume><fpage>1203</fpage><pub-id pub-id-type=""doi"">10.1126/science.1085941</pub-id><pub-id pub-id-type=""pmid"">12947190</pub-id></mixed-citation></ref><ref id=""B98""><mixed-citation publication-type=""journal""><name><surname>Fredriksson</surname><given-names>A</given-names></name><name><surname>Dencker</surname><given-names>L</given-names></name><name><surname>Archer</surname><given-names>T</given-names></name><name><surname>Danielsson</surname><given-names>BR</given-names></name><article-title>Prenatal coexposure to metallic mercury vapour and methylmercury produce interactive behavioural changes in adult rats</article-title><source>Neurotoxicol Teratol</source><year>1996</year><volume>18</volume><fpage>129</fpage><lpage>134</lpage><pub-id pub-id-type=""doi"">10.1016/0892-0362(95)02059-4</pub-id><pub-id pub-id-type=""pmid"">8709923</pub-id></mixed-citation></ref><ref id=""B99""><mixed-citation publication-type=""other""><name><surname>Lettmeier</surname><given-names>B</given-names></name><name><surname>Böse</surname><given-names>o</given-names></name><name><surname>Reilly</surname><given-names>S</given-names></name><name><surname>Drasch</surname><given-names>G</given-names></name><article-title>Proposal for a revised reference concentration (RFC) for mercury vapour in adults</article-title><source>Sci Total Environ</source><year>2010</year></mixed-citation></ref><ref id=""B100""><mixed-citation publication-type=""other""><name><surname>Richardson</surname><given-names>GM</given-names></name><collab>Environment Division of SNC-Lavalin Inc (SLE), Ottawa (Canada).</collab><article-title>Mercury exposure and risks from dental amalgam, part 1: updating exposure, reexamining reference exposure levels, and critically evaluating recent studies</article-title><year>2010</year><ext-link ext-link-type=""uri"" xlink:href=""http://iaomt.org/articles/files/files329/Amalgam%20Risk%20Assessment%20Part%201.SLE%20reference%2010738.Final2.pdf"">http://iaomt.org/articles/files/files329/Amalgam%20Risk%20Assessment%20Part%201.SLE%20reference%2010738.Final2.pdf</ext-link><pub-id pub-id-type=""pmid"">20926115</pub-id></mixed-citation></ref><ref id=""B101""><mixed-citation publication-type=""journal""><name><surname>Schubert</surname><given-names>J</given-names></name><name><surname>Riley</surname><given-names>EJ</given-names></name><name><surname>Tyler</surname><given-names>SA</given-names></name><article-title>Combined effects in toxicology - a rapid systematic testing procedure: cadmium, mercury, and lead</article-title><source>J Toxicol Environ Health</source><year>1978</year><volume>4</volume><fpage>763</fpage><lpage>776</lpage><pub-id pub-id-type=""doi"">10.1080/15287397809529698</pub-id><pub-id pub-id-type=""pmid"">731728</pub-id></mixed-citation></ref><ref id=""B102""><mixed-citation publication-type=""other""><name><surname>Haley</surname><given-names>B</given-names></name><article-title>The relationship of toxic effects of mercury to exacerbation of the medical condition classified as alzheimer's disease</article-title><ext-link ext-link-type=""uri"" xlink:href=""http://www.fda.gov/ohrms/dockets/dailys/02/Sep02/091602/80027dd5.pdf"">http://www.fda.gov/ohrms/dockets/dailys/02/Sep02/091602/80027dd5.pdf</ext-link></mixed-citation></ref><ref id=""B103""><mixed-citation publication-type=""journal""><name><surname>Ericson</surname><given-names>JE</given-names></name><name><surname>Shirahata</surname><given-names>H</given-names></name><name><surname>Patterson</surname><given-names>CC</given-names></name><article-title>Skeletal concentrations of lead in ancient Peruvians</article-title><source>N Engl J Med</source><year>1979</year><volume>300</volume><fpage>946</fpage><lpage>951</lpage><pub-id pub-id-type=""doi"">10.1056/NEJM197904263001703</pub-id><pub-id pub-id-type=""pmid"">372802</pub-id></mixed-citation></ref><ref id=""B104""><mixed-citation publication-type=""journal""><name><surname>Ericson</surname><given-names>JE</given-names></name><name><surname>Smith</surname><given-names>DR</given-names></name><name><surname>Flegal</surname><given-names>AR</given-names></name><article-title>Skeletal concentrations of lead, cadmium, zinc, and silver in ancient North American Pecos Indians</article-title><source>Environ Health Perspect</source><year>1991</year><volume>93</volume><fpage>217</fpage><lpage>223</lpage><pub-id pub-id-type=""doi"">10.2307/3431192</pub-id><pub-id pub-id-type=""pmid"">1773793</pub-id></mixed-citation></ref><ref id=""B105""><mixed-citation publication-type=""journal""><name><surname>Drasch</surname><given-names>G</given-names></name><article-title>Lead burden in prehistorical, historical and modern human bones</article-title><source>Sci Total Environ</source><year>1982</year><volume>24</volume><fpage>199</fpage><lpage>231</lpage><pub-id pub-id-type=""doi"">10.1016/0048-9697(82)90001-8</pub-id><pub-id pub-id-type=""pmid"">7123205</pub-id></mixed-citation></ref><ref id=""B106""><mixed-citation publication-type=""journal""><name><surname>Patterson</surname><given-names>CC</given-names></name><name><surname>Shirahata</surname><given-names>H</given-names></name><name><surname>Ericson</surname><given-names>JE</given-names></name><article-title>Lead in ancient human bones and the relevance to historical developments of social problems with lead</article-title><source>Sci Total Environ</source><year>1987</year><volume>61</volume><fpage>167</fpage><lpage>200</lpage><pub-id pub-id-type=""doi"">10.1016/0048-9697(87)90366-4</pub-id><pub-id pub-id-type=""pmid"">3554506</pub-id></mixed-citation></ref><ref id=""B107""><mixed-citation publication-type=""journal""><name><surname>Patterson</surname><given-names>CC</given-names></name><name><surname>Shirahata</surname><given-names>H</given-names></name><name><surname>Ericson</surname><given-names>JE</given-names></name><article-title>Natural skeletal levels of lead in Homo sapiens sapiens uncontaminated by technological lead</article-title><source>Sci Total Environ</source><year>1991</year><volume>107</volume><fpage>205</fpage><lpage>236</lpage><pub-id pub-id-type=""doi"">10.1016/0048-9697(91)90260-L</pub-id><pub-id pub-id-type=""pmid"">1785050</pub-id></mixed-citation></ref><ref id=""B108""><mixed-citation publication-type=""journal""><name><surname>Haley</surname><given-names>B</given-names></name><article-title>Mercury toxicity: Genetic susceptibilities and synergistic effects</article-title><source>Medical Veritas</source><year>2005</year><volume>2</volume><fpage>535</fpage><lpage>542</lpage><pub-id pub-id-type=""doi"">10.1588/medver.2005.02.00070</pub-id></mixed-citation></ref><ref id=""B109""><mixed-citation publication-type=""journal""><name><surname>Haley</surname><given-names>B</given-names></name><name><surname>Small</surname><given-names>T</given-names></name><article-title>Biomarkers supporting mercury toxicity as the major exacerbator of neurological illness, recent evidence via the urine prophyrin tests</article-title><source>Medical Veritas</source><year>2006</year><volume>3</volume><fpage>1</fpage><lpage>14</lpage></mixed-citation></ref><ref id=""B110""><mixed-citation publication-type=""journal""><name><surname>Kehe</surname><given-names>K</given-names></name><name><surname>Reichl</surname><given-names>FX</given-names></name><name><surname>Durner</surname><given-names>J</given-names></name><name><surname>Walther</surname><given-names>U</given-names></name><name><surname>Hickel</surname><given-names>R</given-names></name><name><surname>Forth</surname><given-names>W</given-names></name><article-title>Cytotoxicity of dental composite components and mercury compounds in pulmonary cells</article-title><source>Biomaterials</source><year>2001</year><volume>22</volume><fpage>317</fpage><lpage>322</lpage><pub-id pub-id-type=""doi"">10.1016/S0142-9612(00)00184-8</pub-id><pub-id pub-id-type=""pmid"">11205434</pub-id></mixed-citation></ref><ref id=""B111""><mixed-citation publication-type=""journal""><name><surname>Reichl</surname><given-names>FX</given-names></name><name><surname>Walther</surname><given-names>UI</given-names></name><name><surname>Durner</surname><given-names>J</given-names></name><name><surname>Kehe</surname><given-names>K</given-names></name><name><surname>Hickel</surname><given-names>R</given-names></name><name><surname>Kunzelmann</surname><given-names>KH</given-names></name><name><surname>Spahl</surname><given-names>W</given-names></name><name><surname>Hume</surname><given-names>WR</given-names></name><name><surname>Benschop</surname><given-names>H</given-names></name><name><surname>Forth</surname><given-names>W</given-names></name><article-title>Cytotoxicity of dental composite components and mercury compounds in lung cells</article-title><source>Dent Mater</source><year>2001</year><volume>17</volume><fpage>95</fpage><lpage>101</lpage><pub-id pub-id-type=""doi"">10.1016/S0109-5641(00)00029-4</pub-id><pub-id pub-id-type=""pmid"">11163377</pub-id></mixed-citation></ref><ref id=""B112""><mixed-citation publication-type=""journal""><name><surname>Reichl</surname><given-names>FX</given-names></name><name><surname>Simon</surname><given-names>S</given-names></name><name><surname>Esters</surname><given-names>M</given-names></name><name><surname>Seiss</surname><given-names>M</given-names></name><name><surname>Kehe</surname><given-names>K</given-names></name><name><surname>Kleinsasser</surname><given-names>N</given-names></name><name><surname>Hickel</surname><given-names>R</given-names></name><article-title>Cytotoxicity of dental composite (co)monomers and the amalgam component Hg(2+) in human gingival fibroblasts</article-title><source>Arch Toxicol</source><year>2006</year><volume>80</volume><fpage>465</fpage><lpage>472</lpage><pub-id pub-id-type=""doi"">10.1007/s00204-006-0073-5</pub-id><pub-id pub-id-type=""pmid"">16474958</pub-id></mixed-citation></ref><ref id=""B113""><mixed-citation publication-type=""journal""><name><surname>Reichl</surname><given-names>FX</given-names></name><name><surname>Esters</surname><given-names>M</given-names></name><name><surname>Simon</surname><given-names>S</given-names></name><name><surname>Seiss</surname><given-names>M</given-names></name><name><surname>Kehe</surname><given-names>K</given-names></name><name><surname>Kleinsasser</surname><given-names>N</given-names></name><name><surname>Folwaczny</surname><given-names>M</given-names></name><name><surname>Glas</surname><given-names>J</given-names></name><name><surname>Hickel</surname><given-names>R</given-names></name><article-title>Cell death effects of resin-based dental material compounds and mercurials in human gingival fibroblast</article-title><source>Arch Toxicol</source><year>2006</year><volume>80</volume><fpage>370</fpage><lpage>377</lpage><pub-id pub-id-type=""doi"">10.1007/s00204-005-0044-2</pub-id><pub-id pub-id-type=""pmid"">16691427</pub-id></mixed-citation></ref><ref id=""B114""><mixed-citation publication-type=""journal""><name><surname>Walther</surname><given-names>UI</given-names></name><name><surname>Walther</surname><given-names>SC</given-names></name><name><surname>Liebl</surname><given-names>B</given-names></name><name><surname>Kehe</surname><given-names>K</given-names></name><name><surname>Hickel</surname><given-names>R</given-names></name><name><surname>Kunzelmann</surname><given-names>KH</given-names></name><name><surname>Spahl</surname><given-names>W</given-names></name><name><surname>Hume</surname><given-names>WR</given-names></name><name><surname>Benschop</surname><given-names>H</given-names></name><name><surname>Forth</surname><given-names>W</given-names></name><article-title>Cytotoxicity of ingredients of various dental materials and related compounds in L2- and A549 cells</article-title><source>J Biomed Mater Res</source><year>2002</year><volume>63</volume><fpage>643</fpage><lpage>649</lpage><pub-id pub-id-type=""doi"">10.1002/jbm.10384</pub-id><pub-id pub-id-type=""pmid"">12209911</pub-id></mixed-citation></ref><ref id=""B115""><mixed-citation publication-type=""journal""><name><surname>Di Pietro</surname><given-names>A</given-names></name><name><surname>Visalli</surname><given-names>G</given-names></name><name><surname>La Maestra</surname><given-names>S</given-names></name><article-title>Biomonitoring of DNA damage in peripheral blood lymphocytes of subjects with dental restorative fillings</article-title><source>Mutat Res</source><year>2008</year><volume>650</volume><fpage>115</fpage><lpage>122</lpage><pub-id pub-id-type=""pmid"">18178127</pub-id></mixed-citation></ref><ref id=""B116""><mixed-citation publication-type=""journal""><name><surname>Schmid</surname><given-names>K</given-names></name><name><surname>Sassen</surname><given-names>A</given-names></name><name><surname>Staudenmaier</surname><given-names>R</given-names></name><article-title>Mercury dichloride induces DNA-damage in human salivary gland tissue calls and lymphocytes</article-title><source>Arch Toxicol</source><year>2007</year><volume>1</volume><fpage>759</fpage><lpage>767</lpage><pub-id pub-id-type=""doi"">10.1007/s00204-007-0208-3</pub-id></mixed-citation></ref><ref id=""B117""><mixed-citation publication-type=""journal""><name><surname>Akiyama</surname><given-names>M</given-names></name><name><surname>Oshima</surname><given-names>H</given-names></name><name><surname>Nakamura</surname><given-names>M</given-names></name><article-title>Genotoxicity of mercury used in chromosome aberration tests</article-title><source>Toxicol in Vitro</source><year>2001</year><volume>15</volume><fpage>463</fpage><lpage>467</lpage><pub-id pub-id-type=""doi"">10.1016/S0887-2333(01)00051-0</pub-id><pub-id pub-id-type=""pmid"">11566579</pub-id></mixed-citation></ref><ref id=""B118""><mixed-citation publication-type=""journal""><name><surname>Pizzichini</surname><given-names>M</given-names></name><name><surname>Fonzi</surname><given-names>M</given-names></name><name><surname>Sugherini</surname><given-names>L</given-names></name><name><surname>Fonzi</surname><given-names>L</given-names></name><name><surname>Gasparoni</surname><given-names>A</given-names></name><name><surname>Comporti</surname><given-names>M</given-names></name><name><surname>Pompella</surname><given-names>A</given-names></name><article-title>Release of mercury from dental amalgam and its influence on salivary antioxidant activity</article-title><source>Bull Group Int Rech Sci Stomatol Odontol</source><year>2000</year><volume>42</volume><fpage>94</fpage><lpage>100</lpage><pub-id pub-id-type=""pmid"">11799733</pub-id></mixed-citation></ref><ref id=""B119""><mixed-citation publication-type=""journal""><name><surname>Pizzichini</surname><given-names>M</given-names></name><name><surname>Fonzi</surname><given-names>M</given-names></name><name><surname>Sugherini</surname><given-names>L</given-names></name><name><surname>Fonzi</surname><given-names>L</given-names></name><name><surname>Comporti</surname><given-names>M</given-names></name><name><surname>Gasparoni</surname><given-names>A</given-names></name><name><surname>Pompella</surname><given-names>A</given-names></name><article-title>Release of mercury from dental amalgam and its influence on salivary antioxidant activity</article-title><source>Sci Total Environ</source><year>2002</year><volume>284</volume><fpage>19</fpage><lpage>25</lpage><pub-id pub-id-type=""doi"">10.1016/S0048-9697(01)00853-1</pub-id><pub-id pub-id-type=""pmid"">11846163</pub-id></mixed-citation></ref><ref id=""B120""><mixed-citation publication-type=""journal""><name><surname>Pizzichini</surname><given-names>M</given-names></name><name><surname>Fonzi</surname><given-names>M</given-names></name><name><surname>Gasparoni</surname><given-names>A</given-names></name><name><surname>Fonzi</surname><given-names>L</given-names></name><name><surname>Comporti</surname><given-names>M</given-names></name><name><surname>Gasparoni</surname><given-names>A</given-names></name><name><surname>Pompella</surname><given-names>A</given-names></name><article-title>Influence of amalgam fillings on Hg levels and total antioxidant activity in plasma of healthy donors</article-title><source>Bull Group Int Rech Sci Stomatol Odontol</source><year>2001</year><volume>43</volume><fpage>62</fpage><lpage>67</lpage><pub-id pub-id-type=""pmid"">11799720</pub-id></mixed-citation></ref><ref id=""B121""><mixed-citation publication-type=""journal""><name><surname>Pizzichini</surname><given-names>M</given-names></name><name><surname>Fonzi</surname><given-names>M</given-names></name><name><surname>Giannerini</surname><given-names>F</given-names></name><name><surname>Mencarelli</surname><given-names>M</given-names></name><name><surname>Gasparoni</surname><given-names>A</given-names></name><name><surname>Rocchi</surname><given-names>G</given-names></name><name><surname>Kaitsas</surname><given-names>V</given-names></name><name><surname>Fonzi</surname><given-names>L</given-names></name><article-title>Influence of amalgam fillings on Hg levels and total antioxidant activity in plasma of healthy donors</article-title><source>Sci Total Environ</source><year>2003</year><volume>301</volume><fpage>43</fpage><lpage>50</lpage><pub-id pub-id-type=""doi"">10.1016/S0048-9697(02)00291-7</pub-id><pub-id pub-id-type=""pmid"">12493183</pub-id></mixed-citation></ref><ref id=""B122""><mixed-citation publication-type=""journal""><name><surname>Ionescu</surname><given-names>JG</given-names></name><name><surname>Novotny</surname><given-names>J</given-names></name><name><surname>Stejskal</surname><given-names>V</given-names></name><name><surname>Lätsch</surname><given-names>A</given-names></name><name><surname>Blaurock-Busch</surname><given-names>E</given-names></name><name><surname>Eisenmann-Klein</surname><given-names>M</given-names></name><article-title>Increased levels of transition metals in breast cancer tissue</article-title><source>Neuro Endocrinol Lett</source><year>2006</year><volume>27</volume><fpage>36</fpage><lpage>39</lpage><pub-id pub-id-type=""pmid"">16804515</pub-id></mixed-citation></ref><ref id=""B123""><mixed-citation publication-type=""journal""><name><surname>Drasch</surname><given-names>G</given-names></name><name><surname>Mailänder</surname><given-names>S</given-names></name><name><surname>Schlosser</surname><given-names>C</given-names></name><name><surname>Roider</surname><given-names>G</given-names></name><article-title>Content of non-mercury-associated selenium in human tissues</article-title><source>Biol Trace Element Res</source><year>2000</year><volume>77</volume><fpage>219</fpage><lpage>230</lpage><pub-id pub-id-type=""doi"">10.1385/BTER:77:3:219</pub-id></mixed-citation></ref><ref id=""B124""><mixed-citation publication-type=""journal""><name><surname>Mutter</surname><given-names>J</given-names></name><name><surname>Curth</surname><given-names>A</given-names></name><name><surname>Naumann</surname><given-names>J</given-names></name><name><surname>Deth</surname><given-names>R</given-names></name><name><surname>Walach</surname><given-names>H</given-names></name><article-title>Does Inorganic Mercury Play a Role in Alzheimer's Disease? A Systematic Review and an Integrated Molecular Mechanism</article-title><source>J Alzheimers Dis</source><year>2010</year><volume>22</volume><fpage>357</fpage><lpage>374</lpage><pub-id pub-id-type=""pmid"">20847438</pub-id></mixed-citation></ref><ref id=""B125""><mixed-citation publication-type=""journal""><name><surname>Liebert</surname><given-names>CA</given-names></name><name><surname>Wireman</surname><given-names>J</given-names></name><name><surname>Smith</surname><given-names>T</given-names></name><name><surname>Summers</surname><given-names>AO</given-names></name><article-title>The impact of mercury released from dental ""silver"" fillings on antibiotic resistances in the primate oral and intestinal bacterial flora</article-title><source>Met Ions Biol Syst</source><year>1997</year><volume>34</volume><fpage>441</fpage><lpage>460</lpage><pub-id pub-id-type=""pmid"">9046579</pub-id></mixed-citation></ref><ref id=""B126""><mixed-citation publication-type=""journal""><name><surname>Lorscheider</surname><given-names>FL</given-names></name><name><surname>Vimy</surname><given-names>MJ</given-names></name><name><surname>Summers</surname><given-names>AO</given-names></name><name><surname>Zwiers</surname><given-names>H</given-names></name><article-title>The dental amalgam mercury controversy--inorganic mercury and the CNS; genetic linkage of mercury and antibiotic resistances in intestinal bacteria</article-title><source>Toxicology</source><year>1995</year><volume>97</volume><fpage>19</fpage><lpage>22</lpage><pub-id pub-id-type=""doi"">10.1016/0300-483X(94)02964-V</pub-id><pub-id pub-id-type=""pmid"">7716785</pub-id></mixed-citation></ref><ref id=""B127""><mixed-citation publication-type=""journal""><name><surname>Summers</surname><given-names>AO</given-names></name><name><surname>Wireman</surname><given-names>J</given-names></name><name><surname>Vimy</surname><given-names>MJ</given-names></name><name><surname>Lorscheider</surname><given-names>FL</given-names></name><name><surname>Marshall</surname><given-names>B</given-names></name><name><surname>Levy</surname><given-names>SB</given-names></name><article-title>Mercury released from dental ""silver"" fillings provokes an increase in mercury- and antibiotic-resistant bacteria in oral and intestinal floras of primates</article-title><source>Antimicrob Agents Chemother</source><year>1993</year><volume>37</volume><fpage>825</fpage><lpage>834</lpage><pub-id pub-id-type=""pmid"">8280208</pub-id></mixed-citation></ref><ref id=""B128""><mixed-citation publication-type=""journal""><name><surname>Davis</surname><given-names>IJ</given-names></name><name><surname>Roberts</surname><given-names>AP</given-names></name><name><surname>Ready</surname><given-names>D</given-names></name><name><surname>Richards</surname><given-names>H</given-names></name><name><surname>Wilson</surname><given-names>M</given-names></name><name><surname>Mullany</surname><given-names>P</given-names></name><article-title>Linkage of a novel mercury resistance operon with streptomycin resistance on a conjugative plasmid in Enterococcus faecium</article-title><source>Plasmid</source><year>2005</year><volume>54</volume><fpage>26</fpage><lpage>38</lpage><pub-id pub-id-type=""doi"">10.1016/j.plasmid.2004.10.004</pub-id><pub-id pub-id-type=""pmid"">15907536</pub-id></mixed-citation></ref><ref id=""B129""><mixed-citation publication-type=""journal""><name><surname>Skurnik</surname><given-names>D</given-names></name><name><surname>Ruimy</surname><given-names>R</given-names></name><name><surname>Ready</surname><given-names>D</given-names></name><name><surname>Ruppe</surname><given-names>E</given-names></name><name><surname>Bernède-Bauduin</surname><given-names>C</given-names></name><name><surname>Djossou</surname><given-names>F</given-names></name><name><surname>Guillemot</surname><given-names>D</given-names></name><name><surname>Pier</surname><given-names>GB</given-names></name><name><surname>Andremont</surname><given-names>A</given-names></name><article-title>Is exposure to mercury a driving force for the carriage of antibiotic resistance genes?</article-title><source>J Med Microbiol</source><year>2010</year><volume>59</volume><fpage>804</fpage><lpage>807</lpage><pub-id pub-id-type=""doi"">10.1099/jmm.0.017665-0</pub-id><pub-id pub-id-type=""pmid"">20339018</pub-id></mixed-citation></ref><ref id=""B130""><mixed-citation publication-type=""journal""><name><surname>Leistevuo</surname><given-names>J</given-names></name><name><surname>Jarvinen</surname><given-names>H</given-names></name><name><surname>Osterblad</surname><given-names>M</given-names></name><name><surname>Leistevuo</surname><given-names>T</given-names></name><name><surname>Huovinen</surname><given-names>P</given-names></name><name><surname>Tenovuo</surname><given-names>J</given-names></name><article-title>Resistance to mercury and antimicrobial agents in Streptococcus mutans isolates from human subjects in relation to exposure to dental amalgam fillings</article-title><source>Antimicrob Agents Chemother</source><year>2000</year><volume>44</volume><fpage>456</fpage><lpage>457</lpage><pub-id pub-id-type=""doi"">10.1128/AAC.44.2.456-457.2000</pub-id><pub-id pub-id-type=""pmid"">10639385</pub-id></mixed-citation></ref><ref id=""B131""><mixed-citation publication-type=""journal""><name><surname>Pike</surname><given-names>R</given-names></name><name><surname>Lucas</surname><given-names>V</given-names></name><name><surname>Stapleton</surname><given-names>P</given-names></name><name><surname>Gilthorpe</surname><given-names>MS</given-names></name><name><surname>Roberts</surname><given-names>G</given-names></name><name><surname>Rowbury</surname><given-names>R</given-names></name><name><surname>Richards</surname><given-names>H</given-names></name><name><surname>Mullany</surname><given-names>P</given-names></name><name><surname>Wilson</surname><given-names>M</given-names></name><article-title>Prevalence and antibiotic resistance profile of mercury-resistant oral bacteria from children with and without mercury amalgam fillings</article-title><source>J Antimicrob Chemother</source><year>2002</year><volume>49</volume><fpage>777</fpage><lpage>783</lpage><pub-id pub-id-type=""doi"">10.1093/jac/dkf019</pub-id><pub-id pub-id-type=""pmid"">12003971</pub-id></mixed-citation></ref><ref id=""B132""><mixed-citation publication-type=""journal""><name><surname>Wireman</surname><given-names>J</given-names></name><name><surname>Liebert</surname><given-names>CA</given-names></name><name><surname>Smith</surname><given-names>T</given-names></name><name><surname>Summers</surname><given-names>AO</given-names></name><article-title>Association of mercury resistance with antibiotic resistance in the gram-negative fecal bacteria of primates</article-title><source>Appl Environ Microbiol</source><year>1997</year><volume>63</volume><fpage>4494</fpage><lpage>4503</lpage><pub-id pub-id-type=""pmid"">9361435</pub-id></mixed-citation></ref><ref id=""B133""><mixed-citation publication-type=""journal""><name><surname>Harris</surname><given-names>HH</given-names></name><name><surname>Vogt</surname><given-names>S</given-names></name><name><surname>Eastgate</surname><given-names>H</given-names></name><name><surname>Legnini</surname><given-names>DG</given-names></name><name><surname>Hornberger</surname><given-names>B</given-names></name><name><surname>Cai</surname><given-names>Z</given-names></name><name><surname>Lai</surname><given-names>B</given-names></name><name><surname>Lay</surname><given-names>PA</given-names></name><article-title>Migration of mercury from dental amalgam through human teeth</article-title><source>J Synchrotron Radiat</source><year>2008</year><volume>15</volume><fpage>123</fpage><lpage>128</lpage><pub-id pub-id-type=""doi"">10.1107/S0909049507061468</pub-id><pub-id pub-id-type=""pmid"">18296776</pub-id></mixed-citation></ref><ref id=""B134""><mixed-citation publication-type=""journal""><name><surname>Weidinger</surname><given-names>S</given-names></name><name><surname>Kramer</surname><given-names>U</given-names></name><name><surname>Dunemann</surname><given-names>L</given-names></name><name><surname>Mohrenschlager</surname><given-names>M</given-names></name><name><surname>Ring</surname><given-names>J</given-names></name><name><surname>Behrendt</surname><given-names>H</given-names></name><article-title>Body burden of mercury is associated with acute atopic eczema and total IgE in children from southern Germany</article-title><source>J Allergy Clin Immunol</source><year>2004</year><volume>114</volume><fpage>457</fpage><lpage>459</lpage><pub-id pub-id-type=""doi"">10.1016/j.jaci.2004.04.011</pub-id><pub-id pub-id-type=""pmid"">15341030</pub-id></mixed-citation></ref><ref id=""B135""><mixed-citation publication-type=""book""><name><surname>Berlin</surname><given-names>M</given-names></name><article-title>Mercury in dental-filling materials - an updated risk analysis in environmental medical terms</article-title><source>The Dental Material Comission - Care and Consideration</source><year>2003</year><publisher-name>Sweden</publisher-name></mixed-citation></ref><ref id=""B136""><mixed-citation publication-type=""journal""><name><surname>Dunsche</surname><given-names>A</given-names></name><name><surname>Frank</surname><given-names>M</given-names></name><name><surname>Luttges</surname><given-names>J</given-names></name><name><surname>Açil</surname><given-names>Y</given-names></name><name><surname>Brasch</surname><given-names>J</given-names></name><name><surname>Christophers</surname><given-names>E</given-names></name><name><surname>Springer</surname><given-names>IN</given-names></name><article-title>Lichenoid reactions of murine mucosa associated with amalgam</article-title><source>Br J Dermatol</source><year>2003</year><volume>148</volume><fpage>741</fpage><lpage>748</lpage><pub-id pub-id-type=""doi"">10.1046/j.1365-2133.2003.05229.x</pub-id><pub-id pub-id-type=""pmid"">12752133</pub-id></mixed-citation></ref><ref id=""B137""><mixed-citation publication-type=""journal""><name><surname>Dunsche</surname><given-names>A</given-names></name><name><surname>Kastel</surname><given-names>I</given-names></name><name><surname>Terheyden</surname><given-names>H</given-names></name><name><surname>Springer</surname><given-names>I</given-names></name><name><surname>Christophers</surname><given-names>E</given-names></name><name><surname>Brasch</surname><given-names>J</given-names></name><article-title>Oral lichenoid reactions associated with amalgam: improvement after amalgam removal</article-title><source>Br J Dermatol</source><year>2003</year><volume>148</volume><fpage>70</fpage><lpage>76</lpage><pub-id pub-id-type=""doi"">10.1046/j.1365-2133.2003.04936.x</pub-id><pub-id pub-id-type=""pmid"">12534597</pub-id></mixed-citation></ref><ref id=""B138""><mixed-citation publication-type=""journal""><name><surname>Martin</surname><given-names>M</given-names></name><name><surname>Broughton</surname><given-names>S</given-names></name><name><surname>Drangsholt</surname><given-names>M</given-names></name><article-title>Oral lichen planus and dental materials: a case-control study</article-title><source>Contact Dermatitis</source><year>2003</year><volume>48</volume><fpage>331</fpage><lpage>336</lpage><pub-id pub-id-type=""doi"">10.1034/j.1600-0536.2003.00146.x</pub-id><pub-id pub-id-type=""pmid"">14531872</pub-id></mixed-citation></ref><ref id=""B139""><mixed-citation publication-type=""journal""><name><surname>Wong</surname><given-names>L</given-names></name><name><surname>Freeman</surname><given-names>S</given-names></name><article-title>Oral lichenid lesions (OLL) and mercury in amalgam fillings</article-title><source>Contact Dermatitis</source><year>2003</year><volume>48</volume><fpage>74</fpage><lpage>79</lpage><pub-id pub-id-type=""doi"">10.1034/j.1600-0536.2003.480204.x</pub-id><pub-id pub-id-type=""pmid"">12694209</pub-id></mixed-citation></ref><ref id=""B140""><mixed-citation publication-type=""journal""><name><surname>Guttman-Yassky</surname><given-names>E</given-names></name><name><surname>Weltfriend</surname><given-names>S</given-names></name><name><surname>Bergman</surname><given-names>R</given-names></name><article-title>Resolution of orofacial granulomatosis with amalgam removal</article-title><source>J Eur Acad Dermatol Venerol</source><year>2003</year><volume>17</volume><fpage>344</fpage><lpage>347</lpage><pub-id pub-id-type=""doi"">10.1046/j.1468-3083.2003.00793.x</pub-id></mixed-citation></ref><ref id=""B141""><mixed-citation publication-type=""journal""><name><surname>Guarneri</surname><given-names>F</given-names></name><name><surname>Marini</surname><given-names>H</given-names></name><article-title>Perioral dermatitis after dental filling in a 12-year-old girl: involvement of cholinergic system in skin neuroinflammation?</article-title><source>ScientificWorldJournal</source><year>2008</year><volume>8</volume><fpage>157</fpage><lpage>163</lpage><pub-id pub-id-type=""doi"">10.1100/tsw.2008.31</pub-id><pub-id pub-id-type=""pmid"">18264633</pub-id></mixed-citation></ref><ref id=""B142""><mixed-citation publication-type=""journal""><name><surname>Pigatto</surname><given-names>PD</given-names></name><name><surname>Brambilla</surname><given-names>L</given-names></name><name><surname>Guzzi</surname><given-names>G</given-names></name><article-title>Mercury pink exanthem after dental amalgam placement</article-title><source>J Eur Acad Dermatol Venereol</source><year>2008</year><volume>22</volume><fpage>377</fpage><lpage>378</lpage><pub-id pub-id-type=""doi"">10.1111/j.1468-3083.2007.02332.x</pub-id><pub-id pub-id-type=""pmid"">18269611</pub-id></mixed-citation></ref><ref id=""B143""><mixed-citation publication-type=""journal""><name><surname>Bartova</surname><given-names>J</given-names></name><name><surname>Prochazkova</surname><given-names>J</given-names></name><name><surname>Kratka</surname><given-names>Z</given-names></name><name><surname>Benetkova</surname><given-names>K</given-names></name><name><surname>Venclikova</surname><given-names>Z</given-names></name><name><surname>Sterzl</surname><given-names>I</given-names></name><article-title>Dental amalgam as one of the risk factors in autoimmune diseases</article-title><source>Neuro Endocrinol Lett</source><year>2003</year><volume>24</volume><fpage>65</fpage><lpage>67</lpage><pub-id pub-id-type=""pmid"">12743535</pub-id></mixed-citation></ref><ref id=""B144""><mixed-citation publication-type=""journal""><name><surname>Hultman</surname><given-names>P</given-names></name><name><surname>Johansson</surname><given-names>U</given-names></name><name><surname>Turley</surname><given-names>S</given-names></name><name><surname>Lindh</surname><given-names>U</given-names></name><name><surname>Enestrom</surname><given-names>S</given-names></name><name><surname>Pollard</surname><given-names>K</given-names></name><article-title>Adverse immunological effects and autoimmunity induced by dental amalgam and alloy in mice</article-title><source>FASEB Journal</source><year>1994</year><volume>8</volume><fpage>1183</fpage><lpage>1190</lpage><pub-id pub-id-type=""pmid"">7958626</pub-id></mixed-citation></ref><ref id=""B145""><mixed-citation publication-type=""journal""><name><surname>Hultman</surname><given-names>P</given-names></name><name><surname>Lindh</surname><given-names>U</given-names></name><name><surname>Horsted-Binslev</surname><given-names>P</given-names></name><article-title>Activation of the immune system and systemic immune-complex deposits in Brown Norway rats with dental amalgam restorations</article-title><source>J Dent Res</source><year>1998</year><volume>77</volume><fpage>1415</fpage><lpage>1425</lpage><pub-id pub-id-type=""doi"">10.1177/00220345980770060601</pub-id><pub-id pub-id-type=""pmid"">9649170</pub-id></mixed-citation></ref><ref id=""B146""><mixed-citation publication-type=""journal""><name><surname>Pollard</surname><given-names>KM</given-names></name><name><surname>Pearson</surname><given-names>DL</given-names></name><name><surname>Hultman</surname><given-names>P</given-names></name><name><surname>Deane</surname><given-names>TN</given-names></name><name><surname>Lindh</surname><given-names>U</given-names></name><name><surname>Kono</surname><given-names>DH</given-names></name><article-title>Xenobiotic acceleration of idiopathic systemic autoimmunity in lupus-prone bxbs mice</article-title><source>Environ Health Persp</source><year>2001</year><volume>109</volume><fpage>27</fpage><lpage>33</lpage><pub-id pub-id-type=""doi"">10.2307/3434917</pub-id></mixed-citation></ref><ref id=""B147""><mixed-citation publication-type=""journal""><name><surname>Prochazkova</surname><given-names>J</given-names></name><name><surname>Sterzl</surname><given-names>I</given-names></name><name><surname>Kucerova</surname><given-names>H</given-names></name><name><surname>Bartova</surname><given-names>J</given-names></name><name><surname>Stejskal</surname><given-names>VDM</given-names></name><article-title>The beneficial effect of amalgam replacement on health in patients with autoimmunity</article-title><source>Neuro Endocrinol Lett</source><year>2004</year><volume>25</volume><fpage>211</fpage><lpage>218</lpage><pub-id pub-id-type=""pmid"">15349088</pub-id></mixed-citation></ref><ref id=""B148""><mixed-citation publication-type=""journal""><name><surname>Stejskal</surname><given-names>J</given-names></name><name><surname>Stejskal</surname><given-names>VD</given-names></name><article-title>The role of metals in autoimmunity and the link to neuroendocrinology</article-title><source>Neuro Endocrinol Lett</source><year>1999</year><volume>20</volume><fpage>351</fpage><lpage>364</lpage><pub-id pub-id-type=""pmid"">11458198</pub-id></mixed-citation></ref><ref id=""B149""><mixed-citation publication-type=""journal""><name><surname>Stejskal</surname><given-names>VD</given-names></name><name><surname>Danersund</surname><given-names>A</given-names></name><name><surname>Lindvall</surname><given-names>A</given-names></name><article-title>Metal-specific lymphocytes: biomarkers of sensitivity in man</article-title><source>Neuro Endocrinol Lett</source><year>1999</year><volume>20</volume><fpage>289</fpage><lpage>298</lpage><pub-id pub-id-type=""pmid"">11460087</pub-id></mixed-citation></ref><ref id=""B150""><mixed-citation publication-type=""journal""><name><surname>Sterzl</surname><given-names>I</given-names></name><name><surname>Procházková</surname><given-names>J</given-names></name><name><surname>Hrdá</surname><given-names>P</given-names></name><name><surname>Bártová</surname><given-names>J</given-names></name><name><surname>Matucha</surname><given-names>P</given-names></name><name><surname>Stejskal</surname><given-names>VDM</given-names></name><article-title>Mercury and nickel allergy: risk factors in fatigue and autoimmunity</article-title><source>Neuro Endocrinol Lett</source><year>1999</year><volume>20</volume><fpage>221</fpage><lpage>228</lpage><pub-id pub-id-type=""pmid"">11462117</pub-id></mixed-citation></ref><ref id=""B151""><mixed-citation publication-type=""journal""><name><surname>Via</surname><given-names>CS</given-names></name><name><surname>Nguyen</surname><given-names>P</given-names></name><name><surname>Niculescu</surname><given-names>F</given-names></name><name><surname>Papadimitriou</surname><given-names>J</given-names></name><name><surname>Hoover</surname><given-names>D</given-names></name><name><surname>Silbergeld</surname><given-names>EK</given-names></name><article-title>Low-dose exposure to inorganic mercury accelerates disease and mortality in acquired murine lupus</article-title><source>Environ Health Perspect</source><year>2003</year><volume>111</volume><fpage>1273</fpage><lpage>1277</lpage><pub-id pub-id-type=""doi"">10.1289/ehp.6064</pub-id><pub-id pub-id-type=""pmid"">12896845</pub-id></mixed-citation></ref><ref id=""B152""><mixed-citation publication-type=""journal""><name><surname>Sterzl</surname><given-names>I</given-names></name><name><surname>Procházková</surname><given-names>J</given-names></name><name><surname>Hrda</surname><given-names>P</given-names></name><name><surname>Matucha</surname><given-names>P</given-names></name><name><surname>Bartova</surname><given-names>J</given-names></name><name><surname>Stejskal</surname><given-names>V</given-names></name><article-title>Removal of dental amalgam decreases anto-TPO and anti-Tg autoantibodies in patients with autoimmune thyroiditis</article-title><source>Neuro Endocrinol Lett</source><year>2006</year><volume>5</volume><issue>27(Suppl 1</issue><fpage>25</fpage><lpage>30</lpage></mixed-citation></ref><ref id=""B153""><mixed-citation publication-type=""journal""><name><surname>Kazantzis</surname><given-names>G</given-names></name><article-title>Mercury exposure and early effects: an overview</article-title><source>Med Lav</source><year>2002</year><volume>93</volume><fpage>139</fpage><lpage>147</lpage><pub-id pub-id-type=""pmid"">12197264</pub-id></mixed-citation></ref><ref id=""B154""><mixed-citation publication-type=""journal""><name><surname>Rampersad</surname><given-names>GC</given-names></name><name><surname>Suck</surname><given-names>G</given-names></name><name><surname>Sakac</surname><given-names>D</given-names></name><name><surname>Fahim</surname><given-names>S</given-names></name><name><surname>Foo</surname><given-names>A</given-names></name><name><surname>Denomme</surname><given-names>GA</given-names></name><name><surname>Langler</surname><given-names>RF</given-names></name><name><surname>Branch</surname><given-names>DR</given-names></name><article-title>Chemical compounds that target thiol-disulfide groups on mononuclear phagocytes inhibit immune mediated phagocytosis of red blood cells</article-title><source>Transfusion</source><year>2005</year><volume>45</volume><fpage>384</fpage><lpage>393</lpage><pub-id pub-id-type=""doi"">10.1111/j.1537-2995.2005.04241.x</pub-id><pub-id pub-id-type=""pmid"">15752156</pub-id></mixed-citation></ref><ref id=""B155""><mixed-citation publication-type=""journal""><name><surname>Bartram</surname><given-names>F</given-names></name><name><surname>Donate</surname><given-names>HP</given-names></name><name><surname>Müller</surname><given-names>KE</given-names></name><name><surname>Bückendorf</surname><given-names>CH</given-names></name><name><surname>Ohnsorge</surname><given-names>P</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name><name><surname>von Baehr</surname><given-names>V</given-names></name><article-title>Significance of the patch test and the lymphocyte transformation test in the diagnostic of type IV-sensitazion</article-title><source>J Lab Med</source><year>2006</year><volume>30</volume><fpage>101</fpage><lpage>106</lpage></mixed-citation></ref><ref id=""B156""><mixed-citation publication-type=""journal""><name><surname>Venclíková</surname><given-names>Z</given-names></name><name><surname>Benada</surname><given-names>O</given-names></name><name><surname>Bártová</surname><given-names>J</given-names></name><name><surname>Joska</surname><given-names>L</given-names></name><name><surname>Mrklas</surname><given-names>L</given-names></name><name><surname>Procházková</surname><given-names>J</given-names></name><name><surname>Stejskal</surname><given-names>V</given-names></name><name><surname>Podzimek</surname><given-names>S</given-names></name><article-title>In vivo effects of dental casting alloys</article-title><source>Neuro Endocrinol Lett</source><year>2006</year><volume>27</volume><issue>Suppl 1</issue><fpage>61</fpage><lpage>68</lpage></mixed-citation></ref><ref id=""B157""><mixed-citation publication-type=""journal""><name><surname>Valentine-Thon</surname><given-names>E</given-names></name><name><surname>Schiwara</surname><given-names>HW</given-names></name><article-title>Validity of MELISA for metal sensitivity testing</article-title><source>Neuro Endocrinol Lett</source><year>2003</year><volume>24</volume><fpage>50</fpage><lpage>55</lpage><pub-id pub-id-type=""pmid"">12743532</pub-id></mixed-citation></ref><ref id=""B158""><mixed-citation publication-type=""journal""><name><surname>Valentine-Thon</surname><given-names>E</given-names></name><name><surname>Sandkamo</surname><given-names>M</given-names></name><name><surname>Müller</surname><given-names>K</given-names></name><name><surname>Guzzi</surname><given-names>G</given-names></name><name><surname>Hartmann</surname><given-names>T</given-names></name><article-title>Metallsensibilisierung: Nachweis, Validierung und Verlaufskontrolle mittels Lymphozyten-Transformations-Test (LTT-Melisa<sup>®</sup>)</article-title><source>Zs f Orthomol Med</source><year>2005</year><volume>1</volume><fpage>12</fpage><lpage>15</lpage></mixed-citation></ref><ref id=""B159""><mixed-citation publication-type=""journal""><name><surname>Valentine-Thon</surname><given-names>E</given-names></name><name><surname>Muller</surname><given-names>KE</given-names></name><name><surname>Guzzi</surname><given-names>G</given-names></name><name><surname>Kreisel</surname><given-names>S</given-names></name><name><surname>Ohnsorge</surname><given-names>P</given-names></name><name><surname>Sandkamp</surname><given-names>M</given-names></name><article-title>LTT-MELISA<sup>®</sup>is clinically relevant for detecting and monitoring metal sensitivity</article-title><source>Neuro Endocrinol Lett</source><year>2006</year><volume>27</volume><issue>Suppl1</issue><fpage>17</fpage><lpage>24</lpage><pub-id pub-id-type=""pmid"">17261998</pub-id></mixed-citation></ref><ref id=""B160""><mixed-citation publication-type=""journal""><name><surname>Yaqob</surname><given-names>A</given-names></name><name><surname>Danersund</surname><given-names>A</given-names></name><name><surname>Stejskal</surname><given-names>VD</given-names></name><name><surname>Lindvall</surname><given-names>A</given-names></name><name><surname>Hudecek</surname><given-names>R</given-names></name><name><surname>Lindh</surname><given-names>U</given-names></name><article-title>Metal-specific lymphocyte reactivity is downregulated after dental metal replacement</article-title><source>Neuro Endocrinol Lett</source><year>2006</year><volume>27</volume><fpage>189</fpage><lpage>197</lpage><pub-id pub-id-type=""pmid"">16648791</pub-id></mixed-citation></ref><ref id=""B161""><mixed-citation publication-type=""journal""><name><surname>Lindh</surname><given-names>U</given-names></name><name><surname>Hudecek</surname><given-names>R</given-names></name><name><surname>Dandersund</surname><given-names>A</given-names></name><name><surname>Eriksson</surname><given-names>S</given-names></name><name><surname>Lindvall</surname><given-names>A</given-names></name><article-title>Removal of dental amalgam and other metal alloys supported by antioxidant therapy alleviates symptoms and improves quality of life in patients with amalgam-associated ill health</article-title><source>Neuro Endocrinol Lett</source><year>2002</year><volume>23</volume><fpage>459</fpage><lpage>482</lpage><pub-id pub-id-type=""pmid"">12500173</pub-id></mixed-citation></ref><ref id=""B162""><mixed-citation publication-type=""journal""><name><surname>Stejskal</surname><given-names>VD</given-names></name><article-title>Diagnosis and treatment of metal-induced side effects</article-title><source>Neuro Endocrinol Lett</source><year>2006</year><volume>27</volume><issue>Suppl 1</issue><fpage>7</fpage><lpage>16</lpage></mixed-citation></ref><ref id=""B163""><mixed-citation publication-type=""journal""><name><surname>Wortberg</surname><given-names>W</given-names></name><article-title>Intrauterine Fruchtschädigung durch Schwermetallbelastung der Mutter</article-title><source>Umwelt Medizin Gesellschaft</source><year>2006</year><volume>19</volume><fpage>274</fpage><lpage>280</lpage></mixed-citation></ref><ref id=""B164""><mixed-citation publication-type=""journal""><name><surname>Houston</surname><given-names>MC</given-names></name><article-title>The role of mercury and cadmium heavy metals in vascular disease, hypertension, coronary heart disease, and myocardial infarction</article-title><source>Altern Ther Health Med</source><year>2007</year><volume>13</volume><fpage>128</fpage><lpage>133,</lpage></mixed-citation></ref><ref id=""B165""><mixed-citation publication-type=""journal""><name><surname>Frustaci</surname><given-names>A</given-names></name><name><surname>Magnavita</surname><given-names>N</given-names></name><name><surname>Chimenti</surname><given-names>C</given-names></name><name><surname>Cladarulo</surname><given-names>M</given-names></name><name><surname>Sabbioni</surname><given-names>E</given-names></name><name><surname>Pietra</surname><given-names>R</given-names></name><article-title>Marked elevation of myocardial trace elements in idiopathic dilated cardiomyopathy compared with secondary cardiac dysfunction</article-title><source>J Am Coll Cardiol</source><year>1999</year><volume>33</volume><fpage>1578</fpage><lpage>1583</lpage><pub-id pub-id-type=""doi"">10.1016/S0735-1097(99)00062-5</pub-id><pub-id pub-id-type=""pmid"">10334427</pub-id></mixed-citation></ref><ref id=""B166""><mixed-citation publication-type=""journal""><name><surname>Dodes</surname><given-names>JE</given-names></name><article-title>The amalgam controversy. An evidence-based analysis</article-title><source>J Am Dent Assoc</source><year>2001</year><volume>132</volume><fpage>348</fpage><lpage>356</lpage><pub-id pub-id-type=""pmid"">11258092</pub-id></mixed-citation></ref><ref id=""B167""><mixed-citation publication-type=""journal""><name><surname>Boyd</surname><given-names>ND</given-names></name><name><surname>Benediktsson</surname><given-names>H</given-names></name><name><surname>Vimy</surname><given-names>MJ</given-names></name><name><surname>Hooper</surname><given-names>DE</given-names></name><name><surname>Lorscheider</surname><given-names>FL</given-names></name><article-title>Mercury from dental ""silver"" tooth fillings impairs sheep kidney function</article-title><source>Am J Physiol</source><year>1991</year><volume>261</volume><fpage>1010</fpage><lpage>1014</lpage></mixed-citation></ref><ref id=""B168""><mixed-citation publication-type=""journal""><name><surname>Trachtenberg</surname><given-names>F</given-names></name><name><surname>Barregård</surname><given-names>L</given-names></name><article-title>The effect of age, sex, and race on urinary markers of kidney damage in children</article-title><source>Am J Kidney Dis</source><year>2007</year><volume>50</volume><fpage>938</fpage><lpage>945</lpage><pub-id pub-id-type=""doi"">10.1053/j.ajkd.2007.08.014</pub-id><pub-id pub-id-type=""pmid"">18037094</pub-id></mixed-citation></ref><ref id=""B169""><mixed-citation publication-type=""journal""><name><surname>Mutter</surname><given-names>J</given-names></name><name><surname>Naumann</surname><given-names>J</given-names></name><name><surname>Sadaghiani</surname><given-names>C</given-names></name><name><surname>Walach</surname><given-names>H</given-names></name><article-title>Quecksilber und die Alzheimer-Erkrankung</article-title><source>Fortschr Neuro Psychiat</source><year>2007</year><volume>75</volume><fpage>528</fpage><lpage>538</lpage><pub-id pub-id-type=""doi"">10.1055/s-2007-959237</pub-id></mixed-citation></ref><ref id=""B170""><mixed-citation publication-type=""journal""><name><surname>Mutter</surname><given-names>J</given-names></name><name><surname>Naumann</surname><given-names>J</given-names></name><name><surname>Guethlin</surname><given-names>C</given-names></name><article-title>Comments on the article ""the toxicology of mercury and its chemical compounds"" by Clarkson and Magos (2006)</article-title><source>Crit Rev Toxicol</source><year>2007</year><volume>37</volume><fpage>537</fpage><lpage>549</lpage><pub-id pub-id-type=""doi"">10.1080/10408440701385770</pub-id><pub-id pub-id-type=""pmid"">17661216</pub-id></mixed-citation></ref><ref id=""B171""><mixed-citation publication-type=""journal""><name><surname>Carpenter</surname><given-names>DO</given-names></name><article-title>Effects of metals on the nervous system of humans and animals</article-title><source>Int J Occup Med Environ Health</source><year>2001</year><volume>14</volume><fpage>209</fpage><lpage>218</lpage><pub-id pub-id-type=""pmid"">11764847</pub-id></mixed-citation></ref><ref id=""B172""><mixed-citation publication-type=""journal""><name><surname>Dantzig</surname><given-names>PI</given-names></name><article-title>Parkinson's disease, macular degeneration and cutaneous signs of mercury toxicity</article-title><source>J Occup Environ Med</source><year>2006</year><volume>48</volume><fpage>656</fpage><pub-id pub-id-type=""pmid"">16832218</pub-id></mixed-citation></ref><ref id=""B173""><mixed-citation publication-type=""journal""><name><surname>Finkelstein</surname><given-names>Y</given-names></name><name><surname>Vardi</surname><given-names>J</given-names></name><name><surname>Kesten</surname><given-names>MM</given-names></name><name><surname>Hod</surname><given-names>I</given-names></name><article-title>The enigma of parkinsonism in chronic borderline mercury intoxication, resolved by challenge with penicillamine</article-title><source>Neurotoxicology</source><year>1996</year><volume>17</volume><fpage>291</fpage><lpage>295</lpage><pub-id pub-id-type=""pmid"">8784840</pub-id></mixed-citation></ref><ref id=""B174""><mixed-citation publication-type=""journal""><name><surname>Gorell</surname><given-names>JM</given-names></name><name><surname>Rybicki</surname><given-names>BA</given-names></name><name><surname>Johnson</surname><given-names>C</given-names></name><name><surname>Peterson</surname><given-names>EL</given-names></name><article-title>Occupational metal exposures and the risk of Parkinson's disease</article-title><source>Neuroepidemiology</source><year>1999</year><volume>18</volume><fpage>303</fpage><lpage>308</lpage><pub-id pub-id-type=""doi"">10.1159/000026225</pub-id><pub-id pub-id-type=""pmid"">10545782</pub-id></mixed-citation></ref><ref id=""B175""><mixed-citation publication-type=""journal""><name><surname>Miller</surname><given-names>K</given-names></name><name><surname>Ochudto</surname><given-names>S</given-names></name><name><surname>Opala</surname><given-names>G</given-names></name><name><surname>Smolicha</surname><given-names>W</given-names></name><name><surname>Siuda</surname><given-names>J</given-names></name><article-title>Parkinsonism in chronic occupational metallic mercury intoxication</article-title><source>Neurol Neurochir Pol</source><year>2003</year><volume>37</volume><fpage>31</fpage><lpage>38</lpage><pub-id pub-id-type=""pmid"">15098329</pub-id></mixed-citation></ref><ref id=""B176""><mixed-citation publication-type=""journal""><name><surname>Ngim</surname><given-names>CH</given-names></name><name><surname>Devathasan</surname><given-names>G</given-names></name><article-title>Epidemiologic study on the association between body burden mercury level and idiopathic Parkinson's disease</article-title><source>Neuroepidemiology</source><year>1989</year><volume>8</volume><fpage>128</fpage><lpage>141</lpage><pub-id pub-id-type=""doi"">10.1159/000110175</pub-id><pub-id pub-id-type=""pmid"">2725805</pub-id></mixed-citation></ref><ref id=""B177""><mixed-citation publication-type=""journal""><name><surname>Ohlson</surname><given-names>CG</given-names></name><name><surname>Hogstedt</surname><given-names>C</given-names></name><article-title>Parkinson's disease and occupational exposure to organic solvents, agricultural chemicals and mercury - a case-referent study</article-title><source>Scand J Work Environ Health</source><year>1981</year><volume>7</volume><fpage>252</fpage><lpage>256</lpage><pub-id pub-id-type=""pmid"">7347910</pub-id></mixed-citation></ref><ref id=""B178""><mixed-citation publication-type=""journal""><name><surname>Rybicki</surname><given-names>BA</given-names></name><name><surname>Johnson</surname><given-names>CC</given-names></name><name><surname>Uman</surname><given-names>J</given-names></name><name><surname>Gorell</surname><given-names>JM</given-names></name><article-title>Parkinson's disease mortality and the industrial use of heavy metals in Michigan</article-title><source>Mov Disord</source><year>1993</year><volume>8</volume><fpage>87</fpage><lpage>92</lpage><pub-id pub-id-type=""doi"">10.1002/mds.870080116</pub-id><pub-id pub-id-type=""pmid"">8419812</pub-id></mixed-citation></ref><ref id=""B179""><mixed-citation publication-type=""journal""><name><surname>Seidler</surname><given-names>A</given-names></name><name><surname>Hellenbrand</surname><given-names>W</given-names></name><name><surname>Robra</surname><given-names>BP</given-names></name><article-title>Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in Germany</article-title><source>Neurology</source><year>1996</year><volume>46</volume><fpage>1275</fpage><lpage>84</lpage><pub-id pub-id-type=""pmid"">8628466</pub-id></mixed-citation></ref><ref id=""B180""><mixed-citation publication-type=""journal""><name><surname>Uversky</surname><given-names>VN</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Fink</surname><given-names>AL</given-names></name><article-title>Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>44284</fpage><lpage>44296</lpage><pub-id pub-id-type=""doi"">10.1074/jbc.M105343200</pub-id><pub-id pub-id-type=""pmid"">11553618</pub-id></mixed-citation></ref><ref id=""B181""><mixed-citation publication-type=""journal""><name><surname>Harakeh</surname><given-names>S</given-names></name><name><surname>Sabra</surname><given-names>N</given-names></name><name><surname>Kassak</surname><given-names>K</given-names></name><name><surname>Doughan</surname><given-names>B</given-names></name><name><surname>Sukhn</surname><given-names>C</given-names></name><article-title>Mercury and arsenic levels among Lebanese dentists: a call for action</article-title><source>Bull Environ Contam Toxicol</source><year>2003</year><volume>70</volume><fpage>629</fpage><lpage>635</lpage><pub-id pub-id-type=""doi"">10.1007/s00128-003-0031-3</pub-id><pub-id pub-id-type=""pmid"">12677371</pub-id></mixed-citation></ref><ref id=""B182""><mixed-citation publication-type=""journal""><name><surname>Tezel</surname><given-names>H</given-names></name><name><surname>Ertas</surname><given-names>OS</given-names></name><name><surname>Ozata</surname><given-names>F</given-names></name><name><surname>Erakin</surname><given-names>C</given-names></name><name><surname>Kayali</surname><given-names>A</given-names></name><article-title>Blood mercury levels of dental students and dentists at a dental school</article-title><source>Br Dent J</source><year>2001</year><volume>191</volume><fpage>449</fpage><lpage>452</lpage><pub-id pub-id-type=""doi"">10.1038/sj.bdj.4801205a</pub-id><pub-id pub-id-type=""pmid"">11720018</pub-id></mixed-citation></ref><ref id=""B183""><mixed-citation publication-type=""journal""><name><surname>Aydin</surname><given-names>N</given-names></name><name><surname>Karaoglanoglu</surname><given-names>S</given-names></name><name><surname>Yigit</surname><given-names>A</given-names></name><name><surname>Keles</surname><given-names>MS</given-names></name><name><surname>Kirpinar</surname><given-names>I</given-names></name><name><surname>Seven</surname><given-names>N</given-names></name><article-title>Neuropsychological effects of low mercury exposure in dental staff in Erzurum, Turkey</article-title><source>Int Dent J</source><year>2003</year><volume>53</volume><fpage>85</fpage><lpage>91</lpage><pub-id pub-id-type=""pmid"">12731695</pub-id></mixed-citation></ref><ref id=""B184""><mixed-citation publication-type=""journal""><name><surname>Bittner</surname><given-names>ACJ</given-names></name><name><surname>Echeverria</surname><given-names>D</given-names></name><name><surname>Woods</surname><given-names>JS</given-names></name><article-title>Behavioral effects of low-level exposure to HgO among dental professional: a cross-study evaluation of psychomotor effects</article-title><source>Neuortoxicol Teratol</source><year>1998</year><volume>17</volume><fpage>161</fpage><lpage>168</lpage></mixed-citation></ref><ref id=""B185""><mixed-citation publication-type=""journal""><name><surname>Echeverria</surname><given-names>D</given-names></name><name><surname>Heyer</surname><given-names>NJ</given-names></name><name><surname>Martin</surname><given-names>MD</given-names></name><name><surname>Naleway</surname><given-names>C</given-names></name><name><surname>Woods</surname><given-names>JS</given-names></name><name><surname>Bittner</surname><given-names>ACJ</given-names></name><article-title>Behavioral effects of low-level exposure to elemental Hg among dentists</article-title><source>Neurotoxicol Teratol</source><year>1995</year><volume>17</volume><fpage>161</fpage><lpage>168</lpage><pub-id pub-id-type=""doi"">10.1016/0892-0362(94)00049-J</pub-id><pub-id pub-id-type=""pmid"">7760775</pub-id></mixed-citation></ref><ref id=""B186""><mixed-citation publication-type=""journal""><name><surname>Echeverria</surname><given-names>D</given-names></name><name><surname>Woods</surname><given-names>JS</given-names></name><name><surname>Heyer</surname><given-names>N</given-names></name><name><surname>Rohlman</surname><given-names>DS</given-names></name><name><surname>Farin</surname><given-names>FM</given-names></name><name><surname>Bittner</surname><given-names>AC</given-names><suffix>Jr</suffix></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Garabedian</surname><given-names>C</given-names></name><article-title>Chronic low-level mercury exposure, BDNF polymorphism and associations with cognitive and motor function</article-title><source>Neurotoxicol Teratol</source><year>2005</year><volume>27</volume><fpage>781</fpage><lpage>796</lpage><pub-id pub-id-type=""doi"">10.1016/j.ntt.2005.08.001</pub-id><pub-id pub-id-type=""pmid"">16301096</pub-id></mixed-citation></ref><ref id=""B187""><mixed-citation publication-type=""journal""><name><surname>Heyer</surname><given-names>NJ</given-names></name><name><surname>Echeverria</surname><given-names>D</given-names></name><name><surname>Bittner</surname><given-names>AJ</given-names></name><name><surname>Farin</surname><given-names>FM</given-names></name><name><surname>Garabedian</surname><given-names>CC</given-names></name><name><surname>Woods</surname><given-names>JS</given-names></name><article-title>Chronic low-level mercury exposure, BDNF polymorphism, and associations with self-reported symptoms and mood</article-title><source>Toxicol Sci</source><year>2004</year><volume>81</volume><fpage>354</fpage><lpage>363</lpage><pub-id pub-id-type=""doi"">10.1093/toxsci/kfh220</pub-id><pub-id pub-id-type=""pmid"">15254338</pub-id></mixed-citation></ref><ref id=""B188""><mixed-citation publication-type=""journal""><name><surname>Heyer</surname><given-names>NJ</given-names></name><name><surname>Bittner</surname><given-names>AJ</given-names></name><name><surname>Echerverria</surname><given-names>D</given-names></name><name><surname>Woods</surname><given-names>J</given-names></name><article-title>A cascade analysis of the interaction of mercury and coproporphyrinogen-oxidase (CPOX) polymorphism on the heme biosynthetic pathway and porphyrin production</article-title><source>Toxicol Lett</source><year>2006</year><volume>161</volume><fpage>159</fpage><lpage>166</lpage><pub-id pub-id-type=""doi"">10.1016/j.toxlet.2005.09.005</pub-id><pub-id pub-id-type=""pmid"">16214298</pub-id></mixed-citation></ref><ref id=""B189""><mixed-citation publication-type=""journal""><name><surname>Gonzalez-Ramirez</surname><given-names>D</given-names></name><name><surname>Maiorino</surname><given-names>RM</given-names></name><name><surname>Zuniga-Charles</surname><given-names>M</given-names></name><article-title>Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans: II. Urinary mercury, porphyrins and neurobehavioral changes of dental workers in Monterrey, Mexico</article-title><source>J Pharmacol Exp Ther</source><year>1995</year><volume>272</volume><fpage>264</fpage><lpage>274</lpage><pub-id pub-id-type=""pmid"">7815341</pub-id></mixed-citation></ref><ref id=""B190""><mixed-citation publication-type=""journal""><name><surname>Langworth</surname><given-names>S</given-names></name><name><surname>Sallsten</surname><given-names>G</given-names></name><name><surname>Barregard</surname><given-names>L</given-names></name><name><surname>Cynkier</surname><given-names>I</given-names></name><name><surname>Lind</surname><given-names>ML</given-names></name><name><surname>Soderman</surname><given-names>E</given-names></name><article-title>Exposure to mercury vapor and impact on health in the dental profession in Sweden</article-title><source>J Dent Res</source><year>1997</year><volume>76</volume><fpage>1397</fpage><lpage>1404</lpage><pub-id pub-id-type=""doi"">10.1177/00220345970760071001</pub-id><pub-id pub-id-type=""pmid"">9207773</pub-id></mixed-citation></ref><ref id=""B191""><mixed-citation publication-type=""journal""><name><surname>Moen</surname><given-names>BE</given-names></name><name><surname>Hollund</surname><given-names>BE</given-names></name><name><surname>Riise</surname><given-names>T</given-names></name><article-title>Neurological symptoms among dental assistants: a cross-sectional study</article-title><source>J Occup Med Toxicol</source><year>2008</year><volume>18</volume><fpage>3</fpage><lpage>10</lpage></mixed-citation></ref><ref id=""B192""><mixed-citation publication-type=""journal""><name><surname>Ngim</surname><given-names>CH</given-names></name><name><surname>Foo</surname><given-names>SC</given-names></name><name><surname>Boey</surname><given-names>KW</given-names></name><name><surname>Jeyaratnam</surname><given-names>J</given-names></name><article-title>Chronic neurobehavioral effects of elemental mercury in dentists</article-title><source>Br J Ind Med</source><year>1992</year><volume>M49</volume><fpage>782</fpage><lpage>790</lpage></mixed-citation></ref><ref id=""B193""><mixed-citation publication-type=""journal""><name><surname>Ritchie</surname><given-names>KA</given-names></name><name><surname>Macdonald</surname><given-names>EB</given-names></name><name><surname>Hammersley</surname><given-names>R</given-names></name><name><surname>O'Neil</surname><given-names>JM</given-names></name><name><surname>McGowan</surname><given-names>DA</given-names></name><name><surname>Dale</surname><given-names>IM</given-names></name><name><surname>Wesnes</surname><given-names>K</given-names></name><article-title>A pilot study of the effect of low level exposure to mercury on the health of dental surgeons</article-title><source>J Occup Environ Med</source><year>1995</year><volume>52</volume><fpage>813</fpage><lpage>817</lpage><pub-id pub-id-type=""doi"">10.1136/oem.52.12.813</pub-id></mixed-citation></ref><ref id=""B194""><mixed-citation publication-type=""journal""><name><surname>Ritchie</surname><given-names>KA</given-names></name><name><surname>Gilmour</surname><given-names>WH</given-names></name><name><surname>Macdonald</surname><given-names>EB</given-names></name><name><surname>Burke</surname><given-names>FJ</given-names></name><name><surname>McGowan</surname><given-names>DA</given-names></name><name><surname>Dale</surname><given-names>IM</given-names></name><name><surname>Hammersley</surname><given-names>R</given-names></name><name><surname>Hamilton</surname><given-names>RM</given-names></name><name><surname>Binnie</surname><given-names>V</given-names></name><name><surname>Collington</surname><given-names>D</given-names></name><article-title>Health and neuropsychological functioning of dentists exposed to mercury</article-title><source>J Occup Environ Med</source><year>2002</year><volume>59</volume><fpage>287</fpage><lpage>293</lpage><pub-id pub-id-type=""doi"">10.1136/oem.59.5.287</pub-id></mixed-citation></ref><ref id=""B195""><mixed-citation publication-type=""journal""><name><surname>Uzzell</surname><given-names>BP</given-names></name><name><surname>Oler</surname><given-names>J</given-names></name><article-title>Chronic low-level mercury exposure and neuropsychological functioning</article-title><source>J Clin Exp Neuropsychol</source><year>1986</year><volume>8</volume><fpage>581</fpage><lpage>593</lpage><pub-id pub-id-type=""doi"">10.1080/01688638608405177</pub-id><pub-id pub-id-type=""pmid"">3805254</pub-id></mixed-citation></ref><ref id=""B196""><mixed-citation publication-type=""journal""><name><surname>Urban</surname><given-names>P</given-names></name><name><surname>Lukas</surname><given-names>E</given-names></name><name><surname>Nerudova</surname><given-names>J</given-names></name><name><surname>Cabelkova</surname><given-names>Z</given-names></name><name><surname>Cikrt</surname><given-names>M</given-names></name><article-title>Neurological and electrophysiological examinations on three groups of workers with different levels of exposure to mercury vapors</article-title><source>Eur J Neurol</source><year>1999</year><volume>6</volume><fpage>571</fpage><lpage>577</lpage><pub-id pub-id-type=""doi"">10.1046/j.1468-1331.1999.650571.x</pub-id><pub-id pub-id-type=""pmid"">10457390</pub-id></mixed-citation></ref><ref id=""B197""><mixed-citation publication-type=""journal""><name><surname>Nadorfy-Lopez</surname><given-names>E</given-names></name><name><surname>Torres</surname><given-names>SH</given-names></name><name><surname>Finol</surname><given-names>H</given-names></name><name><surname>Mendez</surname><given-names>M</given-names></name><name><surname>Bello</surname><given-names>B</given-names></name><article-title>Skeletal muscle abnormalities associated with occupational exposure to mercury vapors</article-title><source>Hist Histopath</source><year>2000</year><volume>15</volume><fpage>673</fpage><lpage>682</lpage></mixed-citation></ref><ref id=""B198""><mixed-citation publication-type=""journal""><name><surname>Rowland</surname><given-names>A</given-names></name><name><surname>Baird</surname><given-names>D</given-names></name><name><surname>Weinberg</surname><given-names>C</given-names></name><name><surname>Shore</surname><given-names>D</given-names></name><name><surname>Shy</surname><given-names>C</given-names></name><name><surname>Wilcox</surname><given-names>A</given-names></name><article-title>The effect of occupational exposure to the mercury vapour on the fertility of female dental assistants</article-title><source>Occup Environ Med</source><year>1994</year><volume>51</volume><fpage>28</fpage><lpage>34</lpage><pub-id pub-id-type=""doi"">10.1136/oem.51.1.28</pub-id><pub-id pub-id-type=""pmid"">8124459</pub-id></mixed-citation></ref><ref id=""B199""><mixed-citation publication-type=""journal""><name><surname>Lindbohm</surname><given-names>ML</given-names></name><name><surname>Ylöstalo</surname><given-names>P</given-names></name><name><surname>Sallmen</surname><given-names>M</given-names></name><article-title>Occupational exposure in dentistry and miscarriage</article-title><source>Occup Environ Med</source><year>2007</year><volume>64</volume><fpage>127</fpage><lpage>133</lpage><pub-id pub-id-type=""doi"">10.1136/oem.2005.026039</pub-id><pub-id pub-id-type=""pmid"">17053021</pub-id></mixed-citation></ref><ref id=""B200""><mixed-citation publication-type=""journal""><name><surname>Jones</surname><given-names>L</given-names></name><name><surname>Bunnell</surname><given-names>J</given-names></name><name><surname>Stillman</surname><given-names>J</given-names></name><article-title>A 30-year follow-up of residual effects on New Zealand School Dental Nurses, from occupational mercury exposure</article-title><source>Hum Exp Toxicol</source><year>2007</year><volume>26</volume><fpage>367</fpage><lpage>374</lpage><pub-id pub-id-type=""doi"">10.1177/0960327107076824</pub-id><pub-id pub-id-type=""pmid"">17615119</pub-id></mixed-citation></ref><ref id=""B201""><mixed-citation publication-type=""journal""><name><surname>Echeverria</surname><given-names>D</given-names></name><name><surname>Woods</surname><given-names>JS</given-names></name><name><surname>Heyer</surname><given-names>NJ</given-names></name><name><surname>Rohlman</surname><given-names>D</given-names></name><name><surname>Farin</surname><given-names>FM</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Garabedian</surname><given-names>CE</given-names></name><article-title>The association between a genetic polymorphism of coproporphyrinogen oxidase, dental mercury exposure and neurobehavioral response in humans</article-title><source>Neurotoxicol Teratol</source><year>2006</year><volume>28</volume><fpage>39</fpage><lpage>48</lpage><pub-id pub-id-type=""doi"">10.1016/j.ntt.2005.10.006</pub-id><pub-id pub-id-type=""pmid"">16343843</pub-id></mixed-citation></ref><ref id=""B202""><mixed-citation publication-type=""other""><name><surname>Gerhard</surname><given-names>I</given-names></name><name><surname>Monga</surname><given-names>B</given-names></name><name><surname>Waldbrenner</surname><given-names>A</given-names></name><name><surname>Runnebaum</surname><given-names>B</given-names></name><article-title>Heavy metals and fertility. J Toxicol Environ Health</article-title><year>1998</year><volume>54</volume><fpage>593</fpage><lpage>611</lpage><pub-id pub-id-type=""pmid"">9726782</pub-id></mixed-citation></ref><ref id=""B203""><mixed-citation publication-type=""journal""><name><surname>Gerhard</surname><given-names>I</given-names></name><name><surname>Waibel</surname><given-names>S</given-names></name><name><surname>Daniel</surname><given-names>V</given-names></name><name><surname>Runnebaum</surname><given-names>B</given-names></name><article-title>Impact of heavy metals on hormonal and immunological factors in women with repeated miscarriages</article-title><source>Hum Reprod Update</source><year>1998</year><volume>4</volume><fpage>301</fpage><lpage>309</lpage><pub-id pub-id-type=""doi"">10.1093/humupd/4.3.301</pub-id><pub-id pub-id-type=""pmid"">9741713</pub-id></mixed-citation></ref><ref id=""B204""><mixed-citation publication-type=""journal""><name><surname>Gerhard</surname><given-names>I</given-names></name><name><surname>Runnebaum</surname><given-names>B</given-names></name><article-title>The limits of hormone substitution in pollutant exposure and fertility disorders</article-title><source>Zentralbl Gynaekol</source><year>1992</year><volume>114</volume><fpage>593</fpage><lpage>602</lpage></mixed-citation></ref><ref id=""B205""><mixed-citation publication-type=""journal""><name><surname>Sheiner</surname><given-names>EK</given-names></name><name><surname>Sheiner</surname><given-names>E</given-names></name><name><surname>Hammel</surname><given-names>RD</given-names></name><name><surname>Potashnik</surname><given-names>G</given-names></name><name><surname>Carel</surname><given-names>R</given-names></name><article-title>Effect of occupational exposures on male fertility: literature review</article-title><source>Ind Health</source><year>2003</year><volume>41:5</volume><fpage>5</fpage><lpage>62</lpage></mixed-citation></ref><ref id=""B206""><mixed-citation publication-type=""journal""><name><surname>Podzimek</surname><given-names>S</given-names></name><name><surname>Prochazkova</surname><given-names>J</given-names></name><name><surname>Pribylova</surname><given-names>L</given-names></name><name><surname>Bártová</surname><given-names>J</given-names></name><name><surname>Ulcová-Gallová</surname><given-names>Z</given-names></name><name><surname>Mrklas</surname><given-names>L</given-names></name><name><surname>Stejskal</surname><given-names>VD</given-names></name><article-title>Effect of heavy metals on immune reactions in patients with infertility</article-title><source>Cas Lek Cesk</source><year>2003</year><volume>142</volume><fpage>285</fpage><lpage>288</lpage><pub-id pub-id-type=""pmid"">12920793</pub-id></mixed-citation></ref><ref id=""B207""><mixed-citation publication-type=""journal""><name><surname>Podzimek</surname><given-names>S</given-names></name><name><surname>Prochazkova</surname><given-names>J</given-names></name><name><surname>Bultasova</surname><given-names>L</given-names></name><name><surname>Bartova</surname><given-names>J</given-names></name><name><surname>Ulcova-Gallova</surname><given-names>Z</given-names></name><name><surname>Mrklas</surname><given-names>L</given-names></name><name><surname>Stejskal</surname><given-names>VD</given-names></name><article-title>Sensitization to inorganic mercury could be a risk factor for infertility</article-title><source>Neuro Endocrinol Lett</source><year>2005</year><volume>26</volume><fpage>277</fpage><lpage>282</lpage><pub-id pub-id-type=""pmid"">16136024</pub-id></mixed-citation></ref><ref id=""B208""><mixed-citation publication-type=""journal""><name><surname>Ahlrot-Westerlund</surname><given-names>B</given-names></name><article-title>Mercury in cerebrospinal fluid in multiple sclerosis</article-title><source>Swed J Biol Med</source><year>1989</year><volume>1</volume><fpage>6</fpage><lpage>7</lpage></mixed-citation></ref><ref id=""B209""><mixed-citation publication-type=""journal""><name><surname>Craelius</surname><given-names>W</given-names></name><article-title>Comperative epidemiology of multiple sclerosis and dental caries</article-title><source>J Epidemiol Comm Health</source><year>1978</year><volume>32</volume><fpage>155</fpage><lpage>165</lpage><pub-id pub-id-type=""doi"">10.1136/jech.32.3.155</pub-id></mixed-citation></ref><ref id=""B210""><mixed-citation publication-type=""journal""><name><surname>McGrother</surname><given-names>C</given-names></name><name><surname>Dugmore</surname><given-names>C</given-names></name><name><surname>Phillips</surname><given-names>M</given-names></name><name><surname>Raymond</surname><given-names>N</given-names></name><name><surname>Garrick</surname><given-names>P</given-names></name><name><surname>Baird</surname><given-names>W</given-names></name><article-title>Multiple sclerosis, dental caries and fillings: a case-control study</article-title><source>Br Dent J</source><year>1999</year><volume>187</volume><fpage>261</fpage><lpage>264</lpage><pub-id pub-id-type=""doi"">10.1038/sj.bdj.4800255a</pub-id><pub-id pub-id-type=""pmid"">10520544</pub-id></mixed-citation></ref><ref id=""B211""><mixed-citation publication-type=""journal""><name><surname>Baasch</surname><given-names>E</given-names></name><article-title>Theoretical considerations on the etiology of multiple sclerosis. Is multiple sclerosis a mercury allergy?</article-title><source>Schweiz Arch Neurol Neurochir Psychiatr</source><year>1966</year><volume>98</volume><fpage>1</fpage><lpage>19</lpage><pub-id pub-id-type=""pmid"">5985125</pub-id></mixed-citation></ref><ref id=""B212""><mixed-citation publication-type=""journal""><name><surname>Ingalls</surname><given-names>T</given-names></name><article-title>Epidemiology, etiology and prevention of multiple sclerosis. Hypothesis and fact</article-title><source>Am J Forensic Med Pathol</source><year>1983</year><volume>4</volume><fpage>55</fpage><lpage>61</lpage><pub-id pub-id-type=""doi"">10.1097/00000433-198303000-00006</pub-id><pub-id pub-id-type=""pmid"">6837537</pub-id></mixed-citation></ref><ref id=""B213""><mixed-citation publication-type=""journal""><name><surname>Ingalls</surname><given-names>T</given-names></name><article-title>Endemic clustering of multiple sclerosis in time and place, 1934-1984. Confirmation of a hypothesis</article-title><source>Am J Forensic Med Pathol</source><year>1986</year><volume>7</volume><fpage>3</fpage><lpage>8</lpage><pub-id pub-id-type=""doi"">10.1097/00000433-198603000-00002</pub-id><pub-id pub-id-type=""pmid"">3728417</pub-id></mixed-citation></ref><ref id=""B214""><mixed-citation publication-type=""journal""><name><surname>Issa</surname><given-names>Y</given-names></name><name><surname>Watts</surname><given-names>D</given-names></name><name><surname>Duxbury</surname><given-names>A</given-names></name><name><surname>Brunton</surname><given-names>P</given-names></name><name><surname>Watson</surname><given-names>M</given-names></name><name><surname>Waters</surname><given-names>C</given-names></name><article-title>Mercuric chloride: toxicity and apoptosis in a human oligodendroglial cell line</article-title><source>Biomaterials</source><year>2003</year><volume>24</volume><fpage>981</fpage><lpage>987</lpage><pub-id pub-id-type=""doi"">10.1016/S0142-9612(02)00436-2</pub-id><pub-id pub-id-type=""pmid"">12504520</pub-id></mixed-citation></ref><ref id=""B215""><mixed-citation publication-type=""journal""><name><surname>Siblerud</surname><given-names>RL</given-names></name><article-title>A comparison of mental health of multiple sclerosis patients with silver/mercury dental fillings and those with fillings removed</article-title><source>Psychol Rep</source><year>1992</year><volume>70</volume><fpage>1139</fpage><lpage>1151</lpage><pub-id pub-id-type=""doi"">10.2466/PR0.70.4.1139-1151</pub-id><pub-id pub-id-type=""pmid"">1496084</pub-id></mixed-citation></ref><ref id=""B216""><mixed-citation publication-type=""journal""><name><surname>Siblerud</surname><given-names>RL</given-names></name><name><surname>Kienholz</surname><given-names>E</given-names></name><name><surname>Motl</surname><given-names>J</given-names></name><article-title>Evidence that mercury from silver dental fillings may be an etiological factor in smoking</article-title><source>Toxicol Lett</source><year>1993</year><volume>68</volume><fpage>307</fpage><lpage>310</lpage><pub-id pub-id-type=""doi"">10.1016/0378-4274(93)90022-P</pub-id><pub-id pub-id-type=""pmid"">8516784</pub-id></mixed-citation></ref><ref id=""B217""><mixed-citation publication-type=""journal""><name><surname>Huggins</surname><given-names>HA</given-names></name><name><surname>Levy</surname><given-names>TE</given-names></name><article-title>Cerebrospinal fluid protein changes in multiple sclerosis after dental amalgam removal</article-title><source>Altern Med Rev</source><year>1998</year><volume>4</volume><fpage>295</fpage><lpage>300</lpage></mixed-citation></ref><ref id=""B218""><mixed-citation publication-type=""journal""><name><surname>Bates</surname><given-names>M</given-names></name><name><surname>Fawcett</surname><given-names>J</given-names></name><name><surname>Garrett</surname><given-names>N</given-names></name><name><surname>Cutress</surname><given-names>T</given-names></name><name><surname>Kjellstrom</surname><given-names>T</given-names></name><article-title>Related articles, health effects of dental amalgam exposure: a retrospective cohort study</article-title><source>Int J Epidemiol</source><year>2004</year><volume>33</volume><fpage>894</fpage><lpage>902</lpage><pub-id pub-id-type=""doi"">10.1093/ije/dyh164</pub-id><pub-id pub-id-type=""pmid"">15155698</pub-id></mixed-citation></ref><ref id=""B219""><mixed-citation publication-type=""journal""><name><surname>Bates</surname><given-names>MN</given-names></name><article-title>Mercury amalgam dental fillings: an epidemiologic assessment</article-title><source>Int J Hyg Environ Health</source><year>2006</year><volume>209</volume><issue>Suppl 4</issue><fpage>309</fpage><lpage>316</lpage><pub-id pub-id-type=""doi"">10.1016/j.ijheh.2005.11.006</pub-id><pub-id pub-id-type=""pmid"">16448848</pub-id></mixed-citation></ref><ref id=""B220""><mixed-citation publication-type=""journal""><name><surname>Aminzadeh</surname><given-names>KK</given-names></name><name><surname>Etminan</surname><given-names>M</given-names></name><article-title>Dental amalgam and multiple sclerosis: a systematic review and meta-analysis</article-title><source>J Public Health Dent</source><year>2007</year><volume>67</volume><fpage>64</fpage><lpage>66</lpage><pub-id pub-id-type=""doi"">10.1111/j.1752-7325.2007.00011.x</pub-id><pub-id pub-id-type=""pmid"">17436982</pub-id></mixed-citation></ref><ref id=""B221""><mixed-citation publication-type=""journal""><name><surname>Pamphlett</surname><given-names>R</given-names></name><name><surname>Coote</surname><given-names>P</given-names></name><article-title>Entry of low doses of mercury vapor into the nervous system</article-title><source>Neurotoxicology</source><year>1998</year><volume>19</volume><fpage>39</fpage><lpage>47</lpage><pub-id pub-id-type=""pmid"">9498219</pub-id></mixed-citation></ref><ref id=""B222""><mixed-citation publication-type=""journal""><name><surname>Pamphlett</surname><given-names>R</given-names></name><name><surname>Slater</surname><given-names>M</given-names></name><name><surname>Thomas</surname><given-names>S</given-names></name><article-title>Oxidative damage to nuclic acids in motor neurons containing mercury</article-title><source>J Neurol Sci</source><year>1998</year><volume>159</volume><fpage>121</fpage><lpage>126</lpage><pub-id pub-id-type=""doi"">10.1016/S0022-510X(98)00161-0</pub-id><pub-id pub-id-type=""pmid"">9741394</pub-id></mixed-citation></ref><ref id=""B223""><mixed-citation publication-type=""journal""><name><surname>Pamphlett</surname><given-names>R</given-names></name><name><surname>Waley</surname><given-names>P</given-names></name><article-title>Motor neuron uptake of low dose inorganic mercury</article-title><source>J Neurol Sci</source><year>1996</year><volume>135</volume><fpage>63</fpage><lpage>67</lpage><pub-id pub-id-type=""doi"">10.1016/0022-510X(95)00258-4</pub-id><pub-id pub-id-type=""pmid"">8926498</pub-id></mixed-citation></ref><ref id=""B224""><mixed-citation publication-type=""journal""><name><surname>Praline</surname><given-names>J</given-names></name><name><surname>Guennoc</surname><given-names>AM</given-names></name><name><surname>Limousin</surname><given-names>N</given-names></name><name><surname>Hallak</surname><given-names>H</given-names></name><name><surname>deToffol</surname><given-names>B</given-names></name><name><surname>Corcia</surname><given-names>P</given-names></name><article-title>ALS and mercury intoxication: a relationship?</article-title><source>Clin Neurol Neurosurg</source><year>2007</year><volume>109</volume><issue>Suppl 10</issue><fpage>880</fpage><lpage>883</lpage><pub-id pub-id-type=""doi"">10.1016/j.clineuro.2007.07.008</pub-id><pub-id pub-id-type=""pmid"">17719172</pub-id></mixed-citation></ref><ref id=""B225""><mixed-citation publication-type=""journal""><name><surname>Stankovic</surname><given-names>R</given-names></name><article-title>Atrophy of large myelinated motor axons and declining muscle grip strength following mercury vapour inhalation in mice</article-title><source>Inhal Toxicol</source><year>2006</year><volume>18</volume><fpage>57</fpage><lpage>69</lpage><pub-id pub-id-type=""doi"">10.1080/08958370500282902</pub-id><pub-id pub-id-type=""pmid"">16326402</pub-id></mixed-citation></ref><ref id=""B226""><mixed-citation publication-type=""journal""><name><surname>Albrecht</surname><given-names>J</given-names></name><name><surname>Matya</surname><given-names>E</given-names></name><article-title>Glutamate: a potential mediator of inorganic mercury neurotoxicity</article-title><source>Metab Brain Dis</source><year>1996</year><volume>11</volume><fpage>175</fpage><lpage>184</lpage><pub-id pub-id-type=""doi"">10.1007/BF02069504</pub-id><pub-id pub-id-type=""pmid"">8776719</pub-id></mixed-citation></ref><ref id=""B227""><mixed-citation publication-type=""journal""><name><surname>Adams</surname><given-names>C</given-names></name><name><surname>Ziegler</surname><given-names>D</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name><article-title>Mercury intoxication simulating amyotrophic lateral sclerosis</article-title><source>JAMA</source><year>1983</year><volume>250</volume><fpage>642</fpage><lpage>643</lpage><pub-id pub-id-type=""doi"">10.1001/jama.250.5.642</pub-id><pub-id pub-id-type=""pmid"">6864963</pub-id></mixed-citation></ref><ref id=""B228""><mixed-citation publication-type=""journal""><name><surname>Schwarz</surname><given-names>S</given-names></name><name><surname>Husstedt</surname><given-names>I</given-names></name><name><surname>Bertram</surname><given-names>H</given-names></name><name><surname>Kuchelmeister</surname><given-names>K</given-names></name><article-title>Amyotrophic lateral sclerosis after accidental injection of mercury</article-title><source>J Neurol Neurosurg Psychiatry</source><year>1996</year><volume>60</volume><fpage>698</fpage><pub-id pub-id-type=""doi"">10.1136/jnnp.60.6.698</pub-id><pub-id pub-id-type=""pmid"">8648348</pub-id></mixed-citation></ref><ref id=""B229""><mixed-citation publication-type=""journal""><name><surname>Redhe</surname><given-names>O</given-names></name><name><surname>Pleva</surname><given-names>J</given-names></name><article-title>Recovery from amyotrophic lateral sclerosis and from allergy after removal of dental amalgam fillings</article-title><source>Int J Risk Saf Med</source><year>1994</year><volume>4</volume><fpage>229</fpage><lpage>236</lpage></mixed-citation></ref><ref id=""B230""><mixed-citation publication-type=""journal""><name><surname>Engel</surname><given-names>P</given-names></name><article-title>Beobachtungen über die Gesundheit vor und nach Amalgamentfernung. [Observations on health before and after removing dental amalgam]</article-title><source>Schweiz Monatsschr Zahnm</source><year>1998</year><volume>108</volume><fpage>2</fpage><lpage>14</lpage></mixed-citation></ref><ref id=""B231""><mixed-citation publication-type=""journal""><name><surname>Godfrey</surname><given-names>ME</given-names></name><name><surname>Wojcik</surname><given-names>DP</given-names></name><name><surname>Krone</surname><given-names>CA</given-names></name><article-title>Apolipoprotein E genotyping as a potential biomarker for mercury neurotoxicity</article-title><source>J Alz Dis</source><year>2003</year><volume>5</volume><fpage>189</fpage><lpage>195</lpage></mixed-citation></ref><ref id=""B232""><mixed-citation publication-type=""journal""><name><surname>Siblerud</surname><given-names>RL</given-names></name><article-title>The relationship between mercury from dental amalgam and mental health</article-title><source>Am J Psychother</source><year>1989</year><volume>43</volume><fpage>575</fpage><lpage>587</lpage><pub-id pub-id-type=""pmid"">2618948</pub-id></mixed-citation></ref><ref id=""B233""><mixed-citation publication-type=""journal""><name><surname>Siblerud</surname><given-names>RL</given-names></name><name><surname>Motl</surname><given-names>J</given-names></name><name><surname>Kienholz</surname><given-names>E</given-names></name><article-title>Psychometric evidence that mercury from silver dental fillings may be an etiological factor in depression, excessive anger, and anxiety</article-title><source>Psychol Rep</source><year>1994</year><volume>74</volume><fpage>67</fpage><lpage>80</lpage><pub-id pub-id-type=""pmid"">8153237</pub-id></mixed-citation></ref><ref id=""B234""><mixed-citation publication-type=""journal""><name><surname>Wojcik</surname><given-names>DP</given-names></name><name><surname>Godfrey</surname><given-names>ME</given-names></name><name><surname>Haley</surname><given-names>B</given-names></name><article-title>Mercury toxicity presenting as chronic fatigue, memory impairment and depression: diagnosis, treatment, susceptibility, and outcomes in a New Zealand general practice setting (1994-2006)</article-title><source>Neuro Endocrinol Lett</source><year>2006</year><volume>27</volume><fpage>415</fpage><lpage>423</lpage><pub-id pub-id-type=""pmid"">16891999</pub-id></mixed-citation></ref><ref id=""B235""><mixed-citation publication-type=""journal""><name><surname>Marcusson</surname><given-names>J</given-names></name><article-title>Psychological and somatic subjective as a result of dermatological patch testing with metallic mercury and phenyl mercuric acetate</article-title><source>Toxicol Lett</source><year>1996</year><volume>84</volume><fpage>113</fpage><lpage>122</lpage><pub-id pub-id-type=""doi"">10.1016/0378-4274(95)03623-7</pub-id><pub-id pub-id-type=""pmid"">8614905</pub-id></mixed-citation></ref><ref id=""B236""><mixed-citation publication-type=""journal""><name><surname>Marcusson</surname><given-names>J</given-names></name><name><surname>Jarstrand</surname><given-names>C</given-names></name><article-title>Oxidative metabolism of neutrophils in vitro and human mercury intolerance</article-title><source>Toxicol in Vitro</source><year>1998</year><volume>12</volume><fpage>383</fpage><lpage>388</lpage><pub-id pub-id-type=""doi"">10.1016/S0887-2333(98)00018-6</pub-id><pub-id pub-id-type=""pmid"">20654420</pub-id></mixed-citation></ref><ref id=""B237""><mixed-citation publication-type=""journal""><name><surname>Marcusson</surname><given-names>J</given-names></name><article-title>The frequency of mercury intolerance in patients with chronic fatigue syndrome and healthy controls</article-title><source>Contact Dermatitis</source><year>1999</year><volume>41</volume><fpage>60</fpage><lpage>61</lpage><pub-id pub-id-type=""doi"">10.1111/j.1600-0536.1999.tb06225.x</pub-id><pub-id pub-id-type=""pmid"">10416724</pub-id></mixed-citation></ref><ref id=""B238""><mixed-citation publication-type=""journal""><name><surname>Woods</surname><given-names>J Martin</given-names></name><name><surname>Naleway</surname><given-names>CA</given-names></name><name><surname>Echeverria</surname><given-names>D</given-names></name><article-title>Urinary porphyrin profiles as a biomarker of mercury exposure: studies on dentists with occupational exposure to mercury vapor</article-title><source>J Toxicol Environ Health</source><year>1993</year><volume>40</volume><fpage>235</fpage><lpage>46</lpage><pub-id pub-id-type=""doi"">10.1080/15287399309531791</pub-id><pub-id pub-id-type=""pmid"">8230299</pub-id></mixed-citation></ref><ref id=""B239""><mixed-citation publication-type=""journal""><name><surname>Nataf</surname><given-names>R</given-names></name><name><surname>Skorupka</surname><given-names>C</given-names></name><name><surname>Amet</surname><given-names>L</given-names></name><name><surname>Lam</surname><given-names>A</given-names></name><name><surname>Springbett</surname><given-names>A</given-names></name><name><surname>Lathe</surname><given-names>R</given-names></name><article-title>Porphyrinuria in childhood autistic disorder: implications for environmental toxicity</article-title><source>Toxicol Appl Pharmacol</source><year>2006</year><volume>214</volume><fpage>99</fpage><lpage>108</lpage><pub-id pub-id-type=""doi"">10.1016/j.taap.2006.04.008</pub-id><pub-id pub-id-type=""pmid"">16782144</pub-id></mixed-citation></ref><ref id=""B240""><mixed-citation publication-type=""journal""><name><surname>Geier</surname><given-names>DA</given-names></name><name><surname>Geier</surname><given-names>MR</given-names></name><article-title>A prospective assessment of porphyrins in autistic disorders: a potential marker for heavy metal exposure</article-title><source>Neurotox Res</source><year>2006</year><volume>10</volume><fpage>57</fpage><lpage>64</lpage><pub-id pub-id-type=""doi"">10.1007/BF03033334</pub-id><pub-id pub-id-type=""pmid"">17000470</pub-id></mixed-citation></ref><ref id=""B241""><mixed-citation publication-type=""journal""><name><surname>Geier</surname><given-names>DA</given-names></name><name><surname>Geier</surname><given-names>MR</given-names></name><article-title>A meta-analysis epidemiological assessment of neurodevelopmental disorders following vaccines administered from 1994 through 2000 in the United States</article-title><source>Neuro Endocrinol Lett</source><year>2006</year><volume>27</volume><fpage>401</fpage><lpage>413</lpage><pub-id pub-id-type=""pmid"">16807526</pub-id></mixed-citation></ref><ref id=""B242""><mixed-citation publication-type=""journal""><name><surname>Woods</surname><given-names>JS</given-names></name><name><surname>Echeverria</surname><given-names>D</given-names></name><name><surname>Heyer</surname><given-names>NJ</given-names></name><name><surname>Simmonds</surname><given-names>PL</given-names></name><name><surname>Wilkerson</surname><given-names>J</given-names></name><name><surname>Farin</surname><given-names>FM</given-names></name><article-title>The association between genetic polymorphisms of coproporphyrinogen oxidase and an atypical porphyrinogenic response to mercury exposure in humans</article-title><source>Toxicol Appl Pharmacol</source><year>2005</year><volume>206</volume><fpage>113</fpage><lpage>120</lpage><pub-id pub-id-type=""doi"">10.1016/j.taap.2004.12.016</pub-id><pub-id pub-id-type=""pmid"">15967199</pub-id></mixed-citation></ref><ref id=""B243""><mixed-citation publication-type=""journal""><name><surname>Atamna</surname><given-names>H</given-names></name><name><surname>Frey</surname><given-names>WH</given-names></name><article-title>A Role for heme in Alzheimer's disease: Heme binds amyolid β and has altered metabolism</article-title><source>PNAS</source><year>2004</year><volume>101</volume><issue>Suppl 30</issue><fpage>153</fpage><lpage>158</lpage><pub-id pub-id-type=""pmid"">14660795</pub-id></mixed-citation></ref><ref id=""B244""><mixed-citation publication-type=""journal""><name><surname>Stewart</surname><given-names>WF</given-names></name><name><surname>Schwartz</surname><given-names>BS</given-names></name><name><surname>Simon</surname><given-names>D</given-names></name><name><surname>Kelsey</surname><given-names>K</given-names></name><name><surname>Todd</surname><given-names>AC</given-names></name><article-title>ApoE genotype, past adult lead exposure, and neurobehavioral function</article-title><source>Environ Health Perspect</source><year>2002</year><volume>110</volume><fpage>501</fpage><lpage>505</lpage><pub-id pub-id-type=""doi"">10.1289/ehp.02110501</pub-id><pub-id pub-id-type=""pmid"">12003753</pub-id></mixed-citation></ref><ref id=""B245""><mixed-citation publication-type=""journal""><name><surname>Mutter</surname><given-names>J</given-names></name><name><surname>Naumann</surname><given-names>J</given-names></name><name><surname>Schneider</surname><given-names>R</given-names></name><name><surname>Walach</surname><given-names>H</given-names></name><name><surname>Haley</surname><given-names>B</given-names></name><article-title>Mercury an autism: Accelerating evidence?</article-title><source>Neuro Endocrinol Lett</source><year>2005</year><volume>26</volume><fpage>431</fpage><lpage>437</lpage></mixed-citation></ref><ref id=""B246""><mixed-citation publication-type=""journal""><name><surname>Mutter</surname><given-names>J</given-names></name><name><surname>Naumann</surname><given-names>J</given-names></name><name><surname>Walach</surname><given-names>H</given-names></name><name><surname>Daschner</surname><given-names>F</given-names></name><article-title>Amalgam: Eine Risikobewertung unter Berücksichtigung der neuen Literatur bis 2005</article-title><source>Gesundheitswesen</source><year>2005</year><volume>67</volume><fpage>204</fpage><lpage>216</lpage><pub-id pub-id-type=""doi"">10.1055/s-2005-857962</pub-id><pub-id pub-id-type=""pmid"">15789284</pub-id></mixed-citation></ref><ref id=""B247""><mixed-citation publication-type=""journal""><name><surname>Mutter</surname><given-names>J</given-names></name><name><surname>Naumann</surname><given-names>J</given-names></name><name><surname>Sadaghiani</surname><given-names>C</given-names></name><name><surname>Walach</surname><given-names>H</given-names></name><name><surname>Drasch</surname><given-names>G</given-names></name><article-title>Mercury an autism: Response to the letter of K.E.v. Muehlendahl</article-title><source>Int J Hyg Environ Health</source><year>2005</year><volume>208</volume><fpage>437</fpage><lpage>438</lpage><pub-id pub-id-type=""doi"">10.1016/j.ijheh.2005.06.001</pub-id></mixed-citation></ref><ref id=""B248""><mixed-citation publication-type=""journal""><name><surname>Kidd</surname><given-names>R</given-names></name><article-title>Results of dental amalgam removal and mercury detoxification using DMPS and neural therapy</article-title><source>Altern Ther Health</source><year>2000</year><volume>6</volume><fpage>49</fpage><lpage>55</lpage></mixed-citation></ref><ref id=""B249""><mixed-citation publication-type=""journal""><name><surname>Lindforss</surname><given-names>H</given-names></name><name><surname>Marqvardsen</surname><given-names>O</given-names></name><name><surname>Olsson</surname><given-names>S</given-names></name><name><surname>Henningson</surname><given-names>M</given-names></name><article-title>Effekter på hälsan efter avlägsnandet av amalgamfyllingar. Enodontologisk, medicinsk och psykosomatisk studie</article-title><source>Tandläkartidningen</source><year>1994</year><volume>86</volume><fpage>205</fpage><lpage>211</lpage></mixed-citation></ref><ref id=""B250""><mixed-citation publication-type=""journal""><name><surname>Lygre</surname><given-names>GB</given-names></name><name><surname>Gjerdet</surname><given-names>NR</given-names></name><name><surname>Bjorkman</surname><given-names>L</given-names></name><article-title>Patients' choice of dental treatment following examination at a specialty unit for adverse reactions to dental materials</article-title><source>Acta Odontol Scand</source><year>2004</year><volume>62</volume><fpage>258</fpage><lpage>263</lpage><pub-id pub-id-type=""doi"">10.1080/00016350410001694</pub-id><pub-id pub-id-type=""pmid"">15841812</pub-id></mixed-citation></ref><ref id=""B251""><mixed-citation publication-type=""book""><name><surname>Stomberg</surname><given-names>R</given-names></name><name><surname>Langworth</surname><given-names>S</given-names></name><person-group person-group-type=""editor"">Berlin M. Sweden</person-group><source>Mercury in dental-filling materials - an updated risk analysis in environmental medical terms. The dental Material Commission - Care and Consideration</source><year>2003</year><fpage>19</fpage><comment>(1998):</comment></mixed-citation></ref><ref id=""B252""><mixed-citation publication-type=""journal""><name><surname>Faustman</surname><given-names>EM</given-names></name><name><surname>Silbernagel</surname><given-names>SM</given-names></name><name><surname>Fenske</surname><given-names>RA</given-names></name><name><surname>Burbacher</surname><given-names>T</given-names></name><name><surname>Ponce</surname><given-names>RA</given-names></name><article-title>Mechanisms underlying children's susceptibility to environmental toxicants</article-title><source>Environ Health Perspect</source><year>2000</year><volume>108</volume><fpage>13</fpage><lpage>21</lpage><pub-id pub-id-type=""doi"">10.2307/3454629</pub-id><pub-id pub-id-type=""pmid"">10698720</pub-id></mixed-citation></ref><ref id=""B253""><mixed-citation publication-type=""journal""><name><surname>Cheuk</surname><given-names>DK</given-names></name><name><surname>Wong</surname><given-names>V</given-names></name><article-title>Attention-deficit hyperactivity disorder and blood mercury level: a case control study in Chinese children</article-title><source>Neuropediatrics</source><year>2006</year><volume>37</volume><fpage>234</fpage><lpage>240</lpage><pub-id pub-id-type=""doi"">10.1055/s-2006-924577</pub-id><pub-id pub-id-type=""pmid"">17177150</pub-id></mixed-citation></ref><ref id=""B254""><mixed-citation publication-type=""journal""><name><surname>Desoto</surname><given-names>MC</given-names></name><name><surname>Hitlan</surname><given-names>RT</given-names></name><article-title>Blood levels of mercury are related to diagnosis of autism: a reanalysis of an important data set</article-title><source>J Child Neurol</source><year>2007</year><volume>22</volume><fpage>1308</fpage><lpage>1311</lpage><pub-id pub-id-type=""doi"">10.1177/0883073807307111</pub-id><pub-id pub-id-type=""pmid"">18006963</pub-id></mixed-citation></ref><ref id=""B255""><mixed-citation publication-type=""journal""><name><surname>Adams</surname><given-names>JB</given-names></name><name><surname>Romdalvik</surname><given-names>J</given-names></name><name><surname>Ramanujam</surname><given-names>VM</given-names></name><name><surname>Legator</surname><given-names>MS</given-names></name><article-title>Mercury, lead, and zinc in baby teeth of children with autism versus controls</article-title><source>J Toxicol Environ Health</source><year>2007</year><volume>70</volume><fpage>1046</fpage><lpage>1051</lpage><pub-id pub-id-type=""doi"">10.1080/15287390601172080</pub-id></mixed-citation></ref><ref id=""B256""><mixed-citation publication-type=""journal""><name><surname>Evans</surname><given-names>TA</given-names></name><name><surname>Siedlak</surname><given-names>SL</given-names></name><name><surname>Lu</surname><given-names>L</given-names></name><article-title>The autistic phenotype exhibits remarkably localized modification of brain protein by products of free radical-induced lipid oxidation</article-title><source>Am J Biochem Biotechnol</source><year>2008</year><volume>4</volume><fpage>61</fpage><lpage>72</lpage><pub-id pub-id-type=""doi"">10.3844/ajbbsp.2008.61.72</pub-id></mixed-citation></ref><ref id=""B257""><mixed-citation publication-type=""journal""><name><surname>Lopez-Hurtado</surname><given-names>E</given-names></name><name><surname>Prieto</surname><given-names>JJ</given-names></name><article-title>A microscopic study of language-related cortex in autism</article-title><source>Am J Biochem Biotechnol</source><year>2008</year><volume>4</volume><fpage>130</fpage><lpage>145</lpage><pub-id pub-id-type=""doi"">10.3844/ajbbsp.2008.130.145</pub-id></mixed-citation></ref><ref id=""B258""><mixed-citation publication-type=""journal""><name><surname>Sajdel-Sulkowska</surname><given-names>EM</given-names></name><name><surname>Lipinski</surname><given-names>B</given-names></name><name><surname>Windom</surname><given-names>H</given-names></name><name><surname>Audhya</surname><given-names>T</given-names></name><name><surname>McGinnis</surname><given-names>W</given-names></name><article-title>Oxidative stress in autism: elevated cerebellar 3-nitrotyrosine levels</article-title><source>Am J Biochem Biotechnol</source><year>2008</year><volume>4</volume><fpage>73</fpage><lpage>84</lpage><pub-id pub-id-type=""doi"">10.3844/ajbbsp.2008.73.84</pub-id></mixed-citation></ref><ref id=""B259""><mixed-citation publication-type=""journal""><name><surname>Bradstreet</surname><given-names>J</given-names></name><name><surname>Geier</surname><given-names>D</given-names></name><name><surname>Kartzinel</surname><given-names>J</given-names></name><name><surname>Adams</surname><given-names>J</given-names></name><name><surname>Geier</surname><given-names>M</given-names></name><article-title>A case-control study of mercury burden in children with autistic spectrum disorders</article-title><source>J Am Phys Surg</source><year>2003</year><volume>8</volume><fpage>76</fpage><lpage>79</lpage></mixed-citation></ref><ref id=""B260""><mixed-citation publication-type=""journal""><name><surname>Geier</surname><given-names>DA</given-names></name><name><surname>Geier</surname><given-names>MR</given-names></name><article-title>A case series of children with apparent mercury toxic encephalopathies manifesting with clinical symptoms of regressive autistic disorders</article-title><source>J Toxicol Environ Health</source><year>2007</year><volume>70</volume><fpage>837</fpage><lpage>851</lpage><pub-id pub-id-type=""doi"">10.1080/15287390701212141</pub-id></mixed-citation></ref><ref id=""B261""><mixed-citation publication-type=""other""><name><surname>Geier</surname><given-names>DA</given-names></name><name><surname>Geier</surname><given-names>MR</given-names></name><article-title>A prospective study of mercury toxicity biomarkers in autistic spectrum disorders. J Toxicol Environ Health</article-title><year>2007</year><volume>70</volume><fpage>1723</fpage><lpage>1730</lpage><pub-id pub-id-type=""pmid"">17885929</pub-id></mixed-citation></ref><ref id=""B262""><mixed-citation publication-type=""journal""><name><surname>Adams</surname><given-names>JB</given-names></name><name><surname>Baral</surname><given-names>M</given-names></name><name><surname>Geis</surname><given-names>E</given-names></name><name><surname>Mitchell</surname><given-names>J</given-names></name><name><surname>Ingram</surname><given-names>J</given-names></name><name><surname>Hensley</surname><given-names>A</given-names></name><name><surname>Zappia</surname><given-names>I</given-names></name><name><surname>Newmark</surname><given-names>S</given-names></name><name><surname>Gehn</surname><given-names>E</given-names></name><name><surname>Rubin</surname><given-names>RA</given-names></name><name><surname>Mitchell</surname><given-names>K</given-names></name><name><surname>Bradstreet</surname><given-names>J</given-names></name><name><surname>El-Dahr</surname><given-names>J</given-names></name><article-title>Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: part B - behavioral results</article-title><source>BMC Clin Pharmacol</source><year>2009</year><volume>9</volume><fpage>17</fpage><pub-id pub-id-type=""doi"">10.1186/1472-6904-9-17</pub-id><pub-id pub-id-type=""pmid"">19852790</pub-id></mixed-citation></ref><ref id=""B263""><mixed-citation publication-type=""journal""><name><surname>Geier</surname><given-names>DA</given-names></name><name><surname>Kern</surname><given-names>JK</given-names></name><name><surname>Geier</surname><given-names>MR</given-names></name><article-title>A prospective study of prenatal mercury exposure from maternal dental amalgams and autism severity</article-title><source>Acta Neurobiol Exp</source><year>2009</year><volume>69</volume><fpage>189</fpage><lpage>197</lpage></mixed-citation></ref><ref id=""B264""><mixed-citation publication-type=""journal""><name><surname>Geier</surname><given-names>DA</given-names></name><name><surname>Mumper</surname><given-names>E</given-names></name><name><surname>Gladfelter</surname><given-names>B</given-names></name><name><surname>Coleman</surname><given-names>L</given-names></name><name><surname>Geier</surname><given-names>MR</given-names></name><article-title>Neurodevelopmental Disorders, Maternal Rh-Negativity, and Rho(D) Immune Globulins: A Multi-Center Assessment</article-title><source>Neuro Endocrinol Lett</source><year>2008</year><volume>29</volume><fpage>272</fpage><lpage>280</lpage><pub-id pub-id-type=""pmid"">18404135</pub-id></mixed-citation></ref><ref id=""B265""><mixed-citation publication-type=""journal""><name><surname>Hornig</surname><given-names>M</given-names></name><name><surname>Chian</surname><given-names>D</given-names></name><name><surname>Lipkin</surname><given-names>W</given-names></name><article-title>Neurotoxic effects of postnatal thimerosal are mouse strain dependent</article-title><source>Mol Psychiatry</source><year>2004</year><volume>9</volume><fpage>833</fpage><lpage>845</lpage><pub-id pub-id-type=""doi"">10.1038/sj.mp.4001529</pub-id><pub-id pub-id-type=""pmid"">15184908</pub-id></mixed-citation></ref><ref id=""B266""><mixed-citation publication-type=""journal""><name><surname>Amin-Zaki</surname><given-names>L</given-names></name><name><surname>Majeed</surname><given-names>MA</given-names></name><name><surname>Greenwood</surname><given-names>MR</given-names></name><name><surname>Elhassani</surname><given-names>SB</given-names></name><name><surname>Clarkson</surname><given-names>TW</given-names></name><name><surname>Doherty</surname><given-names>RA</given-names></name><article-title>Methylmercury poisoning in the Iraqi suckling infant: a longitudinal study over five years</article-title><source>J Appl Toxicol</source><year>1981</year><volume>1</volume><fpage>210</fpage><lpage>214</lpage><pub-id pub-id-type=""doi"">10.1002/jat.2550010405</pub-id><pub-id pub-id-type=""pmid"">6892222</pub-id></mixed-citation></ref><ref id=""B267""><mixed-citation publication-type=""journal""><name><surname>Counter</surname><given-names>SA</given-names></name><name><surname>Buchanan</surname><given-names>LH</given-names></name><name><surname>Ortega</surname><given-names>F</given-names></name><name><surname>Laurell</surname><given-names>G</given-names></name><article-title>Elevated blood mercury and neuro-otological observations in children of the Ecuadorian gold mines</article-title><source>J Toxicol Environ Health</source><year>2002</year><volume>65</volume><fpage>149</fpage><lpage>163</lpage><pub-id pub-id-type=""doi"">10.1080/152873902753396785</pub-id></mixed-citation></ref><ref id=""B268""><mixed-citation publication-type=""journal""><name><surname>Debes</surname><given-names>F</given-names></name><name><surname>Budtz-Jorgensen</surname><given-names>E</given-names></name><name><surname>Weihe</surname><given-names>P</given-names></name><name><surname>White</surname><given-names>RF</given-names></name><name><surname>Grandjean</surname><given-names>P</given-names></name><article-title>Impact of prenatal methylmercury exposure on neurobehavioral function at age 14 years</article-title><source>Neurotoxicol Teratol</source><year>2006</year><volume>28</volume><fpage>363</fpage><lpage>75</lpage><pub-id pub-id-type=""doi"">10.1016/j.ntt.2006.02.004</pub-id><pub-id pub-id-type=""pmid"">16647838</pub-id></mixed-citation></ref><ref id=""B269""><mixed-citation publication-type=""journal""><name><surname>Palmer</surname><given-names>R</given-names></name><name><surname>Blanchard</surname><given-names>S</given-names></name><name><surname>Stein</surname><given-names>Z</given-names></name><name><surname>Mandell</surname><given-names>D</given-names></name><name><surname>Miller</surname><given-names>C</given-names></name><article-title>Environmental mercury release, special education rates and autism disorder: an ecological study of Texas</article-title><source>Health&amp;Place</source><year>2006</year><volume>12</volume><fpage>203</fpage><lpage>209</lpage></mixed-citation></ref><ref id=""B270""><mixed-citation publication-type=""book""><name><surname>Rury</surname><given-names>J</given-names></name><article-title>Links between environmental mercury special education and autism in Louisiana</article-title><source>PhD thesis</source><year>2006</year><publisher-name>Louisiana State University, Baton Rouge (LA)</publisher-name></mixed-citation></ref><ref id=""B271""><mixed-citation publication-type=""journal""><name><surname>Windham</surname><given-names>GC</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Gunier</surname><given-names>R</given-names></name><name><surname>Croen</surname><given-names>LA</given-names></name><name><surname>Grether</surname><given-names>JK</given-names></name><article-title>Autism spectrum disorders in relation to distribution of hazardous air pollutants in the San Francisco Bay area</article-title><source>Environ Health Perspect</source><year>2006</year><volume>114</volume><fpage>1438</fpage><lpage>1444</lpage><pub-id pub-id-type=""doi"">10.1289/ehp.9120</pub-id><pub-id pub-id-type=""pmid"">16966102</pub-id></mixed-citation></ref><ref id=""B272""><mixed-citation publication-type=""journal""><name><surname>James</surname><given-names>S</given-names></name><name><surname>Cutler</surname><given-names>P</given-names></name><name><surname>Melnyk</surname><given-names>S</given-names></name><name><surname>Jernigan</surname><given-names>S</given-names></name><name><surname>Janak</surname><given-names>L</given-names></name><name><surname>Gaylor</surname><given-names>DW</given-names></name><name><surname>Neubrander</surname><given-names>JA</given-names></name><article-title>Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism</article-title><source>Am J Clin Nutr</source><year>2004</year><volume>80</volume><fpage>1611</fpage><lpage>1617</lpage><pub-id pub-id-type=""pmid"">15585776</pub-id></mixed-citation></ref><ref id=""B273""><mixed-citation publication-type=""journal""><name><surname>James</surname><given-names>SJ</given-names></name><name><surname>Slikker</surname><given-names>W</given-names></name><name><surname>Melnyk</surname><given-names>S</given-names></name><name><surname>New</surname><given-names>E</given-names></name><name><surname>Pogribna</surname><given-names>M</given-names></name><name><surname>Jernigan</surname><given-names>S</given-names></name><article-title>Thimerosal neurotoxicity is associated with glutathione depletion: protection with glutathione precursors</article-title><source>Neurotoxicology</source><year>2005</year><volume>26</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type=""doi"">10.1016/j.neuro.2004.07.012</pub-id><pub-id pub-id-type=""pmid"">15527868</pub-id></mixed-citation></ref><ref id=""B274""><mixed-citation publication-type=""other""><collab>Autism Research Institute</collab><article-title>Treatment options for mercury/metal toxicity in autism and related developmental disabilities</article-title><ext-link ext-link-type=""uri"" xlink:href=""http://autism.asu.edu/TreatmentOptions.pdf"">http://autism.asu.edu/TreatmentOptions.pdf</ext-link></mixed-citation></ref><ref id=""B275""><mixed-citation publication-type=""journal""><name><surname>Zahir</surname><given-names>F</given-names></name><name><surname>Rizwi</surname><given-names>SJ</given-names></name><name><surname>Haq</surname><given-names>SK</given-names></name><name><surname>Khan</surname><given-names>RH</given-names></name><article-title>Low dose mercury toxicity and human health</article-title><source>Environ Toxicol Pharmacol</source><year>2005</year><volume>20</volume><fpage>351</fpage><lpage>360</lpage><pub-id pub-id-type=""doi"">10.1016/j.etap.2005.03.007</pub-id></mixed-citation></ref><ref id=""B276""><mixed-citation publication-type=""journal""><name><surname>Bjorkman</surname><given-names>L</given-names></name><name><surname>Pedersen</surname><given-names>NL</given-names></name><name><surname>Lichtenstein</surname><given-names>P</given-names></name><article-title>Physical and mental health related to dental amalgam fillings in Swedish twins</article-title><source>Community Dent Oral Epidemiol</source><year>1996</year><volume>24</volume><fpage>260</fpage><lpage>267</lpage><pub-id pub-id-type=""doi"">10.1111/j.1600-0528.1996.tb00856.x</pub-id><pub-id pub-id-type=""pmid"">8871034</pub-id></mixed-citation></ref><ref id=""B277""><mixed-citation publication-type=""journal""><name><surname>Bellinger</surname><given-names>DC</given-names></name><name><surname>Needleman</surname><given-names>HL</given-names></name><article-title>Intellectual impairment and blood lead levels</article-title><source>N Eng J Med</source><year>2003</year><volume>349</volume><fpage>500</fpage><lpage>502</lpage><pub-id pub-id-type=""doi"">10.1056/NEJM200307313490515</pub-id></mixed-citation></ref><ref id=""B278""><mixed-citation publication-type=""journal""><name><surname>DeRouen</surname><given-names>TA</given-names></name><name><surname>Martin</surname><given-names>MD</given-names></name><name><surname>Leroux</surname><given-names>BG</given-names></name><article-title>Neurobehavioral effects of dental amalgam in children: a randomized clinical trial</article-title><source>JAMA</source><year>2006</year><volume>295</volume><issue>Suppl 15</issue><fpage>1784</fpage><lpage>1792</lpage><pub-id pub-id-type=""doi"">10.1001/jama.295.15.1784</pub-id><pub-id pub-id-type=""pmid"">16622140</pub-id></mixed-citation></ref><ref id=""B279""><mixed-citation publication-type=""journal""><name><surname>Buyske</surname><given-names>S</given-names></name><name><surname>Williams</surname><given-names>TA</given-names></name><name><surname>Mars</surname><given-names>AE</given-names></name><name><surname>Stenroos</surname><given-names>ES</given-names></name><name><surname>Ming</surname><given-names>SX</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Sreenath</surname><given-names>M</given-names></name><name><surname>Factura</surname><given-names>MF</given-names></name><name><surname>Reddy</surname><given-names>C</given-names></name><name><surname>Lambert</surname><given-names>GH</given-names></name><name><surname>Johnson</surname><given-names>WG</given-names></name><article-title>Analysis of case-parent trios at a locus with a deletion allele: association of GSTM1 with autism</article-title><source>BMC Genet</source><year>2006</year><volume>7</volume><fpage>8</fpage><pub-id pub-id-type=""doi"">10.1186/1471-2156-7-8</pub-id><pub-id pub-id-type=""pmid"">16472391</pub-id></mixed-citation></ref><ref id=""B280""><mixed-citation publication-type=""journal""><name><surname>Chew</surname><given-names>CL</given-names></name><name><surname>Soh</surname><given-names>G</given-names></name><name><surname>Lee</surname><given-names>AS</given-names></name><name><surname>Yeoh</surname><given-names>TS</given-names></name><article-title>Long-term dissolution of mercury from a non-mercury-releasing amalgam</article-title><source>Clin Prev Dent</source><year>1991</year><volume>13</volume><issue>Suppl 3</issue><fpage>5</fpage><lpage>7</lpage><pub-id pub-id-type=""pmid"">1860296</pub-id></mixed-citation></ref><ref id=""B281""><mixed-citation publication-type=""other""><collab>UNEP (United Nations Environment Programm Chemicals)</collab><article-title>Global Mercury Assessment 2002</article-title><ext-link ext-link-type=""uri"" xlink:href=""http://www.chem.unep.ch/mercury/Report/GMA-report-TOC.htm"">http://www.chem.unep.ch/mercury/Report/GMA-report-TOC.htm</ext-link></mixed-citation></ref><ref id=""B282""><mixed-citation publication-type=""other""><name><surname>Laks</surname><given-names>DR</given-names></name><article-title>Assessment of chronic mercury exposure within the U.S. population, National Health and Nutrition Examination Survey, 1999-2006</article-title><source>Biometals</source><year>2009</year><comment>[Epub ahead of print]</comment><pub-id pub-id-type=""pmid"">19697139</pub-id></mixed-citation></ref><ref id=""B283""><mixed-citation publication-type=""journal""><name><surname>Hylander</surname><given-names>L</given-names></name><name><surname>Goodsite</surname><given-names>M</given-names></name><article-title>Environmental costs of the mercury pollution</article-title><source>Sci Total Environ</source><year>2006</year><volume>368</volume><fpage>352</fpage><lpage>370</lpage><pub-id pub-id-type=""doi"">10.1016/j.scitotenv.2005.11.029</pub-id><pub-id pub-id-type=""pmid"">16442592</pub-id></mixed-citation></ref><ref id=""B284""><mixed-citation publication-type=""journal""><name><surname>Hylander</surname><given-names>L</given-names></name><name><surname>Lindvall</surname><given-names>A</given-names></name><name><surname>Gahnberg</surname><given-names>L</given-names></name><article-title>High mercury emissions from dental clinics despite amalgam separators</article-title><source>Sci Total Environ</source><year>2006</year><volume>362</volume><fpage>74</fpage><lpage>84</lpage><pub-id pub-id-type=""doi"">10.1016/j.scitotenv.2005.06.008</pub-id><pub-id pub-id-type=""pmid"">16054673</pub-id></mixed-citation></ref><ref id=""B285""><mixed-citation publication-type=""journal""><name><surname>Hylander</surname><given-names>L</given-names></name><name><surname>Lindvall</surname><given-names>A</given-names></name><name><surname>Uhrberg</surname><given-names>R</given-names></name><name><surname>Gahnberg</surname><given-names>L</given-names></name><name><surname>Lindh</surname><given-names>U</given-names></name><article-title>Mercury recovery in situ of four different dental amalgam separators</article-title><source>Sci Total Environ</source><year>2006</year><volume>366</volume><fpage>320</fpage><lpage>336</lpage><pub-id pub-id-type=""doi"">10.1016/j.scitotenv.2005.07.007</pub-id><pub-id pub-id-type=""pmid"">16182343</pub-id></mixed-citation></ref><ref id=""B286""><mixed-citation publication-type=""other""><name><surname>Bender</surname><given-names>M</given-names></name><article-title>Taking a bite out of dental mercury pollution. New England zero Mercury Campaign</article-title><ext-link ext-link-type=""uri"" xlink:href=""http://mpp.cclearn.org/wp-content/uploads/2008/08/nezmc_report_card_on_dental_mercuryfinal.pdf"">http://mpp.cclearn.org/wp-content/uploads/2008/08/nezmc_report_card_on_dental_mercuryfinal.pdf</ext-link></mixed-citation></ref><ref id=""B287""><mixed-citation publication-type=""other""><name><surname>Bengtsson</surname><given-names>U</given-names></name><article-title>The symbiosis between the dental and industrial communities and their scientific journals</article-title><ext-link ext-link-type=""uri"" xlink:href=""http://www.gbg.bonet.se/bwf/art/symbiosis.html"">http://www.gbg.bonet.se/bwf/art/symbiosis.html</ext-link></mixed-citation></ref><ref id=""B288""><mixed-citation publication-type=""other""><collab>Consumer for Dental Choice</collab><article-title>Complaint against FDA</article-title><year>2008</year><ext-link ext-link-type=""uri"" xlink:href=""http://www.toxicteeth.org/natcamp_fedgovt_fda_complaint_Dec07.cfm"">http://www.toxicteeth.org/natcamp_fedgovt_fda_complaint_Dec07.cfm</ext-link></mixed-citation></ref><ref id=""B289""><mixed-citation publication-type=""other""><collab>FDI World Dental Federation</collab><article-title>FDI participates at WHO/UNEP meeting on future use of materials for dental restoration</article-title><year>2009</year><ext-link ext-link-type=""uri"" xlink:href=""http://www.fdiworldental.org/content/fdi-participates-whounep-meeting-future-use-materials-dental-restoration"">http://www.fdiworldental.org/content/fdi-participates-whounep-meeting-future-use-materials-dental-restoration</ext-link></mixed-citation></ref><ref id=""B290""><mixed-citation publication-type=""other""><collab>Mercury Policy Project</collab><name><surname>Bender</surname><given-names>M</given-names></name><article-title>Letter to WHO: WHO meeting report on the future of dental restorative materials</article-title><year>2010</year><ext-link ext-link-type=""uri"" xlink:href=""http://mercurypolicy.org/wp-content/uploads/2010/12/letter_to_who_amalgam_nov_2010_final_final.pdf"">http://mercurypolicy.org/wp-content/uploads/2010/12/letter_to_who_amalgam_nov_2010_final_final.pdf</ext-link></mixed-citation></ref><ref id=""B291""><mixed-citation publication-type=""journal""><name><surname>Gruning</surname><given-names>T</given-names></name><name><surname>Gilmore</surname><given-names>AB</given-names></name><name><surname>McKee</surname><given-names>M</given-names></name><article-title>Tobacco Industry Influence on Science and Scientists in Germany</article-title><source>Am J Public Health</source><year>2006</year><volume>96</volume><fpage>20</fpage><lpage>32</lpage><pub-id pub-id-type=""doi"">10.2105/AJPH.2004.061507</pub-id><pub-id pub-id-type=""pmid"">16317203</pub-id></mixed-citation></ref><ref id=""B292""><mixed-citation publication-type=""journal""><name><surname>Hardell</surname><given-names>L</given-names></name><name><surname>Walker</surname><given-names>MJ</given-names></name><name><surname>Walhjalt</surname><given-names>B</given-names></name><name><surname>Friedman</surname><given-names>LS</given-names></name><name><surname>Richter</surname><given-names>ED</given-names></name><article-title>Secret ties to industry and conflicting interests in cancer research</article-title><source>Am J Ind Med</source><year>2007</year><volume>50</volume><fpage>227</fpage><lpage>233</lpage><pub-id pub-id-type=""doi"">10.1002/ajim.20357</pub-id><pub-id pub-id-type=""pmid"">17086516</pub-id></mixed-citation></ref><ref id=""B293""><mixed-citation publication-type=""journal""><name><surname>Bohm</surname><given-names>SR</given-names></name><name><surname>Dian</surname><given-names>Z</given-names></name><name><surname>Gilman</surname><given-names>DS</given-names></name><article-title>Maximizing profit and endangering health: corporate strategies to avoid litigation and regulation</article-title><source>Int J Occup Environ Health</source><year>2005</year><volume>11</volume><fpage>338</fpage><lpage>348</lpage><pub-id pub-id-type=""pmid"">16350467</pub-id></mixed-citation></ref><ref id=""B294""><mixed-citation publication-type=""journal""><name><surname>Jacobson</surname><given-names>MF</given-names></name><article-title>Lifting the veil of secrecy from industry funding of nonprofit health organizations</article-title><source>Int J Occup Environ Health</source><year>2005</year><volume>11</volume><fpage>349</fpage><lpage>55</lpage><pub-id pub-id-type=""pmid"">16350468</pub-id></mixed-citation></ref><ref id=""B295""><mixed-citation publication-type=""journal""><name><surname>Egilman</surname><given-names>DS</given-names></name><name><surname>Bohme</surname><given-names>SR</given-names></name><article-title>Over a barrel: corporate corruption of science and its effects on workers and the environment</article-title><source>Int J Occup Environ Health</source><year>2005</year><volume>11</volume><fpage>331</fpage><lpage>337</lpage><pub-id pub-id-type=""pmid"">16350466</pub-id></mixed-citation></ref></ref-list>"
10.1055/s-2006-924577	"<html><body><p>J_Occup_Med_Toxicol/PMC4448290.nxml                                                                 0000664 0011011 0007774 00000120734 13031236773 015624  0                                                                                                    ustar   pmc                             pmcdev<!DOCTYPE article PUBLIC ""-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN"" ""JATS-archivearticle1.dtd""><pub-id pub-id-type=""doi"">10.1055/s-2006-924577</pub-id><pub-id pub-id-type=""pmid"">18245408</pub-id><ref id=""pone.0149558.ref050""><label>50</label><mixed-citation publication-type=""journal""><name><surname>Cheuk</surname><given-names>DK</given-names></name>,<name><surname>Wong</surname><given-names>V</given-names></name>.<article-title>Attention-deficit hyperactivity disorder and blood mercury level: a case-control study in Chinese children</article-title>.<source>Neuropediatrics</source>.<year>2006</year>;<volume>37</volume>(<issue>4</issue>):<fpage>234</fpage>–<lpage>40</lpage>. Epub 2006/12/21.<comment>doi:<ext-link ext-link-type=""uri"" xlink:href=""http://dx.doi.org/10.1055/s-2006-924577"">10.1055/s-2006-924577</ext-link></comment>.<pub-id pub-id-type=""pmid"">17177150</pub-id></mixed-citation></ref><ref id=""pone.0149558.ref051""><label>51</label><mixed-citation publication-type=""journal""><name><surname>Linnet</surname><given-names>KM</given-names></name>,<name><surname>Dalsgaard</surname><given-names>S</given-names></name>,<name><surname>Obel</surname><given-names>C</given-names></name>,<name><surname>Wisborg</surname><given-names>K</given-names></name>,<name><surname>Henriksen</surname><given-names>TB</given-names></name>,<name><surname>Rodriguez</surname><given-names>A</given-names></name>,<etal>et al</etal></mixed-citation></ref></p></body></html>"
10.1016/j.cell.2008.01.051	"<html><body><article article-type=""review-article"" xmlns:xlink=""http://www.w3.org/1999/xlink""><?properties open_access?><front><journal-meta><journal-id journal-id-type=""nlm-ta"">Histochem Cell Biol</journal-id><journal-title>Histochemistry and Cell Biology</journal-title><issn pub-type=""ppub"">0948-6143</issn><issn pub-type=""epub"">1432-119X</issn><publisher><publisher-name>Springer-Verlag</publisher-name><publisher-loc>Berlin/Heidelberg</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type=""pmid"">18438682</article-id><article-id pub-id-type=""pmc"">2386527</article-id><article-id pub-id-type=""publisher-id"">430</article-id><article-id pub-id-type=""doi"">10.1007/s00418-008-0430-y</article-id><article-categories><subj-group subj-group-type=""heading""><subject>Review</subject></subj-group></article-categories><title-group><article-title>Actin: its cumbersome pilgrimage through cellular compartments</article-title></title-group><contrib-group><contrib contrib-type=""author""><name name-style=""western""><surname>Schleicher</surname><given-names>Michael</given-names></name><xref ref-type=""aff"" rid=""Aff1"">1</xref></contrib><contrib contrib-type=""author"" corresp=""yes""><name name-style=""western""><surname>Jockusch</surname><given-names>Brigitte M.</given-names></name><address><phone>+49-7664-408004</phone><fax>+49-7664-619948</fax><email>bmj@tu-bs.de</email></address><xref ref-type=""aff"" rid=""Aff2"">2</xref></contrib><aff id=""Aff1""><label>1</label>Adolf-Butenandt-Institute, Cell Biology and Center for Integrated Protein Science (CIPSM), Ludwig-Maximilians-University, 80336 Munich, Germany</aff><aff id=""Aff2""><label>2</label>Cell Biology Group, Technical University of Braunschweig, Spielmannstr. 7, 38092 Braunschweig, Germany</aff></contrib-group><pub-date pub-type=""epub""><day>26</day><month>4</month><year>2008</year></pub-date><pub-date pub-type=""ppub""><month>6</month><year>2008</year></pub-date><volume>129</volume><issue>6</issue><fpage>695</fpage><lpage>704</lpage><history><date date-type=""accepted""><day>14</day><month>4</month><year>2008</year></date></history><permissions><copyright-statement>© Springer-Verlag 2008</copyright-statement></permissions><abstract><p>In this article, we follow the history of one of the most abundant, most intensely studied proteins of the eukaryotic cells: actin. We report on hallmarks of its discovery, its structural and functional characterization and localization over time, and point to present days’ knowledge on its position as a member of a large family. We focus on the rather puzzling number of diverse functions as proposed for actin as a dual compartment protein. Finally, we venture on some speculations as to its origin.</p></abstract><kwd-group><title>Keywords</title><kwd>Actin history</kwd><kwd>Cytoplasmic motility</kwd><kwd>Transcription</kwd><kwd>Chromatin remodelling</kwd><kwd>Nucleocytoplasmic traffick</kwd></kwd-group><custom-meta-wrap><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>© Springer-Verlag 2008</meta-value></custom-meta></custom-meta-wrap></article-meta></front><sec id=""Sec1"" sec-type=""introduction""><title>Introduction</title><p>A common incident, ubiquitous and frequently observed by the experienced teacher: a student wants to purify protein X from an eukaryotic organism Y. Sooner or later the undergraduate stares at SDS polyacrylamide gels and is surprised, disappointed, depressed, furious about those horrible actin contaminations that seem to be everywhere. The student does not care about the advisor’s soothing explanations: “actin is the most abundant protein”, “actin exists as globular monomer (G-actin) in the soluble supernatant”, “but it is also sedimentable as filamentous actin (F-actin)”. It will be difficult to calm the young scientist down. Looking at these copious amounts of the protein, the student cannot believe<list list-type=""order""><list-item><p>that a long time ago it was a scientific breakthrough to show that actin exists at all,</p></list-item><list-item><p>that it took years and years to convince truculent groups of actin pioneers that a non-muscle cell contains actin as well,</p></list-item><list-item><p>that actin is not a singular and once for all invention in evolution, but is the founder of a large family of isoforms and related proteins, and</p></list-item><list-item><p>that quite a number of these proteins can be found in different subcellular compartments. For example, it has been established as a regular component of both, the cytoplasm and the nucleus; but this perception is the result of a fight that went on for decades.</p></list-item></list></p></sec><sec id=""Sec2""><title>The dawn: actin as a muscle component</title><p>The first traceable report that described contractile substances in muscle goes back to 1859 and Wilhelm Friedrich Kühne (Kuehne<xref ref-type=""bibr"" rid=""CR38"">1859</xref>). He belonged to the best known physiologists of his time and coined modern designations like “enzyme” or “myosin”. The latter one he described as a substance that could be isolated from frog muscle and forms a contractile clot under certain conditions. Today we would call this clot a contractile pellet, consisting mainly of actomyosin. Halliburton followed shortly afterwards and was intrigued by this clot formation (Halliburton<xref ref-type=""bibr"" rid=""CR20"">1887</xref>). He compared it to blood clotting and the transformation of fibrinogen to fibrin. In tedious experiments he extracted mammalian muscle tissue at different time scales, temperatures, salt concentrations and found that myosin apparently needed an additional component to perform fast aggregation and contraction. Without really knowing it, Halliburton worked with actin and produced with this so-called “myosin ferment” an actomyosin precipitate. In our days one reads Halliburton’s publication with some amazement. The report covers 70 pages and looks with its descriptions and tables like a lab-book, e.g.: “Extract #1—10 a.m.—Diluted with an equal amount of water—10 a.m. next day—No change”. Surely, at that time editors were not as busy as they are today.</p></sec><sec id=""Sec3""><title>Muscle actin comes of age</title><p>Then, it took almost 60 years until Brúnó F. Straub in Albert Szent-György’s laboratory at the Hungarian University of Szeged was able to purify actin in good qualities and quantities. At that time ATP was known and available, i.e. Straub could study the influence of ATP on the viscosity of myosin preparations in the presence and absence of other extractable muscle components. The decrease in viscosity upon addition of ATP was considered “activation” of myosin, the protein responsible for this activation was named “actin”, and the complex of these two proteins was “actomyosin”. Straub and Szent-Györgyi discovered these interrelationships 1941/1942 in the middle of World War II and, therefore, published the data only in local periodicals (“Studies from the Institute of Medical Chemistry”, University of Szeged). The research on actin and myosin, the political situation and the excitement in Szent-Györgi’s group in the early 1940s are nicely summarized by W.·F. Mommaerts who was a witness of the original experiments (Mommaerts<xref ref-type=""bibr"" rid=""CR46"">1992</xref>), and by A.G. Szent-Györgyi himself (Szent-Gyorgyi<xref ref-type=""bibr"" rid=""CR71"">2004</xref>).</p><p>It is far beyond the scope of this review to cover the avalanche of actin and myosin research that started after those first molecular characterizations. Of course, muscle was and still is the major source to purify actin from, and, consequently, the research during the following decades used exclusively muscle actin.</p></sec><sec id=""Sec4""><title>Actin conquers the cytoplasm</title><p>But as it is in science, one opens one door and discovers ten closed ones. Keeping that in mind a scientist should always be suspicious regarding dogmas of all sorts. For some time it was almost a law that actin exists only in skeletal muscle and that the well-known conventional myosin is the only motor protein which turns the world go round. Today it is a common place that both assumptions were wrong, although it was quite a task to convince the scientific community.</p><p>Many minor publications pointed at the presence of actin in non-muscle cells. For example, one found actomyosin-like components and Mg<sup>2+</sup>ATP-dependent viscosity changes in extracts from sea urchin eggs (Ohnishi<xref ref-type=""bibr"" rid=""CR49"">1962</xref>), and an actin-like protein from calf thymus nuclei (Ohnishi et al.<xref ref-type=""bibr"" rid=""CR50"">1963</xref>), and it was assumed that the filaments seen in fibroblasts are analogous to filaments in muscle, responsible for cell motility (Buckley and Porter<xref ref-type=""bibr"" rid=""CR7"">1967</xref>). Most of these publications never had a really strong impact, especially since they argued against a rock-solid preconception. But to be fair: these tiny reports were the pebbles that paved the road for better equipped groups and more detailed molecular studies. Notably, it was a slime mould,<italic>Physarum polycephalum</italic>that was used as a model organism to prove the existence of actin and myosin in non-muscle cells. The key experiments have been performed in Japan, in Sadashi Hatano’s group (Hatano and Oosawa<xref ref-type=""bibr"" rid=""CR22"">1966a</xref>,<xref ref-type=""bibr"" rid=""CR23"">b</xref>; Hatano and Tazawa<xref ref-type=""bibr"" rid=""CR24"">1968</xref>) and the data were confirmed shortly afterwards by other laboratories. Especially the decoration of actin filaments in non-muscle cells with myosin was a breakthrough technique that unequivocally proved the existence of the actomyosin system in many non-muscle cells (for reviews see: Huxley<xref ref-type=""bibr"" rid=""CR27"">1973</xref>; Pollard and Weihing<xref ref-type=""bibr"" rid=""CR61"">1974</xref>; Pollard<xref ref-type=""bibr"" rid=""CR62"">1981</xref>; Tilney<xref ref-type=""bibr"" rid=""CR73"">1975</xref>).</p></sec><sec id=""Sec5""><title>Actin as the prototype of a large family</title><p>Today conventional actin is thoroughly studied, with respect to its polymerization and depolymerization equilibrium, its function in the cytoskeleton as a morphological stabilizer, its role during motile activities of a cell, its three-dimensional structure, its binding partners, etc. But the traitorous word in this sentence is “conventional”. What hides behind “conventional” actin? And what is an actin-related protein?</p><p>A “conventional” actin consists of 375 highly conserved amino acids, give or take a few. The polypeptide sequence is folded into a roughly U-shaped molecule, exposing well-characterized binding sites for many different ligands. There are several isoforms as products of different genes, coined alpha, beta and gamma actin, all of which are polymorphic proteins capable to form polymers. “Conventional actins” display a particular fold which enables them to interact with a variety of partners, to form specific suprastructures involved in intracellular motility, adhesion and locomotion (see below). Figure<xref ref-type=""fig"" rid=""Fig1"">1</xref>shows the dynamics of the actin cortex in a<italic>Dictyostelium discoideum</italic>amoeba during random migration, pinocytosis, and phagocytosis of a yeast cell. An actin-related protein harbours an actin domain, but it differs from “conventional” actin in size and overall amino acid sequence, usually cannot form polymers and may differ from the conventional form in subcellular distribution and its physiological activity. The increasing number of completely sequenced genomes is an enormous help towards our understanding of actin and actin-related proteins. One can take any sequenced genome to analyze actin as a founder of a large protein family. We chose the recently unravelled<italic>D. discoideum</italic>genome since it represents the genome of a model organism that can locomote as a single cell and in cell assemblies, and can differentiate into simple tissues in a developmental cycle. Hence, it is a social amoeba at the evolutionary border between unicellular and multicellular organisms (Eichinger et al.<xref ref-type=""bibr"" rid=""CR13"">2005</xref>). Notably, the number of actin genes does not tell us very much about the complexity of an organism. Whereas the genome of budding yeast contains only one single and, not surprisingly, essential gene that codes for a conventional actin, mouse harbours 35, and the plant<italic>Arabidopsis thaliana</italic>10 actin genes. The<italic>D. discoideum</italic>genome contains 33 genes that code for a bona fide conventional actin. Most puzzling, 17 of these actins share identical amino acid sequences, but are encoded by 17 distinct genes, and many of these are developmentally regulated. Why would evolution allow this seemingly luxurious feature? Elimination of redundant genes can only be avoided if they represent a selective advantage. If the identical actins are translated in a developmental pattern, then posttranslational modifications might play a much larger role than we are aware of today. Indeed, actin’s posttranslational modifications are numerous. Actins are acetylated, acylated, arginylated, Ser/Thr/Tyr-phosphorylated, ubiquitinylated etc. This suggests that a developmentally regulated expression of actin genes requires a similarly regulated expression of enzymes that catalyze posttranslational modifications. Such a hypothesis opens a completely new search for our understanding of actin and its isoforms.<fig id=""Fig1""><label>Fig. 1</label><caption><p>Dynamics of the actin cortex during amoeboid movement, pino- and phagocytosis.<italic>D. discoideum</italic>was transformed with a truncated LimE construct, tagged to green fluorescent protein (GFP). LimE binds specifically to filamentous actin (Bretschneider et al.<xref ref-type=""bibr"" rid=""CR6"">2004</xref>). The transformed cells are depicted in phase contrast (<italic>left panels</italic>) and fluorescence (<italic>right</italic>), which reveals the concentration of actin filaments by GFP-LimE.<italic>Upper panels</italic>: optical section through the actin cortex during random amoeboid movement.<italic>Bottom panels</italic>: during uptake of a rhodamine-labelled yeast cell the actin cortex forms a phagocytic cup around the particle. The engulfment of liquids by macropinocytosis requires the actin system as well (<italic>arrow</italic>).<italic>Size bar</italic>5 μm</p></caption><graphic id=""MO1"" position=""anchor"" xlink:href=""418_2008_430_Fig1_HTML""></graphic></fig></p><p>The picture became even more complicated after the discovery of the actin-related proteins (Arps). Calculation of the putative structures shows very nicely that actin and Arps share a common three-dimensional fold (Fig.<xref ref-type=""fig"" rid=""Fig2"">2</xref>, taken from Muller et al.<xref ref-type=""bibr"" rid=""CR47"">2005</xref>). Most characteristic is the nucleotide-binding cleft which divides the protein in roughly two halves. The depicted structures all show the same orientation. For actin itself, this means that, when incorporated into a “conventional” actin filament, the bottom part of the folded monomer points towards the fast growing (“barbed”) end, the upper part towards the slow growing (“pointed”) end (see also Fig.<xref ref-type=""fig"" rid=""Fig3"">3</xref>). Figure<xref ref-type=""fig"" rid=""Fig2"">2</xref>shows strikingly (1) that all Arps can be moulded into a structure quite similar to the overall structure of conventional actin and (2) that they display a clearly distinct pattern of patches with conserved amino acids. As seen in the comparative scale (Fig.<xref ref-type=""fig"" rid=""Fig2"">2</xref>, right) Arps 1, 2 and 3 are most closely related to actin, whereas all the other Arps show a much lower percentage of identity. Arps 2 and 3 have been shown to form a tight complex that, after activation through several actin binding proteins and ATP, binds to actin filaments and induces their branching (Kiselar et al.<xref ref-type=""bibr"" rid=""CR32"">2007</xref>). However, it should be noted that the role of the Arp2/3 complex for branching of actin filaments in vivo is still heavily challenged (Koestler et al.<xref ref-type=""bibr"" rid=""CR34"">2008</xref>). It is quite amusing to read Vic Small’s statement in the Research Roundup of<italic>J Cell Biol</italic>: (Feb 25, 2008): “We haven’t disproven branching yet. We’ll need 3D imaging to put the nail in that coffin. But what we’ve seen makes the branching model unlikely”. Undoubtedly, we are still on thin ice with our knowledge on Arp2/3 function in vivo.<fig id=""Fig2""><label>Fig. 2</label><caption><p>Structural conservation in the ARP subfamily (adapted from Muller et al.<xref ref-type=""bibr"" rid=""CR47"">2005</xref>, with permission). The conservation scale weights identity from 0 (<italic>blue</italic>) to 100% (<italic>red</italic>). All Arps can adopt a global actin conformation (<italic>upper left</italic>) but only Arps 1, 2 and 3 show a pronounced sequence homology</p></caption><graphic id=""MO2"" position=""anchor"" xlink:href=""418_2008_430_Fig2_HTML""></graphic></fig><fig id=""Fig3""><label>Fig. 3</label><caption><p>Generation of different actin polymers as a result of different subunit interactions (adapted from Jockusch et al.<xref ref-type=""bibr"" rid=""CR30"">2006</xref>, with permission). The subdomains of the actin monomer, as deduced from the crystal structure, are numbered 1–4. In the process that leads to the “conventional” actin filament (F-actin), three such monomers (<bold>a</bold>–<bold>c</bold>) form intermolecular contact sites involving the subdomains as indicated left of the trimeric seed. Under physiological conditions, these trimers convert subsequently into the polar F-actin filaments that are depicted in the electron micrograph (<italic>top right</italic>). In a more rapid process, the actin monomers may form an antiparallel dimer which, at least in vitro, can form bipolar filaments (LD filaments) that show a strikingly different appearance in the electron microscope (<italic>bottom right</italic>)</p></caption><graphic id=""MO3"" position=""anchor"" xlink:href=""418_2008_430_Fig3_HTML""></graphic></fig></p><p>Let us risk some sort of a heretical view. Trivial as it may be, one has to repeat it again and again: not the three-dimensional fold, but the surface of a protein determines its function. There are curious examples for this. Hisactophilin, a histidine-rich actin-binding protein from<italic>D. discoideum</italic>, has a structure nearly identical to that of interleukin-1β and fibroblast growth factor, despite its unrelated amino acid sequence. Luckily for the authors, these data were published in a high ranking journal (Habazettl et al.<xref ref-type=""bibr"" rid=""CR19"">1992</xref>), although there was no functional similarity between these three proteins whatsoever. Today, their structural similarity is not considered important at all and, like many others, they are just members of the large trefoil protein superfamily (Liu et al.<xref ref-type=""bibr"" rid=""CR42"">2002</xref>). Sippl and coworkers systematically analyzed novel proteins based on known structures (Koppensteiner et al.<xref ref-type=""bibr"" rid=""CR35"">2000</xref>). They came to the conclusion that almost 30% of the studied proteins have similar structures but different functions.</p><p>Coming back to actins and Arps. Is it possible that the name “actin” for all of these proteins is utterly misleading? Are we wasting time in our search for cytoskeleton-related activities just because the fold triggered a wrong name? Is the so-called actin fold another example for a successful superfamily which contains only a few proteins that play a role in the cytoskeleton, while many other members are e.g. subunits of larger protein complexes in chromatin or hexokinases or proteins with yet unknown functions?</p></sec><sec id=""Sec6""><title>Actin-like proteins in the nucleus: the early period</title><p>The first reports on actin as a nuclear protein appeared already 5 years after its acceptance as a ubiquitous cytoplasmic component. Nuclear filament bundles resembling microfilaments were observed in oocytes when transcription was inhibited by actinomycin D (Lane<xref ref-type=""bibr"" rid=""CR39"">1969</xref>), and biochemical analyses identified a prominent protein present in isolated nuclei of the multinucleated plasmodia of<italic>Physarum polycephalum</italic>(Jockusch et al.<xref ref-type=""bibr"" rid=""CR28"">1971</xref>; Jockusch et al.<xref ref-type=""bibr"" rid=""CR29"">1974</xref>; Lestourgeon et al.<xref ref-type=""bibr"" rid=""CR40"">1975</xref>). The concentration of actin in the nucleus fluctuated with the cell cycle phase of the plasmodia, leading to suggestions that nuclear actin might either have a role in the constriction of the nuclear membrane in<italic>Physarum</italic>plasmodia that exhibit an intranuclear mitosis (Jockusch et al.<xref ref-type=""bibr"" rid=""CR28"">1971</xref>), or with changes in transcriptional activity during the cell cycle (Lestourgeon et al.<xref ref-type=""bibr"" rid=""CR40"">1975</xref>), or during transition from active growth to the formation of sklerotia (spherules) from plasmodia after starvation (McAlister et al.<xref ref-type=""bibr"" rid=""CR43"">1977</xref>). All this remained speculation at that time, and the majority of the cell biological community dismissed these findings as an artifact, caused by a contamination of nuclei with cytoplasmic actin. However, between 1979 and 1984 three reports appeared which supported the concept of actin being involved in transcription: (1) actin was identified in a complex of RNA polymerase II from<italic>Physarum</italic>(Smith et al.<xref ref-type=""bibr"" rid=""CR69"">1979</xref>), (2) it stimulated markedly the transcriptional activity of RNA polymerase II purified from HeLa cell extracts at the preinitiation phase (Egly et al.<xref ref-type=""bibr"" rid=""CR12"">1984</xref>), and (3) antibodies specific for actin, when injected into the large amphibian oocyte nuclei, caused a dramatic collapse of lampbrush chromosome loops, concommitant with a complete stop of mRNA transcription (Scheer et al.<xref ref-type=""bibr"" rid=""CR65"">1984</xref>). However, these observations still did not overcome the scepticism at that time—it took another two decades to recognize actin as a dual compartment protein that can execute different functions by selectively associating with ligands specific either for the cytoplasm or the nucleus.</p></sec><sec id=""Sec7""><title>Actin and Arps in the nucleus</title><p>In the last 20 years, studies on nuclear actin became fashionable, and now a new area began which firmly established actin, its relatives and binding partners as nuclear components.</p><p>Several important steps served as signposts in this process:<list list-type=""order""><list-item><p>Cell biologists began to understand that proteins are not necessarily confined to a single intracellular compartment. Numerous examples proved that proteins may shuttle between intracellular regions and even adopt different, compartment-specific activities. Shuttling of actin and actin-related proteins between the nucleus and the cytoplasm cannot be considered any longer as an exceptional, exotic behaviour.</p></list-item><list-item><p>Genetic studies, for example performed with yeast or<italic>Drosophila</italic>, showed that activities specific for the nucleus, like chromatin remodelling or transcription required the presence of the beta actin isoform, in a configuration that could bind to nuclear protein complexes, but were inhibited with actin mutants that failed in this respect.</p></list-item><list-item><p>The development of cell biological and immunological methods over the past 20 years, like cellular expression of flurorochrome-tagged proteins in conjunction with video microscopy, and the generation of epitope-characterized monoclonal antibodies allowed to follow actin trafficking throughout the cell and its location in the nucleus.</p></list-item><list-item><p>And finally, some old observations made in structural biology came back into people’s mind: actin is a highly polymorphic protein, which can give rise to several different and distinct polymers (Aebi et al.<xref ref-type=""bibr"" rid=""CR1"">1981</xref>; Millonig et al.<xref ref-type=""bibr"" rid=""CR45"">1988</xref>). Thus, while there are functionally quite unrelated proteins that may share the same structure (see above), it is also conceivable that a particular protein may adopt slightly different “unconventional forms”, possibly induced by specific binding partners. Such “distortions” may then trigger the formation of specific oligomers or polymers and complex formation with still other partners. Thus, intranuclear actins need not necessarily adopt the same structures found so abundantly in the cytoplasm, like G- or F-actin. This topic is discussed in detail in (Pederson and Aebi<xref ref-type=""bibr"" rid=""CR53"">2002</xref>), and this concept is supported by monoclonal anti-actins that specifically decorate nuclear actin (Gonsior et al.<xref ref-type=""bibr"" rid=""CR17"">1999</xref>; Schoenenberger et al.<xref ref-type=""bibr"" rid=""CR67"">2005</xref>). In Fig.<xref ref-type=""fig"" rid=""Fig3"">3</xref>(taken from Jockusch et al.<xref ref-type=""bibr"" rid=""CR30"">2006</xref>), we show actin in two different forms that both can form polymers. The conventional actin filament requires the interaction of three actin monomers in a specific orientation. Such a trimeric seed will then grow into the polarized F-actin filaments (Fig.<xref ref-type=""fig"" rid=""Fig3"">3</xref>, top). However, there is also evidence for another pathway: two actin monomers can bind to each other in another orientation, and this “lower dimer” may then lead to nonpolar, quite different filaments (Fig.<xref ref-type=""fig"" rid=""Fig3"">3</xref>, bottom). It is of course tempting to speculate that such “unconventional” actin polymers may play a role in vivo, for example in the nucleus, but so far, there is no solid evidence for this assumption.</p></list-item></list></p><p>Not surprisingly, the wealth of data on nuclear actin and its relatives stimulated numerous hypotheses on their function. The relevant findings and the conclusions on putative functions are the topic of a number of interesting reviews, and in this article, we can only refer the reader to them and to the list of original references covered there (Bettinger et al.<xref ref-type=""bibr"" rid=""CR3"">2004</xref>; Blessing et al.<xref ref-type=""bibr"" rid=""CR4"">2004</xref>; Franke<xref ref-type=""bibr"" rid=""CR14"">2004</xref>; Jockusch et al.<xref ref-type=""bibr"" rid=""CR30"">2006</xref>; Pederson and Aebi<xref ref-type=""bibr"" rid=""CR53"">2002</xref>; Rando et al.<xref ref-type=""bibr"" rid=""CR63"">2000</xref>). The brave reader who works himself through all this information will arrive at two conclusions: the actin-like proteins have definitely conquered a firm position among the group of respectable, important nuclear proteins, and they seem to be involved in a plethora of different activities. While the tasks for actin in the cytoplasm all are connected with the conventional G- and F-actin structures and the dynamic equilibrium between these two states, nuclear functions of these proteins seem associated with several different forms or configurations which are ill or even not at all defined.</p><p>In the following paragraphs, we will briefly mention the most important tasks proposed for nuclear actins.</p><sec id=""Sec8""><title>Actin filaments and a caryoskeleton</title><p>It is generally accepted that nuclear activities require a precise topographical arrangement of chromatin, to spatially separate hetero- from euchromatin and allow for the complex mechanism of chromatin remodelling during gene activation and transcription. Hence, when electron microscopy provided elegant images of networks of intranuclear filaments, preferably in large objects like the amphibian oocyte nuclei (germinal vesicles), it seemed quite plausible to conclude that a “nuclear matrix” or scaffold is composed of F-actin filaments (Clark and Merriam<xref ref-type=""bibr"" rid=""CR9"">1977</xref>; Clark and Rosenbaum<xref ref-type=""bibr"" rid=""CR10"">1979</xref>; Gard<xref ref-type=""bibr"" rid=""CR16"">1999</xref>) that could provide mechanical stability to the nucleus and serve as a platform to anchor, at least temporarily, chromatin constituents. Indeed, there is evidence from both earlier and more recent investigations that actin associates with filamentous structures: actin antibodies and myosin subfragment 1 decorate such filaments in amphibian oocyte nuclei (Clark and Rosenbaum<xref ref-type=""bibr"" rid=""CR10"">1979</xref>; Gard<xref ref-type=""bibr"" rid=""CR16"">1999</xref>; Scheer et al.<xref ref-type=""bibr"" rid=""CR65"">1984</xref>), and fluorescently labelled actin is found in a polymeric form in<italic>Xenopus</italic>and HeLa cell nuclei (Kiseleva et al.<xref ref-type=""bibr"" rid=""CR33"">2004</xref>; McDonald et al.<xref ref-type=""bibr"" rid=""CR44"">2006</xref>). Yet, in general, these filaments do not stain with fluorescent phalloidin, a small drug binding with high affinity to actin filaments of the conventional “F-actin” type. It is only after subjecting cells to stress or fixation protocols that nuclear filaments bind phalloidin, thus, the suspicion arises that such treatments rearrange actin into conventional filaments (Gall<xref ref-type=""bibr"" rid=""CR15"">2006</xref>; Jockusch et al.<xref ref-type=""bibr"" rid=""CR30"">2006</xref>). This, of course, does not preclude the concept that actin participates in a nuclear matrix, especially in the very large, actin-rich nuclei of amphibian oocytes. There is good evidence that it engages in providing mechanical support to this cellular compartment (Bohnsack et al.<xref ref-type=""bibr"" rid=""CR5"">2006</xref>; Stuven et al.<xref ref-type=""bibr"" rid=""CR70"">2003</xref>).</p><p>The nuclear Arps from yeast, Arp 7 and Arp 9, have been shown to build heterodimers and have the potential to form filaments from tetramers (Szerlong et al.<xref ref-type=""bibr"" rid=""CR72"">2003</xref>). However, it is not clear whether they do in vivo, and whether they might coassemble with nuclear actin in polymers (Blessing et al.<xref ref-type=""bibr"" rid=""CR4"">2004</xref>).</p></sec><sec id=""Sec9""><title>Actin/Arps and their connection with the nuclear envelope</title><p>Several structural proteins that are essential for the assembly and maintenance of an intact, functional nuclear envelope and its underlying lamina, display well defined binding motifs for actin. These include spectrin, protein 4.1, the nesprins, lamin A and emerin, (Krauss et al.<xref ref-type=""bibr"" rid=""CR37"">2003</xref>; Shumaker et al.<xref ref-type=""bibr"" rid=""CR68"">2003</xref>, more references in Blessing et al.<xref ref-type=""bibr"" rid=""CR4"">2004</xref>; Rando et al.<xref ref-type=""bibr"" rid=""CR63"">2000</xref>). Hence, it has been speculated, but not proven, that at least part of the nuclear actin is involved in the structural organization of the nuclear envelope.</p></sec><sec id=""Sec10""><title>Actin/Arps and the nucleo-cytoplasmic traffic</title><p>Actin-containing, intranuclear filaments were seen to connect to nuclear pore complexes in the amphibian oocyte nucleus (Hofmann et al.<xref ref-type=""bibr"" rid=""CR25"">2001</xref>; Kiseleva et al.<xref ref-type=""bibr"" rid=""CR33"">2004</xref>). In the<italic>Xenopus</italic>oocyte, but also in dipteres and mammalian cells, actin is engaged in the transport and nucleocytoplasmic export of mRNA (Hofmann et al.<xref ref-type=""bibr"" rid=""CR25"">2001</xref>) and RNA-protein complexes, in particular in those containing a subset of hnRNPs (Percipalle et al.<xref ref-type=""bibr"" rid=""CR56"">2001</xref>,<xref ref-type=""bibr"" rid=""CR57"">2002</xref>, reviewed in Bettinger et al.<xref ref-type=""bibr"" rid=""CR3"">2004</xref>; Pederson and Aebi<xref ref-type=""bibr"" rid=""CR54"">2005</xref>).</p></sec><sec id=""Sec11""><title>Actin/Arps and chromatin remodelling</title><p>Actin and nuclear Arps were both reported as being critically involved in chromatin remodelling (reviewed in (Bettinger et al.<xref ref-type=""bibr"" rid=""CR3"">2004</xref>; Blessing et al.<xref ref-type=""bibr"" rid=""CR4"">2004</xref>; Olave et al.<xref ref-type=""bibr"" rid=""CR51"">2002</xref>; Percipalle and Visa<xref ref-type=""bibr"" rid=""CR59"">2006</xref>; Rando et al.<xref ref-type=""bibr"" rid=""CR63"">2000</xref>). Chromatin remodelling complexes operate as large, multiunit machines in mammals, insects, yeast and plants to reorganize the genetic material by unravelling nucleosomes and converting the genetic material into a form suitable for transcription. Many of these steps require energy, and thus many of these protein complexes contain ATPases, comprised of several subunits, that can be grouped into subfamilies. Actin was identified in complex with specific subunits of most ATPases, together with four nuclear Arps (4, 5, 6 and 8) in all organisms, with the exception of yeast. Here, the two yeast-specific nuclear Arps (7 and 9) are found in the corresponding ATPases. One of the histone acetyl transferases that also contribute to chromatin remodelling and subsequent transcription (NuA4, Doyon et al.<xref ref-type=""bibr"" rid=""CR11"">2004</xref>) is highly conserved from yeast to man and is also found in a complex with actin and Arp 4 (Harata et al.<xref ref-type=""bibr"" rid=""CR21"">2002</xref>). Structural organization and function of the actin and Arp molecules in these ATPase and acetyl transferase complexes are largely unknown, and speculations for their respective roles range from stabilizing the enzymatic and a chaperoning activity to connecting these gigantic protein complexes to nuclear filamentous scaffolds.</p></sec><sec id=""Sec12""><title>Actin/Arps and transcription</title><p>Actin has been identified as a regular component of all the three nuclear RNA polymerases (Pol I, II and III), apparently interacting with two subunits that are shared among all three enzyme complexes. In vitro transcription by all three enzymes is actin-dependent (reviewed in Grummt<xref ref-type=""bibr"" rid=""CR18"">2006</xref>; Percipalle and Visa<xref ref-type=""bibr"" rid=""CR59"">2006</xref>). In the nucleus, pre-mRNA is complexed with ribonucleoproteins to form hnRNPs, and, presumably, there is co-translational recruitment of beta actin to these particles during their formation, as deduced from findings that several hnRNP components bind directly actin. Actin’s association with the RNA polymerases may precede, be simultaneous with or follow the initiation of actin-dependent chromatin remodelling by ATP-dependent complexes and/or histone acetylation, as described above (Grummt<xref ref-type=""bibr"" rid=""CR18"">2006</xref>; Percipalle and Visa<xref ref-type=""bibr"" rid=""CR59"">2006</xref>). Most of the data available today are derived from studies with Pol II, in insects and vertebrates, supporting and confirming the conclusions drawn more than two decades earlier from work on<italic>Xenopus</italic>oocyte and HeLa cell nuclei (Egly et al.<xref ref-type=""bibr"" rid=""CR12"">1984</xref>; Scheer et al.<xref ref-type=""bibr"" rid=""CR65"">1984</xref>). There is solid evidence that actin’s role in Pol II-dependent transcription is executed by the beta actin isoform (Hofmann et al.<xref ref-type=""bibr"" rid=""CR26"">2004</xref>; McDonald et al.<xref ref-type=""bibr"" rid=""CR44"">2006</xref>), and no other isoform seems involved. While actin’s contribution to the formation of pre-initiation complexes and subsequent transport of pre-mRNPs through the nucleus towards their export through nuclear pores is well accepted today (Bettinger et al.<xref ref-type=""bibr"" rid=""CR3"">2004</xref>; Franke<xref ref-type=""bibr"" rid=""CR14"">2004</xref>), it is completely unknown whether actin might mediate such intranuclear movements in filamentous or even contractile structures (Pederson and Aebi<xref ref-type=""bibr"" rid=""CR54"">2005</xref>).</p></sec><sec id=""Sec13""><title>Actin ligands in the nucleus</title><p>The nuclear constituents harbouring actin, like those of the nuclear matrix, the nuclear envelope, the nuclear pores, chromatin remodelling complexes, RNA polymerases and pre-mRNPs are all highly insoluble, gigantic structures. However, there are also actin ligands that are found in the cytoplasmic as well in the nuclear compartment, possibly in rather dynamic and temporary complexes with actin. Since the discovery of actin as a prominent component in the cytoplasm of practically all eukaryotic cells, a plethora of such actin-binding proteins has been described and characterized. They arrange actin into the various suprastructures required for cytoplasmic functions, such as intracellular motility and locomotion, by either regulating the balance between monomeric and filamentous actin, or generating networks and bundles of filaments (Winder and Ayscough<xref ref-type=""bibr"" rid=""CR75"">2005</xref>). Remarkably, many of these actin ligands are evolutionary well conserved, like actin itself (Korn<xref ref-type=""bibr"" rid=""CR36"">1982</xref>; Schleicher et al.<xref ref-type=""bibr"" rid=""CR66"">1988</xref>). Members of the various subfamilies, with affinity to either monomeric or filamentous actin, are dual compartment proteins that can shuttle between the nucleus and the cytoplasm, their main location frequently being dependent on the differentiation state of cells. Comprehensive lists of these proteins that have previously been described as cytoplasmic actin ligands but were also identified in the nucleus are given in (Rando et al.<xref ref-type=""bibr"" rid=""CR63"">2000</xref>; Bettinger et al.<xref ref-type=""bibr"" rid=""CR3"">2004</xref>; Pederson and Aebi<xref ref-type=""bibr"" rid=""CR54"">2005</xref>). Among them are several which form complexes with actin and interfere with the formation of conventional actin filaments, like profilin, binding to monomeric actin, and cofilin, a ligand for both, monomeric and polymeric actin. Nuclear profilin is apparently involved in the regulation of the level of nuclear actin, as profilin–actin complexes are recognized and exported from mammalian nuclei by a specific exportin (Stuven et al.<xref ref-type=""bibr"" rid=""CR70"">2003</xref>), while actin free of profilin can apparently be exported by a different exportin, due to its nuclear export sequences (Wada et al.<xref ref-type=""bibr"" rid=""CR74"">1998</xref>). Profilin and cofilin both can sligthly change the fold of actin. Profilin induces a form which faciliates the exchange of bound ATP in G-actin (reviewed in Jockusch et al.<xref ref-type=""bibr"" rid=""CR31"">2007</xref>). Cofilin, a phosphoprotein, contains a nuclear location sequence, and in its dephosphorylated state can transport actin “piggy-back” into the nucleus (Pendleton et al.<xref ref-type=""bibr"" rid=""CR55"">2003</xref>). When bound to actin polymers, it distorts their conformation such that these filaments do not bind phalloidin anymore. Thus, these proteins might be critical in creating forms specific for nuclear actin, as detected by specific antibodies (Gonsior et al.<xref ref-type=""bibr"" rid=""CR17"">1999</xref>; Jockusch et al.<xref ref-type=""bibr"" rid=""CR30"">2006</xref>; Schoenenberger et al.<xref ref-type=""bibr"" rid=""CR67"">2005</xref>). Among the actin ligands solely found in the nuclear compartment are a nuclear actin binding protein identified in<italic>Acanthamoeba</italic>(Rimm and Pollard<xref ref-type=""bibr"" rid=""CR64"">1989</xref>), an actin binding protein composed of two different subunits in mammalian cells (Ankenbauer et al.<xref ref-type=""bibr"" rid=""CR2"">1989</xref>), and a nucleus-specific form of myosin I (Pestic-Dragovich et al.<xref ref-type=""bibr"" rid=""CR60"">2000</xref>). The latter is a small, monomeric myosin that does not form filaments as would be needed for contraction of putative actin filaments in the nucleus. It is apparently involved in transcription of ribosomal genes by Pol I, where it binds to a transcription initiation factor but also to components of a chromatin remodelling complex. It has been speculated that in this location it may recruit actin associated with Pol I to the site of rRNA transcription, but so far, there is no evidence that these two proteins interact directly in vivo (reviewed in (Grummt<xref ref-type=""bibr"" rid=""CR18"">2006</xref>; Percipalle and Farrants<xref ref-type=""bibr"" rid=""CR58"">2006</xref>).</p></sec></sec><sec id=""Sec14"" sec-type=""conclusion""><title>Conclusions</title><p>So, have we now lost the student being confronted with actin for the first time in his scientific education, or have we been able to attract his curiosity for this abundant, highly conserved, mysterious protein?</p><p>Actin has come a long way from the times of its discovery in muscle and we have learned to know it as a member of a large family of structurally related proteins, some of which are dual compartment proteins. Concomitant with this, there is an overwhelming expansion of their putative functions, and both, the fine structural conformation as well as the different functions are probably determined by the numerous actin binding proteins. As a cartoon, Fig.<xref ref-type=""fig"" rid=""Fig4"">4</xref>summarizes the most important players in the cytoplasmic and the nuclear compartment. It is obvious that the putative activities in the nucleus outnumber those in the cytoplasm. Taken together, these findings allow for the view that actin and its relatives were originally engaged in nuclear activities, and that their appearance in the cytoplasm is related to a specialization in functions connected solely with intracellular motility and locomotion (F-actin filament formation, actin dynamics). Further functional narrowing would then result in the special case of skeletal muscle, where a specific isoform, alpha actin, is overexpressed and knows nothing else than to allow myosin-driven contraction.<fig id=""Fig4""><label>Fig. 4</label><caption><p>The manifold functions of nuclear actin. The G-/F-actin equilibrium is only a highly specialized function of actin in the cytoplasm (<italic>top</italic>); in the nucleus (<italic>bottom</italic>) the actin system plays a quite different regulatory and structural role. Actin can execute its tasks as monomer or as nucleus-specific polymer. It interacts with heterogenous ribonucleoproteins (hnRNPs) and is thought to function as a track for RNA transport through NPCs. It remains to be shown how nuclear actin cooperates with nuclear myosin-1 to enhance movement of RNA polymerases or to re-organize chromatin (Nunez et al.<xref ref-type=""bibr"" rid=""CR48"">2008</xref>). Positioning of the nucleus in the cell is achieved by nuclear membrane (NM) proteins that, like the large nesprins, hook the nucleus to the actin cytoskeleton. Anchorage of nesprins is guaranteed by SUN proteins in the inner nuclear membrane (Worman and Gundersen<xref ref-type=""bibr"" rid=""CR76"">2006</xref>). The stabilization of the nucleoskeleton involves the interaction of inner nuclear membrane proteins like emerin or nesprins with lamins as well as polymeric actin (Libotte et al.<xref ref-type=""bibr"" rid=""CR41"">2005</xref>). It should, however, be borne in mind that the level of nuclear actin is apparently tightly regulated in mammalian cells by exportin 6 which selectively transports profilin–actin complexes from the nucleus into the cytoplasm (Bohnsack et al.<xref ref-type=""bibr"" rid=""CR5"">2006</xref>). The nuclear functions of many dual compartment actin binding proteins are not well understood, but one has to assume that their interaction can discriminate between nuclear and cytoplasmic actin (Pederson and Aebi<xref ref-type=""bibr"" rid=""CR54"">2005</xref>). For example, the recently described cyclase associated protein CAP2 is nuclear in myoblasts but sarcomeric in myotubes (Peche et al.<xref ref-type=""bibr"" rid=""CR52"">2007</xref>). Actin-related proteins are only summarized in<italic>one symbol</italic>and are either nucleus specific subunits in chromatin remodelling complexes (Arp4, Arp8 etc.), cytoplasmic or belong also to the group of dual compartment proteins</p></caption><graphic id=""MO4"" position=""anchor"" xlink:href=""418_2008_430_Fig4_HTML""></graphic></fig></p><p>If one was to speculate further, one might imagine that prokaryotic precursors of present days’ actin, related to the proteins that spatially and temporally control macromolecular trafficking, chromosome segregation and cell polarity in recent bacteria (Carballido-Lopez<xref ref-type=""bibr"" rid=""CR8"">2006</xref>), appeared first as “nuclear actin” in an ancestor eukaryotic cell as part of the endosymbiontic engulfment. But, it will require several decades and lots of industrious students to decide whether this is science fiction or facts about actin.</p></sec><back><ack><p>The authors would like to thank the Deutsche Forschungsgemeinschaft (German Research Council) for continuous and generous financial support of their research on actin-based cellular functions, and gratefully acknowledge help from Petros Batsios and Meino Rohlfs (Munich) with Fig.<xref ref-type=""fig"" rid=""Fig1"">1</xref>.</p></ack><ref-list id=""Bib1""><title>References</title><ref id=""CR1""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Aebi</surname><given-names>U</given-names></name><name><surname>Fowler</surname><given-names>WE</given-names></name><name><surname>Isenberg</surname><given-names>G</given-names></name><name><surname>Pollard</surname><given-names>TD</given-names></name><name><surname>Smith</surname><given-names>PR</given-names></name></person-group><article-title>Crystalline actin sheets: their structure and polymorphism</article-title><source>J Cell Biol</source><year>1981</year><volume>91</volume><fpage>340</fpage><lpage>351</lpage><pub-id pub-id-type=""doi"">10.1083/jcb.91.2.340</pub-id></citation><citation citation-type=""display-unstructured"">Aebi U, Fowler WE, Isenberg G, Pollard TD, Smith PR (1981) Crystalline actin sheets: their structure and polymorphism. J Cell Biol 91:340–351<pub-id pub-id-type=""pmid"">7309785</pub-id></citation></ref><ref id=""CR2""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Ankenbauer</surname><given-names>T</given-names></name><name><surname>Kleinschmidt</surname><given-names>JA</given-names></name><name><surname>Walsh</surname><given-names>MJ</given-names></name><name><surname>Weiner</surname><given-names>OH</given-names></name><name><surname>Franke</surname><given-names>WW</given-names></name></person-group><article-title>Identification of a widespread nuclear actin binding protein</article-title><source>Nature</source><year>1989</year><volume>342</volume><fpage>822</fpage><lpage>825</lpage><pub-id pub-id-type=""doi"">10.1038/342822a0</pub-id></citation><citation citation-type=""display-unstructured"">Ankenbauer T, Kleinschmidt JA, Walsh MJ, Weiner OH, Franke WW (1989) Identification of a widespread nuclear actin binding protein. Nature 342:822–825<pub-id pub-id-type=""pmid"">2689884</pub-id></citation></ref><ref id=""CR3""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Bettinger</surname><given-names>BT</given-names></name><name><surname>Gilbert</surname><given-names>DM</given-names></name><name><surname>Amberg</surname><given-names>DC</given-names></name></person-group><article-title>Actin up in the nucleus</article-title><source>Nat Rev Mol Cell Biol</source><year>2004</year><volume>5</volume><fpage>410</fpage><lpage>415</lpage><pub-id pub-id-type=""doi"">10.1038/nrm1370</pub-id></citation><citation citation-type=""display-unstructured"">Bettinger BT, Gilbert DM, Amberg DC (2004) Actin up in the nucleus. Nat Rev Mol Cell Biol 5:410–415<pub-id pub-id-type=""pmid"">15122354</pub-id></citation></ref><ref id=""CR4""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Blessing</surname><given-names>CA</given-names></name><name><surname>Ugrinova</surname><given-names>GT</given-names></name><name><surname>Goodson</surname><given-names>HV</given-names></name></person-group><article-title>Actin and ARPs: action in the nucleus</article-title><source>Trends Cell Biol</source><year>2004</year><volume>14</volume><fpage>435</fpage><lpage>442</lpage><pub-id pub-id-type=""doi"">10.1016/j.tcb.2004.07.009</pub-id></citation><citation citation-type=""display-unstructured"">Blessing CA, Ugrinova GT, Goodson HV (2004) Actin and ARPs: action in the nucleus. Trends Cell Biol 14:435–442<pub-id pub-id-type=""pmid"">15308210</pub-id></citation></ref><ref id=""CR5""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Bohnsack</surname><given-names>MT</given-names></name><name><surname>Stuven</surname><given-names>T</given-names></name><name><surname>Kuhn</surname><given-names>C</given-names></name><name><surname>Cordes</surname><given-names>VC</given-names></name><name><surname>Gorlich</surname><given-names>D</given-names></name></person-group><article-title>A selective block of nuclear actin export stabilizes the giant nuclei of Xenopus oocytes</article-title><source>Nat Cell Biol</source><year>2006</year><volume>8</volume><fpage>257</fpage><lpage>263</lpage><pub-id pub-id-type=""doi"">10.1038/ncb1357</pub-id></citation><citation citation-type=""display-unstructured"">Bohnsack MT, Stuven T, Kuhn C, Cordes VC, Gorlich D (2006) A selective block of nuclear actin export stabilizes the giant nuclei of Xenopus oocytes. Nat Cell Biol 8:257–263<pub-id pub-id-type=""pmid"">16489345</pub-id></citation></ref><ref id=""CR6""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Bretschneider</surname><given-names>T</given-names></name><name><surname>Diez</surname><given-names>S</given-names></name><name><surname>Anderson</surname><given-names>K</given-names></name><name><surname>Heuser</surname><given-names>J</given-names></name><name><surname>Clarke</surname><given-names>M</given-names></name><name><surname>Muller-Taubenberger</surname><given-names>A</given-names></name><name><surname>Kohler</surname><given-names>J</given-names></name><name><surname>Gerisch</surname><given-names>G</given-names></name></person-group><article-title>Dynamic actin patterns and Arp2/3 assembly at the substrate-attached surface of motile cells</article-title><source>Curr Biol</source><year>2004</year><volume>14</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type=""doi"">10.1016/j.cub.2003.12.005</pub-id></citation><citation citation-type=""display-unstructured"">Bretschneider T, Diez S, Anderson K, Heuser J, Clarke M, Muller-Taubenberger A, Kohler J, Gerisch G (2004) Dynamic actin patterns and Arp2/3 assembly at the substrate-attached surface of motile cells. Curr Biol 14:1–10<pub-id pub-id-type=""pmid"">14711408</pub-id></citation></ref><ref id=""CR7""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Buckley</surname><given-names>IK</given-names></name><name><surname>Porter</surname><given-names>KR</given-names></name></person-group><article-title>Cytoplasmic fibrils in living cultured cells. A light and electron microscope study</article-title><source>Protoplasma</source><year>1967</year><volume>64</volume><fpage>349</fpage><lpage>380</lpage><pub-id pub-id-type=""doi"">10.1007/BF01666538</pub-id></citation><citation citation-type=""display-unstructured"">Buckley IK, Porter KR (1967) Cytoplasmic fibrils in living cultured cells. A light and electron microscope study. Protoplasma 64:349–380<pub-id pub-id-type=""pmid"">4866690</pub-id></citation></ref><ref id=""CR8""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Carballido-Lopez</surname><given-names>R</given-names></name></person-group><article-title>The bacterial actin-like cytoskeleton</article-title><source>Microbiol Mol Biol Rev</source><year>2006</year><volume>70</volume><fpage>888</fpage><lpage>909</lpage><pub-id pub-id-type=""doi"">10.1128/MMBR.00014-06</pub-id></citation><citation citation-type=""display-unstructured"">Carballido-Lopez R (2006) The bacterial actin-like cytoskeleton. Microbiol Mol Biol Rev 70:888–909<pub-id pub-id-type=""pmid"">17158703</pub-id></citation></ref><ref id=""CR9""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Clark</surname><given-names>TG</given-names></name><name><surname>Merriam</surname><given-names>RW</given-names></name></person-group><article-title>Diffusible and bound actin nuclei of<italic>Xenopus laevis</italic>oocytes</article-title><source>Cell</source><year>1977</year><volume>12</volume><fpage>883</fpage><lpage>891</lpage><pub-id pub-id-type=""doi"">10.1016/0092-8674(77)90152-0</pub-id></citation><citation citation-type=""display-unstructured"">Clark TG, Merriam RW (1977) Diffusible and bound actin nuclei of Xenopus laevis oocytes. Cell 12:883–891<pub-id pub-id-type=""pmid"">563771</pub-id></citation></ref><ref id=""CR10""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Clark</surname><given-names>TG</given-names></name><name><surname>Rosenbaum</surname><given-names>JL</given-names></name></person-group><article-title>An actin filament matrix in hand-isolated nuclei of<italic>X. laevis</italic>oocytes</article-title><source>Cell</source><year>1979</year><volume>18</volume><fpage>1101</fpage><lpage>1108</lpage><pub-id pub-id-type=""doi"">10.1016/0092-8674(79)90223-X</pub-id></citation><citation citation-type=""display-unstructured"">Clark TG, Rosenbaum JL (1979) An actin filament matrix in hand-isolated nuclei of X. laevis oocytes. Cell 18:1101–1108<pub-id pub-id-type=""pmid"">574804</pub-id></citation></ref><ref id=""CR11""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Doyon</surname><given-names>Y</given-names></name><name><surname>Selleck</surname><given-names>W</given-names></name><name><surname>Lane</surname><given-names>WS</given-names></name><name><surname>Tan</surname><given-names>S</given-names></name><name><surname>Cote</surname><given-names>J</given-names></name></person-group><article-title>Structural and functional conservation of the NuA4 histone acetyltransferase complex from yeast to humans</article-title><source>Mol Cell Biol</source><year>2004</year><volume>24</volume><fpage>1884</fpage><lpage>1896</lpage><pub-id pub-id-type=""doi"">10.1128/MCB.24.5.1884-1896.2004</pub-id></citation><citation citation-type=""display-unstructured"">Doyon Y, Selleck W, Lane WS, Tan S, Cote J (2004) Structural and functional conservation of the NuA4 histone acetyltransferase complex from yeast to humans. Mol Cell Biol 24:1884–1896<pub-id pub-id-type=""pmid"">14966270</pub-id></citation></ref><ref id=""CR12""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Egly</surname><given-names>JM</given-names></name><name><surname>Miyamoto</surname><given-names>NG</given-names></name><name><surname>Moncollin</surname><given-names>V</given-names></name><name><surname>Chambon</surname><given-names>P</given-names></name></person-group><article-title>Is actin a transcription initiation factor for RNA polymerase B?</article-title><source>EMBO J</source><year>1984</year><volume>3</volume><fpage>2363</fpage><lpage>2371</lpage></citation><citation citation-type=""display-unstructured"">Egly JM, Miyamoto NG, Moncollin V, Chambon P (1984) Is actin a transcription initiation factor for RNA polymerase B? EMBO J 3:2363–2371<pub-id pub-id-type=""pmid"">6499833</pub-id></citation></ref><ref id=""CR13""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Eichinger</surname><given-names>L</given-names></name><name><surname>Pachebat</surname><given-names>JA</given-names></name><name><surname>Glockner</surname><given-names>G</given-names></name><name><surname>Rajandream</surname><given-names>MA</given-names></name><name><surname>Sucgang</surname><given-names>R</given-names></name><name><surname>Berriman</surname><given-names>M</given-names></name><name><surname>Song</surname><given-names>J</given-names></name><name><surname>Olsen</surname><given-names>R</given-names></name><name><surname>Szafranski</surname><given-names>K</given-names></name><name><surname>Xu</surname><given-names>Q</given-names></name><etal></etal></person-group><article-title>The genome of the social amoeba<italic>Dictyostelium discoideum</italic></article-title><source>Nature</source><year>2005</year><volume>435</volume><fpage>43</fpage><lpage>57</lpage><pub-id pub-id-type=""doi"">10.1038/nature03481</pub-id></citation><citation citation-type=""display-unstructured"">Eichinger L, Pachebat JA, Glockner G, Rajandream MA, Sucgang R, Berriman M, Song J, Olsen R, Szafranski K, Xu Q et al (2005) The genome of the social amoeba Dictyostelium discoideum. Nature 435:43–57<pub-id pub-id-type=""pmid"">15875012</pub-id></citation></ref><ref id=""CR14""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Franke</surname><given-names>WW</given-names></name></person-group><article-title>Actin’s many actions start at the genes</article-title><source>Nat Cell Biol</source><year>2004</year><volume>6</volume><fpage>1013</fpage><lpage>1014</lpage><pub-id pub-id-type=""doi"">10.1038/ncb1104-1013</pub-id></citation><citation citation-type=""display-unstructured"">Franke WW (2004) Actin’s many actions start at the genes. Nat Cell Biol 6:1013–1014<pub-id pub-id-type=""pmid"">15516991</pub-id></citation></ref><ref id=""CR15""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Gall</surname><given-names>JG</given-names></name></person-group><article-title>Exporting actin</article-title><source>Nat Cell Biol</source><year>2006</year><volume>8</volume><fpage>205</fpage><lpage>207</lpage><pub-id pub-id-type=""doi"">10.1038/ncb0306-205</pub-id></citation><citation citation-type=""display-unstructured"">Gall JG (2006) Exporting actin. Nat Cell Biol 8:205–207<pub-id pub-id-type=""pmid"">16508670</pub-id></citation></ref><ref id=""CR16""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Gard</surname><given-names>DL</given-names></name></person-group><article-title>Confocal microscopy and 3-D reconstruction of the cytoskeleton of Xenopus oocytes</article-title><source>Microsc Res Tech</source><year>1999</year><volume>44</volume><fpage>388</fpage><lpage>414</lpage><pub-id pub-id-type=""doi"">10.1002/(SICI)1097-0029(19990315)44:6&lt;388::AID-JEMT2&gt;3.0.CO;2-L</pub-id></citation><citation citation-type=""display-unstructured"">Gard DL (1999) Confocal microscopy and 3-D reconstruction of the cytoskeleton of Xenopus oocytes. Microsc Res Tech 44:388–414<pub-id pub-id-type=""pmid"">10211674</pub-id></citation></ref><ref id=""CR17""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Gonsior</surname><given-names>SM</given-names></name><name><surname>Platz</surname><given-names>S</given-names></name><name><surname>Buchmeier</surname><given-names>S</given-names></name><name><surname>Scheer</surname><given-names>U</given-names></name><name><surname>Jockusch</surname><given-names>BM</given-names></name><name><surname>Hinssen</surname><given-names>H</given-names></name></person-group><article-title>Conformational difference between nuclear and cytoplasmic actin as detected by a monoclonal antibody</article-title><source>J Cell Sci</source><year>1999</year><volume>112</volume><issue>Pt 6</issue><fpage>797</fpage><lpage>809</lpage></citation><citation citation-type=""display-unstructured"">Gonsior SM, Platz S, Buchmeier S, Scheer U, Jockusch BM, Hinssen H (1999) Conformational difference between nuclear and cytoplasmic actin as detected by a monoclonal antibody. J Cell Sci 112(Pt 6):797–809<pub-id pub-id-type=""pmid"">10036230</pub-id></citation></ref><ref id=""CR18""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Grummt</surname><given-names>I</given-names></name></person-group><article-title>Actin and myosin as transcription factors</article-title><source>Curr Opin Genet Dev</source><year>2006</year><volume>16</volume><fpage>191</fpage><lpage>196</lpage><pub-id pub-id-type=""doi"">10.1016/j.gde.2006.02.001</pub-id></citation><citation citation-type=""display-unstructured"">Grummt I (2006) Actin and myosin as transcription factors. Curr Opin Genet Dev 16:191–196<pub-id pub-id-type=""pmid"">16495046</pub-id></citation></ref><ref id=""CR19""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Habazettl</surname><given-names>J</given-names></name><name><surname>Gondol</surname><given-names>D</given-names></name><name><surname>Wiltscheck</surname><given-names>R</given-names></name><name><surname>Otlewski</surname><given-names>J</given-names></name><name><surname>Schleicher</surname><given-names>M</given-names></name><name><surname>Holak</surname><given-names>TA</given-names></name></person-group><article-title>Structure of hisactophilin is similar to interleukin-1 beta and fibroblast growth factor</article-title><source>Nature</source><year>1992</year><volume>359</volume><fpage>855</fpage><lpage>858</lpage><pub-id pub-id-type=""doi"">10.1038/359855a0</pub-id></citation><citation citation-type=""display-unstructured"">Habazettl J, Gondol D, Wiltscheck R, Otlewski J, Schleicher M, Holak TA (1992) Structure of hisactophilin is similar to interleukin-1 beta and fibroblast growth factor. Nature 359:855–858<pub-id pub-id-type=""pmid"">1436061</pub-id></citation></ref><ref id=""CR20""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Halliburton</surname><given-names>WD</given-names></name></person-group><article-title>On muscle-plasma</article-title><source>J Physiol</source><year>1887</year><volume>8</volume><fpage>133</fpage><lpage>202</lpage></citation><citation citation-type=""display-unstructured"">Halliburton WD (1887) On muscle-plasma. J Physiol 8:133–202<pub-id pub-id-type=""pmid"">16991477</pub-id></citation></ref><ref id=""CR21""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Harata</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Stillman</surname><given-names>DJ</given-names></name><name><surname>Matsui</surname><given-names>D</given-names></name><name><surname>Oma</surname><given-names>Y</given-names></name><name><surname>Nishimori</surname><given-names>K</given-names></name><name><surname>Mochizuki</surname><given-names>R</given-names></name></person-group><article-title>Correlation between chromatin association and transcriptional regulation for the Act3p/Arp4 nuclear actin-related protein of<italic>Saccharomyces cerevisiae</italic></article-title><source>Nucleic Acids Res</source><year>2002</year><volume>30</volume><fpage>1743</fpage><lpage>1750</lpage><pub-id pub-id-type=""doi"">10.1093/nar/30.8.1743</pub-id></citation><citation citation-type=""display-unstructured"">Harata M, Zhang Y, Stillman DJ, Matsui D, Oma Y, Nishimori K, Mochizuki R (2002) Correlation between chromatin association and transcriptional regulation for the Act3p/Arp4 nuclear actin-related protein of Saccharomyces cerevisiae. Nucleic Acids Res 30:1743–1750<pub-id pub-id-type=""pmid"">11937627</pub-id></citation></ref><ref id=""CR22""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Hatano</surname><given-names>S</given-names></name><name><surname>Oosawa</surname><given-names>F</given-names></name></person-group><article-title>Isolation and characterization of plasmodium actin</article-title><source>Biochim Biophys Acta</source><year>1966</year><volume>127</volume><fpage>488</fpage><lpage>498</lpage></citation><citation citation-type=""display-unstructured"">Hatano S, Oosawa F (1966a) Isolation and characterization of plasmodium actin. Biochim Biophys Acta 127:488–498<pub-id pub-id-type=""pmid"">6007360</pub-id></citation></ref><ref id=""CR23""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Hatano</surname><given-names>S</given-names></name><name><surname>Oosawa</surname><given-names>F</given-names></name></person-group><article-title>Extraction of an actin-like protein from the plasmodium of a myxomycete and its interaction with myosin A from rabbit striated muscle</article-title><source>J Cell Physiol</source><year>1966</year><volume>68</volume><fpage>197</fpage><lpage>202</lpage><pub-id pub-id-type=""doi"">10.1002/jcp.1040680214</pub-id></citation><citation citation-type=""display-unstructured"">Hatano S, Oosawa F (1966b) Extraction of an actin-like protein from the plasmodium of a myxomycete and its interaction with myosin A from rabbit striated muscle. J Cell Physiol 68:197–202<pub-id pub-id-type=""pmid"">6007202</pub-id></citation></ref><ref id=""CR24""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Hatano</surname><given-names>S</given-names></name><name><surname>Tazawa</surname><given-names>M</given-names></name></person-group><article-title>Isolation, purification and characterization of myosin B from myxomycete plasmodium</article-title><source>Biochim Biophys Acta</source><year>1968</year><volume>154</volume><fpage>507</fpage><lpage>519</lpage></citation><citation citation-type=""display-unstructured"">Hatano S, Tazawa M (1968) Isolation, purification and characterization of myosin B from myxomycete plasmodium. Biochim Biophys Acta 154:507–519<pub-id pub-id-type=""pmid"">4231303</pub-id></citation></ref><ref id=""CR25""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Hofmann</surname><given-names>W</given-names></name><name><surname>Reichart</surname><given-names>B</given-names></name><name><surname>Ewald</surname><given-names>A</given-names></name><name><surname>Muller</surname><given-names>E</given-names></name><name><surname>Schmitt</surname><given-names>I</given-names></name><name><surname>Stauber</surname><given-names>RH</given-names></name><name><surname>Lottspeich</surname><given-names>F</given-names></name><name><surname>Jockusch</surname><given-names>BM</given-names></name><name><surname>Scheer</surname><given-names>U</given-names></name><name><surname>Hauber</surname><given-names>J</given-names></name><name><surname>Dabauvalle</surname><given-names>MC</given-names></name></person-group><article-title>Cofactor requirements for nuclear export of Rev response element (RRE)- and constitutive transport element (CTE)-containing retroviral RNAs. An unexpected role for actin</article-title><source>J Cell Biol</source><year>2001</year><volume>152</volume><fpage>895</fpage><lpage>910</lpage><pub-id pub-id-type=""doi"">10.1083/jcb.152.5.895</pub-id></citation><citation citation-type=""display-unstructured"">Hofmann W, Reichart B, Ewald A, Muller E, Schmitt I, Stauber RH, Lottspeich F, Jockusch BM, Scheer U, Hauber J, Dabauvalle MC (2001) Cofactor requirements for nuclear export of Rev response element (RRE)- and constitutive transport element (CTE)-containing retroviral RNAs. An unexpected role for actin. J Cell Biol 152:895–910<pub-id pub-id-type=""pmid"">11238447</pub-id></citation></ref><ref id=""CR26""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Hofmann</surname><given-names>WA</given-names></name><name><surname>Stojiljkovic</surname><given-names>L</given-names></name><name><surname>Fuchsova</surname><given-names>B</given-names></name><name><surname>Vargas</surname><given-names>GM</given-names></name><name><surname>Mavrommatis</surname><given-names>E</given-names></name><name><surname>Philimonenko</surname><given-names>V</given-names></name><name><surname>Kysela</surname><given-names>K</given-names></name><name><surname>Goodrich</surname><given-names>JA</given-names></name><name><surname>Lessard</surname><given-names>JL</given-names></name><name><surname>Hope</surname><given-names>TJ</given-names></name><etal></etal></person-group><article-title>Actin is part of pre-initiation complexes and is necessary for transcription by RNA polymerase II</article-title><source>Nat Cell Biol</source><year>2004</year><volume>6</volume><fpage>1094</fpage><lpage>1101</lpage><pub-id pub-id-type=""doi"">10.1038/ncb1182</pub-id></citation><citation citation-type=""display-unstructured"">Hofmann WA, Stojiljkovic L, Fuchsova B, Vargas GM, Mavrommatis E, Philimonenko V, Kysela K, Goodrich JA, Lessard JL, Hope TJ et al (2004) Actin is part of pre-initiation complexes and is necessary for transcription by RNA polymerase II. Nat Cell Biol 6:1094–1101<pub-id pub-id-type=""pmid"">15502823</pub-id></citation></ref><ref id=""CR27""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Huxley</surname><given-names>HE</given-names></name></person-group><article-title>Muscular contraction and cell motility</article-title><source>Nature</source><year>1973</year><volume>243</volume><fpage>445</fpage><lpage>449</lpage><pub-id pub-id-type=""doi"">10.1038/243445a0</pub-id></citation><citation citation-type=""display-unstructured"">Huxley HE (1973) Muscular contraction and cell motility. Nature 243:445–449<pub-id pub-id-type=""pmid"">4275580</pub-id></citation></ref><ref id=""CR28""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Jockusch</surname><given-names>BM</given-names></name><name><surname>Brown</surname><given-names>DF</given-names></name><name><surname>Rusch</surname><given-names>HP</given-names></name></person-group><article-title>Synthesis and some properties of an actin-like nuclear protein in the slime mold<italic>Physarum polycephalum</italic></article-title><source>J Bacteriol</source><year>1971</year><volume>108</volume><fpage>705</fpage><lpage>714</lpage></citation><citation citation-type=""display-unstructured"">Jockusch BM, Brown DF, Rusch HP (1971) Synthesis and some properties of an actin-like nuclear protein in the slime mold Physarum polycephalum. J Bacteriol 108:705–714<pub-id pub-id-type=""pmid"">5166857</pub-id></citation></ref><ref id=""CR29""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Jockusch</surname><given-names>BM</given-names></name><name><surname>Becker</surname><given-names>M</given-names></name><name><surname>Hindennach</surname><given-names>I</given-names></name><name><surname>Jockusch</surname><given-names>E</given-names></name></person-group><article-title>Slime mould actin: homology to vertebrate actin and presence in the nucleus</article-title><source>Exp Cell Res</source><year>1974</year><volume>89</volume><fpage>241</fpage><lpage>246</lpage><pub-id pub-id-type=""doi"">10.1016/0014-4827(74)90787-3</pub-id></citation><citation citation-type=""display-unstructured"">Jockusch BM, Becker M, Hindennach I, Jockusch E (1974) Slime mould actin: homology to vertebrate actin and presence in the nucleus. Exp Cell Res 89:241–246<pub-id pub-id-type=""pmid"">4477071</pub-id></citation></ref><ref id=""CR30""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Jockusch</surname><given-names>BM</given-names></name><name><surname>Schoenenberger</surname><given-names>CA</given-names></name><name><surname>Stetefeld</surname><given-names>J</given-names></name><name><surname>Aebi</surname><given-names>U</given-names></name></person-group><article-title>Tracking down the different forms of nuclear actin</article-title><source>Trends Cell Biol</source><year>2006</year><volume>16</volume><fpage>391</fpage><lpage>396</lpage><pub-id pub-id-type=""doi"">10.1016/j.tcb.2006.06.006</pub-id></citation><citation citation-type=""display-unstructured"">Jockusch BM, Schoenenberger CA, Stetefeld J, Aebi U (2006) Tracking down the different forms of nuclear actin. Trends Cell Biol 16:391–396<pub-id pub-id-type=""pmid"">16828286</pub-id></citation></ref><ref id=""CR31""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Jockusch</surname><given-names>BM</given-names></name><name><surname>Murk</surname><given-names>K</given-names></name><name><surname>Rothkegel</surname><given-names>M</given-names></name></person-group><article-title>The profile of profilins</article-title><source>Rev Physiol Biochem Pharmacol</source><year>2007</year><volume>159</volume><fpage>131</fpage><lpage>149</lpage><pub-id pub-id-type=""doi"">10.1007/112_2007_704</pub-id></citation><citation citation-type=""display-unstructured"">Jockusch BM, Murk K, Rothkegel M (2007) The profile of profilins. Rev Physiol Biochem Pharmacol 159:131–149<pub-id pub-id-type=""pmid"">17682948</pub-id></citation></ref><ref id=""CR32""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Kiselar</surname><given-names>JG</given-names></name><name><surname>Mahaffy</surname><given-names>R</given-names></name><name><surname>Pollard</surname><given-names>TD</given-names></name><name><surname>Almo</surname><given-names>SC</given-names></name><name><surname>Chance</surname><given-names>MR</given-names></name></person-group><article-title>Visualizing Arp2/3 complex activation mediated by binding of ATP and WASp using structural mass spectrometry</article-title><source>Proc Natl Acad Sci USA</source><year>2007</year><volume>104</volume><fpage>1552</fpage><lpage>1557</lpage><pub-id pub-id-type=""doi"">10.1073/pnas.0605380104</pub-id></citation><citation citation-type=""display-unstructured"">Kiselar JG, Mahaffy R, Pollard TD, Almo SC, Chance MR (2007) Visualizing Arp2/3 complex activation mediated by binding of ATP and WASp using structural mass spectrometry. Proc Natl Acad Sci USA 104:1552–1557<pub-id pub-id-type=""pmid"">17251352</pub-id></citation></ref><ref id=""CR33""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Kiseleva</surname><given-names>E</given-names></name><name><surname>Drummond</surname><given-names>SP</given-names></name><name><surname>Goldberg</surname><given-names>MW</given-names></name><name><surname>Rutherford</surname><given-names>SA</given-names></name><name><surname>Allen</surname><given-names>TD</given-names></name><name><surname>Wilson</surname><given-names>KL</given-names></name></person-group><article-title>Actin- and protein-4.1-containing filaments link nuclear pore complexes to subnuclear organelles in Xenopus oocyte nuclei</article-title><source>J Cell Sci</source><year>2004</year><volume>117</volume><fpage>2481</fpage><lpage>2490</lpage><pub-id pub-id-type=""doi"">10.1242/jcs.01098</pub-id></citation><citation citation-type=""display-unstructured"">Kiseleva E, Drummond SP, Goldberg MW, Rutherford SA, Allen TD, Wilson KL (2004) Actin- and protein-4.1-containing filaments link nuclear pore complexes to subnuclear organelles in Xenopus oocyte nuclei. J Cell Sci 117:2481–2490<pub-id pub-id-type=""pmid"">15128868</pub-id></citation></ref><ref id=""CR34""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Koestler</surname><given-names>SA</given-names></name><name><surname>Auinger</surname><given-names>S</given-names></name><name><surname>Vinzenz</surname><given-names>M</given-names></name><name><surname>Rottner</surname><given-names>K</given-names></name><name><surname>Small</surname><given-names>JV</given-names></name></person-group><article-title>Differentially oriented populations of actin filaments generated in lamellipodia collaborate in pushing and pausing at the cell front</article-title><source>Nat Cell Biol</source><year>2008</year><volume>10</volume><fpage>306</fpage><lpage>313</lpage><pub-id pub-id-type=""doi"">10.1038/ncb1692</pub-id></citation><citation citation-type=""display-unstructured"">Koestler SA, Auinger S, Vinzenz M, Rottner K, Small JV (2008) Differentially oriented populations of actin filaments generated in lamellipodia collaborate in pushing and pausing at the cell front. Nat Cell Biol 10:306–313<pub-id pub-id-type=""pmid"">18278037</pub-id></citation></ref><ref id=""CR35""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Koppensteiner</surname><given-names>WA</given-names></name><name><surname>Lackner</surname><given-names>P</given-names></name><name><surname>Wiederstein</surname><given-names>M</given-names></name><name><surname>Sippl</surname><given-names>MJ</given-names></name></person-group><article-title>Characterization of novel proteins based on known protein structures</article-title><source>J Mol Biol</source><year>2000</year><volume>296</volume><fpage>1139</fpage><lpage>1152</lpage><pub-id pub-id-type=""doi"">10.1006/jmbi.1999.3501</pub-id></citation><citation citation-type=""display-unstructured"">Koppensteiner WA, Lackner P, Wiederstein M, Sippl MJ (2000) Characterization of novel proteins based on known protein structures. J Mol Biol 296:1139–1152<pub-id pub-id-type=""pmid"">10686110</pub-id></citation></ref><ref id=""CR36""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Korn</surname><given-names>ED</given-names></name></person-group><article-title>Actin polymerization and its regulation by proteins from nonmuscle cells</article-title><source>Physiol Rev</source><year>1982</year><volume>62</volume><fpage>672</fpage><lpage>737</lpage></citation><citation citation-type=""display-unstructured"">Korn ED (1982) Actin polymerization and its regulation by proteins from nonmuscle cells. Physiol Rev 62:672–737<pub-id pub-id-type=""pmid"">6280220</pub-id></citation></ref><ref id=""CR37""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Krauss</surname><given-names>SW</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Penman</surname><given-names>S</given-names></name><name><surname>Heald</surname><given-names>R</given-names></name></person-group><article-title>Nuclear actin and protein 4.1: essential interactions during nuclear assembly in vitro</article-title><source>Proc Natl Acad Sci USA</source><year>2003</year><volume>100</volume><fpage>10752</fpage><lpage>10757</lpage><pub-id pub-id-type=""doi"">10.1073/pnas.1934680100</pub-id></citation><citation citation-type=""display-unstructured"">Krauss SW, Chen C, Penman S, Heald R (2003) Nuclear actin and protein 4.1: essential interactions during nuclear assembly in vitro. Proc Natl Acad Sci USA 100:10752–10757<pub-id pub-id-type=""pmid"">12960380</pub-id></citation></ref><ref id=""CR38""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Kuehne</surname><given-names>W</given-names></name></person-group><article-title>Untersuchungen über Bewegungen und Veränderungen der contractilen Substanzen. Archiv für Anatomie</article-title><source>Physiologie und wissenschaftliche Medicin Jahrgang</source><year>1859</year><volume>1859</volume><fpage>748</fpage><lpage>835</lpage></citation><citation citation-type=""display-unstructured"">Kuehne W (1859) Untersuchungen über Bewegungen und Veränderungen der contractilen Substanzen. Archiv für Anatomie. Physiologie und wissenschaftliche Medicin Jahrgang 1859:748–835</citation></ref><ref id=""CR39""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Lane</surname><given-names>NJ</given-names></name></person-group><article-title>Intranuclear fibrillar bodies in actinomycin D-treated oocytes</article-title><source>J Cell Biol</source><year>1969</year><volume>40</volume><fpage>286</fpage><lpage>291</lpage><pub-id pub-id-type=""doi"">10.1083/jcb.40.1.286</pub-id></citation><citation citation-type=""display-unstructured"">Lane NJ (1969) Intranuclear fibrillar bodies in actinomycin D-treated oocytes. J Cell Biol 40:286–291<pub-id pub-id-type=""pmid"">5812427</pub-id></citation></ref><ref id=""CR40""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Lestourgeon</surname><given-names>WM</given-names></name><name><surname>Forer</surname><given-names>A</given-names></name><name><surname>Yang</surname><given-names>YZ</given-names></name><name><surname>Bertram</surname><given-names>JS</given-names></name><name><surname>Pusch</surname><given-names>HP</given-names></name></person-group><article-title>Contractile proteins. Major components of nuclear and chromosome non-histone proteins</article-title><source>Biochim Biophys Acta</source><year>1975</year><volume>379</volume><fpage>529</fpage><lpage>552</lpage></citation><citation citation-type=""display-unstructured"">Lestourgeon WM, Forer A, Yang YZ, Bertram JS, Pusch HP (1975) Contractile proteins. Major components of nuclear and chromosome non-histone proteins. Biochim Biophys Acta 379:529–552<pub-id pub-id-type=""pmid"">1091294</pub-id></citation></ref><ref id=""CR41""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Libotte</surname><given-names>T</given-names></name><name><surname>Zaim</surname><given-names>H</given-names></name><name><surname>Abraham</surname><given-names>S</given-names></name><name><surname>Padmakumar</surname><given-names>VC</given-names></name><name><surname>Schneider</surname><given-names>M</given-names></name><name><surname>Lu</surname><given-names>W</given-names></name><name><surname>Munck</surname><given-names>M</given-names></name><name><surname>Hutchison</surname><given-names>C</given-names></name><name><surname>Wehnert</surname><given-names>M</given-names></name><name><surname>Fahrenkrog</surname><given-names>B</given-names></name><etal></etal></person-group><article-title>Lamin A/C-dependent localization of Nesprin-2, a giant scaffolder at the nuclear envelope</article-title><source>Mol Biol Cell</source><year>2005</year><volume>16</volume><fpage>3411</fpage><lpage>3424</lpage><pub-id pub-id-type=""doi"">10.1091/mbc.E04-11-1009</pub-id></citation><citation citation-type=""display-unstructured"">Libotte T, Zaim H, Abraham S, Padmakumar VC, Schneider M, Lu W, Munck M, Hutchison C, Wehnert M, Fahrenkrog B et al (2005) Lamin A/C-dependent localization of Nesprin-2, a giant scaffolder at the nuclear envelope. Mol Biol Cell 16:3411–3424<pub-id pub-id-type=""pmid"">15843432</pub-id></citation></ref><ref id=""CR42""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Gaspar</surname><given-names>JA</given-names></name><name><surname>Wong</surname><given-names>HJ</given-names></name><name><surname>Meiering</surname><given-names>EM</given-names></name></person-group><article-title>Conserved and nonconserved features of the folding pathway of hisactophilin, a beta-trefoil protein</article-title><source>Protein Sci</source><year>2002</year><volume>11</volume><fpage>669</fpage><lpage>679</lpage><pub-id pub-id-type=""doi"">10.1110/ps.31702</pub-id></citation><citation citation-type=""display-unstructured"">Liu C, Gaspar JA, Wong HJ, Meiering EM (2002) Conserved and nonconserved features of the folding pathway of hisactophilin, a beta-trefoil protein. Protein Sci 11:669–679<pub-id pub-id-type=""pmid"">11847289</pub-id></citation></ref><ref id=""CR43""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>McAlister</surname><given-names>LE</given-names></name><name><surname>Allison</surname><given-names>VF</given-names></name><name><surname>Jeter</surname><given-names>JR</given-names></name><name><surname>Nations</surname><given-names>C</given-names></name></person-group><article-title>High-density induction of a quiescent cell state in<italic>Physarum polycephalum</italic></article-title><source>J Cell Sci</source><year>1977</year><volume>25</volume><fpage>179</fpage><lpage>190</lpage></citation><citation citation-type=""display-unstructured"">McAlister LE, Allison VF, Jeter JR, Nations C (1977) High-density induction of a quiescent cell state in Physarum polycephalum. J Cell Sci 25:179–190<pub-id pub-id-type=""pmid"">561094</pub-id></citation></ref><ref id=""CR44""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>McDonald</surname><given-names>D</given-names></name><name><surname>Carrero</surname><given-names>G</given-names></name><name><surname>Andrin</surname><given-names>C</given-names></name><name><surname>Vries</surname><given-names>G</given-names></name><name><surname>Hendzel</surname><given-names>MJ</given-names></name></person-group><article-title>Nucleoplasmic beta-actin exists in a dynamic equilibrium between low-mobility polymeric species and rapidly diffusing populations</article-title><source>J Cell Biol</source><year>2006</year><volume>172</volume><fpage>541</fpage><lpage>552</lpage><pub-id pub-id-type=""doi"">10.1083/jcb.200507101</pub-id></citation><citation citation-type=""display-unstructured"">McDonald D, Carrero G, Andrin C, de Vries G, Hendzel MJ (2006) Nucleoplasmic beta-actin exists in a dynamic equilibrium between low-mobility polymeric species and rapidly diffusing populations. J Cell Biol 172:541–552<pub-id pub-id-type=""pmid"">16476775</pub-id></citation></ref><ref id=""CR45""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Millonig</surname><given-names>R</given-names></name><name><surname>Salvo</surname><given-names>H</given-names></name><name><surname>Aebi</surname><given-names>U</given-names></name></person-group><article-title>Probing actin polymerization by intermolecular cross-linking</article-title><source>J Cell Biol</source><year>1988</year><volume>106</volume><fpage>785</fpage><lpage>796</lpage><pub-id pub-id-type=""doi"">10.1083/jcb.106.3.785</pub-id></citation><citation citation-type=""display-unstructured"">Millonig R, Salvo H, Aebi U (1988) Probing actin polymerization by intermolecular cross-linking. J Cell Biol 106:785–796<pub-id pub-id-type=""pmid"">3346326</pub-id></citation></ref><ref id=""CR46""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Mommaerts</surname><given-names>WF</given-names></name></person-group><article-title>Who discovered actin?</article-title><source>Bioessays</source><year>1992</year><volume>14</volume><fpage>57</fpage><lpage>59</lpage><pub-id pub-id-type=""doi"">10.1002/bies.950140112</pub-id></citation><citation citation-type=""display-unstructured"">Mommaerts WF (1992) Who discovered actin? Bioessays 14:57–59<pub-id pub-id-type=""pmid"">1546981</pub-id></citation></ref><ref id=""CR47""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Muller</surname><given-names>J</given-names></name><name><surname>Oma</surname><given-names>Y</given-names></name><name><surname>Vallar</surname><given-names>L</given-names></name><name><surname>Friederich</surname><given-names>E</given-names></name><name><surname>Poch</surname><given-names>O</given-names></name><name><surname>Winsor</surname><given-names>B</given-names></name></person-group><article-title>Sequence and comparative genomic analysis of actin-related proteins</article-title><source>Mol Biol Cell</source><year>2005</year><volume>16</volume><fpage>5736</fpage><lpage>5748</lpage><pub-id pub-id-type=""doi"">10.1091/mbc.E05-06-0508</pub-id></citation><citation citation-type=""display-unstructured"">Muller J, Oma Y, Vallar L, Friederich E, Poch O, Winsor B (2005) Sequence and comparative genomic analysis of actin-related proteins. Mol Biol Cell 16:5736–5748<pub-id pub-id-type=""pmid"">16195354</pub-id></citation></ref><ref id=""CR48""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Nunez</surname><given-names>E</given-names></name><name><surname>Kwon</surname><given-names>YS</given-names></name><name><surname>Hutt</surname><given-names>KR</given-names></name><name><surname>Hu</surname><given-names>Q</given-names></name><name><surname>Cardamone</surname><given-names>MD</given-names></name><name><surname>Ohgi</surname><given-names>KA</given-names></name><name><surname>Garcia-Bassets</surname><given-names>I</given-names></name><name><surname>Rose</surname><given-names>DW</given-names></name><name><surname>Glass</surname><given-names>CK</given-names></name><name><surname>Rosenfeld</surname><given-names>MG</given-names></name><name><surname>Fu</surname><given-names>XD</given-names></name></person-group><article-title>Nuclear receptor-enhanced transcription requires motor- and LSD1-dependent gene networking in interchromatin granules</article-title><source>Cell</source><year>2008</year><volume>132</volume><fpage>996</fpage><lpage>1010</lpage><pub-id pub-id-type=""doi"">10.1016/j.cell.2008.01.051</pub-id></citation><citation citation-type=""display-unstructured"">Nunez E, Kwon YS, Hutt KR, Hu Q, Cardamone MD, Ohgi KA, Garcia-Bassets I, Rose DW, Glass CK, Rosenfeld MG, Fu XD (2008) Nuclear receptor-enhanced transcription requires motor- and LSD1-dependent gene networking in interchromatin granules. Cell 132:996–1010<pub-id pub-id-type=""pmid"">18358812</pub-id></citation></ref><ref id=""CR49""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Ohnishi</surname><given-names>T</given-names></name></person-group><article-title>Interaction between adenosine triphosphate and potassium chloride-soluble proteins of sea urchin eggs</article-title><source>J Biochem</source><year>1962</year><volume>52</volume><fpage>145</fpage><lpage>147</lpage></citation><citation citation-type=""display-unstructured"">Ohnishi T (1962) Interaction between adenosine triphosphate and potassium chloride-soluble proteins of sea urchin eggs. J Biochem 52:145–147<pub-id pub-id-type=""pmid"">14481399</pub-id></citation></ref><ref id=""CR50""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Ohnishi</surname><given-names>T</given-names></name><name><surname>Kawamura</surname><given-names>H</given-names></name><name><surname>Yamamoto</surname><given-names>T</given-names></name></person-group><article-title>Extraction of a protein resembling actin from the cell nucleus of the calf thymus</article-title><source>J Biochem</source><year>1963</year><volume>54</volume><fpage>298</fpage><lpage>300</lpage></citation><citation citation-type=""display-unstructured"">Ohnishi T, Kawamura H, Yamamoto T (1963) Extraction of a protein resembling actin from the cell nucleus of the calf thymus. J Biochem 54:298–300<pub-id pub-id-type=""pmid"">14070462</pub-id></citation></ref><ref id=""CR51""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Olave</surname><given-names>IA</given-names></name><name><surname>Reck-Peterson</surname><given-names>SL</given-names></name><name><surname>Crabtree</surname><given-names>GR</given-names></name></person-group><article-title>Nuclear actin and actin-related proteins in chromatin remodeling</article-title><source>Annu Rev Biochem</source><year>2002</year><volume>71</volume><fpage>755</fpage><lpage>781</lpage><pub-id pub-id-type=""doi"">10.1146/annurev.biochem.71.110601.135507</pub-id></citation><citation citation-type=""display-unstructured"">Olave IA, Reck-Peterson SL, Crabtree GR (2002) Nuclear actin and actin-related proteins in chromatin remodeling. Annu Rev Biochem 71:755–781<pub-id pub-id-type=""pmid"">12045110</pub-id></citation></ref><ref id=""CR52""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Peche</surname><given-names>V</given-names></name><name><surname>Shekar</surname><given-names>S</given-names></name><name><surname>Leichter</surname><given-names>M</given-names></name><name><surname>Korte</surname><given-names>H</given-names></name><name><surname>Schroder</surname><given-names>R</given-names></name><name><surname>Schleicher</surname><given-names>M</given-names></name><name><surname>Holak</surname><given-names>TA</given-names></name><name><surname>Clemen</surname><given-names>CS</given-names></name><name><surname>Ramanath</surname><given-names>YB</given-names></name><name><surname>Pfitzer</surname><given-names>G</given-names></name><etal></etal></person-group><article-title>CAP2, cyclase-associated protein 2, is a dual compartment protein</article-title><source>Cell Mol Life Sci</source><year>2007</year><volume>64</volume><fpage>2702</fpage><lpage>2715</lpage><pub-id pub-id-type=""doi"">10.1007/s00018-007-7316-3</pub-id></citation><citation citation-type=""display-unstructured"">Peche V, Shekar S, Leichter M, Korte H, Schroder R, Schleicher M, Holak TA, Clemen CS, Ramanath YB, Pfitzer G et al (2007) CAP2, cyclase-associated protein 2, is a dual compartment protein. Cell Mol Life Sci 64:2702–2715<pub-id pub-id-type=""pmid"">17805484</pub-id></citation></ref><ref id=""CR53""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Pederson</surname><given-names>T</given-names></name><name><surname>Aebi</surname><given-names>U</given-names></name></person-group><article-title>Actin in the nucleus: what form and what for?</article-title><source>J Struct Biol</source><year>2002</year><volume>140</volume><fpage>3</fpage><lpage>9</lpage><pub-id pub-id-type=""doi"">10.1016/S1047-8477(02)00528-2</pub-id></citation><citation citation-type=""display-unstructured"">Pederson T, Aebi U (2002) Actin in the nucleus: what form and what for? J Struct Biol 140:3–9<pub-id pub-id-type=""pmid"">12490148</pub-id></citation></ref><ref id=""CR54""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Pederson</surname><given-names>T</given-names></name><name><surname>Aebi</surname><given-names>U</given-names></name></person-group><article-title>Nuclear actin extends, with no contraction in sight</article-title><source>Mol Biol Cell</source><year>2005</year><volume>16</volume><fpage>5055</fpage><lpage>5060</lpage><pub-id pub-id-type=""doi"">10.1091/mbc.E05-07-0656</pub-id></citation><citation citation-type=""display-unstructured"">Pederson T, Aebi U (2005) Nuclear actin extends, with no contraction in sight. Mol Biol Cell 16:5055–5060<pub-id pub-id-type=""pmid"">16148048</pub-id></citation></ref><ref id=""CR55""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Pendleton</surname><given-names>A</given-names></name><name><surname>Pope</surname><given-names>B</given-names></name><name><surname>Weeds</surname><given-names>A</given-names></name><name><surname>Koffer</surname><given-names>A</given-names></name></person-group><article-title>Latrunculin B or ATP depletion induces cofilin-dependent translocation of actin into nuclei of mast cells</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>14394</fpage><lpage>14400</lpage><pub-id pub-id-type=""doi"">10.1074/jbc.M206393200</pub-id></citation><citation citation-type=""display-unstructured"">Pendleton A, Pope B, Weeds A, Koffer A (2003) Latrunculin B or ATP depletion induces cofilin-dependent translocation of actin into nuclei of mast cells. J Biol Chem 278:14394–14400<pub-id pub-id-type=""pmid"">12566455</pub-id></citation></ref><ref id=""CR58""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Percipalle</surname><given-names>P</given-names></name><name><surname>Farrants</surname><given-names>AK</given-names></name></person-group><article-title>Chromatin remodelling and transcription: be-WICHed by nuclear myosin 1</article-title><source>Curr Opin Cell Biol</source><year>2006</year><volume>18</volume><fpage>267</fpage><lpage>274</lpage><pub-id pub-id-type=""doi"">10.1016/j.ceb.2006.03.001</pub-id></citation><citation citation-type=""display-unstructured"">Percipalle P, Farrants AK (2006) Chromatin remodelling and transcription: be-WICHed by nuclear myosin 1. Curr Opin Cell Biol 18:267–274<pub-id pub-id-type=""pmid"">16574391</pub-id></citation></ref><ref id=""CR59""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Percipalle</surname><given-names>P</given-names></name><name><surname>Visa</surname><given-names>N</given-names></name></person-group><article-title>Molecular functions of nuclear actin in transcription</article-title><source>J Cell Biol</source><year>2006</year><volume>172</volume><fpage>967</fpage><lpage>971</lpage><pub-id pub-id-type=""doi"">10.1083/jcb.200512083</pub-id></citation><citation citation-type=""display-unstructured"">Percipalle P, Visa N (2006) Molecular functions of nuclear actin in transcription. J Cell Biol 172:967–971<pub-id pub-id-type=""pmid"">16549500</pub-id></citation></ref><ref id=""CR56""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Percipalle</surname><given-names>P</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Pope</surname><given-names>B</given-names></name><name><surname>Weeds</surname><given-names>A</given-names></name><name><surname>Lindberg</surname><given-names>U</given-names></name><name><surname>Daneholt</surname><given-names>B</given-names></name></person-group><article-title>Actin bound to the heterogeneous nuclear ribonucleoprotein hrp36 is associated with Balbiani ring mRNA from the gene to polysomes</article-title><source>J Cell Biol</source><year>2001</year><volume>153</volume><fpage>229</fpage><lpage>236</lpage><pub-id pub-id-type=""doi"">10.1083/jcb.153.1.229</pub-id></citation><citation citation-type=""display-unstructured"">Percipalle P, Zhao J, Pope B, Weeds A, Lindberg U, Daneholt B (2001) Actin bound to the heterogeneous nuclear ribonucleoprotein hrp36 is associated with Balbiani ring mRNA from the gene to polysomes. J Cell Biol 153:229–236<pub-id pub-id-type=""pmid"">11285288</pub-id></citation></ref><ref id=""CR57""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Percipalle</surname><given-names>P</given-names></name><name><surname>Jonsson</surname><given-names>A</given-names></name><name><surname>Nashchekin</surname><given-names>D</given-names></name><name><surname>Karlsson</surname><given-names>C</given-names></name><name><surname>Bergman</surname><given-names>T</given-names></name><name><surname>Guialis</surname><given-names>A</given-names></name><name><surname>Daneholt</surname><given-names>B</given-names></name></person-group><article-title>Nuclear actin is associated with a specific subset of hnRNP A/B-type proteins</article-title><source>Nucleic Acids Res</source><year>2002</year><volume>30</volume><fpage>1725</fpage><lpage>1734</lpage><pub-id pub-id-type=""doi"">10.1093/nar/30.8.1725</pub-id></citation><citation citation-type=""display-unstructured"">Percipalle P, Jonsson A, Nashchekin D, Karlsson C, Bergman T, Guialis A, Daneholt B (2002) Nuclear actin is associated with a specific subset of hnRNP A/B-type proteins. Nucleic Acids Res 30:1725–1734<pub-id pub-id-type=""pmid"">11937625</pub-id></citation></ref><ref id=""CR60""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Pestic-Dragovich</surname><given-names>L</given-names></name><name><surname>Stojiljkovic</surname><given-names>L</given-names></name><name><surname>Philimonenko</surname><given-names>AA</given-names></name><name><surname>Nowak</surname><given-names>G</given-names></name><name><surname>Ke</surname><given-names>Y</given-names></name><name><surname>Settlage</surname><given-names>RE</given-names></name><name><surname>Shabanowitz</surname><given-names>J</given-names></name><name><surname>Hunt</surname><given-names>DF</given-names></name><name><surname>Hozak</surname><given-names>P</given-names></name><name><surname>Lanerolle</surname><given-names>P</given-names></name></person-group><article-title>A myosin I isoform in the nucleus</article-title><source>Science</source><year>2000</year><volume>290</volume><fpage>337</fpage><lpage>341</lpage><pub-id pub-id-type=""doi"">10.1126/science.290.5490.337</pub-id></citation><citation citation-type=""display-unstructured"">Pestic-Dragovich L, Stojiljkovic L, Philimonenko AA, Nowak G, Ke Y, Settlage RE, Shabanowitz J, Hunt DF, Hozak P, de Lanerolle P (2000) A myosin I isoform in the nucleus. Science 290:337–341<pub-id pub-id-type=""pmid"">11030652</pub-id></citation></ref><ref id=""CR62""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Pollard</surname><given-names>TD</given-names></name></person-group><article-title>Cytoplasmic contractile proteins</article-title><source>J Cell Biol</source><year>1981</year><volume>91</volume><fpage>156s</fpage><lpage>165 s</lpage><pub-id pub-id-type=""doi"">10.1083/jcb.91.3.156s</pub-id></citation><citation citation-type=""display-unstructured"">Pollard TD (1981) Cytoplasmic contractile proteins. J Cell Biol 91:156s–165 s<pub-id pub-id-type=""pmid"">6459328</pub-id></citation></ref><ref id=""CR61""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Pollard</surname><given-names>TD</given-names></name><name><surname>Weihing</surname><given-names>RR</given-names></name></person-group><article-title>Actin and myosin and cell movement</article-title><source>CRC Crit Rev Biochem</source><year>1974</year><volume>2</volume><fpage>1</fpage><lpage>65</lpage><pub-id pub-id-type=""doi"">10.3109/10409237409105443</pub-id></citation><citation citation-type=""display-unstructured"">Pollard TD, Weihing RR (1974) Actin and myosin and cell movement. CRC Crit Rev Biochem 2:1–65<pub-id pub-id-type=""pmid"">4273099</pub-id></citation></ref><ref id=""CR63""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Rando</surname><given-names>OJ</given-names></name><name><surname>Zhao</surname><given-names>K</given-names></name><name><surname>Crabtree</surname><given-names>GR</given-names></name></person-group><article-title>Searching for a function for nuclear actin</article-title><source>Trends Cell Biol</source><year>2000</year><volume>10</volume><fpage>92</fpage><lpage>97</lpage><pub-id pub-id-type=""doi"">10.1016/S0962-8924(99)01713-4</pub-id></citation><citation citation-type=""display-unstructured"">Rando OJ, Zhao K, Crabtree GR (2000) Searching for a function for nuclear actin. Trends Cell Biol 10:92–97<pub-id pub-id-type=""pmid"">10675902</pub-id></citation></ref><ref id=""CR64""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Rimm</surname><given-names>DL</given-names></name><name><surname>Pollard</surname><given-names>TD</given-names></name></person-group><article-title>Purification and characterization of an Acanthamoeba nuclear actin-binding protein</article-title><source>J Cell Biol</source><year>1989</year><volume>109</volume><fpage>585</fpage><lpage>591</lpage><pub-id pub-id-type=""doi"">10.1083/jcb.109.2.585</pub-id></citation><citation citation-type=""display-unstructured"">Rimm DL, Pollard TD (1989) Purification and characterization of an Acanthamoeba nuclear actin-binding protein. J Cell Biol 109:585–591<pub-id pub-id-type=""pmid"">2760108</pub-id></citation></ref><ref id=""CR65""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Scheer</surname><given-names>U</given-names></name><name><surname>Hinssen</surname><given-names>H</given-names></name><name><surname>Franke</surname><given-names>WW</given-names></name><name><surname>Jockusch</surname><given-names>BM</given-names></name></person-group><article-title>Microinjection of actin-binding proteins and actin antibodies demonstrates involvement of nuclear actin in transcription of lampbrush chromosomes</article-title><source>Cell</source><year>1984</year><volume>39</volume><fpage>111</fpage><lpage>122</lpage><pub-id pub-id-type=""doi"">10.1016/0092-8674(84)90196-X</pub-id></citation><citation citation-type=""display-unstructured"">Scheer U, Hinssen H, Franke WW, Jockusch BM (1984) Microinjection of actin-binding proteins and actin antibodies demonstrates involvement of nuclear actin in transcription of lampbrush chromosomes. Cell 39:111–122<pub-id pub-id-type=""pmid"">6386181</pub-id></citation></ref><ref id=""CR66""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Schleicher</surname><given-names>M</given-names></name><name><surname>Andre</surname><given-names>E</given-names></name><name><surname>Hartmann</surname><given-names>H</given-names></name><name><surname>Noegel</surname><given-names>AA</given-names></name></person-group><article-title>Actin-binding proteins are conserved from slime molds to man</article-title><source>Dev Genet</source><year>1988</year><volume>9</volume><fpage>521</fpage><lpage>530</lpage><pub-id pub-id-type=""doi"">10.1002/dvg.1020090428</pub-id></citation><citation citation-type=""display-unstructured"">Schleicher M, Andre E, Hartmann H, Noegel AA (1988) Actin-binding proteins are conserved from slime molds to man. Dev Genet 9:521–530<pub-id pub-id-type=""pmid"">3243032</pub-id></citation></ref><ref id=""CR67""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Schoenenberger</surname><given-names>CA</given-names></name><name><surname>Buchmeier</surname><given-names>S</given-names></name><name><surname>Boerries</surname><given-names>M</given-names></name><name><surname>Sutterlin</surname><given-names>R</given-names></name><name><surname>Aebi</surname><given-names>U</given-names></name><name><surname>Jockusch</surname><given-names>BM</given-names></name></person-group><article-title>Conformation-specific antibodies reveal distinct actin structures in the nucleus and the cytoplasm</article-title><source>J Struct Biol</source><year>2005</year><volume>152</volume><fpage>157</fpage><lpage>168</lpage><pub-id pub-id-type=""doi"">10.1016/j.jsb.2005.09.003</pub-id></citation><citation citation-type=""display-unstructured"">Schoenenberger CA, Buchmeier S, Boerries M, Sutterlin R, Aebi U, Jockusch BM (2005) Conformation-specific antibodies reveal distinct actin structures in the nucleus and the cytoplasm. J Struct Biol 152:157–168<pub-id pub-id-type=""pmid"">16297639</pub-id></citation></ref><ref id=""CR68""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Shumaker</surname><given-names>DK</given-names></name><name><surname>Kuczmarski</surname><given-names>ER</given-names></name><name><surname>Goldman</surname><given-names>RD</given-names></name></person-group><article-title>The nucleoskeleton: lamins and actin are major players in essential nuclear functions</article-title><source>Curr Opin Cell Biol</source><year>2003</year><volume>15</volume><fpage>358</fpage><lpage>366</lpage><pub-id pub-id-type=""doi"">10.1016/S0955-0674(03)00050-4</pub-id></citation><citation citation-type=""display-unstructured"">Shumaker DK, Kuczmarski ER, Goldman RD (2003) The nucleoskeleton: lamins and actin are major players in essential nuclear functions. Curr Opin Cell Biol 15:358–366<pub-id pub-id-type=""pmid"">12787780</pub-id></citation></ref><ref id=""CR69""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Smith</surname><given-names>SS</given-names></name><name><surname>Kelly</surname><given-names>KH</given-names></name><name><surname>Jockusch</surname><given-names>BM</given-names></name></person-group><article-title>Actin co-purifies with RNA polymerase II</article-title><source>Biochem Biophys Res Commun</source><year>1979</year><volume>86</volume><fpage>161</fpage><lpage>166</lpage><pub-id pub-id-type=""doi"">10.1016/0006-291X(79)90395-4</pub-id></citation><citation citation-type=""display-unstructured"">Smith SS, Kelly KH, Jockusch BM (1979) Actin co-purifies with RNA polymerase II. Biochem Biophys Res Commun 86:161–166<pub-id pub-id-type=""pmid"">435297</pub-id></citation></ref><ref id=""CR70""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Stuven</surname><given-names>T</given-names></name><name><surname>Hartmann</surname><given-names>E</given-names></name><name><surname>Gorlich</surname><given-names>D</given-names></name></person-group><article-title>Exportin 6: a novel nuclear export receptor that is specific for profilin-actin complexes</article-title><source>Embo J</source><year>2003</year><volume>22</volume><fpage>5928</fpage><lpage>5940</lpage><pub-id pub-id-type=""doi"">10.1093/emboj/cdg565</pub-id></citation><citation citation-type=""display-unstructured"">Stuven T, Hartmann E, Gorlich D (2003) Exportin 6: a novel nuclear export receptor that is specific for profilin-actin complexes. Embo J 22:5928–5940<pub-id pub-id-type=""pmid"">14592989</pub-id></citation></ref><ref id=""CR71""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Szent-Gyorgyi</surname><given-names>AG</given-names></name></person-group><article-title>The early history of the biochemistry of muscle contraction</article-title><source>J Gen Physiol</source><year>2004</year><volume>123</volume><fpage>631</fpage><lpage>641</lpage><pub-id pub-id-type=""doi"">10.1085/jgp.200409091</pub-id></citation><citation citation-type=""display-unstructured"">Szent-Gyorgyi AG (2004) The early history of the biochemistry of muscle contraction. J Gen Physiol 123:631–641<pub-id pub-id-type=""pmid"">15173217</pub-id></citation></ref><ref id=""CR72""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Szerlong</surname><given-names>H</given-names></name><name><surname>Saha</surname><given-names>A</given-names></name><name><surname>Cairns</surname><given-names>BR</given-names></name></person-group><article-title>The nuclear actin-related proteins Arp7 and Arp9: a dimeric module that cooperates with architectural proteins for chromatin remodeling</article-title><source>EMBO J</source><year>2003</year><volume>22</volume><fpage>3175</fpage><lpage>3187</lpage><pub-id pub-id-type=""doi"">10.1093/emboj/cdg296</pub-id></citation><citation citation-type=""display-unstructured"">Szerlong H, Saha A, Cairns BR (2003) The nuclear actin-related proteins Arp7 and Arp9: a dimeric module that cooperates with architectural proteins for chromatin remodeling. EMBO J 22:3175–3187<pub-id pub-id-type=""pmid"">12805231</pub-id></citation></ref><ref id=""CR73""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Tilney</surname><given-names>LG</given-names></name></person-group><article-title>The role of actin in nonmuscle cell motility</article-title><source>Soc Gen Physiol Ser</source><year>1975</year><volume>30</volume><fpage>339</fpage><lpage>388</lpage></citation><citation citation-type=""display-unstructured"">Tilney LG (1975) The role of actin in nonmuscle cell motility. Soc Gen Physiol Ser 30:339–388<pub-id pub-id-type=""pmid"">1103304</pub-id></citation></ref><ref id=""CR74""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Wada</surname><given-names>A</given-names></name><name><surname>Fukuda</surname><given-names>M</given-names></name><name><surname>Mishima</surname><given-names>M</given-names></name><name><surname>Nishida</surname><given-names>E</given-names></name></person-group><article-title>Nuclear export of actin: a novel mechanism regulating the subcellular localization of a major cytoskeletal protein</article-title><source>EMBO J</source><year>1998</year><volume>17</volume><fpage>1635</fpage><lpage>1641</lpage><pub-id pub-id-type=""doi"">10.1093/emboj/17.6.1635</pub-id></citation><citation citation-type=""display-unstructured"">Wada A, Fukuda M, Mishima M, Nishida E (1998) Nuclear export of actin: a novel mechanism regulating the subcellular localization of a major cytoskeletal protein. EMBO J 17:1635–1641<pub-id pub-id-type=""pmid"">9501085</pub-id></citation></ref><ref id=""CR75""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Winder</surname><given-names>SJ</given-names></name><name><surname>Ayscough</surname><given-names>KR</given-names></name></person-group><article-title>Actin-binding proteins</article-title><source>J Cell Sci</source><year>2005</year><volume>118</volume><fpage>651</fpage><lpage>654</lpage><pub-id pub-id-type=""doi"">10.1242/jcs.01670</pub-id></citation><citation citation-type=""display-unstructured"">Winder SJ, Ayscough KR (2005) Actin-binding proteins. J Cell Sci 118:651–654<pub-id pub-id-type=""pmid"">15701920</pub-id></citation></ref><ref id=""CR76""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Worman</surname><given-names>HJ</given-names></name><name><surname>Gundersen</surname><given-names>GG</given-names></name></person-group><article-title>Here come the SUNs: a nucleocytoskeletal missing link</article-title><source>Trends Cell Biol</source><year>2006</year><volume>16</volume><fpage>67</fpage><lpage>69</lpage><pub-id pub-id-type=""doi"">10.1016/j.tcb.2005.12.006</pub-id></citation><citation citation-type=""display-unstructured"">Worman HJ, Gundersen GG (2006) Here come the SUNs: a nucleocytoskeletal missing link. Trends Cell Biol 16:67–69<pub-id pub-id-type=""pmid"">16406617</pub-id></citation></ref></ref-list>"
10.1016/j.cell.2008.01.051	"<html><body><ref id=""R114""><label>114</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name name-style=""western""><surname>Feldman</surname><given-names>DE</given-names></name>,<name name-style=""western""><surname>Frydman</surname><given-names>J</given-names></name>.</person-group><article-title>Protein folding in vivo: the importance of molecular chaperones</article-title>.<source>Curr Opin Struct Biol</source><year>2000</year>;<volume>10</volume>:<fpage>26</fpage>-<lpage>33</lpage>; http://dx.doi.org/<pub-id pub-id-type=""doi"">10.1016/S0959-440X(99)00044-5</pub-id>; PMID: 10679467<pub-id pub-id-type=""pmid"">10679467</pub-id></mixed-citation></ref><ref id=""R115""><label>115</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name name-style=""western""><surname>Frydman</surname><given-names>J</given-names></name>,<name name-style=""western""><surname>Nimmesgern</surname><given-names>E</given-names></name>,<name name-style=""western""><surname>Erdjument-Bromage</surname><given-names>H</given-names></name>,<name name-style=""western""><surname>Wall</surname><given-names>JS</given-names></name>,<name name-style=""western""><surname>Tempst</surname><given-names>P</given-names></name>,<name name-style=""western""><surname>Hartl</surname><given-names>FU</given-names></name>.</person-group><article-title>Function in protein folding of TRiC, a cytosolic ring complex containing TCP-1 and structurally related subunits</article-title>.<source>EMBO J</source><year>1992</year>;<volume>11</volume>:<fpage>4767</fpage>-<lpage>78</lpage>; PMID: 1361170<pub-id pub-id-type=""pmid"">1361170</pub-id></mixed-citation></ref><ref id=""R116""><label>116</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name name-style=""western""><surname>Gao</surname><given-names>Y</given-names></name>,<name name-style=""western""><surname>Thomas</surname><given-names>JO</given-names></name>,<name name-style=""western""><surname>Chow</surname><given-names>RL</given-names></name>,<name name-style=""western""><surname>Lee</surname><given-names>GH</given-names></name>,<name name-style=""western""><surname>Cowan</surname><given-names>NJ</given-names></name>.</person-group><article-title>A cytoplasmic chaperonin that catalyzes beta-actin folding</article-title>.<source>Cell</source><year>1992</year>;<volume>69</volume>:<fpage>1043</fpage>-<lpage>50</lpage>; http://dx.doi.org/<pub-id pub-id-type=""doi"">10.1016/0092-8674(92)90622-J</pub-id>; PMID: 1351421<pub-id pub-id-type=""pmid"">1351421</pub-id></mixed-citation></ref><ref id=""R117""><label>117</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name name-style=""western""><surname>Lewis</surname><given-names>VA</given-names></name>,<name name-style=""western""><surname>Hynes</surname><given-names>GM</given-names></name>,<name name-style=""western""><surname>Zheng</surname><given-names>D</given-names></name>,<name name-style=""western""><surname>Saibil</surname><given-names>H</given-names></name>,<name name-style=""western""><surname>Willison</surname><given-names>K</given-names></name>.</person-group><article-title>T-complex polypeptide-1 is a subunit of a heteromeric particle in the eukaryotic cytosol</article-title>.<source>Nature</source><year>1992</year>;<volume>358</volume>:<fpage>249</fpage>-<lpage>52</lpage>; http://dx.doi.org/<pub-id pub-id-type=""doi"">10.1038/358249a0</pub-id>; PMID: 1630492<pub-id pub-id-type=""pmid"">1630492</pub-id></mixed-citation></ref><ref id=""R118""><label>118</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name name-style=""western""><surname>Martín-Benito</surname><given-names>J</given-names></name>,<name name-style=""western""><surname>Boskovic</surname><given-names>J</given-names></name>,<name name-style=""western""><surname>Gómez-Puertas</surname><given-names>P</given-names></name>,<name name-style=""western""><surname>Carrascosa</surname><given-names>JL</given-names></name>,<name name-style=""western""><surname>Simons</surname><given-names>CT</given-names></name>,<name name-style=""western""><surname>Lewis</surname><given-names>SA</given-names></name>,<name name-style=""western""><surname>Bartolini</surname><given-names>F</given-names></name>,<name name-style=""western""><surname>Cowan</surname><given-names>NJ</given-names></name>,<name name-style=""western""><surname>Valpuesta</surname><given-names>JM</given-names></name>.</person-group><article-title>Structure of eukaryotic prefoldin and of its complexes with unfolded actin and the cytosolic chaperonin CCT</article-title>.<source>EMBO J</source><year>2002</year>;<volume>21</volume>:<fpage>6377</fpage>-<lpage>86</lpage>; http://dx.doi.org/<pub-id pub-id-type=""doi"">10.1093/emboj/cdf640</pub-id>; PMID: 12456645<pub-id pub-id-type=""pmid"">12456645</pub-id></mixed-citation></ref><ref id=""R119""><label>119</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name name-style=""western""><surname>Neirynck</surname><given-names>K</given-names></name>,<name name-style=""western""><surname>Waterschoot</surname><given-names>D</given-names></name>,<name name-style=""western""><surname>Vandekerckhove</surname><given-names>J</given-names></name>,<name name-style=""western""><surname>Ampe</surname><given-names>C</given-names></name>,<name name-style=""western""><surname>Rommelaere</surname><given-names>H</given-names></name>.</person-group><article-title>Actin interacts with CCT via discrete binding sites: a binding transition-release model for CCT-mediated actin folding</article-title>.<source>J Mol Biol</source><year>2006</year>;<volume>355</volume>:<fpage>124</fpage>-<lpage>38</lpage>; http://dx.doi.org/<pub-id pub-id-type=""doi"">10.1016/j.jmb.2005.10.051</pub-id>; PMID: 16300788<pub-id pub-id-type=""pmid"">16300788</pub-id></mixed-citation></ref><ref id=""R120""><label>120</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name name-style=""western""><surname>Altschuler</surname><given-names>GM</given-names></name>,<name name-style=""western""><surname>Willison</surname><given-names>KR</given-names></name>.</person-group><article-title>Development of free-energy-based models for chaperonin containing TCP-1 mediated folding of actin</article-title>.<source>J R Soc Interface</source><year>2008</year>;<volume>5</volume>:<fpage>1391</fpage>-<lpage>408</lpage>; http://dx.doi.org/<pub-id pub-id-type=""doi"">10.1098/rsif.2008.0185</pub-id>; PMID: 18708324<pub-id pub-id-type=""pmid"">18708324</pub-id></mixed-citation></ref><ref id=""R121""><label>121</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name name-style=""western""><surname>Frankel</surname><given-names>S</given-names></name>,<name name-style=""western""><surname>Condeelis</surname><given-names>J</given-names></name>,<name name-style=""western""><surname>Leinwand</surname><given-names>L</given-names></name>.</person-group><article-title>Expression of actin in Escherichia coli. Aggregation, solubilization, and functional analysis</article-title>.<source>J Biol Chem</source><year>1990</year>;<volume>265</volume>:<fpage>17980</fpage>-<lpage>7</lpage>; PMID: 2211676<pub-id pub-id-type=""pmid"">2211676</pub-id></mixed-citation></ref><ref id=""R122""><label>122</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name name-style=""western""><surname>Karlsson</surname><given-names>R</given-names></name>.</person-group><article-title>Expression of chicken beta-actin in Saccharomyces cerevisiae</article-title>.<source>Gene</source><year>1988</year>;<volume>68</volume>:<fpage>249</fpage>-<lpage>57</lpage>; http://dx.doi.org/<pub-id pub-id-type=""doi"">10.1016/0378-1119(88)90027-3</pub-id>; PMID: 3065145<pub-id pub-id-type=""pmid"">3065145</pub-id></mixed-citation></ref><ref id=""R123""><label>123</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name name-style=""western""><surname>Verkhusha</surname><given-names>VV</given-names></name>,<name name-style=""western""><surname>Shavlovsky</surname><given-names>MM</given-names></name>,<name name-style=""western""><surname>Nevzglyadova</surname><given-names>OV</given-names></name>,<name name-style=""western""><surname>Gaivoronsky</surname><given-names>AA</given-names></name>,<name name-style=""western""><surname>Artemov</surname><given-names>AV</given-names></name>,<name name-style=""western""><surname>Stepanenko</surname><given-names>OV</given-names></name>,<name name-style=""western""><surname>Kuznetsova</surname><given-names>IM</given-names></name>,<name name-style=""western""><surname>Turoverov</surname><given-names>KK</given-names></name>.</person-group><article-title>Expression of recombinant GFP-actin fusion protein in the methylotrophic yeast Pichia pastoris</article-title>.<source>FEMS Yeast Res</source><year>2003</year>;<volume>3</volume>:<fpage>105</fpage>-<lpage>11</lpage>; PMID: 12702253<pub-id pub-id-type=""pmid"">12702253</pub-id></mixed-citation></ref><ref id=""R124""><label>124</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name name-style=""western""><surname>Adams</surname><given-names>CL</given-names></name>,<name name-style=""western""><surname>Nelson</surname><given-names>WJ</given-names></name>,<name name-style=""western""><surname>Smith</surname><given-names>SJ</given-names></name>.</person-group><article-title>Quantitative analysis of cadherin-catenin-actin reorganization during development of cell-cell adhesion</article-title>.<source>J Cell Biol</source><year>1996</year>;<volume>135</volume>:<fpage>1899</fpage>-<lpage>911</lpage>; http://dx.doi.org/<pub-id pub-id-type=""doi"">10.1083/jcb.135.6.1899</pub-id>; PMID: 8991100<pub-id pub-id-type=""pmid"">8991100</pub-id></mixed-citation></ref><ref id=""R125""><label>125</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name name-style=""western""><surname>Fernandez-Valle</surname><given-names>C</given-names></name>,<name name-style=""western""><surname>Gorman</surname><given-names>D</given-names></name>,<name name-style=""western""><surname>Gomez</surname><given-names>AM</given-names></name>,<name name-style=""western""><surname>Bunge</surname><given-names>MB</given-names></name>.</person-group><article-title>Actin plays a role in both changes in cell shape and gene-expression associated with Schwann cell myelination</article-title>.<source>J Neurosci</source><year>1997</year>;<volume>17</volume>:<fpage>241</fpage>-<lpage>50</lpage>; PMID: 8987752<pub-id pub-id-type=""pmid"">8987752</pub-id></mixed-citation></ref><ref id=""R126""><label>126</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name name-style=""western""><surname>Wolyniak</surname><given-names>MJ</given-names></name>,<name name-style=""western""><surname>Sundstrom</surname><given-names>P</given-names></name>.</person-group><article-title>Role of actin cytoskeletal dynamics in activation of the cyclic AMP pathway and HWP1 gene expression in Candida albicans</article-title>.<source>Eukaryot Cell</source><year>2007</year>;<volume>6</volume>:<fpage>1824</fpage>-<lpage>40</lpage>; http://dx.doi.org/<pub-id pub-id-type=""doi"">10.1128/EC.00188-07</pub-id>; PMID: 17715368<pub-id pub-id-type=""pmid"">17715368</pub-id></mixed-citation></ref><ref id=""R127""><label>127</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name name-style=""western""><surname>Fujiwara</surname><given-names>K</given-names></name>,<name name-style=""western""><surname>Porter</surname><given-names>ME</given-names></name>,<name name-style=""western""><surname>Pollard</surname><given-names>TD</given-names></name>.</person-group><article-title>Alpha-actinin localization in the cleavage furrow during cytokinesis</article-title>.<source>J Cell Biol</source><year>1978</year>;<volume>79</volume>:<fpage>268</fpage>-<lpage>75</lpage>; http://dx.doi.org/<pub-id pub-id-type=""doi"">10.1083/jcb.79.1.268</pub-id>; PMID: 359574<pub-id pub-id-type=""pmid"">359574</pub-id></mixed-citation></ref><ref id=""R128""><label>128</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name name-style=""western""><surname>Mashima</surname><given-names>T</given-names></name>,<name name-style=""western""><surname>Naito</surname><given-names>M</given-names></name>,<name name-style=""western""><surname>Noguchi</surname><given-names>K</given-names></name>,<name name-style=""western""><surname>Miller</surname><given-names>DK</given-names></name>,<name name-style=""western""><surname>Nicholson</surname><given-names>DW</given-names></name>,<name name-style=""western""><surname>Tsuruo</surname><given-names>T</given-names></name>.</person-group><article-title>Actin cleavage by CPP-32/apopain during the development of apoptosis</article-title>.<source>Oncogene</source><year>1997</year>;<volume>14</volume>:<fpage>1007</fpage>-<lpage>12</lpage>; http://dx.doi.org/<pub-id pub-id-type=""doi"">10.1038/sj.onc.1200919</pub-id>; PMID: 9070648<pub-id pub-id-type=""pmid"">9070648</pub-id></mixed-citation></ref><ref id=""R129""><label>129</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name name-style=""western""><surname>Wang</surname><given-names>KK</given-names></name>.</person-group><article-title>Calpain and caspase: can you tell the difference?</article-title>.<source>Trends Neurosci</source><year>2000</year>;<volume>23</volume>:<fpage>20</fpage>-<lpage>6</lpage>; http://dx.doi.org/<pub-id pub-id-type=""doi"">10.1016/S0166-2236(99)01479-4</pub-id>; PMID: 10631785<pub-id pub-id-type=""pmid"">10631785</pub-id></mixed-citation></ref><ref id=""R130""><label>130</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name name-style=""western""><surname>Huot</surname><given-names>J</given-names></name>,<name name-style=""western""><surname>Houle</surname><given-names>F</given-names></name>,<name name-style=""western""><surname>Rousseau</surname><given-names>S</given-names></name>,<name name-style=""western""><surname>Deschesnes</surname><given-names>RG</given-names></name>,<name name-style=""western""><surname>Shah</surname><given-names>GM</given-names></name>,<name name-style=""western""><surname>Landry</surname><given-names>J</given-names></name>.</person-group><article-title>SAPK2/p38-dependent F-actin reorganization regulates early membrane blebbing during stress-induced apoptosis</article-title>.<source>J Cell Biol</source><year>1998</year>;<volume>143</volume>:<fpage>1361</fpage>-<lpage>73</lpage>; http://dx.doi.org/<pub-id pub-id-type=""doi"">10.1083/jcb.143.5.1361</pub-id>; PMID: 9832563<pub-id pub-id-type=""pmid"">9832563</pub-id></mixed-citation></ref><ref id=""R131""><label>131</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name name-style=""western""><surname>Dominguez</surname><given-names>R</given-names></name>.</person-group><article-title>Structural insights into de novo actin polymerization</article-title>.<source>Curr Opin Struct Biol</source><year>2010</year>;<volume>20</volume>:<fpage>217</fpage>-<lpage>25</lpage>; http://dx.doi.org/<pub-id pub-id-type=""doi"">10.1016/j.sbi.2009.12.012</pub-id>; PMID: 20096561<pub-id pub-id-type=""pmid"">20096561</pub-id></mixed-citation></ref><ref id=""R132""><label>132</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name name-style=""western""><surname>Evangelista</surname><given-names>M</given-names></name>,<name name-style=""western""><surname>Zigmond</surname><given-names>S</given-names></name>,<name name-style=""western""><surname>Boone</surname><given-names>C</given-names></name>.</person-group><article-title>Formins: signaling effectors for assembly and polarization of actin filaments</article-title>.<source>J Cell Sci</source><year>2003</year>;<volume>116</volume>:<fpage>2603</fpage>-<lpage>11</lpage>; http://dx.doi.org/<pub-id pub-id-type=""doi"">10.1242/jcs.00611</pub-id>; PMID: 12775772<pub-id pub-id-type=""pmid"">12775772</pub-id></mixed-citation></ref><ref id=""R133""><label>133</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name name-style=""western""><surname>Pollard</surname><given-names>TD</given-names></name>,<name name-style=""western""><surname>Blanchoin</surname><given-names>L</given-names></name>,<name name-style=""western""><surname>Mullins</surname><given-names>RD</given-names></name>.</person-group><article-title>Actin dynamics</article-title>.<source>J Cell Sci</source><year>2001</year>;<volume>114</volume>:<fpage>3</fpage>-<lpage>4</lpage>; PMID: 11112680<pub-id pub-id-type=""pmid"">11112680</pub-id></mixed-citation></ref><ref id=""R134""><label>134</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name name-style=""western""><surname>Firat-Karalar</surname><given-names>EN</given-names></name>,<name name-style=""western""><surname>Welch</surname><given-names>MD</given-names></name>.</person-group><article-title>New mechanisms and functions of actin nucleation</article-title>.<source>Curr Opin Cell Biol</source><year>2011</year>;<volume>23</volume>:<fpage>4</fpage>-<lpage>13</lpage>; http://dx.doi.org/<pub-id pub-id-type=""doi"">10.1016/j.ceb.2010.10.007</pub-id>; PMID: 21093244<pub-id pub-id-type=""pmid"">21093244</pub-id></mixed-citation></ref><ref id=""R135""><label>135</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name name-style=""western""><surname>Burtnick</surname><given-names>LD</given-names></name>,<name name-style=""western""><surname>Urosev</surname><given-names>D</given-names></name>,<name name-style=""western""><surname>Irobi</surname><given-names>E</given-names></name>,<name name-style=""western""><surname>Narayan</surname><given-names>K</given-names></name>,<name name-style=""western""><surname>Robinson</surname><given-names>RC</given-names></name>.</person-group><article-title>Structure of the N-terminal half of gelsolin bound to actin: roles in severing, apoptosis and FAF</article-title>.<source>EMBO J</source><year>2004</year>;<volume>23</volume>:<fpage>2713</fpage>-<lpage>22</lpage>; http://dx.doi.org/<pub-id pub-id-type=""doi"">10.1038/sj.emboj.7600280</pub-id>; PMID: 15215896<pub-id pub-id-type=""pmid"">15215896</pub-id></mixed-citation></ref><ref id=""R136""><label>136</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name name-style=""western""><surname>Winder</surname><given-names>SJ</given-names></name>,<name name-style=""western""><surname>Ayscough</surname><given-names>KR</given-names></name>.</person-group><article-title>Actin-binding proteins</article-title>.<source>J Cell Sci</source><year>2005</year>;<volume>118</volume>:<fpage>651</fpage>-<lpage>4</lpage>; http://dx.doi.org/<pub-id pub-id-type=""doi"">10.1242/jcs.01670</pub-id>; PMID: 15701920<pub-id pub-id-type=""pmid"">15701920</pub-id></mixed-citation></ref><ref id=""R137""><label>137</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name name-style=""western""><surname>Hertzog</surname><given-names>M</given-names></name>,<name name-style=""western""><surname>van Heijenoort</surname><given-names>C</given-names></name>,<name name-style=""western""><surname>Didry</surname><given-names>D</given-names></name>,<name name-style=""western""><surname>Gaudier</surname><given-names>M</given-names></name>,<name name-style=""western""><surname>Coutant</surname><given-names>J</given-names></name>,<name name-style=""western""><surname>Gigant</surname><given-names>B</given-names></name>,<name name-style=""western""><surname>Didelot</surname><given-names>G</given-names></name>,<name name-style=""western""><surname>Préat</surname><given-names>T</given-names></name>,<name name-style=""western""><surname>Knossow</surname><given-names>M</given-names></name>,<name name-style=""western""><surname>Guittet</surname><given-names>E</given-names></name>,<etal>et al</etal>.</person-group><article-title>The beta-thymosin/WH2 domain; structural basis for the switch from inhibition to promotion of actin assembly</article-title>.<source>Cell</source><year>2004</year>;<volume>117</volume>:<fpage>611</fpage>-<lpage>23</lpage>; http://dx.doi.org/<pub-id pub-id-type=""doi"">10.1016/S0092-8674(04)00403-9</pub-id>; PMID: 15163409<pub-id pub-id-type=""pmid"">15163409</pub-id></mixed-citation></ref><ref id=""R138""><label>138</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name name-style=""western""><surname>Vartiainen</surname><given-names>MK</given-names></name>.</person-group><article-title>Nuclear actin dynamics--from form to function</article-title>.<source>FEBS Lett</source><year>2008</year>;<volume>582</volume>:<fpage>2033</fpage>-<lpage>40</lpage>; http://dx.doi.org/<pub-id pub-id-type=""doi"">10.1016/j.febslet.2008.04.010</pub-id>; PMID: 18423404<pub-id pub-id-type=""pmid"">18423404</pub-id></mixed-citation></ref><ref id=""R139""><label>139</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name name-style=""western""><surname>Visegrády</surname><given-names>B</given-names></name>,<name name-style=""western""><surname>Lorinczy</surname><given-names>D</given-names></name>,<name name-style=""western""><surname>Hild</surname><given-names>G</given-names></name>,<name name-style=""western""><surname>Somogyi</surname><given-names>B</given-names></name>,<name name-style=""western""><surname>Nyitrai</surname><given-names>M</given-names></name>.</person-group><article-title>A simple model for the cooperative stabilisation of actin filaments by phalloidin and jasplakinolide</article-title>.<source>FEBS Lett</source><year>2005</year>;<volume>579</volume>:<fpage>6</fpage>-<lpage>10</lpage>; http://dx.doi.org/<pub-id pub-id-type=""doi"">10.1016/j.febslet.2004.11.023</pub-id>; PMID: 15620683<pub-id pub-id-type=""pmid"">15620683</pub-id></mixed-citation></ref><ref id=""R140""><label>140</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name name-style=""western""><surname>Gonsior</surname><given-names>SM</given-names></name>,<name name-style=""western""><surname>Platz</surname><given-names>S</given-names></name>,<name name-style=""western""><surname>Buchmeier</surname><given-names>S</given-names></name>,<name name-style=""western""><surname>Scheer</surname><given-names>U</given-names></name>,<name name-style=""western""><surname>Jockusch</surname><given-names>BM</given-names></name>,<name name-style=""western""><surname>Hinssen</surname><given-names>H</given-names></name>.</person-group><article-title>Conformational difference between nuclear and cytoplasmic actin as detected by a monoclonal antibody</article-title>.<source>J Cell Sci</source><year>1999</year>;<volume>112</volume>:<fpage>797</fpage>-<lpage>809</lpage>; PMID: 10036230<pub-id pub-id-type=""pmid"">10036230</pub-id></mixed-citation></ref><ref id=""R141""><label>141</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name name-style=""western""><surname>Hofmann</surname><given-names>W</given-names></name>,<name name-style=""western""><surname>Reichart</surname><given-names>B</given-names></name>,<name name-style=""western""><surname>Ewald</surname><given-names>A</given-names></name>,<name name-style=""western""><surname>Müller</surname><given-names>E</given-names></name>,<name name-style=""western""><surname>Schmitt</surname><given-names>I</given-names></name>,<name name-style=""western""><surname>Stauber</surname><given-names>RH</given-names></name>,<name name-style=""western""><surname>Lottspeich</surname><given-names>F</given-names></name>,<name name-style=""western""><surname>Jockusch</surname><given-names>BM</given-names></name>,<name name-style=""western""><surname>Scheer</surname><given-names>U</given-names></name>,<name name-style=""western""><surname>Hauber</surname><given-names>J</given-names></name>,<etal>et al</etal>.</person-group><article-title>Cofactor requirements for nuclear export of Rev response element (RRE)- and constitutive transport element (CTE)-containing retroviral RNAs. An unexpected role for actin</article-title>.<source>J Cell Biol</source><year>2001</year>;<volume>152</volume>:<fpage>895</fpage>-<lpage>910</lpage>; http://dx.doi.org/<pub-id pub-id-type=""doi"">10.1083/jcb.152.5.895</pub-id>; PMID: 11238447<pub-id pub-id-type=""pmid"">11238447</pub-id></mixed-citation></ref><ref id=""R142""><label>142</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name name-style=""western""><surname>Krauss</surname><given-names>SW</given-names></name>,<name name-style=""western""><surname>Chen</surname><given-names>C</given-names></name>,<name name-style=""western""><surname>Penman</surname><given-names>S</given-names></name>,<name name-style=""western""><surname>Heald</surname><given-names>R</given-names></name>.</person-group><article-title>Nuclear actin and protein 4.1: essential interactions during nuclear assembly in vitro</article-title>.<source>Proc Natl Acad Sci U S A</source><year>2003</year>;<volume>100</volume>:<fpage>10752</fpage>-<lpage>7</lpage>; http://dx.doi.org/<pub-id pub-id-type=""doi"">10.1073/pnas.1934680100</pub-id>; PMID: 12960380<pub-id pub-id-type=""pmid"">12960380</pub-id></mixed-citation></ref><ref id=""R143""><label>143</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name name-style=""western""><surname>McDonald</surname><given-names>D</given-names></name>,<name name-style=""western""><surname>Carrero</surname><given-names>G</given-names></name>,<name name-style=""western""><surname>Andrin</surname><given-names>C</given-names></name>,<name name-style=""western""><surname>de Vries</surname><given-names>G</given-names></name>,<name name-style=""western""><surname>Hendzel</surname><given-names>MJ</given-names></name>.</person-group><article-title>Nucleoplasmic beta-actin exists in a dynamic equilibrium between low-mobility polymeric species and rapidly diffusing populations</article-title>.<source>J Cell Biol</source><year>2006</year>;<volume>172</volume>:<fpage>541</fpage>-<lpage>52</lpage>; http://dx.doi.org/<pub-id pub-id-type=""doi"">10.1083/jcb.200507101</pub-id>; PMID: 16476775<pub-id pub-id-type=""pmid"">16476775</pub-id></mixed-citation></ref><ref id=""R144""><label>144</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name name-style=""western""><surname>Nunez</surname><given-names>E</given-names></name>,<name name-style=""western""><surname>Kwon</surname><given-names>YS</given-names></name>,<name name-style=""western""><surname>Hutt</surname><given-names>KR</given-names></name>,<name name-style=""western""><surname>Hu</surname><given-names>Q</given-names></name>,<name name-style=""western""><surname>Cardamone</surname><given-names>MD</given-names></name>,<name name-style=""western""><surname>Ohgi</surname><given-names>KA</given-names></name>,<name name-style=""western""><surname>Garcia-Bassets</surname><given-names>I</given-names></name>,<name name-style=""western""><surname>Rose</surname><given-names>DW</given-names></name>,<name name-style=""western""><surname>Glass</surname><given-names>CK</given-names></name>,<name name-style=""western""><surname>Rosenfeld</surname><given-names>MG</given-names></name>,<etal>et al</etal>.</person-group><article-title>Nuclear receptor-enhanced transcription requires motor- and LSD1-dependent gene networking in interchromatin granules</article-title>.<source>Cell</source><year>2008</year>;<volume>132</volume>:<fpage>996</fpage>-<lpage>1010</lpage>; http://dx.doi.org/<pub-id pub-id-type=""doi"">10.1016/j.cell.2008.01.051</pub-id>; PMID: 18358812<pub-id pub-id-type=""pmid"">18358812</pub-id></mixed-citation></ref><ref id=""R145""><label>145</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name name-style=""western""><surname>McGough</surname><given-names>A</given-names></name>,<name name-style=""western""><surname>Pope</surname><given-names>B</given-names></name>,<name name-style=""western""><surname>Chiu</surname><given-names>W</given-names></name>,<name name-style=""western""><surname>Weeds</surname><given-names>A</given-names></name>.</person-group><article-title>Cofilin changes the twist of F-actin: implications for actin filament dynamics and cellular function</article-title>.<source>J Cell Biol</source><year>1997</year>;<volume>138</volume>:<fpage>771</fpage>-<lpage>81</lpage>; http://dx.doi.org/<pub-id pub-id-type=""doi"">10.1083/jcb.138.4.771</pub-id>; PMID: 9265645<pub-id pub-id-type=""pmid"">9265645</pub-id></mixed-citation></ref><ref id=""R146""><label>146</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name name-style=""western""><surname>Szklarczyk</surname><given-names>D</given-names></name>,<name name-style=""western""><surname>Franceschini</surname><given-names>A</given-names></name>,<name name-style=""western""><surname>Kuhn</surname><given-names>M</given-names></name>,<name name-style=""western""><surname>Simonovic</surname><given-names>M</given-names></name>,<name name-style=""western""><surname>Roth</surname><given-names>A</given-names></name>,<name name-style=""western""><surname>Minguez</surname><given-names>P</given-names></name>,<name name-style=""western""><surname>Doerks</surname><given-names>T</given-names></name>,<name name-style=""western""><surname>Stark</surname><given-names>M</given-names></name>,<name name-style=""western""><surname>Muller</surname><given-names>J</given-names></name>,<name name-style=""western""><surname>Bork</surname><given-names>P</given-names></name>,<etal>et al</etal>.</person-group><article-title>The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored</article-title>.<source>Nucleic Acids Res</source><year>2011</year>;<volume>39</volume>:<fpage>D561</fpage>-<lpage>8</lpage>; http://dx.doi.org/<pub-id pub-id-type=""doi"">10.1093/nar/gkq973</pub-id>; PMID: 21045058<pub-id pub-id-type=""pmid"">21045058</pub-id></mixed-citation></ref><ref id=""R147""><label>147</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name name-style=""western""><surname>Obradovic</surname><given-names>Z</given-names></name>,<name name-style=""western""><surname>Peng</surname><given-names>K</given-names></name>,<name name-style=""western""><surname>Vucetic</surname><given-names>S</given-names></name>,<name name-style=""western""><surname>Radivojac</surname><given-names>P</given-names></name>,<name name-style=""western""><surname>Dunker</surname><given-names>AK</given-names></name>.</person-group><article-title>Exploiting heterogeneous sequence properties improves prediction of protein disorder</article-title>.<source>Proteins</source><year>2005</year>;<volume>61</volume>:<issue>Suppl 7</issue><fpage>176</fpage>-<lpage>82</lpage>; http://dx.doi.org/<pub-id pub-id-type=""doi"">10.1002/prot.20735</pub-id>; PMID: 16187360<pub-id pub-id-type=""pmid"">16187360</pub-id></mixed-citation></ref><ref id=""R148""><label>148</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name name-style=""western""><surname>Obradovic</surname><given-names>Z</given-names></name>,<name name-style=""western""><surname>Peng</surname><given-names>K</given-names></name>,<name name-style=""western""><surname>Vucetic</surname><given-names>S</given-names></name>,<name name-style=""western""><surname>Radivojac</surname><given-names>P</given-names></name>,<name name-style=""western""><surname>Brown</surname><given-names>CJ</given-names></name>,<name name-style=""western""><surname>Dunker</surname><given-names>AK</given-names></name>.</person-group><article-title>Predicting intrinsic disorder from amino acid sequence</article-title>.<source>Proteins</source><year>2003</year>;<volume>53</volume>:<issue>Suppl 6</issue><fpage>566</fpage>-<lpage>72</lpage>; http://dx.doi.org/<pub-id pub-id-type=""doi"">10.1002/prot.10532</pub-id>; PMID: 14579347<pub-id pub-id-type=""pmid"">14579347</pub-id></mixed-citation></ref><ref id=""R149""><label>149</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name name-style=""western""><surname>Xue</surname><given-names>B</given-names></name>,<name name-style=""western""><surname>Dunbrack</surname><given-names>RL</given-names></name>,<name name-style=""western""><surname>Williams</surname><given-names>RW</given-names></name>,<name name-style=""western""><surname>Dunker</surname><given-names>AK</given-names></name>,<name name-style=""western""><surname>Uversky</surname><given-names>VN</given-names></name>.</person-group><article-title>PONDR-FIT: a meta-predictor of intrinsically disordered amino acids</article-title>.<source>Biochim Biophys Acta</source><year>2010</year>;<volume>1804</volume>:<fpage>996</fpage>-<lpage>1010</lpage>; http://dx.doi.org/<pub-id pub-id-type=""doi"">10.1016/j.bbapap.2010.01.011</pub-id>; PMID: 20100603<pub-id pub-id-type=""pmid"">20100603</pub-id></mixed-citation></ref><ref id=""R150""><label>150</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name name-style=""western""><surname>Oates</surname><given-names>ME</given-names></name>,<name name-style=""western""><surname>Romero</surname><given-names>P</given-names></name>,<name name-style=""western""><surname>Ishida</surname><given-names>T</given-names></name>,<name name-style=""western""><surname>Ghalwash</surname><given-names>M</given-names></name>,<name name-style=""western""><surname>Mizianty</surname><given-names>MJ</given-names></name>,<name name-style=""western""><surname>Xue</surname><given-names>B</given-names></name>,<name name-style=""western""><surname>Dosztányi</surname><given-names>Z</given-names></name>,<name name-style=""western""><surname>Uversky</surname><given-names>VN</given-names></name>,<name name-style=""western""><surname>Obradovic</surname><given-names>Z</given-names></name>,<name name-style=""western""><surname>Kurgan</surname><given-names>L</given-names></name>,<etal>et al</etal>.</person-group><article-title>D²P²: database of disordered protein predictions</article-title>.<source>Nucleic Acids Res</source><year>2013</year>;<volume>41</volume>:<fpage>D508</fpage>-<lpage>16</lpage>; http://dx.doi.org/<pub-id pub-id-type=""doi"">10.1093/nar/gks1226</pub-id>; PMID: 23203878<pub-id pub-id-type=""pmid"">23203878</pub-id></mixed-citation></ref><ref id=""R151""><label>151</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name name-style=""western""><surname>Uversky</surname><given-names>VN</given-names></name>,<name name-style=""western""><surname>Oldfield</surname><given-names>CJ</given-names></name>,<name name-style=""western""><surname>Dunker</surname><given-names>AK</given-names></name>.</person-group><article-title>Showing your ID: intrinsic disorder as an ID for recognition, regulation and cell signaling</article-title>.<source>J Mol Recognit</source><year>2005</year>;<volume>18</volume>:<fpage>343</fpage>-<lpage>84</lpage>; http://dx.doi.org/<pub-id pub-id-type=""doi"">10.1002/jmr.747</pub-id>; PMID: 16094605<pub-id pub-id-type=""pmid"">16094605</pub-id></mixed-citation></ref><ref id=""R152""><label>152</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name name-style=""western""><surname>Hasty</surname><given-names>J</given-names></name>,<name name-style=""western""><surname>Collins</surname><given-names>JJ</given-names></name>.</person-group><article-title>Protein interactions. Unspinning the web</article-title>.<source>Nature</source><year>2001</year>;<volume>411</volume>:<fpage>30</fpage>-<lpage>1</lpage>; http://dx.doi.org/<pub-id pub-id-type=""doi"">10.1038/35075182</pub-id>; PMID: 11333958<pub-id pub-id-type=""pmid"">11333958</pub-id></mixed-citation></ref><ref id=""R153""><label>153</label><mixed-citation publication-type=""book"">Landsteiner K. The Specificity of Serological Reactions. Mineola, New York: Courier Dover Publications, 1936.</mixed-citation></ref><ref id=""R154""><label>154</label><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name name-style=""western""><surname>Pauling</surname><given-names>L</given-names></name>.</person-group><article-title>A theory of the structure and process of formation of antibodies</article-title>.<source>J Am Chem Soc</source><year>1940</year>;<volume>62</volume>:<fpage>2643</fpage>-<lpage>57</lpage>; http://dx.doi.org/<pub-id pub-id-type=""doi"">10.1021/ja01867a018</pub-id></mixed-citation></ref></body></html>"
10.1111/j.1365-2958.2005.04612.x	"<html><body><article-title>luxS in bacteria isolated from 25- to 40-million-year-old amber</article-title>.<source>FEMS Microbiol Lett</source>.<year>2014</year>;<volume>350</volume>(<issue>1</issue>):<fpage>117</fpage>–<lpage>24</lpage>.<comment>doi:<ext-link ext-link-type=""uri"" xlink:href=""http://dx.doi.org/10.1111/1574-6968.12275"">10.1111/1574-6968.12275</ext-link></comment>.<pub-id pub-id-type=""pmid"">24102660</pub-id><ref id=""pone.0157532.ref014""><label>14</label><mixed-citation publication-type=""journal""><name><surname>De Keersmaecker</surname><given-names>SC</given-names></name>,<name><surname>Sonck</surname><given-names>K</given-names></name>,<name><surname>Vanderleyden</surname><given-names>J</given-names></name>.<article-title>Let LuxS speak up in AI-2 signaling</article-title>.<source>Trends Microbiol</source>.<year>2006</year>;<volume>14</volume>(<issue>3</issue>):<fpage>114</fpage>–<lpage>9</lpage>.<comment>doi:<ext-link ext-link-type=""uri"" xlink:href=""http://dx.doi.org/10.1016/j.tim.2006.01.003"">10.1016/j.tim.2006.01.003</ext-link></comment>.<pub-id pub-id-type=""pmid"">16459080</pub-id></mixed-citation></ref><ref id=""pone.0157532.ref015""><label>15</label><mixed-citation publication-type=""journal""><name><surname>Taga</surname><given-names>ME</given-names></name>,<name><surname>Semmelhack</surname><given-names>JL</given-names></name>,<name><surname>Bassler</surname><given-names>BL</given-names></name>.<article-title>The LuxS-dependent autoinducer AI-2 controls the expression of an ABC transporter that functions in AI-2 uptake in Salmonella typhimurium</article-title>.<source>Mol Microbiol</source>.<year>2001</year>;<volume>42</volume>(<issue>3</issue>):<fpage>777</fpage>–<lpage>93</lpage>. .<pub-id pub-id-type=""pmid"">11722742</pub-id></mixed-citation></ref><ref id=""pone.0157532.ref016""><label>16</label><mixed-citation publication-type=""journal""><name><surname>Xavier</surname><given-names>KB</given-names></name>,<name><surname>Bassler</surname><given-names>BL</given-names></name>.<article-title>Regulation of uptake and processing of the quorum-sensing autoinducer AI-2 in Escherichia coli</article-title>.<source>J Bacteriol</source>.<year>2005</year>;<volume>187</volume>(<issue>1</issue>):<fpage>238</fpage>–<lpage>48</lpage>.<comment>doi:<ext-link ext-link-type=""uri"" xlink:href=""http://dx.doi.org/10.1128/JB.187.1.238–248.2005"">10.1128/JB.187.1.238–248.2005</ext-link></comment>; PubMed Central PMCID: PMC538819.<pub-id pub-id-type=""pmid"">15601708</pub-id></mixed-citation></ref><ref id=""pone.0157532.ref017""><label>17</label><mixed-citation publication-type=""journal""><name><surname>Dong</surname><given-names>YH</given-names></name>,<name><surname>Zhang</surname><given-names>XF</given-names></name>,<name><surname>Soo</surname><given-names>HM</given-names></name>,<name><surname>Greenberg</surname><given-names>EP</given-names></name>,<name><surname>Zhang</surname><given-names>LH</given-names></name>.<article-title>The two-component response regulator PprB modulates quorum-sensing signal production and global gene expression in Pseudomonas aeruginosa</article-title>.<source>Mol Microbiol</source>.<year>2005</year>;<volume>56</volume>(<issue>5</issue>):<fpage>1287</fpage>–<lpage>301</lpage>.<comment>doi:<ext-link ext-link-type=""uri"" xlink:href=""http://dx.doi.org/10.1111/j.1365-2958.2005.04612.x"">10.1111/j.1365-2958.2005.04612.x</ext-link></comment>.<pub-id pub-id-type=""pmid"">15882421</pub-id></mixed-citation></ref><ref id=""pone.0157532.ref018""><label>18</label><mixed-citation publication-type=""journal""><name><surname>Fujii</surname><given-names>T</given-names></name>,<name><surname>Ingham</surname><given-names>C</given-names></name>,<name><surname>Nakayama</surname><given-names>J</given-names></name>,<name><surname>Beerthuyzen</surname><given-names>M</given-names></name>,<name><surname>Kunuki</surname><given-names>R</given-names></name>,<name><surname>Molenaar</surname><given-names>D</given-names></name>,<etal>et al</etal></mixed-citation></ref></body></html>"
10.1016/j.str.2008.04.010	"<html><body><inline-formula><mml:math id=""M8"" name=""1472-6807-10-40-i8"" overflow=""scroll""><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mi>l</mml:mi></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mover accent=""true""><mml:mi>X</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mi>a</mml:mi></mml:msub><mml:mo>:</mml:mo><mml:msub><mml:mover accent=""true""><mml:mi>X</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mi>b</mml:mi></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>are expressed in terms of a position (<italic>r<sub>n</sub></italic>) dependent step function<p><disp-formula id=""bmcM3""><label>(3)</label><mml:math id=""M9"" name=""1472-6807-10-40-i9"" overflow=""scroll""><mml:mrow><mml:msup><mml:mi>H</mml:mi><mml:mi>l</mml:mi></mml:msup><mml:mo stretchy=""false"">(</mml:mo><mml:mo stretchy=""false"">|</mml:mo><mml:msub><mml:mi>r</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mi>r</mml:mi><mml:mi>m</mml:mi></mml:msub><mml:mo stretchy=""false"">|</mml:mo><mml:mo stretchy=""false"">)</mml:mo><mml:mo>=</mml:mo><mml:mrow><mml:mo>{</mml:mo><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mn>1</mml:mn><mml:mtext>if</mml:mtext><mml:mo stretchy=""false"">|</mml:mo><mml:msub><mml:mi>r</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mi>r</mml:mi><mml:mi>m</mml:mi></mml:msub><mml:mo stretchy=""false"">|</mml:mo><mml:mo>≤</mml:mo><mml:msubsup><mml:mi>r</mml:mi><mml:mrow><mml:mi>c</mml:mi><mml:mi>u</mml:mi><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi></mml:mrow><mml:mi>l</mml:mi></mml:msubsup></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mn>0</mml:mn><mml:mtext></mml:mtext><mml:mi>o</mml:mi><mml:mi>t</mml:mi><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>w</mml:mi><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mrow></mml:mrow></mml:math></disp-formula></p><p>that extracts all interacting pairs<italic>m</italic>and<italic>n</italic>(in the respective monomers<italic>a</italic>and<italic>b</italic>) within an interaction range<italic>r<sup>l</sup><sub>cutoff</sub></italic>characteristic of the specific type (<italic>l</italic>) of interaction, i.e.</p><p><disp-formula id=""bmcM4""><label>(4)</label><mml:math id=""M10"" name=""1472-6807-10-40-i10"" overflow=""scroll""><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mi>l</mml:mi></mml:msub><mml:mo stretchy=""false"">(</mml:mo><mml:msub><mml:mi>X</mml:mi><mml:mi>a</mml:mi></mml:msub><mml:mo>:</mml:mo><mml:msub><mml:mi>X</mml:mi><mml:mi>b</mml:mi></mml:msub><mml:mo stretchy=""false"">)</mml:mo><mml:mo>=</mml:mo><mml:mstyle displaystyle=""true""><mml:munder><mml:mo>∑</mml:mo><mml:mrow><mml:mi>n</mml:mi><mml:mo>∈</mml:mo><mml:mi>a</mml:mi><mml:mo>,</mml:mo><mml:mi>m</mml:mi><mml:mo>∈</mml:mo><mml:mi>b</mml:mi></mml:mrow></mml:munder><mml:mrow><mml:msup><mml:mi>H</mml:mi><mml:mi>l</mml:mi></mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mo stretchy=""false"">|</mml:mo><mml:msub><mml:mi>r</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mi>r</mml:mi><mml:mi>m</mml:mi></mml:msub><mml:mo stretchy=""false"">|</mml:mo></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mi>δ</mml:mi><mml:mo stretchy=""false"">(</mml:mo><mml:mi>l</mml:mi><mml:mo>,</mml:mo><mml:mi>n</mml:mi><mml:mi>m</mml:mi><mml:mo stretchy=""false"">)</mml:mo></mml:mrow></mml:mstyle></mml:mrow></mml:math></disp-formula></p><p>Hereδ(<italic>l,nm</italic>) is the Kronecker delta, which equals 1 if the type of interaction between sites<italic>m</italic>and<italic>n</italic>is of type<italic>l</italic>, and 0 otherwise. For the side chain-based model we adopted<inline-formula><mml:math id=""M11"" name=""1472-6807-10-40-i11"" overflow=""scroll""><mml:mrow><mml:msubsup><mml:mi>r</mml:mi><mml:mrow><mml:mi>c</mml:mi><mml:mi>u</mml:mi><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi></mml:mrow><mml:mi>l</mml:mi></mml:msubsup></mml:mrow></mml:math></inline-formula>values of 4.4 Å for B-B, 5.6 Å for B-S, and 6.8 Å for S-S interactions, whereas for the atom-based model we adopted an<inline-formula><mml:math id=""M12"" name=""1472-6807-10-40-i11"" overflow=""scroll""><mml:mrow><mml:msubsup><mml:mi>r</mml:mi><mml:mrow><mml:mi>c</mml:mi><mml:mi>u</mml:mi><mml:mi>t</mml:mi><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mi>f</mml:mi></mml:mrow><mml:mi>l</mml:mi></mml:msubsup></mml:mrow></mml:math></inline-formula>value of 6.0 Å. The total energy for a given decoy<italic>i</italic>is reduced to the summation over the effective<italic>P<sub>l</sub></italic>, weighted by the numbers<inline-formula><mml:math id=""M13"" name=""1472-6807-10-40-i12"" overflow=""scroll""><mml:mrow><mml:msubsup><mml:mi>n</mml:mi><mml:mi>l</mml:mi><mml:mi>i</mml:mi></mml:msubsup></mml:mrow></mml:math></inline-formula>of contacts of type<italic>l</italic>occurring in the examined decoy. The<italic>N</italic>inequalities in Eq 1 are thus replaced by</p><p><disp-formula id=""bmcM5""><label>(5)</label><mml:math id=""M14"" name=""1472-6807-10-40-i13"" overflow=""scroll""><mml:mrow><mml:msubsup><mml:mrow><mml:mrow><mml:mo>{</mml:mo><mml:mrow><mml:mstyle displaystyle=""true""><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>l</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>253</mml:mn></mml:mrow></mml:munderover><mml:mrow><mml:msub><mml:mi>p</mml:mi><mml:mi>l</mml:mi></mml:msub><mml:mo stretchy=""false"">(</mml:mo><mml:msubsup><mml:mi>n</mml:mi><mml:mi>l</mml:mi><mml:mi>i</mml:mi></mml:msubsup><mml:mo>−</mml:mo><mml:msub><mml:mover accent=""true""><mml:mi>n</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mi>l</mml:mi></mml:msub><mml:mo stretchy=""false"">)</mml:mo><mml:mo>&gt;</mml:mo><mml:msub><mml:mi>ε</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:mstyle></mml:mrow><mml:mo>}</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>N</mml:mi></mml:msubsup></mml:mrow></mml:math></disp-formula></p><p>where<inline-formula><mml:math id=""M15"" name=""1472-6807-10-40-i14"" overflow=""scroll""><mml:mrow><mml:msub><mml:mover accent=""true""><mml:mi>n</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mi>l</mml:mi></mml:msub></mml:mrow></mml:math></inline-formula>is the number of contacts of type<italic>l</italic>in the native complex.</p><p>With one step contact potentials, a single cutoff distance defines the threshold below which interactions are considered to be ""on"", and above which these are considered to be ""off"". Such potentials may be too simplified to accurately describe the binding energy of interaction proteins. Alternatively, one can design multi-step contact potentials. We replaced the step function<inline-formula><mml:math id=""M16"" name=""1472-6807-10-40-i15"" overflow=""scroll""><mml:mrow><mml:msup><mml:mi>H</mml:mi><mml:mi>l</mml:mi></mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mo stretchy=""false"">|</mml:mo><mml:msub><mml:mi>r</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mi>r</mml:mi><mml:mi>m</mml:mi></mml:msub><mml:mo stretchy=""false"">|</mml:mo></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>by<inline-formula><mml:math id=""M17"" name=""1472-6807-10-40-i16"" overflow=""scroll""><mml:mrow><mml:msup><mml:mi>H</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mo>,</mml:mo><mml:mi>d</mml:mi></mml:mrow></mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mo stretchy=""false"">|</mml:mo><mml:msub><mml:mi>r</mml:mi><mml:mi>n</mml:mi></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mi>r</mml:mi><mml:mi>m</mml:mi></mml:msub><mml:mo stretchy=""false"">|</mml:mo></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>, where the superscript<italic>d</italic>refers to different distance ranges (<italic>r</italic><sub>1</sub>-<italic>r</italic><sub>2</sub>,<italic>r</italic><sub>2</sub>-<italic>r</italic><sub>3</sub>, ...,<italic>r</italic><sub>D-1</sub>-<italic>r</italic><sub>D</sub>). The energy of the<italic>i</italic><sup>th</sup>decoy is computed from the summation over the effective docking potentials<italic>p<sub>l,d</sub></italic>, weighted by the numbers<inline-formula><mml:math id=""M18"" name=""1472-6807-10-40-i17"" overflow=""scroll""><mml:mrow><mml:msubsup><mml:mi>n</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mo>,</mml:mo><mml:mi>d</mml:mi></mml:mrow><mml:mi>i</mml:mi></mml:msubsup></mml:mrow></mml:math></inline-formula>of contacts of type<italic>l</italic>occurring at the distance interval (<italic>d,d+</italic>1] in the examined decoy. The<italic>N</italic>inequalities (eq 5) are thus replaced by</p><p><disp-formula id=""bmcM6""><label>(6)</label><mml:math id=""M19"" name=""1472-6807-10-40-i18"" overflow=""scroll""><mml:mrow><mml:msubsup><mml:mrow><mml:mrow><mml:mo>{</mml:mo><mml:mrow><mml:mstyle displaystyle=""true""><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>l</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>253</mml:mn></mml:mrow></mml:munderover><mml:mrow><mml:mstyle displaystyle=""true""><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>d</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>D</mml:mi></mml:munderover><mml:mrow><mml:msub><mml:mi>p</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mo>,</mml:mo><mml:mi>d</mml:mi></mml:mrow></mml:msub><mml:mo stretchy=""false"">(</mml:mo><mml:msubsup><mml:mi>n</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mo>,</mml:mo><mml:mi>d</mml:mi></mml:mrow><mml:mi>i</mml:mi></mml:msubsup><mml:mo>−</mml:mo><mml:msubsup><mml:mover accent=""true""><mml:mi>n</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mrow><mml:mi>l</mml:mi><mml:mo>,</mml:mo><mml:mi>d</mml:mi></mml:mrow><mml:mrow></mml:mrow></mml:msubsup><mml:mo stretchy=""false"">)</mml:mo><mml:mo>&gt;</mml:mo><mml:msub><mml:mi>ε</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:mstyle></mml:mrow></mml:mstyle></mml:mrow><mml:mo>}</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>N</mml:mi></mml:msubsup></mml:mrow></mml:math></disp-formula></p><p>Determining the cutoff value for distance ranges in multiple step potentials is not trivial. To overcome this problem we derived a set of single step potentials using a series of successive cutoff values and measuring the correlation coefficients between potentials with adjacent cutoff values. If the correlation is relatively low another step is created at this point. In the side chain based-models the following steps were used:<italic>r<sub>1</sub></italic>≤ 4.5 and 4.5 &lt; r<sub>2</sub>≤6 Å for B-B,<italic>r<sub>1</sub></italic>≤ 5.5 and 5.5 &lt;<italic>r<sub>2</sub></italic>≤7 Å for B-S, and<italic>r<sub>1</sub></italic>≤ 6.5 and 6.5 &lt;<italic>r<sub>2</sub></italic>≤8.0 Å for S-S interactions to get a set of 253 × 2 = 506 parameters. In the atom-based models the following steps were used:<italic>r<sub>1</sub></italic>≤ 4 and 4&lt;<italic>r<sub>2</sub></italic>≤6 Å to get a set of 171 × 2 = 342 parameters.</p><sec><title>Generating a population of putative docked conformations</title><p>Decoys for the complexes, in their bound state, were generated in the dataset<italic>Protein-Protein Docking Benchmark 2.0</italic>by Mintseris<italic>et al</italic>. [<xref ref-type=""bibr"" rid=""B35"">35</xref>] (dataset 1). This dataset includes 83 Protein Data Bank (PDB) entries. We adopted the docking algorithm of Palma<italic>et al</italic>. [<xref ref-type=""bibr"" rid=""B8"">8</xref>], taking into consideration only the surface matching criterion to generate docked conformations. Geometric fit was assessed from the number of overlapping<italic>surface nodes</italic>between the receptor (large protein) and the substrate (small protein). The use of this criterion alone in the docking process enables us to generate an unbiased set of decoys, which form many contacts between the receptor and the ligand yet lacking any physicochemical basis. For any given rotation angle, all possible docking positions were divided into cells of 3 × 3 × 3 nodes according to their translation vector, and the best matching position from each cell was preserved. This modification of the algorithm enabled us to generate a comprehensive and unbiased set of misdocked conformations for each complex. To reduce the large numbers of decoys generated for each complex, the conformations were further clustered using a hierarchical clustering algorithm applying a cutoff value of root mean square deviation (RMSD) ≤ 10 Å and the central conformation of each cluster was preserved. On average, 144,000 non-native decoys (RMSD &gt; 5.0 Å) were generated for each complex, which summed up to a total of 11,973,763 non-redundant inequalities or constraints on the potentials' parameters. Another set of complexes (dataset 2), listed in Table<xref ref-type=""table"" rid=""T2"">2</xref>, is based on the work of Lo Conte<italic>et al</italic>. [<xref ref-type=""bibr"" rid=""B27"">27</xref>]. This set contains 40 complexes for which previously [<xref ref-type=""bibr"" rid=""B18"">18</xref>] we had generated decoys excluding those that share more that 60% sequence identity (receptor and ligand) with any of the complexes in dataset 1. Dataset 3 was derived from the dataset of Mintseris and Weng [<xref ref-type=""bibr"" rid=""B36"">36</xref>] as explained in the Results section (see Table<xref ref-type=""table"" rid=""T3"">3</xref>) and decoys were generated as above.</p><table-wrap id=""T2"" position=""float""><label>Table 2</label><caption><p>Dataset 2 contains 40 complexes<sup>1</sup></p></caption><table frame=""hsides"" rules=""groups""><tbody><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1A0O"">1A0O</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1EFN"">1EFN</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1KB5"">1KB5</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1TOC"">1TOC</ext-link></td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1AGR"">1AGR</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1FIN"">1FIN</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1MEL"">1MEL</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1TX4"">1TX4</ext-link></td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1BRS"">1BRS</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1FLE"">1FLE</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1MKW"">1MKW</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1YCS"">1YCS</ext-link></td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1BTH"">1BTH</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1FSS"">1FSS</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1NFD"">1NFD</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1YDR"">1YDR</ext-link></td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1CBW"">1CBW</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1GLA"">1GLA</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1NMB"">1NMB</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""2KAI"">2KAI</ext-link></td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1CHO"">1CHO</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1GUA"">1GUA</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1OSP"">1OSP</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""2PTC"">2PTC</ext-link></td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1CSE"">1CSE</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1HWG"">1HWG</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1PPF"">1PPF</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""2TRC"">2TRC</ext-link></td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1DHK"">1DHK</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1IAI"">1IAI</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1STF"">1STF</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""3SGB"">3SGB</ext-link></td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1DVF"">1DVF</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1IGC"">1IGC</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1TBQ"">1TBQ</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""4CPA"">4CPA</ext-link></td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1EBP"">1EBP</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1JHL"">1JHL</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1TGS"">1TGS</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""4HTC"">4HTC</ext-link></td></tr></tbody></table><table-wrap-foot><p>1. A subset of the Lo Conte<italic>et al</italic>. [<xref ref-type=""bibr"" rid=""B27"">27</xref>] dataset. The table list PDB codes.</p></table-wrap-foot></table-wrap><table-wrap id=""T3"" position=""float""><label>Table 3</label><caption><p>Dataset 3 contains 38 complexes<sup>1</sup></p></caption><table frame=""hsides"" rules=""groups""><tbody><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1TNR"">1TNR</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1FJ1"">1FJ1</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1HEZ"">1HEZ</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1HX1"">1HX1</ext-link></td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1IM3"">1IM3</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1SLU"">1SLU</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1WWW"">1WWW</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1G4Y"">1G4Y</ext-link></td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1DF9"">1DF9</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1CXZ"">1CXZ</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1IM9"">1IM9</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1CIC"">1CIC</ext-link></td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1BDJ"">1BDJ</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1DX5"">1DX5</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1EO8"">1EO8</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1JMA"">1JMA</ext-link></td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1GOY"">1GOY</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1C4Z"">1C4Z</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1ADQ"">1ADQ</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1I8L"">1I8L</ext-link></td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1GH6"">1GH6</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1FNS"">1FNS</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1JDP"">1JDP</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1D2Z"">1D2Z</ext-link></td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1E0O"">1E0O</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1BZQ"">1BZQ</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1DEE"">1DEE</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1AVG"">1AVG</ext-link></td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""3YGS"">3YGS</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1F02"">1F02</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""2VIR"">2VIR</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1AVA"">1AVA</ext-link></td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1NRN"">1NRN</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1EBD"">1EBD</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1QFU"">1QFU</ext-link></td><td></td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1QO3"">1QO3</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1J7V"">1J7V</ext-link></td><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1IAR"">1IAR</ext-link></td><td></td></tr></tbody></table><table-wrap-foot><p>1. A subset of the dataset of 209 transient complexes compiled by Mintseris and Weng [<xref ref-type=""bibr"" rid=""B36"">36</xref>]</p></table-wrap-foot></table-wrap></sec><sec><title>Numerical solution of linear inequalities</title><p>Inequalities were solved as explained in our previous work [<xref ref-type=""bibr"" rid=""B18"">18</xref>]. In short, each of the inequalities divides the parameter space into two regions, one allowed (any point within this space represents a valid solution), and one forbidden. A given inequality may affect the solution in three different ways: It may (1) further restrict the space allowed for the parameter set (most desirable), (2) have no effect on the allowed space, or (3) impose an impossible condition (reducing the allowed parameter space to zero). In the latter case no parameter set could satisfy all inequalities, making the inequalities unsolvable. Linear inequalities were solved using the interior point program BPMPD [<xref ref-type=""bibr"" rid=""B37"">37</xref>].</p></sec><sec><title>Test decoys</title><p>Test decoys were used to compare the performance of resulting potentials in the bound and unbound states. Decoy sets containing near-native complexes were generated for the complexes in dataset 1 (<italic>Benchmark 2.0</italic>by Mintseris<italic>et al</italic>. [<xref ref-type=""bibr"" rid=""B35"">35</xref>]). This dataset contains the bound and unbound structures of each of the complexes' subunits. Near-native decoys are defined as complexes having an RMSD ≤ 5.0 Å from the native state. To each complex, docking simulations close to the native state were performed and near-native decoys were generated. Docking was performed using the algorithm of Palma<italic>et al</italic>. [<xref ref-type=""bibr"" rid=""B8"">8</xref>], taking into consideration only the surface matching criterion to generate docked conformations. Geometric fit was assessed from the number of overlapping<italic>surface nodes</italic>between the receptor and the substrate. The docking was performed close to the native state by rotating the substrate by up to 30° and translating by up to 5Å around the native state. These decoys were clustered using a cutoff RMSD value of ≤ 3 Å and the central conformation of each cluster was preserved. Subsequently, the preserved decoys were sorted according to their RMSD values from the native state, and a subset of on average 95 decoys, uniformly spanning the entire range of near-native decoys, was selected. This subset was combined with the above set of non-native decoys generated for each complex. Test decoys in the unbound state were generated by superimposing the unbound structures on the decoys generated in the bound state. By doing so we generated for each complex a set of decoys containing a representative set of both non-native and near-native decoys that enabled us to accurately compare the performance of the potentials in the<italic>bound</italic>and<italic>unbound</italic>states irrespective of the docking sampling problem.</p></sec><sec><title>Jackknife procedure</title><p>The jackknife test was performed each time by randomly selecting ten complexes from dataset 1. Thereupon, any complex having more than 35% sequence identity with the selected complexes was removed from datasets 1, 2, and 3, and the remaining complexes served as the training set. New potentials were optimized using the reduced training set and tested on the selected ten complexes.</p></sec><sec><title>Results</title><sec><title>Optimizing docking potentials</title><p>When optimizing the single-step potentials using constraints derived from dataset 1 we encountered a state of infeasibility both for the atom-based and the side chain-based models. That is, no set of parameters could satisfy all the constraints. Therefore, two-steps potentials were derived. With these potentials we were able to solve all the constraints that were derived from both dataset 1 and dataset 2. The resulting SDPs and initial set of ADPs (ADPs-I) are presented in the additional file<xref ref-type=""supplementary-material"" rid=""S1"">1</xref>Tables S1 and S2, respectively. Next, we scanned the dataset of transient complexes compiled by Mintseris and Weng [<xref ref-type=""bibr"" rid=""B36"">36</xref>] and identified a subset of 38 complexes (dataset 3, see Table<xref ref-type=""table"" rid=""T3"">3</xref>), for which not all constraints were satisfied using the present ADPs-I and added them to our training dataset. Thereupon, we solved all constraints derived from datasets: 1, 2, and 3 to obtain a new set of atomic contact potentials (ADPs-II). ). The potentials are presented in Table S3 (additional file<xref ref-type=""supplementary-material"" rid=""S1"">1</xref>). In Figure<xref ref-type=""fig"" rid=""F1"">1</xref>, Panels (a) and (b) display the maps of the first and second steps of the ADPs-II, respectively, whereas Panel (c) displays the single step Decoys As the Reference State (DARS) [<xref ref-type=""bibr"" rid=""B15"">15</xref>] potentials. The average contact energy per atom group is displayed in Figure<xref ref-type=""fig"" rid=""F2"">2</xref>. The ADPs-II properties' and the qualitative differences between the two potentials will be discussed below. When attempting to solve these constraints using the side chain-based model a state of infeasibility was encountered, which persisted even when using a different set of cutoff values:<italic>r<sub>1</sub></italic>≤ 4.5 and 4.5 &lt; r<sub>2</sub>≤6 Å for B-B,<italic>r<sub>1</sub></italic>≤ 5.5 and 5.5 &lt;<italic>r<sub>2</sub></italic>≤7.5 Å for B-S, and<italic>r<sub>1</sub></italic>≤ 6.5 and 6.5 &lt;<italic>r<sub>2</sub></italic>≤9.0 Å for S-S interactions.</p><fig id=""F1"" position=""float""><label>Figure 1</label><caption><p><bold>Inter-atomic contact energies for protein-protein docking</bold>. The maps corresponding to the first and second step of the presently obtained Atomic Docking Potentials-II are shown in Panels (a) and (b), respectively. Panel (c) shows the map of the DARS potentials [<xref ref-type=""bibr"" rid=""B15"">15</xref>].</p></caption><graphic xlink:href=""1472-6807-10-40-1""></graphic></fig><fig id=""F2"" position=""float""><label>Figure 2</label><caption><p><bold>Average inter-atomic contact energy per atom type for the first (Panel a) and second (Panel b) step</bold>. Averaging was done over all atom types.</p></caption><graphic xlink:href=""1472-6807-10-40-2""></graphic></fig></sec><sec><title>Optimal tolerance to structural changes</title><p>In order to test the optimal tolerance of the potentials to structural changes between the bound and unbound states of the proteins, the decoys (see Methods) were ranked order exclusively based on the binding-energies. This test enabled comparing the performances of the potentials in the<italic>bound</italic>and the<italic>unbound</italic>states regardless of the sampling. Ranking success for ADPs-II is shown in Figure<xref ref-type=""fig"" rid=""F3"">3</xref>. In the<italic>bound</italic>state a near-native decoy is ranked in the top fifteen places in 72 out of 83 cases, and in the top fifty in 79 out of 83 cases. In the top 200 places a near-native was identified in all cases. These results are expected since these complexes were included in the training dataset. When ranking the<italic>unbound</italic>decoys using ADPs-II, in the top fifteen a near-native complex was ranked in twenty cases, and in the top fifty in twenty six cases. In the top 2000 ranked decoys no near-native complex was detected in sixteen cases.</p><fig id=""F3"" position=""float""><label>Figure 3</label><caption><p><bold>Ranking success histogram of the ADPs-II using dataset 1</bold>[<xref ref-type=""bibr"" rid=""B35"">35</xref>]. For each complex decoys were ranked order according to the binding energy alone and the rank of the best (lowest energy) near-native (RMSD ≤5Å) decoy was counted. The histogram shows the number of complexes, whose hits were ranked at the top 15, 16-50, 51-100, 101-200, 201-500, 501-1000, 1001-2000, and &gt; 2000 places in the bound (black) and unbound (gray) cases.</p></caption><graphic xlink:href=""1472-6807-10-40-3""></graphic></fig><p>In order to estimate the tolerance of the potentials to structural changes we measured the C<sup>α</sup>RMSD and heavy-atom RMSD of the interfacial amino acids (IRMSD) between the bound and unbound structure. Interfacial amino acids are defined as those having at least one atom in close proximity (<italic>r<sub>c</sub></italic>≤ 4.5 Å) to any atom of the other subunit. The average IRMSD vs. the ranking success of each ranked group is plotted in Figure<xref ref-type=""fig"" rid=""F4"">4</xref>. Complexes with a near-native structure ranked in the top 200 places do not show significant structural change between the bound and unbound states (average C<sup>α</sup>/heavy-atom IRMSD 1.35/2.05 Å). Complexes that are ranked in the range of 200-500 places are characterized by increased side chains displacements. Complexes with a near native structure not ranked in the top 500 places are characterized by large side chain and backbone movements (average C<sup>α</sup>/heavy-atom IRMSD &gt; 1.95/2.69 Å).</p><fig id=""F4"" position=""float""><label>Figure 4</label><caption><p><bold>Average interfacial RMSD of each ranked group plotted vs. the ranking success</bold>. The average RMSD of interfacial amino acids was measured using C<sup>α</sup>(red) and heavy-atoms (green). Interfacial amino acids are defined as those having at least one atom in close proximity (<italic>r<sub>c</sub></italic>≤ 4.5 Å) to any atom of the other subunit.</p></caption><graphic xlink:href=""1472-6807-10-40-4""></graphic></fig></sec><sec><title>Rescoring ZDOCK2.3 decoys</title><p>Next, we subjected the potentials to a jackknife test using the ZDOCK2.3 Decoys (6 degrees sampling) [<xref ref-type=""bibr"" rid=""B5"">5</xref>]. This test set contains 54000 predictions for each complex in the unbound state generated by the ZDOCK docking program. Each time ten complexes were selected randomly from dataset 1 (test complexes). Complexes homologous to the test complexes were removed from the training dataset and new sets of ADPs were developed (see Methods). The new potentials were used to rank order the decoys of the test set. This procedure was repeated five times to incorporate a total of fifty proteins. The average correlation coefficient between ADPs-II and the jackknifed potentials is 0.91 indicating the stability of the trained parameters. The ADPs-II performance was compared with two other potentials, the common Atomic Contact Energies (ACE) [<xref ref-type=""bibr"" rid=""B13"">13</xref>] and the newer DARS [<xref ref-type=""bibr"" rid=""B15"">15</xref>], as well with the Zdock2.3 scoring function. A hit was defined if the IRMSD ≤ 4Å, where IRMSD values were taken from the ZDOCK2.3 Decoys' supplied tables. The results have been summarized in Table<xref ref-type=""table"" rid=""T4"">4</xref>, and depicted graphically in Figure<xref ref-type=""fig"" rid=""F5"">5</xref>.</p><table-wrap id=""T4"" position=""float""><label>Table 4</label><caption><p>Ranking ZDOCK2.3 decoys (IRMSD ≤4Å) by the jackknife test</p></caption><table frame=""hsides"" rules=""groups""><tbody><tr><td align=""left""><bold>Complex<sup>a</sup></bold></td><td align=""center"" colspan=""4""><bold>Rank<sup>b</sup></bold></td></tr><tr><td></td><td colspan=""4""><hr/></td></tr><tr><td></td><td align=""center""><bold>ADPs-II<sup>c</sup></bold></td><td align=""center""><bold>Zdock2.3</bold></td><td align=""center""><bold>DARS</bold></td><td align=""center""><bold>ACE</bold></td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1AK4"">1AK4</ext-link></td><td align=""center"">-</td><td align=""center"">-</td><td align=""center"">950</td><td align=""center"">1744</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1B6C"">1B6C</ext-link></td><td align=""center"">95</td><td align=""center"">16</td><td align=""center"">9</td><td align=""center"">178</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1BVK"">1BVK</ext-link></td><td align=""center"">12</td><td align=""center"">268</td><td align=""center"">610</td><td align=""center"">-</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1DQJ"">1DQJ</ext-link></td><td align=""center"">-</td><td align=""center"">1490</td><td align=""center"">-</td><td align=""center"">-</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1EWY"">1EWY</ext-link></td><td align=""center"">164</td><td align=""center"">18</td><td align=""center"">42</td><td align=""center"">364</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1FC2"">1FC2</ext-link></td><td align=""center"">484</td><td align=""center"">-</td><td align=""center"">24</td><td align=""center"">797</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1GHQ"">1GHQ</ext-link></td><td align=""center"">-</td><td align=""center"">-</td><td align=""center"">-</td><td align=""center"">1308</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1HIA"">1HIA</ext-link></td><td align=""center"">21</td><td align=""center"">653</td><td align=""center"">122</td><td align=""center"">-</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1IJK"">1IJK</ext-link></td><td align=""center"">1131</td><td align=""center"">-</td><td align=""center"">368</td><td align=""center"">-</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1KLU"">1KLU</ext-link></td><td align=""center"">-</td><td align=""center"">-</td><td align=""center"">-</td><td align=""center"">-</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1AVX"">1AVX</ext-link></td><td align=""center"">5</td><td align=""center"">46</td><td align=""center"">6</td><td align=""center"">59</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1D6R"">1D6R</ext-link></td><td align=""center"">1840</td><td align=""center"">567</td><td align=""center"">-</td><td align=""center"">-</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1E96"">1E96</ext-link></td><td align=""center"">39</td><td align=""center"">399</td><td align=""center"">42</td><td align=""center"">490</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1F34"">1F34</ext-link></td><td align=""center"">13</td><td align=""center"">26</td><td align=""center"">666</td><td align=""center"">5</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1GCQ"">1GCQ</ext-link></td><td align=""center"">1030</td><td align=""center"">-</td><td align=""center"">1057</td><td align=""center"">1040</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1GRN"">1GRN</ext-link></td><td align=""center"">210</td><td align=""center"">102</td><td align=""center"">-</td><td align=""center"">-</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1I4D"">1I4D</ext-link></td><td align=""center"">84</td><td align=""center"">403</td><td align=""center"">965</td><td align=""center"">616</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1KXP"">1KXP</ext-link></td><td align=""center"">91</td><td align=""center"">7</td><td align=""center"">1</td><td align=""center"">200</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1NSN"">1NSN</ext-link></td><td align=""center"">53</td><td align=""center"">445</td><td align=""center"">-</td><td align=""center"">-</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1SBB"">1SBB</ext-link></td><td align=""center"">-</td><td align=""center"">-</td><td align=""center"">-</td><td align=""center"">-</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1ACB"">1ACB</ext-link></td><td align=""center"">113</td><td align=""center"">55</td><td align=""center"">24</td><td align=""center"">98</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1AKJ"">1AKJ</ext-link></td><td align=""center"">592</td><td align=""center"">40</td><td align=""center"">-</td><td align=""center"">-</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1AY7"">1AY7</ext-link></td><td align=""center"">120</td><td align=""center"">100</td><td align=""center"">-</td><td align=""center"">-</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1DFJ"">1DFJ</ext-link></td><td align=""center"">37</td><td align=""center"">1</td><td align=""center"">-</td><td align=""center"">-</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1EAW"">1EAW</ext-link></td><td align=""center"">65</td><td align=""center"">13</td><td align=""center"">33</td><td align=""center"">309</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1FQ1"">1FQ1</ext-link></td><td align=""center"">-</td><td align=""center"">-</td><td align=""center"">-</td><td align=""center"">-</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1GP2"">1GP2</ext-link></td><td align=""center"">4</td><td align=""center"">389</td><td align=""center"">58</td><td align=""center"">1681</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1I9R"">1I9R</ext-link></td><td align=""center"">184</td><td align=""center"">14</td><td align=""center"">589</td><td align=""center"">-</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1UDI"">1UDI</ext-link></td><td align=""center"">27</td><td align=""center"">13</td><td align=""center"">1</td><td align=""center"">1</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""2PCC"">2PCC</ext-link></td><td align=""center"">203</td><td align=""center"">193</td><td align=""center"">821</td><td align=""center"">120</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1AHW"">1AHW</ext-link></td><td align=""center"">23</td><td align=""center"">14</td><td align=""center"">-</td><td align=""center"">-</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1BUH"">1BUH</ext-link></td><td align=""center"">14</td><td align=""center"">-</td><td align=""center"">555</td><td align=""center"">-</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1E6E"">1E6E</ext-link></td><td align=""center"">2</td><td align=""center"">103</td><td align=""center"">44</td><td align=""center"">520</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1ML0"">1ML0</ext-link></td><td align=""center"">10</td><td align=""center"">1</td><td align=""center"">9</td><td align=""center"">32</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1PPE"">1PPE</ext-link></td><td align=""center"">3</td><td align=""center"">1</td><td align=""center"">1</td><td align=""center"">1</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1QFW"">1QFW</ext-link></td><td align=""center"">544</td><td align=""center"">74</td><td align=""center"">-</td><td align=""center"">-</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1TMQ"">1TMQ</ext-link></td><td align=""center"">9</td><td align=""center"">126</td><td align=""center"">12</td><td align=""center"">22</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1WEJ"">1WEJ</ext-link></td><td align=""center"">3</td><td align=""center"">42</td><td align=""center"">1047</td><td align=""center"">-</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""2JEL"">2JEL</ext-link></td><td align=""center"">307</td><td align=""center"">86</td><td align=""center"">76</td><td align=""center"">579</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""7CEI"">7CEI</ext-link></td><td align=""center"">15</td><td align=""center"">1</td><td align=""center"">920</td><td align=""center"">708</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1ATN"">1ATN</ext-link></td><td align=""center"">-</td><td align=""center"">-</td><td align=""center"">-</td><td align=""center"">-</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1BJ1"">1BJ1</ext-link></td><td align=""center"">6</td><td align=""center"">18</td><td align=""center"">18</td><td align=""center"">85</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1CGI"">1CGI</ext-link></td><td align=""center"">71</td><td align=""center"">247</td><td align=""center"">13</td><td align=""center"">24</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1F51"">1F51</ext-link></td><td align=""center"">1</td><td align=""center"">11</td><td align=""center"">251</td><td align=""center"">797</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1KAC"">1KAC</ext-link></td><td align=""center"">121</td><td align=""center"">1389</td><td align=""center"">-</td><td align=""center"">-</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1KKL"">1KKL</ext-link></td><td align=""center"">283</td><td align=""center"">-</td><td align=""center"">1</td><td align=""center"">222</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1NCA"">1NCA</ext-link></td><td align=""center"">4</td><td align=""center"">4</td><td align=""center"">-</td><td align=""center"">-</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1QA9"">1QA9</ext-link></td><td align=""center"">687</td><td align=""center"">-</td><td align=""center"">-</td><td align=""center"">-</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""2SNI"">2SNI</ext-link></td><td align=""center"">17</td><td align=""center"">618</td><td align=""center"">1</td><td align=""center"">2</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1RLB"">1RLB</ext-link></td><td align=""center"">48</td><td align=""center"">302</td><td align=""center"">5</td><td align=""center"">7</td></tr></tbody></table><table-wrap-foot><p>a-Complex PDB code.</p><p>b-Rank of the lowest energy near-native decoy with IRMSD ≤4Å out of 54000 predictions.</p><p>c-Jackknife test (see Methods)</p><p>-- No near-native decoy identified among the 2000 best ranked decoys.</p></table-wrap-foot></table-wrap><fig id=""F5"" position=""float""><label>Figure 5</label><caption><p><bold>Ranking success of ZDOCK2.3 decoys</bold>. Four potentials, ADPs-II (red), ZDOCK2.3 (green), DARS (blue), and ACE (pink) were tested on of fifty complexes taken from ZDOCK2.3 decoys set. The ADPs-II potentials were subjected to a jackknife test (see Methods). The histogram shows the ranking distribution of the hits (best rank of near native decoy).</p></caption><graphic xlink:href=""1472-6807-10-40-5""></graphic></fig><p>A near-native decoy was ranked in the top 100 places for twenty seven complexes using the ADPs-II, for twenty two using the Zdock2.3 scoring function, for twenty using DARS, and for eleven using ACE. The numbers of times the potentials failed to include a near-native case among the top 2000 raked decoys is: seven for the ADPs-II, twelve for the Zdock2.3 scoring function, seventeen for DARS, and twenty two for ACE. Thus, the ADPs-II outperform the other potentials on this set of decoys generated by a docking program different from the one used to generate the training decoys. The interfacial surface area of each complex was measured using the program Naccess [<xref ref-type=""bibr"" rid=""B38"">38</xref>]. No correlation was found between the size of the interfacial area and the success rate of the ADPs-II.</p><p>We also compared the capabilities of the ADPs-II and Zdock2.3 scoring functions to rank hits in the top ten places. In order to be consistent with the Zdock [<xref ref-type=""bibr"" rid=""B5"">5</xref>] studies, a hit is defined if the interfacial RMSD is ≤ 2.5Å. For thirty-nine out of the fifty complexes used in the Jackknife test such hits do exist in the Zdock2.3 decoy set. The results are presented in Table<xref ref-type=""table"" rid=""T5"">5</xref>. A near-native decoy was ranked in the top 10 places for eight (20.5%) complexes using the ADPs-II, and for six (15.4%) using the Zdock2.3 scoring function.</p><table-wrap id=""T5"" position=""float""><label>Table 5</label><caption><p>Ranking ZDOCK2.3 decoys (IRMSD ≤2.5Å) by the jackknife test</p></caption><table frame=""hsides"" rules=""groups""><tbody><tr><td align=""left""><bold>Complex</bold></td><td align=""center"" colspan=""2""><bold>Rank<sup>a</sup></bold></td></tr><tr><td></td><td colspan=""2""><hr/></td></tr><tr><td></td><td align=""center""><bold>ADPs-II<sup>b</sup></bold></td><td align=""center""><bold>Zdock2.3</bold></td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1B6C"">1B6C</ext-link></td><td align=""center"">311</td><td align=""center"">168</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1BVK"">1BVK</ext-link></td><td align=""center"">-</td><td align=""center"">-</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1DQJ"">1DQJ</ext-link></td><td align=""center"">-</td><td align=""center"">-</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1EWY"">1EWY</ext-link></td><td align=""center"">754</td><td align=""center"">113</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1IJK"">1IJK</ext-link></td><td align=""center"">1131</td><td align=""center"">-</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1AVX"">1AVX</ext-link></td><td align=""center"">955</td><td align=""center"">449</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1D6R"">1D6R</ext-link></td><td align=""center"">-</td><td align=""center"">-</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1E96"">1E96</ext-link></td><td align=""center"">326</td><td align=""center"">399</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1F34"">1F34</ext-link></td><td align=""center"">-</td><td align=""center"">26</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1GCQ"">1GCQ</ext-link></td><td align=""center"">-</td><td align=""center"">-</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1GRN"">1GRN</ext-link></td><td align=""center"">492</td><td align=""center"">807</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1KXP"">1KXP</ext-link></td><td align=""center"">381</td><td align=""center"">7</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1NSN"">1NSN</ext-link></td><td align=""center"">-</td><td align=""center"">445</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1SBB"">1SBB</ext-link></td><td align=""center"">-</td><td align=""center"">-</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1AKJ"">1AKJ</ext-link></td><td align=""center"">-</td><td align=""center"">96</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1AY7"">1AY7</ext-link></td><td align=""center"">236</td><td align=""center"">-</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1DFJ"">1DFJ</ext-link></td><td align=""center"">720</td><td align=""center"">1</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1EAW"">1EAW</ext-link></td><td align=""center"">152</td><td align=""center"">13</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1I9R"">1I9R</ext-link></td><td align=""center"">329</td><td align=""center"">90</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1UDI"">1UDI</ext-link></td><td align=""center"">386</td><td align=""center"">13</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""2PCC"">2PCC</ext-link></td><td align=""center"">-</td><td align=""center"">-</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1AHW"">1AHW</ext-link></td><td align=""center"">23</td><td align=""center"">56</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1BUH"">1BUH</ext-link></td><td align=""center"">16</td><td align=""center"">-</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1E6E"">1E6E</ext-link></td><td align=""center"">2</td><td align=""center"">103</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1ML0"">1ML0</ext-link></td><td align=""center"">10</td><td align=""center"">1</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1PPE"">1PPE</ext-link></td><td align=""center"">3</td><td align=""center"">1</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1QFW"">1QFW</ext-link></td><td align=""center"">1080</td><td align=""center"">74</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1TMQ"">1TMQ</ext-link></td><td align=""center"">9</td><td align=""center"">126</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1WEJ"">1WEJ</ext-link></td><td align=""center"">3</td><td align=""center"">102</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""2JEL"">2JEL</ext-link></td><td align=""center"">307</td><td align=""center"">86</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""7CEI"">7CEI</ext-link></td><td align=""center"">42</td><td align=""center"">1</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1BJ1"">1BJ1</ext-link></td><td align=""center"">6</td><td align=""center"">18</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1CGI"">1CGI</ext-link></td><td align=""center"">-</td><td align=""center"">-</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1F51"">1F51</ext-link></td><td align=""center"">1</td><td align=""center"">11</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1KAC"">1KAC</ext-link></td><td align=""center"">-</td><td align=""center"">1523</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1NCA"">1NCA</ext-link></td><td align=""center"">4</td><td align=""center"">4</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1QA9"">1QA9</ext-link></td><td align=""center"">-</td><td align=""center"">-</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""2SNI"">2SNI</ext-link></td><td align=""center"">17</td><td align=""center"">-</td></tr><tr><td align=""left""><ext-link ext-link-type=""pdb"" xlink:href=""1RLB"">1RLB</ext-link></td><td align=""center"">48</td><td align=""center"">302</td></tr><tr><td align=""left""><bold>Top10</bold></td><td align=""center""><bold>8 (20.5%)</bold></td><td align=""center""><bold>6 (15.4%)</bold></td></tr></tbody></table><table-wrap-foot><p>a-Rank of the lowest energy near-native decoy with IRMSD ≤2.5Å out of 54000 predictions.</p><p>b-Jackknife test (see Methods)</p><p>--No near-native decoy identified among the 2000 best ranked decoys.</p></table-wrap-foot></table-wrap></sec></sec><sec><title>Discussion and Conclusions</title><p>When trying to solve the set of inequalities derived from dataset 1 using the one step potentials (for either the ADPs or the SDPs) we encountered the state of infeasibility. That is, no set of parameters can satisfy all inequalities. These results indicate that neither the common functional form of atomic contact potentials [<xref ref-type=""bibr"" rid=""B13"">13</xref>,<xref ref-type=""bibr"" rid=""B15"">15</xref>] (18 atom types, see Table<xref ref-type=""table"" rid=""T1"">1</xref>and<italic>r<sub>cutoff</sub></italic>values of 6.0 Å), nor the side chain-based potentials we designed [<xref ref-type=""bibr"" rid=""B18"">18</xref>], were adequate to discriminate at a high level between native and non-native docked complexes. We note that infeasibility was encountered for atomic contact potentials even when using a<italic>r<sub>cutoff</sub></italic>value of 5.0 Å or 4.0 Å [<xref ref-type=""bibr"" rid=""B18"">18</xref>]. In the current study were able to overcome the problem by developing two-step potentials and doubling the number of parameters for the ADPs and the SDPs.</p><p>Two types of potentials were developed for protein-protein docking: one heavy atom based (ADPs-I), and one side-chain based (SDPs), using training datasets 1 and 2 for both cases. When we added dataset 3 to the training database we were still able to solve all derived constraints using the atomic model (ADPs-II) but not using the side-chain based model, in spite of the fact that the atomic level model has fewer parameters (342 types of interactions) than the side-chain based one (506 types of interactions). These results are in agreement with two other publications [<xref ref-type=""bibr"" rid=""B17"">17</xref>,<xref ref-type=""bibr"" rid=""B23"">23</xref>] showing that the discriminatory powers of atomic level potentials are superior to those of residue level potentials.</p><p>We have tested the tolerance of the resulting ADPs-II to structural changes between the bound and unbound structures under optimal conditions. That is when the complexes were included in the training set and the unbound decoys were generated by superimposing the unbound structures on the decoys generated in the bound state. This comparison enable us the test the effect of structural changes per se. The results (Figure<xref ref-type=""fig"" rid=""F4"">4</xref>) indicate that structural changes, measured by IRMSD of C<sup>α</sup>/all heavy atoms of more than 1.5Å/2.2Å, impair the ability of the potentials to rank a near native structure in the top 200 places.</p><p>Here we show that the ADPs-II outperforms two other contact potentials: the ACE and DARS. In addition, the ADPs-II outperforms the Zdock2.3 scoring function, which is a combination of desolvation energy (based on the ACE contact potential) electrostatics and shape complementarity [<xref ref-type=""bibr"" rid=""B5"">5</xref>]. The shape complementarity criterion alone was shown to have good ranking ability of near native structures [<xref ref-type=""bibr"" rid=""B39"">39</xref>]. Therefore, the performance of our ADPs-II in conjunction with shape complementarity and electrostatics is likely to improve.</p><p>The colour coded map of the potentials is shown in Figure<xref ref-type=""fig"" rid=""F1"">1a</xref>and<xref ref-type=""fig"" rid=""F1"">1b</xref>for ADPs-II and in Figure<xref ref-type=""fig"" rid=""F1"">1c</xref>for DARS. Analysis of the ADPs-II reveals that the first step potentials (r ≤ 4Å) are stronger in their magnitude than the second step potentials (4 &lt; r ≤ 6Å). The average absolute value of the first and second step potentials is 1.25 and 0.4 respectively. The standard deviation of the ADPs-II is 1.88 and 0.79 for the first and second steps respectively and 0.74 for the DARS potentials. Thus, separating the potentials into two steps allows us to generate more varied potentials in the first step than in the second step that contains more information. While, the variability of the single step DARS potentials appear to be closer to that of the ADPs-II second step. The average interaction per atom type for the first and second step is displayed in Figure<xref ref-type=""fig"" rid=""F2"">2</xref>. Overall, the average interactions of the first step potentials are more repulsive than the second step potentials with hydrogen bond interactions being the most attractive ones in the first step potentials. On the other hand, in the second step potentials hydrophobic interactions are the most attractive ones. Comparing the ADPs-II with the DARS reveals some interesting differences. For example, CSγ-CSγ interaction is the most repulsive ADPs-II potential in both ranges whiles the most attractive DARS potential. We emphasize that our potentials were derived exclusively from transient complexes where the formation of Cys-Cys interactions are undesired, since these complexes are formed and detach from each other in response to specific biological conditions. The DARS potentials assign repulsive to neutral energies to all backbone interactions (atoms: N, Cα, C, and O), except for the Cα-Cα interaction, which is attractive. Our ADPs-II assign a relatively attractive energy to the C-N interactions at the close range and, therefore, captures more accurately H-bond interactions. Interestingly, and unlike the Cα-Cα interactions, GCα-GCα interactions also are assigned a large attractive energy. This may reflect the flexibly and compactness of the Gly side chains, allowing those to be in closer proximity with each other relative to other side chains.</p><p>Most computational approaches for protein-protein docking involve a tradeoff between accuracy and computational power. Therefore, a common scheme for protein docking is an initial on grid exhaustive search [<xref ref-type=""bibr"" rid=""B5"">5</xref>,<xref ref-type=""bibr"" rid=""B8"">8</xref>,<xref ref-type=""bibr"" rid=""B40"">40</xref>] using relatively simple scoring functions followed by off grid refinement and reranking stage using more elaborate energy functions. Several types of docking potentials were developed for these purposes. On one hand are the relatively simple one step potentials such as DARS and ACE, whereas on the other hand are the multiple step potential such as the ITScore-PP (step sizes of 0.2Å and R<sub>cutoff</sub>of 10Å) [<xref ref-type=""bibr"" rid=""B23"">23</xref>]. The latter potentials were shown to successfully rank the Zdock2.3 decoy (Huang and Zou[<xref ref-type=""bibr"" rid=""B23"">23</xref>], Table six), these potentials rank a near-native (IRMSD ≤ 2.5Å) in the top 10 places in 36.3% of the cases compared to a success rate of 20.5% for our ADPs-II (Table<xref ref-type=""table"" rid=""T5"">5</xref>). The ITScore-PP scoring function is very appropriate for the reranking stage of the docked structure as it requires pre-minimization of the structures to remove clashes and its resolution (0.2Å) is much finer than the 1Å spacing usually used for the search grid. Here we developed an intermediate level of complexity potentials, closer in their functional form to the DARS and ACE than to the ITScore-PP. These potentials are likely to improve the initial on grid search step.</p><p>The main challenges in designing transient protein-protein docking potentials using the Boltzmann statistics are: (i) Compiling a none-redundant and representative dataset of protein complexes and, (ii) Setting a reference state. To develop the ACE, Zhang<italic>et al</italic>. used a set of protein folds as a learning dataset and their shuffled structures as a reference state [<xref ref-type=""bibr"" rid=""B13"">13</xref>]. Chuang<italic>et al</italic>. (DARS) used a set of transient and none-transient protein interfaces as a learning set and a large set of misdocked decoys as the reference state [<xref ref-type=""bibr"" rid=""B15"">15</xref>]. Using the LP approach we were able to train our potentials using a dataset of transient complexes<italic>only</italic>with no need to define a reference state. The ability to learn solely from transient complexes may add specificity toward this type of complexes. The above results show that the LP approach is a good alternative to the Boltzmann statistics in designing protein docking potentials.</p></sec><sec><title>List of abbreviations</title><p>(ADPs): atom-based docking potentials; (DP): docking potential; (FP): false positive; (LP): linear programming; (RMSD): root mean square deviation; (IRMSD): interfacial RMSD; (SDPs): side-chain based docking potentials;   (TP): true positive.</p></sec><sec><title>Authors' contributions</title><p>DT preformed the work and wrote the manuscript.</p></sec><sec sec-type=""supplementary-material""><title>Supplementary Material</title><supplementary-material content-type=""local-data"" id=""S1""><caption><title>Additional file 1</title><p><bold>Supplementary material</bold>. Supplementary tables S1, S2 and S3</p></caption><media mime-subtype=""pdf"" mimetype=""application"" xlink:href=""1472-6807-10-40-S1.PDF""><caption><p>Click here for file</p></caption></media></supplementary-material></sec></body><back><sec><title>Acknowledgements</title><p>This research was supported by the Israel Science Foundation (grant No. 713/08).</p></sec><ref-list><ref id=""B1""><mixed-citation publication-type=""journal""><name><surname>Johnston</surname><given-names>CA</given-names></name><name><surname>Kimple</surname><given-names>AJ</given-names></name><name><surname>Giguere</surname><given-names>PM</given-names></name><name><surname>Siderovski</surname><given-names>DP</given-names></name><article-title>Structure of the parathyroid hormone receptor C terminus bound to the G-protein dimer Gbeta1gamma2</article-title><source>Structure</source><year>2008</year><volume>16</volume><issue>7</issue><fpage>1086</fpage><lpage>1094</lpage><pub-id pub-id-type=""doi"">10.1016/j.str.2008.04.010</pub-id><pub-id pub-id-type=""pmid"">18611381</pub-id></mixed-citation></ref><ref id=""B2""><mixed-citation publication-type=""journal""><name><surname>Jeffrey</surname><given-names>PD</given-names></name><name><surname>Russo</surname><given-names>AA</given-names></name><name><surname>Polyak</surname><given-names>K</given-names></name><name><surname>Gibbs</surname><given-names>E</given-names></name><name><surname>Hurwitz</surname><given-names>J</given-names></name><name><surname>Massague</surname><given-names>J</given-names></name><name><surname>Pavletich</surname><given-names>NP</given-names></name><article-title>Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex</article-title><source>Nature</source><year>1995</year><volume>376</volume><issue>6538</issue><fpage>313</fpage><lpage>320</lpage><pub-id pub-id-type=""doi"">10.1038/376313a0</pub-id><pub-id pub-id-type=""pmid"">7630397</pub-id></mixed-citation></ref><ref id=""B3""><mixed-citation publication-type=""journal""><name><surname>Schueler-Furman</surname><given-names>O</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Bradley</surname><given-names>P</given-names></name><name><surname>Misura</surname><given-names>K</given-names></name><name><surname>Baker</surname><given-names>D</given-names></name><article-title>Progress in modeling of protein structures and interactions</article-title><source>Science</source><year>2005</year><volume>310</volume><issue>5748</issue><fpage>638</fpage><lpage>642</lpage><pub-id pub-id-type=""doi"">10.1126/science.1112160</pub-id><pub-id pub-id-type=""pmid"">16254179</pub-id></mixed-citation></ref><ref id=""B4""><mixed-citation publication-type=""journal""><name><surname>Halperin</surname><given-names>I</given-names></name><name><surname>Ma</surname><given-names>B</given-names></name><name><surname>Wolfson</surname><given-names>H</given-names></name><name><surname>Nussinov</surname><given-names>R</given-names></name><article-title>Principles of docking: An overview of search algorithms and a guide to scoring functions</article-title><source>Proteins</source><year>2002</year><volume>47</volume><issue>4</issue><fpage>409</fpage><lpage>443</lpage><pub-id pub-id-type=""doi"">10.1002/prot.10115</pub-id><pub-id pub-id-type=""pmid"">12001221</pub-id></mixed-citation></ref><ref id=""B5""><mixed-citation publication-type=""journal""><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Weng</surname><given-names>Z</given-names></name><article-title>ZDOCK: an initial-stage protein-docking algorithm</article-title><source>Proteins</source><year>2003</year><volume>52</volume><issue>1</issue><fpage>80</fpage><lpage>87</lpage><pub-id pub-id-type=""doi"">10.1002/prot.10389</pub-id><pub-id pub-id-type=""pmid"">12784371</pub-id></mixed-citation></ref><ref id=""B6""><mixed-citation publication-type=""journal""><name><surname>Vajda</surname><given-names>S</given-names></name><name><surname>Kozakov</surname><given-names>D</given-names></name><article-title>Convergence and combination of methods in protein-protein docking</article-title><source>Curr Opin Struct Biol</source><year>2009</year><volume>19</volume><issue>2</issue><fpage>164</fpage><lpage>170</lpage><pub-id pub-id-type=""doi"">10.1016/j.sbi.2009.02.008</pub-id><pub-id pub-id-type=""pmid"">19327983</pub-id></mixed-citation></ref><ref id=""B7""><mixed-citation publication-type=""journal""><name><surname>Ben-Zeev</surname><given-names>E</given-names></name><name><surname>Eisenstein</surname><given-names>M</given-names></name><article-title>Weighted geometric docking: incorporating external information in the rotation-translation scan</article-title><source>Proteins</source><year>2003</year><volume>52</volume><issue>1</issue><fpage>24</fpage><lpage>27</lpage><pub-id pub-id-type=""doi"">10.1002/prot.10391</pub-id><pub-id pub-id-type=""pmid"">12784363</pub-id></mixed-citation></ref><ref id=""B8""><mixed-citation publication-type=""journal""><name><surname>Palma</surname><given-names>PN</given-names></name><name><surname>Krippahl</surname><given-names>L</given-names></name><name><surname>Wampler</surname><given-names>JE</given-names></name><name><surname>Moura</surname><given-names>JJ</given-names></name><article-title>BiGGER: a new (soft) docking algorithm for predicting protein interactions</article-title><source>Proteins</source><year>2000</year><volume>39</volume><issue>4</issue><fpage>372</fpage><lpage>384</lpage><pub-id pub-id-type=""doi"">10.1002/(SICI)1097-0134(20000601)39:4&lt;372::AID-PROT100&gt;3.0.CO;2-Q</pub-id><pub-id pub-id-type=""pmid"">10813819</pub-id></mixed-citation></ref><ref id=""B9""><mixed-citation publication-type=""journal""><name><surname>Zacharias</surname><given-names>M</given-names></name><article-title>Accounting for conformational changes during protein-protein docking</article-title><source>Curr Opin Struct Biol</source><year>2010</year><volume>20</volume><issue>2</issue><fpage>180</fpage><lpage>186</lpage><pub-id pub-id-type=""doi"">10.1016/j.sbi.2010.02.001</pub-id><pub-id pub-id-type=""pmid"">20194014</pub-id></mixed-citation></ref><ref id=""B10""><mixed-citation publication-type=""journal""><name><surname>Camacho</surname><given-names>CJ</given-names></name><name><surname>Ma</surname><given-names>H</given-names></name><name><surname>Champ</surname><given-names>PC</given-names></name><article-title>Scoring a diverse set of high-quality docked conformations: a metascore based on electrostatic and desolvation interactions</article-title><source>Proteins</source><year>2006</year><volume>63</volume><issue>4</issue><fpage>868</fpage><lpage>877</lpage><pub-id pub-id-type=""doi"">10.1002/prot.20932</pub-id><pub-id pub-id-type=""pmid"">16506242</pub-id></mixed-citation></ref><ref id=""B11""><mixed-citation publication-type=""journal""><name><surname>Fernandez-Recio</surname><given-names>J</given-names></name><name><surname>Totrov</surname><given-names>M</given-names></name><name><surname>Abagyan</surname><given-names>R</given-names></name><article-title>ICM-DISCO docking by global energy optimization with fully flexible side-chains</article-title><source>Proteins</source><year>2003</year><volume>52</volume><issue>1</issue><fpage>113</fpage><lpage>117</lpage><pub-id pub-id-type=""doi"">10.1002/prot.10383</pub-id><pub-id pub-id-type=""pmid"">12784376</pub-id></mixed-citation></ref><ref id=""B12""><mixed-citation publication-type=""journal""><name><surname>Mandell</surname><given-names>JG</given-names></name><name><surname>Roberts</surname><given-names>VA</given-names></name><name><surname>Pique</surname><given-names>ME</given-names></name><name><surname>Kotlovyi</surname><given-names>V</given-names></name><name><surname>Mitchell</surname><given-names>JC</given-names></name><name><surname>Nelson</surname><given-names>E</given-names></name><name><surname>Tsigelny</surname><given-names>I</given-names></name><name><surname>Ten Eyck</surname><given-names>LF</given-names></name><article-title>Protein docking using continuum electrostatics and geometric fit</article-title><source>Protein Eng</source><year>2001</year><volume>14</volume><issue>2</issue><fpage>105</fpage><lpage>113</lpage><pub-id pub-id-type=""doi"">10.1093/protein/14.2.105</pub-id><pub-id pub-id-type=""pmid"">11297668</pub-id></mixed-citation></ref><ref id=""B13""><mixed-citation publication-type=""journal""><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Vasmatzis</surname><given-names>G</given-names></name><name><surname>Cornette</surname><given-names>JL</given-names></name><name><surname>DeLisi</surname><given-names>C</given-names></name><article-title>Determination of atomic desolvation energies from the structures of crystallized proteins</article-title><source>J Mol Biol</source><year>1997</year><volume>267</volume><issue>3</issue><fpage>707</fpage><lpage>726</lpage><pub-id pub-id-type=""doi"">10.1006/jmbi.1996.0859</pub-id><pub-id pub-id-type=""pmid"">9126848</pub-id></mixed-citation></ref><ref id=""B14""><mixed-citation publication-type=""journal""><name><surname>Pierce</surname><given-names>B</given-names></name><name><surname>Weng</surname><given-names>Z</given-names></name><article-title>ZRANK: reranking protein docking predictions with an optimized energy function</article-title><source>Proteins</source><year>2007</year><volume>67</volume><issue>4</issue><fpage>1078</fpage><lpage>1086</lpage><pub-id pub-id-type=""doi"">10.1002/prot.21373</pub-id><pub-id pub-id-type=""pmid"">17373710</pub-id></mixed-citation></ref><ref id=""B15""><mixed-citation publication-type=""journal""><name><surname>Chuang</surname><given-names>GY</given-names></name><name><surname>Kozakov</surname><given-names>D</given-names></name><name><surname>Brenke</surname><given-names>R</given-names></name><name><surname>Comeau</surname><given-names>SR</given-names></name><name><surname>Vajda</surname><given-names>S</given-names></name><article-title>DARS (Decoys As the Reference State) potentials for protein-protein docking</article-title><source>Biophys J</source><year>2008</year><volume>95</volume><issue>9</issue><fpage>4217</fpage><lpage>4227</lpage><pub-id pub-id-type=""doi"">10.1529/biophysj.108.135814</pub-id><pub-id pub-id-type=""pmid"">18676649</pub-id></mixed-citation></ref><ref id=""B16""><mixed-citation publication-type=""journal""><name><surname>Mintseris</surname><given-names>J</given-names></name><name><surname>Pierce</surname><given-names>B</given-names></name><name><surname>Wiehe</surname><given-names>K</given-names></name><name><surname>Anderson</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Weng</surname><given-names>Z</given-names></name><article-title>Integrating statistical pair potentials into protein complex prediction</article-title><source>Proteins</source><year>2007</year><volume>69</volume><issue>3</issue><fpage>511</fpage><lpage>520</lpage><pub-id pub-id-type=""doi"">10.1002/prot.21502</pub-id><pub-id pub-id-type=""pmid"">17623839</pub-id></mixed-citation></ref><ref id=""B17""><mixed-citation publication-type=""journal""><name><surname>Lu</surname><given-names>H</given-names></name><name><surname>Lu</surname><given-names>L</given-names></name><name><surname>Skolnick</surname><given-names>J</given-names></name><article-title>Development of unified statistical potentials describing protein-protein interactions</article-title><source>Biophys J</source><year>2003</year><volume>84</volume><issue>3</issue><fpage>1895</fpage><lpage>1901</lpage><pub-id pub-id-type=""doi"">10.1016/S0006-3495(03)74997-2</pub-id><pub-id pub-id-type=""pmid"">12609891</pub-id></mixed-citation></ref><ref id=""B18""><mixed-citation publication-type=""journal""><name><surname>Tobi</surname><given-names>D</given-names></name><name><surname>Bahar</surname><given-names>I</given-names></name><article-title>Optimal design of protein docking potentials: efficiency and limitations</article-title><source>Proteins</source><year>2006</year><volume>62</volume><issue>4</issue><fpage>970</fpage><lpage>981</lpage><pub-id pub-id-type=""doi"">10.1002/prot.20859</pub-id><pub-id pub-id-type=""pmid"">16385562</pub-id></mixed-citation></ref><ref id=""B19""><mixed-citation publication-type=""journal""><name><surname>Clark</surname><given-names>LA</given-names></name><name><surname>van Vlijmen</surname><given-names>HW</given-names></name><article-title>A knowledge-based forcefield for protein-protein interface design</article-title><source>Proteins</source><year>2008</year><volume>70</volume><issue>4</issue><fpage>1540</fpage><lpage>1550</lpage><pub-id pub-id-type=""doi"">10.1002/prot.21694</pub-id><pub-id pub-id-type=""pmid"">17910054</pub-id></mixed-citation></ref><ref id=""B20""><mixed-citation publication-type=""journal""><name><surname>Glaser</surname><given-names>F</given-names></name><name><surname>Steinberg</surname><given-names>DM</given-names></name><name><surname>Vakser</surname><given-names>IA</given-names></name><name><surname>Ben-Tal</surname><given-names>N</given-names></name><article-title>Residue frequencies and pairing preferences at protein-protein interfaces</article-title><source>Proteins</source><year>2001</year><volume>43</volume><issue>2</issue><fpage>89</fpage><lpage>102</lpage><pub-id pub-id-type=""doi"">10.1002/1097-0134(20010501)43:2&lt;89::AID-PROT1021&gt;3.0.CO;2-H</pub-id><pub-id pub-id-type=""pmid"">11276079</pub-id></mixed-citation></ref><ref id=""B21""><mixed-citation publication-type=""journal""><name><surname>Moont</surname><given-names>G</given-names></name><name><surname>Gabb</surname><given-names>HA</given-names></name><name><surname>Sternberg</surname><given-names>MJ</given-names></name><article-title>Use of pair potentials across protein interfaces in screening predicted docked complexes</article-title><source>Proteins</source><year>1999</year><volume>35</volume><issue>3</issue><fpage>364</fpage><lpage>373</lpage><pub-id pub-id-type=""doi"">10.1002/(SICI)1097-0134(19990515)35:3&lt;364::AID-PROT11&gt;3.0.CO;2-4</pub-id><pub-id pub-id-type=""pmid"">10328272</pub-id></mixed-citation></ref><ref id=""B22""><mixed-citation publication-type=""journal""><name><surname>Gray</surname><given-names>JJ</given-names></name><name><surname>Moughon</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Schueler-Furman</surname><given-names>O</given-names></name><name><surname>Kuhlman</surname><given-names>B</given-names></name><name><surname>Rohl</surname><given-names>CA</given-names></name><name><surname>Baker</surname><given-names>D</given-names></name><article-title>Protein-protein docking with simultaneous optimization of rigid-body displacement and side-chain conformations</article-title><source>J Mol Biol</source><year>2003</year><volume>331</volume><issue>1</issue><fpage>281</fpage><lpage>299</lpage><pub-id pub-id-type=""doi"">10.1016/S0022-2836(03)00670-3</pub-id><pub-id pub-id-type=""pmid"">12875852</pub-id></mixed-citation></ref><ref id=""B23""><mixed-citation publication-type=""journal""><name><surname>Huang</surname><given-names>SY</given-names></name><name><surname>Zou</surname><given-names>X</given-names></name><article-title>An iterative knowledge-based scoring function for protein-protein recognition</article-title><source>Proteins</source><year>2008</year><volume>72</volume><issue>2</issue><fpage>557</fpage><lpage>579</lpage><pub-id pub-id-type=""doi"">10.1002/prot.21949</pub-id><pub-id pub-id-type=""pmid"">18247354</pub-id></mixed-citation></ref><ref id=""B24""><mixed-citation publication-type=""journal""><name><surname>Ravikant</surname><given-names>DV</given-names></name><name><surname>Elber</surname><given-names>R</given-names></name><article-title>PIE-efficient filters and coarse grained potentials for unbound protein-protein docking</article-title><source>Proteins</source><year>2009</year><volume>78</volume><issue>2</issue><fpage>400</fpage><lpage>419</lpage><pub-id pub-id-type=""doi"">10.1002/prot.22550</pub-id></mixed-citation></ref><ref id=""B25""><mixed-citation publication-type=""journal""><name><surname>Lorber</surname><given-names>DM</given-names></name><name><surname>Udo</surname><given-names>MK</given-names></name><name><surname>Shoichet</surname><given-names>BK</given-names></name><article-title>Protein-protein docking with multiple residue conformations and residue substitutions</article-title><source>Protein Sci</source><year>2002</year><volume>11</volume><issue>6</issue><fpage>1393</fpage><lpage>1408</lpage><pub-id pub-id-type=""doi"">10.1110/ps.2830102</pub-id><pub-id pub-id-type=""pmid"">12021438</pub-id></mixed-citation></ref><ref id=""B26""><mixed-citation publication-type=""journal""><name><surname>Cheng</surname><given-names>TM</given-names></name><name><surname>Blundell</surname><given-names>TL</given-names></name><name><surname>Fernandez-Recio</surname><given-names>J</given-names></name><article-title>pyDock: electrostatics and desolvation for effective scoring of rigid-body protein-protein docking</article-title><source>Proteins</source><year>2007</year><volume>68</volume><issue>2</issue><fpage>503</fpage><lpage>515</lpage><pub-id pub-id-type=""doi"">10.1002/prot.21419</pub-id><pub-id pub-id-type=""pmid"">17444519</pub-id></mixed-citation></ref><ref id=""B27""><mixed-citation publication-type=""journal""><name><surname>Lo Conte</surname><given-names>L</given-names></name><name><surname>Chothia</surname><given-names>C</given-names></name><name><surname>Janin</surname><given-names>J</given-names></name><article-title>The atomic structure of protein-protein recognition sites</article-title><source>J Mol Biol</source><year>1999</year><volume>285</volume><issue>5</issue><fpage>2177</fpage><lpage>2198</lpage><pub-id pub-id-type=""doi"">10.1006/jmbi.1998.2439</pub-id><pub-id pub-id-type=""pmid"">9925793</pub-id></mixed-citation></ref><ref id=""B28""><mixed-citation publication-type=""journal""><name><surname>Jones</surname><given-names>S</given-names></name><name><surname>Thornton</surname><given-names>JM</given-names></name><article-title>Analysis of protein-protein interaction sites using surface patches</article-title><source>J Mol Biol</source><year>1997</year><volume>272</volume><issue>1</issue><fpage>121</fpage><lpage>132</lpage><pub-id pub-id-type=""doi"">10.1006/jmbi.1997.1234</pub-id><pub-id pub-id-type=""pmid"">9299342</pub-id></mixed-citation></ref><ref id=""B29""><mixed-citation publication-type=""journal""><name><surname>Ofran</surname><given-names>Y</given-names></name><name><surname>Rost</surname><given-names>B</given-names></name><article-title>Analysing six types of protein-protein interfaces</article-title><source>J Mol Biol</source><year>2003</year><volume>325</volume><issue>2</issue><fpage>377</fpage><lpage>387</lpage><pub-id pub-id-type=""doi"">10.1016/S0022-2836(02)01223-8</pub-id><pub-id pub-id-type=""pmid"">12488102</pub-id></mixed-citation></ref><ref id=""B30""><mixed-citation publication-type=""journal""><name><surname>De</surname><given-names>S</given-names></name><name><surname>Krishnadev</surname><given-names>O</given-names></name><name><surname>Srinivasan</surname><given-names>N</given-names></name><name><surname>Rekha</surname><given-names>N</given-names></name><article-title>Interaction preferences across protein-protein interfaces of obligatory and non-obligatory components are different</article-title><source>BMC Struct Biol</source><year>2005</year><volume>5</volume><fpage>15</fpage><pub-id pub-id-type=""doi"">10.1186/1472-6807-5-15</pub-id><pub-id pub-id-type=""pmid"">16105176</pub-id></mixed-citation></ref><ref id=""B31""><mixed-citation publication-type=""journal""><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><article-title>A physical reference state unifies the structure-derived potential of mean force for protein folding and binding</article-title><source>Proteins</source><year>2004</year><volume>56</volume><issue>1</issue><fpage>93</fpage><lpage>101</lpage><pub-id pub-id-type=""doi"">10.1002/prot.20019</pub-id><pub-id pub-id-type=""pmid"">15162489</pub-id></mixed-citation></ref><ref id=""B32""><mixed-citation publication-type=""journal""><name><surname>Tobi</surname><given-names>D</given-names></name><name><surname>Elber</surname><given-names>R</given-names></name><article-title>Distance-dependent, pair potential for protein folding: results from linear optimization</article-title><source>Proteins</source><year>2000</year><volume>41</volume><issue>1</issue><fpage>40</fpage><lpage>46</lpage><pub-id pub-id-type=""doi"">10.1002/1097-0134(20001001)41:1&lt;40::AID-PROT70&gt;3.0.CO;2-U</pub-id><pub-id pub-id-type=""pmid"">10944392</pub-id></mixed-citation></ref><ref id=""B33""><mixed-citation publication-type=""journal""><name><surname>Vallat</surname><given-names>BK</given-names></name><name><surname>Pillardy</surname><given-names>J</given-names></name><name><surname>Majek</surname><given-names>P</given-names></name><name><surname>Meller</surname><given-names>J</given-names></name><name><surname>Blom</surname><given-names>T</given-names></name><name><surname>Cao</surname><given-names>B</given-names></name><name><surname>Elber</surname><given-names>R</given-names></name><article-title>Building and assessing atomic models of proteins from structural templates: Learning and benchmarks</article-title><source>Proteins</source><year>2009</year><volume>76</volume><issue>4</issue><fpage>930</fpage><lpage>945</lpage><pub-id pub-id-type=""doi"">10.1002/prot.22401</pub-id><pub-id pub-id-type=""pmid"">19326457</pub-id></mixed-citation></ref><ref id=""B34""><mixed-citation publication-type=""journal""><name><surname>Maiorov</surname><given-names>VN</given-names></name><name><surname>Crippen</surname><given-names>GM</given-names></name><article-title>Contact potential that recognizes the correct folding of globular proteins</article-title><source>J Mol Biol</source><year>1992</year><volume>227</volume><issue>3</issue><fpage>876</fpage><lpage>888</lpage><pub-id pub-id-type=""doi"">10.1016/0022-2836(92)90228-C</pub-id><pub-id pub-id-type=""pmid"">1404392</pub-id></mixed-citation></ref><ref id=""B35""><mixed-citation publication-type=""journal""><name><surname>Mintseris</surname><given-names>J</given-names></name><name><surname>Wiehe</surname><given-names>K</given-names></name><name><surname>Pierce</surname><given-names>B</given-names></name><name><surname>Anderson</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Janin</surname><given-names>J</given-names></name><name><surname>Weng</surname><given-names>Z</given-names></name><article-title>Protein-Protein Docking Benchmark 2.0: an update</article-title><source>Proteins</source><year>2005</year><volume>60</volume><issue>2</issue><fpage>214</fpage><lpage>216</lpage><pub-id pub-id-type=""doi"">10.1002/prot.20560</pub-id><pub-id pub-id-type=""pmid"">15981264</pub-id></mixed-citation></ref><ref id=""B36""><mixed-citation publication-type=""journal""><name><surname>Mintseris</surname><given-names>J</given-names></name><name><surname>Weng</surname><given-names>Z</given-names></name><article-title>Atomic contact vectors in protein-protein recognition</article-title><source>Proteins</source><year>2003</year><volume>53</volume><issue>3</issue><fpage>629</fpage><lpage>639</lpage><pub-id pub-id-type=""doi"">10.1002/prot.10432</pub-id><pub-id pub-id-type=""pmid"">14579354</pub-id></mixed-citation></ref><ref id=""B37""><mixed-citation publication-type=""journal""><name><surname>Meszaros</surname><given-names>C</given-names></name><article-title>Fast Cholesky factorization for interior point methods of linear programming</article-title><source>Comp Math Appl</source><year>1996</year><volume>31</volume><fpage>49</fpage><lpage>51</lpage><pub-id pub-id-type=""doi"">10.1016/0898-1221(95)00215-4</pub-id></mixed-citation></ref><ref id=""B38""><mixed-citation publication-type=""other""><name><surname>Hubbard</surname><given-names>SJ</given-names></name><name><surname>Thornton</surname><given-names>JM</given-names></name><article-title>NACCESS</article-title><source>Computer Program, Department of Biochemistry and Molecular Biology, University College London</source><year>1993</year></mixed-citation></ref><ref id=""B39""><mixed-citation publication-type=""journal""><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Weng</surname><given-names>Z</given-names></name><article-title>A novel shape complementarity scoring function for protein-protein docking</article-title><source>Proteins</source><year>2003</year><volume>51</volume><issue>3</issue><fpage>397</fpage><lpage>408</lpage><pub-id pub-id-type=""doi"">10.1002/prot.10334</pub-id><pub-id pub-id-type=""pmid"">12696051</pub-id></mixed-citation></ref><ref id=""B40""><mixed-citation publication-type=""journal""><name><surname>Katchalski-Katzir</surname><given-names>E</given-names></name><name><surname>Shariv</surname><given-names>I</given-names></name><name><surname>Eisenstein</surname><given-names>M</given-names></name><name><surname>Friesem</surname><given-names>AA</given-names></name><name><surname>Aflalo</surname><given-names>C</given-names></name><name><surname>Vakser</surname><given-names>IA</given-names></name><article-title>Molecular surface recognition: determination of geometric fit between proteins and their ligands by correlation techniques</article-title><source>Proc Natl Acad Sci USA</source><year>1992</year><volume>89</volume><issue>6</issue><fpage>2195</fpage><lpage>2199</lpage><pub-id pub-id-type=""doi"">10.1073/pnas.89.6.2195</pub-id><pub-id pub-id-type=""pmid"">1549581</pub-id></mixed-citation></ref></ref-list>"
10.1016/j.str.2008.04.010	"<p>BMC_Struct_Biol/PMC2998507.nxml                                                                     0000664 0011011 0007774 00000176034 13032470327 014737  0                                                                                                    ustar   pmc                             pmcdev<!DOCTYPE article PUBLIC ""-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN"" ""JATS-archivearticle1.dtd""><article article-type=""review-article"" xmlns:mml=""http://www.w3.org/1998/Math/MathML"" xmlns:xlink=""http://www.w3.org/1999/xlink""><?properties open_access?><front><journal-meta><journal-id journal-id-type=""nlm-ta"">Cell Commun Signal</journal-id><journal-title-group><journal-title>Cell Communication and Signaling : CCS</journal-title></journal-title-group><issn pub-type=""epub"">1478-811X</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type=""pmid"">21978545</article-id><article-id pub-id-type=""pmc"">3195729</article-id><article-id pub-id-type=""publisher-id"">1478-811X-9-22</article-id><article-id pub-id-type=""doi"">10.1186/1478-811X-9-22</article-id><article-categories><subj-group subj-group-type=""heading""><subject>Review</subject></subj-group></article-categories><title-group><article-title>RACK1, A multifaceted scaffolding protein: Structure and function</article-title></title-group><contrib-group><contrib contrib-type=""author"" id=""A1""><name><surname>Adams</surname><given-names>David R</given-names></name><xref ref-type=""aff"" rid=""I1"">1</xref><email>D.R.Adams@hw.ac.uk</email></contrib><contrib contrib-type=""author"" id=""A2""><name><surname>Ron</surname><given-names>Dorit</given-names></name><xref ref-type=""aff"" rid=""I2"">2</xref><email>dron@gallo.ucsf.edu</email></contrib><contrib contrib-type=""author"" corresp=""yes"" id=""A3""><name><surname>Kiely</surname><given-names>Patrick A</given-names></name><xref ref-type=""aff"" rid=""I3"">3</xref><email>Patrick.Kiely@ul.ie</email></contrib></contrib-group><aff id=""I1""><label>1</label>Department of Chemistry, Heriot-Watt University, Riccarton Campus, Edinburgh EH14AS, UK</aff><aff id=""I2""><label>2</label>Ernest Gallo Research Center, Department of Neurology, University of California, San Francisco, Emeryville, CA, USA 94608</aff><aff id=""I3""><label>3</label>Department of Life Sciences, and Materials and Surface Science Institute, University of Limerick, Limerick, Ireland</aff><pub-date pub-type=""collection""><year>2011</year></pub-date><pub-date pub-type=""epub""><day>6</day><month>10</month><year>2011</year></pub-date><volume>9</volume><fpage>22</fpage><lpage>22</lpage><history><date date-type=""received""><day>7</day><month>8</month><year>2011</year></date><date date-type=""accepted""><day>6</day><month>10</month><year>2011</year></date></history><permissions><copyright-statement>Copyright ©2011 Adams et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2011</copyright-year><copyright-holder>Adams et al; licensee BioMed Central Ltd.</copyright-holder><license license-type=""open-access"" xlink:href=""http://creativecommons.org/licenses/by/2.0""><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type=""uri"" xlink:href=""http://creativecommons.org/licenses/by/2.0"">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href=""http://www.biosignaling.com/content/9/1/22""></self-uri><abstract><p>The Receptor for Activated C Kinase 1 (RACK1) is a member of the tryptophan-aspartate repeat (WD-repeat) family of proteins and shares significant homology to the β subunit of G-proteins (Gβ). RACK1 adopts a seven-bladed β-propeller structure which facilitates protein binding. RACK1 has a significant role to play in shuttling proteins around the cell, anchoring proteins at particular locations and in stabilising protein activity. It interacts with the ribosomal machinery, with several cell surface receptors and with proteins in the nucleus. As a result, RACK1 is a key mediator of various pathways and contributes to numerous aspects of cellular function. Here, we discuss RACK1 gene and structure and its role in specific signaling pathways, and address how posttranslational modifications facilitate subcellular location and translocation of RACK1. This review condenses several recent studies suggesting a role for RACK1 in physiological processes such as development, cell migration, central nervous system (CN) function and circadian rhythm as well as reviewing the role of RACK1 in disease.</p></abstract><kwd-group><kwd>RACK1</kwd><kwd>WD-repeat</kwd><kwd>guanine nucleotide binding protein 2-like 1</kwd><kwd>(Gβ)</kwd><kwd>heterotrimeric G-proteins</kwd><kwd>PKCβII</kwd><kwd>scaffolding protein</kwd></kwd-group></article-meta></front><body><sec><title>Introduction</title><sec><title>The WD-repeat family of proteins</title><p>The tryptophan, aspartic acid repeat (WD-repeat containing proteins are an ancient conservative family of proteins found in prokaryotes and all eukaryotes [<xref ref-type=""bibr"" rid=""B1"">1</xref>]. They are involved in almost every signaling pathway and are associated with many genetic diseases. To date over 100 WD-repeat proteins have been assigned with an approved name and designation in the human nomenclature database. Genes encoding WD-repeat proteins are found on all chromosomes except 20, 22 (a pseudogene FBXW4P1 has been reported in chromosome 22), and the Y chromosome<ext-link ext-link-type=""uri"" xlink:href=""http://www.genenames.org"">http://www.genenames.org</ext-link>This reflects their diversity and importance as a family, and suggests that their expression is regulated by a variety of signaling pathways. WD-repeats themselves are sequences of typically 44-60 amino acids in length ending at the C-terminus with a signature WD dipeptide or its equivalent (Figure<xref ref-type=""fig"" rid=""F1"">1</xref>). The motifs were first identified as repeating segments of homologous sequence within the primary structure of the transducin Gβ subunit and CDC4 [<xref ref-type=""bibr"" rid=""B2"">2</xref>]. Detailed analysis with a larger cohort of proteins revealed that the repeats are also typified by a characteristic GH dipeptide usually residing some 11-24 residues from the N-terminus, though neither the GH nor WD signature is absolutely conserved [<xref ref-type=""bibr"" rid=""B3"">3</xref>-<xref ref-type=""bibr"" rid=""B5"">5</xref>]. Several other characteristic amino acids contribute to the repeat, most notably an aspartic acid located 6 residues before the WD dipetide, but it is the collective critical mass of such features rather than the absolute conservation of any individual amino acid that establishes the identity of a sequence as a WD-repeat [<xref ref-type=""bibr"" rid=""B6"">6</xref>]. Given the variable number of residues at the N-terminal end of these units, sequence databases tend to map the repeats of WD-proteins between GH and WD dipeptides for convenience (Figure<xref ref-type=""fig"" rid=""F1"">1</xref>). The basic criterion for inclusion of a protein into the family is the presence of at least four of these repeat sequences to generate a WD-domain. These domains adopt a β-propeller structure, where the propeller fold is characterised by blades that are arranged radially around a central axis [<xref ref-type=""bibr"" rid=""B3"">3</xref>,<xref ref-type=""bibr"" rid=""B7"">7</xref>-<xref ref-type=""bibr"" rid=""B10"">10</xref>] (Figure<xref ref-type=""fig"" rid=""F2"">2</xref>). The conserved propeller structure is maintained by well-defined hydrogen bonding networks and intra-chain hydrophobic interactions (<italic>vide infra</italic>), although different WD-repeat proteins appear to adopt distinct folding orders for their constituent propeller blades [<xref ref-type=""bibr"" rid=""B9"">9</xref>,<xref ref-type=""bibr"" rid=""B11"">11</xref>]. In principle, a single β-propeller subunit may comprise four to eight blades [<xref ref-type=""bibr"" rid=""B4"">4</xref>,<xref ref-type=""bibr"" rid=""B8"">8</xref>], although at present only 7-bladed or 8-bladed WD-repeat propellers have been characterised by X-ray diffraction studies-the majority being 7-bladed structures consistent with the proposal that this is the optimal β-propeller fold [<xref ref-type=""bibr"" rid=""B12"">12</xref>]. Proteins are known with more than eight WD-repeats, but these assume tertiary structures with multiple propeller subunits (reviewed in [<xref ref-type=""bibr"" rid=""B6"">6</xref>]).</p><fig id=""F1"" position=""float""><label>Figure 1</label><caption><p><bold>Sequence of RACK1 depicting WD-repeats</bold>. RACK1 is a 317 amino acid protein with seven 40 amino acid repeats which are defined by sequences flanked by GH and WD dipeptides.</p></caption><graphic xlink:href=""1478-811X-9-22-1""></graphic></fig><fig id=""F2"" position=""float""><label>Figure 2</label><caption><p><bold>Structural detail for RACK1 proteins</bold>. (A) Crystal structure of RACK1A from<italic>A. thaliana</italic>(PDB:<ext-link ext-link-type=""pdb"" xlink:href=""3DM0"">3DM0</ext-link>), illustrating the seven-bladed β-propeller structure. (B) As (A) but with surface rendition. (C) Schematic representation of RACK1 structure and organisation of WD-repeats (defined in Figure 6); peripheral circles show superimposition of individual propeller blades for Gβ1 (blue) (PDB:<ext-link ext-link-type=""pdb"" xlink:href=""1TBG"">1TBG</ext-link>) and for the structurally defined RACK1 orthologues from<italic>A. thaliana</italic>(green) (PDB:<ext-link ext-link-type=""pdb"" xlink:href=""3DM0"">3DM0</ext-link>),<italic>S. cerevisiae</italic>(orange) (PDB:<ext-link ext-link-type=""pdb"" xlink:href=""3FRX"">3FRX</ext-link>) and<italic>T. thermophila</italic>(pink) (PDB:<ext-link ext-link-type=""pdb"" xlink:href=""2XZN"">2XZN</ext-link>). Gβ is distinguished in blade 7 by a helical N-terminal extension that engages tightly bound Gγ (not shown) in coiled coil interactions.</p></caption><graphic xlink:href=""1478-811X-9-22-2""></graphic></fig><p>Although there is no single function for WD-repeat proteins, they share a common role in scaffolding protein complexes, often with multiple and competing partners, thereby serving as hubs for spatiotemporal orchestration of signaling events across diverse pathways. WD-repeat proteins themselves lack any enzymatic activity, but they are subject to post-translational modification, suggesting ways by which their cellular location and protein partnerships may be modulated. The lack of a direct catalytic enzymatic function for the protein family contrasts with other β-propeller-forming proteins, many of which exhibit enzymatic activity [<xref ref-type=""bibr"" rid=""B8"">8</xref>].</p><p>The most exstensively studied WD-repeat protein to date is the G-protein β subunit (Gβ) [<xref ref-type=""bibr"" rid=""B7"">7</xref>,<xref ref-type=""bibr"" rid=""B13"">13</xref>], which exists in a complex with the γ subunit (Gγ). Gβγ reversibly complexes with the α subunit to form a Gαβγ heteromer that associates with G-protein-coupled receptors (GPCRs) to enable transduction of extracellular signals. Upon ligand binding to a GPCR, the α subunit dissociates from the Gβγ heterodimer, resulting in the activation of various signaling cascades (reviewed in [<xref ref-type=""bibr"" rid=""B14"">14</xref>,<xref ref-type=""bibr"" rid=""B15"">15</xref>]). The mode of interaction of Gβ with binding partners has become increasingly clear with the emergence of crystal structures for Gβ in various complexes with Gα/Gγ, [<xref ref-type=""bibr"" rid=""B9"">9</xref>,<xref ref-type=""bibr"" rid=""B10"">10</xref>,<xref ref-type=""bibr"" rid=""B16"">16</xref>,<xref ref-type=""bibr"" rid=""B17"">17</xref>], phosducin [<xref ref-type=""bibr"" rid=""B18"">18</xref>-<xref ref-type=""bibr"" rid=""B20"">20</xref>], GPCR Receptor Kinase 2 (GRK2) [<xref ref-type=""bibr"" rid=""B21"">21</xref>-<xref ref-type=""bibr"" rid=""B23"">23</xref>], Regulator of G-protein Signaling 9 (RGS9) [<xref ref-type=""bibr"" rid=""B24"">24</xref>,<xref ref-type=""bibr"" rid=""B25"">25</xref>], and the Parathyroid Hormone 1 Receptor (PTH1R) [<xref ref-type=""bibr"" rid=""B26"">26</xref>]. Interestingly, WD-domains do not operate simply as standalone platforms for scaffolding protein complexes. Thus, several WD-proteins including RACK1 form both homodimers and heterodimers [<xref ref-type=""bibr"" rid=""B27"">27</xref>-<xref ref-type=""bibr"" rid=""B29"">29</xref>]. Moreover, some WD-repeat proteins contain other domains in addition to the WD-repeat sequences that increase the number of binding partners, scaffolding properties and overall function of the protein. For example, the β-transducing repeat-containing protein 1 (β-TrCP1) is a ubiquitin ligase with both WD-repeat and F-box domains as well as a RING domain. β-TrCP1 is required for the degradation of regulatory proteins such as Snail and p53 [<xref ref-type=""bibr"" rid=""B30"">30</xref>,<xref ref-type=""bibr"" rid=""B31"">31</xref>], and the WD-repeats increase its binding cohort and regulate its sub-cellular location, allowing the protein to also have a role in transcription and in regulating circadian rhythm [<xref ref-type=""bibr"" rid=""B32"">32</xref>-<xref ref-type=""bibr"" rid=""B34"">34</xref>]. WD-repeat and (suppressor of cytokines signaling) SOCS box-containing protein 1 (WSB1) is a ubiquitin ligase subunit, induced by Hedgehog signaling, that contains in addition to its WD-domain a SOCS-box that mediates its interaction with a ubiquitinating catalytic core complex [<xref ref-type=""bibr"" rid=""B35"">35</xref>,<xref ref-type=""bibr"" rid=""B36"">36</xref>]. WSB1 promotes cell survival in neuroblastoma [<xref ref-type=""bibr"" rid=""B37"">37</xref>]. Novel Nuclear Receptor Interaction Protein (NRIP) is a nuclear receptor with two WD-repeat domains which also has a nuclear localization signal [<xref ref-type=""bibr"" rid=""B38"">38</xref>]. NRIP interacts with the androgen receptor [<xref ref-type=""bibr"" rid=""B39"">39</xref>] and has recently been implicated in viral replication [<xref ref-type=""bibr"" rid=""B40"">40</xref>].</p><p>As our knowledge of the WD-repeat family of proteins expands, we are seeing that the members are involved in most signaling pathways (reviewed in [<xref ref-type=""bibr"" rid=""B1"">1</xref>]). It is no surprise, therefore, that WD-repeat proteins play a critical role in various human diseases. Subtle changes in the expression levels of WD-proteins can have a dramatic effect on protein complex assembly and on key signaling pathways. In this review, we focus on RACK1, a 36-kDa protein with seven WD-repeats that is homologous to Gβ, and that is one of the best known and studied members of the WD-repeat protein family. We focus on its structure, binding partners, subcellular localization, its role in signaling pathways and its function in normal physiological responses as well as in pathological conditions.</p></sec><sec><title>RACK1 is a scaffolding protein</title><p>RACK1 is a highly conserved intracellular adaptor protein with significant homology to Gβ. RACK1 was originally cloned from a chicken liver cDNA library and human B-lymphoblastoid cell line (B-LCL) [<xref ref-type=""bibr"" rid=""B41"">41</xref>]. Several years later, Mochly-Rosen's group cloned the protein from a rat brain c-DNA library which was screened for gene products that bind purified rat brain PKC in the presence of its activators (phosphatidylserine, diacyglycerol and calcium) [<xref ref-type=""bibr"" rid=""B42"">42</xref>]. Given the association of RACK1 with the active conformation of PKCβII, the protein was named Receptor for Activated C Kinase 1 (RACK1) [<xref ref-type=""bibr"" rid=""B42"">42</xref>-<xref ref-type=""bibr"" rid=""B45"">45</xref>] (Figure<xref ref-type=""fig"" rid=""F3"">3</xref>). However, it is now well established that RACK1 interacts with a large number of proteins either directly or as part of a larger complex. As a scaffold protein, RACK1 integrates inputs from distinct signaling pathways and is critical for fundamental cellular activities such as cell proliferation, transcription and protein synthesis, as well as various neuronal functions. RACK1's scaffolding properties are mediated by the presence of seven WD-repeats [<xref ref-type=""bibr"" rid=""B46"">46</xref>,<xref ref-type=""bibr"" rid=""B47"">47</xref>] (see also sections 2.2 and 2.3) that present multiple protein-binding sites and facilitate interaction with specialized protein docking modules, including SH2 domains (Src and Fyn) [<xref ref-type=""bibr"" rid=""B48"">48</xref>,<xref ref-type=""bibr"" rid=""B49"">49</xref>], plextrin homology (PH) domains (dynamin and p120GAP) [<xref ref-type=""bibr"" rid=""B50"">50</xref>,<xref ref-type=""bibr"" rid=""B51"">51</xref>] and C2 domains (PKCs) [<xref ref-type=""bibr"" rid=""B43"">43</xref>,<xref ref-type=""bibr"" rid=""B45"">45</xref>]. In addition, RACK1 was pulled out in a yeast two-hybrid screen as a binding partner of the first PDZ domain of the human Na<sup>+</sup>/H<sup>+</sup>exchanger regulatory factor (NHERF1) [<xref ref-type=""bibr"" rid=""B52"">52</xref>]. RACK1 also forms a heterodimer with at least one other WD-repeat protein, Gβ [<xref ref-type=""bibr"" rid=""B27"">27</xref>,<xref ref-type=""bibr"" rid=""B28"">28</xref>,<xref ref-type=""bibr"" rid=""B53"">53</xref>]. The formation of the RACK1-Gβ heterodimer has been shown to enable efficient cross-talk between signal transduction pathways mediated by GPCRs and by ligand-gated ion channels, specifically between the cAMP/PKA pathway and the N-methyl D-aspartate receptor (NMDAR) [<xref ref-type=""bibr"" rid=""B29"">29</xref>] (Figures<xref ref-type=""fig"" rid=""F4"">4</xref>and<xref ref-type=""fig"" rid=""F5"">5</xref>). RACK1 also functions as a homodimer enabling the expansion of its binding partners [<xref ref-type=""bibr"" rid=""B28"">28</xref>,<xref ref-type=""bibr"" rid=""B29"">29</xref>,<xref ref-type=""bibr"" rid=""B49"">49</xref>,<xref ref-type=""bibr"" rid=""B53"">53</xref>,<xref ref-type=""bibr"" rid=""B54"">54</xref>]. For example, the formation of a homodimer enables the simultaneous interaction of RACK1 with Fyn and with the NR2B subunit of the NMDAR, even though Fyn and NR2B share the same binding site on RACK1 [<xref ref-type=""bibr"" rid=""B29"">29</xref>,<xref ref-type=""bibr"" rid=""B49"">49</xref>,<xref ref-type=""bibr"" rid=""B55"">55</xref>-<xref ref-type=""bibr"" rid=""B57"">57</xref>] (Figure<xref ref-type=""fig"" rid=""F5"">5A</xref>).</p><fig id=""F3"" position=""float""><label>Figure 3</label><caption><p><bold>Model for PKCβII and RACK1 interaction</bold>. (A). In resting state, there is no interaction between RACK1 and inactive PKCβII. (B). Activation of PKCβII leads to the interaction between the active form of the kinase and RACK1. RACK1 then shuttles the active PKCβII to the site of its substrate.</p></caption><graphic xlink:href=""1478-811X-9-22-3""></graphic></fig><fig id=""F4"" position=""float""><label>Figure 4</label><caption><p><bold>Model for cAMP/PKA-mediated nuclear translocation of RACK1</bold>. (A). In resting state, RACK1 forms homodimers as well as heterodimers with Gβ. (B). Activation of the cAMP/PKA pathway leads to the dissociation of RACK1 from the complex and its translocation to the nucleus. In the nucleus RACK1 contributes to cAMP/PKA mediated increase in BDNF transcription.</p></caption><graphic xlink:href=""1478-811X-9-22-4""></graphic></fig><fig id=""F5"" position=""float""><label>Figure 5</label><caption><p><bold>Differential compartmentalization of RACK1 in the brain</bold>. (A). In hippocampal and dorsal striatal neurons, RACK1 is associated with both the NR2B subunit of the NMDAR and Fyn kinase. (B). cAMP/PKA activation or alcohol exposure leads to the release of RACK1 from the complex, enabling Fyn to phoshorylate the tyrosine residues on the cytoplasmic tail of the NR2B. (C). In the cerebral cortex, RACK1 is bound to Fyn but not to the NMDAR. (D). In the ventral striatum, RACK1 is not associated with either protein.</p></caption><graphic xlink:href=""1478-811X-9-22-5""></graphic></fig><p>The proteins interacting with RACK1 fall into two broad categories, those constitutively bound and those that are stimulus-dependent or transient. RACK1 binding partners have been identified at various locations throughout the cell, and one important functional role for RACK1 is undoubtedly to shuttle some of these binding partners to particular intracellular sites. However, in addition to this role, a key aspect of the function of RACK1 is its capacity to modulate the enzymatic activity of its binding partners, either promoting or suppressing the activity of bound enzymes. For example, RACK1 stabilizes the activity of protein phosphatase 2A (PP2A) [<xref ref-type=""bibr"" rid=""B58"">58</xref>,<xref ref-type=""bibr"" rid=""B59"">59</xref>] and maintains the active conformation of PKCβII [<xref ref-type=""bibr"" rid=""B42"">42</xref>,<xref ref-type=""bibr"" rid=""B45"">45</xref>,<xref ref-type=""bibr"" rid=""B60"">60</xref>] (Figure<xref ref-type=""fig"" rid=""F3"">3</xref>). In contrast, RACK1 binds to the tyrosine kinases Src and Fyn to maintain these kinases in an inactive state until the appropriate signal occurs to trigger dissociation of the complex [<xref ref-type=""bibr"" rid=""B29"">29</xref>,<xref ref-type=""bibr"" rid=""B49"">49</xref>,<xref ref-type=""bibr"" rid=""B55"">55</xref>-<xref ref-type=""bibr"" rid=""B57"">57</xref>,<xref ref-type=""bibr"" rid=""B61"">61</xref>,<xref ref-type=""bibr"" rid=""B62"">62</xref>] (see also Figure<xref ref-type=""fig"" rid=""F5"">5A</xref>). Thus, RACK1 plays a key role in stabilizing the active or inactive conformation of its partners.</p></sec></sec><sec><title>RACK1, Gene and Structure</title><sec><title>RACK1: Gene, promoter and expression</title><p>Human RACK1 is encoded by the gene,<italic>GNB2L1</italic>[guanine nucleotide binding protein (G-protein), beta polypeptide 2-like 1], which has 8 exons and 7 introns [<xref ref-type=""bibr"" rid=""B63"">63</xref>,<xref ref-type=""bibr"" rid=""B64"">64</xref>]. The open reading frame of the gene is 1142 bp and it encodes for a protein with 317 amino acids, registering as a 36 kDa protein on an SDS PAGE gel. Studies probing the evolution of human RACK1 suggest that human, rat and mouse RACK1 form a different subgroup and are therefore strictly paralogs of RACK1 in other organisms, but these studies nevertheless indicate that RACK1 is strongly conserved through evolution [<xref ref-type=""bibr"" rid=""B64"">64</xref>]. Indeed, sequence alignments of RACK1 species from diverse organisms --<italic>Tetrahymena thermophila, Saccharomyces cerevisiae, Arabidopsis thaliana</italic>and<italic>Drosophila melanogaster</italic>-- reveals a 43-76% sequence identity (Figure<xref ref-type=""fig"" rid=""F6"">6</xref>).<italic>GNB2L1</italic>is mapped to chromosome 5q35.3, in close proximity to the telomere of chromosome 5 [<xref ref-type=""bibr"" rid=""B63"">63</xref>]. At least 6 other genes have been mapped to this region and it is a reported location for cytogenetic and molecular abnormalities [<xref ref-type=""bibr"" rid=""B65"">65</xref>-<xref ref-type=""bibr"" rid=""B68"">68</xref>]. The promoter region of<italic>GNB2L1</italic>, which was found to have two alternative start sites of transcription, has binding sites for cardiac/smooth muscle specific c-Rel (NF-κB) [<xref ref-type=""bibr"" rid=""B63"">63</xref>,<xref ref-type=""bibr"" rid=""B69"">69</xref>]. RACK1 is highly expressed in most tissues [<xref ref-type=""bibr"" rid=""B70"">70</xref>], including the brain [<xref ref-type=""bibr"" rid=""B71"">71</xref>]. The expression of RACK1 appears to be tightly regulated and changes in RACK1 expression are associated with cancer (see section 6.1.). It has also been suggested that changes in RACK1 expression contribute to brain pathologies [<xref ref-type=""bibr"" rid=""B72"">72</xref>-<xref ref-type=""bibr"" rid=""B74"">74</xref>] (see section 6.2.). This is supported by observations from our group and others that RACK1 is inhibitory to the growth of normal fibroblasts and can only be over-expressed in transformed cells or cells that over-express the IGF-1R [<xref ref-type=""bibr"" rid=""B75"">75</xref>-<xref ref-type=""bibr"" rid=""B77"">77</xref>]. Interestingly, a binding site for the glucocorticoid receptor is present in the<italic>GNB2L1</italic>promoter [<xref ref-type=""bibr"" rid=""B63"">63</xref>], suggesting a mechanism by which RACK1 expression levels may change with aging. This is significant given that RACK1 affects the subcellular distribution and function of numerous proteins and, as a result, plays an essential role in regulating signaling pathways in many key biological processes [<xref ref-type=""bibr"" rid=""B46"">46</xref>,<xref ref-type=""bibr"" rid=""B47"">47</xref>]. Indeed, over 80 binding partners of RACK1 have been reported to date, (although several of these remain uncharacterised and may not bind to RACK1 directly), and as new partner proteins emerge, the important contribution that RACK1 makes to signaling pathways is becoming clearer. It is probable that RACK1 engages in different sets of signaling pathways in different cells, reflecting the cell type and the differential expression of its binding partners. In this way, RACK1 plays distinct roles in different cell types, even when the expression of RACK1 itself remains relatively constant.</p><fig id=""F6"" position=""float""><label>Figure 6</label><caption><p><bold>Sequence alignment of Gβ1 (UniProtKB accession ID: P62873) vs RACK1 orthologues from Homo sapiens (P63244),<italic>Drosophila melanogaster</italic>(O18640),<italic>Arabidopsis thaliana</italic>(O24456),<italic>Saccharomyces cerevisiae</italic>(P38011) and<italic>Tetrahymena thermophila</italic>(E6PBV0)</bold>. This alignment is similar to that presented by Ullah<italic>et al</italic>[<xref ref-type=""bibr"" rid=""B81"">81</xref>] but revised to include the sequence of the T. thermophila protein. WD-repeats and secondary structural elements are defined above the sequences. The percentage sequence identity between human RACK1 and the orthologues from other species is defined at the end of the alignment. The homology index for the proteins (excluding Gβ1) is presented below the sequence, where fully conserved residues are marked with an asterisk; conservative and semiconservative positions are marked with colons and periods respectively. Residues marked in red in the yeast sequence engage rRNA in the eukaryotic 40S ribosomal subunit (see text).</p></caption><graphic xlink:href=""1478-811X-9-22-6""></graphic></fig></sec><sec><title>Structure of RACK1</title><p>Gβ was the first WD-repeat protein to be characterised by X-ray crystallography [<xref ref-type=""bibr"" rid=""B9"">9</xref>,<xref ref-type=""bibr"" rid=""B10"">10</xref>,<xref ref-type=""bibr"" rid=""B16"">16</xref>]. Numerous crystal structures have since emerged for WD-repeat proteins [<xref ref-type=""bibr"" rid=""B9"">9</xref>,<xref ref-type=""bibr"" rid=""B10"">10</xref>,<xref ref-type=""bibr"" rid=""B78"">78</xref>] and these now include recently determined structures for three RACK1 species: RACK1A from<italic>A. thaliana</italic>, Asc1p from<italic>S. cerevisiae</italic>and RACK1 from<italic>T. thermophila</italic>at 2.4, 2.1 and 3.9 Å resolution, respectively [<xref ref-type=""bibr"" rid=""B79"">79</xref>-<xref ref-type=""bibr"" rid=""B82"">82</xref>]. The<italic>T. thermophila</italic>protein structure was obtained as a complex with the 40S small ribosomal subunit from this protozoan. A structure for the yeast RACK1 orthologue was also determined in complex with the 40S ribosomal subunit at similar resolution (4.15 Å) [<xref ref-type=""bibr"" rid=""B83"">83</xref>]. These structural studies confirmed that RACK1 adopts a seven-bladed β-propeller structure consistent with the predictions of earlier homology modelling studies based on Gβ and other WD-repeat proteins [<xref ref-type=""bibr"" rid=""B46"">46</xref>,<xref ref-type=""bibr"" rid=""B78"">78</xref>-<xref ref-type=""bibr"" rid=""B81"">81</xref>]. The<italic>A. thaliana</italic>protein was the first of the three RACK1 orthologues to be structurally defined and, of the three, it exhibits the highest sequence homology to human RACK1, with 64% residue identity [<xref ref-type=""bibr"" rid=""B81"">81</xref>] (Figure<xref ref-type=""fig"" rid=""F6"">6</xref>). In contrast to metazoans, where RACK1 is expressed from a single gene,<italic>A. thaliana</italic>possesses three genes-<italic>RACK1A</italic>,<italic>RACK1B</italic>and<italic>RACK1C</italic>- for closely related proteins, with the sequences for RACK1B and RACK1C (not shown) exhibiting similar levels of homology to the human protein. The structure of RACK1A is shown in Figure<xref ref-type=""fig"" rid=""F2"">2A</xref>. Each propeller blade consists of a four-stranded antiparallel β-sheet, where strand A lines the central canal of the protein, a channel of ~9 Å width (Figure<xref ref-type=""fig"" rid=""F2"">2B</xref>), and strand D is presented on the outer circumference. Adjacent blades are connected by a loop bridging from strand D on one blade to strand A on the next. These loops are exposed on the top face of the propeller blade, as are the β-turns linking strands B and C in each blade. The loops connecting strand A to B and strand C to D in each blade are located on the reverse, slightly larger face of the propeller.</p><p>The WD-repeats of RACK1, as with all proteins that adopt this fold, overlap two adjacent propeller blades to provide an interlocking architecture. Each repeat encompasses the D-strand of one blade and strands A, B and C of the next, terminating in the signature WD dipeptide at the end of strand C such that the aspartic acid (or equivalent residue) is exposed on the propeller's lower face. The tryptophan, which is sometimes replaced by phenylalanine or tyrosine, is sandwiched between adjacent blades and plays an important role in inter-blade spacing (Figures<xref ref-type=""fig"" rid=""F2"">2</xref>and<xref ref-type=""fig"" rid=""F6"">6</xref>). As the N-terminal sequence in the first WD-repeat contributes strand D of the seventh blade, hydrogen bonding to the strand C sequence of the last repeat, the assembly is sealed with a 'Velcro-like' fastening to complete the toroidal structure [<xref ref-type=""bibr"" rid=""B5"">5</xref>]. Superimposition of the available RACK1 crystal structures with human Gβ<sub>1</sub>, shown for individual propeller blades in Figure<xref ref-type=""fig"" rid=""F2"">2C</xref>, reveals that the greatest structural variation lies in the A-B, C-D and D-A loops, which are of variable length. Most notably, the D-A loop between blades 6 and 7 in the RACK1 species is 8-19 residues longer than the cognate region of Gβ<sub>1</sub>and forms a pronounced knob-like projection from the upper face of the propeller (disordered in the crystal structure of<italic>A. thaliana</italic>RACK1A). In contrast to the three other loops, the central B-C hairpin of each blade adopts a tight β-turn with a strongly conserved backbone conformation. Some 85% of known WD-repeats possess an aspartic acid at the middle position of the three residues usually present in the B-C turn [<xref ref-type=""bibr"" rid=""B11"">11</xref>], and this highly conserved residue forms a salt bridge with the histidine of the glycine-histidine (GH) signature dipeptide (when present) as shown in Figure<xref ref-type=""fig"" rid=""F7"">7</xref>. This GH interaction plays an important role in defining the trajectory of the inter-blade D-A loop which hosts the GH dipeptide and therefore in stabilising the propeller structure. A network of additional hydrogen bonded interactions between strongly conserved residues at specific locations within the WD-repeat also maintains the integrity of blade structure. Thus, the histidine of the GH dipeptide is characteristically hydrogen bonded to a serine (or threonine) on β-strand B located in the P-4 position relative to the conserved aspartic acid (P-0) of the B-C turn. This serine is usually hydrogen bonded in turn to the indolic NH of the WD signature tryptophan (occupying the P+6 position). The structure of the B-C turn is additionally defined by an engagement between the P-0 aspartate side chain and the peptide backbone NH at the P+2 position (<italic>i.e</italic>. the first amino acid in β-strand C). The final residue in β-strand B (at the P-2 position) is invariably small (Ser, Gly or Ala) for typical blades<sup>1</sup>in order to accommodate the folding of the aspartic acid side chain. In the majority of instances the P-2 residue is serine, and in these cases the residue also engages the aspartate with a hydrogen bond to strengthen the local structure of the protein in that region. Non-polar interactions also play an important role in establishing the β-propeller structure however. For example, the opening residue in β-strand A that lies proximal to the B-C turn is almost invariably valine or isoleucine and fits into the space between the B- and C-strands of the preceding propeller blade, directly behind the P-0 aspartic acid of the B-C turn on that blade and regulating inter-blade spacing at that point. The WD signature tryptophan (or phenylalanine/tyrosine replacement) projects from the face of each propeller blade to pack against a bulky residue (frequently leucine) located at the end of the D-strand and projecting from the rear of the preceding blade.</p><fig id=""F7"" position=""float""><label>Figure 7</label><caption><p><bold>Summary of conserved interactions in 'typical' WD-repeats responsible for maintaining the structural integrity of propeller blades 1-5 in RACK1</bold>. Interactions are illustrated for blade 2 of the<italic>A. thaliana</italic>RACK1A structure (PDB:<ext-link ext-link-type=""pdb"" xlink:href=""3DM0"">3DM0</ext-link>). The second WD-repeat (as defined in Figure 6) is shown in its entirety (orange ribbon) and contributes β-strand D to blade 1 plus strands A, B and C of blade 2, terminating in the WD signature residues (W90-D91). Strand D of blade 2 is provided by residues in the third WD repeat (yellow ribbon). A highly conserved Asp residue (D84) occupies the central position of the B-C turn and is networked by hydrogen bonds to residues in the P-2 and P+2 positions (S82 side chain, E86 backbone) as well as through a salt bridge to the signature GH His (H62) in the D-A loop between blades 1 and 2. H62 is further networked with a hydrogen bond to S80 on β-strand B and a hydrogen bond between S80 and W90 (β-strand C). Important non-polar interactions regulate blade packing such as contact between W90 and residues on the reverse face of blade 1 (L59) and between V66 (β-strand A) and the reverse face of the B-C hairpin of blade 1 (not shown). B-C hairpin positions relative to the consensus Asp (P0) are marked in blue.</p></caption><graphic xlink:href=""1478-811X-9-22-7""></graphic></fig><p>The features described above and summarised in Figure<xref ref-type=""fig"" rid=""F7"">7</xref>are tightly conserved across blades 1-5 of the RACK1 proteins and are responsible for a highly regular and 'typical' organisation to the core of the propeller blades for this major segment of the proteins. Some notable deviations are seen in the core organisational elements for blades 6 and 7, however, and these are likely associated with the RACK1 sequence insert in the D-A loop between these two blades. This loop lacks the characteristic GH signature dipeptide to engage the conserved Asp of the B-C turn in blade 7. Instead, an Arg on β-strand C of blade 7 provides a surrogate salt bridge in lieu of the signature GH to stabilise the blade 7 B-C hairpin. This is illustrated in Figure<xref ref-type=""fig"" rid=""F8"">8</xref>with the yeast RACK1 orthologue, where the D-A loop between blades 6 and 7 is of similar length to human RACK1 and fully ordered in the crystal structure. The cognate loop of RACK1 proteins in plants, as with<italic>A. thaliana</italic>, is significantly extended by comparison. The arginine residue (R311) that contributes the salt bridge to the B-C hairpin of blade 7 lies in the P+4 position relative to the aspartic acid (D307) and is packed against a tyrosine side chain (Y305) in the P-2 position of this atypical WD-repeat. In contrast, as noted above, the P-2 position is taken by Ser or Gly in typical WD-repeats (Figure<xref ref-type=""fig"" rid=""F7"">7</xref>). In blade 7 this rare occurrence of a Tyr is associated with the establishment of pi-cation interactions with the P+4 Arg (Figure<xref ref-type=""fig"" rid=""F8"">8</xref>). Significantly, the tyrosine is conserved across RACK1 orthologues of higher organisms and is a known phosphorylation site (<italic>vide infra</italic>) [<xref ref-type=""bibr"" rid=""B58"">58</xref>], suggesting a functionally important role for the atypical structure of this RACK1 WD-repeat. Indeed, the scaffolding of several proteins is known to be mediated by blades 5-7 of RACK1.</p><fig id=""F8"" position=""float""><label>Figure 8</label><caption><p><bold>Summary of key interactions in 'atypical' WD-repeats 6 and 7 of RACK1, illustrated with the structure of yeast Asc1p (PDB:</bold><ext-link ext-link-type=""pdb"" xlink:href=""3FRX"">3FRX</ext-link>). RACK1 proteins are characterised by a significant sequence extension between blades 6 and 7, leading to a knob-like protrusion from the upper face of the propeller. The P0 Asp in blade 7 forms a salt bridge to an Arg at the P+4 position and this is packed against a Tyr (or in some orthologues Phe) in the P-2 position. The P0 Asp is absent in blade 6. In principle, these features together with the absence of the GH signature dipeptide on the loops between blades 5 and 6 and between blades 6 and 7 may facilitate structural transitions in this region of the protein that are important for function.</p></caption><graphic xlink:href=""1478-811X-9-22-8""></graphic></fig><p>The D-A and B-C loops of WD-repeat proteins alternate with one another in sequence to generate the upper face of their β-propeller structures (as presented in Figure<xref ref-type=""fig"" rid=""F2"">2</xref>). Thus, the extended D-A loop that forms the RACK1 knob between blades 6 and 7 is followed by the B-C hairpin on blade 7 and preceded by the corresponding hairpin on blade 6. Given the atypical features just described in the B-C hairpin of blade 7, it is unsurprising that the corresponding hairpin of blade 6, immediately preceding the knob, should also differ from the typical consensus features summarised in Figure<xref ref-type=""fig"" rid=""F7"">7</xref>. The key distinction in this hairpin is the deletion of the central aspartic acid residue of the β-turn, and a very tight turn of two residues serves to reverse the backbone between β-strands B and C in blade 6, though neither of the residues at this site is conserved across RACK1 orthologues (Figure<xref ref-type=""fig"" rid=""F6"">6</xref>). In the yeast structure, the turn comprises A257 and T258 (Figure<xref ref-type=""fig"" rid=""F8"">8</xref>). Deletion of the aspartic acid from the B-C turn also appears to be associated with loss of the signature GH dipeptide from the preceding D-A loop between blades 5 and 6, where, in a typical WD-repeat, the histidine would engage the aspartic acid of the B-C turn. Thus, RACK1 proteins lack the GH motif in the D-A loops between both blades 5/6 and blades 6/7. Significantly, the absence of the GH in these loops appears to make the presence of the consensus P-4 serine on β-strand B redundant in blades 6 and 7, and the serine is replaced by alanine in both blades of yeast and mammalian RACK1 proteins. As shown in Figure<xref ref-type=""fig"" rid=""F7"">7</xref>, the P-4 serine hydrogen bonds to the preceding GH signature histidine in typical WD-repeats. Substitution of the P-4 serine by alanine has a further effect, however, and abolishes the additional hydrogen bond to the WD signature tryptophan that is seen in typical WD-repeats. The abolition of this hydrogen bond appears to be associated with a change in the conformation of the tryptophan side chain in blade 7 of the yeast protein, where the indolic NH is no longer constrained in a hydrogen bond towards strand B but re-orientated towards strand D instead. Interestingly, in blade 6 of the yeast structure, the WD tryptophan is replaced by phenylalanine, and it is conceivable that where the P-4 serine of the B-strand is substituted by a non-hydrogen bonding residue evolutionary conservation of the signature tryptophan is also relaxed.</p></sec><sec><title>Structural basis for RACK1-scaffolded protein associations</title><p>The available crystal structures for Gβ and other WD-repeat proteins have established the structural basis for scaffolded interactions with a range of partner proteins-Gα/Gγ, phosducin, GRK2, RGS9 and PTH1R in the case of Gβ for example (<italic>vide supra</italic>)-and the current understanding of WD-repeat protein docking modes has recently been reviewed in detail [<xref ref-type=""bibr"" rid=""B6"">6</xref>]. Unfortunately, structural information relating specifically to the interactions of RACK1 with its numerous protein partners currently remains very limited.</p><p>Scanning peptide arrays, mutagenesis studies and competition experiments with RACK1-derived peptides have identified probable loci on the surface of RACK1 that may contribute to protein-protein interfaces for some of RACK1's partners. The most detailed information relating to RACK1-biomolecule associations currently available, however, has emerged from structural studies with ribosomes. Initial breakthroughs came with the use of cryoelectron microscopy (cryo-EM) techniques, affording a low resolution (11.7 Å) structure for the yeast 40S ribosomal subunit that identified the position of bound RACK1 on the head region proximal to the mRNA exit channel [<xref ref-type=""bibr"" rid=""B84"">84</xref>]. The cryo-EM map of a mammalian 40S subunit followed at slightly higher resolution (8.7 Å) [<xref ref-type=""bibr"" rid=""B85"">85</xref>]. These studies pre-dated the RACK1 X-ray crystal structures, and the ribosome structure was constructed by fitting homology models of individual ribosomal components (templated on Gβ in the case of RACK1) to the cryo-EM map. Both models implicated helices 39 and 40 of the 18S ribosomal RNA as the primary anchoring region for RACK1, with contact mediated largely by blades 1 and 2 and their associated loops. Consistent with this, binding of RACK1 to ribosomes is compromised by mutation of a number of basic residues that are conserved across the identified RNA binding interface of RACK1 species but that are absent at the cognate sites in Gβ (Figure<xref ref-type=""fig"" rid=""F6"">6</xref>). Thus, a double charge reversal mutation (R38D:K40E) in the RDK B-C turn of blade 1 almost fully ablates binding of the yeast protein (Asc1p) to the ribosome [<xref ref-type=""bibr"" rid=""B79"">79</xref>,<xref ref-type=""bibr"" rid=""B84"">84</xref>]. Alanine mutations for K87, R90 and R102, residues that project from the B-C turn and edge of blade 2 in Asc1p, also attenuate binding to the ribosome [<xref ref-type=""bibr"" rid=""B79"">79</xref>]. Similarly, alanine mutagenesis of K62, located on the edge of blade 1, weakens binding to the ribosome [<xref ref-type=""bibr"" rid=""B79"">79</xref>]. At least four of these residues (K40, K87, R90, R102) are expected to make direct contact with the sugar-phosphate backbone of the ribosomal RNA, forming salt bridge interactions with the phosphates. Interestingly, neither K62 nor K87 are fully conserved across RACK1 homologues, however, indicating some species differences in the interaction of RACK1 with the RNA of the 40S ribosomal subunit. Nevertheless, all the available data from structural studies with eukaryotic ribosomes points to a similar mode of engagement involving the edge of blades 1 and 2 and accompanying loops on the top face of the β-propeller. Interestingly, RACK1 associates with polysome bound polyA-mRNA enabling PKCβII to phosphorylate polyA-mRNA-associated proteins and control localized protein synthesis in neurons [<xref ref-type=""bibr"" rid=""B86"">86</xref>].</p><p>RACK1 binding to the eukaryotic ribosome is not purely mediated by interactions with the 18S RNA however. Additional contact occurs between RACK1 and co-associated ribosomal proteins and, following the studies described above, cryo-EM maps have emerged for ribosomes providing more detail for the assembled proteins [<xref ref-type=""bibr"" rid=""B87"">87</xref>-<xref ref-type=""bibr"" rid=""B89"">89</xref>]. Very recently X-ray crystal structures have also been obtained for complete eukaryotic ribosomal subunits [<xref ref-type=""bibr"" rid=""B80"">80</xref>,<xref ref-type=""bibr"" rid=""B83"">83</xref>]. These studies have defined the interfaces on RACK1 for co-association with three eukaryotic ribosomal proteins -- rpS3e, rpS16e and rpS17e -- as illustrated with the 40S subunit from<italic>T. thermophila</italic>at 3.9 Å resolution (Figure<xref ref-type=""fig"" rid=""F9"">9</xref>). The most extensive protein contacts occur with a three-helix bundle formed by the N-terminal region of rpS17e, which occupies one face of the RACK1 propeller. The model suggests that a number of salt bridges are formed at the interface between the two proteins, and these contacts involve the RDK turn between strands B and C of blade 1 in RACK1. Charge reversal mutations of the two basic residues in this conserved turn had earlier been found to abrogate binding of the yeast RACK1 ortholog (Asc1p) to the ribosome (<italic>vide supra</italic>). The additional detail provided by the crystal structure suggests that, whereas the Lys is orientated towards phosphates on the nearby rRNA backbone, the Arg of the RDK motif engages an Asp residue (D27) on rpS17e. A phenylalanine side chain (F30) on rpS17e, proximal to this Asp, inserts into the mouth of the RACK1 tunnel to form extensive packing interactions against aromatic side chains lining the inner rim formed by the RACK1 D-A and B-C loops. Contact between RACK1 and rpS16e is less extensive and focused almost entirely on the edge of blade 1. The third ribosomal protein, rpS3e, engages RACK1 with an extended C-terminal strand that runs diagonally across the edge of blade 4 and terminates in contact with the C-D loop of blade 5. This strand is not defined in a crystal structure for the yeast ribosome at 4.15 Å resolution and adopts a rather different trajectory across blades 4 and 5 in a model derived from a cryo-EM map of the ribosome at 6.1 Å resolution [<xref ref-type=""bibr"" rid=""B83"">83</xref>,<xref ref-type=""bibr"" rid=""B89"">89</xref>,<xref ref-type=""bibr"" rid=""B90"">90</xref>].</p><fig id=""F9"" position=""float""><label>Figure 9</label><caption><p><bold>Structure of RACK1 bound to the 40S eukaryotic ribosomal subunit and interaction with co-associated ribosomal proteins</bold>. (A) Surface rendition of<italic>T. thermophila</italic>(PDB:<ext-link ext-link-type=""pdb"" xlink:href=""2XZN"">2XZN</ext-link>) 40S subunit: rRNA (white); RACK1 coloured as in Figure 2A/B; ribosomal proteins are shown in grey with the exception of those in direct contact with RACK1 -- rpS3e (light brown), rpS16e (light blue), rpS17e (pale cyan). (B) As (A) but with 90° rotation about the y-axis; position of mRNA exit tunnel is marked (dashed oval). (C) Detail of ribosome-bound RACK1 structure, highlighting PKC-binding loci on blades 2 and 6; RACK1 and rRNA are shown in ribbon format, interacting ribosomal proteins are surface-rendered. (D) Detail of key contacts between RACK1 residues (italicised) and rpS17e residues (non-italicised): D27 (rpS17e) forms a salt bridge with R47 (RACK1); F30 (rpS17e) packs against aromatic RACK1 side chains (W, Y, W, W). R47 (RACK1) engages rRNA backbone phosphates.</p></caption><graphic xlink:href=""1478-811X-9-22-9""></graphic></fig><p>The ribosome binding mode for RACK1 established through the recent cryo-EM and X-ray diffraction studies indicates that the top face of the RACK1 propeller, as presented in Figure<xref ref-type=""fig"" rid=""F2"">2</xref>, is fully blocked when RACK1 is bound to the ribosome. In contrast, access to the reverse face of RACK1 and several of the blade edges is unobstructed, and these surfaces may serve as a platform for recruitment of proteins to the ribosome. One such protein known to be recruited to the translating ribosome is PKCβII [<xref ref-type=""bibr"" rid=""B91"">91</xref>-<xref ref-type=""bibr"" rid=""B93"">93</xref>]. Competition experiments with peptide sequences derived from WD-repeats 3 and 6 suggest that these regions of RACK1 contribute to the PKCβII binding interface [<xref ref-type=""bibr"" rid=""B92"">92</xref>,<xref ref-type=""bibr"" rid=""B93"">93</xref>]. Significantly, both loci are accessible in the established ribosome-bound RACK1 structures. Thus, a mammalian RACK1 sequence (99-RRFVGHTKDV-108) corresponding to the outer β-strand of blade 2 and D-A loop into blade 3 disrupts association of RACK1 and PKC [<xref ref-type=""bibr"" rid=""B92"">92</xref>]. This sequence, although located proximal to the rRNA of the 40S subunit (Figure<xref ref-type=""fig"" rid=""F9"">9</xref>), has significant surface exposure. Remarkably, sequences from WD6 that are implicated in PKC binding include both β-strands A (234-DIINALCF-241) and C (255-SIKIWD-260) of blade 6 [<xref ref-type=""bibr"" rid=""B42"">42</xref>-<xref ref-type=""bibr"" rid=""B44"">44</xref>,<xref ref-type=""bibr"" rid=""B94"">94</xref>-<xref ref-type=""bibr"" rid=""B96"">96</xref>]. Direct contact with residues in these strands can only reasonably occur by intercalation of structural elements from PKC between propeller blades 6 and 7 or, as has been proposed by others, [<xref ref-type=""bibr"" rid=""B46"">46</xref>] through the peeling off of the outer strands in blade 6 to allow hybridisation with surrogate strands from PKC. The sequence extension between blades 6 and 7 that forms the RACK1 knob may be important in providing flexibility for the structural transition required to accommodate PKC by either of these modes. This knob structure is bound close to rRNA and rp17e in the established 40S structures, but mutagenesis and sequence deletion studies indicate that it is not actually essential for binding of RACK1 to the ribosome, at least in the case of yeast [<xref ref-type=""bibr"" rid=""B79"">79</xref>]. Further work is required to provide a detailed structural understanding of the interaction between PKC and RACK1 and this should include consideration of the role of the RACK1 knob.</p><p>A very recent and exciting development in regards to RACK1 structure has been the acquisition of an X-ray crystal structure for the yeast protein, Asc1p, as a homodimer [<xref ref-type=""bibr"" rid=""B82"">82</xref>]. This new structure has revealed a previously unprecedented mode of β-propeller dimerisation involving blade hybridisation. Specifically, β-strands B and C in blade 4 are extruded from the upper face of the propeller as an extended loop for each of the protomers in the dimeric assembly. The remaining strands (A and D) from blade 4 stay within the propeller core but now hydrogen bond directly to one another. Thus, in effect strand D migrates radially inwards to take the position that the extruded strand B ordinarily occupies in the monomeric protein. The two RACK1 protomers then dimerise by hybridisation of the blade 4 D-strands, forming a shared four-stranded antiparallel β-sheet in the format, Protomer-A-D:D-A-Protomer. This mode of dimerisation also brings the blade 3 edges of each protomer sufficiently proximal to one another to hydrogen bond, forming an extended eight-stranded β-sheet. Remarkably, the extrusion-hybridisation mode of dimerisation centred on blade 4 causes little perturbation in the rest of the protein structure, and the protomers in the dimeric assembly superimpose tightly onto the structure of the monomeric RACK1 protein over the blades not directly involved in dimerisation. The emerging picture for the RACK1 homodimer provides important new insights into the potential interactions between RACK1 and its partner proteins. Firstly, it accounts for the capacity of RACK1 to simultaneously scaffold the NMDA receptor and Fyn (<italic>vide infra</italic>), where both of these proteins target overlapping binding loci on RACK1. Secondly, the model shows how buried sequences within the core propeller blades may potentially be exposed by extrusion to provide binding surfaces that are not exposed in the monomeric state. The model is particularly significant in relation to the association of PKC (discussed above), where one model for the interaction involves β-strand swapping between RACK1 and the β-sandwich C2 domain of the kinase. The RACK1 homodimer structure provides the first direct evidence that such strand extrusion-insertion mechanisms may indeed be important for the interaction of RACK1 with its partners, and, if this is applicable to the binding of PKCβII, that such mechanisms may occur with blades other than blade 4 alone.</p></sec></sec><sec><title>RACK1 and Signaling</title><sec><title>RACK1 and PKC</title><p>As detailed above, RACK1 was first described as a PKCβII anchoring protein [<xref ref-type=""bibr"" rid=""B42"">42</xref>], and has since been extensively studied in relation to PKC signaling [<xref ref-type=""bibr"" rid=""B46"">46</xref>,<xref ref-type=""bibr"" rid=""B97"">97</xref>]. RACK1 binds activated PKCβII and the interaction serves to stabilize the active conformation of the kinase [<xref ref-type=""bibr"" rid=""B42"">42</xref>,<xref ref-type=""bibr"" rid=""B45"">45</xref>,<xref ref-type=""bibr"" rid=""B60"">60</xref>] (Figure<xref ref-type=""fig"" rid=""F3"">3</xref>). In addition, RACK1 serves as a PKCβII shuttling protein, enabling the kinase to phosphorylate its substrate at the appropriate site [<xref ref-type=""bibr"" rid=""B60"">60</xref>] (Figure<xref ref-type=""fig"" rid=""F2"">2</xref>). Although most of the studies are focused on the interaction of RACK1 with PKCβII isoform, several other PKC isoforms bind RACK1 upon activation [<xref ref-type=""bibr"" rid=""B46"">46</xref>,<xref ref-type=""bibr"" rid=""B98"">98</xref>,<xref ref-type=""bibr"" rid=""B99"">99</xref>]. In addition, the RACK1/PKC partnership was suggested to be intrinsically linked and PKCs have been shown to regulate RACK1 expression in cardiac myocytes [<xref ref-type=""bibr"" rid=""B100"">100</xref>]. As well as stabilising PKC activity, RACK1 introduces activated PKC to new signaling proteins and pathways. These signaling proteins may be directly scaffolded by RACK1 or RACK1 may shuttle its cohort of bound PKC to particular cellular locations and anchor a subset of activated PKC at specific receptor sites. For example, RACK1 was shown to scaffold the MAP kinase (MAPK), Jun N-terminal kinase (JNK) and various PKC isoforms (αβγ) upon stimuli leading to PKC phosphorylation of JNK [<xref ref-type=""bibr"" rid=""B101"">101</xref>]. Thus, RACK1 allows the cross-talk between the PKC and MAPK pathways.</p><p>Recently, very exciting data published by the Lebel group suggests that depletion of Werner syndrome, RecQ helicase-like (WRN) protein in the nucleus causes RACK1 to move out of the nucleus and to collocate with PKCβII and PKCδ [<xref ref-type=""bibr"" rid=""B102"">102</xref>]. This suggests that PKC may also function as a 'sink' for RACK1 in the cytoplasm, preventing RACK1 from going to the nucleus non-specifically. The interaction between RACK1 and PKC family members in the nucleus has also been reported however. Specifically, RACK1 and PKCα are recruited in a circadian manner into a nuclear brain and muscle aryl hydrocarbon receptor nuclear translocator 1 (BMAL1) complex during the negative feedback phase of the cycle [<xref ref-type=""bibr"" rid=""B103"">103</xref>]. This finding suggests that PKCα is rhythmically activated during this process and that both RACK1 and PKCα are an integral part of the oscillatory mechanism. Finally, the interaction between RACK1 and PKC isozymes plays a role in development [<xref ref-type=""bibr"" rid=""B104"">104</xref>], as discussed in section 5.1.</p></sec><sec><title>RACK1 and the cAMP/PKA pathway</title><p>The cAMP/PKA signaling pathway is also tightly linked to RACK1 [<xref ref-type=""bibr"" rid=""B29"">29</xref>,<xref ref-type=""bibr"" rid=""B56"">56</xref>,<xref ref-type=""bibr"" rid=""B105"">105</xref>-<xref ref-type=""bibr"" rid=""B107"">107</xref>]. Specifically, cAMP is hydrolysed through the action of cAMP phosphodiesterases (PDEs) [<xref ref-type=""bibr"" rid=""B108"">108</xref>], and RACK1 interacts with phosphodiesterase isoform PDE4D5 [<xref ref-type=""bibr"" rid=""B107"">107</xref>,<xref ref-type=""bibr"" rid=""B109"">109</xref>,<xref ref-type=""bibr"" rid=""B110"">110</xref>]. Interestingly, RACK1 and the scaffolding protein β-arrestin compete for binding to PDE4D5 [<xref ref-type=""bibr"" rid=""B109"">109</xref>]. Furthermore, and as detailed in section 5.2., RACK1 serves as the molecular bridge linking the Focal Adhesion Kinase (FAK) to PDE4D5 to control cell polarity [<xref ref-type=""bibr"" rid=""B111"">111</xref>,<xref ref-type=""bibr"" rid=""B112"">112</xref>]. In addition, we previously reported that upon activation of PKA by the adenylate cyclase forskolin, or the pituitary adenylate cyclase activating peptide (PACAP), RACK1 translocates to the nucleus where it mediates the expression of the brain-derived neurotrophic factor (<italic>BDNF</italic>) [<xref ref-type=""bibr"" rid=""B56"">56</xref>,<xref ref-type=""bibr"" rid=""B106"">106</xref>] (Figure<xref ref-type=""fig"" rid=""F4"">4</xref>). Finally, the activation of the cAMP/PKA pathway in hippocampal neurons also leads to the dissociation of RACK1 from its binding partners Fyn kinase and the NR2B subunit of the NMDAR, leading to the phosphorylation of the subunit by Fyn, and to enhancement of the channel's activity [<xref ref-type=""bibr"" rid=""B49"">49</xref>,<xref ref-type=""bibr"" rid=""B56"">56</xref>] (Figure<xref ref-type=""fig"" rid=""F5"">5A</xref>) (see also sections 3.3 and 3.4.2).</p></sec><sec><title>RACK1 and the Src family of non-receptor protein tyrosine kinases</title><p>RACK1 plays an inhibitory role with the Src family of non-receptor protein tyrosine kinases (PTKs), specifically with Src and Fyn. Thus, RACK1 interacts with Src and Fyn respectively in cultured cancer cells and in neurons, and this interaction inhibits the activity of the kinases, suggesting that RACK1 plays an inhibitory role on Src and Fyn kinase's function [<xref ref-type=""bibr"" rid=""B29"">29</xref>,<xref ref-type=""bibr"" rid=""B49"">49</xref>,<xref ref-type=""bibr"" rid=""B57"">57</xref>,<xref ref-type=""bibr"" rid=""B61"">61</xref>,<xref ref-type=""bibr"" rid=""B113"">113</xref>,<xref ref-type=""bibr"" rid=""B114"">114</xref>]. Suppression of Src activity by RACK1 is central to the regulation of the growth of colon cells [<xref ref-type=""bibr"" rid=""B114"">114</xref>] and a new report suggests that by inhibiting Src activity, RACK1 stabilises E-cadherin and catenins at cell-cell contacts [<xref ref-type=""bibr"" rid=""B115"">115</xref>]. The release of RACK1 from Src is mediated by IGF-I [<xref ref-type=""bibr"" rid=""B113"">113</xref>], and the release of RACK1 from Fyn is mediated by activation of the cAMP/PKA pathway [<xref ref-type=""bibr"" rid=""B56"">56</xref>], resulting in the activation of both kinases (see also sections 5.3 and 6.2).</p></sec><sec><title>RACK1 and transmembrane receptors</title><p>RACK1 interacts with cytoplasmic tails of several receptors including the Insulin-like Growth Factor Receptor I (IGF-IR), β-integrin receptor, the common beta-chain of the IL-5/IL-3/GM-CSF receptor [<xref ref-type=""bibr"" rid=""B116"">116</xref>], type I interferon receptor [<xref ref-type=""bibr"" rid=""B117"">117</xref>], inositol 1,4,5-trisphosphate receptors (IP3R) when at the cell membrane [<xref ref-type=""bibr"" rid=""B118"">118</xref>], the muscarinic M2 receptor [<xref ref-type=""bibr"" rid=""B119"">119</xref>], the adiponectin receptor [<xref ref-type=""bibr"" rid=""B120"">120</xref>] the androgen receptor [<xref ref-type=""bibr"" rid=""B121"">121</xref>], as well as several ion channels. As described below, the interaction of RACK1 with intracellular domains of transmembrane receptors results in the positive or negative regulation of receptor function.</p></sec><sec><title>RACK1 and receptor tyrosine kinases</title><p>One of the best studied receptor tyrosine kinase (RTK)/RACK1 associations is the one between RACK1 and the IGF-IR [<xref ref-type=""bibr"" rid=""B76"">76</xref>,<xref ref-type=""bibr"" rid=""B77"">77</xref>]. RACK1 interacts with the IGF-IR in a wide variety of cells and the interaction site has been mapped to the C-terminus of the IGF-IR. RACK1 also interacts with the closely related Insulin receptor [<xref ref-type=""bibr"" rid=""B77"">77</xref>,<xref ref-type=""bibr"" rid=""B122"">122</xref>]. At the IGF-IR, RACK1 recruits a series of proteins including the adaptor proteins, Shc and IRS-1/2, the phosphatase, Shp2, and the transcription factor, STAT3 [<xref ref-type=""bibr"" rid=""B77"">77</xref>,<xref ref-type=""bibr"" rid=""B113"">113</xref>,<xref ref-type=""bibr"" rid=""B122"">122</xref>]. In doing so, RACK1 builds protein complexes to facilitate signaling downstream of the IGF-IR. RACK1 also binds the β subunits of integrin [<xref ref-type=""bibr"" rid=""B123"">123</xref>] and integrates and facilitates signaling between the IGF-IR and integrins during tumour cell migration [<xref ref-type=""bibr"" rid=""B76"">76</xref>,<xref ref-type=""bibr"" rid=""B77"">77</xref>,<xref ref-type=""bibr"" rid=""B124"">124</xref>]. This is mediated in part by the serine/threonine phosphatase PP2A as RACK1 binds PP2A and β1 integrin in a mutually exclusive manner [<xref ref-type=""bibr"" rid=""B58"">58</xref>,<xref ref-type=""bibr"" rid=""B59"">59</xref>]. In bridging the IGF-IR and β1 integrin into one complex, RACK1 facilitates the IGF-I and adhesion-mediated recruitment of other proteins to the complex to promote cell migration. Binding of RACK1 to integrins also promotes the engagement of survival signaling pathways [<xref ref-type=""bibr"" rid=""B125"">125</xref>], the MAPK pathway [<xref ref-type=""bibr"" rid=""B126"">126</xref>] and the recruitment of several PKC isoforms [<xref ref-type=""bibr"" rid=""B127"">127</xref>-<xref ref-type=""bibr"" rid=""B129"">129</xref>].</p></sec><sec><title>RACK1 and ion channels</title><p>RACK1 is highly expressed in the CNS, mainly in neurons, during development and also throughout the adult brain, where it is localized to the neural cell bodies and dendrites [<xref ref-type=""bibr"" rid=""B71"">71</xref>,<xref ref-type=""bibr"" rid=""B86"">86</xref>]. In the CNS, RACK1 interacts with the cytoplasmic tail of ligand-gated and ion-gated channels and plays an important role in the regulation of the channels' functions. Specifically, RACK1 binds the cytoplasmic domain of the β1 and β3 subunits of the GABA<sub>A</sub>receptor (GABA<sub>A</sub>R) [<xref ref-type=""bibr"" rid=""B96"">96</xref>,<xref ref-type=""bibr"" rid=""B130"">130</xref>]. The interaction between RACK1 and the GABA<sub>A</sub>R plays an important role in facilitating the phosphorylation of the GABA<sub>A</sub>Rs by PKCβII, thereby modulating GABA<sub>A</sub>R function in response to the activation of muscarinic acetylcholine and the serotonin receptors [<xref ref-type=""bibr"" rid=""B96"">96</xref>,<xref ref-type=""bibr"" rid=""B130"">130</xref>,<xref ref-type=""bibr"" rid=""B131"">131</xref>].</p><p>RACK1 also plays an important role in regulating the function of the NMDAR. In the hippocampus and the dorsal striatum, RACK1 interacts with the cytoplasmic tail of the NR2B subunit of the NMDAR and simultaneously with the kinase, Fyn [<xref ref-type=""bibr"" rid=""B49"">49</xref>]. This simultaneous interaction allows Fyn to be localized in close proximity to its substrate, NR2B (Figure<xref ref-type=""fig"" rid=""F5"">5</xref>). However, as long as RACK1 is present in the complex, Fyn cannot phosphorylate the subunit [<xref ref-type=""bibr"" rid=""B49"">49</xref>]. Activation of the cAMP/PKA pathway leads to the dissociation of RACK1 from NR2B and Fyn [<xref ref-type=""bibr"" rid=""B29"">29</xref>,<xref ref-type=""bibr"" rid=""B56"">56</xref>]. Once RACK1 is removed from the NMDAR, Fyn is then free to phosphorylate NR2B, which in turn results in an increase in the activity of the channel [<xref ref-type=""bibr"" rid=""B29"">29</xref>,<xref ref-type=""bibr"" rid=""B49"">49</xref>,<xref ref-type=""bibr"" rid=""B57"">57</xref>] (Figure<xref ref-type=""fig"" rid=""F5"">5A</xref>). Interestingly, although the three proteins are expressed throughout the brain, the compartmentalization of Fyn to the NR2B subunit of the NMDAR by RACK1 is detected in some brain regions but not others. Specifically, the tri-molecular complex is detected in the hippocampus and dorsal striatum but is not found in the cerebral cortex or the ventral striatum [<xref ref-type=""bibr"" rid=""B49"">49</xref>,<xref ref-type=""bibr"" rid=""B55"">55</xref>-<xref ref-type=""bibr"" rid=""B57"">57</xref>] (Figure<xref ref-type=""fig"" rid=""F5"">5B, C</xref>). Furthermore, the compartmentalization of Fyn in close proximity to, or away from, the NMDAR bears functional consequences and provides the molecular mechanism underlying the difference in the sensitivity of the NMDAR to alcohol in these brain regions [<xref ref-type=""bibr"" rid=""B55"">55</xref>,<xref ref-type=""bibr"" rid=""B57"">57</xref>] (see also section 6.2).</p><p>Finally, RACK1 has been pulled out in a yeast 2-hybrid screen with the cytoplasmic tail of the large conductance Ca<sup>2+</sup>activated potassium (BK) channel [<xref ref-type=""bibr"" rid=""B132"">132</xref>]. RACK1 was shown to slow the activation of the channel [<xref ref-type=""bibr"" rid=""B132"">132</xref>], although the functional experiments were conducted in<italic>Xenopus Oocytes</italic>and must be confirmed in a more physiologically relevant system. Nevertheless, this study serves as an example of the ability of RACK1 to interact with ion-gated channels as well.</p></sec></sec><sec><title>RACK1 and Examples of Other Interacting Proteins</title><sec><title>RACK1 and the Androgen Receptor</title><p>RACK1 has been shown to interact with the androgen receptor (AR). In binding to the AR, RACK1 mediates translocation of the receptor into the nucleus [<xref ref-type=""bibr"" rid=""B121"">121</xref>], and also facilitates the cross-talk of the AR with other kinases [<xref ref-type=""bibr"" rid=""B133"">133</xref>]. Specifically, the recruitment of Src to AR-bound RACK1 facilitates the phosphorylation of the AR on tyrosine residues and regulates its transcriptional activity [<xref ref-type=""bibr"" rid=""B133"">133</xref>].</p></sec><sec><title>RACK1 and 14-3-3</title><p>Very recently, using a proteomics strategy, we identified the scaffolding protein 14-3-3ζ as a binding partner of RACK1 (Neasta<italic>et al</italic>. 14-3-3/RACK1, in revision). We found that the interaction between the two scaffolding proteins is direct and does not require the prior phosphorylation of RACK1 on consensus phospho-14-3-3ζ binding sites. Using a RACK1-derived peptide array approach, we identified two putative binding sites for 14-3-3ζ located within the WD2-3 and WD4-5 propeller blade regions of RACK1. We found further evidence to suggest that 14-3-3ζ is necessary for the shuttling of RACK1 to the nucleus and to the subsequent activation of<italic>BDNF</italic>transcription in response to activation of the cAMP/PKA pathway (Neasta<italic>et al</italic>., 14-3-3/RACK1 in revision). These findings provide the first intriguing example that the interaction between two multifunctional scaffolding proteins, RACK1 and 14-3-3ζ, can provide a multiprotein signaling platform to tether signalosome.</p></sec><sec><title>RACK1 and acetylcholinesterase</title><p>RACK1 interacts with the stress-induced splice variant of acetylcholinesterase (AChE-R) ([<xref ref-type=""bibr"" rid=""B134"">134</xref>]. The interaction between AChE-R and RACK1 leads to the recruitment of PKCβII in the CA1 and CA3 regions of the hippocampus, as well as the basolateral amygdala [<xref ref-type=""bibr"" rid=""B134"">134</xref>]. Furthermore, peripheral anionic site (PAS) inhibition of AChE in primary hippocampal neurons led to the redistribution of RACK1, decreased Fyn expression and NR2B insertion into the synaptic membrane, resulting in spontaneous excitatory post-synaptic currents (sEPSCs) [<xref ref-type=""bibr"" rid=""B135"">135</xref>].</p></sec></sec><sec><title>RACK1, Postranslational Modifications and Subcellular Compartmentalisation</title><sec><title>Post-translational modifications</title><p>In response to stress, RACK1 is sequestered into stress granules and inhibits apoptosis by suppressing stress-responsive MAPK pathways [<xref ref-type=""bibr"" rid=""B136"">136</xref>] Elegent studies carried out by Ohn<italic>et al</italic>, [<xref ref-type=""bibr"" rid=""B137"">137</xref>], have revealed that in response to arsenite-induced stress, RACK1 is reversibly modified by<italic>O</italic>-linked<italic>N</italic>-acetylglucosamine (O-GlcNAc) and moves from polysome-containing fractions to monosome-containing fractions of the cell. This study also indicates that when modified by O-GlcNAc, RACK1 moves to ribosomal subunit-containing fractions where it associates with the translational machinery and promotes stress granule assembly. Little is known about other post-translational modifications of RACK1 apart from phosphorylation which is emerging as an important factor that modulates the binding of proteins to RACK1. RACK1's sequence contains six tyrosine residues: Tyr-52 (located at the boundary of WD1 and WD2), Tyr-140 (WD 4), Tyr-194 (WD5), Tyr-228 and Tyr-246 (WD 6), and Tyr-302 (WD7). Phosphorylation of RACK1 on Tyr-52 by c-Abl mediates the interaction with FAK [<xref ref-type=""bibr"" rid=""B124"">124</xref>], which is required for cell adhesion and cell migration while phosphorylation/dephosphorylation of Tyr-302 in WD7 of RACK1 regulates the mutually exclusive association of RACK1 with PP2A and β1 Integrin [<xref ref-type=""bibr"" rid=""B58"">58</xref>,<xref ref-type=""bibr"" rid=""B59"">59</xref>]. Phosphorylation of RACK1 on Tyr-246 is required for the binding of Src kinase to RACK1 [<xref ref-type=""bibr"" rid=""B138"">138</xref>]. The interaction between RACK1 and Src is essential for the regulation of Src activity during the cell cycle [<xref ref-type=""bibr"" rid=""B114"">114</xref>,<xref ref-type=""bibr"" rid=""B139"">139</xref>]. RACK1 is also a substrate of Src. Specifically, Src phosphorylates RACK1 on Tyr-228 and strong evidence suggests that Src phosphorylates RACK1 on Tyr 246 also [<xref ref-type=""bibr"" rid=""B48"">48</xref>]. In addition, serine phosphorylation of RACK1 is also reported. Phosphorylation of RACK1 on Ser-146 promotes its dimerization which is required for the degradation of HIF-1α [<xref ref-type=""bibr"" rid=""B140"">140</xref>]. Taken together, these studies suggest that RACK1 is modified by signaling pathways which is important for protein binding and RACK1 location.</p></sec><sec><title>Subcellular localization and translocation</title><p>RACK1 immunoreactivity can be detected in various cellular compartments including the cytosol, endoplasmic reticulum and the nucleus. In neurons, RACK1 is detected in cell bodies and dendrites but not in axons [<xref ref-type=""bibr"" rid=""B71"">71</xref>,<xref ref-type=""bibr"" rid=""B86"">86</xref>]. In addition, translocation of RACK1 from one subcellular location to another has been shown to mediate various cellular responses following a stimulus. For example, in response to PKC activation, RACK1 accompanies PKCβII to its site of action [<xref ref-type=""bibr"" rid=""B60"">60</xref>] (Figure<xref ref-type=""fig"" rid=""F2"">2</xref>), and as mentioned above, upon cellular stress induced by hypoxia or heat shock, RACK1 is sequestered into cytoplasmic stress granules preventing the activation of a stress-responsive MAPK pathway, which in turn leads to cell survival instead of cell apoptosis [<xref ref-type=""bibr"" rid=""B136"">136</xref>]. Moreover, the activation of the cAMP/PKA pathway in various types of cells, including neurons, induces RACK1 translocation to the nucleus [<xref ref-type=""bibr"" rid=""B56"">56</xref>,<xref ref-type=""bibr"" rid=""B106"">106</xref>,<xref ref-type=""bibr"" rid=""B141"">141</xref>,<xref ref-type=""bibr"" rid=""B142"">142</xref>] subsequently leading to the transcription of the brain-derived neurotrophic factor (<italic>BDNF</italic>) [<xref ref-type=""bibr"" rid=""B56"">56</xref>,<xref ref-type=""bibr"" rid=""B57"">57</xref>,<xref ref-type=""bibr"" rid=""B106"">106</xref>,<xref ref-type=""bibr"" rid=""B143"">143</xref>] and (Neasta<italic>et al</italic>14-3-3/RACK1 in Revision) (Figure<xref ref-type=""fig"" rid=""F4"">4</xref>). The RACK1 sequence does not contain known organelle localization motifs, or N-terminal lipid modification sites; nor does the sequence contain nuclear entry or nuclear export signals. In addition, there are no conclusive reports that the subcellular location of RACK1 is controlled by post-translational modification of RACK1 itself. Thus, the movement of RACK1 around the cell is most likely influenced by the particular cohort of proteins associated with RACK1 at any one time. An example, of such interacting protein is 14-3-3 which enables RACK1 to be transported to the nucleus in response to the activation of the cAMP/PKA pathway (Neasta et al 14-3-3/RACK1 in Revision).</p></sec><sec><title>RACK1 in the nucleus</title><p>As detailed above, activation of the cAMP pathway in various types of cells, including neurons induces RACK1 translocation to the nucleus, subsequently leading to the transcription of several genes including<italic>BDNF</italic>[<xref ref-type=""bibr"" rid=""B56"">56</xref>,<xref ref-type=""bibr"" rid=""B106"">106</xref>,<xref ref-type=""bibr"" rid=""B141"">141</xref>,<xref ref-type=""bibr"" rid=""B143"">143</xref>] and (Neasta et al 14-3-3/RACK1 in Revision). In relation to<italic>BDNF</italic>transcription, using adenovirus-mediated siRNA delivery to knockdown the level of RACK1 in differentiated SHSY5Y cells and hippocampal neurons, we showed that activation of the cAMP pathway results in the association of RACK1 with the promoter IV region of the<italic>BDNF</italic>gene, leading to an increase in exon IV specific<italic>BDNF</italic>transcription [<xref ref-type=""bibr"" rid=""B106"">106</xref>]. RACK1 has been identified in several other complexes in the nucleus. It binds to the RQC domain and the acidic region of WRN and WRN may play an important role in retaining RACK1 in the nucleus [<xref ref-type=""bibr"" rid=""B102"">102</xref>]. Ki-1/57, a Ser/Thr protein kinase that interacts with chromo-helicase DNA-binding domain protein 3, forms a tight complex with RACK1 in the nucleus and treatment of cells with the PKC activator, PMA, mediates threonine phosphorylation of Ki-1/57 and disrupts the interaction with RACK1 [<xref ref-type=""bibr"" rid=""B144"">144</xref>]. Finally, RACK1 is also an essential component of systems required for regulating HIF-1α stability [<xref ref-type=""bibr"" rid=""B54"">54</xref>,<xref ref-type=""bibr"" rid=""B145"">145</xref>] and it does so by competing with HSP90 for binding to HIF-1α.</p></sec><sec><title>RACK1 and ribosomes</title><p>An exciting development in RACK1 physiology is the realisation that RACK1 has a key role to play in the translation machinery [<xref ref-type=""bibr"" rid=""B146"">146</xref>]. The identification of RACK1 as a ribosome-associated protein was first made by mass spectroscopy [<xref ref-type=""bibr"" rid=""B147"">147</xref>], and in recent years RACK1 has become a well-established component of the ribosomal machinery through studies with ribosomes from yeast [<xref ref-type=""bibr"" rid=""B83"">83</xref>,<xref ref-type=""bibr"" rid=""B84"">84</xref>,<xref ref-type=""bibr"" rid=""B89"">89</xref>,<xref ref-type=""bibr"" rid=""B148"">148</xref>-<xref ref-type=""bibr"" rid=""B151"">151</xref>] and fungi [<xref ref-type=""bibr"" rid=""B88"">88</xref>], from unicellular algae [<xref ref-type=""bibr"" rid=""B152"">152</xref>] and plants [<xref ref-type=""bibr"" rid=""B89"">89</xref>,<xref ref-type=""bibr"" rid=""B90"">90</xref>,<xref ref-type=""bibr"" rid=""B153"">153</xref>-<xref ref-type=""bibr"" rid=""B156"">156</xref>] from protozoa [<xref ref-type=""bibr"" rid=""B80"">80</xref>] and mammals [<xref ref-type=""bibr"" rid=""B85"">85</xref>,<xref ref-type=""bibr"" rid=""B86"">86</xref>,<xref ref-type=""bibr"" rid=""B137"">137</xref>]. As discussed (Part 2), the RACK1 binding site, located on the 40S subunit of the eukaryotic ribosome, is now well defined by several structural studies.</p><p>Although ribosome-bound RACK1 might directly regulate translation<italic>per se</italic>, its function as a ribosomal protein is likely linked to its capacity to recruit a particular cohort of RACK1-associated proteins such as activated PKCβII. Indeed, PKC-mediated translational control has recently been shown to be dependent upon RACK1, and a RACK1-derived peptide that disrupts PKCβII binding to RACK1 or down-regulation of RACK1 with siRNA impairs PKC-stimulated translation [<xref ref-type=""bibr"" rid=""B92"">92</xref>]. The action of PKCβII in stimulating translation is thought to arise, at least in part, from its phosphorylation of eukaryotic initiation factor 6 (eIF6) bound to the 60S ribosomal subunit. Specifically, assembly of the ribosome by joining of 40S and 60S subunits is a rate-limiting step in translation, and PKCβII-mediated phosphorylation of a carboxy terminal serine (S235) in eIF6 triggers release of the initiation factor to facilitate this [<xref ref-type=""bibr"" rid=""B91"">91</xref>]. Identification of the ribosomal binding site for RACK1 has therefore suggested a model for ribosome assembly in which phosphorylation of eIF6 by PKC occurs on the 60S subunit as a result of an interaction with eIF6 and PKC bound to a nearby 40S subunit via RACK1 [<xref ref-type=""bibr"" rid=""B84"">84</xref>]. RACK1 is also known to bind eIF6 directly, although the loci on RACK1 for this interaction have not yet been defined and it is unclear whether phosphorylation of eIF6 by PKC involves simultaneous association of both enzyme and substrate initiation factor on the ribosome-bound RACK1.</p><p>In contrast to its role in promoting translation, other studies suggest that RACK1 may act at the ribosome to repress gene expression [<xref ref-type=""bibr"" rid=""B148"">148</xref>,<xref ref-type=""bibr"" rid=""B157"">157</xref>]. Specifically, very recently it has been shown that RACK1 interacts with components of the microRNA-induced gene silencing complex, contributing to recruitment of the complex to the site of translation and suggesting that RACK1 facilitates a post-initiation mode of miRNA-mediated gene repression [<xref ref-type=""bibr"" rid=""B157"">157</xref>]. RACK1 may also be involved in translation arrest, and its binding at the 40S subunit has been shown to be essential for nascent polypeptide-dependent translation arrest [<xref ref-type=""bibr"" rid=""B158"">158</xref>]. Finally, it is also feasible that the action of RACK1 at the ribosome may result in varying effects on gene expression by recruiting proteins that regulate translation of specific mRNAs in different ways. For example, Baum<italic>et al</italic>. suggested that recruitment of the mRNA-binding protein, Scp160p, to the yeast homolog (Asc1p) of RACK1 may influence the translation of specific mRNAs [<xref ref-type=""bibr"" rid=""B159"">159</xref>]. In addition to affecting the rate of translation of mRNAs, RACK1 is thought to play a role in influencing the location of translation, for example, in neurones [<xref ref-type=""bibr"" rid=""B86"">86</xref>].</p></sec></sec><sec><title>RACK1 and Physiological Functions</title><sec><title>RACK1 and development</title><p>In recent years, a critical role for RACK1 in development has been emerging. For example, in zebrafish, RACK1 affects membrane localization of van gogh-like 2 (Vangl2), and the Vangl2-interacting region of RACK1 has been shown to exert a dominant-negative effect on Vangl2 localization and gastrulation [<xref ref-type=""bibr"" rid=""B160"">160</xref>]. The interaction between RACK1 and tyrosine-protein kinase-like 7 (PTK7) has also been shown to be a requirement for neural tube closure in<italic>Xenopus</italic>[<xref ref-type=""bibr"" rid=""B161"">161</xref>]. In<italic>Arabidopsis</italic>, where three RACK1 homologs are present, the RACK1 gene products are essential regulators of plant development [<xref ref-type=""bibr"" rid=""B162"">162</xref>,<xref ref-type=""bibr"" rid=""B163"">163</xref>]. RACK1 homologs in<italic>Drosophilia</italic>[<xref ref-type=""bibr"" rid=""B164"">164</xref>],<italic>Aspergillus nidulans</italic>[<xref ref-type=""bibr"" rid=""B165"">165</xref>],<italic>Schizosaccharomyces pombe</italic>[<xref ref-type=""bibr"" rid=""B166"">166</xref>] and<italic>Trypanosoma brucei</italic>[<xref ref-type=""bibr"" rid=""B167"">167</xref>] have similarly been shown to be central to various stages of the developmental process.</p></sec><sec><title>RACK1 and circadian rhythm</title><p>Recent elegant studies by Robles<italic>et al</italic>. [<xref ref-type=""bibr"" rid=""B103"">103</xref>] have identified RACK1 as an integral component of the mammalian circadian clock. Their findings suggest that RACK1 and PKCα regulate CLOCK-BMAL1 transcriptional activity [<xref ref-type=""bibr"" rid=""B103"">103</xref>]. Their findings also indicate that the mechanism of action of RACK1 and PKCα are intrinsically linked and that the function of one is dependent on the other. Although it is well established that RACK1 regulates PKC location [<xref ref-type=""bibr"" rid=""B60"">60</xref>,<xref ref-type=""bibr"" rid=""B92"">92</xref>,<xref ref-type=""bibr"" rid=""B134"">134</xref>,<xref ref-type=""bibr"" rid=""B142"">142</xref>], this exciting development in RACK1 biology reveals a novel mechanism of action.</p></sec><sec><title>RACK1 and cell migration</title><p>The scaffolding of signaling proteins by RACK1 at receptors is particularly important in dynamic processes such as cell migration, cell adhesion and cell spreading [<xref ref-type=""bibr"" rid=""B76"">76</xref>,<xref ref-type=""bibr"" rid=""B77"">77</xref>,<xref ref-type=""bibr"" rid=""B113"">113</xref>,<xref ref-type=""bibr"" rid=""B124"">124</xref>]. All of these processes require the highly regulated converging of transient signaling between receptors. For example, RACK1 was first found to be a mediator of cell spreading by establishing contact with the extracellular matrix and growth factor receptors at adhesion sites [<xref ref-type=""bibr"" rid=""B76"">76</xref>].</p><p>The role of RACK1 as a scaffolding protein is clearly evident during cell migration. Cell migration is a fundamental process required for embryonic development, wound healing and immune responses, and the components of cell migration are functionally conserved in evolution. The failure of cells to migrate, or indeed their migration to the wrong location, gives rise to serious life threatening consequences such as defective brain development, a malfunctioning immune system and leads to the materialization of cancer. Understanding cell migration presents a considerable challenge because it results from the coordinated activity of several individual intra- and extracellular component processes. These processes include several signaling pathways, and require significant and well-orchestrated cross-talk between cell surface receptors and elements of the cell cytoskeleton. RACK1 is essential for cell migration, and the protein binds to many components of the cell migration machinery including kinases, phosphatases and the cytoplasmic domains of cell surface receptors [<xref ref-type=""bibr"" rid=""B46"">46</xref>,<xref ref-type=""bibr"" rid=""B47"">47</xref>]. RACK1 is located in areas of cell protrusion that are rich in paxillin [<xref ref-type=""bibr"" rid=""B168"">168</xref>,<xref ref-type=""bibr"" rid=""B169"">169</xref>] and can increase the phosphorylation of FAK [<xref ref-type=""bibr"" rid=""B169"">169</xref>]. The interaction of RACK1 with β1 and β2 integrins and Src regulates cell adhesion and cell spreading [<xref ref-type=""bibr"" rid=""B123"">123</xref>,<xref ref-type=""bibr"" rid=""B168"">168</xref>]. RACK1 has been reported to bind to components of the cell cytoskeleton [<xref ref-type=""bibr"" rid=""B128"">128</xref>,<xref ref-type=""bibr"" rid=""B170"">170</xref>]. The identification of proteins such as these as RACK1 partners has led to the establishment of RACK1 as a key regulator of Focal Adhesion assembly (Figure<xref ref-type=""fig"" rid=""F10"">10</xref>). Focal adhesions are large dynamic macromolecular assemblies with both mechanical components and cell signaling components [<xref ref-type=""bibr"" rid=""B171"">171</xref>-<xref ref-type=""bibr"" rid=""B175"">175</xref>]. Specifically, focal adhesions are the mechanical link between the cell and the extra cellular matrix (ECM), that are formed after integrins are clustered on the cell surface. Integrin clustering is sufficient to promote the phosphorylation of FAK on Tyr-397. This in turn generates a binding site for the Src homology 2 (SH2) domain of Src Family protein tyrosine kinases (Src-family PTKs). The recruitment of Src-family PTKs to FAK is dependent on the initial autophosphorylation of Tyr-397 and results in the phosphorylation of FAK at secondary sites to ensure full activation of FAK. This correlates with an increase in kinase activity and the ability of FAK to cooperate with multiple signaling pathways through its direct interaction with other non-receptor tyrosine kinases, cell surface receptors, cytoskeletal proteins and other adaptor proteins. FAK is widely regarded as being the convergence point of growth factor and integrin signaling [<xref ref-type=""bibr"" rid=""B176"">176</xref>,<xref ref-type=""bibr"" rid=""B177"">177</xref>], yet how FAK phosphorylation is regulated within the growth factor and integrin network is not fully understood. Nevertheless, the phosphorylation status of FAK clearly regulates cell adhesion and cell migration in response to growth factors, integrin stimulation and components of the extracellular matrix. RACK1 is essential for FAK's function as it scaffolds the kinase for activation by both IGF-I and adhesion signals [<xref ref-type=""bibr"" rid=""B124"">124</xref>] and the binding locus for FAK on RACK1 has been mapped to Tyr-52 in WD2 of RACK1 [<xref ref-type=""bibr"" rid=""B124"">124</xref>] and the interaction site of RACK1 on FAK was subsequently identified [<xref ref-type=""bibr"" rid=""B112"">112</xref>]. Suppression of RACK1 expression disrupts FAK activity, cell adhesion and cell spreading [<xref ref-type=""bibr"" rid=""B113"">113</xref>,<xref ref-type=""bibr"" rid=""B124"">124</xref>,<xref ref-type=""bibr"" rid=""B169"">169</xref>], two essential steps in the cell migration process, by the interaction of RACK1 with FAK and by the ability of RACK1 to regulate FAK activity. In addition, recent studies suggest that attenuation of RACK1 expression suppresses VEGF-mediated cell migration by disrupting the path between VEGF, the PI3K pathway and Rac1 [<xref ref-type=""bibr"" rid=""B178"">178</xref>]. RACK1 (and RACK1A) is known to interact with several components of the Rac1 complex that are involved in cell migration [<xref ref-type=""bibr"" rid=""B179"">179</xref>,<xref ref-type=""bibr"" rid=""B180"">180</xref>]. Cell migration is dependent on the response to chemoattractant gradients, and in Jurkat cells RACK1 interacts with Gβγ at the leading edge of cells [<xref ref-type=""bibr"" rid=""B181"">181</xref>]. In this system, RACK1 inhibits cell migration and overexpression of full length RACK1 or truncation mutations that retain the Gβγ binding, actually inhibit cell migration [<xref ref-type=""bibr"" rid=""B181"">181</xref>]. There are other reports suggesting that RACK1 inhibits cell migration [<xref ref-type=""bibr"" rid=""B128"">128</xref>] but under most circumstances, RACK1 facilitates cell migration. A large part of what RACK1 does in cell migration, at least in adherent cells, is mediated by its ability to bind to a series of kinases and phosphatases that affect the phosphorylation and subsequent activity of other RACK1 binding partners or proteins in complexes where RACK1 is found. RACK1 interacts with several PKC isoforms during cell migration including PKCβ [<xref ref-type=""bibr"" rid=""B170"">170</xref>] and PKCε [<xref ref-type=""bibr"" rid=""B127"">127</xref>]. Activation of the PKC signaling pathway also enhances the interaction between RACK1 and Src [<xref ref-type=""bibr"" rid=""B138"">138</xref>]. Src tyrosine kinase phosphorylates RACK1 and phosphorylation of RACK1 is required for Src binding to RACK1 via its SH2 domain [<xref ref-type=""bibr"" rid=""B48"">48</xref>]. Src is a well-known regulator of cell adhesion, cell spreading and cell migration [<xref ref-type=""bibr"" rid=""B61"">61</xref>,<xref ref-type=""bibr"" rid=""B62"">62</xref>,<xref ref-type=""bibr"" rid=""B114"">114</xref>,<xref ref-type=""bibr"" rid=""B168"">168</xref>]. Src activity is inhibited by the binding of RACK1 but RACK1 can transport Src to specific cellular compartments where Src can function. In fibroblasts and epithelial cells, the interaction between RACK1 and Src is disrupted by IGF-I stimulation of the IGF-IR signaling pathway [<xref ref-type=""bibr"" rid=""B113"">113</xref>]. This results in the release of now active Src at a specific location and is an example of how RACK1 can regulate the local activation of proteins. The regulation of Src activity by RACK1 is also required for modulating paxillin during cell migration [<xref ref-type=""bibr"" rid=""B182"">182</xref>], for regulating Sam68 and p190RhoGAP signaling [<xref ref-type=""bibr"" rid=""B183"">183</xref>], to control cell protrusion during cell migration [<xref ref-type=""bibr"" rid=""B168"">168</xref>] and for regulating cell cycle checkpoints [<xref ref-type=""bibr"" rid=""B62"">62</xref>,<xref ref-type=""bibr"" rid=""B114"">114</xref>,<xref ref-type=""bibr"" rid=""B139"">139</xref>]. The dynamic interaction between RACK1 and Src is also required for regulation of the phosphorylation and function of the Androgen receptor [<xref ref-type=""bibr"" rid=""B133"">133</xref>]. There are now data suggesting that the interaction between RACK1 and Src goes beyond regulating cell adhesion and cell migration and Mamidipudi<italic>et al</italic>, have shown that the interaction has a pro-apoptotic function [<xref ref-type=""bibr"" rid=""B184"">184</xref>]. The interaction of RACK1 with phosphatases during cell adhesion is equally important and mounting evidence suggests that RACK1 receives signals to recruit phosphatases that dismantle specific signaling pathways and cytoplasmic support systems such as focal adhesions [<xref ref-type=""bibr"" rid=""B58"">58</xref>,<xref ref-type=""bibr"" rid=""B124"">124</xref>,<xref ref-type=""bibr"" rid=""B185"">185</xref>]. In IGF-IR signaling, RACK1 promotes IGF-I-mediated cell migration by regulating the formation of a RACK1-IGF-IR and β1 integrin complexes, which is mediated by the mutually exclusive association of RACK1 with PP2A and β1 integrin [<xref ref-type=""bibr"" rid=""B58"">58</xref>,<xref ref-type=""bibr"" rid=""B59"">59</xref>]. In pancreatic cells, RACK1 and PP2A form a complex with IRE1α in a signaling pathway that regulates insulin production [<xref ref-type=""bibr"" rid=""B186"">186</xref>]. In addition, RACK1 and phosphatases are involved in cell migration in other systems. Fo example, in the retina, retinal ganglion cell axons are guided by signaling pathways that are regulated by an interaction between RACK1 and PTP μ [<xref ref-type=""bibr"" rid=""B185"">185</xref>,<xref ref-type=""bibr"" rid=""B187"">187</xref>-<xref ref-type=""bibr"" rid=""B189"">189</xref>].</p><fig id=""F10"" position=""float""><label>Figure 10</label><caption><p><bold>RACK1 is an important regulator of Focal Adhesion assembly</bold>. When a cell is in contact with the Extracellular Matrix, integrins are clustered on the cell surface. This clustering of integrins leads to the recruitment of FAK and to the establishment of focal adhesions. At focal adhesions, RACK1 recruits key structural proteins, kinases and phosphatases to help nurture the developing focal adhesion. It is likely that at focal adhesions RACK1 brings in phosphodiesterases and ribosomes which facilitate local signaling and translation. A change in RACK1 expression (both up and down) has consequences for the activity and stability of RACK1-associated proteins and is believed to be a contributing factor in the development and progression of cancer.</p></caption><graphic xlink:href=""1478-811X-9-22-10""></graphic></fig></sec></sec><sec><title>RACK1 in Disease</title><p>Since its discovery, RACK1 has been associated with various aspects of diseases. Alterations in RACK1 homeostasis is associated with brain developmental disorders [<xref ref-type=""bibr"" rid=""B161"">161</xref>], heart failure [<xref ref-type=""bibr"" rid=""B99"">99</xref>], pulmonary arterial hypertension [<xref ref-type=""bibr"" rid=""B190"">190</xref>], renal failure [<xref ref-type=""bibr"" rid=""B191"">191</xref>], muscle atrophy [<xref ref-type=""bibr"" rid=""B192"">192</xref>] and dysfunctional sperm development [<xref ref-type=""bibr"" rid=""B193"">193</xref>], as well as cancer and addiction (detailed in sections 6.1 and 6.2). In addition, altered RACK1 expression has negative consequences for the properties and activity of RACK1 binding partners. The association of RACK1, PKCβII and a variant of the acetylcholinesterase AChE has been implicated in stress-induced behaviors [<xref ref-type=""bibr"" rid=""B134"">134</xref>] (see also section 6.2). Increased RACK1 expression has also been observed in the frontal cortex of patients with bipolar disorder [<xref ref-type=""bibr"" rid=""B194"">194</xref>], while decreased RACK1 expression is reported in the cortex of Down syndrome patients [<xref ref-type=""bibr"" rid=""B74"">74</xref>]. In addition, RACK1 levels are significantly reduced in aged rats [<xref ref-type=""bibr"" rid=""B195"">195</xref>], and decreased RACK1 expression is reported in post-mortem brains of Alzheimer's disease (AD) patients [<xref ref-type=""bibr"" rid=""B72"">72</xref>,<xref ref-type=""bibr"" rid=""B73"">73</xref>]. However these changes were not found in another study, which compared the levels of RACK1 in AD patients and age-matched controls [<xref ref-type=""bibr"" rid=""B196"">196</xref>]. Nevertheless, the pathophysiology of AD patients also highlights defective PKC activity and localisation which correlates with decreased RACK1 expression [<xref ref-type=""bibr"" rid=""B197"">197</xref>]. PKC and muscarinic receptor signaling are intrinsically linked, and amyloid-β impairs the regulation of PKC and GABAergic signaling. Overexpression of RACK1 has been shown to restore the regulation of these processes [<xref ref-type=""bibr"" rid=""B198"">198</xref>].</p><p>Several reports suggest a role for RACK1 in the immune system. Specifically, studies carried out in T Jurkat cells indicate that RACK1 regulates directional cell migration [<xref ref-type=""bibr"" rid=""B181"">181</xref>] while other reports suggest that RACK1 regulates T cell apoptosis [<xref ref-type=""bibr"" rid=""B199"">199</xref>]. In Rice, RACK1A functions in innate immunity by interacting with the GTP form of Rac1 [<xref ref-type=""bibr"" rid=""B179"">179</xref>] and having a central role in the production of reactive oxygen species in response to infection. Because of its role in several signaling pathways, it is not surprising, therefore, that RACK1 is hijacked by viruses to facilitate viral replication [<xref ref-type=""bibr"" rid=""B200"">200</xref>-<xref ref-type=""bibr"" rid=""B202"">202</xref>].</p><sec><title>RACK1 and cancer</title><p>Many reports indicate that RACK1 plays an important role in cancer progression and that its expression is altered during angiogenesis and in many human carcinomas. Specifically, RACK1 expression is being assessed as a prognostic indicator in breast cancer [<xref ref-type=""bibr"" rid=""B203"">203</xref>,<xref ref-type=""bibr"" rid=""B204"">204</xref>], where increased RACK1 expression is strongly related to advanced clinical stage [<xref ref-type=""bibr"" rid=""B205"">205</xref>]. In pulmonary adenocarcinomas, increased RACK1 expression is associated with pathological stage and tumor size and is also a potential diagnostic marker [<xref ref-type=""bibr"" rid=""B206"">206</xref>]. In contrast, some reports suggest that RACK1 expression is reduced in breast cancer [<xref ref-type=""bibr"" rid=""B207"">207</xref>]. In addition, RACK1 may protect cells from apoptosis in breast cancer [<xref ref-type=""bibr"" rid=""B204"">204</xref>,<xref ref-type=""bibr"" rid=""B208"">208</xref>]. RACK1 is upregulated in hepatocellular carcinoma where it increases the translocation of A Disintegrin And Metalloprotease 12 (ADAM12) to the plasma membrane in response to PKC activation [<xref ref-type=""bibr"" rid=""B209"">209</xref>] and it is upregulated in metastatic melanoma, where it amplifies PKCα and PKCβ activity [<xref ref-type=""bibr"" rid=""B210"">210</xref>]. In melanoma, constitutive activation of the MEK-ERK signaling pathway leads to elevated c-Jun activity and increased the transcription of RACK1 [<xref ref-type=""bibr"" rid=""B211"">211</xref>]. RACK1 is also implicated as a key player in ovarian cancer [<xref ref-type=""bibr"" rid=""B212"">212</xref>], prostate cancer [<xref ref-type=""bibr"" rid=""B188"">188</xref>] and in cancers caused by pathogens such as human papillomavirus 16 (HPV 16) [<xref ref-type=""bibr"" rid=""B213"">213</xref>] and<italic>Helicobacter pylori</italic>[<xref ref-type=""bibr"" rid=""B214"">214</xref>].</p><p>There are several mechanisms by which RACK1 contributes to the progression of cancer. Firstly, RACK1 is upregulated during angiogenesis [<xref ref-type=""bibr"" rid=""B215"">215</xref>] where it promotes activation of the PI3K/Akt/Rac1 pathway [<xref ref-type=""bibr"" rid=""B178"">178</xref>] and regulates HIF-1 transcriptional activity [<xref ref-type=""bibr"" rid=""B216"">216</xref>,<xref ref-type=""bibr"" rid=""B217"">217</xref>]. RACK1 also plays an important role in cell proliferation, cell adhesion and cell migration, which are all essential components of transformation as described in section 5.3. The interaction between RACK1 and FAK is constitutive and FAK phosphorylation on the RACK1 scaffold is mediated by the IGF-IR [<xref ref-type=""bibr"" rid=""B124"">124</xref>]. The interaction between RACK1 and FAK is found at nascent adhesions and is required at the leading edge of polarized cancer cells to sense direction. RACK1 also brings FAK and PDE4D5 together which strongly suggests that adhesion signaling and cAMP signaling are linked in cancer [<xref ref-type=""bibr"" rid=""B111"">111</xref>,<xref ref-type=""bibr"" rid=""B112"">112</xref>]. At adhesion sites, RACK1 recruits paxillin [<xref ref-type=""bibr"" rid=""B168"">168</xref>,<xref ref-type=""bibr"" rid=""B169"">169</xref>], integrins and Src to regulate cell adhesion and cell spreading [<xref ref-type=""bibr"" rid=""B113"">113</xref>,<xref ref-type=""bibr"" rid=""B123"">123</xref>,<xref ref-type=""bibr"" rid=""B124"">124</xref>,<xref ref-type=""bibr"" rid=""B168"">168</xref>], β-tubulin [<xref ref-type=""bibr"" rid=""B218"">218</xref>] and other components of the cell cytoskeleton [<xref ref-type=""bibr"" rid=""B170"">170</xref>]. Thus, in cancer, RACK1 becomes a focal point for transformation signaling (Figure<xref ref-type=""fig"" rid=""F10"">10</xref>). RACK1 recruits ribosomes and PKC (discussed above) and scaffolds central components of the MAPK pathway [<xref ref-type=""bibr"" rid=""B126"">126</xref>] and the PI3K pathway [<xref ref-type=""bibr"" rid=""B76"">76</xref>,<xref ref-type=""bibr"" rid=""B77"">77</xref>,<xref ref-type=""bibr"" rid=""B113"">113</xref>]. As well as this, RACK1 scaffolds a host of other different kinases and phosphatases, and the activity of several of these proteins is altered in cancer. All of these proteins, signaling pathways and protein complexes require tight regulation. Subtle changes in the protein expression (both up and down) of a fundamental protein such as RACK1 can be expected to have dramatic consequences on the regulation of these key pathways and therefore on the development and progression of neoplastic disease.</p></sec><sec><title>RACK1 and addiction</title><p>Addiction is a costly, devastating psychiatric disorder. The disease manifests itself in the intake of the drug regardless of the negative consequences, and is associated with tolerance, dependence, withdrawal, relapse and craving [<xref ref-type=""bibr"" rid=""B219"">219</xref>]. Altered levels and compartmentalization of RACK1 was reported by us and others to be linked to exposure to drugs of abuse. Specifically, changes in RACK1 levels have also been described in response to the treatment of rodents acutely and chronically with morphine. Escriba<italic>et al</italic>. found that acute treatment of rats with morphine results in increased RACK1 levels in the frontal cortex, whereas chronic treatment with morphine led to a decrease in the level of RACK1 in this brain region [<xref ref-type=""bibr"" rid=""B220"">220</xref>]. The authors also report that changes in RACK1 levels paralleled with changes in the levels of PKCα and PKCβ [<xref ref-type=""bibr"" rid=""B220"">220</xref>]. In contrast, Wan<italic>et al</italic>. found that chronic treatment of mice with morphine led to an increase in the level of RACK1 in this brain region [<xref ref-type=""bibr"" rid=""B221"">221</xref>]. Finally, Liu<italic>et al</italic>. reported that alteration of RACK1 levels result in changes in the rewarding properties of morphine [<xref ref-type=""bibr"" rid=""B222"">222</xref>,<xref ref-type=""bibr"" rid=""B223"">223</xref>]. In summary, although changes in RACK1 expression are linked to morphine administration, further studies are needed before any conclusions can be drawn.</p><p>In addition, over the past several years, we have demonstrated that one of the molecular mechanisms by which alcohol can simultaneously alter several signaling pathways is by altering the cellular compartmentalization of RACK1. Furthermore, we obtained data to suggest that the functional outcomes of the altered localization of RACK1 in the presence of alcohol are diverse, as RACK1 contributes both to mechanisms that underlie but also those that prevent the escalation of behaviors that underlie alcohol addiction. The interest in the potential role of RACK1 in alcohol addiction was initiated with the observation that exposure of several cell lines as well as primary neurons to alcohol results in a dose- and time-dependent translocation of RACK1 to the nucleus [<xref ref-type=""bibr"" rid=""B141"">141</xref>-<xref ref-type=""bibr"" rid=""B143"">143</xref>,<xref ref-type=""bibr"" rid=""B224"">224</xref>]. The nuclear translocation of RACK1 in response to alcohol was shown to be dependent on the activation of the cAMP/PKA pathway [<xref ref-type=""bibr"" rid=""B141"">141</xref>]. Interestingly, prolonged incubation of cells with alcohol (12-48 hrs) results in the gradual distribution of RACK1 out of the nucleus, which was resistant to an acute challenge of alcohol [<xref ref-type=""bibr"" rid=""B143"">143</xref>,<xref ref-type=""bibr"" rid=""B224"">224</xref>]. These results suggest a cellular alcohol tolerance leads to altered compartmentalization of RACK1. Furthermore, as a result of the nuclear localization of RACK1 in response to acute alcohol exposure, the translocation of active PKCβII is inhibited [<xref ref-type=""bibr"" rid=""B142"">142</xref>], and the transcription of several genes are induced [<xref ref-type=""bibr"" rid=""B141"">141</xref>-<xref ref-type=""bibr"" rid=""B143"">143</xref>,<xref ref-type=""bibr"" rid=""B224"">224</xref>].</p><p>Of great interest is the observation that the expression of the growth factor BDNF is increased in response to alcohol-mediated RACK1 nuclear localization [<xref ref-type=""bibr"" rid=""B143"">143</xref>]. Importantly, molecular and behavioral studies suggest that RACK1 and BDNF are part of an endogenous homeostatic pathway that delays or prevents the development of alcohol addiction. Specifically, acute increase of RACK1 protein levels in hippocampal and striatal neurons using the Tat protein transduction approach (Tat-RACK1), led to increases in the levels of BDNF and a similar increase in BDNF expression was observed after systemic injection of the Tat-fusion protein in mice [<xref ref-type=""bibr"" rid=""B143"">143</xref>]. The systemic administration of mice with Tat-RACK1 resulted in a robust decrease in alcohol but not water consumption in mice in a BDNF-dependent manner [<xref ref-type=""bibr"" rid=""B143"">143</xref>,<xref ref-type=""bibr"" rid=""B225"">225</xref>]. Specifically, the activity of Tat-RACK1 on alcohol consumption was reduced in BDNF heterozygote mice as compared to wild-type mice, and, systemic administration of a BDNF receptor TrkB inhibitor increased alcohol consumption in wild-type controls, but not in BDNF heterozygote mice [<xref ref-type=""bibr"" rid=""B143"">143</xref>,<xref ref-type=""bibr"" rid=""B225"">225</xref>]. We also provide data that the inhibitory actions of RACK1 on alcohol intake are localized to the dorsal striatum as infusion of Tat-RACK1 directly into the dorsal striatum of rats reduced rat operant self-administration of alcohol [<xref ref-type=""bibr"" rid=""B225"">225</xref>]. Finally, we obtained data to suggest that the consequence of RACK1 mediated increase in BDNF expression in response to alcohol is the increase in the expression of the dopamine D3 receptor and Dynorphin which in turn mediate the reduction in the sensitivity of rodents to alcohol [<xref ref-type=""bibr"" rid=""B225"">225</xref>,<xref ref-type=""bibr"" rid=""B226"">226</xref>]. Together, these results suggest that RACK1 inhibits alcohol consumption by increasing the expression and secretion of BDNF, and that secreted BDNF counteracts the reinforcing or rewarding effects of alcohol. Thus, the RACK1 and BDNF pathway contributes to cellular and molecular processes that influence the motivation to seek alcohol.</p><p>Interestingly, the altered compartmentalization of RACK1 in response to alcohol exposure in specific brain regions also contributes to neuroadaptations that underlie the development of alcohol addiction. As described in section 1.2, in the hippocampus and the dorsal striatum but not in the cerebral cortex or ventral striatum, RACK1 localizes Fyn in close proximity to the NR2B subunit of the NMDAR, but inhibits the ability of Fyn to phosphorylate the channel until the appropriate signal occurs [<xref ref-type=""bibr"" rid=""B29"">29</xref>,<xref ref-type=""bibr"" rid=""B49"">49</xref>,<xref ref-type=""bibr"" rid=""B55"">55</xref>,<xref ref-type=""bibr"" rid=""B57"">57</xref>,<xref ref-type=""bibr"" rid=""B141"">141</xref>] (Figure<xref ref-type=""fig"" rid=""F5"">5A</xref>). This specific compartmentalization of Fyn to the NMDAR complex via RACK1 has broad implications for the actions of alcohol on the channel. In the hippocampus, alcohol treatment results in the release of RACK1 from the NMDAR complex in a mechanism that depends on the activation of the cAMP/PKA signaling cascade [<xref ref-type=""bibr"" rid=""B57"">57</xref>]. The dissociation of the tri-molecular complex in response to alcohol enables Fyn to phosphorylate NR2B [<xref ref-type=""bibr"" rid=""B57"">57</xref>]. These molecular changes in the hippocampus lead to a reduction in the inhibitory actions of alcohol on channel activity, in rebound potentiation of the activity of the channel when alcohol is washed out, and to the development of acute desensitization to the inhibitory actions of alcohol on the activity of the channel [<xref ref-type=""bibr"" rid=""B57"">57</xref>]. In the dorsal striatum, RACK1 dissociation from Fyn and NR2B and the phosphorylation of the subunit by Fyn leads to long-lasting long-term facilitation of the activity of the channel [<xref ref-type=""bibr"" rid=""B55"">55</xref>]. Importantly, this biochemical neuroadaptation in the dorsal striatum is part of a mechanism that underlies excessive alcohol consumption and relapse [<xref ref-type=""bibr"" rid=""B55"">55</xref>,<xref ref-type=""bibr"" rid=""B227"">227</xref>].</p><p>In summary, the altered compartmentalization of RACK1 in the presence of alcohol in specific brain regions results in diverse physiological consequences that both contribute to, and prevent, the development of behaviors associated with alcohol addiction.</p></sec></sec><sec><title>Summary and Future Perspectives</title><p>Since its identification as an anchoring protein for active βIIPKC [<xref ref-type=""bibr"" rid=""B42"">42</xref>], the number of binding partners and functions for RACK1 have increased exponentially. It is intriguing that a single protein can be involved in such a large number of diverse biological functions. One possibility is that the different intracellular compartmentalization of RACK1 in different cell types and regions allows the scaffolding protein to interact with multiple proteins and to regulate various functions in a cell specific manner (see Figure<xref ref-type=""fig"" rid=""F10"">10</xref>as an example). Another possibility to explain the multiple functions of RACK1 is that although the protein itself is ubiquitously expressed, its binding partners are not. For example, RACK1 is ubiquitously expressed in the adult mouse brain, however, a much more restricted expression pattern is observed for PKCβII [<xref ref-type=""bibr"" rid=""B71"">71</xref>,<xref ref-type=""bibr"" rid=""B228"">228</xref>]. Interestingly, as described above, RACK1 can be associated with different binding partners in different brain regions. Specifically, although similar type of neurons are found in the hippocampus and cortex as well as in the ventral and dorsal striatum, RACK1 is associated the NR2B subunit of the NMDAR in the hippocampus and the dorsal striatum, [<xref ref-type=""bibr"" rid=""B49"">49</xref>,<xref ref-type=""bibr"" rid=""B55"">55</xref>-<xref ref-type=""bibr"" rid=""B57"">57</xref>]but not cerebral cortex but not in the ventral striatum [<xref ref-type=""bibr"" rid=""B55"">55</xref>,<xref ref-type=""bibr"" rid=""B57"">57</xref>]. These findings suggest that RACK1 scaffolds different proteins in these brain regions. The reasons for cell type or brain region specificity of RACK1 association with its binding partner is unclear and therefore it would be of great interest to explore this further.</p><p>Furthermore, we now know that proteins, such as PP2A and β1 integrin, compete for binding to RACK1 [<xref ref-type=""bibr"" rid=""B58"">58</xref>,<xref ref-type=""bibr"" rid=""B59"">59</xref>], and that phosphorylation of RACK1 on tyrosine and serine residues is critical for the way in which RACK1 functions during cell adhesion and cell migration [<xref ref-type=""bibr"" rid=""B61"">61</xref>,<xref ref-type=""bibr"" rid=""B114"">114</xref>,<xref ref-type=""bibr"" rid=""B124"">124</xref>]. It is thus essential that we gain a better understanding of what determines the hierarchy of protein binding to RACK1 and what signals orchestrate complex formation on RACK1. For example, growth factor and adhesion signaling converge on RACK1 [<xref ref-type=""bibr"" rid=""B76"">76</xref>,<xref ref-type=""bibr"" rid=""B113"">113</xref>,<xref ref-type=""bibr"" rid=""B122"">122</xref>,<xref ref-type=""bibr"" rid=""B124"">124</xref>], but it of interest to now focus on how other external environmental cues dictate the binding profile and cellular distribution of RACK1 and how RACK1 integrates these signals with such a high degree of specificity and regulation.</p><p>Finally, the unique structure of RACK1 and the expansion of knowledge of the protein-protein interactions mediating the binding of RACK1 to partners provide us with a great opportunity to develop new therapeutics by the design and development of peptides, and in the future possibly small organic compounds, which will interfere with specific binding of proteins to RACK1. This will permit subtle manipulation of the activity of specific enzymes, receptors and signaling pathways.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>DA, DR and PK contributed equally to the writing of the manuscript. All authors read and approved the final version of the manuscript.</p></sec><sec><title>Endnotes</title><sec><title>Footnote 1</title><p><sup>1</sup>A convenient graphical representation of consensus residues at particular sites within WD-repeats has been given by Xu and Min [<xref ref-type=""bibr"" rid=""B6"">6</xref>]. Significant diversity is seen across repeats in WD40 proteins and we refer to 'typical' repeats as ones that preserve the core interactions summarised in Figure<xref ref-type=""fig"" rid=""F7"">7</xref>.</p></sec></sec></body><back><sec><title>Acknowledgements</title><p>We are grateful to Susan Dwane in the Laboratory of Cellular and Molecular Biology for their assistance and critical review (P.K). The authors would like to thank Marcus Cavness and Carol Webb. This review was supported by the Health Research Board of Ireland HRA/2009/188 (P.K.), the Irish Cancer Society (P.K.), the NIH-NIAAA R01 AA016848 (D.R.), NIAAA (R01AA/MH13438) (D.R.), the Department of the Army, Grant #W81XWH-05-1-0212 (D.R.), the State of California, for Medical Research on Alcohol and Substance Abuse through the University of California, San Francisco (D.R.). We used PyMOL from W. L. DeLano, DeLano Scientific to create the protein structure images in this work (D.A.).</p></sec><ref-list><ref id=""B1""><mixed-citation publication-type=""journal""><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Roberts</surname><given-names>R</given-names></name><article-title>WD-repeat proteins: structure characteristics, biological function, and their involvement in human diseases</article-title><source>Cell Mol Life Sci</source><year>2001</year><volume>58</volume><fpage>2085</fpage><lpage>2097</lpage><pub-id pub-id-type=""doi"">10.1007/PL00000838</pub-id><pub-id pub-id-type=""pmid"">11814058</pub-id></mixed-citation></ref><ref id=""B2""><mixed-citation publication-type=""journal""><name><surname>Fong</surname><given-names>HK</given-names></name><name><surname>Hurley</surname><given-names>JB</given-names></name><name><surname>Hopkins</surname><given-names>RS</given-names></name><name><surname>Miake-Lye</surname><given-names>R</given-names></name><name><surname>Johnson</surname><given-names>MS</given-names></name><name><surname>Doolittle</surname><given-names>RF</given-names></name><name><surname>Simon</surname><given-names>MI</given-names></name><article-title>Repetitive segmental structure of the transducin beta subunit: homology with the CDC4 gene and identification of related mRNAs</article-title><source>Proc Natl Acad Sci USA</source><year>1986</year><volume>83</volume><fpage>2162</fpage><lpage>2166</lpage><pub-id pub-id-type=""doi"">10.1073/pnas.83.7.2162</pub-id><pub-id pub-id-type=""pmid"">3083416</pub-id></mixed-citation></ref><ref id=""B3""><mixed-citation publication-type=""journal""><name><surname>Neer</surname><given-names>EJ</given-names></name><name><surname>Schmidt</surname><given-names>CJ</given-names></name><name><surname>Nambudripad</surname><given-names>R</given-names></name><name><surname>Smith</surname><given-names>TF</given-names></name><article-title>The ancient regulatory-protein family of WD-repeat proteins</article-title><source>Nature</source><year>1994</year><volume>371</volume><fpage>297</fpage><lpage>300</lpage><pub-id pub-id-type=""doi"">10.1038/371297a0</pub-id><pub-id pub-id-type=""pmid"">8090199</pub-id></mixed-citation></ref><ref id=""B4""><mixed-citation publication-type=""journal""><name><surname>Smith</surname><given-names>TF</given-names></name><article-title>Diversity of WD-repeat proteins</article-title><source>Subcell Biochem</source><year>2008</year><volume>48</volume><fpage>20</fpage><lpage>30</lpage><pub-id pub-id-type=""doi"">10.1007/978-0-387-09595-0_3</pub-id><pub-id pub-id-type=""pmid"">18925368</pub-id></mixed-citation></ref><ref id=""B5""><mixed-citation publication-type=""journal""><name><surname>Smith</surname><given-names>TF</given-names></name><name><surname>Gaitatzes</surname><given-names>C</given-names></name><name><surname>Saxena</surname><given-names>K</given-names></name><name><surname>Neer</surname><given-names>EJ</given-names></name><article-title>The WD repeat: a common architecture for diverse functions</article-title><source>Trends Biochem Sci</source><year>1999</year><volume>24</volume><fpage>181</fpage><lpage>185</lpage><pub-id pub-id-type=""doi"">10.1016/S0968-0004(99)01384-5</pub-id><pub-id pub-id-type=""pmid"">10322433</pub-id></mixed-citation></ref><ref id=""B6""><mixed-citation publication-type=""journal""><name><surname>Xu</surname><given-names>C</given-names></name><name><surname>Min</surname><given-names>J</given-names></name><article-title>Structure and function of WD40 domain proteins</article-title><source>Protein Cell</source><year>2011</year><volume>2</volume><fpage>202</fpage><lpage>214</lpage><pub-id pub-id-type=""doi"">10.1007/s13238-011-1018-1</pub-id><pub-id pub-id-type=""pmid"">21468892</pub-id></mixed-citation></ref><ref id=""B7""><mixed-citation publication-type=""journal""><name><surname>Neer</surname><given-names>EJ</given-names></name><article-title>Heterotrimeric G proteins: organizers of transmembrane signals</article-title><source>Cell</source><year>1995</year><volume>80</volume><fpage>249</fpage><lpage>257</lpage><pub-id pub-id-type=""doi"">10.1016/0092-8674(95)90407-7</pub-id><pub-id pub-id-type=""pmid"">7834744</pub-id></mixed-citation></ref><ref id=""B8""><mixed-citation publication-type=""journal""><name><surname>Paoli</surname><given-names>M</given-names></name><article-title>Protein folds propelled by diversity</article-title><source>Prog Biophys Mol Biol</source><year>2001</year><volume>76</volume><fpage>103</fpage><lpage>130</lpage><pub-id pub-id-type=""doi"">10.1016/S0079-6107(01)00007-4</pub-id><pub-id pub-id-type=""pmid"">11389935</pub-id></mixed-citation></ref><ref id=""B9""><mixed-citation publication-type=""journal""><name><surname>Sondek</surname><given-names>J</given-names></name><name><surname>Bohm</surname><given-names>A</given-names></name><name><surname>Lambright</surname><given-names>DG</given-names></name><name><surname>Hamm</surname><given-names>HE</given-names></name><name><surname>Sigler</surname><given-names>PB</given-names></name><article-title>Crystal structure of a G-protein beta gamma dimer at 2.1A resolution</article-title><source>Nature</source><year>1996</year><volume>379</volume><fpage>369</fpage><lpage>374</lpage><pub-id pub-id-type=""doi"">10.1038/379369a0</pub-id><pub-id pub-id-type=""pmid"">8552196</pub-id></mixed-citation></ref><ref id=""B10""><mixed-citation publication-type=""journal""><name><surname>Wall</surname><given-names>MA</given-names></name><name><surname>Coleman</surname><given-names>DE</given-names></name><name><surname>Lee</surname><given-names>E</given-names></name><name><surname>Iniguez-Lluhi</surname><given-names>JA</given-names></name><name><surname>Posner</surname><given-names>BA</given-names></name><name><surname>Gilman</surname><given-names>AG</given-names></name><name><surname>Sprang</surname><given-names>SR</given-names></name><article-title>The structure of the G protein heterotrimer Gi alpha 1 beta 1 gamma 2</article-title><source>Cell</source><year>1995</year><volume>83</volume><fpage>1047</fpage><lpage>1058</lpage><pub-id pub-id-type=""doi"">10.1016/0092-8674(95)90220-1</pub-id><pub-id pub-id-type=""pmid"">8521505</pub-id></mixed-citation></ref><ref id=""B11""><mixed-citation publication-type=""journal""><name><surname>Garcia-Higuera</surname><given-names>I</given-names></name><name><surname>Gaitatzes</surname><given-names>C</given-names></name><name><surname>Smith</surname><given-names>TF</given-names></name><name><surname>Neer</surname><given-names>EJ</given-names></name><article-title>Folding a WD repeat propeller</article-title><source>Role of highly conserved aspartic acid residues in the G protein beta subunit and Sec13. J Biol Chem</source><year>1998</year><volume>273</volume><fpage>9041</fpage><lpage>9049</lpage></mixed-citation></ref><ref id=""B12""><mixed-citation publication-type=""journal""><name><surname>Murzin</surname><given-names>AG</given-names></name><article-title>Structural principles for the propeller assembly of beta-sheets: the preference for seven-fold symmetry</article-title><source>Proteins</source><year>1992</year><volume>14</volume><fpage>191</fpage><lpage>201</lpage><pub-id pub-id-type=""doi"">10.1002/prot.340140206</pub-id><pub-id pub-id-type=""pmid"">1409568</pub-id></mixed-citation></ref><ref id=""B13""><mixed-citation publication-type=""journal""><name><surname>Sondek</surname><given-names>J</given-names></name><name><surname>Siderovski</surname><given-names>DP</given-names></name><article-title>Ggamma-like (GGL) domains: new frontiers in G-protein signaling and beta-propeller scaffolding</article-title><source>Biochem Pharmacol</source><year>2001</year><volume>61</volume><fpage>1329</fpage><lpage>1337</lpage><pub-id pub-id-type=""doi"">10.1016/S0006-2952(01)00633-5</pub-id><pub-id pub-id-type=""pmid"">11331068</pub-id></mixed-citation></ref><ref id=""B14""><mixed-citation publication-type=""journal""><name><surname>Schwindinger</surname><given-names>WF</given-names></name><name><surname>Robishaw</surname><given-names>JD</given-names></name><article-title>Heterotrimeric G-protein betagamma-dimers in growth and differentiation</article-title><source>Oncogene</source><year>2001</year><volume>20</volume><fpage>1653</fpage><lpage>1660</lpage><pub-id pub-id-type=""doi"">10.1038/sj.onc.1204181</pub-id><pub-id pub-id-type=""pmid"">11313913</pub-id></mixed-citation></ref><ref id=""B15""><mixed-citation publication-type=""journal""><name><surname>Tuteja</surname><given-names>N</given-names></name><article-title>Signaling through G protein coupled receptors</article-title><source>Plant Signal Behav</source><year>2009</year><volume>4</volume><fpage>942</fpage><lpage>947</lpage><pub-id pub-id-type=""doi"">10.4161/psb.4.10.9530</pub-id><pub-id pub-id-type=""pmid"">19826234</pub-id></mixed-citation></ref><ref id=""B16""><mixed-citation publication-type=""journal""><name><surname>Lambright</surname><given-names>DG</given-names></name><name><surname>Sondek</surname><given-names>J</given-names></name><name><surname>Bohm</surname><given-names>A</given-names></name><name><surname>Skiba</surname><given-names>NP</given-names></name><name><surname>Hamm</surname><given-names>HE</given-names></name><name><surname>Sigler</surname><given-names>PB</given-names></name><article-title>The 2.0 A crystal structure of a heterotrimeric G protein</article-title><source>Nature</source><year>1996</year><volume>379</volume><fpage>311</fpage><lpage>319</lpage><pub-id pub-id-type=""doi"">10.1038/379311a0</pub-id><pub-id pub-id-type=""pmid"">8552184</pub-id></mixed-citation></ref><ref id=""B17""><mixed-citation publication-type=""journal""><name><surname>Nishimura</surname><given-names>A</given-names></name><name><surname>Kitano</surname><given-names>K</given-names></name><name><surname>Takasaki</surname><given-names>J</given-names></name><name><surname>Taniguchi</surname><given-names>M</given-names></name><name><surname>Mizuno</surname><given-names>N</given-names></name><name><surname>Tago</surname><given-names>K</given-names></name><name><surname>Hakoshima</surname><given-names>T</given-names></name><name><surname>Itoh</surname><given-names>H</given-names></name><article-title>Structural basis for the specific inhibition of heterotrimeric Gq protein by a small molecule</article-title><source>Proc Natl Acad Sci USA</source><year>2010</year><volume>107</volume><fpage>13666</fpage><lpage>13671</lpage><pub-id pub-id-type=""doi"">10.1073/pnas.1003553107</pub-id><pub-id pub-id-type=""pmid"">20639466</pub-id></mixed-citation></ref><ref id=""B18""><mixed-citation publication-type=""journal""><name><surname>Gaudet</surname><given-names>R</given-names></name><name><surname>Bohm</surname><given-names>A</given-names></name><name><surname>Sigler</surname><given-names>PB</given-names></name><article-title>Crystal structure at 2.4 angstroms resolution of the complex of transducin betagamma and its regulator, phosducin</article-title><source>Cell</source><year>1996</year><volume>87</volume><fpage>577</fpage><lpage>588</lpage><pub-id pub-id-type=""doi"">10.1016/S0092-8674(00)81376-8</pub-id><pub-id pub-id-type=""pmid"">8898209</pub-id></mixed-citation></ref><ref id=""B19""><mixed-citation publication-type=""journal""><name><surname>Gaudet</surname><given-names>R</given-names></name><name><surname>Savage</surname><given-names>JR</given-names></name><name><surname>McLaughlin</surname><given-names>JN</given-names></name><name><surname>Willardson</surname><given-names>BM</given-names></name><name><surname>Sigler</surname><given-names>PB</given-names></name><article-title>A molecular mechanism for the phosphorylation-dependent regulation of heterotrimeric G proteins by phosducin</article-title><source>Mol Cell</source><year>1999</year><volume>3</volume><fpage>649</fpage><lpage>660</lpage><pub-id pub-id-type=""doi"">10.1016/S1097-2765(00)80358-5</pub-id><pub-id pub-id-type=""pmid"">10360181</pub-id></mixed-citation></ref><ref id=""B20""><mixed-citation publication-type=""journal""><name><surname>Loew</surname><given-names>A</given-names></name><name><surname>Ho</surname><given-names>YK</given-names></name><name><surname>Blundell</surname><given-names>T</given-names></name><name><surname>Bax</surname><given-names>B</given-names></name><article-title>Phosducin induces a structural change in transducin beta gamma</article-title><source>Structure</source><year>1998</year><volume>6</volume><fpage>1007</fpage><lpage>1019</lpage><pub-id pub-id-type=""doi"">10.1016/S0969-2126(98)00102-6</pub-id><pub-id pub-id-type=""pmid"">9739091</pub-id></mixed-citation></ref><ref id=""B21""><mixed-citation publication-type=""journal""><name><surname>Lodowski</surname><given-names>DT</given-names></name><name><surname>Pitcher</surname><given-names>JA</given-names></name><name><surname>Capel</surname><given-names>WD</given-names></name><name><surname>Lefkowitz</surname><given-names>RJ</given-names></name><name><surname>Tesmer</surname><given-names>JJ</given-names></name><article-title>Keeping G proteins at bay: a complex between G protein-coupled receptor kinase 2 and Gbetagamma</article-title><source>Science</source><year>2003</year><volume>300</volume><fpage>1256</fpage><lpage>1262</lpage><pub-id pub-id-type=""doi"">10.1126/science.1082348</pub-id><pub-id pub-id-type=""pmid"">12764189</pub-id></mixed-citation></ref><ref id=""B22""><mixed-citation publication-type=""journal""><name><surname>Tesmer</surname><given-names>JJ</given-names></name><name><surname>Tesmer</surname><given-names>VM</given-names></name><name><surname>Lodowski</surname><given-names>DT</given-names></name><name><surname>Steinhagen</surname><given-names>H</given-names></name><name><surname>Huber</surname><given-names>J</given-names></name><article-title>Structure of human G protein-coupled receptor kinase 2 in complex with the kinase inhibitor balanol</article-title><source>J Med Chem</source><year>2010</year><volume>53</volume><fpage>1867</fpage><lpage>1870</lpage><pub-id pub-id-type=""doi"">10.1021/jm9017515</pub-id><pub-id pub-id-type=""pmid"">20128603</pub-id></mixed-citation></ref><ref id=""B23""><mixed-citation publication-type=""journal""><name><surname>Tesmer</surname><given-names>VM</given-names></name><name><surname>Kawano</surname><given-names>T</given-names></name><name><surname>Shankaranarayanan</surname><given-names>A</given-names></name><name><surname>Kozasa</surname><given-names>T</given-names></name><name><surname>Tesmer</surname><given-names>JJ</given-names></name><article-title>Snapshot of activated G proteins at the membrane: the Galphaq-GRK2-Gbetagamma complex</article-title><source>Science</source><year>2005</year><volume>310</volume><fpage>1686</fpage><lpage>1690</lpage><pub-id pub-id-type=""doi"">10.1126/science.1118890</pub-id><pub-id pub-id-type=""pmid"">16339447</pub-id></mixed-citation></ref><ref id=""B24""><mixed-citation publication-type=""journal""><name><surname>Cheever</surname><given-names>ML</given-names></name><name><surname>Snyder</surname><given-names>JT</given-names></name><name><surname>Gershburg</surname><given-names>S</given-names></name><name><surname>Siderovski</surname><given-names>DP</given-names></name><name><surname>Harden</surname><given-names>TK</given-names></name><name><surname>Sondek</surname><given-names>J</given-names></name><article-title>Crystal structure of the multifunctional Gbeta5-RGS9 complex</article-title><source>Nat Struct Mol Biol</source><year>2008</year><volume>15</volume><fpage>155</fpage><lpage>162</lpage><pub-id pub-id-type=""doi"">10.1038/nsmb.1377</pub-id><pub-id pub-id-type=""pmid"">18204463</pub-id></mixed-citation></ref><ref id=""B25""><mixed-citation publication-type=""journal""><name><surname>Slep</surname><given-names>KC</given-names></name><name><surname>Kercher</surname><given-names>MA</given-names></name><name><surname>He</surname><given-names>W</given-names></name><name><surname>Cowan</surname><given-names>CW</given-names></name><name><surname>Wensel</surname><given-names>TG</given-names></name><name><surname>Sigler</surname><given-names>PB</given-names></name><article-title>Structural determinants for regulation of phosphodiesterase by a G protein at 2.0 A</article-title><source>Nature</source><year>2001</year><volume>409</volume><fpage>1071</fpage><lpage>1077</lpage><pub-id pub-id-type=""doi"">10.1038/35059138</pub-id><pub-id pub-id-type=""pmid"">11234020</pub-id></mixed-citation></ref><ref id=""B26""><mixed-citation publication-type=""journal""><name><surname>Johnston</surname><given-names>CA</given-names></name><name><surname>Kimple</surname><given-names>AJ</given-names></name><name><surname>Giguere</surname><given-names>PM</given-names></name><name><surname>Siderovski</surname><given-names>DP</given-names></name><article-title>Structure of the parathyroid hormone receptor C terminus bound to the G-protein dimer Gbeta1gamma2</article-title><source>Structure</source><year>2008</year><volume>16</volume><fpage>1086</fpage><lpage>1094</lpage><pub-id pub-id-type=""doi"">10.1016/j.str.2008.04.010</pub-id><pub-id pub-id-type=""pmid"">18611381</pub-id></mixed-citation></ref><ref id=""B27""><mixed-citation publication-type=""journal""><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Dell</surname><given-names>EJ</given-names></name><name><surname>Lin</surname><given-names>F</given-names></name><name><surname>Sai</surname><given-names>J</given-names></name><name><surname>Hamm</surname><given-names>HE</given-names></name><article-title>RACK1 regulates specific functions of Gbetagamma</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><fpage>17861</fpage><lpage>17868</lpage><pub-id pub-id-type=""doi"">10.1074/jbc.M313727200</pub-id><pub-id pub-id-type=""pmid"">14963031</pub-id></mixed-citation></ref><ref id=""B28""><mixed-citation publication-type=""journal""><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Lin</surname><given-names>F</given-names></name><name><surname>Hamm</surname><given-names>HE</given-names></name><article-title>RACK1 binds to a signal transfer region of G betagamma and inhibits phospholipase C beta2 activation</article-title><source>J Biol Chem</source><year>2005</year><volume>280</volume><fpage>33445</fpage><lpage>33452</lpage><pub-id pub-id-type=""doi"">10.1074/jbc.M505422200</pub-id><pub-id pub-id-type=""pmid"">16051595</pub-id></mixed-citation></ref><ref id=""B29""><mixed-citation publication-type=""journal""><name><surname>Thornton</surname><given-names>C</given-names></name><name><surname>Tang</surname><given-names>KC</given-names></name><name><surname>Phamluong</surname><given-names>K</given-names></name><name><surname>Luong</surname><given-names>K</given-names></name><name><surname>Vagts</surname><given-names>A</given-names></name><name><surname>Nikanjam</surname><given-names>D</given-names></name><name><surname>Yaka</surname><given-names>R</given-names></name><name><surname>Ron</surname><given-names>D</given-names></name><article-title>Spatial and temporal regulation of RACK1 function and N-methyl-D-aspartate receptor activity through WD40 motif-mediated dimerization</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><fpage>31357</fpage><lpage>31364</lpage><pub-id pub-id-type=""doi"">10.1074/jbc.M402316200</pub-id><pub-id pub-id-type=""pmid"">15140893</pub-id></mixed-citation></ref><ref id=""B30""><mixed-citation publication-type=""journal""><name><surname>Vinas-Castells</surname><given-names>R</given-names></name><name><surname>Beltran</surname><given-names>M</given-names></name><name><surname>Valls</surname><given-names>G</given-names></name><name><surname>Gomez</surname><given-names>I</given-names></name><name><surname>Garcia</surname><given-names>JM</given-names></name><name><surname>Montserrat-Sentis</surname><given-names>B</given-names></name><name><surname>Baulida</surname><given-names>J</given-names></name><name><surname>Bonilla</surname><given-names>F</given-names></name><name><surname>de Herreros</surname><given-names>AG</given-names></name><name><surname>Diaz</surname><given-names>VM</given-names></name><article-title>The hypoxia-controlled FBXL14 ubiquitin ligase targets SNAIL1 for proteasome degradation</article-title><source>J Biol Chem</source><year>2010</year><volume>285</volume><fpage>3794</fpage><lpage>3805</lpage><pub-id pub-id-type=""doi"">10.1074/jbc.M109.065995</pub-id><pub-id pub-id-type=""pmid"">19955572</pub-id></mixed-citation></ref><ref id=""B31""><mixed-citation publication-type=""journal""><name><surname>Xia</surname><given-names>Y</given-names></name><name><surname>Padre</surname><given-names>RC</given-names></name><name><surname>De Mendoza</surname><given-names>TH</given-names></name><name><surname>Bottero</surname><given-names>V</given-names></name><name><surname>Tergaonkar</surname><given-names>VB</given-names></name><name><surname>Verma</surname><given-names>IM</given-names></name><article-title>Phosphorylation of p53 by IkappaB kinase 2 promotes its degradation by beta-TrCP</article-title><source>Proc Natl Acad Sci USA</source><year>2009</year><volume>106</volume><fpage>2629</fpage><lpage>2634</lpage><pub-id pub-id-type=""doi"">10.1073/pnas.0812256106</pub-id><pub-id pub-id-type=""pmid"">19196987</pub-id></mixed-citation></ref><ref id=""B32""><mixed-citation publication-type=""journal""><name><surname>Seo</surname><given-names>E</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>R</given-names></name><name><surname>Yun</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>M</given-names></name><name><surname>Han</surname><given-names>JK</given-names></name><name><surname>Costantini</surname><given-names>F</given-names></name><name><surname>Jho</surname><given-names>EH</given-names></name><article-title>Multiple isoforms of beta-TrCP display differential activities in the regulation of Wnt signaling</article-title><source>Cell Signal</source><year>2009</year><volume>21</volume><fpage>43</fpage><lpage>51</lpage><pub-id pub-id-type=""doi"">10.1016/j.cellsig.2008.09.009</pub-id><pub-id pub-id-type=""pmid"">18929646</pub-id></mixed-citation></ref><ref id=""B33""><mixed-citation publication-type=""journal""><name><surname>Kimbrel</surname><given-names>EA</given-names></name><name><surname>Kung</surname><given-names>AL</given-names></name><article-title>The F-box protein beta-TrCp1/Fbw1a interacts with p300 to enhance beta-catenin transcriptional activity</article-title><source>J Biol Chem</source><year>2009</year><volume>284</volume><fpage>13033</fpage><lpage>13044</lpage><pub-id pub-id-type=""doi"">10.1074/jbc.M901248200</pub-id><pub-id pub-id-type=""pmid"">19297328</pub-id></mixed-citation></ref><ref id=""B34""><mixed-citation publication-type=""journal""><name><surname>Ohsaki</surname><given-names>K</given-names></name><name><surname>Oishi</surname><given-names>K</given-names></name><name><surname>Kozono</surname><given-names>Y</given-names></name><name><surname>Nakayama</surname><given-names>K</given-names></name><name><surname>Nakayama</surname><given-names>KI</given-names></name><name><surname>Ishida</surname><given-names>N</given-names></name><article-title>The role of {beta}-TrCP1 and {beta}-TrCP2 in circadian rhythm generation by mediating degradation of clock protein PER2</article-title><source>J Biochem</source><year>2008</year><volume>144</volume><fpage>609</fpage><lpage>618</lpage><pub-id pub-id-type=""doi"">10.1093/jb/mvn112</pub-id><pub-id pub-id-type=""pmid"">18782782</pub-id></mixed-citation></ref><ref id=""B35""><mixed-citation publication-type=""journal""><name><surname>Dentice</surname><given-names>M</given-names></name><name><surname>Bandyopadhyay</surname><given-names>A</given-names></name><name><surname>Gereben</surname><given-names>B</given-names></name><name><surname>Callebaut</surname><given-names>I</given-names></name><name><surname>Christoffolete</surname><given-names>MA</given-names></name><name><surname>Kim</surname><given-names>BW</given-names></name><name><surname>Nissim</surname><given-names>S</given-names></name><name><surname>Mornon</surname><given-names>JP</given-names></name><name><surname>Zavacki</surname><given-names>AM</given-names></name><name><surname>Zeold</surname><given-names>A</given-names></name><etal></etal><article-title>The Hedgehog-inducible ubiquitin ligase subunit WSB-1 modulates thyroid hormone activation and PTHrP secretion in the developing growth plate</article-title><source>Nat Cell Biol</source><year>2005</year><volume>7</volume><fpage>698</fpage><lpage>705</lpage><pub-id pub-id-type=""doi"">10.1038/ncb1272</pub-id><pub-id pub-id-type=""pmid"">15965468</pub-id></mixed-citation></ref><ref id=""B36""><mixed-citation publication-type=""journal""><name><surname>Choi</surname><given-names>DW</given-names></name><name><surname>Seo</surname><given-names>YM</given-names></name><name><surname>Kim</surname><given-names>EA</given-names></name><name><surname>Sung</surname><given-names>KS</given-names></name><name><surname>Ahn</surname><given-names>JW</given-names></name><name><surname>Park</surname><given-names>SJ</given-names></name><name><surname>Lee</surname><given-names>SR</given-names></name><name><surname>Choi</surname><given-names>CY</given-names></name><article-title>Ubiquitination and degradation of homeodomain-interacting protein kinase 2 by WD40 repeat/SOCS box protein WSB-1</article-title><source>J Biol Chem</source><year>2008</year><volume>283</volume><fpage>4682</fpage><lpage>4689</lpage><pub-id pub-id-type=""pmid"">18093972</pub-id></mixed-citation></ref><ref id=""B37""><mixed-citation publication-type=""journal""><name><surname>Chen</surname><given-names>QR</given-names></name><name><surname>Bilke</surname><given-names>S</given-names></name><name><surname>Wei</surname><given-names>JS</given-names></name><name><surname>Greer</surname><given-names>BT</given-names></name><name><surname>Steinberg</surname><given-names>SM</given-names></name><name><surname>Westermann</surname><given-names>F</given-names></name><name><surname>Schwab</surname><given-names>M</given-names></name><name><surname>Khan</surname><given-names>J</given-names></name><article-title>Increased WSB1 copy number correlates with its over-expression which associates with increased survival in neuroblastoma</article-title><source>Genes Chromosomes Cancer</source><year>2006</year><volume>45</volume><fpage>856</fpage><lpage>862</lpage><pub-id pub-id-type=""doi"">10.1002/gcc.20349</pub-id><pub-id pub-id-type=""pmid"">16804916</pub-id></mixed-citation></ref><ref id=""B38""><mixed-citation publication-type=""journal""><name><surname>Tsai</surname><given-names>TC</given-names></name><name><surname>Lee</surname><given-names>YL</given-names></name><name><surname>Hsiao</surname><given-names>WC</given-names></name><name><surname>Tsao</surname><given-names>YP</given-names></name><name><surname>Chen</surname><given-names>SL</given-names></name><article-title>NRIP, a novel nuclear receptor interaction protein, enhances the transcriptional activity of nuclear receptors</article-title><source>J Biol Chem</source><year>2005</year><volume>280</volume><fpage>20000</fpage><lpage>20009</lpage><pub-id pub-id-type=""doi"">10.1074/jbc.M412169200</pub-id><pub-id pub-id-type=""pmid"">15784617</pub-id></mixed-citation></ref><ref id=""B39""><mixed-citation publication-type=""journal""><name><surname>Chen</surname><given-names>PH</given-names></name><name><surname>Tsao</surname><given-names>YP</given-names></name><name><surname>Wang</surname><given-names>CC</given-names></name><name><surname>Chen</surname><given-names>SL</given-names></name><article-title>Nuclear receptor interaction protein, a coactivator of androgen receptors (AR), is regulated by AR and Sp1 to feed forward and activate its own gene expression through AR protein stability</article-title><source>Nucleic Acids Res</source><year>2008</year><volume>36</volume><fpage>51</fpage><lpage>66</lpage><pub-id pub-id-type=""doi"">10.1093/nar/gkn151</pub-id><pub-id pub-id-type=""pmid"">17984071</pub-id></mixed-citation></ref><ref id=""B40""><mixed-citation publication-type=""journal""><name><surname>Chang</surname><given-names>SW</given-names></name><name><surname>Tsao</surname><given-names>YP</given-names></name><name><surname>Lin</surname><given-names>CY</given-names></name><name><surname>Chen</surname><given-names>SL</given-names></name><article-title>NRIP, a Novel Calmodulin Binding Protein, Activates Calcineurin To Dephosphorylate Human Papillomavirus E2 Protein</article-title><source>J Virol</source><year>2011</year><volume>85</volume><fpage>6750</fpage><lpage>6763</lpage><pub-id pub-id-type=""doi"">10.1128/JVI.02453-10</pub-id><pub-id pub-id-type=""pmid"">21543494</pub-id></mixed-citation></ref><ref id=""B41""><mixed-citation publication-type=""journal""><name><surname>Guillemot</surname><given-names>F</given-names></name><name><surname>Billault</surname><given-names>A</given-names></name><name><surname>Auffray</surname><given-names>C</given-names></name><article-title>Physical linkage of a guanine nucleotide-binding protein-related gene to the chicken major histocompatibility complex</article-title><source>Proc Natl Acad Sci USA</source><year>1989</year><volume>86</volume><fpage>4594</fpage><lpage>4598</lpage><pub-id pub-id-type=""doi"">10.1073/pnas.86.12.4594</pub-id><pub-id pub-id-type=""pmid"">2499885</pub-id></mixed-citation></ref><ref id=""B42""><mixed-citation publication-type=""journal""><name><surname>Ron</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>CH</given-names></name><name><surname>Caldwell</surname><given-names>J</given-names></name><name><surname>Jamieson</surname><given-names>L</given-names></name><name><surname>Orr</surname><given-names>E</given-names></name><name><surname>Mochly-Rosen</surname><given-names>D</given-names></name><article-title>Cloning of an intracellular receptor for protein kinase C: a homolog of the beta subunit of G proteins</article-title><source>Proc Natl Acad Sci USA</source><year>1994</year><volume>91</volume><fpage>839</fpage><lpage>843</lpage><pub-id pub-id-type=""doi"">10.1073/pnas.91.3.839</pub-id><pub-id pub-id-type=""pmid"">8302854</pub-id></mixed-citation></ref><ref id=""B43""><mixed-citation publication-type=""journal""><name><surname>Ron</surname><given-names>D</given-names></name><name><surname>Luo</surname><given-names>J</given-names></name><name><surname>Mochly-Rosen</surname><given-names>D</given-names></name><article-title>C2 region-derived peptides inhibit translocation and function of beta protein kinase C in vivo</article-title><source>J Biol Chem</source><year>1995</year><volume>270</volume><fpage>24180</fpage><lpage>24187</lpage><pub-id pub-id-type=""doi"">10.1074/jbc.270.41.24180</pub-id><pub-id pub-id-type=""pmid"">7592622</pub-id></mixed-citation></ref><ref id=""B44""><mixed-citation publication-type=""journal""><name><surname>Ron</surname><given-names>D</given-names></name><name><surname>Mochly-Rosen</surname><given-names>D</given-names></name><article-title>An autoregulatory region in protein kinase C: the pseudoanchoring site</article-title><source>Proc Natl Acad Sci USA</source><year>1995</year><volume>92</volume><fpage>492</fpage><lpage>496</lpage><pub-id pub-id-type=""doi"">10.1073/pnas.92.2.492</pub-id><pub-id pub-id-type=""pmid"">7831317</pub-id></mixed-citation></ref><ref id=""B45""><mixed-citation publication-type=""journal""><name><surname>Stebbins</surname><given-names>EG</given-names></name><name><surname>Mochly-Rosen</surname><given-names>D</given-names></name><article-title>Binding specificity for RACK1 resides in the V5 region of beta II protein kinase C</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>29644</fpage><lpage>29650</lpage><pub-id pub-id-type=""doi"">10.1074/jbc.M101044200</pub-id><pub-id pub-id-type=""pmid"">11387319</pub-id></mixed-citation></ref><ref id=""B46""><mixed-citation publication-type=""journal""><name><surname>McCahill</surname><given-names>A</given-names></name><name><surname>Warwicker</surname><given-names>J</given-names></name><name><surname>Bolger</surname><given-names>GB</given-names></name><name><surname>Houslay</surname><given-names>MD</given-names></name><name><surname>Yarwood</surname><given-names>SJ</given-names></name><article-title>The RACK1 scaffold protein: a dynamic cog in cell response mechanisms</article-title><source>Mol Pharmacol</source><year>2002</year><volume>62</volume><fpage>1261</fpage><lpage>1273</lpage><pub-id pub-id-type=""doi"">10.1124/mol.62.6.1261</pub-id><pub-id pub-id-type=""pmid"">12435793</pub-id></mixed-citation></ref><ref id=""B47""><mixed-citation publication-type=""journal""><name><surname>Sklan</surname><given-names>EH</given-names></name><name><surname>Podoly</surname><given-names>E</given-names></name><name><surname>Soreq</surname><given-names>H</given-names></name><article-title>RACK1 has the nerve to act: structure meets function in the nervous system</article-title><source>Prog Neurobiol</source><year>2006</year><volume>78</volume><fpage>117</fpage><lpage>134</lpage><pub-id pub-id-type=""doi"">10.1016/j.pneurobio.2005.12.002</pub-id><pub-id pub-id-type=""pmid"">16457939</pub-id></mixed-citation></ref><ref id=""B48""><mixed-citation publication-type=""journal""><name><surname>Chang</surname><given-names>BY</given-names></name><name><surname>Harte</surname><given-names>RA</given-names></name><name><surname>Cartwright</surname><given-names>CA</given-names></name><article-title>RACK1: a novel substrate for the Src protein-tyrosine kinase</article-title><source>Oncogene</source><year>2002</year><volume>21</volume><fpage>7619</fpage><lpage>7629</lpage><pub-id pub-id-type=""doi"">10.1038/sj.onc.1206002</pub-id><pub-id pub-id-type=""pmid"">12400005</pub-id></mixed-citation></ref><ref id=""B49""><mixed-citation publication-type=""journal""><name><surname>Yaka</surname><given-names>R</given-names></name><name><surname>Thornton</surname><given-names>C</given-names></name><name><surname>Vagts</surname><given-names>AJ</given-names></name><name><surname>Phamluong</surname><given-names>K</given-names></name><name><surname>Bonci</surname><given-names>A</given-names></name><name><surname>Ron</surname><given-names>D</given-names></name><article-title>NMDA receptor function is regulated by the inhibitory scaffolding protein, RACK1</article-title><source>Proc Natl Acad Sci USA</source><year>2002</year><volume>99</volume><fpage>5710</fpage><lpage>5715</lpage><pub-id pub-id-type=""doi"">10.1073/pnas.062046299</pub-id><pub-id pub-id-type=""pmid"">11943848</pub-id></mixed-citation></ref><ref id=""B50""><mixed-citation publication-type=""journal""><name><surname>Koehler</surname><given-names>JA</given-names></name><name><surname>Moran</surname><given-names>MF</given-names></name><article-title>RACK1, a protein kinase C scaffolding protein, interacts with the PH domain of p120GAP</article-title><source>Biochem Biophys Res Commun</source><year>2001</year><volume>283</volume><fpage>888</fpage><lpage>895</lpage><pub-id pub-id-type=""doi"">10.1006/bbrc.2001.4889</pub-id><pub-id pub-id-type=""pmid"">11350068</pub-id></mixed-citation></ref><ref id=""B51""><mixed-citation publication-type=""journal""><name><surname>Rodriguez</surname><given-names>MM</given-names></name><name><surname>Ron</surname><given-names>D</given-names></name><name><surname>Touhara</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>CH</given-names></name><name><surname>Mochly-Rosen</surname><given-names>D</given-names></name><article-title>RACK1, a protein kinase C anchoring protein, coordinates the binding of activated protein kinase C and select pleckstrin homology domains in vitro</article-title><source>Biochemistry</source><year>1999</year><volume>38</volume><fpage>13787</fpage><lpage>13794</lpage><pub-id pub-id-type=""doi"">10.1021/bi991055k</pub-id><pub-id pub-id-type=""pmid"">10529223</pub-id></mixed-citation></ref><ref id=""B52""><mixed-citation publication-type=""journal""><name><surname>Liedtke</surname><given-names>CM</given-names></name><name><surname>Raghuram</surname><given-names>V</given-names></name><name><surname>Yun</surname><given-names>CC</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><article-title>Role of a PDZ1 domain of NHERF1 in the binding of airway epithelial RACK1 to NHERF1</article-title><source>Am J Physiol Cell Physiol</source><year>2004</year><volume>286</volume><fpage>C1037</fpage><lpage>1044</lpage><pub-id pub-id-type=""pmid"">15075202</pub-id></mixed-citation></ref><ref id=""B53""><mixed-citation publication-type=""journal""><name><surname>Dell</surname><given-names>EJ</given-names></name><name><surname>Connor</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Stebbins</surname><given-names>EG</given-names></name><name><surname>Skiba</surname><given-names>NP</given-names></name><name><surname>Mochly-Rosen</surname><given-names>D</given-names></name><name><surname>Hamm</surname><given-names>HE</given-names></name><article-title>The betagamma subunit of heterotrimeric G proteins interacts with RACK1 and two other WD repeat proteins</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>49888</fpage><lpage>49895</lpage><pub-id pub-id-type=""doi"">10.1074/jbc.M202755200</pub-id><pub-id pub-id-type=""pmid"">12359736</pub-id></mixed-citation></ref><ref id=""B54""><mixed-citation publication-type=""journal""><name><surname>Liu</surname><given-names>YV</given-names></name><name><surname>Semenza</surname><given-names>GL</given-names></name><article-title>RACK1 vs. HSP90: competition for HIF-1 alpha degradation vs. stabilization</article-title><source>Cell Cycle</source><year>2007</year><volume>6</volume><fpage>656</fpage><lpage>659</lpage><pub-id pub-id-type=""doi"">10.4161/cc.6.6.3981</pub-id><pub-id pub-id-type=""pmid"">17361105</pub-id></mixed-citation></ref><ref id=""B55""><mixed-citation publication-type=""journal""><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Carnicella</surname><given-names>S</given-names></name><name><surname>Phamluong</surname><given-names>K</given-names></name><name><surname>Jeanblanc</surname><given-names>J</given-names></name><name><surname>Ronesi</surname><given-names>JA</given-names></name><name><surname>Chaudhri</surname><given-names>N</given-names></name><name><surname>Janak</surname><given-names>PH</given-names></name><name><surname>Lovinger</surname><given-names>DM</given-names></name><name><surname>Ron</surname><given-names>D</given-names></name><article-title>Ethanol induces long-term facilitation of NR2B-NMDA receptor activity in the dorsal striatum: implications for alcohol drinking behavior</article-title><source>J Neurosci</source><year>2007</year><volume>27</volume><fpage>3593</fpage><lpage>3602</lpage><pub-id pub-id-type=""doi"">10.1523/JNEUROSCI.4749-06.2007</pub-id><pub-id pub-id-type=""pmid"">17392475</pub-id></mixed-citation></ref><ref id=""B56""><mixed-citation publication-type=""journal""><name><surname>Yaka</surname><given-names>R</given-names></name><name><surname>He</surname><given-names>DY</given-names></name><name><surname>Phamluong</surname><given-names>K</given-names></name><name><surname>Ron</surname><given-names>D</given-names></name><article-title>Pituitary adenylate cyclase-activating polypeptide (PACAP(1-38)) enhances N-methyl-D-aspartate receptor function and brain-derived neurotrophic factor expression via RACK1</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>9630</fpage><lpage>9638</lpage><pub-id pub-id-type=""doi"">10.1074/jbc.M209141200</pub-id><pub-id pub-id-type=""pmid"">12524444</pub-id></mixed-citation></ref><ref id=""B57""><mixed-citation publication-type=""journal""><name><surname>Yaka</surname><given-names>R</given-names></name><name><surname>Phamluong</surname><given-names>K</given-names></name><name><surname>Ron</surname><given-names>D</given-names></name><article-title>Scaffolding of Fyn kinase to the NMDA receptor determines brain region sensitivity to ethanol</article-title><source>J Neurosci</source><year>2003</year><volume>23</volume><fpage>3623</fpage><lpage>3632</lpage><pub-id pub-id-type=""pmid"">12736333</pub-id></mixed-citation></ref><ref id=""B58""><mixed-citation publication-type=""journal""><name><surname>Kiely</surname><given-names>PA</given-names></name><name><surname>Baillie</surname><given-names>GS</given-names></name><name><surname>Lynch</surname><given-names>MJ</given-names></name><name><surname>Houslay</surname><given-names>MD</given-names></name><name><surname>O'Connor</surname><given-names>R</given-names></name><article-title>Tyrosine 302 in RACK1 is essential for insulin-like growth factor-I-mediated competitive binding of PP2A and beta1 integrin and for tumor cell proliferation and migration</article-title><source>J Biol Chem</source><year>2008</year><volume>283</volume><fpage>22952</fpage><lpage>22961</lpage><pub-id pub-id-type=""doi"">10.1074/jbc.M800802200</pub-id><pub-id pub-id-type=""pmid"">18567578</pub-id></mixed-citation></ref><ref id=""B59""><mixed-citation publication-type=""journal""><name><surname>Kiely</surname><given-names>PA</given-names></name><name><surname>O'Gorman</surname><given-names>D</given-names></name><name><surname>Luong</surname><given-names>K</given-names></name><name><surname>Ron</surname><given-names>D</given-names></name><name><surname>O'Connor</surname><given-names>R</given-names></name><article-title>Insulin-like growth factor I controls a mutually exclusive association of RACK1 with protein phosphatase 2A and beta1 integrin to promote cell migration</article-title><source>Mol Cell Biol</source><year>2006</year><volume>26</volume><fpage>4041</fpage><lpage>4051</lpage><pub-id pub-id-type=""doi"">10.1128/MCB.01868-05</pub-id><pub-id pub-id-type=""pmid"">16705158</pub-id></mixed-citation></ref><ref id=""B60""><mixed-citation publication-type=""journal""><name><surname>Ron</surname><given-names>D</given-names></name><name><surname>Jiang</surname><given-names>Z</given-names></name><name><surname>Yao</surname><given-names>L</given-names></name><name><surname>Vagts</surname><given-names>A</given-names></name><name><surname>Diamond</surname><given-names>I</given-names></name><name><surname>Gordon</surname><given-names>A</given-names></name><article-title>Coordinated movement of RACK1 with activated betaIIPKC</article-title><source>J Biol Chem</source><year>1999</year><volume>274</volume><fpage>27039</fpage><lpage>27046</lpage><pub-id pub-id-type=""doi"">10.1074/jbc.274.38.27039</pub-id><pub-id pub-id-type=""pmid"">10480917</pub-id></mixed-citation></ref><ref id=""B61""><mixed-citation publication-type=""journal""><name><surname>Mamidipudi</surname><given-names>V</given-names></name><name><surname>Chang</surname><given-names>BY</given-names></name><name><surname>Harte</surname><given-names>RA</given-names></name><name><surname>Lee</surname><given-names>KC</given-names></name><name><surname>Cartwright</surname><given-names>CA</given-names></name><article-title>RACK1 inhibits the serum- and anchorage-independent growth of v-Src transformed cells</article-title><source>FEBS Lett</source><year>2004</year><volume>567</volume><fpage>321</fpage><lpage>326</lpage><pub-id pub-id-type=""doi"">10.1016/j.febslet.2004.03.125</pub-id><pub-id pub-id-type=""pmid"">15178345</pub-id></mixed-citation></ref><ref id=""B62""><mixed-citation publication-type=""journal""><name><surname>Mamidipudi</surname><given-names>V</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>KC</given-names></name><name><surname>Cartwright</surname><given-names>CA</given-names></name><article-title>RACK1 regulates G1/S progression by suppressing Src kinase activity</article-title><source>Mol Cell Biol</source><year>2004</year><volume>24</volume><fpage>6788</fpage><lpage>6798</lpage><pub-id pub-id-type=""doi"">10.1128/MCB.24.15.6788-6798.2004</pub-id><pub-id pub-id-type=""pmid"">15254245</pub-id></mixed-citation></ref><ref id=""B63""><mixed-citation publication-type=""journal""><name><surname>Del Vecchio</surname><given-names>I</given-names></name><name><surname>Zuccotti</surname><given-names>A</given-names></name><name><surname>Pisano</surname><given-names>F</given-names></name><name><surname>Canneva</surname><given-names>F</given-names></name><name><surname>Lenzken</surname><given-names>SC</given-names></name><name><surname>Rousset</surname><given-names>F</given-names></name><name><surname>Corsini</surname><given-names>E</given-names></name><name><surname>Govoni</surname><given-names>S</given-names></name><name><surname>Racchi</surname><given-names>M</given-names></name><article-title>Functional mapping of the promoter region of the GNB2L1 human gene coding for RACK1 scaffold protein</article-title><source>Gene</source><year>2009</year><volume>430</volume><fpage>17</fpage><lpage>29</lpage><pub-id pub-id-type=""doi"">10.1016/j.gene.2008.10.005</pub-id><pub-id pub-id-type=""pmid"">19000751</pub-id></mixed-citation></ref><ref id=""B64""><mixed-citation publication-type=""journal""><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>JZ</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Gu</surname><given-names>S</given-names></name><name><surname>Ji</surname><given-names>C</given-names></name><name><surname>Tang</surname><given-names>R</given-names></name><name><surname>Ying</surname><given-names>K</given-names></name><name><surname>Xie</surname><given-names>Y</given-names></name><name><surname>Mao</surname><given-names>Y</given-names></name><article-title>Cloning, expression and genomic structure of a novel human GNB2L1 gene, which encodes a receptor of activated protein kinase C (RACK)</article-title><source>Mol Biol Rep</source><year>2003</year><volume>30</volume><fpage>53</fpage><lpage>60</lpage><pub-id pub-id-type=""doi"">10.1023/A:1022212731316</pub-id><pub-id pub-id-type=""pmid"">12688536</pub-id></mixed-citation></ref><ref id=""B65""><mixed-citation publication-type=""journal""><name><surname>Glessner</surname><given-names>JT</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Sleiman</surname><given-names>PM</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>CE</given-names></name><name><surname>Flory</surname><given-names>JH</given-names></name><name><surname>Bradfield</surname><given-names>JP</given-names></name><name><surname>Imielinski</surname><given-names>M</given-names></name><name><surname>Frackelton</surname><given-names>EC</given-names></name><name><surname>Qiu</surname><given-names>H</given-names></name><etal></etal><article-title>Duplication of the SLIT3 locus on 5q35.1 predisposes to major depressive disorder</article-title><source>PLoS One</source><year>2010</year><volume>5</volume><fpage>e15463</fpage><pub-id pub-id-type=""doi"">10.1371/journal.pone.0015463</pub-id><pub-id pub-id-type=""pmid"">21152026</pub-id></mixed-citation></ref><ref id=""B66""><mixed-citation publication-type=""journal""><name><surname>Rivera</surname><given-names>H</given-names></name><name><surname>Vasquez-Velasquez</surname><given-names>AI</given-names></name><article-title>5q35 duplication and Hunter-McAlpine syndrome: missing the link</article-title><source>Am J Med Genet A</source><year>2010</year><volume>152A</volume><fpage>802</fpage><lpage>803</lpage><comment>author reply 804</comment><pub-id pub-id-type=""doi"">10.1002/ajmg.a.33262</pub-id><pub-id pub-id-type=""pmid"">20186800</pub-id></mixed-citation></ref><ref id=""B67""><mixed-citation publication-type=""journal""><name><surname>Rauch</surname><given-names>A</given-names></name><name><surname>Beese</surname><given-names>M</given-names></name><name><surname>Mayatepek</surname><given-names>E</given-names></name><name><surname>Dorr</surname><given-names>HG</given-names></name><name><surname>Wenzel</surname><given-names>D</given-names></name><name><surname>Reis</surname><given-names>A</given-names></name><name><surname>Trautmann</surname><given-names>U</given-names></name><article-title>A novel 5q35.3 subtelomeric deletion syndrome</article-title><source>Am J Med Genet A</source><year>2003</year><volume>121A</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type=""doi"">10.1002/ajmg.a.20173</pub-id><pub-id pub-id-type=""pmid"">12900893</pub-id></mixed-citation></ref><ref id=""B68""><mixed-citation publication-type=""journal""><name><surname>Laurin</surname><given-names>N</given-names></name><name><surname>Brown</surname><given-names>JP</given-names></name><name><surname>Lemainque</surname><given-names>A</given-names></name><name><surname>Duchesne</surname><given-names>A</given-names></name><name><surname>Huot</surname><given-names>D</given-names></name><name><surname>Lacourciere</surname><given-names>Y</given-names></name><name><surname>Drapeau</surname><given-names>G</given-names></name><name><surname>Verreault</surname><given-names>J</given-names></name><name><surname>Raymond</surname><given-names>V</given-names></name><name><surname>Morissette</surname><given-names>J</given-names></name><article-title>Paget disease of bone: mapping of two loci at 5q35-qter and 5q31</article-title><source>Am J Hum Genet</source><year>2001</year><volume>69</volume><fpage>528</fpage><lpage>543</lpage><pub-id pub-id-type=""doi"">10.1086/322975</pub-id><pub-id pub-id-type=""pmid"">11473345</pub-id></mixed-citation></ref><ref id=""B69""><mixed-citation publication-type=""journal""><name><surname>Choi</surname><given-names>DS</given-names></name><name><surname>Young</surname><given-names>H</given-names></name><name><surname>McMahon</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Messing</surname><given-names>RO</given-names></name><article-title>The mouse RACK1 gene is regulated by nuclear factor-kappa B and contributes to cell survival</article-title><source>Mol Pharmacol</source><year>2003</year><volume>64</volume><fpage>1541</fpage><lpage>1548</lpage><pub-id pub-id-type=""doi"">10.1124/mol.64.6.1541</pub-id><pub-id pub-id-type=""pmid"">14645685</pub-id></mixed-citation></ref><ref id=""B70""><mixed-citation publication-type=""journal""><name><surname>Chou</surname><given-names>YC</given-names></name><name><surname>Chou</surname><given-names>CC</given-names></name><name><surname>Chen</surname><given-names>YK</given-names></name><name><surname>Tsai</surname><given-names>S</given-names></name><name><surname>Hsieh</surname><given-names>FM</given-names></name><name><surname>Liu</surname><given-names>HJ</given-names></name><name><surname>Hseu</surname><given-names>TH</given-names></name><article-title>Structure and genomic organization of porcine RACK1 gene</article-title><source>Biochim Biophys Acta</source><year>1999</year><volume>1489</volume><fpage>315</fpage><lpage>322</lpage><pub-id pub-id-type=""pmid"">10673032</pub-id></mixed-citation></ref><ref id=""B71""><mixed-citation publication-type=""journal""><name><surname>Ashique</surname><given-names>AM</given-names></name><name><surname>Kharazia</surname><given-names>V</given-names></name><name><surname>Yaka</surname><given-names>R</given-names></name><name><surname>Phamluong</surname><given-names>K</given-names></name><name><surname>Peterson</surname><given-names>AS</given-names></name><name><surname>Ron</surname><given-names>D</given-names></name><article-title>Localization of the scaffolding protein RACK1 in the developing and adult mouse brain</article-title><source>Brain Res</source><year>2006</year><volume>1069</volume><fpage>31</fpage><lpage>38</lpage><pub-id pub-id-type=""doi"">10.1016/j.brainres.2005.11.018</pub-id><pub-id pub-id-type=""pmid"">16414032</pub-id></mixed-citation></ref><ref id=""B72""><mixed-citation publication-type=""journal""><name><surname>Battaini</surname><given-names>F</given-names></name><name><surname>Pascale</surname><given-names>A</given-names></name><article-title>Protein kinase C signal transduction regulation in physiological and pathological aging</article-title><source>Ann N Y Acad Sci</source><year>2005</year><volume>1057</volume><fpage>177</fpage><lpage>192</lpage><pub-id pub-id-type=""doi"">10.1196/annals.1356.011</pub-id><pub-id pub-id-type=""pmid"">16399894</pub-id></mixed-citation></ref><ref id=""B73""><mixed-citation publication-type=""journal""><name><surname>Battaini</surname><given-names>F</given-names></name><name><surname>Pascale</surname><given-names>A</given-names></name><name><surname>Lucchi</surname><given-names>L</given-names></name><name><surname>Pasinetti</surname><given-names>GM</given-names></name><name><surname>Govoni</surname><given-names>S</given-names></name><article-title>Protein kinase C anchoring deficit in postmortem brains of Alzheimer's disease patients</article-title><source>Exp Neurol</source><year>1999</year><volume>159</volume><fpage>559</fpage><lpage>564</lpage><pub-id pub-id-type=""doi"">10.1006/exnr.1999.7151</pub-id><pub-id pub-id-type=""pmid"">10506528</pub-id></mixed-citation></ref><ref id=""B74""><mixed-citation publication-type=""journal""><name><surname>Peyrl</surname><given-names>A</given-names></name><name><surname>Weitzdoerfer</surname><given-names>R</given-names></name><name><surname>Gulesserian</surname><given-names>T</given-names></name><name><surname>Fountoulakis</surname><given-names>M</given-names></name><name><surname>Lubec</surname><given-names>G</given-names></name><article-title>Aberrant expression of signaling-related proteins 14-3-3 gamma and RACK1 in fetal Down syndrome brain (trisomy 21)</article-title><source>Electrophoresis</source><year>2002</year><volume>23</volume><fpage>152</fpage><lpage>157</lpage><pub-id pub-id-type=""doi"">10.1002/1522-2683(200201)23:1&lt;152::AID-ELPS152&gt;3.0.CO;2-T</pub-id><pub-id pub-id-type=""pmid"">11824616</pub-id></mixed-citation></ref><ref id=""B75""><mixed-citation publication-type=""journal""><name><surname>Chang</surname><given-names>BY</given-names></name><name><surname>Conroy</surname><given-names>KB</given-names></name><name><surname>Machleder</surname><given-names>EM</given-names></name><name><surname>Cartwright</surname><given-names>CA</given-names></name><article-title>RACK1, a receptor for activated C kinase and a homolog of the beta subunit of G proteins, inhibits activity of src tyrosine kinases and growth of NIH 3T3 cells</article-title><source>Mol Cell Biol</source><year>1998</year><volume>18</volume><fpage>3245</fpage><lpage>3256</lpage><pub-id pub-id-type=""pmid"">9584165</pub-id></mixed-citation></ref><ref id=""B76""><mixed-citation publication-type=""journal""><name><surname>Hermanto</surname><given-names>U</given-names></name><name><surname>Zong</surname><given-names>CS</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>LH</given-names></name><article-title>RACK1, an insulin-like growth factor I (IGF-I) receptor-interacting protein, modulates IGF-I-dependent integrin signaling and promotes cell spreading and contact with extracellular matrix</article-title><source>Mol Cell Biol</source><year>2002</year><volume>22</volume><fpage>2345</fpage><lpage>2365</lpage><pub-id pub-id-type=""doi"">10.1128/MCB.22.7.2345-2365.2002</pub-id><pub-id pub-id-type=""pmid"">11884618</pub-id></mixed-citation></ref><ref id=""B77""><mixed-citation publication-type=""journal""><name><surname>Kiely</surname><given-names>PA</given-names></name><name><surname>Sant</surname><given-names>A</given-names></name><name><surname>O'Connor</surname><given-names>R</given-names></name><article-title>RACK1 is an insulin-like growth factor 1 (IGF-1) receptor-interacting protein that can regulate IGF-1-mediated Akt activation and protection from cell death</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>22581</fpage><lpage>22589</lpage><pub-id pub-id-type=""doi"">10.1074/jbc.M201758200</pub-id><pub-id pub-id-type=""pmid"">11964397</pub-id></mixed-citation></ref><ref id=""B78""><mixed-citation publication-type=""journal""><name><surname>Stirnimann</surname><given-names>CU</given-names></name><name><surname>Petsalaki</surname><given-names>E</given-names></name><name><surname>Russell</surname><given-names>RB</given-names></name><name><surname>Muller</surname><given-names>CW</given-names></name><article-title>WD40 proteins propel cellular networks</article-title><source>Trends Biochem Sci</source><year>2010</year><volume>35</volume><fpage>565</fpage><lpage>574</lpage><pub-id pub-id-type=""doi"">10.1016/j.tibs.2010.04.003</pub-id><pub-id pub-id-type=""pmid"">20451393</pub-id></mixed-citation></ref><ref id=""B79""><mixed-citation publication-type=""journal""><name><surname>Coyle</surname><given-names>SM</given-names></name><name><surname>Gilbert</surname><given-names>WV</given-names></name><name><surname>Doudna</surname><given-names>JA</given-names></name><article-title>Direct link between RACK1 function and localization at the ribosome in vivo</article-title><source>Mol Cell Biol</source><year>2009</year><volume>29</volume><fpage>1626</fpage><lpage>1634</lpage><pub-id pub-id-type=""doi"">10.1128/MCB.01718-08</pub-id><pub-id pub-id-type=""pmid"">19114558</pub-id></mixed-citation></ref><ref id=""B80""><mixed-citation publication-type=""journal""><name><surname>Rabl</surname><given-names>J</given-names></name><name><surname>Leibundgut</surname><given-names>M</given-names></name><name><surname>Ataide</surname><given-names>SF</given-names></name><name><surname>Haag</surname><given-names>A</given-names></name><name><surname>Ban</surname><given-names>N</given-names></name><article-title>Crystal structure of the eukaryotic 40S ribosomal subunit in complex with initiation factor 1</article-title><source>Science</source><year>2011</year><volume>331</volume><fpage>730</fpage><lpage>736</lpage><pub-id pub-id-type=""doi"">10.1126/science.1198308</pub-id><pub-id pub-id-type=""pmid"">21205638</pub-id></mixed-citation></ref><ref id=""B81""><mixed-citation publication-type=""journal""><name><surname>Ullah</surname><given-names>H</given-names></name><name><surname>Scappini</surname><given-names>EL</given-names></name><name><surname>Moon</surname><given-names>AF</given-names></name><name><surname>Williams</surname><given-names>LV</given-names></name><name><surname>Armstrong</surname><given-names>DL</given-names></name><name><surname>Pedersen</surname><given-names>LC</given-names></name><article-title>Structure of a signal transduction regulator, RACK1, from Arabidopsis thaliana</article-title><source>Protein Sci</source><year>2008</year><volume>17</volume><fpage>1771</fpage><lpage>1780</lpage><pub-id pub-id-type=""doi"">10.1110/ps.035121.108</pub-id><pub-id pub-id-type=""pmid"">18715992</pub-id></mixed-citation></ref><ref id=""B82""><mixed-citation publication-type=""journal""><name><surname>Yatime</surname><given-names>L</given-names></name><name><surname>Hein</surname><given-names>KL</given-names></name><name><surname>Nilsson</surname><given-names>J</given-names></name><name><surname>Nissen</surname><given-names>P</given-names></name><article-title>Structure of the RACK1 Dimer from Saccharomyces cerevisiae</article-title><source>J Mol Biol</source><year>2011</year><volume>411</volume><fpage>486</fpage><lpage>498</lpage><pub-id pub-id-type=""doi"">10.1016/j.jmb.2011.06.017</pub-id><pub-id pub-id-type=""pmid"">21704636</pub-id></mixed-citation></ref><ref id=""B83""><mixed-citation publication-type=""journal""><name><surname>Ben-Shem</surname><given-names>A</given-names></name><name><surname>Jenner</surname><given-names>L</given-names></name><name><surname>Yusupova</surname><given-names>G</given-names></name><name><surname>Yusupov</surname><given-names>M</given-names></name><article-title>Crystal structure of the eukaryotic ribosome</article-title><source>Science</source><year>2010</year><volume>330</volume><fpage>1203</fpage><lpage>1209</lpage><pub-id pub-id-type=""doi"">10.1126/science.1194294</pub-id><pub-id pub-id-type=""pmid"">21109664</pub-id></mixed-citation></ref><ref id=""B84""><mixed-citation publication-type=""journal""><name><surname>Sengupta</surname><given-names>J</given-names></name><name><surname>Nilsson</surname><given-names>J</given-names></name><name><surname>Gursky</surname><given-names>R</given-names></name><name><surname>Spahn</surname><given-names>CM</given-names></name><name><surname>Nissen</surname><given-names>P</given-names></name><name><surname>Frank</surname><given-names>J</given-names></name><article-title>Identification of the versatile scaffold protein RACK1 on the eukaryotic ribosome by cryo-EM</article-title><source>Nat Struct Mol Biol</source><year>2004</year><volume>11</volume><fpage>957</fpage><lpage>962</lpage><pub-id pub-id-type=""doi"">10.1038/nsmb822</pub-id><pub-id pub-id-type=""pmid"">15334071</pub-id></mixed-citation></ref><ref id=""B85""><mixed-citation publication-type=""journal""><name><surname>Chandramouli</surname><given-names>P</given-names></name><name><surname>Topf</surname><given-names>M</given-names></name><name><surname>Menetret</surname><given-names>JF</given-names></name><name><surname>Eswar</surname><given-names>N</given-names></name><name><surname>Cannone</surname><given-names>JJ</given-names></name><name><surname>Gutell</surname><given-names>RR</given-names></name><name><surname>Sali</surname><given-names>A</given-names></name><name><surname>Akey</surname><given-names>CW</given-names></name><article-title>Structure of the mammalian 80S ribosome at 8.7 A resolution</article-title><source>Structure</source><year>2008</year><volume>16</volume><fpage>535</fpage><lpage>548</lpage><pub-id pub-id-type=""doi"">10.1016/j.str.2008.01.007</pub-id><pub-id pub-id-type=""pmid"">18400176</pub-id></mixed-citation></ref><ref id=""B86""><mixed-citation publication-type=""journal""><name><surname>Angenstein</surname><given-names>F</given-names></name><name><surname>Evans</surname><given-names>AM</given-names></name><name><surname>Settlage</surname><given-names>RE</given-names></name><name><surname>Moran</surname><given-names>ST</given-names></name><name><surname>Ling</surname><given-names>SC</given-names></name><name><surname>Klintsova</surname><given-names>AY</given-names></name><name><surname>Shabanowitz</surname><given-names>J</given-names></name><name><surname>Hunt</surname><given-names>DF</given-names></name><name><surname>Greenough</surname><given-names>WT</given-names></name><article-title>A receptor for activated C kinase is part of messenger ribonucleoprotein complexes associated with polyA-mRNAs in neurons</article-title><source>J Neurosci</source><year>2002</year><volume>22</volume><fpage>8827</fpage><lpage>8837</lpage><pub-id pub-id-type=""pmid"">12388589</pub-id></mixed-citation></ref><ref id=""B87""><mixed-citation publication-type=""journal""><name><surname>Becker</surname><given-names>T</given-names></name><name><surname>Bhushan</surname><given-names>S</given-names></name><name><surname>Jarasch</surname><given-names>A</given-names></name><name><surname>Armache</surname><given-names>JP</given-names></name><name><surname>Funes</surname><given-names>S</given-names></name><name><surname>Jossinet</surname><given-names>F</given-names></name><name><surname>Gumbart</surname><given-names>J</given-names></name><name><surname>Mielke</surname><given-names>T</given-names></name><name><surname>Berninghausen</surname><given-names>O</given-names></name><name><surname>Schulten</surname><given-names>K</given-names></name><etal></etal><article-title>Structure of monomeric yeast and mammalian Sec61 complexes interacting with the translating ribosome</article-title><source>Science</source><year>2009</year><volume>326</volume><fpage>1369</fpage><lpage>1373</lpage><pub-id pub-id-type=""doi"">10.1126/science.1178535</pub-id><pub-id pub-id-type=""pmid"">19933108</pub-id></mixed-citation></ref><ref id=""B88""><mixed-citation publication-type=""journal""><name><surname>Taylor</surname><given-names>DJ</given-names></name><name><surname>Devkota</surname><given-names>B</given-names></name><name><surname>Huang</surname><given-names>AD</given-names></name><name><surname>Topf</surname><given-names>M</given-names></name><name><surname>Narayanan</surname><given-names>E</given-names></name><name><surname>Sali</surname><given-names>A</given-names></name><name><surname>Harvey</surname><given-names>SC</given-names></name><name><surname>Frank</surname><given-names>J</given-names></name><article-title>Comprehensive molecular structure of the eukaryotic ribosome</article-title><source>Structure</source><year>2009</year><volume>17</volume><fpage>1591</fpage><lpage>1604</lpage><pub-id pub-id-type=""doi"">10.1016/j.str.2009.09.015</pub-id><pub-id pub-id-type=""pmid"">20004163</pub-id></mixed-citation></ref><ref id=""B89""><mixed-citation publication-type=""journal""><name><surname>Armache</surname><given-names>JP</given-names></name><name><surname>Jarasch</surname><given-names>A</given-names></name><name><surname>Anger</surname><given-names>AM</given-names></name><name><surname>Villa</surname><given-names>E</given-names></name><name><surname>Becker</surname><given-names>T</given-names></name><name><surname>Bhushan</surname><given-names>S</given-names></name><name><surname>Jossinet</surname><given-names>F</given-names></name><name><surname>Habeck</surname><given-names>M</given-names></name><name><surname>Dindar</surname><given-names>G</given-names></name><name><surname>Franckenberg</surname><given-names>S</given-names></name><etal></etal><article-title>Localization of eukaryote-specific ribosomal proteins in a 5.5-A cryo-EM map of the 80S eukaryotic ribosome</article-title><source>Proc Natl Acad Sci USA</source><year>2010</year><volume>107</volume><fpage>19754</fpage><lpage>19759</lpage><pub-id pub-id-type=""doi"">10.1073/pnas.1010005107</pub-id><pub-id pub-id-type=""pmid"">20974910</pub-id></mixed-citation></ref><ref id=""B90""><mixed-citation publication-type=""journal""><name><surname>Armache</surname><given-names>JP</given-names></name><name><surname>Jarasch</surname><given-names>A</given-names></name><name><surname>Anger</surname><given-names>AM</given-names></name><name><surname>Villa</surname><given-names>E</given-names></name><name><surname>Becker</surname><given-names>T</given-names></name><name><surname>Bhushan</surname><given-names>S</given-names></name><name><surname>Jossinet</surname><given-names>F</given-names></name><name><surname>Habeck</surname><given-names>M</given-names></name><name><surname>Dindar</surname><given-names>G</given-names></name><name><surname>Franckenberg</surname><given-names>S</given-names></name><etal></etal><article-title>Cryo-EM structure and rRNA model of a translating eukaryotic 80S ribosome at 5.5-A resolution</article-title><source>Proc Natl Acad Sci USA</source><year>2010</year><volume>107</volume><fpage>19748</fpage><lpage>19753</lpage><pub-id pub-id-type=""doi"">10.1073/pnas.1009999107</pub-id><pub-id pub-id-type=""pmid"">20980660</pub-id></mixed-citation></ref><ref id=""B91""><mixed-citation publication-type=""journal""><name><surname>Ceci</surname><given-names>M</given-names></name><name><surname>Gaviraghi</surname><given-names>C</given-names></name><name><surname>Gorrini</surname><given-names>C</given-names></name><name><surname>Sala</surname><given-names>LA</given-names></name><name><surname>Offenhauser</surname><given-names>N</given-names></name><name><surname>Marchisio</surname><given-names>PC</given-names></name><name><surname>Biffo</surname><given-names>S</given-names></name><article-title>Release of eIF6 (p27BBP) from the 60S subunit allows 80S ribosome assembly</article-title><source>Nature</source><year>2003</year><volume>426</volume><fpage>579</fpage><lpage>584</lpage><pub-id pub-id-type=""doi"">10.1038/nature02160</pub-id><pub-id pub-id-type=""pmid"">14654845</pub-id></mixed-citation></ref><ref id=""B92""><mixed-citation publication-type=""journal""><name><surname>Grosso</surname><given-names>S</given-names></name><name><surname>Volta</surname><given-names>V</given-names></name><name><surname>Sala</surname><given-names>LA</given-names></name><name><surname>Vietri</surname><given-names>M</given-names></name><name><surname>Marchisio</surname><given-names>PC</given-names></name><name><surname>Ron</surname><given-names>D</given-names></name><name><surname>Biffo</surname><given-names>S</given-names></name><article-title>PKCbetaII modulates translation independently from mTOR and through RACK1</article-title><source>Biochem J</source><year>2008</year><volume>415</volume><fpage>77</fpage><lpage>85</lpage><pub-id pub-id-type=""doi"">10.1042/BJ20080463</pub-id><pub-id pub-id-type=""pmid"">18557705</pub-id></mixed-citation></ref><ref id=""B93""><mixed-citation publication-type=""journal""><name><surname>Grosso</surname><given-names>S</given-names></name><name><surname>Volta</surname><given-names>V</given-names></name><name><surname>Vietri</surname><given-names>M</given-names></name><name><surname>Gorrini</surname><given-names>C</given-names></name><name><surname>Marchisio</surname><given-names>PC</given-names></name><name><surname>Biffo</surname><given-names>S</given-names></name><article-title>Eukaryotic ribosomes host PKC activity</article-title><source>Biochem Biophys Res Commun</source><year>2008</year><volume>376</volume><fpage>65</fpage><lpage>69</lpage><pub-id pub-id-type=""doi"">10.1016/j.bbrc.2008.08.118</pub-id><pub-id pub-id-type=""pmid"">18768137</pub-id></mixed-citation></ref><ref id=""B94""><mixed-citation publication-type=""journal""><name><surname>Banci</surname><given-names>L</given-names></name><name><surname>Cavallaro</surname><given-names>G</given-names></name><name><surname>Kheifets</surname><given-names>V</given-names></name><name><surname>Mochly-Rosen</surname><given-names>D</given-names></name><article-title>Molecular dynamics characterization of the C2 domain of protein kinase Cbeta</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>12988</fpage><lpage>12997</lpage><pub-id pub-id-type=""doi"">10.1074/jbc.M106875200</pub-id><pub-id pub-id-type=""pmid"">11782454</pub-id></mixed-citation></ref><ref id=""B95""><mixed-citation publication-type=""journal""><name><surname>Ron</surname><given-names>D</given-names></name><name><surname>Mochly-Rosen</surname><given-names>D</given-names></name><article-title>Agonists and antagonists of protein kinase C function, derived from its binding proteins</article-title><source>J Biol Chem</source><year>1994</year><volume>269</volume><fpage>21395</fpage><lpage>21398</lpage><pub-id pub-id-type=""pmid"">8063768</pub-id></mixed-citation></ref><ref id=""B96""><mixed-citation publication-type=""journal""><name><surname>Brandon</surname><given-names>NJ</given-names></name><name><surname>Jovanovic</surname><given-names>JN</given-names></name><name><surname>Smart</surname><given-names>TG</given-names></name><name><surname>Moss</surname><given-names>SJ</given-names></name><article-title>Receptor for activated C kinase-1 facilitates protein kinase C-dependent phosphorylation and functional modulation of GABA(A) receptors with the activation of G-protein-coupled receptors</article-title><source>J Neurosci</source><year>2002</year><volume>22</volume><fpage>6353</fpage><lpage>6361</lpage><pub-id pub-id-type=""pmid"">12151513</pub-id></mixed-citation></ref><ref id=""B97""><mixed-citation publication-type=""journal""><name><surname>Schechtman</surname><given-names>D</given-names></name><name><surname>Mochly-Rosen</surname><given-names>D</given-names></name><article-title>Adaptor proteins in protein kinase C-mediated signal transduction</article-title><source>Oncogene</source><year>2001</year><volume>20</volume><fpage>6339</fpage><lpage>6347</lpage><pub-id pub-id-type=""doi"">10.1038/sj.onc.1204778</pub-id><pub-id pub-id-type=""pmid"">11607837</pub-id></mixed-citation></ref><ref id=""B98""><mixed-citation publication-type=""journal""><name><surname>Haberman</surname><given-names>Y</given-names></name><name><surname>Alon</surname><given-names>LT</given-names></name><name><surname>Eliyahu</surname><given-names>E</given-names></name><name><surname>Shalgi</surname><given-names>R</given-names></name><article-title>Receptor for activated C kinase (RACK) and protein kinase C (PKC) in egg activation</article-title><source>Theriogenology</source><year>2011</year><volume>75</volume><fpage>80</fpage><lpage>89</lpage><pub-id pub-id-type=""doi"">10.1016/j.theriogenology.2010.07.013</pub-id><pub-id pub-id-type=""pmid"">20843544</pub-id></mixed-citation></ref><ref id=""B99""><mixed-citation publication-type=""journal""><name><surname>Pass</surname><given-names>JM</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name><name><surname>Jones</surname><given-names>WK</given-names></name><name><surname>Wead</surname><given-names>WB</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Baines</surname><given-names>CP</given-names></name><name><surname>Bolli</surname><given-names>R</given-names></name><name><surname>Zheng</surname><given-names>YT</given-names></name><name><surname>Joshua</surname><given-names>IG</given-names></name><name><surname>Ping</surname><given-names>P</given-names></name><article-title>Enhanced PKC beta II translocation and PKC beta II-RACK1 interactions in PKC epsilon-induced heart failure: a role for RACK1</article-title><source>Am J Physiol Heart Circ Physiol</source><year>2001</year><volume>281</volume><fpage>H2500</fpage><lpage>2510</lpage><pub-id pub-id-type=""pmid"">11709417</pub-id></mixed-citation></ref><ref id=""B100""><mixed-citation publication-type=""journal""><name><surname>Pass</surname><given-names>JM</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Wead</surname><given-names>WB</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>RC</given-names></name><name><surname>Bolli</surname><given-names>R</given-names></name><name><surname>Ping</surname><given-names>P</given-names></name><article-title>PKCepsilon activation induces dichotomous cardiac phenotypes and modulates PKCepsilon-RACK interactions and RACK expression</article-title><source>Am J Physiol Heart Circ Physiol</source><year>2001</year><volume>280</volume><fpage>H946</fpage><lpage>955</lpage><pub-id pub-id-type=""pmid"">11179034</pub-id></mixed-citation></ref><ref id=""B101""><mixed-citation publication-type=""journal""><name><surname>Lopez-Bergami</surname><given-names>P</given-names></name><name><surname>Habelhah</surname><given-names>H</given-names></name><name><surname>Bhoumik</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>LH</given-names></name><name><surname>Ronai</surname><given-names>Z</given-names></name><article-title>RACK1 mediates activation of JNK by protein kinase C [corrected]</article-title><source>Mol Cell</source><year>2005</year><volume>19</volume><fpage>309</fpage><lpage>320</lpage><pub-id pub-id-type=""doi"">10.1016/j.molcel.2005.06.025</pub-id><pub-id pub-id-type=""pmid"">16061178</pub-id></mixed-citation></ref><ref id=""B102""><mixed-citation publication-type=""journal""><name><surname>Massip</surname><given-names>L</given-names></name><name><surname>Garand</surname><given-names>C</given-names></name><name><surname>Labbe</surname><given-names>A</given-names></name><name><surname>Perreault</surname><given-names>E</given-names></name><name><surname>Turaga</surname><given-names>RV</given-names></name><name><surname>Bohr</surname><given-names>VA</given-names></name><name><surname>Lebel</surname><given-names>M</given-names></name><article-title>Depletion of WRN protein causes RACK1 to activate several protein kinase C isoforms</article-title><source>Oncogene</source><year>2010</year><volume>29</volume><fpage>1486</fpage><lpage>1497</lpage><pub-id pub-id-type=""doi"">10.1038/onc.2009.443</pub-id><pub-id pub-id-type=""pmid"">19966859</pub-id></mixed-citation></ref><ref id=""B103""><mixed-citation publication-type=""journal""><name><surname>Robles</surname><given-names>MS</given-names></name><name><surname>Boyault</surname><given-names>C</given-names></name><name><surname>Knutti</surname><given-names>D</given-names></name><name><surname>Padmanabhan</surname><given-names>K</given-names></name><name><surname>Weitz</surname><given-names>CJ</given-names></name><article-title>Identification of RACK1 and protein kinase Calpha as integral components of the mammalian circadian clock</article-title><source>Science</source><year>2010</year><volume>327</volume><fpage>463</fpage><lpage>466</lpage><pub-id pub-id-type=""doi"">10.1126/science.1180067</pub-id><pub-id pub-id-type=""pmid"">20093473</pub-id></mixed-citation></ref><ref id=""B104""><mixed-citation publication-type=""journal""><name><surname>Dehghani</surname><given-names>H</given-names></name><name><surname>Hahnel</surname><given-names>AC</given-names></name><article-title>Expression profile of protein kinase C isozymes in preimplantation mouse development</article-title><source>Reproduction</source><year>2005</year><volume>130</volume><fpage>441</fpage><lpage>451</lpage><pub-id pub-id-type=""doi"">10.1530/rep.1.00571</pub-id><pub-id pub-id-type=""pmid"">16183862</pub-id></mixed-citation></ref><ref id=""B105""><mixed-citation publication-type=""journal""><name><surname>Bird</surname><given-names>RJ</given-names></name><name><surname>Baillie</surname><given-names>GS</given-names></name><name><surname>Yarwood</surname><given-names>SJ</given-names></name><article-title>Interaction with receptor for activated C-kinase 1 (RACK1) sensitizes the phosphodiesterase PDE4D5 towards hydrolysis of cAMP and activation by protein kinase C</article-title><source>Biochem J</source><year>2010</year><volume>432</volume><fpage>207</fpage><lpage>216</lpage><pub-id pub-id-type=""doi"">10.1042/BJ20101010</pub-id><pub-id pub-id-type=""pmid"">20819076</pub-id></mixed-citation></ref><ref id=""B106""><mixed-citation publication-type=""journal""><name><surname>He</surname><given-names>DY</given-names></name><name><surname>Neasta</surname><given-names>J</given-names></name><name><surname>Ron</surname><given-names>D</given-names></name><article-title>Epigenetic regulation of BDNF expression via the scaffolding protein RACK1</article-title><source>J Biol Chem</source><year>2010</year><volume>285</volume><fpage>19043</fpage><lpage>19050</lpage><pub-id pub-id-type=""doi"">10.1074/jbc.M110.100693</pub-id><pub-id pub-id-type=""pmid"">20410295</pub-id></mixed-citation></ref><ref id=""B107""><mixed-citation publication-type=""journal""><name><surname>Yarwood</surname><given-names>SJ</given-names></name><name><surname>Steele</surname><given-names>MR</given-names></name><name><surname>Scotland</surname><given-names>G</given-names></name><name><surname>Houslay</surname><given-names>MD</given-names></name><name><surname>Bolger</surname><given-names>GB</given-names></name><article-title>The RACK1 signaling scaffold protein selectively interacts with the cAMP-specific phosphodiesterase PDE4D5 isoform</article-title><source>J Biol Chem</source><year>1999</year><volume>274</volume><fpage>14909</fpage><lpage>14917</lpage><pub-id pub-id-type=""doi"">10.1074/jbc.274.21.14909</pub-id><pub-id pub-id-type=""pmid"">10329691</pub-id></mixed-citation></ref><ref id=""B108""><mixed-citation publication-type=""journal""><name><surname>Houslay</surname><given-names>MD</given-names></name><name><surname>Adams</surname><given-names>DR</given-names></name><article-title>PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization</article-title><source>Biochem J</source><year>2003</year><volume>370</volume><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type=""doi"">10.1042/BJ20021698</pub-id><pub-id pub-id-type=""pmid"">12444918</pub-id></mixed-citation></ref><ref id=""B109""><mixed-citation publication-type=""journal""><name><surname>Bolger</surname><given-names>GB</given-names></name><name><surname>Baillie</surname><given-names>GS</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Lynch</surname><given-names>MJ</given-names></name><name><surname>Herzyk</surname><given-names>P</given-names></name><name><surname>Mohamed</surname><given-names>A</given-names></name><name><surname>Mitchell</surname><given-names>LH</given-names></name><name><surname>McCahill</surname><given-names>A</given-names></name><name><surname>Hundsrucker</surname><given-names>C</given-names></name><name><surname>Klussmann</surname><given-names>E</given-names></name><etal></etal><article-title>Scanning peptide array analyses identify overlapping binding sites for the signalling scaffold proteins, beta-arrestin and RACK1, in cAMP-specific phosphodiesterase PDE4D5</article-title><source>Biochem J</source><year>2006</year><volume>398</volume><fpage>23</fpage><lpage>36</lpage><pub-id pub-id-type=""doi"">10.1042/BJ20060423</pub-id><pub-id pub-id-type=""pmid"">16689683</pub-id></mixed-citation></ref><ref id=""B110""><mixed-citation publication-type=""journal""><name><surname>Bolger</surname><given-names>GB</given-names></name><name><surname>McCahill</surname><given-names>A</given-names></name><name><surname>Yarwood</surname><given-names>SJ</given-names></name><name><surname>Steele</surname><given-names>MR</given-names></name><name><surname>Warwicker</surname><given-names>J</given-names></name><name><surname>Houslay</surname><given-names>MD</given-names></name><article-title>Delineation of RAID1, the RACK1 interaction domain located within the unique N-terminal region of the cAMP-specific phosphodiesterase, PDE4D5</article-title><source>BMC Biochem</source><year>2002</year><volume>3</volume><fpage>24</fpage><pub-id pub-id-type=""doi"">10.1186/1471-2091-3-24</pub-id><pub-id pub-id-type=""pmid"">12193273</pub-id></mixed-citation></ref><ref id=""B111""><mixed-citation publication-type=""journal""><name><surname>Serrels</surname><given-names>B</given-names></name><name><surname>Sandilands</surname><given-names>E</given-names></name><name><surname>Frame</surname><given-names>MC</given-names></name><article-title>Signaling of the direction-sensing FAK/RACK1/PDE4D5 complex to the small GTPase Rap1</article-title><source>Small Gtpases</source><year>2011</year><volume>2</volume><fpage>54</fpage><lpage>61</lpage><pub-id pub-id-type=""doi"">10.4161/sgtp.2.1.15137</pub-id><pub-id pub-id-type=""pmid"">21686284</pub-id></mixed-citation></ref><ref id=""B112""><mixed-citation publication-type=""journal""><name><surname>Serrels</surname><given-names>B</given-names></name><name><surname>Sandilands</surname><given-names>E</given-names></name><name><surname>Serrels</surname><given-names>A</given-names></name><name><surname>Baillie</surname><given-names>G</given-names></name><name><surname>Houslay</surname><given-names>MD</given-names></name><name><surname>Brunton</surname><given-names>VG</given-names></name><name><surname>Canel</surname><given-names>M</given-names></name><name><surname>Machesky</surname><given-names>LM</given-names></name><name><surname>Anderson</surname><given-names>KI</given-names></name><name><surname>Frame</surname><given-names>MC</given-names></name><article-title>A complex between FAK, RACK1, and PDE4D5 controls spreading initiation and cancer cell polarity</article-title><source>Curr Biol</source><year>2010</year><volume>20</volume><fpage>1086</fpage><lpage>1092</lpage><pub-id pub-id-type=""doi"">10.1016/j.cub.2010.04.042</pub-id><pub-id pub-id-type=""pmid"">20493699</pub-id></mixed-citation></ref><ref id=""B113""><mixed-citation publication-type=""journal""><name><surname>Kiely</surname><given-names>PA</given-names></name><name><surname>Leahy</surname><given-names>M</given-names></name><name><surname>O'Gorman</surname><given-names>D</given-names></name><name><surname>O'Connor</surname><given-names>R</given-names></name><article-title>RACK1-mediated integration of adhesion and insulin-like growth factor I (IGF-I) signaling and cell migration are defective in cells expressing an IGF-I receptor mutated at tyrosines 1250 and 1251</article-title><source>J Biol Chem</source><year>2005</year><volume>280</volume><fpage>7624</fpage><lpage>7633</lpage><pub-id pub-id-type=""pmid"">15611085</pub-id></mixed-citation></ref><ref id=""B114""><mixed-citation publication-type=""journal""><name><surname>Mamidipudi</surname><given-names>V</given-names></name><name><surname>Dhillon</surname><given-names>NK</given-names></name><name><surname>Parman</surname><given-names>T</given-names></name><name><surname>Miller</surname><given-names>LD</given-names></name><name><surname>Lee</surname><given-names>KC</given-names></name><name><surname>Cartwright</surname><given-names>CA</given-names></name><article-title>RACK1 inhibits colonic cell growth by regulating Src activity at cell cycle checkpoints</article-title><source>Oncogene</source><year>2007</year><volume>26</volume><fpage>2914</fpage><lpage>2924</lpage><pub-id pub-id-type=""doi"">10.1038/sj.onc.1210091</pub-id><pub-id pub-id-type=""pmid"">17072338</pub-id></mixed-citation></ref><ref id=""B115""><mixed-citation publication-type=""other""><name><surname>Swaminathan</surname><given-names>G</given-names></name><name><surname>Cartwright</surname><given-names>CA</given-names></name><article-title>Rack1 promotes epithelial cell-cell adhesion by regulating E-cadherin endocytosis</article-title><source>Oncogene</source><year>2011</year><comment>in press</comment></mixed-citation></ref><ref id=""B116""><mixed-citation publication-type=""journal""><name><surname>Geijsen</surname><given-names>N</given-names></name><name><surname>Spaargaren</surname><given-names>M</given-names></name><name><surname>Raaijmakers</surname><given-names>JA</given-names></name><name><surname>Lammers</surname><given-names>JW</given-names></name><name><surname>Koenderman</surname><given-names>L</given-names></name><name><surname>Coffer</surname><given-names>PJ</given-names></name><article-title>Association of RACK1 and PKCbeta with the common beta-chain of the IL-5/IL-3/GM-CSF receptor</article-title><source>Oncogene</source><year>1999</year><volume>18</volume><fpage>5126</fpage><lpage>5130</lpage><pub-id pub-id-type=""doi"">10.1038/sj.onc.1202896</pub-id><pub-id pub-id-type=""pmid"">10490850</pub-id></mixed-citation></ref><ref id=""B117""><mixed-citation publication-type=""journal""><name><surname>Usacheva</surname><given-names>A</given-names></name><name><surname>Smith</surname><given-names>R</given-names></name><name><surname>Minshall</surname><given-names>R</given-names></name><name><surname>Baida</surname><given-names>G</given-names></name><name><surname>Seng</surname><given-names>S</given-names></name><name><surname>Croze</surname><given-names>E</given-names></name><name><surname>Colamonici</surname><given-names>O</given-names></name><article-title>The WD motif-containing protein receptor for activated protein kinase C (RACK1) is required for recruitment and activation of signal transducer and activator of transcription 1 through the type I interferon receptor</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>22948</fpage><lpage>22953</lpage><pub-id pub-id-type=""doi"">10.1074/jbc.M100087200</pub-id><pub-id pub-id-type=""pmid"">11301323</pub-id></mixed-citation></ref><ref id=""B118""><mixed-citation publication-type=""journal""><name><surname>Patterson</surname><given-names>RL</given-names></name><name><surname>van Rossum</surname><given-names>DB</given-names></name><name><surname>Barrow</surname><given-names>RK</given-names></name><name><surname>Snyder</surname><given-names>SH</given-names></name><article-title>RACK1 binds to inositol 1,4,5-trisphosphate receptors and mediates Ca2+ release</article-title><source>Proc Natl Acad Sci USA</source><year>2004</year><volume>101</volume><fpage>2328</fpage><lpage>2332</lpage><pub-id pub-id-type=""doi"">10.1073/pnas.0308567100</pub-id><pub-id pub-id-type=""pmid"">14983009</pub-id></mixed-citation></ref><ref id=""B119""><mixed-citation publication-type=""journal""><name><surname>Reiner</surname><given-names>CL</given-names></name><name><surname>McCullar</surname><given-names>JS</given-names></name><name><surname>Kow</surname><given-names>RL</given-names></name><name><surname>Le</surname><given-names>JH</given-names></name><name><surname>Goodlett</surname><given-names>DR</given-names></name><name><surname>Nathanson</surname><given-names>NM</given-names></name><article-title>RACK1 associates with muscarinic receptors and regulates M(2) receptor trafficking</article-title><source>PLoS One</source><year>2010</year><volume>5</volume><fpage>e13517</fpage><pub-id pub-id-type=""doi"">10.1371/journal.pone.0013517</pub-id><pub-id pub-id-type=""pmid"">20976005</pub-id></mixed-citation></ref><ref id=""B120""><mixed-citation publication-type=""journal""><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>N</given-names></name><name><surname>Ling</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><article-title>Receptor for activated C-kinase 1, a novel binding partner of adiponectin receptor 1</article-title><source>Biochem Biophys Res Commun</source><year>2009</year><volume>378</volume><fpage>95</fpage><lpage>98</lpage><pub-id pub-id-type=""doi"">10.1016/j.bbrc.2008.11.026</pub-id><pub-id pub-id-type=""pmid"">19010305</pub-id></mixed-citation></ref><ref id=""B121""><mixed-citation publication-type=""journal""><name><surname>Rigas</surname><given-names>AC</given-names></name><name><surname>Ozanne</surname><given-names>DM</given-names></name><name><surname>Neal</surname><given-names>DE</given-names></name><name><surname>Robson</surname><given-names>CN</given-names></name><article-title>The scaffolding protein RACK1 interacts with androgen receptor and promotes cross-talk through a protein kinase C signaling pathway</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>46087</fpage><lpage>46093</lpage><pub-id pub-id-type=""doi"">10.1074/jbc.M306219200</pub-id><pub-id pub-id-type=""pmid"">12958311</pub-id></mixed-citation></ref><ref id=""B122""><mixed-citation publication-type=""journal""><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Zong</surname><given-names>CS</given-names></name><name><surname>Hermanto</surname><given-names>U</given-names></name><name><surname>Lopez-Bergami</surname><given-names>P</given-names></name><name><surname>Ronai</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>LH</given-names></name><article-title>RACK1 recruits STAT3 specifically to insulin and insulin-like growth factor 1 receptors for activation, which is important for regulating anchorage-independent growth</article-title><source>Mol Cell Biol</source><year>2006</year><volume>26</volume><fpage>413</fpage><lpage>424</lpage><pub-id pub-id-type=""doi"">10.1128/MCB.26.2.413-424.2006</pub-id><pub-id pub-id-type=""pmid"">16382134</pub-id></mixed-citation></ref><ref id=""B123""><mixed-citation publication-type=""journal""><name><surname>Liliental</surname><given-names>J</given-names></name><name><surname>Chang</surname><given-names>DD</given-names></name><article-title>Rack1, a receptor for activated protein kinase C, interacts with integrin beta subunit</article-title><source>J Biol Chem</source><year>1998</year><volume>273</volume><fpage>2379</fpage><lpage>2383</lpage><pub-id pub-id-type=""doi"">10.1074/jbc.273.4.2379</pub-id><pub-id pub-id-type=""pmid"">9442085</pub-id></mixed-citation></ref><ref id=""B124""><mixed-citation publication-type=""journal""><name><surname>Kiely</surname><given-names>PA</given-names></name><name><surname>Baillie</surname><given-names>GS</given-names></name><name><surname>Barrett</surname><given-names>R</given-names></name><name><surname>Buckley</surname><given-names>DA</given-names></name><name><surname>Adams</surname><given-names>DR</given-names></name><name><surname>Houslay</surname><given-names>MD</given-names></name><name><surname>O'Connor</surname><given-names>R</given-names></name><article-title>Phosphorylation of RACK1 on tyrosine 52 by c-Abl is required for insulin-like growth factor I-mediated regulation of focal adhesion kinase</article-title><source>J Biol Chem</source><year>2009</year><volume>284</volume><fpage>20263</fpage><lpage>20274</lpage><pub-id pub-id-type=""doi"">10.1074/jbc.M109.017640</pub-id><pub-id pub-id-type=""pmid"">19423701</pub-id></mixed-citation></ref><ref id=""B125""><mixed-citation publication-type=""journal""><name><surname>De Toni-Costes</surname><given-names>F</given-names></name><name><surname>Despeaux</surname><given-names>M</given-names></name><name><surname>Bertrand</surname><given-names>J</given-names></name><name><surname>Bourogaa</surname><given-names>E</given-names></name><name><surname>Ysebaert</surname><given-names>L</given-names></name><name><surname>Payrastre</surname><given-names>B</given-names></name><name><surname>Racaud-Sultan</surname><given-names>C</given-names></name><article-title>A New alpha5beta1 integrin-dependent survival pathway through GSK3beta activation in leukemic cells</article-title><source>PLoS One</source><year>2010</year><volume>5</volume><fpage>e9807</fpage><pub-id pub-id-type=""doi"">10.1371/journal.pone.0009807</pub-id><pub-id pub-id-type=""pmid"">20352103</pub-id></mixed-citation></ref><ref id=""B126""><mixed-citation publication-type=""journal""><name><surname>Vomastek</surname><given-names>T</given-names></name><name><surname>Iwanicki</surname><given-names>MP</given-names></name><name><surname>Schaeffer</surname><given-names>HJ</given-names></name><name><surname>Tarcsafalvi</surname><given-names>A</given-names></name><name><surname>Parsons</surname><given-names>JT</given-names></name><name><surname>Weber</surname><given-names>MJ</given-names></name><article-title>RACK1 targets the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway to link integrin engagement with focal adhesion disassembly and cell motility</article-title><source>Mol Cell Biol</source><year>2007</year><volume>27</volume><fpage>8296</fpage><lpage>8305</lpage><pub-id pub-id-type=""doi"">10.1128/MCB.00598-07</pub-id><pub-id pub-id-type=""pmid"">17908799</pub-id></mixed-citation></ref><ref id=""B127""><mixed-citation publication-type=""journal""><name><surname>Besson</surname><given-names>A</given-names></name><name><surname>Wilson</surname><given-names>TL</given-names></name><name><surname>Yong</surname><given-names>VW</given-names></name><article-title>The anchoring protein RACK1 links protein kinase Cepsilon to integrin beta chains</article-title><source>Requirements for adhesion and motility. J Biol Chem</source><year>2002</year><volume>277</volume><fpage>22073</fpage><lpage>22084</lpage></mixed-citation></ref><ref id=""B128""><mixed-citation publication-type=""journal""><name><surname>Buensuceso</surname><given-names>CS</given-names></name><name><surname>Woodside</surname><given-names>D</given-names></name><name><surname>Huff</surname><given-names>JL</given-names></name><name><surname>Plopper</surname><given-names>GE</given-names></name><name><surname>O'Toole</surname><given-names>TE</given-names></name><article-title>The WD protein Rack1 mediates protein kinase C and integrin-dependent cell migration</article-title><source>J Cell Sci</source><year>2001</year><volume>114</volume><fpage>1691</fpage><lpage>1698</lpage><pub-id pub-id-type=""pmid"">11309199</pub-id></mixed-citation></ref><ref id=""B129""><mixed-citation publication-type=""journal""><name><surname>Lee</surname><given-names>HS</given-names></name><name><surname>Millward-Sadler</surname><given-names>SJ</given-names></name><name><surname>Wright</surname><given-names>MO</given-names></name><name><surname>Nuki</surname><given-names>G</given-names></name><name><surname>Al-Jamal</surname><given-names>R</given-names></name><name><surname>Salter</surname><given-names>DM</given-names></name><article-title>Activation of Integrin-RACK1/PKCalpha signalling in human articular chondrocyte mechanotransduction</article-title><source>Osteoarthritis Cartilage</source><year>2002</year><volume>10</volume><fpage>890</fpage><lpage>897</lpage><pub-id pub-id-type=""doi"">10.1053/joca.2002.0842</pub-id><pub-id pub-id-type=""pmid"">12435334</pub-id></mixed-citation></ref><ref id=""B130""><mixed-citation publication-type=""journal""><name><surname>Brandon</surname><given-names>NJ</given-names></name><name><surname>Uren</surname><given-names>JM</given-names></name><name><surname>Kittler</surname><given-names>JT</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Olsen</surname><given-names>R</given-names></name><name><surname>Parker</surname><given-names>PJ</given-names></name><name><surname>Moss</surname><given-names>SJ</given-names></name><article-title>Subunit-specific association of protein kinase C and the receptor for activated C kinase with GABA type A receptors</article-title><source>J Neurosci</source><year>1999</year><volume>19</volume><fpage>9228</fpage><lpage>9234</lpage><pub-id pub-id-type=""pmid"">10531426</pub-id></mixed-citation></ref><ref id=""B131""><mixed-citation publication-type=""journal""><name><surname>Feng</surname><given-names>J</given-names></name><name><surname>Cai</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Yan</surname><given-names>Z</given-names></name><article-title>Serotonin receptors modulate GABA(A) receptor channels through activation of anchored protein kinase C in prefrontal cortical neurons</article-title><source>J Neurosci</source><year>2001</year><volume>21</volume><fpage>6502</fpage><lpage>6511</lpage><pub-id pub-id-type=""pmid"">11517239</pub-id></mixed-citation></ref><ref id=""B132""><mixed-citation publication-type=""journal""><name><surname>Isacson</surname><given-names>CK</given-names></name><name><surname>Lu</surname><given-names>Q</given-names></name><name><surname>Karas</surname><given-names>RH</given-names></name><name><surname>Cox</surname><given-names>DH</given-names></name><article-title>RACK1 is a BKCa channel binding protein</article-title><source>Am J Physiol Cell Physiol</source><year>2007</year><volume>292</volume><fpage>C1459</fpage><lpage>1466</lpage><pub-id pub-id-type=""pmid"">17166942</pub-id></mixed-citation></ref><ref id=""B133""><mixed-citation publication-type=""journal""><name><surname>Kraus</surname><given-names>S</given-names></name><name><surname>Gioeli</surname><given-names>D</given-names></name><name><surname>Vomastek</surname><given-names>T</given-names></name><name><surname>Gordon</surname><given-names>V</given-names></name><name><surname>Weber</surname><given-names>MJ</given-names></name><article-title>Receptor for activated C kinase 1 (RACK1) and Src regulate the tyrosine phosphorylation and function of the androgen receptor</article-title><source>Cancer Res</source><year>2006</year><volume>66</volume><fpage>11047</fpage><lpage>11054</lpage><pub-id pub-id-type=""doi"">10.1158/0008-5472.CAN-06-0596</pub-id><pub-id pub-id-type=""pmid"">17108144</pub-id></mixed-citation></ref><ref id=""B134""><mixed-citation publication-type=""journal""><name><surname>Birikh</surname><given-names>KR</given-names></name><name><surname>Sklan</surname><given-names>EH</given-names></name><name><surname>Shoham</surname><given-names>S</given-names></name><name><surname>Soreq</surname><given-names>H</given-names></name><article-title>Interaction of ""readthrough"" acetylcholinesterase with RACK1 and PKCbeta II correlates with intensified fear-induced conflict behavior</article-title><source>Proc Natl Acad Sci USA</source><year>2003</year><volume>100</volume><fpage>283</fpage><lpage>288</lpage><pub-id pub-id-type=""doi"">10.1073/pnas.0135647100</pub-id><pub-id pub-id-type=""pmid"">12509514</pub-id></mixed-citation></ref><ref id=""B135""><mixed-citation publication-type=""journal""><name><surname>Farchi</surname><given-names>N</given-names></name><name><surname>Ofek</surname><given-names>K</given-names></name><name><surname>Podoly</surname><given-names>E</given-names></name><name><surname>Dong</surname><given-names>H</given-names></name><name><surname>Xiang</surname><given-names>YY</given-names></name><name><surname>Diamant</surname><given-names>S</given-names></name><name><surname>Livnah</surname><given-names>O</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Hochner</surname><given-names>B</given-names></name><name><surname>Lu</surname><given-names>WY</given-names></name><name><surname>Soreq</surname><given-names>H</given-names></name><article-title>Peripheral site acetylcholinesterase blockade induces RACK1-associated neuronal remodeling</article-title><source>Neurodegener Dis</source><year>2007</year><volume>4</volume><fpage>171</fpage><lpage>184</lpage><pub-id pub-id-type=""doi"">10.1159/000101842</pub-id><pub-id pub-id-type=""pmid"">17596712</pub-id></mixed-citation></ref><ref id=""B136""><mixed-citation publication-type=""journal""><name><surname>Arimoto</surname><given-names>K</given-names></name><name><surname>Fukuda</surname><given-names>H</given-names></name><name><surname>Imajoh-Ohmi</surname><given-names>S</given-names></name><name><surname>Saito</surname><given-names>H</given-names></name><name><surname>Takekawa</surname><given-names>M</given-names></name><article-title>Formation of stress granules inhibits apoptosis by suppressing stress-responsive MAPK pathways</article-title><source>Nat Cell Biol</source><year>2008</year><volume>10</volume><fpage>1324</fpage><lpage>1332</lpage><pub-id pub-id-type=""doi"">10.1038/ncb1791</pub-id><pub-id pub-id-type=""pmid"">18836437</pub-id></mixed-citation></ref><ref id=""B137""><mixed-citation publication-type=""journal""><name><surname>Ohn</surname><given-names>T</given-names></name><name><surname>Kedersha</surname><given-names>N</given-names></name><name><surname>Hickman</surname><given-names>T</given-names></name><name><surname>Tisdale</surname><given-names>S</given-names></name><name><surname>Anderson</surname><given-names>P</given-names></name><article-title>A functional RNAi screen links O-GlcNAc modification of ribosomal proteins to stress granule and processing body assembly</article-title><source>Nat Cell Biol</source><year>2008</year><volume>10</volume><fpage>1224</fpage><lpage>1231</lpage><pub-id pub-id-type=""doi"">10.1038/ncb1783</pub-id><pub-id pub-id-type=""pmid"">18794846</pub-id></mixed-citation></ref><ref id=""B138""><mixed-citation publication-type=""journal""><name><surname>Chang</surname><given-names>BY</given-names></name><name><surname>Chiang</surname><given-names>M</given-names></name><name><surname>Cartwright</surname><given-names>CA</given-names></name><article-title>The interaction of Src and RACK1 is enhanced by activation of protein kinase C and tyrosine phosphorylation of RACK1</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>20346</fpage><lpage>20356</lpage><pub-id pub-id-type=""doi"">10.1074/jbc.M101375200</pub-id><pub-id pub-id-type=""pmid"">11279199</pub-id></mixed-citation></ref><ref id=""B139""><mixed-citation publication-type=""journal""><name><surname>Mamidipudi</surname><given-names>V</given-names></name><name><surname>Miller</surname><given-names>LD</given-names></name><name><surname>Mochly-Rosen</surname><given-names>D</given-names></name><name><surname>Cartwright</surname><given-names>CA</given-names></name><article-title>Peptide modulators of Src activity in G1 regulate entry into S phase and proliferation of NIH 3T3 cells</article-title><source>Biochem Biophys Res Commun</source><year>2007</year><volume>352</volume><fpage>423</fpage><lpage>430</lpage><pub-id pub-id-type=""doi"">10.1016/j.bbrc.2006.11.034</pub-id><pub-id pub-id-type=""pmid"">17118337</pub-id></mixed-citation></ref><ref id=""B140""><mixed-citation publication-type=""journal""><name><surname>Liu</surname><given-names>YV</given-names></name><name><surname>Hubbi</surname><given-names>ME</given-names></name><name><surname>Pan</surname><given-names>F</given-names></name><name><surname>McDonald</surname><given-names>KR</given-names></name><name><surname>Mansharamani</surname><given-names>M</given-names></name><name><surname>Cole</surname><given-names>RN</given-names></name><name><surname>Liu</surname><given-names>JO</given-names></name><name><surname>Semenza</surname><given-names>GL</given-names></name><article-title>Calcineurin promotes hypoxia-inducible factor 1alpha expression by dephosphorylating RACK1 and blocking RACK1 dimerization</article-title><source>J Biol Chem</source><year>2007</year><volume>282</volume><fpage>37064</fpage><lpage>37073</lpage><pub-id pub-id-type=""doi"">10.1074/jbc.M705015200</pub-id><pub-id pub-id-type=""pmid"">17965024</pub-id></mixed-citation></ref><ref id=""B141""><mixed-citation publication-type=""journal""><name><surname>He</surname><given-names>DY</given-names></name><name><surname>Vagts</surname><given-names>AJ</given-names></name><name><surname>Yaka</surname><given-names>R</given-names></name><name><surname>Ron</surname><given-names>D</given-names></name><article-title>Ethanol induces gene expression via nuclear compartmentalization of receptor for activated C kinase 1</article-title><source>Mol Pharmacol</source><year>2002</year><volume>62</volume><fpage>272</fpage><lpage>280</lpage><pub-id pub-id-type=""doi"">10.1124/mol.62.2.272</pub-id><pub-id pub-id-type=""pmid"">12130678</pub-id></mixed-citation></ref><ref id=""B142""><mixed-citation publication-type=""journal""><name><surname>Ron</surname><given-names>D</given-names></name><name><surname>Vagts</surname><given-names>AJ</given-names></name><name><surname>Dohrman</surname><given-names>DP</given-names></name><name><surname>Yaka</surname><given-names>R</given-names></name><name><surname>Jiang</surname><given-names>Z</given-names></name><name><surname>Yao</surname><given-names>L</given-names></name><name><surname>Crabbe</surname><given-names>J</given-names></name><name><surname>Grisel</surname><given-names>JE</given-names></name><name><surname>Diamond</surname><given-names>I</given-names></name><article-title>Uncoupling of betaIIPKC from its targeting protein RACK1 in response to ethanol in cultured cells and mouse brain</article-title><source>FASEB J</source><year>2000</year><volume>14</volume><fpage>2303</fpage><lpage>2314</lpage><pub-id pub-id-type=""doi"">10.1096/fj.00-0143com</pub-id><pub-id pub-id-type=""pmid"">11053252</pub-id></mixed-citation></ref><ref id=""B143""><mixed-citation publication-type=""journal""><name><surname>McGough</surname><given-names>NN</given-names></name><name><surname>He</surname><given-names>DY</given-names></name><name><surname>Logrip</surname><given-names>ML</given-names></name><name><surname>Jeanblanc</surname><given-names>J</given-names></name><name><surname>Phamluong</surname><given-names>K</given-names></name><name><surname>Luong</surname><given-names>K</given-names></name><name><surname>Kharazia</surname><given-names>V</given-names></name><name><surname>Janak</surname><given-names>PH</given-names></name><name><surname>Ron</surname><given-names>D</given-names></name><article-title>RACK1 and brain-derived neurotrophic factor: a homeostatic pathway that regulates alcohol addiction</article-title><source>J Neurosci</source><year>2004</year><volume>24</volume><fpage>10542</fpage><lpage>10552</lpage><pub-id pub-id-type=""doi"">10.1523/JNEUROSCI.3714-04.2004</pub-id><pub-id pub-id-type=""pmid"">15548669</pub-id></mixed-citation></ref><ref id=""B144""><mixed-citation publication-type=""journal""><name><surname>Nery</surname><given-names>FC</given-names></name><name><surname>Passos</surname><given-names>DO</given-names></name><name><surname>Garcia</surname><given-names>VS</given-names></name><name><surname>Kobarg</surname><given-names>J</given-names></name><article-title>Ki-1/57 interacts with RACK1 and is a substrate for the phosphorylation by phorbol 12-myristate 13-acetate-activated protein kinase C</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><fpage>11444</fpage><lpage>11455</lpage><pub-id pub-id-type=""doi"">10.1074/jbc.M306672200</pub-id><pub-id pub-id-type=""pmid"">14699138</pub-id></mixed-citation></ref><ref id=""B145""><mixed-citation publication-type=""journal""><name><surname>Liu</surname><given-names>YV</given-names></name><name><surname>Baek</surname><given-names>JH</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Diez</surname><given-names>R</given-names></name><name><surname>Cole</surname><given-names>RN</given-names></name><name><surname>Semenza</surname><given-names>GL</given-names></name><article-title>RACK1 competes with HSP90 for binding to HIF-1alpha and is required for O(2)-independent and HSP90 inhibitor-induced degradation of HIF-1alpha</article-title><source>Mol Cell</source><year>2007</year><volume>25</volume><fpage>207</fpage><lpage>217</lpage><pub-id pub-id-type=""doi"">10.1016/j.molcel.2007.01.001</pub-id><pub-id pub-id-type=""pmid"">17244529</pub-id></mixed-citation></ref><ref id=""B146""><mixed-citation publication-type=""journal""><name><surname>Nilsson</surname><given-names>J</given-names></name><name><surname>Sengupta</surname><given-names>J</given-names></name><name><surname>Frank</surname><given-names>J</given-names></name><name><surname>Nissen</surname><given-names>P</given-names></name><article-title>Regulation of eukaryotic translation by the RACK1 protein: a platform for signalling molecules on the ribosome</article-title><source>EMBO Rep</source><year>2004</year><volume>5</volume><fpage>1137</fpage><lpage>1141</lpage><pub-id pub-id-type=""doi"">10.1038/sj.embor.7400291</pub-id><pub-id pub-id-type=""pmid"">15577927</pub-id></mixed-citation></ref><ref id=""B147""><mixed-citation publication-type=""journal""><name><surname>Link</surname><given-names>AJ</given-names></name><name><surname>Eng</surname><given-names>J</given-names></name><name><surname>Schieltz</surname><given-names>DM</given-names></name><name><surname>Carmack</surname><given-names>E</given-names></name><name><surname>Mize</surname><given-names>GJ</given-names></name><name><surname>Morris</surname><given-names>DR</given-names></name><name><surname>Garvik</surname><given-names>BM</given-names></name><name><surname>Yates</surname><given-names>JR</given-names></name><article-title>Direct analysis of protein complexes using mass spectrometry</article-title><source>Nat Biotechnol</source><year>1999</year><volume>17</volume><fpage>676</fpage><lpage>682</lpage><pub-id pub-id-type=""doi"">10.1038/10890</pub-id><pub-id pub-id-type=""pmid"">10404161</pub-id></mixed-citation></ref><ref id=""B148""><mixed-citation publication-type=""journal""><name><surname>Gerbasi</surname><given-names>VR</given-names></name><name><surname>Weaver</surname><given-names>CM</given-names></name><name><surname>Hill</surname><given-names>S</given-names></name><name><surname>Friedman</surname><given-names>DB</given-names></name><name><surname>Link</surname><given-names>AJ</given-names></name><article-title>Yeast Asc1p and mammalian RACK1 are functionally orthologous core 40S ribosomal proteins that repress gene expression</article-title><source>Mol Cell Biol</source><year>2004</year><volume>24</volume><fpage>8276</fpage><lpage>8287</lpage><pub-id pub-id-type=""doi"">10.1128/MCB.24.18.8276-8287.2004</pub-id><pub-id pub-id-type=""pmid"">15340087</pub-id></mixed-citation></ref><ref id=""B149""><mixed-citation publication-type=""journal""><name><surname>Nunez</surname><given-names>A</given-names></name><name><surname>Franco</surname><given-names>A</given-names></name><name><surname>Madrid</surname><given-names>M</given-names></name><name><surname>Soto</surname><given-names>T</given-names></name><name><surname>Vicente</surname><given-names>J</given-names></name><name><surname>Gacto</surname><given-names>M</given-names></name><name><surname>Cansado</surname><given-names>J</given-names></name><article-title>Role for RACK1 orthologue Cpc2 in the modulation of stress response in fission yeast</article-title><source>Mol Biol Cell</source><year>2009</year><volume>20</volume><fpage>3996</fpage><lpage>4009</lpage><pub-id pub-id-type=""doi"">10.1091/mbc.E09-05-0388</pub-id><pub-id pub-id-type=""pmid"">19625445</pub-id></mixed-citation></ref><ref id=""B150""><mixed-citation publication-type=""journal""><name><surname>Nunez</surname><given-names>A</given-names></name><name><surname>Franco</surname><given-names>A</given-names></name><name><surname>Soto</surname><given-names>T</given-names></name><name><surname>Vicente</surname><given-names>J</given-names></name><name><surname>Gacto</surname><given-names>M</given-names></name><name><surname>Cansado</surname><given-names>J</given-names></name><article-title>Fission yeast receptor of activated C kinase (RACK1) ortholog Cpc2 regulates mitotic commitment through Wee1 kinase</article-title><source>J Biol Chem</source><year>2010</year><volume>285</volume><fpage>41366</fpage><lpage>41373</lpage><pub-id pub-id-type=""doi"">10.1074/jbc.M110.173815</pub-id><pub-id pub-id-type=""pmid"">20974849</pub-id></mixed-citation></ref><ref id=""B151""><mixed-citation publication-type=""journal""><name><surname>Shor</surname><given-names>B</given-names></name><name><surname>Calaycay</surname><given-names>J</given-names></name><name><surname>Rushbrook</surname><given-names>J</given-names></name><name><surname>McLeod</surname><given-names>M</given-names></name><article-title>Cpc2/RACK1 is a ribosome-associated protein that promotes efficient translation in Schizosaccharomyces pombe</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>49119</fpage><lpage>49128</lpage><pub-id pub-id-type=""doi"">10.1074/jbc.M303968200</pub-id><pub-id pub-id-type=""pmid"">12972434</pub-id></mixed-citation></ref><ref id=""B152""><mixed-citation publication-type=""journal""><name><surname>Manuell</surname><given-names>AL</given-names></name><name><surname>Yamaguchi</surname><given-names>K</given-names></name><name><surname>Haynes</surname><given-names>PA</given-names></name><name><surname>Milligan</surname><given-names>RA</given-names></name><name><surname>Mayfield</surname><given-names>SP</given-names></name><article-title>Composition and structure of the 80S ribosome from the green alga Chlamydomonas reinhardtii: 80S ribosomes are conserved in plants and animals</article-title><source>J Mol Biol</source><year>2005</year><volume>351</volume><fpage>266</fpage><lpage>279</lpage><pub-id pub-id-type=""doi"">10.1016/j.jmb.2005.06.022</pub-id><pub-id pub-id-type=""pmid"">16005888</pub-id></mixed-citation></ref><ref id=""B153""><mixed-citation publication-type=""journal""><name><surname>Chang</surname><given-names>IF</given-names></name><name><surname>Szick-Miranda</surname><given-names>K</given-names></name><name><surname>Pan</surname><given-names>S</given-names></name><name><surname>Bailey-Serres</surname><given-names>J</given-names></name><article-title>Proteomic characterization of evolutionarily conserved and variable proteins of Arabidopsis cytosolic ribosomes</article-title><source>Plant Physiol</source><year>2005</year><volume>137</volume><fpage>848</fpage><lpage>862</lpage><pub-id pub-id-type=""doi"">10.1104/pp.104.053637</pub-id><pub-id pub-id-type=""pmid"">15734919</pub-id></mixed-citation></ref><ref id=""B154""><mixed-citation publication-type=""journal""><name><surname>Giavalisco</surname><given-names>P</given-names></name><name><surname>Wilson</surname><given-names>D</given-names></name><name><surname>Kreitler</surname><given-names>T</given-names></name><name><surname>Lehrach</surname><given-names>H</given-names></name><name><surname>Klose</surname><given-names>J</given-names></name><name><surname>Gobom</surname><given-names>J</given-names></name><name><surname>Fucini</surname><given-names>P</given-names></name><article-title>High heterogeneity within the ribosomal proteins of the Arabidopsis thaliana 80S ribosome</article-title><source>Plant Mol Biol</source><year>2005</year><volume>57</volume><fpage>577</fpage><lpage>591</lpage><pub-id pub-id-type=""doi"">10.1007/s11103-005-0699-3</pub-id><pub-id pub-id-type=""pmid"">15821981</pub-id></mixed-citation></ref><ref id=""B155""><mixed-citation publication-type=""journal""><name><surname>Guo</surname><given-names>J</given-names></name><name><surname>Jin</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>JF</given-names></name><name><surname>Chen</surname><given-names>JG</given-names></name><article-title>Eukaryotic Initiation Factor 6, an evolutionarily conserved regulator of ribosome biogenesis and protein translation</article-title><source>Plant Signal Behav</source><year>2011</year><volume>6</volume><fpage>766</fpage><lpage>771</lpage><pub-id pub-id-type=""doi"">10.4161/psb.6.5.15438</pub-id><pub-id pub-id-type=""pmid"">21543889</pub-id></mixed-citation></ref><ref id=""B156""><mixed-citation publication-type=""journal""><name><surname>Guo</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Valerius</surname><given-names>O</given-names></name><name><surname>Hall</surname><given-names>H</given-names></name><name><surname>Zeng</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>JF</given-names></name><name><surname>Weston</surname><given-names>DJ</given-names></name><name><surname>Ellis</surname><given-names>BE</given-names></name><name><surname>Chen</surname><given-names>JG</given-names></name><article-title>Involvement of Arabidopsis RACK1 in protein translation and its regulation by abscisic acid</article-title><source>Plant Physiol</source><year>2011</year><volume>155</volume><fpage>370</fpage><lpage>383</lpage><pub-id pub-id-type=""doi"">10.1104/pp.110.160663</pub-id><pub-id pub-id-type=""pmid"">21098678</pub-id></mixed-citation></ref><ref id=""B157""><mixed-citation publication-type=""journal""><name><surname>Jannot</surname><given-names>G</given-names></name><name><surname>Bajan</surname><given-names>S</given-names></name><name><surname>Giguere</surname><given-names>NJ</given-names></name><name><surname>Bouasker</surname><given-names>S</given-names></name><name><surname>Banville</surname><given-names>IH</given-names></name><name><surname>Piquet</surname><given-names>S</given-names></name><name><surname>Hutvagner</surname><given-names>G</given-names></name><name><surname>Simard</surname><given-names>MJ</given-names></name><article-title>The ribosomal protein RACK1 is required for microRNA function in both C</article-title><source>elegans and humans. EMBO Rep</source><year>2011</year><volume>12</volume><fpage>581</fpage><lpage>586</lpage></mixed-citation></ref><ref id=""B158""><mixed-citation publication-type=""journal""><name><surname>Kuroha</surname><given-names>K</given-names></name><name><surname>Akamatsu</surname><given-names>M</given-names></name><name><surname>Dimitrova</surname><given-names>L</given-names></name><name><surname>Ito</surname><given-names>T</given-names></name><name><surname>Kato</surname><given-names>Y</given-names></name><name><surname>Shirahige</surname><given-names>K</given-names></name><name><surname>Inada</surname><given-names>T</given-names></name><article-title>Receptor for activated C kinase 1 stimulates nascent polypeptide-dependent translation arrest</article-title><source>EMBO Rep</source><year>2010</year><volume>11</volume><fpage>956</fpage><lpage>961</lpage><pub-id pub-id-type=""doi"">10.1038/embor.2010.169</pub-id><pub-id pub-id-type=""pmid"">21072063</pub-id></mixed-citation></ref><ref id=""B159""><mixed-citation publication-type=""journal""><name><surname>Baum</surname><given-names>S</given-names></name><name><surname>Bittins</surname><given-names>M</given-names></name><name><surname>Frey</surname><given-names>S</given-names></name><name><surname>Seedorf</surname><given-names>M</given-names></name><article-title>Asc1p, a WD40-domain containing adaptor protein, is required for the interaction of the RNA-binding protein Scp160p with polysomes</article-title><source>Biochem J</source><year>2004</year><volume>380</volume><fpage>823</fpage><lpage>830</lpage><pub-id pub-id-type=""doi"">10.1042/BJ20031962</pub-id><pub-id pub-id-type=""pmid"">15012629</pub-id></mixed-citation></ref><ref id=""B160""><mixed-citation publication-type=""journal""><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Esterberg</surname><given-names>R</given-names></name><name><surname>Lachance</surname><given-names>V</given-names></name><name><surname>Ren</surname><given-names>D</given-names></name><name><surname>Radde-Gallwitz</surname><given-names>K</given-names></name><name><surname>Chi</surname><given-names>F</given-names></name><name><surname>Parent</surname><given-names>JL</given-names></name><name><surname>Fritz</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>P</given-names></name><article-title>Rack1 is required for Vangl2 membrane localization and planar cell polarity signaling while attenuating canonical Wnt activity</article-title><source>Proc Natl Acad Sci USA</source><year>2011</year><volume>108</volume><fpage>2264</fpage><lpage>2269</lpage><pub-id pub-id-type=""doi"">10.1073/pnas.1013170108</pub-id><pub-id pub-id-type=""pmid"">21262816</pub-id></mixed-citation></ref><ref id=""B161""><mixed-citation publication-type=""journal""><name><surname>Wehner</surname><given-names>P</given-names></name><name><surname>Shnitsar</surname><given-names>I</given-names></name><name><surname>Urlaub</surname><given-names>H</given-names></name><name><surname>Borchers</surname><given-names>A</given-names></name><article-title>RACK1 is a novel interaction partner of PTK7 that is required for neural tube closure</article-title><source>Development</source><year>2011</year><volume>138</volume><fpage>1321</fpage><lpage>1327</lpage><pub-id pub-id-type=""doi"">10.1242/dev.056291</pub-id><pub-id pub-id-type=""pmid"">21350015</pub-id></mixed-citation></ref><ref id=""B162""><mixed-citation publication-type=""journal""><name><surname>Chen</surname><given-names>JG</given-names></name><name><surname>Ullah</surname><given-names>H</given-names></name><name><surname>Temple</surname><given-names>B</given-names></name><name><surname>Liang</surname><given-names>J</given-names></name><name><surname>Guo</surname><given-names>J</given-names></name><name><surname>Alonso</surname><given-names>JM</given-names></name><name><surname>Ecker</surname><given-names>JR</given-names></name><name><surname>Jones</surname><given-names>AM</given-names></name><article-title>RACK1 mediates multiple hormone responsiveness and developmental processes in Arabidopsis</article-title><source>J Exp Bot</source><year>2006</year><volume>57</volume><fpage>2697</fpage><lpage>2708</lpage><pub-id pub-id-type=""doi"">10.1093/jxb/erl035</pub-id><pub-id pub-id-type=""pmid"">16829549</pub-id></mixed-citation></ref><ref id=""B163""><mixed-citation publication-type=""journal""><name><surname>Guo</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>JG</given-names></name><article-title>RACK1 genes regulate plant development with unequal genetic redundancy in Arabidopsis</article-title><source>BMC Plant Biol</source><year>2008</year><volume>8</volume><fpage>108</fpage><pub-id pub-id-type=""doi"">10.1186/1471-2229-8-108</pub-id><pub-id pub-id-type=""pmid"">18947417</pub-id></mixed-citation></ref><ref id=""B164""><mixed-citation publication-type=""journal""><name><surname>Kadrmas</surname><given-names>JL</given-names></name><name><surname>Smith</surname><given-names>MA</given-names></name><name><surname>Pronovost</surname><given-names>SM</given-names></name><name><surname>Beckerle</surname><given-names>MC</given-names></name><article-title>Characterization of RACK1 function in Drosophila development</article-title><source>Dev Dyn</source><year>2007</year><volume>236</volume><fpage>2207</fpage><lpage>2215</lpage><pub-id pub-id-type=""doi"">10.1002/dvdy.21217</pub-id><pub-id pub-id-type=""pmid"">17584887</pub-id></mixed-citation></ref><ref id=""B165""><mixed-citation publication-type=""journal""><name><surname>Hoffmann</surname><given-names>B</given-names></name><name><surname>Wanke</surname><given-names>C</given-names></name><name><surname>Lapaglia</surname><given-names>SK</given-names></name><name><surname>Braus</surname><given-names>GH</given-names></name><article-title>c-Jun and RACK1 homologues regulate a control point for sexual development in Aspergillus nidulans</article-title><source>Mol Microbiol</source><year>2000</year><volume>37</volume><fpage>28</fpage><lpage>41</lpage><pub-id pub-id-type=""doi"">10.1046/j.1365-2958.2000.01954.x</pub-id><pub-id pub-id-type=""pmid"">10931303</pub-id></mixed-citation></ref><ref id=""B166""><mixed-citation publication-type=""journal""><name><surname>McLeod</surname><given-names>M</given-names></name><name><surname>Shor</surname><given-names>B</given-names></name><name><surname>Caporaso</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Hu</surname><given-names>L</given-names></name><article-title>Cpc2, a fission yeast homologue of mammalian RACK1 protein, interacts with Ran1 (Pat1) kinase To regulate cell cycle progression and meiotic development</article-title><source>Mol Cell Biol</source><year>2000</year><volume>20</volume><fpage>4016</fpage><lpage>4027</lpage><pub-id pub-id-type=""doi"">10.1128/MCB.20.11.4016-4027.2000</pub-id><pub-id pub-id-type=""pmid"">10805744</pub-id></mixed-citation></ref><ref id=""B167""><mixed-citation publication-type=""journal""><name><surname>Rothberg</surname><given-names>KG</given-names></name><name><surname>Burdette</surname><given-names>DL</given-names></name><name><surname>Pfannstiel</surname><given-names>J</given-names></name><name><surname>Jetton</surname><given-names>N</given-names></name><name><surname>Singh</surname><given-names>R</given-names></name><name><surname>Ruben</surname><given-names>L</given-names></name><article-title>The RACK1 homologue from Trypanosoma brucei is required for the onset and progression of cytokinesis</article-title><source>J Biol Chem</source><year>2006</year><volume>281</volume><fpage>9781</fpage><lpage>9790</lpage><pub-id pub-id-type=""pmid"">16469736</pub-id></mixed-citation></ref><ref id=""B168""><mixed-citation publication-type=""journal""><name><surname>Cox</surname><given-names>EA</given-names></name><name><surname>Bennin</surname><given-names>D</given-names></name><name><surname>Doan</surname><given-names>AT</given-names></name><name><surname>O'Toole</surname><given-names>T</given-names></name><name><surname>Huttenlocher</surname><given-names>A</given-names></name><article-title>RACK1 regulates integrin-mediated adhesion, protrusion, and chemotactic cell migration via its Src-binding site</article-title><source>Mol Biol Cell</source><year>2003</year><volume>14</volume><fpage>658</fpage><lpage>669</lpage><pub-id pub-id-type=""doi"">10.1091/mbc.E02-03-0142</pub-id><pub-id pub-id-type=""pmid"">12589061</pub-id></mixed-citation></ref><ref id=""B169""><mixed-citation publication-type=""journal""><name><surname>Onishi</surname><given-names>I</given-names></name><name><surname>Lin</surname><given-names>PJ</given-names></name><name><surname>Diering</surname><given-names>GH</given-names></name><name><surname>Williams</surname><given-names>WP</given-names></name><name><surname>Numata</surname><given-names>M</given-names></name><article-title>RACK1 associates with NHE5 in focal adhesions and positively regulates the transporter activity</article-title><source>Cell Signal</source><year>2007</year><volume>19</volume><fpage>194</fpage><lpage>203</lpage><pub-id pub-id-type=""doi"">10.1016/j.cellsig.2006.06.011</pub-id><pub-id pub-id-type=""pmid"">16920332</pub-id></mixed-citation></ref><ref id=""B170""><mixed-citation publication-type=""journal""><name><surname>Buensuceso</surname><given-names>CS</given-names></name><name><surname>Obergfell</surname><given-names>A</given-names></name><name><surname>Soriani</surname><given-names>A</given-names></name><name><surname>Eto</surname><given-names>K</given-names></name><name><surname>Kiosses</surname><given-names>WB</given-names></name><name><surname>Arias-Salgado</surname><given-names>EG</given-names></name><name><surname>Kawakami</surname><given-names>T</given-names></name><name><surname>Shattil</surname><given-names>SJ</given-names></name><article-title>Regulation of outside-in signaling in platelets by integrin-associated protein kinase C beta</article-title><source>J Biol Chem</source><year>2005</year><volume>280</volume><fpage>644</fpage><lpage>653</lpage><pub-id pub-id-type=""pmid"">15536078</pub-id></mixed-citation></ref><ref id=""B171""><mixed-citation publication-type=""journal""><name><surname>Lo</surname><given-names>SH</given-names></name><article-title>Focal adhesions: what's new inside</article-title><source>Dev Biol</source><year>2006</year><volume>294</volume><fpage>280</fpage><lpage>291</lpage><pub-id pub-id-type=""doi"">10.1016/j.ydbio.2006.03.029</pub-id><pub-id pub-id-type=""pmid"">16650401</pub-id></mixed-citation></ref><ref id=""B172""><mixed-citation publication-type=""journal""><name><surname>Romer</surname><given-names>LH</given-names></name><name><surname>Birukov</surname><given-names>KG</given-names></name><name><surname>Garcia</surname><given-names>JG</given-names></name><article-title>Focal adhesions: paradigm for a signaling nexus</article-title><source>Circ Res</source><year>2006</year><volume>98</volume><fpage>606</fpage><lpage>616</lpage><pub-id pub-id-type=""doi"">10.1161/01.RES.0000207408.31270.db</pub-id><pub-id pub-id-type=""pmid"">16543511</pub-id></mixed-citation></ref><ref id=""B173""><mixed-citation publication-type=""journal""><name><surname>Petit</surname><given-names>V</given-names></name><name><surname>Thiery</surname><given-names>JP</given-names></name><article-title>Focal adhesions: structure and dynamics</article-title><source>Biol Cell</source><year>2000</year><volume>92</volume><fpage>477</fpage><lpage>494</lpage><pub-id pub-id-type=""doi"">10.1016/S0248-4900(00)01101-1</pub-id><pub-id pub-id-type=""pmid"">11229600</pub-id></mixed-citation></ref><ref id=""B174""><mixed-citation publication-type=""journal""><name><surname>Martin</surname><given-names>GM</given-names></name><article-title>Fak and focal adhesions</article-title><source>Jpn J Cancer Res</source><year>1996</year><volume>87</volume><comment>inside front cover</comment></mixed-citation></ref><ref id=""B175""><mixed-citation publication-type=""journal""><name><surname>Burridge</surname><given-names>K</given-names></name><name><surname>Chrzanowska-Wodnicka</surname><given-names>M</given-names></name><article-title>Focal adhesions, contractility, and signaling</article-title><source>Annu Rev Cell Dev Biol</source><year>1996</year><volume>12</volume><fpage>463</fpage><lpage>518</lpage><pub-id pub-id-type=""doi"">10.1146/annurev.cellbio.12.1.463</pub-id><pub-id pub-id-type=""pmid"">8970735</pub-id></mixed-citation></ref><ref id=""B176""><mixed-citation publication-type=""journal""><name><surname>Guan</surname><given-names>JL</given-names></name><article-title>Integrin signaling through FAK in the regulation of mammary stem cells and breast cancer</article-title><source>IUBMB Life</source><year>2010</year><volume>62</volume><fpage>268</fpage><lpage>276</lpage><pub-id pub-id-type=""pmid"">20101634</pub-id></mixed-citation></ref><ref id=""B177""><mixed-citation publication-type=""journal""><name><surname>Mitra</surname><given-names>SK</given-names></name><name><surname>Schlaepfer</surname><given-names>DD</given-names></name><article-title>Integrin-regulated FAK-Src signaling in normal and cancer cells</article-title><source>Curr Opin Cell Biol</source><year>2006</year><volume>18</volume><fpage>516</fpage><lpage>523</lpage><pub-id pub-id-type=""doi"">10.1016/j.ceb.2006.08.011</pub-id><pub-id pub-id-type=""pmid"">16919435</pub-id></mixed-citation></ref><ref id=""B178""><mixed-citation publication-type=""journal""><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Yamauchi</surname><given-names>M</given-names></name><name><surname>Muramatsu</surname><given-names>M</given-names></name><name><surname>Osawa</surname><given-names>T</given-names></name><name><surname>Tsuchida</surname><given-names>R</given-names></name><name><surname>Shibuya</surname><given-names>M</given-names></name><article-title>RACK1 regulates VEGF/Flt1-mediated cell migration via activation of a PI3K/Akt pathway</article-title><source>J Biol Chem</source><year>2011</year><volume>286</volume><fpage>9097</fpage><lpage>9106</lpage><pub-id pub-id-type=""doi"">10.1074/jbc.M110.165605</pub-id><pub-id pub-id-type=""pmid"">21212275</pub-id></mixed-citation></ref><ref id=""B179""><mixed-citation publication-type=""journal""><name><surname>Nakashima</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Thao</surname><given-names>NP</given-names></name><name><surname>Fujiwara</surname><given-names>M</given-names></name><name><surname>Wong</surname><given-names>HL</given-names></name><name><surname>Kuwano</surname><given-names>M</given-names></name><name><surname>Umemura</surname><given-names>K</given-names></name><name><surname>Shirasu</surname><given-names>K</given-names></name><name><surname>Kawasaki</surname><given-names>T</given-names></name><name><surname>Shimamoto</surname><given-names>K</given-names></name><article-title>RACK1 functions in rice innate immunity by interacting with the Rac1 immune complex</article-title><source>Plant Cell</source><year>2008</year><volume>20</volume><fpage>2265</fpage><lpage>2279</lpage><pub-id pub-id-type=""doi"">10.1105/tpc.107.054395</pub-id><pub-id pub-id-type=""pmid"">18723578</pub-id></mixed-citation></ref><ref id=""B180""><mixed-citation publication-type=""journal""><name><surname>Orlichenko</surname><given-names>L</given-names></name><name><surname>Geyer</surname><given-names>R</given-names></name><name><surname>Yanagisawa</surname><given-names>M</given-names></name><name><surname>Khauv</surname><given-names>D</given-names></name><name><surname>Radisky</surname><given-names>ES</given-names></name><name><surname>Anastasiadis</surname><given-names>PZ</given-names></name><name><surname>Radisky</surname><given-names>DC</given-names></name><article-title>The 19-amino acid insertion in the tumor-associated splice isoform Rac1b confers specific binding to p120 catenin</article-title><source>J Biol Chem</source><year>2010</year><volume>285</volume><fpage>19153</fpage><lpage>19161</lpage><pub-id pub-id-type=""doi"">10.1074/jbc.M109.099382</pub-id><pub-id pub-id-type=""pmid"">20395297</pub-id></mixed-citation></ref><ref id=""B181""><mixed-citation publication-type=""journal""><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Lin</surname><given-names>F</given-names></name><name><surname>Shin</surname><given-names>ME</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Shen</surname><given-names>L</given-names></name><name><surname>Hamm</surname><given-names>HE</given-names></name><article-title>RACK1 regulates directional cell migration by acting on G betagamma at the interface with its effectors PLC beta and PI3K gamma</article-title><source>Mol Biol Cell</source><year>2008</year><volume>19</volume><fpage>3909</fpage><lpage>3922</lpage><pub-id pub-id-type=""doi"">10.1091/mbc.E08-04-0433</pub-id><pub-id pub-id-type=""pmid"">18596232</pub-id></mixed-citation></ref><ref id=""B182""><mixed-citation publication-type=""journal""><name><surname>Doan</surname><given-names>AT</given-names></name><name><surname>Huttenlocher</surname><given-names>A</given-names></name><article-title>RACK1 regulates Src activity and modulates paxillin dynamics during cell migration</article-title><source>Exp Cell Res</source><year>2007</year><volume>313</volume><fpage>2667</fpage><lpage>2679</lpage><pub-id pub-id-type=""doi"">10.1016/j.yexcr.2007.05.013</pub-id><pub-id pub-id-type=""pmid"">17574549</pub-id></mixed-citation></ref><ref id=""B183""><mixed-citation publication-type=""journal""><name><surname>Miller</surname><given-names>LD</given-names></name><name><surname>Lee</surname><given-names>KC</given-names></name><name><surname>Mochly-Rosen</surname><given-names>D</given-names></name><name><surname>Cartwright</surname><given-names>CA</given-names></name><article-title>RACK1 regulates Src-mediated Sam68 and p190RhoGAP signaling</article-title><source>Oncogene</source><year>2004</year><volume>23</volume><fpage>5682</fpage><lpage>5686</lpage><pub-id pub-id-type=""doi"">10.1038/sj.onc.1207735</pub-id><pub-id pub-id-type=""pmid"">15184885</pub-id></mixed-citation></ref><ref id=""B184""><mixed-citation publication-type=""journal""><name><surname>Mamidipudi</surname><given-names>V</given-names></name><name><surname>Cartwright</surname><given-names>CA</given-names></name><article-title>A novel pro-apoptotic function of RACK1: suppression of Src activity in the intrinsic and Akt pathways</article-title><source>Oncogene</source><year>2009</year><volume>28</volume><fpage>4421</fpage><lpage>4433</lpage><pub-id pub-id-type=""doi"">10.1038/onc.2009.293</pub-id><pub-id pub-id-type=""pmid"">19767770</pub-id></mixed-citation></ref><ref id=""B185""><mixed-citation publication-type=""journal""><name><surname>Mourton</surname><given-names>T</given-names></name><name><surname>Hellberg</surname><given-names>CB</given-names></name><name><surname>Burden-Gulley</surname><given-names>SM</given-names></name><name><surname>Hinman</surname><given-names>J</given-names></name><name><surname>Rhee</surname><given-names>A</given-names></name><name><surname>Brady-Kalnay</surname><given-names>SM</given-names></name><article-title>The PTPmu protein-tyrosine phosphatase binds and recruits the scaffolding protein RACK1 to cell-cell contacts</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>14896</fpage><lpage>14901</lpage><pub-id pub-id-type=""doi"">10.1074/jbc.M010823200</pub-id><pub-id pub-id-type=""pmid"">11278757</pub-id></mixed-citation></ref><ref id=""B186""><mixed-citation publication-type=""journal""><name><surname>Qiu</surname><given-names>Y</given-names></name><name><surname>Mao</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Shao</surname><given-names>M</given-names></name><name><surname>You</surname><given-names>J</given-names></name><name><surname>Ding</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Xie</surname><given-names>D</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><etal></etal><article-title>A crucial role for RACK1 in the regulation of glucose-stimulated IRE1alpha activation in pancreatic beta cells</article-title><source>Sci Signal</source><year>2010</year><volume>3</volume><fpage>ra7</fpage><pub-id pub-id-type=""doi"">10.1126/scisignal.2000514</pub-id><pub-id pub-id-type=""pmid"">20103773</pub-id></mixed-citation></ref><ref id=""B187""><mixed-citation publication-type=""journal""><name><surname>Ensslen</surname><given-names>SE</given-names></name><name><surname>Brady-Kalnay</surname><given-names>SM</given-names></name><article-title>PTPmu signaling via PKCdelta is instructive for retinal ganglion cell guidance</article-title><source>Mol Cell Neurosci</source><year>2004</year><volume>25</volume><fpage>558</fpage><lpage>571</lpage><pub-id pub-id-type=""doi"">10.1016/j.mcn.2003.12.003</pub-id><pub-id pub-id-type=""pmid"">15080886</pub-id></mixed-citation></ref><ref id=""B188""><mixed-citation publication-type=""journal""><name><surname>Hellberg</surname><given-names>CB</given-names></name><name><surname>Burden-Gulley</surname><given-names>SM</given-names></name><name><surname>Pietz</surname><given-names>GE</given-names></name><name><surname>Brady-Kalnay</surname><given-names>SM</given-names></name><article-title>Expression of the receptor protein-tyrosine phosphatase, PTPmu, restores E-cadherin-dependent adhesion in human prostate carcinoma cells</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>11165</fpage><lpage>11173</lpage><pub-id pub-id-type=""doi"">10.1074/jbc.M112157200</pub-id><pub-id pub-id-type=""pmid"">11801604</pub-id></mixed-citation></ref><ref id=""B189""><mixed-citation publication-type=""journal""><name><surname>Rosdahl</surname><given-names>JA</given-names></name><name><surname>Mourton</surname><given-names>TL</given-names></name><name><surname>Brady-Kalnay</surname><given-names>SM</given-names></name><article-title>Protein kinase C delta (PKCdelta) is required for protein tyrosine phosphatase mu (PTPmu)-dependent neurite outgrowth</article-title><source>Mol Cell Neurosci</source><year>2002</year><volume>19</volume><fpage>292</fpage><lpage>306</lpage><pub-id pub-id-type=""doi"">10.1006/mcne.2001.1071</pub-id><pub-id pub-id-type=""pmid"">11860281</pub-id></mixed-citation></ref><ref id=""B190""><mixed-citation publication-type=""journal""><name><surname>Zakrzewicz</surname><given-names>A</given-names></name><name><surname>Hecker</surname><given-names>M</given-names></name><name><surname>Marsh</surname><given-names>LM</given-names></name><name><surname>Kwapiszewska</surname><given-names>G</given-names></name><name><surname>Nejman</surname><given-names>B</given-names></name><name><surname>Long</surname><given-names>L</given-names></name><name><surname>Seeger</surname><given-names>W</given-names></name><name><surname>Schermuly</surname><given-names>RT</given-names></name><name><surname>Morrell</surname><given-names>NW</given-names></name><name><surname>Morty</surname><given-names>RE</given-names></name><name><surname>Eickelberg</surname><given-names>O</given-names></name><article-title>Receptor for activated C-kinase 1, a novel interaction partner of type II bone morphogenetic protein receptor, regulates smooth muscle cell proliferation in pulmonary arterial hypertension</article-title><source>Circulation</source><year>2007</year><volume>115</volume><fpage>2957</fpage><lpage>2968</lpage><pub-id pub-id-type=""doi"">10.1161/CIRCULATIONAHA.106.670026</pub-id><pub-id pub-id-type=""pmid"">17515463</pub-id></mixed-citation></ref><ref id=""B191""><mixed-citation publication-type=""journal""><name><surname>Padanilam</surname><given-names>BJ</given-names></name><article-title>Induction and subcellular localization of protein kinase C isozymes following renal ischemia</article-title><source>Kidney Int</source><year>2001</year><volume>59</volume><fpage>1789</fpage><lpage>1797</lpage><pub-id pub-id-type=""doi"">10.1046/j.1523-1755.2001.0590051789.x</pub-id><pub-id pub-id-type=""pmid"">11318949</pub-id></mixed-citation></ref><ref id=""B192""><mixed-citation publication-type=""journal""><name><surname>Calura</surname><given-names>E</given-names></name><name><surname>Cagnin</surname><given-names>S</given-names></name><name><surname>Raffaello</surname><given-names>A</given-names></name><name><surname>Laveder</surname><given-names>P</given-names></name><name><surname>Lanfranchi</surname><given-names>G</given-names></name><name><surname>Romualdi</surname><given-names>C</given-names></name><article-title>Meta-analysis of expression signatures of muscle atrophy: gene interaction networks in early and late stages</article-title><source>BMC Genomics</source><year>2008</year><volume>9</volume><fpage>630</fpage><pub-id pub-id-type=""doi"">10.1186/1471-2164-9-630</pub-id><pub-id pub-id-type=""pmid"">19108710</pub-id></mixed-citation></ref><ref id=""B193""><mixed-citation publication-type=""journal""><name><surname>Mor</surname><given-names>I</given-names></name><name><surname>Sklan</surname><given-names>EH</given-names></name><name><surname>Podoly</surname><given-names>E</given-names></name><name><surname>Pick</surname><given-names>M</given-names></name><name><surname>Kirschner</surname><given-names>M</given-names></name><name><surname>Yogev</surname><given-names>L</given-names></name><name><surname>Bar-Sheshet Itach</surname><given-names>S</given-names></name><name><surname>Schreiber</surname><given-names>L</given-names></name><name><surname>Geyer</surname><given-names>B</given-names></name><name><surname>Mor</surname><given-names>T</given-names></name><etal></etal><article-title>Acetylcholinesterase-R increases germ cell apoptosis but enhances sperm motility</article-title><source>J Cell Mol Med</source><year>2008</year><volume>12</volume><fpage>479</fpage><lpage>495</lpage><pub-id pub-id-type=""doi"">10.1111/j.1582-4934.2008.00231.x</pub-id><pub-id pub-id-type=""pmid"">18194455</pub-id></mixed-citation></ref><ref id=""B194""><mixed-citation publication-type=""journal""><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Friedman</surname><given-names>E</given-names></name><article-title>Increased association of brain protein kinase C with the receptor for activated C kinase-1 (RACK1) in bipolar affective disorder</article-title><source>Biol Psychiatry</source><year>2001</year><volume>50</volume><fpage>364</fpage><lpage>370</lpage><pub-id pub-id-type=""doi"">10.1016/S0006-3223(01)01147-7</pub-id><pub-id pub-id-type=""pmid"">11543740</pub-id></mixed-citation></ref><ref id=""B195""><mixed-citation publication-type=""journal""><name><surname>Pascale</surname><given-names>A</given-names></name><name><surname>Fortino</surname><given-names>I</given-names></name><name><surname>Govoni</surname><given-names>S</given-names></name><name><surname>Trabucchi</surname><given-names>M</given-names></name><name><surname>Wetsel</surname><given-names>WC</given-names></name><name><surname>Battaini</surname><given-names>F</given-names></name><article-title>Functional impairment in protein kinase C by RACK1 (receptor for activated C kinase 1) deficiency in aged rat brain cortex</article-title><source>J Neurochem</source><year>1996</year><volume>67</volume><fpage>2471</fpage><lpage>2477</lpage><pub-id pub-id-type=""pmid"">8931480</pub-id></mixed-citation></ref><ref id=""B196""><mixed-citation publication-type=""journal""><name><surname>Shimohama</surname><given-names>S</given-names></name><name><surname>Kamiya</surname><given-names>S</given-names></name><name><surname>Taniguchi</surname><given-names>T</given-names></name><name><surname>Kimura</surname><given-names>J</given-names></name><article-title>Intracellular receptors for activated C-kinase in the postmortem human brain: no alteration in Alzheimer disease</article-title><source>Alzheimer Dis Assoc Disord</source><year>1998</year><volume>12</volume><fpage>384</fpage><lpage>386</lpage><pub-id pub-id-type=""doi"">10.1097/00002093-199812000-00022</pub-id><pub-id pub-id-type=""pmid"">9876970</pub-id></mixed-citation></ref><ref id=""B197""><mixed-citation publication-type=""journal""><name><surname>Matsushima</surname><given-names>H</given-names></name><name><surname>Shimohama</surname><given-names>S</given-names></name><name><surname>Chachin</surname><given-names>M</given-names></name><name><surname>Taniguchi</surname><given-names>T</given-names></name><name><surname>Kimura</surname><given-names>J</given-names></name><article-title>Ca2+-dependent and Ca2+-independent protein kinase C changes in the brain of patients with Alzheimer's disease</article-title><source>J Neurochem</source><year>1996</year><volume>67</volume><fpage>317</fpage><lpage>323</lpage><pub-id pub-id-type=""pmid"">8667008</pub-id></mixed-citation></ref><ref id=""B198""><mixed-citation publication-type=""other""><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Dou</surname><given-names>F</given-names></name><name><surname>Feng</surname><given-names>J</given-names></name><name><surname>Yan</surname><given-names>Z</given-names></name><article-title>RACK1 is involved in beta-amyloid impairment of muscarinic regulation of GABAergic transmission</article-title><source>Neurobiol Aging</source><year>2009</year></mixed-citation></ref><ref id=""B199""><mixed-citation publication-type=""journal""><name><surname>Mourtada-Maarabouni</surname><given-names>M</given-names></name><name><surname>Kirkham</surname><given-names>L</given-names></name><name><surname>Farzaneh</surname><given-names>F</given-names></name><name><surname>Williams</surname><given-names>GT</given-names></name><article-title>Functional expression cloning reveals a central role for the receptor for activated protein kinase C 1 (RACK1) in T cell apoptosis</article-title><source>J Leukoc Biol</source><year>2005</year><volume>78</volume><fpage>503</fpage><lpage>514</lpage><pub-id pub-id-type=""doi"">10.1189/jlb.0205070</pub-id><pub-id pub-id-type=""pmid"">15870214</pub-id></mixed-citation></ref><ref id=""B200""><mixed-citation publication-type=""journal""><name><surname>Baumann</surname><given-names>M</given-names></name><name><surname>Gires</surname><given-names>O</given-names></name><name><surname>Kolch</surname><given-names>W</given-names></name><name><surname>Mischak</surname><given-names>H</given-names></name><name><surname>Zeidler</surname><given-names>R</given-names></name><name><surname>Pich</surname><given-names>D</given-names></name><name><surname>Hammerschmidt</surname><given-names>W</given-names></name><article-title>The PKC targeting protein RACK1 interacts with the Epstein-Barr virus activator protein BZLF1</article-title><source>Eur J Biochem</source><year>2000</year><volume>267</volume><fpage>3891</fpage><lpage>3901</lpage><pub-id pub-id-type=""pmid"">10849009</pub-id></mixed-citation></ref><ref id=""B201""><mixed-citation publication-type=""journal""><name><surname>Daniels</surname><given-names>CC</given-names></name><name><surname>Rovnak</surname><given-names>J</given-names></name><name><surname>Quackenbush</surname><given-names>SL</given-names></name><article-title>Walleye dermal sarcoma virus Orf B functions through receptor for activated C kinase (RACK1) and protein kinase C</article-title><source>Virology</source><year>2008</year><volume>375</volume><fpage>550</fpage><lpage>560</lpage><pub-id pub-id-type=""doi"">10.1016/j.virol.2008.01.034</pub-id><pub-id pub-id-type=""pmid"">18343476</pub-id></mixed-citation></ref><ref id=""B202""><mixed-citation publication-type=""journal""><name><surname>Kubota</surname><given-names>T</given-names></name><name><surname>Yokosawa</surname><given-names>N</given-names></name><name><surname>Yokota</surname><given-names>S</given-names></name><name><surname>Fujii</surname><given-names>N</given-names></name><article-title>Association of mumps virus V protein with RACK1 results in dissociation of STAT-1 from the alpha interferon receptor complex</article-title><source>J Virol</source><year>2002</year><volume>76</volume><fpage>12676</fpage><lpage>12682</lpage><pub-id pub-id-type=""doi"">10.1128/JVI.76.24.12676-12682.2002</pub-id><pub-id pub-id-type=""pmid"">12438593</pub-id></mixed-citation></ref><ref id=""B203""><mixed-citation publication-type=""journal""><name><surname>Al-Reefy</surname><given-names>S</given-names></name><name><surname>Mokbel</surname><given-names>K</given-names></name><article-title>The role of RACK1 as an independent prognostic indicator in human breast cancer</article-title><source>Breast Cancer Res Treat</source><year>2010</year><volume>123</volume><fpage>911</fpage><comment>author reply 912</comment><pub-id pub-id-type=""doi"">10.1007/s10549-010-1020-y</pub-id><pub-id pub-id-type=""pmid"">20632085</pub-id></mixed-citation></ref><ref id=""B204""><mixed-citation publication-type=""journal""><name><surname>Al-Reefy</surname><given-names>S</given-names></name><name><surname>Osman</surname><given-names>H</given-names></name><name><surname>Jiang</surname><given-names>W</given-names></name><name><surname>Mokbel</surname><given-names>K</given-names></name><article-title>Evidence for a pro-apoptotic function of RACK1 in human breast cancer</article-title><source>Oncogene</source><year>2010</year><volume>29</volume><fpage>5651</fpage><comment>author reply 5652</comment><pub-id pub-id-type=""doi"">10.1038/onc.2010.291</pub-id><pub-id pub-id-type=""pmid"">20697360</pub-id></mixed-citation></ref><ref id=""B205""><mixed-citation publication-type=""journal""><name><surname>Cao</surname><given-names>XX</given-names></name><name><surname>Xu</surname><given-names>JD</given-names></name><name><surname>Liu</surname><given-names>XL</given-names></name><name><surname>Xu</surname><given-names>JW</given-names></name><name><surname>Wang</surname><given-names>WJ</given-names></name><name><surname>Li</surname><given-names>QQ</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Xu</surname><given-names>ZD</given-names></name><name><surname>Liu</surname><given-names>XP</given-names></name><article-title>RACK1: A superior independent predictor for poor clinical outcome in breast cancer</article-title><source>Int J Cancer</source><year>2010</year><volume>127</volume><fpage>1172</fpage><lpage>1179</lpage><pub-id pub-id-type=""pmid"">20020495</pub-id></mixed-citation></ref><ref id=""B206""><mixed-citation publication-type=""journal""><name><surname>Nagashio</surname><given-names>R</given-names></name><name><surname>Sato</surname><given-names>Y</given-names></name><name><surname>Matsumoto</surname><given-names>T</given-names></name><name><surname>Kageyama</surname><given-names>T</given-names></name><name><surname>Satoh</surname><given-names>Y</given-names></name><name><surname>Shinichiro</surname><given-names>R</given-names></name><name><surname>Masuda</surname><given-names>N</given-names></name><name><surname>Goshima</surname><given-names>N</given-names></name><name><surname>Jiang</surname><given-names>SX</given-names></name><name><surname>Okayasu</surname><given-names>I</given-names></name><article-title>Expression of RACK1 is a novel biomarker in pulmonary adenocarcinomas</article-title><source>Lung Cancer</source><year>2010</year><volume>69</volume><fpage>54</fpage><lpage>59</lpage><pub-id pub-id-type=""doi"">10.1016/j.lungcan.2009.09.015</pub-id><pub-id pub-id-type=""pmid"">19892429</pub-id></mixed-citation></ref><ref id=""B207""><mixed-citation publication-type=""journal""><name><surname>Seidl</surname><given-names>P</given-names></name><name><surname>Huettinger</surname><given-names>R</given-names></name><name><surname>Knuechel</surname><given-names>R</given-names></name><name><surname>Kunz-Schughart</surname><given-names>LA</given-names></name><article-title>Three-dimensional fibroblast-tumor cell interaction causes downregulation of RACK1 mRNA expression in breast cancer cells in vitro</article-title><source>Int J Cancer</source><year>2002</year><volume>102</volume><fpage>129</fpage><lpage>136</lpage><pub-id pub-id-type=""doi"">10.1002/ijc.10675</pub-id><pub-id pub-id-type=""pmid"">12385007</pub-id></mixed-citation></ref><ref id=""B208""><mixed-citation publication-type=""journal""><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Cheng</surname><given-names>GZ</given-names></name><name><surname>Gong</surname><given-names>J</given-names></name><name><surname>Hermanto</surname><given-names>U</given-names></name><name><surname>Zong</surname><given-names>CS</given-names></name><name><surname>Chan</surname><given-names>J</given-names></name><name><surname>Cheng</surname><given-names>JQ</given-names></name><name><surname>Wang</surname><given-names>LH</given-names></name><article-title>RACK1 and CIS mediate the degradation of BimEL in cancer cells</article-title><source>J Biol Chem</source><year>2008</year><volume>283</volume><fpage>16416</fpage><lpage>16426</lpage><pub-id pub-id-type=""doi"">10.1074/jbc.M802360200</pub-id><pub-id pub-id-type=""pmid"">18420585</pub-id></mixed-citation></ref><ref id=""B209""><mixed-citation publication-type=""journal""><name><surname>Bourd-Boittin</surname><given-names>K</given-names></name><name><surname>Le Pabic</surname><given-names>H</given-names></name><name><surname>Bonnier</surname><given-names>D</given-names></name><name><surname>L'Helgoualc'h</surname><given-names>A</given-names></name><name><surname>Theret</surname><given-names>N</given-names></name><article-title>RACK1, a new ADAM12 interacting protein</article-title><source>Contribution to liver fibrogenesis. J Biol Chem</source><year>2008</year><volume>283</volume><fpage>26000</fpage><lpage>26009</lpage></mixed-citation></ref><ref id=""B210""><mixed-citation publication-type=""journal""><name><surname>Egidy</surname><given-names>G</given-names></name><name><surname>Jule</surname><given-names>S</given-names></name><name><surname>Bosse</surname><given-names>P</given-names></name><name><surname>Bernex</surname><given-names>F</given-names></name><name><surname>Geffrotin</surname><given-names>C</given-names></name><name><surname>Vincent-Naulleau</surname><given-names>S</given-names></name><name><surname>Horak</surname><given-names>V</given-names></name><name><surname>Sastre-Garau</surname><given-names>X</given-names></name><name><surname>Panthier</surname><given-names>JJ</given-names></name><article-title>Transcription analysis in the MeLiM swine model identifies RACK1 as a potential marker of malignancy for human melanocytic proliferation</article-title><source>Mol Cancer</source><year>2008</year><volume>7</volume><fpage>34</fpage><pub-id pub-id-type=""doi"">10.1186/1476-4598-7-34</pub-id><pub-id pub-id-type=""pmid"">18442364</pub-id></mixed-citation></ref><ref id=""B211""><mixed-citation publication-type=""journal""><name><surname>Lopez-Bergami</surname><given-names>P</given-names></name><name><surname>Huang</surname><given-names>C</given-names></name><name><surname>Goydos</surname><given-names>JS</given-names></name><name><surname>Yip</surname><given-names>D</given-names></name><name><surname>Bar-Eli</surname><given-names>M</given-names></name><name><surname>Herlyn</surname><given-names>M</given-names></name><name><surname>Smalley</surname><given-names>KS</given-names></name><name><surname>Mahale</surname><given-names>A</given-names></name><name><surname>Eroshkin</surname><given-names>A</given-names></name><name><surname>Aaronson</surname><given-names>S</given-names></name><name><surname>Ronai</surname><given-names>Z</given-names></name><article-title>Rewired ERK-JNK signaling pathways in melanoma</article-title><source>Cancer Cell</source><year>2007</year><volume>11</volume><fpage>447</fpage><lpage>460</lpage><pub-id pub-id-type=""doi"">10.1016/j.ccr.2007.03.009</pub-id><pub-id pub-id-type=""pmid"">17482134</pub-id></mixed-citation></ref><ref id=""B212""><mixed-citation publication-type=""journal""><name><surname>Williams</surname><given-names>SR</given-names></name><name><surname>Son</surname><given-names>DS</given-names></name><name><surname>Terranova</surname><given-names>PF</given-names></name><article-title>Protein kinase C delta is activated in mouse ovarian surface epithelial cancer cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)</article-title><source>Toxicology</source><year>2004</year><volume>195</volume><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type=""doi"">10.1016/j.tox.2003.08.005</pub-id><pub-id pub-id-type=""pmid"">14698564</pub-id></mixed-citation></ref><ref id=""B213""><mixed-citation publication-type=""journal""><name><surname>Boner</surname><given-names>W</given-names></name><name><surname>Morgan</surname><given-names>IM</given-names></name><article-title>Novel cellular interacting partners of the human papillomavirus 16 transcription/replication factor E2</article-title><source>Virus Res</source><year>2002</year><volume>90</volume><fpage>113</fpage><lpage>118</lpage><pub-id pub-id-type=""doi"">10.1016/S0168-1702(02)00145-4</pub-id><pub-id pub-id-type=""pmid"">12457967</pub-id></mixed-citation></ref><ref id=""B214""><mixed-citation publication-type=""journal""><name><surname>Hennig</surname><given-names>EE</given-names></name><name><surname>Butruk</surname><given-names>E</given-names></name><name><surname>Ostrowski</surname><given-names>J</given-names></name><article-title>RACK1 protein interacts with Helicobacter pylori VacA cytotoxin: the yeast two-hybrid approach</article-title><source>Biochem Biophys Res Commun</source><year>2001</year><volume>289</volume><fpage>103</fpage><lpage>110</lpage><pub-id pub-id-type=""doi"">10.1006/bbrc.2001.5950</pub-id><pub-id pub-id-type=""pmid"">11708784</pub-id></mixed-citation></ref><ref id=""B215""><mixed-citation publication-type=""journal""><name><surname>Berns</surname><given-names>H</given-names></name><name><surname>Humar</surname><given-names>R</given-names></name><name><surname>Hengerer</surname><given-names>B</given-names></name><name><surname>Kiefer</surname><given-names>FN</given-names></name><name><surname>Battegay</surname><given-names>EJ</given-names></name><article-title>RACK1 is up-regulated in angiogenesis and human carcinomas</article-title><source>FASEB J</source><year>2000</year><volume>14</volume><fpage>2549</fpage><lpage>2558</lpage><pub-id pub-id-type=""doi"">10.1096/fj.99-1038com</pub-id><pub-id pub-id-type=""pmid"">11099474</pub-id></mixed-citation></ref><ref id=""B216""><mixed-citation publication-type=""journal""><name><surname>Amir</surname><given-names>S</given-names></name><name><surname>Golan</surname><given-names>M</given-names></name><name><surname>Mabjeesh</surname><given-names>NJ</given-names></name><article-title>Targeted knockdown of SEPT9_v1 inhibits tumor growth and angiogenesis of human prostate cancer cells concomitant with disruption of hypoxia-inducible factor-1 pathway</article-title><source>Mol Cancer Res</source><year>2010</year><volume>8</volume><fpage>643</fpage><lpage>652</lpage><pub-id pub-id-type=""doi"">10.1158/1541-7786.MCR-09-0497</pub-id><pub-id pub-id-type=""pmid"">20407014</pub-id></mixed-citation></ref><ref id=""B217""><mixed-citation publication-type=""journal""><name><surname>Amir</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Simons</surname><given-names>JW</given-names></name><name><surname>Mabjeesh</surname><given-names>NJ</given-names></name><article-title>SEPT9_v1 up-regulates hypoxia-inducible factor 1 by preventing its RACK1-mediated degradation</article-title><source>J Biol Chem</source><year>2009</year><volume>284</volume><fpage>11142</fpage><lpage>11151</lpage><pub-id pub-id-type=""pmid"">19251694</pub-id></mixed-citation></ref><ref id=""B218""><mixed-citation publication-type=""journal""><name><surname>Huang</surname><given-names>CF</given-names></name><name><surname>Fan</surname><given-names>JH</given-names></name><name><surname>Chuang</surname><given-names>NN</given-names></name><article-title>Farnesyl pyrophosphate promotes and is essential for the binding of RACK1 with beta-tubulin</article-title><source>J Exp Zool A Comp Exp Biol</source><year>2003</year><volume>298</volume><fpage>119</fpage><lpage>127</lpage><pub-id pub-id-type=""pmid"">12884273</pub-id></mixed-citation></ref><ref id=""B219""><mixed-citation publication-type=""journal""><name><surname>Koob</surname><given-names>GF</given-names></name><name><surname>Volkow</surname><given-names>ND</given-names></name><article-title>Neurocircuitry of addiction</article-title><source>Neuropsychopharmacology</source><year>2010</year><volume>35</volume><fpage>217</fpage><lpage>238</lpage><pub-id pub-id-type=""doi"">10.1038/npp.2009.110</pub-id><pub-id pub-id-type=""pmid"">19710631</pub-id></mixed-citation></ref><ref id=""B220""><mixed-citation publication-type=""journal""><name><surname>Escriba</surname><given-names>PV</given-names></name><name><surname>Garcia-Sevilla</surname><given-names>JA</given-names></name><article-title>Parallel modulation of receptor for activated C kinase 1 and protein kinase C-alpha and beta isoforms in brains of morphine-treated rats</article-title><source>Br J Pharmacol</source><year>1999</year><volume>127</volume><fpage>343</fpage><lpage>348</lpage><pub-id pub-id-type=""doi"">10.1038/sj.bjp.0702555</pub-id><pub-id pub-id-type=""pmid"">10385232</pub-id></mixed-citation></ref><ref id=""B221""><mixed-citation publication-type=""journal""><name><surname>Wan</surname><given-names>L</given-names></name><name><surname>Su</surname><given-names>L</given-names></name><name><surname>Xie</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><article-title>Protein receptor for activated C kinase 1 is involved in morphine reward in mice</article-title><source>Neuroscience</source><year>2009</year><volume>161</volume><fpage>734</fpage><lpage>742</lpage><pub-id pub-id-type=""doi"">10.1016/j.neuroscience.2009.03.064</pub-id><pub-id pub-id-type=""pmid"">19341783</pub-id></mixed-citation></ref><ref id=""B222""><mixed-citation publication-type=""journal""><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>R</given-names></name><name><surname>Yuan</surname><given-names>Q</given-names></name><name><surname>Yang</surname><given-names>B</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><article-title>RACK1 inhibits morphine re-exposure via inhibition of Src</article-title><source>Neurol Res</source><year>2011</year><volume>33</volume><fpage>56</fpage><lpage>62</lpage><pub-id pub-id-type=""doi"">10.1179/016164110X12714125204236</pub-id><pub-id pub-id-type=""pmid"">20483033</pub-id></mixed-citation></ref><ref id=""B223""><mixed-citation publication-type=""journal""><name><surname>Liu</surname><given-names>QF</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Yuan</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>YY</given-names></name><name><surname>Lu</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>YH</given-names></name><name><surname>Jiang</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>ZR</given-names></name><article-title>RACK1, a potential target to decrease morphine reward in mice</article-title><source>Arch Ital Biol</source><year>2009</year><volume>147</volume><fpage>131</fpage><lpage>140</lpage><pub-id pub-id-type=""pmid"">20162862</pub-id></mixed-citation></ref><ref id=""B224""><mixed-citation publication-type=""journal""><name><surname>Vagts</surname><given-names>AJ</given-names></name><name><surname>He</surname><given-names>DY</given-names></name><name><surname>Yaka</surname><given-names>R</given-names></name><name><surname>Ron</surname><given-names>D</given-names></name><article-title>Cellular adaptation to chronic ethanol results in altered compartmentalization and function of the scaffolding protein RACK1</article-title><source>Alcohol Clin Exp Res</source><year>2003</year><volume>27</volume><fpage>1599</fpage><lpage>1605</lpage><pub-id pub-id-type=""doi"">10.1097/01.ALC.0000089957.63597.A4</pub-id><pub-id pub-id-type=""pmid"">14574230</pub-id></mixed-citation></ref><ref id=""B225""><mixed-citation publication-type=""journal""><name><surname>Jeanblanc</surname><given-names>J</given-names></name><name><surname>He</surname><given-names>DY</given-names></name><name><surname>McGough</surname><given-names>NN</given-names></name><name><surname>Logrip</surname><given-names>ML</given-names></name><name><surname>Phamluong</surname><given-names>K</given-names></name><name><surname>Janak</surname><given-names>PH</given-names></name><name><surname>Ron</surname><given-names>D</given-names></name><article-title>The dopamine D3 receptor is part of a homeostatic pathway regulating ethanol consumption</article-title><source>J Neurosci</source><year>2006</year><volume>26</volume><fpage>1457</fpage><lpage>1464</lpage><pub-id pub-id-type=""doi"">10.1523/JNEUROSCI.3786-05.2006</pub-id><pub-id pub-id-type=""pmid"">16452669</pub-id></mixed-citation></ref><ref id=""B226""><mixed-citation publication-type=""journal""><name><surname>Logrip</surname><given-names>ML</given-names></name><name><surname>Janak</surname><given-names>PH</given-names></name><name><surname>Ron</surname><given-names>D</given-names></name><article-title>Dynorphin is a downstream effector of striatal BDNF regulation of ethanol intake</article-title><source>FASEB J</source><year>2008</year><volume>22</volume><fpage>2393</fpage><lpage>2404</lpage><pub-id pub-id-type=""doi"">10.1096/fj.07-099135</pub-id><pub-id pub-id-type=""pmid"">18310464</pub-id></mixed-citation></ref><ref id=""B227""><mixed-citation publication-type=""journal""><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Lanfranco</surname><given-names>MF</given-names></name><name><surname>Gibb</surname><given-names>SL</given-names></name><name><surname>Yowell</surname><given-names>QV</given-names></name><name><surname>Carnicella</surname><given-names>S</given-names></name><name><surname>Ron</surname><given-names>D</given-names></name><article-title>Long-lasting adaptations of the NR2B-containing NMDA receptors in the dorsomedial striatum play a crucial role in alcohol consumption and relapse</article-title><source>J Neurosci</source><year>2010</year><volume>30</volume><fpage>10187</fpage><lpage>10198</lpage><pub-id pub-id-type=""doi"">10.1523/JNEUROSCI.2268-10.2010</pub-id><pub-id pub-id-type=""pmid"">20668202</pub-id></mixed-citation></ref><ref id=""B228""><mixed-citation publication-type=""journal""><name><surname>Zylinska</surname><given-names>L</given-names></name><name><surname>Guerini</surname><given-names>D</given-names></name><name><surname>Gromadzinska</surname><given-names>E</given-names></name><name><surname>Lachowicz</surname><given-names>L</given-names></name><article-title>Protein kinases A and C phosphorylate purified Ca2+-ATPase from rat cortex, cerebellum and hippocampus</article-title><source>Biochim Biophys Acta</source><year>1998</year><volume>1448</volume><fpage>99</fpage><lpage>108</lpage><pub-id pub-id-type=""doi"">10.1016/S0167-4889(98)00128-1</pub-id><pub-id pub-id-type=""pmid"">9824678</pub-id></mixed-citation></ref></ref-list>"
10.1002/ajh.20284	"<html><body><article article-type=""research-article"" xmlns:mml=""http://www.w3.org/1998/Math/MathML"" xmlns:xlink=""http://www.w3.org/1999/xlink""><?properties open_access?><front><journal-meta><journal-id journal-id-type=""nlm-ta"">Oncotarget</journal-id><journal-id journal-id-type=""iso-abbrev"">Oncotarget</journal-id><journal-id journal-id-type=""publisher-id"">Oncotarget</journal-id><journal-id journal-id-type=""publisher-id"">ImpactJ</journal-id><journal-title-group><journal-title>Oncotarget</journal-title></journal-title-group><issn pub-type=""epub"">1949-2553</issn><publisher><publisher-name>Impact Journals LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type=""pmid"">28035072</article-id><article-id pub-id-type=""pmc"">5352415</article-id><article-id pub-id-type=""publisher-id"">14295</article-id><article-id pub-id-type=""doi"">10.18632/oncotarget.14295</article-id><article-categories><subj-group subj-group-type=""heading""><subject>Research Paper</subject></subj-group></article-categories><title-group><article-title>ΔNp73 overexpression promotes resistance to apoptosis but does not cooperate with PML/RARA in the induction of an APL-leukemic phenotype</article-title></title-group><contrib-group><contrib contrib-type=""author""><name><surname>Lucena-Araujo</surname><given-names>Antonio R.</given-names></name><xref ref-type=""aff"" rid=""A1""><sup>1</sup></xref><xref ref-type=""aff"" rid=""A2""><sup>2</sup></xref></contrib><contrib contrib-type=""author""><name><surname>Coelho-Silva</surname><given-names>Juan L.</given-names></name><xref ref-type=""aff"" rid=""A2""><sup>2</sup></xref></contrib><contrib contrib-type=""author""><name><surname>Pereira-Martins</surname><given-names>Diego A.</given-names></name><xref ref-type=""aff"" rid=""A2""><sup>2</sup></xref></contrib><contrib contrib-type=""author""><name><surname>Thomé</surname><given-names>Carolina</given-names></name><xref ref-type=""aff"" rid=""A3""><sup>3</sup></xref></contrib><contrib contrib-type=""author""><name><surname>Scheucher</surname><given-names>Priscila S.</given-names></name><xref ref-type=""aff"" rid=""A1""><sup>1</sup></xref></contrib><contrib contrib-type=""author""><name><surname>Lange</surname><given-names>Ana P.</given-names></name><xref ref-type=""aff"" rid=""A1""><sup>1</sup></xref></contrib><contrib contrib-type=""author""><name><surname>Paiva</surname><given-names>Helder H.</given-names></name><xref ref-type=""aff"" rid=""A1""><sup>1</sup></xref></contrib><contrib contrib-type=""author""><name><surname>Hemmelgarn</surname><given-names>Benjamin T.</given-names></name><xref ref-type=""aff"" rid=""A4""><sup>4</sup></xref></contrib><contrib contrib-type=""author""><name><surname>Morais-Sobral</surname><given-names>Mariana C.</given-names></name><xref ref-type=""aff"" rid=""A5""><sup>5</sup></xref></contrib><contrib contrib-type=""author""><name><surname>Azevedo</surname><given-names>Elisa A.</given-names></name><xref ref-type=""aff"" rid=""A6""><sup>6</sup></xref></contrib><contrib contrib-type=""author""><name><surname>Franca-Neto</surname><given-names>Pedro L.</given-names></name><xref ref-type=""aff"" rid=""A2""><sup>2</sup></xref></contrib><contrib contrib-type=""author""><name><surname>Franca</surname><given-names>Rafael F.</given-names></name><xref ref-type=""aff"" rid=""A6""><sup>6</sup></xref></contrib><contrib contrib-type=""author""><name><surname>Silva</surname><given-names>Cleide L.</given-names></name><xref ref-type=""aff"" rid=""A3""><sup>3</sup></xref></contrib><contrib contrib-type=""author""><name><surname>Krause</surname><given-names>Alexandre</given-names></name><xref ref-type=""aff"" rid=""A1""><sup>1</sup></xref></contrib><contrib contrib-type=""author""><name><surname>Rego</surname><given-names>Eduardo M.</given-names></name><xref ref-type=""aff"" rid=""A1""><sup>1</sup></xref><xref ref-type=""aff"" rid=""A3""><sup>3</sup></xref></contrib></contrib-group><aff id=""A1""><sup>1</sup>Department of Internal Medicine, Medical School of Ribeirao Preto, Brazil</aff><aff id=""A2""><sup>2</sup>Department of Genetics, Federal University of Pernambuco, Recife, Brazil</aff><aff id=""A3""><sup>3</sup>Center for Cell Based Therapy, University of Sao Paulo, Ribeirao Preto, Brazil</aff><aff id=""A4""><sup>4</sup>The Ohio State University, Columbus, USA</aff><aff id=""A5""><sup>5</sup>Department of Microbiology, Fundação Oswaldo Cruz, Centro de Pesquisas Aggeu Magalhães, Recife, Brazil</aff><aff id=""A6""><sup>6</sup>Department of Virology, Fundação Oswaldo Cruz, Centro de Pesquisas Aggeu Magalhães, Recife, Brazil</aff><author-notes><corresp id=""cor1""><bold><italic>Correspondence to:</italic></bold><italic>Antonio R. Lucena-Araujo,</italic><email>araujoarl@hotmail.com</email></corresp></author-notes><pub-date pub-type=""collection""><day>31</day><month>1</month><year>2017</year></pub-date><pub-date pub-type=""epub""><day>27</day><month>12</month><year>2016</year></pub-date><volume>8</volume><issue>5</issue><fpage>8475</fpage><lpage>8483</lpage><history><date date-type=""received""><day>18</day><month>5</month><year>2016</year></date><date date-type=""accepted""><day>30</day><month>11</month><year>2016</year></date></history><permissions><copyright-statement>Copyright: © 2017 Lucena-Araujo et al.</copyright-statement><copyright-year>2017</copyright-year><license license-type=""open-access"" xlink:href=""http://creativecommons.org/licenses/by/3.0/""><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><abstract><p>Here, we evaluated whether the overexpression of transcriptionally inactive ΔNp73 cooperates with PML/RARA fusion protein in the induction of an APL-leukemic phenotype, as well as its role<italic>in vitro</italic>in proliferation, myeloid differentiation, and drug-induced apoptosis. Using lentiviral gene transfer, we showed<italic>in vitro</italic>that ΔNp73 overexpression resulted in increased proliferation in murine bone marrow (BM) cells from hCG-PML/RARA transgenic mice and their wild-type (WT) counterpart, with no accumulation of cells at G2/M or S phases; instead, ΔNp73-expressing cells had a lower rate of induced apoptosis. Next, we evaluated the effect of ΔNp73 on stem-cell self-renewal and myeloid differentiation. Primary BM cells lentivirally infected with human ΔNp73 were not immortalized in culture and did not present significant changes in the percentage of CD11b. Finally, we assessed the impact of ΔNp73 on leukemogenesis or its possible cooperation with PML/RARA fusion protein in the induction of an APL-leukemic phenotype. After 120 days of follow-up, all transplanted mice were clinically healthy and, no evidence of leukemia/myelodysplasia was apparent. Taken together, our data suggest that ΔNp73 had no leukemic transformation capacity by itself and apparently did not cooperate with the PML/RARA fusion protein to induce a leukemic phenotype in a murine BM transplantation model. In addition, the forced expression of ΔNp73 in murine BM progenitors did not alter the ATRA-induced differentiation rate<italic>in vitro</italic>or induce aberrant cell proliferation, but exerted an important role in cell survival, providing resistance to drug-induced apoptosis.</p></abstract><kwd-group><kwd>acute promyelocytic leukemia</kwd><kwd>ΔNp73</kwd><kwd>apoptosis</kwd><kwd>bone marrow transplantation</kwd><kwd>lentiviral gene transfer</kwd></kwd-group></article-meta></front><sec id=""s1""><title>INTRODUCTION</title><p>In the clinical setting, high expression of the NH2-terminal truncated ΔNp73 isoforms (alone or in association with full-length transcriptionally active TAp73, i.e., a high ΔNp73/TAp73 ratio) has been associated with poor prognosis in primary human tumors [<xref ref-type=""bibr"" rid=""R1"">1</xref>–<xref ref-type=""bibr"" rid=""R3"">3</xref>], including hematological malignancies [<xref ref-type=""bibr"" rid=""R4"">4</xref>–<xref ref-type=""bibr"" rid=""R6"">6</xref>]. Recently [<xref ref-type=""bibr"" rid=""R7"">7</xref>], we demonstrated that a high ΔNp73/TAp73 ratio is associated with inferior outcome in patients with acute promyelocytic leukemia (APL) treated with all-<italic>trans</italic>retinoic acid (ATRA) and anthracycline-based chemotherapy according to the International Consortium on APL 2005 protocol [<xref ref-type=""bibr"" rid=""R8"">8</xref>]. However, the mechanism through which ΔNp73 leads to adverse outcomes in APL remains to be elucidated and if ΔNp73 works as a driver oncogene in APL is unknown. Using lentiviral gene transfer and murine bone marrow (BM) transplantation, we evaluated whether the forced expression of ΔNp73 cooperates with PML/RARA fusion protein in the induction of an APL-leukemic phenotype. We also investigated the role of ΔNp73 in proliferation, myeloid differentiation, and drug-induced apoptosis.</p></sec><sec id=""s2""><title>RESULTS AND DISCUSSION</title><p>First, we evaluated the role of ΔNp73 in cell proliferation. At the end of the fifth day of culture, the forced expression of human ΔNp73 in hCG-PML/RARA and WT murine cells resulted in increased proliferation compared to respective controls (Figure<xref ref-type=""fig"" rid=""F1"">1A</xref>). Intriguingly, after subsequent cell cycle analysis, we found no accumulation of cells at G2/M or S phases. On the other hand, number of cells at sub-G0 fraction was significantly lower in ΔNp73-expressing cells than empty vector controls (Figure<xref ref-type=""fig"" rid=""F1"">1B</xref>). We subsequently validated these findings through annexin-V/propidium iodide staining method, demonstrating that the basal apoptosis rate (i.e., spontaneous apoptosis) was less pronounced in ΔNp73-expressing cells, regardless the presence of PML/RARA fusion gene (Figure<xref ref-type=""fig"" rid=""F1"">1C</xref>).</p><fig id=""F1"" orientation=""portrait"" position=""float""><label>Figure 1</label><caption><title>Characterization (in vitro assays) of primary hCG-PML/RARA-positive and WT hematopoietic progenitors infected with empty vector (pMEG) or pMEG-ΔNp73 lentiviruses</title><p>Growth curves<bold>A.</bold>and subsequent cell cycle analysis<bold>B.</bold>in vitro of hCG-PML/RARA-positive and WT cells. Data are expressed as mean ± standard error of the mean<bold>C.</bold>Representative analysis of the number of apoptotic cells by Annexin-V/propidium iodide binding assay according to the presence or absence of ΔNp73. Primary BM cells from hCG-PML/RARA and WT mice were incubated with complete medium and no stimulus for apoptosis (spontaneous apoptosis) for 48-72 hours. * P &lt; 0.05. Note: Comparison among all four groups were performed for proliferation assays using Kruskal-Wallis test with Dunn's multiple comparison post test. No significant differences was observed between WT pMEG and PML/RARA pMEG or WT pMEG-ΔNp73 and PML/RARA pMEG-ΔNp73 groups.</p></caption><graphic xlink:href=""oncotarget-08-8475-g001""></graphic></fig><p>These findings prompted us to investigate whether ΔNp73 overexpression results in resistance to drug-induced apoptosis. We performed an<italic>in vitro</italic>assay of apoptosis using cytarabine (Ara-C, IC50: 100μg/ml) as the apoptotic stimulus [<xref ref-type=""bibr"" rid=""R9"">9</xref>]. Twenty-four hours later, ΔNp73-expressing cells had a lower rate of apoptosis than empty vector controls (Figure<xref ref-type=""fig"" rid=""F2"">2A–2B</xref>). Next, we examined genes related to apoptosis and cell cycle pathways that were differentially expressed between hCG-PML/RARA cells (expressing or not the human ΔNp73 gene) upon Ara-C treatment. Using PCR array procedure, we identified a set of 42 genes (39 upregulated and three downregulated) differentially expressed in hCG-PML/RARA Np73-expressing cells in comparison with empty vector control (Figure<xref ref-type=""fig"" rid=""F2"">2C</xref>). As expected, most of genes were linked to apoptosis pathways. Only three genes related to cell cycle arrest were modulated by the presence of ΔNp73 in hCG-PM/RARA-positive cells (Mdm2, Cdkn2a (p21), Mtbp). Of interest, apoptosis-associated genes in Np73-expressing cells belonged to both mitochondrial-mediated (intrinsic pathway) and receptor-mediated pathways (extrinsic pathway).</p><fig id=""F2"" orientation=""portrait"" position=""float""><label>Figure 2</label><caption><title>Drug-induced apoptosis assay</title><p><bold>A.</bold>Representative example of one out of five independent experiments of apoptosis using Ara-C 100μg/ml as standard stimulus for apoptosis.<bold>B.</bold>Percentage of apoptotic cells after 24h in culture after apoptotic stimulus.<bold>C.</bold>Fold induction upon Ara-C treatment of the top genes differentially expressed in hCG-PML-RARA cells overexpressing or not the ΔNp73. Genes related to intrinsic or extrinsic pathways are indicated. Genes highlighted in gray represent those related to cell cycle control. (Ø) represents non treated samples. * indicates P &lt; 0.05.</p></caption><graphic xlink:href=""oncotarget-08-8475-g002""></graphic></fig><p>Next, we evaluated the effect of ΔNp73 on stem cell self-renewal and myeloid differentiation. Primary BM cells from hCG-PML/RARA and WT mice infected with human ΔNp73 were not immortalized in methylcellulose culture. At first plating, the final number of myeloid colonies was not different between ΔNp73-expressing cells and their respective controls (Figure<xref ref-type=""fig"" rid=""F3"">3A</xref>). In addition, the formation of colonies in methylcellulose was not sustained after the third to fourth plating in none of the groups (Figure<xref ref-type=""fig"" rid=""F3"">3B</xref>). Nevertheless, the final number of ΔNp73-expressing myeloid colonies was significantly higher compared to their respective controls after adding Ara-C 100 μg/ml to the methylcellulose cultures (Figure<xref ref-type=""fig"" rid=""F3"">3C</xref>), corroborating the resistance to drug-induced apoptosis observed in liquid culture. To check whether the forced expression of ΔNp73 affects myeloid differentiation, we evaluated the percentage of CD11b-positive cells using ATRA (1 μM, 7 days in liquid culture) as the standard stimulus for differentiation. Immunophenotypic analysis revealed that induced expression of human ΔNp73 did not significantly change the percentage of CD11b-positive cells (Figure<xref ref-type=""fig"" rid=""F3"">3D</xref>).</p><fig id=""F3"" orientation=""portrait"" position=""float""><label>Figure 3</label><caption><title>Effect of ΔNp73 on stem cell self-renewal and myeloid differentiation</title><p><bold>A.</bold>Number of colony-forming cells and<bold>B.</bold>clonogenic assay. Analysis of the number of colonies in methylcellulose. Bars represent the number of colonies counted after each plating.<bold>C.</bold>Colony forming assays performed in the presence of Ara-c 100 μg/ml.<bold>D.</bold>Myeloid differentiation. Percentage of CD11b-positive cells in hCG-PML/RARA cells or WT primary cells (infected with empty vector, pMEG or pMEG-ΔNp73 lentiviruses) using ATRA 1μM as the standard stimulus for differentiation. (Ø) represent non treated samples. * P &lt; 0.05. NS: not significant. Note: Comparison among all four groups were performed using Kruskal-Wallis test with Dunn's multiple comparison post test. No significant differences was observed between WT pMEG and PML/RARA pMEG or WT pMEG-ΔNp73 and PML/RARA pMEG-ΔNp73 groups.</p></caption><graphic xlink:href=""oncotarget-08-8475-g003""></graphic></fig><p>Finally, we assessed the impact of ΔNp73 on leukemogenesis or its possible cooperation<italic>in vivo</italic>with PML/RARA fusion protein in the induction of an APL-leukemic phenotype by transplanting lethally irradiated NOD/SCID mice (10 animals per group) with 3×10<sup>5</sup>GFP-positive BM cells (with or without human ΔNp73) from hCG-PML/RARA cells or WT mice, along with 2×10<sup>5</sup>recipient-type BM cells. Following repopulation (at day 21 after transplantation), hemoglobin levels (P=0.03) and platelet counts (P=0.044) were significantly higher in both groups of mice transplanted with WT cells, regardless of the presence of ΔNp73 (<xref ref-type=""supplementary-material"" rid=""SD1"">Supplementary Table 1</xref>). Forty-five days after transplantation, a higher percentage of ΔNp73-expressing cells was detected in the peripheral blood of recipients compared to empty vector controls (P&lt;0.05, Figure<xref ref-type=""fig"" rid=""F4"">4A</xref>). However, after 120 days of follow-up [<xref ref-type=""bibr"" rid=""R10"">10</xref>–<xref ref-type=""bibr"" rid=""R12"">12</xref>], all transplanted mice were clinically healthy and, according to the Bethesda criteria for hematopoietic neoplasms in mice [<xref ref-type=""bibr"" rid=""R13"">13</xref>], no evidence of leukemia or myelodysplasia was apparent after morphological evaluation of BM or spleen cells. Immunophenotypic analysis of BM recipients’ cells revealed no significant difference between ΔNp73-expressing and non-ΔNp73-expressing cells with respect to myeloid and lymphoid cell markers (Figure<xref ref-type=""fig"" rid=""F4"">4B</xref>).</p><fig id=""F4"" orientation=""portrait"" position=""float""><label>Figure 4</label><caption><title>In vivo assays</title><p><bold>A.</bold>Percentage of GFP-positive cells in the peripheral blood of lethally irradiated recipient mice transplanted with PML/RARA-positive or WT bone marrow cells in the presence or absence of ΔNp73 overexpression.<bold>B.</bold>Immunophenotypic analysis of bone marrow recipients’ cells with respect to myeloid and lymphoid cell markers after transplantation. Box plots show the summarized data for immunophenotypic analyses of bone marrow from survival mice that received a transplant of empty vector control (WT, 7 animals; hCG-PML/RARA, 8 animals) or ΔNp73 (WT, 8 animals; hCG-PML/RARA, 6 animals). hGC-PML/RARA transplanted mice were not leukemic at the time of analysis. Bone marrow cells were stained for the indicated surface markers as indicated in the bottom of the figure. No significant difference between groups were detected.</p></caption><graphic xlink:href=""oncotarget-08-8475-g004""></graphic></fig><p>The hypothesis that ΔNp73 harbors oncogenic potential is based on classical<italic>in vitro</italic>and<italic>in vivo</italic>transformation assays that demonstrated a proliferative advantage and/or cell immortalization of ΔNp73-expressing cells [<xref ref-type=""bibr"" rid=""R14"">14</xref>–<xref ref-type=""bibr"" rid=""R16"">16</xref>]. Other studies have suggested that differentiation, rather than proliferation and cell immortalization, dictates the oncogenic potential of ΔNp73 [<xref ref-type=""bibr"" rid=""R17"">17</xref>]. By delaying or blocking differentiation, ΔNp73 could prevent progenitors from reaching terminal differentiation, keeping these cells in a constant proliferative state and thereby enabling tumor development driven by cooperating oncogenes. Interestingly, ΔNp73 has been associated with the initiation of metastasis in melanoma cells [<xref ref-type=""bibr"" rid=""R18"">18</xref>] and several lines of evidence support ΔNp73 as an important determinant for apoptotic response to therapy [<xref ref-type=""bibr"" rid=""R2"">2</xref>,<xref ref-type=""bibr"" rid=""R9"">9</xref>,<xref ref-type=""bibr"" rid=""R19"">19</xref>]. Accordingly, cells from transgenic mice selectively deficient for the ΔNp73 isoforms have been shown to be more sensitive to DNA-damaging agents and undergo increased p53-dependent apoptosis [<xref ref-type=""bibr"" rid=""R20"">20</xref>]. On the other hand, the ectopic expression of transcriptionally active TAp73 was able to reduce drug resistance to chemotherapy in metastatic melanoma cells, which expressed high levels of ΔNp73 [<xref ref-type=""bibr"" rid=""R21"">21</xref>]. In agreement with this finding, down-regulation of the ΔNp73 isoforms by antisense techniques has been shown to enhance TP53/TAp73-mediated apoptosis in cancer cells in response to chemotherapy [<xref ref-type=""bibr"" rid=""R22"">22</xref>,<xref ref-type=""bibr"" rid=""R23"">23</xref>].</p><p>Here, we did not see evidence of malignant transformation of pre-leukemic PML/RARA-positive cells by the forced expression of ΔNp73 in<italic>in vitro</italic>or<italic>in vivo</italic>experiments, but instead ΔNp73 overexpression provided an adaptive clonal advantage in the presence of a pro-apoptotic stimulus. One may argue that mice transplanted with PML/RARA-positive cells should develop an APL-leukemic phenotype; nevertheless, it worth to note that only 8-12% of hCG-PML/RARA transgenic mice develop leukemia [<xref ref-type=""bibr"" rid=""R24"">24</xref>], and several evidence have demonstrated that the presence of PML/RARA fusion oncoprotein in transgenic mice is not<italic>per se</italic>sufficient to cause leukemia [<xref ref-type=""bibr"" rid=""R25"">25</xref>–<xref ref-type=""bibr"" rid=""R27"">27</xref>]. Interestingly, the protective effect of ΔNp73 on cell death apparently was not influenced by the presence of the PML/RARA oncoprotein. Such an interaction would be expected, considering the intricate functional relationship between PML-p73-PML/RARA in APL blasts. At least when overexpressed, wild-type PML stabilizes p73 protein through acetylation, preventing its ubiquitination and subsequent degradation [<xref ref-type=""bibr"" rid=""R28"">28</xref>]. In APL, p73 stability/activity may be impaired mainly due to the disruption of PML-nuclear bodies by PML/RARA oncoprotein. Currently, whether distinct p73 isoforms (including the transactivation-deficient ΔNp73 isoform) are differentially affected by impaired PML functions is unknown.</p><p>Although the aforementioned and others issues remain to be elucidated, it is undeniable the role of the<italic>TP53</italic>family members and their intricate relationship in APL, in both onset and eradication of the disease. Gaillard et al. compared the gene expression and methylation profiles of purified promyelocyte populations from pre-leukemic MRP8-PML/RARA transgenic mice and showed that, in the absence of secondary lesions, PML/RARA has an overall limited impact on both the transcriptome and methylome [<xref ref-type=""bibr"" rid=""R29"">29</xref>]. The authors observed significant enrichment of the expression of cell cycle-related genes in PML/RARA promyelocytes, which led to expansion of the promyelocyte compartment and hypothesized that PML/RARA initiates leukemia by subtly shifting cell fate decisions within the promyelocyte compartment. Because our data suggest that ΔNp73 plays an important role in cell survival, it is conceivable that ΔNp73 participates in expansion of the promyelocytic compartment as an additional/secondary event. Following this reasoning, Ablain et al. [<xref ref-type=""bibr"" rid=""R30"">30</xref>] demonstrated that a functional Pml-p53 axis is required to eradicate leukemia-initiating cells in a mouse model of APL. Upon ATRA-induced PML/RARA degradation, normal Pml elicits nuclear bodies reformation and induces a p53 response, which exhibits features of senescence, but not apoptosis. According to our hypothesis, even with the restoration of the nuclear bodies upon ATRA treatment and subsequent activation of Trp53 signaling, it is theoretically possible that the overexpression of ΔNp73 protein impairs p53 tumor suppressor functions, and thus coffering survival advantage and/or resistance to chemotherapy to leukemic cells.</p><p>Taken together, these findings lead us to two major conclusions. First, ΔNp73 had no leukemic transformation capacity by itself and apparently did not cooperate with the PML/RARA fusion protein to induce a leukemic phenotype in a murine BM transplantation model. Second, the forced expression of ΔNp73 in murine BM progenitors did not alter the ATRA-induced differentiation rate<italic>in vitro</italic>or induce aberrant cell proliferation, but exerted an important role in cell survival, providing resistance to drug-induced apoptosis. We and others [<xref ref-type=""bibr"" rid=""R2"">2</xref>,<xref ref-type=""bibr"" rid=""R3"">3</xref>,<xref ref-type=""bibr"" rid=""R6"">6</xref>,<xref ref-type=""bibr"" rid=""R7"">7</xref>,<xref ref-type=""bibr"" rid=""R19"">19</xref>,<xref ref-type=""bibr"" rid=""R23"">23</xref>,<xref ref-type=""bibr"" rid=""R31"">31</xref>–<xref ref-type=""bibr"" rid=""R34"">34</xref>] support the idea that ΔNp73 overexpression may be an important determinant of the clinical response to chemotherapy and may offer a therapeutic target for enhancing chemosensitivity in human tumors, including APL. Of course, in the current scenario, the combination of ATRA and arsenic trioxide must be tested in ΔNp73-expressing cells in order to develop better strategies for patients who need special care, particularly those considered high-risk.</p></sec><sec id=""s3"" sec-type=""methods""><title>MATERIALS AND METHODS</title><sec id=""s3_1""><title>Lentiviral transduction of primary murine bone marrow cells</title><sec id=""s3_1_1""><title>Mice</title><p>Parental strain mice were bred and maintained at the Center for Cell Based Therapy Animal Facility. All experiments using mice were approved by the Institutional Animal Experimentation Ethics Committee (protocol number #088/2007) and conducted according to national guidelines for care and use of laboratory animals. Cathepsin G-PML/RARA (hCG-PML/RARA) transgenic mice [<xref ref-type=""bibr"" rid=""R24"">24</xref>] and their wild-type (WT) counterparts, at 8 to 12 weeks of age, were used as donors of primary BM for lentiviral infection and subsequent<italic>in vitro</italic>assays and BM transplantation. Female NOD/SCID mice, older than 8 weeks of age, were used as recipients for BM transplantation model. hCG-PML/RARA transgenic mice and WT littermates were kindly provided by Dr. Pier Paolo Pandolfi (Beth Israel Deaconess Medical Center, Harvard Stem Cell Institute, Boston, USA). All animals were housed under specific pathogen free conditions in individually ventilated cages during the whole experiment and were maintained according to the Guide for Care and Use of Laboratory Animals of the National Research Council, USA, and to the National Council of Animal Experiment Control recommendations.</p></sec><sec id=""s3_1_2""><title>Lentivirus production</title><p>Recombinant lentivirus encoding ΔNp73 gene was generated using pCDH1-MCS1-EF1-GFP-Puro (pMEG) (<xref ref-type=""supplementary-material"" rid=""SD1"">Supplementary Figure 1A</xref>) self-inactivating lentivector (#CD713B-1; System Biosciences, Mountain View, CA, USA) in 293T cells by following the three-plasmid packaging procedure as described elsewhere [<xref ref-type=""bibr"" rid=""R35"">35</xref>]. Briefly, the cDNA encoding hemagglutinin (HA)-tagged-ΔNp73 was subcloned into Xbal and BamHI sites downstream to murine stem cell virus (MSCV) promoter. The complete sequence of ΔNp73 gene was synthesized and fully sequenced in both directions by GenScript (Piscataway Township, NJ, USA). In addition to the MSCV promoter, the pMEG lentivector harbors the enhanced GFP (EGFP) gene and the puromycin resistance gene (PURO) under the control of the constitutive human elongation factor 1α (EF1) promoter. pMEG-lentivector (containing or not the encoding ΔNp73 gene; 22.5 μg/plate), pCMVΔR8.74 expressing HIV gag/pol, Rev and tat (15 μg/plate), and pMD2G vector expressing VSV-G (8 μg/plate) were transfected into five 100 mm culture dishes containing 293T cells using Lipofectamine 2000 (Invitrogen), according to manufacturer recommendations. Twenty-four hours later, the fresh lentiviral particle-containing supernatants were collected, filtered through 0.45-μm filters (Sarstedt, Nümbrecht, Germany) and used to infect the target cells.</p></sec><sec id=""s3_1_3""><title>Primary BM cell isolation and lentiviral infection</title><p>We used murine BM cells from healthy and age-matched hCG-PML/RARA transgenic mice and their WT counterparts as the target for lentiviral infection. Briefly, mice were treated with 150 mg/kg 5-fluorouracil for 5 days, sacrificed, and BM cells obtained by bone crushing. The cells were pre-stimulated for 48 hours in medium supplemented with 20% fetal bovine serum, murine interleukin-3 (6 ng/ml), murine interleukin-6 (10 ng/ml), and murine stem cell factor (100 ng/ml) in a humidified incubator at 37°C and 5% CO<sub>2</sub>. Next, the murine BM cells were infected with empty vector (pMEG) or pMEG-ΔNp73 lentiviruses for 4 to 6 hours, purified based on the expression of GFP protein (<xref ref-type=""supplementary-material"" rid=""SD1"">Supplementary Figure 1B</xref>), and posteriorly used for BM transplantation and<italic>in vitro</italic>assays.</p></sec></sec><sec id=""s3_2""><title>Western blotting and antibodies</title><p>Whole-cell lysates were prepared as previously described [<xref ref-type=""bibr"" rid=""R36"">36</xref>]. Mouse anti-β-actin (sc-81178) was purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA) and horseradish peroxidase-conjugated secondary antibody horse anti-mouse IgG (#7076) was purchased from Cell Signaling (Beverly, MA, USA). Anti-HA (NH2-terminal)-HRP Antibody (R930-25) was purchased from Life Technologies (Carlsbad, CA, USA). The antibody-protein complex was detected using the ECL Western Blotting Detection Reagents (GE Lifesciences Amersham, Buckinghamshire, Buckinghamshire, England).</p></sec><sec id=""s3_3""><title><italic>In vitro</italic>assays</title><sec id=""s3_3_1""><title>Cell proliferation assay</title><p>Cell suspensions containing 1 × 10<sup>5</sup>cells/mL of highly purified murine BM cells were seeded in triplicate in 25cm<sup>2</sup>flask. Cell counts were performed daily for five days. Concomitantly, cell viability was determined by the Trypan blue dye exclusion method. Growth curves were drawn according to the number of cells/mL taking in account the final number of cells/incubation time. To calculate the cell proliferation only viable cells were considered. Three independent experiments were performed for each group of cells.</p></sec><sec id=""s3_3_2""><title>Cell cycle assay</title><p>For the cell cycle analysis, 1 × 10<sup>6</sup>of highly purified murine BM cells were cultured in triplicate for 24 hours using complete medium in a 6-well plate and then were subjected to immunofluorescent staining of incorporated bromodeoxyuridine (BrdU) and 7-amino-actinomycin (7-AAD), followed by flow cytometric analysis using the BrdU Flow Kit (BD Biosciences, San Jose, CA, USA). Cells were incubated with 10μM of BrdU for 30 minutes, and then processed according to the manufacturer's recommendations.</p></sec><sec id=""s3_3_3""><title>Apoptosis assay</title><p>For the apoptosis analysis, 5 × 10<sup>5</sup>of highly purified murine BM cells were incubated in complete medium for 24 hours in the presence of vehicle or Ara-C 100μg/ml. The apoptosis rate was determined using the Annexin V-APC and propidium iodide (PI) binding assay (BD Biosciences, San Jose, CA, USA), and analyzed by flow cytometry. All experiments were performed in triplicate and in each sample a minimum of 10 000 events were acquired in a FACSCalibur flow cytometer (BD Biosciences, San Jose, CA, USA).</p></sec><sec id=""s3_3_4""><title>Colony-forming cell (CFC) assay</title><p>CFCs were assayed in methylcellulose (Methocult M3434; STEMCELL Technologies Inc., Vancouver, Canada) supplemented with mIL-3 (6 ng/ml), mIL-6 (10 ng/ml), and mSCF (100 ng/ml), following the manufacturer's recommendations. One thousand viable cells/dish were plated in triplicate. Colonies were evaluated microscopically on day 8 after plating by using standard criteria.</p></sec><sec id=""s3_3_5""><title>Differentiation assay</title><p>Cell suspensions containing 5 × 10<sup>5</sup>of highly purified murine BM cells were incubated in complete medium for seven days in the presence of ATRA (1μM). The differentiation rate was determined by immunophenotyping using the percentage of CD11b-positive cells (BD Biosciences, San Jose, CA, USA) as maturity marker. All experiments were performed in triplicate and in each sample a minimum of 10 000 events were acquired in a FACSCalibur flow cytometer (BD Biosciences, San Jose, CA, USA).</p></sec></sec><sec id=""s3_4""><title>PCR array</title><p>Both RT<sup>2</sup>Profiler™ PCR Array Mouse Apoptosis™ and Mouse Cell Cycle (Qiagen, VA, USA) was employed to analyze the expression of a focused panel of genes in hCG-PML/RARA cells infected with empty vector (pMEG) or pMEG-ΔNp73 lentiviruses. Samples were run at the ABI 7500 (Applied Biosystems, CA, USA). The data analysis was performed in SDS software 2.3 (SABiosciences). Genes were analyzed using two-way hierarchical cluster analysis based on the relative expression (2<sup>-ΔΔCt</sup>) by Ward's method (JMP version 10.0.0, SAS Institute).</p></sec><sec id=""s3_5""><title>Bone marrow transplantation</title><p>A total of 3 × 10<sup>5</sup>of highly purified murine BM cells from WT mice and non-leukemic hCG-PML/RARA mice (containing or not ΔNp73) along with 2 × 10<sup>5</sup>non-transfected cells of each background were injected into the lateral tail vein of lethally irradiated (3.5 Gy) NOD/SCID recipient mice. Recipients were aged older than 8 up to 12-weeks. During the whole experiment, all animals were maintained under specific pathogen-free environment in individually ventilated cages and observed for signs of disease. Sparfloxacin (10 μg/ml) was given into the drinking water for 2 to 3 weeks after BM transplantation. Viability of mice was monitored daily. Engraftment of donor cells was monitored by tail vein bleeds and FACS analysis of GFP positive cells was performed after 45 days.</p></sec><sec id=""s3_6""><title>Flow cytometry</title><p>Freshly harvested BM cells from previously transplanted mice were suspended in phosphate-buffered saline contain 1% fetal bovine serum. The erythrocytes were lysed by alkaline lysis using AKC lysis buffer (0.15M NH4Cl, 1mM KHCO3, 0.1mM Na–ethylenediaminetetraacetic acid, pH: 7.4). The nucleated cells were then stained using fluorescence labeled antibodies to Gr1, CD11b, B220, CD3, Ter119, CD117, Sca1, or isotype controls (BD Biosciences, San Jose, CA, USA) following the manufacturer's recommendations. The flow cytometric data were collected using a BD FACSCalibur, and analyzed using CellQuest Pro software (BD Biosciences, San Jose, CA, USA).</p></sec><sec id=""s3_7""><title>Statistical analysis</title><p>All calculations were performed using statistical package for the social sciences (SPSS) 19.0 software (IBM SPSS software, Chicago, IL, USA). All<italic>P</italic>-values were two sided with significance set to 5%.</p></sec></sec><sec id=""s4"" sec-type=""supplementary-material""><title>SUPPLEMENTARY DATA FIGURES AND TABLES</title><supplementary-material content-type=""local-data"" id=""SD1""><media id=""d35e687"" mime-subtype=""pdf"" mimetype=""application"" orientation=""portrait"" position=""anchor"" xlink:href=""oncotarget-08-8475-s001.pdf"" xlink:type=""simple""></media></supplementary-material></sec><back><ack><p>We thank to Dr. Osvaldo Pompilio de Melo Neto and all members of his laboratory for their technical support in cloning experiments.</p></ack><fn-group><fn fn-type=""COI-statement""><p><bold>CONFLICTS OF INTEREST</bold></p><p>The authors have no competing financial interests.</p></fn><fn fn-type=""supported-by""><p><bold>GRANT SUPPORT</bold></p><p>This investigation was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Grant #2013/08135-2) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNpQ, Grant #573754/2008-0). A.R.L-A. received a fellowship from FAPESP (Grant #2007/55067-1). J.L.C-S, D.A.P-M and P.L.F-N received fellowships from Fundação de Amparo a Ciência e Tecnologia de Pernambuco (FACEPE; Grants #IBPG-1433-2.02/13) and CNpQ (Grant #130614/2015-7), respectively.</p></fn><fn fn-type=""con""><p><bold>Authorship contributions</bold></p><p>A.R.L-A. performed experiments, analyzed and interpreted data, performed the statistical analyses, and drafted the article. J.L.C-S, D.A.P-M., C.T., P.S.S., A.P.L., H.H.P., B.T.H., M.C.M-S, E.A.A., P.L.F-N, R.F.F, C.L.S., and A.K. performed experiments, collected data, and reviewed the paper. E.M.R. reviewed the manuscript and gave the final approval of the submitted version.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id=""R1""><label>1</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Buhlmann</surname><given-names>S</given-names></name><name><surname>Putzer</surname><given-names>BM</given-names></name></person-group><article-title>DNp73 a matter of cancer: mechanisms and clinical implications</article-title><source>Biochim Biophys Acta</source><year>2008</year><volume>1785</volume><fpage>207</fpage><lpage>216</lpage><pub-id pub-id-type=""doi"">10.1016/j.bbcan.2008.01.002</pub-id><pub-id pub-id-type=""pmid"">18302944</pub-id></element-citation></ref><ref id=""R2""><label>2</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Leung</surname><given-names>TH</given-names></name><name><surname>Wong</surname><given-names>SC</given-names></name><name><surname>Chan</surname><given-names>KK</given-names></name><name><surname>Chan</surname><given-names>DW</given-names></name><name><surname>Cheung</surname><given-names>AN</given-names></name><name><surname>Ngan</surname><given-names>HY</given-names></name></person-group><article-title>The interaction between C35 and DeltaNp73 promotes chemo-resistance in ovarian cancer cells</article-title><source>Br J Cancer</source><year>2013</year><volume>109</volume><fpage>965</fpage><lpage>975</lpage><pub-id pub-id-type=""doi"">10.1038/bjc.2013.397</pub-id><pub-id pub-id-type=""pmid"">23880825</pub-id></element-citation></ref><ref id=""R3""><label>3</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Soldevilla</surname><given-names>B</given-names></name><name><surname>Diaz</surname><given-names>R</given-names></name><name><surname>Silva</surname><given-names>J</given-names></name><name><surname>Campos-Martin</surname><given-names>Y</given-names></name><name><surname>Munoz</surname><given-names>C</given-names></name><name><surname>Garcia</surname><given-names>V</given-names></name><name><surname>Garcia</surname><given-names>JM</given-names></name><name><surname>Pena</surname><given-names>C</given-names></name><name><surname>Herrera</surname><given-names>M</given-names></name><name><surname>Rodriguez</surname><given-names>M</given-names></name><name><surname>Gomez</surname><given-names>I</given-names></name><name><surname>Mohamed</surname><given-names>N</given-names></name><name><surname>Marques</surname><given-names>MM</given-names></name><etal></etal></person-group><article-title>Prognostic impact of DeltaTAp73 isoform levels and their target genes in colon cancer patients</article-title><source>Clin Cancer Res</source><year>2011</year><volume>17</volume><fpage>6029</fpage><lpage>6039</lpage><pub-id pub-id-type=""doi"">10.1158/1078-0432.CCR-10-2388</pub-id><pub-id pub-id-type=""pmid"">21807636</pub-id></element-citation></ref><ref id=""R4""><label>4</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Peters</surname><given-names>UR</given-names></name><name><surname>Tschan</surname><given-names>MP</given-names></name><name><surname>Kreuzer</surname><given-names>KA</given-names></name><name><surname>Baskaynak</surname><given-names>G</given-names></name><name><surname>Lass</surname><given-names>U</given-names></name><name><surname>Tobler</surname><given-names>A</given-names></name><name><surname>Fey</surname><given-names>MF</given-names></name><name><surname>Schmidt</surname><given-names>CA</given-names></name></person-group><article-title>Distinct expression patterns of the p53-homologue p73 in malignant and normal hematopoiesis assessed by a novel real-time reverse transcription-polymerase chain reaction assay and protein analysis</article-title><source>Cancer Res</source><year>1999</year><volume>59</volume><fpage>4233</fpage><lpage>4236</lpage><pub-id pub-id-type=""pmid"">10485463</pub-id></element-citation></ref><ref id=""R5""><label>5</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Sahu</surname><given-names>GR</given-names></name><name><surname>Mishra</surname><given-names>R</given-names></name><name><surname>Nagpal</surname><given-names>JK</given-names></name><name><surname>Das</surname><given-names>BR</given-names></name></person-group><article-title>Alteration of p73 in acute myelogenous leukemia</article-title><source>Am J Hematol</source><year>2005</year><volume>79</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type=""doi"">10.1002/ajh.20284</pub-id><pub-id pub-id-type=""pmid"">15849769</pub-id></element-citation></ref><ref id=""R6""><label>6</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Meier</surname><given-names>M</given-names></name><name><surname>den Boer</surname><given-names>ML</given-names></name><name><surname>Meijerink</surname><given-names>JP</given-names></name><name><surname>Broekhuis</surname><given-names>MJ</given-names></name><name><surname>Passier</surname><given-names>MM</given-names></name><name><surname>van Wering</surname><given-names>ER</given-names></name><name><surname>Janka-Schaub</surname><given-names>GE</given-names></name><name><surname>Pieters</surname><given-names>R</given-names></name></person-group><article-title>Differential expression of p73 isoforms in relation to drug resistance in childhood T-lineage acute lymphoblastic leukaemia</article-title><source>Leukemia</source><year>2006</year><volume>20</volume><fpage>1377</fpage><lpage>1384</lpage><pub-id pub-id-type=""doi"">10.1038/sj.leu.2404288</pub-id><pub-id pub-id-type=""pmid"">16791269</pub-id></element-citation></ref><ref id=""R7""><label>7</label><element-citation publication-type=""other""><person-group person-group-type=""author""><name><surname>Lucena-Araujo</surname><given-names>AR</given-names></name><name><surname>Kim</surname><given-names>HT</given-names></name><name><surname>Thome</surname><given-names>C</given-names></name><name><surname>Jacomo</surname><given-names>RH</given-names></name><name><surname>Melo</surname><given-names>RA</given-names></name><name><surname>Bittencourt</surname><given-names>R</given-names></name><name><surname>Pasquini</surname><given-names>R</given-names></name><name><surname>Pagnano</surname><given-names>K</given-names></name><name><surname>Gloria</surname><given-names>AB</given-names></name><name><surname>Chauffaille</surname><given-names>ML</given-names></name><name><surname>Athayde</surname><given-names>M</given-names></name><name><surname>Chiattone</surname><given-names>CS</given-names></name><name><surname>Mito</surname><given-names>I</given-names></name><etal></etal></person-group><article-title>High DeltaNp73/TAp73 ratio is associated with poor prognosis in acute promyelocytic leukemia</article-title><source>Blood</source><year>2015</year><pub-id pub-id-type=""doi"">10.1182/blood-2015-01-623330</pub-id></element-citation></ref><ref id=""R8""><label>8</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Rego</surname><given-names>EM</given-names></name><name><surname>Kim</surname><given-names>HT</given-names></name><name><surname>Ruiz-Arguelles</surname><given-names>GJ</given-names></name><name><surname>Undurraga</surname><given-names>MS</given-names></name><name><surname>Uriarte</surname><given-names>MR</given-names></name><name><surname>Jacomo</surname><given-names>RH</given-names></name><name><surname>Gutierrez-Aguirre</surname><given-names>H</given-names></name><name><surname>Melo</surname><given-names>RA</given-names></name><name><surname>Bittencourt</surname><given-names>R</given-names></name><name><surname>Pasquini</surname><given-names>R</given-names></name><name><surname>Pagnano</surname><given-names>K</given-names></name><name><surname>Fagundes</surname><given-names>EM</given-names></name><name><surname>Chauffaille</surname><given-names>ML</given-names></name><etal></etal></person-group><article-title>Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the</article-title><source>International Consortium on APL. Blood</source><year>2013</year><volume>121</volume><fpage>1935</fpage><lpage>1943</lpage><pub-id pub-id-type=""doi"">10.1182/blood-2012-08-449918</pub-id><pub-id pub-id-type=""pmid"">23319575</pub-id></element-citation></ref><ref id=""R9""><label>9</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Lucena-Araujo</surname><given-names>AR</given-names></name><name><surname>Panepucci</surname><given-names>RA</given-names></name><name><surname>dos Santos</surname><given-names>GA</given-names></name><name><surname>Jacomo</surname><given-names>RH</given-names></name><name><surname>Santana-Lemos</surname><given-names>BA</given-names></name><name><surname>Lima</surname><given-names>AS</given-names></name><name><surname>Garcia</surname><given-names>AB</given-names></name><name><surname>Araujo</surname><given-names>AG</given-names></name><name><surname>Falcao</surname><given-names>RP</given-names></name><name><surname>Rego</surname><given-names>EM</given-names></name></person-group><article-title>The expression of DeltaNTP73, TATP73 and TP53 genes in acute myeloid leukaemia is associated with recurrent cytogenetic abnormalities and in vitro susceptibility to cytarabine cytotoxicity</article-title><source>Br J Haematol</source><year>2008</year><volume>142</volume><fpage>74</fpage><lpage>78</lpage><pub-id pub-id-type=""doi"">10.1111/j.1365-2141.2008.07160.x</pub-id><pub-id pub-id-type=""pmid"">18422993</pub-id></element-citation></ref><ref id=""R10""><label>10</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Jacomo</surname><given-names>RH</given-names></name><name><surname>Santana-Lemos</surname><given-names>BA</given-names></name><name><surname>Lima</surname><given-names>AS</given-names></name><name><surname>Assis</surname><given-names>PA</given-names></name><name><surname>Lange</surname><given-names>AP</given-names></name><name><surname>Figueiredo-Pontes</surname><given-names>LL</given-names></name><name><surname>Oliveira</surname><given-names>LO</given-names></name><name><surname>Bassi</surname><given-names>SC</given-names></name><name><surname>Benicio</surname><given-names>MT</given-names></name><name><surname>Baggio</surname><given-names>MS</given-names></name><name><surname>Garcia</surname><given-names>AB</given-names></name><name><surname>Falcao</surname><given-names>RP</given-names></name><name><surname>Rego</surname><given-names>EM</given-names></name></person-group><article-title>Methionine-induced hyperhomocysteinemia reverts fibrinolytic pathway activation in a murine model of acute promyelocytic leukemia</article-title><source>Blood</source><year>2012</year><volume>120</volume><fpage>207</fpage><lpage>213</lpage><pub-id pub-id-type=""doi"">10.1182/blood-2011-04-347187</pub-id><pub-id pub-id-type=""pmid"">22517898</pub-id></element-citation></ref><ref id=""R11""><label>11</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>dos Santos</surname><given-names>GA</given-names></name><name><surname>Abreu e Lima</surname><given-names>RS</given-names></name><name><surname>Pestana</surname><given-names>CR</given-names></name><name><surname>Lima</surname><given-names>AS</given-names></name><name><surname>Scheucher</surname><given-names>PS</given-names></name><name><surname>Thome</surname><given-names>CH</given-names></name><name><surname>Gimenes-Teixeira</surname><given-names>HL</given-names></name><name><surname>Santana-Lemos</surname><given-names>BA</given-names></name><name><surname>Lucena-Araujo</surname><given-names>AR</given-names></name><name><surname>Rodrigues</surname><given-names>FP</given-names></name><name><surname>Nasr</surname><given-names>R</given-names></name><name><surname>Uyemura</surname><given-names>SA</given-names></name><name><surname>Falcao</surname><given-names>RP</given-names></name><etal></etal></person-group><article-title>(+)alpha-Tocopheryl succinate inhibits the mitochondrial respiratory chain complex I and is as effective as arsenic trioxide or ATRA against acute promyelocytic leukemia in vivo</article-title><source>Leukemia</source><year>2012</year><volume>26</volume><fpage>451</fpage><lpage>460</lpage><pub-id pub-id-type=""doi"">10.1038/leu.2011.216</pub-id><pub-id pub-id-type=""pmid"">21869839</pub-id></element-citation></ref><ref id=""R12""><label>12</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Guibal</surname><given-names>FC</given-names></name><name><surname>Alberich-Jorda</surname><given-names>M</given-names></name><name><surname>Hirai</surname><given-names>H</given-names></name><name><surname>Ebralidze</surname><given-names>A</given-names></name><name><surname>Levantini</surname><given-names>E</given-names></name><name><surname>P</surname><given-names>Di RA Zhang</given-names></name><name><surname>Santana-Lemos</surname><given-names>BA</given-names></name><name><surname>Neuberg</surname><given-names>D</given-names></name><name><surname>Wagers</surname><given-names>AJ</given-names></name><name><surname>Rego</surname><given-names>EM</given-names></name><name><surname>Tenen</surname><given-names>DG</given-names></name></person-group><article-title>Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia</article-title><source>Blood</source><year>2009</year><volume>114</volume><fpage>5415</fpage><lpage>5425</lpage><pub-id pub-id-type=""doi"">10.1182/blood-2008-10-182071</pub-id><pub-id pub-id-type=""pmid"">19797526</pub-id></element-citation></ref><ref id=""R13""><label>13</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Kogan</surname><given-names>SC</given-names></name><name><surname>Ward</surname><given-names>JM</given-names></name><name><surname>Anver</surname><given-names>MR</given-names></name><name><surname>Berman</surname><given-names>JJ</given-names></name><name><surname>Brayton</surname><given-names>C</given-names></name><name><surname>Cardiff</surname><given-names>RD</given-names></name><name><surname>Carter</surname><given-names>JS</given-names></name><name><surname>JR</surname><given-names>de CS Downing</given-names></name><name><surname>Fredrickson</surname><given-names>TN</given-names></name><name><surname>Haines</surname><given-names>DC</given-names></name><name><surname>Harris</surname><given-names>AW</given-names></name><name><surname>Harris</surname><given-names>NL</given-names></name><etal></etal></person-group><article-title>Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice</article-title><source>Blood</source><year>2002</year><volume>100</volume><fpage>238</fpage><lpage>245</lpage><pub-id pub-id-type=""pmid"">12070033</pub-id></element-citation></ref><ref id=""R14""><label>14</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Stiewe</surname><given-names>T</given-names></name><name><surname>Zimmermann</surname><given-names>S</given-names></name><name><surname>Frilling</surname><given-names>A</given-names></name><name><surname>Esche</surname><given-names>H</given-names></name><name><surname>Putzer</surname><given-names>BM</given-names></name></person-group><article-title>Transactivation-deficient DeltaTA-p73 acts as an oncogene</article-title><source>Cancer Res</source><year>2002</year><volume>62</volume><fpage>3598</fpage><lpage>3602</lpage><pub-id pub-id-type=""pmid"">12097259</pub-id></element-citation></ref><ref id=""R15""><label>15</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Petrenko</surname><given-names>O</given-names></name><name><surname>Zaika</surname><given-names>A</given-names></name><name><surname>Moll</surname><given-names>UM</given-names></name></person-group><article-title>deltaNp73 facilitates cell immortalization and cooperates with oncogenic Ras in cellular transformation in vivo</article-title><source>Mol Cell Biol</source><year>2003</year><volume>23</volume><fpage>5540</fpage><lpage>5555</lpage><pub-id pub-id-type=""pmid"">12897129</pub-id></element-citation></ref><ref id=""R16""><label>16</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Tannapfel</surname><given-names>A</given-names></name><name><surname>John</surname><given-names>K</given-names></name><name><surname>Mise</surname><given-names>N</given-names></name><name><surname>Schmidt</surname><given-names>A</given-names></name><name><surname>Buhlmann</surname><given-names>S</given-names></name><name><surname>Ibrahim</surname><given-names>SM</given-names></name><name><surname>Putzer</surname><given-names>BM</given-names></name></person-group><article-title>Autonomous growth and hepatocarcinogenesis in transgenic mice expressing the p53 family inhibitor DNp73</article-title><source>Carcinogenesis</source><year>2008</year><volume>29</volume><fpage>211</fpage><lpage>218</lpage><pub-id pub-id-type=""doi"">10.1093/carcin/bgm236</pub-id><pub-id pub-id-type=""pmid"">17984115</pub-id></element-citation></ref><ref id=""R17""><label>17</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name></person-group><article-title>DeltaNp73 modulates nerve growth factor-mediated neuronal differentiation through repression of TrkA</article-title><source>Mol Cell Biol</source><year>2007</year><volume>27</volume><fpage>3868</fpage><lpage>3880</lpage><pub-id pub-id-type=""doi"">10.1128/MCB.02112-06</pub-id><pub-id pub-id-type=""pmid"">17353261</pub-id></element-citation></ref><ref id=""R18""><label>18</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Steder</surname><given-names>M</given-names></name><name><surname>Alla</surname><given-names>V</given-names></name><name><surname>Meier</surname><given-names>C</given-names></name><name><surname>Spitschak</surname><given-names>A</given-names></name><name><surname>Pahnke</surname><given-names>J</given-names></name><name><surname>Furst</surname><given-names>K</given-names></name><name><surname>Kowtharapu</surname><given-names>BS</given-names></name><name><surname>Engelmann</surname><given-names>D</given-names></name><name><surname>Petigk</surname><given-names>J</given-names></name><name><surname>Egberts</surname><given-names>F</given-names></name><name><surname>Schad-Trcka</surname><given-names>SG</given-names></name><name><surname>Gross</surname><given-names>G</given-names></name><name><surname>Nettelbeck</surname><given-names>DM</given-names></name><etal></etal></person-group><article-title>DNp73 exerts function in metastasis initiation by disconnecting the inhibitory role of EPLIN on IGF1R-AKT/STAT3 signaling</article-title><source>Cancer Cell</source><year>2013</year><volume>24</volume><fpage>512</fpage><lpage>527</lpage><pub-id pub-id-type=""doi"">10.1016/j.ccr.2013.08.023</pub-id><pub-id pub-id-type=""pmid"">24135282</pub-id></element-citation></ref><ref id=""R19""><label>19</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Muller</surname><given-names>M</given-names></name><name><surname>Schilling</surname><given-names>T</given-names></name><name><surname>Sayan</surname><given-names>AE</given-names></name><name><surname>Kairat</surname><given-names>A</given-names></name><name><surname>Lorenz</surname><given-names>K</given-names></name><name><surname>Schulze-Bergkamen</surname><given-names>H</given-names></name><name><surname>Oren</surname><given-names>M</given-names></name><name><surname>Koch</surname><given-names>A</given-names></name><name><surname>Tannapfel</surname><given-names>A</given-names></name><name><surname>Stremmel</surname><given-names>W</given-names></name><name><surname>Melino</surname><given-names>G</given-names></name><name><surname>Krammer</surname><given-names>PH</given-names></name></person-group><article-title>TAp73/Delta Np73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinoma</article-title><source>Cell Death Differ</source><year>2005</year><volume>12</volume><fpage>1564</fpage><lpage>1577</lpage><pub-id pub-id-type=""doi"">10.1038/sj.cdd.4401774</pub-id><pub-id pub-id-type=""pmid"">16195739</pub-id></element-citation></ref><ref id=""R20""><label>20</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Wilhelm</surname><given-names>MT</given-names></name><name><surname>Rufini</surname><given-names>A</given-names></name><name><surname>Wetzel</surname><given-names>MK</given-names></name><name><surname>Tsuchihara</surname><given-names>K</given-names></name><name><surname>Inoue</surname><given-names>S</given-names></name><name><surname>Tomasini</surname><given-names>R</given-names></name><name><surname>Itie-Youten</surname><given-names>A</given-names></name><name><surname>Wakeham</surname><given-names>A</given-names></name><name><surname>Arsenian-Henriksson</surname><given-names>M</given-names></name><name><surname>Melino</surname><given-names>G</given-names></name><name><surname>Kaplan</surname><given-names>DR</given-names></name><name><surname>Miller</surname><given-names>FD</given-names></name><name><surname>Mak</surname><given-names>TW</given-names></name></person-group><article-title>Isoform-specific p73 knockout mice reveal a novel role for delta Np73 in the DNA damage response pathway</article-title><source>Genes Dev</source><year>2010</year><volume>24</volume><fpage>549</fpage><lpage>560</lpage><pub-id pub-id-type=""doi"">10.1101/gad.1873910</pub-id><pub-id pub-id-type=""pmid"">20194434</pub-id></element-citation></ref><ref id=""R21""><label>21</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Tuve</surname><given-names>S</given-names></name><name><surname>Racek</surname><given-names>T</given-names></name><name><surname>Niemetz</surname><given-names>A</given-names></name><name><surname>Schultz</surname><given-names>J</given-names></name><name><surname>Soengas</surname><given-names>MS</given-names></name><name><surname>Putzer</surname><given-names>BM</given-names></name></person-group><article-title>Adenovirus-mediated TA-p73beta gene transfer increases chemosensitivity of human malignant melanomas</article-title><source>Apoptosis</source><year>2006</year><volume>11</volume><fpage>235</fpage><lpage>243</lpage><pub-id pub-id-type=""doi"">10.1007/s10495-006-3407-0</pub-id><pub-id pub-id-type=""pmid"">16502261</pub-id></element-citation></ref><ref id=""R22""><label>22</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Ishimoto</surname><given-names>O</given-names></name><name><surname>Kawahara</surname><given-names>C</given-names></name><name><surname>Enjo</surname><given-names>K</given-names></name><name><surname>Obinata</surname><given-names>M</given-names></name><name><surname>Nukiwa</surname><given-names>T</given-names></name><name><surname>Ikawa</surname><given-names>S</given-names></name></person-group><article-title>Possible oncogenic potential of DeltaNp73: a newly identified isoform of human p73</article-title><source>Cancer Res</source><year>2002</year><volume>62</volume><fpage>636</fpage><lpage>641</lpage><pub-id pub-id-type=""pmid"">11830511</pub-id></element-citation></ref><ref id=""R23""><label>23</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Zaika</surname><given-names>AI</given-names></name><name><surname>Slade</surname><given-names>N</given-names></name><name><surname>Erster</surname><given-names>SH</given-names></name><name><surname>Sansome</surname><given-names>C</given-names></name><name><surname>Joseph</surname><given-names>TW</given-names></name><name><surname>Pearl</surname><given-names>M</given-names></name><name><surname>Chalas</surname><given-names>E</given-names></name><name><surname>Moll</surname><given-names>UM</given-names></name></person-group><article-title>DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors</article-title><source>J Exp Med</source><year>2002</year><volume>196</volume><fpage>765</fpage><lpage>780</lpage><pub-id pub-id-type=""pmid"">12235210</pub-id></element-citation></ref><ref id=""R24""><label>24</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>He</surname><given-names>LZ</given-names></name><name><surname>Tribioli</surname><given-names>C</given-names></name><name><surname>Rivi</surname><given-names>R</given-names></name><name><surname>Peruzzi</surname><given-names>D</given-names></name><name><surname>Pelicci</surname><given-names>PG</given-names></name><name><surname>Soares</surname><given-names>V</given-names></name><name><surname>Cattoretti</surname><given-names>G</given-names></name><name><surname>Pandolfi</surname><given-names>PP</given-names></name></person-group><article-title>Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice</article-title><source>Proc Natl Acad Sci U S A</source><year>1997</year><volume>94</volume><fpage>5302</fpage><lpage>5307</lpage><pub-id pub-id-type=""pmid"">9144232</pub-id></element-citation></ref><ref id=""R25""><label>25</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Grignani</surname><given-names>F</given-names></name><name><surname>C</surname><given-names>De MS Nervi</given-names></name><name><surname>Tomassoni</surname><given-names>L</given-names></name><name><surname>Gelmetti</surname><given-names>V</given-names></name><name><surname>Cioce</surname><given-names>M</given-names></name><name><surname>Fanelli</surname><given-names>M</given-names></name><name><surname>Ruthardt</surname><given-names>M</given-names></name><name><surname>Ferrara</surname><given-names>FF</given-names></name><name><surname>Zamir</surname><given-names>I</given-names></name><name><surname>Seiser</surname><given-names>C</given-names></name><name><surname>Grignani</surname><given-names>F</given-names></name><name><surname>Lazar</surname><given-names>MA</given-names></name><etal></etal></person-group><article-title>Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia</article-title><source>Nature</source><year>1998</year><volume>391</volume><fpage>815</fpage><lpage>818</lpage><pub-id pub-id-type=""doi"">10.1038/35901</pub-id><pub-id pub-id-type=""pmid"">9486655</pub-id></element-citation></ref><ref id=""R26""><label>26</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Grignani</surname><given-names>F</given-names></name><name><surname>Ferrucci</surname><given-names>PF</given-names></name><name><surname>Testa</surname><given-names>U</given-names></name><name><surname>Talamo</surname><given-names>G</given-names></name><name><surname>Fagioli</surname><given-names>M</given-names></name><name><surname>Alcalay</surname><given-names>M</given-names></name><name><surname>Mencarelli</surname><given-names>A</given-names></name><name><surname>Grignani</surname><given-names>F</given-names></name><name><surname>Peschle</surname><given-names>C</given-names></name><name><surname>Nicoletti</surname><given-names>I</given-names></name><name><surname>Pelicci</surname><given-names>PG</given-names></name></person-group><article-title>The acute promyelocytic leukemia-specific PML-RAR alpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cells</article-title><source>Cell</source><year>1993</year><volume>74</volume><fpage>423</fpage><lpage>431</lpage><pub-id pub-id-type=""pmid"">8394219</pub-id></element-citation></ref><ref id=""R27""><label>27</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Grisolano</surname><given-names>JL</given-names></name><name><surname>Wesselschmidt</surname><given-names>RL</given-names></name><name><surname>Pelicci</surname><given-names>PG</given-names></name><name><surname>Ley</surname><given-names>TJ</given-names></name></person-group><article-title>Altered myeloid development and acute leukemia in transgenic mice expressing PML-RAR alpha under control of cathepsin G regulatory sequences</article-title><source>Blood</source><year>1997</year><volume>89</volume><fpage>376</fpage><lpage>387</lpage><pub-id pub-id-type=""pmid"">9002938</pub-id></element-citation></ref><ref id=""R28""><label>28</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Bernassola</surname><given-names>F</given-names></name><name><surname>Salomoni</surname><given-names>P</given-names></name><name><surname>Oberst</surname><given-names>A</given-names></name><name><surname>Di Como</surname><given-names>CJ</given-names></name><name><surname>Pagano</surname><given-names>M</given-names></name><name><surname>Melino</surname><given-names>G</given-names></name><name><surname>Pandolfi</surname><given-names>PP</given-names></name></person-group><article-title>Ubiquitin-dependent degradation of p73 is inhibited by PML</article-title><source>J Exp Med</source><year>2004</year><volume>199</volume><fpage>1545</fpage><lpage>1557</lpage><pub-id pub-id-type=""doi"">10.1084/jem.20031943</pub-id><pub-id pub-id-type=""pmid"">15184504</pub-id></element-citation></ref><ref id=""R29""><label>29</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Gaillard</surname><given-names>C</given-names></name><name><surname>Tokuyasu</surname><given-names>TA</given-names></name><name><surname>Rosen</surname><given-names>G</given-names></name><name><surname>Sotzen</surname><given-names>J</given-names></name><name><surname>Vitaliano-Prunier</surname><given-names>A</given-names></name><name><surname>Roy</surname><given-names>R</given-names></name><name><surname>Passegue</surname><given-names>E</given-names></name><name><surname>ME</surname><given-names>de TH Figueroa</given-names></name><name><surname>Kogan</surname><given-names>SC</given-names></name></person-group><article-title>Transcription and methylation analyses of preleukemic promyelocytes indicate a dual role for PML/RARA in leukemia initiation</article-title><source>Haematologica</source><year>2015</year><volume>100</volume><fpage>1064</fpage><lpage>1075</lpage><pub-id pub-id-type=""doi"">10.3324/haematol.2014.123018</pub-id><pub-id pub-id-type=""pmid"">26088929</pub-id></element-citation></ref><ref id=""R30""><label>30</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Ablain</surname><given-names>J</given-names></name><name><surname>Rice</surname><given-names>K</given-names></name><name><surname>Soilihi</surname><given-names>H</given-names></name><name><surname>de RA Minucci</surname><given-names>S</given-names></name><name><surname>de</surname><given-names>TH</given-names></name></person-group><article-title>Activation of a promyelocytic leukemia-tumor protein 53 axis underlies acute promyelocytic leukemia cure</article-title><source>Nat Med</source><year>2014</year><volume>20</volume><fpage>167</fpage><lpage>174</lpage><pub-id pub-id-type=""doi"">10.1038/nm.3441</pub-id><pub-id pub-id-type=""pmid"">24412926</pub-id></element-citation></ref><ref id=""R31""><label>31</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Casciano</surname><given-names>I</given-names></name><name><surname>Mazzocco</surname><given-names>K</given-names></name><name><surname>Boni</surname><given-names>L</given-names></name><name><surname>Pagnan</surname><given-names>G</given-names></name><name><surname>Banelli</surname><given-names>B</given-names></name><name><surname>Allemanni</surname><given-names>G</given-names></name><name><surname>Ponzoni</surname><given-names>M</given-names></name><name><surname>Tonini</surname><given-names>GP</given-names></name><name><surname>Romani</surname><given-names>M</given-names></name></person-group><article-title>Expression of DeltaNp73 is a molecular marker for adverse outcome in neuroblastoma patients</article-title><source>Cell Death Differ</source><year>2002</year><volume>9</volume><fpage>246</fpage><lpage>251</lpage><pub-id pub-id-type=""doi"">10.1038/sj.cdd.4400993</pub-id><pub-id pub-id-type=""pmid"">11859407</pub-id></element-citation></ref><ref id=""R32""><label>32</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Dominguez</surname><given-names>G</given-names></name><name><surname>Garcia</surname><given-names>JM</given-names></name><name><surname>Pena</surname><given-names>C</given-names></name><name><surname>Silva</surname><given-names>J</given-names></name><name><surname>Garcia</surname><given-names>V</given-names></name><name><surname>Martinez</surname><given-names>L</given-names></name><name><surname>Maximiano</surname><given-names>C</given-names></name><name><surname>Gomez</surname><given-names>ME</given-names></name><name><surname>Rivera</surname><given-names>JA</given-names></name><name><surname>Garcia-Andrade</surname><given-names>C</given-names></name><name><surname>Bonilla</surname><given-names>F</given-names></name></person-group><article-title>DeltaTAp73 upregulation correlates with poor prognosis in human tumors: putative in vivo network involving p73 isoforms, p53, and E2F-1</article-title><source>J Clin Oncol</source><year>2006</year><volume>24</volume><fpage>805</fpage><lpage>815</lpage><pub-id pub-id-type=""doi"">10.1200/JCO.2005.02.2350</pub-id><pub-id pub-id-type=""pmid"">16380414</pub-id></element-citation></ref><ref id=""R33""><label>33</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Liu</surname><given-names>SS</given-names></name><name><surname>Chan</surname><given-names>KY</given-names></name><name><surname>Cheung</surname><given-names>AN</given-names></name><name><surname>Liao</surname><given-names>XY</given-names></name><name><surname>Leung</surname><given-names>TW</given-names></name><name><surname>Ngan</surname><given-names>HY</given-names></name></person-group><article-title>Expression of deltaNp73 and TAp73alpha independently associated with radiosensitivities and prognoses in cervical squamous cell carcinoma</article-title><source>Clin Cancer Res</source><year>2006</year><volume>12</volume><fpage>3922</fpage><lpage>3927</lpage><pub-id pub-id-type=""doi"">10.1158/1078-0432.CCR-05-2573</pub-id><pub-id pub-id-type=""pmid"">16818688</pub-id></element-citation></ref><ref id=""R34""><label>34</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Uramoto</surname><given-names>H</given-names></name><name><surname>Sugio</surname><given-names>K</given-names></name><name><surname>Oyama</surname><given-names>T</given-names></name><name><surname>Nakata</surname><given-names>S</given-names></name><name><surname>Ono</surname><given-names>K</given-names></name><name><surname>Morita</surname><given-names>M</given-names></name><name><surname>Funa</surname><given-names>K</given-names></name><name><surname>Yasumoto</surname><given-names>K</given-names></name></person-group><article-title>Expression of deltaNp73 predicts poor prognosis in lung cancer</article-title><source>Clin Cancer Res</source><year>2004</year><volume>10</volume><fpage>6905</fpage><lpage>6911</lpage><pub-id pub-id-type=""doi"">10.1158/1078-0432.CCR-04-0290</pub-id><pub-id pub-id-type=""pmid"">15501968</pub-id></element-citation></ref><ref id=""R35""><label>35</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Naldini</surname><given-names>L</given-names></name><name><surname>Blomer</surname><given-names>U</given-names></name><name><surname>Gage</surname><given-names>FH</given-names></name><name><surname>Trono</surname><given-names>D</given-names></name><name><surname>Verma</surname><given-names>IM</given-names></name></person-group><article-title>Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector</article-title><source>Proc Natl Acad Sci U S A</source><year>1996</year><volume>93</volume><fpage>11382</fpage><lpage>11388</lpage><pub-id pub-id-type=""pmid"">8876144</pub-id></element-citation></ref><ref id=""R36""><label>36</label><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Thome</surname><given-names>CH</given-names></name><name><surname>dos Santos</surname><given-names>GA</given-names></name><name><surname>Ferreira</surname><given-names>GA</given-names></name><name><surname>Scheucher</surname><given-names>PS</given-names></name><name><surname>Izumi</surname><given-names>C</given-names></name><name><surname>Leopoldino</surname><given-names>AM</given-names></name><name><surname>Simao</surname><given-names>AM</given-names></name><name><surname>Ciancaglini</surname><given-names>P</given-names></name><name><surname>de Oliveira</surname><given-names>KT</given-names></name><name><surname>Chin</surname><given-names>A</given-names></name><name><surname>Hanash</surname><given-names>SM</given-names></name><name><surname>Falcao</surname><given-names>RP</given-names></name><etal></etal></person-group><article-title>Linker for activation of T-cell family member2 (LAT2) a lipid raft adaptor protein for AKT signaling, is an early mediator of alkylphospholipid anti-leukemic activity</article-title><source>Mol Cell Proteomics</source><year>2012</year><volume>11</volume><fpage>1898</fpage><lpage>1912</lpage><pub-id pub-id-type=""doi"">10.1074/mcp.M112.019661</pub-id><pub-id pub-id-type=""pmid"">23001822</pub-id></element-citation></ref></ref-list>"
10.1038/35102506	"<html><body><article article-type=""review-article"" xmlns:mml=""http://www.w3.org/1998/Math/MathML"" xmlns:xlink=""http://www.w3.org/1999/xlink""><?properties open_access?><front><journal-meta><journal-id journal-id-type=""nlm-ta"">BMC Neurosci</journal-id><journal-id journal-id-type=""iso-abbrev"">BMC Neurosci</journal-id><journal-title-group><journal-title>BMC Neuroscience</journal-title></journal-title-group><issn pub-type=""epub"">1471-2202</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type=""pmid"">17903277</article-id><article-id pub-id-type=""pmc"">1995455</article-id><article-id pub-id-type=""publisher-id"">1471-2202-8-S3-S1</article-id><article-id pub-id-type=""doi"">10.1186/1471-2202-8-S3-S1</article-id><article-categories><subj-group subj-group-type=""heading""><subject>Review</subject></subj-group></article-categories><title-group><article-title>The sense of smell, its signalling pathways, and the dichotomy of cilia and microvilli in olfactory sensory cells</article-title></title-group><contrib-group><contrib contrib-type=""author"" id=""A1""><name><surname>Elsaesser</surname><given-names>Rebecca</given-names></name><xref ref-type=""aff"" rid=""I1"">1</xref><email>selsaes3@jhmi.edu</email></contrib><contrib contrib-type=""author"" corresp=""yes"" id=""A2""><name><surname>Paysan</surname><given-names>Jacques</given-names></name><xref ref-type=""aff"" rid=""I2"">2</xref><email>paysan@bio.tu-darmstadt.de</email></contrib></contrib-group><aff id=""I1""><label>1</label>Johns Hopkins University School of Medicine, 725 N. Wolfe St., 408 WBSB, Baltimore, MD 21205, USA</aff><aff id=""I2""><label>2</label>Technical University of Darmstadt, Institute of Zoology, Schnittspahnstrasse 3, D-64287 Darmstadt, Germany</aff><pub-date pub-type=""collection""><year>2007</year></pub-date><pub-date pub-type=""epub""><day>18</day><month>9</month><year>2007</year></pub-date><volume>8</volume><issue>Suppl 3</issue><supplement><named-content content-type=""supplement-title"">The chemical senses: recent advances and new promises</named-content><named-content content-type=""supplement-editor"">Steven D Munger</named-content></supplement><fpage>S1</fpage><lpage>S1</lpage><permissions><copyright-statement>Copyright ©2007 Elsaesser and Paysan; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2007</copyright-year><copyright-holder>Elsaesser and Paysan; licensee BioMed Central Ltd.</copyright-holder><license license-type=""open-access"" xlink:href=""http://creativecommons.org/licenses/by/2.0""><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type=""uri"" xlink:href=""http://creativecommons.org/licenses/by/2.0"">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href=""http://www.biomedcentral.com/1471-2202/8/S3/S1""></self-uri><abstract><p>Smell is often regarded as an ancillary perception in primates, who seem so dominated by their sense of vision. In this paper, we will portray some aspects of the significance of olfaction to human life and speculate on what evolutionary factors contribute to keeping it alive. We then outline the functional architecture of olfactory sensory neurons and their signal transduction pathways, which are the primary detectors that render olfactory perception possible. Throughout the phylogenetic tree, olfactory neurons, at their apical tip, are either decorated with cilia or with microvilli. The significance of this dichotomy is unknown. It is generally assumed that mammalian olfactory neurons are of the ciliary type only. The existance of so-called<italic>olfactory microvillar cells</italic>in mammals, however, is well documented, but their nature remains unclear and their function orphaned. This paper discusses the possibility, that in the main olfactory epithelium of mammals ciliated and microvillar sensory cells exist concurrently. We review evidence related to this hypothesis and ask, what function olfactory microvillar cells might have and what signalling mechanisms they use.</p></abstract></article-meta></front><sec><title>The ""scentimental"" nose</title><p>Wine experts occasionally identify a broad variety of aromas such as »bacon fat, pain grillé, black raspberries, cassis, white flowers, and Provençal olives« when they taste, for example, a vintage of Côte Rôtie [<xref ref-type=""bibr"" rid=""B1"">1</xref>]. Even an expert's nose, however, can get surprisingly confused in the presence of misleading visual cues. In a noteworthy study performed at the University of Bordeaux, Gil Morrot and collaborators asked 54 undergraduate students from the Faculty of Oenology to compare a glass of white Bordeaux wine (containing Sémillon and Sauvignon grapes) to a glass of exactly the same wine, which had been coloured by a mixture of red anthocyanins. Although the added anthocyanins had no perceptible taste or odour, the subjects identified remarkably different sets of aromas in both glasses [<xref ref-type=""bibr"" rid=""B2"">2</xref>]. Despite this surprising lack of discriminatory skills, it seems our sense of smell has other proficiencies, such as a remarkable power of attributing emotional qualities to objects that we see. The attributive nature of the sense of smell is illustrated by the fact that we need so-called descriptors to communicate odours [<xref ref-type=""bibr"" rid=""B3"">3</xref>]. What alternatives do we have but to portray an olfactory perception as »black raspberries-like«, or »Provençal olives-like«? None of these scents can be addressed directly, without reference to its respective source [<xref ref-type=""bibr"" rid=""B4"">4</xref>]. Other perceptual qualities can often be named independently. We can speak, for example, of »red« and »sweet« without employing metaphors and similes such as »anthocyanin-like« or »sucrose-like«. Odours, on the other hand, can affect our emotional state profoundly [<xref ref-type=""bibr"" rid=""B5"">5</xref>-<xref ref-type=""bibr"" rid=""B7"">7</xref>]. A gustatory stimulus, such as »too salty«, effectively keeps us from drinking sea water, but compared to bad odours, the aversion evoked by the taste of salt is less affective. This is vividly illustrated by an authentic report by the early Gabriel Garcia Marquez, who describes the fate of a shipwrecked sailor who drifts on his raft through the Caribbean sea. After four days of suffering the agonies of thirst, he decides to drink salt water. ""This water does not satisfy your thirst"", the salvaged sailor later testifies, ""but it refreshes"" [<xref ref-type=""bibr"" rid=""B8"">8</xref>]. Apparently, the repulsion evoked by the salty taste is based on reflex and rational thinking rather than on emotional disgust. By the same token, sweetness alone will rarely make us long for artificial sweeteners and it is unlikely to evoke a similar savouriness as the scent of freshly baked bread. In contrast, the repulsiveness of the nauseating stench of rotting meat is so effective that the use of this smell was suggested as a powerful stimulus for therapeutical conditioning of sexual offenders [<xref ref-type=""bibr"" rid=""B9"">9</xref>,<xref ref-type=""bibr"" rid=""B10"">10</xref>].</p><p>It seems that an important role of the human sense of smell is adding emotional qualities to situations and objects that we see, and not so much to making an essential contribution to finding or identifying things. Of course we can recognize typical odours even with our eyes shut, but the scent of ripe bananas, for example, rather influences our appetite than being necessary to distinguish bananas from pineapples. This observation raises questions about the biological purpose of the olfactory sense in a visually dominated species, such as man. What is so important about watering our mouth that it exerts sufficient selection pressure to sustain several hundreds of functional olfactory receptor genes through evolution? Why do we even maintain the ability to regenerate olfactory neurons from adult stem cells, just to make sure that our sense of smell stays alive as long as we do?</p><p>The functional anatomy of the mammalian nose and its close contact to the oral cavity point to possible answers to these questions. Odour molecules approach the olfactory epithelium along two principle routes: When we sniff or breathe with our mouth closed, the inhaled air enters the lumen of the nasal cavity through external nostrils. Food almost touches our nares before it enters the oral cavity, and it is almost impossible not to stick our nose into a glass of wine that we taste. When we chew, we break down the food into a mush from which favours exhale. These volatile odour molecules then travel up the retro-nasal passage and reach the olfactory epithelium through internal nostrils, which connect the pharynx to the nasal cavity [<xref ref-type=""bibr"" rid=""B11"">11</xref>]. The phylogenetic emergence of these internal nostrils (or choanae) was an important step in the adaptation of the olfactory system to air breathing [<xref ref-type=""bibr"" rid=""B12"">12</xref>]. It now enables us to employ olfactory perception in the assessment of nutrients at every level of uptake. We can now even evaluate compounds in our food that are made accessible only by mechanical exposure. This close involvement of the olfactory system in the analysis of food along with the attributive nature of olfactory perception allow us to employ the sense of smell in aquiring refined food preferences. In this respect, humans are uniquely flexible. There might be some inherently aversive odours (such as the smell of rotting meat), but depending on trends and cultural background, we can enjoy almost everything, from fried locusts spiced with salt and lime (as served in the Mexican region of Oaxaca) to live oysters (which are perceived as a delicacy in a lot of wealthy Western societies). We can even ""learn to enjoy things that we should not enjoy"" [<xref ref-type=""bibr"" rid=""B13"">13</xref>]. Used as flavoring agents, bitter compounds, including plant-derived phenols and polyphenols, flavonoids, catechins, and caffeine, enhance the sensory appeal of beverages and food, such as beer, coffee, chocolate, tea, and tonic water [<xref ref-type=""bibr"" rid=""B14"">14</xref>]. This flexibility effectively supports opening up new food resources. In this context, olfactory conditioning helps us to pass on approved food preferences to our infant offspring, while at the same time protecting them from exploring potentially noxious material while unattended (long before they understand the advise that we give). Cooking-ambitious parents often experience how cautious and how annoyingly conservative their children can be, when it comes to trying out unknown delicacies. The juveniles may well obstinately insist on fish sticks with mashed potatoes when served cod steaks cooked in an »interesting spice mixture of ginger, cloves, chilies, cilantro leaves, and lemon juice« [<xref ref-type=""bibr"" rid=""B15"">15</xref>]. Training pays out, however, and we can learn to expand our pool of nutrients to include surprisingly variable ingredients.</p><p>For free living rats, the importance of social learning of food preferences has also been demonstrated [<xref ref-type=""bibr"" rid=""B16"">16</xref>], and olfaction certainly plays an important role in this process [<xref ref-type=""bibr"" rid=""B17"">17</xref>]. Mice prefer sweet over bitter, even if the sweet perception is triggered erroneously by a bitter compound [<xref ref-type=""bibr"" rid=""B18"">18</xref>]. Humans, in contrast, are capable of expanding their menu well beyond sweet and non-bitter aliments, and they seem to do so by prioritizing hedonic odour qualities over gustatory perception, and by dynamically adapting their food preferences to changing age, resources, and trends.</p><p>The production of aromas and scents has long been an important economical factor [<xref ref-type=""bibr"" rid=""B19"">19</xref>] and an interesting perspective for biotechnological fabrication [<xref ref-type=""bibr"" rid=""B20"">20</xref>]. Olfactory signals can act as mediator of social interactions [<xref ref-type=""bibr"" rid=""B21"">21</xref>] and the potential of olfactory cues as marketing tools in social and economical context has long been recognized [<xref ref-type=""bibr"" rid=""B22"">22</xref>-<xref ref-type=""bibr"" rid=""B24"">24</xref>]. Nevertheless, empirical research in the field of how we perceive odours is still fairly new, although we know more today about our brain's strategy in computing odour perception [<xref ref-type=""bibr"" rid=""B25"">25</xref>-<xref ref-type=""bibr"" rid=""B28"">28</xref>] than we did only a few years ago. Innovative techniques such as genetic tracing of neural circuits [<xref ref-type=""bibr"" rid=""B29"">29</xref>-<xref ref-type=""bibr"" rid=""B31"">31</xref>] and functional magnetic resonance imaging (fMRI) [<xref ref-type=""bibr"" rid=""B32"">32</xref>-<xref ref-type=""bibr"" rid=""B36"">36</xref>] produced exciting new results. It turns out, that, even in insects, coding and representation of odours is highly complex and dynamic [<xref ref-type=""bibr"" rid=""B27"">27</xref>,<xref ref-type=""bibr"" rid=""B28"">28</xref>,<xref ref-type=""bibr"" rid=""B37"">37</xref>-<xref ref-type=""bibr"" rid=""B39"">39</xref>], but significant progress is made, and, for example, we now begin to understand why a typical white wine tastes like a typical red wine, just because we added a tiny pinch of neutral anthocyanins. In a striking fMRI study, Jay Gottfried and Raymond Dolan recently found evidence of why ""the nose smells what the eye sees"". Their data indicate that the ""human hippocampus mediates a reactivation of crossmodal semantic associations, even in the absence of explicit memory processing"" [<xref ref-type=""bibr"" rid=""B32"">32</xref>,<xref ref-type=""bibr"" rid=""B33"">33</xref>]. Apparently, »black raspberries and Provençal olives« are imprinted in our brain, while the nose just pulls the trigger to unfold them in our mind.</p></sec><sec><title>Olfactory sensory neurons</title><p>The initial event in all these fascinating aspects of odour sensation is the binding of odorant molecules [<xref ref-type=""bibr"" rid=""B40"">40</xref>] to olfactory receptor proteins [<xref ref-type=""bibr"" rid=""B41"">41</xref>,<xref ref-type=""bibr"" rid=""B42"">42</xref>]. The released binding energy is transduced by a complex chain of molecular interactions into electrochemical membrane potentials, which dynamically modulate neuronal odour representation [<xref ref-type=""bibr"" rid=""B19"">19</xref>,<xref ref-type=""bibr"" rid=""B43"">43</xref>-<xref ref-type=""bibr"" rid=""B56"">56</xref>]. How do these primary olfactory processes work and where do they occur?</p><p>A crux of this matter are the bipolar chemosensory neurons in the olfactory epithelium of the nose. Olfactory neurons are based at the front line between the brain and the odour-containing air that we breathe. Their surface membrane can be divided into two major spatial compartments, which are separated by a belt of tight junctional proteins [<xref ref-type=""bibr"" rid=""B57"">57</xref>]. The basolateral surface membrane lies well protected inside of the olfactory epithelial tissue. It covers large part of the apical dendrite, the cell body, and an unbranched axon that projects to the brain. On the other hand, there is an apical surface membrane compartment, the size of which is comparable to that of the basal compartment. It is located externally, directly exposed to the air, and attached to the rest of the cell only through the nexus of a thin apical dendrite, which reaches into the lumen of the nasal cavity with its terminal knob. The apical surface membrane is embedded into mucus and airway surface fluid. These represent ionic and biochemical compartments, which are important for olfactory signal transduction [<xref ref-type=""bibr"" rid=""B58"">58</xref>,<xref ref-type=""bibr"" rid=""B59"">59</xref>], as well as for innate defense of all airway epithelial surfaces [<xref ref-type=""bibr"" rid=""B60"">60</xref>]. Disturbances of the composition of these fluids, e.g. by mutation of ion transport systems, can cause severe pathologies, including cystic fibrosis [<xref ref-type=""bibr"" rid=""B61"">61</xref>].</p><p>Through their apical membrane compartment, olfactory sensory neurons contact the ambient air. At this surface, they collect information about volatile odour molecules, and here odours are transduced into neuronal signals, which the brain can read and analyse [<xref ref-type=""bibr"" rid=""B62"">62</xref>-<xref ref-type=""bibr"" rid=""B64"">64</xref>]. The molecular machinery that mediates olfactory signal transduction has been thoroughly characterized. Briefly, volatile odour molecules bind to odorant receptors [<xref ref-type=""bibr"" rid=""B65"">65</xref>] and trigger the activation of G-proteins (Gα<sub>olf</sub>) [<xref ref-type=""bibr"" rid=""B47"">47</xref>]. This in turn stimulates adenylyl cyclase (type III) activity [<xref ref-type=""bibr"" rid=""B66"">66</xref>], and the resulting rise of intracellular adenosine 3',5'-cyclic monophosphate (cAMP) opens cyclic nucleotide-gated (CNG) cation channels [<xref ref-type=""bibr"" rid=""B67"">67</xref>]. The elicited influx of Ca<sup>2+</sup>from the extracellular space depolarizes the ciliary membrane and prompts a secondary opening of Ca<sup>2+</sup>-gated chloride channels. These are responsible for large part of the depolarizing current across the olfactory ciliary membrane [<xref ref-type=""bibr"" rid=""B68"">68</xref>,<xref ref-type=""bibr"" rid=""B69"">69</xref>]. The depolarizing nature of the induced chloride current is based on an unusually high intracellular chloride concentration in the cytoplasm and cilia of olfactory sensory neurons, which is replenished by sodium-potassium-chloride co-transporters (NKCC-1) in the basolateral surface membrane compartment [<xref ref-type=""bibr"" rid=""B68"">68</xref>,<xref ref-type=""bibr"" rid=""B69"">69</xref>]. Odour-induced signals are thought to be terminated as a result of multiple factors and mechanisms [<xref ref-type=""bibr"" rid=""B70"">70</xref>], although recent evidence indicates that the dwell-time of the receptor-odorant complex might be too small for some inactivation processes to occur under physiological conditions [<xref ref-type=""bibr"" rid=""B71"">71</xref>].</p><p>Beside this main stream model of olfactory signal transduction survived a scuff resistant hypothesis, proposing InsP<sub>3</sub>as an alternative second messenger in olfaction [<xref ref-type=""bibr"" rid=""B50"">50</xref>,<xref ref-type=""bibr"" rid=""B72"">72</xref>,<xref ref-type=""bibr"" rid=""B73"">73</xref>]. The possibility of a supplementary signalling pathway in olfactory neurons was initially raised by a study, in which the authors found that in contrast to most odours, some potent odorants failed to induce cAMP when applied to isolated olfactory cilia in biochemical assays [<xref ref-type=""bibr"" rid=""B74"">74</xref>]. It was later found that these ""non cAMP odours"" induced InsP<sub>3</sub>instead [<xref ref-type=""bibr"" rid=""B75"">75</xref>,<xref ref-type=""bibr"" rid=""B76"">76</xref>], and that odorant receptors coupled to either cAMP or InsP<sub>3</sub>when they were functionally expressed in insect cells, depending on the receptor's specificity for either ""cAMP-"" or ""IP3-odours"" [<xref ref-type=""bibr"" rid=""B77"">77</xref>]. Despite these findings, the resulting speculation around a possible duality of signalling pathways in olfactory neurons remained controversial [<xref ref-type=""bibr"" rid=""B49"">49</xref>,<xref ref-type=""bibr"" rid=""B78"">78</xref>]. The goose of InsP<sub>3</sub>as an alternative second messenger in olfactory neurons got cooked, when mutant mice that lacked functional expression of Gα<sub>olf</sub>[<xref ref-type=""bibr"" rid=""B79"">79</xref>], adenylyl cyclase (type III) [<xref ref-type=""bibr"" rid=""B80"">80</xref>], and cyclic nucleotide-gated ion channels [<xref ref-type=""bibr"" rid=""B81"">81</xref>] came out anosmic for both cAMP- and InsP<sub>3</sub>-odours. Consequently, many researchers began to accept that cAMP might be the sole excitatory second messenger in olfaction [<xref ref-type=""bibr"" rid=""B82"">82</xref>-<xref ref-type=""bibr"" rid=""B84"">84</xref>]. The evidence linking phosphoinositide-related signalling to the mammalian olfactory epithelium, however, remained orphaned.</p></sec><sec><title>Cilia and microvilli</title><p>The apical surface membrane of olfactory sensory neurons is a platform that links the physical world of odour molecules to the mental world of odour perception. At this interface, the physiochemical properties of volatile compounds are transduced into the electrochemical membrane potentials, which modulate the information from which the brain constructs, for example, the aromas of »black raspberries« and »pain grillé«. The apical surface membrane compartment therefore represents a most important cell organelle. It is significantly enlarged by cilia or microvilli, which emerge from the terminal knob of the apical dendrite to protrude into the mucus [<xref ref-type=""bibr"" rid=""B85"">85</xref>]. What is the biological significance of this enlargement? Why do some sensory neurons sustain this extension with cilia, while others possess microvilli or both?</p><p>A requirement for high sensitivity is often regarded as a sufficiently meaningful biological reason for the enlargement of the surface area of sensory membranes. In photoreceptor cells, this argument intuitively makes sense. A photon on its path through a photoreceptor cell is either captured by a photosensitive rhodopsin molecule or the information it carries will be lost by absorption in non sensory material. Therefore, photoreceptor cells increase their quantum efficiency by forming multilayered stacks of membranes that are tightly packed with photosensitive rhodopsin molecules. This functional cytoarchitecture can likewise be observed in vertebrate [<xref ref-type=""bibr"" rid=""B86"">86</xref>] and invertebrate eyes [<xref ref-type=""bibr"" rid=""B87"">87</xref>], where stacks of membrane discs or rhabdomeric microvilli ensure high quantum efficiency of each photosensitive cell. In the case of olfactory sensory neurons, however, the situation is slightly different. Compared to photons, odour molecules are stable and could theoretically be trapped and retained in a lipophilic environment until receptor activation has occurred. Furthermore, the physiological purpose of increasing sensitivity is also not as obvious as a first glance might suggest. It has been reported that olfactory neurons are sufficiently sensitive to detect even single odour molecules [<xref ref-type=""bibr"" rid=""B88"">88</xref>], but the biological significance of this finding was challenged [<xref ref-type=""bibr"" rid=""B49"">49</xref>,<xref ref-type=""bibr"" rid=""B89"">89</xref>,<xref ref-type=""bibr"" rid=""B90"">90</xref>]. Extraordinary sensitivity has undoubtedly been observed in the olfactory system of moths [<xref ref-type=""bibr"" rid=""B91"">91</xref>], but since only a few mammals fly around in the dark with a need to smell their food or mating partner from miles away, it remains unclear how solitary odour molecules could carry meaningful information and why they should be detected at all. Quantal sensitivity of olfactory neurons, similar to that observed in photoreceptor cells [<xref ref-type=""bibr"" rid=""B92"">92</xref>,<xref ref-type=""bibr"" rid=""B93"">93</xref>], could also provide confusing sensory input to the brain. Olfactory neurons express only one or a few olfactory receptors [<xref ref-type=""bibr"" rid=""B94"">94</xref>,<xref ref-type=""bibr"" rid=""B95"">95</xref>] and many olfactory receptors are broadly tuned to overlapping sets of qualitatively distinct odour molecules [<xref ref-type=""bibr"" rid=""B62"">62</xref>-<xref ref-type=""bibr"" rid=""B64"">64</xref>]. Thus, two identical solitary odour molecules could trigger different sensory input into the olfactory system, depending on which receptor they hit by chance. Such an arrangement does not appear like a plausible approach to ensure reliable and reproducible sensory input, particularly at extremely low levels of odorant concentration. Accordingly, in contrast to phototransduction, olfactory signal transduction lacks amplification at one of its very basic levels, namely that of receptor-G-protein-activation. The life-time of the receptor-odorant complex was found to be so short, that the complex might often dissociate even before a single G-protein was activated. Consequently, signal amplification by one active receptor triggering multiple downstream G-protein/effector enzyme molecules seems unplausible [<xref ref-type=""bibr"" rid=""B71"">71</xref>].</p><p>Alternative explanations for the observed enlargement of the apical membrane compartment of olfactory neurons include the outstanding ability of these cells to provide information that allows the detection of even minute differences between odour concentrations, or, equivalently, differential affinities of odour molecules to distinct receptor populations.</p><p>Even humans are capable of extracting spatial information from smell [<xref ref-type=""bibr"" rid=""B96"">96</xref>-<xref ref-type=""bibr"" rid=""B98"">98</xref>]. Dogs just need five footsteps to determine the direction of an odour trail [<xref ref-type=""bibr"" rid=""B99"">99</xref>] and a rat can determine the location of an odour source by stereo-localisation in a single sniff [<xref ref-type=""bibr"" rid=""B100"">100</xref>]. To enable such impressing performances, it will most likely be necessary to maximize the dynamic sensitivity of olfactory neurons. The dynamic sensitivity represents the ability of a signalling system to respond to a small change of the input signal by modulating the output signal in a statistically significant manner. The dynamic sensitivity of an olfactory neuron is directly influenced by the size of its apical membrane surface compartment, because the latter is correlated to the number of signalling proteins (i.e. receptor molecules, G-proteins, and ion channels) and thus to the total number of elementary responses that can simultaneously be generated in each cell.</p><p>The requirements to a high performance odorant detector can be illustrated by comparing it to a light detecting device, such as a charge-coupled device (CCD) camera. Here, each photosensitive element (analogous to an olfactory neuron in the nose) is characterized by its background noise, its quantum efficiency,<italic>and</italic>its full well capacity [<xref ref-type=""bibr"" rid=""B101"">101</xref>]. In a high performance CCD camera, noise reduction is achieved by cooling the sensor to low temperatures. Quantum efficiency of a photon detector describes the ratio between the number of photons registered by the detector to the number of photons entering the device. Lastly, the full well capacity of the photon detector describes the total number of photons that can be registered within a single readout cycle. To improve the dynamic sensitivity of any charge-coupled device, it is necessary to combine high quantum efficiency with a large full well capacity. If the ratio between full well capacity and quantum efficiency of the detector is low, the slope of its response curve will be shallow. This, in turn, makes it difficult to reliably detect minute differences in signal amplitude, particularly when background noise is high. Therefore, high performance light detectors require the optimization of all three parameters combined: low background noise, high quantum sensitivity, and large full well capacity.</p><p>For olfactory sensory neurons, similar requirements might apply. In the olfactory sytem, noise reduction is a multi level process [<xref ref-type=""bibr"" rid=""B102"">102</xref>]. It begins with a nonlinear signal amplification by Ca<sup>2+</sup>-activated chloride currents [<xref ref-type=""bibr"" rid=""B103"">103</xref>,<xref ref-type=""bibr"" rid=""B104"">104</xref>], continues by the convergence of dozens of cilia onto the terminal knob of the sensory neuron's apical dendrite, and is further sophisticated by the convergence of hundreds of olfactory neurons on a single glomerulus in the olfactory bulb [<xref ref-type=""bibr"" rid=""B105"">105</xref>-<xref ref-type=""bibr"" rid=""B107"">107</xref>]. This multilevel integration with the possibility of adjusting thresholds at each level enables effective filtering of background noise, which has been observed as an intrinsic feature of olfactory signal transduction [<xref ref-type=""bibr"" rid=""B102"">102</xref>,<xref ref-type=""bibr"" rid=""B108"">108</xref>-<xref ref-type=""bibr"" rid=""B111"">111</xref>]. To represent high performance detectors for chemical constituents of the air, olfactory neurons might also have to improve quantum efficiency and full well capacity by enlarging their apical membrane compartment. At a given odour concentration and affinity of the odorant to its receptor, the quantum efficiency of the olfactory neuron as a whole will directly depend on the total number of receptors present. The same holds true for the neuron's ""full well capacity"", which represents its capacity to register odorant-to-receptor-docking-events within a single readout cycle (which in this case might be equivalent to the duration of a sniff). Since there is a limit to packaging density of receptors and other signaling molecules within the surface membrane, these parameters will also depend on the total apical surface membrane area. Olfactory neurons therefore enlarge this area by the folding the apical membrane into cilia and/or microvilli [<xref ref-type=""bibr"" rid=""B85"">85</xref>]. Interestingly, it seems that olfactory neurons further improve their physiological performance by additional measures. As mentioned above, the receptor-odorant dwell-time is very short, enabling repeated binding of odorant molecules to the same receptor. Furthermore, the quantal responses of olfactory neurons are very small. At the same time, the density of receptors in the ciliary membrane is so high that their response domains overlap, which causes non linear summation of the odour-induced unitary responses [<xref ref-type=""bibr"" rid=""B71"">71</xref>]. Since linearity is neither necessary for detecting differential activation patterns (i.e. specific odours), nor for sensing relative differences in odour concentration, this strategy seems to improve the dynamic resolution of each olfactory neuron over a broad range of odour concentration levels and thus perfectly serves to the needs of a biological high performance chemodetector.</p><sec><title>Ciliary and microvillar (rhabdomeric) photoreceptor cells</title><p>For animal photoreceptor cells, two types of membrane enlargement have been recognized. Rhabdomeric photoreceptor cells, as they occur in the compound eye of arthropods, carry microvilli, while the rods and cones of the mammalian retina and the light sensitive cells of the pineal organ are of a ciliary type. The evolutionary origin of both cell types was unclear [<xref ref-type=""bibr"" rid=""B112"">112</xref>], until Detlev Arendt and his collaborators found a polychaete marine worm,<italic>Platynereis dumerilii</italic>, which possesses both, rhabdomeric and ciliary photoreceptors [<xref ref-type=""bibr"" rid=""B113"">113</xref>]. On the basis of these findings, the authors proposed an attractive model for the evolution of metazoan photoreceptor cells. Accordingly, rhabdomeric and ciliary photoreceptors have emerged from a common ancestor that used an ancestral opsin for photodetection. The ancestral opsin gene then duplicated into the paralogs rhabdomeric opsin (r-opsin) and ciliary opsin (c-opsin), supporting the emergence of ciliated and rhabdomeric photoreceptor cells and their functional diversification. This dualism of light sensitive cells can also be observed within the mammalian retina. Melanopsin, the vertebrate ortholog of invertebrate r-opsin, is expressed in some light-sensitive retinal ganglion cells, which are involved in synchronizing the primary circadian pacemaker in the suprachiasmatic nucleus to the light-dark cycle [<xref ref-type=""bibr"" rid=""B114"">114</xref>].</p><p>Light transduction in invertebrates is mediated by an eye-specific phospholipase C (norpA), phosphatidylinositol 4,5-bisphosphate (PIP<sub>2</sub>), its downstream products InsP<sub>3</sub>and diacylglycerol [<xref ref-type=""bibr"" rid=""B115"">115</xref>-<xref ref-type=""bibr"" rid=""B117"">117</xref>], and transient receptor potential (TRP and TRPL) channels [<xref ref-type=""bibr"" rid=""B118"">118</xref>,<xref ref-type=""bibr"" rid=""B119"">119</xref>]. Interestingly, the vertebrate ortholog (PLC β4) of norpA is also expressed in the mammalian retina [<xref ref-type=""bibr"" rid=""B120"">120</xref>] and melanopsin signalling has been linked to InsP<sub>3</sub>in cultured<italic>Xenopus</italic>melanophores [<xref ref-type=""bibr"" rid=""B121"">121</xref>-<xref ref-type=""bibr"" rid=""B124"">124</xref>]. This raises the question, whether cells expressing r-opsin and its orthologs generally utilize phosphoinositides as second messengers. Although melanopsin-expressing retinal ganglion cells do neither appear to be normal retinal ganglion cells nor specialized rhabdomeric or microvillar sensory neurons [<xref ref-type=""bibr"" rid=""B125"">125</xref>,<xref ref-type=""bibr"" rid=""B126"">126</xref>], this evidence nevertheless points towards a possible phylogenetic link between rhabdomeric photoreceptor cells and phosphoinositide-mediated signalling processes. In contrast, ciliary photoreceptors prefer phosphodiesterase-mediated signal transduction with cGMP as a second messenger [<xref ref-type=""bibr"" rid=""B121"">121</xref>,<xref ref-type=""bibr"" rid=""B122"">122</xref>].</p><p>A functional reason for the possible allocation between microvilli and InsP<sub>3</sub>signalling has been proposed by Klaus Lange [<xref ref-type=""bibr"" rid=""B127"">127</xref>]. He suggested that F-actin, which is a major constituent of the cytoskeleton of microvilli, represents an InsP<sub>3</sub>-sensitive, non vesicular Ca<sup>2+</sup>-store. Accordingly, a stimulation of phospholipase C will release the actin-binding proteins profilin and gelsolin from phospholipids, which in turn liberates Ca<sup>2+</sup>from F-actin. InsP<sub>3</sub>stabilizes the active state of profilin/gelsolin. Furthermore, PIP<sub>2</sub>, a substrate of phospholipase C, is preferentially localised to raft-like lipid domains, which are typically observed in conjunction with microvilli [<xref ref-type=""bibr"" rid=""B128"">128</xref>,<xref ref-type=""bibr"" rid=""B129"">129</xref>]. This raises the possibility that, for principle reasons, signal transduction processes in cilia and microvilli preferentially utilize cyclic nucleotides and phosphoinositides as second messengers, respectively.</p></sec><sec><title>Ciliated and microvillar olfactory neurons</title><p>In mammals, the apical cell surface of typical olfactory neurons is enlarged by a species-dependant number of cilia. In microvillar olfactory neurons the enlargement occurs by the folding of the membrane into microvilli. Both types of olfactory sensory neurons have been observed without perceivable phylogenetic boundaries throughout the clade of vertebrates. In her excellent and comprehensive review, Heather Eisthen pointed out that sharks, rays, and ratfish have only microvillar olfactory neurons, while lampreys, frogs, snakes, and turtles have only ciliated ones. In hagfish, bony fishes, and salamanders, both types of olfactory neurons can be observed next to each other, while in birds individual olfactory neurons simultaneously carry cilia and microvilli [<xref ref-type=""bibr"" rid=""B85"">85</xref>]. The situation in mammals is not entirely clear. Many researchers assume that only ciliated olfactory neurons are present, but the occurrence of microvillar olfactory neurons has also been proposed [<xref ref-type=""bibr"" rid=""B130"">130</xref>,<xref ref-type=""bibr"" rid=""B131"">131</xref>]. Surprisingly, this finding has never attracted much attention.</p></sec></sec><sec><title>Olfactory microvillar cells</title><p>The olfactory epithelium of mammals consists of a relatively small number of cell types [<xref ref-type=""bibr"" rid=""B132"">132</xref>]. A monolayer of supporting or sustentacular cells separates the nasal cavity from the sensory neuroepithelium. This palisade-like monolayer covers a pseudostratified layer of bipolar sensory neurons, which basally project an axon to the olfactory bulb (Figure<xref ref-type=""fig"" rid=""F1"">1</xref>). Apically, the olfactory neurons contact the lumen of the nasal cavity with the terminal knob of their apical dendrite (Figure<xref ref-type=""fig"" rid=""F2"">2</xref>). Between the cell bodies of the chemosensory neurons and the basal lamina is a thin layer of so-called globose and horizontal basal cells, which contains a population of adult neuronal stem cells [<xref ref-type=""bibr"" rid=""B133"">133</xref>-<xref ref-type=""bibr"" rid=""B136"">136</xref>]. These stem cells are important to maintain function and histology of the olfactory epithelium, because based on their exposed situation in contact to ambient air, olfactory neurons are prone to damage and infection. Consequently, olfactory neurons have a limited lifetime before they are periodically replaced [<xref ref-type=""bibr"" rid=""B137"">137</xref>-<xref ref-type=""bibr"" rid=""B141"">141</xref>].</p><fig id=""F1"" position=""float""><label>Figure 1</label><caption><p><bold>Olfactory bulb</bold>. Section through the olfactory bulb of a 16 days old rat brain. The tissue has been fixed and immunoperoxidase-stained with antibodies against GABAA-receptor_1-subunit (brown) as described elsewhere [157]. Nissl staining was performed to counter stain (blue). Clearly visible are the accessory olfactory bulb (AOB), to which chemosensory neurons from the vomeronasal organ project, the intensely labelled layer of mitral cells (MC), and the glomeruli (G), which represent the first relay station for sensory information transmitted from the nose to the brain (Jacques Paysan, unpublished).</p></caption><graphic xlink:href=""1471-2202-8-S3-S1-1""></graphic></fig><fig id=""F2"" position=""float""><label>Figure 2</label><caption><p><bold>Olfactory epithelium</bold>. This image shows a vertical projection of a stack of confocal images taken from a transgenic mouse, in which green fluorescent protein (GFP) is expressed in all ciliated olfactory sensory neurons. GFP brightly labels the olfactory neuronal cell bodies (OCB), their apical dendrites (AD), and terminal knobs (TK). Staining does not extend into the sensory cilia, which remain invisible in this preparation. Basally to the olfactory neuronal cell bodies is the unstained layer of basal stem cells (LBC), from which degenerating neurons are constantly regenerated. The olfactory axons grow in bundles (AB) through the basal lamina (BL), and then fasciculate to form the tracts of the olfactory nerve, which projects into the brain. (Rebecca Elsaesser and Jacques Paysan, unpublished).</p></caption><graphic xlink:href=""1471-2202-8-S3-S1-2""></graphic></fig><p>In addition to these three well established major olfactory epithelial cell types, i.e. ciliated olfactory sensory neurons, microvillous supporting or sustentacular cells, and basal cells, at least five classes of so-called olfactory microvillar cells exist [<xref ref-type=""bibr"" rid=""B132"">132</xref>]. To prevent confusion, Bert Menco and Edward Morrison suggested to systematically re-classify olfactory microvillar cells, and to combine all olfactory epithelial cells that have microvilli under the term ""microvillous cells"" [<xref ref-type=""bibr"" rid=""B132"">132</xref>]. The function of this peculiar type of cells is totally unknown.</p><p>Some microvillous cells have been proposed to represent a second class of bipolar sensory neurons. Based on an electron microscopic study of the olfactory epithelium of rat, François Jourdan first made this suggestion in 1975 [<xref ref-type=""bibr"" rid=""B130"">130</xref>]. In his thesis, he described a microvillar type of bipolar olfactory cells (type B cells), the morphology of which, in his view, was that of a typical bipolar receptor neuron (Figure<xref ref-type=""fig"" rid=""F3"">3</xref>). Similar cells were later reexamined by David Moran, Carter Rowley, and Bruce Jafek [<xref ref-type=""bibr"" rid=""B131"">131</xref>], who also found evidence that supported the existence of a second morphologically distinct class of bipolar sensory neurons in the mammalian olfactory epithelium [<xref ref-type=""bibr"" rid=""B142"">142</xref>,<xref ref-type=""bibr"" rid=""B143"">143</xref>]. The authors injected horseradish peroxidase into the olfactory bulb of rat and detected retrograde labelling of olfactory epithelial microvillar cell bodies. They concluded that microvillar cells are connected by an axon to the olfactory bulb, and that the rat olfactory system will thus ""need to be expanded to include two morphologically distinct classes of sensory receptors, ciliated olfactory receptors and microvillar cells"" [<xref ref-type=""bibr"" rid=""B143"">143</xref>]. This hypothesis seemed plausible on the basis of the observation that ciliated and microvillar olfactory neurons occur in many other species throughout the clade of vertebrates [<xref ref-type=""bibr"" rid=""B85"">85</xref>,<xref ref-type=""bibr"" rid=""B144"">144</xref>]. However, the evidence that microvillar cells are neuronal remained controversial. When Virginia Carr and collaborators stained rat olfactory epithelia with monoclonal antibody 1A-6, they labelled microvillar cells that were not immunoreactive with SUS-1 antibodies (which is a marker for supporting cells). The 1A-6 immunoreactive cells, however, neither expressed olfactory marker protein (OMP), nor did they possess an identifiable axonal process. Since the cells also survived bulbectomy-induced degeneration of olfactory sensory neurons, the authors concluded that olfactory microvillar cells are of non-neuronal nature [<xref ref-type=""bibr"" rid=""B145"">145</xref>]. The absence of OMP in microvillar cells was confirmed by Edward Johnson and collaborators [<xref ref-type=""bibr"" rid=""B146"">146</xref>]. These authors also acknowledged some arguments that speak for a non-neuronal function of microvillar cells, but pointed out that the peroxidase backfill experiments [<xref ref-type=""bibr"" rid=""B143"">143</xref>] and the expression of Spot-35 protein [<xref ref-type=""bibr"" rid=""B147"">147</xref>] are in favour of positioning microvillar cells ""in with known microvillar olfactory receptor cells of other vertebrates"". They carefully concluded, that the function of the olfactory microvillar cell remains enigmatic [<xref ref-type=""bibr"" rid=""B146"">146</xref>].</p><fig id=""F3"" position=""float""><label>Figure 3</label><caption><p><bold>Microvillar and ciliated olfactory sensory cells</bold>. Electron micrograph showing the apical poles of an olfactory microvillar cell (MVC) and a typical olfactory sensory neuron (OSN). This image was generated in 1975 at the Centre de microscopie électronique (Claude Bernard University, Lyon 1, France) and kindly provided by François Jourdan. See [130] for details.</p></caption><graphic xlink:href=""1471-2202-8-S3-S1-3""></graphic></fig><p>Recently, we have examined the distribution of phosphoinositide-related signalling proteins in the mammalian olfactory epithelium and found that some elements of InsP<sub>3</sub>-mediated signal transduction were found exclusively in olfactory microvillar cells [<xref ref-type=""bibr"" rid=""B19"">19</xref>,<xref ref-type=""bibr"" rid=""B148"">148</xref>]. These cells that we call ""Jourdan cells"", were labelled with antibodies against phospholipase C beta-2 (PLC β2), type 3 InsP<sub>3</sub>-receptors (InsP<sub>3</sub>R-III), type 6 transient receptor potential channels (TRPC6), and other proteins, including neuronal marker protein MAP2b [<xref ref-type=""bibr"" rid=""B148"">148</xref>]. In contrast, no co-expression with OMP, cyclic nucleotide-gated channels, or adenylyl cyclase could be detected. When dissociated and exposed<italic>in vitro</italic>to depolarizing concentrations of potassium chloride, Jourdan cells reacted with a transient increase of their intracellular Ca<sup>2+</sup>concentration. A similar reaction was observed, when the cells were exposed to odours. They also possessed a basal axon-like protrusion, which raised the possibility that they in fact represent a second class of olfactory sensory neurons. In contrast to ciliated olfactory sensory neurons [<xref ref-type=""bibr"" rid=""B149"">149</xref>-<xref ref-type=""bibr"" rid=""B151"">151</xref>], however, microvillar cells did not degenerated upon bulbectomy. This has been interpreted as one argument for a non neuronal nature of olfactory microvillar cells [<xref ref-type=""bibr"" rid=""B145"">145</xref>,<xref ref-type=""bibr"" rid=""B152"">152</xref>].</p><p>Is there a duality of signalling pathways and sensory neurons in the mammalian olfactory epithelium, similar to the existence of ciliary and rhabdomeric photoreceptor cells? Unfortunately, it is too early to submit such an admittedly attractive proposal. At present, only a few arguments that can be brought in position to support any concept on what olfactory microvillar cells might do. First, these cells look like sensory neurons [<xref ref-type=""bibr"" rid=""B130"">130</xref>]. They show a strong bipolar asymmetry, with a distinctive array of microvilli protruding towards the nasal cavity at their apical pole, and an axon-like process, the distal extension of which often crosses the basal lamina and seems to join the submucosal tracts of the olfactory nerve [<xref ref-type=""bibr"" rid=""B148"">148</xref>]. This bipolar architecture of microvillar cells would at least be tailor made to enable the cells to collect signals at the olfactory mucosal surface and transmit this information across the epithelium. This view is supported by the localization of PLC β2 in the apical microvilli. PLC β2 is a G-protein-activated signal transduction enzyme and thus points towards the presence of yet unidentified upstream G-protein-coupled receptors. Moreover, the cells express neuronal marker protein MAP2b [<xref ref-type=""bibr"" rid=""B148"">148</xref>], Ca<sup>2+</sup>-binding protein SPOT-35 [<xref ref-type=""bibr"" rid=""B153"">153</xref>], and they are depolarized by high potassium chloride [<xref ref-type=""bibr"" rid=""B148"">148</xref>]. All of these findings are compatible with a role of olfactory sensory neurons, but none of them is a persuasive argument. To determine, whether or not olfactory microvillar cells in fact represent sensory neurons, it will be necessary to characterize them by electrophysiological recordings and to analyze their cell morphology and gene expression profile in greater detail.</p><p>Albeit their (un)neuronal nature, we have now found evidence that points towards a possible function of olfactory microvillar cells. As pointed out above, olfactory sensory neurons periodically die by apoptosis, being constantly regenerated from a distinct population of adult neuronal stem cells. To avoid unproportional growth or degeneration of the olfactory epithelial tissue throughout life, both processes – cell death and regeneration – must be precisely coordinated over many decades. It has been demonstrated by Donna Hansel, Betty Eipper, and Gabriele Ronnett, that among the factors, which contribute to this control, are amidated neuropeptides [<xref ref-type=""bibr"" rid=""B154"">154</xref>]. In the adult olfactory neuroepithelium, neuropeptide Y is released from an uncharacterized set of cells [<xref ref-type=""bibr"" rid=""B155"">155</xref>]. We were now able to show that the NPY-expressing cells are identical to the olfactory microvillar cells that we had previously characterized [<xref ref-type=""bibr"" rid=""B156"">156</xref>]. This finding raises the possibility, that olfactory microvillar cells link signals on the surface of the olfactory mucosa to proliferation and differentiation of olfactory stem cells at the basis of the epithelium. Whether or not olfactory microvillar cells indeed represent a second class of olfactory sensory neurons remains elusive. In analogy to melanopsin-expressing retinal ganglion cells, they could be derived from an ancient type of microvillar olfactory neurons, which in the course of evolution have aquired a new physiological function. These thoughts, however, are totally speculative. Our efforts to understand their biological significance have just begun. A first step must be to unravel their input specificity by identifying the G-protein-coupled receptors, which act upstream of PLC β2.</p></sec><sec><title>Authors' contributions</title><p>JP outlined the manuscript and wrote the initial draft. RE significantly contributed to its contents, figures, and to finalizing the manuscript. Both authors read and approved the final manuscript.</p></sec><sec><title>Competing interests</title><p>The authors have no competing interests.</p></sec><back><sec><title>Acknowledgements</title><p>This work was funded by the German Research Foundation (DFG). The authors thank François Jourdan, for kindly providing us with the electron micrograph shown in Fig.<xref ref-type=""fig"" rid=""F2"">2</xref>; Martin Meyer and Dagmar Püschel (Dolmetscher-Services, Wiesbaden), who supported us with valuable linguistic advise; Peter Mombaerts, for allowing us to work with the OMP-GFP mice; and Stefania Petrucco and Roberto Tirindelli, for their charming hospitality and critical input.</p><p>This article has been published as part of<italic>BMC Neuroscience</italic>Volume 8 Supplement 3, 2007: The chemical senses: recent advances and new promises. The full contents of the supplement are available online at<ext-link ext-link-type=""uri"" xlink:href=""http://www.biomedcentral.com/1471-2202/8?issue=S3"">http://www.biomedcentral.com/1471-2202/8?issue=S3</ext-link>.</p></sec><ref-list><ref id=""B1""><mixed-citation publication-type=""book""><name><surname>McCoy</surname><given-names>E</given-names></name><source>The emperor of wine : the rise of Robert M. Parker, Jr. and the reign of American taste</source><year>2005</year><edition>1</edition><publisher-name>New York: ECCO</publisher-name></mixed-citation></ref><ref id=""B2""><mixed-citation publication-type=""journal""><name><surname>Morrot</surname><given-names>G</given-names></name><name><surname>Brochet</surname><given-names>F</given-names></name><name><surname>Dubourdieu</surname><given-names>D</given-names></name><article-title>The color of odors</article-title><source>Brain Lang</source><year>2001</year><volume>79</volume><issue>2</issue><fpage>309</fpage><lpage>320</lpage><pub-id pub-id-type=""doi"">10.1006/brln.2001.2493</pub-id><pub-id pub-id-type=""pmid"">11712849</pub-id></mixed-citation></ref><ref id=""B3""><mixed-citation publication-type=""journal""><name><surname>Cain</surname><given-names>WS</given-names></name><article-title>Know with the Nose – Keys to Odor Identification</article-title><source>Science</source><year>1979</year><volume>203</volume><issue>4379</issue><fpage>467</fpage><lpage>470</lpage><pub-id pub-id-type=""doi"">10.1126/science.760202</pub-id><pub-id pub-id-type=""pmid"">760202</pub-id></mixed-citation></ref><ref id=""B4""><mixed-citation publication-type=""journal""><name><surname>Dravnieks</surname><given-names>A</given-names></name><name><surname>Masurat</surname><given-names>T</given-names></name><name><surname>Lamm</surname><given-names>RA</given-names></name><article-title>Hedonics of Odors and Odor Descriptors</article-title><source>Journal of the Air Pollution Control Association</source><year>1984</year><volume>34</volume><issue>7</issue><fpage>752</fpage><lpage>755</lpage></mixed-citation></ref><ref id=""B5""><mixed-citation publication-type=""journal""><name><surname>Zald</surname><given-names>DH</given-names></name><name><surname>Pardo</surname><given-names>JV</given-names></name><article-title>Emotion, olfaction, and the human amygdala: Amygdala activation during aversive olfactory stimulation</article-title><source>Proceedings of the National Academy of Sciences of the United States of America</source><year>1997</year><volume>94</volume><issue>8</issue><fpage>4119</fpage><lpage>4124</lpage><pub-id pub-id-type=""pmid"">9108115</pub-id><pub-id pub-id-type=""doi"">10.1073/pnas.94.8.4119</pub-id></mixed-citation></ref><ref id=""B6""><mixed-citation publication-type=""journal""><name><surname>AlaouiIsmaili</surname><given-names>O</given-names></name><name><surname>VernetMaury</surname><given-names>E</given-names></name><name><surname>Dittmar</surname><given-names>A</given-names></name><name><surname>Delhomme</surname><given-names>G</given-names></name><name><surname>Chanel</surname><given-names>J</given-names></name><article-title>Odor hedonics: Connection with emotional response estimated by autonomic parameters</article-title><source>Chemical Senses</source><year>1997</year><volume>22</volume><issue>3</issue><fpage>237</fpage><lpage>248</lpage><pub-id pub-id-type=""doi"">10.1093/chemse/22.3.237</pub-id><pub-id pub-id-type=""pmid"">9218136</pub-id></mixed-citation></ref><ref id=""B7""><mixed-citation publication-type=""journal""><name><surname>Vernet-Maury</surname><given-names>E</given-names></name><name><surname>Alaoui-Ismaili</surname><given-names>O</given-names></name><name><surname>Dittmar</surname><given-names>A</given-names></name><name><surname>Delhomme</surname><given-names>G</given-names></name><name><surname>Chanel</surname><given-names>J</given-names></name><article-title>Basic emotions induced by odorants: a new approach based on autonomic pattern results</article-title><source>Journal of the Autonomic Nervous System</source><year>1999</year><volume>75</volume><issue>2–3</issue><fpage>176</fpage><lpage>183</lpage><pub-id pub-id-type=""doi"">10.1016/S0165-1838(98)00168-4</pub-id><pub-id pub-id-type=""pmid"">10189120</pub-id></mixed-citation></ref><ref id=""B8""><mixed-citation publication-type=""book""><name><surname>García Márquez</surname><given-names>G</given-names></name><source>The story of a shipwrecked sailor : who drifted on a life raft for ten days without food or water, was proclaimed a national hero, kissed by beauty queens, made rich through publicity, and then spurned by the government and forgotten for all time. 1st Vintage Books edition</source><year>1987</year><publisher-name>New York: Vintage Books</publisher-name></mixed-citation></ref><ref id=""B9""><mixed-citation publication-type=""journal""><name><surname>Maletzky</surname><given-names>BM</given-names></name><name><surname>Steinhauser</surname><given-names>C</given-names></name><article-title>Olfactory aversion and its mechanism of action represents an excellent summary of this useful technique</article-title><source>Sex Abuse</source><year>2003</year><volume>15</volume><issue>3</issue><fpage>215</fpage><lpage>217</lpage><pub-id pub-id-type=""doi"">10.1023/A:1023503501408</pub-id><pub-id pub-id-type=""pmid"">12889325</pub-id></mixed-citation></ref><ref id=""B10""><mixed-citation publication-type=""journal""><name><surname>Laws</surname><given-names>DR</given-names></name><article-title>Olfactory aversion: notes on procedure, with speculations on its mechanism of effect</article-title><source>Sex Abuse</source><year>2001</year><volume>13</volume><issue>4</issue><fpage>275</fpage><lpage>287</lpage><pub-id pub-id-type=""doi"">10.1023/A:1017522515854</pub-id><pub-id pub-id-type=""pmid"">11677928</pub-id></mixed-citation></ref><ref id=""B11""><mixed-citation publication-type=""book""><name><surname>Robinson</surname><given-names>J</given-names></name><name><surname>Robinson</surname><given-names>J</given-names></name><source>How to taste : a guide to enjoying wine</source><year>2000</year><publisher-name>New York: Simon &amp; Schuster</publisher-name></mixed-citation></ref><ref id=""B12""><mixed-citation publication-type=""journal""><name><surname>Zhu</surname><given-names>M</given-names></name><name><surname>Ahlberg</surname><given-names>PE</given-names></name><article-title>The origin of the internal nostril of tetrapods</article-title><source>Nature</source><year>2004</year><volume>432</volume><issue>7013</issue><fpage>94</fpage><lpage>97</lpage><pub-id pub-id-type=""doi"">10.1038/nature02843</pub-id><pub-id pub-id-type=""pmid"">15525987</pub-id></mixed-citation></ref><ref id=""B13""><mixed-citation publication-type=""other""><name><surname>Zuker</surname><given-names>CS</given-names></name><article-title>Neuron Satellite Meeting. Washington DC</article-title><year>2005</year></mixed-citation></ref><ref id=""B14""><mixed-citation publication-type=""journal""><name><surname>Drewnowski</surname><given-names>A</given-names></name><article-title>The science and complexity of bitter taste</article-title><source>Nutrition Reviews</source><year>2001</year><volume>59</volume><issue>6</issue><fpage>163</fpage><lpage>169</lpage><pub-id pub-id-type=""pmid"">11444592</pub-id></mixed-citation></ref><ref id=""B15""><mixed-citation publication-type=""book""><collab>Octopus Publishing Group Limited</collab><source>Complete Indian Cooking. U.S. edition</source><year>1999</year><publisher-name>London New York, NY: Hamlyn</publisher-name></mixed-citation></ref><ref id=""B16""><mixed-citation publication-type=""journal""><name><surname>Galef</surname><given-names>BG</given-names></name><name><surname>Lee</surname><given-names>WY</given-names></name><name><surname>Whiskin</surname><given-names>EE</given-names></name><article-title>Lack of interference in long-term memory for socially learned food preferences in rats (Rattus norvegicus)</article-title><source>Journal of Comparative Psychology</source><year>2005</year><volume>119</volume><issue>2</issue><fpage>131</fpage><lpage>135</lpage><pub-id pub-id-type=""doi"">10.1037/0735-7036.119.2.131</pub-id><pub-id pub-id-type=""pmid"">15982156</pub-id></mixed-citation></ref><ref id=""B17""><mixed-citation publication-type=""journal""><name><surname>Baker</surname><given-names>BJ</given-names></name><name><surname>Booth</surname><given-names>DA</given-names></name><article-title>Genuinely Olfactory Preferences Conditioned by Protein Repletion</article-title><source>Appetite</source><year>1989</year><volume>13</volume><issue>3</issue><fpage>223</fpage><lpage>227</lpage><pub-id pub-id-type=""doi"">10.1016/0195-6663(89)90015-9</pub-id><pub-id pub-id-type=""pmid"">2596844</pub-id></mixed-citation></ref><ref id=""B18""><mixed-citation publication-type=""journal""><name><surname>Mueller</surname><given-names>KL</given-names></name><name><surname>Hoon</surname><given-names>MA</given-names></name><name><surname>Erlenbach</surname><given-names>I</given-names></name><name><surname>Chandrashekar</surname><given-names>J</given-names></name><name><surname>Zuker</surname><given-names>CS</given-names></name><name><surname>Ryba</surname><given-names>NJP</given-names></name><article-title>The receptors and coding logic for bitter taste</article-title><source>Nature</source><year>2005</year><volume>434</volume><issue>7030</issue><fpage>225</fpage><lpage>229</lpage><pub-id pub-id-type=""doi"">10.1038/nature03352</pub-id><pub-id pub-id-type=""pmid"">15759003</pub-id></mixed-citation></ref><ref id=""B19""><mixed-citation publication-type=""journal""><name><surname>Elsaesser</surname><given-names>R</given-names></name><name><surname>Paysan</surname><given-names>A</given-names></name><article-title>Morituri te salutant? Olfactory signal transduction and the role of phosphoinositides</article-title><source>Journal of Neurocytology</source><year>2005</year><volume>34</volume><issue>1–2</issue><fpage>97</fpage><lpage>116</lpage><pub-id pub-id-type=""doi"">10.1007/s11068-005-5050-z</pub-id><pub-id pub-id-type=""pmid"">16374712</pub-id></mixed-citation></ref><ref id=""B20""><mixed-citation publication-type=""journal""><name><surname>Hrazdina</surname><given-names>G</given-names></name><article-title>Aroma production by tissue cultures</article-title><source>J Agric Food Chem</source><year>2006</year><volume>54</volume><issue>4</issue><fpage>1116</fpage><lpage>1123</lpage><pub-id pub-id-type=""doi"">10.1021/jf053146w</pub-id><pub-id pub-id-type=""pmid"">16478225</pub-id></mixed-citation></ref><ref id=""B21""><mixed-citation publication-type=""journal""><name><surname>Lin</surname><given-names>DY</given-names></name><name><surname>Zhang</surname><given-names>SZ</given-names></name><name><surname>Block</surname><given-names>E</given-names></name><name><surname>Katz</surname><given-names>LC</given-names></name><article-title>Encoding social signals in the mouse main olfactory bulb</article-title><source>Nature</source><year>2005</year><volume>434</volume><issue>7032</issue><fpage>470</fpage><lpage>477</lpage><pub-id pub-id-type=""doi"">10.1038/nature03414</pub-id><pub-id pub-id-type=""pmid"">15724148</pub-id></mixed-citation></ref><ref id=""B22""><mixed-citation publication-type=""journal""><name><surname>Brun</surname><given-names>JP</given-names></name><article-title>The production of perfumes in antiquity: The cases of Delos and Paestum</article-title><source>American Journal of Archaeology</source><year>2000</year><volume>104</volume><issue>2</issue><fpage>277</fpage><lpage>308</lpage><pub-id pub-id-type=""doi"">10.2307/507452</pub-id></mixed-citation></ref><ref id=""B23""><mixed-citation publication-type=""journal""><name><surname>Debonoayrout</surname><given-names>J</given-names></name><article-title>Perfume-Making in Ancient Egypt</article-title><source>Historia</source><year>1995</year><volume>588</volume><fpage>48</fpage><lpage>53</lpage></mixed-citation></ref><ref id=""B24""><mixed-citation publication-type=""journal""><name><surname>Mitchell</surname><given-names>MA</given-names></name><name><surname>Edman</surname><given-names>WW</given-names></name><name><surname>Konigsbacher</surname><given-names>KS</given-names></name><article-title>Importance of Odor as Nonfunctional Component or Odor-Tool of Marketing</article-title><source>Annals of the New York Academy of Sciences</source><year>1964</year><volume>116</volume><issue>A2</issue><fpage>685</fpage><pub-id pub-id-type=""doi"">10.1111/j.1749-6632.1964.tb45103.x</pub-id><pub-id pub-id-type=""pmid"">14220566</pub-id></mixed-citation></ref><ref id=""B25""><mixed-citation publication-type=""journal""><name><surname>Zou</surname><given-names>ZH</given-names></name><name><surname>Buck</surname><given-names>LB</given-names></name><article-title>Combinatorial effects of odorant mixes in olfactory cortex</article-title><source>Science</source><year>2006</year><volume>311</volume><issue>5766</issue><fpage>1477</fpage><lpage>1481</lpage><pub-id pub-id-type=""doi"">10.1126/science.1124755</pub-id><pub-id pub-id-type=""pmid"">16527983</pub-id></mixed-citation></ref><ref id=""B26""><mixed-citation publication-type=""journal""><name><surname>Zou</surname><given-names>ZH</given-names></name><name><surname>Li</surname><given-names>FS</given-names></name><name><surname>Buck</surname><given-names>LB</given-names></name><article-title>Odor maps in the olfactory cortex</article-title><source>Proceedings of the National Academy of Sciences of the United States of America</source><year>2005</year><volume>102</volume><issue>21</issue><fpage>7724</fpage><lpage>7729</lpage><pub-id pub-id-type=""pmid"">15911779</pub-id><pub-id pub-id-type=""doi"">10.1073/pnas.0503027102</pub-id></mixed-citation></ref><ref id=""B27""><mixed-citation publication-type=""journal""><name><surname>Laurent</surname><given-names>G</given-names></name><article-title>A systems perspective on early olfactory coding</article-title><source>Science</source><year>1999</year><volume>286</volume><issue>5440</issue><fpage>723</fpage><lpage>728</lpage><pub-id pub-id-type=""doi"">10.1126/science.286.5440.723</pub-id><pub-id pub-id-type=""pmid"">10531051</pub-id></mixed-citation></ref><ref id=""B28""><mixed-citation publication-type=""journal""><name><surname>Laurent</surname><given-names>G</given-names></name><article-title>Olfactory network dynamics and the coding of multidimensional signals</article-title><source>Nature Reviews Neuroscience</source><year>2002</year><volume>3</volume><issue>11</issue><fpage>884</fpage><lpage>895</lpage><pub-id pub-id-type=""doi"">10.1038/nrn964</pub-id><pub-id pub-id-type=""pmid"">12415296</pub-id></mixed-citation></ref><ref id=""B29""><mixed-citation publication-type=""journal""><name><surname>Horowitz</surname><given-names>LF</given-names></name><name><surname>Montmayeur</surname><given-names>JP</given-names></name><name><surname>Echelard</surname><given-names>Y</given-names></name><name><surname>Buck</surname><given-names>LB</given-names></name><article-title>A genetic approach to trace neural circuits</article-title><source>Proceedings of the National Academy of Sciences of the United States of America</source><year>1999</year><volume>96</volume><issue>6</issue><fpage>3194</fpage><lpage>3199</lpage><pub-id pub-id-type=""pmid"">10077660</pub-id><pub-id pub-id-type=""doi"">10.1073/pnas.96.6.3194</pub-id></mixed-citation></ref><ref id=""B30""><mixed-citation publication-type=""journal""><name><surname>Zou</surname><given-names>ZH</given-names></name><name><surname>Horowitz</surname><given-names>LF</given-names></name><name><surname>Montmayeur</surname><given-names>JP</given-names></name><name><surname>Snapper</surname><given-names>S</given-names></name><name><surname>Buck</surname><given-names>LB</given-names></name><article-title>Genetic tracing reveals a stereotyped sensory map in the olfactory cortex</article-title><source>Nature</source><year>2001</year><volume>414</volume><issue>6860</issue><fpage>173</fpage><lpage>179</lpage><pub-id pub-id-type=""doi"">10.1038/35102506</pub-id><pub-id pub-id-type=""pmid"">11700549</pub-id></mixed-citation></ref><ref id=""B31""><mixed-citation publication-type=""journal""><name><surname>Boehm</surname><given-names>U</given-names></name><name><surname>Zou</surname><given-names>ZH</given-names></name><name><surname>Buck</surname><given-names>LB</given-names></name><article-title>Feedback loops link odor and pheromone signaling with reproduction</article-title><source>Cell</source><year>2005</year><volume>123</volume><issue>4</issue><fpage>683</fpage><lpage>695</lpage><pub-id pub-id-type=""doi"">10.1016/j.cell.2005.09.027</pub-id><pub-id pub-id-type=""pmid"">16290036</pub-id></mixed-citation></ref><ref id=""B32""><mixed-citation publication-type=""journal""><name><surname>Gottfried</surname><given-names>JA</given-names></name><name><surname>Dolan</surname><given-names>RJ</given-names></name><article-title>The nose smells what the eye sees: Crossmodal visual facilitation of human olfactory perception</article-title><source>Neuron</source><year>2003</year><volume>39</volume><issue>2</issue><fpage>375</fpage><lpage>386</lpage><pub-id pub-id-type=""doi"">10.1016/S0896-6273(03)00392-1</pub-id><pub-id pub-id-type=""pmid"">12873392</pub-id></mixed-citation></ref><ref id=""B33""><mixed-citation publication-type=""journal""><name><surname>Gottfried</surname><given-names>JA</given-names></name><name><surname>Smith</surname><given-names>APR</given-names></name><name><surname>Rugg</surname><given-names>MD</given-names></name><name><surname>Dolan</surname><given-names>RJ</given-names></name><article-title>Remembrance of odors past: Human olfactory cortex in cross-modal recognition memory</article-title><source>Neuron</source><year>2004</year><volume>42</volume><issue>4</issue><fpage>687</fpage><lpage>695</lpage><pub-id pub-id-type=""doi"">10.1016/S0896-6273(04)00270-3</pub-id><pub-id pub-id-type=""pmid"">15157428</pub-id></mixed-citation></ref><ref id=""B34""><mixed-citation publication-type=""journal""><name><surname>Gottfried</surname><given-names>JA</given-names></name><name><surname>Winston</surname><given-names>JS</given-names></name><name><surname>Dolan</surname><given-names>RJ</given-names></name><article-title>Dissociable codes of odor quality and odorant structure in human piriform cortex</article-title><source>Neuron</source><year>2006</year><volume>49</volume><issue>3</issue><fpage>467</fpage><lpage>479</lpage><pub-id pub-id-type=""doi"">10.1016/j.neuron.2006.01.007</pub-id><pub-id pub-id-type=""pmid"">16446149</pub-id></mixed-citation></ref><ref id=""B35""><mixed-citation publication-type=""journal""><name><surname>Osterbauer</surname><given-names>RA</given-names></name><name><surname>Matthews</surname><given-names>PM</given-names></name><name><surname>Jenkinson</surname><given-names>M</given-names></name><name><surname>Beckmann</surname><given-names>CF</given-names></name><name><surname>Hansen</surname><given-names>PC</given-names></name><name><surname>Calvert</surname><given-names>GA</given-names></name><article-title>Color of scents: Chromatic stimuli modulate odor responses in the human brain</article-title><source>Journal of Neurophysiology</source><year>2005</year><volume>93</volume><issue>6</issue><fpage>3434</fpage><lpage>3441</lpage><pub-id pub-id-type=""doi"">10.1152/jn.00555.2004</pub-id><pub-id pub-id-type=""pmid"">15689393</pub-id></mixed-citation></ref><ref id=""B36""><mixed-citation publication-type=""journal""><name><surname>Castriota-Scanderbeg</surname><given-names>A</given-names></name><name><surname>Hagberg</surname><given-names>GE</given-names></name><name><surname>Cerasa</surname><given-names>A</given-names></name><name><surname>Committeri</surname><given-names>G</given-names></name><name><surname>Galati</surname><given-names>G</given-names></name><name><surname>Patria</surname><given-names>F</given-names></name><name><surname>Pitzalis</surname><given-names>S</given-names></name><name><surname>Caltagirone</surname><given-names>C</given-names></name><name><surname>Frackowlak</surname><given-names>R</given-names></name><article-title>The appreciation of wine by sommeliers: a functional magnetic resonance study of sensory integration</article-title><source>Neuroimage</source><year>2005</year><volume>25</volume><issue>2</issue><fpage>570</fpage><lpage>578</lpage><pub-id pub-id-type=""doi"">10.1016/j.neuroimage.2004.11.045</pub-id><pub-id pub-id-type=""pmid"">15784436</pub-id></mixed-citation></ref><ref id=""B37""><mixed-citation publication-type=""journal""><name><surname>Laurent</surname><given-names>G</given-names></name><article-title>Olfactory processing: maps, time and codes</article-title><source>Current Opinion in Neurobiology</source><year>1997</year><volume>7</volume><issue>4</issue><fpage>547</fpage><lpage>553</lpage><pub-id pub-id-type=""doi"">10.1016/S0959-4388(97)80035-9</pub-id><pub-id pub-id-type=""pmid"">9287196</pub-id></mixed-citation></ref><ref id=""B38""><mixed-citation publication-type=""journal""><name><surname>Laurent</surname><given-names>G</given-names></name><name><surname>Wehr</surname><given-names>M</given-names></name><name><surname>Davidowitz</surname><given-names>H</given-names></name><article-title>Temporal representations of odors in an olfactory network</article-title><source>Journal of Neuroscience</source><year>1996</year><volume>16</volume><issue>12</issue><fpage>3837</fpage><lpage>3847</lpage><pub-id pub-id-type=""pmid"">8656278</pub-id></mixed-citation></ref><ref id=""B39""><mixed-citation publication-type=""journal""><name><surname>Stopfer</surname><given-names>M</given-names></name><name><surname>Jayaraman</surname><given-names>V</given-names></name><name><surname>Laurent</surname><given-names>G</given-names></name><article-title>Intensity versus identity coding in an olfactory system</article-title><source>Neuron</source><year>2003</year><volume>39</volume><issue>6</issue><fpage>991</fpage><lpage>1004</lpage><pub-id pub-id-type=""doi"">10.1016/j.neuron.2003.08.011</pub-id><pub-id pub-id-type=""pmid"">12971898</pub-id></mixed-citation></ref><ref id=""B40""><mixed-citation publication-type=""book""><name><surname>Amoore</surname><given-names>JE</given-names></name><person-group person-group-type=""editor"">Theimer ET</person-group><article-title>Odor theory and odor classification</article-title><source>Fragrance chemistry : the science of the sense of smell</source><year>1982</year><publisher-name>New York: Academic Press</publisher-name><fpage>27</fpage><lpage>76</lpage></mixed-citation></ref><ref id=""B41""><mixed-citation publication-type=""journal""><name><surname>Buck</surname><given-names>L</given-names></name><name><surname>Axel</surname><given-names>R</given-names></name><article-title>A novel multigene family may encode odorant receptors: a molecular basis for odor recognition</article-title><source>Cell</source><year>1991</year><volume>65</volume><issue>1</issue><fpage>175</fpage><lpage>187</lpage><pub-id pub-id-type=""doi"">10.1016/0092-8674(91)90418-X</pub-id><pub-id pub-id-type=""pmid"">1840504</pub-id></mixed-citation></ref><ref id=""B42""><mixed-citation publication-type=""journal""><name><surname>Chess</surname><given-names>A</given-names></name><name><surname>Buck</surname><given-names>L</given-names></name><name><surname>Dowling</surname><given-names>MM</given-names></name><name><surname>Axel</surname><given-names>R</given-names></name><name><surname>Ngai</surname><given-names>J</given-names></name><article-title>Molecular biology of smell: expression of the multigene family encoding putative odorant receptors</article-title><source>Cold Spring Harb Symp Quant Biol</source><year>1992</year><volume>57</volume><fpage>505</fpage><lpage>516</lpage><pub-id pub-id-type=""pmid"">1339687</pub-id></mixed-citation></ref><ref id=""B43""><mixed-citation publication-type=""journal""><name><surname>Touhara</surname><given-names>K</given-names></name><article-title>Odor discrimination by G protein-coupled olfactory receptors</article-title><source>Microsc Res Tech</source><year>2002</year><volume>58</volume><issue>3</issue><fpage>135</fpage><lpage>141</lpage><pub-id pub-id-type=""doi"">10.1002/jemt.10131</pub-id><pub-id pub-id-type=""pmid"">12203691</pub-id></mixed-citation></ref><ref id=""B44""><mixed-citation publication-type=""journal""><name><surname>Serizawa</surname><given-names>S</given-names></name><name><surname>Miyamichi</surname><given-names>K</given-names></name><name><surname>Sakano</surname><given-names>H</given-names></name><article-title>One neuron-one receptor rule in the mouse olfactory system</article-title><source>Trends Genet</source><year>2004</year><volume>20</volume><issue>12</issue><fpage>648</fpage><lpage>653</lpage><pub-id pub-id-type=""doi"">10.1016/j.tig.2004.09.006</pub-id><pub-id pub-id-type=""pmid"">15522461</pub-id></mixed-citation></ref><ref id=""B45""><mixed-citation publication-type=""journal""><name><surname>Reed</surname><given-names>RR</given-names></name><article-title>After the holy grail: establishing a molecular basis for Mammalian olfaction</article-title><source>Cell</source><year>2004</year><volume>116</volume><issue>2</issue><fpage>329</fpage><lpage>336</lpage><pub-id pub-id-type=""doi"">10.1016/S0092-8674(04)00047-9</pub-id><pub-id pub-id-type=""pmid"">14744441</pub-id></mixed-citation></ref><ref id=""B46""><mixed-citation publication-type=""journal""><name><surname>Matthews</surname><given-names>HR</given-names></name><name><surname>Reisert</surname><given-names>J</given-names></name><article-title>Calcium, the two-faced messenger of olfactory transduction and adaptation</article-title><source>Curr Opin Neurobiol</source><year>2003</year><volume>13</volume><issue>4</issue><fpage>469</fpage><lpage>475</lpage><pub-id pub-id-type=""doi"">10.1016/S0959-4388(03)00097-7</pub-id><pub-id pub-id-type=""pmid"">12965295</pub-id></mixed-citation></ref><ref id=""B47""><mixed-citation publication-type=""journal""><name><surname>Ronnett</surname><given-names>GV</given-names></name><name><surname>Moon</surname><given-names>C</given-names></name><article-title>G proteins and olfactory signal transduction</article-title><source>Annu Rev Physiol</source><year>2002</year><volume>64</volume><fpage>189</fpage><lpage>222</lpage><pub-id pub-id-type=""doi"">10.1146/annurev.physiol.64.082701.102219</pub-id><pub-id pub-id-type=""pmid"">11826268</pub-id></mixed-citation></ref><ref id=""B48""><mixed-citation publication-type=""journal""><name><surname>Frings</surname><given-names>S</given-names></name><article-title>Chemoelectrical signal transduction in olfactory sensory neurons of air-breathing vertebrates</article-title><source>Cell Mol Life Sci</source><year>2001</year><volume>58</volume><issue>4</issue><fpage>510</fpage><lpage>519</lpage><pub-id pub-id-type=""doi"">10.1007/PL00000876</pub-id><pub-id pub-id-type=""pmid"">11361086</pub-id></mixed-citation></ref><ref id=""B49""><mixed-citation publication-type=""journal""><name><surname>Gold</surname><given-names>GH</given-names></name><article-title>Controversial issues in vertebrate olfactory transduction</article-title><source>Annu Rev Physiol</source><year>1999</year><volume>61</volume><fpage>857</fpage><lpage>871</lpage><pub-id pub-id-type=""doi"">10.1146/annurev.physiol.61.1.857</pub-id><pub-id pub-id-type=""pmid"">10099713</pub-id></mixed-citation></ref><ref id=""B50""><mixed-citation publication-type=""journal""><name><surname>Schild</surname><given-names>D</given-names></name><name><surname>Restrepo</surname><given-names>D</given-names></name><article-title>Transduction mechanisms in vertebrate olfactory receptor cells</article-title><source>Physiol Rev</source><year>1998</year><volume>78</volume><issue>2</issue><fpage>429</fpage><lpage>466</lpage><pub-id pub-id-type=""pmid"">9562035</pub-id></mixed-citation></ref><ref id=""B51""><mixed-citation publication-type=""journal""><name><surname>Ebrahimi</surname><given-names>FA</given-names></name><name><surname>Chess</surname><given-names>A</given-names></name><article-title>Olfactory G proteins: simple and complex signal transduction</article-title><source>Curr Biol</source><year>1998</year><volume>8</volume><issue>12</issue><fpage>R431</fpage><lpage>433</lpage><pub-id pub-id-type=""doi"">10.1016/S0960-9822(98)70271-4</pub-id><pub-id pub-id-type=""pmid"">9637917</pub-id></mixed-citation></ref><ref id=""B52""><mixed-citation publication-type=""journal""><name><surname>Firestein</surname><given-names>S</given-names></name><article-title>How the olfactory system makes sense of scents</article-title><source>Nature</source><year>2001</year><volume>413</volume><issue>6852</issue><fpage>211</fpage><lpage>218</lpage><pub-id pub-id-type=""doi"">10.1038/35093026</pub-id><pub-id pub-id-type=""pmid"">11557990</pub-id></mixed-citation></ref><ref id=""B53""><mixed-citation publication-type=""journal""><name><surname>Menini</surname><given-names>A</given-names></name><name><surname>Lagostena</surname><given-names>L</given-names></name><name><surname>Boccaccio</surname><given-names>A</given-names></name><article-title>Olfaction: from odorant molecules to the olfactory cortex</article-title><source>News Physiol Sci</source><year>2004</year><volume>19</volume><fpage>101</fpage><lpage>104</lpage><pub-id pub-id-type=""pmid"">15143202</pub-id></mixed-citation></ref><ref id=""B54""><mixed-citation publication-type=""journal""><name><surname>Paysan</surname><given-names>J</given-names></name><name><surname>Breer</surname><given-names>H</given-names></name><article-title>Molecular physiology of odor detection: current views</article-title><source>Pflugers Archiv-European Journal of Physiology</source><year>2001</year><volume>441</volume><issue>5</issue><fpage>579</fpage><lpage>586</lpage><pub-id pub-id-type=""doi"">10.1007/s004240000492</pub-id><pub-id pub-id-type=""pmid"">11294238</pub-id></mixed-citation></ref><ref id=""B55""><mixed-citation publication-type=""journal""><name><surname>Buck</surname><given-names>LB</given-names></name><article-title>Olfactory receptors and odor coding in mammals</article-title><source>Nutr Rev</source><year>2004</year><volume>62</volume><issue>11 Pt 2</issue><fpage>S184</fpage><lpage>188</lpage><comment>discussion S224–141</comment><pub-id pub-id-type=""doi"">10.1301/nr.2004.nov.S184-S188</pub-id><pub-id pub-id-type=""pmid"">15630933</pub-id></mixed-citation></ref><ref id=""B56""><mixed-citation publication-type=""journal""><name><surname>Mombaerts</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Dulac</surname><given-names>C</given-names></name><name><surname>Vassar</surname><given-names>R</given-names></name><name><surname>Chao</surname><given-names>SK</given-names></name><name><surname>Nemes</surname><given-names>A</given-names></name><name><surname>Mendelsohn</surname><given-names>M</given-names></name><name><surname>Edmondson</surname><given-names>J</given-names></name><name><surname>Axel</surname><given-names>R</given-names></name><article-title>The molecular biology of olfactory perception</article-title><source>Cold Spring Harb Symp Quant Biol</source><year>1996</year><volume>61</volume><fpage>135</fpage><lpage>145</lpage><pub-id pub-id-type=""pmid"">9246442</pub-id></mixed-citation></ref><ref id=""B57""><mixed-citation publication-type=""journal""><name><surname>Menco</surname><given-names>BPM</given-names></name><article-title>Ciliated and Microvillous Structures of Rat Olfactory and Nasal Respiratory Epithelia – a Study Using Ultra-Rapid Cryo-Fixation Followed by Freeze-Substitution or Freeze-Etching</article-title><source>Cell and Tissue Research</source><year>1984</year><volume>235</volume><issue>2</issue><fpage>225</fpage><lpage>241</lpage><pub-id pub-id-type=""doi"">10.1007/BF00217846</pub-id></mixed-citation></ref><ref id=""B58""><mixed-citation publication-type=""journal""><name><surname>Reuter</surname><given-names>D</given-names></name><name><surname>Zierold</surname><given-names>K</given-names></name><name><surname>Schroder</surname><given-names>W</given-names></name><name><surname>Frings</surname><given-names>S</given-names></name><article-title>Contribution of chloride to receptor current in olfactory neurons: Cl-equilibrium potential and ionic composition of olfactory mucus</article-title><source>European Journal of Neuroscience</source><year>1998</year><volume>10</volume><fpage>360</fpage><lpage>360</lpage></mixed-citation></ref><ref id=""B59""><mixed-citation publication-type=""journal""><name><surname>Reuter</surname><given-names>D</given-names></name><name><surname>Zierold</surname><given-names>K</given-names></name><name><surname>Schroder</surname><given-names>WH</given-names></name><name><surname>Frings</surname><given-names>S</given-names></name><article-title>A depolarizing chloride current contributes to chemoelectrical transduction in olfactory sensory neurons in situ</article-title><source>Journal of Neuroscience</source><year>1998</year><volume>18</volume><issue>17</issue><fpage>6623</fpage><lpage>6630</lpage><pub-id pub-id-type=""pmid"">9712634</pub-id></mixed-citation></ref><ref id=""B60""><mixed-citation publication-type=""journal""><name><surname>Smith</surname><given-names>JJ</given-names></name><name><surname>Travis</surname><given-names>SM</given-names></name><name><surname>Greenberg</surname><given-names>EP</given-names></name><name><surname>Welsh</surname><given-names>MJ</given-names></name><article-title>Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid</article-title><source>Cell</source><year>1996</year><volume>85</volume><issue>2</issue><fpage>229</fpage><lpage>236</lpage><pub-id pub-id-type=""doi"">10.1016/S0092-8674(00)81099-5</pub-id><pub-id pub-id-type=""pmid"">8612275</pub-id></mixed-citation></ref><ref id=""B61""><mixed-citation publication-type=""journal""><name><surname>Tarran</surname><given-names>R</given-names></name><name><surname>Trout</surname><given-names>L</given-names></name><name><surname>Donaldson</surname><given-names>SH</given-names></name><name><surname>Boucher</surname><given-names>RC</given-names></name><article-title>Soluble mediators, not cilia, determine airway surface liquid volume in normal and cystic fibrosis superficial airway epithelia</article-title><source>Journal of General Physiology</source><year>2006</year><volume>127</volume><issue>5</issue><fpage>591</fpage><lpage>604</lpage><pub-id pub-id-type=""doi"">10.1085/jgp.200509468</pub-id><pub-id pub-id-type=""pmid"">16636206</pub-id></mixed-citation></ref><ref id=""B62""><mixed-citation publication-type=""journal""><name><surname>Duchamp-Viret</surname><given-names>P</given-names></name><name><surname>Chaput</surname><given-names>MA</given-names></name><name><surname>Duchamp</surname><given-names>A</given-names></name><article-title>Odor response properties of rat olfactory receptor neurons</article-title><source>Science</source><year>1999</year><volume>284</volume><issue>5423</issue><fpage>2171</fpage><lpage>2174</lpage><pub-id pub-id-type=""doi"">10.1126/science.284.5423.2171</pub-id><pub-id pub-id-type=""pmid"">10381881</pub-id></mixed-citation></ref><ref id=""B63""><mixed-citation publication-type=""journal""><name><surname>Duchamp-Viret</surname><given-names>P</given-names></name><name><surname>Duchamp</surname><given-names>A</given-names></name><name><surname>Chaput</surname><given-names>MA</given-names></name><article-title>Peripheral odor coding in the rat and frog: Quality and intensity specification</article-title><source>Journal of Neuroscience</source><year>2000</year><volume>20</volume><issue>6</issue><fpage>2383</fpage><lpage>2390</lpage><pub-id pub-id-type=""pmid"">10704512</pub-id></mixed-citation></ref><ref id=""B64""><mixed-citation publication-type=""journal""><name><surname>Duchamp-Viret</surname><given-names>P</given-names></name><name><surname>Duchamp</surname><given-names>A</given-names></name><name><surname>Chaput</surname><given-names>MA</given-names></name><article-title>Single olfactory sensory neurons simultaneously integrate the components of an odour mixture</article-title><source>European Journal of Neuroscience</source><year>2003</year><volume>18</volume><issue>10</issue><fpage>2690</fpage><lpage>2696</lpage><pub-id pub-id-type=""doi"">10.1111/j.1460-9568.2003.03001.x</pub-id><pub-id pub-id-type=""pmid"">14656317</pub-id></mixed-citation></ref><ref id=""B65""><mixed-citation publication-type=""journal""><name><surname>Mombaerts</surname><given-names>P</given-names></name><article-title>Molecular biology of odorant receptors in vertebrates</article-title><source>Annu Rev Neurosci</source><year>1999</year><volume>22</volume><fpage>487</fpage><lpage>509</lpage><pub-id pub-id-type=""doi"">10.1146/annurev.neuro.22.1.487</pub-id><pub-id pub-id-type=""pmid"">10202546</pub-id></mixed-citation></ref><ref id=""B66""><mixed-citation publication-type=""journal""><name><surname>Pace</surname><given-names>U</given-names></name><name><surname>Hanski</surname><given-names>E</given-names></name><name><surname>Salomon</surname><given-names>Y</given-names></name><name><surname>Lancet</surname><given-names>D</given-names></name><article-title>Odorant-sensitive adenylate cyclase may mediate olfactory reception</article-title><source>Nature</source><year>1985</year><volume>316</volume><issue>6025</issue><fpage>255</fpage><lpage>258</lpage><pub-id pub-id-type=""doi"">10.1038/316255a0</pub-id><pub-id pub-id-type=""pmid"">3927168</pub-id></mixed-citation></ref><ref id=""B67""><mixed-citation publication-type=""journal""><name><surname>Kaupp</surname><given-names>UB</given-names></name><name><surname>Seifert</surname><given-names>R</given-names></name><article-title>Cyclic nucleotide-gated ion channels</article-title><source>Physiol Rev</source><year>2002</year><volume>82</volume><issue>3</issue><fpage>769</fpage><lpage>824</lpage><pub-id pub-id-type=""pmid"">12087135</pub-id></mixed-citation></ref><ref id=""B68""><mixed-citation publication-type=""journal""><name><surname>Restrepo</surname><given-names>D</given-names></name><article-title>The ins and outs of intracellular chloride in olfactory receptor neurons</article-title><source>Neuron</source><year>2005</year><volume>45</volume><issue>4</issue><fpage>481</fpage><lpage>482</lpage><pub-id pub-id-type=""doi"">10.1016/j.neuron.2005.02.002</pub-id><pub-id pub-id-type=""pmid"">15721233</pub-id></mixed-citation></ref><ref id=""B69""><mixed-citation publication-type=""journal""><name><surname>Reisert</surname><given-names>J</given-names></name><name><surname>Lai</surname><given-names>J</given-names></name><name><surname>Yau</surname><given-names>KW</given-names></name><name><surname>Bradley</surname><given-names>J</given-names></name><article-title>Mechanism of the excitatory Cl-response in mouse olfactory receptor neurons</article-title><source>Neuron</source><year>2005</year><volume>45</volume><issue>4</issue><fpage>553</fpage><lpage>561</lpage><pub-id pub-id-type=""doi"">10.1016/j.neuron.2005.01.012</pub-id><pub-id pub-id-type=""pmid"">15721241</pub-id></mixed-citation></ref><ref id=""B70""><mixed-citation publication-type=""journal""><name><surname>Zufall</surname><given-names>F</given-names></name><name><surname>Leinders-Zufall</surname><given-names>T</given-names></name><article-title>The cellular and molecular basis of odor adaptation</article-title><source>Chem Senses</source><year>2000</year><volume>25</volume><issue>4</issue><fpage>473</fpage><lpage>481</lpage><pub-id pub-id-type=""doi"">10.1093/chemse/25.4.473</pub-id><pub-id pub-id-type=""pmid"">10944513</pub-id></mixed-citation></ref><ref id=""B71""><mixed-citation publication-type=""journal""><name><surname>Bhandawat</surname><given-names>V</given-names></name><name><surname>Reisert</surname><given-names>J</given-names></name><name><surname>Yau</surname><given-names>KW</given-names></name><article-title>Elementary response of olfactory receptor neurons to odorants</article-title><source>Science</source><year>2005</year><volume>308</volume><issue>5730</issue><fpage>1931</fpage><lpage>1934</lpage><pub-id pub-id-type=""doi"">10.1126/science.1109886</pub-id><pub-id pub-id-type=""pmid"">15976304</pub-id></mixed-citation></ref><ref id=""B72""><mixed-citation publication-type=""journal""><name><surname>Ache</surname><given-names>BW</given-names></name><name><surname>Zhainazarov</surname><given-names>A</given-names></name><article-title>Dual 2Nd-Messenger Pathways in Olfactory Transduction</article-title><source>Current Opinion in Neurobiology</source><year>1995</year><volume>5</volume><issue>4</issue><fpage>461</fpage><lpage>466</lpage><pub-id pub-id-type=""doi"">10.1016/0959-4388(95)80006-9</pub-id><pub-id pub-id-type=""pmid"">7488847</pub-id></mixed-citation></ref><ref id=""B73""><mixed-citation publication-type=""journal""><name><surname>Breer</surname><given-names>H</given-names></name><article-title>2Nd Messenger Signaling in Olfaction</article-title><source>Ciba Foundation Symposia</source><year>1993</year><volume>179</volume><fpage>97</fpage><lpage>114</lpage><pub-id pub-id-type=""pmid"">8168385</pub-id></mixed-citation></ref><ref id=""B74""><mixed-citation publication-type=""journal""><name><surname>Sklar</surname><given-names>PB</given-names></name><name><surname>Anholt</surname><given-names>RR</given-names></name><name><surname>Snyder</surname><given-names>SH</given-names></name><article-title>The odorant-sensitive adenylate cyclase of olfactory receptor cells. Differential stimulation by distinct classes of odorants</article-title><source>J Biol Chem</source><year>1986</year><volume>261</volume><issue>33</issue><fpage>15538</fpage><lpage>15543</lpage><pub-id pub-id-type=""pmid"">3536906</pub-id></mixed-citation></ref><ref id=""B75""><mixed-citation publication-type=""journal""><name><surname>Boekhoff</surname><given-names>I</given-names></name><name><surname>Tareilus</surname><given-names>E</given-names></name><name><surname>Strotmann</surname><given-names>J</given-names></name><name><surname>Breer</surname><given-names>H</given-names></name><article-title>Rapid activation of alternative second messenger pathways in olfactory cilia from rats by different odorants</article-title><source>Embo J</source><year>1990</year><volume>9</volume><issue>8</issue><fpage>2453</fpage><lpage>2458</lpage><pub-id pub-id-type=""pmid"">2164471</pub-id></mixed-citation></ref><ref id=""B76""><mixed-citation publication-type=""journal""><name><surname>Breer</surname><given-names>H</given-names></name><name><surname>Boekhoff</surname><given-names>I</given-names></name><name><surname>Tareilus</surname><given-names>E</given-names></name><article-title>Rapid kinetics of second messenger formation in olfactory transduction</article-title><source>Nature</source><year>1990</year><volume>345</volume><issue>6270</issue><fpage>65</fpage><lpage>68</lpage><pub-id pub-id-type=""doi"">10.1038/345065a0</pub-id><pub-id pub-id-type=""pmid"">2158631</pub-id></mixed-citation></ref><ref id=""B77""><mixed-citation publication-type=""journal""><name><surname>Raming</surname><given-names>K</given-names></name><name><surname>Krieger</surname><given-names>J</given-names></name><name><surname>Strotmann</surname><given-names>J</given-names></name><name><surname>Boekhoff</surname><given-names>I</given-names></name><name><surname>Kubick</surname><given-names>S</given-names></name><name><surname>Baumstark</surname><given-names>C</given-names></name><name><surname>Breer</surname><given-names>H</given-names></name><article-title>Cloning and expression of odorant receptors</article-title><source>Nature</source><year>1993</year><volume>361</volume><issue>6410</issue><fpage>353</fpage><lpage>356</lpage><pub-id pub-id-type=""doi"">10.1038/361353a0</pub-id><pub-id pub-id-type=""pmid"">7678922</pub-id></mixed-citation></ref><ref id=""B78""><mixed-citation publication-type=""journal""><name><surname>Barinaga</surname><given-names>M</given-names></name><article-title>Mutant mice and worms help solve mysteries of olfaction</article-title><source>Science</source><year>1996</year><volume>274</volume><issue>5287</issue><fpage>500</fpage><lpage>501</lpage><pub-id pub-id-type=""doi"">10.1126/science.274.5287.500</pub-id><pub-id pub-id-type=""pmid"">8928002</pub-id></mixed-citation></ref><ref id=""B79""><mixed-citation publication-type=""journal""><name><surname>Belluscio</surname><given-names>L</given-names></name><name><surname>Gold</surname><given-names>GH</given-names></name><name><surname>Nemes</surname><given-names>A</given-names></name><name><surname>Axel</surname><given-names>R</given-names></name><article-title>Mice deficient in G(olf) are anosmic</article-title><source>Neuron</source><year>1998</year><volume>20</volume><issue>1</issue><fpage>69</fpage><lpage>81</lpage><pub-id pub-id-type=""doi"">10.1016/S0896-6273(00)80435-3</pub-id><pub-id pub-id-type=""pmid"">9459443</pub-id></mixed-citation></ref><ref id=""B80""><mixed-citation publication-type=""journal""><name><surname>Wong</surname><given-names>ST</given-names></name><name><surname>Trinh</surname><given-names>K</given-names></name><name><surname>Hacker</surname><given-names>B</given-names></name><name><surname>Chan</surname><given-names>GC</given-names></name><name><surname>Lowe</surname><given-names>G</given-names></name><name><surname>Gaggar</surname><given-names>A</given-names></name><name><surname>Xia</surname><given-names>Z</given-names></name><name><surname>Gold</surname><given-names>GH</given-names></name><name><surname>Storm</surname><given-names>DR</given-names></name><article-title>Disruption of the type III adenylyl cyclase gene leads to peripheral and behavioral anosmia in transgenic mice</article-title><source>Neuron</source><year>2000</year><volume>27</volume><issue>3</issue><fpage>487</fpage><lpage>497</lpage><pub-id pub-id-type=""doi"">10.1016/S0896-6273(00)00060-X</pub-id><pub-id pub-id-type=""pmid"">11055432</pub-id></mixed-citation></ref><ref id=""B81""><mixed-citation publication-type=""journal""><name><surname>Brunet</surname><given-names>LJ</given-names></name><name><surname>Gold</surname><given-names>GH</given-names></name><name><surname>Ngai</surname><given-names>J</given-names></name><article-title>General anosmia caused by a targeted disruption of the mouse olfactory cyclic nucleotide-gated cation channel</article-title><source>Neuron</source><year>1996</year><volume>17</volume><issue>4</issue><fpage>681</fpage><lpage>693</lpage><pub-id pub-id-type=""doi"">10.1016/S0896-6273(00)80200-7</pub-id><pub-id pub-id-type=""pmid"">8893025</pub-id></mixed-citation></ref><ref id=""B82""><mixed-citation publication-type=""journal""><name><surname>Barry</surname><given-names>PH</given-names></name><article-title>The relative contributions of cAMP and InSP3 pathways to olfactory responses in vertebrate olfactory receptor neurons and the specificity of odorants for both pathways</article-title><source>Journal of General Physiology</source><year>2003</year><volume>122</volume><issue>3</issue><fpage>247</fpage><lpage>250</lpage><pub-id pub-id-type=""doi"">10.1085/jgp.200308910</pub-id><pub-id pub-id-type=""pmid"">12939389</pub-id></mixed-citation></ref><ref id=""B83""><mixed-citation publication-type=""journal""><name><surname>Takeuchi</surname><given-names>H</given-names></name><name><surname>Imanaka</surname><given-names>Y</given-names></name><name><surname>Hirono</surname><given-names>J</given-names></name><name><surname>Kurahashi</surname><given-names>T</given-names></name><article-title>Cross-adaptation between olfactory responses induced by two subgroups of odorant molecules</article-title><source>Journal of General Physiology</source><year>2003</year><volume>122</volume><issue>3</issue><fpage>255</fpage><lpage>264</lpage><pub-id pub-id-type=""doi"">10.1085/jgp.200308867</pub-id><pub-id pub-id-type=""pmid"">12939391</pub-id></mixed-citation></ref><ref id=""B84""><mixed-citation publication-type=""journal""><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Lane</surname><given-names>AP</given-names></name><name><surname>Bock</surname><given-names>R</given-names></name><name><surname>Leinders-Zufall</surname><given-names>T</given-names></name><name><surname>Zufall</surname><given-names>F</given-names></name><article-title>Blocking adenylyl cyclase inhibits olfactory generator currents induced by ""IP(3)-odors""</article-title><source>J Neurophysiol</source><year>2000</year><volume>84</volume><issue>1</issue><fpage>575</fpage><lpage>580</lpage><pub-id pub-id-type=""pmid"">10899229</pub-id></mixed-citation></ref><ref id=""B85""><mixed-citation publication-type=""journal""><name><surname>Eisthen</surname><given-names>HL</given-names></name><article-title>Phylogeny of the Vomeronasal System and of Receptor Cell-Types in the Olfactory and Vomeronasal Epithelia of Vertebrates</article-title><source>Microsc Rese Tech</source><year>1992</year><volume>23</volume><issue>1</issue><fpage>1</fpage><lpage>21</lpage><pub-id pub-id-type=""doi"">10.1002/jemt.1070230102</pub-id></mixed-citation></ref><ref id=""B86""><mixed-citation publication-type=""journal""><name><surname>Carter-Dawson</surname><given-names>LD</given-names></name><name><surname>LaVail</surname><given-names>MM</given-names></name><article-title>Rods and cones in the mouse retina. I. Structural analysis using light and electron microscopy</article-title><source>J Comp Neurol</source><year>1979</year><volume>188</volume><issue>2</issue><fpage>245</fpage><lpage>262</lpage><pub-id pub-id-type=""doi"">10.1002/cne.901880204</pub-id><pub-id pub-id-type=""pmid"">500858</pub-id></mixed-citation></ref><ref id=""B87""><mixed-citation publication-type=""journal""><name><surname>Lee</surname><given-names>RD</given-names></name><name><surname>Thomas</surname><given-names>CF</given-names></name><name><surname>Marietta</surname><given-names>RG</given-names></name><name><surname>Stark</surname><given-names>WS</given-names></name><article-title>Vitamin A, visual pigments, and visual receptors in Drosophila</article-title><source>Microsc Res Tech</source><year>1996</year><volume>35</volume><issue>6</issue><fpage>418</fpage><lpage>430</lpage><pub-id pub-id-type=""doi"">10.1002/(SICI)1097-0029(19961215)35:6&lt;418::AID-JEMT2&gt;3.0.CO;2-E</pub-id><pub-id pub-id-type=""pmid"">9016446</pub-id></mixed-citation></ref><ref id=""B88""><mixed-citation publication-type=""journal""><name><surname>Menini</surname><given-names>A</given-names></name><name><surname>Picco</surname><given-names>C</given-names></name><name><surname>Firestein</surname><given-names>S</given-names></name><article-title>Quantal-Like Current Fluctuations Induced by Odorants in Olfactory Receptor-Cells</article-title><source>Nature</source><year>1995</year><volume>373</volume><issue>6513</issue><fpage>435</fpage><lpage>437</lpage><pub-id pub-id-type=""doi"">10.1038/373435a0</pub-id><pub-id pub-id-type=""pmid"">7830795</pub-id></mixed-citation></ref><ref id=""B89""><mixed-citation publication-type=""journal""><name><surname>Gold</surname><given-names>GH</given-names></name><name><surname>Lowe</surname><given-names>G</given-names></name><article-title>Single Odorant Molecules</article-title><source>Nature</source><year>1995</year><volume>376</volume><issue>6535</issue><fpage>27</fpage><lpage>27</lpage><pub-id pub-id-type=""doi"">10.1038/376027a0</pub-id><pub-id pub-id-type=""pmid"">7646719</pub-id></mixed-citation></ref><ref id=""B90""><mixed-citation publication-type=""journal""><name><surname>Lowe</surname><given-names>G</given-names></name><name><surname>Gold</surname><given-names>GH</given-names></name><article-title>Olfactory Transduction Is Intrinsically Noisy</article-title><source>Proceedings of the National Academy of Sciences of the United States of America</source><year>1995</year><volume>92</volume><issue>17</issue><fpage>7864</fpage><lpage>7868</lpage><pub-id pub-id-type=""pmid"">7544007</pub-id><pub-id pub-id-type=""doi"">10.1073/pnas.92.17.7864</pub-id></mixed-citation></ref><ref id=""B91""><mixed-citation publication-type=""journal""><name><surname>Angioy</surname><given-names>AM</given-names></name><name><surname>Desogus</surname><given-names>A</given-names></name><name><surname>Barbarossa</surname><given-names>IT</given-names></name><name><surname>Anderson</surname><given-names>P</given-names></name><name><surname>Hansson</surname><given-names>BS</given-names></name><article-title>Extreme sensitivity in an olfactory system</article-title><source>Chemical Senses</source><year>2003</year><volume>28</volume><issue>4</issue><fpage>279</fpage><lpage>284</lpage><pub-id pub-id-type=""doi"">10.1093/chemse/28.4.279</pub-id><pub-id pub-id-type=""pmid"">12771014</pub-id></mixed-citation></ref><ref id=""B92""><mixed-citation publication-type=""journal""><name><surname>Henderson</surname><given-names>SR</given-names></name><name><surname>Reuss</surname><given-names>H</given-names></name><name><surname>Hardie</surname><given-names>RC</given-names></name><article-title>Single photon responses in Drosophila photoreceptors and their regulation by Ca2+</article-title><source>J Physiol</source><year>2000</year><volume>524</volume><issue>1</issue><fpage>179</fpage><lpage>194</lpage><pub-id pub-id-type=""doi"">10.1111/j.1469-7793.2000.00179.x</pub-id><pub-id pub-id-type=""pmid"">10747191</pub-id></mixed-citation></ref><ref id=""B93""><mixed-citation publication-type=""journal""><name><surname>Scott</surname><given-names>K</given-names></name><name><surname>Zuker</surname><given-names>CS</given-names></name><article-title>Assembly of the Drosophila phototransduction cascade into a signalling complex shapes elementary responses</article-title><source>Nature</source><year>1998</year><volume>395</volume><issue>6704</issue><fpage>805</fpage><lpage>808</lpage><pub-id pub-id-type=""doi"">10.1038/27448</pub-id><pub-id pub-id-type=""pmid"">9796815</pub-id></mixed-citation></ref><ref id=""B94""><mixed-citation publication-type=""journal""><name><surname>Firestein</surname><given-names>S</given-names></name><article-title>A code in the nose</article-title><source>Sci STKE</source><year>2004</year><volume>2004</volume><issue>227</issue><fpage>pe15</fpage><pub-id pub-id-type=""doi"">10.1126/stke.2272004pe15</pub-id><pub-id pub-id-type=""pmid"">15069207</pub-id></mixed-citation></ref><ref id=""B95""><mixed-citation publication-type=""journal""><name><surname>Spehr</surname><given-names>M</given-names></name><name><surname>Leinders-Zufall</surname><given-names>T</given-names></name><article-title>One neuron – multiple receptors: increased complexity in olfactory coding?</article-title><source>Sci STKE</source><year>2005</year><volume>2005</volume><issue>285</issue><fpage>pe25</fpage><pub-id pub-id-type=""doi"">10.1126/stke.2852005pe25</pub-id><pub-id pub-id-type=""pmid"">15914726</pub-id></mixed-citation></ref><ref id=""B96""><mixed-citation publication-type=""journal""><name><surname>Porter</surname><given-names>J</given-names></name><name><surname>Anand</surname><given-names>T</given-names></name><name><surname>Johnson</surname><given-names>B</given-names></name><name><surname>Khan</surname><given-names>RM</given-names></name><name><surname>Sobel</surname><given-names>N</given-names></name><article-title>Brain mechanisms for extracting spatial information from smell</article-title><source>Neuron</source><year>2005</year><volume>47</volume><issue>4</issue><fpage>581</fpage><lpage>592</lpage><pub-id pub-id-type=""doi"">10.1016/j.neuron.2005.06.028</pub-id><pub-id pub-id-type=""pmid"">16102540</pub-id></mixed-citation></ref><ref id=""B97""><mixed-citation publication-type=""journal""><name><surname>Gottfried</surname><given-names>JA</given-names></name><article-title>A truffle in the mouth is worth two in the bush: odor localization in the human brain</article-title><source>Neuron</source><year>2005</year><volume>47</volume><issue>4</issue><fpage>473</fpage><lpage>476</lpage><pub-id pub-id-type=""doi"">10.1016/j.neuron.2005.08.002</pub-id><pub-id pub-id-type=""pmid"">16102528</pub-id></mixed-citation></ref><ref id=""B98""><mixed-citation publication-type=""journal""><name><surname>Small</surname><given-names>DM</given-names></name><name><surname>Gerber</surname><given-names>JC</given-names></name><name><surname>Mak</surname><given-names>YE</given-names></name><name><surname>Hummel</surname><given-names>T</given-names></name><article-title>Differential neural responses evoked by orthonasal versus retronasal odorant perception in humans</article-title><source>Neuron</source><year>2005</year><volume>47</volume><issue>4</issue><fpage>593</fpage><lpage>605</lpage><pub-id pub-id-type=""doi"">10.1016/j.neuron.2005.07.022</pub-id><pub-id pub-id-type=""pmid"">16102541</pub-id></mixed-citation></ref><ref id=""B99""><mixed-citation publication-type=""journal""><name><surname>Hepper</surname><given-names>PG</given-names></name><name><surname>Wells</surname><given-names>DL</given-names></name><article-title>How many footsteps do dogs need to determine the direction of an odour trail?</article-title><source>Chem Senses</source><year>2005</year><volume>30</volume><issue>4</issue><fpage>291</fpage><lpage>298</lpage><pub-id pub-id-type=""doi"">10.1093/chemse/bji023</pub-id><pub-id pub-id-type=""pmid"">15741595</pub-id></mixed-citation></ref><ref id=""B100""><mixed-citation publication-type=""journal""><name><surname>Rajan</surname><given-names>R</given-names></name><name><surname>Clement</surname><given-names>JP</given-names></name><name><surname>Bhalla</surname><given-names>US</given-names></name><article-title>Rats smell in stereo</article-title><source>Science</source><year>2006</year><volume>311</volume><issue>5761</issue><fpage>666</fpage><lpage>670</lpage><pub-id pub-id-type=""doi"">10.1126/science.1122096</pub-id><pub-id pub-id-type=""pmid"">16456082</pub-id></mixed-citation></ref><ref id=""B101""><mixed-citation publication-type=""journal""><name><surname>Prettyjohns</surname><given-names>KN</given-names></name><article-title>Imaging Arrays, Solid State</article-title><source>Encyclopedia of physical science and technology</source><year>1992</year><volume>7</volume><fpage>797</fpage><lpage>810</lpage></mixed-citation></ref><ref id=""B102""><mixed-citation publication-type=""journal""><name><surname>Kleene</surname><given-names>SJ</given-names></name><article-title>High-gain, low-noise amplification in olfactory transduction</article-title><source>Biophysical Journal</source><year>1997</year><volume>73</volume><issue>2</issue><fpage>1110</fpage><lpage>1117</lpage><pub-id pub-id-type=""pmid"">9251827</pub-id></mixed-citation></ref><ref id=""B103""><mixed-citation publication-type=""journal""><name><surname>Lowe</surname><given-names>G</given-names></name><name><surname>Gold</surname><given-names>GH</given-names></name><article-title>Nonlinear Amplification by Calcium-Dependent Chloride Channels in Olfactory Receptor-Cells</article-title><source>Nature</source><year>1993</year><volume>366</volume><issue>6452</issue><fpage>283</fpage><lpage>286</lpage><pub-id pub-id-type=""doi"">10.1038/366283a0</pub-id><pub-id pub-id-type=""pmid"">8232590</pub-id></mixed-citation></ref><ref id=""B104""><mixed-citation publication-type=""journal""><name><surname>Lowe</surname><given-names>G</given-names></name><name><surname>Gold</surname><given-names>GH</given-names></name><article-title>Nonlinear Amplification by Calcium-Dependent Chloride Channels in Olfactory Receptor-Cells</article-title><source>Biophysical Journal</source><year>1994</year><volume>66</volume><issue>2</issue><fpage>A100</fpage><lpage>a100</lpage></mixed-citation></ref><ref id=""B105""><mixed-citation publication-type=""journal""><name><surname>Franks</surname><given-names>KM</given-names></name><name><surname>Isaacson</surname><given-names>JS</given-names></name><article-title>Strong single-fiber sensory inputs to olfactory cortex: Implications for olfactory coding</article-title><source>Neuron</source><year>2006</year><volume>49</volume><issue>3</issue><fpage>357</fpage><lpage>363</lpage><pub-id pub-id-type=""doi"">10.1016/j.neuron.2005.12.026</pub-id><pub-id pub-id-type=""pmid"">16446140</pub-id></mixed-citation></ref><ref id=""B106""><mixed-citation publication-type=""journal""><name><surname>Mori</surname><given-names>K</given-names></name><name><surname>Nagao</surname><given-names>H</given-names></name><name><surname>Yoshihara</surname><given-names>Y</given-names></name><article-title>The olfactory bulb: Coding and processing of odor molecule information</article-title><source>Science</source><year>1999</year><volume>286</volume><issue>5440</issue><fpage>711</fpage><lpage>715</lpage><pub-id pub-id-type=""doi"">10.1126/science.286.5440.711</pub-id><pub-id pub-id-type=""pmid"">10531048</pub-id></mixed-citation></ref><ref id=""B107""><mixed-citation publication-type=""journal""><name><surname>Mombaerts</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Dulac</surname><given-names>C</given-names></name><name><surname>Chao</surname><given-names>SK</given-names></name><name><surname>Nemes</surname><given-names>A</given-names></name><name><surname>Mendelsohn</surname><given-names>M</given-names></name><name><surname>Edmondson</surname><given-names>J</given-names></name><name><surname>Axel</surname><given-names>R</given-names></name><article-title>Visualizing an olfactory sensory map</article-title><source>Cell</source><year>1996</year><volume>87</volume><issue>4</issue><fpage>675</fpage><lpage>686</lpage><pub-id pub-id-type=""doi"">10.1016/S0092-8674(00)81387-2</pub-id><pub-id pub-id-type=""pmid"">8929536</pub-id></mixed-citation></ref><ref id=""B108""><mixed-citation publication-type=""journal""><name><surname>Lowe</surname><given-names>G</given-names></name><name><surname>Gold</surname><given-names>GH</given-names></name><article-title>Olfactory transduction is intrinsically noisy</article-title><source>Chemical Senses</source><year>1995</year><volume>20</volume><issue>6</issue><fpage>174</fpage><lpage>174</lpage></mixed-citation></ref><ref id=""B109""><mixed-citation publication-type=""journal""><name><surname>Ahn</surname><given-names>SM</given-names></name><name><surname>Freeman</surname><given-names>WJ</given-names></name><article-title>Neural Dynamics under Noise in Olfactory System</article-title><source>Biological Cybernetics</source><year>1975</year><volume>17</volume><issue>3</issue><fpage>165</fpage><lpage>168</lpage><pub-id pub-id-type=""doi"">10.1007/BF00364165</pub-id><pub-id pub-id-type=""pmid"">1125343</pub-id></mixed-citation></ref><ref id=""B110""><mixed-citation publication-type=""journal""><name><surname>Cain</surname><given-names>WS</given-names></name><article-title>Noise at Nose – Limitations on Olfactory Discrimination</article-title><source>Bulletin of the Psychonomic Society</source><year>1976</year><volume>8</volume><issue>4</issue><fpage>249</fpage><lpage>249</lpage></mixed-citation></ref><ref id=""B111""><mixed-citation publication-type=""journal""><name><surname>Kleene</surname><given-names>SJ</given-names></name><name><surname>Larsson</surname><given-names>HP</given-names></name><name><surname>Lecar</surname><given-names>H</given-names></name><article-title>Noise analysis of cAMP- and Ca2+-gated channels in isolated olfactory cilia</article-title><source>Chemical Senses</source><year>1995</year><volume>20</volume><issue>6</issue><fpage>143</fpage><lpage>143</lpage></mixed-citation></ref><ref id=""B112""><mixed-citation publication-type=""journal""><name><surname>Arendt</surname><given-names>D</given-names></name><article-title>Evolution of eyes and photoreceptor cell types</article-title><source>International Journal of Developmental Biology</source><year>2003</year><volume>47</volume><issue>7–8</issue><fpage>563</fpage><lpage>571</lpage><pub-id pub-id-type=""pmid"">14756332</pub-id></mixed-citation></ref><ref id=""B113""><mixed-citation publication-type=""journal""><name><surname>Arendt</surname><given-names>D</given-names></name><name><surname>Tessmar-Raible</surname><given-names>K</given-names></name><name><surname>Snyman</surname><given-names>H</given-names></name><name><surname>Dorresteijn</surname><given-names>AW</given-names></name><name><surname>Wittbrodt</surname><given-names>J</given-names></name><article-title>Ciliary photoreceptors with a vertebrate-type opsin in an invertebrate brain</article-title><source>Science</source><year>2004</year><volume>306</volume><issue>5697</issue><fpage>869</fpage><lpage>871</lpage><pub-id pub-id-type=""doi"">10.1126/science.1099955</pub-id><pub-id pub-id-type=""pmid"">15514158</pub-id></mixed-citation></ref><ref id=""B114""><mixed-citation publication-type=""journal""><name><surname>Hattar</surname><given-names>S</given-names></name><name><surname>Liao</surname><given-names>HW</given-names></name><name><surname>Takao</surname><given-names>M</given-names></name><name><surname>Berson</surname><given-names>DM</given-names></name><name><surname>Yau</surname><given-names>KW</given-names></name><article-title>Melanopsin-containing retinal. ganglion cells: Architecture, projections, and intrinsic photosensitivity</article-title><source>Science</source><year>2002</year><volume>295</volume><issue>5557</issue><fpage>1065</fpage><lpage>1070</lpage><pub-id pub-id-type=""doi"">10.1126/science.1069609</pub-id><pub-id pub-id-type=""pmid"">11834834</pub-id></mixed-citation></ref><ref id=""B115""><mixed-citation publication-type=""journal""><name><surname>Pak</surname><given-names>WL</given-names></name><name><surname>Grossfie</surname><given-names>J</given-names></name><name><surname>White</surname><given-names>NV</given-names></name><article-title>Nonphototactic Mutants in a Study of Vision of Drosophila</article-title><source>Nature</source><year>1969</year><volume>222</volume><issue>5191</issue><fpage>351</fpage><pub-id pub-id-type=""doi"">10.1038/222351a0</pub-id><pub-id pub-id-type=""pmid"">5782110</pub-id></mixed-citation></ref><ref id=""B116""><mixed-citation publication-type=""journal""><name><surname>Bloomquist</surname><given-names>BT</given-names></name><name><surname>Shortridge</surname><given-names>RD</given-names></name><name><surname>Schneuwly</surname><given-names>S</given-names></name><name><surname>Perdew</surname><given-names>M</given-names></name><name><surname>Montell</surname><given-names>C</given-names></name><name><surname>Steller</surname><given-names>H</given-names></name><name><surname>Rubin</surname><given-names>G</given-names></name><name><surname>Pak</surname><given-names>WL</given-names></name><article-title>Isolation of a Putative Phospholipase-C Gene of Drosophila, Norpa, and Its Role in Phototransduction</article-title><source>Cell</source><year>1988</year><volume>54</volume><issue>5</issue><fpage>723</fpage><lpage>733</lpage><pub-id pub-id-type=""doi"">10.1016/S0092-8674(88)80017-5</pub-id><pub-id pub-id-type=""pmid"">2457447</pub-id></mixed-citation></ref><ref id=""B117""><mixed-citation publication-type=""journal""><name><surname>Montell</surname><given-names>C</given-names></name><article-title>Visual transduction in Drosophila</article-title><source>Annu Rev Cell Dev Biol</source><year>1999</year><volume>15</volume><fpage>231</fpage><lpage>268</lpage><pub-id pub-id-type=""doi"">10.1146/annurev.cellbio.15.1.231</pub-id><pub-id pub-id-type=""pmid"">10611962</pub-id></mixed-citation></ref><ref id=""B118""><mixed-citation publication-type=""journal""><name><surname>Montell</surname><given-names>C</given-names></name><article-title>TRP channels in Drosophila photoreceptor cells</article-title><source>J Physiol</source><year>2005</year><volume>567</volume><issue>Pt 1</issue><fpage>45</fpage><lpage>51</lpage><pub-id pub-id-type=""pmid"">15961416</pub-id><pub-id pub-id-type=""doi"">10.1113/jphysiol.2005.092551</pub-id></mixed-citation></ref><ref id=""B119""><mixed-citation publication-type=""journal""><name><surname>Montell</surname><given-names>C</given-names></name><name><surname>Rubin</surname><given-names>GM</given-names></name><article-title>Molecular Characterization of the Drosophila Trp Locus – a Putative Integral Membrane-Protein Required for Phototransduction</article-title><source>Neuron</source><year>1989</year><volume>2</volume><issue>4</issue><fpage>1313</fpage><lpage>1323</lpage><pub-id pub-id-type=""doi"">10.1016/0896-6273(89)90069-X</pub-id><pub-id pub-id-type=""pmid"">2516726</pub-id></mixed-citation></ref><ref id=""B120""><mixed-citation publication-type=""journal""><name><surname>Jiang</surname><given-names>HP</given-names></name><name><surname>Lyubarsky</surname><given-names>A</given-names></name><name><surname>Dodd</surname><given-names>R</given-names></name><name><surname>Vardi</surname><given-names>N</given-names></name><name><surname>Pugh</surname><given-names>E</given-names></name><name><surname>Baylor</surname><given-names>D</given-names></name><name><surname>Simon</surname><given-names>MI</given-names></name><name><surname>Wu</surname><given-names>DQ</given-names></name><article-title>Phospholipase C beta 4 is involved in modulating the visual response in mice</article-title><source>Proceedings of the National Academy of Sciences of the United States of America</source><year>1996</year><volume>93</volume><issue>25</issue><fpage>14598</fpage><lpage>14601</lpage><pub-id pub-id-type=""pmid"">8962098</pub-id><pub-id pub-id-type=""doi"">10.1073/pnas.93.25.14598</pub-id></mixed-citation></ref><ref id=""B121""><mixed-citation publication-type=""journal""><name><surname>Isoldi</surname><given-names>MC</given-names></name><name><surname>Rollag</surname><given-names>M</given-names></name><name><surname>Castrucci</surname><given-names>AM</given-names></name><name><surname>Provencio</surname><given-names>I</given-names></name><article-title>Melanopsin signals through a phosphoinositide pathway</article-title><source>Investigative Ophthalmology &amp; Visual Science</source><year>2005</year><volume>46</volume></mixed-citation></ref><ref id=""B122""><mixed-citation publication-type=""journal""><name><surname>Isoldi</surname><given-names>MC</given-names></name><name><surname>Rollag</surname><given-names>MD</given-names></name><name><surname>Castrucci</surname><given-names>AMD</given-names></name><name><surname>Provencio</surname><given-names>I</given-names></name><article-title>Rhabdomeric phototransduction initiated by the vertebrate photopigment melanopsin</article-title><source>Proc Natl Acad Sci U S A</source><year>2005</year><volume>102</volume><issue>4</issue><fpage>1217</fpage><lpage>1221</lpage><pub-id pub-id-type=""pmid"">15653769</pub-id><pub-id pub-id-type=""doi"">10.1073/pnas.0409252102</pub-id></mixed-citation></ref><ref id=""B123""><mixed-citation publication-type=""journal""><name><surname>Panda</surname><given-names>S</given-names></name><name><surname>Nayak</surname><given-names>SK</given-names></name><name><surname>Campo</surname><given-names>B</given-names></name><name><surname>Walker</surname><given-names>JR</given-names></name><name><surname>Hogenesch</surname><given-names>JB</given-names></name><name><surname>Jegla</surname><given-names>T</given-names></name><article-title>Illumination of the melanopsin signaling pathway</article-title><source>Science</source><year>2005</year><volume>307</volume><issue>5709</issue><fpage>600</fpage><lpage>604</lpage><pub-id pub-id-type=""doi"">10.1126/science.1105121</pub-id><pub-id pub-id-type=""pmid"">15681390</pub-id></mixed-citation></ref><ref id=""B124""><mixed-citation publication-type=""journal""><name><surname>Qiu</surname><given-names>XD</given-names></name><name><surname>Kumbalasiri</surname><given-names>T</given-names></name><name><surname>Carlson</surname><given-names>SM</given-names></name><name><surname>Wong</surname><given-names>KY</given-names></name><name><surname>Krishna</surname><given-names>V</given-names></name><name><surname>Provencio</surname><given-names>I</given-names></name><name><surname>Berson</surname><given-names>DM</given-names></name><article-title>Induction of photosensitivity by heterologous expression of melanopsin</article-title><source>Nature</source><year>2005</year><volume>433</volume><issue>7027</issue><fpage>745</fpage><lpage>749</lpage><pub-id pub-id-type=""doi"">10.1038/nature03345</pub-id><pub-id pub-id-type=""pmid"">15674243</pub-id></mixed-citation></ref><ref id=""B125""><mixed-citation publication-type=""journal""><name><surname>Hattar</surname><given-names>S</given-names></name><name><surname>Kumar</surname><given-names>M</given-names></name><name><surname>Park</surname><given-names>A</given-names></name><name><surname>Tong</surname><given-names>P</given-names></name><name><surname>Tung</surname><given-names>J</given-names></name><name><surname>Yau</surname><given-names>KW</given-names></name><name><surname>Berson</surname><given-names>DM</given-names></name><article-title>Central projections of melanopsin-expressing retinal ganglion cells in the mouse</article-title><source>J Comp Neurol</source><year>2006</year><volume>497</volume><issue>3</issue><fpage>326</fpage><lpage>349</lpage><pub-id pub-id-type=""doi"">10.1002/cne.20970</pub-id><pub-id pub-id-type=""pmid"">16736474</pub-id></mixed-citation></ref><ref id=""B126""><mixed-citation publication-type=""journal""><name><surname>Hattar</surname><given-names>S</given-names></name><name><surname>Liao</surname><given-names>HW</given-names></name><name><surname>Takao</surname><given-names>M</given-names></name><name><surname>Berson</surname><given-names>DM</given-names></name><name><surname>Yau</surname><given-names>KW</given-names></name><article-title>Melanopsin-containing retinal ganglion cells: architecture, projections, and intrinsic photosensitivity</article-title><source>Science</source><year>2002</year><volume>295</volume><issue>5557</issue><fpage>1065</fpage><lpage>1070</lpage><pub-id pub-id-type=""doi"">10.1126/science.1069609</pub-id><pub-id pub-id-type=""pmid"">11834834</pub-id></mixed-citation></ref><ref id=""B127""><mixed-citation publication-type=""journal""><name><surname>Lange</surname><given-names>K</given-names></name><article-title>Microvillar Ca++ signaling: A new view of an old problem</article-title><source>Journal of Cellular Physiology</source><year>1999</year><volume>180</volume><issue>1</issue><fpage>19</fpage><lpage>34</lpage><pub-id pub-id-type=""doi"">10.1002/(SICI)1097-4652(199907)180:1&lt;19::AID-JCP3&gt;3.0.CO;2-K</pub-id><pub-id pub-id-type=""pmid"">10362014</pub-id></mixed-citation></ref><ref id=""B128""><mixed-citation publication-type=""journal""><name><surname>Martin</surname><given-names>TFJ</given-names></name><article-title>PI(4,5)P-2 regulation of surface membrane traffic</article-title><source>Current Opinion in Cell Biology</source><year>2001</year><volume>13</volume><issue>4</issue><fpage>493</fpage><lpage>499</lpage><pub-id pub-id-type=""doi"">10.1016/S0955-0674(00)00241-6</pub-id><pub-id pub-id-type=""pmid"">11454457</pub-id></mixed-citation></ref><ref id=""B129""><mixed-citation publication-type=""journal""><name><surname>Hansen</surname><given-names>GH</given-names></name><name><surname>Immerdal</surname><given-names>L</given-names></name><name><surname>Thorsen</surname><given-names>E</given-names></name><name><surname>Niels-Christiansen</surname><given-names>LL</given-names></name><name><surname>Nystrom</surname><given-names>BT</given-names></name><name><surname>Demant</surname><given-names>EJ</given-names></name><name><surname>Danielsen</surname><given-names>EM</given-names></name><article-title>Lipid rafts exist as stable cholesterol-independent microdomains in the brush border membrane of enterocytes</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><issue>34</issue><fpage>32338</fpage><lpage>32344</lpage><pub-id pub-id-type=""doi"">10.1074/jbc.M102667200</pub-id><pub-id pub-id-type=""pmid"">11389144</pub-id></mixed-citation></ref><ref id=""B130""><mixed-citation publication-type=""journal""><name><surname>Jourdan</surname><given-names>F</given-names></name><article-title>Ultrastructural Study of Olfactory Epithelium of Rat – Occurrence of Several Morphological Types of Receptor Cells</article-title><source>Comptes Rendus Hebdomadaires Des Seances De L Academie Des Sciences Serie D</source><year>1975</year><volume>280</volume><issue>4</issue><fpage>443</fpage></mixed-citation></ref><ref id=""B131""><mixed-citation publication-type=""journal""><name><surname>Moran</surname><given-names>DT</given-names></name><name><surname>Rowley</surname><given-names>JC</given-names></name><name><surname>Jafek</surname><given-names>BW</given-names></name><article-title>Electron-Microscopy of Human Olfactory Epithelium Reveals a New Cell Type – the Microvillar Cell</article-title><source>Brain Research</source><year>1982</year><volume>253</volume><issue>1–2</issue><fpage>39</fpage><lpage>46</lpage><pub-id pub-id-type=""doi"">10.1016/0006-8993(82)90671-0</pub-id><pub-id pub-id-type=""pmid"">7150975</pub-id></mixed-citation></ref><ref id=""B132""><mixed-citation publication-type=""book""><name><surname>Menco</surname><given-names>BPM</given-names></name><name><surname>Morrison</surname><given-names>EE</given-names></name><person-group person-group-type=""editor"">Doty RL</person-group><article-title>Morphology of the mammalian olfactory epithelium: form, fine structure, function, and pathology</article-title><source>Handbook of olfaction and gustation</source><year>2003</year><edition>2</edition><publisher-name>New York: Marcel Dekker</publisher-name><fpage>17</fpage><lpage>49</lpage></mixed-citation></ref><ref id=""B133""><mixed-citation publication-type=""journal""><name><surname>Calof</surname><given-names>AL</given-names></name><name><surname>Mumm</surname><given-names>JS</given-names></name><name><surname>Rim</surname><given-names>PC</given-names></name><name><surname>Shou</surname><given-names>JY</given-names></name><article-title>The neuronal stem cell of the olfactory epithelium</article-title><source>Journal of Neurobiology</source><year>1998</year><volume>36</volume><issue>2</issue><fpage>190</fpage><lpage>205</lpage><pub-id pub-id-type=""doi"">10.1002/(SICI)1097-4695(199808)36:2&lt;190::AID-NEU7&gt;3.0.CO;2-X</pub-id><pub-id pub-id-type=""pmid"">9712304</pub-id></mixed-citation></ref><ref id=""B134""><mixed-citation publication-type=""journal""><name><surname>Murrell</surname><given-names>W</given-names></name><name><surname>Feron</surname><given-names>F</given-names></name><name><surname>Wetzig</surname><given-names>A</given-names></name><name><surname>Cameron</surname><given-names>N</given-names></name><name><surname>Splatt</surname><given-names>K</given-names></name><name><surname>Bellette</surname><given-names>B</given-names></name><name><surname>Bianco</surname><given-names>J</given-names></name><name><surname>Perry</surname><given-names>C</given-names></name><name><surname>Lee</surname><given-names>G</given-names></name><name><surname>Mackay-Sim</surname><given-names>A</given-names></name><article-title>Multipotent stem cells from adult olfactory mucosa</article-title><source>Developmental Dynamics</source><year>2005</year><volume>233</volume><issue>2</issue><fpage>496</fpage><lpage>515</lpage><pub-id pub-id-type=""doi"">10.1002/dvdy.20360</pub-id><pub-id pub-id-type=""pmid"">15782416</pub-id></mixed-citation></ref><ref id=""B135""><mixed-citation publication-type=""journal""><name><surname>Caggiano</surname><given-names>M</given-names></name><name><surname>Kauer</surname><given-names>JS</given-names></name><name><surname>Hunter</surname><given-names>DD</given-names></name><article-title>Globose Basal Cells Are Neuronal Progenitors in the Olfactory Epithelium – a Lineage Analysis Using a Replication-Incompetent Retrovirus</article-title><source>Neuron</source><year>1994</year><volume>13</volume><issue>2</issue><fpage>339</fpage><lpage>352</lpage><pub-id pub-id-type=""doi"">10.1016/0896-6273(94)90351-4</pub-id><pub-id pub-id-type=""pmid"">8060615</pub-id></mixed-citation></ref><ref id=""B136""><mixed-citation publication-type=""journal""><name><surname>Chen</surname><given-names>XY</given-names></name><name><surname>Fang</surname><given-names>HS</given-names></name><name><surname>Schwob</surname><given-names>JE</given-names></name><article-title>Multipotency of purified, transplanted globose basal cells in olfactory epithelium</article-title><source>Journal of Comparative Neurology</source><year>2004</year><volume>469</volume><issue>4</issue><fpage>457</fpage><lpage>474</lpage><pub-id pub-id-type=""doi"">10.1002/cne.11031</pub-id><pub-id pub-id-type=""pmid"">14755529</pub-id></mixed-citation></ref><ref id=""B137""><mixed-citation publication-type=""journal""><name><surname>Farbman</surname><given-names>AI</given-names></name><name><surname>Buchholz</surname><given-names>JA</given-names></name><name><surname>Suzuki</surname><given-names>Y</given-names></name><name><surname>Coines</surname><given-names>A</given-names></name><name><surname>Speert</surname><given-names>D</given-names></name><article-title>A molecular basis of cell death in olfactory epithelium</article-title><source>J Comp Neurol</source><year>1999</year><volume>414</volume><issue>3</issue><fpage>306</fpage><lpage>314</lpage><pub-id pub-id-type=""doi"">10.1002/(SICI)1096-9861(19991122)414:3&lt;306::AID-CNE2&gt;3.0.CO;2-#</pub-id><pub-id pub-id-type=""pmid"">10516598</pub-id></mixed-citation></ref><ref id=""B138""><mixed-citation publication-type=""journal""><name><surname>Suzuki</surname><given-names>Y</given-names></name><article-title>Fine structural aspects of apoptosis in the olfactory epithelium</article-title><source>J Neurocytol</source><year>2004</year><volume>33</volume><issue>6</issue><fpage>693</fpage><lpage>702</lpage><pub-id pub-id-type=""doi"">10.1007/s11068-005-3337-8</pub-id><pub-id pub-id-type=""pmid"">16217624</pub-id></mixed-citation></ref><ref id=""B139""><mixed-citation publication-type=""journal""><name><surname>Suzuki</surname><given-names>Y</given-names></name><name><surname>Takeda</surname><given-names>M</given-names></name><name><surname>Obara</surname><given-names>N</given-names></name><name><surname>Suzuki</surname><given-names>N</given-names></name><name><surname>Takeichi</surname><given-names>N</given-names></name><article-title>Olfactory epithelium consisting of supporting cells and horizontal basal cells in the posterior nasal cavity of mice</article-title><source>Cell Tissue Res</source><year>2000</year><volume>299</volume><issue>3</issue><fpage>313</fpage><lpage>325</lpage><pub-id pub-id-type=""doi"">10.1007/s004410050030</pub-id><pub-id pub-id-type=""pmid"">10772246</pub-id></mixed-citation></ref><ref id=""B140""><mixed-citation publication-type=""journal""><name><surname>Moulton</surname><given-names>DG</given-names></name><article-title>Dynamics of cell populations in the olfactory epithelium</article-title><source>Ann N Y Acad Sci</source><year>1974</year><volume>237</volume><issue>0</issue><fpage>52</fpage><lpage>61</lpage><pub-id pub-id-type=""doi"">10.1111/j.1749-6632.1974.tb49843.x</pub-id><pub-id pub-id-type=""pmid"">4214101</pub-id></mixed-citation></ref><ref id=""B141""><mixed-citation publication-type=""journal""><name><surname>Mackay-Sim</surname><given-names>A</given-names></name><name><surname>Kittel</surname><given-names>PW</given-names></name><article-title>On the Life Span of Olfactory Receptor Neurons</article-title><source>Eur J Neurosci</source><year>1991</year><volume>3</volume><issue>3</issue><fpage>209</fpage><lpage>215</lpage><pub-id pub-id-type=""doi"">10.1111/j.1460-9568.1991.tb00081.x</pub-id><pub-id pub-id-type=""pmid"">12106197</pub-id></mixed-citation></ref><ref id=""B142""><mixed-citation publication-type=""journal""><name><surname>Rowley</surname><given-names>JC</given-names></name><name><surname>Moran</surname><given-names>DT</given-names></name><name><surname>Jafek</surname><given-names>BW</given-names></name><article-title>Tracer Studies of Microvillar Cells Suggest a 2Nd Morphologically Distinct Class of Sensory Neuron Exists in Mammalian Olfactory Epithelia</article-title><source>Chemical Senses</source><year>1987</year><volume>12</volume><issue>4</issue><fpage>692</fpage><lpage>692</lpage></mixed-citation></ref><ref id=""B143""><mixed-citation publication-type=""journal""><name><surname>Rowley</surname><given-names>JC</given-names><suffix>3rd</suffix></name><name><surname>Moran</surname><given-names>DT</given-names></name><name><surname>Jafek</surname><given-names>BW</given-names></name><article-title>Peroxidase backfills suggest the mammalian olfactory epithelium contains a second morphologically distinct class of bipolar sensory neuron: the microvillar cell</article-title><source>Brain Res</source><year>1989</year><volume>502</volume><issue>2</issue><fpage>387</fpage><lpage>400</lpage><pub-id pub-id-type=""doi"">10.1016/0006-8993(89)90635-5</pub-id><pub-id pub-id-type=""pmid"">2819473</pub-id></mixed-citation></ref><ref id=""B144""><mixed-citation publication-type=""journal""><name><surname>Eisthen</surname><given-names>HL</given-names></name><article-title>Evolution of vertebrate olfactory systems</article-title><source>Brain Behav Evol</source><year>1997</year><volume>50</volume><issue>4</issue><fpage>222</fpage><lpage>233</lpage><pub-id pub-id-type=""pmid"">9310197</pub-id></mixed-citation></ref><ref id=""B145""><mixed-citation publication-type=""journal""><name><surname>Carr</surname><given-names>VM</given-names></name><name><surname>Farbman</surname><given-names>AI</given-names></name><name><surname>Colletti</surname><given-names>LM</given-names></name><name><surname>Morgan</surname><given-names>JI</given-names></name><article-title>Identification of a New Nonneuronal Cell Type in Rat Olfactory Epithelium</article-title><source>Neuroscience</source><year>1991</year><volume>45</volume><issue>2</issue><fpage>433</fpage><lpage>449</lpage><pub-id pub-id-type=""doi"">10.1016/0306-4522(91)90239-K</pub-id><pub-id pub-id-type=""pmid"">1762687</pub-id></mixed-citation></ref><ref id=""B146""><mixed-citation publication-type=""journal""><name><surname>Johnson</surname><given-names>EW</given-names></name><name><surname>Eller</surname><given-names>PM</given-names></name><name><surname>Jafek</surname><given-names>BW</given-names></name><article-title>An Immunoelectron Microscopic Comparison of Olfactory Marker Protein Localization in the Supranuclear Regions of the Rat Olfactory Epithelium and Vomeronasal Organ Neuroepithelium</article-title><source>Acta Oto-Laryngologica</source><year>1993</year><volume>113</volume><issue>6</issue><fpage>766</fpage><lpage>771</lpage><pub-id pub-id-type=""pmid"">8291436</pub-id></mixed-citation></ref><ref id=""B147""><mixed-citation publication-type=""journal""><name><surname>Iwanaga</surname><given-names>T</given-names></name><name><surname>Takahashiiwanaga</surname><given-names>H</given-names></name><name><surname>Fujita</surname><given-names>T</given-names></name><name><surname>Yamakuni</surname><given-names>T</given-names></name><name><surname>Takahashi</surname><given-names>Y</given-names></name><article-title>Immunohistochemical Demonstration of a Cerebellar Protein (Spot-35 Protein) in Some Sensory Cells of Guinea-Pigs</article-title><source>Biomedical Research-Tokyo</source><year>1985</year><volume>6</volume><issue>5</issue><fpage>329</fpage><lpage>334</lpage></mixed-citation></ref><ref id=""B148""><mixed-citation publication-type=""journal""><name><surname>Elsaesser</surname><given-names>R</given-names></name><name><surname>Montani</surname><given-names>G</given-names></name><name><surname>Tirindelli</surname><given-names>R</given-names></name><name><surname>Paysan</surname><given-names>J</given-names></name><article-title>Phosphatidyl-inositide signalling proteins in a novel class of sensory cells in the mammalian olfactory epithelium</article-title><source>Eur J Neurosci</source><year>2005</year><volume>21</volume><issue>10</issue><fpage>2692</fpage><lpage>2700</lpage><pub-id pub-id-type=""doi"">10.1111/j.1460-9568.2005.04108.x</pub-id><pub-id pub-id-type=""pmid"">15926917</pub-id></mixed-citation></ref><ref id=""B149""><mixed-citation publication-type=""journal""><name><surname>Costanzo</surname><given-names>RM</given-names></name><name><surname>Graziadei</surname><given-names>PPC</given-names></name><article-title>A Quantitative-Analysis of Changes in the Olfactory Epithelium Following Bulbectomy in Hamster</article-title><source>Journal of Comparative Neurology</source><year>1983</year><volume>215</volume><issue>4</issue><fpage>370</fpage><lpage>381</lpage><pub-id pub-id-type=""doi"">10.1002/cne.902150403</pub-id><pub-id pub-id-type=""pmid"">6863590</pub-id></mixed-citation></ref><ref id=""B150""><mixed-citation publication-type=""journal""><name><surname>Graziadei</surname><given-names>GAM</given-names></name><article-title>Experimental Studies on the Olfactory Marker Protein. 3. The Olfactory Marker Protein in the Olfactory Neuroepithelium Lacking Connections with the Forebrain</article-title><source>Brain Research</source><year>1983</year><volume>262</volume><issue>2</issue><fpage>303</fpage><lpage>308</lpage><pub-id pub-id-type=""doi"">10.1016/0006-8993(83)91023-5</pub-id><pub-id pub-id-type=""pmid"">6839159</pub-id></mixed-citation></ref><ref id=""B151""><mixed-citation publication-type=""journal""><name><surname>Michel</surname><given-names>D</given-names></name><name><surname>Moyse</surname><given-names>E</given-names></name><name><surname>Brun</surname><given-names>G</given-names></name><name><surname>Jourdan</surname><given-names>F</given-names></name><article-title>Induction of Apoptosis in Rat Olfactory Neuroepithelium by Synaptic Target Ablation</article-title><source>Neuroreport</source><year>1994</year><volume>5</volume><issue>11</issue><fpage>1329</fpage><lpage>1332</lpage><pub-id pub-id-type=""pmid"">7919191</pub-id></mixed-citation></ref><ref id=""B152""><mixed-citation publication-type=""journal""><name><surname>Asan</surname><given-names>E</given-names></name><name><surname>Drenckhahn</surname><given-names>D</given-names></name><article-title>Immunocytochemical characterization of two types of microvillar cells in rodent olfactory epithelium</article-title><source>Histochem Cell Biol</source><year>2005</year><volume>123</volume><issue>2</issue><fpage>157</fpage><lpage>168</lpage><pub-id pub-id-type=""doi"">10.1007/s00418-005-0759-4</pub-id><pub-id pub-id-type=""pmid"">15856279</pub-id></mixed-citation></ref><ref id=""B153""><mixed-citation publication-type=""journal""><name><surname>Yamagishi</surname><given-names>M</given-names></name><name><surname>Ishizuka</surname><given-names>Y</given-names></name><name><surname>Fujiwara</surname><given-names>M</given-names></name><name><surname>Nakamura</surname><given-names>H</given-names></name><name><surname>Igarashi</surname><given-names>S</given-names></name><name><surname>Nakano</surname><given-names>Y</given-names></name><name><surname>Kuwano</surname><given-names>R</given-names></name><article-title>Distribution of Calcium-Binding Proteins in Sensory Organs of the Ear, Nose and Throat</article-title><source>Acta Otolaryngol Suppl</source><year>1993</year><volume>506</volume><fpage>85</fpage><lpage>89</lpage><pub-id pub-id-type=""pmid"">8256606</pub-id></mixed-citation></ref><ref id=""B154""><mixed-citation publication-type=""journal""><name><surname>Hansel</surname><given-names>DE</given-names></name><name><surname>Eipper</surname><given-names>BA</given-names></name><name><surname>Ronnett</surname><given-names>GV</given-names></name><article-title>Regulation of olfactory neurogenesis by amidated neuropeptides</article-title><source>Journal of Neuroscience Research</source><year>2001</year><volume>66</volume><issue>1</issue><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type=""doi"">10.1002/jnr.1191</pub-id><pub-id pub-id-type=""pmid"">11598996</pub-id></mixed-citation></ref><ref id=""B155""><mixed-citation publication-type=""journal""><name><surname>Hansel</surname><given-names>DE</given-names></name><name><surname>Eipper</surname><given-names>BA</given-names></name><name><surname>Ronnett</surname><given-names>GV</given-names></name><article-title>Neuropeptide Y functions as a neuroproliferative factor</article-title><source>Nature</source><year>2001</year><volume>410</volume><issue>6831</issue><fpage>940</fpage><lpage>944</lpage><pub-id pub-id-type=""doi"">10.1038/35073601</pub-id><pub-id pub-id-type=""pmid"">11309620</pub-id></mixed-citation></ref><ref id=""B156""><mixed-citation publication-type=""other""><name><surname>Montani</surname><given-names>G</given-names></name><name><surname>Tonelli</surname><given-names>S</given-names></name><name><surname>Elsaesser</surname><given-names>R</given-names></name><name><surname>Paysan</surname><given-names>J</given-names></name><name><surname>Tirindelli</surname><given-names>R</given-names></name><article-title>Neuropeptide Y in the olfactory microvillar cells</article-title><source>Eur J Neurosci</source><year>2006</year><comment>in press</comment><pub-id pub-id-type=""pmid"">16800866</pub-id></mixed-citation></ref><ref id=""B157""><mixed-citation publication-type=""journal""><name><surname>Paysan</surname><given-names>J</given-names></name><name><surname>Bolz</surname><given-names>J</given-names></name><name><surname>Mohler</surname><given-names>H</given-names></name><name><surname>Fritschy</surname><given-names>JM</given-names></name><article-title>Gaba(a) Receptor Alpha-1 Subunit, an Early Marker for Area Specification in Developing Rat Cerebral-Cortex</article-title><source>Journal of Comparative Neurology</source><year>1994</year><volume>350</volume><issue>1</issue><fpage>133</fpage><lpage>149</lpage><pub-id pub-id-type=""doi"">10.1002/cne.903500110</pub-id><pub-id pub-id-type=""pmid"">7860797</pub-id></mixed-citation></ref></ref-list>"
10.1038/35102506	"<html><body><p>BMC_Neurosci/PMC4453034.nxml                                                                        0000664 0011011 0007774 00000306053 13033015613 014242  0                                                                                                    ustar   pmc                             pmcdev<!DOCTYPE article PUBLIC ""-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN"" ""JATS-archivearticle1.dtd""></p><p>The importance of the facial mesenchyme in the development of the olfactory placode and its derivatives must not be forgotten (Szabo-Rogers et al.,<xref ref-type=""bibr"" rid=""B187"">2009</xref>).</p><p>The particular characteristics of OSNs, together with the idea that the OB represents a developmental independent domain (López-Mascaraque and de Castro,<xref ref-type=""bibr"" rid=""B108"">2002</xref>), support the existence of a protomap for the initial development of the olfactory system, from which three major components must be identified: the olfactory epithelium, OB and olfactory cortex. The differences in the molecular orchestraes underlying the formation of the tracts interconnecting the olfactory structures (see above) would also be interpreted as a support for the protomap theory (see<xref ref-type=""sec"" rid=""s1"">Introduction: A Brief Sketch of the Olfactory System and its Development</xref>). This protomap is important during development, although recent reports have questioned if it is also applicable to the mature olfactory system, where it is now believed that olfactory nerve inputs to the OB are sparse (like the connections between projection neurons from the OB and their targets in the olfactory cortex) with no functional map (Fantana et al.,<xref ref-type=""bibr"" rid=""B52"">2008</xref>; Geffen et al.,<xref ref-type=""bibr"" rid=""B61"">2009</xref>; Soucy et al.,<xref ref-type=""bibr"" rid=""B177"">2009</xref>).</p><p>Another point that merits detailed discussion is the role of activity in the formation of the synaptic connections between the different structures of the olfactory system. To date, the activity of neurons has been demonstrated to play an important role in the morphogenesis of the olfactory nerve, concretely, in the final refinement of their connections within the OB (Trinh and Storm,<xref ref-type=""bibr"" rid=""B199"">2003</xref>; Yu et al.,<xref ref-type=""bibr"" rid=""B216"">2004</xref>; Zou et al.,<xref ref-type=""bibr"" rid=""B225"">2004</xref>; Mombaerts,<xref ref-type=""bibr"" rid=""B124"">2006</xref>; Chesler et al.,<xref ref-type=""bibr"" rid=""B32"">2007</xref>; Dal Col et al.,<xref ref-type=""bibr"" rid=""B41"">2007</xref>), although it would be also relevant for the development of the LOT and for the intracortical connections, and also for the accessory olfactory system. The activity-dependency of the projections from the olfactory epithelium to the OB could also provide functional correlates for the demonstrated role of olfactory activity in the survival of newly-generated interneuron precursors which migrate to the OB (Rochefort et al.,<xref ref-type=""bibr"" rid=""B152"">2002</xref>; Alonso et al.,<xref ref-type=""bibr"" rid=""B5"">2006</xref>,<xref ref-type=""bibr"" rid=""B4"">2008</xref>; Mandairon et al.,<xref ref-type=""bibr"" rid=""B116"">2006</xref>). The effects of sensorial activity in the plasticity of the olfactory system have been discussed above.</p><p>In despite of its origin and clear influences in the formation of the main olfactory system (i.e.: the influence of AOB axons in the organization of the LOT), as well as of the recent research regarding types of vomeronasal receptors and the organization of the vomeronasal cortex (reviewed in Martínez-Marcos,<xref ref-type=""bibr"" rid=""B121"">2009</xref>), the main conclusion that we can extract from the studies published to date is that the molecular mechanisms involved in the development of the connectivity in the accessory olfactory system are far from being ellucidated.</p><p>Finally, it should be highlighted the increasingly relevance of the molecules reviewed in the present work for Neurological pathology (de Castro,<xref ref-type=""bibr"" rid=""B42"">2001</xref>; Sarnat and Flores-Sarnat,<xref ref-type=""bibr"" rid=""B158"">2001</xref>; Sarnat,<xref ref-type=""bibr"" rid=""B157"">2007</xref>). Their impact in pathologies which affect the olfactory system remains to be elucidated, with the exception of Anosmin-1 and FGFs, which seems clear that plays a major functional role in Kallmann syndrome (Dodé and Hardelin,<xref ref-type=""bibr"" rid=""B46"">2009</xref>).</p><sec><title>Conflict of Interest Statement</title><p>The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><ack><p>I am indebted to Prof. Fernando Martínez-Gacía, Dr Javier Arenzana and Diego García-González for their comments and suggestions on the manuscript and for their technical support and help in the final editing of this work. This work was supported by grants SAF2007-65845 (MICINN), PI2007-66 (FISCAM), G-2008-C8 (FISCAM) and ICS06024-00 (Consejería de Sanidad de la Junta de Comunidades de Castilla-La Mancha), and both FUHNPAIIN and SESCAM generously support different aspects of our research group's activities.</p></ack><fn-group><fn id=""fn1""><p><sup>1</sup>This brings to relevant researchers to claim for an unidentified factor secreted by the septum (known as Pini's factor, see Figure<xref ref-type=""fig"" rid=""F3"">3</xref>) as responsible for the chemorepellent effect on OB axons, either alone or in concomitance with Slit-2 (Patel et al.,<xref ref-type=""bibr"" rid=""B138"">2001</xref>).</p></fn></fn-group><ref-list><title>References</title><ref id=""B1""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Akins</surname><given-names>M. R.</given-names></name><name><surname>Benson</surname><given-names>D. L.</given-names></name><name><surname>Greer</surname><given-names>C. A.</given-names></name></person-group>(<year>2007</year>).<article-title>Cadherin expression in the developing mouse olfactory system</article-title>.<source>J. Comp. Neurol.</source><volume>501</volume>,<fpage>483</fpage>–<lpage>497</lpage><pub-id pub-id-type=""doi"">10.1002/cne.21270</pub-id><pub-id pub-id-type=""pmid"">17278136</pub-id></mixed-citation></ref><ref id=""B2""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Akins</surname><given-names>M. R.</given-names></name><name><surname>Greer</surname><given-names>C. A.</given-names></name></person-group>(<year>2006</year>).<article-title>Axon behavior in the olfactory nerve reflects the involvement of catenin-cadherin mediated adhesion</article-title>.<source>J. Comp. Neurol.</source><volume>499</volume>,<fpage>979</fpage>–<lpage>989</lpage><pub-id pub-id-type=""doi"">10.1002/cne.21147</pub-id><pub-id pub-id-type=""pmid"">17072833</pub-id></mixed-citation></ref><ref id=""B3""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Alenius</surname><given-names>M.</given-names></name><name><surname>Bohm</surname><given-names>S.</given-names></name></person-group>(<year>2003</year>).<article-title>Differential function of RNCAM isoforms in precise target selection of olfactory sensory neurons</article-title>.<source>Development</source><volume>130</volume>,<fpage>917</fpage>–<lpage>927</lpage><pub-id pub-id-type=""doi"">10.1242/dev.00317</pub-id><pub-id pub-id-type=""pmid"">12538518</pub-id></mixed-citation></ref><ref id=""B4""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Alonso</surname><given-names>M.</given-names></name><name><surname>Ortega-Pérez</surname><given-names>I.</given-names></name><name><surname>Grubb</surname><given-names>M. S.</given-names></name><name><surname>Bourgeois</surname><given-names>J. P.</given-names></name><name><surname>Charneau</surname><given-names>P.</given-names></name><name><surname>Lledó</surname><given-names>P. M.</given-names></name></person-group>(<year>2008</year>).<article-title>Turning astrocytes from the rostral migratory stream into neurons: a role for the olfactory sensory organ</article-title>.<source>J. Neurosci.</source><volume>28</volume>,<fpage>11089</fpage>–<lpage>11102</lpage><pub-id pub-id-type=""doi"">10.1523/JNEUROSCI.3713-08.2008</pub-id><pub-id pub-id-type=""pmid"">18945916</pub-id></mixed-citation></ref><ref id=""B5""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Alonso</surname><given-names>M.</given-names></name><name><surname>Viollet</surname><given-names>C.</given-names></name><name><surname>Gabellec</surname><given-names>M. M.</given-names></name><name><surname>Meas-Yedid</surname><given-names>V.</given-names></name><name><surname>Olivo-Marín</surname><given-names>J. C.</given-names></name><name><surname>Lledó</surname><given-names>P. M.</given-names></name></person-group>(<year>2006</year>).<article-title>Olfactory discrimination learning increases the survival of adult-born neurons in the olfactory bulb</article-title>.<source>J. Neurosci.</source><volume>26</volume>,<fpage>10508</fpage>–<lpage>10513</lpage><pub-id pub-id-type=""doi"">10.1523/JNEUROSCI.2633-06.2006</pub-id><pub-id pub-id-type=""pmid"">17035535</pub-id></mixed-citation></ref><ref id=""B6""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Aoki</surname><given-names>K.</given-names></name><name><surname>Ankara</surname><given-names>Y.</given-names></name><name><surname>Yamada</surname><given-names>S.</given-names></name><name><surname>Eto</surname><given-names>K.</given-names></name></person-group>(<year>1999</year>).<article-title>Role of polysialic acid on outgrowth of rat olfactory receptor neurons</article-title>.<source>Mech. Dev.</source><volume>85</volume>,<fpage>103</fpage>–<lpage>110</lpage><pub-id pub-id-type=""doi"">10.1016/S0925-4773(99)00092-1</pub-id><pub-id pub-id-type=""pmid"">10415351</pub-id></mixed-citation></ref><ref id=""B7""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Ardiles</surname><given-names>Y.</given-names></name><name><surname>de la Puente</surname><given-names>R.</given-names></name><name><surname>Toledo</surname><given-names>R.</given-names></name><name><surname>Isgor</surname><given-names>C.</given-names></name><name><surname>Guthrie</surname><given-names>K.</given-names></name></person-group>(<year>2007</year>).<article-title>Response of olfactory axons to loss of synaptic targets in the adult mouse</article-title>.<source>Exp. Neurol.</source><volume>207</volume>,<fpage>275</fpage>–<lpage>288</lpage><pub-id pub-id-type=""doi"">10.1016/j.expneurol.2007.06.022</pub-id><pub-id pub-id-type=""pmid"">17674970</pub-id></mixed-citation></ref><ref id=""B8""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Armentano</surname><given-names>M.</given-names></name><name><surname>Filosa</surname><given-names>A.</given-names></name><name><surname>Andolfi</surname><given-names>G.</given-names></name><name><surname>Studer</surname><given-names>M.</given-names></name></person-group>(<year>2006</year>).<article-title>COUP-TFI is required for the formation of commissural projections in the forebrain by regulating axonal growth</article-title>.<source>Development</source><volume>133</volume>,<fpage>4151</fpage>–<lpage>4162</lpage><pub-id pub-id-type=""doi"">10.1242/dev.02600</pub-id><pub-id pub-id-type=""pmid"">17021036</pub-id></mixed-citation></ref><ref id=""B9""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Astic</surname><given-names>L.</given-names></name><name><surname>Pellier-Monnin</surname><given-names>V.</given-names></name><name><surname>Saucier</surname><given-names>D.</given-names></name><name><surname>Charrier</surname><given-names>C.</given-names></name><name><surname>Mehlen</surname><given-names>P.</given-names></name></person-group>(<year>2002</year>).<article-title>Expression of netrin-1 and netrin-1 receptor, DCC, in the rat olfactory nerve pathway during development and axonal regeneration</article-title>.<source>Neuroscience</source><volume>109</volume>,<fpage>643</fpage>–<lpage>656</lpage><pub-id pub-id-type=""doi"">10.1016/S0306-4522(01)00535-8</pub-id><pub-id pub-id-type=""pmid"">11927147</pub-id></mixed-citation></ref><ref id=""B10""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Baker</surname><given-names>H.</given-names></name><name><surname>Cummings</surname><given-names>D. M.</given-names></name><name><surname>Munger</surname><given-names>S. D.</given-names></name><name><surname>Margolis</surname><given-names>J. W.</given-names></name><name><surname>Franzen</surname><given-names>L.</given-names></name><name><surname>Reed</surname><given-names>R. R.</given-names></name><name><surname>Margolis</surname><given-names>F. L.</given-names></name></person-group>(<year>1999</year>).<article-title>Targeted deletion of a cyclic nucleotide-gated channel subunit (OCNC1): biochemical and morphological consequences in adult mice</article-title>.<source>J. Neurosci.</source><volume>19</volume>,<fpage>9313</fpage>–<lpage>9321</lpage><pub-id pub-id-type=""pmid"">10531436</pub-id></mixed-citation></ref><ref id=""B11""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Barnea</surname><given-names>G.</given-names></name><name><surname>O'Donnell</surname><given-names>S.</given-names></name><name><surname>Mancia</surname><given-names>F.</given-names></name><name><surname>Sun</surname><given-names>X.</given-names></name><name><surname>Nemes</surname><given-names>A.</given-names></name><name><surname>Mendelsohn</surname><given-names>M.</given-names></name><name><surname>Axel</surname><given-names>R.</given-names></name></person-group>(<year>2004</year>).<article-title>Odorant receptors on axon termini in the brain</article-title>.<source>Science</source><volume>304</volume>,<fpage>1468</fpage><pub-id pub-id-type=""doi"">10.1126/science.1096146</pub-id><pub-id pub-id-type=""pmid"">15178793</pub-id></mixed-citation></ref><ref id=""B12""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Barresi</surname><given-names>M. J.</given-names></name><name><surname>Hutson</surname><given-names>L. D.</given-names></name><name><surname>Chien</surname><given-names>C. B.</given-names></name><name><surname>Karlstrom</surname><given-names>R. O.</given-names></name></person-group>(<year>2005</year>).<article-title>Hedgehog regulated Slit expression determines commissure and glial cell position in the zebrafish forebrain</article-title>.<source>Development</source><volume>132</volume>,<fpage>3643</fpage>–<lpage>3656</lpage><pub-id pub-id-type=""doi"">10.1242/dev.01929</pub-id><pub-id pub-id-type=""pmid"">16033800</pub-id></mixed-citation></ref><ref id=""B13""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Bayer</surname><given-names>S. A.</given-names></name></person-group>(<year>1983</year>).<article-title>3H-thymidine-radiographic studies of neurogenesis in the rat olfactory bulb</article-title>.<source>Exp. Brain Res.</source><volume>50</volume>,<fpage>329</fpage>–<lpage>340</lpage><pub-id pub-id-type=""doi"">10.1007/BF00239197</pub-id><pub-id pub-id-type=""pmid"">6641865</pub-id></mixed-citation></ref><ref id=""B14""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Belluscio</surname><given-names>L.</given-names></name><name><surname>Gold</surname><given-names>G. H.</given-names></name><name><surname>Nemes</surname><given-names>A.</given-names></name><name><surname>Axel</surname><given-names>R.</given-names></name></person-group>(<year>1998</year>).<article-title>Mice deficient in G(olf) are anosmic</article-title>.<source>Neuron</source><volume>20</volume>,<fpage>69</fpage>–<lpage>81</lpage><pub-id pub-id-type=""doi"">10.1016/S0896-6273(00)80435-3</pub-id><pub-id pub-id-type=""pmid"">9459443</pub-id></mixed-citation></ref><ref id=""B15""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Belluzzi</surname><given-names>O.</given-names></name><name><surname>Benedusi</surname><given-names>M.</given-names></name><name><surname>Ackman</surname><given-names>J.</given-names></name><name><surname>LoTurco</surname><given-names>J. J.</given-names></name></person-group>(<year>2003</year>).<article-title>Electrophysiological differentiation of new neurons in the olfactory bulb</article-title>.<source>J. Neurosci.</source><volume>23</volume>,<fpage>10411</fpage>–<lpage>10418</lpage><pub-id pub-id-type=""pmid"">14614100</pub-id></mixed-citation></ref><ref id=""B16""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Biju</surname><given-names>K. C.</given-names></name><name><surname>Marks</surname><given-names>D. R.</given-names></name><name><surname>Mast</surname><given-names>T. G.</given-names></name><name><surname>Fadool</surname><given-names>D. A.</given-names></name></person-group>(<year>2008</year>).<article-title>Deletion of voltage-gated channel affects glomerular refinement and odorant receptor expression in the mouse olfactory system</article-title>.<source>J. Comp. Neurol.</source><volume>506</volume>,<fpage>161</fpage>–<lpage>179</lpage><pub-id pub-id-type=""doi"">10.1002/cne.21540</pub-id><pub-id pub-id-type=""pmid"">18022950</pub-id></mixed-citation></ref><ref id=""B17""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Blanchart</surname><given-names>A.</given-names></name><name><surname>De Carlos</surname><given-names>J. A.</given-names></name><name><surname>López-Mascaraque</surname><given-names>L.</given-names></name></person-group>(<year>2006</year>).<article-title>Time frame of mitral cell development in the mice olfactory bulb</article-title>.<source>J. Comp. Neurol.</source><volume>496</volume>,<fpage>529</fpage>–<lpage>543</lpage><pub-id pub-id-type=""doi"">10.1002/cne.20941</pub-id><pub-id pub-id-type=""pmid"">16572431</pub-id></mixed-citation></ref><ref id=""B18""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Bonfanti</surname><given-names>L.</given-names></name></person-group>(<year>2006</year>).<article-title>PSA-NCAM in mammalian structural plasticity and neurogenesis</article-title>.<source>Prog. Neurobiol.</source><volume>80</volume>,<fpage>129</fpage>–<lpage>164</lpage><pub-id pub-id-type=""doi"">10.1016/j.pneurobio.2006.08.003</pub-id><pub-id pub-id-type=""pmid"">17029752</pub-id></mixed-citation></ref><ref id=""B19""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Briançon-Marjollet</surname><given-names>A.</given-names></name><name><surname>Ghogha</surname><given-names>A.</given-names></name><name><surname>Nawabi</surname><given-names>H.</given-names></name><name><surname>Triki</surname><given-names>I.</given-names></name><name><surname>Auziol</surname><given-names>C.</given-names></name><name><surname>Fromont</surname><given-names>S.</given-names></name><name><surname>Piché</surname><given-names>C.</given-names></name><name><surname>Enslen</surname><given-names>H.</given-names></name><name><surname>Chebli</surname><given-names>K.</given-names></name><name><surname>Cloutier</surname><given-names>J. F.</given-names></name><name><surname>Castellani</surname><given-names>V.</given-names></name><name><surname>Debant</surname><given-names>A.</given-names></name><name><surname>Lamarche-Vane</surname><given-names>N.</given-names></name></person-group>(<year>2008</year>).<article-title>Trio mediates netrin-1-induced Rac1 activation in axon outgrowth and guidance</article-title>.<source>Mol. Cell. Biol.</source><volume>28</volume>,<fpage>2314</fpage>–<lpage>2323</lpage><pub-id pub-id-type=""doi"">10.1128/MCB.00998-07</pub-id><pub-id pub-id-type=""pmid"">18212043</pub-id></mixed-citation></ref><ref id=""B20""><mixed-citation publication-type=""book""><person-group person-group-type=""author""><name><surname>Brodal</surname><given-names>P.</given-names></name></person-group>(<year>2004</year>).<article-title>The Central Nervous System: Structure and Function</article-title>.<publisher-loc>Oxford</publisher-loc>,<publisher-name>Oxford University Press</publisher-name></mixed-citation></ref><ref id=""B21""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Buck</surname><given-names>L.</given-names></name><name><surname>Axel</surname><given-names>R.</given-names></name></person-group>(<year>1991</year>).<article-title>A novel multigene family may encode odorant receptors: a molecular basis for odor recognition</article-title>.<source>Cell</source><volume>65</volume>,<fpage>175</fpage>–<lpage>187</lpage><pub-id pub-id-type=""doi"">10.1016/0092-8674(91)90418-X</pub-id><pub-id pub-id-type=""pmid"">1840504</pub-id></mixed-citation></ref><ref id=""B22""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Buck</surname><given-names>L. B.</given-names></name></person-group>(<year>2000</year>).<article-title>The molecular architecture of odor and pheromone sensing in mammals</article-title>.<source>Cell</source><volume>100</volume>,<fpage>611</fpage>–<lpage>618</lpage><pub-id pub-id-type=""doi"">10.1016/S0092-8674(00)80698-4</pub-id><pub-id pub-id-type=""pmid"">10761927</pub-id></mixed-citation></ref><ref id=""B23""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Bulfone</surname><given-names>A.</given-names></name><name><surname>Wang</surname><given-names>F.</given-names></name><name><surname>Hevner</surname><given-names>R.</given-names></name><name><surname>Anderson</surname><given-names>S.</given-names></name><name><surname>Cutforth</surname><given-names>T.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Meneses</surname><given-names>J.</given-names></name><name><surname>Pedersen</surname><given-names>R.</given-names></name><name><surname>Axel</surname><given-names>R.</given-names></name><name><surname>Rubenstein</surname><given-names>J. L.</given-names></name></person-group>(<year>1998</year>).<article-title>An olfactory sensory map develops in the absence of normal projection neurons or GABAergic interneurons</article-title>.<source>Neuron</source><volume>21</volume>,<fpage>1273</fpage>–<lpage>1282</lpage><pub-id pub-id-type=""doi"">10.1016/S0896-6273(00)80647-9</pub-id><pub-id pub-id-type=""pmid"">9883721</pub-id></mixed-citation></ref><ref id=""B24""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Cajal</surname><given-names>S. R.</given-names></name></person-group>(<year>1890</year>).<article-title>Origen y terminación de las fibras nerviosas olfatorias</article-title>.<source>Gac. San. Barcelona.</source><volume>3</volume>,<fpage>133</fpage>–<lpage>139</lpage>,<fpage>174</fpage>–<lpage>181</lpage>,<fpage>206</fpage>–<lpage>212</lpage></mixed-citation></ref><ref id=""B25""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Carleton</surname><given-names>A.</given-names></name><name><surname>Petreanu</surname><given-names>L. T.</given-names></name><name><surname>Lansford</surname><given-names>R.</given-names></name><name><surname>Álvarez-Buylla</surname><given-names>A.</given-names></name><name><surname>Lledó</surname><given-names>P. M.</given-names></name></person-group>(<year>2003</year>).<article-title>Becoming a new neuron in the adult olfactory bulb</article-title>.<source>Nat. Neurosci.</source><volume>6</volume>,<fpage>507</fpage>–<lpage>518</lpage><pub-id pub-id-type=""pmid"">12704391</pub-id></mixed-citation></ref><ref id=""B26""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Carson</surname><given-names>C.</given-names></name><name><surname>Saleh</surname><given-names>M.</given-names></name><name><surname>Fung</surname><given-names>F. W.</given-names></name><name><surname>Nicholson</surname><given-names>D. W.</given-names></name><name><surname>Roskams</surname><given-names>A. J.</given-names></name></person-group>(<year>2005</year>).<article-title>Axonal dynactin p150Glued transports caspase-8 to drive retrograde olfactory receptor neuron apoptosis</article-title>.<source>J. Neurosci.</source><volume>25</volume>,<fpage>6092</fpage>–<lpage>6104</lpage><pub-id pub-id-type=""doi"">10.1523/JNEUROSCI.0707-05.2005</pub-id><pub-id pub-id-type=""pmid"">15987939</pub-id></mixed-citation></ref><ref id=""B27""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Caviness</surname><given-names>V. S.</given-names><suffix>Jr.</suffix></name><name><surname>Sidman</surname><given-names>R. L.</given-names></name></person-group>(<year>1972</year>).<article-title>Olfactory structures of the forebrain in the reeler mutant mouse</article-title>.<source>J. Comp. Neurol.</source><volume>145</volume>,<fpage>85</fpage>–<lpage>104</lpage><pub-id pub-id-type=""doi"">10.1002/cne.901450106</pub-id><pub-id pub-id-type=""pmid"">5036667</pub-id></mixed-citation></ref><ref id=""B28""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Chehrehasa</surname><given-names>F.</given-names></name><name><surname>St John</surname><given-names>J. A.</given-names></name><name><surname>Key</surname><given-names>B.</given-names></name></person-group>(<year>2006</year>).<article-title>Implantation of a scaffold following bulbectomy induces laminar organization of regenerating olfactory axons</article-title>.<source>Brain Res.</source><volume>1119</volume>,<fpage>58</fpage>–<lpage>64</lpage><pub-id pub-id-type=""doi"">10.1016/j.brainres.2006.08.060</pub-id><pub-id pub-id-type=""pmid"">16996489</pub-id></mixed-citation></ref><ref id=""B29""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Flanagan</surname><given-names>J. G.</given-names></name></person-group>(<year>2006</year>).<article-title>Follow your nose: axon pathfinding in olfactory map formation</article-title>.<source>Cell</source><volume>127</volume>,<fpage>881</fpage>–<lpage>884</lpage><pub-id pub-id-type=""doi"">10.1016/j.cell.2006.11.017</pub-id><pub-id pub-id-type=""pmid"">17129775</pub-id></mixed-citation></ref><ref id=""B30""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Bagri</surname><given-names>A.</given-names></name><name><surname>Zupicich</surname><given-names>J. A.</given-names></name><name><surname>Zou</surname><given-names>Y.</given-names></name><name><surname>Stoeckli</surname><given-names>E.</given-names></name><name><surname>Pleasure</surname><given-names>S. J.</given-names></name><name><surname>Lowenstein</surname><given-names>D. H.</given-names></name><name><surname>Skarnes</surname><given-names>W. C.</given-names></name><name><surname>Chédotal</surname><given-names>A.</given-names></name><name><surname>Tessier-Lavigne</surname><given-names>M.</given-names></name></person-group>(<year>2000</year>).<article-title>Neuropilin-2 regulates the development of selective cranial and sensory nerves and hippocampal mossy fiber projections</article-title>.<source>Neuron</source><volume>25</volume>,<fpage>43</fpage>–<lpage>56</lpage><pub-id pub-id-type=""doi"">10.1016/S0896-6273(00)80870-3</pub-id><pub-id pub-id-type=""pmid"">10707971</pub-id></mixed-citation></ref><ref id=""B31""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Liao</surname><given-names>G.</given-names></name><name><surname>Waclaw</surname><given-names>R. R.</given-names></name><name><surname>Burns</surname><given-names>K. A.</given-names></name><name><surname>Linquist</surname><given-names>D.</given-names></name><name><surname>Campbell</surname><given-names>K.</given-names></name><name><surname>Zheng</surname><given-names>Y.</given-names></name><name><surname>Kuan</surname><given-names>C. Y.</given-names></name></person-group>(<year>2007</year>).<article-title>Rac1 controls the formation of midline commissures and the competency of tangential migration in ventral telencephalic neurons</article-title>.<source>J. Neurosci.</source><volume>27</volume>,<fpage>3884</fpage>–<lpage>3893</lpage><pub-id pub-id-type=""doi"">10.1523/JNEUROSCI.3509-06.2007</pub-id><pub-id pub-id-type=""pmid"">17409253</pub-id></mixed-citation></ref><ref id=""B32""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Chesler</surname><given-names>A. T.</given-names></name><name><surname>Zou</surname><given-names>D. J.</given-names></name><name><surname>Le Pichon</surname><given-names>C. E.</given-names></name><name><surname>Peterlin</surname><given-names>Z. A.</given-names></name><name><surname>Matthews</surname><given-names>G. A.</given-names></name><name><surname>Pei</surname><given-names>X.</given-names></name><name><surname>Miller</surname><given-names>M. C.</given-names></name><name><surname>Firestein</surname><given-names>S.</given-names></name></person-group>(<year>2007</year>).<article-title>A G protein/cAMP signal cascade is required for axonal convergence into olfactory glomeruli</article-title>.<source>Proc. Natl. Acad. Sci. U.S.A.</source><volume>104</volume>,<fpage>1039</fpage>–<lpage>1044</lpage><pub-id pub-id-type=""doi"">10.1073/pnas.0609215104</pub-id><pub-id pub-id-type=""pmid"">17215378</pub-id></mixed-citation></ref><ref id=""B33""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Cho</surname><given-names>H.</given-names></name><name><surname>Lépine</surname><given-names>M.</given-names></name><name><surname>Andrews</surname><given-names>W.</given-names></name><name><surname>Parnavelas</surname><given-names>J.</given-names></name><name><surname>Cloutier</surname><given-names>J. F.</given-names></name></person-group>(<year>2007</year>).<article-title>Requirement for Slit-1 and Robo-2 in zonal segregation of olfactory sensory neuron axons in the main olfactory bulb</article-title>.<source>J. Neurosci.</source><volume>27</volume>,<fpage>9094</fpage>–<lpage>9104</lpage><pub-id pub-id-type=""doi"">10.1523/JNEUROSCI.2217-07.2007</pub-id><pub-id pub-id-type=""pmid"">17715346</pub-id></mixed-citation></ref><ref id=""B34""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Cloutier</surname><given-names>J. F.</given-names></name><name><surname>Giger</surname><given-names>R. J.</given-names></name><name><surname>Koentges</surname><given-names>G.</given-names></name><name><surname>Dulac</surname><given-names>C.</given-names></name><name><surname>Kolodkin</surname><given-names>A. L.</given-names></name><name><surname>Ginty</surname><given-names>D. D.</given-names></name></person-group>(<year>2002</year>).<article-title>Neuropilin-2 mediates axonal fasciculation, zonal segregation, but not axonal convergence, of primary accessory olfactory neurons</article-title>.<source>Neuron</source><volume>33</volume>,<fpage>877</fpage>–<lpage>892</lpage><pub-id pub-id-type=""doi"">10.1016/S0896-6273(02)00635-9</pub-id><pub-id pub-id-type=""pmid"">11906695</pub-id></mixed-citation></ref><ref id=""B35""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Cloutier</surname><given-names>J. F.</given-names></name><name><surname>Sahay</surname><given-names>A.</given-names></name><name><surname>Chang</surname><given-names>E. C.</given-names></name><name><surname>Tessier-Lavigne</surname><given-names>M.</given-names></name><name><surname>Dulac</surname><given-names>C.</given-names></name><name><surname>Kolodkin</surname><given-names>A. L.</given-names></name><name><surname>Ginty</surname><given-names>D. D.</given-names></name></person-group>(<year>2004</year>).<article-title>Differential requirements for semaphorin 3F and Slit-1 in axonal targeting, fasciculation, and segregation of olfactory sensory neuron projections</article-title>.<source>J. Neurosci.</source><volume>24</volume>,<fpage>9087</fpage>–<lpage>9096</lpage><pub-id pub-id-type=""doi"">10.1523/JNEUROSCI.2786-04.2004</pub-id><pub-id pub-id-type=""pmid"">15483127</pub-id></mixed-citation></ref><ref id=""B36""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Colón-Ramos</surname><given-names>D. A.</given-names></name><name><surname>Shen</surname><given-names>K.</given-names></name></person-group>(<year>2008</year>).<article-title>Cellular conductors: glial cells as guideposts during neural circuit development</article-title>.<source>PLoS Biol.</source><volume>6</volume>,<fpage>e112</fpage><pub-id pub-id-type=""doi"">10.1371/journal.pbio.0060112.</pub-id><pub-id pub-id-type=""pmid"">18447586</pub-id></mixed-citation></ref><ref id=""B37""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Conzelmann</surname><given-names>S.</given-names></name><name><surname>Malun</surname><given-names>D.</given-names></name><name><surname>Breer</surname><given-names>H.</given-names></name><name><surname>Strotmann</surname><given-names>J.</given-names></name></person-group>(<year>2001</year>).<article-title>Brain targeting and glomerulus formation of two olfactory neuron populations expressing related receptor types</article-title>.<source>Eur. J. Neurosci.</source><volume>14</volume>,<fpage>1623</fpage>–<lpage>1632</lpage><pub-id pub-id-type=""doi"">10.1046/j.0953-816x.2001.01788.x</pub-id><pub-id pub-id-type=""pmid"">11860457</pub-id></mixed-citation></ref><ref id=""B38""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Costanzo</surname><given-names>R. M.</given-names></name></person-group>(<year>2000</year>).<article-title>Rewiring the olfactory bulb: changes in odor maps following recovery from nerve transection</article-title>.<source>Chem. Senses</source><volume>25</volume>,<fpage>199</fpage>–<lpage>205</lpage><pub-id pub-id-type=""doi"">10.1093/chemse/25.2.199</pub-id><pub-id pub-id-type=""pmid"">10781027</pub-id></mixed-citation></ref><ref id=""B39""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Cummings</surname><given-names>D. M.</given-names></name><name><surname>Malun</surname><given-names>D.</given-names></name><name><surname>Brunjes</surname><given-names>P. C.</given-names></name></person-group>(<year>1997</year>).<article-title>Development of the anterior commissure in the opossum: midline extracellular space and glia coincide with early axon decussation</article-title>.<source>J. Neurobiol.</source><volume>32</volume>,<fpage>403</fpage>–<lpage>414</lpage><pub-id pub-id-type=""doi"">10.1002/(SICI)1097-4695(199704)32:4&lt;403::AID-NEU4&gt;3.0.CO;2-A</pub-id><pub-id pub-id-type=""pmid"">9087892</pub-id></mixed-citation></ref><ref id=""B40""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Cutforth</surname><given-names>T.</given-names></name><name><surname>Moring</surname><given-names>L.</given-names></name><name><surname>Mendelsohn</surname><given-names>M.</given-names></name><name><surname>Nemes</surname><given-names>A.</given-names></name><name><surname>Shah</surname><given-names>N. M.</given-names></name><name><surname>Kim</surname><given-names>M. M.</given-names></name><name><surname>Frisén</surname><given-names>J.</given-names></name><name><surname>Axel</surname><given-names>R.</given-names></name></person-group>(<year>2003</year>).<article-title>Axonal ephrin-As and odorant receptors: coordinate determination of the olfactory sensory map</article-title>.<source>Cell</source><volume>114</volume>,<fpage>311</fpage>–<lpage>322</lpage><pub-id pub-id-type=""doi"">10.1016/S0092-8674(03)00568-3</pub-id><pub-id pub-id-type=""pmid"">12914696</pub-id></mixed-citation></ref><ref id=""B41""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Dal Col</surname><given-names>J. A.</given-names></name><name><surname>Matsuo</surname><given-names>T.</given-names></name><name><surname>Storm</surname><given-names>D. R.</given-names></name><name><surname>Rodriguez</surname><given-names>I.</given-names></name></person-group>(<year>2007</year>).<article-title>Adenylyl cyclase-dependent axonal targeting in the olfactory system</article-title>.<source>Development</source><volume>134</volume>,<fpage>2481</fpage>–<lpage>2489</lpage><pub-id pub-id-type=""doi"">10.1242/dev.006346</pub-id><pub-id pub-id-type=""pmid"">17537788</pub-id></mixed-citation></ref><ref id=""B42""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>de Castro</surname><given-names>F.</given-names></name></person-group>(<year>2001</year>).<article-title>Moléculas quimiotrópicas como mecanismo de orientación del crecimiento axonal y de la migración neuronal durante el desarrollo del sistema nervioso de los mamíferos</article-title>.<source>Rev. Neurol.</source><volume>33</volume>,<fpage>54</fpage>–<lpage>68</lpage><pub-id pub-id-type=""pmid"">11562862</pub-id></mixed-citation></ref><ref id=""B43""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>de Castro</surname><given-names>F.</given-names></name><name><surname>Hu</surname><given-names>L.</given-names></name><name><surname>Drabkin</surname><given-names>H.</given-names></name><name><surname>Sotelo</surname><given-names>C.</given-names></name><name><surname>Chédotal</surname><given-names>A.</given-names></name></person-group>(<year>1999</year>).<article-title>Chemoattraction and chemorepulsion of olfactory bulb axons by different secreted semaphorins</article-title>.<source>J. Neurosci.</source><volume>19</volume>,<fpage>4428</fpage>–<lpage>4436</lpage><pub-id pub-id-type=""pmid"">10341244</pub-id></mixed-citation></ref><ref id=""B44""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Derer</surname><given-names>P.</given-names></name><name><surname>Caviness</surname><given-names>V.S.</given-names><suffix>Jr.</suffix></name><name><surname>Sidman</surname><given-names>R. L.</given-names></name></person-group>(<year>1977</year>).<article-title>Early cortical histogenesis in the primary olfactory cortex of the mouse</article-title>.<source>Brain Res.</source><volume>123</volume>,<fpage>27</fpage>–<lpage>40</lpage><pub-id pub-id-type=""doi"">10.1016/0006-8993(77)90641-2</pub-id><pub-id pub-id-type=""pmid"">843920</pub-id></mixed-citation></ref><ref id=""B45""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Devor</surname><given-names>M.</given-names></name></person-group>(<year>1976</year>).<article-title>Fiber trajectories of olfactory bulb efferents in the hamster</article-title>.<source>J. Comp. Neurol.</source><volume>166</volume>,<fpage>31</fpage>–<lpage>48</lpage><pub-id pub-id-type=""doi"">10.1002/cne.901660104</pub-id><pub-id pub-id-type=""pmid"">1262548</pub-id></mixed-citation></ref><ref id=""B46""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Dodé</surname><given-names>C.</given-names></name><name><surname>Hardelin</surname><given-names>J. P.</given-names></name></person-group>(<year>2009</year>).<article-title>Kallmann syndrome</article-title>.<source>Eur. J. Hum. Genet.</source><volume>17</volume>,<fpage>139</fpage>–<lpage>146</lpage><pub-id pub-id-type=""doi"">10.1038/ejhg.2008.206</pub-id><pub-id pub-id-type=""pmid"">18985070</pub-id></mixed-citation></ref><ref id=""B47""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Dottori</surname><given-names>M.</given-names></name><name><surname>Hartley</surname><given-names>L.</given-names></name><name><surname>Galea</surname><given-names>M.</given-names></name><name><surname>Paxinos</surname><given-names>G.</given-names></name><name><surname>Polizzotto</surname><given-names>M.</given-names></name><name><surname>Kilpatrick</surname><given-names>T.</given-names></name><name><surname>Bartlett</surname><given-names>P. F.</given-names></name><name><surname>Murphy</surname><given-names>M.</given-names></name><name><surname>Köntgen</surname><given-names>F.</given-names></name><name><surname>Boyd</surname><given-names>A. W.</given-names></name></person-group>(<year>1998</year>).<article-title>EphA4 (Sek1) receptor tyrosine kinase is required for the development of the corticospinal tract</article-title>.<source>Proc. Natl. Acad. Sci. U.S.A.</source><volume>95</volume>,<fpage>13248</fpage>–<lpage>13253</lpage><pub-id pub-id-type=""doi"">10.1073/pnas.95.22.13248</pub-id><pub-id pub-id-type=""pmid"">9789074</pub-id></mixed-citation></ref><ref id=""B48""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Doucette</surname><given-names>R.</given-names></name></person-group>(<year>1989</year>).<article-title>Development of the nerve fiber layer in the olfactory bulb of mouse embryos</article-title>.<source>J. Comp. Neurol.</source><volume>285</volume>,<fpage>514</fpage>–<lpage>527</lpage><pub-id pub-id-type=""doi"">10.1002/cne.902850407</pub-id><pub-id pub-id-type=""pmid"">2760269</pub-id></mixed-citation></ref><ref id=""B49""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Dulac</surname><given-names>C.</given-names></name><name><surname>Torello</surname><given-names>A. T.</given-names></name></person-group>(<year>2003</year>).<article-title>Molecular detection of pheromone signals in mammals: from genes to behaviour</article-title>.<source>Nat. Rev. Neurosci.</source><volume>7</volume>,<fpage>551</fpage>–<lpage>562</lpage><pub-id pub-id-type=""doi"">10.1038/nrn1140</pub-id><pub-id pub-id-type=""pmid"">12838330</pub-id></mixed-citation></ref><ref id=""B50""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Elsaesser</surname><given-names>R.</given-names></name><name><surname>Paysan</surname><given-names>J.</given-names></name></person-group>(<year>2007</year>).<article-title>The sense of smell, its signalling pathways, and the dichotomy of cilia and microvilli in olfactory sensory cells</article-title>.<source>BMC Neurosci.</source><volume>8</volume>,<fpage>S1</fpage><pub-id pub-id-type=""doi"">10.1186/1471-2202-8-S3-S1</pub-id><pub-id pub-id-type=""pmid"">17903277</pub-id></mixed-citation></ref><ref id=""B51""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Falk</surname><given-names>J.</given-names></name><name><surname>Bechara</surname><given-names>A.</given-names></name><name><surname>Fiore</surname><given-names>R.</given-names></name><name><surname>Nawabi</surname><given-names>H.</given-names></name><name><surname>Zhou</surname><given-names>H.</given-names></name><name><surname>Hoyo-Becerra</surname><given-names>C.</given-names></name><name><surname>Bozon</surname><given-names>M.</given-names></name><name><surname>Rougon</surname><given-names>G.</given-names></name><name><surname>Grumet</surname><given-names>M.</given-names></name><name><surname>Püschel</surname><given-names>A. W.</given-names></name><name><surname>Sanes</surname><given-names>J. R.</given-names></name><name><surname>Castellani</surname><given-names>V.</given-names></name></person-group>(<year>2005</year>).<article-title>Dual functional activity of semaphorin 3B is required for positioning the anterior commissure</article-title>.<source>Neuron</source><volume>48</volume>,<fpage>63</fpage>–<lpage>75</lpage><pub-id pub-id-type=""doi"">10.1016/j.neuron.2005.10.024</pub-id><pub-id pub-id-type=""pmid"">16202709</pub-id></mixed-citation></ref><ref id=""B52""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Fantana</surname><given-names>A. L.</given-names></name><name><surname>Soucy</surname><given-names>E. R.</given-names></name><name><surname>Meister</surname><given-names>M.</given-names></name></person-group>(<year>2008</year>).<article-title>Rat olfactory bulb mitral cells receive sparse glomerular inputs</article-title>.<source>Neuron</source><volume>59</volume>,<fpage>802</fpage>–<lpage>814</lpage><pub-id pub-id-type=""doi"">10.1016/j.neuron.2008.07.039</pub-id><pub-id pub-id-type=""pmid"">18786363</pub-id></mixed-citation></ref><ref id=""B53""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Fazeli</surname><given-names>A.</given-names></name><name><surname>Dickinson</surname><given-names>S. L.</given-names></name><name><surname>Hermiston</surname><given-names>M. L.</given-names></name><name><surname>Tighe</surname><given-names>R. V.</given-names></name><name><surname>Steen</surname><given-names>R. G.</given-names></name><name><surname>Small</surname><given-names>C. G.</given-names></name><name><surname>Stoeckli</surname><given-names>E. T.</given-names></name><name><surname>Keino-Masu</surname><given-names>K.</given-names></name><name><surname>Masu</surname><given-names>M.</given-names></name><name><surname>Rayburn</surname><given-names>H.</given-names></name><name><surname>Simons</surname><given-names>J.</given-names></name><name><surname>Bronson</surname><given-names>R. T.</given-names></name><name><surname>Gordon</surname><given-names>J. I.</given-names></name><name><surname>Tessier-Lavigne</surname><given-names>M.</given-names></name><name><surname>Weinberg</surname><given-names>R. A.</given-names></name></person-group>(<year>1997</year>).<article-title>Phenotype of mice lacking functional deleted in colorectal cancer (Dcc) gene</article-title>.<source>Nature</source><volume>386</volume>,<fpage>796</fpage>–<lpage>804</lpage><pub-id pub-id-type=""doi"">10.1038/386796a0</pub-id><pub-id pub-id-type=""pmid"">9126737</pub-id></mixed-citation></ref><ref id=""B54""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Feinstein</surname><given-names>P.</given-names></name><name><surname>Bozza</surname><given-names>T.</given-names></name><name><surname>Rodriguez</surname><given-names>I.</given-names></name><name><surname>Vassalli</surname><given-names>A.</given-names></name><name><surname>Mombaerts</surname><given-names>P.</given-names></name></person-group>(<year>2004</year>).<article-title>Axon guidance of mouse olfactory sensory neurons by odorant receptors and the beta2 adrenergic receptor</article-title>.<source>Cell</source><volume>117</volume>,<fpage>833</fpage>–<lpage>846</lpage><pub-id pub-id-type=""doi"">10.1016/j.cell.2004.05.013</pub-id><pub-id pub-id-type=""pmid"">15186782</pub-id></mixed-citation></ref><ref id=""B55""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Feinstein</surname><given-names>P.</given-names></name><name><surname>Mombaerts</surname><given-names>P.</given-names></name></person-group>(<year>2004</year>).<article-title>A contextual model for axonal sorting into glomeruli in the mouse olfactory system</article-title>.<source>Cell</source><volume>117</volume>,<fpage>817</fpage>–<lpage>831</lpage><pub-id pub-id-type=""doi"">10.1016/j.cell.2004.05.011</pub-id><pub-id pub-id-type=""pmid"">15186781</pub-id></mixed-citation></ref><ref id=""B56""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Feldheim</surname><given-names>D. A.</given-names></name><name><surname>Kim</surname><given-names>Y. I.</given-names></name><name><surname>Bergemann</surname><given-names>A. D.</given-names></name><name><surname>Frisén</surname><given-names>J.</given-names></name><name><surname>Barbacid</surname><given-names>M.</given-names></name><name><surname>Flanagan</surname><given-names>J. G.</given-names></name></person-group>(<year>2000</year>).<article-title>Genetic analysis of ephrin-A2 and ephrin-A5 shows their requirement in multiple aspects of retinocollicular mapping</article-title>.<source>Neuron</source><volume>25</volume>,<fpage>563</fpage>–<lpage>574</lpage><pub-id pub-id-type=""doi"">10.1016/S0896-6273(00)81060-0</pub-id><pub-id pub-id-type=""pmid"">10774725</pub-id></mixed-citation></ref><ref id=""B57""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Firestein</surname><given-names>S.</given-names></name></person-group>(<year>2001</year>).<article-title>How the olfactory system makes sense of scents</article-title>.<source>Nature</source><volume>413</volume>,<fpage>211</fpage>–<lpage>218</lpage><pub-id pub-id-type=""doi"">10.1038/35093026</pub-id><pub-id pub-id-type=""pmid"">11557990</pub-id></mixed-citation></ref><ref id=""B58""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Fleischmann</surname><given-names>A.</given-names></name><name><surname>Shykind</surname><given-names>B. M.</given-names></name><name><surname>Sosulski</surname><given-names>D. L.</given-names></name><name><surname>Franks</surname><given-names>K. M.</given-names></name><name><surname>Glinka</surname><given-names>M. E.</given-names></name><name><surname>Mei</surname><given-names>D. F.</given-names></name><name><surname>Sun</surname><given-names>Y.</given-names></name><name><surname>Kirkland</surname><given-names>J.</given-names></name><name><surname>Mendelsohn</surname><given-names>M.</given-names></name><name><surname>Albers</surname><given-names>M. W.</given-names></name><name><surname>Axel</surname><given-names>R.</given-names></name></person-group>(<year>2008</year>).<article-title>Mice with a “monoclonal nose”: perturbations in an olfactory map impair odor discrimination</article-title>.<source>Neuron</source><volume>60</volume>,<fpage>1068</fpage>–<lpage>1681</lpage><pub-id pub-id-type=""doi"">10.1016/j.neuron.2008.10.046</pub-id><pub-id pub-id-type=""pmid"">19109912</pub-id></mixed-citation></ref><ref id=""B59""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Fouquet</surname><given-names>C.</given-names></name><name><surname>Di Meglio</surname><given-names>T.</given-names></name><name><surname>Ma</surname><given-names>L.</given-names></name><name><surname>Kawasaki</surname><given-names>T.</given-names></name><name><surname>Long</surname><given-names>H.</given-names></name><name><surname>Hirata</surname><given-names>T.</given-names></name><name><surname>Tessier-Lavigne</surname><given-names>M.</given-names></name><name><surname>Chédotal</surname><given-names>A.</given-names></name><name><surname>N'Guyen-Ba-Charvet</surname><given-names>K. T.</given-names></name></person-group>(<year>2007</year>).<article-title>Robo1 and robo2 control the development of the lateral olfactory tract</article-title>.<source>J. Neurosci.</source><volume>27</volume>,<fpage>3037</fpage>–<lpage>3045</lpage><pub-id pub-id-type=""doi"">10.1523/JNEUROSCI.0172-07.2007</pub-id><pub-id pub-id-type=""pmid"">17360927</pub-id></mixed-citation></ref><ref id=""B60""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Fukuchi-Shimogori</surname><given-names>T.</given-names></name><name><surname>Grove</surname><given-names>E. A.</given-names></name></person-group>(<year>2001</year>).<article-title>Neocortex patterning by the secreted signaling molecule FGF8</article-title>.<source>Science</source><volume>294</volume>,<fpage>1071</fpage>–<lpage>1074</lpage><pub-id pub-id-type=""doi"">10.1126/science.1064252</pub-id><pub-id pub-id-type=""pmid"">11567107</pub-id></mixed-citation></ref><ref id=""B61""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Geffen</surname><given-names>M. N.</given-names></name><name><surname>Broome</surname><given-names>B. M.</given-names></name><name><surname>Laurent</surname><given-names>G.</given-names></name><name><surname>Meister</surname><given-names>M.</given-names></name></person-group>(<year>2009</year>).<article-title>Neural encoding of rapidly fluctuating odors</article-title>.<source>Neuron</source><volume>61</volume>,<fpage>570</fpage>–<lpage>586</lpage><pub-id pub-id-type=""doi"">10.1016/j.neuron.2009.01.021</pub-id><pub-id pub-id-type=""pmid"">19249277</pub-id></mixed-citation></ref><ref id=""B62""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Giacobini</surname><given-names>P.</given-names></name><name><surname>Messina</surname><given-names>A.</given-names></name><name><surname>Wray</surname><given-names>S.</given-names></name><name><surname>Giampietro</surname><given-names>C.</given-names></name><name><surname>Crepaldi</surname><given-names>T.</given-names></name><name><surname>Carmeliet</surname><given-names>P.</given-names></name><name><surname>Fasolo</surname><given-names>A.</given-names></name></person-group>(<year>2007</year>).<article-title>Hepatocyte growth factor acts as a motogen and guidance signal for gonadotropin hormone-releasing hormone-1 neuronal migration</article-title>.<source>J. Neurosci.</source><volume>27</volume>,<fpage>431</fpage>–<lpage>445</lpage><pub-id pub-id-type=""doi"">10.1523/JNEUROSCI.4979-06.2007</pub-id><pub-id pub-id-type=""pmid"">17215404</pub-id></mixed-citation></ref><ref id=""B63""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Gianola</surname><given-names>S.</given-names></name><name><surname>de Castro</surname><given-names>F.</given-names></name><name><surname>Rossi</surname><given-names>F.</given-names></name></person-group>(<year>2009</year>).<article-title>Anosmin-1 stimulates outgrowth and branching of developing Purkinje axons</article-title>.<source>Neuroscience</source><volume>158</volume>,<fpage>570</fpage>–<lpage>584</lpage><pub-id pub-id-type=""doi"">10.1016/j.neuroscience.2008.10.022</pub-id><pub-id pub-id-type=""pmid"">19013504</pub-id></mixed-citation></ref><ref id=""B64""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Giger</surname><given-names>R. J.</given-names></name><name><surname>Cloutier</surname><given-names>J. F.</given-names></name><name><surname>Sahay</surname><given-names>A.</given-names></name><name><surname>Prinjha</surname><given-names>R. K.</given-names></name><name><surname>Levengood</surname><given-names>D. V.</given-names></name><name><surname>Moore</surname><given-names>S. E.</given-names></name><name><surname>Pickering</surname><given-names>S.</given-names></name><name><surname>Simmons</surname><given-names>D.</given-names></name><name><surname>Rastan</surname><given-names>S.</given-names></name><name><surname>Walsh</surname><given-names>F. S.</given-names></name><name><surname>Kolodkin</surname><given-names>A. L.</given-names></name><name><surname>Ginty</surname><given-names>D. D.</given-names></name><name><surname>Geppert</surname><given-names>M.</given-names></name></person-group>(<year>2000</year>).<article-title>Neuropilin-2 is required in vivo for selective axon guidance responses to secreted semaphorins</article-title>.<source>Neuron</source><volume>25</volume>,<fpage>29</fpage>–<lpage>41</lpage><pub-id pub-id-type=""doi"">10.1016/S0896-6273(00)80869-7</pub-id><pub-id pub-id-type=""pmid"">10707970</pub-id></mixed-citation></ref><ref id=""B65""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Gogos</surname><given-names>J. A.</given-names></name><name><surname>Osborne</surname><given-names>J.</given-names></name><name><surname>Nemes</surname><given-names>A.</given-names></name><name><surname>Mendelsohn</surname><given-names>M.</given-names></name><name><surname>Axel</surname><given-names>R.</given-names></name></person-group>(<year>2000</year>).<article-title>Genetic ablation and restoration of the olfactory topographic map</article-title>.<source>Cell</source><volume>103</volume>,<fpage>609</fpage>–<lpage>620</lpage><pub-id pub-id-type=""doi"">10.1016/S0092-8674(00)00164-1</pub-id><pub-id pub-id-type=""pmid"">11106731</pub-id></mixed-citation></ref><ref id=""B66""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Goldman</surname><given-names>S. A.</given-names></name><name><surname>Luskin</surname><given-names>M. B.</given-names></name></person-group>(<year>1998</year>).<article-title>Strategies utilized by migrating neurons of the postnatal vertebrate forebrain</article-title>.<source>Trends Neurosci.</source><volume>21</volume>,<fpage>107</fpage>–<lpage>114</lpage><pub-id pub-id-type=""doi"">10.1016/S0166-2236(97)01191-0</pub-id><pub-id pub-id-type=""pmid"">9530917</pub-id></mixed-citation></ref><ref id=""B67""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Gong</surname><given-names>Q.</given-names></name><name><surname>Shipley</surname><given-names>M. T.</given-names></name></person-group>(<year>1996</year>).<article-title>Expression of extracellular matrix molecules and cell surface molecules in the olfactory nerve pathway during early development</article-title>.<source>J. Comp. Neurol.</source><volume>366</volume>,<fpage>1</fpage>–<lpage>14</lpage><pub-id pub-id-type=""doi"">10.1002/(SICI)1096-9861(19960226)366:1&lt;1::AID-CNE1&gt;3.0.CO;2-7</pub-id><pub-id pub-id-type=""pmid"">8866842</pub-id></mixed-citation></ref><ref id=""B68""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Graziadei</surname><given-names>P. P.</given-names></name><name><surname>Monti-Graziadei</surname><given-names>G. A.</given-names></name></person-group>(<year>1980</year>).<article-title>Neurogenesis and neuron regeneration in the olfactory system of mammals. III. Deafferentation and reinnervation of the olfactory bulb following section of the fila olfactoria in rat</article-title>.<source>J. Neurocytol.</source><volume>9</volume>,<fpage>145</fpage>–<lpage>162</lpage><pub-id pub-id-type=""doi"">10.1007/BF01205155</pub-id><pub-id pub-id-type=""pmid"">7441292</pub-id></mixed-citation></ref><ref id=""B69""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Graziadei</surname><given-names>P. P.</given-names></name><name><surname>Monti Graziadei</surname><given-names>G. A.</given-names></name></person-group>(<year>1986</year>).<article-title>Neuronal changes in the forebrain of mice following penetration by regenerating olfactory axons</article-title>.<source>J. Comp. Neurol.</source><volume>247</volume>,<fpage>344</fpage>–<lpage>356</lpage><pub-id pub-id-type=""doi"">10.1002/cne.902470305</pub-id><pub-id pub-id-type=""pmid"">3722442</pub-id></mixed-citation></ref><ref id=""B70""><mixed-citation publication-type=""book""><person-group person-group-type=""author""><name><surname>Greer</surname><given-names>C. A.</given-names></name></person-group>(<year>1991</year>).<article-title>Structural organization of the olfactory system</article-title>. In<source>Smell and Taste in Health and Disease</source>,<person-group person-group-type=""editor""><name><surname>Getchell</surname><given-names>T.V.</given-names></name><name><surname>Doty</surname><given-names>R.L.</given-names></name><name><surname>Bartoshuk</surname><given-names>L.M.</given-names></name><name><surname>Snow</surname><given-names>J.B.</given-names><suffix>Jr.</suffix></name></person-group>, eds (<publisher-loc>New York</publisher-loc>,<publisher-name>Raven</publisher-name>), pp.<fpage>65</fpage>–<lpage>81</lpage></mixed-citation></ref><ref id=""B71""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Greferath</surname><given-names>U.</given-names></name><name><surname>Canty</surname><given-names>A. J.</given-names></name><name><surname>Messenger</surname><given-names>J.</given-names></name><name><surname>Murphy</surname><given-names>M.</given-names></name></person-group>(<year>2002</year>).<article-title>Developmental expression of EphA4-tyrosine kinase receptor in the mouse brain and spinal cord</article-title>.<source>Mech. Dev.</source><volume>119</volume>,<fpage>S231</fpage>–<lpage>S238</lpage><pub-id pub-id-type=""doi"">10.1016/S0925-4773(03)00122-9</pub-id><pub-id pub-id-type=""pmid"">14516691</pub-id></mixed-citation></ref><ref id=""B72""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Grubb</surname><given-names>M. S.</given-names></name><name><surname>Nissant</surname><given-names>A.</given-names></name><name><surname>Murray</surname><given-names>K.</given-names></name><name><surname>Lledó</surname><given-names>P. M.</given-names></name></person-group>(<year>2008</year>).<article-title>Functional maturation of the first synapse in olfaction: development and adult neurogenesis</article-title>.<source>J. Neurosci.</source><volume>28</volume>,<fpage>2919</fpage>–<lpage>2932</lpage><pub-id pub-id-type=""doi"">10.1523/JNEUROSCI.5550-07.2008</pub-id><pub-id pub-id-type=""pmid"">18337423</pub-id></mixed-citation></ref><ref id=""B73""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Ha</surname><given-names>H. Y.</given-names></name><name><surname>Cho</surname><given-names>I. H.</given-names></name><name><surname>Lee</surname><given-names>K. W.</given-names></name><name><surname>Lee</surname><given-names>K. W.</given-names></name><name><surname>Song</surname><given-names>J. Y.</given-names></name><name><surname>Kim</surname><given-names>K. S.</given-names></name><name><surname>Yu</surname><given-names>Y. M.</given-names></name><name><surname>Lee</surname><given-names>J. K.</given-names></name><name><surname>Song</surname><given-names>J. S.</given-names></name><name><surname>Yang</surname><given-names>S. D.</given-names></name><name><surname>Shin</surname><given-names>H. S.</given-names></name><name><surname>Han</surname><given-names>P. L.</given-names></name></person-group>(<year>2005</year>).<article-title>The axon guidance defect of the telencephalic commissures of the JSAP1-deficient brain was partially rescued by the transgenic expression of JIP1</article-title>.<source>Dev. Biol.</source><volume>277</volume>,<fpage>184</fpage>–<lpage>199</lpage><pub-id pub-id-type=""doi"">10.1016/j.ydbio.2004.09.019</pub-id><pub-id pub-id-type=""pmid"">15572149</pub-id></mixed-citation></ref><ref id=""B74""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Halpern</surname><given-names>M.</given-names></name></person-group>(<year>1987</year>).<article-title>The organization and function of the vomeronasal system</article-title>.<source>Annu. Rev. Neurosci.</source><volume>10</volume>,<fpage>325</fpage>–<lpage>362</lpage><pub-id pub-id-type=""doi"">10.1146/annurev.ne.10.030187.001545</pub-id><pub-id pub-id-type=""pmid"">3032065</pub-id></mixed-citation></ref><ref id=""B75""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Henion</surname><given-names>T. R.</given-names></name><name><surname>Schwarting</surname><given-names>G. A.</given-names></name></person-group>(<year>2007</year>).<article-title>Patterning the developing and regenerating olfactory system</article-title>.<source>J. Cell. Physiol.</source><volume>210</volume>,<fpage>290</fpage>–<lpage>297</lpage><pub-id pub-id-type=""doi"">10.1002/jcp.20888</pub-id><pub-id pub-id-type=""pmid"">17111357</pub-id></mixed-citation></ref><ref id=""B76""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Henion</surname><given-names>T. R.</given-names></name><name><surname>Raitcheva</surname><given-names>D.</given-names></name><name><surname>Grosholz</surname><given-names>R.</given-names></name><name><surname>Biellmann</surname><given-names>F.</given-names></name><name><surname>Skarnes</surname><given-names>W. C.</given-names></name><name><surname>Hennet</surname><given-names>T.</given-names></name><name><surname>Schwarting</surname><given-names>G. A.</given-names></name></person-group>(<year>2005</year>).<article-title>Beta1,3-<italic>N</italic>-acetylglucosaminyltransferase 1 glycosylation is required for axon pathfinding by olfactory sensory neurons</article-title>.<source>J. Neurosci.</source><volume>25</volume>,<fpage>1894</fpage>–<lpage>1903</lpage><pub-id pub-id-type=""doi"">10.1523/JNEUROSCI.4654-04.2005</pub-id><pub-id pub-id-type=""pmid"">15728829</pub-id></mixed-citation></ref><ref id=""B77""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Henkemeyer</surname><given-names>M.</given-names></name><name><surname>Orioli</surname><given-names>D.</given-names></name><name><surname>Henderson</surname><given-names>J. T.</given-names></name><name><surname>Saxton</surname><given-names>T. M.</given-names></name><name><surname>Roder</surname><given-names>J.</given-names></name><name><surname>Pawson</surname><given-names>T.</given-names></name><name><surname>Klein</surname><given-names>R.</given-names></name></person-group>(<year>1996</year>).<article-title>Nuk controls pathfinding of commissural axons in the mammalian central nervous system</article-title>.<source>Cell</source><volume>86</volume>,<fpage>35</fpage>–<lpage>46</lpage><pub-id pub-id-type=""doi"">10.1016/S0092-8674(00)80075-6</pub-id><pub-id pub-id-type=""pmid"">8689685</pub-id></mixed-citation></ref><ref id=""B78""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Heyden</surname><given-names>A.</given-names></name><name><surname>Angenstein</surname><given-names>F.</given-names></name><name><surname>Sallaz</surname><given-names>M.</given-names></name><name><surname>Seidenbecher</surname><given-names>C.</given-names></name><name><surname>Montag</surname><given-names>D.</given-names></name></person-group>(<year>2008</year>).<article-title>Abnormal axonal guidance and brain anatomy in mouse mutants for the cell recognition molecules close homolog of L1 and NgCAM-related cell adhesion molecule</article-title>.<source>Neuroscience</source><volume>155</volume>,<fpage>221</fpage>–<lpage>233</lpage><pub-id pub-id-type=""doi"">10.1016/j.neuroscience.2008.04.080</pub-id><pub-id pub-id-type=""pmid"">18588951</pub-id></mixed-citation></ref><ref id=""B79""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Hinds</surname><given-names>J. W.</given-names></name></person-group>(<year>1968</year>).<article-title>Autoradiographic study of histogenesis in the mouse olfactory bulb. II. Cell proliferation and migration</article-title>.<source>J. Comp. Neurol.</source><volume>134</volume>,<fpage>305</fpage>–<lpage>322</lpage><pub-id pub-id-type=""doi"">10.1002/cne.901340305</pub-id><pub-id pub-id-type=""pmid"">5721257</pub-id></mixed-citation></ref><ref id=""B80""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Hirata</surname><given-names>T.</given-names></name><name><surname>Fujisawa</surname><given-names>H.</given-names></name></person-group>(<year>1997</year>).<article-title>Cortex-specific distribution of membrane-bound factors that promote neurite outgrowth of mitral cells in culture</article-title>.<source>J. Neurobiol.</source><volume>32</volume>,<fpage>415</fpage>–<lpage>425</lpage><pub-id pub-id-type=""doi"">10.1002/(SICI)1097-4695(199704)32:4&lt;415::AID-NEU5&gt;3.0.CO;2-9</pub-id><pub-id pub-id-type=""pmid"">9087893</pub-id></mixed-citation></ref><ref id=""B81""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Hirata</surname><given-names>T.</given-names></name><name><surname>Fujisawa</surname><given-names>H.</given-names></name></person-group>(<year>1999</year>).<article-title>Environmental control of collateral branching and target invasion of mitral cell axons during development</article-title>.<source>J. Neurobiol.</source><volume>38</volume>,<fpage>93</fpage>–<lpage>104</lpage><pub-id pub-id-type=""doi"">10.1002/(SICI)1097-4695(199901)38:1&lt;93::AID-NEU7&gt;3.0.CO;2-N</pub-id><pub-id pub-id-type=""pmid"">10027565</pub-id></mixed-citation></ref><ref id=""B82""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Hirata</surname><given-names>T.</given-names></name><name><surname>Fujisawa</surname><given-names>H.</given-names></name><name><surname>Wu</surname><given-names>J. Y.</given-names></name><name><surname>Rao</surname><given-names>Y.</given-names></name></person-group>(<year>2001</year>).<article-title>Short-range guidance of olfactory bulb axons is independent of repulsive factor slit</article-title>.<source>J. Neurosci.</source><volume>21</volume>,<fpage>2373</fpage>–<lpage>2379</lpage><pub-id pub-id-type=""pmid"">11264311</pub-id></mixed-citation></ref><ref id=""B83""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Ho</surname><given-names>S. K.</given-names></name><name><surname>Kovacevic´</surname><given-names>N.</given-names></name><name><surname>Henkelman</surname><given-names>R. M.</given-names></name><name><surname>Boyd</surname><given-names>A.</given-names></name><name><surname>Pawson</surname><given-names>T.</given-names></name><name><surname>Henderson</surname><given-names>J. T.</given-names></name></person-group>(<year>2009</year>).<article-title>EphB2 and EphA4 receptors regulate formation of the principal inter-hemispheric tracts of the mammalian forebrain</article-title>.<source>Neuroscience</source><volume>160</volume>,<fpage>784</fpage>–<lpage>795</lpage><pub-id pub-id-type=""doi"">10.1016/j.neuroscience.2009.03.013</pub-id><pub-id pub-id-type=""pmid"">19289155</pub-id></mixed-citation></ref><ref id=""B84""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Holmberg</surname><given-names>J.</given-names></name><name><surname>Frisén</surname><given-names>J.</given-names></name></person-group>(<year>2002</year>).<article-title>Ephrins are not only unattractive</article-title>.<source>Trends Neurosci.</source><volume>25</volume>,<fpage>239</fpage>–<lpage>243</lpage><pub-id pub-id-type=""doi"">10.1016/S0166-2236(02)02149-5</pub-id><pub-id pub-id-type=""pmid"">11972959</pub-id></mixed-citation></ref><ref id=""B85""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Imai</surname><given-names>T.</given-names></name><name><surname>Sakano</surname><given-names>H.</given-names></name></person-group>(<year>2008</year>).<article-title>Interhemispheric olfactory circuit and the memory beyond</article-title>.<source>Neuron</source><volume>58</volume>,<fpage>465</fpage>–<lpage>467</lpage><pub-id pub-id-type=""doi"">10.1016/j.neuron.2008.05.004</pub-id><pub-id pub-id-type=""pmid"">18498728</pub-id></mixed-citation></ref><ref id=""B86""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Imai</surname><given-names>T.</given-names></name><name><surname>Suzuki</surname><given-names>M.</given-names></name><name><surname>Sakano</surname><given-names>H.</given-names></name></person-group>(<year>2006</year>).<article-title>Odorant receptor-derived cAMP signals direct axonal targeting</article-title>.<source>Science</source><volume>314</volume>,<fpage>657</fpage>–<lpage>661</lpage><pub-id pub-id-type=""doi"">10.1126/science.1131794</pub-id><pub-id pub-id-type=""pmid"">16990513</pub-id></mixed-citation></ref><ref id=""B87""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Inaki</surname><given-names>K.</given-names></name><name><surname>Nishimura</surname><given-names>S.</given-names></name><name><surname>Nakashiba</surname><given-names>T.</given-names></name><name><surname>Itohara</surname><given-names>S.</given-names></name><name><surname>Yoshihara</surname><given-names>Y.</given-names></name></person-group>(<year>2004</year>).<article-title>Laminar organization of the developing lateral olfactory tract revealed by differential expression of cell recognition molecules</article-title>.<source>J. Comp. Neurol.</source><volume>479</volume>,<fpage>243</fpage>–<lpage>256</lpage><pub-id pub-id-type=""doi"">10.1002/cne.20270</pub-id><pub-id pub-id-type=""pmid"">15457507</pub-id></mixed-citation></ref><ref id=""B88""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Ito</surname><given-names>K.</given-names></name><name><surname>Kawasaki</surname><given-names>T.</given-names></name><name><surname>Takashima</surname><given-names>S.</given-names></name><name><surname>Matsuda</surname><given-names>I.</given-names></name><name><surname>Aiba</surname><given-names>A.</given-names></name><name><surname>Hirata</surname><given-names>T.</given-names></name></person-group>(<year>2008</year>).<article-title>Semaphorin 3F confines ventral tangential migration of lateral olfactory tract neurons onto the telencephalon surface</article-title>.<source>J. Neurosci.</source><volume>28</volume>,<fpage>4414</fpage>–<lpage>4422</lpage><pub-id pub-id-type=""doi"">10.1523/JNEUROSCI.0372-08.2008</pub-id><pub-id pub-id-type=""pmid"">18434520</pub-id></mixed-citation></ref><ref id=""B89""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Iwema</surname><given-names>C. L.</given-names></name><name><surname>Schwob</surname><given-names>J. E.</given-names></name></person-group>(<year>2003</year>).<article-title>Odorant receptor expression as a function of neuronal maturity in the adult rodent olfactory system</article-title>.<source>J. Comp. Neurol.</source><volume>459</volume>,<fpage>209</fpage>–<lpage>222</lpage><pub-id pub-id-type=""doi"">10.1002/cne.10583</pub-id><pub-id pub-id-type=""pmid"">12655505</pub-id></mixed-citation></ref><ref id=""B90""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Jhaveri</surname><given-names>D.</given-names></name><name><surname>Saharan</surname><given-names>S.</given-names></name><name><surname>Sen</surname><given-names>A.</given-names></name><name><surname>Rodrigues</surname><given-names>V.</given-names></name></person-group>(<year>2003</year>).<article-title>Positioning sensory terminals in the olfactory lobe of Drosophila by Robo signalling</article-title>.<source>Development</source><volume>131</volume>,<fpage>1903</fpage>–<lpage>1912</lpage><pub-id pub-id-type=""doi"">10.1242/dev.01083</pub-id><pub-id pub-id-type=""pmid"">15056612</pub-id></mixed-citation></ref><ref id=""B91""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Jiménez</surname><given-names>D.</given-names></name><name><surname>García</surname><given-names>C.</given-names></name><name><surname>de Castro</surname><given-names>F.</given-names></name><name><surname>Chédotal</surname><given-names>A.</given-names></name><name><surname>Sotelo</surname><given-names>C.</given-names></name><name><surname>De Carlos</surname><given-names>J. A.</given-names></name><name><surname>Valverde</surname><given-names>F.</given-names></name><name><surname>López-Mascaraque</surname><given-names>L.</given-names></name></person-group>(<year>2000</year>).<article-title>Evidence for intrinsic development of olfactory structures in Pax-6 mutant mice</article-title>.<source>J. Comp. Neurol.</source><volume>428</volume>,<fpage>511</fpage>–<lpage>526</lpage><pub-id pub-id-type=""doi"">10.1002/1096-9861(20001218)428:3&lt;511::AID-CNE8&gt;3.0.CO;2-I</pub-id><pub-id pub-id-type=""pmid"">11074448</pub-id></mixed-citation></ref><ref id=""B92""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Kalil</surname><given-names>K.</given-names></name><name><surname>Szebenyi</surname><given-names>G.</given-names></name><name><surname>Dent</surname><given-names>E. W.</given-names></name></person-group>(<year>2000</year>).<article-title>Common mechanisms underlying growth cone guidance and axon branching</article-title>.<source>J. Neurobiol.</source><volume>44</volume>,<fpage>145</fpage>–<lpage>158</lpage><pub-id pub-id-type=""doi"">10.1002/1097-4695(200008)44:2&lt;145::AID-NEU5&gt;3.0.CO;2-X</pub-id><pub-id pub-id-type=""pmid"">10934318</pub-id></mixed-citation></ref><ref id=""B93""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Kaneko-Goto</surname><given-names>T.</given-names></name><name><surname>Yoshihara</surname><given-names>S.</given-names></name><name><surname>Miyazaki</surname><given-names>H.</given-names></name><name><surname>Yoshihara</surname><given-names>Y.</given-names></name></person-group>(<year>2008</year>).<article-title>BIG-2 mediates olfactory axon convergence to target glomeruli</article-title>.<source>Neuron</source><volume>57</volume>,<fpage>834</fpage>–<lpage>846</lpage><pub-id pub-id-type=""doi"">10.1016/j.neuron.2008.01.023</pub-id><pub-id pub-id-type=""pmid"">18367085</pub-id></mixed-citation></ref><ref id=""B94""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Kassai</surname><given-names>H.</given-names></name><name><surname>Terashima</surname><given-names>T.</given-names></name><name><surname>Fukaya</surname><given-names>M.</given-names></name><name><surname>Nakao</surname><given-names>K.</given-names></name><name><surname>Sakahara</surname><given-names>M.</given-names></name><name><surname>Watanabe</surname><given-names>M.</given-names></name><name><surname>Aiba</surname><given-names>A.</given-names></name></person-group>(<year>2008</year>).<article-title>Rac1 in cortical projection neurons is selectively required for midline crossing of commissural axonal formation</article-title>.<source>Eur. J. Neurosci.</source><volume>28</volume>,<fpage>257</fpage>–<lpage>267</lpage><pub-id pub-id-type=""doi"">10.1111/j.1460-9568.2008.06343.x</pub-id><pub-id pub-id-type=""pmid"">18702697</pub-id></mixed-citation></ref><ref id=""B95""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Kawakami</surname><given-names>A.</given-names></name><name><surname>Kitsukawa</surname><given-names>T.</given-names></name><name><surname>Takagi</surname><given-names>S.</given-names></name><name><surname>Fujisawa</surname><given-names>H.</given-names></name></person-group>(<year>1996</year>).<article-title>Developmentally regulated expression of a cell surface protein neuropilin in the mouse nervous system</article-title>.<source>J. Neurobiol.</source><volume>29</volume>,<fpage>1</fpage>–<lpage>17</lpage><pub-id pub-id-type=""doi"">10.1002/(SICI)1097-4695(199601)29:1&lt;1::AID-NEU1&gt;3.0.CO;2-F</pub-id><pub-id pub-id-type=""pmid"">8748368</pub-id></mixed-citation></ref><ref id=""B96""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Kawasaki</surname><given-names>T.</given-names></name><name><surname>Ito</surname><given-names>K.</given-names></name><name><surname>Hirata</surname><given-names>T.</given-names></name></person-group>(<year>2006</year>).<article-title>Netrin 1 regulates ventral tangential migration of guidepost neurons in the lateral olfactory tract</article-title>.<source>Development</source><volume>133</volume>,<fpage>845</fpage>–<lpage>853</lpage><pub-id pub-id-type=""doi"">10.1242/dev.02257</pub-id><pub-id pub-id-type=""pmid"">16439477</pub-id></mixed-citation></ref><ref id=""B97""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Kitsukawa</surname><given-names>T.</given-names></name><name><surname>Shimizu</surname><given-names>M.</given-names></name><name><surname>Sanbo</surname><given-names>M.</given-names></name><name><surname>Hirata</surname><given-names>T.</given-names></name><name><surname>Taniguchi</surname><given-names>M.</given-names></name><name><surname>Bekku</surname><given-names>Y.</given-names></name><name><surname>Yagi</surname><given-names>T.</given-names></name><name><surname>Fujisawa</surname><given-names>H.</given-names></name></person-group>(<year>1997</year>).<article-title>Neuropilin-semaphorin III/D-mediated chemorepulsive signals play a crucial role in peripheral nerve projection in mice</article-title>.<source>Neuron</source><volume>19</volume>,<fpage>995</fpage>–<lpage>1005</lpage><pub-id pub-id-type=""doi"">10.1016/S0896-6273(00)80392-X</pub-id><pub-id pub-id-type=""pmid"">9390514</pub-id></mixed-citation></ref><ref id=""B98""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Knöll</surname><given-names>B.</given-names></name><name><surname>Schmidt</surname><given-names>H.</given-names></name><name><surname>Andrews</surname><given-names>W.</given-names></name><name><surname>Guthrie</surname><given-names>S.</given-names></name><name><surname>Pini</surname><given-names>A.</given-names></name><name><surname>Sundaresan</surname><given-names>V.</given-names></name><name><surname>Drescher</surname><given-names>U.</given-names></name></person-group>(<year>2003</year>).<article-title>On the topographic targeting of basal vomeronasal axons through Slit-mediated chemorepulsion</article-title>.<source>Development</source><volume>130</volume>,<fpage>5073</fpage>–<lpage>5082</lpage><pub-id pub-id-type=""doi"">10.1242/dev.00726</pub-id><pub-id pub-id-type=""pmid"">12954717</pub-id></mixed-citation></ref><ref id=""B99""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Kullander</surname><given-names>K.</given-names></name><name><surname>Mather</surname><given-names>N. K.</given-names></name><name><surname>Diella</surname><given-names>F.</given-names></name><name><surname>Dottori</surname><given-names>M.</given-names></name><name><surname>Boyd</surname><given-names>A. W.</given-names></name><name><surname>Klein</surname><given-names>R.</given-names></name></person-group>(<year>2001</year>).<article-title>Kinase-dependent and kinase-independent functions of EphA4 receptors in major axon tract formation in vivo</article-title>.<source>Neuron</source><volume>29</volume>,<fpage>73</fpage>–<lpage>84</lpage><pub-id pub-id-type=""doi"">10.1016/S0896-6273(01)00181-7</pub-id><pub-id pub-id-type=""pmid"">11182082</pub-id></mixed-citation></ref><ref id=""B100""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Lee</surname><given-names>W.</given-names></name><name><surname>Cheng</surname><given-names>T. W.</given-names></name><name><surname>Gong</surname><given-names>Q.</given-names></name></person-group>(<year>2008</year>).<article-title>Olfactory sensory neuron-specific and sexually dimorphic expression of protocadherin 20</article-title>.<source>J. Comp. Neurol.</source><volume>507</volume>,<fpage>1076</fpage>–<lpage>1086</lpage><pub-id pub-id-type=""doi"">10.1002/cne.21569</pub-id><pub-id pub-id-type=""pmid"">18095321</pub-id></mixed-citation></ref><ref id=""B101""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Lemasson</surname><given-names>M.</given-names></name><name><surname>Saghatelyan</surname><given-names>A.</given-names></name><name><surname>Olivo-Marín</surname><given-names>J. C.</given-names></name><name><surname>Lledó</surname><given-names>P. M.</given-names></name></person-group>(<year>2005</year>).<article-title>Neonatal and adult neurogenesis provide two distinct populations of newborn neurons to the mouse olfactory bulb</article-title>.<source>J. Neurosci.</source><volume>25</volume>,<fpage>6816</fpage>–<lpage>6825</lpage><pub-id pub-id-type=""doi"">10.1523/JNEUROSCI.1114-05.2005</pub-id><pub-id pub-id-type=""pmid"">16033891</pub-id></mixed-citation></ref><ref id=""B102""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Li</surname><given-names>H. S.</given-names></name><name><surname>Chen</surname><given-names>J. H.</given-names></name><name><surname>Wu</surname><given-names>W.</given-names></name><name><surname>Fagaly</surname><given-names>T.</given-names></name><name><surname>Zhou</surname><given-names>L.</given-names></name><name><surname>Yuan</surname><given-names>W.</given-names></name><name><surname>Dupuis</surname><given-names>S.</given-names></name><name><surname>Jiang</surname><given-names>Z. H.</given-names></name><name><surname>Nash</surname><given-names>W.</given-names></name><name><surname>Gick</surname><given-names>C.</given-names></name><name><surname>Ornitz</surname><given-names>D. M.</given-names></name><name><surname>Wu</surname><given-names>J. Y.</given-names></name><name><surname>Rao</surname><given-names>Y.</given-names></name></person-group>(<year>1999</year>).<article-title>Vertebrate slit, a secreted ligand for the transmembrane protein roundabout, is a repellent for olfactory bulb axons</article-title>.<source>Cell</source><volume>96</volume>,<fpage>807</fpage>–<lpage>818</lpage><pub-id pub-id-type=""doi"">10.1016/S0092-8674(00)80591-7</pub-id><pub-id pub-id-type=""pmid"">10102269</pub-id></mixed-citation></ref><ref id=""B103""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Ransohoff</surname><given-names>R. M.</given-names></name></person-group>(<year>2008</year>).<article-title>Multiple roles of chemokine CXCL12 in the central nervous system: a migration from immunology to neurobiology</article-title>.<source>Prog. Neurobiol.</source><volume>84</volume>,<fpage>116</fpage>–<lpage>131</lpage><pub-id pub-id-type=""doi"">10.1016/j.pneurobio.2007.11.003</pub-id><pub-id pub-id-type=""pmid"">18177992</pub-id></mixed-citation></ref><ref id=""B104""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Lin</surname><given-names>D. M.</given-names></name><name><surname>Wang</surname><given-names>F.</given-names></name><name><surname>Lowe</surname><given-names>G.</given-names></name><name><surname>Gold</surname><given-names>G. H.</given-names></name><name><surname>Axel</surname><given-names>R.</given-names></name><name><surname>Ngai</surname><given-names>J.</given-names></name><name><surname>Brunet</surname><given-names>L.</given-names></name></person-group>(<year>2000</year>).<article-title>Formation of precise connections in the olfactory bulb occurs in the absence of odorant-evoked neuronal activity</article-title>.<source>Neuron</source><volume>26</volume>,<fpage>69</fpage>–<lpage>80</lpage><pub-id pub-id-type=""doi"">10.1016/S0896-6273(00)81139-3</pub-id><pub-id pub-id-type=""pmid"">10798393</pub-id></mixed-citation></ref><ref id=""B105""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Lipscomb</surname><given-names>B. W.</given-names></name><name><surname>Treloar</surname><given-names>H. B.</given-names></name><name><surname>Klenoff</surname><given-names>J.</given-names></name><name><surname>Greer</surname><given-names>C. A.</given-names></name></person-group>(<year>2003</year>).<article-title>Cell surface carbohydrates and glomerular targeting of olfactory sensory neuron axons in the mouse</article-title>.<source>J. Comp. Neurol.</source><volume>467</volume>,<fpage>22</fpage>–<lpage>31</lpage><pub-id pub-id-type=""doi"">10.1002/cne.10910</pub-id><pub-id pub-id-type=""pmid"">14574677</pub-id></mixed-citation></ref><ref id=""B106""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Lledó</surname><given-names>P. M.</given-names></name><name><surname>Merkle</surname><given-names>F. T.</given-names></name><name><surname>Álvarez-Buylla</surname><given-names>A.</given-names></name></person-group>(<year>2008</year>).<article-title>Origin and function of olfactory bulb interneuron diversity</article-title>.<source>Trends Neurosci.</source><volume>31</volume>,<fpage>392</fpage>–<lpage>400</lpage><pub-id pub-id-type=""doi"">10.1016/j.tins.2008.05.006</pub-id><pub-id pub-id-type=""pmid"">18603310</pub-id></mixed-citation></ref><ref id=""B107""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Lois</surname><given-names>C.</given-names></name><name><surname>Álvarez-Buylla</surname><given-names>A.</given-names></name></person-group>(<year>1994</year>).<article-title>Long-distance neuronal migration in the adult mammalian brain</article-title>.<source>Science</source><volume>264</volume>,<fpage>1145</fpage>–<lpage>1148</lpage><pub-id pub-id-type=""doi"">10.1126/science.8178174</pub-id><pub-id pub-id-type=""pmid"">8178174</pub-id></mixed-citation></ref><ref id=""B108""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>López-Mascaraque</surname><given-names>L.</given-names></name><name><surname>de Castro</surname><given-names>F.</given-names></name></person-group>(<year>2002</year>).<article-title>The olfactory bulb as an independent developmental domain</article-title>.<source>Cell Death Differ.</source><volume>9</volume>,<fpage>1279</fpage>–<lpage>1286</lpage><pub-id pub-id-type=""doi"">10.1038/sj.cdd.4401076</pub-id><pub-id pub-id-type=""pmid"">12478464</pub-id></mixed-citation></ref><ref id=""B109""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>López-Mascaraque</surname><given-names>L.</given-names></name><name><surname>de Castro</surname><given-names>F.</given-names></name></person-group>(<year>2004</year>).<article-title>Protocortex versus protomap: a perspective from the olfactory bulb</article-title>.<source>Rev. Neurol.</source><volume>39</volume>,<fpage>146</fpage>–<lpage>155</lpage><pub-id pub-id-type=""pmid"">15264166</pub-id></mixed-citation></ref><ref id=""B110""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>López-Mascaraque</surname><given-names>L.</given-names></name><name><surname>De Carlos</surname><given-names>J. A.</given-names></name><name><surname>Valverde</surname><given-names>F.</given-names></name></person-group>(<year>1996</year>).<article-title>Early onset of the rat olfactory bulb projections</article-title>.<source>Neuroscience</source><volume>70</volume>,<fpage>255</fpage>–<lpage>266</lpage><pub-id pub-id-type=""doi"">10.1016/0306-4522(95)00360-U</pub-id><pub-id pub-id-type=""pmid"">8848129</pub-id></mixed-citation></ref><ref id=""B111""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Luskin</surname><given-names>M. B.</given-names></name></person-group>(<year>1993</year>).<article-title>Restricted proliferation and migration of postnatally generated neurons derived from the forebrain subventricular zone</article-title>.<source>Neuron</source><volume>11</volume>,<fpage>173</fpage>–<lpage>189</lpage><pub-id pub-id-type=""doi"">10.1016/0896-6273(93)90281-U</pub-id><pub-id pub-id-type=""pmid"">8338665</pub-id></mixed-citation></ref><ref id=""B112""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Luskin</surname><given-names>M. B.</given-names></name><name><surname>Price</surname><given-names>J. L.</given-names></name></person-group>(<year>1982</year>).<article-title>The distribution of axon collaterals from the olfactory bulb and the nucleus of the horizontal limb of the diagonal band to the olfactory cortex demonstrated by double retrograde labeling techniques</article-title>.<source>J. Comp. Neurol.</source><volume>209</volume>,<fpage>249</fpage>–<lpage>263</lpage><pub-id pub-id-type=""doi"">10.1002/cne.902090304</pub-id><pub-id pub-id-type=""pmid"">7130455</pub-id></mixed-citation></ref><ref id=""B113""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Luxenhofer</surname><given-names>G.</given-names></name><name><surname>Breer</surname><given-names>H.</given-names></name><name><surname>Strotmann</surname><given-names>J.</given-names></name></person-group>(<year>2008</year>).<article-title>Differential reaction of outgrowing olfactory neurites monitored in explant culture</article-title>.<source>J. Comp. Neurol.</source><volume>509</volume>,<fpage>580</fpage>–<lpage>593</lpage><pub-id pub-id-type=""doi"">10.1002/cne.21766</pub-id><pub-id pub-id-type=""pmid"">18546281</pub-id></mixed-citation></ref><ref id=""B114""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Ma</surname><given-names>L.</given-names></name><name><surname>Tessier-Lavigne</surname><given-names>M.</given-names></name></person-group>(<year>2007</year>).<article-title>Dual branch-promoting and branch-repelling actions of Slit/Robo signaling on peripheral and central branches of developing sensory axons</article-title>.<source>J. Neurosci.</source><volume>27</volume>,<fpage>6843</fpage>–<lpage>6851</lpage><pub-id pub-id-type=""doi"">10.1523/JNEUROSCI.1479-07.2007</pub-id><pub-id pub-id-type=""pmid"">17581972</pub-id></mixed-citation></ref><ref id=""B115""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Malnic</surname><given-names>B.</given-names></name><name><surname>Hirono</surname><given-names>J.</given-names></name><name><surname>Sato</surname><given-names>T.</given-names></name><name><surname>Buck</surname><given-names>L. B.</given-names></name></person-group>(<year>1999</year>).<article-title>Combinatorial receptor codes for odors</article-title>.<source>Cell</source><volume>96</volume>,<fpage>713</fpage>–<lpage>723</lpage><pub-id pub-id-type=""doi"">10.1016/S0092-8674(00)80581-4</pub-id><pub-id pub-id-type=""pmid"">10089886</pub-id></mixed-citation></ref><ref id=""B116""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Mandairon</surname><given-names>N.</given-names></name><name><surname>Sacquet</surname><given-names>J.</given-names></name><name><surname>Jourdan</surname><given-names>F.</given-names></name><name><surname>Didier</surname><given-names>A.</given-names></name></person-group>(<year>2006</year>).<article-title>Long-term fate and distribution of newborn cells in the adult mouse olfactory bulb: influences of olfactory deprivation</article-title>.<source>Neuroscience</source><volume>141</volume>,<fpage>443</fpage>–<lpage>451</lpage><pub-id pub-id-type=""doi"">10.1016/j.neuroscience.2006.03.066</pub-id><pub-id pub-id-type=""pmid"">16713121</pub-id></mixed-citation></ref><ref id=""B117""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Mann</surname><given-names>F.</given-names></name><name><surname>Ray</surname><given-names>S.</given-names></name><name><surname>Harris</surname><given-names>W.</given-names></name><name><surname>Holt</surname><given-names>C.</given-names></name></person-group>(<year>2002</year>).<article-title>Topographic mapping in dorsoventral axis of the Xenopus retinotectal system depends on signaling through ephrin-B ligands</article-title>.<source>Neuron</source><volume>35</volume>,<fpage>461</fpage>–<lpage>473</lpage><pub-id pub-id-type=""doi"">10.1016/S0896-6273(02)00786-9</pub-id><pub-id pub-id-type=""pmid"">12165469</pub-id></mixed-citation></ref><ref id=""B118""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Maresh</surname><given-names>A.</given-names></name><name><surname>Rodríguez Gil</surname><given-names>D.</given-names></name><name><surname>Whitman</surname><given-names>M. C.</given-names></name><name><surname>Greer</surname><given-names>C. A.</given-names></name></person-group>(<year>2008</year>).<article-title>Principles of glomerular organization in the human olfactory bulb-implications for odor processing</article-title>.<source>PLoS ONE</source><volume>3</volume>,<fpage>e2640</fpage><pub-id pub-id-type=""doi"">10.1371/journal.pone.0002640.</pub-id><pub-id pub-id-type=""pmid"">18612420</pub-id></mixed-citation></ref><ref id=""B119""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Marillat</surname><given-names>V.</given-names></name><name><surname>Cases</surname><given-names>O.</given-names></name><name><surname>N'Guyen-Ba-Charvet</surname><given-names>K. T.</given-names></name><name><surname>Tessier-Lavigne</surname><given-names>M.</given-names></name><name><surname>Sotelo</surname><given-names>C.</given-names></name><name><surname>Chedotal</surname><given-names>A.</given-names></name></person-group>(<year>2002</year>).<article-title>Spatiotemporal expression patterns of slit and robo genes in the rat brain</article-title>.<source>J. Comp. Neurol.</source><volume>442</volume>,<fpage>130</fpage>–<lpage>155</lpage><pub-id pub-id-type=""doi"">10.1002/cne.10068</pub-id><pub-id pub-id-type=""pmid"">11754167</pub-id></mixed-citation></ref><ref id=""B120""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Marín</surname><given-names>O.</given-names></name><name><surname>Rubenstein</surname><given-names>J. L.</given-names></name></person-group>(<year>2003</year>).<article-title>Cell migration in the forebrain</article-title>.<source>Annu. Rev. Neurosci.</source><volume>26</volume>,<fpage>441</fpage>–<lpage>483</lpage><pub-id pub-id-type=""doi"">10.1146/annurev.neuro.26.041002.131058</pub-id><pub-id pub-id-type=""pmid"">12626695</pub-id></mixed-citation></ref><ref id=""B121""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Martínez-Marcos</surname><given-names>A.</given-names></name></person-group>(<year>2009</year>).<article-title>On the organization of olfactory and vomeronasal cortices</article-title>.<source>Prog. Neurobiol.</source><volume>87</volume>,<fpage>21</fpage>–<lpage>30</lpage><pub-id pub-id-type=""doi"">10.1016/j.pneurobio.2008.09.010</pub-id><pub-id pub-id-type=""pmid"">18929620</pub-id></mixed-citation></ref><ref id=""B122""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Mombaerts</surname><given-names>P.</given-names></name></person-group>(<year>1996</year>).<article-title>Targeting olfaction</article-title>.<source>Curr. Opin. Neurobiol.</source><volume>6</volume>,<fpage>481</fpage>–<lpage>486</lpage><pub-id pub-id-type=""doi"">10.1016/S0959-4388(96)80053-5</pub-id><pub-id pub-id-type=""pmid"">8794106</pub-id></mixed-citation></ref><ref id=""B123""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Mombaerts</surname><given-names>P.</given-names></name></person-group>(<year>2001</year>).<article-title>How smell develops</article-title>.<source>Nat. Neurosci.</source><volume>4</volume>(<issue>Suppl.</issue>),<fpage>1192</fpage>–<lpage>1198</lpage><pub-id pub-id-type=""doi"">10.1038/nn751</pub-id><pub-id pub-id-type=""pmid"">11687829</pub-id></mixed-citation></ref><ref id=""B124""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Mombaerts</surname><given-names>P.</given-names></name></person-group>(<year>2006</year>).<article-title>Axonal wiring in the mouse olfactory system</article-title>.<source>Annu. Rev. Cell Dev. Biol.</source><volume>22</volume>,<fpage>713</fpage>–<lpage>737</lpage><pub-id pub-id-type=""doi"">10.1146/annurev.cellbio.21.012804.093915</pub-id><pub-id pub-id-type=""pmid"">17029582</pub-id></mixed-citation></ref><ref id=""B125""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Mouret</surname><given-names>A.</given-names></name><name><surname>Gheusi</surname><given-names>G.</given-names></name><name><surname>Gabellec</surname><given-names>M. M.</given-names></name><name><surname>de Chaumont</surname><given-names>F.</given-names></name><name><surname>Olivo-Marin</surname><given-names>J. C.</given-names></name><name><surname>Lledó</surname><given-names>P. M.</given-names></name></person-group>(<year>2008</year>).<article-title>Learning and survival of newly generated neurons: when time matters</article-title>.<source>J. Neurosci.</source><volume>28</volume>,<fpage>11511</fpage>–<lpage>11516</lpage><pub-id pub-id-type=""doi"">10.1523/JNEUROSCI.2954-08.2008</pub-id><pub-id pub-id-type=""pmid"">18987187</pub-id></mixed-citation></ref><ref id=""B126""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Mouret</surname><given-names>A.</given-names></name><name><surname>Lepousez</surname><given-names>G.</given-names></name><name><surname>Gras</surname><given-names>J.</given-names></name><name><surname>Gabellec</surname><given-names>M. M.</given-names></name><name><surname>Lledó</surname><given-names>P. M.</given-names></name></person-group>(<year>2009</year>).<article-title>Turnover of newborn olfactory bulb neurons optimizes olfaction</article-title>.<source>J. Neurosci.</source><volume>29</volume>,<fpage>12302</fpage>–<lpage>12314</lpage><pub-id pub-id-type=""doi"">10.1523/JNEUROSCI.3383-09.2009</pub-id><pub-id pub-id-type=""pmid"">19793989</pub-id></mixed-citation></ref><ref id=""B127""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Nacher</surname><given-names>J.</given-names></name><name><surname>Alonso-Llosa</surname><given-names>G.</given-names></name><name><surname>Rosell</surname><given-names>D.</given-names></name><name><surname>McEwen</surname><given-names>B.</given-names></name></person-group>(<year>2002a</year>).<article-title>PSA-NCAM expression in the piriform cortex of the adult rat. Modulation by NMDA receptor antagonist administration</article-title>.<source>Brain Res.</source><volume>927</volume>,<fpage>111</fpage>–<lpage>121</lpage><pub-id pub-id-type=""doi"">10.1016/S0006-8993(01)03241-3</pub-id><pub-id pub-id-type=""pmid"">11821005</pub-id></mixed-citation></ref><ref id=""B128""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Nacher</surname><given-names>J.</given-names></name><name><surname>Lanuza</surname><given-names>E.</given-names></name><name><surname>McEwen</surname><given-names>B. S.</given-names></name></person-group>(<year>2002b</year>).<article-title>Distribution of PSA-NCAM expression in the amygdale of the adult rat</article-title>.<source>Neuroscience</source><volume>113</volume>,<fpage>479</fpage>–<lpage>484</lpage><pub-id pub-id-type=""doi"">10.1016/S0306-4522(02)00219-1</pub-id><pub-id pub-id-type=""pmid"">12150768</pub-id></mixed-citation></ref><ref id=""B129""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Nakashiba</surname><given-names>T.</given-names></name><name><surname>Ikeda</surname><given-names>T.</given-names></name><name><surname>Nishimura</surname><given-names>S.</given-names></name><name><surname>Tashiro</surname><given-names>K.</given-names></name><name><surname>Honjo</surname><given-names>T.</given-names></name><name><surname>Culotti</surname><given-names>J. G.</given-names></name><name><surname>Itohara</surname><given-names>S.</given-names></name></person-group>(<year>2000</year>).<article-title>Netrin-G1:anovel glycosyl phosphatidylinositol-linkedmammalian netrin that is functionally divergent from classical netrins</article-title>.<source>J. Neurosci.</source><volume>20</volume>,<fpage>6540</fpage>–<lpage>6550</lpage><pub-id pub-id-type=""pmid"">10964959</pub-id></mixed-citation></ref><ref id=""B130""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>N'Guyen-Ba-Charvet</surname><given-names>K. T.</given-names></name><name><surname>Brose</surname><given-names>K.</given-names></name><name><surname>Ma</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>K. H.</given-names></name><name><surname>Marillat</surname><given-names>V.</given-names></name><name><surname>Sotelo</surname><given-names>C.</given-names></name><name><surname>Tessier-Lavigne</surname><given-names>M.</given-names></name><name><surname>Chédotal</surname><given-names>A.</given-names></name></person-group>(<year>2001</year>).<article-title>Diversity and specificity of actions of Slit2 proteolytic fragments in axon guidance</article-title>.<source>J. Neurosci.</source><volume>21</volume>,<fpage>4281</fpage>–<lpage>4289</lpage><pub-id pub-id-type=""pmid"">11404413</pub-id></mixed-citation></ref><ref id=""B131""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>N'Guyen-Ba-Charvet</surname><given-names>K. T.</given-names></name><name><surname>Brose</surname><given-names>K.</given-names></name><name><surname>Marillat</surname><given-names>V.</given-names></name><name><surname>Kidd</surname><given-names>T.</given-names></name><name><surname>Goodman</surname><given-names>C. S.</given-names></name><name><surname>Tessier-Lavigne</surname><given-names>M.</given-names></name><name><surname>Sotelo</surname><given-names>C.</given-names></name><name><surname>Chédotal</surname><given-names>A.</given-names></name></person-group>(<year>1999</year>).<article-title>Slit2-mediated chemorepulsion and collapse of developing forebrain axons</article-title>.<source>Neuron</source><volume>22</volume>,<fpage>463</fpage>–<lpage>473</lpage><pub-id pub-id-type=""doi"">10.1016/S0896-6273(00)80702-3</pub-id><pub-id pub-id-type=""pmid"">10197527</pub-id></mixed-citation></ref><ref id=""B132""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>N'Guyen-Ba-Charvet</surname><given-names>K. T.</given-names></name><name><surname>Di Meglio</surname><given-names>T.</given-names></name><name><surname>Fouquet</surname><given-names>C.</given-names></name><name><surname>Chédotal</surname><given-names>A.</given-names></name></person-group>(<year>2008</year>).<article-title>Robos and slits control the pathfinding and targeting of mouse olfactory sensory axons</article-title>.<source>J. Neurosci.</source><volume>28</volume>,<fpage>4244</fpage>–<lpage>4249</lpage><pub-id pub-id-type=""doi"">10.1523/JNEUROSCI.5671-07.2008</pub-id><pub-id pub-id-type=""pmid"">18417704</pub-id></mixed-citation></ref><ref id=""B133""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>N'Guyen-Ba-Charvet</surname><given-names>K. T.</given-names></name><name><surname>Plump</surname><given-names>A. S.</given-names></name><name><surname>Tessier-Lavigne</surname><given-names>M.</given-names></name><name><surname>Chedotal</surname><given-names>A.</given-names></name></person-group>(<year>2002</year>).<article-title>Slit1 and slit2 proteins control the development of the lateral olfactory tract</article-title>.<source>J. Neurosci.</source><volume>22</volume>,<fpage>5473</fpage>–<lpage>5480</lpage><pub-id pub-id-type=""pmid"">12097499</pub-id></mixed-citation></ref><ref id=""B134""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Nomura</surname><given-names>T.</given-names></name><name><surname>Osumi</surname><given-names>N.</given-names></name></person-group>(<year>2004</year>).<article-title>Misrouting of mitral cell progenitors in the Pax6/small eye rat telencephalon</article-title>.<source>Development</source><volume>131</volume>,<fpage>787</fpage>–<lpage>796</lpage><pub-id pub-id-type=""doi"">10.1242/dev.00984</pub-id><pub-id pub-id-type=""pmid"">14736749</pub-id></mixed-citation></ref><ref id=""B135""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>O'Leary</surname><given-names>D. D.</given-names></name></person-group>(<year>1989</year>).<article-title>Do cortical areas emerge from a protocortex?</article-title><source>Trends Neurosci.</source><volume>12</volume>,<fpage>400</fpage>–<lpage>406</lpage><pub-id pub-id-type=""doi"">10.1016/0166-2236(89)90080-5</pub-id><pub-id pub-id-type=""pmid"">2479138</pub-id></mixed-citation></ref><ref id=""B136""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Orioli</surname><given-names>D.</given-names></name><name><surname>Henkemeyer</surname><given-names>M.</given-names></name><name><surname>Lemke</surname><given-names>G.</given-names></name><name><surname>Klein</surname><given-names>R.</given-names></name><name><surname>Pawon</surname><given-names>T.</given-names></name></person-group>(<year>1996</year>).<article-title>Sek4 and Nuk receptors cooperate in guidance of commissural axons and in palate formation</article-title>.<source>EMBO J.</source><volume>15</volume>,<fpage>6035</fpage>–<lpage>6049</lpage><pub-id pub-id-type=""pmid"">8947026</pub-id></mixed-citation></ref><ref id=""B137""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Pasterkamp</surname><given-names>R. J.</given-names></name><name><surname>Peschon</surname><given-names>J. J.</given-names></name><name><surname>Spriggs</surname><given-names>M. K.</given-names></name><name><surname>Kolodkin</surname><given-names>A. L.</given-names></name></person-group>(<year>2003</year>).<article-title>Semaphorin 7A promotes axon outgrowth through integrins and MAPKs</article-title>.<source>Nature</source><volume>424</volume>,<fpage>398</fpage>–<lpage>405</lpage><pub-id pub-id-type=""doi"">10.1038/nature01790</pub-id><pub-id pub-id-type=""pmid"">12879062</pub-id></mixed-citation></ref><ref id=""B138""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Patel</surname><given-names>K.</given-names></name><name><surname>Nash</surname><given-names>J. A.</given-names></name><name><surname>Itoh</surname><given-names>A.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Sundaresan</surname><given-names>V.</given-names></name><name><surname>Pini</surname><given-names>A.</given-names></name></person-group>(<year>2001</year>).<article-title>Slit proteins are not dominant chemorepellents for olfactory tract and spinal motor axons</article-title>.<source>Development</source><volume>128</volume>,<fpage>5031</fpage>–<lpage>5037</lpage><pub-id pub-id-type=""pmid"">11748139</pub-id></mixed-citation></ref><ref id=""B139""><mixed-citation publication-type=""book""><person-group person-group-type=""author""><name><surname>Paxinos</surname><given-names>G.</given-names></name></person-group>(<year>2004</year>).<article-title>The Rat Nervous System, 3rd edn</article-title>.<publisher-loc>London</publisher-loc>,<publisher-name>Elsevier Academic Press</publisher-name></mixed-citation></ref><ref id=""B140""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Petreanu</surname><given-names>L.</given-names></name><name><surname>Álvarez-Buylla</surname><given-names>A.</given-names></name></person-group>(<year>2002</year>).<article-title>Maturation and death of adultborn olfactory bulb granule neurons: role of olfaction</article-title>.<source>J. Neurosci.</source><volume>22</volume>,<fpage>6106</fpage>–<lpage>6113</lpage><pub-id pub-id-type=""pmid"">12122071</pub-id></mixed-citation></ref><ref id=""B141""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Pini</surname><given-names>A.</given-names></name></person-group>(<year>1993</year>).<article-title>Chemorepulsion of axons in the developing mammalian central nervous system</article-title>.<source>Science</source><volume>261</volume>,<fpage>95</fpage>–<lpage>98</lpage><pub-id pub-id-type=""doi"">10.1126/science.8316861</pub-id><pub-id pub-id-type=""pmid"">8316861</pub-id></mixed-citation></ref><ref id=""B142""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Pires-Neto</surname><given-names>M. A.</given-names></name><name><surname>Lent</surname><given-names>R.</given-names></name></person-group>(<year>1993</year>).<article-title>The prenatal development of the anterior commissure in hamsters: pioneer fibers lead the way</article-title>.<source>Brain Res. Dev. Brain Res.</source><volume>72</volume>,<fpage>59</fpage>–<lpage>66</lpage><pub-id pub-id-type=""doi"">10.1016/0165-3806(93)90159-8</pub-id><pub-id pub-id-type=""pmid"">8453765</pub-id></mixed-citation></ref><ref id=""B143""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Potter</surname><given-names>S. M.</given-names></name><name><surname>Zheng</surname><given-names>C.</given-names></name><name><surname>Koos</surname><given-names>D. S.</given-names></name><name><surname>Feinstein</surname><given-names>P.</given-names></name><name><surname>Fraser</surname><given-names>S. E.</given-names></name><name><surname>Mombaerts</surname><given-names>P.</given-names></name></person-group>(<year>2001</year>).<article-title>Structure and emergence of specific olfactory glomeruli in the mouse</article-title>.<source>J. Neurosci.</source><volume>21</volume>,<fpage>9713</fpage>–<lpage>9723</lpage><pub-id pub-id-type=""pmid"">11739580</pub-id></mixed-citation></ref><ref id=""B144""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Price</surname><given-names>D. J.</given-names></name><name><surname>Kennedy</surname><given-names>H.</given-names></name><name><surname>Dehay</surname><given-names>C.</given-names></name><name><surname>Zhou</surname><given-names>L.</given-names></name><name><surname>Mercier</surname><given-names>M.</given-names></name><name><surname>Jossin</surname><given-names>Y.</given-names></name><name><surname>Goffinet</surname><given-names>A. M.</given-names></name><name><surname>Tissir</surname><given-names>F.</given-names></name><name><surname>Blakey</surname><given-names>D.</given-names></name><name><surname>MolnÁr</surname><given-names>Z.</given-names></name></person-group>(<year>2006</year>).<article-title>The development of cortical connections</article-title>.<source>Eur. J. Neurosci.</source><volume>23</volume>,<fpage>910</fpage>–<lpage>920</lpage><pub-id pub-id-type=""doi"">10.1111/j.1460-9568.2006.04620.x</pub-id><pub-id pub-id-type=""pmid"">16519656</pub-id></mixed-citation></ref><ref id=""B145""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Priest</surname><given-names>C. A.</given-names></name><name><surname>Puche</surname><given-names>A. C.</given-names></name></person-group>(<year>2004</year>).<article-title>GABAB receptor expression and function in olfactory receptor neuron axon growth</article-title>.<source>J. Neurobiol.</source><volume>60</volume>,<fpage>154</fpage>–<lpage>165</lpage><pub-id pub-id-type=""doi"">10.1002/neu.20011</pub-id><pub-id pub-id-type=""pmid"">15266647</pub-id></mixed-citation></ref><ref id=""B146""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Przyborski</surname><given-names>S. A.</given-names></name><name><surname>Knowles</surname><given-names>B. B.</given-names></name><name><surname>Ackerman</surname><given-names>S. L.</given-names></name></person-group>(<year>1998</year>).<article-title>Embryonic phenotype of Unc5h3 mutant mice suggests chemorepulsion during the formation of the rostral cerebellar boundary</article-title>.<source>Development</source><volume>125</volume>,<fpage>41</fpage>–<lpage>50</lpage><pub-id pub-id-type=""pmid"">9389662</pub-id></mixed-citation></ref><ref id=""B147""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Rakic</surname><given-names>P.</given-names></name></person-group>(<year>1988</year>).<article-title>Specification of cerebral cortical areas</article-title>.<source>Science</source><volume>241</volume>,<fpage>170</fpage>–<lpage>176</lpage><pub-id pub-id-type=""doi"">10.1126/science.3291116</pub-id><pub-id pub-id-type=""pmid"">3291116</pub-id></mixed-citation></ref><ref id=""B148""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Rakic</surname><given-names>P.</given-names></name><name><surname>Ayoub</surname><given-names>A. E.</given-names></name><name><surname>Breunig</surname><given-names>J. J.</given-names></name><name><surname>Domínguez</surname><given-names>M. H.</given-names></name></person-group>(<year>2009</year>).<article-title>Decision by division: making cortical maps</article-title>.<source>Trends Neurosci.</source><volume>32</volume>,<fpage>291</fpage>–<lpage>301</lpage><pub-id pub-id-type=""doi"">10.1016/j.tins.2009.01.007</pub-id><pub-id pub-id-type=""pmid"">19380167</pub-id></mixed-citation></ref><ref id=""B149""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Reed</surname><given-names>R. R.</given-names></name></person-group>(<year>2004</year>).<article-title>After the holy grail: establishing a molecular basis for mammalian olfaction</article-title>.<source>Cell</source><volume>116</volume>,<fpage>329</fpage>–<lpage>336</lpage><pub-id pub-id-type=""doi"">10.1016/S0092-8674(04)00047-9</pub-id><pub-id pub-id-type=""pmid"">14744441</pub-id></mixed-citation></ref><ref id=""B150""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Ren</surname><given-names>T.</given-names></name><name><surname>Anderson</surname><given-names>A.</given-names></name><name><surname>Shen</surname><given-names>W. B.</given-names></name><name><surname>Huang</surname><given-names>H.</given-names></name><name><surname>Plachez</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Mori</surname><given-names>S.</given-names></name><name><surname>Kinsman</surname><given-names>S. L.</given-names></name><name><surname>Richards</surname><given-names>L. J.</given-names></name></person-group>(<year>2006</year>).<article-title>Imaging, anatomical, and molecular analysis of callosal formation in the developing human fetal brain</article-title>.<source>Anat. Rec. A Discov. Mol. Cell. Evol. Biol.</source><volume>288</volume>,<fpage>191</fpage>–<lpage>204</lpage><pub-id pub-id-type=""doi"">10.1002/ar.a.20282</pub-id><pub-id pub-id-type=""pmid"">16411247</pub-id></mixed-citation></ref><ref id=""B151""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Renzi</surname><given-names>M. J.</given-names></name><name><surname>Wexler</surname><given-names>T. L.</given-names></name><name><surname>Raper</surname><given-names>J. A.</given-names></name></person-group>(<year>2000</year>).<article-title>Olfactory sensory axons expressing a dominant-negative semaphorin receptor enter the CNS early and overshoot their target</article-title>.<source>Neuron</source><volume>28</volume>,<fpage>437</fpage>–<lpage>447</lpage><pub-id pub-id-type=""doi"">10.1016/S0896-6273(00)00123-9</pub-id><pub-id pub-id-type=""pmid"">11144354</pub-id></mixed-citation></ref><ref id=""B152""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Rochefort</surname><given-names>C.</given-names></name><name><surname>Gheusi</surname><given-names>G.</given-names></name><name><surname>Vincent</surname><given-names>J. D.</given-names></name><name><surname>Lledó</surname><given-names>P. M.</given-names></name></person-group>(<year>2002</year>).<article-title>Enriched odor exposure increases the number of newborn neurons in the adult olfactory bulb and improves odor memory</article-title>.<source>J. Neurosci.</source><volume>22</volume>,<fpage>2679</fpage>–<lpage>2689</lpage><pub-id pub-id-type=""pmid"">11923433</pub-id></mixed-citation></ref><ref id=""B153""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Rodriguez-Gil</surname><given-names>D. J.</given-names></name><name><surname>Greer</surname><given-names>C. A.</given-names></name></person-group>(<year>2008</year>).<article-title>Wnt/Frizzled family members mediate olfactory sensory neuron axon extension</article-title>.<source>J. Comp. Neurol.</source><volume>511</volume>,<fpage>301</fpage>–<lpage>317</lpage><pub-id pub-id-type=""doi"">10.1002/cne.21834</pub-id><pub-id pub-id-type=""pmid"">18803244</pub-id></mixed-citation></ref><ref id=""B154""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Saha</surname><given-names>B.</given-names></name><name><surname>Hari</surname><given-names>P.</given-names></name><name><surname>Huilgol</surname><given-names>D.</given-names></name><name><surname>Tole</surname><given-names>S.</given-names></name></person-group>(<year>2007</year>).<article-title>Dual role for LIM-homeodomain gene Lhx2 in the formation of the lateral olfactory tract</article-title>.<source>J. Neurosci.</source><volume>27</volume>,<fpage>2290</fpage>–<lpage>2297</lpage><pub-id pub-id-type=""doi"">10.1523/JNEUROSCI.5571-06.2007</pub-id><pub-id pub-id-type=""pmid"">17329426</pub-id></mixed-citation></ref><ref id=""B155""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Sahay</surname><given-names>A.</given-names></name><name><surname>Molliver</surname><given-names>M. E.</given-names></name><name><surname>Ginty</surname><given-names>D. D.</given-names></name><name><surname>Kolodkin</surname><given-names>A. L.</given-names></name></person-group>(<year>2003</year>).<article-title>Semaphorin 3F is critical for development of limbic system circuitry and is required in neurons for selective CNS axon guidance events</article-title>.<source>J. Neurosci.</source><volume>23</volume>,<fpage>6671</fpage>–<lpage>6680</lpage><pub-id pub-id-type=""pmid"">12890759</pub-id></mixed-citation></ref><ref id=""B156""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Santacana</surname><given-names>M.</given-names></name><name><surname>Heredia</surname><given-names>M.</given-names></name><name><surname>Valverde</surname><given-names>F.</given-names></name></person-group>(<year>1992</year>).<article-title>Transient pattern of exuberant projections of olfactory axons during development in the rat</article-title>.<source>Brain Res. Dev. Brain Res.</source><volume>70</volume>,<fpage>213</fpage>–<lpage>222</lpage><pub-id pub-id-type=""doi"">10.1016/0165-3806(92)90200-G</pub-id><pub-id pub-id-type=""pmid"">1477955</pub-id></mixed-citation></ref><ref id=""B157""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Sarnat</surname><given-names>H. B.</given-names></name></person-group>(<year>2007</year>).<article-title>Embryology and malformations of the forebrain commissures</article-title>.<source>Handb. Clin. Neurol.</source><volume>87</volume>,<fpage>67</fpage>–<lpage>87</lpage><pub-id pub-id-type=""doi"">10.1016/S0072-9752(07)87005-9</pub-id><pub-id pub-id-type=""pmid"">18809019</pub-id></mixed-citation></ref><ref id=""B158""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Sarnat</surname><given-names>H. B.</given-names></name><name><surname>Flores-Sarnat</surname><given-names>L.</given-names></name></person-group>(<year>2001</year>).<article-title>Neuropathologic research strategies in holoprosencephaly</article-title>.<source>J. Child Neurol.</source><volume>16</volume>,<fpage>918</fpage>–<lpage>931</lpage><pub-id pub-id-type=""doi"">10.1177/088307380101601211</pub-id><pub-id pub-id-type=""pmid"">11785508</pub-id></mixed-citation></ref><ref id=""B159""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Sato</surname><given-names>Y.</given-names></name><name><surname>Hirata</surname><given-names>T.</given-names></name><name><surname>Ogawa</surname><given-names>M.</given-names></name><name><surname>Fujisawa</surname><given-names>H.</given-names></name></person-group>(<year>1998</year>).<article-title>Requirement for early-generated neurons recognized by monoclonal antibody lot1 in the formation of lateral olfactory tract</article-title>.<source>J. Neurosci.</source><volume>18</volume>,<fpage>7800</fpage>–<lpage>7810</lpage><pub-id pub-id-type=""pmid"">9742149</pub-id></mixed-citation></ref><ref id=""B160""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Schwarting</surname><given-names>G. A.</given-names></name><name><surname>Henion</surname><given-names>T. R.</given-names></name></person-group>(<year>2008</year>).<article-title>Olfactory axon guidance: the modified rules</article-title>.<source>J. Neurosci. Res.</source><volume>86</volume>,<fpage>11</fpage>–<lpage>17</lpage><pub-id pub-id-type=""doi"">10.1002/jnr.21373</pub-id><pub-id pub-id-type=""pmid"">17549746</pub-id></mixed-citation></ref><ref id=""B161""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Schwarting</surname><given-names>G. A.</given-names></name><name><surname>Kostek</surname><given-names>C.</given-names></name><name><surname>Ahmad</surname><given-names>N.</given-names></name><name><surname>Dibble</surname><given-names>C.</given-names></name><name><surname>Pays</surname><given-names>L.</given-names></name><name><surname>Püschel</surname><given-names>A. W.</given-names></name></person-group>(<year>2000</year>).<article-title>Semaphorin 3A is required for guidance of olfactory axons in mice</article-title>.<source>J. Neurosci.</source><volume>20</volume>,<fpage>7691</fpage>–<lpage>7697</lpage><pub-id pub-id-type=""pmid"">11027230</pub-id></mixed-citation></ref><ref id=""B162""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Schwarting</surname><given-names>G. A.</given-names></name><name><surname>Raitcheva</surname><given-names>D.</given-names></name><name><surname>Bless</surname><given-names>E. P.</given-names></name><name><surname>Ackerman</surname><given-names>S. L.</given-names></name><name><surname>Tobet</surname><given-names>S.</given-names></name></person-group>(<year>2004</year>).<article-title>Netrin 1-mediated chemoattraction regulates the migratory pathway of LHRH neurons</article-title>.<source>Eur. J. Neurosci.</source><volume>19</volume>,<fpage>11</fpage>–<lpage>20</lpage><pub-id pub-id-type=""doi"">10.1111/j.1460-9568.2004.03094.x</pub-id><pub-id pub-id-type=""pmid"">14750959</pub-id></mixed-citation></ref><ref id=""B163""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Schwob</surname><given-names>J. E.</given-names></name><name><surname>Price</surname><given-names>J. L.</given-names></name></person-group>(<year>1984</year>).<article-title>The development of axonal connections in the central olfactory system of rats</article-title>.<source>J. Comp. Neurol.</source><volume>223</volume>,<fpage>177</fpage>–<lpage>202</lpage><pub-id pub-id-type=""doi"">10.1002/cne.902230204</pub-id><pub-id pub-id-type=""pmid"">6200518</pub-id></mixed-citation></ref><ref id=""B164""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Schwob</surname><given-names>J. E.</given-names></name><name><surname>Szumowski</surname><given-names>K. E.</given-names></name><name><surname>Stasky</surname><given-names>A. A.</given-names></name></person-group>(<year>1992</year>).<article-title>Olfactory sensory neurons are trophically dependent on the olfactory bulb for their prolonged survival</article-title>.<source>J. Neurosci.</source><volume>12</volume>,<fpage>3896</fpage>–<lpage>3919</lpage><pub-id pub-id-type=""pmid"">1403089</pub-id></mixed-citation></ref><ref id=""B165""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Scolnick</surname><given-names>J. A.</given-names></name><name><surname>Cui</surname><given-names>K.</given-names></name><name><surname>Duggan</surname><given-names>C. D.</given-names></name><name><surname>Xuan</surname><given-names>S.</given-names></name><name><surname>Yuan</surname><given-names>X. B.</given-names></name><name><surname>Efstratiadis</surname><given-names>A.</given-names></name><name><surname>Ngai</surname><given-names>J.</given-names></name></person-group>(<year>2008</year>).<article-title>Role of IGF signaling in olfactory sensory map formation and axon guidance</article-title>.<source>Neuron</source><volume>57</volume>,<fpage>847</fpage>–<lpage>857</lpage><pub-id pub-id-type=""doi"">10.1016/j.neuron.2008.01.027</pub-id><pub-id pub-id-type=""pmid"">18367086</pub-id></mixed-citation></ref><ref id=""B166""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Scott</surname><given-names>J. W.</given-names></name><name><surname>McBride</surname><given-names>R. L.</given-names></name><name><surname>Schneider</surname><given-names>S. P.</given-names></name></person-group>(<year>1980</year>).<article-title>The organization of projections from the olfactory bulb to the piriform cortex and olfactory tubercle in the rat</article-title>.<source>J. Comp. Neurol.</source><volume>194</volume>,<fpage>519</fpage>–<lpage>534</lpage><pub-id pub-id-type=""doi"">10.1002/cne.901940304</pub-id><pub-id pub-id-type=""pmid"">7451680</pub-id></mixed-citation></ref><ref id=""B167""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Seki</surname><given-names>T.</given-names></name><name><surname>Arai</surname><given-names>Y.</given-names></name></person-group>(<year>1991</year>).<article-title>Expression of highly polysialylated NCAM in the neocortex and piriform cortex of the developing and the adult rat</article-title>.<source>Anat. Embryol.</source><volume>184</volume>,<fpage>395</fpage>–<lpage>401</lpage><pub-id pub-id-type=""doi"">10.1007/BF00957900</pub-id><pub-id pub-id-type=""pmid"">1952111</pub-id></mixed-citation></ref><ref id=""B168""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Serafini</surname><given-names>T.</given-names></name><name><surname>Colamarino</surname><given-names>S. A.</given-names></name><name><surname>Leonardo</surname><given-names>E. D.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Beddington</surname><given-names>R.</given-names></name><name><surname>Skarnes</surname><given-names>W. C.</given-names></name><name><surname>Tessier-Lavigne</surname><given-names>M.</given-names></name></person-group>(<year>1996</year>).<article-title>Netrin-1 is required for commissural axon guidance in the developing vertebrate nervous system</article-title>.<source>Cell</source><volume>87</volume>,<fpage>1001</fpage>–<lpage>1014</lpage><pub-id pub-id-type=""doi"">10.1016/S0092-8674(00)81795-X</pub-id><pub-id pub-id-type=""pmid"">8978605</pub-id></mixed-citation></ref><ref id=""B169""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Serizawa</surname><given-names>S.</given-names></name><name><surname>Miyamichi</surname><given-names>K.</given-names></name><name><surname>Takeuchi</surname><given-names>H.</given-names></name><name><surname>Yamagishi</surname><given-names>Y.</given-names></name><name><surname>Suzuki</surname><given-names>M.</given-names></name><name><surname>Sakano</surname><given-names>H.</given-names></name></person-group>(<year>2006</year>).<article-title>A neuronal identity code for the odorant receptor-specific and activity-dependent axon sorting</article-title>.<source>Cell</source><volume>127</volume>,<fpage>1057</fpage>–<lpage>1069</lpage><pub-id pub-id-type=""doi"">10.1016/j.cell.2006.10.031</pub-id><pub-id pub-id-type=""pmid"">17129788</pub-id></mixed-citation></ref><ref id=""B170""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Shay</surname><given-names>E. L.</given-names></name><name><surname>Greer</surname><given-names>C. A.</given-names></name><name><surname>Treloar</surname><given-names>H. B.</given-names></name></person-group>(<year>2008</year>).<article-title>Dynamic expression patterns of ECM molecules in the developing mouse olfactory pathway</article-title>.<source>Dev. Dyn.</source><volume>237</volume>,<fpage>1837</fpage>–<lpage>1850</lpage><pub-id pub-id-type=""doi"">10.1002/dvdy.21595</pub-id><pub-id pub-id-type=""pmid"">18570250</pub-id></mixed-citation></ref><ref id=""B171""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Shen</surname><given-names>Y.</given-names></name><name><surname>Mani</surname><given-names>S.</given-names></name><name><surname>Donovan</surname><given-names>S. L.</given-names></name><name><surname>Schwob</surname><given-names>J. E.</given-names></name><name><surname>Meiri</surname><given-names>K. F.</given-names></name></person-group>(<year>2002</year>).<article-title>Growth-associated protein-43 is required for commissural axon guidance in the developing vertebrate nervous system</article-title>.<source>J. Neurosci.</source><volume>22</volume>,<fpage>239</fpage>–<lpage>247</lpage><pub-id pub-id-type=""pmid"">11756507</pub-id></mixed-citation></ref><ref id=""B172""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Shipley</surname><given-names>M. T.</given-names></name><name><surname>Adamek</surname><given-names>G. D.</given-names></name></person-group>(<year>1984</year>).<article-title>The connections of the mouse olfactory bulb: a study using orthograde and retrograde transport of wheat germ agglutinin conjugated to horseradish peroxidase</article-title>.<source>Brain Res. Bull.</source><volume>12</volume>,<fpage>669</fpage>–<lpage>688</lpage><pub-id pub-id-type=""doi"">10.1016/0361-9230(84)90148-5</pub-id><pub-id pub-id-type=""pmid"">6206930</pub-id></mixed-citation></ref><ref id=""B173""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Shipley</surname><given-names>M. T.</given-names></name><name><surname>Ennis</surname><given-names>M.</given-names></name></person-group>(<year>1996</year>).<article-title>Functional organization of olfactory system</article-title>.<source>J. Neurobiol.</source><volume>30</volume>,<fpage>123</fpage>–<lpage>176</lpage><pub-id pub-id-type=""doi"">10.1002/(SICI)1097-4695(199605)30:1&lt;123::AID-NEU11&gt;3.0.CO;2-N</pub-id><pub-id pub-id-type=""pmid"">8727988</pub-id></mixed-citation></ref><ref id=""B174""><mixed-citation publication-type=""book""><person-group person-group-type=""author""><name><surname>Shipley</surname><given-names>M. T.</given-names></name><name><surname>Ennis</surname><given-names>M.</given-names></name><name><surname>Puche</surname><given-names>A. C.</given-names></name></person-group>(<year>2004</year>).<article-title>Olfactory system</article-title>. In<source>The Rat Nervous System</source>,<edition>3rd edn</edition>,<person-group person-group-type=""editor""><name><surname>Paxinos</surname><given-names>G.</given-names></name></person-group>, ed. (<publisher-loc>London</publisher-loc>,<publisher-name>Elsevier Academic Press</publisher-name>), pp.<fpage>923</fpage>–<lpage>964</lpage><pub-id pub-id-type=""doi"">10.1016/B978-012547638-6/50030-4</pub-id></mixed-citation></ref><ref id=""B175""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Shu</surname><given-names>T.</given-names></name><name><surname>Valentino</surname><given-names>K. M.</given-names></name><name><surname>Seaman</surname><given-names>C.</given-names></name><name><surname>Cooper</surname><given-names>H. M.</given-names></name><name><surname>Richards</surname><given-names>L. J.</given-names></name></person-group>(<year>2000</year>).<article-title>Expression of the netrin-1 receptor deleted in colorectal cancer (DCC) is largely confined to projecting neurons in the developing forebrain</article-title>.<source>J. Comp. Neurol.</source><volume>416</volume>,<fpage>201</fpage>–<lpage>212</lpage><pub-id pub-id-type=""doi"">10.1002/(SICI)1096-9861(20000110)416:2&lt;201::AID-CNE6&gt;3.0.CO;2-Z</pub-id><pub-id pub-id-type=""pmid"">10581466</pub-id></mixed-citation></ref><ref id=""B176""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Silver</surname><given-names>J.</given-names></name><name><surname>Lorenz</surname><given-names>S. E.</given-names></name><name><surname>Wahlsten</surname><given-names>D.</given-names></name><name><surname>Coughlin</surname><given-names>J.</given-names></name></person-group>(<year>1982</year>).<article-title>Axonal guidance during development of the great cerebral commissures: descriptive and experimental studies, in vivo, on the role of preformed glial pathways</article-title>.<source>J. Comp. Neurol.</source><volume>210</volume>,<fpage>10</fpage>–<lpage>29</lpage><pub-id pub-id-type=""doi"">10.1002/cne.902100103</pub-id><pub-id pub-id-type=""pmid"">7130467</pub-id></mixed-citation></ref><ref id=""B177""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Soucy</surname><given-names>E. R.</given-names></name><name><surname>Albeanu</surname><given-names>D. F.</given-names></name><name><surname>Fantana</surname><given-names>A. L.</given-names></name><name><surname>Murthy</surname><given-names>V. N.</given-names></name><name><surname>Meister</surname><given-names>M.</given-names></name></person-group>(<year>2009</year>).<article-title>Precision and diversity in an odor map on the olfactory bulb</article-title>.<source>Nat. Neurosci.</source><volume>12</volume>,<fpage>210</fpage>–<lpage>220</lpage><pub-id pub-id-type=""doi"">10.1038/nn.2262</pub-id><pub-id pub-id-type=""pmid"">19151709</pub-id></mixed-citation></ref><ref id=""B178""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Soussi-Yanicostas</surname><given-names>N.</given-names></name><name><surname>de Castro</surname><given-names>F.</given-names></name><name><surname>Julliard</surname><given-names>K.</given-names></name><name><surname>Perfettini</surname><given-names>I.</given-names></name><name><surname>Chédotal</surname><given-names>A.</given-names></name><name><surname>Petit</surname><given-names>C.</given-names></name></person-group>(<year>2002</year>).<article-title>Anosmin-1 defective in the X-linked form of Kallmann syndrome promotes axonal branch formation from olfactory bulb output neurons</article-title>.<source>Cell</source><volume>109</volume>,<fpage>217</fpage>–<lpage>228</lpage><pub-id pub-id-type=""doi"">10.1016/S0092-8674(02)00713-4</pub-id><pub-id pub-id-type=""pmid"">12007408</pub-id></mixed-citation></ref><ref id=""B179""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>St John</surname><given-names>J. A.</given-names></name><name><surname>Clarris</surname><given-names>H. J.</given-names></name><name><surname>Key</surname><given-names>B.</given-names></name></person-group>(<year>2002</year>).<article-title>Multiple axon guidance cues establish the olfactory topographic map: how do these cues interact?</article-title><source>Int. J. Dev. Biol.</source><volume>46</volume>,<fpage>639</fpage>–<lpage>647</lpage><pub-id pub-id-type=""pmid"">12141452</pub-id></mixed-citation></ref><ref id=""B180""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>St John</surname><given-names>J. A.</given-names></name><name><surname>Key</surname><given-names>B.</given-names></name></person-group>(<year>2001</year>).<article-title>Chemically and morphologically identifiable glomeruli in the rat olfactory bulb</article-title>.<source>J. Comp. Neurol.</source><volume>436</volume>,<fpage>497</fpage>–<lpage>507</lpage><pub-id pub-id-type=""doi"">10.1002/cne.1083</pub-id><pub-id pub-id-type=""pmid"">11447592</pub-id></mixed-citation></ref><ref id=""B181""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Stein</surname><given-names>E.</given-names></name><name><surname>Tessier-Lavigne</surname><given-names>M.</given-names></name></person-group>(<year>2001</year>).<article-title>Hierarchical organization of guidance receptors: silencing of netrin attraction by slit through Robo/DCC receptor complex</article-title>.<source>Science</source><volume>291</volume>,<fpage>1928</fpage>–<lpage>1938</lpage><pub-id pub-id-type=""doi"">10.1126/science.1058445</pub-id><pub-id pub-id-type=""pmid"">11239147</pub-id></mixed-citation></ref><ref id=""B182""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Stoeckli</surname><given-names>E. T.</given-names></name><name><surname>Landmesser</surname><given-names>L. T.</given-names></name></person-group>(<year>1995</year>).<article-title>Axonin-1 Nr-CAM and Ng-CAM play different roles in the in vivo guidance of chick commissural neurons</article-title>.<source>Neuron</source><volume>14</volume>,<fpage>1165</fpage>–<lpage>1179</lpage><pub-id pub-id-type=""doi"">10.1016/0896-6273(95)90264-3</pub-id><pub-id pub-id-type=""pmid"">7541632</pub-id></mixed-citation></ref><ref id=""B183""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Stoeckli</surname><given-names>E. T.</given-names></name><name><surname>Landmesser</surname><given-names>L. T.</given-names></name></person-group>(<year>1998</year>).<article-title>Axon guidance at choice points</article-title>.<source>Curr. Opin. Neurobiol.</source><volume>8</volume>,<fpage>73</fpage>–<lpage>79</lpage><pub-id pub-id-type=""doi"">10.1016/S0959-4388(98)80010-X</pub-id><pub-id pub-id-type=""pmid"">9568394</pub-id></mixed-citation></ref><ref id=""B184""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Strotmann</surname><given-names>J.</given-names></name><name><surname>Levai</surname><given-names>O.</given-names></name><name><surname>Fleischer</surname><given-names>J.</given-names></name><name><surname>Schwarzenbacher</surname><given-names>K.</given-names></name><name><surname>Breer</surname><given-names>H.</given-names></name></person-group>(<year>2004</year>).<article-title>Olfactory receptor proteins in axonal processes of chemosensory neurons</article-title>.<source>J. Neurosci.</source><volume>24</volume>,<fpage>7754</fpage>–<lpage>7761</lpage><pub-id pub-id-type=""doi"">10.1523/JNEUROSCI.2588-04.2004</pub-id><pub-id pub-id-type=""pmid"">15342743</pub-id></mixed-citation></ref><ref id=""B185""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Sugisaki</surname><given-names>N.</given-names></name><name><surname>Hirata</surname><given-names>T.</given-names></name><name><surname>Naruse</surname><given-names>I.</given-names></name><name><surname>Kawakami</surname><given-names>A.</given-names></name><name><surname>Kitsukawa</surname><given-names>T.</given-names></name><name><surname>Fujisawa</surname><given-names>H.</given-names></name></person-group>(<year>1996</year>).<article-title>Positional cues that are strictly localized in the telencephalon induce preferential growth of mitral cell axons</article-title>.<source>J. Neurobiol.</source><volume>29</volume>,<fpage>127</fpage>–<lpage>137</lpage><pub-id pub-id-type=""doi"">10.1002/(SICI)1097-4695(199602)29:2&lt;127::AID-NEU1&gt;3.0.CO;2-C</pub-id><pub-id pub-id-type=""pmid"">8821172</pub-id></mixed-citation></ref><ref id=""B186""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Suto</surname><given-names>F.</given-names></name><name><surname>Ito</surname><given-names>K.</given-names></name><name><surname>Uemura</surname><given-names>M.</given-names></name><name><surname>Shimizu</surname><given-names>M.</given-names></name><name><surname>Shinkawa</surname><given-names>Y.</given-names></name><name><surname>Sanbo</surname><given-names>M.</given-names></name><name><surname>Shinoda</surname><given-names>T.</given-names></name><name><surname>Tsuboi</surname><given-names>M.</given-names></name><name><surname>Takashima</surname><given-names>S.</given-names></name><name><surname>Yagi</surname><given-names>T.</given-names></name><name><surname>Fujisawa</surname><given-names>H.</given-names></name></person-group>(<year>2005</year>).<article-title>Plexin-a4 mediates axon-repulsive activities of both secreted and transmembrane semaphorins and plays roles in nerve fiber guidance</article-title>.<source>J. Neurosci.</source><volume>25</volume>,<fpage>3628</fpage>–<lpage>3637</lpage><pub-id pub-id-type=""doi"">10.1523/JNEUROSCI.4480-04.2005</pub-id><pub-id pub-id-type=""pmid"">15814794</pub-id></mixed-citation></ref><ref id=""B187""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Szabo-Rogers</surname><given-names>H. L.</given-names></name><name><surname>Geetha-Loganathan</surname><given-names>P.</given-names></name><name><surname>Whiting</surname><given-names>C. J.</given-names></name><name><surname>Nimmagadda</surname><given-names>S.</given-names></name><name><surname>Fu</surname><given-names>K.</given-names></name><name><surname>Richman</surname><given-names>J. M.</given-names></name></person-group>(<year>2009</year>).<article-title>Novel skeletogenic patterning roles for the olfactory pit</article-title>.<source>Development</source><volume>136</volume>,<fpage>219</fpage>–<lpage>229</lpage><pub-id pub-id-type=""doi"">10.1242/dev.023978</pub-id><pub-id pub-id-type=""pmid"">19056832</pub-id></mixed-citation></ref><ref id=""B188""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Taniguchi</surname><given-names>M.</given-names></name><name><surname>Nagao</surname><given-names>H.</given-names></name><name><surname>Takahashi</surname><given-names>Y. K.</given-names></name><name><surname>Yamaguchi</surname><given-names>M.</given-names></name><name><surname>Mitsui</surname><given-names>S.</given-names></name><name><surname>Yagi</surname><given-names>T.</given-names></name><name><surname>Mori</surname><given-names>K.</given-names></name><name><surname>Shimizu</surname><given-names>T.</given-names></name></person-group>(<year>2003</year>).<article-title>Distorted odor maps in the olfactory bulb of semaphorin 3A-deficient mice</article-title>.<source>J. Neurosci.</source><volume>23</volume>,<fpage>1390</fpage>–<lpage>1397</lpage><pub-id pub-id-type=""pmid"">12598627</pub-id></mixed-citation></ref><ref id=""B189""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Teillon</surname><given-names>S. M.</given-names></name><name><surname>Yiu</surname><given-names>G.</given-names></name><name><surname>Walsh</surname><given-names>C. A.</given-names></name></person-group>(<year>2003</year>).<article-title>Reelin is expressed in the accessory olfactory system, but is not a guidance cue for vomeronasal axons</article-title>.<source>Brain Res. Dev. Brain Res.</source><volume>140</volume>,<fpage>303</fpage>–<lpage>307</lpage><pub-id pub-id-type=""doi"">10.1016/S0165-3806(02)00616-8</pub-id><pub-id pub-id-type=""pmid"">12586436</pub-id></mixed-citation></ref><ref id=""B190""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Tessier-Lavigne</surname><given-names>M.</given-names></name><name><surname>Goodman</surname><given-names>C. S.</given-names></name></person-group>(<year>1996</year>).<article-title>The molecular biology of axon guidance</article-title>.<source>Science</source><volume>274</volume>,<fpage>1123</fpage>–<lpage>1133</lpage><pub-id pub-id-type=""doi"">10.1126/science.274.5290.1123</pub-id><pub-id pub-id-type=""pmid"">8895455</pub-id></mixed-citation></ref><ref id=""B191""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Tissir</surname><given-names>F.</given-names></name><name><surname>Bar</surname><given-names>I.</given-names></name><name><surname>Jossin</surname><given-names>Y.</given-names></name><name><surname>De Backer</surname><given-names>O.</given-names></name><name><surname>Goffinet</surname><given-names>A. M.</given-names></name></person-group>(<year>2005</year>).<article-title>Protocadherin Celsr3 is crucial in axonal tract development</article-title>.<source>Nat. Neurosci.</source><volume>8</volume>,<fpage>451</fpage>–<lpage>457</lpage><pub-id pub-id-type=""pmid"">15778712</pub-id></mixed-citation></ref><ref id=""B192""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Tiveron</surname><given-names>M. C.</given-names></name><name><surname>Cremer</surname><given-names>H.</given-names></name></person-group>(<year>2008</year>).<article-title>CXCL12/CXCR4 signalling in neuronal cell migration</article-title>.<source>Curr. Opin. Neurobiol.</source><volume>18</volume>,<fpage>237</fpage>–<lpage>244</lpage><pub-id pub-id-type=""doi"">10.1016/j.conb.2008.06.004</pub-id><pub-id pub-id-type=""pmid"">18644448</pub-id></mixed-citation></ref><ref id=""B193""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Toba</surname><given-names>Y.</given-names></name><name><surname>Tiong</surname><given-names>J. D.</given-names></name><name><surname>Ma</surname><given-names>Q.</given-names></name><name><surname>Wray</surname><given-names>S.</given-names></name></person-group>(<year>2008</year>).<article-title>CXCR4/SDF-1 system modulates development of GnRH-1 neurons and the olfactory system</article-title>.<source>Dev. Neurobiol.</source><volume>68</volume>,<fpage>487</fpage>–<lpage>503</lpage><pub-id pub-id-type=""doi"">10.1002/dneu.20594</pub-id><pub-id pub-id-type=""pmid"">18188864</pub-id></mixed-citation></ref><ref id=""B194""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Tran</surname><given-names>H.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Walz</surname><given-names>A.</given-names></name><name><surname>Posthumus</surname><given-names>J. C.</given-names></name><name><surname>Gong</surname><given-names>Q.</given-names></name></person-group>(<year>2008</year>).<article-title>Influence of olfactory epithelium on mitral/tufted cell dendritic outgrowth</article-title>.<source>PLoS ONE</source><volume>3</volume>,<fpage>e3816</fpage><pub-id pub-id-type=""doi"">10.1371/journal.pone.0003816.</pub-id><pub-id pub-id-type=""pmid"">19043569</pub-id></mixed-citation></ref><ref id=""B195""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Treloar</surname><given-names>H. B.</given-names></name><name><surname>Feinstein</surname><given-names>P.</given-names></name><name><surname>Mombaerts</surname><given-names>P.</given-names></name><name><surname>Greer</surname><given-names>C. A.</given-names></name></person-group>(<year>2002</year>).<article-title>Specificity of glomerular targeting by olfactory sensory axons</article-title>.<source>J. Neurosci.</source><volume>22</volume>,<fpage>2469</fpage>–<lpage>2477</lpage><pub-id pub-id-type=""pmid"">11923411</pub-id></mixed-citation></ref><ref id=""B196""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Treloar</surname><given-names>H. B.</given-names></name><name><surname>Gabeau</surname><given-names>D.</given-names></name><name><surname>Yoshihara</surname><given-names>Y.</given-names></name><name><surname>Mori</surname><given-names>K.</given-names></name><name><surname>Greer</surname><given-names>C. A.</given-names></name></person-group>(<year>2003</year>).<article-title>Inverse expression of olfactory cell adhesion molecule in a subset of olfactory axons and a subset of mitral/tufted cells in the developing rat main olfactory bulb</article-title>.<source>J. Comp. Neurol.</source><volume>458</volume>,<fpage>389</fpage>–<lpage>403</lpage><pub-id pub-id-type=""doi"">10.1002/cne.10590</pub-id><pub-id pub-id-type=""pmid"">12619073</pub-id></mixed-citation></ref><ref id=""B197""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Treloar</surname><given-names>H. B.</given-names></name><name><surname>Nurcombe</surname><given-names>V.</given-names></name><name><surname>Key</surname><given-names>B.</given-names></name></person-group>(<year>1996</year>).<article-title>Expression of extracellular matrix molecules in the embryonic rat olfactory pathway</article-title>.<source>J. Neurobiol.</source><volume>31</volume>,<fpage>41</fpage>–<lpage>55</lpage><pub-id pub-id-type=""doi"">10.1002/(SICI)1097-4695(199609)31:1&lt;41::AID-NEU4&gt;3.0.CO;2-F</pub-id><pub-id pub-id-type=""pmid"">9120435</pub-id></mixed-citation></ref><ref id=""B198""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Treloar</surname><given-names>H. B.</given-names></name><name><surname>Ray</surname><given-names>A.</given-names></name><name><surname>Dinglasan</surname><given-names>L. A.</given-names></name><name><surname>Schachner</surname><given-names>M.</given-names></name><name><surname>Greer</surname><given-names>C. A.</given-names></name></person-group>(<year>2009</year>).<article-title>Tenascin-C is an inhibitory boundary molecule in the developing olfactory bulb</article-title>.<source>J. Neurosci.</source><volume>29</volume>,<fpage>9405</fpage>–<lpage>9416</lpage><pub-id pub-id-type=""doi"">10.1523/JNEUROSCI.2356-09.2009</pub-id><pub-id pub-id-type=""pmid"">19641104</pub-id></mixed-citation></ref><ref id=""B199""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Trinh</surname><given-names>K.</given-names></name><name><surname>Storm</surname><given-names>D. R.</given-names></name></person-group>(<year>2003</year>).<article-title>Vomeronasal organ detects odorants in absence of signaling through main olfactory epithelium</article-title>.<source>Nat. Neurosci.</source><volume>6</volume>,<fpage>519</fpage>–<lpage>525</lpage><pub-id pub-id-type=""pmid"">12665798</pub-id></mixed-citation></ref><ref id=""B200""><mixed-citation publication-type=""book""><person-group person-group-type=""author""><name><surname>Valverde</surname><given-names>F.</given-names></name></person-group>(<year>1965</year>).<article-title>Studies on the Piriform Lobe</article-title>.<publisher-loc>Harvard</publisher-loc>,<publisher-name>Harvard University Press</publisher-name></mixed-citation></ref><ref id=""B201""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Valverde</surname><given-names>F.</given-names></name><name><surname>Santacana</surname><given-names>M.</given-names></name><name><surname>Heredia</surname><given-names>M.</given-names></name></person-group>(<year>1992</year>).<article-title>Formation of an olfactory glomerulus: morphological aspects of development and organization</article-title>.<source>Neuroscience</source><volume>49</volume>,<fpage>255</fpage>–<lpage>275</lpage><pub-id pub-id-type=""doi"">10.1016/0306-4522(92)90094-I</pub-id><pub-id pub-id-type=""pmid"">1436469</pub-id></mixed-citation></ref><ref id=""B202""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>von Campenhausen</surname><given-names>H.</given-names></name><name><surname>Yoshihara</surname><given-names>Y.</given-names></name><name><surname>Mori</surname><given-names>K.</given-names></name></person-group>(<year>1997</year>).<article-title>OCAM reveals segregated mitral/tufted cell pathways in developing accessory olfactory bulb</article-title>.<source>Neuroreport</source><volume>28</volume>,<fpage>2607</fpage>–<lpage>2612</lpage><pub-id pub-id-type=""pmid"">9261836</pub-id></mixed-citation></ref><ref id=""B203""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Walz</surname><given-names>A.</given-names></name><name><surname>Mombaerts</surname><given-names>P.</given-names></name><name><surname>Greer</surname><given-names>C. A.</given-names></name><name><surname>Treloar</surname><given-names>H. B.</given-names></name></person-group>(<year>2006a</year>).<article-title>Disrupted compartmental organization of axons and dendrites within olfactory glomeruli of mice deficient in the olfactory cell adhesion molecule, OCAM</article-title>.<source>Mol. Cell Neurosci.</source><volume>32</volume>,<fpage>1</fpage>–<lpage>14</lpage><pub-id pub-id-type=""doi"">10.1016/j.mcn.2006.01.013</pub-id><pub-id pub-id-type=""pmid"">16531066</pub-id></mixed-citation></ref><ref id=""B204""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Walz</surname><given-names>A.</given-names></name><name><surname>Omura</surname><given-names>M.</given-names></name><name><surname>Mombaerts</surname><given-names>P.</given-names></name></person-group>(<year>2006b</year>).<article-title>Development and topography of the lateral olfactory tract in the mouse: imaging by genetically encoded and injected fluorescent markers</article-title>.<source>J. Neurobiol.</source><volume>66</volume>,<fpage>835</fpage>–<lpage>846</lpage><pub-id pub-id-type=""doi"">10.1002/neu.20266</pub-id><pub-id pub-id-type=""pmid"">16673392</pub-id></mixed-citation></ref><ref id=""B205""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Walz</surname><given-names>A.</given-names></name><name><surname>Rodriguez</surname><given-names>I.</given-names></name><name><surname>Mombaerts</surname><given-names>P.</given-names></name></person-group>(<year>2002</year>).<article-title>Aberrant sensory innervation of the olfactory bulb in neuropilin-2 mutant mice</article-title>.<source>J. Neurosci.</source><volume>22</volume>,<fpage>4025</fpage>–<lpage>4035</lpage><pub-id pub-id-type=""pmid"">12019322</pub-id></mixed-citation></ref><ref id=""B206""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Wang</surname><given-names>K. H.</given-names></name><name><surname>Brose</surname><given-names>K.</given-names></name><name><surname>Arnott</surname><given-names>D.</given-names></name><name><surname>Kidd</surname><given-names>T.</given-names></name><name><surname>Goodman</surname><given-names>C. S.</given-names></name><name><surname>Henzel</surname><given-names>W.</given-names></name><name><surname>Tessier-Lavigne</surname><given-names>M.</given-names></name></person-group>(<year>1999</year>).<article-title>Biochemical purification of a mammalian slit protein as a positive regulator of sensory axon elongation and branching</article-title>.<source>Cell</source><volume>96</volume>,<fpage>71</fpage>–<lpage>784</lpage><pub-id pub-id-type=""doi"">10.1016/S0092-8674(00)80588-7</pub-id></mixed-citation></ref><ref id=""B207""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Thekdi</surname><given-names>N.</given-names></name><name><surname>Smallwood</surname><given-names>P. M.</given-names></name><name><surname>Macke</surname><given-names>J. P.</given-names></name><name><surname>Nathans</surname><given-names>J.</given-names></name></person-group>(<year>2002</year>).<article-title>Frizzled-3 is required for the development of major fiber tracts in the rostral CNS</article-title>.<source>J. Neurosci.</source><volume>22</volume>,<fpage>8563</fpage>–<lpage>8573</lpage><pub-id pub-id-type=""pmid"">12351730</pub-id></mixed-citation></ref><ref id=""B208""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Mori</surname><given-names>S.</given-names></name><name><surname>Nathans</surname><given-names>J.</given-names></name></person-group>(<year>2006</year>).<article-title>Axonal growth and guidance defects in Frizzled3 knock-out mice: a comparison of diffusion tensor magnetic resonance imaging, neurofilament staining, and genetically directed cell labeling</article-title>.<source>J. Neurosci.</source><volume>26</volume>,<fpage>355</fpage>–<lpage>364</lpage><pub-id pub-id-type=""doi"">10.1523/JNEUROSCI.3221-05.2006</pub-id><pub-id pub-id-type=""pmid"">16407530</pub-id></mixed-citation></ref><ref id=""B209""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Watanabe</surname><given-names>K.</given-names></name><name><surname>Tamamaki</surname><given-names>N.</given-names></name><name><surname>Furuta</surname><given-names>T.</given-names></name><name><surname>Ackerman</surname><given-names>S. L.</given-names></name><name><surname>Ikenaka</surname><given-names>K.</given-names></name><name><surname>Ono</surname><given-names>K.</given-names></name></person-group>(<year>2006</year>).<article-title>Dorsally derived netrin 1 provides an inhibitory cue and elaborates the ‘waiting period’ for primary sensory axons in the developing spinal cord</article-title>.<source>Development</source><volume>133</volume>,<fpage>1379</fpage>–<lpage>1387</lpage><pub-id pub-id-type=""doi"">10.1242/dev.02312</pub-id><pub-id pub-id-type=""pmid"">16510500</pub-id></mixed-citation></ref><ref id=""B210""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Weiler</surname><given-names>E.</given-names></name><name><surname>Farbman</surname><given-names>A. I.</given-names></name></person-group>(<year>1999</year>).<article-title>Mitral cell loss following lateral olfactory tract transection increases proliferation density in rat olfactory epithelium</article-title>.<source>Eur. J. Neurosci.</source><volume>11</volume>,<fpage>3265</fpage>–<lpage>3275</lpage><pub-id pub-id-type=""doi"">10.1046/j.1460-9568.1999.00748.x</pub-id><pub-id pub-id-type=""pmid"">10510190</pub-id></mixed-citation></ref><ref id=""B211""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Whitesides</surname><given-names>J. G.</given-names></name><name><surname>LaMantia</surname><given-names>A.-S.</given-names></name></person-group>(<year>1998</year>).<article-title>Differential adhesion and the initial assembly of the mammalian olfactory nerve</article-title>.<source>J. Comp. Neurol.</source><volume>373</volume>,<fpage>240</fpage>–<lpage>254</lpage><pub-id pub-id-type=""doi"">10.1002/(SICI)1096-9861(19960916)373:2&lt;240::AID-CNE7&gt;3.0.CO;2-3</pub-id><pub-id pub-id-type=""pmid"">8889925</pub-id></mixed-citation></ref><ref id=""B212""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Wu</surname><given-names>H. H.</given-names></name><name><surname>Ivkovic</surname><given-names>S.</given-names></name><name><surname>Murray</surname><given-names>R. C.</given-names></name><name><surname>Jaramillo</surname><given-names>S.</given-names></name><name><surname>Lyons</surname><given-names>K. M.</given-names></name><name><surname>Johnson</surname><given-names>J. E.</given-names></name><name><surname>Calof</surname><given-names>A. L.</given-names></name></person-group>(<year>2003</year>).<article-title>Autoregulation of neurogenesis by GDF11</article-title>.<source>Neuron</source><volume>37</volume>,<fpage>197</fpage>–<lpage>207</lpage><pub-id pub-id-type=""doi"">10.1016/S0896-6273(02)01172-8</pub-id><pub-id pub-id-type=""pmid"">12546816</pub-id></mixed-citation></ref><ref id=""B213""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Yamaguchi</surname><given-names>M.</given-names></name><name><surname>Mori</surname><given-names>K.</given-names></name></person-group>(<year>2005</year>).<article-title>Critical period for sensory experience-dependent survival of newly generated granule cells in the adult mouse olfactory bulb</article-title>.<source>Proc. Natl. Acad. Sci. U.S.A.</source><volume>102</volume>,<fpage>9697</fpage>–<lpage>9702</lpage><pub-id pub-id-type=""doi"">10.1073/pnas.0406082102</pub-id><pub-id pub-id-type=""pmid"">15976032</pub-id></mixed-citation></ref><ref id=""B214""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Yamatani</surname><given-names>H.</given-names></name><name><surname>Sato</surname><given-names>Y.</given-names></name><name><surname>Fujisawa</surname><given-names>H.</given-names></name><name><surname>Hirata</surname><given-names>T.</given-names></name></person-group>(<year>2004</year>).<article-title>Chronotopic organization of olfactory bulb axons in the lateral olfactory tract</article-title>.<source>J. Comp. Neurol.</source><volume>475</volume>,<fpage>247</fpage>–<lpage>260</lpage><pub-id pub-id-type=""doi"">10.1002/cne.20155</pub-id><pub-id pub-id-type=""pmid"">15211465</pub-id></mixed-citation></ref><ref id=""B215""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Yoshihara</surname><given-names>Y.</given-names></name><name><surname>Kawasaki</surname><given-names>M.</given-names></name><name><surname>Tamada</surname><given-names>A.</given-names></name><name><surname>Fujita</surname><given-names>H.</given-names></name><name><surname>Hayashi</surname><given-names>H.</given-names></name><name><surname>Kagamiyama</surname><given-names>H.</given-names></name><name><surname>Mori</surname><given-names>K.</given-names></name></person-group>(<year>1997</year>).<article-title>OCAM: a new member of the neural cell adhesion molecule family related to zone-to-zone projection of olfactory and vomeronasal axons</article-title>.<source>J. Neurosci.</source><volume>17</volume>,<fpage>5830</fpage>–<lpage>5842</lpage><pub-id pub-id-type=""pmid"">9221781</pub-id></mixed-citation></ref><ref id=""B216""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Yu</surname><given-names>C. R.</given-names></name><name><surname>Power</surname><given-names>J.</given-names></name><name><surname>Barnea</surname><given-names>G.</given-names></name><name><surname>O'Donnell</surname><given-names>S.</given-names></name><name><surname>Brown</surname><given-names>H. E.</given-names></name><name><surname>Osborne</surname><given-names>J.</given-names></name><name><surname>Axel</surname><given-names>R.</given-names></name><name><surname>Gogos</surname><given-names>JA.</given-names></name></person-group>(<year>2004</year>).<article-title>Spontaneous neural activity is required for the establishment and maintenance of the olfactory sensory map</article-title>.<source>Neuron</source><volume>42</volume>,<fpage>553</fpage>–<lpage>566</lpage><pub-id pub-id-type=""doi"">10.1016/S0896-6273(04)00224-7</pub-id><pub-id pub-id-type=""pmid"">15157418</pub-id></mixed-citation></ref><ref id=""B217""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Zhang</surname><given-names>L. I.</given-names></name><name><surname>Poo</surname><given-names>M. M.</given-names></name></person-group>(<year>2001</year>).<article-title>Electrical activity and development of neural circuits</article-title>.<source>Nat. Neurosci.</source><volume>4</volume>(<issue>Suppl.</issue>),<fpage>1207</fpage>–<lpage>1214</lpage><pub-id pub-id-type=""doi"">10.1038/nn753</pub-id><pub-id pub-id-type=""pmid"">11687831</pub-id></mixed-citation></ref><ref id=""B218""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Firestein</surname><given-names>S.</given-names></name></person-group>(<year>2002</year>).<article-title>The olfactory receptor gene superfamily of the mouse</article-title>.<source>Nat. Neurosci.</source><volume>5</volume>,<fpage>124</fpage>–<lpage>133</lpage><pub-id pub-id-type=""pmid"">11802173</pub-id></mixed-citation></ref><ref id=""B219""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Zhao</surname><given-names>H.</given-names></name><name><surname>Reed</surname><given-names>R. R.</given-names></name></person-group>(<year>2001</year>).<article-title>X inactivation of the OCNC1 channel gene reveals a role for activity-dependent competition in the olfactory system</article-title>.<source>Cell</source><volume>104</volume>,<fpage>651</fpage>–<lpage>660</lpage><pub-id pub-id-type=""doi"">10.1016/S0092-8674(01)00262-8</pub-id><pub-id pub-id-type=""pmid"">11257220</pub-id></mixed-citation></ref><ref id=""B220""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Zheng</surname><given-names>C.</given-names></name><name><surname>Feinstein</surname><given-names>P.</given-names></name><name><surname>Bozza</surname><given-names>T.</given-names></name><name><surname>Rodriguez</surname><given-names>I.</given-names></name><name><surname>Mombaerts</surname><given-names>P.</given-names></name></person-group>(<year>2000</year>).<article-title>Peripheral olfactory projections are differentially affected in mice deficient in a cyclic nucleotide-gated channel subunit</article-title>.<source>Neuron</source><volume>26</volume>,<fpage>81</fpage>–<lpage>91</lpage><pub-id pub-id-type=""doi"">10.1016/S0896-6273(00)81140-X</pub-id><pub-id pub-id-type=""pmid"">10798394</pub-id></mixed-citation></ref><ref id=""B221""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Zheng</surname><given-names>J. Q.</given-names></name><name><surname>Poo</surname><given-names>M. M.</given-names></name></person-group>(<year>2007</year>).<article-title>Calcium signaling in neuronal motility</article-title>.<source>Annu. Rev. Cell. Dev. Biol.</source><volume>23</volume>,<fpage>375</fpage>–<lpage>404</lpage><pub-id pub-id-type=""doi"">10.1146/annurev.cellbio.23.090506.123221</pub-id><pub-id pub-id-type=""pmid"">17944572</pub-id></mixed-citation></ref><ref id=""B222""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Zhou</surname><given-names>C.</given-names></name><name><surname>Qiu</surname><given-names>Y.</given-names></name><name><surname>Pereira</surname><given-names>F. A.</given-names></name><name><surname>Crair</surname><given-names>M. C.</given-names></name><name><surname>Tsai</surname><given-names>S. Y.</given-names></name><name><surname>Tsai</surname><given-names>M. J.</given-names></name></person-group>(<year>1999</year>).<article-title>The nuclear orphan receptor COUP-TFI is required for differentiation of subplate neurons and guidance of thalamocortical axons</article-title>.<source>Neuron</source><volume>24</volume>,<fpage>847</fpage>–<lpage>859</lpage><pub-id pub-id-type=""doi"">10.1016/S0896-6273(00)81032-6</pub-id><pub-id pub-id-type=""pmid"">10624948</pub-id></mixed-citation></ref><ref id=""B223""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Zhou</surname><given-names>L.</given-names></name><name><surname>Bar</surname><given-names>I.</given-names></name><name><surname>Achouri</surname><given-names>Y.</given-names></name><name><surname>Campbell</surname><given-names>K.</given-names></name><name><surname>De Backer</surname><given-names>O.</given-names></name><name><surname>Hebert</surname><given-names>J. M.</given-names></name><name><surname>Jones</surname><given-names>K.</given-names></name><name><surname>Kessaris</surname><given-names>N.</given-names></name><name><surname>de Rouvroit</surname><given-names>C. L.</given-names></name><name><surname>O'Leary</surname><given-names>D.</given-names></name><name><surname>Richardson</surname><given-names>W. D.</given-names></name><name><surname>Goffinet</surname><given-names>A. M.</given-names></name><name><surname>Tissir</surname><given-names>F.</given-names></name></person-group>(<year>2008</year>).<article-title>Early forebrain wiring: genetic dissection using conditional Celsr3 mutant mice</article-title>.<source>Science</source><volume>320</volume>,<fpage>946</fpage>–<lpage>949</lpage><pub-id pub-id-type=""doi"">10.1126/science.1155244</pub-id><pub-id pub-id-type=""pmid"">18487195</pub-id></mixed-citation></ref><ref id=""B224""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Zou</surname><given-names>D. J.</given-names></name><name><surname>Chesler</surname><given-names>A. T.</given-names></name><name><surname>Le Pichon</surname><given-names>C. E.</given-names></name><name><surname>Kuznetsov</surname><given-names>A.</given-names></name><name><surname>Pei</surname><given-names>X.</given-names></name><name><surname>Hwang</surname><given-names>E. L.</given-names></name><name><surname>Firestein</surname><given-names>S.</given-names></name></person-group>(<year>2007</year>).<article-title>Absence of adenylyl cyclase 3 perturbs peripheral olfactory projections in mice</article-title>.<source>J. Neurosci.</source><volume>27</volume>,<fpage>6675</fpage>–<lpage>6683</lpage><pub-id pub-id-type=""doi"">10.1523/JNEUROSCI.0699-07.2007</pub-id><pub-id pub-id-type=""pmid"">17581954</pub-id></mixed-citation></ref><ref id=""B225""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Zou</surname><given-names>D. J.</given-names></name><name><surname>Feinstein</surname><given-names>P.</given-names></name><name><surname>Rivers</surname><given-names>A. L.</given-names></name><name><surname>Mathews</surname><given-names>G. A.</given-names></name><name><surname>Kim</surname><given-names>A.</given-names></name><name><surname>Greer</surname><given-names>C. A.</given-names></name><name><surname>Mombaerts</surname><given-names>P.</given-names></name><name><surname>Firestein</surname><given-names>S.</given-names></name></person-group>(<year>2004</year>).<article-title>Postnatal refinement of peripheral olfactory projections</article-title>.<source>Science</source><volume>304</volume>,<fpage>1976</fpage>–<lpage>1979</lpage><pub-id pub-id-type=""doi"">10.1126/science.1093468</pub-id><pub-id pub-id-type=""pmid"">15178749</pub-id></mixed-citation></ref><ref id=""B226""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Zou</surname><given-names>Y.</given-names></name><name><surname>Stoeckli</surname><given-names>E.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Tessier-Lavigne</surname><given-names>M.</given-names></name></person-group>(<year>2000</year>).<article-title>Squeezing axons out of the gray matter: a role for slit and semaphorin proteins from midline and ventral spinal cord</article-title>.<source>Cell</source><volume>102</volume>,<fpage>363</fpage>–<lpage>375</lpage><pub-id pub-id-type=""doi"">10.1016/S0092-8674(00)00041-6</pub-id><pub-id pub-id-type=""pmid"">10975526</pub-id></mixed-citation></ref><ref id=""B227""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Zou</surname><given-names>Z.</given-names></name><name><surname>Horowitz</surname><given-names>L. F.</given-names></name><name><surname>Montmayeur</surname><given-names>J. P.</given-names></name><name><surname>Snapper</surname><given-names>S.</given-names></name><name><surname>Buck</surname><given-names>L. B.</given-names></name></person-group>(<year>2001</year>).<article-title>Genetic tracing reveals a stereotyped sensory map in the olfactory cortex</article-title>.<source>Nature</source><volume>414</volume>,<fpage>173</fpage>–<lpage>179</lpage><pub-id pub-id-type=""doi"">10.1038/35102506</pub-id><pub-id pub-id-type=""pmid"">11700549</pub-id></mixed-citation></ref><ref id=""B228""><mixed-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Zou</surname><given-names>Z.</given-names></name><name><surname>Horowitz</surname><given-names>L. F.</given-names></name><name><surname>Montmayeur</surname><given-names>J. P.</given-names></name><name><surname>Snapper</surname><given-names>S.</given-names></name><name><surname>Buck</surname><given-names>L. B.</given-names></name></person-group>(<year>2008</year>).<article-title>Genetic tracing reveals a stereotyped sensory map in the olfactory cortex</article-title>.<source>Nature</source><volume>452</volume>,<fpage>120</fpage><pub-id pub-id-type=""doi"">10.1038/nature06819</pub-id><pub-id pub-id-type=""pmid"">18322536</pub-id></mixed-citation></ref></ref-list>"
10.1021/bi050786j	"<html><body><year>2005</year>,<volume>44</volume>,<fpage>9275</fpage>–<lpage>9279</lpage><pub-id pub-id-type=""doi"">10.1021/bi050786j</pub-id>.<pub-id pub-id-type=""pmid"">15981993</pub-id><ref id=""ref111""><mixed-citation id=""cit111"" publication-type=""journal""><name><surname>Bryant</surname><given-names>J. E.</given-names></name>;<name><surname>Lecomte</surname><given-names>J. T. J.</given-names></name>;<name><surname>Lee</surname><given-names>A. L.</given-names></name>;<name><surname>Young</surname><given-names>G. B.</given-names></name>;<name><surname>Pielak</surname><given-names>G. J.</given-names></name></mixed-citation></ref></body></html>"
10.1104/pp.103.037770	"<html><body><p>MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGqbaudaqadaqaaiabdUgaRjabgwMiZkabdIha4bGaayjkaiaawMcaaiabg2da9maaqahabaWaaeWaaeaafaqabeGabaaabaGaemOBa4gabaGaem4AaSgaaaGaayjkaiaawMcaaiabdchaWnaaCaaaleqabaGaem4AaSgaaOWaaeWaaeaacqaIXaqmcqGHsislcqWGWbaCaiaawIcacaGLPaaadaahaaWcbeqaaiabd6gaUjabgkHiTiabdUgaRbaaaeaacqWGRbWAcqGHsislcqWG4baEaeaacqWGUbGBa0GaeyyeIuoaaaa@4C69@</p><p>where n is the number of all studied genes associated with a specific GO annotation, x is the number of observed genes correlated to a particular SRF and associated with this GO annotation, and p is the genomic frequency of this GO annotation, i.e. the number of genes annotated for this GO identifier divided by the number of all studied genes. P-values were Bonferroni-corrected for multiple hypothesis testing. For each SRF, the total number of tests corresponded to the number of different GO annotations of its correlated gene set.</p><sec><title>Authors' contributions</title><p>BE, KP, GH, DC and AF designed and performed experiments. KS conceived the study. KFXM and KS designed and coordinated the study. GH and KS wrote the paper. All authors read and approved the final manuscript.</p></sec><sec sec-type=""supplementary-material""><title>Supplementary Material</title><supplementary-material content-type=""local-data"" id=""S1""><caption><title>Additional file 1</title><p>Supplement. A Microsoft Excel file with a description of<italic>srf</italic>T-DNA insertion lines and a complete list of primer sequences.</p></caption><media mime-subtype=""vnd.ms-excel"" mimetype=""application"" xlink:href=""1471-2229-7-16-S1.xls""><caption><p>Click here for file</p></caption></media></supplementary-material></sec></body><back><ack><sec><title>Acknowledgements</title><p>We thank Lynette Fulton and Sureshkumar Balasubramanian for critical reading of the manuscript. We also thank members of the Schneitz lab for stimulating discussions. This work was funded by the Arabidopsis Functional Genomics Network (AFGN/NSF2010) through grants SCHN 723/2-1 and SCHN 723/2-2 from the German Research Council (DFG) to KS, by an EMBO young investigator (EMBO-YIP) fellowship to KS, and by the Free State of Bavaria. Work at MIPS (GH and KFXM) was funded by the GABI program of the German Ministry of Education and Research (BMBF).</p></sec></ack><ref-list><ref id=""B1""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Walker</surname><given-names>JC</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name></person-group><article-title>Relationship of a putative receptor protein kinase from maize to the S-locus glycoprotein of<italic>Brassica</italic></article-title><source>Nature</source><year>1990</year><volume>345</volume><fpage>743</fpage><lpage>746</lpage><pub-id pub-id-type=""pmid"">2163028</pub-id><pub-id pub-id-type=""doi"">10.1038/345743a0</pub-id></citation></ref><ref id=""B2""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Becraft</surname><given-names>PW</given-names></name></person-group><article-title>Receptor kinase signaling in plant development</article-title><source>Annu Rev Cell Dev Biol</source><year>2002</year><volume>18</volume><fpage>163</fpage><lpage>192</lpage><pub-id pub-id-type=""pmid"">12142267</pub-id><pub-id pub-id-type=""doi"">10.1146/annurev.cellbio.18.012502.083431</pub-id></citation></ref><ref id=""B3""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Diévart</surname><given-names>A</given-names></name><name><surname>Clark</surname><given-names>SE</given-names></name></person-group><article-title>LRR-containing receptors regulating plant development and defense</article-title><source>Development</source><year>2004</year><volume>131</volume><fpage>251</fpage><lpage>261</lpage><pub-id pub-id-type=""pmid"">14701679</pub-id><pub-id pub-id-type=""doi"">10.1242/dev.00998</pub-id></citation></ref><ref id=""B4""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Haffani</surname><given-names>YZ</given-names></name><name><surname>Silva</surname><given-names>NF</given-names></name><name><surname>Goring</surname><given-names>DR</given-names></name></person-group><article-title>Receptor kinase signalling in plants</article-title><source>Can J Bot</source><year>2004</year><volume>82</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type=""doi"">10.1139/b03-126</pub-id></citation></ref><ref id=""B5""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Morris</surname><given-names>ER</given-names></name><name><surname>Walker</surname><given-names>JC</given-names></name></person-group><article-title>Receptor-like protein kinases: the keys to response</article-title><source>Curr Opin Plant Biol</source><year>2003</year><volume>6</volume><fpage>339</fpage><lpage>342</lpage><pub-id pub-id-type=""pmid"">12873528</pub-id><pub-id pub-id-type=""doi"">10.1016/S1369-5266(03)00055-4</pub-id></citation></ref><ref id=""B6""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Torii</surname><given-names>KU</given-names></name></person-group><article-title>Leucine-rich repeat receptor kinases in plants: structure, function, and signal transduction pathways</article-title><source>Int Rev Cytol</source><year>2004</year><volume>234</volume><fpage>1</fpage><lpage>46</lpage><pub-id pub-id-type=""pmid"">15066372</pub-id></citation></ref><ref id=""B7""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Shiu</surname><given-names>S-H</given-names></name><name><surname>Bleecker</surname><given-names>AB</given-names></name></person-group><article-title>Receptor-like kinases from<italic>Arabidopsis</italic>form a monophyletic gene family related to animal receptor kinases</article-title><source>Proc Natl Acad of Sci USA</source><year>2001</year><volume>98</volume><fpage>10763</fpage><lpage>10768</lpage><pub-id pub-id-type=""pmid"">11526204</pub-id><pub-id pub-id-type=""doi"">10.1073/pnas.181141598</pub-id></citation></ref><ref id=""B8""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Shiu</surname><given-names>SH</given-names></name><name><surname>Bleecker</surname><given-names>AB</given-names></name></person-group><article-title>Expansion of the receptor-like kinase/Pelle gene family and receptor-like proteins in Arabidopsis</article-title><source>Plant Physiol</source><year>2003</year><volume>132</volume><fpage>530</fpage><lpage>543</lpage><pub-id pub-id-type=""pmid"">12805585</pub-id><pub-id pub-id-type=""doi"">10.1104/pp.103.021964</pub-id></citation></ref><ref id=""B9""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Kobe</surname><given-names>B</given-names></name><name><surname>Kajava</surname><given-names>AV</given-names></name></person-group><article-title>The leucine-rich repeat as a protein recognition motif</article-title><source>Curr Opin Struct Biol</source><year>2001</year><volume>11</volume><fpage>725</fpage><lpage>732</lpage><pub-id pub-id-type=""pmid"">11751054</pub-id><pub-id pub-id-type=""doi"">10.1016/S0959-440X(01)00266-4</pub-id></citation></ref><ref id=""B10""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Canales</surname><given-names>C</given-names></name><name><surname>Bhatt</surname><given-names>AM</given-names></name><name><surname>Scott</surname><given-names>R</given-names></name><name><surname>Dickinson</surname><given-names>H</given-names></name></person-group><article-title>EXS, a putative LRR receptor kinase, regulates male germline cell number and tapetal identity and promotes seed development in Arabidopsis</article-title><source>Curr Biol</source><year>2002</year><volume>12</volume><fpage>1718</fpage><lpage>1727</lpage><pub-id pub-id-type=""pmid"">12401166</pub-id><pub-id pub-id-type=""doi"">10.1016/S0960-9822(02)01151-X</pub-id></citation></ref><ref id=""B11""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Zhao</surname><given-names>DZ</given-names></name><name><surname>Wang</surname><given-names>GF</given-names></name><name><surname>Speal</surname><given-names>B</given-names></name><name><surname>Ma</surname><given-names>H</given-names></name></person-group><article-title>The excess microsporocytes1 gene encodes a putative leucine-rich repeat receptor protein kinase that controls somatic and reproductive cell fates in the Arabidopsis anther</article-title><source>Genes Dev</source><year>2002</year><volume>16</volume><fpage>2021</fpage><lpage>2031</lpage><pub-id pub-id-type=""pmid"">12154130</pub-id><pub-id pub-id-type=""doi"">10.1101/gad.997902</pub-id></citation></ref><ref id=""B12""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Albrecht</surname><given-names>C</given-names></name><name><surname>Russinova</surname><given-names>E</given-names></name><name><surname>Hecht</surname><given-names>V</given-names></name><name><surname>Baaijens</surname><given-names>E</given-names></name><name><surname>de Vries</surname><given-names>S</given-names></name></person-group><article-title>The Arabidopsis thaliana SOMATIC EMBRYOGENESIS RECEPTOR-LIKE KINASES1 and 2 control male sporogenesis</article-title><source>Plant Cell</source><year>2005</year><volume>17</volume><fpage>3337</fpage><lpage>3349</lpage><pub-id pub-id-type=""pmid"">16284305</pub-id><pub-id pub-id-type=""doi"">10.1105/tpc.105.036814</pub-id></citation></ref><ref id=""B13""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Colcombet</surname><given-names>J</given-names></name><name><surname>Boisson-Dernier</surname><given-names>A</given-names></name><name><surname>Ros-Palau</surname><given-names>R</given-names></name><name><surname>Vera</surname><given-names>CE</given-names></name><name><surname>Schroeder</surname><given-names>JI</given-names></name></person-group><article-title>Arabidopsis SOMATIC EMBRYOGENESIS RECEPTOR KINASES1 and 2 are essential for tapetum development and microspore maturation</article-title><source>Plant Cell</source><year>2005</year><volume>17</volume><fpage>3350</fpage><lpage>3361</lpage><pub-id pub-id-type=""pmid"">16284306</pub-id><pub-id pub-id-type=""doi"">10.1105/tpc.105.036731</pub-id></citation></ref><ref id=""B14""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Hord</surname><given-names>CL</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Deyoung</surname><given-names>BJ</given-names></name><name><surname>Clark</surname><given-names>SE</given-names></name><name><surname>Ma</surname><given-names>H</given-names></name></person-group><article-title>The BAM1/BAM2 Receptor-Like Kinases Are Important Regulators of Arabidopsis Early Anther Development</article-title><source>Plant Cell</source><year>2006</year><volume>18</volume><fpage>1667</fpage><lpage>1680</lpage><pub-id pub-id-type=""pmid"">16751349</pub-id><pub-id pub-id-type=""doi"">10.1105/tpc.105.036871</pub-id></citation></ref><ref id=""B15""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>DeYoung</surname><given-names>BJ</given-names></name><name><surname>Bickle</surname><given-names>KL</given-names></name><name><surname>Schrage</surname><given-names>KJ</given-names></name><name><surname>Muskett</surname><given-names>P</given-names></name><name><surname>Patel</surname><given-names>K</given-names></name><name><surname>Clark</surname><given-names>SE</given-names></name></person-group><article-title>The CLAVATA1-related BAM1, BAM2 and BAM3 receptor kinase-like proteins are required for meristem function in Arabidopsis</article-title><source>Plant J</source><year>2006</year><volume>45</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type=""pmid"">16367950</pub-id><pub-id pub-id-type=""doi"">10.1111/j.1365-313X.2005.02592.x</pub-id></citation></ref><ref id=""B16""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Li</surname><given-names>J</given-names></name></person-group><article-title>Brassinosteroid signaling: from receptor kinases to transcription factors</article-title><source>Curr Opin Plant Biol</source><year>2005</year><volume>8</volume><fpage>526</fpage><lpage>531</lpage><pub-id pub-id-type=""pmid"">16054433</pub-id><pub-id pub-id-type=""doi"">10.1016/j.pbi.2005.07.009</pub-id></citation></ref><ref id=""B17""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Vert</surname><given-names>G</given-names></name><name><surname>Nemhauser</surname><given-names>JL</given-names></name><name><surname>Geldner</surname><given-names>N</given-names></name><name><surname>Hong</surname><given-names>F</given-names></name><name><surname>Chory</surname><given-names>J</given-names></name></person-group><article-title>Molecular mechanisms of steroid hormone signaling in plants</article-title><source>Annu Rev Cell Dev Biol</source><year>2005</year><volume>21</volume><fpage>177</fpage><lpage>201</lpage><pub-id pub-id-type=""pmid"">16212492</pub-id><pub-id pub-id-type=""doi"">10.1146/annurev.cellbio.21.090704.151241</pub-id></citation></ref><ref id=""B18""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Li</surname><given-names>JM</given-names></name><name><surname>Chory</surname><given-names>J</given-names></name></person-group><article-title>A putative leucine-rich repeat receptor kinase involved in brassinosteroid signal transduction</article-title><source>Cell</source><year>1997</year><volume>90</volume><fpage>929</fpage><lpage>938</lpage><pub-id pub-id-type=""pmid"">9298904</pub-id><pub-id pub-id-type=""doi"">10.1016/S0092-8674(00)80357-8</pub-id></citation></ref><ref id=""B19""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Kinoshita</surname><given-names>T</given-names></name><name><surname>Caño-Delgado</surname><given-names>A</given-names></name><name><surname>Seto</surname><given-names>H</given-names></name><name><surname>Hiranuma</surname><given-names>S</given-names></name><name><surname>Fujioka</surname><given-names>S</given-names></name><name><surname>Yoshida</surname><given-names>S</given-names></name><name><surname>Chory</surname><given-names>J</given-names></name></person-group><article-title>Binding of brassinosteroids to the extracellular domain of plant receptor kinase BRI1</article-title><source>Nature</source><year>2005</year><volume>433</volume><fpage>167</fpage><lpage>171</lpage><pub-id pub-id-type=""pmid"">15650741</pub-id><pub-id pub-id-type=""doi"">10.1038/nature03227</pub-id></citation></ref><ref id=""B20""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Wang</surname><given-names>Z-Y</given-names></name><name><surname>Seto</surname><given-names>H</given-names></name><name><surname>Fujioka</surname><given-names>S</given-names></name><name><surname>Yoshida</surname><given-names>S</given-names></name><name><surname>Chory</surname><given-names>J</given-names></name></person-group><article-title>BR1 is a critical component of a plasma-membrane receptor for plant steroids</article-title><source>Nature</source><year>2001</year><volume>410</volume><fpage>380</fpage><lpage>383</lpage><pub-id pub-id-type=""pmid"">11268216</pub-id><pub-id pub-id-type=""doi"">10.1038/35066597</pub-id></citation></ref><ref id=""B21""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Clay</surname><given-names>NK</given-names></name><name><surname>Nelson</surname><given-names>T</given-names></name></person-group><article-title>VH1, a provascular cell-specific receptor kinase that influences leaf cell patterns in Arabidopsis</article-title><source>Plant Cell</source><year>2002</year><volume>14</volume><fpage>2707</fpage><lpage>2722</lpage><pub-id pub-id-type=""pmid"">12417696</pub-id><pub-id pub-id-type=""doi"">10.1105/tpc.005884</pub-id></citation></ref><ref id=""B22""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Caño-Delgado</surname><given-names>A</given-names></name><name><surname>Yin</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>C</given-names></name><name><surname>Vafeados</surname><given-names>D</given-names></name><name><surname>Mora-García</surname><given-names>S</given-names></name><name><surname>Cheng</surname><given-names>JC</given-names></name><name><surname>Nam</surname><given-names>KH</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Chory</surname><given-names>J</given-names></name></person-group><article-title>BRL1 and BRL3 are novel brassinosteroid receptors that function in vascular differentiation in Arabidopsis</article-title><source>Development</source><year>2004</year><volume>131</volume><fpage>5341</fpage><lpage>5351</lpage><pub-id pub-id-type=""pmid"">15486337</pub-id><pub-id pub-id-type=""doi"">10.1242/dev.01403</pub-id></citation></ref><ref id=""B23""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Zhou</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Walker</surname><given-names>JC</given-names></name><name><surname>Li</surname><given-names>J</given-names></name></person-group><article-title>BRL1, a leucine-rich repeat receptor-like protein kinase, is functionally redundant with BRI1 in regulating Arabidopsis brassinosteroid signaling</article-title><source>Plant J</source><year>2004</year><volume>40</volume><fpage>399</fpage><lpage>409</lpage><pub-id pub-id-type=""pmid"">15469497</pub-id><pub-id pub-id-type=""doi"">10.1111/j.1365-313X.2004.02214.x</pub-id></citation></ref><ref id=""B24""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Friedrichsen</surname><given-names>DM</given-names></name><name><surname>Joazeiro</surname><given-names>CAP</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Hunter</surname><given-names>T</given-names></name><name><surname>Chory</surname><given-names>J</given-names></name></person-group><article-title>Brassinosteroid-insensitive-1 is a ubiquitously expressed leucine-rich repeat receptor serine/threonine kinase</article-title><source>Plant Physiol</source><year>2000</year><volume>123</volume><fpage>1247</fpage><lpage>1255</lpage><pub-id pub-id-type=""pmid"">10938344</pub-id><pub-id pub-id-type=""doi"">10.1104/pp.123.4.1247</pub-id></citation></ref><ref id=""B25""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Shpak</surname><given-names>ED</given-names></name><name><surname>Berthiaume</surname><given-names>CT</given-names></name><name><surname>Hill</surname><given-names>EJ</given-names></name><name><surname>Torii</surname><given-names>KU</given-names></name></person-group><article-title>Synergistic interaction of three ERECTA-family receptor-like kinases controls Arabidopsis organ growth and flower development by promoting cell proliferation</article-title><source>Development</source><year>2004</year><volume>131</volume><fpage>1491</fpage><lpage>1501</lpage><pub-id pub-id-type=""pmid"">14985254</pub-id><pub-id pub-id-type=""doi"">10.1242/dev.01028</pub-id></citation></ref><ref id=""B26""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Shpak</surname><given-names>ED</given-names></name><name><surname>McAbee</surname><given-names>JM</given-names></name><name><surname>Pillitteri</surname><given-names>LJ</given-names></name><name><surname>Torii</surname><given-names>KU</given-names></name></person-group><article-title>Stomatal patterning and differentiation by synergistic interactions of receptor kinases</article-title><source>Science</source><year>2005</year><volume>309</volume><fpage>290</fpage><lpage>293</lpage><pub-id pub-id-type=""pmid"">16002616</pub-id><pub-id pub-id-type=""doi"">10.1126/science.1109710</pub-id></citation></ref><ref id=""B27""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Torii</surname><given-names>KU</given-names></name><name><surname>Mitsukawa</surname><given-names>N</given-names></name><name><surname>Oosumi</surname><given-names>T</given-names></name><name><surname>Matsuura</surname><given-names>Y</given-names></name><name><surname>Yokoyama</surname><given-names>R</given-names></name><name><surname>Whittier</surname><given-names>RF</given-names></name><name><surname>Komeda</surname><given-names>Y</given-names></name></person-group><article-title>The Arabidopsis<italic>ERECTA</italic>gene encodes a putative receptor protein kinase with extracellular leucine-rich repeats</article-title><source>Plant Cell</source><year>1996</year><volume>8</volume><fpage>735</fpage><lpage>746</lpage><pub-id pub-id-type=""pmid"">8624444</pub-id><pub-id pub-id-type=""doi"">10.1105/tpc.8.4.735</pub-id></citation></ref><ref id=""B28""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Schneitz</surname><given-names>K</given-names></name><name><surname>Hülskamp</surname><given-names>M</given-names></name><name><surname>Kopczak</surname><given-names>SD</given-names></name><name><surname>Pruitt</surname><given-names>RE</given-names></name></person-group><article-title>Dissection of sexual organ ontogenesis: a genetic analysis of ovule development in<italic>Arabidopsis thaliana</italic></article-title><source>Development</source><year>1997</year><volume>124</volume><fpage>1367</fpage><lpage>1376</lpage><pub-id pub-id-type=""pmid"">9118807</pub-id></citation></ref><ref id=""B29""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Chevalier</surname><given-names>D</given-names></name><name><surname>Batoux</surname><given-names>M</given-names></name><name><surname>Fulton</surname><given-names>L</given-names></name><name><surname>Pfister</surname><given-names>K</given-names></name><name><surname>Yadav</surname><given-names>RK</given-names></name><name><surname>Schellenberg</surname><given-names>M</given-names></name><name><surname>Schneitz</surname><given-names>K</given-names></name></person-group><article-title><italic>STRUBBELIG</italic>defines a receptor kinase-mediated signaling pathway regulating organ development in<italic>Arabidopsis</italic></article-title><source>Proc Natl Acad Sci USA</source><year>2005</year><volume>102</volume><fpage>9074</fpage><lpage>9079</lpage><pub-id pub-id-type=""pmid"">15951420</pub-id><pub-id pub-id-type=""doi"">10.1073/pnas.0503526102</pub-id></citation></ref><ref id=""B30""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Kwak</surname><given-names>SH</given-names></name><name><surname>Schiefelbein</surname><given-names>J</given-names></name></person-group><article-title>The role of the SCRAMBLED receptor-like kinase in patterning the Arabidopsis root epidermis</article-title><source>Dev Biol</source><year>2007</year><volume>302</volume><fpage>118</fpage><lpage>131</lpage><pub-id pub-id-type=""pmid"">17027738</pub-id><pub-id pub-id-type=""doi"">10.1016/j.ydbio.2006.09.009</pub-id></citation></ref><ref id=""B31""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Kwak</surname><given-names>SH</given-names></name><name><surname>Shen</surname><given-names>R</given-names></name><name><surname>Schiefelbein</surname><given-names>J</given-names></name></person-group><article-title>Positional signaling mediated by a receptor-like kinase in Arabidopsis</article-title><source>Science</source><year>2005</year><volume>307</volume><fpage>1111</fpage><lpage>1113</lpage><pub-id pub-id-type=""pmid"">15618487</pub-id><pub-id pub-id-type=""doi"">10.1126/science.1105373</pub-id></citation></ref><ref id=""B32""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Kroiher</surname><given-names>M</given-names></name><name><surname>Miller</surname><given-names>MA</given-names></name><name><surname>Steele</surname><given-names>RE</given-names></name></person-group><article-title>Deceiving appearances: signaling by ""dead"" and ""fractured"" receptor protein-tyrosine kinases</article-title><source>Bioessays</source><year>2001</year><volume>23</volume><fpage>69</fpage><lpage>76</lpage><pub-id pub-id-type=""pmid"">11135311</pub-id><pub-id pub-id-type=""doi"">10.1002/1521-1878(200101)23:1&lt;69::AID-BIES1009&gt;3.0.CO;2-K</pub-id></citation></ref><ref id=""B33""><citation citation-type=""other""><article-title>Arabidopsis Strubbelig Receptor Gene Family</article-title><ext-link ext-link-type=""uri"" xlink:href=""http://www.arabidopsis.org/browse/genefamily/lrrv.jsp""></ext-link></citation></ref><ref id=""B34""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Wurtzel</surname><given-names>ET</given-names></name></person-group><article-title>The<italic>ltk</italic>gene family encodes novel receptor-like kinases with temporal expression in developing maize endosperm</article-title><source>Plant Mol Biol</source><year>1998</year><volume>37</volume><fpage>749</fpage><lpage>761</lpage><pub-id pub-id-type=""pmid"">9678570</pub-id><pub-id pub-id-type=""doi"">10.1023/A:1006012530241</pub-id></citation></ref><ref id=""B35""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Blanc</surname><given-names>G</given-names></name><name><surname>Hokamp</surname><given-names>K</given-names></name><name><surname>Wolfe</surname><given-names>KH</given-names></name></person-group><article-title>A recent polyploidy superimposed on older large-scale duplications in the Arabidopsis genome</article-title><source>Genome Res</source><year>2003</year><volume>13</volume><fpage>137</fpage><lpage>144</lpage><pub-id pub-id-type=""pmid"">12566392</pub-id><pub-id pub-id-type=""doi"">10.1101/gr.751803</pub-id></citation></ref><ref id=""B36""><citation citation-type=""other""><article-title>MIPS Arabidopsis thaliana Database</article-title><ext-link ext-link-type=""uri"" xlink:href=""http://mips.gsf.de/proj/plant/jsf/athal/index.jsp""></ext-link></citation></ref><ref id=""B37""><citation citation-type=""other""><article-title>The Arabidopsis Information Resource</article-title><ext-link ext-link-type=""uri"" xlink:href=""http://www.arabidopsis.org""></ext-link></citation></ref><ref id=""B38""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Hanks</surname><given-names>SK</given-names></name><name><surname>Quinn</surname><given-names>AM</given-names></name></person-group><article-title>Protein kinase catalytic domain sequence database: identification of conserved features of primary structure and classification of family members</article-title><source>Methods in Enzymology</source><year>1991</year><volume>200</volume><fpage>38</fpage><lpage>62</lpage><pub-id pub-id-type=""pmid"">1956325</pub-id></citation></ref><ref id=""B39""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Scheeff</surname><given-names>ED</given-names></name><name><surname>Bourne</surname><given-names>PE</given-names></name></person-group><article-title>Structural evolution of the protein kinase-like superfamily</article-title><source>PLoS Comput Biol</source><year>2005</year><volume>1</volume><fpage>e49</fpage><pub-id pub-id-type=""pmid"">16244704</pub-id><pub-id pub-id-type=""doi"">10.1371/journal.pcbi.0010049</pub-id></citation></ref><ref id=""B40""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Huse</surname><given-names>M</given-names></name><name><surname>Kuriyan</surname><given-names>J</given-names></name></person-group><article-title>The conformational plasticity of protein kinases</article-title><source>Cell</source><year>2002</year><volume>109</volume><fpage>275</fpage><lpage>282</lpage><pub-id pub-id-type=""pmid"">12015977</pub-id><pub-id pub-id-type=""doi"">10.1016/S0092-8674(02)00741-9</pub-id></citation></ref><ref id=""B41""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Johnson</surname><given-names>LN</given-names></name><name><surname>Noble</surname><given-names>MEM</given-names></name><name><surname>Owen</surname><given-names>DJ</given-names></name></person-group><article-title>Active and inactive protein kinases: structural basis for regulation</article-title><source>Cell</source><year>1996</year><volume>85</volume><fpage>149</fpage><lpage>158</lpage><pub-id pub-id-type=""pmid"">8612268</pub-id><pub-id pub-id-type=""doi"">10.1016/S0092-8674(00)81092-2</pub-id></citation></ref><ref id=""B42""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Nühse</surname><given-names>TS</given-names></name><name><surname>Stensballe</surname><given-names>A</given-names></name><name><surname>Jensen</surname><given-names>ON</given-names></name><name><surname>Peck</surname><given-names>SC</given-names></name></person-group><article-title>Phosphoproteomics of the Arabidopsis plasma membrane and a new phosphorylation site database</article-title><source>Plant Cell</source><year>2004</year><volume>16</volume><fpage>2394</fpage><lpage>2405</lpage><pub-id pub-id-type=""pmid"">15308754</pub-id><pub-id pub-id-type=""doi"">10.1105/tpc.104.023150</pub-id></citation></ref><ref id=""B43""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Jeong</surname><given-names>S</given-names></name><name><surname>Trotochaud</surname><given-names>AE</given-names></name><name><surname>Clark</surname><given-names>SE</given-names></name></person-group><article-title>The<italic>Arabidopsis CLAVATA2</italic>gene encodes a receptor-like protein required for the stability of the CLAVATA1 receptor-like kinase</article-title><source>Plant Cell</source><year>1999</year><volume>11</volume><fpage>1925</fpage><lpage>1934</lpage><pub-id pub-id-type=""pmid"">10521522</pub-id><pub-id pub-id-type=""doi"">10.1105/tpc.11.10.1925</pub-id></citation></ref><ref id=""B44""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Jones</surname><given-names>DA</given-names></name><name><surname>Thomas</surname><given-names>CM</given-names></name><name><surname>Hammond-Kosack</surname><given-names>KE</given-names></name><name><surname>Balint-Kurti</surname><given-names>PJ</given-names></name><name><surname>Jones</surname><given-names>JD</given-names></name></person-group><article-title>Isolation of the tomato<italic>Cf-9</italic>gene for resistance to<italic>Cladosporium fulvum</italic>by transposon tagging</article-title><source>Science</source><year>1994</year><volume>266</volume><fpage>789</fpage><lpage>793</lpage><pub-id pub-id-type=""pmid"">7973631</pub-id><pub-id pub-id-type=""doi"">10.1126/science.7973631</pub-id></citation></ref><ref id=""B45""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Nadeau</surname><given-names>JA</given-names></name><name><surname>Sack</surname><given-names>FD</given-names></name></person-group><article-title>Control of stomatal distribution on the Arabidopsis leaf surface</article-title><source>Science</source><year>2002</year><volume>296</volume><fpage>1697</fpage><lpage>1700</lpage><pub-id pub-id-type=""pmid"">12040198</pub-id><pub-id pub-id-type=""doi"">10.1126/science.1069596</pub-id></citation></ref><ref id=""B46""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Tör</surname><given-names>M</given-names></name><name><surname>Brown</surname><given-names>D</given-names></name><name><surname>Cooper</surname><given-names>A</given-names></name><name><surname>Woods-Tor</surname><given-names>A</given-names></name><name><surname>Sjölander</surname><given-names>K</given-names></name><name><surname>Jones</surname><given-names>JD</given-names></name><name><surname>Holub</surname><given-names>EB</given-names></name></person-group><article-title>Arabidopsis downy mildew resistance gene RPP27 encodes a receptor-like protein similar to CLAVATA2 and tomato Cf-9</article-title><source>Plant Physiol</source><year>2004</year><volume>135</volume><fpage>1100</fpage><lpage>1112</lpage><pub-id pub-id-type=""pmid"">15155873</pub-id><pub-id pub-id-type=""doi"">10.1104/pp.103.037770</pub-id></citation></ref><ref id=""B47""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Nordborg</surname><given-names>M</given-names></name><name><surname>Hu</surname><given-names>TT</given-names></name><name><surname>Ishino</surname><given-names>Y</given-names></name><name><surname>Jhaveri</surname><given-names>J</given-names></name><name><surname>Toomajian</surname><given-names>C</given-names></name><name><surname>Zheng</surname><given-names>H</given-names></name><name><surname>Bakker</surname><given-names>E</given-names></name><name><surname>Calabrese</surname><given-names>P</given-names></name><name><surname>Gladstone</surname><given-names>J</given-names></name><name><surname>Goyal</surname><given-names>R</given-names></name><etal></etal></person-group><article-title>The pattern of polymorphism in Arabidopsis thaliana</article-title><source>PLoS Biol</source><year>2005</year><volume>3</volume><fpage>e196</fpage><pub-id pub-id-type=""pmid"">15907155</pub-id><pub-id pub-id-type=""doi"">10.1371/journal.pbio.0030196</pub-id></citation></ref><ref id=""B48""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Tsuge</surname><given-names>T</given-names></name><name><surname>Tsukaya</surname><given-names>H</given-names></name><name><surname>Uchimiya</surname><given-names>H</given-names></name></person-group><article-title>Two independent and poarized processes of cell elongation regulate leaf blade expansion in<italic>Arabidopsis</italic></article-title><source>Development</source><year>1996</year><volume>122</volume><fpage>1589</fpage><lpage>1600</lpage><pub-id pub-id-type=""pmid"">8625845</pub-id></citation></ref><ref id=""B49""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Odell</surname><given-names>JT</given-names></name><name><surname>Nagy</surname><given-names>F</given-names></name><name><surname>Chua</surname><given-names>NH</given-names></name></person-group><article-title>Identification of DNA sequences required for activity of the cauliflower mosaic virus 35S promoter</article-title><source>Nature</source><year>1985</year><volume>313</volume><fpage>810</fpage><lpage>812</lpage><pub-id pub-id-type=""pmid"">3974711</pub-id><pub-id pub-id-type=""doi"">10.1038/313810a0</pub-id></citation></ref><ref id=""B50""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Craigon</surname><given-names>DJ</given-names></name><name><surname>James</surname><given-names>N</given-names></name><name><surname>Okyere</surname><given-names>J</given-names></name><name><surname>Higgins</surname><given-names>J</given-names></name><name><surname>Jotham</surname><given-names>J</given-names></name><name><surname>May</surname><given-names>S</given-names></name></person-group><article-title>NASCArrays: a repository for microarray data generated by NASC's transcriptomics service</article-title><source>Nucleic Acids Res</source><year>2004</year><volume>32</volume><fpage>D575</fpage><lpage>577</lpage><pub-id pub-id-type=""pmid"">14681484</pub-id><pub-id pub-id-type=""doi"">10.1093/nar/gkh133</pub-id></citation></ref><ref id=""B51""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Schmid</surname><given-names>M</given-names></name><name><surname>Davison</surname><given-names>TS</given-names></name><name><surname>Henz</surname><given-names>SR</given-names></name><name><surname>Pape</surname><given-names>UJ</given-names></name><name><surname>Demar</surname><given-names>M</given-names></name><name><surname>Vingron</surname><given-names>M</given-names></name><name><surname>Scholkopf</surname><given-names>B</given-names></name><name><surname>Weigel</surname><given-names>D</given-names></name><name><surname>Lohmann</surname><given-names>JU</given-names></name></person-group><article-title>A gene expression map of<italic>Arabidopsis thaliana</italic>development</article-title><source>Nat Genet</source><year>2005</year><volume>37</volume><fpage>501</fpage><lpage>506</lpage><pub-id pub-id-type=""pmid"">15806101</pub-id><pub-id pub-id-type=""doi"">10.1038/ng1543</pub-id></citation></ref><ref id=""B52""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Becker</surname><given-names>JD</given-names></name><name><surname>Boavida</surname><given-names>LC</given-names></name><name><surname>Carneiro</surname><given-names>J</given-names></name><name><surname>Haury</surname><given-names>M</given-names></name><name><surname>Feijo</surname><given-names>JA</given-names></name></person-group><article-title>Transcriptional profiling of Arabidopsis tissues reveals the unique characteristics of the pollen transcriptome</article-title><source>Plant Physiol</source><year>2003</year><volume>133</volume><fpage>713</fpage><lpage>725</lpage><pub-id pub-id-type=""pmid"">14500793</pub-id><pub-id pub-id-type=""doi"">10.1104/pp.103.028241</pub-id></citation></ref><ref id=""B53""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Schiefelbein</surname><given-names>J</given-names></name><name><surname>Somerville</surname><given-names>C</given-names></name></person-group><article-title>Genetic control of root hair development in<italic>Arabidopsis thaliana</italic></article-title><source>Plant Cell</source><year>1990</year><volume>2</volume><fpage>235</fpage><lpage>243</lpage><pub-id pub-id-type=""pmid"">12354956</pub-id><pub-id pub-id-type=""doi"">10.1105/tpc.2.3.235</pub-id></citation></ref><ref id=""B54""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>DeRisi</surname><given-names>JL</given-names></name><name><surname>Iyer</surname><given-names>VR</given-names></name><name><surname>Brown</surname><given-names>PO</given-names></name></person-group><article-title>Exploring the metabolic and genetic control of gene expression on a genomic scale</article-title><source>Science</source><year>1997</year><volume>278</volume><fpage>680</fpage><lpage>686</lpage><pub-id pub-id-type=""pmid"">9381177</pub-id><pub-id pub-id-type=""doi"">10.1126/science.278.5338.680</pub-id></citation></ref><ref id=""B55""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Hughes</surname><given-names>TR</given-names></name><name><surname>Marton</surname><given-names>MJ</given-names></name><name><surname>Jones</surname><given-names>AR</given-names></name><name><surname>Roberts</surname><given-names>CJ</given-names></name><name><surname>Stoughton</surname><given-names>R</given-names></name><name><surname>Armour</surname><given-names>CD</given-names></name><name><surname>Bennett</surname><given-names>HA</given-names></name><name><surname>Coffey</surname><given-names>E</given-names></name><name><surname>Dai</surname><given-names>H</given-names></name><name><surname>He</surname><given-names>YD</given-names></name><etal></etal></person-group><article-title>Functional discovery via a compendium of expression profiles</article-title><source>Cell</source><year>2000</year><volume>102</volume><fpage>109</fpage><lpage>126</lpage><pub-id pub-id-type=""pmid"">10929718</pub-id><pub-id pub-id-type=""doi"">10.1016/S0092-8674(00)00015-5</pub-id></citation></ref><ref id=""B56""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Rautengarten</surname><given-names>C</given-names></name><name><surname>Steinhauser</surname><given-names>D</given-names></name><name><surname>Büssis</surname><given-names>D</given-names></name><name><surname>Stintzi</surname><given-names>A</given-names></name><name><surname>Schaller</surname><given-names>A</given-names></name><name><surname>Kopka</surname><given-names>J</given-names></name><name><surname>Altmann</surname><given-names>T</given-names></name></person-group><article-title>Inferring hypotheses on functional relationships of genes: analysis of the<italic>Arabidopsis thaliana</italic>subtilase gene family</article-title><source>PLoS Comput Biol</source><year>2005</year><volume>1</volume><fpage>e40</fpage><pub-id pub-id-type=""pmid"">16193095</pub-id><pub-id pub-id-type=""doi"">10.1371/journal.pcbi.0010040</pub-id></citation></ref><ref id=""B57""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Berardini</surname><given-names>TZ</given-names></name><name><surname>Mundodi</surname><given-names>S</given-names></name><name><surname>Reiser</surname><given-names>L</given-names></name><name><surname>Huala</surname><given-names>E</given-names></name><name><surname>Garcia-Hernandez</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Mueller</surname><given-names>LA</given-names></name><name><surname>Yoon</surname><given-names>J</given-names></name><name><surname>Doyle</surname><given-names>A</given-names></name><name><surname>Lander</surname><given-names>G</given-names></name><etal></etal></person-group><article-title>Functional annotation of the Arabidopsis genome using controlled vocabularies</article-title><source>Plant Physiol</source><year>2004</year><volume>135</volume><fpage>745</fpage><lpage>755</lpage><pub-id pub-id-type=""pmid"">15173566</pub-id><pub-id pub-id-type=""doi"">10.1104/pp.104.040071</pub-id></citation></ref><ref id=""B58""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Fritz-Laylin</surname><given-names>LK</given-names></name><name><surname>Krishnamurthy</surname><given-names>N</given-names></name><name><surname>Tör</surname><given-names>M</given-names></name><name><surname>Sjölander</surname><given-names>KV</given-names></name><name><surname>Jones</surname><given-names>JD</given-names></name></person-group><article-title>Phylogenomic analysis of the receptor-like proteins of rice and Arabidopsis</article-title><source>Plant Physiol</source><year>2005</year><volume>138</volume><fpage>611</fpage><lpage>623</lpage><pub-id pub-id-type=""pmid"">15955925</pub-id><pub-id pub-id-type=""doi"">10.1104/pp.104.054452</pub-id></citation></ref><ref id=""B59""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Giranton</surname><given-names>JL</given-names></name><name><surname>Ariza</surname><given-names>MJ</given-names></name><name><surname>Dumas</surname><given-names>C</given-names></name><name><surname>Cock</surname><given-names>JM</given-names></name><name><surname>Gaude</surname><given-names>T</given-names></name></person-group><article-title>The S locus receptor kinase gene encodes a soluble glycoprotein corresponding to the SKR extracellular domain in Brassica oleracea</article-title><source>Plant J</source><year>1995</year><volume>8</volume><fpage>827</fpage><lpage>834</lpage><pub-id pub-id-type=""pmid"">8580956</pub-id></citation></ref><ref id=""B60""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Suzuki</surname><given-names>G</given-names></name><name><surname>Watanabe</surname><given-names>M</given-names></name><name><surname>Toriyama</surname><given-names>K</given-names></name><name><surname>Isogai</surname><given-names>A</given-names></name><name><surname>Hinata</surname><given-names>K</given-names></name></person-group><article-title>Expression of SLG9 and SRK9 genes in transgenic tobacco</article-title><source>Plant and Cell Physiology</source><year>1996</year><volume>37</volume><fpage>866</fpage><lpage>869</lpage></citation></ref><ref id=""B61""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Dixon</surname><given-names>MS</given-names></name><name><surname>Jones</surname><given-names>DA</given-names></name><name><surname>Keddie</surname><given-names>JS</given-names></name><name><surname>Thomas</surname><given-names>CM</given-names></name><name><surname>Harrison</surname><given-names>K</given-names></name><name><surname>Jones</surname><given-names>JD</given-names></name></person-group><article-title>The tomato<italic>Cf-2</italic>disease resistance locus comprises two functional genes encoding leucine-rich repeat proteins</article-title><source>Cell</source><year>1996</year><volume>84</volume><fpage>451</fpage><lpage>459</lpage><pub-id pub-id-type=""pmid"">8608599</pub-id><pub-id pub-id-type=""doi"">10.1016/S0092-8674(00)81290-8</pub-id></citation></ref><ref id=""B62""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Nasrallah</surname><given-names>JB</given-names></name><name><surname>Kao</surname><given-names>T-H</given-names></name><name><surname>Goldberg</surname><given-names>ML</given-names></name><name><surname>Nasrallah</surname><given-names>ME</given-names></name></person-group><article-title>A cDNA clone encoding an S-locus-specific glycoprotein from<italic>Brassica oleracea</italic></article-title><source>Nature</source><year>1985</year><volume>318</volume><fpage>263</fpage><lpage>267</lpage><pub-id pub-id-type=""doi"">10.1038/318263a0</pub-id></citation></ref><ref id=""B63""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Wang</surname><given-names>GL</given-names></name><name><surname>Ruan</surname><given-names>DL</given-names></name><name><surname>Song</surname><given-names>WY</given-names></name><name><surname>Sideris</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Pi</surname><given-names>LY</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Fauquet</surname><given-names>C</given-names></name><name><surname>Gaut</surname><given-names>BS</given-names></name><etal></etal></person-group><article-title>Xa21D encodes a receptor-like molecule with a leucine-rich repeat domain that determines race-specific recognition and is subject to adaptive evolution</article-title><source>Plant Cell</source><year>1998</year><volume>10</volume><fpage>765</fpage><lpage>779</lpage><pub-id pub-id-type=""pmid"">9596635</pub-id><pub-id pub-id-type=""doi"">10.1105/tpc.10.5.765</pub-id></citation></ref><ref id=""B64""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Song</surname><given-names>W-Y</given-names></name><name><surname>Wang</surname><given-names>G-L</given-names></name><name><surname>Chen</surname><given-names>L-L</given-names></name><name><surname>Kim</surname><given-names>H-S</given-names></name><name><surname>Pi</surname><given-names>L-Y</given-names></name><name><surname>Holsten</surname><given-names>T</given-names></name><name><surname>Gardner</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Zhai</surname><given-names>W-X</given-names></name><name><surname>Zhu</surname><given-names>L-H</given-names></name><etal></etal></person-group><article-title>A receptor kinase-like protein encoded by the rice resistance gene,<italic>Xa21</italic></article-title><source>Science</source><year>1995</year><volume>270</volume><fpage>1804</fpage><lpage>1806</lpage><pub-id pub-id-type=""pmid"">8525370</pub-id><pub-id pub-id-type=""doi"">10.1126/science.270.5243.1804</pub-id></citation></ref><ref id=""B65""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Wang</surname><given-names>GL</given-names></name><name><surname>Song</surname><given-names>WY</given-names></name><name><surname>Ruan</surname><given-names>DL</given-names></name><name><surname>Sideris</surname><given-names>S</given-names></name><name><surname>Ronald</surname><given-names>PC</given-names></name></person-group><article-title>The cloned gene, Xa21, confers resistance to multiple Xanthomonas oryzae pv. oryzae isolates in transgenic plants</article-title><source>Mol Plant Microbe Interact</source><year>1996</year><volume>9</volume><fpage>850</fpage><lpage>855</lpage><pub-id pub-id-type=""pmid"">8969533</pub-id></citation></ref><ref id=""B66""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Kayes</surname><given-names>JM</given-names></name><name><surname>Clark</surname><given-names>SE</given-names></name></person-group><article-title><italic>CLAVATA2</italic>, a regulator of meristem and organ development in<italic>Arabidopsis</italic></article-title><source>Development</source><year>1998</year><volume>125</volume><fpage>3843</fpage><lpage>3851</lpage><pub-id pub-id-type=""pmid"">9729492</pub-id></citation></ref><ref id=""B67""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Trotochaud</surname><given-names>AE</given-names></name><name><surname>Hao</surname><given-names>T</given-names></name><name><surname>Wu</surname><given-names>G</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Clark</surname><given-names>SE</given-names></name></person-group><article-title>The CLAVATA1 receptor-like kinase requires CLAVATA3 for its assembly into a signaling complex that includes KAPP and a Rho-related protein</article-title><source>Plant Cell</source><year>1999</year><volume>11</volume><fpage>393</fpage><lpage>406</lpage><pub-id pub-id-type=""pmid"">10072399</pub-id><pub-id pub-id-type=""doi"">10.1105/tpc.11.3.393</pub-id></citation></ref><ref id=""B68""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Kemp</surname><given-names>BP</given-names></name><name><surname>Doughty</surname><given-names>J</given-names></name></person-group><article-title>Just how complex is the Brassica S-receptor complex?</article-title><source>J Exp Bot</source><year>2003</year><volume>54</volume><fpage>157</fpage><lpage>168</lpage><pub-id pub-id-type=""pmid"">12456766</pub-id><pub-id pub-id-type=""doi"">10.1093/jxb/54.380.157</pub-id></citation></ref><ref id=""B69""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Takayama</surname><given-names>S</given-names></name><name><surname>Isogai</surname><given-names>A</given-names></name></person-group><article-title>Molecular mechanism of self-recognition in Brassica self-incompatibility</article-title><source>J Exp Bot</source><year>2003</year><volume>54</volume><fpage>149</fpage><lpage>156</lpage><pub-id pub-id-type=""pmid"">12456765</pub-id><pub-id pub-id-type=""doi"">10.1093/jxb/54.380.149</pub-id></citation></ref><ref id=""B70""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Giranton</surname><given-names>JL</given-names></name><name><surname>Dumas</surname><given-names>C</given-names></name><name><surname>Cock</surname><given-names>JM</given-names></name><name><surname>Gaude</surname><given-names>T</given-names></name></person-group><article-title>The integral membrane<italic>S</italic>-locus receptor kinase of<italic>Brassica</italic>has serine/threonine kinase activity in a membranous environment and spontaneously forms oligomers<italic>in planta</italic></article-title><source>Proc Natl Acad Sci USA</source><year>2000</year><volume>97</volume><fpage>3759</fpage><lpage>3764</lpage><pub-id pub-id-type=""pmid"">10725390</pub-id><pub-id pub-id-type=""doi"">10.1073/pnas.070025097</pub-id></citation></ref><ref id=""B71""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Takayama</surname><given-names>S</given-names></name><name><surname>Shimosato</surname><given-names>H</given-names></name><name><surname>Shiba</surname><given-names>H</given-names></name><name><surname>Funato</surname><given-names>M</given-names></name><name><surname>Che</surname><given-names>F-S</given-names></name><name><surname>Watanabe</surname><given-names>M</given-names></name><name><surname>Iwano</surname><given-names>M</given-names></name><name><surname>Isogai</surname><given-names>A</given-names></name></person-group><article-title>Direct ligand-receptor complex interaction controls<italic>Brassica</italic>self-incompatibility</article-title><source>Nature</source><year>2001</year><volume>413</volume><fpage>535</fpage><lpage>538</lpage><pub-id pub-id-type=""doi"">10.1038/35097104</pub-id></citation></ref><ref id=""B72""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Takasaki</surname><given-names>T</given-names></name><name><surname>Hatakeyama</surname><given-names>K</given-names></name><name><surname>Suzuki</surname><given-names>G</given-names></name><name><surname>Watanabe</surname><given-names>M</given-names></name><name><surname>Isogai</surname><given-names>A</given-names></name><name><surname>Hinata</surname><given-names>K</given-names></name></person-group><article-title>The<italic>S</italic>receptor kinase determines self-incompatibility in Brassica stigma</article-title><source>Nature</source><year>2000</year><volume>403</volume><fpage>913</fpage><lpage>916</lpage><pub-id pub-id-type=""pmid"">10706292</pub-id><pub-id pub-id-type=""doi"">10.1038/35002628</pub-id></citation></ref><ref id=""B73""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Dixit</surname><given-names>R</given-names></name><name><surname>Nasrallah</surname><given-names>ME</given-names></name><name><surname>Nasrallah</surname><given-names>JB</given-names></name></person-group><article-title>Post-transcriptional maturation of the S receptor kinase of Brassica correlates with co-expression of the S-locus glycoprotein in the stigmas of two Brassica strains and in transgenic tobacco plants</article-title><source>Plant Physiol</source><year>2000</year><volume>124</volume><fpage>297</fpage><lpage>311</lpage><pub-id pub-id-type=""pmid"">10982444</pub-id><pub-id pub-id-type=""doi"">10.1104/pp.124.1.297</pub-id></citation></ref><ref id=""B74""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Meyers</surname><given-names>BC</given-names></name><name><surname>Kozik</surname><given-names>A</given-names></name><name><surname>Griego</surname><given-names>A</given-names></name><name><surname>Kuang</surname><given-names>H</given-names></name><name><surname>Michelmore</surname><given-names>RW</given-names></name></person-group><article-title>Genome-wide analysis of NBS-LRR-encoding genes in Arabidopsis</article-title><source>Plant Cell</source><year>2003</year><volume>15</volume><fpage>809</fpage><lpage>834</lpage><pub-id pub-id-type=""pmid"">12671079</pub-id><pub-id pub-id-type=""doi"">10.1105/tpc.009308</pub-id></citation></ref><ref id=""B75""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Michelmore</surname><given-names>RW</given-names></name><name><surname>Meyers</surname><given-names>BC</given-names></name></person-group><article-title>Clusters of resistance genes in plants evolve by divergent selection and a birth-and-death process</article-title><source>Genome Res</source><year>1998</year><volume>8</volume><fpage>1113</fpage><lpage>1130</lpage><pub-id pub-id-type=""pmid"">9847076</pub-id></citation></ref><ref id=""B76""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Richly</surname><given-names>E</given-names></name><name><surname>Kurth</surname><given-names>J</given-names></name><name><surname>Leister</surname><given-names>D</given-names></name></person-group><article-title>Mode of amplification and reorganization of resistance genes during recent Arabidopsis thaliana evolution</article-title><source>Mol Biol Evol</source><year>2002</year><volume>19</volume><fpage>76</fpage><lpage>84</lpage><pub-id pub-id-type=""pmid"">11752192</pub-id></citation></ref><ref id=""B77""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Purugganan</surname><given-names>MD</given-names></name><name><surname>Suddith</surname><given-names>JI</given-names></name></person-group><article-title>Molecular population genetics of floral homeotic loci. Departures from the equilibrium-neutral model at the APETALA3 and PISTILLATA genes of Arabidopsis thaliana</article-title><source>Genetics</source><year>1999</year><volume>151</volume><fpage>839</fpage><lpage>848</lpage><pub-id pub-id-type=""pmid"">9927474</pub-id></citation></ref><ref id=""B78""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Purugganan</surname><given-names>MD</given-names></name><name><surname>Suddith</surname><given-names>JI</given-names></name></person-group><article-title>Molecular population genetics of the Arabidopsis CAULIFLOWER regulatory gene: nonneutral evolution and naturally occurring variation in floral homeotic function</article-title><source>Proc Natl Acad Sci USA</source><year>1998</year><volume>95</volume><fpage>8130</fpage><lpage>8134</lpage><pub-id pub-id-type=""pmid"">9653152</pub-id><pub-id pub-id-type=""doi"">10.1073/pnas.95.14.8130</pub-id></citation></ref><ref id=""B79""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Chisholm</surname><given-names>ST</given-names></name><name><surname>Coaker</surname><given-names>G</given-names></name><name><surname>Day</surname><given-names>B</given-names></name><name><surname>Staskawicz</surname><given-names>BJ</given-names></name></person-group><article-title>Host-microbe interactions: shaping the evolution of the plant immune response</article-title><source>Cell</source><year>2006</year><volume>124</volume><fpage>803</fpage><lpage>814</lpage><pub-id pub-id-type=""pmid"">16497589</pub-id><pub-id pub-id-type=""doi"">10.1016/j.cell.2006.02.008</pub-id></citation></ref><ref id=""B80""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Dangl</surname><given-names>JL</given-names></name><name><surname>Jones</surname><given-names>JD</given-names></name></person-group><article-title>Plant pathogens and integrated defence responses to infection</article-title><source>Nature</source><year>2001</year><volume>411</volume><fpage>826</fpage><lpage>833</lpage><pub-id pub-id-type=""pmid"">11459065</pub-id><pub-id pub-id-type=""doi"">10.1038/35081161</pub-id></citation></ref><ref id=""B81""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Bakker</surname><given-names>EG</given-names></name><name><surname>Toomajian</surname><given-names>C</given-names></name><name><surname>Kreitman</surname><given-names>M</given-names></name><name><surname>Bergelson</surname><given-names>J</given-names></name></person-group><article-title>A genome-wide survey of R gene polymorphisms in Arabidopsis</article-title><source>Plant Cell</source><year>2006</year><volume>18</volume><fpage>1803</fpage><lpage>1818</lpage><pub-id pub-id-type=""pmid"">16798885</pub-id><pub-id pub-id-type=""doi"">10.1105/tpc.106.042614</pub-id></citation></ref><ref id=""B82""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Botella</surname><given-names>MA</given-names></name><name><surname>Parker</surname><given-names>JE</given-names></name><name><surname>Frost</surname><given-names>LN</given-names></name><name><surname>Bittner-Eddy</surname><given-names>PD</given-names></name><name><surname>Beynon</surname><given-names>JL</given-names></name><name><surname>Daniels</surname><given-names>MJ</given-names></name><name><surname>Holub</surname><given-names>EB</given-names></name><name><surname>Jones</surname><given-names>JDG</given-names></name></person-group><article-title>Three genes of the<italic>Arabidopsis RPP1</italic>complex resistance locus recognizes distinct<italic>Peronospora parasitica</italic>avirulence determinants</article-title><source>Plant Cell</source><year>1998</year><volume>10</volume><fpage>1847</fpage><lpage>1860</lpage><pub-id pub-id-type=""pmid"">9811793</pub-id><pub-id pub-id-type=""doi"">10.1105/tpc.10.11.1847</pub-id></citation></ref><ref id=""B83""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Caicedo</surname><given-names>AL</given-names></name><name><surname>Schaal</surname><given-names>BA</given-names></name><name><surname>Kunkel</surname><given-names>BN</given-names></name></person-group><article-title>Diversity and molecular evolution of the RPS2 resistance gene in Arabidopsis thaliana</article-title><source>Proc Natl Acad Sci USA</source><year>1999</year><volume>96</volume><fpage>302</fpage><lpage>306</lpage><pub-id pub-id-type=""pmid"">9874813</pub-id><pub-id pub-id-type=""doi"">10.1073/pnas.96.1.302</pub-id></citation></ref><ref id=""B84""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Noël</surname><given-names>L</given-names></name><name><surname>Moores</surname><given-names>TL</given-names></name><name><surname>van Der Biezen</surname><given-names>EA</given-names></name><name><surname>Parniske</surname><given-names>M</given-names></name><name><surname>Daniels</surname><given-names>MJ</given-names></name><name><surname>Parker</surname><given-names>JE</given-names></name><name><surname>Jones</surname><given-names>JD</given-names></name></person-group><article-title>Pronounced intraspecific haplotype divergence at the RPP5 complex disease resistance locus of Arabidopsis</article-title><source>Plant Cell</source><year>1999</year><volume>11</volume><fpage>2099</fpage><lpage>2112</lpage><pub-id pub-id-type=""pmid"">10559437</pub-id><pub-id pub-id-type=""doi"">10.1105/tpc.11.11.2099</pub-id></citation></ref><ref id=""B85""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Stahl</surname><given-names>EA</given-names></name><name><surname>Dwyer</surname><given-names>G</given-names></name><name><surname>Mauricio</surname><given-names>R</given-names></name><name><surname>Kreitman</surname><given-names>M</given-names></name><name><surname>Bergelson</surname><given-names>J</given-names></name></person-group><article-title>Dynamics of disease resistance polymorphism at the Rpm1 locus of Arabidopsis</article-title><source>Nature</source><year>1999</year><volume>400</volume><fpage>667</fpage><lpage>671</lpage><pub-id pub-id-type=""pmid"">10458161</pub-id><pub-id pub-id-type=""doi"">10.1038/23260</pub-id></citation></ref><ref id=""B86""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Tian</surname><given-names>D</given-names></name><name><surname>Araki</surname><given-names>H</given-names></name><name><surname>Stahl</surname><given-names>E</given-names></name><name><surname>Bergelson</surname><given-names>J</given-names></name><name><surname>Kreitman</surname><given-names>M</given-names></name></person-group><article-title>Signature of balancing selection in Arabidopsis</article-title><source>Proc Natl Acad Sci USA</source><year>2002</year><volume>99</volume><fpage>11525</fpage><lpage>11530</lpage><pub-id pub-id-type=""pmid"">12172007</pub-id><pub-id pub-id-type=""doi"">10.1073/pnas.172203599</pub-id></citation></ref><ref id=""B87""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Beemster</surname><given-names>GTS</given-names></name><name><surname>Fiorani</surname><given-names>F</given-names></name><name><surname>Inzé</surname><given-names>D</given-names></name></person-group><article-title>Cell cycle: the key to plant growth control?</article-title><source>Trends Plant Sci</source><year>2003</year><volume>8</volume><fpage>154</fpage><lpage>158</lpage><pub-id pub-id-type=""pmid"">12711226</pub-id><pub-id pub-id-type=""doi"">10.1016/S1360-1385(03)00046-3</pub-id></citation></ref><ref id=""B88""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Ingram</surname><given-names>GC</given-names></name><name><surname>Waites</surname><given-names>R</given-names></name></person-group><article-title>Keeping it together: co-ordinating plant growth</article-title><source>Curr Opin Plant Biol</source><year>2006</year><volume>9</volume><fpage>12</fpage><lpage>20</lpage><pub-id pub-id-type=""pmid"">16326130</pub-id><pub-id pub-id-type=""doi"">10.1016/j.pbi.2005.11.007</pub-id></citation></ref><ref id=""B89""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Mizukami</surname><given-names>Y</given-names></name></person-group><article-title>A matter of size: developmental control of organ size in plants</article-title><source>Curr Opin Plant Biol</source><year>2001</year><volume>4</volume><fpage>533</fpage><lpage>539</lpage><pub-id pub-id-type=""pmid"">11641070</pub-id><pub-id pub-id-type=""doi"">10.1016/S1369-5266(00)00212-0</pub-id></citation></ref><ref id=""B90""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Tsukaya</surname><given-names>H</given-names></name></person-group><article-title>Organ shape and size: a lesson from studies of leaf morphogenesis</article-title><source>Curr Opin Plant Biol</source><year>2003</year><volume>6</volume><fpage>57</fpage><lpage>62</lpage><pub-id pub-id-type=""pmid"">12495752</pub-id><pub-id pub-id-type=""doi"">10.1016/S1369526602000055</pub-id></citation></ref><ref id=""B91""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Mizukami</surname><given-names>Y</given-names></name><name><surname>Fischer</surname><given-names>RL</given-names></name></person-group><article-title>Plant organ size control:<italic>AINTEGUMENTA</italic>regulates growth and cell numbers during organogenesis</article-title><source>Proc Natl Acad Sci USA</source><year>2000</year><volume>97</volume><fpage>942</fpage><lpage>947</lpage><pub-id pub-id-type=""pmid"">10639184</pub-id><pub-id pub-id-type=""doi"">10.1073/pnas.97.2.942</pub-id></citation></ref><ref id=""B92""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Xie</surname><given-names>Q</given-names></name><name><surname>Chua</surname><given-names>NH</given-names></name></person-group><article-title>The Arabidopsis auxin-inducible gene ARGOS controls lateral organ size</article-title><source>Plant Cell</source><year>2003</year><volume>15</volume><fpage>1951</fpage><lpage>1961</lpage><pub-id pub-id-type=""pmid"">12953103</pub-id><pub-id pub-id-type=""doi"">10.1105/tpc.013557</pub-id></citation></ref><ref id=""B93""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Elliott</surname><given-names>RC</given-names></name><name><surname>Betzner</surname><given-names>AS</given-names></name><name><surname>Huttner</surname><given-names>E</given-names></name><name><surname>Oakes</surname><given-names>MP</given-names></name><name><surname>Tucker</surname><given-names>WQJ</given-names></name><name><surname>Gerentes</surname><given-names>D</given-names></name><name><surname>Perez</surname><given-names>P</given-names></name><name><surname>Smyth</surname><given-names>DR</given-names></name></person-group><article-title><italic>AINTEGUMENTA</italic>, an<italic>APETALA2</italic>-like gene of<italic>Arabidopsis</italic>with pleiotropic roles in ovule development and floral organ growth</article-title><source>Plant Cell</source><year>1996</year><volume>8</volume><fpage>155</fpage><lpage>168</lpage><pub-id pub-id-type=""pmid"">8742707</pub-id><pub-id pub-id-type=""doi"">10.1105/tpc.8.2.155</pub-id></citation></ref><ref id=""B94""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Klucher</surname><given-names>KM</given-names></name><name><surname>Chow</surname><given-names>H</given-names></name><name><surname>Reiser</surname><given-names>L</given-names></name><name><surname>Fischer</surname><given-names>RL</given-names></name></person-group><article-title>The<italic>AINTEGUMENTA</italic>gene of<italic>Arabidopsis</italic>required for ovule and female gametophyte development is related to the floral homeotic gene<italic>APETALA2</italic></article-title><source>Plant Cell</source><year>1996</year><volume>8</volume><fpage>137</fpage><lpage>153</lpage><pub-id pub-id-type=""pmid"">8742706</pub-id><pub-id pub-id-type=""doi"">10.1105/tpc.8.2.137</pub-id></citation></ref><ref id=""B95""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Weigel</surname><given-names>D</given-names></name></person-group><article-title>The APETALA2 domain is related to a novel type of DNA binding domain</article-title><source>Plant Cell</source><year>1995</year><volume>7</volume><fpage>388</fpage><lpage>389</lpage><pub-id pub-id-type=""pmid"">7773013</pub-id><pub-id pub-id-type=""doi"">10.1105/tpc.7.4.388</pub-id></citation></ref><ref id=""B96""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Baker</surname><given-names>SC</given-names></name><name><surname>Robinson-Beers</surname><given-names>K</given-names></name><name><surname>Villanueva</surname><given-names>JM</given-names></name><name><surname>Gaiser</surname><given-names>JC</given-names></name><name><surname>Gasser</surname><given-names>CS</given-names></name></person-group><article-title>Interactions among genes regulating ovule development in<italic>Arabidopsis thaliana</italic></article-title><source>Genetics</source><year>1997</year><volume>145</volume><fpage>1109</fpage><lpage>1124</lpage><pub-id pub-id-type=""pmid"">9093862</pub-id></citation></ref><ref id=""B97""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Schneitz</surname><given-names>K</given-names></name><name><surname>Baker</surname><given-names>SC</given-names></name><name><surname>Gasser</surname><given-names>CS</given-names></name><name><surname>Redweik</surname><given-names>A</given-names></name></person-group><article-title>Pattern formation and growth during floral organogenesis:<italic>HUELLENLOS</italic>and<italic>AINTEGUMENTA</italic>are required for the formation of the proximal region of the ovule primordium in<italic>Arabidopsis thaliana</italic></article-title><source>Development</source><year>1998</year><volume>125</volume><fpage>2555</fpage><lpage>2563</lpage><pub-id pub-id-type=""pmid"">9636071</pub-id></citation></ref><ref id=""B98""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Krizek</surname><given-names>BA</given-names></name></person-group><article-title>Ectopic expression of<italic>AINTEGUMENTA</italic>in Arabidopsis plants results in increased growth of floral organs</article-title><source>Dev Genet</source><year>1999</year><volume>25</volume><fpage>224</fpage><lpage>236</lpage><pub-id pub-id-type=""pmid"">10528263</pub-id><pub-id pub-id-type=""doi"">10.1002/(SICI)1520-6408(1999)25:3&lt;224::AID-DVG5&gt;3.0.CO;2-Y</pub-id></citation></ref><ref id=""B99""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Dewitte</surname><given-names>W</given-names></name><name><surname>Riou-Khamlichi</surname><given-names>C</given-names></name><name><surname>Scofield</surname><given-names>S</given-names></name><name><surname>Healy</surname><given-names>JM</given-names></name><name><surname>Jacqmard</surname><given-names>A</given-names></name><name><surname>Kilby</surname><given-names>NJ</given-names></name><name><surname>Murray</surname><given-names>JA</given-names></name></person-group><article-title>Altered cell cycle distribution, hyperplasia, and inhibited differentiation in Arabidopsis caused by the D-type cyclin CYCD3</article-title><source>Plant Cell</source><year>2003</year><volume>15</volume><fpage>79</fpage><lpage>92</lpage><pub-id pub-id-type=""pmid"">12509523</pub-id><pub-id pub-id-type=""doi"">10.1105/tpc.004838</pub-id></citation></ref><ref id=""B100""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Tsukaya</surname><given-names>H</given-names></name></person-group><article-title>Mechanism of leaf shape determination</article-title><source>Annu Rev Plant Biol</source><year>2006</year><volume>57</volume><fpage>477</fpage><lpage>496</lpage><pub-id pub-id-type=""pmid"">16669771</pub-id><pub-id pub-id-type=""doi"">10.1146/annurev.arplant.57.032905.105320</pub-id></citation></ref><ref id=""B101""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Donnelly</surname><given-names>PM</given-names></name><name><surname>Bonetta</surname><given-names>D</given-names></name><name><surname>Tsukaya</surname><given-names>H</given-names></name><name><surname>Dengler</surname><given-names>RE</given-names></name><name><surname>Dengler</surname><given-names>NG</given-names></name></person-group><article-title>Cell cycling and cell enlargement in developing leaves of<italic>Arabidopsis</italic></article-title><source>Dev Biol</source><year>1999</year><volume>215</volume><fpage>407</fpage><lpage>419</lpage><pub-id pub-id-type=""pmid"">10545247</pub-id><pub-id pub-id-type=""doi"">10.1006/dbio.1999.9443</pub-id></citation></ref><ref id=""B102""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Horiguchi</surname><given-names>G</given-names></name><name><surname>Kim</surname><given-names>GT</given-names></name><name><surname>Tsukaya</surname><given-names>H</given-names></name></person-group><article-title>The transcription factor AtGRF5 and the transcription coactivator AN3 regulate cell proliferation in leaf primordia of Arabidopsis thaliana</article-title><source>Plant J</source><year>2005</year><volume>43</volume><fpage>68</fpage><lpage>78</lpage><pub-id pub-id-type=""pmid"">15960617</pub-id><pub-id pub-id-type=""doi"">10.1111/j.1365-313X.2005.02429.x</pub-id></citation></ref><ref id=""B103""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Choi</surname><given-names>D</given-names></name><name><surname>Kende</surname><given-names>H</given-names></name></person-group><article-title>The AtGRF family of putative transcription factors is involved in leaf and cotyledon growth in Arabidopsis</article-title><source>Plant J</source><year>2003</year><volume>36</volume><fpage>94</fpage><lpage>104</lpage><pub-id pub-id-type=""pmid"">12974814</pub-id><pub-id pub-id-type=""doi"">10.1046/j.1365-313X.2003.01862.x</pub-id></citation></ref><ref id=""B104""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Kende</surname><given-names>H</given-names></name></person-group><article-title>A transcriptional coactivator, AtGIF1, is involved in regulating leaf growth and morphology in Arabidopsis</article-title><source>Proc Natl Acad Sci USA</source><year>2004</year><volume>101</volume><fpage>13374</fpage><lpage>13379</lpage><pub-id pub-id-type=""pmid"">15326298</pub-id><pub-id pub-id-type=""doi"">10.1073/pnas.0405450101</pub-id></citation></ref><ref id=""B105""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Poh</surname><given-names>HM</given-names></name><name><surname>Chua</surname><given-names>NH</given-names></name></person-group><article-title>The Arabidopsis ARGOS-LIKE gene regulates cell expansion during organ growth</article-title><source>Plant J</source><year>2006</year><volume>47</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type=""pmid"">16824178</pub-id><pub-id pub-id-type=""doi"">10.1111/j.1365-313X.2006.02750.x</pub-id></citation></ref><ref id=""B106""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Fujikura</surname><given-names>U</given-names></name><name><surname>Horiguchi</surname><given-names>G</given-names></name><name><surname>Tsukaya</surname><given-names>H</given-names></name></person-group><article-title>Dissection of enhanced cell expansion processes in leaves triggered by a defect in cell proliferation, with reference to roles of endoreduplication</article-title><source>Plant Cell Physiol</source><year>2007</year><volume>48</volume><fpage>278</fpage><lpage>286</lpage><pub-id pub-id-type=""pmid"">17205970</pub-id><pub-id pub-id-type=""doi"">10.1093/pcp/pcm002</pub-id></citation></ref><ref id=""B107""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Shpak</surname><given-names>ED</given-names></name><name><surname>Lakeman</surname><given-names>MB</given-names></name><name><surname>Torii</surname><given-names>KU</given-names></name></person-group><article-title>Dominant-negative receptor uncovers redundancy in the Arabidopsis ERECTA Leucine-rich repeat receptor-like kinase signaling pathway that regulates organ shape</article-title><source>Plant Cell</source><year>2003</year><volume>15</volume><fpage>1095</fpage><lpage>1110</lpage><pub-id pub-id-type=""pmid"">12724536</pub-id><pub-id pub-id-type=""doi"">10.1105/tpc.010413</pub-id></citation></ref><ref id=""B108""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Diener</surname><given-names>AC</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Whoriskey</surname><given-names>WJ</given-names></name><name><surname>Nes</surname><given-names>WD</given-names></name><name><surname>Fink</surname><given-names>GR</given-names></name></person-group><article-title>Sterol methyltransferase 1 controls the level of cholesterol in plants</article-title><source>Plant Cell</source><year>2000</year><volume>12</volume><fpage>853</fpage><lpage>870</lpage><pub-id pub-id-type=""pmid"">10852933</pub-id><pub-id pub-id-type=""doi"">10.1105/tpc.12.6.853</pub-id></citation></ref><ref id=""B109""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>He</surname><given-names>JX</given-names></name><name><surname>Fujioka</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>TC</given-names></name><name><surname>Kang</surname><given-names>SG</given-names></name><name><surname>Seto</surname><given-names>H</given-names></name><name><surname>Takatsuto</surname><given-names>S</given-names></name><name><surname>Yoshida</surname><given-names>S</given-names></name><name><surname>Jang</surname><given-names>JC</given-names></name></person-group><article-title>Sterols regulate development and gene expression in Arabidopsis</article-title><source>Plant Physiol</source><year>2003</year><volume>131</volume><fpage>1258</fpage><lpage>1269</lpage><pub-id pub-id-type=""pmid"">12644676</pub-id><pub-id pub-id-type=""doi"">10.1104/pp.014605</pub-id></citation></ref><ref id=""B110""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Jang</surname><given-names>JC</given-names></name><name><surname>Fujioka</surname><given-names>S</given-names></name><name><surname>Tasaka</surname><given-names>M</given-names></name><name><surname>Seto</surname><given-names>H</given-names></name><name><surname>Takatsuto</surname><given-names>S</given-names></name><name><surname>Ishii</surname><given-names>A</given-names></name><name><surname>Aida</surname><given-names>M</given-names></name><name><surname>Yoshida</surname><given-names>S</given-names></name><name><surname>Sheen</surname><given-names>J</given-names></name></person-group><article-title>A critical role of sterols in embryonic patterning and meristem programming revealed by the fackel mutants of Arabidopsis thaliana</article-title><source>Genes Dev</source><year>2000</year><volume>14</volume><fpage>1485</fpage><lpage>1497</lpage><pub-id pub-id-type=""pmid"">10859167</pub-id></citation></ref><ref id=""B111""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Schaller</surname><given-names>H</given-names></name></person-group><article-title>The role of sterols in plant growth and development</article-title><source>Prog Lipid Res</source><year>2003</year><volume>42</volume><fpage>163</fpage><lpage>175</lpage><pub-id pub-id-type=""pmid"">12689617</pub-id><pub-id pub-id-type=""doi"">10.1016/S0163-7827(02)00047-4</pub-id></citation></ref><ref id=""B112""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Schrick</surname><given-names>K</given-names></name><name><surname>Mayer</surname><given-names>U</given-names></name><name><surname>Horrichs</surname><given-names>A</given-names></name><name><surname>Kuhnt</surname><given-names>C</given-names></name><name><surname>Bellini</surname><given-names>C</given-names></name><name><surname>Dangl</surname><given-names>J</given-names></name><name><surname>Schmidt</surname><given-names>J</given-names></name><name><surname>Jürgens</surname><given-names>G</given-names></name></person-group><article-title>FACKEL is a sterol C-14 reductase required for organized cell division and expansion in<italic>Arabidopsis</italic>embryogenesis</article-title><source>Genes Dev</source><year>2000</year><volume>14</volume><fpage>1471</fpage><lpage>1484</lpage><pub-id pub-id-type=""pmid"">10859166</pub-id></citation></ref><ref id=""B113""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Schrick</surname><given-names>K</given-names></name><name><surname>Mayer</surname><given-names>U</given-names></name><name><surname>Martin</surname><given-names>G</given-names></name><name><surname>Bellini</surname><given-names>C</given-names></name><name><surname>Kuhnt</surname><given-names>C</given-names></name><name><surname>Schmidt</surname><given-names>J</given-names></name><name><surname>Jürgens</surname><given-names>G</given-names></name></person-group><article-title>Interactions between sterol biosynthesis genes in embryonic development of Arabidopsis</article-title><source>Plant J</source><year>2002</year><volume>31</volume><fpage>61</fpage><lpage>73</lpage><pub-id pub-id-type=""pmid"">12100483</pub-id><pub-id pub-id-type=""doi"">10.1046/j.1365-313X.2002.01333.x</pub-id></citation></ref><ref id=""B114""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Souter</surname><given-names>M</given-names></name><name><surname>Topping</surname><given-names>J</given-names></name><name><surname>Pullen</surname><given-names>M</given-names></name><name><surname>Friml</surname><given-names>J</given-names></name><name><surname>Palme</surname><given-names>K</given-names></name><name><surname>Hackett</surname><given-names>R</given-names></name><name><surname>Grierson</surname><given-names>D</given-names></name><name><surname>Lindsey</surname><given-names>K</given-names></name></person-group><article-title>hydra Mutants of Arabidopsis are defective in sterol profiles and auxin and ethylene signaling</article-title><source>Plant Cell</source><year>2002</year><volume>14</volume><fpage>1017</fpage><lpage>1031</lpage><pub-id pub-id-type=""pmid"">12034894</pub-id><pub-id pub-id-type=""doi"">10.1105/tpc.001248</pub-id></citation></ref><ref id=""B115""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Peng</surname><given-names>L</given-names></name><name><surname>Kawagoe</surname><given-names>Y</given-names></name><name><surname>Hogan</surname><given-names>P</given-names></name><name><surname>Delmer</surname><given-names>D</given-names></name></person-group><article-title>Sitosterol-beta-glucoside as primer for cellulose synthesis in plants</article-title><source>Science</source><year>2002</year><volume>295</volume><fpage>147</fpage><lpage>150</lpage><pub-id pub-id-type=""pmid"">11778054</pub-id><pub-id pub-id-type=""doi"">10.1126/science.1064281</pub-id></citation></ref><ref id=""B116""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Schrick</surname><given-names>K</given-names></name><name><surname>Fujioka</surname><given-names>S</given-names></name><name><surname>Takatsuto</surname><given-names>S</given-names></name><name><surname>Stierhof</surname><given-names>YD</given-names></name><name><surname>Stransky</surname><given-names>H</given-names></name><name><surname>Yoshida</surname><given-names>S</given-names></name><name><surname>Jürgens</surname><given-names>G</given-names></name></person-group><article-title>A link between sterol biosynthesis, the cell wall, and cellulose in Arabidopsis</article-title><source>Plant J</source><year>2004</year><volume>38</volume><fpage>227</fpage><lpage>243</lpage><pub-id pub-id-type=""pmid"">15078327</pub-id><pub-id pub-id-type=""doi"">10.1111/j.1365-313X.2004.02039.x</pub-id></citation></ref><ref id=""B117""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Alonso</surname><given-names>JM</given-names></name><name><surname>Stepanova</surname><given-names>AN</given-names></name><name><surname>Leisse</surname><given-names>TJ</given-names></name><name><surname>Kim</surname><given-names>CJ</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Shinn</surname><given-names>P</given-names></name><name><surname>Stevenson</surname><given-names>DK</given-names></name><name><surname>Zimmerman</surname><given-names>J</given-names></name><name><surname>Barajas</surname><given-names>P</given-names></name><name><surname>Cheuk</surname><given-names>R</given-names></name><etal></etal></person-group><article-title>Genome-wide insertional mutagenesis of<italic>Arabidopsis thaliana</italic></article-title><source>Science</source><year>2003</year><volume>301</volume><fpage>653</fpage><lpage>657</lpage><pub-id pub-id-type=""pmid"">12893945</pub-id><pub-id pub-id-type=""doi"">10.1126/science.1086391</pub-id></citation></ref><ref id=""B118""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Krysan</surname><given-names>PJ</given-names></name><name><surname>Young</surname><given-names>JK</given-names></name><name><surname>Sussman</surname><given-names>MR</given-names></name></person-group><article-title>T-DNA as an insertional mutagen in Arabidopsis</article-title><source>Plant Cell</source><year>1999</year><volume>11</volume><fpage>2283</fpage><lpage>2290</lpage><pub-id pub-id-type=""pmid"">10590158</pub-id><pub-id pub-id-type=""doi"">10.1105/tpc.11.12.2283</pub-id></citation></ref><ref id=""B119""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Sessions</surname><given-names>A</given-names></name><name><surname>Burke</surname><given-names>E</given-names></name><name><surname>Presting</surname><given-names>G</given-names></name><name><surname>Aux</surname><given-names>G</given-names></name><name><surname>McElver</surname><given-names>J</given-names></name><name><surname>Patton</surname><given-names>D</given-names></name><name><surname>Dietrich</surname><given-names>B</given-names></name><name><surname>Ho</surname><given-names>P</given-names></name><name><surname>Bacwaden</surname><given-names>J</given-names></name><name><surname>Ko</surname><given-names>C</given-names></name><etal></etal></person-group><article-title>A high-throughput Arabidopsis reverse genetics system</article-title><source>Plant Cell</source><year>2002</year><volume>14</volume><fpage>2985</fpage><lpage>2994</lpage><pub-id pub-id-type=""pmid"">12468722</pub-id><pub-id pub-id-type=""doi"">10.1105/tpc.004630</pub-id></citation></ref><ref id=""B120""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Rosso</surname><given-names>MG</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Strizhov</surname><given-names>N</given-names></name><name><surname>Reiss</surname><given-names>B</given-names></name><name><surname>Dekker</surname><given-names>K</given-names></name><name><surname>Weisshaar</surname><given-names>B</given-names></name></person-group><article-title>An<italic>Arabidopsis thaliana</italic>T-DNA mutagenized population (GABI-Kat) for flanking sequence tag-based reverse genetics</article-title><source>Plant Mol Biol</source><year>2003</year><volume>53</volume><fpage>247</fpage><lpage>259</lpage><pub-id pub-id-type=""pmid"">14756321</pub-id><pub-id pub-id-type=""doi"">10.1023/B:PLAN.0000009297.37235.4a</pub-id></citation></ref><ref id=""B121""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Murashige</surname><given-names>T</given-names></name><name><surname>Skoog</surname><given-names>F</given-names></name></person-group><article-title>A revised medium for a rapid growth and bioassays with tobacco tissue cultures</article-title><source>Physiologia Plantarum</source><year>1962</year><volume>15</volume><fpage>473</fpage><lpage>497</lpage><pub-id pub-id-type=""doi"">10.1111/j.1399-3054.1962.tb08052.x</pub-id></citation></ref><ref id=""B122""><citation citation-type=""other""><article-title>ImageJ – Image Processing and Analysis in Java</article-title><ext-link ext-link-type=""uri"" xlink:href=""http://rsb.info.nih.gov/ij/""></ext-link></citation></ref><ref id=""B123""><citation citation-type=""book""><person-group person-group-type=""author""><name><surname>Sambrook</surname><given-names>J</given-names></name><name><surname>Fritsch</surname><given-names>EF</given-names></name><name><surname>Maniatis</surname><given-names>T</given-names></name></person-group><source>Molecular Cloning</source><year>1989</year><edition>2</edition><publisher-name>Plainview, NY: Cold Spring Harbor Laboratory Press</publisher-name></citation></ref><ref id=""B124""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Frohman</surname><given-names>MA</given-names></name><name><surname>Dush</surname><given-names>MK</given-names></name><name><surname>Martin</surname><given-names>GR</given-names></name></person-group><article-title>Rapid production of full-length cDNAs from rare transcripts-amplification using a single gene-specific oligonucleotide primer</article-title><source>Proc Natl Acad Sci USA</source><year>1988</year><volume>85</volume><fpage>8998</fpage><lpage>9002</lpage><pub-id pub-id-type=""pmid"">2461560</pub-id><pub-id pub-id-type=""doi"">10.1073/pnas.85.23.8998</pub-id></citation></ref><ref id=""B125""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Smyth</surname><given-names>DR</given-names></name><name><surname>Bowman</surname><given-names>JL</given-names></name><name><surname>Meyerowitz</surname><given-names>EM</given-names></name></person-group><article-title>Early flower development in<italic>Arabidopsis</italic></article-title><source>Plant Cell</source><year>1990</year><volume>2</volume><fpage>755</fpage><lpage>767</lpage><pub-id pub-id-type=""pmid"">2152125</pub-id><pub-id pub-id-type=""doi"">10.1105/tpc.2.8.755</pub-id></citation></ref><ref id=""B126""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Shih</surname><given-names>MC</given-names></name><name><surname>Heinrich</surname><given-names>P</given-names></name><name><surname>Goodmann</surname><given-names>HM</given-names></name></person-group><article-title>Cloning and chromosomal mapping of nuclear genes encoding chloroplast and cytosolic glyceraldehyde-3-phosphate dehydrogenase from<italic>Arabidopsis thaliana</italic></article-title><source>Gene</source><year>1991</year><volume>104</volume><fpage>133</fpage><lpage>138</lpage><pub-id pub-id-type=""pmid"">1916285</pub-id><pub-id pub-id-type=""doi"">10.1016/0378-1119(91)90242-4</pub-id></citation></ref><ref id=""B127""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Altschul</surname><given-names>SF</given-names></name><name><surname>Gish</surname><given-names>W</given-names></name><name><surname>Miller</surname><given-names>W</given-names></name><name><surname>Myers</surname><given-names>EW</given-names></name><name><surname>Lipman</surname><given-names>DJ</given-names></name></person-group><article-title>Basic local alignment search tool</article-title><source>J Mol Biol</source><year>1990</year><volume>215</volume><fpage>403</fpage><lpage>410</lpage><pub-id pub-id-type=""pmid"">2231712</pub-id></citation></ref><ref id=""B128""><citation citation-type=""other""><article-title>SMART</article-title><ext-link ext-link-type=""uri"" xlink:href=""http://smart.embl-heidelberg.de""></ext-link></citation></ref><ref id=""B129""><citation citation-type=""other""><article-title>PROSITE</article-title><ext-link ext-link-type=""uri"" xlink:href=""http://www.expasy.ch/prosite/""></ext-link></citation></ref><ref id=""B130""><citation citation-type=""other""><article-title>PSORT</article-title><ext-link ext-link-type=""uri"" xlink:href=""http://psort.ims.u-tokyo.ac.jp/form.html""></ext-link></citation></ref><ref id=""B131""><citation citation-type=""other""><article-title>PESTfind</article-title><ext-link ext-link-type=""uri"" xlink:href=""https://emb1.bcc.univie.ac.at/toolbox/pestfind/pestfind-analysis-webtool.htm""></ext-link></citation></ref><ref id=""B132""><citation citation-type=""other""><article-title>PLANTSP</article-title><ext-link ext-link-type=""uri"" xlink:href=""http://plantsp.genomics.purdue.edu""></ext-link></citation></ref><ref id=""B133""><citation citation-type=""other""><article-title>MULTALIGN</article-title><ext-link ext-link-type=""uri"" xlink:href=""http://bioinfo.genopole-toulouse.prd.fr/multalin/multalin.html""></ext-link></citation></ref><ref id=""B134""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Corpet</surname><given-names>F</given-names></name></person-group><article-title>Multiple sequence alignment with hierarchical clustering</article-title><source>Nucleic Acids Res</source><year>1988</year><volume>16</volume><fpage>10881</fpage><lpage>10890</lpage><pub-id pub-id-type=""pmid"">2849754</pub-id><pub-id pub-id-type=""doi"">10.1093/nar/16.22.10881</pub-id></citation></ref><ref id=""B135""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Xia</surname><given-names>X</given-names></name><name><surname>Xie</surname><given-names>Z</given-names></name></person-group><article-title>DAMBE: software package for data analysis in molecular biology and evolution</article-title><source>J Hered</source><year>2001</year><volume>92</volume><fpage>371</fpage><lpage>373</lpage><pub-id pub-id-type=""pmid"">11535656</pub-id><pub-id pub-id-type=""doi"">10.1093/jhered/92.4.371</pub-id></citation></ref><ref id=""B136""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Schmidt</surname><given-names>HA</given-names></name><name><surname>Strimmer</surname><given-names>K</given-names></name><name><surname>Vingron</surname><given-names>M</given-names></name><name><surname>von Haeseler</surname><given-names>A</given-names></name></person-group><article-title>TREE-PUZZLE: maximum likelihood phylogenetic analysis using quartets and parallel computing</article-title><source>Bioinformatics</source><year>2002</year><volume>18</volume><fpage>502</fpage><lpage>504</lpage><pub-id pub-id-type=""pmid"">11934758</pub-id><pub-id pub-id-type=""doi"">10.1093/bioinformatics/18.3.502</pub-id></citation></ref><ref id=""B137""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Seitz</surname><given-names>C</given-names></name><name><surname>Eder</surname><given-names>C</given-names></name><name><surname>Deiml</surname><given-names>B</given-names></name><name><surname>Kellner</surname><given-names>S</given-names></name><name><surname>Martens</surname><given-names>S</given-names></name><name><surname>Forkmann</surname><given-names>G</given-names></name></person-group><article-title>Cloning, functional identification and sequence analysis of flavonoid 3'-hydroxylase and flavonoid 3',5'-hydroxylase cDNAs reveals independent evolution of flavonoid 3',5'-hydroxylase in the Asteraceae family</article-title><source>Plant Mol Biol</source><year>2006</year><volume>61</volume><fpage>365</fpage><lpage>381</lpage><pub-id pub-id-type=""pmid"">16830174</pub-id><pub-id pub-id-type=""doi"">10.1007/s11103-006-0012-0</pub-id></citation></ref><ref id=""B138""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Page</surname><given-names>RD</given-names></name></person-group><article-title>TreeView: an application to display phylogenetic trees on personal computers</article-title><source>Comput Appl Biosci</source><year>1996</year><volume>12</volume><fpage>357</fpage><lpage>358</lpage><pub-id pub-id-type=""pmid"">8902363</pub-id></citation></ref><ref id=""B139""><citation citation-type=""other""><article-title>CAMBIA</article-title><ext-link ext-link-type=""uri"" xlink:href=""http://www.cambia.org""></ext-link></citation></ref><ref id=""B140""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Van Larebeke</surname><given-names>N</given-names></name><name><surname>Engler</surname><given-names>G</given-names></name><name><surname>Holsters</surname><given-names>M</given-names></name><name><surname>Van den Elsacker</surname><given-names>S</given-names></name><name><surname>Zaenen</surname><given-names>J</given-names></name><name><surname>Schilperoort</surname><given-names>RA</given-names></name><name><surname>Schell</surname><given-names>J</given-names></name></person-group><article-title>Large plasmid in Agrobacterium tumefaciens essential for crown gall-inducing ability</article-title><source>Nature</source><year>1974</year><volume>252</volume><fpage>169</fpage><lpage>170</lpage><pub-id pub-id-type=""pmid"">4419109</pub-id><pub-id pub-id-type=""doi"">10.1038/252169a0</pub-id></citation></ref><ref id=""B141""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Clough</surname><given-names>SJ</given-names></name><name><surname>Bent</surname><given-names>AF</given-names></name></person-group><article-title>Floral dip: a simplified method for<italic>Agrobacterium</italic>-mediated transformation of<italic>Arabidopsis thaliana</italic></article-title><source>Plant J</source><year>1998</year><volume>16</volume><fpage>735</fpage><lpage>743</lpage><pub-id pub-id-type=""pmid"">10069079</pub-id><pub-id pub-id-type=""doi"">10.1046/j.1365-313x.1998.00343.x</pub-id></citation></ref><ref id=""B142""><citation citation-type=""other""><article-title>NASC's Affymetrix Service: AffyWatch</article-title><ext-link ext-link-type=""uri"" xlink:href=""http://affymetrix.arabidopsis.info/AffyWatch.html""></ext-link></citation></ref><ref id=""B143""><citation citation-type=""other""><article-title>Affymetrix</article-title><ext-link ext-link-type=""uri"" xlink:href=""http://www.affymetrix.com""></ext-link></citation></ref><ref id=""B144""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Schoof</surname><given-names>H</given-names></name><name><surname>Ernst</surname><given-names>R</given-names></name><name><surname>Nazarov</surname><given-names>V</given-names></name><name><surname>Pfeifer</surname><given-names>L</given-names></name><name><surname>Mewes</surname><given-names>HW</given-names></name><name><surname>Mayer</surname><given-names>KF</given-names></name></person-group><article-title>MIPS Arabidopsis thaliana Database (MAtDB): an integrated biological knowledge resource for plant genomics</article-title><source>Nucleic Acids Res</source><year>2004</year><volume>32</volume><fpage>D373</fpage><lpage>376</lpage><pub-id pub-id-type=""pmid"">14681437</pub-id><pub-id pub-id-type=""doi"">10.1093/nar/gkh068</pub-id></citation></ref><ref id=""B145""><citation citation-type=""other""><article-title>FunDaMiner – a functional analysis tool for expression data</article-title><ext-link ext-link-type=""uri"" xlink:href=""http://mips.gsf.de/proj/express/""></ext-link></citation></ref><ref id=""B146""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Wong</surname><given-names>WH</given-names></name></person-group><article-title>Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection</article-title><source>Proc Natl Acad Sci USA</source><year>2001</year><volume>98</volume><fpage>31</fpage><lpage>36</lpage><pub-id pub-id-type=""pmid"">11134512</pub-id><pub-id pub-id-type=""doi"">10.1073/pnas.011404098</pub-id></citation></ref><ref id=""B147""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Bolstad</surname><given-names>BM</given-names></name><name><surname>Irizarry</surname><given-names>RA</given-names></name><name><surname>Astrand</surname><given-names>M</given-names></name><name><surname>Speed</surname><given-names>TP</given-names></name></person-group><article-title>A comparison of normalization methods for high density oligonucleotide array data based on variance and bias</article-title><source>Bioinformatics</source><year>2003</year><volume>19</volume><fpage>185</fpage><lpage>193</lpage><pub-id pub-id-type=""pmid"">12538238</pub-id><pub-id pub-id-type=""doi"">10.1093/bioinformatics/19.2.185</pub-id></citation></ref><ref id=""B148""><citation citation-type=""journal""><person-group person-group-type=""author""><name><surname>Cleveland</surname><given-names>W</given-names></name></person-group><article-title>Robust locally weighted regression and smoothing scatterplots</article-title><source>J Am Stat Assoc</source><year>1979</year><volume>74</volume><fpage>829</fpage><lpage>836</lpage><pub-id pub-id-type=""doi"">10.2307/2286407</pub-id></citation></ref><ref id=""B149""><citation citation-type=""book""><person-group person-group-type=""author""><name><surname>Cleveland</surname><given-names>WS</given-names></name><name><surname>Grosse</surname><given-names>E</given-names></name><name><surname>Shyu</surname><given-names>WM</given-names></name></person-group><source>Statistical Models in S Local Regression Models</source><year>1992</year><publisher-name>Wadsworth &amp; Brooks/Cole</publisher-name></citation></ref><ref id=""B150""><citation citation-type=""book""><person-group person-group-type=""author""><name><surname>Dudoit</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>YH</given-names></name><name><surname>Callow</surname><given-names>MJ</given-names></name><name><surname>Speed</surname><given-names>TP</given-names></name></person-group><article-title>Statistical methods for identifying differentially expressed genes in replicated cDNA microarray experiments</article-title><source>Technical Report</source><year>2000</year><volume>578</volume><publisher-name>Stanford University School of Medicine</publisher-name></citation></ref></ref-list>"
10.1126/science.1107733	"<html><body><article-title>Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding</article-title>.<source>Science</source>.<year>2009</year>;<volume>323</volume>(<issue>5922</issue>):<fpage>1718</fpage>–<lpage>22</lpage>.<comment>doi:<ext-link ext-link-type=""uri"" xlink:href=""http://dx.doi.org/10.1126/science.1168750"">10.1126/science.1168750</ext-link></comment>;<pub-id pub-id-type=""pmid"">19325113</pub-id><ref id=""pone.0178238.ref020""><label>20</label><mixed-citation publication-type=""journal""><name><surname>Jin</surname><given-names>MS</given-names></name>,<name><surname>Oldham</surname><given-names>ML</given-names></name>,<name><surname>Zhang</surname><given-names>Q</given-names></name>,<name><surname>Chen</surname><given-names>J</given-names></name>.<article-title>Crystal structure of the multidrug transporter P-glycoprotein from Caenorhabditis elegans</article-title>.<source>Nature</source>.<year>2012</year>;<volume>490</volume>(<issue>7421</issue>):<fpage>566</fpage>–<lpage>9</lpage>.<comment>doi:<ext-link ext-link-type=""uri"" xlink:href=""http://dx.doi.org/10.1038/nature11448"">10.1038/nature11448</ext-link></comment>;<pub-id pub-id-type=""pmid"">23000902</pub-id></mixed-citation></ref><ref id=""pone.0178238.ref021""><label>21</label><mixed-citation publication-type=""journal""><name><surname>Hohl</surname><given-names>M</given-names></name>,<name><surname>Briand</surname><given-names>C</given-names></name>,<name><surname>Grutter</surname><given-names>MG</given-names></name>,<name><surname>Seeger</surname><given-names>MA</given-names></name>.<article-title>Crystal structure of a heterodimeric ABC transporter in its inward-facing conformation</article-title>.<source>Nat Struct Mol Biol</source>.<year>2012</year>;<volume>19</volume>(<issue>4</issue>):<fpage>395</fpage>–<lpage>402</lpage>.<comment>doi:<ext-link ext-link-type=""uri"" xlink:href=""http://dx.doi.org/10.1038/nsmb.2267"">10.1038/nsmb.2267</ext-link></comment>.<pub-id pub-id-type=""pmid"">22447242</pub-id></mixed-citation></ref><ref id=""pone.0178238.ref022""><label>22</label><mixed-citation publication-type=""journal""><name><surname>Reyes</surname><given-names>CL</given-names></name>,<name><surname>Chang</surname><given-names>G</given-names></name>.<article-title>Structure of the ABC transporter MsbA in complex with ADP.vanadate and lipopolysaccharide</article-title>.<source>Science</source>.<year>2005</year>;<volume>308</volume>(<issue>5724</issue>):<fpage>1028</fpage>–<lpage>31</lpage>.<comment>doi:<ext-link ext-link-type=""uri"" xlink:href=""http://dx.doi.org/10.1126/science.1107733"">10.1126/science.1107733</ext-link></comment><pub-id pub-id-type=""pmid"">15890884</pub-id></mixed-citation></ref><ref id=""pone.0178238.ref023""><label>23</label><mixed-citation publication-type=""journal""><name><surname>Linton</surname><given-names>KJ</given-names></name>,<name><surname>Higgins</surname><given-names>CF</given-names></name>.<article-title>Structure and function of ABC transporters: the ATP switch provides flexible control</article-title>.<source>Pflugers Arch</source>.<year>2007</year>;<volume>453</volume>(<issue>5</issue>):<fpage>555</fpage>–<lpage>67</lpage>.<comment>doi:<ext-link ext-link-type=""uri"" xlink:href=""http://dx.doi.org/10.1007/s00424-006-0126-x"">10.1007/s00424-006-0126-x</ext-link></comment>.<pub-id pub-id-type=""pmid"">16937116</pub-id></mixed-citation></ref><ref id=""pone.0178238.ref024""><label>24</label><mixed-citation publication-type=""journal""><name><surname>Higgins</surname><given-names>CF</given-names></name>,<name><surname>Linton</surname><given-names>KJ</given-names></name>.<article-title>The ATP switch model for ABC transporters</article-title>.<source>Nat Struct Mol Biol</source>.<year>2004</year>;<volume>11</volume>(<issue>10</issue>):<fpage>918</fpage>–<lpage>26</lpage>.<comment>doi:<ext-link ext-link-type=""uri"" xlink:href=""http://dx.doi.org/10.1038/nsmb836"">10.1038/nsmb836</ext-link></comment>.<pub-id pub-id-type=""pmid"">15452563</pub-id></mixed-citation></ref><ref id=""pone.0178238.ref025""><label>25</label><mixed-citation publication-type=""journal""><name><surname>Khare</surname><given-names>D</given-names></name>,<name><surname>Oldham</surname><given-names>ML</given-names></name>,<name><surname>Orelle</surname><given-names>C</given-names></name>,<name><surname>Davidson</surname><given-names>AL</given-names></name>,<name><surname>Chen</surname><given-names>J</given-names></name>.<article-title>Alternating access in maltose transporter mediated by rigid-body rotations</article-title>.<source>Mol Cell</source>.<year>2009</year>;<volume>33</volume>(<issue>4</issue>):<fpage>528</fpage>–<lpage>36</lpage>.<comment>doi:<ext-link ext-link-type=""uri"" xlink:href=""http://dx.doi.org/10.1016/j.molcel.2009.01.035"">10.1016/j.molcel.2009.01.035</ext-link></comment>;<pub-id pub-id-type=""pmid"">19250913</pub-id></mixed-citation></ref><ref id=""pone.0178238.ref026""><label>26</label><mixed-citation publication-type=""journal""><name><surname>Orelle</surname><given-names>C</given-names></name>,<name><surname>Alvarez</surname><given-names>FJ</given-names></name>,<name><surname>Oldham</surname><given-names>ML</given-names></name>,<name><surname>Orelle</surname><given-names>A</given-names></name>,<name><surname>Wiley</surname><given-names>TE</given-names></name>,<name><surname>Chen</surname><given-names>J</given-names></name>,<etal>et al</etal><sec sec-type=""supplementary-material""><title>Electronic supplementary material</title><sec id=""Sec16""><supplementary-material content-type=""local-data"" id=""MOESM1""><media xlink:href=""13238_2015_211_MOESM1_ESM.pdf""><caption><p>Supplementary material 1 (PDF 630 kb)</p></caption></media></supplementary-material></sec></sec></mixed-citation></ref></body><back><glossary><title>ABBREVIATIONS</title><def-list><def-item><term>ABC</term><def><p>ATP binding cassette (transporters)</p></def></def-item><def-item><term>ATP</term><def><p>adenosine triphosphate</p></def></def-item><def-item><term>C<sub>In</sub></term><def><p>inward-facing conformation</p></def></def-item><def-item><term>C<sub>Out</sub></term><def><p>outward-facing conformation</p></def></def-item><def-item><term>NBD</term><def><p>nucleotide binding domain</p></def></def-item><def-item><term>SBP</term><def><p>substrate binding protein</p></def></def-item><def-item><term>TMD</term><def><p>transmembrane domain</p></def></def-item></def-list></glossary><ack><title>ACKNOWLEDGMENTS</title><p>The authors thank Dr. T. Juelich for linguistic assistance during the preparation of this manuscript. This work was supported by the National Basic Research Program (973 Program) (Nos. 2011CB910301 and 2014CB910104 to XCZ), by the Chinese Academy of Sciences (XDB08020301 to XCZ), and by the National Natural Science Foundation of China (Grant No. 31470745 to XCZ).</p><sec id=""d30e1561""><title>COMPLIANCE WITH ETHICS GUIDELINES</title><p>Xuejun C. Zhang, Lei Han, and Yan Zhao declare that they have no conflict of interest. This article does not contain any studies with human or animal subjects performed by any of the authors.</p></sec></ack><ref-list id=""Bib1""><title>References</title><ref id=""CR1""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Austermuhle</surname><given-names>MI</given-names></name><name><surname>Hall</surname><given-names>JA</given-names></name><name><surname>Klug</surname><given-names>CS</given-names></name><name><surname>Davidson</surname><given-names>AL</given-names></name></person-group><article-title>Maltose-binding protein is open in the catalytic transition state for ATP hydrolysis during maltose transport</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><fpage>28243</fpage><lpage>28250</lpage><pub-id pub-id-type=""doi"">10.1074/jbc.M403508200</pub-id><pub-id pub-id-type=""pmid"">15117946</pub-id></element-citation></ref><ref id=""CR2""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Berntsson</surname><given-names>RP</given-names></name><name><surname>Smits</surname><given-names>SH</given-names></name><name><surname>Schmitt</surname><given-names>L</given-names></name><name><surname>Slotboom</surname><given-names>DJ</given-names></name><name><surname>Poolman</surname><given-names>B</given-names></name></person-group><article-title>A structural classification of substrate-binding proteins</article-title><source>FEBS Lett</source><year>2010</year><volume>584</volume><fpage>2606</fpage><lpage>2617</lpage><pub-id pub-id-type=""doi"">10.1016/j.febslet.2010.04.043</pub-id><pub-id pub-id-type=""pmid"">20412802</pub-id></element-citation></ref><ref id=""CR3""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Bouige</surname><given-names>P</given-names></name><name><surname>Laurent</surname><given-names>D</given-names></name><name><surname>Piloyan</surname><given-names>L</given-names></name><name><surname>Dassa</surname><given-names>E</given-names></name></person-group><article-title>Phylogenetic and functional classification of ATP-binding cassette (ABC) systems</article-title><source>Curr Protein Pept Sci</source><year>2002</year><volume>3</volume><fpage>541</fpage><lpage>559</lpage><pub-id pub-id-type=""doi"">10.2174/1389203023380486</pub-id><pub-id pub-id-type=""pmid"">12370001</pub-id></element-citation></ref><ref id=""CR4""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Bublitz</surname><given-names>M</given-names></name><name><surname>Morth</surname><given-names>JP</given-names></name><name><surname>Nissen</surname><given-names>P</given-names></name></person-group><article-title>P-type ATPases at a glance</article-title><source>J Cell Sci</source><year>2011</year><volume>124</volume><fpage>2515</fpage><lpage>2519</lpage><pub-id pub-id-type=""doi"">10.1242/jcs.088716</pub-id><pub-id pub-id-type=""pmid"">21768325</pub-id></element-citation></ref><ref id=""CR5""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Chen</surname><given-names>J</given-names></name></person-group><article-title>Molecular mechanism of the<italic>Escherichia coli</italic>maltose transporter</article-title><source>Curr Opin Struct Biol</source><year>2013</year><volume>23</volume><fpage>492</fpage><lpage>498</lpage><pub-id pub-id-type=""doi"">10.1016/j.sbi.2013.03.011</pub-id><pub-id pub-id-type=""pmid"">23628288</pub-id></element-citation></ref><ref id=""CR6""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Covitz</surname><given-names>KM</given-names></name><name><surname>Panagiotidis</surname><given-names>CH</given-names></name><name><surname>Hor</surname><given-names>LI</given-names></name><name><surname>Reyes</surname><given-names>M</given-names></name><name><surname>Treptow</surname><given-names>NA</given-names></name><name><surname>Shuman</surname><given-names>HA</given-names></name></person-group><article-title>Mutations that alter the transmembrane signalling pathway in an ATP binding cassette (ABC) transporter</article-title><source>EMBO J</source><year>1994</year><volume>13</volume><fpage>1752</fpage><lpage>1759</lpage><pub-id pub-id-type=""pmid"">8157012</pub-id></element-citation></ref><ref id=""CR7""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Davidson</surname><given-names>AL</given-names></name><name><surname>Shuman</surname><given-names>HA</given-names></name><name><surname>Nikaido</surname><given-names>H</given-names></name></person-group><article-title>Mechanism of maltose transport in<italic>Escherichia coli</italic>: transmembrane signaling by periplasmic binding proteins</article-title><source>Proc Natl Acad Sci USA</source><year>1992</year><volume>89</volume><fpage>2360</fpage><lpage>2364</lpage><pub-id pub-id-type=""doi"">10.1073/pnas.89.6.2360</pub-id><pub-id pub-id-type=""pmid"">1549599</pub-id></element-citation></ref><ref id=""CR8""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Davidson</surname><given-names>AL</given-names></name><name><surname>Laghaeian</surname><given-names>SS</given-names></name><name><surname>Mannering</surname><given-names>DE</given-names></name></person-group><article-title>The maltose transport system of<italic>Escherichia coli</italic>displays positive cooperativity in ATP hydrolysis</article-title><source>J Biol Chem</source><year>1996</year><volume>271</volume><fpage>4858</fpage><lpage>4863</lpage><pub-id pub-id-type=""doi"">10.1074/jbc.271.39.23792</pub-id><pub-id pub-id-type=""pmid"">8617756</pub-id></element-citation></ref><ref id=""CR9""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Davidson</surname><given-names>AL</given-names></name><name><surname>Dassa</surname><given-names>E</given-names></name><name><surname>Orelle</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name></person-group><article-title>Structure, function, and evolution of bacterial ATP-binding cassette systems</article-title><source>Microbiol Mol Biol Rev</source><year>2008</year><volume>72</volume><fpage>317</fpage><lpage>364</lpage><pub-id pub-id-type=""doi"">10.1128/MMBR.00031-07</pub-id><pub-id pub-id-type=""pmid"">18535149</pub-id></element-citation></ref><ref id=""CR10""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Deeley</surname><given-names>RG</given-names></name><name><surname>Westlake</surname><given-names>C</given-names></name><name><surname>Cole</surname><given-names>SP</given-names></name></person-group><article-title>Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins</article-title><source>Physiol Rev</source><year>2006</year><volume>86</volume><fpage>849</fpage><lpage>899</lpage><pub-id pub-id-type=""doi"">10.1152/physrev.00035.2005</pub-id><pub-id pub-id-type=""pmid"">16816140</pub-id></element-citation></ref><ref id=""CR11""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Gadsby</surname><given-names>DC</given-names></name><name><surname>Vergani</surname><given-names>P</given-names></name><name><surname>Csanady</surname><given-names>L</given-names></name></person-group><article-title>The ABC protein turned chloride channel whose failure causes cystic fibrosis</article-title><source>Nature</source><year>2006</year><volume>440</volume><fpage>477</fpage><lpage>483</lpage><pub-id pub-id-type=""doi"">10.1038/nature04712</pub-id><pub-id pub-id-type=""pmid"">16554808</pub-id></element-citation></ref><ref id=""CR12""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Grossmann</surname><given-names>N</given-names></name><name><surname>Vakkasoglu</surname><given-names>AS</given-names></name><name><surname>Hulpke</surname><given-names>S</given-names></name><name><surname>Abele</surname><given-names>R</given-names></name><name><surname>Gaudet</surname><given-names>R</given-names></name><name><surname>Tampe</surname><given-names>R</given-names></name></person-group><article-title>Mechanistic determinants of the directionality and energetics of active export by a heterodimeric ABC transporter</article-title><source>Nat Commun</source><year>2014</year><volume>5</volume><fpage>5419</fpage><pub-id pub-id-type=""doi"">10.1038/ncomms6419</pub-id><pub-id pub-id-type=""pmid"">25377891</pub-id></element-citation></ref><ref id=""CR13""><mixed-citation publication-type=""other"">Heng J, Zhao Y, Liu M, Liu Y, Fan J, Wang X, Zhang XC (2015) Substrate-bound structure of the<italic>E. coli</italic>multidrug resistance transporter MdfA. Cell research 25:1060–1073</mixed-citation></ref><ref id=""CR14""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Higgins</surname><given-names>CF</given-names></name><name><surname>Linton</surname><given-names>KJ</given-names></name></person-group><article-title>The ATP switch model for ABC transporters</article-title><source>Nat Struct Mol Biol</source><year>2004</year><volume>11</volume><fpage>918</fpage><lpage>926</lpage><pub-id pub-id-type=""doi"">10.1038/nsmb836</pub-id><pub-id pub-id-type=""pmid"">15452563</pub-id></element-citation></ref><ref id=""CR15""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Hollenstein</surname><given-names>K</given-names></name><name><surname>Frei</surname><given-names>DC</given-names></name><name><surname>Locher</surname><given-names>KP</given-names></name></person-group><article-title>Structure of an ABC transporter in complex with its binding protein</article-title><source>Nature</source><year>2007</year><volume>446</volume><fpage>213</fpage><lpage>216</lpage><pub-id pub-id-type=""doi"">10.1038/nature05626</pub-id><pub-id pub-id-type=""pmid"">17322901</pub-id></element-citation></ref><ref id=""CR16""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Lemieux</surname><given-names>MJ</given-names></name><name><surname>Song</surname><given-names>J</given-names></name><name><surname>Auer</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>DN</given-names></name></person-group><article-title>Structure and mechanism of the glycerol-3-phosphate transporter from<italic>Escherichia coli</italic></article-title><source>Science</source><year>2003</year><volume>301</volume><fpage>616</fpage><lpage>620</lpage><pub-id pub-id-type=""doi"">10.1126/science.1087619</pub-id><pub-id pub-id-type=""pmid"">12893936</pub-id></element-citation></ref><ref id=""CR17""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Jardetzky</surname><given-names>O</given-names></name></person-group><article-title>Simple allosteric model for membrane pumps</article-title><source>Nature</source><year>1966</year><volume>211</volume><fpage>969</fpage><lpage>970</lpage><pub-id pub-id-type=""doi"">10.1038/211969a0</pub-id><pub-id pub-id-type=""pmid"">5968307</pub-id></element-citation></ref><ref id=""CR18""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Jiang</surname><given-names>D</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Fan</surname><given-names>J</given-names></name><name><surname>Heng</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Feng</surname><given-names>W</given-names></name><name><surname>Kang</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>B</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><etal></etal></person-group><article-title>Structure of the YajR transporter suggests a transport mechanism based on the conserved motif A</article-title><source>Proc Natl Acad Sci USA</source><year>2013</year><volume>110</volume><fpage>14664</fpage><lpage>14669</lpage><pub-id pub-id-type=""doi"">10.1073/pnas.1308127110</pub-id><pub-id pub-id-type=""pmid"">23950222</pub-id></element-citation></ref><ref id=""CR19""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Jones</surname><given-names>PM</given-names></name><name><surname>O’Mara</surname><given-names>ML</given-names></name><name><surname>George</surname><given-names>AM</given-names></name></person-group><article-title>ABC transporters: a riddle wrapped in a mystery inside an enigma</article-title><source>Trends Biochem Sci</source><year>2009</year><volume>34</volume><fpage>520</fpage><lpage>531</lpage><pub-id pub-id-type=""doi"">10.1016/j.tibs.2009.06.004</pub-id><pub-id pub-id-type=""pmid"">19748784</pub-id></element-citation></ref><ref id=""CR20""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Kadaba</surname><given-names>NS</given-names></name><name><surname>Kaiser</surname><given-names>JT</given-names></name><name><surname>Johnson</surname><given-names>E</given-names></name><name><surname>Lee</surname><given-names>A</given-names></name><name><surname>Rees</surname><given-names>DC</given-names></name></person-group><article-title>The high-affinity<italic>E. coli</italic>methionine ABC transporter: structure and allosteric regulation</article-title><source>Science</source><year>2008</year><volume>321</volume><fpage>250</fpage><lpage>253</lpage><pub-id pub-id-type=""doi"">10.1126/science.1157987</pub-id><pub-id pub-id-type=""pmid"">18621668</pub-id></element-citation></ref><ref id=""CR21""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Khare</surname><given-names>D</given-names></name><name><surname>Oldham</surname><given-names>ML</given-names></name><name><surname>Orelle</surname><given-names>C</given-names></name><name><surname>Davidson</surname><given-names>AL</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name></person-group><article-title>Alternating access in maltose transporter mediated by rigid-body rotations</article-title><source>Mol Cell</source><year>2009</year><volume>33</volume><fpage>528</fpage><lpage>536</lpage><pub-id pub-id-type=""doi"">10.1016/j.molcel.2009.01.035</pub-id><pub-id pub-id-type=""pmid"">19250913</pub-id></element-citation></ref><ref id=""CR22""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Chang</surname><given-names>AB</given-names></name><name><surname>Saier</surname><given-names>MH</given-names><suffix>Jr</suffix></name></person-group><article-title>Sequence similarity between multidrug resistance efflux pumps of the ABC and RND superfamilies</article-title><source>Microbiology</source><year>2004</year><volume>150</volume><fpage>2493</fpage><lpage>2495</lpage><pub-id pub-id-type=""doi"">10.1099/mic.0.27312-0</pub-id><pub-id pub-id-type=""pmid"">15289545</pub-id></element-citation></ref><ref id=""CR23""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>S</given-names></name><name><surname>Tomasiak</surname><given-names>TM</given-names></name><name><surname>Mergel</surname><given-names>C</given-names></name><name><surname>Winter</surname><given-names>MB</given-names></name><name><surname>Stiller</surname><given-names>SB</given-names></name><name><surname>Robles-Colmanares</surname><given-names>Y</given-names></name><name><surname>Stroud</surname><given-names>RM</given-names></name><name><surname>Tampe</surname><given-names>R</given-names></name><name><surname>Craik</surname><given-names>CS</given-names></name><etal></etal></person-group><article-title>Subnanometre-resolution electron cryomicroscopy structure of a heterodimeric ABC exporter</article-title><source>Nature</source><year>2014</year><volume>517</volume><fpage>396</fpage><lpage>400</lpage><pub-id pub-id-type=""doi"">10.1038/nature13872</pub-id><pub-id pub-id-type=""pmid"">25363761</pub-id></element-citation></ref><ref id=""CR24""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Korkhov</surname><given-names>VM</given-names></name><name><surname>Mireku</surname><given-names>SA</given-names></name><name><surname>Locher</surname><given-names>KP</given-names></name></person-group><article-title>Structure of AMP-PNP-bound vitamin B12 transporter BtuCD-F</article-title><source>Nature</source><year>2012</year><volume>490</volume><fpage>367</fpage><lpage>372</lpage><pub-id pub-id-type=""doi"">10.1038/nature11442</pub-id><pub-id pub-id-type=""pmid"">23000901</pub-id></element-citation></ref><ref id=""CR25""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Korkhov</surname><given-names>VM</given-names></name><name><surname>Mireku</surname><given-names>SA</given-names></name><name><surname>Veprintsev</surname><given-names>DB</given-names></name><name><surname>Locher</surname><given-names>KP</given-names></name></person-group><article-title>Structure of AMP-PNP-bound BtuCD and mechanism of ATP-powered vitamin B12 transport by BtuCD-F</article-title><source>Nat Struct Mol Biol</source><year>2014</year><volume>21</volume><fpage>1097</fpage><lpage>1099</lpage><pub-id pub-id-type=""doi"">10.1038/nsmb.2918</pub-id><pub-id pub-id-type=""pmid"">25402482</pub-id></element-citation></ref><ref id=""CR26""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Sham</surname><given-names>YY</given-names></name><name><surname>Bikadi</surname><given-names>Z</given-names></name><name><surname>Elmquist</surname><given-names>WF</given-names></name></person-group><article-title>pH-Dependent transport of pemetrexed by breast cancer resistance protein</article-title><source>Drug Metab Dispos</source><year>2011</year><volume>39</volume><fpage>1478</fpage><lpage>1485</lpage><pub-id pub-id-type=""doi"">10.1124/dmd.111.039370</pub-id><pub-id pub-id-type=""pmid"">21628496</pub-id></element-citation></ref><ref id=""CR27""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Linton</surname><given-names>KJ</given-names></name><name><surname>Higgins</surname><given-names>CF</given-names></name></person-group><article-title>The<italic>Escherichia coli</italic>ATP-binding cassette (ABC) proteins</article-title><source>Mol Microbiol</source><year>1998</year><volume>28</volume><fpage>5</fpage><lpage>13</lpage><pub-id pub-id-type=""doi"">10.1046/j.1365-2958.1998.00764.x</pub-id><pub-id pub-id-type=""pmid"">9593292</pub-id></element-citation></ref><ref id=""CR28""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Locher</surname><given-names>KP</given-names></name><name><surname>Lee</surname><given-names>AT</given-names></name><name><surname>Rees</surname><given-names>DC</given-names></name></person-group><article-title>The<italic>E. coli</italic>BtuCD structure: a framework for ABC transporter architecture and mechanism</article-title><source>Science</source><year>2002</year><volume>296</volume><fpage>1091</fpage><lpage>1098</lpage><pub-id pub-id-type=""doi"">10.1126/science.1071142</pub-id><pub-id pub-id-type=""pmid"">12004122</pub-id></element-citation></ref><ref id=""CR29""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Oldham</surname><given-names>ML</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name></person-group><article-title>Crystal structure of the maltose transporter in a pretranslocation intermediate state</article-title><source>Science</source><year>2011</year><volume>332</volume><fpage>1202</fpage><lpage>1205</lpage><pub-id pub-id-type=""doi"">10.1126/science.1200767</pub-id><pub-id pub-id-type=""pmid"">21566157</pub-id></element-citation></ref><ref id=""CR30""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Oldham</surname><given-names>ML</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name></person-group><article-title>Structural basis for substrate specificity in the<italic>Escherichia coli</italic>maltose transport system</article-title><source>Proc Natl Acad Sci USA</source><year>2013</year><volume>110</volume><fpage>18132</fpage><lpage>18137</lpage><pub-id pub-id-type=""doi"">10.1073/pnas.1311407110</pub-id><pub-id pub-id-type=""pmid"">24145421</pub-id></element-citation></ref><ref id=""CR31""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Orelle</surname><given-names>C</given-names></name><name><surname>Ayvaz</surname><given-names>T</given-names></name><name><surname>Everly</surname><given-names>RM</given-names></name><name><surname>Klug</surname><given-names>CS</given-names></name><name><surname>Davidson</surname><given-names>AL</given-names></name></person-group><article-title>Both maltose-binding protein and ATP are required for nucleotide-binding domain closure in the intact maltose ABC transporter</article-title><source>Proc Natl Acad Sci USA</source><year>2008</year><volume>105</volume><fpage>12837</fpage><lpage>12842</lpage><pub-id pub-id-type=""doi"">10.1073/pnas.0803799105</pub-id><pub-id pub-id-type=""pmid"">18725638</pub-id></element-citation></ref><ref id=""CR32""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Perez</surname><given-names>C</given-names></name><name><surname>Gerber</surname><given-names>S</given-names></name><name><surname>Boilevin</surname><given-names>J</given-names></name><name><surname>Bucher</surname><given-names>M</given-names></name><name><surname>Darbre</surname><given-names>T</given-names></name><name><surname>Aebi</surname><given-names>M</given-names></name><name><surname>Reymond</surname><given-names>JL</given-names></name><name><surname>Locher</surname><given-names>KP</given-names></name></person-group><article-title>Structure and mechanism of an active lipid-linked oligosaccharide flippase</article-title><source>Nature</source><year>2015</year><volume>524</volume><fpage>433</fpage><lpage>438</lpage><pub-id pub-id-type=""doi"">10.1038/nature14953</pub-id><pub-id pub-id-type=""pmid"">26266984</pub-id></element-citation></ref><ref id=""CR33""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Phillips</surname><given-names>R</given-names></name><name><surname>Ursell</surname><given-names>T</given-names></name><name><surname>Wiggins</surname><given-names>P</given-names></name><name><surname>Sens</surname><given-names>P</given-names></name></person-group><article-title>Emerging roles for lipids in shaping membrane-protein function</article-title><source>Nature</source><year>2009</year><volume>459</volume><fpage>379</fpage><lpage>385</lpage><pub-id pub-id-type=""doi"">10.1038/nature08147</pub-id><pub-id pub-id-type=""pmid"">19458714</pub-id></element-citation></ref><ref id=""CR34""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Pinkett</surname><given-names>HW</given-names></name><name><surname>Lee</surname><given-names>AT</given-names></name><name><surname>Lum</surname><given-names>P</given-names></name><name><surname>Locher</surname><given-names>KP</given-names></name><name><surname>Rees</surname><given-names>DC</given-names></name></person-group><article-title>An inward-facing conformation of a putative metal-chelate-type ABC transporter</article-title><source>Science</source><year>2007</year><volume>315</volume><fpage>373</fpage><lpage>377</lpage><pub-id pub-id-type=""doi"">10.1126/science.1133488</pub-id><pub-id pub-id-type=""pmid"">17158291</pub-id></element-citation></ref><ref id=""CR35""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Poolman</surname><given-names>B</given-names></name><name><surname>Konings</surname><given-names>WN</given-names></name></person-group><article-title>Secondary solute transport in bacteria</article-title><source>Biochim Biophys Acta</source><year>1993</year><volume>1183</volume><fpage>5</fpage><lpage>39</lpage><pub-id pub-id-type=""doi"">10.1016/0005-2728(93)90003-X</pub-id><pub-id pub-id-type=""pmid"">8399376</pub-id></element-citation></ref><ref id=""CR36""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Qiao</surname><given-names>S</given-names></name><name><surname>Luo</surname><given-names>Q</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>XC</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name></person-group><article-title>Structural basis for lipopolysaccharide insertion in the bacterial outer membrane</article-title><source>Nature</source><year>2014</year><volume>511</volume><fpage>108</fpage><lpage>111</lpage><pub-id pub-id-type=""doi"">10.1038/nature13484</pub-id><pub-id pub-id-type=""pmid"">24990751</pub-id></element-citation></ref><ref id=""CR37""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Reyes</surname><given-names>CL</given-names></name><name><surname>Chang</surname><given-names>G</given-names></name></person-group><article-title>Structure of the ABC transporter MsbA in complex with ADP·vanadate and lipopolysaccharide</article-title><source>Science</source><year>2005</year><volume>308</volume><fpage>1028</fpage><lpage>1031</lpage><pub-id pub-id-type=""doi"">10.1126/science.1107733</pub-id><pub-id pub-id-type=""pmid"">15890884</pub-id></element-citation></ref><ref id=""CR38""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Rice</surname><given-names>AJ</given-names></name><name><surname>Park</surname><given-names>A</given-names></name><name><surname>Pinkett</surname><given-names>HW</given-names></name></person-group><article-title>Diversity in ABC transporters: type I, II and III importers</article-title><source>Crit Rev Biochem Mol Biol</source><year>2014</year><volume>49</volume><fpage>426</fpage><lpage>437</lpage><pub-id pub-id-type=""doi"">10.3109/10409238.2014.953626</pub-id><pub-id pub-id-type=""pmid"">25155087</pub-id></element-citation></ref><ref id=""CR39""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Sauna</surname><given-names>ZE</given-names></name><name><surname>Ambudkar</surname><given-names>SV</given-names></name></person-group><article-title>Evidence for a requirement for ATP hydrolysis at two distinct steps during a single turnover of the catalytic cycle of human P-glycoprotein</article-title><source>Proc Natl Acad Sci USA</source><year>2000</year><volume>97</volume><fpage>2515</fpage><lpage>2520</lpage><pub-id pub-id-type=""doi"">10.1073/pnas.97.6.2515</pub-id><pub-id pub-id-type=""pmid"">10716986</pub-id></element-citation></ref><ref id=""CR40""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Saurin</surname><given-names>W</given-names></name><name><surname>Hofnung</surname><given-names>M</given-names></name><name><surname>Dassa</surname><given-names>E</given-names></name></person-group><article-title>Getting in or out: early segregation between importers and exporters in the evolution of ATP-binding cassette (ABC) transporters</article-title><source>J Mol Evol</source><year>1999</year><volume>48</volume><fpage>22</fpage><lpage>41</lpage><pub-id pub-id-type=""doi"">10.1007/PL00006442</pub-id><pub-id pub-id-type=""pmid"">9873074</pub-id></element-citation></ref><ref id=""CR41""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Seelig</surname><given-names>A</given-names></name><name><surname>Blatter</surname><given-names>XL</given-names></name><name><surname>Wohnsland</surname><given-names>F</given-names></name></person-group><article-title>Substrate recognition by P-glycoprotein and the multidrug resistance-associated protein MRP1: a comparison</article-title><source>Int J Clin Pharmacol Ther</source><year>2000</year><volume>38</volume><fpage>111</fpage><lpage>121</lpage><pub-id pub-id-type=""doi"">10.5414/CPP38111</pub-id><pub-id pub-id-type=""pmid"">10739114</pub-id></element-citation></ref><ref id=""CR42""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Senior</surname><given-names>AE</given-names></name><name><surname>Al-Shawi</surname><given-names>MK</given-names></name><name><surname>Urbatsch</surname><given-names>IL</given-names></name></person-group><article-title>The catalytic cycle of P-glycoprotein</article-title><source>FEBS Lett</source><year>1995</year><volume>377</volume><fpage>285</fpage><lpage>289</lpage><pub-id pub-id-type=""doi"">10.1016/0014-5793(95)01345-8</pub-id><pub-id pub-id-type=""pmid"">8549739</pub-id></element-citation></ref><ref id=""CR43""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Sherman</surname><given-names>DJ</given-names></name><name><surname>Lazarus</surname><given-names>MB</given-names></name><name><surname>Murphy</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Walker</surname><given-names>S</given-names></name><name><surname>Ruiz</surname><given-names>N</given-names></name><name><surname>Kahne</surname><given-names>D</given-names></name></person-group><article-title>Decoupling catalytic activity from biological function of the ATPase that powers lipopolysaccharide transport</article-title><source>Proc Natl Acad Sci USA</source><year>2014</year><volume>111</volume><fpage>4982</fpage><lpage>4987</lpage><pub-id pub-id-type=""doi"">10.1073/pnas.1323516111</pub-id><pub-id pub-id-type=""pmid"">24639492</pub-id></element-citation></ref><ref id=""CR44""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Shilling</surname><given-names>R</given-names></name><name><surname>Federici</surname><given-names>L</given-names></name><name><surname>Walas</surname><given-names>F</given-names></name><name><surname>Venter</surname><given-names>H</given-names></name><name><surname>Velamakanni</surname><given-names>S</given-names></name><name><surname>Woebking</surname><given-names>B</given-names></name><name><surname>Balakrishnan</surname><given-names>L</given-names></name><name><surname>Luisi</surname><given-names>B</given-names></name><name><surname>van Veen</surname><given-names>HW</given-names></name></person-group><article-title>A critical role of a carboxylate in proton conduction by the ATP-binding cassette multidrug transporter LmrA</article-title><source>FASEB J</source><year>2005</year><volume>19</volume><fpage>1698</fpage><lpage>1700</lpage><pub-id pub-id-type=""pmid"">16040836</pub-id></element-citation></ref><ref id=""CR45""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Srinivasan</surname><given-names>V</given-names></name><name><surname>Pierik</surname><given-names>AJ</given-names></name><name><surname>Lill</surname><given-names>R</given-names></name></person-group><article-title>Crystal structures of nucleotide-free and glutathione-bound mitochondrial ABC transporter Atm1</article-title><source>Science</source><year>2014</year><volume>343</volume><fpage>1137</fpage><lpage>1140</lpage><pub-id pub-id-type=""doi"">10.1126/science.1246729</pub-id><pub-id pub-id-type=""pmid"">24604199</pub-id></element-citation></ref><ref id=""CR46""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Varma</surname><given-names>MV</given-names></name><name><surname>Sarkar</surname><given-names>M</given-names></name><name><surname>Kapoor</surname><given-names>N</given-names></name><name><surname>Panchagnula</surname><given-names>R</given-names></name></person-group><article-title>pH-dependent functional activity of P-glycoprotein in limiting intestinal absorption of protic drugs 1. Simultaneous determination of quinidine and permeability markers in rat in situ perfusion samples</article-title><source>J Chromatog B Analyt Technol Biomed Life Sci</source><year>2005</year><volume>816</volume><fpage>243</fpage><lpage>249</lpage><pub-id pub-id-type=""doi"">10.1016/j.jchromb.2004.11.040</pub-id></element-citation></ref><ref id=""CR47""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Venter</surname><given-names>H</given-names></name><name><surname>Shilling</surname><given-names>RA</given-names></name><name><surname>Velamakanni</surname><given-names>S</given-names></name><name><surname>Balakrishnan</surname><given-names>L</given-names></name><name><surname>Van Veen</surname><given-names>HW</given-names></name></person-group><article-title>An ABC transporter with a secondary-active multidrug translocator domain</article-title><source>Nature</source><year>2003</year><volume>426</volume><fpage>866</fpage><lpage>870</lpage><pub-id pub-id-type=""doi"">10.1038/nature02173</pub-id><pub-id pub-id-type=""pmid"">14685244</pub-id></element-citation></ref><ref id=""CR48""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Wesolowska</surname><given-names>O</given-names></name></person-group><article-title>Interaction of phenothiazines, stilbenes and flavonoids with multidrug resistance-associated transporters, P-glycoprotein and MRP1</article-title><source>Acta Biochim Pol</source><year>2011</year><volume>58</volume><fpage>433</fpage><lpage>448</lpage><pub-id pub-id-type=""pmid"">22187677</pub-id></element-citation></ref><ref id=""CR49""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Woo</surname><given-names>JS</given-names></name><name><surname>Zeltina</surname><given-names>A</given-names></name><name><surname>Goetz</surname><given-names>BA</given-names></name><name><surname>Locher</surname><given-names>KP</given-names></name></person-group><article-title>X-ray structure of the<italic>Yersinia pestis</italic>heme transporter HmuUV</article-title><source>Nat Struct Mol Biol</source><year>2012</year><volume>19</volume><fpage>1310</fpage><lpage>1315</lpage><pub-id pub-id-type=""doi"">10.1038/nsmb.2417</pub-id><pub-id pub-id-type=""pmid"">23142986</pub-id></element-citation></ref><ref id=""CR50""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Xu</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>Q</given-names></name><name><surname>Yu</surname><given-names>F</given-names></name><name><surname>Guo</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>He</surname><given-names>F</given-names></name><name><surname>Ding</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name></person-group><article-title>Crystal structure of a folate energy-coupling factor transporter from<italic>Lactobacillus brevis</italic></article-title><source>Nature</source><year>2013</year><volume>497</volume><fpage>268</fpage><lpage>271</lpage><pub-id pub-id-type=""doi"">10.1038/nature12046</pub-id><pub-id pub-id-type=""pmid"">23584589</pub-id></element-citation></ref><ref id=""CR51""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Zhang</surname><given-names>DW</given-names></name><name><surname>Gu</surname><given-names>HM</given-names></name><name><surname>Situ</surname><given-names>D</given-names></name><name><surname>Haimeur</surname><given-names>A</given-names></name><name><surname>Cole</surname><given-names>SP</given-names></name><name><surname>Deeley</surname><given-names>RG</given-names></name></person-group><article-title>Functional importance of polar and charged amino acid residues in transmembrane helix 14 of multidrug resistance protein 1 (MRP1/ABCC1): identification of an aspartate residue critical for conversion from a high to low affinity substrate binding state</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>46052</fpage><lpage>46063</lpage><pub-id pub-id-type=""doi"">10.1074/jbc.M308403200</pub-id><pub-id pub-id-type=""pmid"">12954620</pub-id></element-citation></ref><ref id=""CR52""><element-citation publication-type=""journal""><person-group person-group-type=""author""><name><surname>Zhang</surname><given-names>XC</given-names></name><name><surname>Cao</surname><given-names>C</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name></person-group><article-title>Proton transfer-mediated GPCR activation</article-title><source>Protein Cell</source><year>2014</year><volume>6</volume><fpage>12</fpage><lpage>17</lpage><pub-id pub-id-type=""doi"">10.1007/s13238-014-0106-4</pub-id><pub-id pub-id-type=""pmid"">25319942</pub-id></element-citation></ref><ref id=""CR53""><mixed-citation publication-type=""other"">Zhang XC, Zhao Y, Heng J, Jiang D (2015) Energy coupling mechanisms of MFS transporters. Protein Sci. doi:10.1002/pro.2759</mixed-citation></ref></ref-list>"
10.1126/science.1119776	"<html><body><article article-type=""research-article"" xmlns:mml=""http://www.w3.org/1998/Math/MathML"" xmlns:xlink=""http://www.w3.org/1999/xlink""><?properties open_access?><front><journal-meta><journal-id journal-id-type=""nlm-ta"">BMC Genomics</journal-id><journal-title-group><journal-title>BMC Genomics</journal-title></journal-title-group><issn pub-type=""epub"">1471-2164</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type=""pmid"">20167121</article-id><article-id pub-id-type=""pmc"">2834635</article-id><article-id pub-id-type=""publisher-id"">1471-2164-11-120</article-id><article-id pub-id-type=""doi"">10.1186/1471-2164-11-120</article-id><article-categories><subj-group subj-group-type=""heading""><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>High-throughput genome sequencing of two<italic>Listeria monocytogenes</italic>clinical isolates during a large foodborne outbreak</article-title></title-group><contrib-group><contrib contrib-type=""author"" corresp=""yes"" id=""A1""><name><surname>Gilmour</surname><given-names>Matthew W</given-names></name><xref ref-type=""aff"" rid=""I1"">1</xref><xref ref-type=""aff"" rid=""I2"">2</xref><email>Matthew_Gilmour@phac-aspc.gc.ca</email></contrib><contrib contrib-type=""author"" id=""A2""><name><surname>Graham</surname><given-names>Morag</given-names></name><xref ref-type=""aff"" rid=""I1"">1</xref><xref ref-type=""aff"" rid=""I2"">2</xref><email>Morag_Graham@phac-aspc.gc.ca</email></contrib><contrib contrib-type=""author"" id=""A3""><name><surname>Van Domselaar</surname><given-names>Gary</given-names></name><xref ref-type=""aff"" rid=""I1"">1</xref><email>Gary_Van_Domselaar@phac-aspc.gc.ca</email></contrib><contrib contrib-type=""author"" id=""A4""><name><surname>Tyler</surname><given-names>Shaun</given-names></name><xref ref-type=""aff"" rid=""I1"">1</xref><email>Shaun_Tyler@phac-aspc.gc.ca</email></contrib><contrib contrib-type=""author"" id=""A5""><name><surname>Kent</surname><given-names>Heather</given-names></name><xref ref-type=""aff"" rid=""I1"">1</xref><email>Heather_Kent@phac-aspc.gc.ca</email></contrib><contrib contrib-type=""author"" id=""A6""><name><surname>Trout-Yakel</surname><given-names>Keri M</given-names></name><xref ref-type=""aff"" rid=""I1"">1</xref><email>Keri_M_Trout-Yakel@phac-aspc.gc.ca</email></contrib><contrib contrib-type=""author"" id=""A7""><name><surname>Larios</surname><given-names>Oscar</given-names></name><xref ref-type=""aff"" rid=""I2"">2</xref><email>olarios@gmail.com</email></contrib><contrib contrib-type=""author"" id=""A8""><name><surname>Allen</surname><given-names>Vanessa</given-names></name><xref ref-type=""aff"" rid=""I3"">3</xref><email>Vanessa.Allen@oahpp.ca</email></contrib><contrib contrib-type=""author"" id=""A9""><name><surname>Lee</surname><given-names>Barbara</given-names></name><xref ref-type=""aff"" rid=""I4"">4</xref><email>Barbara.Lee@inspection.gc.ca</email></contrib><contrib contrib-type=""author"" id=""A10""><name><surname>Nadon</surname><given-names>Celine</given-names></name><xref ref-type=""aff"" rid=""I1"">1</xref><xref ref-type=""aff"" rid=""I2"">2</xref><email>Celine_Nadon@phac-aspc.gc.ca</email></contrib></contrib-group><aff id=""I1""><label>1</label>National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada</aff><aff id=""I2""><label>2</label>Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB, Canada</aff><aff id=""I3""><label>3</label>Public Health Laboratories, Ontario Agency for Health Protection and Promotion, Toronto, ON, Canada</aff><aff id=""I4""><label>4</label>Canadian Food Inspection Agency, Ottawa, ON, Canada</aff><pub-date pub-type=""collection""><year>2010</year></pub-date><pub-date pub-type=""epub""><day>18</day><month>2</month><year>2010</year></pub-date><volume>11</volume><fpage>120</fpage><lpage>120</lpage><history><date date-type=""received""><day>30</day><month>6</month><year>2009</year></date><date date-type=""accepted""><day>18</day><month>2</month><year>2010</year></date></history><permissions><copyright-statement>Copyright ©2010 Gilmour et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2010</copyright-year><copyright-holder>Gilmour et al; licensee BioMed Central Ltd.</copyright-holder><license license-type=""open-access"" xlink:href=""http://creativecommons.org/licenses/by/2.0""><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type=""uri"" xlink:href=""http://creativecommons.org/licenses/by/2.0"">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href=""http://www.biomedcentral.com/1471-2164/11/120""></self-uri><abstract><sec><title>Background</title><p>A large, multi-province outbreak of listeriosis associated with ready-to-eat meat products contaminated with<italic>Listeria monocytogenes</italic>serotype 1/2a occurred in Canada in 2008. Subtyping of outbreak-associated isolates using pulsed-field gel electrophoresis (PFGE) revealed two similar but distinct<italic>Asc</italic>I PFGE patterns. High-throughput pyrosequencing of two<italic>L. monocytogenes</italic>isolates was used to rapidly provide the genome sequence of the primary outbreak strain and to investigate the extent of genetic diversity associated with a change of a single restriction enzyme fragment during PFGE.</p></sec><sec><title>Results</title><p>The chromosomes were collinear, but differences included 28 single nucleotide polymorphisms (SNPs) and three indels, including a 33 kbp prophage that accounted for the observed difference in<italic>Asc</italic>I PFGE patterns. The distribution of these traits was assessed within further clinical, environmental and food isolates associated with the outbreak, and this comparison indicated that three distinct, but highly related strains may have been involved in this nationwide outbreak. Notably, these two isolates were found to harbor a 50 kbp putative mobile genomic island encoding translocation and efflux functions that has not been observed in other<italic>Listeria</italic>genomes.</p></sec><sec><title>Conclusions</title><p>High-throughput genome sequencing provided a more detailed real-time assessment of genetic traits characteristic of the outbreak strains than could be achieved with routine subtyping methods. This study confirms that the latest generation of DNA sequencing technologies can be applied during high priority public health events, and laboratories need to prepare for this inevitability and assess how to properly analyze and interpret whole genome sequences in the context of molecular epidemiology.</p></sec></abstract></article-meta></front><sec><title>Background</title><p><italic>Listeria monocytogenes</italic>is a Gram-positive, facultative intracellular bacterial pathogen that can cause severe disease in humans, other mammals and birds [<xref ref-type=""bibr"" rid=""B1"">1</xref>]. Human listeriosis is relatively rare despite our likely frequent encounters with<italic>L. monocytogenes</italic>, which is ubiquitously present in the environment (including water, soil, vegetation), farm and rural environments, and urban environments [<xref ref-type=""bibr"" rid=""B2"">2</xref>-<xref ref-type=""bibr"" rid=""B6"">6</xref>]. The vast majority of human listeriosis is foodborne and the most commonly implicated vehicles are ready-to-eat food products such as meat, dairy, seafood, and fresh produce that are contaminated with<italic>L. monocytogenes</italic>during processing [<xref ref-type=""bibr"" rid=""B6"">6</xref>,<xref ref-type=""bibr"" rid=""B7"">7</xref>].<italic>L. monocytogenes</italic>can be introduced into food processing facilities and food products due to cross-contamination with environmental sources or from the feces of food production animals.<italic>L. monocytogenes</italic>can persist within food processing environments for long periods of time, due in part to its ability to grow at wide-ranging temperatures and pH (0.4°C to 45°C, pH 4 to 9.6) and the ability to form biofilms promoting adherence to food processing surfaces [<xref ref-type=""bibr"" rid=""B8"">8</xref>-<xref ref-type=""bibr"" rid=""B11"">11</xref>]. The persistence of a single subtype of<italic>L. monocytogenes</italic>in processing facilities or on equipment has been reported from several months to more than 10 years [<xref ref-type=""bibr"" rid=""B12"">12</xref>,<xref ref-type=""bibr"" rid=""B13"">13</xref>].</p><p>Given the widespread occurrence of<italic>L. monocytogenes</italic>, subtyping of clinical and food isolates is required to establish epidemiologic links during routine surveillance, outbreak investigations, and for source tracking. There are 13 known serotypes of<italic>L. monocytogenes</italic>but the vast majority of human disease cases are caused by strains belonging to serotypes 4b, 1/2a, and 1/2b, severely limiting the utility of this subtyping method for differentiating<italic>L. monocytogenes</italic>[<xref ref-type=""bibr"" rid=""B14"">14</xref>]. Large clonal outbreaks owing to contaminated food sources such as coleslaw, milk, cheese, hot dogs and deli meats, have been predominately caused by serotypes 4b and 1/2a strains [<xref ref-type=""bibr"" rid=""B15"">15</xref>]. Accordingly, additional subtyping methods are required to better characterize outbreak isolates. Several molecular subtyping methods have been developed and applied to<italic>L. monocytogenes</italic>, including pulsed-field gel electrophoresis (PFGE), ribotyping, multilocus variable-number tandem repeat analysis (MLVA), and sequence-based subtyping [<xref ref-type=""bibr"" rid=""B14"">14</xref>,<xref ref-type=""bibr"" rid=""B16"">16</xref>,<xref ref-type=""bibr"" rid=""B17"">17</xref>]. PFGE has been adopted by PulseNet as the internationally standardized method for molecular subtyping of<italic>L</italic>.<italic>monocytogenes</italic>and has been essential in the detection and investigation of listeriosis outbreaks in Canada and worldwide [<xref ref-type=""bibr"" rid=""B18"">18</xref>-<xref ref-type=""bibr"" rid=""B20"">20</xref>].</p><p>DNA sequencing has enabled analyses of<italic>L. monocytogenes</italic>genomes and furthered the understanding of this pathogen's biology and phylogeny. Comparative analyses of genome sequences have elucidated the genetic differences between<italic>L. monocytogenes</italic>serotypes, the acquisition and evolution of virulence and pathogenic traits among<italic>Listeria</italic>spp., and the genetic basis underlying the unique survival and growth characteristics of<italic>L. monocytogenes</italic>[<xref ref-type=""bibr"" rid=""B21"">21</xref>-<xref ref-type=""bibr"" rid=""B23"">23</xref>]. Genome sequencing has also permitted the development of multi-locus sequence typing (MLST) protocols, which in combination with other typing methods, have validated three evolutionary lineages for<italic>L. monocytogenes</italic>[<xref ref-type=""bibr"" rid=""B24"">24</xref>-<xref ref-type=""bibr"" rid=""B29"">29</xref>]. The lineages reflect the serotype distribution, with serotypes 1/2b, 3b and 4b segregating to lineage I and serotypes 1/2a and 1/2c segregating to lineage II. Risk assessments based upon genetic lineages have suggested that<italic>L. monocytogenes</italic>subtypes may have unique ecological niches and may also differ in their pathogenic potential or host adaptations [<xref ref-type=""bibr"" rid=""B30"">30</xref>,<xref ref-type=""bibr"" rid=""B31"">31</xref>].</p><p>The majority of available bacterial genome sequences have been generated using the Sanger chain termination sequencing chemistries. Although this technology was instrumental in the emergence of the field of genomics, it is time and resource intensive [<xref ref-type=""bibr"" rid=""B32"">32</xref>,<xref ref-type=""bibr"" rid=""B33"">33</xref>]. Several post-Sanger sequencing technologies (also referred to as next-generation sequencing technologies) have since been developed that enable extremely rapid whole-genome sequencing and a broader application of comparative genomics [<xref ref-type=""bibr"" rid=""B33"">33</xref>,<xref ref-type=""bibr"" rid=""B34"">34</xref>]. The high-throughput pyrosequencing method commercialized as the 454 or GS FLX™ platform has been applied for rapidly determining the genome sequences of bacterial isolates.</p><p><italic>L. monocytogenes</italic>serotype 1/2a caused a nationwide outbreak of listeriosis associated with ready-to-eat meat products in Canada during the summer of 2008. The outbreak resulted in 22 deaths and at least 57 illnesses. Whereas the majority of outbreak-associated isolates (human clinical and food isolates) had an indistinguishable<italic>Asc</italic>I PFGE pattern, one clinical isolate from Ontario and several isolates from the affected food production facility exhibited an<italic>Asc</italic>I PFGE pattern that differed by a single restriction enzyme fragment compared to the primary outbreak strain. We report herein the first real-time application of whole-genome sequencing during an active listeriosis outbreak investigation. High-throughput pyrosequencing was applied to characterize two outbreak-associated isolates of<italic>L. monocytogenes</italic>in order to obtain a thorough genetic characterization of the outbreak strains and to determine the genetic basis for the single<italic>Asc</italic>I restriction fragment change.</p></sec><sec><title>Results and Discussion</title><sec><title>Primary outbreak isolate harbors unique plasmid pLM5578 and prophage ϕLMC1</title><p>Public health responses to foodborne outbreaks require bacterial subtyping data to definitively link affected individuals with contaminated food sources and other suspected patients. The genetic relatedness between clinical and food isolates is routinely determined using methods such as PFGE, however, with the latest generation of DNA sequencing technologies it is theoretically possible to now determine the complete genetic blueprint of bacterial isolates within the scope of an outbreak. In this study, draft genome sequences suitable for comparative analysis between outbreak isolates and to reference genomes were available within three days. These data allowed for discovery of novel prophage and genomic islands, and the subsequent sequence closure and the confirmation of sequence variants allowed for annotation of polymorphisms and other traits associated with micro-diversity.</p><p>Clinical isolate 08-5578 was selected as the reference outbreak strain (serotype 1/2a; PFGE patterns LMACI.0040 and LMAAI.0001; Table<xref ref-type=""table"" rid=""T1"">1</xref>) and clinical isolate 08-5923 differed only in the<italic>Asc</italic>I restriction pattern (LMACI.0001; Fig.<xref ref-type=""fig"" rid=""F1"">1</xref>). High-throughput pyrosequencing was performed on both isolates and closed circular chromosomal sequences were obtained for each isolate (Table<xref ref-type=""table"" rid=""T2"">2</xref>; Fig.<xref ref-type=""fig"" rid=""F2"">2</xref>). A 77 kbp contig present in the 08-5578 sequence assembly but absent in 08-5923 was identified as a circular plasmid and designated pLM5578 (Table<xref ref-type=""table"" rid=""T2"">2</xref>). Comparison of the chromosomal sequences for isolates 08-5578 and 08-5923 with publicly available<italic>Listeria spp.</italic>genomes (Fig.<xref ref-type=""fig"" rid=""F3"">3A</xref>) and with select loci used for MLST (Fig.<xref ref-type=""fig"" rid=""F3"">3B</xref>) indicated that these isolates were members of evolutionary lineage II and clonal complex 8 (discussed further below).</p><fig id=""F1"" position=""float""><label>Figure 1</label><caption><p><bold><italic>Asc</italic>I pulsed-field gel electrophoresis of two<italic>Listeria monocytogenes</italic>PFGE patterns associated with a large foodborne outbreak</bold>. A: LMACI.0040; B: LMACI.0001. Restriction fragment sizes were estimated using BioNumerics relative to the control standard. Unmatched bands are highlighted (red arrow).</p></caption><graphic xlink:href=""1471-2164-11-120-1""></graphic></fig><fig id=""F2"" position=""float""><label>Figure 2</label><caption><p><bold>Circular map and genetic features of<italic>Listeria monocytogenes</italic>isolate 08-5578</bold>. The outer ring denotes genetic coordinates, and prophage and the novel 50 kbp<italic>Listeria</italic>genomic island (LGI1) are indicated in grey text. Prophage ϕLMC1 is not encoded within isolate 08-5923. Light blue bars (2<sup>nd</sup>and 3<sup>rd</sup>rings) denote coding sequences on the positive and negative strands, respectively. Red bars (4<sup>th</sup>ring) denote those coding sequences present in 08-5578 but absent in the genome sequence of strain EGDe. Dark blue bars (5<sup>th</sup>ring) indicate confirmed single nucleotide polymorphisms between isolate 08-5578 and 08-5923. The black/grey and blue/green plots indicate G+C content and G+C skew, respectively.</p></caption><graphic xlink:href=""1471-2164-11-120-2""></graphic></fig><fig id=""F3"" position=""float""><label>Figure 3</label><caption><p><bold>Maximum likelihood phylogenetic trees determined for<italic>Listeria</italic>genome sequences (A) and MLST loci (B)</bold>.<italic>L. monocytogenes</italic>lineages and serotypes are indicated (grey text). 'CC' denotes clonal complexes and 'ST' denotes sequence types. Strain F2365 was isolated from a 1985 California cheese outbreak; H7858 from a 1998-9 Multistate hotdog oubreak; F6854 from a 1988 Oklahoma turkey hot dog sporadic case; EGDe is a laboratory strain passaged from an animal isolate from 1924.</p></caption><graphic xlink:href=""1471-2164-11-120-3""></graphic></fig><table-wrap id=""T1"" position=""float""><label>Table 1</label><caption><p>Bacterial isolates used in this study and results of PCR-based screening assays.</p></caption><table frame=""hsides"" rules=""groups""><thead><tr><th></th><th></th><th></th><th></th><th align=""center"" colspan=""2"">Pulsed-field gel electrophoresis</th><th align=""center"" colspan=""2"">Prophage ϕLMC3<sup>b</sup></th><th align=""center"" colspan=""2"">pLM5578</th><th></th><th></th><th></th></tr><tr><th></th><th></th><th></th><th></th><th colspan=""6""><hr/></th><th></th><th></th><th></th></tr><tr><th align=""left"">Isolate No.</th><th align=""left"">Source</th><th align=""left"">Specimen type<sup>a</sup></th><th align=""left"">Serotype</th><th align=""left""><italic>Asc</italic>I</th><th align=""left""><italic>Apa</italic>I</th><th align=""center"">terminase</th><th align=""center"">tail protein</th><th align=""center""><italic>virD4</italic></th><th align=""center""><italic>fic</italic></th><th align=""center""><italic>buk</italic><sup>c</sup></th><th align=""center""><italic>gltX</italic><sup>d</sup></th><th align=""center"">SNPs<sup>e</sup></th></tr></thead><tbody><tr><td align=""left"">08-5578</td><td align=""left"">Human</td><td align=""left"">Blood</td><td align=""left"">1/2a</td><td align=""left"">LMACI.0040</td><td align=""left"">LMAAI.0001</td><td align=""center"">+</td><td align=""center"">+</td><td align=""center"">+</td><td align=""center"">+</td><td align=""center"">FS</td><td align=""center"">- 21 bp</td><td align=""center"">1</td></tr><tr><td align=""left"">08-5923</td><td align=""left"">Human</td><td align=""left"">Blood</td><td align=""left"">1/2a</td><td align=""left"">LMACI.0001</td><td align=""left"">LMAAI.0001</td><td align=""center"">-</td><td align=""center"">-</td><td align=""center"">-</td><td align=""center"">-</td><td align=""center"">WT</td><td align=""center"">WT</td><td align=""center"">27</td></tr><tr><td align=""left"">08-6040</td><td align=""left"">Food</td><td align=""left"">RTE meat</td><td align=""left"">1/2a</td><td align=""left"">LMACI.0040</td><td align=""left"">LMAAI.0001</td><td align=""center"">+</td><td align=""center"">+</td><td align=""center"">+</td><td align=""center"">+</td><td align=""center"">FS</td><td align=""center"">- 21 bp</td><td align=""center"">1</td></tr><tr><td align=""left"">08-6055</td><td align=""left"">Food</td><td align=""left"">RTE meat</td><td align=""left"">1/2a</td><td align=""left"">LMACI.0040</td><td align=""left"">LMAAI.0001</td><td align=""center"">+</td><td align=""center"">+</td><td align=""center"">-</td><td align=""center"">-</td><td align=""center"">FS</td><td align=""center"">- 21 bp</td><td align=""center"">1</td></tr><tr><td align=""left"">08-6135</td><td align=""left"">Human</td><td align=""left"">CSF</td><td align=""left"">1/2a</td><td align=""left"">LMACI.0040</td><td align=""left"">LMAAI.0001</td><td align=""center"">+</td><td align=""center"">+</td><td align=""center"">+</td><td align=""center"">+</td><td align=""center"">FS</td><td align=""center"">- 21 bp</td><td align=""center"">1</td></tr><tr><td align=""left"">08-6567</td><td align=""left"">Environment</td><td align=""left"">Food processing</td><td align=""left"">1/2a</td><td align=""left"">LMACI.0040</td><td align=""left"">LMAAI.0001</td><td align=""center"">+</td><td align=""center"">+</td><td align=""center"">+</td><td align=""center"">+</td><td align=""center"">FS</td><td align=""center"">- 21 bp</td><td align=""center"">1</td></tr><tr><td align=""left"">08-6061</td><td align=""left"">Food</td><td align=""left"">RTE meat</td><td align=""left"">1/2a</td><td align=""left"">LMACI.0040</td><td align=""left"">LMAAI.0001</td><td align=""center"">+</td><td align=""center"">+</td><td align=""center"">+</td><td align=""center"">+</td><td align=""center"">FS</td><td align=""center"">- 21 bp</td><td align=""center"">1</td></tr><tr><td align=""left"">08-6421</td><td align=""left"">Human</td><td align=""left"">Blood</td><td align=""left"">1/2a</td><td align=""left"">LMACI.0040</td><td align=""left"">LMAAI.0001</td><td align=""center"">+</td><td align=""center"">+</td><td align=""center"">+</td><td align=""center"">+</td><td align=""center"">FS</td><td align=""center"">- 21 bp</td><td align=""center"">1</td></tr><tr><td align=""left"">08-5828</td><td align=""left"">Human</td><td align=""left"">Blood</td><td align=""left"">1/2a</td><td align=""left"">LMACI.0040</td><td align=""left"">LMAAI.0001</td><td align=""center"">+</td><td align=""center"">+</td><td align=""center"">-</td><td align=""center"">-</td><td align=""center"">FS</td><td align=""center"">- 21 bp</td><td align=""center"">1</td></tr><tr><td align=""left"">08-7374</td><td align=""left"">Environment</td><td align=""left"">Food processing</td><td align=""left"">1/2a</td><td align=""left"">LMACI.0001</td><td align=""left"">LMAAI.0001</td><td align=""center"">-</td><td align=""center"">-</td><td align=""center"">-</td><td align=""center"">-</td><td align=""center"">FS</td><td align=""center"">WT</td><td align=""center"">0</td></tr><tr><td align=""left"">08-7376</td><td align=""left"">Environment</td><td align=""left"">Food processing</td><td align=""left"">1/2a</td><td align=""left"">LMACI.0001</td><td align=""left"">LMAAI.0001</td><td align=""center"">-</td><td align=""center"">-</td><td align=""center"">-</td><td align=""center"">-</td><td align=""center"">FS</td><td align=""center"">WT</td><td align=""center"">0</td></tr><tr><td align=""left"">08-7381</td><td align=""left"">Environment</td><td align=""left"">Food processing</td><td align=""left"">1/2a</td><td align=""left"">LMACI.0001</td><td align=""left"">LMAAI.0001</td><td align=""center"">-</td><td align=""center"">-</td><td align=""center"">-</td><td align=""center"">-</td><td align=""center"">FS</td><td align=""center"">WT</td><td align=""center"">0</td></tr><tr><td align=""left"">08-7382</td><td align=""left"">Environment</td><td align=""left"">Food processing</td><td align=""left"">1/2a</td><td align=""left"">LMACI.0001</td><td align=""left"">LMAAI.0001</td><td align=""center"">-</td><td align=""center"">-</td><td align=""center"">-</td><td align=""center"">-</td><td align=""center"">FS</td><td align=""center"">WT</td><td align=""center"">0</td></tr></tbody></table><table-wrap-foot><p>a. 'RTE', ready to eat; 'CSF', cerebrospinal fluid</p><p>b. '+', amplicon of expected size detected using PCR using oligonucleotides described in Additional file<xref ref-type=""supplementary-material"" rid=""S1"">6</xref>; '-', no amplicon detected</p><p>c. 'FS', frameshift resulting in a truncated coding sequence encoding butyrate kinase; 'WT', wild type. Confirmed by Sanger-based DNA sequencing of amplicons generated by high fidelity PCR.</p><p>d. 'WT', wild type; '-21 bp', in-frame deletion of 7 codons. Confirmed by Sanger-based DNA sequencing of amplicons generated by PCR.</p><p>e. Number of SNP's relative to the hypothetical last common ancestor presented in Fig.<xref ref-type=""fig"" rid=""F6"">6</xref>. Sanger-based DNA sequence confirmation of SNPs was completed after PCR amplification using oligonucleotides described in Additional file<xref ref-type=""supplementary-material"" rid=""S6"">6</xref>.</p></table-wrap-foot></table-wrap><table-wrap id=""T2"" position=""float""><label>Table 2</label><caption><p>General genomic characteristics of<italic>Listeria monocytogenes</italic>isolates 08-5578, 08-5923, and plasmid pLM5578.</p></caption><table frame=""hsides"" rules=""groups""><thead><tr><th></th><th align=""center"">08-5578</th><th align=""center"">pLM5578</th><th align=""center"">08-5923</th></tr></thead><tbody><tr><td align=""left"">Genome size (bp)</td><td align=""center"">3 032 288</td><td align=""center"">77 054</td><td align=""center"">2 999 054</td></tr><tr><td align=""left"">G/C content</td><td align=""center"">37.96</td><td align=""center"">36.59</td><td align=""center"">37.96</td></tr><tr><td align=""left"">No. of predicted coding sequences</td><td align=""center"">3010</td><td align=""center"">79</td><td align=""center"">2966</td></tr><tr><td align=""left"">Average length of coding sequences (bp)</td><td align=""center"">900</td><td align=""center"">833</td><td align=""center"">903</td></tr><tr><td align=""left"">Coding percentage</td><td align=""center"">89.3</td><td align=""center"">85.4</td><td align=""center"">89.3</td></tr><tr><td align=""left"">rRNA loci</td><td align=""center"">13</td><td align=""center"">0</td><td align=""center"">13</td></tr><tr><td align=""left"">Bacteriophage</td><td align=""center"">3</td><td align=""center"">0</td><td align=""center"">2</td></tr></tbody></table></table-wrap><p>The<italic>Asc</italic>I restriction patterns of 08-5578 and 08-5923 were indistinguishable, except for a single band shift of approximately 32 kbp (from 476 kbp in 08-5578 to 444 kbp in 08-5923; Fig.<xref ref-type=""fig"" rid=""F1"">1</xref>). Accordingly, comparative sequence alignment revealed a 33 kbp contiguous region integrated adjacent to (but not disrupting) the tRNA-Ser gene that was unique to 08-5578 and encoding several putative bacteriophage-related coding sequences (designated ϕLMC1) (Fig.<xref ref-type=""fig"" rid=""F4"">4</xref>). BLAST analyses indicated that this prophage was unique among sequenced<italic>Listeria</italic>genomes, although it was comprised of coding sequences similar to determinants from several known phages associated with Gram-positive microbes, including<italic>L. monocytogenes</italic>phages A006, A118 and B025 (see Additional file<xref ref-type=""supplementary-material"" rid=""S1"">1</xref>). The presence of prophage ϕLMC1 accounted for the<italic>Asc</italic>I restriction pattern difference between isolates 08-5578 and 08-5923.</p><fig id=""F4"" position=""float""><label>Figure 4</label><caption><p><bold>Schematic of a 33 kbp prophage unique to<italic>Listeria monocytogenes</italic>isolate 08-5578</bold>. Blue-colored loci represent a contiguous segment within the isolate 08-5923 genome. Similarly, regions flanking the prophage of isolate 08-5578 are also denoted in blue. The interrupting contiguous coding sequences (red) represent prophage ϕLMC1 in 08-5578. The tRNA-Ser gene is denoted with a green box. Putative phage-related functions or structures are indicated above the locus tag identifiers. A nucleotide scale bar for size estimation is included.</p></caption><graphic xlink:href=""1471-2164-11-120-4""></graphic></fig><p>The extrachromosomal circular plasmid (pLM5578) harbored in isolate 08-5578 encoded putative determinants for replication, partitioning, heavy metal resistance and DNA translocation (Fig.<xref ref-type=""fig"" rid=""F5"">5a</xref>, and Additional file<xref ref-type=""supplementary-material"" rid=""S2"">2</xref>). Many of these features were homologous to sequences encoded by plasmids from<italic>L. innocua</italic>(pLI100),<italic>L. monocytogenes</italic>serotype 4b isolate H7858 (pLM80) and<italic>Bacillus anthracis</italic>(pXO2), including a replication and regulation control center (pLM5578_17 - 20). Two regions of pLM5578 were related to heavy metal resistance, including a transposon-associated<italic>cadA</italic>that exhibited high sequence identity to pLI100. A second, distinct region unique to pLM5578 was comprised of<italic>cadA</italic>(second copy) and<italic>cadC</italic>genes, with the latter encoding a cadmium-efflux ArsR-family regulatory accessory protein (repressor) homolog. Resistance to the heavy metal cadmium has been recently discovered to be associated with resistance to quaternary ammonium compounds (sanitizers), which may contribute to<italic>L. monocytogenes</italic>persistence in food production facilities [<xref ref-type=""bibr"" rid=""B35"">35</xref>]. Notably, several coding sequences exhibited sequence similarity to type IV secretion systems (T4SS), including DNA processing (<italic>virD2</italic>), DNA coupling (<italic>virD4</italic>) and membrane channel formation (<italic>virB1, -B4, -B5, -B6, -B11</italic>) (see Additional file<xref ref-type=""supplementary-material"" rid=""S2"">2</xref>). Additional predicted membrane-associated proteins were present within this region, and all coding sequences were oriented in the same direction (Fig.<xref ref-type=""fig"" rid=""F5"">5A</xref>), which is consistent with the operon-style organization of most known T4SS. Varying degrees of similarity between pLI100, pLM80 and pXO2 plasmids have already been established [<xref ref-type=""bibr"" rid=""B21"">21</xref>], and our data further support a chimeric nature for<italic>Listeria</italic>plasmids.</p><fig id=""F5"" position=""float""><label>Figure 5</label><caption><p><bold>Genetic organization and predicted functions of pLM5578 (A) and the<italic>Listeria</italic>genomic island 1 (LGI1) (B)</bold>. Both sequences represent contiguous genetic regions but are split onto two lines for visual clarity, with the site of the artificial segmentation denoted with angled lines. Locus tags are as denoted above the CDS map and predicted gene names (italics) denoted below. Coding sequences are color-coded based on predicted function, with the legend included in the inset. Black-colored coding sequences are similar to<italic>L. monocytogenes</italic>EGDe (locus tags,<italic>lmo</italic>) and the imperfect inverted 16 bp repeats surrounding the genomic island are indicated. A nucleotide scale bar for size estimation is included.</p></caption><graphic xlink:href=""1471-2164-11-120-5""></graphic></fig></sec><sec><title>pLM5578 and ϕLMC1 exhibit non-homogeneous distribution within a wider panel of outbreak-associated isolates</title><p>During the outbreak, serotype 1/2a<italic>L. monocytogenes</italic>isolates were recovered from clinical samples, contaminated food products and the food processing environment that shared the two<italic>Asc</italic>I PFGE patterns observed for the sequenced isolates (Table<xref ref-type=""table"" rid=""T1"">1</xref>). To determine the distribution of ϕLMC1 and pLM5578 amongst outbreak-associated isolates, PCR-based screening was conducted by targeting ϕLMC1 loci encoding a putative phage terminase large subunit and phage tail tape measure protein, and pLM5578 loci encoding<italic>virD4</italic>and<italic>fic</italic>(Table<xref ref-type=""table"" rid=""T1"">1</xref>). All isolates with<italic>Asc</italic>I pattern LMACI.0001 lacked the ϕLMC1 determinants by PCR, confirming that this novel sequence insertion accounts for the restriction enzyme pattern shift relative to PFGE pattern LMACI.0040. Bacteriophage insertions have previously been recognized as contributing to macromolecular genetic diversity between related outbreak-associated<italic>L. monocytogenes</italic>strains [<xref ref-type=""bibr"" rid=""B12"">12</xref>,<xref ref-type=""bibr"" rid=""B36"">36</xref>].</p><p>The PCR screening assays for plasmid determinants confirmed that pLM5578 was absent in isolate 08-5923, and this plasmid was also absent in other outbreak-related isolates (independent of PFGE profile), including one clinical isolate (Table<xref ref-type=""table"" rid=""T1"">1</xref>). The sequence of pLM5578 revealed an absence of<italic>Asc</italic>I restriction sites and presence of a single<italic>Apa</italic>I restriction site, but this element did not contribute to the PFGE patterns resulting from these enzymes. In contrast, plasmid pLM80 (containing a single<italic>Apa</italic>I recognition site) had been reported as visible in<italic>Apa</italic>I PFGE digests [<xref ref-type=""bibr"" rid=""B36"">36</xref>]. Just as a variable presence of plasmid pLM5578 was observed in this Canadian outbreak, plasmid pLM80 was sporadically present in isolates during the 1998-99 multi-state serotype 4b frankfurter USA outbreak [<xref ref-type=""bibr"" rid=""B36"">36</xref>]. Lack of stable vertical transmission of pLM5578 during the outbreak or laboratory culture (despite the presence of a partitioning determinant, pLM5578_15) might account for plasmid absence. Alternatively, pLM5578 may have been carried only in a subset of<italic>L. monocytogenes</italic>strains that subsequently caused the outbreak. Presence of determinants related to bacterial conjugation (Fig.<xref ref-type=""fig"" rid=""F5"">5A</xref>) further confounds any speculation on the transmission of this plasmid.</p></sec><sec><title>Whole genome comparisons enable construction of an evolutionary model of the outbreak isolates</title><p>The genomes of 08-5578 and 08-5923 were collinear, and with the exception of the prophage and plasmid unique to 08-5578, all genetic diversity was accounted for by 2 short indels and 28 confirmed SNPs. The two indels included a single C/T base pair insertion in 08-5578 that introduced a frameshift truncation into coding sequence LM5578_1509 (<italic>buk</italic>, encoding a putative butyrate kinase). Secondly, there was a 21 bp (7 codon) in-frame deletion in the<italic>gltX</italic>gene (LM5578_0279) of 08-5578 encoding a putative glutamyl-tRNA synthetase. DNA sequencing confirmed that this<italic>gltX</italic>deletion was present in all examined LMACI.0040 isolates but that a wild type allele was present in all isolates typed as LMACI.0001 (Table<xref ref-type=""table"" rid=""T1"">1</xref>). Alternatively, a wild type<italic>buk</italic>gene was only observed in isolate 08-5923 and a truncated butyrate kinase was encoded in all other isolates, independent of PFGE pattern (Table<xref ref-type=""table"" rid=""T1"">1</xref>). Directed PCR and DNA sequencing of the SNP sites within the panel of clinical, food and environmental isolates was also performed (Table<xref ref-type=""table"" rid=""T1"">1</xref>). Of the 28 SNPs, 27 were only present in isolate 08-5923. The singular remaining non-coding SNP was observed in each of LMACI.0040 isolates (at intergenic coordinate 2691224 of 08-5578) but was absent in all of the LMACI.0001 isolates, including 08-5923.</p><p>The 27 SNPs observed in the genome of clinical isolate 08-5923 included 20 non-synonymous, 5 synonymous and 2 intergenic mutations (Table<xref ref-type=""table"" rid=""T3"">3</xref>). Such a predominance of non-synonymous changes suggests that isolate 08-5923 was under strong positive selection for functional divergence rather than purifying selection (wherein synonymous exceed non-synonymous mutation rates). The non-synonymous mutations occurred in nine COG categories, including four changes related to transcription, but no mutations occurred in COGs related to DNA repair, recombination or replication (Table<xref ref-type=""table"" rid=""T3"">3</xref>). Only four non-synonymous changes represented functionally analogous amino acid changes (e.g, I/L/V/G) and none were in exported proteins carrying signal peptides. To place this finding into context,<italic>Listeria</italic>species have been reported as having the strongest purifying selection (elevated synonymous mutation rates) of all the prokaryotes following comparison of multiple completed genome sequences [<xref ref-type=""bibr"" rid=""B37"">37</xref>]. Furthermore, genome sequencing of four serotype 1/2a lineage II isolates from an endemic clone contaminating a single food production facility from 1988 to 2000 revealed only 11 total SNPs outside of the bacteriophage determinants, and a maximum of 8 SNPs were observed between any two given strains [<xref ref-type=""bibr"" rid=""B12"">12</xref>]. This low number of SNPs in an endemic clone spanning over 12 years suggested that non-controlled natural populations of<italic>L. monocytogenes</italic>are stable and exhibit limited genetic micro-diversity [<xref ref-type=""bibr"" rid=""B12"">12</xref>]. If a similar mutation rate occurred in the serotype 1/2a<italic>L. monocytogenes</italic>isolates recovered during this 2008 Canadian outbreak, passage of several decades would be expected in order to attain 28 total SNPs. We are assuming that 08-5923 shares a very recent ancestor as 08-5578 and thus speculate that 08-5923 was subjected to pressures resulting in elevated mutation rates and an abundance of non-synonymous changes.</p><table-wrap id=""T3"" position=""float""><label>Table 3</label><caption><p>Single nucleotide polymorphisms (SNPs) identified within chromosomal sequences of isolate 08-5923 relative to 08-5578.</p></caption><table frame=""hsides"" rules=""groups""><thead><tr><th align=""left"">SNP position</th><th align=""left"">CDS/Intergenic</th><th align=""left"">gene</th><th align=""center"">08-5578 sequence</th><th align=""center"">08-5923 sequence</th><th align=""center"">08-5578 codon</th><th align=""center"">08-5923 codon</th><th align=""center"">08-5578 residue</th><th align=""center"">08-5923 residue</th><th align=""left"">Predicted Product</th></tr></thead><tbody><tr><td align=""left"">47737</td><td align=""left"">non-synonymous</td><td></td><td align=""center"">T</td><td align=""center"">C</td><td align=""center"">ATA</td><td align=""center"">ACA</td><td align=""center"">I</td><td align=""center"">T</td><td align=""left"">hypothetical protein</td></tr><tr><td align=""left"">113283</td><td align=""left"">non-synonymous</td><td></td><td align=""center"">(G)</td><td align=""center"">(A)</td><td align=""center"">(GAT)</td><td align=""center"">(AAT)</td><td align=""center"">D</td><td align=""center"">N</td><td align=""left"">ATP-binding cassette, subfamily B</td></tr><tr><td align=""left"">172841</td><td align=""left"">synonymous</td><td align=""left""><italic>yaaQ</italic></td><td align=""center"">A</td><td align=""center"">G</td><td align=""center"">CCA</td><td align=""center"">CCG</td><td align=""center"">P</td><td align=""center"">P</td><td align=""left"">hypothetical protein</td></tr><tr><td align=""left"">213957</td><td align=""left"">non-synonymous</td><td align=""left""><italic>fusA</italic></td><td align=""center"">T</td><td align=""center"">A</td><td align=""center"">TTC</td><td align=""center"">TAC</td><td align=""center"">F</td><td align=""center"">Y</td><td align=""left"">elongation factor G</td></tr><tr><td align=""left"">291652</td><td align=""left"">non-synonymous</td><td align=""left""><italic>cytR</italic></td><td align=""center"">T</td><td align=""center"">G</td><td align=""center"">AGT</td><td align=""center"">AGG</td><td align=""center"">S</td><td align=""center"">R</td><td align=""left"">transcriptional regulator, LacI family</td></tr><tr><td align=""left"">291653</td><td align=""left"">non-synonymous</td><td align=""left""><italic>cytR</italic></td><td align=""center"">G</td><td align=""center"">T</td><td align=""center"">GTG</td><td align=""center"">TTG</td><td align=""center"">V</td><td align=""center"">L</td><td align=""left"">transcriptional regulator, LacI family</td></tr><tr><td align=""left"">552482</td><td align=""left"">non-synonymous</td><td align=""left""><italic>hsdR</italic></td><td align=""center"">C</td><td align=""center"">G</td><td align=""center"">TGC</td><td align=""center"">TGG</td><td align=""center"">C</td><td align=""center"">W</td><td align=""left"">type I restriction enzyme, R subunit</td></tr><tr><td align=""left"">577443</td><td align=""left"">non-synonymous</td><td align=""left""><italic>celF</italic></td><td align=""center"">A</td><td align=""center"">G</td><td align=""center"">GAC</td><td align=""center"">GGC</td><td align=""center"">D</td><td align=""center"">G</td><td align=""left"">6-phospho-beta-glucosidase</td></tr><tr><td align=""left"">630182</td><td align=""left"">non-synonymous</td><td></td><td align=""center"">C</td><td align=""center"">A</td><td align=""center"">ACA</td><td align=""center"">AAA</td><td align=""center"">T</td><td align=""center"">K</td><td align=""left"">hypothetical protein</td></tr><tr><td align=""left"">833717</td><td align=""left"">non-synonymous</td><td align=""left""><italic>araR</italic></td><td align=""center"">(A)</td><td align=""center"">(T)</td><td align=""center"">(AAC)</td><td align=""center"">(TAC)</td><td align=""center"">N</td><td align=""center"">Y</td><td align=""left"">arabinose operon transcriptional repressor</td></tr><tr><td align=""left"">850721</td><td align=""left"">intergenic</td><td></td><td align=""center"">G</td><td align=""center"">C</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align=""left"">940888</td><td align=""left"">non-synonymous</td><td align=""left""><italic>pgcA</italic></td><td align=""center"">A</td><td align=""center"">G</td><td align=""center"">GAA</td><td align=""center"">GGA</td><td align=""center"">E</td><td align=""center"">G</td><td align=""left"">phosphomannomutase</td></tr><tr><td align=""left"">1076779</td><td align=""left"">synonymous</td><td align=""left""><italic>ykuQ</italic></td><td align=""center"">C</td><td align=""center"">T</td><td align=""center"">TTC</td><td align=""center"">TTT</td><td align=""center"">F</td><td align=""center"">F</td><td align=""left"">Tetrahydrodipicolinate N-succinyltransferase</td></tr><tr><td align=""left"">1096500</td><td align=""left"">non-synonymous</td><td></td><td align=""center"">A</td><td align=""center"">T</td><td align=""center"">ATA</td><td align=""center"">TTA</td><td align=""center"">I</td><td align=""center"">L</td><td align=""left"">hypothetical protein</td></tr><tr><td align=""left"">1319530</td><td align=""left"">non-synonymous</td><td></td><td align=""center"">T</td><td align=""center"">G</td><td align=""center"">TGT</td><td align=""center"">GGT</td><td align=""center"">C</td><td align=""center"">G</td><td align=""left"">hypothetical protein</td></tr><tr><td align=""left"">1462121</td><td align=""left"">non-synonymous</td><td align=""left""><italic>pta2</italic></td><td align=""center"">C</td><td align=""center"">T</td><td align=""center"">GCT</td><td align=""center"">GTT</td><td align=""center"">A</td><td align=""center"">V</td><td align=""left"">phosphate butyryltransferase</td></tr><tr><td align=""left"">1660409</td><td align=""left"">synonymous</td><td align=""left""><italic>hemL</italic></td><td align=""center"">(C)</td><td align=""center"">(G)</td><td align=""center"">(CGC)</td><td align=""center"">(CGG)</td><td align=""center"">R</td><td align=""center"">R</td><td align=""left"">glutamate-1-semialdehyde aminotransferase</td></tr><tr><td align=""left"">1787404</td><td align=""left"">non-synonymous</td><td></td><td align=""center"">T</td><td align=""center"">A</td><td align=""center"">TTT</td><td align=""center"">TTA</td><td align=""center"">F</td><td align=""center"">L</td><td align=""left"">hypothetical protein</td></tr><tr><td align=""left"">1901622</td><td align=""left"">non-synonymous</td><td></td><td align=""center"">(T)</td><td align=""center"">(C)</td><td align=""center"">(GTA)</td><td align=""center"">(GCA)</td><td align=""center"">V</td><td align=""center"">A</td><td align=""left"">sigma-54 dependent transcriptional regulator</td></tr><tr><td align=""left"">1910870</td><td align=""left"">non-synonymous</td><td></td><td align=""center"">(C)</td><td align=""center"">(G)</td><td align=""center"">(CGC)</td><td align=""center"">(GGC)</td><td align=""center"">R</td><td align=""center"">G</td><td align=""left"">hypothetical protein</td></tr><tr><td align=""left"">2117257</td><td align=""left"">non-synonymous</td><td align=""left""><italic>aroA</italic></td><td align=""center"">(T)</td><td align=""center"">(G)</td><td align=""center"">(GTC)</td><td align=""center"">(GGC)</td><td align=""center"">V</td><td align=""center"">G</td><td align=""left"">3-phosphoshikimate 1-carboxyvinyltransferase</td></tr><tr><td align=""left"">2124375</td><td align=""left"">non-synonymous</td><td align=""left""><italic>hepT</italic></td><td align=""center"">(C)</td><td align=""center"">(T)</td><td align=""center"">(GCA)</td><td align=""center"">(GTA)</td><td align=""center"">A</td><td align=""center"">V</td><td align=""left"">trans-hexaprenyltranstransferase</td></tr><tr><td align=""left"">2146277</td><td align=""left"">non-synonymous</td><td align=""left""><italic>punA</italic></td><td align=""center"">(A)</td><td align=""center"">(G)</td><td align=""center"">(ATA)</td><td align=""center"">(GTA)</td><td align=""center"">I</td><td align=""center"">V</td><td align=""left"">purine-nucleoside phosphorylase</td></tr><tr><td align=""left"">2261927</td><td align=""left"">intergenic</td><td></td><td align=""center"">C</td><td align=""center"">A</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align=""left"">2404315</td><td align=""left"">non-synonymous</td><td></td><td align=""center"">G</td><td align=""center"">A</td><td align=""center"">AGT</td><td align=""center"">AAT</td><td align=""center"">S</td><td align=""center"">N</td><td align=""left"">hypothetical protein</td></tr><tr><td align=""left"">2603164</td><td align=""left"">synonymous</td><td></td><td align=""center"">(T)</td><td align=""center"">(G)</td><td align=""center"">(CTT)</td><td align=""center"">(CTG)</td><td align=""center"">L</td><td align=""center"">L</td><td align=""left"">D-methionine transport system ATP-binding protein</td></tr><tr><td align=""left"">2691224</td><td align=""left"">intergenic</td><td></td><td align=""center"">G</td><td align=""center"">T</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align=""left"">2929661</td><td align=""left"">synonymous</td><td align=""left""><italic>atpA</italic></td><td align=""center"">(A)</td><td align=""center"">(G)</td><td align=""center"">(TCA)</td><td align=""center"">(TCG)</td><td align=""center"">S</td><td align=""center"">S</td><td align=""left"">F-type H+-transporting ATPase alpha chain</td></tr></tbody></table><table-wrap-foot><p>SNP coordinates are in relation to the genome of 08-5578 and the nucleotide composition refers to the positive DNA strand unless the SNP lies within a coding sequence on the negative (complementary) strand, and in these instances are marked in brackets.</p></table-wrap-foot></table-wrap><p>We propose a model to describe the chromosomal evolution of strains involved in this nation-wide outbreak using the distribution and segregation of genetic traits such as SNPs, indels and prophage (Fig.<xref ref-type=""fig"" rid=""F6"">6</xref>). This model assumes that the last common ancestor (LCA) of all strains encoded wild type<italic>buk</italic>and<italic>gltX</italic>loci, ϕLMC1 was absent, and the wild type state of all SNP positions was represented by the sequences in 08-5578 with the exception of intergenic SNP at 2691224. Isolate 08-5923 is predicted to be a direct descendent of the LCA, as it is the only isolate encoding a wild type<italic>buk</italic>gene. The remainder of the LMACI.0001 isolates differed from the LCA by only the single frameshift in<italic>buk</italic>, generating ancestor 2 (Fig.<xref ref-type=""fig"" rid=""F6"">6</xref>). From ancestor 2, acquisition of three independent traits (ϕLMC1, the 21 bp deletion in<italic>gltX</italic>and the intergenic SNP at coordinate 2691224) occurred, resulting in a third lineage defined by the LMACI.0040 PFGE pattern. In light of the high numbers of non-synonymous SNPs in 08-5923 and macromolecular genetic changes such as bacteriophage integration in the lineage represented by 08-5578, we speculate that three distinct, but highly related strains were circulating in this outbreak (Fig.<xref ref-type=""fig"" rid=""F6"">6</xref>). The diversifying SNPs in 08-5923 may have occurred in response to adverse environmental conditions prior to infection or host-specific conditions during infection, and ϕLMC1 likely arose by acquisition from other natural populations in the affected production facility.</p><fig id=""F6"" position=""float""><label>Figure 6</label><caption><p><bold>Evolutionary model for the<italic>Listeria monocytogenes</italic>isolates recovered during the 2008 nation-wide foodborne outbreak</bold>. Predicted mutational events are indicated on the diagonal lines, genotypes of the resulting lineages are denoted within circles, and isolates representative of those lineages are indicated to the right of solid dots. Sequenced isolates are denoted with bold text.</p></caption><graphic xlink:href=""1471-2164-11-120-6""></graphic></fig></sec><sec><title>Genome sequence alignments reveal that the outbreak isolates belong to evolutionary lineage II - clonal complex 8</title><p>Phylogenetic comparison to<italic>Listeria</italic>genome sequences representing each of the three<italic>L. monocytogenes</italic>evolutionary lineages,<italic>L. welshimeri</italic>and<italic>L. innocua</italic>indicated that 08-5578 and 08-5923 are both lineage II strains (Fig.<xref ref-type=""fig"" rid=""F3"">3A</xref>). The most closely related genome was strain EGDe, a serotype 1/2a lab-passaged animal isolate from 1924 [<xref ref-type=""bibr"" rid=""B22"">22</xref>]. For detection of large-scale genomic rearrangements, a dot plot comparison of 08-5578 versus the EGDe genome sequence was performed (see Additional file<xref ref-type=""supplementary-material"" rid=""S3"">3</xref>). This revealed that the common chromosomal sequences were collinear, with the exception of a large 50 kbp inverted segment around the putative origin of replication (coordinate 1 of EGDe) (see Additional file<xref ref-type=""supplementary-material"" rid=""S3"">3</xref>). Symmetric inversions around the origin of replication have previously been observed between other bacterial genome sequences [<xref ref-type=""bibr"" rid=""B38"">38</xref>]. In contrast to only 28 SNPs being observed between 08-5578 and 08-5923, 24660 high quality SNPs and 941 estimated indels were revealed in a comparison of 08-5578 and EGDe (data not shown). These included 17874 synonymous SNPs, 4692 non-synonymous SNPs and 475 indels occurring within 1214 predicted coding sequences, with 1 to 167 non-synonymous SNPs and/or indels occurring per gene. Moreover, two large contiguous regions present in both 08-5578 and 08-5923 represent probable prophages (designated ϕLMC2 and ϕLMC3) that are absent in EGDe (Fig.<xref ref-type=""fig"" rid=""F2"">2</xref>, see Additional file<xref ref-type=""supplementary-material"" rid=""S3"">3</xref>). ϕLMC2 was highly related to phage B025, and ϕLMC3 was inserted at<italic>comK</italic>and related to<italic>Listeria</italic>phage A006.</p><p>Comparative analysis of the regions used for multi-locus sequence typing (MLST) indicated that isolates 08-5578 and 08-5923 are more closely related to lineage II clonal complex 8 (CC8) than to EGDe (Fig.<xref ref-type=""fig"" rid=""F3"">3B</xref>). The MLST determinants used by Ragon<italic>et. al.</italic>[<xref ref-type=""bibr"" rid=""B24"">24</xref>] were extracted<italic>in silico</italic>from the genome sequences and 08-5923 was identical to a previously characterized CC8, sequence type 120 (ST120) strain (encoding<italic>abcZ</italic>allele 5,<italic>bglA</italic>allele 6,<italic>cat</italic>allele 2,<italic>dapE</italic>allele 29,<italic>dat</italic>allele 5,<italic>ldh</italic>allele 3,<italic>lhkA</italic>allele 1). The extracted sequences for 08-5578 were also identical to ST120 except for one SNP within the<italic>abcZ</italic>locus not currently listed in the Institute Pasteur's<italic>L. monocytogenes</italic>MLST database. The sole previous member of ST120 was identified as a clinical serotype 1/2a isolate derived from a CNS infection in New Zealand in 1995 [<xref ref-type=""bibr"" rid=""B24"">24</xref>]. Phylogenetic trees based on MLST and whole genome sequences were relatively congruent when considering evolutionary lineages, however genome sequences provide a more precise placement relative to other examined isolates. The pyrosequencing data also provided the opportunity to analyze the entire genome for micro and macro-diversity, including the full repertoire of phylogenetically relevant loci.</p></sec><sec><title>Virulence-associated determinants of the outbreak isolates informs lineage- and strain-specific virulence potential</title><p>The surface protein internalin, encoded by the<italic>inlA</italic>locus, is a principal virulence determinant promoting mammalian host cell invasion via interaction with E-cadherin on epithelial cells [<xref ref-type=""bibr"" rid=""B39"">39</xref>]. Truncation variants of<italic>inlA</italic>have been associated with decreased pathogenicity and significantly reduced invasiveness for human intestinal epithelial cells [<xref ref-type=""bibr"" rid=""B40"">40</xref>,<xref ref-type=""bibr"" rid=""B41"">41</xref>]. Using nomenclature assigned by Ragon<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B24"">24</xref>], isolates 08-5578 and 08-5923 both encode a full length<italic>inlA</italic>allele type 2 that has previously been observed in isolates related to human illness [<xref ref-type=""bibr"" rid=""B24"">24</xref>]. This singular determinant however cannot account for differences in pathogenicity since foodborne isolates have been observed with intact<italic>inlA</italic>loci [<xref ref-type=""bibr"" rid=""B42"">42</xref>] and<italic>inlA</italic>allele 2 is also encoded by environmental isolates [<xref ref-type=""bibr"" rid=""B43"">43</xref>].<italic>L. monocytogenes</italic>does encode multiple additional internalin and internalin-like coding sequences, although the function of each paralog is currently unknown [<xref ref-type=""bibr"" rid=""B21"">21</xref>,<xref ref-type=""bibr"" rid=""B44"">44</xref>]. Isolates 08-5578 and 08-5923 both encode<italic>inlB, inlC, inlC2, inlD, inlE, inlF, inlG, inlI, inlJ</italic>and 11 other leucine-rich internalin-like coding sequences (see Additional file<xref ref-type=""supplementary-material"" rid=""S4"">4</xref>). The presence of an intact<italic>inlA</italic>locus and this compilation of other internalin-like loci may account in part for the pathogenicity of the serotype 1/2a outbreak strains sequenced in this study, but this requires further examination.</p><p>The<italic>Listeria</italic>pathogenicity island 1 (LIPI-1) encodes six significant virulence-associated loci:<italic>prfA</italic>(pleiotropic virulence transcriptional regulator),<italic>plcA, plcB</italic>(both encoding phospholipases),<italic>hly</italic>(listeriolysin O),<italic>mpl</italic>(metalloprotease) and<italic>actA</italic>(involved in actin-mediated motility). Previous phylogenetic analysis of this region from food, clinical, animal and environmental isolates indicated that this gene cluster was genetically diverse and clustered based on the three<italic>L. monocytogenes</italic>evolutionary lineages [<xref ref-type=""bibr"" rid=""B25"">25</xref>,<xref ref-type=""bibr"" rid=""B45"">45</xref>]. BLASTn comparative analyses of this ~9 kbp region from 08-5578 and 08-5923 identified a very high sequence identity with other lineage II isolates, including 99.5% identity to the EDGe reference genome; ≥ 98% identity to all 23 lineage II isolates characterized by Ward<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B25"">25</xref>], and ≥ 98% nucleotide identity to all 21 lineage II isolates characterized by Orsi<italic>et al.</italic>[<xref ref-type=""bibr"" rid=""B45"">45</xref>]. In comparison, all LIPI-1 regions encoded by evolutionary lineage I and III strains in these previous studies were ≤ 95% identical to our lineage II strains.</p><p>PrfA regulates additional virulence determinants encoded elsewhere on the chromosome, such as<italic>bsh</italic>encoding a bile salt hydrolase that promotes survival within the gut [<xref ref-type=""bibr"" rid=""B46"">46</xref>] and<italic>uhpT</italic>encoding for a hexose phosphate permease for utilization of host carbon sources [<xref ref-type=""bibr"" rid=""B47"">47</xref>]. These latter two determinants were also encoded within 08-5578 and 08-5923. The presence of these determinants along with LIPI-1 is well conserved across<italic>L. monocytogenes</italic>strains independent of evolutionary lineage, so are unlikely to enhance virulence potential unless the allelic diversity observed between lineages results in a phenotypic change. In general, the contribution of lineage-specific genome differences to virulence and pathogenicity of<italic>L. monocytogenes</italic>are not well understood. For example, recent<italic>in silico</italic>analyses have indicated that while there are lineage II-specific genomic regions not present in lineage I, their role in virulence is not clear [<xref ref-type=""bibr"" rid=""B30"">30</xref>]. Furthermore, the presence of the<italic>Listeria</italic>pathogenicity island LIPI-3 operon encoding Listeriolysin S has been associated with evolutionary lineage I strains causing foodborne outbreaks [<xref ref-type=""bibr"" rid=""B48"">48</xref>]. This region was absent in the genomes of both 08-5578 and 08-5923.</p></sec><sec><title>Outbreak isolates harbor a putative mobile genetic island encoding translocation functions</title><p>A large 49.8 kbp contiguous region (coordinates 1836435-1886209 of 08-5578; coding sequences LM5578_1850 to LM5578_1903) was present in both sequenced genomes yet absent in all publicly available<italic>Listeria</italic>genome sequences to date, including EGDe (Fig.<xref ref-type=""fig"" rid=""F2"">2</xref>). The bordering coding sequences LM5578_1849 and LM5578_1904 were each 98% identical to contiguous EGDe coding sequences lmo1702 and lmo1703, respectively, implying that the 50 kbp operon-like structured region represents a genomic insertion within the ancestral chromosome of these isolates. Accordingly, putative serine recombinases are encoded in this region (loci LM5578_1855-58) and 16 bp imperfect inverted repeats are present at the borders in the intergenic regions between loci 1849/50 and 1903/04 (Fig.<xref ref-type=""fig"" rid=""F5"">5B</xref>), indicating that this is a horizontally acquired genetic island, hereafter designated<italic>Listeria</italic>genomic island 1 (LGI1).</p><p>Coding sequences within LGI1 exhibited sequence homology and were similarly organized as contiguous regions present within several environmental firmicutes, including<italic>Clostridium kluyveri</italic>,<italic>C. bolteae</italic>and<italic>Desulfitobacterium hafniense</italic>. These LGI1-like regions also appeared to be horizontally-acquired, based on skewed G/C content relative to neighboring sequences [<xref ref-type=""bibr"" rid=""B49"">49</xref>]. The genetic organization and predicted functions of several LGI1 loci resembled the proposed<italic>B. anthracis</italic>pXO1 plasmid-encoded secretion system [<xref ref-type=""bibr"" rid=""B50"">50</xref>], including several coding sequences that resembled putative type II and type IV secretion systems (T4SS) (Fig.<xref ref-type=""fig"" rid=""F5"">5B</xref>; and Additional file<xref ref-type=""supplementary-material"" rid=""S2"">2</xref>). Prototypical members of these systems are involved in pilus biogenesis and translocation of DNA-protein complexes or virulence effectors, respectively. Canonical T4SS genes predicted within LGI1 include<italic>virB4, virD4</italic>, and<italic>virB11</italic>, which encode ATPases involved in substrate recruitment to the transfer complex and substrate translocation, and<italic>virB5</italic>and<italic>virB6</italic>subunit genes, which form the core membrane-spanning transfer complex (Fig.<xref ref-type=""fig"" rid=""F5"">5B</xref>; and Additional file<xref ref-type=""supplementary-material"" rid=""S2"">2</xref>). Genes that likely contribute to pilus-like surface appendages were also detected (<italic>cpa</italic>,<italic>tad</italic>), and the presence of a<italic>dnaG</italic>gene encoding a putative primase neighboring the<italic>virD4</italic>coupling protein homolog suggests that this genetic island may be mobilizable (see Additional file<xref ref-type=""supplementary-material"" rid=""S2"">2</xref>). Besides pXO1, Type IV secretion-like systems (T4SLS) features have also been described in Gram-positive plasmids such as<italic>B. anthracis</italic>plasmid pXO2 [<xref ref-type=""bibr"" rid=""B51"">51</xref>,<xref ref-type=""bibr"" rid=""B52"">52</xref>] and the pheromone-inducible conjugative plasmid pCF10 of<italic>Enterococcus faecalis</italic>[<xref ref-type=""bibr"" rid=""B53"">53</xref>].</p><p>Gram-positive T4SLS also encode a putative peptidoglycan hydrolase and adhesin, both of which are predicted functions in LGI1 (LM5788_1873 and LM5578_1866, respectively). LM5788_1873 encodes a C-terminal NlpC/P60 domain, and is predicted to be involved in assembly of the core substrate transfer complex as a VirB1-like peptidoglycan hydrolase. A P60 domain is also present in the autolytic virulence determinant designated<italic>Listeria</italic>invasion associated protein (Iap) [<xref ref-type=""bibr"" rid=""B54"">54</xref>]. LM5578_1866 is predicted to encode a Sel1-like repeat (SLR) family protein that contains helical domains mediating protein-protein interactions [<xref ref-type=""bibr"" rid=""B55"">55</xref>]. Although protein adhesins are often used in Gram-positive bacteria to mediate conjugative attachment to target cells, SLR proteins also are involved for eukaryotic cell entry by<italic>Legionella pneumophilia</italic>[<xref ref-type=""bibr"" rid=""B56"">56</xref>,<xref ref-type=""bibr"" rid=""B57"">57</xref>]. Whether this T4SLS is involved in translocation of pathogenicity effector molecule(s) (in addition to probable DNA-protein translocation) is tempting to speculate, but further study is required.</p><p>LGI1 also encoded a homolog (LM5578_1862) to the multidrug efflux proton:drug antiporter EmrE implicated in resistance to toxic cationic hydrophobic compounds such as quaternary ammonium compounds and tetracycline [<xref ref-type=""bibr"" rid=""B58"">58</xref>]. This gene was flanked by a MarR-family transcriptional regulator loci (1425) and a putative DNA-directed RNA polymerase sigma-24 subunit (<italic>rpoE</italic>, 1861) encoding a specialized ECF (extracytoplasmic function) family sigma factor, which is part of the bacterial stress response regulon [<xref ref-type=""bibr"" rid=""B59"">59</xref>]. A two component signal transduction system (sensor histidine kinase and response regulator; LM5578_1852 and 1851) and restriction modification components (LM5578_1850 and 1853) also were present. Cumulatively, LGI1 is unique compared to all currently sequenced<italic>L. monocytogenes</italic>but the contribution to pathogenicity or environmental persistence is unconfirmed.</p></sec></sec><sec><title>Conclusions</title><p>High-throughput DNA sequencing rapidly provided the complete genetic content of two<italic>L. monocytogenes</italic>outbreak isolates. Within three days of project commencement, draft genome sequences were available that were suitable to begin comparative analyses such as genome alignments, preliminary annotation of coding sequences, and identification of traits associated with macro-diversity and micro-diversity. This allowed us to determine evolutionary lineages and unequivocally define the full breadth of genetic variation between two subtype variants identified by the internationally PulseNet standardized PFGE typing method. Whole genome sequencing therefore enabled robust real-time characterization of virulence determinants and genetic diversity (prophage and plasmid elements; SNP and indel mutations) within a natural<italic>L. monocytogenes</italic>population. These novel markers were then applied for a rapid assessment of the genetic relatedness of additional clinical, food, and environmental isolates recovered during the outbreak. The distribution of the SNP, indel and prophage traits indicated that three distinct but highly related strains were likely involved. Further characterization of the SNPs indicated that clinical isolate 08-5923 was likely subjected to positive selective pressures resulting in a higher frequency of non-synonymous mutation than would normally be expected for<italic>L. monocytogenes</italic>. Selective pressure for adaptive change could have resulted from host specific conditions during infection or adverse food storage conditions, but with only a single available isolate representative of this SNP genotype it is not possible to identify the micro-diversification timeline.</p><p>Previous comparative genomic studies of outbreak-associated<italic>L. monocytogenes</italic>have found several strain and serotype-specific coding sequences between serotype 4b and 1/2a strains, but amongst these there were few relevant genetic traits suggestive of virulence potential [<xref ref-type=""bibr"" rid=""B21"">21</xref>,<xref ref-type=""bibr"" rid=""B30"">30</xref>]. One notable exception was variation in the complement of internalin-like coding determinants [<xref ref-type=""bibr"" rid=""B21"">21</xref>], and consistent with this finding, a large composition of internalin-like determinants was observed in the current study. In addition, there were two large-scale genetic insertions unique to our serotype 1/2a strains. Prophage ϕLMC1 was composed of genes related to previously characterized phage determinants, but on the whole, represented a novel<italic>Listeria</italic>phage. A ~50 kbp genetic island (LGI1) unique amongst all other currently sequenced<italic>L. monocytogenes</italic>isolates was also present in 08-5578, encoding putative translocation, resistance, and regulatory determinants.</p><p>While<italic>L. monocytogenes</italic>serotype 1/2a can be frequently isolated from food processing environments, the majority of invasive listeriosis outbreaks to date have resulted from lineage I serotype 4b strains [<xref ref-type=""bibr"" rid=""B15"">15</xref>]. Lineage II serotype 1/2a strains have more frequently been associated with outbreaks of listerial gastroenteritis [<xref ref-type=""bibr"" rid=""B15"">15</xref>]. Our current study demonstrates that lineage II strains can also cause large outbreaks of severe invasive disease and is consistent with a global trend towards serotype 1/2a predominance. Whole genome sequencing allowed us to detect within these outbreak isolates a repertoire of genetic determinants involved in diversification and microevolution. These features may have a role in virulence and pathogenicity, as well as survival within food processing environments and in foods. Genomic studies can therefore facilitate a greater understanding of the lineage-specific and strain-specific features of<italic>L. monocytogenes</italic>and how they contribute to this pathogen's ecology and virulence. This knowledge may ultimately lead to the development of methods to better assess the risks posed by individual<italic>L. monocytogenes</italic>strains.</p><p>This study also provides a proof-of-concept that the latest generation DNA sequencing platforms have a place in real-time public health responses to bacterial pathogens. Whole genome sequencing may not be ready to be applied routinely as a subtyping method, but public health laboratories need to prepare for this inevitability and assess how to properly analyze and interpret whole genome sequences in the context of molecular epidemiology. Most of the current subtyping methods such as PFGE and MLST capture only a small proportion of the true genetic content, so it is still difficult to interpret robust data sets such as whole genomes when all previous characterizations have been comparatively limited in detail. It is foreseeable that the burgeoning capacity for whole genome sequencing will soon provide a cost effective alternative to the current subtyping methods after a reconciliation has been made between the true nature of subtypes, the diversity revealed by classical methods and the micro- and macro-diversity readily identified by next-generation sequencing technologies. As more genomes from clinical isolates are completed and compared (as in this study), it will become increasingly feasible to apply genome sequencing for responses to bacterial outbreaks.</p></sec><sec sec-type=""methods""><title>Methods</title><sec><title>Bacterial isolates</title><p>Clinical, food and environmental isolates (Table<xref ref-type=""table"" rid=""T1"">1</xref>) were collected by the Ontario Central Public Health Laboratory and the Canadian Food Inspection Agency during an outbreak investigation of<italic>L. monocytogenes</italic>and transferred to the National Microbiology Laboratory (NML) for additional subtyping. The clinical isolates examined in this study were collected from individual outbreak-associated cases.</p></sec><sec><title>Serotyping and Pulsed-field Gel Electrophoresis</title><p>Serotyping was performed by slide agglutination with antisera prepared at the NML according to Seeliger and Höhne [<xref ref-type=""bibr"" rid=""B60"">60</xref>]. Molecular serotyping was completed using a multiplex PCR scheme [<xref ref-type=""bibr"" rid=""B61"">61</xref>]. Pulsed-field gel electrophoresis (PFGE) was performed according to the PulseNet standardized protocol using restriction enzymes<italic>Asc</italic>I and<italic>Apa</italic>I. PFGE patterns were designated using BioNumerics after comparison to the PulseNet Canada database.</p></sec><sec><title>Genome sequencing and bioinformatics</title><p>Genome sequencing was performed on the Roche GS FLX™ standard platform, as per the manufacturer's recommendations. The relative genome coverage achieved was approximately 40× for 08-5578 (Q40+ bases = 99.88%) and 36× for 08-5923 (Q40+ bases = 99.91%). Within the 08-5578 project the coverage of pLM5578 was 68×, indicating that the plasmid copy number was between 1-2 copies per cell.<italic>De novo</italic>sequence assembly was completed using Roche's Newbler assembler and the Staden software package [<xref ref-type=""bibr"" rid=""B62"">62</xref>] after a fosmid mate-pair end library was constructed. Gap closure was completed by Sanger-based sequencing of select regions to bridge contigs. Presumptive insertion/deletions (indels) associated with homopolymeric regions were verified or corrected after Sanger-based sequencing of directed PCR amplicon templates generated from the corresponding regions in both 08-5578 and 08-5923 by proof-reading Taq polymerase. Sequences were deposited into GenBank under the accession numbers<ext-link ext-link-type=""gen"" xlink:href=""CP001602"">CP001602</ext-link>(08-5578),<ext-link ext-link-type=""gen"" xlink:href=""CP001603"">CP001603</ext-link>(pLM5578) and<ext-link ext-link-type=""gen"" xlink:href=""CP001604"">CP001604</ext-link>(08-5923).</p><p>Pyrosequencing was completed within three days to provide greater than 99% of the genome coverage. This was sufficient for preliminary analysis such as identification of plasmid and phage determinants and candidate SNP's. Closed circular chromosomal sequences were obtained within an additional 5 weeks after fosmid libraries were constructed, contigs ordered and all gaps closed. Three additional weeks were required for resequencing of SNP and homopolymeric regions to confirm polymorphisms and indels between the two sequenced isolates. The costs associated with this project (in US dollars) were $5000 for the GS-FLX run covering both isolates, $500/isolate for the fosmid libraries and related consumables, and $2000/isolate for primer synthesis and Sanger-based sequencing for gap closure and resequencing.</p><p>Annotation of coding sequences for isolate 08-5578 was completed using GenDB v2.2 [<xref ref-type=""bibr"" rid=""B63"">63</xref>], BASys [<xref ref-type=""bibr"" rid=""B64"">64</xref>], Glimmer3 [<xref ref-type=""bibr"" rid=""B65"">65</xref>] and by comparison to RefSeq annotations completed for<italic>L. monocytogenes</italic>strain EGDe [<xref ref-type=""bibr"" rid=""B22"">22</xref>]. Sequences encoding rRNA and tRNA were identified by RNAmmer version 1.2 [<xref ref-type=""bibr"" rid=""B66"">66</xref>] and tRNAscan-SE version 1.23 [<xref ref-type=""bibr"" rid=""B67"">67</xref>], respectively. Artemis was used for manual annotation and additional manipulations [<xref ref-type=""bibr"" rid=""B68"">68</xref>]. Multiple sequence alignments of whole genomes and select loci were generated using MAUVE [<xref ref-type=""bibr"" rid=""B69"">69</xref>] and ClustalW [<xref ref-type=""bibr"" rid=""B70"">70</xref>], respectively, and maximum likelihood phylogenetic trees were generated using the Phylogeny Inference Package (Phylip version 3.68). Distant homologies between hypothetical coding sequences and entries at the PDB, COG, PFAM and SCOP databases were detected using the FFAS03 server [<xref ref-type=""bibr"" rid=""B71"">71</xref>]. Single nucleotide polymorphisms (SNPs) were identified between the sequenced isolates using NUCMER and dot plots were generated using MUMmerplot [<xref ref-type=""bibr"" rid=""B72"">72</xref>]. The circular representation of the genome of 08-5578 was created using DNAplotter [<xref ref-type=""bibr"" rid=""B73"">73</xref>] and feature tables generated using Artemis.</p><p>Reference<italic>Listeria</italic>genome sequences were obtained from GenBank for isolates EGDe (accession number<ext-link ext-link-type=""gen"" xlink:href=""NC_003210"">NC_003210</ext-link>), F2365 (<ext-link ext-link-type=""gen"" xlink:href=""NC_002973"">NC_002973</ext-link>), HCC23 (<ext-link ext-link-type=""gen"" xlink:href=""NC_011660"">NC_011660</ext-link>), Clip11262 (<ext-link ext-link-type=""gen"" xlink:href=""NC_003212"">NC_003212</ext-link>;<italic>L. innocua</italic>), SLCC5334 (<ext-link ext-link-type=""gen"" xlink:href=""NC_008555"">NC_008555</ext-link>;<italic>L. welshimeri</italic>) and<italic>L. monocytogenes</italic>phage B025 (<ext-link ext-link-type=""gen"" xlink:href=""NC_009812"">NC_009812</ext-link>). Accession numbers for plasmid DNA sequences of pLI100 and pXO2 were<ext-link ext-link-type=""gen"" xlink:href=""NC_003383"">NC_003383</ext-link>and<ext-link ext-link-type=""gen"" xlink:href=""NC_001496"">NC_001496</ext-link>, respectively. In addition, the DNA sequences of<italic>L. monocytogenes</italic>strains F6854 and H7858 [<xref ref-type=""bibr"" rid=""B21"">21</xref>] and plasmid pLM80 from strain H7858 were obtained from the J. Craig Venter Institute Comprehensive Microbial Resource<ext-link ext-link-type=""uri"" xlink:href=""http://cmr.jcvi.org/cgi-bin/CMR/CmrHomePage.cgi"">http://cmr.jcvi.org/cgi-bin/CMR/CmrHomePage.cgi</ext-link>. A cross match table (Additional file<xref ref-type=""supplementary-material"" rid=""S5"">5</xref>) of the coding sequences between all of these<italic>L. monocytogenes</italic>genomes was generated using the publically available annotations as of September 18<sup>th</sup>, 2009 with a reciprocal BLASTp alignment threshold of 80% identity and 80% hsp. Draft genomes sequences at the Broad Institute were also screened for select regions using BLAST available at their database<ext-link ext-link-type=""uri"" xlink:href=""http://www.broad.mit.edu/annotation/genome/listeria_group/MultiHome.html"">http://www.broad.mit.edu/annotation/genome/listeria_group/MultiHome.html</ext-link>. MLST loci data were downloaded from the Institute Pasteur<italic>Listeria monocytogenes</italic>MLST Database<ext-link ext-link-type=""uri"" xlink:href=""http://www.pasteur.fr/recherche/genopole/PF8/mlst/Lmono.html"">http://www.pasteur.fr/recherche/genopole/PF8/mlst/Lmono.html</ext-link>.</p></sec><sec><title>PCR screening and SNP confirmation</title><p>All polymerase chain reactions were performed with Invitrogen HiFi Platinum proof-reading Taq polymerase following the manufacturer's directions, and with 1 uM of each oligonucleotide (see Additional file<xref ref-type=""supplementary-material"" rid=""S6"">6</xref>) using the following thermocycling conditions: 94°C for 5 min.; 35 cycles of 94°C for 30 sec., 50°C for 30 sec. and 68°C for 45 sec.; followed by 68°C for 5 min. Amplicons were visualized after electrophoresis in 1% agarose-TBE gels. Confirmation of SNP sites was achieved by Sanger-based sequencing of targeted amplicons using the same oligonucleotides as used for PCR amplification.</p></sec></sec><sec><title>Authors' contributions</title><p>Conceived and designed the experiments: MWG ST MG KT-Y OL GVD CN. Performed the experiments: ST KT-Y OL CN. Analyzed the data: MWG MG GVD ST HK KT-Y OL VA BA CN. Contributed reagents/materials/analysis tools: VA BA GVD HK. Wrote the paper: MWG MG GVD CN. Edited the manuscript: MWG ST MG GVD HK KT-Y OL VA BA CN. All authors read and approved the final manuscript.</p></sec><sec sec-type=""supplementary-material""><title>Supplementary Material</title><supplementary-material content-type=""local-data"" id=""S1""><caption><title>Additional file 1</title><p>Identification of bacteriophage-related sequences in the putative prophage ϕLMC1.</p></caption><media mime-subtype=""vnd.ms-excel"" mimetype=""application"" xlink:href=""1471-2164-11-120-S1.XLS""><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type=""local-data"" id=""S2""><caption><title>Additional file 2</title><p><bold>Coding sequences on plasmid pLM5578 and the<italic>Listeria</italic>genetic island (LGI1) predicted to encode translocation functions</bold>. FFAS03 scores above -9.0 are not significant, but three predictions near this threshold were included.</p></caption><media mime-subtype=""vnd.ms-excel"" mimetype=""application"" xlink:href=""1471-2164-11-120-S2.XLS""><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type=""local-data"" id=""S3""><caption><title>Additional file 3</title><p><bold>Dot plot comparison of collinearity of<italic>Listeria monocytogenes</italic>genome 08-5578 relative to EGDe</bold>. Dots or lines represent segments of conservation between the two sequences. Blue lines represent collinear sequence similarities between the reverse complement of 08-5578 and EGDe and represent a symmetrical inversion around the origin of replication. Outlier dots indicate duplicated regions. A break in the main diagonal of a linear segment supports an insertion or deletion in either one of the sequences, and the associated features are identified with arrows ('LGI1',<italic>Listeria</italic>genomic island 1).</p></caption><media mime-subtype=""tiff"" mimetype=""image"" xlink:href=""1471-2164-11-120-S3.TIFF""><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type=""local-data"" id=""S4""><caption><title>Additional file 4</title><p><bold>Internalin and Internalin-like leucine rich coding sequences present in isolate 08-5578</bold>. The conserved LPxTG cell wall anchor domains were identified using HMMER TIGR01167.</p></caption><media mime-subtype=""vnd.ms-excel"" mimetype=""application"" xlink:href=""1471-2164-11-120-S4.XLS""><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type=""local-data"" id=""S5""><caption><title>Additional file 5</title><p><bold>Cross-match table of all protein-encoding loci encoded by two serotype 1/2a outbreak-associated<italic>Listeria monocytogenes</italic>(08-5578 and 08-5923) versus other publically available, annotated<italic>L. monocytogenes</italic>genomes</bold>. Description and references are included in the Methods section.</p></caption><media mime-subtype=""vnd.ms-excel"" mimetype=""application"" xlink:href=""1471-2164-11-120-S5.XLS""><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type=""local-data"" id=""S6""><caption><title>Additional file 6</title><p><bold>Oligonucleotides used in this study</bold>. All coordinates are in reference to the sequence of isolate 08-5578.</p></caption><media mime-subtype=""msword"" mimetype=""application"" xlink:href=""1471-2164-11-120-S6.DOC""><caption><p>Click here for file</p></caption></media></supplementary-material></sec><back><sec><title>Acknowledgements</title><p>We thank the PulseNet Canada laboratory team (A. Desrochers, L. Tschetter, E. Ballegeer, and C. Munro), G. Peters, K. Melnychuk, C. Bonner, T. Murphy, A. Kearney, V. Wolf and M. Jerome for technical assistance; Canadian Food Inspection Agency Laboratories for food isolates; N. Thomson, D. Walker, M. He, A. Cerdeno-Tarraga, N. Croucher, T. Matthews, P. Mabon and T. Lawley for bioinformatic assistance; and F. Plummer, G. Glavin, M. Drebot, H. Tabor, C. Clark, D. Rasko, J. Farber, F. Pagotto and F. Jamieson for guidance during this study.</p></sec><ref-list><ref id=""B1""><mixed-citation publication-type=""journal""><name><surname>Seeliger</surname><given-names>HP</given-names></name><article-title>Listeriosis--history and actual developments</article-title><source>Infection</source><year>1988</year><volume>16</volume><issue>Suppl 2</issue><fpage>S80</fpage><lpage>4</lpage><pub-id pub-id-type=""doi"">10.1007/BF01639726</pub-id><pub-id pub-id-type=""pmid"">3138193</pub-id></mixed-citation></ref><ref id=""B2""><mixed-citation publication-type=""journal""><name><surname>Ivanek</surname><given-names>R</given-names></name><name><surname>Grohn</surname><given-names>YT</given-names></name><name><surname>Wiedmann</surname><given-names>M</given-names></name><article-title><italic>Listeria monocytogenes</italic>in multiple habitats and host populations: review of available data for mathematical modeling</article-title><source>Foodborne Pathog Dis</source><year>2006</year><volume>3</volume><issue>4</issue><fpage>319</fpage><lpage>336</lpage><pub-id pub-id-type=""doi"">10.1089/fpd.2006.3.319</pub-id><pub-id pub-id-type=""pmid"">17199514</pub-id></mixed-citation></ref><ref id=""B3""><mixed-citation publication-type=""journal""><name><surname>Sauders</surname><given-names>BD</given-names></name><name><surname>Durak</surname><given-names>MZ</given-names></name><name><surname>Fortes</surname><given-names>E</given-names></name><name><surname>Windham</surname><given-names>K</given-names></name><name><surname>Schukken</surname><given-names>Y</given-names></name><name><surname>Lembo</surname><given-names>AJ</given-names><suffix>Jr</suffix></name><name><surname>Akey</surname><given-names>B</given-names></name><name><surname>Nightingale</surname><given-names>KK</given-names></name><name><surname>Wiedmann</surname><given-names>M</given-names></name><article-title>Molecular characterization of<italic>Listeria monocytogenes</italic>from natural and urban environments</article-title><source>J Food Prot</source><year>2006</year><volume>69</volume><issue>1</issue><fpage>93</fpage><lpage>105</lpage><pub-id pub-id-type=""pmid"">16416906</pub-id></mixed-citation></ref><ref id=""B4""><mixed-citation publication-type=""journal""><name><surname>Weis</surname><given-names>J</given-names></name><name><surname>Seeliger</surname><given-names>HP</given-names></name><article-title>Incidence of<italic>Listeria monocytogenes</italic>in nature</article-title><source>Appl Microbiol</source><year>1975</year><volume>30</volume><issue>1</issue><fpage>29</fpage><lpage>32</lpage><pub-id pub-id-type=""pmid"">807164</pub-id></mixed-citation></ref><ref id=""B5""><mixed-citation publication-type=""journal""><name><surname>Colburn</surname><given-names>KG</given-names></name><name><surname>Kaysner</surname><given-names>CA</given-names></name><name><surname>Abeyta</surname><given-names>C</given-names><suffix>Jr</suffix></name><name><surname>Wekell</surname><given-names>MM</given-names></name><article-title><italic>Listeria</italic>species in a California coast estuarine environment</article-title><source>Appl Environ Microbiol</source><year>1990</year><volume>56</volume><issue>7</issue><fpage>2007</fpage><lpage>2011</lpage><pub-id pub-id-type=""pmid"">2117874</pub-id></mixed-citation></ref><ref id=""B6""><mixed-citation publication-type=""journal""><name><surname>Mead</surname><given-names>PS</given-names></name><name><surname>Slutsker</surname><given-names>L</given-names></name><name><surname>Dietz</surname><given-names>V</given-names></name><name><surname>McCaig</surname><given-names>LF</given-names></name><name><surname>Bresee</surname><given-names>JS</given-names></name><name><surname>Shapiro</surname><given-names>C</given-names></name><name><surname>Griffin</surname><given-names>PM</given-names></name><name><surname>Tauxe</surname><given-names>RV</given-names></name><article-title>Food-related illness and death in the United States</article-title><source>Emerg Infect Dis</source><year>1999</year><volume>5</volume><issue>5</issue><fpage>607</fpage><lpage>625</lpage><pub-id pub-id-type=""doi"">10.3201/eid0505.990502</pub-id><pub-id pub-id-type=""pmid"">10511517</pub-id></mixed-citation></ref><ref id=""B7""><mixed-citation publication-type=""journal""><name><surname>Lianou</surname><given-names>A</given-names></name><name><surname>Sofos</surname><given-names>JN</given-names></name><article-title>A review of the incidence and transmission of<italic>Listeria monocytogenes</italic>in ready-to-eat products in retail and food service environments</article-title><source>J Food Prot</source><year>2007</year><volume>70</volume><issue>9</issue><fpage>2172</fpage><lpage>2198</lpage><pub-id pub-id-type=""pmid"">17900099</pub-id></mixed-citation></ref><ref id=""B8""><mixed-citation publication-type=""journal""><name><surname>Beresford</surname><given-names>MR</given-names></name><name><surname>Andrew</surname><given-names>PW</given-names></name><name><surname>Shama</surname><given-names>G</given-names></name><article-title><italic>Listeria monocytogenes</italic>adheres to many materials found in food-processing environments</article-title><source>J Appl Microbiol</source><year>2001</year><volume>90</volume><issue>6</issue><fpage>1000</fpage><lpage>1005</lpage><pub-id pub-id-type=""doi"">10.1046/j.1365-2672.2001.01330.x</pub-id><pub-id pub-id-type=""pmid"">11412331</pub-id></mixed-citation></ref><ref id=""B9""><mixed-citation publication-type=""journal""><name><surname>Walker</surname><given-names>SJ</given-names></name><name><surname>Archer</surname><given-names>P</given-names></name><name><surname>Banks</surname><given-names>JG</given-names></name><article-title>Growth of<italic>Listeria monocytogenes</italic>at refrigeration temperatures</article-title><source>J Appl Bacteriol</source><year>1990</year><volume>68</volume><issue>2</issue><fpage>157</fpage><lpage>162</lpage><pub-id pub-id-type=""pmid"">2108109</pub-id></mixed-citation></ref><ref id=""B10""><mixed-citation publication-type=""journal""><name><surname>Gandhi</surname><given-names>M</given-names></name><name><surname>Chikindas</surname><given-names>ML</given-names></name><article-title><italic>Listeria</italic>: A foodborne pathogen that knows how to survive</article-title><source>Int J Food Microbiol</source><year>2007</year><volume>113</volume><issue>1</issue><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type=""doi"">10.1016/j.ijfoodmicro.2006.07.008</pub-id><pub-id pub-id-type=""pmid"">17010463</pub-id></mixed-citation></ref><ref id=""B11""><mixed-citation publication-type=""journal""><name><surname>Wong</surname><given-names>AC</given-names></name><article-title>Biofilms in food processing environments</article-title><source>J Dairy Sci</source><year>1998</year><volume>81</volume><issue>10</issue><fpage>2765</fpage><lpage>2770</lpage><pub-id pub-id-type=""pmid"">9812282</pub-id></mixed-citation></ref><ref id=""B12""><mixed-citation publication-type=""journal""><name><surname>Orsi</surname><given-names>RH</given-names></name><name><surname>Borowsky</surname><given-names>ML</given-names></name><name><surname>Lauer</surname><given-names>P</given-names></name><name><surname>Young</surname><given-names>SK</given-names></name><name><surname>Nusbaum</surname><given-names>C</given-names></name><name><surname>Galagan</surname><given-names>JE</given-names></name><name><surname>Birren</surname><given-names>BW</given-names></name><name><surname>Ivy</surname><given-names>RA</given-names></name><name><surname>Sun</surname><given-names>Q</given-names></name><name><surname>Graves</surname><given-names>LM</given-names></name><name><surname>Swaminathan</surname><given-names>B</given-names></name><name><surname>Wiedmann</surname><given-names>M</given-names></name><article-title>Short-term genome evolution of<italic>Listeria monocytogenes</italic>in a non-controlled environment</article-title><source>BMC Genomics</source><year>2008</year><volume>9</volume><fpage>539</fpage><pub-id pub-id-type=""doi"">10.1186/1471-2164-9-539</pub-id><pub-id pub-id-type=""pmid"">19014550</pub-id></mixed-citation></ref><ref id=""B13""><mixed-citation publication-type=""journal""><name><surname>Tompkin</surname><given-names>RB</given-names></name><article-title>Control of<italic>Listeria monocytogenes</italic>in the food-processing environment</article-title><source>J Food Prot</source><year>2002</year><volume>65</volume><issue>4</issue><fpage>709</fpage><lpage>725</lpage><pub-id pub-id-type=""pmid"">11952224</pub-id></mixed-citation></ref><ref id=""B14""><mixed-citation publication-type=""journal""><name><surname>Wiedmann</surname><given-names>M</given-names></name><article-title>Molecular subtyping methods for<italic>Listeria monocytogenes</italic></article-title><source>J AOAC Int</source><year>2002</year><volume>85</volume><issue>2</issue><fpage>524</fpage><lpage>531</lpage><pub-id pub-id-type=""pmid"">11990041</pub-id></mixed-citation></ref><ref id=""B15""><mixed-citation publication-type=""journal""><name><surname>Swaminathan</surname><given-names>B</given-names></name><name><surname>Gerner-Smidt</surname><given-names>P</given-names></name><article-title>The epidemiology of human listeriosis</article-title><source>Microbes Infect</source><year>2007</year><volume>9</volume><issue>10</issue><fpage>1236</fpage><lpage>1243</lpage><pub-id pub-id-type=""doi"">10.1016/j.micinf.2007.05.011</pub-id><pub-id pub-id-type=""pmid"">17720602</pub-id></mixed-citation></ref><ref id=""B16""><mixed-citation publication-type=""journal""><name><surname>Miya</surname><given-names>S</given-names></name><name><surname>Kimura</surname><given-names>B</given-names></name><name><surname>Sato</surname><given-names>M</given-names></name><name><surname>Takahashi</surname><given-names>H</given-names></name><name><surname>Ishikawa</surname><given-names>T</given-names></name><name><surname>Suda</surname><given-names>T</given-names></name><name><surname>Takakura</surname><given-names>C</given-names></name><name><surname>Fujii</surname><given-names>T</given-names></name><name><surname>Wiedmann</surname><given-names>M</given-names></name><article-title>Development of a multilocus variable-number of tandem repeat typing method for<italic>Listeria monocytogenes</italic>serotype 4b strains</article-title><source>Int J Food Microbiol</source><year>2008</year><volume>124</volume><issue>3</issue><fpage>239</fpage><lpage>249</lpage><pub-id pub-id-type=""doi"">10.1016/j.ijfoodmicro.2008.03.023</pub-id><pub-id pub-id-type=""pmid"">18457891</pub-id></mixed-citation></ref><ref id=""B17""><mixed-citation publication-type=""journal""><name><surname>Liu</surname><given-names>D</given-names></name><article-title>Identification, subtyping and virulence determination of<italic>Listeria monocytogenes</italic>, an important foodborne pathogen</article-title><source>J Med Microbiol</source><year>2006</year><volume>55</volume><issue>Pt 6</issue><fpage>645</fpage><lpage>659</lpage><pub-id pub-id-type=""doi"">10.1099/jmm.0.46495-0</pub-id><pub-id pub-id-type=""pmid"">16687581</pub-id></mixed-citation></ref><ref id=""B18""><mixed-citation publication-type=""journal""><name><surname>Graves</surname><given-names>LM</given-names></name><name><surname>Swaminathan</surname><given-names>B</given-names></name><article-title>PulseNet standardized protocol for subtyping<italic>Listeria monocytogenes</italic>by macrorestriction and pulsed-field gel electrophoresis</article-title><source>Int J Food Microbiol</source><year>2001</year><volume>65</volume><issue>1-2</issue><fpage>55</fpage><lpage>62</lpage><pub-id pub-id-type=""doi"">10.1016/S0168-1605(00)00501-8</pub-id><pub-id pub-id-type=""pmid"">11322701</pub-id></mixed-citation></ref><ref id=""B19""><mixed-citation publication-type=""journal""><name><surname>Mead</surname><given-names>PS</given-names></name><name><surname>Dunne</surname><given-names>EF</given-names></name><name><surname>Graves</surname><given-names>L</given-names></name><name><surname>Wiedmann</surname><given-names>M</given-names></name><name><surname>Patrick</surname><given-names>M</given-names></name><name><surname>Hunter</surname><given-names>S</given-names></name><name><surname>Salehi</surname><given-names>E</given-names></name><name><surname>Mostashari</surname><given-names>F</given-names></name><name><surname>Craig</surname><given-names>A</given-names></name><name><surname>Mshar</surname><given-names>P</given-names></name><name><surname>Bannerman</surname><given-names>T</given-names></name><name><surname>Sauders</surname><given-names>BD</given-names></name><name><surname>Hayes</surname><given-names>P</given-names></name><name><surname>Dewitt</surname><given-names>W</given-names></name><name><surname>Sparling</surname><given-names>P</given-names></name><name><surname>Griffin</surname><given-names>P</given-names></name><name><surname>Morse</surname><given-names>D</given-names></name><name><surname>Slutsker</surname><given-names>L</given-names></name><name><surname>Swaminathan</surname><given-names>B</given-names></name><collab>Listeria Outbreak Working Group</collab><article-title>Nationwide outbreak of listeriosis due to contaminated meat</article-title><source>Epidemiol Infect</source><year>2006</year><volume>134</volume><issue>4</issue><fpage>744</fpage><lpage>751</lpage><pub-id pub-id-type=""doi"">10.1017/S0950268805005376</pub-id><pub-id pub-id-type=""pmid"">16318652</pub-id></mixed-citation></ref><ref id=""B20""><mixed-citation publication-type=""journal""><name><surname>Pagotto</surname><given-names>F</given-names></name><name><surname>Ng</surname><given-names>LK</given-names></name><name><surname>Clark</surname><given-names>C</given-names></name><name><surname>Farber</surname><given-names>J</given-names></name><collab>Canadian Public Health Laboratory Network</collab><article-title>Canadian listeriosis reference service</article-title><source>Foodborne Pathog Dis</source><year>2006</year><volume>3</volume><issue>1</issue><fpage>132</fpage><lpage>137</lpage><pub-id pub-id-type=""doi"">10.1089/fpd.2006.3.132</pub-id><pub-id pub-id-type=""pmid"">16602988</pub-id></mixed-citation></ref><ref id=""B21""><mixed-citation publication-type=""journal""><name><surname>Nelson</surname><given-names>KE</given-names></name><name><surname>Fouts</surname><given-names>DE</given-names></name><name><surname>Mongodin</surname><given-names>EF</given-names></name><name><surname>Ravel</surname><given-names>J</given-names></name><name><surname>DeBoy</surname><given-names>RT</given-names></name><name><surname>Kolonay</surname><given-names>JF</given-names></name><name><surname>Rasko</surname><given-names>DA</given-names></name><name><surname>Angiuoli</surname><given-names>SV</given-names></name><name><surname>Gill</surname><given-names>SR</given-names></name><name><surname>Paulsen</surname><given-names>IT</given-names></name><name><surname>Peterson</surname><given-names>J</given-names></name><name><surname>White</surname><given-names>O</given-names></name><name><surname>Nelson</surname><given-names>WC</given-names></name><name><surname>Nierman</surname><given-names>W</given-names></name><name><surname>Beanan</surname><given-names>MJ</given-names></name><name><surname>Brinkac</surname><given-names>LM</given-names></name><name><surname>Daugherty</surname><given-names>SC</given-names></name><name><surname>Dodson</surname><given-names>RJ</given-names></name><name><surname>Durkin</surname><given-names>AS</given-names></name><name><surname>Madupu</surname><given-names>R</given-names></name><name><surname>Haft</surname><given-names>DH</given-names></name><name><surname>Selengut</surname><given-names>J</given-names></name><name><surname>Van Aken</surname><given-names>S</given-names></name><name><surname>Khouri</surname><given-names>H</given-names></name><name><surname>Fedorova</surname><given-names>N</given-names></name><name><surname>Forberger</surname><given-names>H</given-names></name><name><surname>Tran</surname><given-names>B</given-names></name><name><surname>Kathariou</surname><given-names>S</given-names></name><name><surname>Wonderling</surname><given-names>LD</given-names></name><name><surname>Uhlich</surname><given-names>GA</given-names></name><name><surname>Bayles</surname><given-names>DO</given-names></name><name><surname>Luchansky</surname><given-names>JB</given-names></name><name><surname>Fraser</surname><given-names>CM</given-names></name><article-title>Whole genome comparisons of serotype 4b and 1/2a strains of the food-borne pathogen<italic>Listeria monocytogenes</italic>reveal new insights into the core genome components of this species</article-title><source>Nucleic Acids Res</source><year>2004</year><volume>32</volume><issue>8</issue><fpage>2386</fpage><lpage>2395</lpage><pub-id pub-id-type=""doi"">10.1093/nar/gkh562</pub-id><pub-id pub-id-type=""pmid"">15115801</pub-id></mixed-citation></ref><ref id=""B22""><mixed-citation publication-type=""journal""><name><surname>Glaser</surname><given-names>P</given-names></name><name><surname>Frangeul</surname><given-names>L</given-names></name><name><surname>Buchrieser</surname><given-names>C</given-names></name><name><surname>Rusniok</surname><given-names>C</given-names></name><name><surname>Amend</surname><given-names>A</given-names></name><name><surname>Baquero</surname><given-names>F</given-names></name><name><surname>Berche</surname><given-names>P</given-names></name><name><surname>Bloecker</surname><given-names>H</given-names></name><name><surname>Brandt</surname><given-names>P</given-names></name><name><surname>Chakraborty</surname><given-names>T</given-names></name><name><surname>Charbit</surname><given-names>A</given-names></name><name><surname>Chetouani</surname><given-names>F</given-names></name><name><surname>Couve</surname><given-names>E</given-names></name><name><surname>de Daruvar</surname><given-names>A</given-names></name><name><surname>Dehoux</surname><given-names>P</given-names></name><name><surname>Domann</surname><given-names>E</given-names></name><name><surname>Dominguez-Bernal</surname><given-names>G</given-names></name><name><surname>Duchaud</surname><given-names>E</given-names></name><name><surname>Durant</surname><given-names>L</given-names></name><name><surname>Dussurget</surname><given-names>O</given-names></name><name><surname>Entian</surname><given-names>KD</given-names></name><name><surname>Fsihi</surname><given-names>H</given-names></name><name><surname>Garcia-del Portillo</surname><given-names>F</given-names></name><name><surname>Garrido</surname><given-names>P</given-names></name><name><surname>Gautier</surname><given-names>L</given-names></name><name><surname>Goebel</surname><given-names>W</given-names></name><name><surname>Gomez-Lopez</surname><given-names>N</given-names></name><name><surname>Hain</surname><given-names>T</given-names></name><name><surname>Hauf</surname><given-names>J</given-names></name><name><surname>Jackson</surname><given-names>D</given-names></name><name><surname>Jones</surname><given-names>LM</given-names></name><name><surname>Kaerst</surname><given-names>U</given-names></name><name><surname>Kreft</surname><given-names>J</given-names></name><name><surname>Kuhn</surname><given-names>M</given-names></name><name><surname>Kunst</surname><given-names>F</given-names></name><name><surname>Kurapkat</surname><given-names>G</given-names></name><name><surname>Madueno</surname><given-names>E</given-names></name><name><surname>Maitournam</surname><given-names>A</given-names></name><name><surname>Vicente</surname><given-names>JM</given-names></name><name><surname>Ng</surname><given-names>E</given-names></name><name><surname>Nedjari</surname><given-names>H</given-names></name><name><surname>Nordsiek</surname><given-names>G</given-names></name><name><surname>Novella</surname><given-names>S</given-names></name><name><surname>de Pablos</surname><given-names>B</given-names></name><name><surname>Perez-Diaz</surname><given-names>JC</given-names></name><name><surname>Purcell</surname><given-names>R</given-names></name><name><surname>Remmel</surname><given-names>B</given-names></name><name><surname>Rose</surname><given-names>M</given-names></name><name><surname>Schlueter</surname><given-names>T</given-names></name><name><surname>Simoes</surname><given-names>N</given-names></name><name><surname>Tierrez</surname><given-names>A</given-names></name><name><surname>Vazquez-Boland</surname><given-names>JA</given-names></name><name><surname>Voss</surname><given-names>H</given-names></name><name><surname>Wehland</surname><given-names>J</given-names></name><name><surname>Cossart</surname><given-names>P</given-names></name><article-title>Comparative genomics of<italic>Listeria</italic>species</article-title><source>Science</source><year>2001</year><volume>294</volume><issue>5543</issue><fpage>849</fpage><lpage>852</lpage><pub-id pub-id-type=""pmid"">11679669</pub-id></mixed-citation></ref><ref id=""B23""><mixed-citation publication-type=""journal""><name><surname>Hain</surname><given-names>T</given-names></name><name><surname>Steinweg</surname><given-names>C</given-names></name><name><surname>Kuenne</surname><given-names>CT</given-names></name><name><surname>Billion</surname><given-names>A</given-names></name><name><surname>Ghai</surname><given-names>R</given-names></name><name><surname>Chatterjee</surname><given-names>SS</given-names></name><name><surname>Domann</surname><given-names>E</given-names></name><name><surname>Karst</surname><given-names>U</given-names></name><name><surname>Goesmann</surname><given-names>A</given-names></name><name><surname>Bekel</surname><given-names>T</given-names></name><name><surname>Bartels</surname><given-names>D</given-names></name><name><surname>Kaiser</surname><given-names>O</given-names></name><name><surname>Meyer</surname><given-names>F</given-names></name><name><surname>Puhler</surname><given-names>A</given-names></name><name><surname>Weisshaar</surname><given-names>B</given-names></name><name><surname>Wehland</surname><given-names>J</given-names></name><name><surname>Liang</surname><given-names>C</given-names></name><name><surname>Dandekar</surname><given-names>T</given-names></name><name><surname>Lampidis</surname><given-names>R</given-names></name><name><surname>Kreft</surname><given-names>J</given-names></name><name><surname>Goebel</surname><given-names>W</given-names></name><name><surname>Chakraborty</surname><given-names>T</given-names></name><article-title>Whole-genome sequence of<italic>Listeria welshimeri</italic>reveals common steps in genome reduction with<italic>Listeria innocua</italic>as compared to<italic>Listeria monocytogenes</italic></article-title><source>J Bacteriol</source><year>2006</year><volume>188</volume><issue>21</issue><fpage>7405</fpage><lpage>7415</lpage><pub-id pub-id-type=""doi"">10.1128/JB.00758-06</pub-id><pub-id pub-id-type=""pmid"">16936040</pub-id></mixed-citation></ref><ref id=""B24""><mixed-citation publication-type=""journal""><name><surname>Ragon</surname><given-names>M</given-names></name><name><surname>Wirth</surname><given-names>T</given-names></name><name><surname>Hollandt</surname><given-names>F</given-names></name><name><surname>Lavenir</surname><given-names>R</given-names></name><name><surname>Lecuit</surname><given-names>M</given-names></name><name><surname>Le Monnier</surname><given-names>A</given-names></name><name><surname>Brisse</surname><given-names>S</given-names></name><article-title>A new perspective on<italic>Listeria monocytogenes</italic>evolution</article-title><source>PLoS Pathog</source><year>2008</year><volume>4</volume><issue>9</issue><fpage>e1000146</fpage><pub-id pub-id-type=""doi"">10.1371/journal.ppat.1000146</pub-id><pub-id pub-id-type=""pmid"">18773117</pub-id></mixed-citation></ref><ref id=""B25""><mixed-citation publication-type=""journal""><name><surname>Ward</surname><given-names>TJ</given-names></name><name><surname>Gorski</surname><given-names>L</given-names></name><name><surname>Borucki</surname><given-names>MK</given-names></name><name><surname>Mandrell</surname><given-names>RE</given-names></name><name><surname>Hutchins</surname><given-names>J</given-names></name><name><surname>Pupedis</surname><given-names>K</given-names></name><article-title>Intraspecific phylogeny and lineage group identification based on the<italic>prfA</italic>virulence gene cluster of<italic>Listeria monocytogenes</italic></article-title><source>J Bacteriol</source><year>2004</year><volume>186</volume><issue>15</issue><fpage>4994</fpage><lpage>5002</lpage><pub-id pub-id-type=""doi"">10.1128/JB.186.15.4994-5002.2004</pub-id><pub-id pub-id-type=""pmid"">15262937</pub-id></mixed-citation></ref><ref id=""B26""><mixed-citation publication-type=""journal""><name><surname>Wiedmann</surname><given-names>M</given-names></name><name><surname>Bruce</surname><given-names>JL</given-names></name><name><surname>Keating</surname><given-names>C</given-names></name><name><surname>Johnson</surname><given-names>AE</given-names></name><name><surname>McDonough</surname><given-names>PL</given-names></name><name><surname>Batt</surname><given-names>CA</given-names></name><article-title>Ribotypes and virulence gene polymorphisms suggest three distinct<italic>Listeria monocytogenes</italic>lineages with differences in pathogenic potential</article-title><source>Infect Immun</source><year>1997</year><volume>65</volume><issue>7</issue><fpage>2707</fpage><lpage>2716</lpage><pub-id pub-id-type=""pmid"">9199440</pub-id></mixed-citation></ref><ref id=""B27""><mixed-citation publication-type=""journal""><name><surname>Piffaretti</surname><given-names>JC</given-names></name><name><surname>Kressebuch</surname><given-names>H</given-names></name><name><surname>Aeschbacher</surname><given-names>M</given-names></name><name><surname>Bille</surname><given-names>J</given-names></name><name><surname>Bannerman</surname><given-names>E</given-names></name><name><surname>Musser</surname><given-names>JM</given-names></name><name><surname>Selander</surname><given-names>RK</given-names></name><name><surname>Rocourt</surname><given-names>J</given-names></name><article-title>Genetic characterization of clones of the bacterium<italic>Listeria monocytogenes</italic>causing epidemic disease</article-title><source>Proc Natl Acad Sci USA</source><year>1989</year><volume>86</volume><issue>10</issue><fpage>3818</fpage><lpage>3822</lpage><pub-id pub-id-type=""doi"">10.1073/pnas.86.10.3818</pub-id><pub-id pub-id-type=""pmid"">2498876</pub-id></mixed-citation></ref><ref id=""B28""><mixed-citation publication-type=""journal""><name><surname>Brosch</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Luchansky</surname><given-names>JB</given-names></name><article-title>Pulsed-field fingerprinting of listeriae: identification of genomic divisions for<italic>Listeria monocytogenes</italic>and their correlation with serovar</article-title><source>Appl Environ Microbiol</source><year>1994</year><volume>60</volume><issue>7</issue><fpage>2584</fpage><lpage>2592</lpage><pub-id pub-id-type=""pmid"">8074531</pub-id></mixed-citation></ref><ref id=""B29""><mixed-citation publication-type=""journal""><name><surname>Graves</surname><given-names>LM</given-names></name><name><surname>Swaminathan</surname><given-names>B</given-names></name><name><surname>Reeves</surname><given-names>MW</given-names></name><name><surname>Hunter</surname><given-names>SB</given-names></name><name><surname>Weaver</surname><given-names>RE</given-names></name><name><surname>Plikaytis</surname><given-names>BD</given-names></name><name><surname>Schuchat</surname><given-names>A</given-names></name><article-title>Comparison of ribotyping and multilocus enzyme electrophoresis for subtyping of<italic>Listeria monocytogenes</italic>isolates</article-title><source>J Clin Microbiol</source><year>1994</year><volume>32</volume><issue>12</issue><fpage>2936</fpage><lpage>2943</lpage><pub-id pub-id-type=""pmid"">7883880</pub-id></mixed-citation></ref><ref id=""B30""><mixed-citation publication-type=""journal""><name><surname>Milillo</surname><given-names>SR</given-names></name><name><surname>Badamo</surname><given-names>JM</given-names></name><name><surname>Wiedmann</surname><given-names>M</given-names></name><article-title>Contributions to selected phenotypic characteristics of large species- and lineage-specific genomic regions in<italic>Listeria monocytogenes</italic></article-title><source>Food Microbiol</source><year>2009</year><volume>26</volume><issue>2</issue><fpage>212</fpage><lpage>223</lpage><pub-id pub-id-type=""doi"">10.1016/j.fm.2008.08.010</pub-id><pub-id pub-id-type=""pmid"">19171265</pub-id></mixed-citation></ref><ref id=""B31""><mixed-citation publication-type=""journal""><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Ross</surname><given-names>WH</given-names></name><name><surname>Gray</surname><given-names>MJ</given-names></name><name><surname>Wiedmann</surname><given-names>M</given-names></name><name><surname>Whiting</surname><given-names>RC</given-names></name><name><surname>Scott</surname><given-names>VN</given-names></name><article-title>Attributing risk to<italic>Listeria monocytogenes</italic>subgroups: dose response in relation to genetic lineages</article-title><source>J Food Prot</source><year>2006</year><volume>69</volume><issue>2</issue><fpage>335</fpage><lpage>344</lpage><pub-id pub-id-type=""pmid"">16496574</pub-id></mixed-citation></ref><ref id=""B32""><mixed-citation publication-type=""journal""><name><surname>Sanger</surname><given-names>F</given-names></name><name><surname>Nicklen</surname><given-names>S</given-names></name><name><surname>Coulson</surname><given-names>AR</given-names></name><article-title>DNA sequencing with chain-terminating inhibitors</article-title><source>Proc Natl Acad Sci USA</source><year>1977</year><volume>74</volume><issue>12</issue><fpage>5463</fpage><lpage>5467</lpage><pub-id pub-id-type=""doi"">10.1073/pnas.74.12.5463</pub-id><pub-id pub-id-type=""pmid"">271968</pub-id></mixed-citation></ref><ref id=""B33""><mixed-citation publication-type=""journal""><name><surname>Medini</surname><given-names>D</given-names></name><name><surname>Serruto</surname><given-names>D</given-names></name><name><surname>Parkhill</surname><given-names>J</given-names></name><name><surname>Relman</surname><given-names>DA</given-names></name><name><surname>Donati</surname><given-names>C</given-names></name><name><surname>Moxon</surname><given-names>R</given-names></name><name><surname>Falkow</surname><given-names>S</given-names></name><name><surname>Rappuoli</surname><given-names>R</given-names></name><article-title>Microbiology in the post-genomic era</article-title><source>Nat Rev Microbiol</source><year>2008</year><volume>6</volume><issue>6</issue><fpage>419</fpage><lpage>430</lpage><pub-id pub-id-type=""pmid"">18475305</pub-id></mixed-citation></ref><ref id=""B34""><mixed-citation publication-type=""journal""><name><surname>Shendure</surname><given-names>J</given-names></name><name><surname>Ji</surname><given-names>H</given-names></name><article-title>Next-generation DNA sequencing</article-title><source>Nat Biotechnol</source><year>2008</year><volume>26</volume><issue>10</issue><fpage>1135</fpage><lpage>1145</lpage><pub-id pub-id-type=""doi"">10.1038/nbt1486</pub-id><pub-id pub-id-type=""pmid"">18846087</pub-id></mixed-citation></ref><ref id=""B35""><mixed-citation publication-type=""journal""><name><surname>Mullapudi</surname><given-names>S</given-names></name><name><surname>Siletzky</surname><given-names>RM</given-names></name><name><surname>Kathariou</surname><given-names>S</given-names></name><article-title>Heavy-metal and benzalkonium chloride resistance of<italic>Listeria monocytogenes</italic>isolates from the environment of turkey-processing plants</article-title><source>Appl Environ Microbiol</source><year>2008</year><volume>74</volume><issue>5</issue><fpage>1464</fpage><lpage>1468</lpage><pub-id pub-id-type=""doi"">10.1128/AEM.02426-07</pub-id><pub-id pub-id-type=""pmid"">18192428</pub-id></mixed-citation></ref><ref id=""B36""><mixed-citation publication-type=""journal""><name><surname>Kathariou</surname><given-names>S</given-names></name><name><surname>Graves</surname><given-names>L</given-names></name><name><surname>Buchrieser</surname><given-names>C</given-names></name><name><surname>Glaser</surname><given-names>P</given-names></name><name><surname>Siletzky</surname><given-names>RM</given-names></name><name><surname>Swaminathan</surname><given-names>B</given-names></name><article-title>Involvement of closely related strains of a new clonal group of<italic>Listeria monocytogenes</italic>in the 1998-99 and 2002 multistate outbreaks of foodborne listeriosis in the United States</article-title><source>Foodborne Pathog Dis</source><year>2006</year><volume>3</volume><issue>3</issue><fpage>292</fpage><lpage>302</lpage><pub-id pub-id-type=""doi"">10.1089/fpd.2006.3.292</pub-id><pub-id pub-id-type=""pmid"">16972778</pub-id></mixed-citation></ref><ref id=""B37""><mixed-citation publication-type=""journal""><name><surname>Novichkov</surname><given-names>PS</given-names></name><name><surname>Wolf</surname><given-names>YI</given-names></name><name><surname>Dubchak</surname><given-names>I</given-names></name><name><surname>Koonin</surname><given-names>EV</given-names></name><article-title>Trends in prokaryotic evolution revealed by comparison of closely related bacterial and archaeal genomes</article-title><source>J Bacteriol</source><year>2009</year><volume>191</volume><issue>1</issue><fpage>65</fpage><lpage>73</lpage><pub-id pub-id-type=""doi"">10.1128/JB.01237-08</pub-id><pub-id pub-id-type=""pmid"">18978059</pub-id></mixed-citation></ref><ref id=""B38""><mixed-citation publication-type=""journal""><name><surname>Eisen</surname><given-names>JA</given-names></name><name><surname>Heidelberg</surname><given-names>JF</given-names></name><name><surname>White</surname><given-names>O</given-names></name><name><surname>Salzberg</surname><given-names>SL</given-names></name><article-title>Evidence for symmetric chromosomal inversions around the replication origin in bacteria</article-title><source>Genome Biol</source><year>2000</year><volume>1</volume><issue>6</issue><fpage>RESEARCH0011</fpage><pub-id pub-id-type=""doi"">10.1186/gb-2000-1-6-research0011</pub-id><pub-id pub-id-type=""pmid"">11178265</pub-id></mixed-citation></ref><ref id=""B39""><mixed-citation publication-type=""journal""><name><surname>Vazquez-Boland</surname><given-names>JA</given-names></name><name><surname>Kuhn</surname><given-names>M</given-names></name><name><surname>Berche</surname><given-names>P</given-names></name><name><surname>Chakraborty</surname><given-names>T</given-names></name><name><surname>Dominguez-Bernal</surname><given-names>G</given-names></name><name><surname>Goebel</surname><given-names>W</given-names></name><name><surname>Gonzalez-Zorn</surname><given-names>B</given-names></name><name><surname>Wehland</surname><given-names>J</given-names></name><name><surname>Kreft</surname><given-names>J</given-names></name><article-title><italic>Listeria</italic>pathogenesis and molecular virulence determinants</article-title><source>Clin Microbiol Rev</source><year>2001</year><volume>14</volume><issue>3</issue><fpage>584</fpage><lpage>640</lpage><pub-id pub-id-type=""doi"">10.1128/CMR.14.3.584-640.2001</pub-id><pub-id pub-id-type=""pmid"">11432815</pub-id></mixed-citation></ref><ref id=""B40""><mixed-citation publication-type=""journal""><name><surname>Jacquet</surname><given-names>C</given-names></name><name><surname>Doumith</surname><given-names>M</given-names></name><name><surname>Gordon</surname><given-names>JI</given-names></name><name><surname>Martin</surname><given-names>PM</given-names></name><name><surname>Cossart</surname><given-names>P</given-names></name><name><surname>Lecuit</surname><given-names>M</given-names></name><article-title>A molecular marker for evaluating the pathogenic potential of foodborne<italic>Listeria monocytogenes</italic></article-title><source>J Infect Dis</source><year>2004</year><volume>189</volume><issue>11</issue><fpage>2094</fpage><lpage>2100</lpage><pub-id pub-id-type=""doi"">10.1086/420853</pub-id><pub-id pub-id-type=""pmid"">15143478</pub-id></mixed-citation></ref><ref id=""B41""><mixed-citation publication-type=""journal""><name><surname>Nightingale</surname><given-names>KK</given-names></name><name><surname>Windham</surname><given-names>K</given-names></name><name><surname>Martin</surname><given-names>KE</given-names></name><name><surname>Yeung</surname><given-names>M</given-names></name><name><surname>Wiedmann</surname><given-names>M</given-names></name><article-title>Select<italic>Listeria monocytogenes</italic>subtypes commonly found in foods carry distinct nonsense mutations in<italic>inlA</italic>, leading to expression of truncated and secreted internalin A, and are associated with a reduced invasion phenotype for human intestinal epithelial cells</article-title><source>Appl Environ Microbiol</source><year>2005</year><volume>71</volume><issue>12</issue><fpage>8764</fpage><lpage>8772</lpage><pub-id pub-id-type=""doi"">10.1128/AEM.71.12.8764-8772.2005</pub-id><pub-id pub-id-type=""pmid"">16332872</pub-id></mixed-citation></ref><ref id=""B42""><mixed-citation publication-type=""journal""><name><surname>Handa-Miya</surname><given-names>S</given-names></name><name><surname>Kimura</surname><given-names>B</given-names></name><name><surname>Takahashi</surname><given-names>H</given-names></name><name><surname>Sato</surname><given-names>M</given-names></name><name><surname>Ishikawa</surname><given-names>T</given-names></name><name><surname>Igarashi</surname><given-names>K</given-names></name><name><surname>Fujii</surname><given-names>T</given-names></name><article-title>Nonsense-mutated<italic>inlA</italic>and<italic>prfA</italic>not widely distributed in<italic>Listeria monocytogenes</italic>isolates from ready-to-eat seafood products in Japan</article-title><source>Int J Food Microbiol</source><year>2007</year><volume>117</volume><issue>3</issue><fpage>312</fpage><lpage>318</lpage><pub-id pub-id-type=""doi"">10.1016/j.ijfoodmicro.2007.05.003</pub-id><pub-id pub-id-type=""pmid"">17566579</pub-id></mixed-citation></ref><ref id=""B43""><mixed-citation publication-type=""journal""><name><surname>Orsi</surname><given-names>RH</given-names></name><name><surname>Ripoll</surname><given-names>DR</given-names></name><name><surname>Yeung</surname><given-names>M</given-names></name><name><surname>Nightingale</surname><given-names>KK</given-names></name><name><surname>Wiedmann</surname><given-names>M</given-names></name><article-title>Recombination and positive selection contribute to evolution of<italic>Listeria monocytogenes inlA</italic></article-title><source>Microbiology</source><year>2007</year><volume>153</volume><issue>Pt 8</issue><fpage>2666</fpage><lpage>2678</lpage><pub-id pub-id-type=""doi"">10.1099/mic.0.2007/007310-0</pub-id><pub-id pub-id-type=""pmid"">17660431</pub-id></mixed-citation></ref><ref id=""B44""><mixed-citation publication-type=""journal""><name><surname>Jia</surname><given-names>Y</given-names></name><name><surname>Nightingale</surname><given-names>KK</given-names></name><name><surname>Boor</surname><given-names>KJ</given-names></name><name><surname>Ho</surname><given-names>A</given-names></name><name><surname>Wiedmann</surname><given-names>M</given-names></name><name><surname>McGann</surname><given-names>P</given-names></name><article-title>Distribution of internalin gene profiles of<italic>Listeria monocytogenes</italic>isolates from different sources associated with phylogenetic lineages</article-title><source>Foodborne Pathog Dis</source><year>2007</year><volume>4</volume><issue>2</issue><fpage>222</fpage><lpage>232</lpage><pub-id pub-id-type=""doi"">10.1089/fpd.2006.0081</pub-id><pub-id pub-id-type=""pmid"">17600490</pub-id></mixed-citation></ref><ref id=""B45""><mixed-citation publication-type=""journal""><name><surname>Orsi</surname><given-names>RH</given-names></name><name><surname>Maron</surname><given-names>SB</given-names></name><name><surname>Nightingale</surname><given-names>KK</given-names></name><name><surname>Jerome</surname><given-names>M</given-names></name><name><surname>Tabor</surname><given-names>H</given-names></name><name><surname>Wiedmann</surname><given-names>M</given-names></name><article-title>Lineage specific recombination and positive selection in coding and intragenic regions contributed to evolution of the main<italic>Listeria monocytogenes</italic>virulence gene cluster</article-title><source>Infect Genet Evol</source><year>2008</year><volume>8</volume><issue>5</issue><fpage>566</fpage><lpage>576</lpage><pub-id pub-id-type=""doi"">10.1016/j.meegid.2008.04.006</pub-id><pub-id pub-id-type=""pmid"">18499533</pub-id></mixed-citation></ref><ref id=""B46""><mixed-citation publication-type=""journal""><name><surname>Dussurget</surname><given-names>O</given-names></name><name><surname>Cabanes</surname><given-names>D</given-names></name><name><surname>Dehoux</surname><given-names>P</given-names></name><name><surname>Lecuit</surname><given-names>M</given-names></name><name><surname>Buchrieser</surname><given-names>C</given-names></name><name><surname>Glaser</surname><given-names>P</given-names></name><name><surname>Cossart</surname><given-names>P</given-names></name><collab>European Listeria Genome Consortium</collab><article-title><italic>Listeria monocytogenes</italic>bile salt hydrolase is a PrfA-regulated virulence factor involved in the intestinal and hepatic phases of listeriosis</article-title><source>Mol Microbiol</source><year>2002</year><volume>45</volume><issue>4</issue><fpage>1095</fpage><lpage>1106</lpage><pub-id pub-id-type=""doi"">10.1046/j.1365-2958.2002.03080.x</pub-id><pub-id pub-id-type=""pmid"">12180927</pub-id></mixed-citation></ref><ref id=""B47""><mixed-citation publication-type=""journal""><name><surname>Chico-Calero</surname><given-names>I</given-names></name><name><surname>Suarez</surname><given-names>M</given-names></name><name><surname>Gonzalez-Zorn</surname><given-names>B</given-names></name><name><surname>Scortti</surname><given-names>M</given-names></name><name><surname>Slaghuis</surname><given-names>J</given-names></name><name><surname>Goebel</surname><given-names>W</given-names></name><name><surname>Vazquez-Boland</surname><given-names>JA</given-names></name><collab>European Listeria Genome Consortium</collab><article-title>Hpt, a bacterial homolog of the microsomal glucose-6-phosphate translocase, mediates rapid intracellular proliferation in<italic>Listeria</italic></article-title><source>Proc Natl Acad Sci USA</source><year>2002</year><volume>99</volume><issue>1</issue><fpage>431</fpage><lpage>436</lpage><pub-id pub-id-type=""doi"">10.1073/pnas.012363899</pub-id><pub-id pub-id-type=""pmid"">11756655</pub-id></mixed-citation></ref><ref id=""B48""><mixed-citation publication-type=""journal""><name><surname>Cotter</surname><given-names>PD</given-names></name><name><surname>Draper</surname><given-names>LA</given-names></name><name><surname>Lawton</surname><given-names>EM</given-names></name><name><surname>Daly</surname><given-names>KM</given-names></name><name><surname>Groeger</surname><given-names>DS</given-names></name><name><surname>Casey</surname><given-names>PG</given-names></name><name><surname>Ross</surname><given-names>RP</given-names></name><name><surname>Hill</surname><given-names>C</given-names></name><article-title>Listeriolysin S, a novel peptide haemolysin associated with a subset of lineage I<italic>Listeria monocytogenes</italic></article-title><source>PLoS Pathog</source><year>2008</year><volume>4</volume><issue>9</issue><fpage>e1000144</fpage><pub-id pub-id-type=""doi"">10.1371/journal.ppat.1000144</pub-id><pub-id pub-id-type=""pmid"">18787690</pub-id></mixed-citation></ref><ref id=""B49""><mixed-citation publication-type=""journal""><name><surname>Pundhir</surname><given-names>S</given-names></name><name><surname>Vijayvargiya</surname><given-names>H</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><article-title>PredictBias: a server for the identification of genomic and pathogenicity islands in prokaryotes</article-title><source>In Silico Biol</source><year>2008</year><volume>8</volume><issue>3-4</issue><fpage>223</fpage><lpage>234</lpage><pub-id pub-id-type=""pmid"">19032158</pub-id></mixed-citation></ref><ref id=""B50""><mixed-citation publication-type=""journal""><name><surname>Grynberg</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Szczurek</surname><given-names>E</given-names></name><name><surname>Godzik</surname><given-names>A</given-names></name><article-title>Putative type IV secretion genes in<italic>Bacillus anthracis</italic></article-title><source>Trends Microbiol</source><year>2007</year><volume>15</volume><issue>5</issue><fpage>191</fpage><lpage>195</lpage><pub-id pub-id-type=""doi"">10.1016/j.tim.2007.03.002</pub-id><pub-id pub-id-type=""pmid"">17387016</pub-id></mixed-citation></ref><ref id=""B51""><mixed-citation publication-type=""journal""><name><surname>Auwera</surname><given-names>GA Van der</given-names></name><name><surname>Andrup</surname><given-names>L</given-names></name><name><surname>Mahillon</surname><given-names>J</given-names></name><article-title>Conjugative plasmid pAW63 brings new insights into the genesis of the<italic>Bacillus anthracis</italic>virulence plasmid pXO2 and of the<italic>Bacillus thuringiensis</italic>plasmid pBT9727</article-title><source>BMC Genomics</source><year>2005</year><volume>6</volume><fpage>103</fpage><pub-id pub-id-type=""doi"">10.1186/1471-2164-6-103</pub-id><pub-id pub-id-type=""pmid"">16042811</pub-id></mixed-citation></ref><ref id=""B52""><mixed-citation publication-type=""journal""><name><surname>Auwera</surname><given-names>GA Van der</given-names></name><name><surname>Timmery</surname><given-names>S</given-names></name><name><surname>Mahillon</surname><given-names>J</given-names></name><article-title>Self-transfer and mobilisation capabilities of the pXO2-like plasmid pBT9727 from<italic>Bacillus thuringiensis</italic>subsp. konkukian 97-27</article-title><source>Plasmid</source><year>2008</year><volume>59</volume><issue>2</issue><fpage>134</fpage><lpage>138</lpage><pub-id pub-id-type=""doi"">10.1016/j.plasmid.2007.11.007</pub-id><pub-id pub-id-type=""pmid"">18272219</pub-id></mixed-citation></ref><ref id=""B53""><mixed-citation publication-type=""journal""><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Manias</surname><given-names>D</given-names></name><name><surname>Yeo</surname><given-names>HJ</given-names></name><name><surname>Dunny</surname><given-names>GM</given-names></name><name><surname>Christie</surname><given-names>PJ</given-names></name><article-title><italic>Enterococcus faecalis</italic>PcfC, a spatially localized substrate receptor for type IV secretion of the pCF10 transfer intermediate</article-title><source>J Bacteriol</source><year>2008</year><volume>190</volume><issue>10</issue><fpage>3632</fpage><lpage>3645</lpage><pub-id pub-id-type=""doi"">10.1128/JB.01999-07</pub-id><pub-id pub-id-type=""pmid"">18326569</pub-id></mixed-citation></ref><ref id=""B54""><mixed-citation publication-type=""journal""><name><surname>Schmid</surname><given-names>M</given-names></name><name><surname>Walcher</surname><given-names>M</given-names></name><name><surname>Bubert</surname><given-names>A</given-names></name><name><surname>Wagner</surname><given-names>M</given-names></name><name><surname>Wagner</surname><given-names>M</given-names></name><name><surname>Schleifer</surname><given-names>KH</given-names></name><article-title>Nucleic acid-based, cultivation-independent detection of<italic>Listeria</italic>spp and genotypes of<italic>L monocytogenes</italic></article-title><source>FEMS Immunol Med Microbiol</source><year>2003</year><volume>35</volume><issue>3</issue><fpage>215</fpage><lpage>225</lpage><pub-id pub-id-type=""doi"">10.1016/S0928-8244(02)00456-X</pub-id><pub-id pub-id-type=""pmid"">12648840</pub-id></mixed-citation></ref><ref id=""B55""><mixed-citation publication-type=""journal""><name><surname>Mittl</surname><given-names>PR</given-names></name><name><surname>Schneider-Brachert</surname><given-names>W</given-names></name><article-title>Sel1-like repeat proteins in signal transduction</article-title><source>Cell Signal</source><year>2007</year><volume>19</volume><issue>1</issue><fpage>20</fpage><lpage>31</lpage><pub-id pub-id-type=""doi"">10.1016/j.cellsig.2006.05.034</pub-id><pub-id pub-id-type=""pmid"">16870393</pub-id></mixed-citation></ref><ref id=""B56""><mixed-citation publication-type=""journal""><name><surname>Newton</surname><given-names>HJ</given-names></name><name><surname>Sansom</surname><given-names>FM</given-names></name><name><surname>Dao</surname><given-names>J</given-names></name><name><surname>McAlister</surname><given-names>AD</given-names></name><name><surname>Sloan</surname><given-names>J</given-names></name><name><surname>Cianciotto</surname><given-names>NP</given-names></name><name><surname>Hartland</surname><given-names>EL</given-names></name><article-title>Sel1 repeat protein LpnE is a<italic>Legionella pneumophila</italic>virulence determinant that influences vacuolar trafficking</article-title><source>Infect Immun</source><year>2007</year><volume>75</volume><issue>12</issue><fpage>5575</fpage><lpage>5585</lpage><pub-id pub-id-type=""doi"">10.1128/IAI.00443-07</pub-id><pub-id pub-id-type=""pmid"">17893138</pub-id></mixed-citation></ref><ref id=""B57""><mixed-citation publication-type=""journal""><name><surname>Cirillo</surname><given-names>SL</given-names></name><name><surname>Lum</surname><given-names>J</given-names></name><name><surname>Cirillo</surname><given-names>JD</given-names></name><article-title>Identification of novel loci involved in entry by<italic>Legionella pneumophila</italic></article-title><source>Microbiology</source><year>2000</year><volume>146</volume><issue>Pt 6</issue><fpage>1345</fpage><lpage>1359</lpage><pub-id pub-id-type=""pmid"">10846213</pub-id></mixed-citation></ref><ref id=""B58""><mixed-citation publication-type=""journal""><name><surname>Pornillos</surname><given-names>O</given-names></name><name><surname>Chen</surname><given-names>YJ</given-names></name><name><surname>Chen</surname><given-names>AP</given-names></name><name><surname>Chang</surname><given-names>G</given-names></name><article-title>X-ray structure of the EmrE multidrug transporter in complex with a substrate</article-title><source>Science</source><year>2005</year><volume>310</volume><issue>5756</issue><fpage>1950</fpage><lpage>1953</lpage><pub-id pub-id-type=""doi"">10.1126/science.1119776</pub-id><pub-id pub-id-type=""pmid"">16373573</pub-id></mixed-citation></ref><ref id=""B59""><mixed-citation publication-type=""journal""><name><surname>Brooks</surname><given-names>BE</given-names></name><name><surname>Buchanan</surname><given-names>SK</given-names></name><article-title>Signaling mechanisms for activation of extracytoplasmic function (ECF) sigma factors</article-title><source>Biochim Biophys Acta</source><year>2008</year><volume>1778</volume><issue>9</issue><fpage>1930</fpage><lpage>1945</lpage><pub-id pub-id-type=""doi"">10.1016/j.bbamem.2007.06.005</pub-id><pub-id pub-id-type=""pmid"">17673165</pub-id></mixed-citation></ref><ref id=""B60""><mixed-citation publication-type=""book""><name><surname>Seeliger</surname><given-names>HPR</given-names></name><name><surname>Höhne</surname><given-names>K</given-names></name><person-group person-group-type=""editor"">Bergen T, Norris JR</person-group><article-title>Serotyping of<italic>Listeria monocytogenes</italic>and related species</article-title><source>Methods in Microbiology</source><year>1979</year><volume>13</volume><publisher-name>London: Academic Press</publisher-name><fpage>31</fpage><comment>full_text</comment></mixed-citation></ref><ref id=""B61""><mixed-citation publication-type=""journal""><name><surname>Doumith</surname><given-names>M</given-names></name><name><surname>Buchrieser</surname><given-names>C</given-names></name><name><surname>Glaser</surname><given-names>P</given-names></name><name><surname>Jacquet</surname><given-names>C</given-names></name><name><surname>Martin</surname><given-names>P</given-names></name><article-title>Differentiation of the major<italic>Listeria monocytogenes</italic>serovars by multiplex PCR</article-title><source>J Clin Microbiol</source><year>2004</year><volume>42</volume><issue>8</issue><fpage>3819</fpage><lpage>3822</lpage><pub-id pub-id-type=""doi"">10.1128/JCM.42.8.3819-3822.2004</pub-id><pub-id pub-id-type=""pmid"">15297538</pub-id></mixed-citation></ref><ref id=""B62""><mixed-citation publication-type=""journal""><name><surname>Staden</surname><given-names>R</given-names></name><name><surname>Beal</surname><given-names>KF</given-names></name><name><surname>Bonfield</surname><given-names>JK</given-names></name><article-title>The Staden package, 1998</article-title><source>Methods Mol Biol</source><year>2000</year><volume>132</volume><fpage>115</fpage><lpage>130</lpage><pub-id pub-id-type=""pmid"">10547834</pub-id></mixed-citation></ref><ref id=""B63""><mixed-citation publication-type=""journal""><name><surname>Meyer</surname><given-names>F</given-names></name><name><surname>Goesmann</surname><given-names>A</given-names></name><name><surname>McHardy</surname><given-names>AC</given-names></name><name><surname>Bartels</surname><given-names>D</given-names></name><name><surname>Bekel</surname><given-names>T</given-names></name><name><surname>Clausen</surname><given-names>J</given-names></name><name><surname>Kalinowski</surname><given-names>J</given-names></name><name><surname>Linke</surname><given-names>B</given-names></name><name><surname>Rupp</surname><given-names>O</given-names></name><name><surname>Giegerich</surname><given-names>R</given-names></name><name><surname>Puhler</surname><given-names>A</given-names></name><article-title>GenDB--an open source genome annotation system for prokaryote genomes</article-title><source>Nucleic Acids Res</source><year>2003</year><volume>31</volume><issue>8</issue><fpage>2187</fpage><lpage>2195</lpage><pub-id pub-id-type=""doi"">10.1093/nar/gkg312</pub-id><pub-id pub-id-type=""pmid"">12682369</pub-id></mixed-citation></ref><ref id=""B64""><mixed-citation publication-type=""other""><name><surname>Van Domselaar</surname><given-names>GH</given-names></name><name><surname>Stothard</surname><given-names>P</given-names></name><name><surname>Shrivastava</surname><given-names>S</given-names></name><name><surname>Cruz</surname><given-names>JA</given-names></name><name><surname>Guo</surname><given-names>A</given-names></name><name><surname>Dong</surname><given-names>X</given-names></name><name><surname>Lu</surname><given-names>P</given-names></name><name><surname>Szafron</surname><given-names>D</given-names></name><name><surname>Greiner</surname><given-names>R</given-names></name><name><surname>Wishart</surname><given-names>DS</given-names></name><article-title>BASys: a web server for automated bacterial genome annotation</article-title><source>Nucleic Acids Res</source><year>2005</year><issue>33 Web Server</issue><fpage>W455</fpage><lpage>9</lpage><pub-id pub-id-type=""doi"">10.1093/nar/gki593</pub-id><pub-id pub-id-type=""pmid"">15980511</pub-id></mixed-citation></ref><ref id=""B65""><mixed-citation publication-type=""journal""><name><surname>Delcher</surname><given-names>AL</given-names></name><name><surname>Bratke</surname><given-names>KA</given-names></name><name><surname>Powers</surname><given-names>EC</given-names></name><name><surname>Salzberg</surname><given-names>SL</given-names></name><article-title>Identifying bacterial genes and endosymbiont DNA with Glimmer</article-title><source>Bioinformatics</source><year>2007</year><volume>23</volume><issue>6</issue><fpage>673</fpage><lpage>679</lpage><pub-id pub-id-type=""doi"">10.1093/bioinformatics/btm009</pub-id><pub-id pub-id-type=""pmid"">17237039</pub-id></mixed-citation></ref><ref id=""B66""><mixed-citation publication-type=""journal""><name><surname>Lagesen</surname><given-names>K</given-names></name><name><surname>Hallin</surname><given-names>P</given-names></name><name><surname>Rodland</surname><given-names>EA</given-names></name><name><surname>Staerfeldt</surname><given-names>HH</given-names></name><name><surname>Rognes</surname><given-names>T</given-names></name><name><surname>Ussery</surname><given-names>DW</given-names></name><article-title>RNAmmer: consistent and rapid annotation of ribosomal RNA genes</article-title><source>Nucleic Acids Res</source><year>2007</year><volume>35</volume><issue>9</issue><fpage>3100</fpage><lpage>3108</lpage><pub-id pub-id-type=""doi"">10.1093/nar/gkm160</pub-id><pub-id pub-id-type=""pmid"">17452365</pub-id></mixed-citation></ref><ref id=""B67""><mixed-citation publication-type=""journal""><name><surname>Lowe</surname><given-names>TM</given-names></name><name><surname>Eddy</surname><given-names>SR</given-names></name><article-title>tRNAscan-SE: a program for improved detection of transfer RNA genes in genomic sequence</article-title><source>Nucleic Acids Res</source><year>1997</year><volume>25</volume><issue>5</issue><fpage>955</fpage><lpage>964</lpage><pub-id pub-id-type=""doi"">10.1093/nar/25.5.955</pub-id><pub-id pub-id-type=""pmid"">9023104</pub-id></mixed-citation></ref><ref id=""B68""><mixed-citation publication-type=""journal""><name><surname>Rutherford</surname><given-names>K</given-names></name><name><surname>Parkhill</surname><given-names>J</given-names></name><name><surname>Crook</surname><given-names>J</given-names></name><name><surname>Horsnell</surname><given-names>T</given-names></name><name><surname>Rice</surname><given-names>P</given-names></name><name><surname>Rajandream</surname><given-names>MA</given-names></name><name><surname>Barrell</surname><given-names>B</given-names></name><article-title>Artemis: sequence visualization and annotation</article-title><source>Bioinformatics</source><year>2000</year><volume>16</volume><issue>10</issue><fpage>944</fpage><lpage>945</lpage><pub-id pub-id-type=""doi"">10.1093/bioinformatics/16.10.944</pub-id><pub-id pub-id-type=""pmid"">11120685</pub-id></mixed-citation></ref><ref id=""B69""><mixed-citation publication-type=""journal""><name><surname>Darling</surname><given-names>AC</given-names></name><name><surname>Mau</surname><given-names>B</given-names></name><name><surname>Blattner</surname><given-names>FR</given-names></name><name><surname>Perna</surname><given-names>NT</given-names></name><article-title>Mauve: multiple alignment of conserved genomic sequence with rearrangements</article-title><source>Genome Res</source><year>2004</year><volume>14</volume><issue>7</issue><fpage>1394</fpage><lpage>1403</lpage><pub-id pub-id-type=""doi"">10.1101/gr.2289704</pub-id><pub-id pub-id-type=""pmid"">15231754</pub-id></mixed-citation></ref><ref id=""B70""><mixed-citation publication-type=""journal""><name><surname>Larkin</surname><given-names>MA</given-names></name><name><surname>Blackshields</surname><given-names>G</given-names></name><name><surname>Brown</surname><given-names>NP</given-names></name><name><surname>Chenna</surname><given-names>R</given-names></name><name><surname>McGettigan</surname><given-names>PA</given-names></name><name><surname>McWilliam</surname><given-names>H</given-names></name><name><surname>Valentin</surname><given-names>F</given-names></name><name><surname>Wallace</surname><given-names>IM</given-names></name><name><surname>Wilm</surname><given-names>A</given-names></name><name><surname>Lopez</surname><given-names>R</given-names></name><name><surname>Thompson</surname><given-names>JD</given-names></name><name><surname>Gibson</surname><given-names>TJ</given-names></name><name><surname>Higgins</surname><given-names>DG</given-names></name><article-title>Clustal W and Clustal X version 2.0</article-title><source>Bioinformatics</source><year>2007</year><volume>23</volume><issue>21</issue><fpage>2947</fpage><lpage>2948</lpage><pub-id pub-id-type=""doi"">10.1093/bioinformatics/btm404</pub-id><pub-id pub-id-type=""pmid"">17846036</pub-id></mixed-citation></ref><ref id=""B71""><mixed-citation publication-type=""other""><name><surname>Jaroszewski</surname><given-names>L</given-names></name><name><surname>Rychlewski</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Godzik</surname><given-names>A</given-names></name><article-title>FFAS03: a server for profile--profile sequence alignments</article-title><source>Nucleic Acids Res</source><year>2005</year><issue>33 Web Server</issue><fpage>W284</fpage><lpage>8</lpage><pub-id pub-id-type=""doi"">10.1093/nar/gki418</pub-id><pub-id pub-id-type=""pmid"">15980471</pub-id></mixed-citation></ref><ref id=""B72""><mixed-citation publication-type=""journal""><name><surname>Kurtz</surname><given-names>S</given-names></name><name><surname>Phillippy</surname><given-names>A</given-names></name><name><surname>Delcher</surname><given-names>AL</given-names></name><name><surname>Smoot</surname><given-names>M</given-names></name><name><surname>Shumway</surname><given-names>M</given-names></name><name><surname>Antonescu</surname><given-names>C</given-names></name><name><surname>Salzberg</surname><given-names>SL</given-names></name><article-title>Versatile and open software for comparing large genomes</article-title><source>Genome Biol</source><year>2004</year><volume>5</volume><issue>2</issue><fpage>R12</fpage><pub-id pub-id-type=""doi"">10.1186/gb-2004-5-2-r12</pub-id><pub-id pub-id-type=""pmid"">14759262</pub-id></mixed-citation></ref><ref id=""B73""><mixed-citation publication-type=""journal""><name><surname>Carver</surname><given-names>T</given-names></name><name><surname>Thomson</surname><given-names>N</given-names></name><name><surname>Bleasby</surname><given-names>A</given-names></name><name><surname>Berriman</surname><given-names>M</given-names></name><name><surname>Parkhill</surname><given-names>J</given-names></name><article-title>DNAPlotter: circular and linear interactive genome visualization</article-title><source>Bioinformatics</source><year>2009</year><volume>25</volume><issue>1</issue><fpage>119</fpage><lpage>120</lpage><pub-id pub-id-type=""doi"">10.1093/bioinformatics/btn578</pub-id><pub-id pub-id-type=""pmid"">18990721</pub-id></mixed-citation></ref></ref-list>"
10.1084/jem.20020881	"<html><body><article article-type=""research-article"" xmlns:xlink=""http://www.w3.org/1999/xlink""><?properties open_access?><front><journal-meta><journal-id journal-id-type=""nlm-ta"">J Exp Med</journal-id><journal-title>The Journal of Experimental Medicine</journal-title><issn pub-type=""ppub"">0022-1007</issn><issn pub-type=""epub"">1540-9538</issn><publisher><publisher-name>The Rockefeller University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type=""pmid"">12438421</article-id><article-id pub-id-type=""pmc"">2193982</article-id><article-id pub-id-type=""publisher-id"">20020881</article-id><article-id pub-id-type=""doi"">10.1084/jem.20020881</article-id><article-categories><subj-group subj-group-type=""heading""><subject>Article</subject></subj-group></article-categories><title-group><article-title>Silencing of B Cell Receptor Signals in Human Naive B Cells</article-title></title-group><contrib-group><contrib contrib-type=""author""><name><surname>Feldhahn</surname><given-names>Niklas</given-names></name><xref ref-type=""aff"" rid=""aff1"">1</xref><xref ref-type=""aff"" rid=""aff2"">2</xref></contrib><contrib contrib-type=""author""><name><surname>Schwering</surname><given-names>Ines</given-names></name><xref ref-type=""aff"" rid=""aff2"">2</xref></contrib><contrib contrib-type=""author""><name><surname>Lee</surname><given-names>Sanggyu</given-names></name><xref ref-type=""aff"" rid=""aff4"">4</xref></contrib><contrib contrib-type=""author""><name><surname>Wartenberg</surname><given-names>Maria</given-names></name><xref ref-type=""aff"" rid=""aff3"">3</xref></contrib><contrib contrib-type=""author""><name><surname>Klein</surname><given-names>Florian</given-names></name><xref ref-type=""aff"" rid=""aff1"">1</xref><xref ref-type=""aff"" rid=""aff2"">2</xref></contrib><contrib contrib-type=""author""><name><surname>Wang</surname><given-names>Hui</given-names></name><xref ref-type=""aff"" rid=""aff1"">1</xref><xref ref-type=""aff"" rid=""aff2"">2</xref></contrib><contrib contrib-type=""author""><name><surname>Zhou</surname><given-names>Guolin</given-names></name><xref ref-type=""aff"" rid=""aff4"">4</xref></contrib><contrib contrib-type=""author""><name><surname>Wang</surname><given-names>San Ming</given-names></name><xref ref-type=""aff"" rid=""aff4"">4</xref></contrib><contrib contrib-type=""author""><name><surname>Rowley</surname><given-names>Janet D.</given-names></name><xref ref-type=""aff"" rid=""aff4"">4</xref></contrib><contrib contrib-type=""author""><name><surname>Hescheler</surname><given-names>Jürgen</given-names></name><xref ref-type=""aff"" rid=""aff3"">3</xref></contrib><contrib contrib-type=""author""><name><surname>Krönke</surname><given-names>Martin</given-names></name><xref ref-type=""aff"" rid=""aff1"">1</xref></contrib><contrib contrib-type=""author""><name><surname>Rajewsky</surname><given-names>Klaus</given-names></name><xref ref-type=""aff"" rid=""aff5"">5</xref></contrib><contrib contrib-type=""author""><name><surname>Küppers</surname><given-names>Ralf</given-names></name><xref ref-type=""aff"" rid=""aff2"">2</xref></contrib><contrib contrib-type=""author""><name><surname>Müschen</surname><given-names>Markus</given-names></name><xref ref-type=""aff"" rid=""aff1"">1</xref><xref ref-type=""aff"" rid=""aff2"">2</xref></contrib></contrib-group><aff id=""aff1""><label>1</label>Institute for Medical Microbiology, Immunology and Hygiene</aff><aff id=""aff2""><label>2</label>Institute for Genetics, University of Cologne, 50931 Köln, Germany</aff><aff id=""aff3""><label>3</label>Institute for Neurophysiology, University of Cologne, 50931 Köln, Germany</aff><aff id=""aff4""><label>4</label>Department of Medicine, University of Chicago, Chicago, IL 60637</aff><aff id=""aff5""><label>5</label>Center for Blood Research, Harvard Medical School, Boston, MA 02115</aff><author-notes><fn><p>Address correspondence to Dr. Markus Müschen, Emmy-Noether-Group at the Institute for Genetics, University of Cologne, Room III.10, Weyertal 121, 50931 Köln, Germany. Phone: 49-221-470-3408; Fax: 49-221-470-5170; E-mail:<email>markus.mueschen@uni-koeln.de</email></p></fn></author-notes><pub-date pub-type=""ppub""><day>18</day><month>11</month><year>2002</year></pub-date><volume>196</volume><issue>10</issue><fpage>1291</fpage><lpage>1305</lpage><history><date date-type=""received""><day>30</day><month>5</month><year>2002</year></date><date date-type=""rev-recd""><day>12</day><month>8</month><year>2002</year></date><date date-type=""accepted""><day>13</day><month>9</month><year>2002</year></date></history><permissions><copyright-statement>Copyright © 2002, The Rockefeller University Press</copyright-statement></permissions><abstract><p>To identify changes in the regulation of B cell receptor (BCR) signals during the development of human B cells, we generated genome-wide gene expression profiles using the serial analysis of gene expression (SAGE) technique for CD34<sup>+</sup>hematopoietic stem cells (HSCs), pre-B cells, naive, germinal center (GC), and memory B cells. Comparing these SAGE profiles, genes encoding positive regulators of BCR signaling were expressed at consistently lower levels in naive B cells than in all other B cell subsets. Conversely, a large group of inhibitory signaling molecules, mostly belonging to the immunoglobulin superfamily (IgSF), were specifically or predominantly expressed in naive B cells. The quantitative differences observed by SAGE were corroborated by semiquantitative reverse transcription–polymerase chain reaction (RT-PCR) and flow cytometry. In a functional assay, we show that down-regulation of inhibitory IgSF receptors and increased responsiveness to BCR stimulation in memory as compared with naive B cells at least partly results from interleukin (IL)-4 receptor signaling. Conversely, activation or impairment of the inhibitory IgSF receptor<italic>LIRB1</italic>affected BCR-dependent Ca<sup>2+</sup>mobilization only in naive but not memory B cells. Thus,<italic>LIRB1</italic>and<italic>IL-4</italic>may represent components of two nonoverlapping gene expression programs in naive and memory B cells, respectively: in naive B cells, a large group of inhibitory IgSF receptors can elevate the BCR signaling threshold to prevent these cells from premature activation and clonal expansion before GC-dependent affinity maturation. In memory B cells, facilitated responsiveness upon reencounter of the immunizing antigen may result from amplification of BCR signals at virtually all levels of signal transduction.</p></abstract><kwd-group><kwd>B cell receptor</kwd><kwd>IL-4</kwd><kwd>ITIM</kwd><kwd>memory B cells</kwd><kwd>SAGE</kwd></kwd-group></article-meta></front><sec><title>Introduction</title><p>Signal transduction pathways initiated through the B cell receptor (BCR)<xref ref-type=""fn"" rid=""fn1"">*</xref>determine the fate of B cells within a context of BCR-affinity to antigen, expression levels of stimulatory or inhibitory coreceptors and the differentiation stage of B cells (<xref ref-type=""bibr"" rid=""bib1"">1</xref>). Whereas BCR engagement by self-antigen in immature bone marrow B cells induces receptor editing, deletion, or inactivation (anergy), BCR cross-linking in mature B cells initiates a signaling cascade that ultimately confers positive selection, proliferation, and differentiation.</p><p>Early B cell differentiation is defined by a sequence of Ig gene rearrangements determining the configuration of the (pre)-BCR. The recombination machinery first targets<italic>D</italic><sub>H</sub>and<italic>J</italic><sub>H</sub>gene segments at the pro-B cell stage followed by<italic>V</italic><sub>H</sub>-D<sub>H</sub>J<sub>H</sub>gene rearrangement in pre-B cells, which subsequently express a pre-BCR, composed of Ig heavy and surrogate light chains, on their cell surface. Expression of<italic>Vpre-B</italic>and<italic>λ-5</italic>surrogate light chain genes precedes the expression of<italic>V</italic>κ<italic>-J</italic>κ or<italic>V</italic>λ<italic>-J</italic>λ light chain gene rearrangements at the immature B cell stage, at which, for the first time, a BCR is expressed and the cells enter the peripheral blood as naive B cells. The specificity and structure of the BCR is further modified by somatic hypermutation and class switch recombination during the affinity maturation process within germinal centers (GCs), in which GC B cells are destined to die by apoptosis unless they are rescued through BCR-dependent survival signals upon antigen cross-linking. GC B cells expressing a BCR of high affinity to their cognate antigen subsequently differentiate into memory B cells or antibody-secreting plasma cells. Notably, signaling through the BCR not only determines the fate of a B cell at developmental checkpoints within the bone marrow and in GCs. Also mature B cells depend on the presence of a functional BCR, which continuously delivers a “maintenance” signal (<xref ref-type=""bibr"" rid=""bib2"">2</xref>).</p><p>The BCR signaling cascade is initiated by rapid phosphorylation of tyrosine residues in the immunoreceptor tyrosine-based activation motifs (ITAMs) of the BCR coreceptors Igα and Igβ upon antigen cross-linking. The proximal signal transduction mainly involves three different protein tyrosine kinase (PTK) activities including src-family PTKs,<italic>SYK</italic>, and<italic>BTK</italic>(<xref ref-type=""bibr"" rid=""bib3"">3</xref>). In addition to kinases, several phosphatases (SHP1, SHP2, CD45, SHIP) and linker proteins (BLNK, GRB2, SHC, NCK) also regulate BCR signal transduction. BLNK was recently shown to act as a scaffolding protein, which mediates the interaction between SYK and the downstream signaling molecules VAV (<xref ref-type=""bibr"" rid=""bib4"">4</xref>) and PLCγ. The latter can hydrolyse PIP2 to IP3 and diacylglycerol, which increases the levels of free cytoplasmic Ca<sup>2+</sup>and result in subsequent protein kinase C (PKC) and mitogen-activated protein (MAP) kinase activation, which ultimately initiates functional B cell responses including proliferation, isotype switching and antibody secretion. However, the downstream propagation of activation signals may be attenuated by inhibitory receptor molecules bearing one or more immunoreceptor tyrosine-based inhibitory motifs (ITIMs). Many of these inhibitory receptors belong to the Ig superfamily (IgSF), which includes surface molecules such as CD5, CD22, and FcγRII/ CD32 (<xref ref-type=""bibr"" rid=""bib5"">5</xref>).</p><p>To identify changes in the regulation of BCR-dependent activation signals at checkpoints during normal human B cell development, we analyzed and compared genome-wide gene expression profiles from human bone marrow hematopoietic stem cell (HSC), bone marrow pre-B cells, naive B cells, GC B cells, and memory B cells. These gene expression profiles were generated using the serial analysis of gene expression (SAGE) technique, which allows for the genome-wide quantitative analysis of any expressed mRNA in a given cell population (<xref ref-type=""bibr"" rid=""bib6"">6</xref>).</p></sec><sec sec-type=""materials|methods""><title>Materials and Methods</title><sec><title>Isolation of Human Hematopoietic Stem Cells, Pre-B Cells, and Mature B Cell Subsets.</title><p>HSCs and pre-B cells were purified from bone marrow and umbilical cord blood. Purification of bone marrow CD34<sup>+</sup>HSC was described (<xref ref-type=""bibr"" rid=""bib7"">7</xref>). Cord blood HSC were isolated using anti-CD34 immunomagnetic beads (Miltenyi Biotec). For enrichment of pre-B cells, mononuclear cells were isolated from four bone marrow samples (Poietics) and from 28 umbilical cord blood samples (according to the principle of informed consent) by Ficoll density gradient centrifugation. T cells and myeloid cells were depleted using anti-CD3 and anti-CD15 immunomagnetic beads (Dynal). Among the remaining cells, immature CD10<sup>low</sup>CD19<sup>+</sup>CD20<sup>+</sup>B cells and CD138<sup>+</sup>plasma cells were depleted using an anti-CD20 IgG1 antibody (BD Biosciences) together with anti-IgG1 beads and anti-CD138 beads (Miltenyi Biotec), respectively (<xref ref-type=""bibr"" rid=""bib8"">8</xref>). Thereafter, pre-B cells were enriched using anti-CD19 immunomagnetic multisort-beads (Miltenyi Biotec). The beads were released from the CD19<sup>+</sup>cells enzymatically. The purified cells were subsequently labeled by a mouse anti-CD10 IgG1 antibody (CALLA; BD Biosciences) and separated using anti–mouse IgG1 beads (Miltenyi Biotec). IgD<sup>+</sup>CD19<sup>+</sup>CD27<sup>−</sup>naive B cells and CD19<sup>+</sup>CD27<sup>+</sup>memory B cells were isolated from peripheral blood using anti-CD19 and anti-CD27 immunomagnetic beads (Miltenyi Biotec) as described (<xref ref-type=""bibr"" rid=""bib9"">9</xref>) and from seven tonsilectomy specimens. For enrichment of tonsillar memory B cells, CD27<sup>low</sup>CD38<sup>+</sup>GC B cells were depleted using an anti-CD38 PE antibody (BD Biosciences) together with anti-PE microbeads (Miltenyi Biotec). Tonsillar CD77<sup>+</sup>GC B cells were isolated as described previously (<xref ref-type=""bibr"" rid=""bib9"">9</xref>) using a rat anti-CD77 IgM antibody (BD Biosciences) together with a mouse anti–rat IgM IgG1 antibody (Serotec) and anti–mouse IgG1 microbeads (Miltenyi Biotec). Only cell purifications of a purity &gt;90% were included in the SAGE analysis.</p></sec><sec><title>Verification of B Cell Subset Purification.</title><p>The identity of the purified B cell subsets was verified genotypically and phenotypically. The genotype of purified preB cells and mature B cell subsets (naive and memory B cells) was assessed by PCR amplification of rearranged<italic>V</italic><sub>H</sub>1 genes from genomic DNA and subsequent cloning and sequencing of the PCR products as described (<xref ref-type=""bibr"" rid=""bib10"">10</xref>). In addition, the phenotype of the purified HSC, pre-B cells, naive B cells, GC B cells, and memory B cells was assessed by semiquantitative RT-PCR at the mRNA level using<italic>IgH C</italic>μ-,<italic>IgH C</italic>γ<italic>1</italic>-,<italic>Ig C</italic>κ<italic>-</italic>,<italic>Ig C</italic>λ<italic>-</italic>,<italic>VpreB1-</italic>,<italic>λ5-</italic>, and<italic>β2M</italic>-specific primers (Integrated DNA Technologies). To distinguish “mature” from germline Cγ1 transcripts, primers were chosen for a fragment between the J<sub>H</sub>and the hinge region of the constant region (<xref ref-type=""bibr"" rid=""bib11"">11</xref>). The phenotype of purified preB cells was also verified by flow cytometry using CD10- and CD19-specific antibodies for pre-B cells, CD20-, and CD27-specific antibodies for naive and memory B cells, CD38- and CD77-specific antibodies for GC B cells, respectively (FITC- and PE-conjugated antibodies from BD Biosciences).</p></sec><sec><title>SAGE Analysis.</title><p>cDNA-synthesis, SAGE analysis, cloning, and sequencing of SAGE concatemers was performed according to Velculescu et al. (<xref ref-type=""bibr"" rid=""bib6"">6</xref>). The UniGene reference database (March 2001) was obtained at<ext-link ext-link-type=""uri"" xlink:href=""http://www.sagenet.org/SAGEDatabases/unigene.htm"">http://www.sagenet.org/SAGEDatabases/unigene.htm</ext-link>. A total of 306,000 SAGE tags were collected for the five SAGE profiles. 106,000 tags were analyzed from the HSC library, 110,000 for pre-B cells, and each ∼30,000 tags for naive, GC, and memory B cells. All SAGE libraries were normalized to 100,000 tags.</p></sec><sec><title>Controls for the Accuracy of SAGE Library Construction.</title><p>RNA-degradation and incomplete digestion of 3′cDNAs by the so-called tagging enzyme NlaIII may interfere with the quantitative representation of expressed genes in SAGE libraries. RNA degradation within 3′ regions would result in the underrepresentation of genes, whose last NlaIII recognition site (CATG) is particularly far from the poly(dA) tail. The average distance between the last CATG site and the poly(dA) tail is ∼250 bp (<xref ref-type=""bibr"" rid=""bib6"">6</xref>). To search for a potential bias against SAGE tags derived from 5′ sequences, we selected 10 housekeeping genes, whose extreme 3′ CATG site was more than 450 bp distant from the poly(dA) tail. We compared the tag counts for these genes with the tag counts in 55 published SAGE libraries (at<ext-link ext-link-type=""uri"" xlink:href=""http://www.ncbi.nlm.nih.gov/SAGE/index.cgi?cmd=tagsearch"">http://www.ncbi.nlm.nih.gov/SAGE/index.cgi?cmd=tagsearch</ext-link>). In the SAGE libraries described here, tags for these genes were found at frequencies close to the average of 55 reference SAGE libraries, which argues against bias of quantitative representation introduced by RNA degradation.</p><p>Incomplete NlaIII digestion would result in the generation of SAGE tags that are aberrantly derived from upstream CATG sites instead of the extreme 3′ CATG site. To address this issue, we amplified cDNA fragments of the<italic>GAPDH</italic>and<italic>EF1</italic>genes for the SAGE libraries for naive and memory B cells. Primers were chosen so that cleavage by NlaIII would result in the loss of the 5′ primer binding site for<italic>GAPDH</italic>but not for<italic>EF1</italic>. Consistent with high efficiency of NlaIII digestion, either no or only very small amounts of PCR product were obtained for<italic>GAPDH</italic>while amplification of<italic>EF1</italic>fragments yielded abundant amplification products (unpublished data).</p></sec><sec><title>Selection of BCR-related Signaling Molecules.</title><p>In a comprehensive search for positive and negative BCR-related signaling molecules in PubMed, UniGene (<ext-link ext-link-type=""uri"" xlink:href=""http://www.ncbi.nlm.nih.gov/UniGene/"">http://www.ncbi.nlm.nih.gov/UniGene/</ext-link>) and OMIM (<ext-link ext-link-type=""uri"" xlink:href=""http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM"">http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM</ext-link>), we collected 211 genes, for which a role in positive (129) or negative (82) regulation of BCR-dependent signals was shown. Based on their UniGene-ID, 148 (97 positive and 51 inhibitory signaling molecules) of these genes could be retrieved from at least one of the five SAGE libraries.</p></sec><sec><title>Verification of Quantitative Accuracy of SAGE Data.</title><p>To corroborate quantitative differences in gene expression among the five populations as determined by SAGE, semiquantitative RT-PCR analysis was performed for a set of 41 selected genes. For verification of SAGE data, unrelated cDNAs from HSC and pre-B cells purified from umbilical cord blood (see above), naive, and memory B cells from peripheral blood were used as template. To specifically address quantitative differences in the expression of positive and inhibitory BCR signaling molecules in naive and memory B cells, we performed semiquantitative RT-PCR verification for 22 genes implicated in propagation and 19 genes involved in attenuation of BCR signals, respectively. RT-PCR was done for 18, 20, 24, 28, 30, or 32 cycles as indicated and normalized for the<italic>COX6B</italic>gene encoding the cytochrome c oxidase subunit VI and the<italic>β2M</italic>gene encoding β2-microglobulin.</p></sec><sec><title>Effect of mRNA Content per Cell on the Interpretation of SAGE Data.</title><p>For all SAGE profiles, expression levels of genes are given as tags per 100,000. This is based on the assumption that the relative contribution of a gene to the transcriptome of a cell population accurately reflects its expression level. However, an alternative viewpoint would be that gene expression levels should be given as absolute number of transcripts per cell. It is critical in the latter but not in the former case that the overall amounts of mRNA are similar in the cell populations compared by SAGE and semiquantitative RT-PCR. For instance, B lymphoblasts such as centroblasts within GCs may double their size and mRNA content as compared with their resting precursors (<xref ref-type=""bibr"" rid=""bib12"">12</xref>). Thus, up-regulation of positive regulators of BCR signals in blastoid GC as compared with resting naive B cells as observed by SAGE (see<xref ref-type=""fig"" rid=""fig2"">Fig. 2, A and B</xref>) should be even higher if individual cells are analyzed. On the other hand, the quantitative difference of the expression of inhibitory BCR signaling molecules between individual resting naive or blastoid GC B cells would be lower than suggested by SAGE. As for size and mRNA content of memory versus naive B cells no pertinent information was available, total RNA and mRNA was isolated from 10<sup>6</sup>naive and 10<sup>6</sup>memory B cells. OD measurements did not reveal a significant difference between the two populations. In addition, we repeated semiquantitative RT-PCR for five genes for 200 and 1,000 cells, which were sorted into reaction tubes by a FACStar™ 440 cell sorter (BD Biosciences). RNA isolation, cDNA synthesis and PCR amplification was done in two independent experiments. The RT-PCR analysis was performed in 30 (for 200 cells) and 26 (for 1,000 cells) cycles for the<italic>BAM32</italic>,<italic>BLNK</italic>,<italic>SIgLec5</italic>,<italic>LIRB1</italic>, and<italic>COX6B</italic>genes (not shown). The quantitative proportions were similar as in the RT-PCR analysis, which was normalized for equal mRNA amounts (see<xref ref-type=""fig"" rid=""fig3"">Fig. 3</xref>). Thus, mRNA contents in naive versus memory B cells appear to be similar and do not significantly interfere with quantitative accuracy of SAGE- and RT-PCR data.</p></sec><sec><title>Clustering Analysis of SAGE Data.</title><p>For graphic representation of SAGE data, SAGE tags derived from known transcripts were arranged in functional clusters including positive and inhibitory BCR signaling molecules. The SAGE data were sorted based on the ratio of their frequency in memory B cells and naive B cells. For transformation and graphic representation of SAGE tag counts, the Cluster and Treeview software was used (kindly provided by Dr. Michael B. Eisen, Berkeley, CA, at<ext-link ext-link-type=""uri"" xlink:href=""http://rana.lbl.gov/"">http://rana.lbl.gov/</ext-link>).</p></sec><sec><title>Assessment of Expression of BCR Signaling-related Surface Molecules.</title><p>To verify differential expression of molecules related to BCR-signaling in naive and memory B cells at the protein level, we analyzed a panel of 10 positive and 10 negative regulators of BCR signaling by flow cytometry. Therefore, naive and memory B cells were purified from peripheral blood from 12 donors. Anti-CD5 PE, anti-CD19 PE, anti-CD21 PE, anti-CD22 FITC, anti-CD24 FITC, anti-CD31 FITC, anti-CD32/ FcRγII FITC, anti-CD40 PE, anti-CD66 FITC, anti-CD72 FITC, anti-CD74 FITC, anti-CD79a/ Igα PE, anti-LIRB1 FITC, anti-CD100 FITC, anti-CD124/ IL-4R PE, anti-CD130/gp130 PE, anti-CD150/SLAM PE, biotinylated anti-CD153/CD30 ligand, anti-PD1 PE, and streptavidin PE were from BD Biosciences. Goat anti-BCMA IgG and donkey anti–goat IgG FITC are from Santa Cruz Biotechnology, Inc.</p></sec><sec><title>IL-4–dependent Regulation of BCR Signaling-associated Genes in Naive and Memory B Cells.</title><p>Naive and memory B cells were purified from peripheral blood as described above and cultured at 37°C either in RPMI medium (including 10% fetal calf serum) alone, or with 1 ng/ml recombinant human IL-4 (Genzyme) or 50 μg of a neutralizing anti–IL-4Rα antibody (Genzyme)/ml, which was added after 8 h preincubation with IL-4. The cells were cultured at a density of 5 × 10<sup>5</sup>cells/100 μl/well in 96-well plates. After 48 h, the cells were subjected to RNA isolation and subsequent semiquantitative RT-PCR analysis for<italic>COX6</italic>,<italic>BLK</italic>,<italic>BTK</italic>,<italic>BLNK</italic>,<italic>SYK</italic>,<italic>LIRB1</italic>,<italic>LIRB2</italic>,<italic>LIRB5</italic>,<italic>SIgLec5</italic>,<italic>SIgLec8</italic>,<italic>CD66</italic>,<italic>CSK</italic>,<italic>SHIP</italic>, and<italic>SHP1</italic>at 28 cycles and for<italic>LAIR1</italic>at 32 cycles.</p></sec><sec><title>Effect of LIRB1 Signaling on BCR-dependent Ca<sup>2+</sup>Mobilization in Naive and Memory B Cells.</title><p>To address directly how<italic>LIRB1</italic>(an inhibitory IgSF receptor found prominently expressed on naive B cells) can affect responsiveness of the BCR to antigen in naive and memory B cells, BCR-dependent Ca<sup>2+</sup>mobilization was studied. To this end, peripheral blood naive and memory B cells were purified from four healthy donors as described above and cultured in medium, which had been conditioned for 24 h by PBMCs at a density of 10<sup>6</sup>PBMCs/ml. PBMCs were stimulated with 1 μg LPS/ml to induce secretion of soluble MHC class I molecules (<xref ref-type=""bibr"" rid=""bib13"">13</xref>), which act as natural ligand of LIRB1 (<xref ref-type=""bibr"" rid=""bib14"">14</xref>). To study the effect of LIRB1 on BCR signals, naive and memory B cells were cultured for 24 h in the presence or absence of an antagonistic (clone HP-F1; reference 14) or agonistic (clone GVI/ 75; BD Biosciences; reference<xref ref-type=""bibr"" rid=""bib15"">15</xref>) LIRB1 antibody cross-linked by goat anti–mouse IgG serum (Jackson ImmunoResearch Laboratories). HP-F1 was a gift from Dr. Miguel López-Botet, Universitat Pompeu Fabra, Barcelona, Spain. After the preincubation, cells were washed and stained with Fluo-3 dye (Calbiochem) for 30 min. Changes of cytosolic Ca<sup>2+</sup>were measured by laser scans using confocal microscopy (<xref ref-type=""bibr"" rid=""bib16"">16</xref>). After 30 s of measurement, anti-human IgM F(ab′)<sub>2</sub>and anti–human IgG + IgM F(ab′)<sub>2</sub>fragments (Jackson ImmunoResearch Laboratories) were added to naive and memory B cells, respectively. Cytosolic Ca<sup>2+</sup>concentrations were calculated as described previously (<xref ref-type=""bibr"" rid=""bib17"">17</xref>). As a negative control, purified B cell populations were also treated with an anti-CD3 antibody (BD Biosciences), which induces Ca<sup>2+</sup>mobilization in T but not B cells. For statistical analysis, area under curve values were calculated and compared using Fisher's exact test. P &lt; 0.05 was considered statistically significant.</p></sec><sec><title>Effect of IL-4R Signaling on BCR-dependent Ca<sup>2+</sup>Mobilization in Memory B Cells.</title><p>As treatment of naive B cells with IL-4 had no effect on the expression of genes related to BCR signaling (see above; see<xref ref-type=""fig"" rid=""fig5"">Fig. 5</xref>), modulation of BCR signals by IL-4 was studied in memory B cells only. Memory B cells from four healthy donors were purified and cultured in supernatant from LPS-stimulated PBMCs for 24 h in the presence or absence of human recombinant IL-4 or an inhibitory anti–IL-4Rα antibody (Genzyme). Changes of cytosolic Ca<sup>2+</sup>concentrations upon BCR engagement were measured and analyzed as described above.</p></sec></sec><sec><title>Results and Discussion</title><sec><title>Verification of the Identity of Purified B Cell Subsets.</title><p>CD34<sup>+</sup>HSCs (reference<xref ref-type=""bibr"" rid=""bib7"">7</xref>) and CD10<sup>+</sup>CD19<sup>+</sup>pre-B cells (<xref ref-type=""fig"" rid=""fig1"">Fig. 1</xref>B) were purified from human bone marrow, CD19<sup>+</sup>CD27<sup>−</sup>naive and CD19<sup>+</sup>CD27<sup>+</sup>memory B cells were purified from peripheral blood and CD38<sup>+</sup>CD77<sup>+</sup>GC B cells from tonsils and analyzed by flow cytometry (<xref ref-type=""fig"" rid=""fig1"">Fig. 1</xref>B). The identity of the purified subsets was further supported by the analysis of their genotype (<xref ref-type=""table"" rid=""tbl1"">Table I</xref>). As opposed to memory B cells, Ig<italic>V</italic><sub>H</sub>1-gene rearrangements amplified from pre-B cells and naive B cells were virtually devoid of somatic mutations. Consistent with ongoing selection for the expression of a functional Ig heavy chain in bone marrow pre-B cells, nonproductive<italic>V</italic><sub>H</sub>1-gene rearrangements (either due to loss of reading frame or rearrangement of a pseudogene of the<italic>V</italic><sub>H</sub>1 family) were overrepresented in the isolated pre-B cell population (<xref ref-type=""table"" rid=""tbl1"">Table I</xref>). Prior to the SAGE analysis, specific fragments of the<italic>C</italic>μ-,<italic>C</italic>γ<italic>1</italic>-,<italic>C</italic>κ, and<italic>VpreB</italic>genes were amplified from pre-B cells, naive, and memory B cells by RT-PCR, which was normalized for<italic>β2-microglobulin</italic>(<xref ref-type=""fig"" rid=""fig1"">Fig. 1</xref>A). As expected, expression of<italic>VpreB</italic>is confined to pre-B cells, which, in turn, lack expression of Igκ light chains and IgG1 heavy chains. Cγ1 transcripts were detected in memory but not pre-GC B cells (<xref ref-type=""fig"" rid=""fig1"">Fig. 1</xref>A). The identity of the purified B cell subsets was also confirmed retrospectively by the expression pattern of a set of subset-specific markers within the SAGE-libraries (<xref ref-type=""table"" rid=""tbl2"">Table II</xref>).</p><fig id=""fig1"" position=""float""><label>Figure 1.</label><caption><p>Genotype and phenotype of purified B cell subsets. Bone marrow pre-B cells (CD10<sup>+</sup>CD19<sup>+</sup>), peripheral blood naive B cells (CD19<sup>+</sup>CD27<sup>−</sup>), tonsillar GC B cells (CD20<sup>+</sup>CD77<sup>+</sup>), and peripheral blood memory B cells (CD19<sup>+</sup>CD27<sup>+</sup>) were purified as described in Materials and Methods. The mRNA expression of<italic>C</italic>μ,<italic>C</italic>γ<italic>1</italic>,<italic>C</italic>κ, and<italic>VpreB</italic>was analyzed by semiquantitative RT-PCR analysis (A). The identity of the purified subsets was further verified by flow cytometry (B): FACS<sup>®</sup>plots for preB cells (CD10<sup>+</sup>CD19<sup>+</sup>), naive (CD20<sup>+</sup>CD27<sup>−</sup>), GC (CD20<sup>+</sup>CD77<sup>+</sup>), and memory B cells (CD20<sup>+</sup>CD27<sup>+</sup>; from top to bottom) are given.</p></caption><graphic xlink:href=""20020881f1a""></graphic><graphic xlink:href=""20020881f1b""></graphic></fig><table-wrap id=""tbl1"" position=""float""><label>Table I.</label><caption><p>Sequence Analysis of V<sub>H</sub>1-Gene Rearrangements in Purified B Cell Subsets</p></caption><table frame=""hsides"" rules=""groups""><thead><tr><th align=""left"" colspan=""1"" rowspan=""1""><italic>V<sub>H</sub>1</italic>-gene<break></break>rearrangements</th><th align=""center"" colspan=""1"" rowspan=""1""></th><th align=""center"" colspan=""1"" rowspan=""1""></th><th align=""center"" colspan=""1"" rowspan=""1""></th></tr><tr><th align=""left"" colspan=""1"" rowspan=""1"">Among 10 clones</th><th align=""center"" colspan=""1"" rowspan=""1"">Pre-B cells</th><th align=""center"" colspan=""1"" rowspan=""1"">Naive<break></break>B cells</th><th align=""center"" colspan=""1"" rowspan=""1"">Memory<break></break>B cells</th></tr></thead><tbody><tr><td align=""left"" colspan=""1"" rowspan=""1"">In-frame</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">3</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">7</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">8</td></tr><tr><td align=""left"" colspan=""1"" rowspan=""1"">Out-of-frame</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">7</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">3</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">2</td></tr><tr><td align=""left"" colspan=""1"" rowspan=""1"">Pseudogene</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">3</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">0</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">0</td></tr><tr><td align=""left"" colspan=""1"" rowspan=""1"">Potentially functional</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">2</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">7</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">8</td></tr><tr><td align=""left"" colspan=""1"" rowspan=""1"">Average mutation<break></break>frequency (10<sup>−2</sup>bp)</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">0.4</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">0.6</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">7.7</td></tr></tbody></table></table-wrap><table-wrap id=""tbl2"" position=""float""><label>Table II.</label><caption><p>SAGE-tag Counts for Differentiation Stage–specific Genes</p></caption><table frame=""hsides"" rules=""groups""><thead><tr><th align=""left"" colspan=""1"" rowspan=""1""></th><th align=""center"" colspan=""1"" rowspan=""1"">CD34<sup>+</sup><break></break>HSC</th><th align=""center"" colspan=""1"" rowspan=""1"">Pre-B cells</th><th align=""center"" colspan=""1"" rowspan=""1"">Naive<break></break>B cells</th><th align=""center"" colspan=""1"" rowspan=""1"">GC<break></break>B cells</th><th align=""center"" colspan=""1"" rowspan=""1"">Memory<break></break>B cells</th></tr></thead><tbody><tr><td align=""left"" colspan=""1"" rowspan=""1""><italic>CD34</italic></td><td align=""center"" colspan=""1"" rowspan=""1"">19</td><td align=""center"" colspan=""1"" rowspan=""1"">2</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1""></td><td align=""char"" char=""."" colspan=""1"" rowspan=""1""></td><td align=""char"" char=""."" colspan=""1"" rowspan=""1""></td></tr><tr><td align=""left"" colspan=""1"" rowspan=""1""><italic>CD164</italic></td><td align=""center"" colspan=""1"" rowspan=""1"">27</td><td align=""center"" colspan=""1"" rowspan=""1"">1</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1""></td><td align=""char"" char=""."" colspan=""1"" rowspan=""1""></td><td align=""char"" char=""."" colspan=""1"" rowspan=""1""></td></tr><tr><td align=""left"" colspan=""1"" rowspan=""1""><italic>CD10</italic></td><td align=""center"" colspan=""1"" rowspan=""1"">2</td><td align=""center"" colspan=""1"" rowspan=""1"">40</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1""></td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">17</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">3</td></tr><tr><td align=""left"" colspan=""1"" rowspan=""1""><italic>TdT</italic></td><td align=""center"" colspan=""1"" rowspan=""1"">16</td><td align=""center"" colspan=""1"" rowspan=""1"">173</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">4</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">3</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1""></td></tr><tr><td align=""left"" colspan=""1"" rowspan=""1""><italic>RAG-2</italic></td><td align=""center"" colspan=""1"" rowspan=""1""></td><td align=""center"" colspan=""1"" rowspan=""1"">125</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1""></td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">3</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1""></td></tr><tr><td align=""left"" colspan=""1"" rowspan=""1""><italic>IL-7R</italic></td><td align=""center"" colspan=""1"" rowspan=""1"">3</td><td align=""center"" colspan=""1"" rowspan=""1"">41</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1""></td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">3</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">7</td></tr><tr><td align=""left"" colspan=""1"" rowspan=""1""><italic>CD23</italic></td><td align=""center"" colspan=""1"" rowspan=""1""></td><td align=""center"" colspan=""1"" rowspan=""1"">2</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">20</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">3</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">3</td></tr><tr><td align=""left"" colspan=""1"" rowspan=""1""><italic>CD38</italic></td><td align=""center"" colspan=""1"" rowspan=""1"">2</td><td align=""center"" colspan=""1"" rowspan=""1"">9</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1""></td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">24</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">7</td></tr><tr><td align=""left"" colspan=""1"" rowspan=""1""><italic>BCL-6</italic></td><td align=""center"" colspan=""1"" rowspan=""1"">1</td><td align=""center"" colspan=""1"" rowspan=""1""></td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">4</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">27</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">7</td></tr><tr><td align=""left"" colspan=""1"" rowspan=""1""><italic>AID</italic></td><td align=""center"" colspan=""1"" rowspan=""1""></td><td align=""center"" colspan=""1"" rowspan=""1"">2</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1""></td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">17</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">3</td></tr><tr><td align=""left"" colspan=""1"" rowspan=""1""><italic>CD21</italic></td><td align=""center"" colspan=""1"" rowspan=""1""></td><td align=""center"" colspan=""1"" rowspan=""1""></td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">4</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">20</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">51</td></tr><tr><td align=""left"" colspan=""1"" rowspan=""1""><italic>CD27</italic></td><td align=""center"" colspan=""1"" rowspan=""1""></td><td align=""center"" colspan=""1"" rowspan=""1""></td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">8</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">17</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">78</td></tr></tbody></table></table-wrap></sec><sec><title>Verification of Quantitative Accuracy of SAGE Profiles.</title><p>In the analysis of SAGE profiles for CD34<sup>+</sup>HSC, pre-B, naive, GC, and memory B cells, we identified a particular gene expression pattern, which involves positive and negative regulatory BCR signaling molecules (see references in<xref ref-type=""fig"" rid=""fig2"">Fig. 2</xref>)  . To corroborate the quantitative differences in the expression of BCR signaling molecules as observed by SAGE, semiquantitative RT-PCR was performed for 22 positive and 19 negative regulatory BCR signaling molecules (<xref ref-type=""fig"" rid=""fig3"">Fig. 3</xref>)  . For all 41 genes tested, the amounts of the amplification product mirrored the SAGE tag counts in the libraries for naive and memory B cells. Moreover, the expression of 10 costimulatory and 10 inhibitory surface molecules implicated in the propagation or attenuation of BCR-dependent signals was analyzed at the protein level by flow cytometry (<xref ref-type=""fig"" rid=""fig4"">Fig. 4</xref>)  . For all 20 surface molecules, the FACS<sup>®</sup>data correlated with SAGE tag counts, indicating that the large majority of SAGE data are indeed reproducible by alternative methods.</p><fig id=""fig2"" position=""float""><label>Figure 2.</label><caption><p>Cluster analysis of activating and inhibitory B cell receptor signaling molecules. In a systematic survey of PubMed, UniGene and OMIM databases, 211 BCR-related genes were identified, 148 of which could be retrieved from at least one of the SAGE libraries for CD34<sup>+</sup>HSC (HSC), pre-B cells (PBC), naive B cells (NBC), GC B cells (GCB), and memory B cells (MBC). In total, 97 activating (A and B) and 51 inhibitory (C) signaling molecules were identified the five SAGE libraries and listed with their gene names, SAGE tag counts for each library, UniGene ID, a brief description of their putative function including a reference. It should be noted that because of limited space in many cases only one functional aspect among others has been included. The SAGE data were sorted based on the ratio of tag counts in memory and naive B cells. For calculation of ratios, a tag count of 0 was set to 0.5. For graphic representation of SAGE data, tag counts have been transformed using the Cluster and Treeview softwares by M.B. Eisen, in which red denotes strong and black no or low expression.</p></caption><graphic xlink:href=""20020881f2a""></graphic><graphic xlink:href=""20020881f2b""></graphic><graphic xlink:href=""20020881f2c""></graphic></fig><fig id=""fig3"" position=""float""><label>Figure 3.</label><caption><p>Assessment of quantitative accuracy of SAGE data by RT-PCR. To corroborate quantitative differences of gene expression in naive and memory B cells as observed by SAGE, semiquantitative RT-PCR analysis was performed for 41 selected genes coding for 22 known positive (top) and 19 negative (bottom) regulatory molecules of BCR-dependent activation signals. RT-PCR was performed for 20, 24, 28, and 32 cycles. The amounts of cDNA were comparable for naive and memory B cells as determined by photometry and RT-PCR analysis of the<italic>COX6B</italic>(cytochrome c oxidase subunit VI) and<italic>B2M</italic>(β2-microglobulin) genes. For all 41 genes tested, the amount of the amplification product roughly reflects the quantitative distribution of SAGE tags in the libraries for naive and memory B cells. In some instances, no SAGE tag was detected for a given gene. However, in all these cases, an RT-PCR product was obtained at least after 28 cycles of amplification, which indicates that sensitivity of SAGE for low abundance-class genes is inferior to that of RT-PCR.</p></caption><graphic xlink:href=""20020881f3""></graphic></fig><fig id=""fig4"" position=""float""><label>Figure 4.</label><caption><p>FACS<sup>®</sup>analysis of costimulatory and inhibitory receptor molecules. To assess whether quantitative differences in mRNA expression as assessed by SAGE and RT-PCR also translate into protein, the surface expression of 10 costimulatory (top) and 10 inhibitory (bottom) surface molecules was analyzed by flow cytometry. Histograms for the expression of surface molecules, whose differential expression was identified by SAGE, are shown for naive (top panel) and memory (bottom panel) B cells. Numbers indicate the tag counts in 100,000 tags in the respective SAGE library.</p></caption><graphic xlink:href=""20020881f4a""></graphic><graphic xlink:href=""20020881f4b""></graphic></fig></sec><sec><title>Opposing Regulation of BCR Signaling in Naive and Memory B Cells.</title><p>In a comprehensive search throughout the five SAGE profiles and the UniGene database, we identified 148 molecules involved in positive (97 genes) and negative (51 genes) regulation of BCR signaling present in at least one SAGE library. Whereas most of the genes that positively regulate BCR-dependent activation signals are expressed at high levels in pre-B, GC, and memory B cells, this was not the case for naive B cells (<xref ref-type=""fig"" rid=""fig2"">Fig. 2, A and B</xref>, and<xref ref-type=""fig"" rid=""fig3"">Figs. 3</xref>and<xref ref-type=""fig"" rid=""fig4"">4</xref>). In many cases, expression of positive BCR signaling molecules was either missing in the SAGE library for naive B cells or reduced to expression levels as in CD34<sup>+</sup>HSC. Conversely, inhibitory molecules were expressed either exclusively or predominantly in naive B cells (<xref ref-type=""fig"" rid=""fig2"">Figs. 2</xref>C, 3, and 4).</p><p>Concomitant down-regulation of mediators of BCR-related activation together with increased expression of inhibitory molecules in naive B cells (<xref ref-type=""fig"" rid=""fig2"">Fig. 2, A–C</xref>) suggests that an elevated signaling threshold prevents naive B cells from being inappropriately activated upon antigen encounter. There are, however, some exceptions to this seemingly uniform picture: for instance,<italic>IKAROS</italic>, which appears to reduce BCR-dependent B cell activation (<xref ref-type=""bibr"" rid=""bib18"">18</xref>) is expressed at higher levels in pre-B cells and memory B cells as compared with naive B cells. Also, SAGE tags matching the<italic>LYN</italic>gene, which is critical for ITIM-dependent negative signaling, and the<italic>I</italic>κ<italic>B</italic>α gene, encoding an inhibitor of nuclear factor (NF)-κB, were found most frequently in pre-B cells, while expression levels in naive, GC, and memory B cells are similar. Many of the signaling molecules included in this study are also involved in signaling pathways that are not related to the BCR. This applies in particular to downstream kinases (e.g.,<italic>p85</italic>α,<italic>JAK3</italic>,<italic>p110, LCK</italic>,<italic>FAK</italic>,<italic>IKK</italic>,<italic>AKT</italic>,<italic>HPK1</italic>,<italic>p115</italic>,<italic>PKC</italic>μ,<italic>PKC</italic>β,<italic>PKA</italic>;<xref ref-type=""fig"" rid=""fig2"">Fig. 2</xref>) and receptors that are not specific for the B lineage, whose intra-cellular signals may converge with those of the BCR (<italic>SLAM</italic>,<italic>PDGFR</italic>α,<italic>CD38</italic>,<italic>CD27</italic>,<italic>FcRH1</italic>,<italic>HRH1</italic>,<italic>CD86</italic>,<italic>NGFR</italic>,<italic>CD36</italic>,<italic>CD74</italic>,<italic>CD66</italic>,<italic>CD31</italic>,<italic>LAIR1</italic>,<italic>CD5</italic>,<italic>CD33</italic>,<italic>LLIR</italic>,<italic>LIRB1</italic>,<italic>LIRB2</italic>,<italic>LIRB5</italic>,<italic>PIR</italic>β;<xref ref-type=""fig"" rid=""fig2"">Fig. 2</xref>).</p><p>However, mouse mutants for some of these genes exhibit a particular B cell phenotype, and many receptor molecules are involved in either ITAM- or ITIM-dependent signaling, which allows a prediction of their role in either amplification or attenuation of BCR-dependent activation signals. The five SAGE libraries also identified a number of components of the proximal BCR-signaling complex, which have an unambiguous function in (pre)-B cells. These “classical” BCR signaling molecules include<italic>BLK</italic>,<italic>BLNK</italic>,<italic>BTK</italic>,<italic>Ig</italic>α,<italic>Ig</italic>β,<italic>SYK</italic>, and<italic>CD19</italic>, whose expression levels are consistently lower in naive B cells as compared with other B cell subsets (<xref ref-type=""fig"" rid=""fig2"">Fig. 2</xref>A and B, and<xref ref-type=""fig"" rid=""fig3"">Figs. 3</xref>and<xref ref-type=""fig"" rid=""fig4"">4</xref>). To the contrary, well characterized inhibitors of BCR-induced activation signals including the protein tyrosine phosphatases (PTPs)<italic>SHP1</italic>and<italic>SHIP</italic>(<xref ref-type=""bibr"" rid=""bib19"">19</xref>), the PTK<italic>CSK</italic>, the PTK-associated ubiquitin ligase<italic>CBL</italic>, and the ITIM-bearing surface receptors<italic>CD22</italic>,<italic>CD32</italic>and<italic>CD72</italic>are expressed at high levels in naive B cells but not in pre-B, GC, or memory B cells (<xref ref-type=""fig"" rid=""fig2"">Figs. 2</xref>C, 3, and 4).</p><p>Facilitated responsiveness of memory B cells to BCR engagement was suggested from earlier findings, namely the expression of the activating coreceptors CD21 (<xref ref-type=""bibr"" rid=""bib20"">20</xref>) and CD27 (<xref ref-type=""bibr"" rid=""bib21"">21</xref>) together with increased expression levels of the costimulatory molecules CD80 and CD86 (<xref ref-type=""bibr"" rid=""bib22"">22</xref>) and in vitro experimentation, which demonstrated that memory cells have higher propensity to undergo activation-induced terminal differentiation than naive B cells (<xref ref-type=""bibr"" rid=""bib23"">23</xref>). To date, a genome-wide analysis of BCR signaling molecules in pre- and (post-) GC B cells is missing. As shown in<xref ref-type=""fig"" rid=""fig2"">Fig. 2, A and B</xref>, sensitization of memory B cells to BCR-dependent activation signals is not only related to upregulation of surface molecules such as CD21, CD27, CD80, and CD86 but involves virtually all levels of intracellular signal transduction including transmembrane receptors, kinases, linker molecules, phosphatases, Ca<sup>2+</sup>channels and transcription factors.</p><p>In particular, it was not known that BCR signals in naive B cells can be specifically silenced by the prominent expression of ITIM-bearing molecules belonging to the emerging group of inhibitory immunoglobulin superfamily (IgSF) receptors (<xref ref-type=""fig"" rid=""fig2"">Figs. 2</xref>C, 3, and 4). In the following, we describe the expression pattern of inhibitory and stimulatory BCR signaling molecules in naive and memory B cells more in detail, dividing these molecules into functional groups.</p></sec><sec><title>Regulation of the Expression of Constituents of the BCR in Human B Cell Subsets.</title><p>In mature B cells, the BCR is composed of surface Ig, the coreceptors CD19, CD21, and CD81 and the Igα- and Igβ-signaling chains (<xref ref-type=""bibr"" rid=""bib1"">1</xref>). In naive B cells, mRNA levels of BCR-related molecules are either moderately (Igβ, CD19, CD81;<xref ref-type=""fig"" rid=""fig2"">Fig. 2</xref>B) or substantially (Igα, CD21;<xref ref-type=""fig"" rid=""fig2"">Fig. 2</xref>A) lower than in other B cell subsets.</p><p>Also, expression levels of Ig genes are lower in naive B cells as compared with other B cell subsets: in the SAGE library for naive B cells, we found 143 tags matching to the<italic>C</italic>μ gene (pre-B cells: 826; GC B cells: 329; memory B cells: 450), 29 tags for<italic>V</italic>κ- and<italic>C</italic>κ-genes (pre-B cells: 5; GC B cells: 54; memory B cells: 101) and 199 tags for<italic>C</italic>λ-genes (pre-B cells: 10; GC B cells: 447; memory B cells: 1,337). Instead of<italic>Ig</italic>κ- and<italic>Ig</italic>λ- light chain genes, pre-B cells mostly express<italic>VpreB</italic>(287 tags) and<italic>λ-5</italic>(1,975 tags) surrogate light chains. Higher levels of<italic>Ig</italic>κ gene expression in memory than in naive B cells is in agreement with a previous study, in which<italic>Ig</italic>κ mRNA levels were 3- to 11-fold higher in memory as compared with naive B cells (<xref ref-type=""bibr"" rid=""bib24"">24</xref>). As expected, SAGE tags matching to Cγ genes are frequent in memory (1,929 tags) and GC B cells (217 tags), but virtually missing in the libraries for naive (13 tags) and pre-B cells (16 tags).</p></sec><sec><title>TNF Receptors May Act as Costimulatory Molecules in GC and Memory B Cells.</title><p>The genes downregulated in naive B cells include members of the TNF receptor superfamily: in contrast to GC and memory B cells,<italic>CD40</italic>(<italic>TNFRSF5</italic>),<italic>CD27</italic>(<italic>TNFRSF7</italic>), and<italic>NGFR</italic>(<italic>TNFRSF16</italic>) are either missing or expressed only at low levels in naive B cells (<xref ref-type=""fig"" rid=""fig2"">Fig. 2, A and B</xref>). While CD40-engagement is known to cooperate with IL-4R- and BCR-dependent signals during the GC reaction (<xref ref-type=""bibr"" rid=""bib25"">25</xref>), ligation of the “memory-specific” receptor CD27 (<xref ref-type=""bibr"" rid=""bib21"">21</xref>) by CD70 increases responsiveness of memory B cells to BCR signals and induces plasma cell differentiation. Also, three recently identified members of the TNF receptor superfamily are differentially expressed in naive B cells compared with GC- and memory B cells:<italic>BAFF-R</italic>(<italic>TNFRSF13B</italic>) and<italic>BCMA</italic>(B cell maturation antigen;<italic>TNFRSF17</italic>) are receptors of the B cell activation factor BAFF and are expressed in GC and memory B but not naive B cells (<xref ref-type=""fig"" rid=""fig2"">Fig. 2, A and B</xref>, and<xref ref-type=""fig"" rid=""fig3"">Fig. 3</xref>). Unlike BCMA (<xref ref-type=""bibr"" rid=""bib26"">26</xref>), BAFF-R is critical for the development of marginal zone (i.e., mostly memory) B cells and the T cell–dependent B cell response (<xref ref-type=""bibr"" rid=""bib27"">27</xref>). Although not essential for B cell activation,<italic>BCMA</italic>was shown to induce<italic>NF-</italic>κ<italic>B</italic>–activation and<italic>p38 MAP</italic>kinase-dependent proliferation in synergism with the BCR (<xref ref-type=""bibr"" rid=""bib28"">28</xref>). A third receptor for<italic>BAFF</italic>, termed<italic>TACI</italic>, however, is, although at low level, only expressed in naive B cells (<xref ref-type=""fig"" rid=""fig2"">Figs. 2</xref>C and 3) and acts as a negative regulator of BCR-dependent B cell activation (<xref ref-type=""bibr"" rid=""bib29"">29</xref>).<italic>CD30 ligand</italic>(<italic>TNFSF8</italic>), an inhibitor of B cell costimulation and class switch recombination (CSR; reference<xref ref-type=""bibr"" rid=""bib30"">30</xref>), is expressed in naive B cells but virtually missing in GC- and memory B cells<xref ref-type=""fig"" rid=""fig2"">Figs. 2</xref>C, 3, and 4). In this regard, it is notable that<italic>SWAP70</italic>, which promotes both B cell activation and CSR (<xref ref-type=""bibr"" rid=""bib31"">31</xref>), is expressed reciprocally with<italic>CD30 ligand</italic>in naive and (post) GC B cells (<xref ref-type=""fig"" rid=""fig2"">Fig. 2</xref>B).</p></sec><sec><title>Specific Expression of Inhibitory Ig Superfamily Members in Naive B Cells.</title><p>Many of the inhibitory receptors, which we find expressed at high levels in naive B cells belong to the Ig superfamily (IgSF). The inhibitory IgSF molecules are predominantly or exclusively expressed by naive B cells (<xref ref-type=""fig"" rid=""fig2"">Fig. 2</xref>C) and typically carry one or more ITIMs within their cytoplasmic tail. Negative regulatory IgSF molecules specifically or predominantly expressed in naive B cells include<italic>SIgLec5</italic>,<italic>SIgLec6</italic>, and<italic>SIgLec8</italic>, members of the sialic acid binding Ig-like lectin-like family, and<italic>LIRB1</italic>,<italic>LIRB2</italic>, and<italic>LIRB5</italic>, which belong to the B group of leukocyte Ig-like receptors (collectively termed<italic>CD85</italic>,<xref ref-type=""fig"" rid=""fig3"">Figs. 3</xref>and<xref ref-type=""fig"" rid=""fig4"">4</xref>). Also, ITIM-bearing IgSF molecules, the lectin-like immunoreceptor<italic>LLIR</italic>, the paired Ig-like receptor<italic>PIR</italic>β, as well as<italic>CD22</italic>,<italic>CD31</italic>,<italic>CD32/FcR</italic>γ<italic>II</italic>, the biliary glycoprotein<italic>CD66</italic>are expressed by naive B cells and, if at all, only at reduced levels in GC and memory B cells (<xref ref-type=""fig"" rid=""fig2"">Figs. 2</xref>C, 3, and 4). This also applies to the newly identified IgSF molecules<italic>PD1</italic>(<xref ref-type=""bibr"" rid=""bib32"">32</xref>),<italic>G6B</italic>(<xref ref-type=""bibr"" rid=""bib33"">33</xref>), and<italic>CMRF35H</italic>(<xref ref-type=""bibr"" rid=""bib34"">34</xref>). Also, ITIM-bearing but a member of the C-type lectin family, the<italic>CD72</italic>molecule is highly expressed in naive B cells (<xref ref-type=""fig"" rid=""fig2"">Figs. 2</xref>C, 3, and 4). On the other hand, its antagonistic ligand<italic>CD100</italic>can relieve<italic>CD72</italic>-mediated inhibition of BCR-signals and is predominantly expressed in memory B cells (<xref ref-type=""fig"" rid=""fig2"">Figs. 2</xref>B, 3, and 4). Within the IgSF, a group of Fc receptor homologues was recently identified, which comprises positive and negative regulatory coreceptors based on whether they harbor ITAMs or ITIMs within their cytoplasmic tail (<xref ref-type=""bibr"" rid=""bib35"">35</xref>). Like many other inhibitory IgSF receptors, the ITIM-bearing<italic>FcRH2/SPAP1</italic>(<xref ref-type=""bibr"" rid=""bib35"">35</xref>) was only found in naive B cells (<xref ref-type=""fig"" rid=""fig2"">Fig. 2</xref>C), whereas its ITAM-carrying homologue,<italic>FcRH1</italic>was expressed in GC and memory but not naive B cells (<xref ref-type=""fig"" rid=""fig2"">Fig. 2</xref>A).</p></sec><sec><title>Cytokine Receptor Signaling in Naive and Memory B Cells.</title><p>The B cell–homing chemokine receptor<italic>BLR1</italic>, also termed<italic>CXCR5</italic>, can cooperate with the BCR by stimulation of Ca<sup>2+</sup>influx (<xref ref-type=""bibr"" rid=""bib36"">36</xref>) and is stronger expressed in GC and memory B cells as compared with their naive precursors (<xref ref-type=""fig"" rid=""fig2"">Fig. 2</xref>B). Naive B cells also differ from GC B cells and memory B cells in that they lack expression of the signal transducer for IL-6 (<italic>CD130</italic>or<italic>gp130</italic>) and the receptor for IL-4 (<italic>CD124</italic>).<italic>gp130</italic>has been implicated in post-GC development of B cells, as mice expressing a dominant negative form of gp130 exhibit a marked reduction of Ig production (<xref ref-type=""bibr"" rid=""bib37"">37</xref>). Engagement of IL-4R can augment activation signals through the BCR (for a review, see reference 38; see below).</p></sec><sec><title>Regulation of BCR-Downstream Linker Molecules and Kinases in Human B Cell Subsets.</title><p>A large group of activating linker molecules and PTKs contributes to propagation of activation-stimuli within the distal BCR-signaling cascade. Without exception, activating linker molecules identified in the SAGE libraries, including<italic>BLNK</italic>,<italic>BAM32</italic>,<italic>GRB2</italic>,<italic>SOS1</italic>,<italic>SHC1</italic>,<italic>GAB1</italic>,<italic>GAB2</italic>,<italic>BRDG1</italic>,<italic>NCK</italic>, and<italic>BANK</italic>, were up-regulated in GC and memory as compared with naive B cells (<xref ref-type=""fig"" rid=""fig2"">Fig. 2, A and B</xref>). In contrast, inhibitory linker molecules including<italic>p62DOK</italic>(<xref ref-type=""bibr"" rid=""bib39"">39</xref>) and the<italic>SRC</italic>-like adaptor proteins<italic>SLAP1</italic>and<italic>SLAP2</italic>(<xref ref-type=""bibr"" rid=""bib40"">40</xref>) inhibit BCR downstream signals, predominantly in naive B cells (<xref ref-type=""fig"" rid=""fig2"">Fig. 2</xref>C).</p><p>Activating kinase molecules, as far as identified in the SAGE libraries, are expressed at higher levels in (post) GC B cells as compared with their naive precursors (<xref ref-type=""fig"" rid=""fig2"">Fig. 2, A and B</xref>).<italic>PI-3</italic>kinases<italic>p85</italic>α and<italic>p110</italic>have in common that they may activate<italic>AKT/PKB</italic>(<xref ref-type=""bibr"" rid=""bib41"">41</xref>) and<italic>BTK</italic>(<xref ref-type=""bibr"" rid=""bib42"">42</xref>), while activated<italic>BTK</italic>can induce degradation of the<italic>NF-</italic>κ<italic>B</italic>inhibitor<italic>I</italic>κ<italic>B</italic>α by phosphorylation through<italic>IKK</italic>(<xref ref-type=""bibr"" rid=""bib43"">43</xref>). Only moderately up-regulated in GC and memory B cells, the MAP kinase<italic>HPK1</italic>(<xref ref-type=""bibr"" rid=""bib44"">44</xref>) and the PTK<italic>PYK2</italic>(<xref ref-type=""bibr"" rid=""bib45"">45</xref>) can augment BCR signals, the former through interaction with<italic>BLNK</italic>, the latter with<italic>BRDG1</italic>(<xref ref-type=""fig"" rid=""fig2"">Fig. 2</xref>B). Interestingly,<italic>PYK2</italic>-deficient mice lack splenic marginal zones, which are thought to be mainly composed of memory B cells (<xref ref-type=""bibr"" rid=""bib45"">45</xref>). Not specific for the B cell lineage, but expressed in GC and memory B cells (<xref ref-type=""fig"" rid=""fig2"">Fig. 2</xref>A), the receptor of platelet derived growth factor<italic>PDGFR</italic>α can act as a stimulatory PTK and promote proliferation (<xref ref-type=""bibr"" rid=""bib46"">46</xref>).</p><p>Among the inhibitory kinases, the<italic>CD45</italic>-antagonist<italic>CSK</italic>(<xref ref-type=""bibr"" rid=""bib47"">47</xref>) and the<italic>PKCs</italic>β (<xref ref-type=""bibr"" rid=""bib48"">48</xref>) and<italic>μ</italic>(<xref ref-type=""bibr"" rid=""bib49"">49</xref>) acting as inhibitors of<italic>BTK</italic>and<italic>SYK</italic>, respectively, are expressed at higher levels in naive B cells as compared with GC and memory B cells (<xref ref-type=""fig"" rid=""fig2"">Fig. 2</xref>C). However, expression levels of<italic>LYN</italic>, a key mediator of ITIM-dependent negative signaling is expressed at similar levels throughout all B cell subsets. Specific inhibition of the tyrosine kinase<italic>BTK</italic>represents another level of BCR-signal attenuation, at which the<italic>IBTK</italic>(<xref ref-type=""bibr"" rid=""bib50"">50</xref>) and<italic>SAB/SH3BP-5</italic>(<xref ref-type=""bibr"" rid=""bib51"">51</xref>) molecules are acting, mostly in naive B cells (<xref ref-type=""fig"" rid=""fig2"">Fig. 2</xref>C).</p></sec><sec><title>Regulation of PTPs during B Cell Development.</title><p>The PTP<italic>CD45</italic>represents a critical component of the proximal BCR-signaling cascade (<xref ref-type=""bibr"" rid=""bib52"">52</xref>). Together with its antagonist,<italic>CSK</italic>,<italic>CD45</italic>sets the threshold for antigen receptor signals in B and T cells by reversing CSK-mediated phosphorylation of negative regulatory tyrosine-based motifs in src-family PTKs (<xref ref-type=""bibr"" rid=""bib53"">53</xref>). As opposed to its antagonist<italic>CSK</italic>, the<italic>CD45</italic>gene is higher expressed in memory B cells, GC B cells, and pre-B cells as compared with naive B cells (<xref ref-type=""fig"" rid=""fig2"">Fig. 2, A and C</xref>). From the five SAGE libraries, multiple SAGE tags matching to the<italic>CD45</italic>gene were retrieved, which most likely reflects the expression of multiple splice variants of the<italic>CD45</italic>gene. Consistent with the notion of BCR-signal inhibition in naive B cells, the inhibitory PTPs<italic>SHP1</italic>,<italic>SHIP</italic>, and the recently identified<italic>PTP-PEST</italic>molecule (<xref ref-type=""bibr"" rid=""bib54"">54</xref>) are expressed at high levels in naive but not GC or memory B cells (<xref ref-type=""fig"" rid=""fig2"">Fig. 2</xref>C). Another PTP, encoded by the<italic>PTEN</italic>gene, inhibits the activation of<italic>BTK</italic>in B cells (<xref ref-type=""bibr"" rid=""bib38"">38</xref>), is frequently inactivated by somatic mutation in advanced malignancies resulting in uninhibited PTK activity and expressed at higher levels in naive than (post) GC B cells (<xref ref-type=""fig"" rid=""fig2"">Fig. 2</xref>C).</p></sec><sec><title>Role of Transcription Factors in the Regulation of BCR Signals.</title><p>The genes up-regulated in memory and GC B cells include classical transcriptional activators of Ig genes including<italic>OCT2</italic>,<italic>OBF1</italic>,<italic>NF-</italic>κ<italic>B1</italic>, and<italic>NF-</italic>κ<italic>B2</italic>(<xref ref-type=""fig"" rid=""fig2"">Fig. 2, A and B</xref>). These genes are involved in autocatalytic loops initiated from the BCR through transcriptional activation of<italic>Ig</italic>α (by<italic>OCT2</italic>; reference<xref ref-type=""bibr"" rid=""bib55"">55</xref>), synergism with<italic>BTK</italic>(by<italic>OBF1</italic>; reference<xref ref-type=""bibr"" rid=""bib56"">56</xref>), and amplification of BCR-dependent anti-apoptotic signals and proliferation-stimuli (by<italic>NF-</italic>κ<italic>B</italic>; reference 43). BCR engagement and subsequent<italic>NF-</italic>κ<italic>B</italic>activation are linked by the protooncogene<italic>BCL10</italic>(<xref ref-type=""bibr"" rid=""bib57"">57</xref>), which is expressed at high levels in pre-B and memory but not naive B cells (<xref ref-type=""fig"" rid=""fig2"">Fig. 2</xref>B). In GC and memory B cells,<italic>OCT2</italic>was found up-regulated together with its transcriptional target gene<italic>CD36</italic>(<xref ref-type=""fig"" rid=""fig2"">Fig. 2</xref>B). Stage-specific expression of<italic>CD36</italic>could be meaningful because based on the dependence of<italic>CD36</italic>expression on transcriptional activation by<italic>OCT2</italic>, it was speculated that<italic>OCT2</italic>could regulate B cell differentiation through<italic>CD36</italic>(<xref ref-type=""bibr"" rid=""bib58"">58</xref>). The members of the<italic>ETS</italic>family of transcription factors,<italic>FLI-1</italic>(<xref ref-type=""bibr"" rid=""bib59"">59</xref>),<italic>PU.1</italic>, and<italic>SPI-B</italic>(<xref ref-type=""bibr"" rid=""bib60"">60</xref>) have recently been demonstrated as critical components of BCR-dependent activation-signaling pathways.<italic>FLI-1</italic>,<italic>PU.1</italic>, and<italic>SPI-B</italic>are expressed at high or intermediate levels in GC and memory B cells but are missing in the SAGE library for naive B cells (<xref ref-type=""fig"" rid=""fig2"">Fig. 2</xref>A).</p></sec><sec><title>Relief of BCR Signal Inhibition by Engagement of IL-4R in (Post) GC B Cells.</title><p>Recent data indicate that enhancement of BCR-dependent B cell activation by IL-4 at least in part results from the relief of inhibitory signals through negative regulatory receptor molecules (<xref ref-type=""bibr"" rid=""bib61"">61</xref>). In agreement with these findings, we observe specific expression of ITIM-bearing inhibitory IgSF receptors on naive B cells (<xref ref-type=""fig"" rid=""fig2"">Figs. 2</xref>C and 3), which also lack expression of IL-4R (<xref ref-type=""fig"" rid=""fig2"">Figs. 2</xref>B, 3, and 4). Conversely, the SAGE libraries for GC B cells and memory B cells show a correlation between the expression of IL-4R and the absence of ITIM-bearing and other inhibitory receptors (<xref ref-type=""fig"" rid=""fig2"">Fig. 2</xref>C). IL-4–dependent changes of gene expression are largely mediated by<italic>STAT6</italic>(<xref ref-type=""bibr"" rid=""bib38"">38</xref>), which we find expressed at higher levels in GC (17 tags) and memory B cells (33 tags) than in naive B cells (4 tags).</p><p>Thus, antigen-encounter during the GC reaction, up-regulation of IL-4R, and initiation of IL-4–dependent signals might result in a far-reaching phenotypic change, namely transcriptional silencing of a large group of inhibitory receptors that are abundantly expressed in naive B cells. Whether and to which extent the inverse regulation of responsiveness to BCR cross-linking in naive and memory B cells results from differential IL-4R signaling was tested in a cell culture experiment (<xref ref-type=""fig"" rid=""fig5"">Fig. 5</xref>)  . Naive and memory B cells were purified from peripheral blood and cultured either in medium alone, or with human recombinant IL-4. In another set of experiments, memory B cells were preincubated with IL-4 and subsequently treated with a neutralizing anti–IL-4Rα antibody. After 48 h, the cells were subjected to RNA isolation and subsequent semiquantitative RT-PCR analysis for mRNA expression of the positive regulatory BCR signaling molecules<italic>BLK</italic>,<italic>BTK</italic>,<italic>BLNK</italic>, and<italic>SYK</italic>, their inhibitors<italic>CSK</italic>,<italic>SHIP</italic>, and<italic>SHP1</italic>and negative regulatory IgSF receptors including<italic>LIRB1</italic>,<italic>LIRB2</italic>,<italic>LIRB5</italic>,<italic>SIgLec5</italic>,<italic>SIgLec8</italic>,<italic>LAIR1</italic>, and<italic>CD66</italic>(<xref ref-type=""fig"" rid=""fig5"">Fig. 5</xref>).</p><fig id=""fig5"" position=""float""><label>Figure 5.</label><caption><p>Regulation of inhibitory IgSF receptors in memory B cells by IL-4. Naive and memory B cells were purified from peripheral blood and cultured either in medium alone, or with IL-4. In another set of experiments, memory B cells were cultured in the presence of a neutralizing anti–IL-4Rα antibody, which was added after 8 h of preincubation with IL-4. The left and center panels show amplification products of semiquantitative RT-PCR for positive regulatory PTKs (<italic>BLK</italic>,<italic>BTK</italic>,<italic>SYK</italic>), the linker molecule<italic>BLNK</italic>, the negative regulatory PTK<italic>CSK</italic>, the inhibitory PTPs<italic>SHIP</italic>and<italic>SHP1</italic>, and the inhibitory IgSF receptors<italic>LIRB1</italic>,<italic>LIRB2</italic>,<italic>LIRB5</italic>,<italic>SIgLec5</italic>,<italic>SIgLec8</italic>, and<italic>CD66</italic>. In the right panel, the genomic loci of these genes are indicated.</p></caption><graphic xlink:href=""20020881f5""></graphic></fig><p>In naive B cells, presence or absence of IL-4 did not affect the expression of positive or negative regulatory BCR signaling molecules. In peripheral blood memory B cells, however, complete deprivation from IL-4 in cell culture medium for 48 h resulted in a concomitant decrease of mRNA levels of<italic>BLK</italic>,<italic>BTK</italic>,<italic>BLNK</italic>, and<italic>SYK</italic>with markedly increased expression levels of inhibitory IgSF receptors (<xref ref-type=""fig"" rid=""fig5"">Fig. 5</xref>) as compared with expression levels in ex vivo analyzed peripheral blood memory B cells (for comparison, see amplification products in<xref ref-type=""fig"" rid=""fig3"">Fig. 3</xref>, at 32 cycles for<italic>LAIR1</italic>and 28 cycles for the other genes studied here). Loss of positive and gain of negative regulatory BCR signaling molecules upon withdrawal of IL-4 in peripheral blood memory B cells indicates that gene regulation through IL-4R requires continuous presence of its ligand. However, serum levels of IL-4 are low in healthy individuals (i.e., &lt;0.1 pg/ml; reference 38), which suggests that peripheral blood memory B cells are able to respond also in the presence of low concentrations of IL-4. It is indeed conceivable, that memory B cells have acquired higher responsiveness to IL-4 (e.g., by up-regulation of IL-4R) during maturation within GCs, in which IL-4–producing TH2-cells are highly concentrated (<xref ref-type=""bibr"" rid=""bib62"">62</xref>). Treatment of memory B cells with IL-4 at high concentrations induced a slight increase of mRNA levels of<italic>BLK</italic>,<italic>BTK</italic>,<italic>BLNK</italic>, and<italic>SYK</italic>but a marked reduction of mRNA levels of the inhibitory IgSF receptors<italic>LIRB1</italic>,<italic>LIRB2</italic>,<italic>LIRB5</italic>,<italic>SIgLec5</italic>,<italic>SIgLec8</italic>,<italic>LAIR1</italic>, and<italic>CD66.</italic>IL-4 treatment did not affect expression levels of other inhibitory BCR signaling molecules in memory B cells including<italic>CSK</italic>,<italic>SHIP</italic>, and<italic>SHP1</italic>, which are expressed at constitutively lower levels in memory than in naive B cells (<xref ref-type=""fig"" rid=""fig5"">Fig. 5</xref>). Consistent with low-level expression of IL-4R in naive B cells (<xref ref-type=""fig"" rid=""fig2"">Figs. 2</xref>A, 3, and 4), IL-4 can induce transcriptional repression of inhibitory IgSF receptors in memory but not naive B cells. Inhibition of IL-4R–dependent signals by a neutralizing antibody, which was added after preincubation with high concentrations of IL-4, only slightly reduced mRNA levels of the positive mediators of BCR signaling<italic>BLK</italic>,<italic>BTK</italic>,<italic>BLNK</italic>, and<italic>SYK</italic>and had no effect on expression levels of their inhibitors<italic>CSK</italic>,<italic>SHIP</italic>, and<italic>SHP1</italic>. However, inhibitory IgSF receptors including<italic>LIRB1</italic>,<italic>LIRB2</italic>,<italic>LIRB5</italic>,<italic>SIgLec5</italic>,<italic>SIgLec8</italic>,<italic>LAIR1</italic>, and<italic>CD66</italic>were markedly up-regulated in memory B cells in the presence of the neutralizing anti–IL-4R antibody and reached similar expression levels as in naive B cells. Thus, down-regulation of inhibitory IgSF receptors in memory B cells largely depends on IL-4R engagement.</p></sec><sec><title>Clustering of IgSF Genes Overexpressed in Naive B Cells to a Region on Chromosome 19.</title><p>As expression levels of other negative regulatory BCR signaling molecules such as<italic>CSK</italic>,<italic>SHIP</italic>, and<italic>SHP1</italic>remain stable in the presence or absence of IL-4R signaling, transcriptional repression induced by IL-4 in memory B cells seems to be specific for inhibitory IgSF receptors. In this regard, it is notable that the genes coding for the ITIM-bearing IgSF receptors studied here and also many inhibitory killer cell Ig-like receptors are arranged in a cluster within a 2.9 Mbp region on chromosome 19 (19q13.2–q13.4; see<xref ref-type=""fig"" rid=""fig5"">Fig. 5</xref>). This cluster of genes also includes the inhibitory IgSF receptors<italic>CD22</italic>,<italic>GP6</italic>and<italic>CD33</italic>, which are highly expressed in naive but not GC and memory B cells (<xref ref-type=""fig"" rid=""fig2"">Figs. 2</xref>C, 3, and 4). Therefore, it is tempting to speculate that this cluster on chromosome 19 harbors a large number of IgSF genes sharing a common mechanism of transcriptional regulation in that they can be silenced by IL-4R–dependent signals.</p><p>Differential responsiveness to IL-4 in naive and memory B cells suggests that human B cells may acquire sensitivity to IL-4 during the GC reaction, while IL-4R–dependent signaling itself facilitates transduction of signals initiated from the BCR. Further studies are needed to identify other mediators of the relief of the “inhibition-phenotype” in human B cells after antigen-encounter in the GC.</p></sec><sec><title>Regulation of BCR Responsiveness by IL-4R Signals in Memory B Cells.</title><p>Having shown that IL-4 can down-regulate inhibitory IgSF receptors in memory but not naive B cells (<xref ref-type=""fig"" rid=""fig5"">Fig. 5</xref>), we studied the effect of IL-4R signals on BCR-dependent Ca<sup>2+</sup>mobilization in memory B cells. After preincubation of memory B cells in PBMC-conditioned medium in the presence or absence of human recombinant IL-4 or an inhibitory anti–IL-4Rα antibody, memory B cells were challenged with anti–human IgG + IgM F(ab′)<sub>2</sub>fragments and Ca<sup>2+</sup>flux was measured. Addition of IL-4 beyond physiological concentrations had no effect on BCR responsiveness of memory B cells (<xref ref-type=""fig"" rid=""fig6"">Fig. 6</xref>C). However, inhibition of IL-4Rα resulted in a decrease of the peak size and a rapid decline of the calcium signal, which suggests that integrity of BCR responsiveness in memory B cells requires signals through the IL-4R (<xref ref-type=""fig"" rid=""fig6"">Fig. 6</xref>C). This was expected, as inhibition of IL-4R signaling resulted in reexpression of inhibitory IgSF molecules in memory B cells (<xref ref-type=""fig"" rid=""fig5"">Fig. 5</xref>). The failure of supraphysiological IL-4 concentrations to further augment BCR-dependent Ca<sup>2+</sup>mobilization in memory B cells suggests that already low IL-4 concentrations (e.g., as in human serum) may be sufficient to maintain full BCR responsiveness to antigen.</p><fig id=""fig6"" position=""float""><label>Figure 6.</label><caption><p>Regulation of BCR-dependent Ca<sup>2+</sup>mobilization by LIRB1 and IL-4 in naive and memory B cells. Naive (A) and memory (B) B cells (B) were preincubated for 24 h in medium, which had been conditioned by LPS-stimulated PBMCs, in the presence of either an antagonistic (light gray curve, αLIRB1 HP-F1) or an agonistic antibody to LIRB1 cross-linked by goat anti–mouse IgG serum (dark gray curve, αLIRB1 GVI/ 75-GAM) or no antibody (black curve, none). Naive and memory B cells were stimulated with anti–human IgM F(ab′)<sub>2</sub>and anti–human IgG + IgM F(ab′)<sub>2</sub>fragments, respectively, at the indicated times (arrows) and changes of intracellular Ca<sup>2+</sup>concentrations in response to BCR engagement were measured by confocal microscopy. In another set of experiments (C), memory B cells were cultured in supernatants from LPS-stimulated PBMCs for 24 h in the presence of human recombinant IL-4 (light gray curve, IL-4), an inhibitory anti–IL-4Rα antibody (dark gray curve, αIL-4Rα) or no further reagents (black curve, none). For each experiment, cells from four donors were purified and separately analyzed, yielding similar results. For quantitation, area under curve (AUC) values were calculated. Statistically significant differences from controls (black curves; none) with P &lt; 0.05 were determined using Fisher's exact test and indicated by asterisks.</p></caption><graphic xlink:href=""20020881f6""></graphic></fig></sec><sec><title>Regulation of BCR Responsiveness by the IgSF Receptor LIRB1 in Naive and Memory B Cells.</title><p>As IL-4 can repress inhibitory IgSF receptors in memory but not naive B cells, we next investigated the direct consequences of IgSF receptor signaling on the responsiveness of the BCR in both B cell subsets. As an example for inhibitory IgSF receptors, we chose<italic>LIRB1</italic>, which is most prominently expressed in naive B cells (45 tags;<xref ref-type=""fig"" rid=""fig2"">Figs. 2</xref>C, 3, and 4) but missing in the SAGE profiles for GC and memory B cells (<xref ref-type=""fig"" rid=""fig2"">Figs. 2</xref>C, 3, and 4). To determine how<italic>LIRB1</italic>can modify BCR responsiveness, changes of cytoplasmic Ca<sup>2+</sup>concentration in response to BCR engagement were measured. To this end, naive and memory B cells were preincubated in supernatants conditioned by LPS-stimulated PBMCs in the presence or absence of agonistic (clone GVI/75 cross-linked by goat anti–mouse serum) or antagonistic (clone HP-F1 noncross-linked) antibodies against LIRB1. After LPS treatment, PBMCs release high levels of soluble MHC class I molecules, which can act as natural ligand for LIRB1 (<xref ref-type=""bibr"" rid=""bib13"">13</xref>,<xref ref-type=""bibr"" rid=""bib14"">14</xref>). After preincubation, naive and memory B cells were stimulated with anti–human IgM F(ab′)<sub>2</sub>and anti–human IgG + IgM F(ab′)<sub>2</sub>fragments, respectively, and changes of intracellular Ca<sup>2+</sup>concentrations in response to BCR engagement were measured by confocal microscopy. Whereas treatment of naive and memory B cells with an anti-CD3 antibody had no effect on intracellular Ca<sup>2+</sup>levels (not shown), stimulation with anti–human IgM F(ab′)<sub>2</sub>and anti–human IgG + IgM F(ab′)<sub>2</sub>fragments increased the concentration of cytoplasmic Ca<sup>2+</sup>in naive and memory B cells (<xref ref-type=""fig"" rid=""fig6"">Fig. 6</xref>). While stimulation (GAM-cross-linked GVI/75 antibody) and inhibition (noncross-linked HP-F1 antibody) of LIRB1 significantly affected the peak amplitude and duration of the calcium signal in naive B cells (<xref ref-type=""fig"" rid=""fig6"">Fig. 6</xref>A), agonistic and antagonistic antibodies had no significant effect on BCR-dependent Ca<sup>2+</sup>mobilization in memory B cells (<xref ref-type=""fig"" rid=""fig6"">Fig. 6</xref>B). As expected, the overall signal intensity of BCR engagement was significantly higher in memory (peak [Ca<sup>2+</sup>]i concentration 220 nmol/L) than in naive B cells (peak [Ca<sup>2+</sup>]i concentration 140 nmol/L). Also, steady-state levels of cytoplasmic Ca<sup>2+</sup>were higher in memory (∼100 nmol/L) as compared with naive B cells (∼50 nmol/L). Interestingly, occupancy of LIRB1 by the inhibitory antibody raised Ca<sup>2+</sup>mobilization in response to BCR engagement to similar levels as in memory B cells (<xref ref-type=""fig"" rid=""fig6"">Fig. 6, A and B</xref>). That inhibition of LIRB1 alone could nearly restore BCR-responsiveness in naive B cells in vitro does not rule out an important contribution of other inhibitory IgSF receptors identified in this study to silencing of BCR signals in vivo. This is supported by a number of animal models, in which inactivation of a single gene similarly resulted in profound changes of BCR responsiveness (<xref ref-type=""bibr"" rid=""bib63"">63</xref>–<xref ref-type=""bibr"" rid=""bib66"">66</xref>). That other inhibitory IgSF receptors, which were found specifically expressed in naive B cells by SAGE, RT-PCR and flow cytometry (<xref ref-type=""fig"" rid=""fig2"">Figs. 2</xref>C, 3, and 4), have a similar effect on BCR signals in naive B cells appears likely but remains to be established. Conversely, engagement of LIRB1 by the agonistic cross-linked antibody further suppressed and shortened the calcium signal in naive B cells initiated by BCR ligation (<xref ref-type=""fig"" rid=""fig6"">Fig. 6</xref>A). None of these effects could be seen in memory B cells (<xref ref-type=""fig"" rid=""fig6"">Fig. 6</xref>B), which is consistent with absence of LIRB1 expression in memory B cells (<xref ref-type=""fig"" rid=""fig2"">Fig. 2</xref>C, 3, and 4).</p><p>We conclude that IL-4 is essential to down-regulate inhibitory IgSF receptors in antigen-experienced B cells. As inhibitory IgSF receptors can indeed silence BCR signals, their repression by IL-4 is required to maintain an intense signaling capacity and responsiveness of the BCR to antigen.</p></sec><sec><title>Concluding Remarks.</title><p>Unlike naive or memory B cells, pre- and GC B cells exhibit a particular propensity to apoptosis in that they enter a readily initiated apoptosis program unless they are rescued by survival signals from the (pre)-BCR. Intensified activation signaling in the surviving pre and GC B cells can, therefore, be an effect of selection. Neither naive nor memory B cells are directly involved in selection processes. In the case of naive and memory B cells, the distinct gene expression pattern of activating and inhibitory BCR signaling molecules is probably largely B cell autonomous and marks a constitutive difference between the two subsets.</p><p>In naive B cells, attenuation of BCR signals (e.g., by inhibitory IgSF receptors) may prevent these cells from premature activation upon antigen encounter or represent a safeguard against expansion of autoreactive clones. Conversely, amplification of BCR signals may contribute to facilitated responsiveness to BCR engagement and longevity of memory B cells (<xref ref-type=""bibr"" rid=""bib67"">67</xref>). Sustained expression of activating signaling molecules initiated from the BCR seems to be a characteristic of memory B cells as the expression levels of activating BCR signaling molecules in memory B cells also tend to be higher than those in pre-B or GC B cells (<xref ref-type=""fig"" rid=""fig2"">Fig. 2, A and B</xref>). High expression levels of costimulatory molecules may reflect activation in pre-B and GC B cells and sensitization and increased responsiveness to antigen in memory B cells.</p><p>A constitutively active signaling machinery in memory B cells may not only increase responsiveness to but also confer independence from BCR cross-linking by antigen. Indeed, the capacity to persist independently from the immunizing antigen was thought to define “true immunological memory” (<xref ref-type=""bibr"" rid=""bib68"">68</xref>) as opposed to survival within a chronic immune response, in which the immunizing antigen can be retained and presented for extended periods of time by follicular dendritic cells within GCs. To ensure persistence of B cell memory, perpetuation of a B cell–autonomous “maintenance signal” would be required in the former but not in the latter case. Recent data suggest that the continuous presence of the immunizing antigen is indeed dispensable for the survival of memory B cells provided that a functional BCR is expressed on the cell surface to initiate the “maintenance signal” (<xref ref-type=""bibr"" rid=""bib68"">68</xref>). The concept that the BCR in memory B cells has distinct intrinsic signaling properties is further supported by recent data on a burst-enhancing role of the membrane spanning region of IgG in memory B cells (<xref ref-type=""bibr"" rid=""bib69"">69</xref>). Earlier findings suggested that, unlike IgM (three cytoplasmic residues), the cytoplasmic tail of IgG1 (28 residues) as such can contribute to signal transduction through the BCR, presumably involving a tyrosine-based motif within Cγ1 (<xref ref-type=""bibr"" rid=""bib70"">70</xref>).</p><p>Although both naive and memory B cells critically depend on continuous survival signals from a functional BCR (<xref ref-type=""bibr"" rid=""bib2"">2</xref>), we show in a genome-wide gene expression analysis that BCR-dependent signals in naive and memory B cells differ fundamentally from each other. Conceivably, these differences may owe to some extent to IL-4–dependent ablation of negative regulatory signals from inhibitory receptor molecules. However, IL-4R signals, although required for transcriptional suppression of inhibitory IgSF receptors and for integrity of BCR-dependent Ca<sup>2+</sup>mobilization in memory B cells, had no effect on their naive precursors. Therefore, the mechanism establishing restraint of BCR signals in naive B cells and its relief upon antigen-encounter within the GC remains elusive and awaits further investigation.</p></sec></sec><back><ack><p>We would like to thank Stefanie Jauch for excellent technical assistance and Dr. Miguel López-Botet, Universitat Pompeu Fabra, Barcelona, Spain, for kindly providing us with the HP-F1 antibody.</p><p>H. Wang is supported by the DAAD Bioscience Program, M. Müschen is supported by the Cancer Research Institute, New York, NY, through the Tumor Immunology Program. This work was supported by the Deutsche Forschungsgemeinschaft through the<italic>Emmy-Noether-</italic>Programm (to M. Müschen; MU1616/2-1 and MU1616/2-2), Harold and Lelia Y. Mathers Foundation (S.M. Wang and J.D. Rowley), SFB 502 and a Heisenberg award to R. Küppers, by the Köln Fortune Program/Faculty of Medicine, University of Cologne, and the German José Carreras Leukemia Foundation (grant to M. Müschen).</p></ack><ref-list><ref id=""bib1""><label>1</label><citation citation-type=""journal"">Rajewsky, K.<year>1996</year>. Clonal selection and learning in the antibody system.<source>Nature.</source><volume>381</volume>:<fpage>751</fpage>–758.<pub-id pub-id-type=""pmid"">8657279</pub-id></citation></ref><ref id=""bib2""><label>2</label><citation citation-type=""journal"">Lam, K.P., R. Kühn, and K. Rajewsky.<year>1997</year>. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death.<source>Cell.</source><volume>90</volume>:<fpage>1073</fpage>–1083.<pub-id pub-id-type=""pmid"">9323135</pub-id></citation></ref><ref id=""bib3""><label>3</label><citation citation-type=""journal"">Kurosaki, T.<year>1999</year>. Genetic analysis of B cell antigen receptor signaling.<source>Annu. Rev. Immunol.</source><volume>17</volume>:<fpage>555</fpage>–592.<pub-id pub-id-type=""pmid"">10358768</pub-id></citation></ref><ref id=""bib4""><label>4</label><citation citation-type=""journal"">Tarakhovsky, A., M. Turner, S. Schaal, P.J. Mee, L.P. Duddy, K. Rajewsky, and V.L. Tybulewicz.<year>1995</year>. Defective antigen receptor-mediated proliferation of B and T cells in the absence of<italic>VAV</italic>.<source>Nature.</source><volume>374</volume>:<fpage>467</fpage>–470.<pub-id pub-id-type=""pmid"">7700358</pub-id></citation></ref><ref id=""bib5""><label>5</label><citation citation-type=""journal"">Ravetch, J.V., and L.L. Lanier.<year>2000</year>. Immune inhibitory receptors.<source>Science.</source><volume>290</volume>:<fpage>84</fpage>–89.<pub-id pub-id-type=""pmid"">11021804</pub-id></citation></ref><ref id=""bib6""><label>6</label><citation citation-type=""journal"">Velculescu, V.E., L. Zhang, B. Vogelstein, and K.W. Kinzler.<year>1995</year>. Serial analysis of gene expression.<source>Science.</source><volume>270</volume>:<fpage>484</fpage>–487.<pub-id pub-id-type=""pmid"">7570003</pub-id></citation></ref><ref id=""bib7""><label>7</label><citation citation-type=""journal"">Zhou, G., J. Chen, S. Lee, T. Clark, J.D. Rowley, and S.M. Wang.<year>2001</year>. The pattern of gene expression in human CD34<sup>+</sup>stem/progenitor cells.<source>Proc. Natl. Acad. Sci. USA.</source><volume>98</volume>:<fpage>13966</fpage>–13971.<pub-id pub-id-type=""pmid"">11717454</pub-id></citation></ref><ref id=""bib8""><label>8</label><citation citation-type=""journal"">Müschen, M., S. Lee, G. Zhou, N. Feldhahn, V.S. Barath, J. Chen, C. Moers, M. Krönke, J.D. Rowley, and S.M. Wang.<year>2002</year>. Molecular portraits of B cell lineage commitment.<source>Proc. Natl. Acad. Sci. USA.</source><volume>99</volume>:<fpage>10014</fpage>–10019.<pub-id pub-id-type=""pmid"">12119411</pub-id></citation></ref><ref id=""bib9""><label>9</label><citation citation-type=""journal"">Müschen, M., D. Re, B. Jungnickel, V. Diehl, K. Rajewsky, and R. Küppers.<year>2000</year>. Somatic mutation of the<italic>CD95</italic>gene in human B cells as a side-effect of the germinal center reaction.<source>J. Exp. Med.</source><volume>192</volume>:<fpage>1833</fpage>–1840.<pub-id pub-id-type=""pmid"">11120779</pub-id></citation></ref><ref id=""bib10""><label>10</label><citation citation-type=""journal"">Müschen, M., K. Rajewsky, A. Bräuninger, A.S. Baur, J.J. Oudejans, A. Roers, M.-L. Hansmann, and R. Küppers.<year>2000</year>. Rare occurrence of classical Hodgkin's disease as a T cell lymphoma.<source>J. Exp. Med.</source><volume>191</volume>:<fpage>387</fpage>–394.<pub-id pub-id-type=""pmid"">10637283</pub-id></citation></ref><ref id=""bib11""><label>11</label><citation citation-type=""journal"">Nagumo, H., K. Agematsu, N. Kobayashi, K. Shinozaki, S. Hokibara, H. Nagase, M. Takamoto, K. Yasui, K. Sugane, and A. Komiyama.<year>2002</year>. Different process of class switching and somatic hypermutation; a novel analysis by CD27<sup>−</sup>naive B cells.<source>Blood.</source><volume>99</volume>:<fpage>567</fpage>–575.<pub-id pub-id-type=""pmid"">11781240</pub-id></citation></ref><ref id=""bib12""><label>12</label><citation citation-type=""journal"">Monroe, J.G., and J.C. Cambier.<year>1983</year>. Sorting of B lymphoblasts based upon cell diameter provides cell populations enriched in different stages of cell cycle.<source>J. Immunol. Methods.</source><volume>63</volume>:<fpage>45</fpage>–56.<pub-id pub-id-type=""pmid"">6604756</pub-id></citation></ref><ref id=""bib13""><label>13</label><citation citation-type=""journal"">Brieva, J.A., L.M. Villar, G. Leoro, J.C. Alvarez-Cermeno, E. Roldan, and P. Gonzalez-Porque.<year>1990</year>. Soluble HLA class I antigen secretion by normal lymphocytes: relationship with cell activation and effect of interferon-gamma.<source>Clin. Exp. Immunol.</source><volume>82</volume>:<fpage>390</fpage>–395.<pub-id pub-id-type=""pmid"">2122936</pub-id></citation></ref><ref id=""bib14""><label>14</label><citation citation-type=""journal"">Colonna, M., F. Navarro, T. Bellon, M. Llano, P. Garcia, J. Samaridis, L. Angman, M. Cella, and M. Lopez-Botet.<year>1997</year>. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells.<source>J. Exp. Med.</source><volume>186</volume>:<fpage>1809</fpage>–1818.<pub-id pub-id-type=""pmid"">9382880</pub-id></citation></ref><ref id=""bib15""><label>15</label><citation citation-type=""journal"">Banham, A.H., M. Colonna, M. Cella, K.J. Micklem, K. Pulford, A.C. Willis, and D.Y. Mason.<year>1999</year>. Identification of the CD85 antigen as ILT2, an inhibitory MHC class I receptor of the immunoglobulin superfamily.<source>J. Leukoc. Biol.</source><volume>65</volume>:<fpage>841</fpage>–845.<pub-id pub-id-type=""pmid"">10380908</pub-id></citation></ref><ref id=""bib16""><label>16</label><citation citation-type=""journal"">Williams, D.A.<year>1990</year>. Quantitative intracellular calcium imaging with laser-scanning confocal microscopy.<source>Cell Calcium.</source><volume>11</volume>:<fpage>589</fpage>–597.<pub-id pub-id-type=""pmid"">2285927</pub-id></citation></ref><ref id=""bib17""><label>17</label><citation citation-type=""journal"">Satoh, H., L.A. Blatter, and D.M. Bers.<year>1997</year>. Effects of [Ca<sup>2+</sup>]i, SR Ca<sup>2+</sup>load, and rest on Ca<sup>2+</sup>spark frequency in ventricular myocytes.<source>Am. J. Physiol.</source><volume>272</volume>:<fpage>H657</fpage>–H668.<pub-id pub-id-type=""pmid"">9124422</pub-id></citation></ref><ref id=""bib18""><label>18</label><citation citation-type=""journal"">Kirstetter, P., M. Thomas, A. Dierich, P. Kastner, and S. Chan.<year>2002</year>.<italic>IKAROS</italic>is critical for B cell differentiation and function.<source>Eur. J. Immunol.</source><volume>32</volume>:<fpage>720</fpage>–730.<pub-id pub-id-type=""pmid"">11870616</pub-id></citation></ref><ref id=""bib19""><label>19</label><citation citation-type=""journal"">Ono, M., H. Okada, S. Bolland, S. Yanagi, T. Kurosaki, and J.V. Ravetch.<year>1997</year>. Deletion of<italic>SHIP</italic>or<italic>SHP1</italic>reveals two distinct pathways for inhibitory signaling.<source>Cell.</source><volume>90</volume>:<fpage>293</fpage>–301.<pub-id pub-id-type=""pmid"">9244303</pub-id></citation></ref><ref id=""bib20""><label>20</label><citation citation-type=""journal"">Cariappa, A., M. Tang, C. Parng, E. Nebelitskiy, M. Carroll, K. Georgopoulos, and S. Pillai.<year>2001</year>. The follicular versus marginal zone B lymphocyte cell fate decision is regulated by<italic>AIOLOS</italic>,<italic>BTK</italic>, and<italic>CD21</italic>.<source>Immunity.</source><volume>14</volume>:<fpage>603</fpage>–615.<pub-id pub-id-type=""pmid"">11371362</pub-id></citation></ref><ref id=""bib21""><label>21</label><citation citation-type=""journal"">Klein, U., K. Rajewsky, and R. Küppers.<year>1998</year>. Human immunoglobulin (Ig)M<sup>+</sup>IgD<sup>+</sup>peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells.<source>J. Exp. Med.</source><volume>188</volume>:<fpage>1679</fpage>–1689.<pub-id pub-id-type=""pmid"">9802980</pub-id></citation></ref><ref id=""bib22""><label>22</label><citation citation-type=""journal"">Liu, Y.J., C. Barthelemy, O. de Bouteiller, C. Arpin, I. Durand, and J. Banchereau.<year>1995</year>. Memory B cells from human tonsils colonize mucosal epithelium and directly present antigen to T cells by rapid up-regulation of B7-1 and B7-2.<source>Immunity.</source><volume>2</volume>:<fpage>239</fpage>–248.<pub-id pub-id-type=""pmid"">7535180</pub-id></citation></ref><ref id=""bib23""><label>23</label><citation citation-type=""journal"">Arpin, C., J. Banchereau, and Y.J. Liu.<year>1997</year>. Memory B cells are biased towards terminal differentiation: a strategy to prevent repertoire freezing.<source>J. Exp. Med.</source><volume>186</volume>:<fpage>931</fpage>–940.<pub-id pub-id-type=""pmid"">9294147</pub-id></citation></ref><ref id=""bib24""><label>24</label><citation citation-type=""journal"">Klein, U., R. Küppers, and K. Rajewsky.<year>1997</year>. Evidence for a large compartment of IgM-expressing memory B cells in humans.<source>Blood.</source><volume>89</volume>:<fpage>1288</fpage>–1298.<pub-id pub-id-type=""pmid"">9028952</pub-id></citation></ref><ref id=""bib25""><label>25</label><citation citation-type=""journal"">Galibert, L., N. Burdin, B. de Saint-Vis, P. Garrone, C. Van Kooten, J. Banchereau, and F. Rousset.<year>1996</year>. CD40 and B cell antigen receptor dual triggering of resting B lymphocytes turns on a partial germinal center phenotype.<source>J. Exp. Med.</source><volume>183</volume>:<fpage>77</fpage>–85.<pub-id pub-id-type=""pmid"">8551247</pub-id></citation></ref><ref id=""bib26""><label>26</label><citation citation-type=""journal"">Xu, S., and K.P. Lam.<year>2001</year>. B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses.<source>Mol. Cell. Biol.</source><volume>21</volume>:<fpage>4067</fpage>–4074.<pub-id pub-id-type=""pmid"">11359913</pub-id></citation></ref><ref id=""bib27""><label>27</label><citation citation-type=""journal"">Schiemann, B., J.L. Gommerman, K. Vora, T.G. Cachero, S. Shulga-Morskaya, M. Dobles, E. Frew, and M.L. Scott.<year>2001</year>. An essential role for<italic>BAFF</italic>in the normal development of B cells through a<italic>BCMA</italic>-independent pathway.<source>Science.</source><volume>293</volume>:<fpage>2111</fpage>–2114.<pub-id pub-id-type=""pmid"">11509691</pub-id></citation></ref><ref id=""bib28""><label>28</label><citation citation-type=""journal"">Hatzoglou, A., J. Roussel, M.F. Bourgeade, E. Rogier, C. Madry, J. Inoue, O. Devergne, and A. Tsapis.<year>2000</year>. BCMA associates with TRAF1, TRAF2, and TRAF3 and activates NF-κB and p38 mitogen-activated protein kinase.<source>J. Immunol.</source><volume>165</volume>:<fpage>1322</fpage>–1330.<pub-id pub-id-type=""pmid"">10903733</pub-id></citation></ref><ref id=""bib29""><label>29</label><citation citation-type=""other"">Yan, M., H. Wang, B. Chan, M. Roose-Girma, S. Erickson, T. Baker, D. Tumas, I.S. Grewal, and V.M. Dixit. 2001. Activation and accumulation of B cells in<italic>TACI</italic>-deficient mice.<italic>Nat. Immunol.</italic>2:638–643.</citation></ref><ref id=""bib30""><label>30</label><citation citation-type=""journal"">Cerutti, A., A. Schaffer, R.G. Goodwin, S. Shah, H. Zan, S. Ely, and P. Casali.<year>2000</year>. Engagement of CD153 (CD30 ligand) by CD30<sup>+</sup>T cells inhibits class switch DNA recombination and antibody production in human IgD<sup>+</sup>IgM<sup>+</sup>B cells.<source>J. Immunol.</source><volume>165</volume>:<fpage>786</fpage>–794.<pub-id pub-id-type=""pmid"">10878352</pub-id></citation></ref><ref id=""bib31""><label>31</label><citation citation-type=""journal"">Masat, L., J. Caldwell, R. Armstrong, H. Khoshnevisan, R. Jessberger, B. Herndier, M. Wabl, and D. Ferrick.<year>2000</year>. Association of SWAP-70 with the B cell antigen receptor complex.<source>Proc. Natl. Acad. Sci. USA.</source><volume>97</volume>:<fpage>2180</fpage>–2184.<pub-id pub-id-type=""pmid"">10681448</pub-id></citation></ref><ref id=""bib32""><label>32</label><citation citation-type=""journal"">Okazaki, T., A. Maeda, H. Nishimura, T. Kurosaki, and T. Honjo.<year>2001</year>. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting SH2-domain-containing tyrosine phosphatase 2 to phosphotyrosine.<source>Proc. Natl. Acad. Sci. USA.</source><volume>98</volume>:<fpage>13866</fpage>–13871.<pub-id pub-id-type=""pmid"">11698646</pub-id></citation></ref><ref id=""bib33""><label>33</label><citation citation-type=""journal"">de Vet, E.C., B. Aguado, and R.D. Campbell.<year>2001</year>.<italic>G6B</italic>, a novel immunoglobulin superfamily member encoded in the human major histocompatibility complex, interacts with SHP-1 and SHP-2.<source>J. Biol. Chem.</source><volume>276</volume>:<fpage>42070</fpage>–42076.<pub-id pub-id-type=""pmid"">11544253</pub-id></citation></ref><ref id=""bib34""><label>34</label><citation citation-type=""journal"">Clark, G.J., B.J. Green, and D.N. Hart.<year>2000</year>. The<italic>CMRF35H</italic>gene structure predicts for an independently expressed member of an ITIM pair of molecules localized to human chromosome 17.<source>Tissue Antigens.</source><volume>55</volume>:<fpage>101</fpage>–109.<pub-id pub-id-type=""pmid"">10746781</pub-id></citation></ref><ref id=""bib35""><label>35</label><citation citation-type=""journal"">Davis, R.S., Y.H. Wang, H. Kubagawa, and M.D. Cooper.<year>2001</year>. Identification of a family of Fc receptor homologs with preferential B cell expression.<source>Proc. Natl. Acad. Sci. USA.</source><volume>98</volume>:<fpage>9772</fpage>–9777.<pub-id pub-id-type=""pmid"">11493702</pub-id></citation></ref><ref id=""bib36""><label>36</label><citation citation-type=""journal"">Gunn, M.D., V.N. Ngo, K.M. Ansel, E.H. Ekland, J.G. Cyster, and L.T. Williams.<year>1998</year>. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1.<source>Nature.</source><volume>391</volume>:<fpage>799</fpage>–803.<pub-id pub-id-type=""pmid"">9486651</pub-id></citation></ref><ref id=""bib37""><label>37</label><citation citation-type=""journal"">Kumanogoh, A., S. Marukawa, T. Kumanogoh, H. Hirota, K. Yoshida, I.S. Lee, T. Yasui, K. Yoshida, T. Taga, and T. Kishimoto.<year>1997</year>. Impairment of antigen-specific antibody production in transgenic mice expressing a dominant-negative form of gp130.<source>Proc. Natl. Acad. Sci. USA.</source><volume>94</volume>:<fpage>2478</fpage>–2482.<pub-id pub-id-type=""pmid"">9122220</pub-id></citation></ref><ref id=""bib38""><label>38</label><citation citation-type=""journal"">Nelms, K., A.D. Keegan, J. Zamorano, J.J. Ryan, and W.E. Paul.<year>1999</year>. The IL4 receptor: signaling mechanisms and biologic functions.<source>Annu. Rev. Immunol.</source><volume>17</volume>:<fpage>701</fpage>–738.<pub-id pub-id-type=""pmid"">10358772</pub-id></citation></ref><ref id=""bib39""><label>39</label><citation citation-type=""journal"">Tamir, I., J.C. Stolpa, C.D. Helgason, K. Nakamura, P. Bruhns, M. Daeron, and J.C. Cambier.<year>2000</year>. The RasGAP-binding protein p62dok is a mediator of inhibitory FcγRIIB signals in B cells.<source>Immunity.</source><volume>12</volume>:<fpage>347</fpage>–358.<pub-id pub-id-type=""pmid"">10755621</pub-id></citation></ref><ref id=""bib40""><label>40</label><citation citation-type=""journal"">Holland, S.J., X.C. Liao, M.K. Mendenhall, X. Zhou, J. Pardo, P. Chu, C. Spencer, A. Fu, and N. Sheng, P. Yu, et al.<year>2001</year>. Functional cloning of Src-like adapter protein-2 (<italic>SLAP2</italic>), a novel inhibitor of antigen receptor signaling.<source>J. Exp. Med.</source><volume>194</volume>:<fpage>1263</fpage>–1276.<pub-id pub-id-type=""pmid"">11696592</pub-id></citation></ref><ref id=""bib41""><label>41</label><citation citation-type=""journal"">Astoul, E., S. Watton, and D. Cantrell.<year>1999</year>. The dynamics of protein kinase B regulation during B cell antigen receptor engagement.<source>J. Cell Biol.</source><volume>145</volume>:<fpage>1511</fpage>–1520.<pub-id pub-id-type=""pmid"">10385529</pub-id></citation></ref><ref id=""bib42""><label>42</label><citation citation-type=""journal"">Satterthwaite, A.B., F. Willis, P. Kanchanastit, D. Fruman, L.C. Cantley, C.D. Helgason, R.K. Humphries, C.A. Lowell, M. Simon, M. Leitges, et al.<year>2000</year>. A sensitized genetic system for the analysis of murine B lymphocyte signal transduction pathways dependent on Bruton's tyrosine kinase.<source>Proc. Natl. Acad. Sci. USA.</source><volume>97</volume>:<fpage>6687</fpage>–6692.<pub-id pub-id-type=""pmid"">10829070</pub-id></citation></ref><ref id=""bib43""><label>43</label><citation citation-type=""journal"">Petro, J.B., S.M. Rahman, D.W. Ballard, and W.N. Khan.<year>2000</year>. Bruton's tyrosine kinase is required for activation of IκB kinase and nuclear factor κB in response to B cell receptor engagement.<source>J. Exp. Med.</source><volume>191</volume>:<fpage>1745</fpage>–1754.<pub-id pub-id-type=""pmid"">10811867</pub-id></citation></ref><ref id=""bib44""><label>44</label><citation citation-type=""journal"">Tsuji, S., M. Okamoto, K. Yamada, N. Okamoto, R. Goitsuka, R. Arnold, F. Kiefer, and D. Kitamura.<year>2001</year>. B cell adaptor containing src homology 2 domain (<italic>BASH</italic>) links B cell receptor signaling to the activation of<italic>HPK1</italic>.<source>J. Exp. Med.</source><volume>194</volume>:<fpage>529</fpage>–539.<pub-id pub-id-type=""pmid"">11514608</pub-id></citation></ref><ref id=""bib45""><label>45</label><citation citation-type=""journal"">Guinamard, R., M. Okigaki, J. Schlessinger, and J.V. Ravetch.<year>2000</year>. Absence of marginal zone B cells in<italic>PYK2</italic>-deficient mice defines their role in the humoral response.<source>Nat. Immunol.</source><volume>1</volume>:<fpage>31</fpage>–36.<pub-id pub-id-type=""pmid"">10881171</pub-id></citation></ref><ref id=""bib46""><label>46</label><citation citation-type=""journal"">Yokouchi, M., T. Wakioka, H. Sakamoto, H. Yasukawa, S. Ohtsuka, A. Sasaki, M. Ohtsubo, M. Valius, A. Inoue, S. Komiya, and A. Yoshimura.<year>1999</year>.<italic>APS</italic>, an adaptor protein containing PH and SH2 domains, is associated with the<italic>PDGF</italic>receptor and<italic>c-Cbl</italic>and inhibits PDGF-induced mitogenesis.<source>Oncogene.</source><volume>18</volume>:<fpage>759</fpage>–767.<pub-id pub-id-type=""pmid"">9989826</pub-id></citation></ref><ref id=""bib47""><label>47</label><citation citation-type=""journal"">Vuica, M., S. Desiderio, and J.P. Schneck.<year>1997</year>. Differential effects of B cell receptor and B cell receptor-FcγRIIB1 engagement on docking of Csk to GTPase-activating protein (GAP)-associated p62.<source>J. Exp. Med.</source><volume>186</volume>:<fpage>259</fpage>–267.<pub-id pub-id-type=""pmid"">9221755</pub-id></citation></ref><ref id=""bib48""><label>48</label><citation citation-type=""journal"">Kang, S.W., M.I. Wahl, J. Chu, J. Kitaura, Y. Kawakami, R.M. Kato, R. Tabuchi, A. Tarakhovsky, T. Kawakami, C.W. Turck, et al.<year>2001</year>. PKCβ modulates antigen receptor signaling via regulation of Btk membrane localization.<source>EMBO J.</source><volume>20</volume>:<fpage>5692</fpage>–5702.<pub-id pub-id-type=""pmid"">11598012</pub-id></citation></ref><ref id=""bib49""><label>49</label><citation citation-type=""journal"">Sidorenko, S.P., C.L. Law, S.J. Klaus, K.A. Chandran, M. Takata, T. Kurosaki, and E.A. Clark.<year>1996</year>. Protein kinase Cμ (PKCμ) associates with the B cell antigen receptor complex and regulates lymphocyte signaling.<source>Immunity.</source><volume>5</volume>:<fpage>353</fpage>–363.<pub-id pub-id-type=""pmid"">8885868</pub-id></citation></ref><ref id=""bib50""><label>50</label><citation citation-type=""journal"">Liu, W., I. Quinto, X. Chen, C. Palmieri, R.L. Rabin, O.M. Schwartz, D.L. Nelson, and G. Scala.<year>2001</year>. Direct inhibition of Bruton's tyrosine kinase by<italic>IBTK</italic>, a Btk-binding protein.<source>Nat. Immunol.</source><volume>2</volume>:<fpage>939</fpage>–946.<pub-id pub-id-type=""pmid"">11577348</pub-id></citation></ref><ref id=""bib51""><label>51</label><citation citation-type=""journal"">Yamadori, T., Y. Baba, M. Matsushita, S. Hashimoto, M. Kurosaki, T. Kurosaki, T. Kishimoto, and S. Tsukada.<year>1999</year>. Bruton's tyrosine kinase activity is negatively regulated by Sab, the Btk-SH3 domain-binding protein.<source>Proc. Natl. Acad. Sci. USA.</source><volume>96</volume>:<fpage>6341</fpage>–6346.<pub-id pub-id-type=""pmid"">10339589</pub-id></citation></ref><ref id=""bib52""><label>52</label><citation citation-type=""journal"">Justement, L.B., K.S. Campbell, N.C. Chien, and J.C. Cambier.<year>1991</year>. Regulation of B cell antigen receptor signal transduction and phosphorylation by CD45.<source>Science.</source><volume>252</volume>:<fpage>1839</fpage>–1842.<pub-id pub-id-type=""pmid"">1648262</pub-id></citation></ref><ref id=""bib53""><label>53</label><citation citation-type=""journal"">Schmedt, C., K. Saijo, T. Niidome, R. Kühn, S. Aizawa, and A. Tarakhovsky.<year>1998</year>.<italic>CSK</italic>controls antigen receptor-mediated development and selection of T-lineage cells.<source>Nature.</source><volume>394</volume>:<fpage>901</fpage>–904.<pub-id pub-id-type=""pmid"">9732874</pub-id></citation></ref><ref id=""bib54""><label>54</label><citation citation-type=""journal"">Davidson, D., and A. Veillette.<year>2001</year>.<italic>PTP-PEST</italic>, a scaffold protein tyrosine phosphatase, negatively regulates lymphocyte activation by targeting a unique set of substrates.<source>EMBO J.</source><volume>20</volume>:<fpage>3414</fpage>–3426.<pub-id pub-id-type=""pmid"">11432829</pub-id></citation></ref><ref id=""bib55""><label>55</label><citation citation-type=""journal"">Malone, C.S., L. Patrone, and R. Wall.<year>2000</year>. An essential octamer motif in the<italic>mb-1</italic>(<italic>Ig</italic>α) promoter.<source>Mol. Immunol.</source><volume>37</volume>:<fpage>321</fpage>–328.<pub-id pub-id-type=""pmid"">11000405</pub-id></citation></ref><ref id=""bib56""><label>56</label><citation citation-type=""journal"">Qin, X.F., A. Reichlin, Y. Luo, R.G. Roeder, and M.C. Nussenzweig.<year>1998</year>.<italic>OCA-B</italic>integrates B cell antigen receptor-, CD40L- and IL 4-mediated signals for the germinal center pathway of B cell development.<source>EMBO J.</source><volume>17</volume>:<fpage>5066</fpage>–5075.<pub-id pub-id-type=""pmid"">9724642</pub-id></citation></ref><ref id=""bib57""><label>57</label><citation citation-type=""journal"">Ruland, J., G.S. Duncan, A. Elia, I. del Barco Barrantes, L. Nguyen, S. Plyte, D.G. Millar, D. Bouchard, A. Wakeham, P.S. Ohashi, and T.W. Mak.<year>2001</year>.<italic>BCL10</italic>is a positive regulator of antigen-receptor-induced activation of NF-κB and neural tube closure.<source>Cell.</source><volume>104</volume>:<fpage>33</fpage>–42.<pub-id pub-id-type=""pmid"">11163238</pub-id></citation></ref><ref id=""bib58""><label>58</label><citation citation-type=""journal"">König, H., P. Pfisterer, L.M. Corcoran, and T. Wirth.<year>1995</year>. Identification of<italic>CD36</italic>as the first gene dependent on the B-cell differentiation factor Oct-2.<source>Genes Dev.</source><volume>9</volume>:<fpage>1598</fpage>–1607.<pub-id pub-id-type=""pmid"">7543064</pub-id></citation></ref><ref id=""bib59""><label>59</label><citation citation-type=""journal"">Zhang, L., A. Eddy, Y.T. Teng, M. Fritzler, M. Kluppel, F. Melet, and A. Bernstein.<year>1995</year>. An immunological renal disease in transgenic mice that overexpress<italic>FLI-1</italic>, a member of the ets family of transcription factor genes.<source>Mol. Cell. Biol.</source><volume>15</volume>:<fpage>6961</fpage>–6970.<pub-id pub-id-type=""pmid"">8524263</pub-id></citation></ref><ref id=""bib60""><label>60</label><citation citation-type=""journal"">Garrett-Sinha, L.A., G.H. Su, S. Rao, S. Kabak, Z. Hao, M.R. Clark, and M.C. Simon.<year>1999</year>.<italic>PU.1</italic>and<italic>SPI-B</italic>are required for normal B cell receptor-mediated signal transduction.<source>Immunity.</source><volume>10</volume>:<fpage>399</fpage>–408.<pub-id pub-id-type=""pmid"">10229183</pub-id></citation></ref><ref id=""bib61""><label>61</label><citation citation-type=""journal"">Rudge, E.U., A.J. Cutler, N.R. Pritchard, and K.G. Smith.<year>2002</year>. Interleukin 4 reduces expression of inhibitory receptors on B cells and abolishes CD22 and FcγRII-mediated B cell suppression.<source>J. Exp. Med.</source><volume>195</volume>:<fpage>1079</fpage>–1085.<pub-id pub-id-type=""pmid"">11956299</pub-id></citation></ref><ref id=""bib62""><label>62</label><citation citation-type=""journal"">Liu, Y.J., O. de Bouteiller, and I. Fugier-Vivier.<year>1997</year>. Mechanisms of selection and differentiation in germinal centers.<source>Curr. Opin. Immunol.</source><volume>9</volume>:<fpage>256</fpage>–262.<pub-id pub-id-type=""pmid"">9099789</pub-id></citation></ref><ref id=""bib63""><label>63</label><citation citation-type=""journal"">Muta, T., T. Kurosaki, Z. Misulovin, M. Sanchez, M.C. Nussenzweig, and J.V. Ravetch.<year>1994</year>. A 13-amino-acid motif in the cytoplasmic domain of FcγRIIB modulates B-cell receptor signalling.<source>Nature.</source><volume>368</volume>:<fpage>70</fpage>–73.<pub-id pub-id-type=""pmid"">8107887</pub-id></citation></ref><ref id=""bib64""><label>64</label><citation citation-type=""journal"">Bikah, G., J. Carey, J.R. Ciallella, A. Tarakhovsky, and S. Bondada.<year>1996</year>. CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells.<source>Science.</source><volume>274</volume>:<fpage>1906</fpage>–1909.<pub-id pub-id-type=""pmid"">8943203</pub-id></citation></ref><ref id=""bib65""><label>65</label><citation citation-type=""journal"">Yokoyama, K., I.H. Su Ih, T. Tezuka, T. Yasuda, K. Mikoshiba, A. Tarakhovsky, and T. Yamamoto.<year>2002</year>.<italic>BANK</italic>regulates BCR-induced calcium mobilization by promoting tyrosine phosphorylation of IP(3) receptor.<source>EMBO J.</source><volume>21</volume>:<fpage>83</fpage>–92.<pub-id pub-id-type=""pmid"">11782428</pub-id></citation></ref><ref id=""bib66""><label>66</label><citation citation-type=""journal"">Mecklenbräuker, I., K. Saijo, N.Y. Zheng, M. Leitges, and A. Tarakhovsky.<year>2002</year>. Protein kinase Cδ controls self-antigen-induced B-cell tolerance.<source>Nature.</source><volume>416</volume>:<fpage>860</fpage>–865.<pub-id pub-id-type=""pmid"">11976686</pub-id></citation></ref><ref id=""bib67""><label>67</label><citation citation-type=""journal"">Liu, Y.J., and J. Banchereau.<year>1997</year>. Regulation of B-cell commitment to plasma cells or to memory B cells.<source>Semin. Immunol.</source><volume>9</volume>:<fpage>235</fpage>–240.<pub-id pub-id-type=""pmid"">9237929</pub-id></citation></ref><ref id=""bib68""><label>68</label><citation citation-type=""journal"">Maruyama, M., K.P. Lam, and K. Rajewsky.<year>2000</year>. Memory B-cell persistence is independent of persisting immunizing antigen.<source>Nature.</source><volume>407</volume>:<fpage>636</fpage>–642.<pub-id pub-id-type=""pmid"">11034213</pub-id></citation></ref><ref id=""bib69""><label>69</label><citation citation-type=""journal"">Martin, S.W., and C.C. Goodnow.<year>2002</year>. Burst-enhancing role of the IgG membrane tail as a molecular determinant of memory.<source>Nat. Immunol.</source><volume>3</volume>:<fpage>182</fpage>–188.<pub-id pub-id-type=""pmid"">11812996</pub-id></citation></ref><ref id=""bib70""><label>70</label><citation citation-type=""journal"">Kaisho, T., F. Schwenk, and K. Rajewsky.<year>1997</year>. The roles of γ1 heavy chain membrane expression and cytoplasmic tail in IgG1 responses.<source>Science.</source><volume>276</volume>:<fpage>412</fpage>–415.<pub-id pub-id-type=""pmid"">9103199</pub-id></citation></ref></ref-list><fn-group><fn id=""fn1""><label>*</label><p><italic>Abbreviations used in this paper:</italic>BCR, B cell receptor; GC, germinal center; IgSF, Ig superfamily; ITAM, immunoreceptor tyrosine-based activation motif; HSC, hematopoietic stem/progenitor cell; ITIM, immunoreceptor tyrosine-based inhibitory motif; MAP, mitogen-activated protein; PKC, protein kinase C; PTK, protein tyrosine kinase; PTP, protein tyrosine phosphatase; SAGE, serial analysis of gene expression.</p></fn></fn-group>"
10.1084/jem.20020881	"<html><body><article article-type=""retraction"" xmlns:xlink=""http://www.w3.org/1999/xlink""><?properties open_access?><front><journal-meta><journal-id journal-id-type=""nlm-ta"">J Exp Med</journal-id><journal-title>The Journal of Experimental Medicine</journal-title><issn pub-type=""ppub"">0022-1007</issn><issn pub-type=""epub"">1540-9538</issn><publisher><publisher-name>The Rockefeller University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type=""pmid"">17074927</article-id><article-id pub-id-type=""pmc"">2118152</article-id><article-id pub-id-type=""publisher-id"">2002088173106c</article-id><article-id pub-id-type=""doi"">10.1084/jem.2002088173106c</article-id><article-categories><subj-group subj-group-type=""heading""><subject>Retraction</subject></subj-group></article-categories><contrib-group><contrib contrib-type=""author""><name><surname>Feldhahn</surname><given-names>Niklas</given-names></name></contrib><contrib contrib-type=""author""><name><surname>Schwering</surname><given-names>Ines</given-names></name></contrib><contrib contrib-type=""author""><name><surname>Lee</surname><given-names>Sanggyu</given-names></name></contrib><contrib contrib-type=""author""><name><surname>Wartenberg</surname><given-names>Maria</given-names></name></contrib><contrib contrib-type=""author""><name><surname>Klein</surname><given-names>Florian</given-names></name></contrib><contrib contrib-type=""author""><name><surname>Wang</surname><given-names>Hui</given-names></name></contrib><contrib contrib-type=""author""><name><surname>Zhou</surname><given-names>Guolin</given-names></name></contrib><contrib contrib-type=""author""><name><surname>Wang</surname><given-names>San Ming</given-names></name></contrib><contrib contrib-type=""author""><name><surname>Rowley</surname><given-names>Janet D.</given-names></name></contrib><contrib contrib-type=""author""><name><surname>Hescheler</surname><given-names>Jürgen</given-names></name></contrib><contrib contrib-type=""author""><name><surname>Krönke</surname><given-names>Martin</given-names></name></contrib><contrib contrib-type=""author""><name><surname>Rajewsky</surname><given-names>Klaus</given-names></name></contrib><contrib contrib-type=""author""><name><surname>Küppers</surname><given-names>Ralf</given-names></name></contrib><contrib contrib-type=""author""><name><surname>Müschen</surname><given-names>Markus</given-names></name></contrib></contrib-group><pub-date pub-type=""ppub""><day>27</day><month>11</month><year>2006</year></pub-date><volume>203</volume><issue>12</issue><fpage>2779</fpage><lpage>2779</lpage><permissions><copyright-statement>Copyright © 2006, The Rockefeller University Press</copyright-statement></permissions><self-uri xlink:href=""jem2032779.pdf"" xlink:title=""pdf""></self-uri></article-meta></front><p>Vol. 196, No. 10, November 18, 2002. Pages<related-article ext-link-type=""pubmed"" id=""N0x1c0c020N0x3a24750"" page=""1291"" related-article-type=""retracted-article"" vol=""196"" xlink:href=""12438421"" xmlns:xlink=""http://www.w3.org/1999/xlink"">1291–1305</related-article>.</p><p>The editors of<italic>The Journal of Experimental Medicine</italic>have been notified by Dr. Markus Müschen of the University of Cologne, Germany, that he and the other authors of the above article wish to retract the paper.</p><p>The authors state:</p><p>“In an attempt to repeat the FACS analyses of surface antigens that were described as differentially expressed between naive and memory B cells in our paper, we observed no or only minor differences for most of these molecules. A systematic reanalysis of the primary data in the laboratories of R. Küppers and M. Müschen revealed that incorrect FACS instrument compensations were responsible for the discrepancy (double stainings were performed, laboratory of M. Müschen).</p><p>This prompted us to systematically reanalyze all aspects of our paper. The reanalysis revealed that normalization of SAGE libraries of different sizes had introduced a bias toward larger differences in gene expression between naive and memory B cells when the SAGE tag count was 0 for 1 of the two libraries. In these cases, differences in mRNA expression identified by SAGE are in reality smaller than reported in the paper and often not significant. Experiments to confirm and extend the main conclusion of our article that B cell receptor signaling is silenced in naive as opposed to memory B cells (laboratories of J. Hescheler and M. Müschen) will be presented elsewhere.”</p><p>The authors extend their apologies to the scientific community.</p></article></body></html>"
